100650	217	ALDH2	0001	ALCOHOL SENSITIVITY, ACUTE ALCOHOL DEPENDENCE, PROTECTION AGAINST, INCLUDED;; HANGOVER, SUSCEPTIBILITY TO, INCLUDED;; SUBLINGUAL NITROGLYCERIN, SUSCEPTIBILITY TO POOR RESPONSE TO, INCLUDED;; ESOPHAGEAL CANCER, ALCOHOL-RELATED, SUSCEPTIBILITY TO, INCLUDED	ALDH2, GLU504LYS	671
100690	1134	CHRNA1	0001	MYASTHENIC SYNDROME, CONGENITAL, SLOW-CHANNEL	CHRNA1, ASN217LYS	137852798
100690	1134	CHRNA1	0002	MYASTHENIC SYNDROME, CONGENITAL, SLOW-CHANNEL	CHRNA1, VAL156MET	137852799
100690	1134	CHRNA1	0003	MYASTHENIC SYNDROME, CONGENITAL, SLOW-CHANNEL	CHRNA1, THR254ILE	137852800
100690	1134	CHRNA1	0004	MYASTHENIC SYNDROME, CONGENITAL, SLOW-CHANNEL	CHRNA1, GLY153SER	137852801
100690	1134	CHRNA1	0005	MYASTHENIC SYNDROME, CONGENITAL, SLOW-CHANNEL	CHRNA1, SER269ILE	137852802
100690	1134	CHRNA1	0006	MYASTHENIC SYNDROME, CONGENITAL, SLOW-CHANNEL	CHRNA1, VAL249PHE	137852803
100690	1134	CHRNA1	0007	MYASTHENIC SYNDROME, CONGENITAL, FAST-CHANNEL	CHRNA1, VAL285ILE	137852804
100690	1134	CHRNA1	0008	MYASTHENIC SYNDROME, CONGENITAL, FAST-CHANNEL	CHRNA1, PHE233VAL	137852805
100690	1134	CHRNA1	0009	MYASTHENIC SYNDROME, CONGENITAL, FAST-CHANNEL	CHRNA1, PHE256LEU	137852806
100690	1134	CHRNA1	0010	MYASTHENIC SYNDROME, CONGENITAL, FAST-CHANNEL	CHRNA1, VAL132LEU	137852807
100690	1134	CHRNA1	0011	MYASTHENIC SYNDROME, CONGENITAL, FAST-CHANNEL	CHRNA1, 1-BP DEL, 381C	
100690	1134	CHRNA1	0012	MYASTHENIC SYNDROME, CONGENITAL, SLOW-CHANNEL	CHRNA1, CYS418TRP	137852808
100690	1134	CHRNA1	0013	MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE	CHRNA1, ARG254LEU	137852809
100690	1134	CHRNA1	0014	MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE	CHRNA1, 17-BP DUP, NT117	
100690	1134	CHRNA1	0015	MYASTHENIC SYNDROME, CONGENITAL, FAST-CHANNEL	CHRNA1, IVS3AS, G-A, -8	
100690	1134	CHRNA1	0016	MYASTHENIC SYNDROME, CONGENITAL, FAST-CHANNEL	CHRNA1, ARG313TRP	
100710	1140	CHRNB1	0001	MYASTHENIC SYNDROME, CONGENITAL, SLOW-CHANNEL	CHRNB1, VAL266MET	137852810
100710	1140	CHRNB1	0002	MYASTHENIC SYNDROME, CONGENITAL, SLOW-CHANNEL	CHRNB1, LEU263MET	137852811
100710	1140	CHRNB1	0003	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	CHRNB1, 9-BP DEL, NT1276	
100710	1140	CHRNB1	0004	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	CHRNB1, EX8DEL	
100720	1144	CHRND	0001	MYASTHENIC SYNDROME, CONGENITAL, SLOW-CHANNEL	CHRND, SER268PHE	121909502
100720	1144	CHRND	0002	MYASTHENIC SYNDROME, CONGENITAL, FAST-CHANNEL	CHRND, PRO250GLN	121909503
100720	1144	CHRND	0003	MYASTHENIC SYNDROME, CONGENITAL, FAST-CHANNEL	CHRND, GLU59LYS	121909504
100720	1144	CHRND	0004	MYASTHENIC SYNDROME, CONGENITAL, FAST-CHANNEL	CHRND, 2-BP DEL, 756AG	
100720	1144	CHRND	0005	MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE	CHRND, TRP57TER	121909505
100720	1144	CHRND	0006	MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE	CHRND, PHE74LEU	121909506
100720	1144	CHRND	0007	MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE	CHRND, ARG443TER	121909507
100720	1144	CHRND	0008	MYASTHENIC SYNDROME, CONGENITAL, FAST-CHANNEL	CHRND, LEU42PRO	121909508
100720	1144	CHRND	0009	MYASTHENIC SYNDROME, CONGENITAL, FAST-CHANNEL	CHRND, ILE58LYS	121909509
100725	1145	CHRNE	0001	MYASTHENIC SYNDROME, CONGENITAL, SLOW-CHANNEL	CHRNE, THR264PRO	121909510
100725	1145	CHRNE	0002	MYASTHENIC SYNDROME, CONGENITAL, SLOW-CHANNEL	CHRNE, LEU269PHE	121909511
100725	1145	CHRNE	0003	MYASTHENIC SYNDROME, CONGENITAL, FAST-CHANNEL	CHRNE, PRO121LEU	121909512
100725	1145	CHRNE	0004	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	CHRNE, ARG64TER	121909513
100725	1145	CHRNE	0005	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	CHRNE, ARG147LEU	121909514
100725	1145	CHRNE	0006	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	CHRNE, 1-BP DEL, 911T	
100725	1145	CHRNE	0007	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	CHRNE, IVS4DS, G-A, +1	
100725	1145	CHRNE	0008	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	CHRNE, 1-BP DEL, 1030C	
100725	1145	CHRNE	0010	MYASTHENIC SYNDROME, CONGENITAL, SLOW-CHANNEL	CHRNE, LEU221PHE	28999110
100725	1145	CHRNE	0011	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	CHRNE, 156C-T	
100725	1145	CHRNE	0012	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	CHRNE, 1-BP DEL, 1267G	
100725	1145	CHRNE	0013	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	CHRNE, 1-BP INS, 1101T	
100725	1145	CHRNE	0014	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	CHRNE, 1-BP INS, 1293G	
100725	1145	CHRNE	0015	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	CHRNE, 7-BP DEL, 553	
100725	1145	CHRNE	0016	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	CHRNE, ARG311TRP	121909515
100725	1145	CHRNE	0017	MYASTHENIC SYNDROME, CONGENITAL, FAST-CHANNEL	CHRNE, GLY-8ARG	
100725	1145	CHRNE	0018	MYASTHENIC SYNDROME, CONGENITAL, FAST-CHANNEL	CHRNE, SER143LEU	121909516
100725	1145	CHRNE	0019	MYASTHENIC SYNDROME, CONGENITAL, FAST-CHANNEL	CHRNE, ALA411PRO	121909517
100725	1145	CHRNE	0020	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	CHRNE, IVS5AS, G-A, -16	
100725	1145	CHRNE	0021	MYASTHENIC SYNDROME, CONGENITAL, FAST-CHANNEL	CHRNE, TRP55ARG	
100725	1145	CHRNE	0022	MYASTHENIC SYNDROME, CONGENITAL, SLOW-CHANNEL, AUTOSOMAL RECESSIVE	CHRNE, SER278DEL	
100725	1145	CHRNE	0023	MYASTHENIC SYNDROME, CONGENITAL, SLOW-CHANNEL, AUTOSOMAL RECESSIVE	CHRNE, ARG217LEU	
100730	1146	CHRNG	0001	ESCOBAR SYNDROME	CHRNG, GLN18TER	
100730	1146	CHRNG	0002	ESCOBAR SYNDROME MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE, INCLUDED	CHRNG, ARG217CYS	121912670
100730	1146	CHRNG	0003	ESCOBAR SYNDROME	CHRNG, 9-BP DUP	
100730	1146	CHRNG	0004	ESCOBAR SYNDROME	CHRNG, ARG448TER	121912671
100730	1146	CHRNG	0005	ESCOBAR SYNDROME MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE, INCLUDED	CHRNG, 320T-G, VAL107GLY	
100730	1146	CHRNG	0006	ESCOBAR SYNDROME	CHRNG, ARG46TER	121912672
100730	1146	CHRNG	0007	MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE	CHRNG, 2-BP DEL, 753CT	
100730	1146	CHRNG	0008	MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE ESCOBAR SYNDROME, INCLUDED	CHRNG, 1-BP DUP, 459A	
100740	43	ACHE	0001	YT BLOOD GROUP POLYMORPHISM	ACHE, HIS322ASN	1799805
100790	429	ASCL1	0001	CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL	ASCL1, C52A, PRO18THR	
100790	429	ASCL1	0002	CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL	ASCL1, 15-BP DEL, NT111	
100790	429	ASCL1	0003	HADDAD SYNDROME	ASCL1, 24-BP DEL, NT108	
100850	50	ACO2	0001	INFANTILE CEREBELLAR-RETINAL DEGENERATION	ACO2, SER112ARG	
102540	70	ACTC1	0001	CARDIOMYOPATHY, DILATED, 1R	ACTC1, ARG312HIS	121912673
102540	70	ACTC1	0002	CARDIOMYOPATHY, DILATED, 1R	ACTC1, GLU361GLY	121912674
102540	70	ACTC1	0003	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 11	ACTC1, ALA295SER	121912675
102540	70	ACTC1	0004	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 11	ACTC1, HIS90TYR	121912676
102540	70	ACTC1	0005	ATRIAL SEPTAL DEFECT 5	ACTC1, MET123VAL	121912677
102540	70	ACTC1	0006	ATRIAL SEPTAL DEFECT 5	ACTC1, 17-BP DEL, NT251	
102540	70	ACTC1	0007	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 11	ACTC1, ALA331PRO	
102540	70	ACTC1	0008	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 11	ACTC1, PRO164ALA	
102540	70	ACTC1	0009	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 11 LEFT VENTRICULAR NONCOMPACTION 4, INCLUDED	ACTC1, GLU101LYS	
102560	71	ACTG1	0001	DEAFNESS, AUTOSOMAL DOMINANT 20	ACTG1, THR89ILE	28999111
102560	71	ACTG1	0002	DEAFNESS, AUTOSOMAL DOMINANT 20	ACTG1, LYS118MET	104894544
102560	71	ACTG1	0003	DEAFNESS, AUTOSOMAL DOMINANT 20	ACTG1, PRO332ALA	104894545
102560	71	ACTG1	0004	DEAFNESS, AUTOSOMAL DOMINANT 20	ACTG1, PRO264LEU	104894546
102560	71	ACTG1	0005	DEAFNESS, AUTOSOMAL DOMINANT 20	ACTG1, THR278ILE	28999112
102560	71	ACTG1	0006	DEAFNESS, AUTOSOMAL DOMINANT 20	ACTG1, VAL370ALA	104894547
102560	71	ACTG1	0007	DEAFNESS, AUTOSOMAL DOMINANT 20	ACTG1, LYS118ASN	
102560	71	ACTG1	0008	DEAFNESS, AUTOSOMAL DOMINANT 20	ACTG1, GLU241LYS	
102560	71	ACTG1	0009	BARAITSER-WINTER SYNDROME 2	ACTG1, SER155PHE	
102560	71	ACTG1	0010	BARAITSER-WINTER SYNDROME 2	ACTG1, THR120ILE	
102560	71	ACTG1	0011	BARAITSER-WINTER SYNDROME 2	ACTG1, ALA135VAL	
102560	71	ACTG1	0012	BARAITSER-WINTER SYNDROME 2	ACTG1, THR203LYS	
102560	71	ACTG1	0013	BARAITSER-WINTER SYNDROME 2	ACTG1, ARG254TRP	
102560	71	ACTG1	0014	BARAITSER-WINTER SYNDROME 2	ACTG1, ARG256TRP	
102565	2318	FLNC	0001	MYOPATHY, MYOFIBRILLAR, FILAMIN C-RELATED	FLNC, TRP2710TER	121909518
102565	2318	FLNC	0002	MYOPATHY, MYOFIBRILLAR, FILAMIN C-RELATED	FLNC, 12-BP DEL, NT2997	
102565	2318	FLNC	0003	MYOPATHY, DISTAL, 4	FLNC, MET251THR	
102565	2318	FLNC	0004	MYOPATHY, DISTAL, 4	FLNC, ALA193THR	
102573	88	ACTN2	0001	CARDIOMYOPATHY, DILATED, 1AA	ACTN2, GLN9ARG	121434525
102574	89	ACTN3	0001	ACTININ, ALPHA-3 POLYMORPHISM ACTN3 DEFICIENCY;; SPRINTING PERFORMANCE	ACTN3, ARG577TER	1815739
102575	87	ACTN1	0001	BLEEDING DISORDER, PLATELET-TYPE, 15	ACTN1, VAL105ILE	
102575	87	ACTN1	0002	BLEEDING DISORDER, PLATELET-TYPE, 15	ACTN1, GLN32LYS	
102575	87	ACTN1	0003	BLEEDING DISORDER, PLATELET-TYPE, 15	ACTN1, ARG752GLN	
102575	87	ACTN1	0004	BLEEDING DISORDER, PLATELET-TYPE, 15	ACTN1, ARG46GLN	
102575	87	ACTN1	0005	BLEEDING DISORDER, PLATELET-TYPE, 15	ACTN1, ARG738TRP	
102575	87	ACTN1	0006	BLEEDING DISORDER, PLATELET-TYPE, 15	ACTN1, GLU225LYS	
102576	90	ACVR1	0001	FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	ACVR1, ARG206HIS	121912678
102576	90	ACVR1	0002	FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	ACVR1, GLY356ASP	121912679
102576	90	ACVR1	0003	FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	ACVR1, ARG258SER	121912680
102576	90	ACVR1	0004	FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	ACVR1, GLY328ARG, 982G-A	
102576	90	ACVR1	0005	FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	ACVR1, GLY328TRP	
102576	90	ACVR1	0006	FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	ACVR1, GLY328GLU	
102576	90	ACVR1	0007	FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	ACVR1, ARG375PRO	
102576	90	ACVR1	0008	FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	ACVR1, ARG202ILE	
102582	6774	STAT3	0001	HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	STAT3, VAL463DEL	113994138
102582	6774	STAT3	0002	HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	STAT3, ARG382TRP	113994135
102582	6774	STAT3	0003	HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	STAT3, ARG382GLN	113994136
102582	6774	STAT3	0004	HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	STAT3, ARG423GLN	113994137
102582	6774	STAT3	0005	HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	STAT3, ARG383LEU	
102582	6774	STAT3	0006	HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	STAT3, VAL637MET	113994139
102600	353	APRT	0001	APRT DEFICIENCY	APRT, 3-BP DEL, 2179TTC	121912681
102600	353	APRT	0002	APRT DEFICIENCY	APRT, 1-BP INS, 1834T	
102600	353	APRT	0003	APRT DEFICIENCY, JAPANESE TYPE	APRT, MET136THR	28999113
102600	353	APRT	0004	APRT DEFICIENCY	APRT, ASP65VAL	104894506
102600	353	APRT	0005	APRT DEFICIENCY	APRT, TRP98TER	104894507
102600	353	APRT	0006	APRT DEFICIENCY	APRT, 4-BP DUP, EX3	
102600	353	APRT	0007	APRT DEFICIENCY	APRT, LEU110PRO	104894508
102600	353	APRT	0008	APRT DEFICIENCY	APRT, 254-BP DEL AND 8-BP INS	
102600	353	APRT	0009	APRT DEFICIENCY	APRT, TER-SER	
102610	58	ACTA1	0001	NEMALINE MYOPATHY 3	ACTA1, LEU94PRO	121909519
102610	58	ACTA1	0002	NEMALINE MYOPATHY 3	ACTA1, ASN115SER	121909520
102610	58	ACTA1	0003	MYOPATHY, ACTIN, CONGENITAL, WITH EXCESS OF THIN MYOFILAMENTS	ACTA1, GLY15ARG	121909521
102610	58	ACTA1	0004	NEMALINE MYOPATHY 3	ACTA1, VAL163LEU	121909522
102610	58	ACTA1	0005	NEMALINE MYOPATHY 3	ACTA1, GLU259VAL	121909523
102610	58	ACTA1	0006	NEMALINE MYOPATHY 3	ACTA1, ILE357LEU	121909524
102610	58	ACTA1	0007	NEMALINE MYOPATHY 3	ACTA1, GLY268CYS	121909525
102610	58	ACTA1	0008	NEMALINE MYOPATHY 3	ACTA1, ILE136MET	121909526
102610	58	ACTA1	0009	MYOPATHY, ACTIN, CONGENITAL, WITH CORES	ACTA1, ASP1TYR	121909527
102610	58	ACTA1	0010	MYOPATHY, ACTIN, CONGENITAL, WITH CORES	ACTA1, GLU334ALA	121909528
102610	58	ACTA1	0011	MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION	ACTA1, ASP292VAL	121909529
102610	58	ACTA1	0012	MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION	ACTA1, LEU221PRO	121909530
102610	58	ACTA1	0013	MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION	ACTA1, PRO332SER	121909531
102610	58	ACTA1	0014	NEMALINE MYOPATHY 3	ACTA1, VAL163MET	
102610	58	ACTA1	0015	NEMALINE MYOPATHY 3	ACTA1, GLU74ASP AND HIS75TYR	
102610	58	ACTA1	0016	NEMALINE MYOPATHY 3	ACTA1, LYS328ASN	
102620	59	ACTA2	0001	AORTIC ANEURYSM, FAMILIAL THORACIC 6	ACTA2, ARG149CYS	121434526
102620	59	ACTA2	0002	AORTIC ANEURYSM, FAMILIAL THORACIC 6 MOYAMOYA DISEASE 5, INCLUDED	ACTA2, ARG258HIS	121434527
102620	59	ACTA2	0003	AORTIC ANEURYSM, FAMILIAL THORACIC 6 MOYAMOYA DISEASE 5, INCLUDED	ACTA2, ARG258CYS	121434528
102620	59	ACTA2	0004	MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME MOYAMOYA DISEASE 5, INCLUDED	ACTA2, ARG179HIS	
102630	60	ACTB	0001	DYSTONIA, JUVENILE-ONSET	ACTB, ARG183TRP	104894003
102630	60	ACTB	0002	BARAITSER-WINTER SYNDROME 1	ACTB, ARG196HIS	
102630	60	ACTB	0003	BARAITSER-WINTER SYNDROME 1	ACTB, ARG196CYS	
102630	60	ACTB	0004	BARAITSER-WINTER SYNDROME 1	ACTB, LEU65VAL	
102630	60	ACTB	0005	BARAITSER-WINTER SYNDROME 1	ACTB, ASN12ASP	
102680	118	ADD1	0001	HYPERTENSION, SALT-SENSITIVE ESSENTIAL, SUSCEPTIBILITY TO	ADD1, GLY460TRP	4961
102750	132	ADK	0001	HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	ADK, ALA301GLU	
102750	132	ADK	0002	HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	ADK, ASP218ALA	
102750	132	ADK	0003	HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	ADK, GLY13GLU	
102770	270	AMPD1	0001	MYOADENYLATE DEAMINASE DEFICIENCY, MYOPATHY DUE TO	AMPD1, GLN12TER, PRO48LEU	17602729
102770	270	AMPD1	0002	MYOADENYLATE DEAMINASE DEFICIENCY, MYOPATHY DUE TO	AMPD1, ARG388TRP	35859650
102770	270	AMPD1	0003	MYOADENYLATE DEAMINASE DEFICIENCY, MYOPATHY DUE TO	AMPD1, ARG425HIS	121912682
102772	272	AMPD3	0001	ERYTHROCYTE AMP DEAMINASE DEFICIENCY	AMPD3, ARG573CYS	3741040
103000	203	AK1	0001	ADENYLATE KINASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO	AK1, ARG128TRP	104894101
103000	203	AK1	0002	ADENYLATE KINASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO	AK1, ARG107TER	104894102
103000	203	AK1	0003	ADENYLATE KINASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO	AK1, TYR164CYS	137853203
103000	203	AK1	0004	ADENYLATE KINASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO	AK1, GLY40ARG	137853204
103000	203	AK1	0005	ADENYLATE KINASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO	AK1, GLY64ARG	137853205
103000	203	AK1	0006	ADENYLATE KINASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO	AK1, 3-BP DEL, 498GAC	
103000	203	AK1	0007	ADENYLATE KINASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO	AK1, 1-BP DEL, 138G	
103020	204	AK2	0001	RETICULAR DYSGENESIS	AK2, 5,038-BP DEL	
103020	204	AK2	0002	RETICULAR DYSGENESIS	AK2, 1-BP DEL, 118T	
103020	204	AK2	0003	RETICULAR DYSGENESIS	AK2, MET1VAL	137853206
103020	204	AK2	0004	RETICULAR DYSGENESIS	AK2, 331, G-A, -1	
103020	204	AK2	0005	RETICULAR DYSGENESIS	AK2, 1-BP DEL, 453C	
103020	204	AK2	0006	RETICULAR DYSGENESIS	AK2, 498, G-A, +1	
103020	204	AK2	0007	RETICULAR DYSGENESIS	AK2, ASP165GLY	
103020	204	AK2	0008	RETICULAR DYSGENESIS	AK2, LEU183TER	
103020	204	AK2	0009	RETICULAR DYSGENESIS	AK2, ARG186CYS	
103020	204	AK2	0010	RETICULAR DYSGENESIS	AK2, EX2 DEL	
103020	204	AK2	0011	RETICULAR DYSGENESIS	AK2, ARG103TRP	
103020	204	AK2	0012	RETICULAR DYSGENESIS	AK2, LYS233TER	
103020	204	AK2	0013	RETICULAR DYSGENESIS	AK2, GLU9TER	
103220	291	SLC25A4	0001	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 2	SLC25A4, ALA114PRO	104893873
103220	291	SLC25A4	0002	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 2	SLC25A4, VAL289MET	104893874
103220	291	SLC25A4	0003	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 2	SLC25A4, LEU98PRO	104893876
103220	291	SLC25A4	0004	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 2	SLC25A4, ASP104GLY	28999114
103220	291	SLC25A4	0005	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC	SLC25A4, ALA123ASP	121912683
103280	283120	H19	0001	BECKWITH-WIEDEMANN SYNDROME	H19, 1.8-KB DEL	
103280	283120	H19	0002	WILMS TUMOR 2 BECKWITH-WIEDEMANN SYNDROME, INCLUDED	H19, 5.3-KB DEL	
103280	283120	H19	0003	WILMS TUMOR 2	H19, 1.43-KB TRIPLICATION	
103320	375790	AGRN	0001	MYASTHENIA, LIMB-GIRDLE, FAMILIAL	AGRN, GLY1709ARG	
103600	213	ALB	0001	ALBUMIN FUKUOKA 2 ALBUMIN TAIPEI;; ALBUMIN LILLE;; ALBUMIN VARESE	ALB, ARG-2HIS	
103600	213	ALB	0002	ALBUMIN HONOLULU 2 PROALBUMIN CHRISTCHURCH;; PROALBUMIN GAINESVILLE;; PROALBUMIN FUKUOKA 3	ALB, ARG-1GLN	74821926
103600	213	ALB	0003	ALBUMIN HONOLULU 1 PROALBUMIN TAKEFU	ALB, ARG-1PRO	74821926
103600	213	ALB	0004	ALBUMIN BREMEN ALBUMIN BLENHEIM;; ALBUMIN IOWA CITY 2	ALB, ASP1VAL	75353611
103600	213	ALB	0005	ALBUMIN NAGASAKI 3	ALB, HIS3GLN	76285851
103600	213	ALB	0006	ALBUMIN YANOMAMA 2	ALB, ARG114GLY	77238412
103600	213	ALB	0007	ALBUMIN NAGOYA	ALB, GLU119LYS	75522063
103600	213	ALB	0008	ALBUMIN NAGASAKI 1 ALBUMIN NIIGATA	ALB, ASP269GLY	79744198
103600	213	ALB	0009	ALBUMIN NEW GUINEA ALBUMIN TAGLIACOZZO;; ALBUMIN COOPERSTOWN	ALB, LYS313ASN	72552710
103600	213	ALB	0010	ALBUMIN REDHILL	ALB, ALA320THR AND ARG-2CYS	
103600	213	ALB	0011	ALBUMIN ROMA	ALB, GLU321LYS	72552711
103600	213	ALB	0012	ALBUMIN HIROSHIMA 1	ALB, GLU354LYS	76593094
103600	213	ALB	0013	ALBUMIN PORTO ALEGRE 1 ALBUMIN COARI 1	ALB, GLU358LYS	75791663
103600	213	ALB	0014	ALBUMIN PARKLANDS	ALB, ASP365HIS	77187142
103600	213	ALB	0015	ALBUMIN MERSIN ALBUMIN NASKAPI;; ALBUMIN MEXICO 1	ALB, LYS372GLU	78166690
103600	213	ALB	0016	ALBUMIN NAGASAKI 2	ALB, ASP375ASN	77514449
103600	213	ALB	0017	ALBUMIN TOCHIGI	ALB, GLU376LYS	79047363
103600	213	ALB	0018	ALBUMIN HIROSHIMA 2	ALB, GLU382LYS	76483862
103600	213	ALB	0019	ALBUMIN LAMBADI ALBUMIN MANAUS-1;; ALBUMIN VANCOUVER;; ALBUMIN BIRMINGHAM;; ALBUMIN ADANA;; ALBUMIN PORTO ALEGRE 2	ALB, GLU501LYS	75523493
103600	213	ALB	0020	ALBUMIN MAKU ALBUMIN ORIXIMINA-1	ALB, LYS541GLU	
103600	213	ALB	0021	ALBUMIN MEXICO 2	ALB, ASP550GLY	79738788
103600	213	ALB	0022	ALBUMIN FUKUOKA 1	ALB, ASP563ASN	76587671
103600	213	ALB	0023	ALBUMIN OSAKA 1	ALB, GLU565LYS	75709682
103600	213	ALB	0024	ALBUMIN OSAKA 2 ALBUMIN PHNOM PENH;; ALBUMIN B;; ALBUMIN OLIPHANT;; ALBUMIN NAGANO;; ALBUMIN VERONA B	ALB, GLU570LYS	79228041
103600	213	ALB	0025	ALBUMIN GHENT ALBUMIN MILANO FAST	ALB, LYS573GLU	80106970
103600	213	ALB	0026	ALBUMIN VANVES	ALB, LYS574ASN	75738598
103600	213	ALB	0027	ANALBUMINEMIA, AMERICAN INDIAN TYPE	ALB, IVS6, A-G, -2	77335374
103600	213	ALB	0028	ALBUMIN VENEZIA	ALB, EX14DEL	
103600	213	ALB	0029	ALBUMIN CASTEL DI SANGRO	ALB, LYS536GLU	77645174
103600	213	ALB	0030	PROALBUMIN MALMO PROALBUMIN TRADATE	ALB, ARG-2CYS	
103600	213	ALB	0031	PROALBUMIN JAFFNA	ALB, ARG-1LEU	74821926
103600	213	ALB	0032	ALBUMIN GE/CT ALBUMIN CATANIA	ALB, GLN580LYS	77158239
103600	213	ALB	0033	ALBUMIN TORINO	ALB, GLU60LYS	77050410
103600	213	ALB	0034	ALBUMIN VIBO VALENTIA	ALB, GLU82LYS	80296402
103600	213	ALB	0035	ALBUMIN CASEBROOK	ALB, ASP494ASN	75920790
103600	213	ALB	0036	ALBUMIN IOWA CITY 1	ALB, ASP365VAL	78538497
103600	213	ALB	0037	ALBUMIN KOMAGOME 2	ALB, HIS128ARG	80095457
103600	213	ALB	0038	ALBUMIN RUGBY PARK	ALB, IVS13DS, G-C, +1	1800580
103600	213	ALB	0039	ALBUMIN HERBORN	ALB, LYS240GLU	79377490
103600	213	ALB	0040	ANALBUMINEMIA ROMA	ALB, 1-BP INS, AAT267AAAT, FS274TER	
103600	213	ALB	0041	DYSALBUMINEMIC HYPERTHYROXINEMIA	ALB, ARG218HIS	75002628
103600	213	ALB	0042	ALBUMIN LARINO	ALB, HIS3TYR	
103600	213	ALB	0043	ALBUMIN TRADATE 2	ALB, LYS225GLN	79804069
103600	213	ALB	0044	ALBUMIN CASERTA	ALB, LYS276ASN	74718349
103600	213	ALB	0045	ALBUMIN BAZZANO	ALB, TGC567GC, FS583TER	74674594
103600	213	ALB	0046	ALBUMIN ASOLA	ALB, TYR140CYS	78283180
103600	213	ALB	0047	ALBUMIN MALMO 95	ALB, ASP63ASN	78574148
103600	213	ALB	0048	ALBUMIN HAWKES BAY	ALB, CYS177PHE	77656691
103600	213	ALB	0049	ALBUMIN MALMO 10	ALB, GLN268ARG	80002911
103600	213	ALB	0050	ALBUMIN MALMO 47	ALB, ASN318LYS	
103600	213	ALB	0051	ALBUMIN SONDRIA	ALB, GLU333LYS	77354753
103600	213	ALB	0052	ALBUMIN MALMO 5	ALB, GLU376ASN	79047363
103600	213	ALB	0053	ALBUMIN DUBLIN	ALB, GLU479LYS	80259813
103600	213	ALB	0054	ALBUMIN ORTONOVO	ALB, GLU505LYS	74826639
103600	213	ALB	0055	DYSALBUMINEMIC HYPERTHYROXINEMIA	ALB, ARG218PRO	75002628
103600	213	ALB	0056	DYSALBUMINEMIC HYPERTHYROXINEMIA	ALB, LEU66PRO	77892378
103600	213	ALB	0057	ANALBUMINEMIA	ALB, IVS1DS, G-A, +1	77408163
103720	125	ADH1B	0001	ALCOHOL DEPENDENCE, PROTECTION AGAINST AERODIGESTIVE TRACT CANCER, SQUAMOUS CELL, ALCOHOL-RELATED, PROTECTION AGAINST, INCLUDED	ADH1B, ARG48HIS,	1229984
103720	125	ADH1B	0002	ALCOHOL DEPENDENCE, PROTECTION AGAINST	ADH1B, ARG370CYS	2066702
103730	126	ADH1C	0001	ALCOHOL DEPENDENCE, PROTECTION AGAINST	ADH1C, ARG272GLN	1693482
103730	126	ADH1C	0002	ALCOHOL DEPENDENCE, PROTECTION AGAINST	ADH1C, ILE350VAL	698
103730	126	ADH1C	0003	PARKINSON DISEASE, SUSCEPTIBILITY TO	ADH1C, GLY78TER	283413
103850	226	ALDOA	0001	GLYCOGEN STORAGE DISEASE XII	ALDOA, ASP128GLY	121909533
103850	226	ALDOA	0002	GLYCOGEN STORAGE DISEASE XII	ALDOA, GLU206LYS	121909534
103950	2	A2M	0001	ALPHA-2-MACROGLOBULIN POLYMORPHISM ALZHEIMER DISEASE, SUSCEPTIBILITY TO, INCLUDED	A2M, VAL1000ILE	669
103950	2	A2M	0002	ALPHA-2-MACROGLOBULIN POLYMORPHISM	A2M, CYS972TYR	1800433
103950	2	A2M	0003	ALPHA-2-MACROGLOBULIN POLYMORPHISM	A2M, IVS1DEL	121912684
103950	2	A2M	0004	ALPHA-2-MACROGLOBULIN POLYMORPHISM	A2M, ARG681HIS	1800434
103950	2	A2M	0005	ALZHEIMER DISEASE, SUSCEPTIBILITY TO	A2M, EX18DEL	
103950	2	A2M	0006	ALPHA-2-MACROGLOBULIN POLYMORPHISM	A2M, 5-BP DEL	
104150	174	AFP	0001	ALPHA-FETOPROTEIN, HEREDITARY PERSISTENCE OF	AFP, G-A, -119	
104150	174	AFP	0002	ALPHA-FETOPROTEIN DEFICIENCY	AFP, 2-BP DEL, 882CT	
104150	174	AFP	0003	ALPHA-FETOPROTEIN DEFICIENCY	AFP, TRP181TER	121912685
104155	463	ZFHX3	0001	PROSTATE CANCER	ZFHX3, 24-BP DEL, NT10814	
104170	4668	NAGA	0001	SCHINDLER DISEASE, TYPE I	NAGA, GLU325LYS	121434529
104170	4668	NAGA	0002	KANZAKI DISEASE	NAGA, ARG329TRP	121434530
104170	4668	NAGA	0003	KANZAKI DISEASE	NAGA, GLU193TER	121434531
104170	4668	NAGA	0004	SCHINDLER DISEASE, TYPE III	NAGA, SER160CYS	121434532
104170	4668	NAGA	0005	KANZAKI DISEASE	NAGA, ARG329GLN	121434533
104210	150	ADRA2A	0001	ALPHA-2A ADRENERGIC RECEPTOR, OVEREXPRESSION  or TYPE 2 DIABETES SUSCEPTIBILITY (safer to say the former than the latter)	ADRA2A, 3-PRIME UTR 427A-G	553668
104250	152	ADRA2C	0001	CONGESTIVE HEART FAILURE AND BETA-BLOCKER RESPONSE, MODIFIER OF	ADRA2C, 12-BP DEL, NT964	
104311	5663	PSEN1	0001	ALZHEIMER DISEASE, FAMILIAL, 3	PSEN1, MET146LEU	63750306
104311	5663	PSEN1	0002	ALZHEIMER DISEASE, FAMILIAL, 3	PSEN1, HIS163ARG	63750590
104311	5663	PSEN1	0003	ALZHEIMER DISEASE, FAMILIAL, 3	PSEN1, ALA246GLU	63750526
104311	5663	PSEN1	0004	ALZHEIMER DISEASE, FAMILIAL, 3	PSEN1, LEU286VAL	63751235
104311	5663	PSEN1	0005	ALZHEIMER DISEASE, FAMILIAL, 3	PSEN1, CYS410TYR	661
104311	5663	PSEN1	0006	ALZHEIMER DISEASE, FAMILIAL, 3	PSEN1, MET139VAL	63751037
104311	5663	PSEN1	0007	ALZHEIMER DISEASE, FAMILIAL, 3	PSEN1, MET146VAL	
104311	5663	PSEN1	0008	ALZHEIMER DISEASE, FAMILIAL, 3	PSEN1, HIS163TYR	63749885
104311	5663	PSEN1	0009	ALZHEIMER DISEASE, FAMILIAL, 3	PSEN1, GLU280ALA	63750231
104311	5663	PSEN1	0010	ALZHEIMER DISEASE, FAMILIAL, 3 ALZHEIMER DISEASE, FAMILIAL, WITH SPASTIC PARAPARESIS AND UNUSUAL PLAQUES, INCLUDED	PSEN1, GLU280GLY	
104311	5663	PSEN1	0011	ALZHEIMER DISEASE, FAMILIAL, 3	PSEN1, PRO267SER	63751229
104311	5663	PSEN1	0012	ALZHEIMER DISEASE, FAMILIAL, 3 ALZHEIMER DISEASE, FAMILIAL, WITH SPASTIC PARAPARESIS AND UNUSUAL PLAQUES, INCLUDED	PSEN1, IVS8AS, G-T, -1, EX9DEL	
104311	5663	PSEN1	0013	ALZHEIMER DISEASE, FAMILIAL, 3	PSEN1, GLU120ASP	63751272
104311	5663	PSEN1	0014	ALZHEIMER DISEASE, FAMILIAL, 3	PSEN1, ALA426PRO	63751223
104311	5663	PSEN1	0015	ALZHEIMER DISEASE, FAMILIAL, 3	PSEN1, MET146ILE	63750391
104311	5663	PSEN1	0016	ALZHEIMER DISEASE, FAMILIAL, 3	PSEN1, LEU250SER	63751163
104311	5663	PSEN1	0017	ALZHEIMER DISEASE, FAMILIAL, WITH SPASTIC PARAPARESIS AND UNUSUAL PLAQUES	PSEN1, ARG278THR	63749891
104311	5663	PSEN1	0018	ALZHEIMER DISEASE, FAMILIAL, 3	PSEN1, IVS4DS, 1-BP DEL, G	
104311	5663	PSEN1	0019	ALZHEIMER DISEASE, FAMILIAL, 3	PSEN1, 1548GC-TG	
104311	5663	PSEN1	0020	ALZHEIMER DISEASE, FAMILIAL, 3	PSEN1, CYS92SER	63751141
104311	5663	PSEN1	0021	ALZHEIMER DISEASE, FAMILIAL, 3	PSEN1, GLY206ALA	63750082
104311	5663	PSEN1	0022	ALZHEIMER DISEASE, FAMILIAL, 3, WITH SPASTIC PARAPARESIS AND APRAXIA	PSEN1, GLY266SER	121917807
104311	5663	PSEN1	0023	DEMENTIA, FRONTOTEMPORAL	PSEN1, LEU113PRO	63751399
104311	5663	PSEN1	0024	ALZHEIMER DISEASE, FAMILIAL, 3	PSEN1, LEU166PRO	63750265
104311	5663	PSEN1	0025	ALZHEIMER DISEASE, FAMILIAL, 3	PSEN1, LEU174MET	63751144
104311	5663	PSEN1	0026	ALZHEIMER DISEASE, FAMILIAL, 3, WITH UNUSUAL PLAQUES	PSEN1, LEU271VAL	63750886
104311	5663	PSEN1	0027	PICK DISEASE OF BRAIN	PSEN1, GLY183VAL	63751068
104311	5663	PSEN1	0028	ALZHEIMER DISEASE, FAMILIAL, 3	PSEN1, PRO436GLN	121917808
104311	5663	PSEN1	0029	ALZHEIMER DISEASE, FAMILIAL, 3, WITH SPASTIC PARAPARESIS AND UNUSUAL PLAQUES	PSEN1, 6-BP INS, NT715	
104311	5663	PSEN1	0030	ALZHEIMER DISEASE, FAMILIAL, 3	PSEN1, ARG278ILE	63749891
104311	5663	PSEN1	0031	ALZHEIMER DISEASE, FAMILIAL, 3, WITH SPASTIC PARAPARESIS AND APRAXIA	PSEN1, LEU85PRO	63750599
104311	5663	PSEN1	0032	ALZHEIMER DISEASE, FAMILIAL, 3, WITH SPASTIC PARAPARESIS AND UNUSUAL PLAQUES	PSEN1, 3-BP DEL	
104311	5663	PSEN1	0033	ALZHEIMER DISEASE, FAMILIAL, 3	PSEN1, ALA431GLU	63750083
104311	5663	PSEN1	0034	CARDIOMYOPATHY, DILATED, 1U	PSEN1, ASP333GLY	121917809
104311	5663	PSEN1	0035	ALZHEIMER DISEASE, FAMILIAL, 3	PSEN1, ALA79VAL	63749824
104311	5663	PSEN1	0036	ALZHEIMER DISEASE, FAMILIAL, 3	PSEN1, SER170PHE	63750577
104311	5663	PSEN1	0037	ALZHEIMER DISEASE, FAMILIAL, 3, WITH UNUSUAL PLAQUES	PSEN1, GLY217ARG	
104311	5663	PSEN1	0038	ACNE INVERSA, FAMILIAL, 3	PSEN1, 1-BP DEL, 725C	
104614	6519	SLC3A1	0001	CYSTINURIA	SLC3A1, MET467THR	121912691
104614	6519	SLC3A1	0002	CYSTINURIA	SLC3A1, MET467LYS	
104614	6519	SLC3A1	0003	CYSTINURIA	SLC3A1, LEU678PRO	121912693
104614	6519	SLC3A1	0004	CYSTINURIA	SLC3A1, ARG181GLN	121912694
104614	6519	SLC3A1	0005	CYSTINURIA	SLC3A1, THR652ARG	121912695
104614	6519	SLC3A1	0006	CYSTINURIA	SLC3A1, PRO615THR	121912696
104614	6519	SLC3A1	0007	CYSTINURIA	SLC3A1, EX5-9DUP	
104614	6519	SLC3A1	0008	CYSTINURIA	SLC3A1, ARG362HIS	121912697
104614	6519	SLC3A1	0009	CYSTINURIA	SLC3A1, TYR533ASN	
104620	95	ACY1	0001	AMINOACYLASE 1 DEFICIENCY	ACY1, 2-BP INS, 1105AC	
104620	95	ACY1	0002	AMINOACYLASE 1 DEFICIENCY	ACY1, ARG353CYS	121912698
104620	95	ACY1	0003	AMINOACYLASE 1 DEFICIENCY	ACY1, GLU233ASP	121912699
104620	95	ACY1	0004	AMINOACYLASE 1 DEFICIENCY	ACY1, IVS5AS, -1, G-A	
104620	95	ACY1	0005	AMINOACYLASE 1 DEFICIENCY	ACY1, ARG197TRP	121912700
104620	95	ACY1	0006	AMINOACYLASE 1 DEFICIENCY	ACY1, ARG393HIS	121912701
104750	6288	SAA1	0001	SERUM AMYLOID A VARIANT	SAA1, GLY72ASP	79681911
104750	6288	SAA1	0002	SERUM AMYLOID A VARIANT	SAA1, VAL52ALA	1136743
104760	351	APP	0001	CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, DUTCH VARIANT	APP, GLU693GLN	63750579
104760	351	APP	0002	ALZHEIMER DISEASE, FAMILIAL, 1	APP, VAL717ILE	63750264
104760	351	APP	0003	ALZHEIMER DISEASE, FAMILIAL, 1	APP, VAL717PHE	63750264
104760	351	APP	0004	ALZHEIMER DISEASE, FAMILIAL, 1	APP, VAL717GLY	63749964
104760	351	APP	0005	CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, FLEMISH VARIANT ALZHEIMER DISEASE, FAMILIAL, 1, INCLUDED	APP, ALA692GLY	63750671
104760	351	APP	0007	APP POLYMORPHISM	APP, 2124C-T	
104760	351	APP	0008	ALZHEIMER DISEASE, FAMILIAL, 1	APP, LYS670ASN AND MET671LEU	
104760	351	APP	0009	ALZHEIMER DISEASE, FAMILIAL, 1	APP, ALA713THR	63750066
104760	351	APP	0010	ALZHEIMER DISEASE, FAMILIAL, 1	APP, GLU665ASP	63750363
104760	351	APP	0011	ALZHEIMER DISEASE, FAMILIAL, 1	APP, ILE716VAL	63750399
104760	351	APP	0012	ALZHEIMER DISEASE, FAMILIAL, 1	APP, VAL715MET	63750734
104760	351	APP	0013	ALZHEIMER DISEASE, FAMILIAL, 1 CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, ARCTIC VARIANT, INCLUDED	APP, GLU693GLY	63751039
104760	351	APP	0014	CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, ITALIAN VARIANT	APP, GLU693LYS	63750579
104760	351	APP	0015	ALZHEIMER DISEASE, FAMILIAL, 1	APP, THR714ILE	63750973
104760	351	APP	0016	CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, IOWA VARIANT	APP, ASN694ASP	63749810
104760	351	APP	0017	ALZHEIMER DISEASE, FAMILIAL, 1	APP, THR714ALA	63750643
104760	351	APP	0019	CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, PIEDMONT VARIANT	APP, LEU705VAL	63750921
104760	351	APP	0020	ALZHEIMER DISEASE, EARLY-ONSET, WITH CEREBRAL AMYLOID ANGIOPATHY	APP, DUP	
104760	351	APP	0021	ALZHEIMER DISEASE, FAMILIAL, 1	APP, VAL717LEU	63750264
104760	351	APP	0022	ALZHEIMER DISEASE, FAMILIAL, 1, AUTOSOMAL RECESSIVE	APP, ALA673VAL	193922916
104760	351	APP	0023	ALZHEIMER DISEASE, PROTECTION AGAINST	APP, ALA673THR	
105590	238	ALK	0001	NEUROBLASTOMA, SUSCEPTIBILITY TO, 3	ALK, ARG1275GLN	113994087
105590	238	ALK	0002	NEUROBLASTOMA, SUSCEPTIBILITY TO, 3	ALK, GLY1128ALA	113994088
105590	238	ALK	0003	NEUROBLASTOMA, SUSCEPTIBILITY TO, 3	ALK, ARG1192PRO	113994089
105590	238	ALK	0004	NEUROBLASTOMA, SUSCEPTIBILITY TO, 3	ALK, THR1151MET	113994091
105850	283	ANG	0001	AMYOTROPHIC LATERAL SCLEROSIS 9	ANG, GLN12LEU	121909535
105850	283	ANG	0002	AMYOTROPHIC LATERAL SCLEROSIS 9	ANG, LYS17ILE	121909536
105850	283	ANG	0003	AMYOTROPHIC LATERAL SCLEROSIS 9	ANG, LYS17GLU	121909537
105850	283	ANG	0004	AMYOTROPHIC LATERAL SCLEROSIS 9	ANG, ARG31LYS	121909538
105850	283	ANG	0005	AMYOTROPHIC LATERAL SCLEROSIS 9	ANG, CYS39TRP	121909539
105850	283	ANG	0006	AMYOTROPHIC LATERAL SCLEROSIS 9	ANG, LYS40ILE	121909540
105850	283	ANG	0007	AMYOTROPHIC LATERAL SCLEROSIS 9	ANG, ILE46VAL	121909541
105850	283	ANG	0008	AMYOTROPHIC LATERAL SCLEROSIS 9	ANG, SER28ASN	121909542
105850	283	ANG	0009	AMYOTROPHIC LATERAL SCLEROSIS 9	ANG, PRO112LEU	121909543
105850	283	ANG	0010	AMYOTROPHIC LATERAL SCLEROSIS 9	ANG, VAL113ILE	121909544
106150	183	AGT	0001	HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO PREECLAMPSIA, SUSCEPTIBILITY TO, INCLUDED;; IgA NEPHROPATHY, PROGRESSION TO RENAL FAILURE IN, SUSCEPTIBILITY TO, INCLUDED	AGT, MET235THR	699
106150	183	AGT	0002	HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO CROHN DISEASE, ASSOCIATION WITH, INCLUDED	AGT, -6A HAPLOTYPE	
106150	183	AGT	0003	RENAL TUBULAR DYSGENESIS	AGT, ARG375GLN	74315283
106150	183	AGT	0004	RENAL TUBULAR DYSGENESIS	AGT, GLU202TER	121912702
106150	183	AGT	0005	RENAL TUBULAR DYSGENESIS	AGT, 1-BP DEL, 1290T	
106165	185	AGTR1	0001	HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO	AGTR1, 1166A-C, 3-PRIME UTR	5186
106165	185	AGTR1	0003	RENAL TUBULAR DYSGENESIS	AGTR1, 1-BP INS, 110T	
106165	185	AGTR1	0004	RENAL TUBULAR DYSGENESIS	AGTR1, THR282MET	104893677
106165	185	AGTR1	0005	RENAL TUBULAR DYSGENESIS	AGTR1, TRP84TER	
106165	185	AGTR1	0006	RENAL TUBULAR DYSGENESIS	AGTR1, ARG126TER	
106180	1636	ACE	0001	ANGIOTENSIN I-CONVERTING ENZYME INSERTION/DELETION POLYMORPHISM MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, INCLUDED;; MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 3, INCLUDED;; STROKE, HEMORRHAGIC, SUSCEPTIBILITY TO, INCLUDED;; STROKE, ISCHEMIC, SUSCEPTIBILITY TO, INCLUDED;; SEVERE ACUTE RESPIRATORY SYNDROME, PROGRESSION OF, INCLUDED;; IgA NEPHROPATHY, PROGRESSION TO RENAL FAILURE IN, SUSCEPTIBILITY TO, INCLUDED	ACE, INS/DEL	4340
106180	1636	ACE	0002	ANGIOTENSIN I-CONVERTING ENZYME, BENIGN SERUM INCREASE	ACE, PRO1199LEU	121912703
106180	1636	ACE	0003	RENAL TUBULAR DYSGENESIS	ACE, TYR266TER	121912704
106180	1636	ACE	0004	RENAL TUBULAR DYSGENESIS	ACE, 4-BP DEL, 1319TGGA	
106180	1636	ACE	0005	RENAL TUBULAR DYSGENESIS	ACE, ARG496TER	
106180	1636	ACE	0006	RENAL TUBULAR DYSGENESIS	ACE, ARG791TER	
106410	287	ANK2	0001	LONG QT SYNDROME 4 CARDIAC ARRHYTHMIA, ANKYRIN-B-RELATED, INCLUDED	ANK2, GLU1425GLY	72544141
106410	287	ANK2	0002	CARDIAC ARRHYTHMIA, ANKYRIN-B-RELATED	ANK2, THR1626ASN	121912705
106410	287	ANK2	0003	CARDIAC ARRHYTHMIA, ANKYRIN-B-RELATED	ANK2, LEU1622ILE	35530544
106410	287	ANK2	0004	LONG QT SYNDROME 4	ANK2, ARG1788TRP	121912706
106410	287	ANK2	0005	CARDIAC ARRHYTHMIA, ANKYRIN-B-RELATED	ANK2, GLU1813LYS	45454496
107265	930	CD19	0001	IMMUNODEFICIENCY, COMMON VARIABLE, 3	CD19, 1-BP INS, 972A	
107265	930	CD19	0002	IMMUNODEFICIENCY, COMMON VARIABLE, 3	CD19, 2-BP DEL, 1384GA	
107269	960	CD44	0001	INDIAN BLOOD GROUP SYSTEM POLYMORPHISM	CD44, ARG46GLY	121909545
107271	966	CD59	0001	CD59 DEFICIENCY	CD59, 1-BP DEL, CODON 16	
107280	12	SERPINA3	0001	ANTICHYMOTRYPSIN ISEHARA 1	SERPINA3, MET389VAL	116929575
107280	12	SERPINA3	0002	ANTICHYMOTRYPSIN ISEHARA 2	SERPINA3, 2-BP DEL	
107280	12	SERPINA3	0003	ANTICHYMOTRYPSIN BOCHUM 1	SERPINA3, LEU55PRO	1800463
107280	12	SERPINA3	0004	ANTICHYMOTRYPSIN BONN 1	SERPINA3, PRO229ALA	17473
107280	12	SERPINA3	0005	ANTICHYMOTRYPSIN SIGNAL PEPTIDE POLYMORPHISM	SERPINA3, ALA-15THR	
107300	462	SERPINC1	0001	THROMBOPHILIA DUE TO ANTITHROMBIN III DEFICIENCY	SERPINC1, ALA404THR	121909546
107300	462	SERPINC1	0003	THROMBOPHILIA DUE TO ANTITHROMBIN III DEFICIENCY	SERPINC1, ARG47CYS	121909547
107300	462	SERPINC1	0004	THROMBOPHILIA DUE TO ANTITHROMBIN III DEFICIENCY	SERPINC1	
107300	462	SERPINC1	0006	THROMBOPHILIA DUE TO ANTITHROMBIN III DEFICIENCY	SERPINC1	
107300	462	SERPINC1	0007	THROMBOPHILIA DUE TO ANTITHROMBIN III DEFICIENCY	SERPINC1, ALA384PRO	121909548
107300	462	SERPINC1	0009	THROMBOPHILIA DUE TO ANTITHROMBIN III DEFICIENCY	SERPINC1	
107300	462	SERPINC1	0010	THROMBOPHILIA DUE TO ANTITHROMBIN III DEFICIENCY	SERPINC1, ARG393PRO	121909549
107300	462	SERPINC1	0011	THROMBOPHILIA DUE TO ANTITHROMBIN III DEFICIENCY	SERPINC1, SER394LEU	121909550
107300	462	SERPINC1	0012	THROMBOPHILIA DUE TO ANTITHROMBIN III DEFICIENCY	SERPINC1, PRO41LEU	121909551
107300	462	SERPINC1	0013	THROMBOPHILIA DUE TO ANTITHROMBIN III DEFICIENCY	SERPINC1, VAL-3GLU	
107300	462	SERPINC1	0014	THROMBOPHILIA DUE TO ANTITHROMBIN III DEFICIENCY	SERPINC1	
107300	462	SERPINC1	0015	THROMBOPHILIA DUE TO ANTITHROMBIN III DEFICIENCY	SERPINC1, ARG47HIS	121909552
107300	462	SERPINC1	0016	THROMBOPHILIA DUE TO ANTITHROMBIN III DEFICIENCY	SERPINC1, ARG47SER	
107300	462	SERPINC1	0018	THROMBOPHILIA DUE TO ANTITHROMBIN III DEFICIENCY	SERPINC1, ARG393CYS	121909554
107300	462	SERPINC1	0019	THROMBOPHILIA DUE TO ANTITHROMBIN III DEFICIENCY	SERPINC1, PRO407LEU	121909555
107300	462	SERPINC1	0020	THROMBOPHILIA DUE TO ANTITHROMBIN III DEFICIENCY	SERPINC1, ARG393CYS	
107300	462	SERPINC1	0021	THROMBOPHILIA DUE TO ANTITHROMBIN III DEFICIENCY	SERPINC1, ARG393HIS	
107300	462	SERPINC1	0022	THROMBOPHILIA DUE TO ANTITHROMBIN III DEFICIENCY	SERPINC1, ALA382THR	121909557
107300	462	SERPINC1	0023	THROMBOPHILIA DUE TO ANTITHROMBIN III DEFICIENCY	SERPINC1, ILE7ASN	121909558
107300	462	SERPINC1	0025	MOVED TO 107300.0003 .0026 THROMBOPHILIA DUE TO ANTITHROMBIN III DEFICIENCY	SERPINC1, ARG24CYS	
107300	462	SERPINC1	0027	THROMBOPHILIA DUE TO ANTITHROMBIN III DEFICIENCY	SERPINC1, ALA384SER	121909548
107300	462	SERPINC1	0028	THROMBOPHILIA DUE TO ANTITHROMBIN III DEFICIENCY	SERPINC1, 1-BP DEL, A	
107300	462	SERPINC1	0029	THROMBOPHILIA DUE TO ANTITHROMBIN III DEFICIENCY	SERPINC1, 2-BP DEL, AG	
107300	462	SERPINC1	0030	THROMBOPHILIA DUE TO ANTITHROMBIN III DEFICIENCY	SERPINC1, 1-BP INS, 780A	
107300	462	SERPINC1	0031	THROMBOPHILIA DUE TO ANTITHROMBIN III DEFICIENCY	SERPINC1, SER291PRO	121909560
107300	462	SERPINC1	0032	THROMBOPHILIA DUE TO ANTITHROMBIN III DEFICIENCY	SERPINC1, ASP309LYS	121909561
107300	462	SERPINC1	0033	THROMBOPHILIA DUE TO ANTITHROMBIN III DEFICIENCY	SERPINC1, ARG129TER	121909562
107300	462	SERPINC1	0034	THROMBOPHILIA DUE TO ANTITHROMBIN III DEFICIENCY	SERPINC1, ARG129GLN	121909563
107300	462	SERPINC1	0035	THROMBOPHILIA DUE TO ANTITHROMBIN III DEFICIENCY	SERPINC1, PRO429LEU	121909564
107300	462	SERPINC1	0036	THROMBOPHILIA DUE TO ANTITHROMBIN III DEFICIENCY	SERPINC1, SER349PRO	121909565
107300	462	SERPINC1	0037	THROMBOPHILIA DUE TO ANTITHROMBIN III DEFICIENCY	SERPINC1, GLY392ASP	121909566
107300	462	SERPINC1	0038	THROMBOPHILIA DUE TO ANTITHROMBIN III DEFICIENCY	SERPINC1, LEU99PHE	121909567
107300	462	SERPINC1	0039	THROMBOPHILIA DUE TO ANTITHROMBIN III DEFICIENCY	SERPINC1, 1-BP INS, T, CODON 48	
107300	462	SERPINC1	0040	THROMBOPHILIA DUE TO ANTITHROMBIN III DEFICIENCY	SERPINC1, 1-BP INS, A, CODON 208	
107300	462	SERPINC1	0041	THROMBOPHILIA DUE TO ANTITHROMBIN III DEFICIENCY	SERPINC1, 1-BP DEL, A, CODON 370	
107300	462	SERPINC1	0042	THROMBOPHILIA DUE TO ANTITHROMBIN III DEFICIENCY	SERPINC1, ALA387VAL	121909568
107300	462	SERPINC1	0043	THROMBOPHILIA DUE TO ANTITHROMBIN III DEFICIENCY	SERPINC1, SER116PRO	121909569
107300	462	SERPINC1	0044	THROMBOPHILIA DUE TO ANTITHROMBIN III DEFICIENCY	SERPINC1, LEU-10PRO	
107300	462	SERPINC1	0045	THROMBOPHILIA DUE TO ANTITHROMBIN III DEFICIENCY	SERPINC1, ASN135THR	121909570
107300	462	SERPINC1	0046	THROMBOPHILIA DUE TO ANTITHROMBIN III DEFICIENCY	SERPINC1, ASN187ASP	121909571
107300	462	SERPINC1	0047	THROMBOPHILIA DUE TO ANTITHROMBIN III DEFICIENCY	SERPINC1, SER191PRO	121909572
107300	462	SERPINC1	0048	THROMBOPHILIA DUE TO ANTITHROMBIN III DEFICIENCY	SERPINC1, CYS95ARG	121909573
107300	462	SERPINC1	0049	THROMBOPHILIA DUE TO ANTITHROMBIN III DEFICIENCY	SERPINC1, 3-BP DEL	
107300	462	SERPINC1	0050	THROMBOPHILIA DUE TO ANTITHROMBIN III DEFICIENCY	SERPINC1, 9-BP DEL, NT13395	
107323	501	ALDH7A1	0001	EPILEPSY, PYRIDOXINE-DEPENDENT	ALDH7A1, GLU399GLN	121912707
107323	501	ALDH7A1	0002	EPILEPSY, PYRIDOXINE-DEPENDENT	ALDH7A1, ARG82TER	121912708
107323	501	ALDH7A1	0003	EPILEPSY, PYRIDOXINE-DEPENDENT	ALDH7A1, IVS5AS, G-C, -1	
107323	501	ALDH7A1	0004	EPILEPSY, PYRIDOXINE-DEPENDENT	ALDH7A1, IVS3DS, T-A, +2	
107323	501	ALDH7A1	0005	EPILEPSY, PYRIDOXINE-DEPENDENT	ALDH7A1, ALA171VAL	121912709
107323	501	ALDH7A1	0006	EPILEPSY, PYRIDOXINE-DEPENDENT	ALDH7A1, 1-BP DEL, 1512G	
107323	501	ALDH7A1	0007	EPILEPSY, PYRIDOXINE-DEPENDENT	ALDH7A1, TYR380TER	121912710
107323	501	ALDH7A1	0008	EPILEPSY, PYRIDOXINE-DEPENDENT	ALDH7A1, ASN273ILE	121912711
107323	501	ALDH7A1	0009	EPILEPSY, PYRIDOXINE-DEPENDENT	ALDH7A1, 750G-A	
107400	5265	SERPINA1	0001	PI M1-ALA213 PI, M1A	PI, ALA213	
107400	5265	SERPINA1	0002	PI M1-VAL213 PI, M1V	PI, ALA213	6647
107400	5265	SERPINA1	0003	PI M2	PI, ARG101HIS ON M3	709932
107400	5265	SERPINA1	0004	PI M3	PI, GLU376ASP ON M1V	1303
107400	5265	SERPINA1	0005	PI M4	PI, ARG101HIS ON M1V	709932
107400	5265	SERPINA1	0006	PI B(ALHAMBRA)	PI, ASP-LYS	
107400	5265	SERPINA1	0007	PI F	PI, ARG223CYS ON M1V	
107400	5265	SERPINA1	0008	PI P(ST. ALBANS)	PI, ASP341ASN ON M1V	143370956
107400	5265	SERPINA1	0009	PI X	PI, GLU204LYS ON M1V	199422208
107400	5265	SERPINA1	0010	PI CHRISTCHURCH	PI, GLU363LYS	121912712
107400	5265	SERPINA1	0011	PI Z	PI, GLU342LYS ON M1A	28929474
107400	5265	SERPINA1	0012	PI M(MALTON)	PI, PHE52DEL ON M2	
107400	5265	SERPINA1	0013	PI S	PI, GLU264VAL ON M1V	17580
107400	5265	SERPINA1	0014	PI M(HEERLEN)	PI, PRO369LEU ON M1A	199422209
107400	5265	SERPINA1	0015	PI M(MINERAL SPRINGS)	PI, GLY67GLU ON M1A	
107400	5265	SERPINA1	0016	PI M(PROCIDA)	PI, LEU41PRO ON M1V	28931569
107400	5265	SERPINA1	0017	PI M(NICHINAN)	PI, PHE52DEL AND GLY148ARG	
107400	5265	SERPINA1	0018	PI I	PI, ARG39CYS ON M1V	28931570
107400	5265	SERPINA1	0019	PI P(LOWELL) PI NULL(CARDIFF);; PI Q0(CARDIFF)	PI, ASP256VAL ON M1V	121912714
107400	5265	SERPINA1	0020	PI NULL(GRANITE FALLS) PI Q0(GRANITE FALLS)	PI, TYR160TER ON M1A	199422210
107400	5265	SERPINA1	0021	PI NULL(BELLINGHAM) PI Q0(BELLINGHAM)	PI, LYS217TER ON M1V	199422211
107400	5265	SERPINA1	0022	PI NULL(MATTAWA)	PI, LEU353PHE ON M1V	28929473
107400	5265	SERPINA1	0023	PI NULL(PROCIDA) PI NULL(ISOLA DI PROCIDA);; PI Q0(PROCIDA)	PI, 17-KB DEL	
107400	5265	SERPINA1	0024	PI NULL(HONG KONG 1) PI Q0(HONG KONG 1)	PI, 2-BP DEL, FS334TER	
107400	5265	SERPINA1	0025	PI NULL(BOLTON) PI Q0(BOLTON)	PI, 1-BP DEL	
107400	5265	SERPINA1	0026	PI PITTSBURGH 'ANTITHROMBIN' PITTSBURGH	PI, MET358ARG	121912713
107400	5265	SERPINA1	0027	PI V(MUNICH)	PI, ASP2ALA ON M1V	199422212
107400	5265	SERPINA1	0028	PI Z(AUGSBURG) PI Z(TUN)	PI, GLU342LYS ON M2	
107400	5265	SERPINA1	0029	PI W(BETHESDA)	PI, ALA336THR ON M1A	1802959
107400	5265	SERPINA1	0030	PI NULL(DEVON) PI Q0(DEVON);; PI NULL(NEWPORT);; PI Q0(NEWPORT)	PI, GLY115SER	11558261
107400	5265	SERPINA1	0031	PI NULL(LUDWIGSHAFEN) PI Q0(LUDWIGSHAFEN)	PI, ILE92ASN	28931572
107400	5265	SERPINA1	0032	PI Z(WREXHAM)	PI, SER-19LEU	
107400	5265	SERPINA1	0034	PI NULL(HONG KONG 2) PI Q0(HONG KONG 2)	PI	
107400	5265	SERPINA1	0035	PI NULL(RIEDENBURG)	PI, DEL	
107400	5265	SERPINA1	0036	PI KALSHEKER-POLLER	PI, G-A, 3-PRIME UTR ENHANCER	
107400	5265	SERPINA1	0037	PI P(DUARTE)	PI, ASP256VAL	121912714
107400	5265	SERPINA1	0038	PI NULL(WEST) PI Q0(WEST)	PI, IVS2DS, G-T, +1	
107400	5265	SERPINA1	0039	PI S(IIYAMA)	PI, SER53PHE	55819880
107400	5265	SERPINA1	0040	PI Z(BRISTOL)	PI, THR85MET ON M1V	199422213
107470	3459	IFNGR1	0001	ATYPICAL MYCOBACTERIAL INFECTION, FAMILIAL DISSEMINATED	IFNGR1, 395C-A, SER-TER	
107470	3459	IFNGR1	0002	BCG INFECTION, GENERALIZED FAMILIAL	IFNGR1, 1-BP DEL	
107470	3459	IFNGR1	0003	BCG INFECTION, TUBERCULOID, ANTIBIOTIC-RESPONSIVE MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO INFECTION BY	IFNGR1, ILE87THR	104893973
107470	3459	IFNGR1	0004	ATYPICAL MYCOBACTERIAL INFECTION, FAMILIAL DISSEMINATED	IFNGR1, 4-BP INS, 107TTAC	
107470	3459	IFNGR1	0005	ATYPICAL MYCOBACTERIAL INFECTION, FAMILIAL DISSEMINATED	IFNGR1, IVS3DS, G-A, +1	
107470	3459	IFNGR1	0006	BCG INFECTION, GENERALIZED FAMILIAL SEMIBENIGN	IFNGR1, 4-BP DEL, NT818	
107470	3459	IFNGR1	0007	ATYPICAL MYCOBACTERIAL INFECTION, DISSEMINATED	IFNGR1, 12-BP DEL, NT295	
107470	3459	IFNGR1	0008	ATYPICAL MYCOBACTERIAL INFECTION, DISSEMINATED FAMILIAL	IFNGR1, CYS77TYR	104893974
107470	3459	IFNGR1	0009	ATYPICAL MYCOBACTERIAL INFECTION, DISSEMINATED	IFNGR1, VAL61GLN	121912715
107470	3459	IFNGR1	0010	ATYPICAL MYCOBACTERIAL INFECTION, DISSEMINATED	IFNGR1, 3-BP DEL, 652GAA or 653AAG	
107470	3459	IFNGR1	0011	ATYPICAL MYCOBACTERIAL INFECTION, AUTOSOMAL DOMINANT	IFNGR1, 818 DEL	
107470	3459	IFNGR1	0012	HELICOBACTER PYLORI INFECTION, SUSCEPTIBILITY TO MYCOBACTERIUM TUBERCULOSIS, PROTECTION AGAINST, INCLUDED;; HEPATITIS B VIRUS, SUSCEPTIBILITY TO	IFNGR1, -56C-T	
107470	3459	IFNGR1	0013	ATYPICAL MYCOBACTERIAL INFECTION, DISSEMINATED	IFNGR1, 1-BP DEL, 794T	
107470	3459	IFNGR1	0014	ATYPICAL MYCOBACTERIAL INFECTION, DISSEMINATED	IFNGR1, MET1LYS	
107580	7020	TFAP2A	0001	BRANCHIOOCULOFACIAL SYNDROME	TFAP2A, ARG255GLY	121909574
107580	7020	TFAP2A	0002	BRANCHIOOCULOFACIAL SYNDROME	TFAP2A, GLY262GLU	121909575
107580	7020	TFAP2A	0003	BRANCHIOOCULOFACIAL SYNDROME	TFAP2A, 12-BP DEL, NT697	
107580	7020	TFAP2A	0004	BRANCHIOOCULOFACIAL SYNDROME	TFAP2A, PHE319SER	
107580	7020	TFAP2A	0005	BRANCHIOOCULOFACIAL SYNDROME	TFAP2A, 18-BP DEL/6-BP INS, NT828	
107580	7020	TFAP2A	0006	BRANCHIOOCULOFACIAL SYNDROME	TFAP2A, GLU269LYS	
107580	7020	TFAP2A	0007	BRANCHIOOCULOFACIAL SYNDROME	TFAP2A, ARG237GLN	
107670	336	APOA2	0001	APOLIPOPROTEIN A-II DEFICIENCY, FAMILIAL, DUE TO APOA-II (HIROSHIMA)	APOA2, IVS3, G-A, +1	
107670	336	APOA2	0002	HYPERCHOLESTEROLEMIA, FAMILIAL, MODIFICATION OF	APOA2, -265T-C	
107680	335	APOA1	0001	APOLIPOPROTEIN A-I (MILANO)	APOA1, ARG173CYS	28931573
107680	335	APOA1	0002	APOLIPOPROTEIN A-I (MARBURG)	APOA1, LYS107TER	121912716
107680	335	APOA1	0003	APOLIPOPROTEIN A-I (MUNSTER4)	APOA1, GLU198LYS	121912717
107680	335	APOA1	0004	APOLIPOPROTEIN A-I (NORWAY)	APOA1, GLU136LYS	121912718
107680	335	APOA1	0006	APOLIPOPROTEIN A-I (GIESSEN)	APOA1, PRO143ARG	121912719
107680	335	APOA1	0007	APOLIPOPROTEIN A-I (MUNSTER3C)	APOA1, PRO3ARG	121912720
107680	335	APOA1	0008	APOLIPOPROTEIN A-I (MUNSTER3B)	APOA1, PRO4ARG	121912721
107680	335	APOA1	0009	APOLIPOPROTEIN A-I DEFICIENCY	APOA1, PRO165ARG	121912722
107680	335	APOA1	0010	AMYLOID POLYNEUROPATHY-NEPHROPATHY, IOWA TYPE AMYLOIDOSIS, VAN ALLEN TYPE;; AMYLOIDOSIS IV, FORMERLY	APOA1, GLY26ARG	28931574
107680	335	APOA1	0011	APOLIPOPROTEINS A-I AND C-III, COMBINED DEFICIENCY OF HIGH DENSITY LIPOPROTEIN DEFICIENCY, DETROIT TYPE;; HDL DEFICIENCY, DETROIT TYPE	APOA1, APOA1/APOC3 FUSION	
107680	335	APOA1	0012	APOLIPOPROTEIN A-I, ABSENCE OF, DUE TO DELETION OF APOA1/APOC3/APOA4 GENE COMPLEX	APOA1, DEL	
107680	335	APOA1	0013	APOLIPOPROTEIN A-I (BALTIMORE)	APOA1, ARG10LEU	28929476
107680	335	APOA1	0014	CORNEAL CLOUDING DUE TO APOLIPOPROTEIN A-I DEFICIENCY	APOA1, 1-BP DEL, CODON 202	
107680	335	APOA1	0015	APOLIPOPROTEIN A-I DEFICIENCY	APOA1, GLN84TER	121912723
107680	335	APOA1	0016	AMYLOIDOSIS, SYSTEMIC NONNEUROPATHIC	APOA1, LEU60ARG	121912724
107680	335	APOA1	0017	ANALPHALIPOPROTEINEMIA	APOA1, GLN-2TER	
107680	335	APOA1	0018	HYPOALPHALIPOPROTEINEMIA, PRIMARY	APOA1, 1-BP INS	
107680	335	APOA1	0019	XANTHELASMAS, PERIORBITAL	APOA1, GLN32TER	121912725
107680	335	APOA1	0020	AMYLOIDOSIS, HEPATIC AND SYSTEMIC	APOA1, 12-BP DEL AND 2-BP INS	
107680	335	APOA1	0021	AMYLOIDOSIS, SYSTEMIC NONNEUROPATHIC	APOA1, TRP50ARG	121912726
107680	335	APOA1	0022	APOLIPOPROTEIN A-I DEFICIENCY	APOA1, VAL156GLU	121912727
107680	335	APOA1	0023	HYPOALPHALIPOPROTEINEMIA, PRIMARY	APOA1, IVS2, G-C, +1	
107680	335	APOA1	0024	AMYLOIDOSIS, CARDIAC AND CUTANEOUS	APOA1, LEU90PRO	28931575
107680	335	APOA1	0025	AMYLOIDOSIS, CARDIAC AND CUTANEOUS	APOA1, ARG173PRO	121912728
107680	335	APOA1	0026	AMYLOIDOSIS, SYSTEMIC NONNEUROPATHIC	APOA1, LEU174SER	121912729
107680	335	APOA1	0027	AMYLOIDOSIS, SYSTEMIC NONNEUROPATHIC	APOA1, ALA175PRO	121912730
107690	337	APOA4	0001	APOLIPOPROTEIN A-IV POLYMORPHISM, APOA4*1/APOA4*2	APOA4, GLN360HIS	5110
107690	337	APOA4	0002	APOLIPOPROTEIN A-IV RARE VARIANT, APOA4*0	APOA4, 12-BP INS, GLU-GLN-GLN-GLN INS, CODONS 361-362	
107690	337	APOA4	0003	APOLIPOPROTEIN A-IV RARE VARIANT, APOA4*3	APOA4, GLU230LYS	121909576
107690	337	APOA4	0004	APOLIPOPROTEIN A-IV RARE VARIANT, APOA4*5	APOA4, 12-BP INS, GLU-GLN-GLN-GLN INS	
107720	345	APOC3	0001	APOLIPOPROTEIN C-III, NONGLYCOSYLATED	APOC3, THR74ALA	121918381
107720	345	APOC3	0002	HYPERALPHALIPOPROTEINEMIA 2	APOC3, LYS58GLU	121918382
107720	345	APOC3	0003	HYPERALPHALIPOPROTEINEMIA 2	APOC3, ARG19TER	76353203
107730	338	APOB	0001	HYPOBETALIPOPROTEINEMIA, FAMILIAL	APOB, ASN1728THR AND SER1729TER	
107730	338	APOB	0002	HYPOBETALIPOPROTEINEMIA, FAMILIAL, ASSOCIATED WITH APOB39	APOB, 1-BP DEL, FS1799TER	
107730	338	APOB	0003	HYPOBETALIPOPROTEINEMIA, FAMILIAL	APOB, ARG1306TER	121918383
107730	338	APOB	0004	HYPOBETALIPOPROTEINEMIA, FAMILIAL, ASSOCIATED WITH APOB40	APOB, VAL1829CYS	121918384
107730	338	APOB	0005	HYPOBETALIPOPROTEINEMIA, FAMILIAL, ASSOCIATED WITH APOB90 OR APOB89	APOB, GLU4034ARG	121918385
107730	338	APOB	0006	HYPOBETALIPOPROTEINEMIA, FAMILIAL, ASSOCIATED WITH APOB46	APOB, ARG2058TER	121918386
107730	338	APOB	0007	HYPOBETALIPOPROTEINEMIA, FAMILIAL, ASSOCIATED WITH APOB87	APOB, 1-BP DEL, 12032G	
107730	338	APOB	0008	HYPOBETALIPOPROTEINEMIA, FAMILIAL, ASSOCIATED WITH APOB31	APOB, 1-BP DEL, 1425G	
107730	338	APOB	0009	HYPERCHOLESTEROLEMIA DUE TO LIGAND-DEFECTIVE APOLIPOPROTEIN B100	APOB, ARG3500GLN	5742904
107730	338	APOB	0010	HYPOBETALIPOPROTEINEMIA, FAMILIAL	APOB, EX21DEL	
107730	338	APOB	0011	APOB POLYMORPHISM IN SIGNAL PEPTIDE	APOB, INS AND DEL	
107730	338	APOB	0012	HYPOBETALIPOPROTEINEMIA, FAMILIAL	APOB, LEU3041TER	121918387
107730	338	APOB	0013	HYPOBETALIPOPROTEINEMIA, NORMOTRIGLYCERIDEMIC	APOB, GLN2252TER	121918388
107730	338	APOB	0014	HYPOBETALIPOPROTEINEMIA, FAMILIAL, ASSOCIATED WITH APOB32	APOB, GLN1450TER	121918389
107730	338	APOB	0015	HYPOBETALIPOPROTEINEMIA, FAMILIAL	APOB, ARG2495TER	121918390
107730	338	APOB	0016	HYPOBETALIPOPROTEINEMIA, FAMILIAL	APOB, 1-BP DEL	
107730	338	APOB	0017	HYPERCHOLESTEROLEMIA DUE TO LIGAND-DEFECTIVE APOLIPOPROTEIN B	APOB, ARG3531CYS	12713559
107730	338	APOB	0018	HYPOBETALIPOPROTEINEMIA, FAMILIAL	APOB, IVS7, A-G, -2	
107730	338	APOB	0019	HYPOBETALIPOPROTEINEMIA, FAMILIAL	APOB, 1-BP DEL, 4432T	
107730	338	APOB	0020	HYPOBETALIPOPROTEINEMIA, NORMOTRIGLYCERIDEMIC	APOB, 4-BP DEL, NT36491	
107730	338	APOB	0021	HYPOBETALIPOPROTEINEMIA, NORMOTRIGLYCERIDEMIC	APOB, TYR1173TER	121918391
107730	338	APOB	0022	HYPOBETALIPOPROTEINEMIA, FAMILIAL	APOB, 2-BP INS, 825GG	
107741	348	APOE	0001	APOE2 ISOFORMS HYPERLIPOPROTEINEMIA, TYPE III, AUTOSOMAL RECESSIVE	APOE, ARG158CYS	7412
107741	348	APOE	0002	HYPERLIPOPROTEINEMIA AND ATHEROSCLEROSIS ASSOCIATED WITH APOE5	APOE, GLU3LYS	121918392
107741	348	APOE	0003	HYPERLIPOPROTEINEMIA, TYPE III, DUE TO APOE2-CHRISTCHURCH	APOE, ARG136SER	121918393
107741	348	APOE	0004	HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE2 FAMILIAL DYSBETALIPOPROTEINEMIA	APOE, ARG145CYS	769455
107741	348	APOE	0005	HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE DEFICIENCY	APOE, IVS3AS, A-G, -1	
107741	348	APOE	0006	HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE LEIDEN	APOE, 21-BP INS, DUP CODONS 121-127	
107741	348	APOE	0007	HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE7 APOE-SUITA	APOE, GLU244LYS AND GLU245LYS	
107741	348	APOE	0008	HYPERLIPOPROTEINEMIA, TYPE III, AUTOSOMAL DOMINANT FAMILIAL DYSBETALIPOPROTEINEMIA	APOE, CYS112ARG AND ARG142CYS	429358
107741	348	APOE	0009	APOLIPOPROTEINEMIA E1	APOE, GLY127ASP AND ARG148CYS	
107741	348	APOE	0010	HYPERLIPOPROTEINEMIA, TYPE III, DUE TO APOE1-HARRISBURG	APOE, LYS146GLU	121918394
107741	348	APOE	0011	DYSBETALIPOPROTEINEMIA DUE TO APOE2	APOE, LYS146GLN	121918394
107741	348	APOE	0012	APOE2-DUNEDIN	APOE, ARG228CYS	121918395
107741	348	APOE	0013	HYPERLIPOPROTEINEMIA, TYPE III, DUE TO APOE4-PHILADELPHIA	APOE, GLU13LYS AND ARG145CYS	
107741	348	APOE	0014	HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE DEFICIENCY APOE3-WASHINGTON	APOE, TRP210TER	121918396
107741	348	APOE	0015	APOE3 ISOFORM	APOE, CYS112 AND ARG158	
107741	348	APOE	0016	ALZHEIMER DISEASE 2	APOE, CYS112ARG	429358
107741	348	APOE	0017	HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE DEFICIENCY, AUTOSOMAL RECESSIVE	APOE, 1-BP DEL, 2919G DEL, FS60TER	
107741	348	APOE	0018	HYPERLIPOPROTEINEMIA, TYPE III APOE3(-)-KOCHI	APOE, ARG145HIS	121918397
107741	348	APOE	0019	HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE2-FUKUOKA APOE2-FUKUOKA	APOE, ARG158CYS AND ARG224GLN	
107741	348	APOE	0020	HYPERCHOLESTEROLEMIA AND HYPERTRIGLYCERIDEMIA, TYPE III	APOE, GLU3LYS AND GLU13LYS	
107741	348	APOE	0021	HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE2	APOE, ARG158CYS AND VAL236GLU	
107741	348	APOE	0022	HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE4	APOE, CYS112ARG AND ARG251GLY	
107741	348	APOE	0023	APOE4(-)-FREIBURG	APOE, LEU28PRO AND CYS112ARG	769452
107741	348	APOE	0024	APOE3(-)-FREIBURG	APOE, THR42ALA	28931576
107741	348	APOE	0025	APOE4 VARIANT	APOE, PRO84ARG AND CYS112ARG	
107741	348	APOE	0026	APOE3 VARIANT	APOE, ALA99THR AND ALA152PRO	
107741	348	APOE	0027	APOE2 VARIANT	APOE, ARG134GLN	28931578
107741	348	APOE	0028	APOE4 VARIANT	APOE, ARG274HIS	121918398
107741	348	APOE	0029	APOE4(+)	APOE, SER296ARG	28931579
107741	348	APOE	0030	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO CORONARY ARTERY DISEASE, SEVERE, SUSCEPTIBILITY TO, INCLUDED	APOE, -219G-T	
107741	348	APOE	0031	SEA-BLUE HISTIOCYTE DISEASE	APOE, 3-BP DEL, 499CTC	
107741	348	APOE	0032	LIPOPROTEIN GLOMERULOPATHY APOE SENDAI	APOE, ARG145PRO	121918397
107741	348	APOE	0033	LIPOPROTEIN GLOMERULOPATHY APOE KYOTO	APOE, ARG25CYS	121918399
107770	4035	LRP1	0001	VARIANT OF UNKNOWN SIGNIFICANCE	LRP1, HIS3258GLN	
107776	358	AQP1	0001	COLTON BLOOD GROUP POLYMORPHISM	AQP1, ALA45VAL	28362692
107776	358	AQP1	0002	AQUAPORIN 1 DEFICIENCY COLTON-NULL, INCLUDED	AQP1, PRO38LEU	104894004
107777	359	AQP2	0001	DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL RECESSIVE	AQP2, ARG187CYS	104894328
107777	359	AQP2	0002	DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL RECESSIVE	AQP2, SER216PRO	104894329
107777	359	AQP2	0004	DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL RECESSIVE	AQP2, GLY64ARG	104894326
107777	359	AQP2	0005	DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL RECESSIVE	AQP2, 1-BP DEL, 369C	
107777	359	AQP2	0006	DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL RECESSIVE	AQP2, ALA147THR	104894334
107777	359	AQP2	0007	DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL RECESSIVE	AQP2, THR126MET	104894330
107777	359	AQP2	0008	DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL RECESSIVE	AQP2, ASN68SER	104894331
107777	359	AQP2	0009	DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL DOMINANT	AQP2, GLU258LYS	104894332
107777	359	AQP2	0010	DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL RECESSIVE	AQP2, THR125MET	104894333
107777	359	AQP2	0011	DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL RECESSIVE	AQP2, GLY175ARG	104894335
107777	359	AQP2	0012	DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL RECESSIVE	AQP2, LEU22VAL	104894336
107777	359	AQP2	0013	DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL RECESSIVE	AQP2, CYS181TRP	104894337
107777	359	AQP2	0014	DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL DOMINANT	AQP2, 1-BP DEL, 721G	
107777	359	AQP2	0015	DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL DOMINANT	AQP2, 1-BP DEL, 727G	
107777	359	AQP2	0016	DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL RECESSIVE	AQP2, GLN57PRO	28931580
107777	359	AQP2	0017	DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL RECESSIVE	AQP2, GLY100VAL	104894338
107777	359	AQP2	0018	DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL RECESSIVE	AQP2, PRO262LEU	104894339
107777	359	AQP2	0019	DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL RECESSIVE	AQP2, ALA190THR	104894341
107910	1588	CYP19A1	0001	AROMATASE DEFICIENCY	CYP19A1, ARG435CYS	121434534
107910	1588	CYP19A1	0002	AROMATASE DEFICIENCY	CYP19A1, CYS437TYR	78310315
107910	1588	CYP19A1	0003	AROMATASE DEFICIENCY	CYP19A1, IVS6, T-C, +2	
107910	1588	CYP19A1	0004	AROMATASE DEFICIENCY	CYP19A1, ARG375CYS	121434536
107910	1588	CYP19A1	0005	AROMATASE DEFICIENCY	CYP19A1, 1-BP DEL, C, CODON 408	
107910	1588	CYP19A1	0006	AROMATASE DEFICIENCY	CYP19A1, IVS3, G-A, +1	
107910	1588	CYP19A1	0007	AROMATASE DEFICIENCY	CYP19A1, ARG365GLN	80051519
107910	1588	CYP19A1	0008	AROMATASE DEFICIENCY	CYP19A1, 1-BP DEL, C, CODON 156	
107910	1588	CYP19A1	0009	AROMATASE DEFICIENCY	CYP19A1, IVS4, C-A, -3	
107910	1588	CYP19A1	0010	AROMATASE EXCESS SYNDROME	CYP19A1, INV, CGNL1 PROMOTER	
107910	1588	CYP19A1	0011	AROMATASE EXCESS SYNDROME	CYP19A1, INV, TMOD3 PROMOTER	
107910	1588	CYP19A1	0012	AROMATASE DEFICIENCY	CYP19A1, GLU210LYS	121434538
107910	1588	CYP19A1	0013	AROMATASE EXCESS SYNDROME	CYP19A1, CYP19A1/TRPM7 FUSION	
107930	1644	DDC	0001	AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	DDC, GLY102SER	137853207
107930	1644	DDC	0002	AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	DDC, SER250PHE	137853208
107930	1644	DDC	0003	AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	DDC, PHE309LEU	137853209
107930	1644	DDC	0004	AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	DDC, SER147ARG	137853210
107930	1644	DDC	0005	AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	DDC, ALA91VAL	137853211
107930	1644	DDC	0006	AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	DDC, ALA275THR	137853212
107930	1644	DDC	0007	AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	DDC, IVS6DS, A-T, +4	
108345	9	NAT1	0001	NAT1*10 ALLELE	NAT1, NAT1 POLYADENYLATION SIGNAL VARIANT	
108345	9	NAT1	0002	NAT1*17 ALLELE	NAT1, VAL149ILE	4987076
108730	487	ATP2A1	0001	BRODY MYOPATHY	ATP2A1, ARG198TER	121918113
108730	487	ATP2A1	0002	BRODY MYOPATHY	ATP2A1, CYS675TER	121918114
108730	487	ATP2A1	0003	BRODY MYOPATHY	ATP2A1, IVS3DS, G-C, -2	
108730	487	ATP2A1	0004	BRODY MYOPATHY	ATP2A1, 1-BP DEL, 437C	
108730	487	ATP2A1	0005	BRODY MYOPATHY	ATP2A1, PRO789LEU	121918115
108733	491	ATP2B2	0001	DEAFNESS, AUTOSOMAL RECESSIVE 12, MODIFIER OF	ATP2B2, VAL586MET	61736451
108740	488	ATP2A2	0001	DARIER DISEASE	ATP2A2, GLY23GLU	28929478
108740	488	ATP2A2	0002	DARIER DISEASE	ATP2A2, GLN108TER	121912731
108740	488	ATP2A2	0003	DARIER DISEASE	ATP2A2, IVS6DS, G-A, +1	
108740	488	ATP2A2	0004	DARIER DISEASE, ACRAL HEMORRHAGIC TYPE	ATP2A2, ASN767SER	121912732
108740	488	ATP2A2	0005	DARIER DISEASE, ACRAL HEMORRHAGIC TYPE	ATP2A2, CYS268PHE	121912733
108740	488	ATP2A2	0006	DARIER DISEASE	ATP2A2, CYS560ARG	121912734
108740	488	ATP2A2	0007	DARIER DISEASE	ATP2A2, 18-BP INS, IVS2, -12	
108740	488	ATP2A2	0008	DARIER DISEASE	ATP2A2, ASN754 DEL	
108740	488	ATP2A2	0009	DARIER DISEASE, SEGMENTAL	ATP2A2, TYR894TER	121912735
108740	488	ATP2A2	0010	DARIER DISEASE, SEGMENTAL	ATP2A2, GLY769ARG	121912736
108740	488	ATP2A2	0011	ACROKERATOSIS VERRUCIFORMIS	ATP2A2, PRO602LEU	121912737
108740	488	ATP2A2	0012	DARIER DISEASE	ATP2A2, ARG131GLN	121912738
108740	488	ATP2A2	0013	ACROKERATOSIS VERRUCIFORMIS	ATP2A2, ALA698VAL	
108780	4878	NPPA	0001	ATRIAL FIBRILLATION, FAMILIAL, 6	NPPA, 2-BP DEL, 456AA	
108961	4882	NPR2	0001	ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE	NPR2, PRO32THR	28931581
108961	4882	NPR2	0002	ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE	NPR2, TRP115GLY	28931582
108961	4882	NPR2	0003	ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE	NPR2, ASP176GLU	28929479
108961	4882	NPR2	0004	ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE	NPR2, ARG388TER	121912739
109270	6521	SLC4A1	0001	BAND 3 MEMPHIS	SLC4A1, LYS56GLU	5036
109270	6521	SLC4A1	0002	OVALOCYTOSIS, SOUTHEAST ASIAN MALARIA, CEREBRAL, RESISTANCE TO	SLC4A1, 27-BP DEL, CODONS 400-408	
109270	6521	SLC4A1	0003	SPHEROCYTOSIS, TYPE 4, DUE TO BAND 3 TUSCALOOSA	SLC4A1, PRO327ARG	28931583
109270	6521	SLC4A1	0004	SPHEROCYTOSIS, TYPE 4, DUE TO BAND 3 MONTEFIORE	SLC4A1, GLU40LYS	45562031
109270	6521	SLC4A1	0005	SPHEROCYTOSIS, TYPE 4, DUE TO BAND 3 PRAGUE	SLC4A1, 10-BP DUP	
109270	6521	SLC4A1	0006	WRIGHT BLOOD GROUP ANTIGEN	SLC4A1, GLU658LYS	75731670
109270	6521	SLC4A1	0007	SPHEROCYTOSIS, TYPE 4, DUE TO BAND 3 CHUR	SLC4A1, GLY771ASP	121912741
109270	6521	SLC4A1	0008	SPHEROCYTOSIS, TYPE 4, DUE TO BAND 3 NOIRTERRE	SLC4A1, GLN330TER	121912742
109270	6521	SLC4A1	0009	SPHEROCYTOSIS, TYPE 4, DUE TO BAND 3 LYON	SLC4A1, ARG150TER	56361140
109270	6521	SLC4A1	0010	SPHEROCYTOSIS, TYPE 4, DUE TO BAND 3 GENAS	SLC4A1, 89G-A	
109270	6521	SLC4A1	0011	WALDNER BLOOD GROUP ANTIGEN	SLC4A1, VAL557MET	121912743
109270	6521	SLC4A1	0012	RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL DOMINANT	SLC4A1, ARG589HIS	121912744
109270	6521	SLC4A1	0013	RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL DOMINANT	SLC4A1, ARG589CYS	121912745
109270	6521	SLC4A1	0014	RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL DOMINANT	SLC4A1, SER613PHE	121912746
109270	6521	SLC4A1	0015	RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL DOMINANT	SLC4A1, ARG589SER	
109270	6521	SLC4A1	0016	RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	SLC4A1, GLY701ASP	121912748
109270	6521	SLC4A1	0017	DIEGO BLOOD GROUP ANTIGEN	SLC4A1, PRO854LEU	2285644
109270	6521	SLC4A1	0018	SPHEROCYTOSIS, TYPE 4, DUE TO BAND 3 FUKUOKA	SLC4A1, GLY130ARG	121912749
109270	6521	SLC4A1	0019	SPHEROCYTOSIS, TYPE 4, DUE TO BAND 3 TOKYO	SLC4A1, THR837ALA	121912750
109270	6521	SLC4A1	0020	RENAL TUBULAR ACIDOSIS, AUTOSOMAL DOMINANT	SLC4A1, ALA858ASP	121912751
109270	6521	SLC4A1	0021	RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	SLC4A1, VAL850DEL	121912752
109270	6521	SLC4A1	0022	SPHEROCYTOSIS, TYPE 4, DUE TO BAND 3 COIMBRA RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA, INCLUDED	SLC4A1, VAL488MET	28931584
109270	6521	SLC4A1	0023	SPHEROCYTOSIS, TYPE 4, DUE TO BAND 3 CAPE TOWN	SLC4A1, GLU90LYS	28929480
109270	6521	SLC4A1	0024	SPHEROCYTOSIS, TYPE 4, DUE TO BAND 3 PRAGUE III	SLC4A1, ARG870TRP	28931585
109270	6521	SLC4A1	0025	RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL DOMINANT	SLC4A1, 13-BP INS, 9-BP DEL	
109270	6521	SLC4A1	0026	RENAL TUBULAR ACIDOSIS, DISTAL, WITH NORMAL RED CELL MORPHOLOGY	SLC4A1, SER773PRO	121912753
109270	6521	SLC4A1	0027	RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	SLC4A1, ARG602PRO	121912754
109270	6521	SLC4A1	0028	SPHEROCYTOSIS, TYPE 4, DUE TO BAND 3 PRAGUE II	SLC4A1, ARG760GLN	121912755
109270	6521	SLC4A1	0029	FROESE BLOOD GROUP ANTIGEN	SLC4A1, GLU480LYS	121912756
109270	6521	SLC4A1	0030	SWANN BLOOD GROUP ANTIGEN	SLC4A1, ARG646GLN	121912757
109270	6521	SLC4A1	0031	SWANN BLOOD GROUP ANTIGEN	SLC4A1, ARG646TRP	121912758
109270	6521	SLC4A1	0032	ACANTHOCYTOSIS DUE TO BAND 3 HT	SLC4A1, PRO878LEU	121912759
109480	682	BSG	0001	BLOOD GROUP--OK	BSG, GLU92LYS	104894669
109535	958	CD40	0001	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 3	CD40, 455A-T, +5, EX5	
109535	958	CD40	0002	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 3	CD40, CYS83ARG	28931586
109535	958	CD40	0003	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 3	CD40, IVS3, A-T, -2	
109535	958	CD40	0004	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 3	CD40, 3-BP DEL, 175TAA	
109630	153	ADRB1	0001	CONGESTIVE HEART FAILURE AND BETA-BLOCKER RESPONSE, MODIFIER OF	ADRB1, ARG389GLY	1801253
109630	153	ADRB1	0002	RESTING HEART RATE, VARIATION IN	ADRB1, SER49GLY	1801252
109690	154	ADRB2	0001	ASTHMA, NOCTURNAL, SUSCEPTIBILITY TO METABOLIC SYNDROME, SUSCEPTIBILITY TO, INCLUDED	ADRB2, ARG16GLY	1042713
109690	154	ADRB2	0002	OBESITY, SUSCEPTIBILITY TO ASTHMA, CHILDHOOD, SUSCEPTIBILITY TO, INCLUDED;; METABOLIC SYNDROME, SUSCEPTIBILITY TO, INCLUDED	ADRB2, GLN27GLU	1042714
109690	154	ADRB2	0003	BETA-2-ADRENORECEPTOR AGONIST, REDUCED RESPONSE TO	ADRB2, THR164ILE	1800888
109690	154	ADRB2	0004	BETA-2-ADRENORECEPTOR AGONIST, REDUCED RESPONSE TO	ADRB2, -47C-T	
109691	155	ADRB3	0001	OBESITY, SUSCEPTIBILITY TO	ADRB3, TRP64ARG	4994
109700	567	B2M	0001	HYPOPROTEINEMIA, HYPERCATABOLIC	B2M, ALA11PRO	104894481
109700	567	B2M	0002	AMYLOIDOSIS, FAMILIAL VISCERAL	B2M, ASP76ASN	
109750	644	BLVRA	0001	HYPERBILIVERDINEMIA	BLVRA, ARG18TER	
109750	644	BLVRA	0002	HYPERBILIVERDINEMIA	BLVRA, SER44TER	
109760	3350	HTR1A	0001	PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	HTR1A, 1-BP DEL, -480A	
110300	28	ABO	0001	BLOOD GROUP O	ABO, 1-BP DEL, 258G	
110300	28	ABO	0002	BLOOD GROUP A/B POLYMORPHISM	ABO, 7 NUCLEOTIDE SUBSTITUTIONS	
110300	28	ABO	0003	BLOOD GROUP A2	ABO, 1-BP DEL	
110300	28	ABO	0004	BLOOD GROUP CIS-AB	ABO, PRO156LEU, GLY268ALA	1053878
110300	28	ABO	0005	BLOOD GROUP B(A)	ABO, PRO234ALA	55722397
110600	420	ART4	0001	DOMBROCK BLOOD GROUP	ART4, ASN265ASP	11276
110600	420	ART4	0002	DOMBROCK-NULL PHENOTYPE	ART4, IVS1AS, A-G, -2	
110600	420	ART4	0003	DOMBROCK-NULL PHENOTYPE	ART4, 8-BP DEL, NT343	
110600	420	ART4	0004	DOMBROCK-NULL PHENOTYPE	ART4, IVS1DS, T-C, +2	
110600	420	ART4	0005	DOMBROCK-NULL PHENOTYPE	ART4, GLN148TER	56340844
110750	2995	GYPC	0001	GLYCOPHORIN C, YUS VARIANT	GYPC, EX2DEL	
110750	2995	GYPC	0002	GLYCOPHORIN C, GERBICH VARIANT MALARIA, RESISTANCE TO	GYPC, EX3DEL	
110750	2995	GYPC	0003	GLYCOPHORIN D, WEBB VARIANT BLOOD GROUP--WEBB ANTIGEN WB	GYPD, ASN8SER	121912760
110750	2995	GYPC	0004	GLYCOPHORIN D, DUCH VARIANT BLOOD GROUP DH	GYPD, LEU14PHE	121912761
111100	2525	FUT3	0001	Le(-) PHENOTYPE	FUT3, LEU20ARG AND GLY170SER	3745635
111300	2993	GYPA	0001	BLOOD GROUP ERIK	GPA, GLY59ARG	1800582
111680	6007	RHD	0001	RHD-NEGATIVE POLYMORPHISM	RHD, DEL	
111680	6007	RHD	0002	RHD CATEGORY D-VII	RHD, LEU110PRO	121912762
111680	6007	RHD	0003	RHD, WEAK D, TYPE I	RHD, VAL270GLY	121912763
111700	6006	RHCE	0001	RH E/e POLYMORPHISM	RHCE, PRO226ALA	609320
111700	6006	RHCE	0002	RH C/c POLYMORPHISM	RHCE, CYS16TRP, ILE60LEU, SER68ASN, AND SER103PRO	676785
111700	6006	RHCE	0003	RH-NULL DISEASE, AMORPH TYPE	RHCE, 2-BP DEL, 966T AND 968A	
112205	973	CD79A	0001	AGAMMAGLOBULINEMIA 3	CD79A, IVS3AS, A-G, -2	
112205	973	CD79A	0002	AGAMMAGLOBULINEMIA 3	CD79A, IVS2DS, G-A, +1	
112210	931	MS4A1	0001	IMMUNODEFICIENCY, COMMON VARIABLE, 5	MS4A1, IVS5DS, 11-BP INS AND 2-BP DEL	
112261	650	BMP2	0001	BRACHYDACTYLY, TYPE A2	BMP2, 2.1-KB DUP, +110 KB	
112262	652	BMP4	0001	MICROPHTHALMIA, SYNDROMIC 6	BMP4, 2-BP DEL, 226AG	
112262	652	BMP4	0002	MICROPHTHALMIA, SYNDROMIC 6	BMP4, GLU93GLY	121912765
112262	652	BMP4	0003	OROFACIAL CLEFT 11	BMP4, ALA346VAL	121912766
112262	652	BMP4	0004	OROFACIAL CLEFT 11	BMP4, SER91CYS	121912767
112262	652	BMP4	0005	OROFACIAL CLEFT 11	BMP4, ARG287HIS	121912768
112262	652	BMP4	0006	MICROPHTHALMIA, SYNDROMIC 6	BMP4, DEL	
112262	652	BMP4	0007	OROFACIAL CLEFT 11 MICROPHTHALMIA, SYNDROMIC 6, INCLUDED	BMP4, ARG198TER	
112262	652	BMP4	0008	MICROPHTHALMIA, SYNDROMIC 6	BMP4, 1-BP DUP, 171C	
112262	652	BMP4	0009	MICROPHTHALMIA, SYNDROMIC 6	BMP4, HIS121ARG	
112264	649	BMP1	0001	OSTEOGENESIS IMPERFECTA, TYPE XIII	BMP1, PHE249LEU	
112264	649	BMP1	0002	OSTEOGENESIS IMPERFECTA, TYPE XIII	BMP1, GLY12ARG	
113505	627	BDNF	0001	CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL	BDNF, THR2ILE	8192466
113505	627	BDNF	0002	MEMORY IMPAIRMENT, SUSCEPTIBILITY TO OBSESSIVE-COMPULSIVE DISORDER, PROTECTION AGAINST, INCLUDED;; ANOREXIA NERVOSA, SUSCEPTIBILITY TO, 2, INCLUDED;; BULIMIA NERVOSA, SUSCEPTIBILITY TO, 2, INCLUDED;; BIPOLAR AFFECTIVE DISORDER, SUSCEPTIBILITY TO, INCLUDED;; PARKINSON DISEASE, AGE AT ONSET, SUSCEPTIBILITY TO, INCLUDED	BDNF, VAL66MET	6265
113505	627	BDNF	0003	BULIMIA NERVOSA, AGE OF ONSET OF WEIGHT LOSS IN	BDNF, -270C-T	
113705	672	BRCA1	0001	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	BRCA1, CYS64GLY	80357064
113705	672	BRCA1	0002	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	BRCA1, CYS61GLY	28897672
113705	672	BRCA1	0003	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1 PANCREATIC CANCER, SUSCEPTIBILITY TO, 4, INCLUDED	BRCA1, 2-BP DEL, 185AG	
113705	672	BRCA1	0004	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	BRCA1, 59-BP INS	
113705	672	BRCA1	0005	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	BRCA1, 1-BP INS	
113705	672	BRCA1	0006	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	BRCA1, 40-BP DEL, NT1294	
113705	672	BRCA1	0007	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	BRCA1, SER766TER	80357780
113705	672	BRCA1	0008	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	BRCA1, 2-BP DEL, 2800AA	
113705	672	BRCA1	0009	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	BRCA1, SER915TER	80357540
113705	672	BRCA1	0010	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	BRCA1, 1-BP DEL, 3121A	
113705	672	BRCA1	0011	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	BRCA1, SER1040ASN	4986852
113705	672	BRCA1	0012	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	BRCA1, ARG1203TER	62625308
113705	672	BRCA1	0013	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	BRCA1, GLU1250TER	28897686
113705	672	BRCA1	0014	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	BRCA1, 4-BP DEL, NT3875	
113705	672	BRCA1	0015	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	BRCA1, 4-BP DEL, 4185TCAA	
113705	672	BRCA1	0016	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	BRCA1, ARG1443TER	41293455
113705	672	BRCA1	0017	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	BRCA1, ARG1443GLY	41293455
113705	672	BRCA1	0018	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1 PANCREATIC CANCER, SUSCEPTIBILITY TO, INCLUDED	BRCA1, 1-BP INS, 5382C	
113705	672	BRCA1	0019	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	BRCA1, TYR1853TER	80357629
113705	672	BRCA1	0020	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	BRCA1, 19-BP DEL, NT5085	
113705	672	BRCA1	0021	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	BRCA1, 1-BP INS, 5438C	
113705	672	BRCA1	0022	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	BRCA1, ARG841TRP	1800709
113705	672	BRCA1	0023	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	BRCA1, 2508G-T	
113705	672	BRCA1	0024	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	BRCA1, 4-BP DEL, 962CTCA	
113705	672	BRCA1	0025	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	BRCA1, 11-BP DEL, NT3600	
113705	672	BRCA1	0026	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	BRCA1, 1675A DEL	
113705	672	BRCA1	0027	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	BRCA1, 1-BP INS, 1135A	
113705	672	BRCA1	0028	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	BRCA1, 2-BP DEL, 3888GA	
113705	672	BRCA1	0029	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	BRCA1, 10-BP INS, NT943	
113705	672	BRCA1	0030	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	BRCA1, 1-BP DEL, 4153A	
113705	672	BRCA1	0031	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	BRCA1, 16-KB INS, EX13	
113705	672	BRCA1	0032	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	BRCA1, 1-BP DEL, 3744T	
113705	672	BRCA1	0033	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	BRCA1, 5-BP INS, NT3171	
113705	672	BRCA1	0034	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	BRCA1, ARG71GLY	80357382
113705	672	BRCA1	0035	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	BRCA1, MET1775ARG	41293463
113705	672	BRCA1	0036	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	BRCA1, MET1775LYS	
113705	672	BRCA1	0037	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	BRCA1, ARG1669GLU	
113730	7350	UCP1	0001	UCP1 POLYMORPHISM	UCP1, -3826A-G	
113810	667	DST	0001	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI	DST, 1-BP DEL, 14,865A	
113811	1308	COL17A1	0001	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE EPIDERMOLYSIS BULLOSA, JUNCTIONAL, LOCALISATA VARIANT, INCLUDED	COL17A1, ARG1226TER	121912769
113811	1308	COL17A1	0002	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE	COL17A1, 1-BP INS, 4150G	
113811	1308	COL17A1	0003	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE	COL17A1, 5-BP DEL, NT2944	
113811	1308	COL17A1	0004	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE	COL17A1, GLN1023TER	121912770
113811	1308	COL17A1	0005	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE	COL17A1, 1-BP DEL, 1706A	
113811	1308	COL17A1	0006	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, LOCALISATA VARIANT	COL17A1, ARG1303GLN	121912771
113811	1308	COL17A1	0007	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE	COL17A1, IVS31AS, A-G, -2	
113811	1308	COL17A1	0008	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE	COL17A1, IVS31AS, G-T, -1	
113811	1308	COL17A1	0009	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE	COL17A1, 2-BP DEL, 4003TC	
113811	1308	COL17A1	0010	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE	COL17A1, 2-BP DEL, 520AG	
113811	1308	COL17A1	0011	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE	COL17A1, 1-BP DEL, 2965G	
113811	1308	COL17A1	0012	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE	COL17A1, LEU855TER	121912772
113811	1308	COL17A1	0013	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE	COL17A1, GLY633ASP	121912773
113811	1308	COL17A1	0014	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE	COL17A1, ARG145TER	121912774
114019	1013	CDH15	0001	MENTAL RETARDATION, AUTOSOMAL DOMINANT 3	CDH15, ARG60CYS	121434539
114019	1013	CDH15	0002	MENTAL RETARDATION, AUTOSOMAL DOMINANT 3	CDH15, ARG92TRP	121434540
114019	1013	CDH15	0003	MENTAL RETARDATION, AUTOSOMAL DOMINANT 3	CDH15, ALA122VAL	121434541
114021	1001	CDH3	0001	HYPOTRICHOSIS, CONGENITAL, WITH JUVENILE MACULAR DYSTROPHY	CDH3, 1-BP DEL, 981G	
114021	1001	CDH3	0002	HYPOTRICHOSIS, CONGENITAL, WITH JUVENILE MACULAR DYSTROPHY	CDH3, ARG503HIS	121434542
114021	1001	CDH3	0003	ECTODERMAL DYSPLASIA, ECTRODACTYLY, AND MACULAR DYSTROPHY	CDH3, ASN322ILE	121434543
114021	1001	CDH3	0004	ECTODERMAL DYSPLASIA, ECTRODACTYLY, AND MACULAR DYSTROPHY	CDH3, 1-BP DEL, 829G	
114130	796	CALCA	0001	RECLASSIFIED - CALCITONIN POLYMORPHISM	CALCA, 1-BP INS, IVS4	
114131	799	CALCR	0001	OSTEOPOROSIS, SUSCEPTIBILITY TO	CALCR, PRO463LEU	1801197
114180	801	CALM1	0001	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 4	CALM1, ASN53ILE	
114180	801	CALM1	0002	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 4	CALM1, ASN97SER	
114205	775	CACNA1C	0001	TIMOTHY SYNDROME	CACNA1C, GLY406ARG	79891110
114205	775	CACNA1C	0002	TIMOTHY SYNDROME	CACNA1C, GLY402SER	80315385
114205	775	CACNA1C	0003	BRUGADA SYNDROME 3	CACNA1C, GLY490ARG	121912775
114205	775	CACNA1C	0004	BRUGADA SYNDROME 3	CACNA1C, ALA39VAL	121912776
114206	776	CACNA1D	0001	SINOATRIAL NODE DYSFUNCTION AND DEAFNESS	CACNA1D, 3-BP INS, 1208GGG	
114208	779	CACNA1S	0001	HYPOKALEMIC PERIODIC PARALYSIS, TYPE 1	CACNA1S, ARG1239HIS	28930068
114208	779	CACNA1S	0002	HYPOKALEMIC PERIODIC PARALYSIS, TYPE 1	CACNA1S, ARG1239GLY	28930069
114208	779	CACNA1S	0003	HYPOKALEMIC PERIODIC PARALYSIS, TYPE 1	CACNA1S, ARG528HIS	80338777
114208	779	CACNA1S	0004	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5	CACNA1S, ARG1086HIS	1800559
114208	779	CACNA1S	0005	THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 1	CACNA1S, -476G-A	2281845
114208	779	CACNA1S	0006	THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 1	CACNA1S, IVS2, G-A	1325310
114208	779	CACNA1S	0007	THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 1	CACNA1S, IVS26, A-G	3831308
114208	779	CACNA1S	0008	HYPOKALEMIC PERIODIC PARALYSIS, TYPE 1	CACNA1S, ARG897SER	80338779
114208	779	CACNA1S	0009	HYPOKALEMIC PERIODIC PARALYSIS, TYPE 1	CACNA1S, VAL876GLU	
114240	825	CAPN3	0001	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A, AMISH	CAPN3, ARG769GLN	80338802
114240	825	CAPN3	0002	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A	CAPN3, ARG572GLN	121434544
114240	825	CAPN3	0003	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A	CAPN3, ARG110TER	121434545
114240	825	CAPN3	0004	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A	CAPN3, SER86PHE	121434546
114240	825	CAPN3	0005	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A	CAPN3, PRO319LEU	121434547
114240	825	CAPN3	0006	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A MYOSITIS, EOSINOPHILIC, INCLUDED	CAPN3, 2362AG-TCATCT	80338804
114240	825	CAPN3	0007	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A	CAPN3, 1080G-C, TRP360ARG	
114240	825	CAPN3	0008	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A	CAPN3, 1-BP INS, 1796A	80338803
114240	825	CAPN3	0009	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A	CAPN3, 1-BP DEL, 550A	80338800
114240	825	CAPN3	0010	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A	CAPN3, ARG490GLN	121434548
114251	845	CASQ2	0001	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2	CASQ2, ASP307HIS	121434549
114251	845	CASQ2	0002	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2	CASQ2, 16-BP DEL, NT339	
114251	845	CASQ2	0003	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2	CASQ2, LEU167HIS	121434550
114760	762	CA4	0001	RETINITIS PIGMENTOSA 17	CA4, ARG14TRP	104894559
114760	762	CA4	0002	RETINITIS PIGMENTOSA 17	CA4, ARG219SER	121434551
114760	762	CA4	0003	RETINITIS PIGMENTOSA 17	CA4, ARG69HIS	121434552
114800	759	CA1	0001	CARBONIC ANHYDRASE I, GUAM	CA1, GLY253ARG	121909577
114800	759	CA1	0002	CARBONIC ANHYDRASE I DEFICIENCY	CA1, ARG246HIS	121909578
114815	767	CA8	0001	CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDAL LOCOMOTION 3	CA8, SER100PRO	
114815	767	CA8	0002	CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDAL LOCOMOTION 3	CA8, ARG237GLN	
114835	1066	CES1	0001	CARBOXYLESTERASE 1 DEFICIENCY	CES1, GLY143GLU	71647871
114835	1066	CES1	0002	CARBOXYLESTERASE 1 DEFICIENCY	CES1, 1-BP DEL, 780T	
114840	1056	CEL	0001	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION	CEL, 1-BP DEL, 1686T	
114840	1056	CEL	0002	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION	CEL, 1-BP DEL, 1785C	
115500	847	CAT	0001	ACATALASEMIA, JAPANESE TYPE	CAT, IVS4, G-A, +5	
115500	847	CAT	0002	ACATALASEMIA, JAPANESE TYPE	CAT, 1-BP DEL, 358T	
115500	847	CAT	0003	ACATALASEMIA, HUNGARIAN TYPE	CAT, 2-BP INS, 138GA	
115501	7306	TYRP1	0001	ALBINISM, OCULOCUTANEOUS, TYPE III	TYRP1, 1-BP DEL, 368A	
115501	7306	TYRP1	0002	ALBINISM, OCULOCUTANEOUS, TYPE III ALBINISM, OCULOCUTANEOUS, TYPE II, MODIFIER OF, INCLUDED	TYRP1, SER166TER	104894130
115501	7306	TYRP1	0003	ALBINISM, OCULOCUTANEOUS, TYPE III	TYRP1, ARG373TER	121912778
115501	7306	TYRP1	0004	ALBINISM, OCULOCUTANEOUS, TYPE III	TYRP1, ARG356GLU	
115501	7306	TYRP1	0005	ALBINISM, OCULOCUTANEOUS, TYPE III	TYRP1, 1-BP DEL, 106T	
115501	7306	TYRP1	0006	ALBINISM, OCULOCUTANEOUS, TYPE III	TYRP1, 4-BP DEL, 1057AACA	
115501	7306	TYRP1	0007	MELANESIAN BLOND HAIR	TYRP1, ARG93CYS	
116790	1312	COMT	0001	CATECHOL-O-METHYLTRANSFERASE POLYMORPHISM	COMT, VAL158MET	4680
116790	1312	COMT	0002	SCHIZOPHRENIA, SUSCEPTIBILITY TO	COMT, ALA72SER	6267
116806	1499	CTNNB1	0001	COLORECTAL CANCER, SOMATIC	CTNNB1, 3-BP DEL, SER45DEL	
116806	1499	CTNNB1	0002	COLORECTAL CANCER, SOMATIC PILOMATRICOMA, SOMATIC, INCLUDED	CTNNB1, SER33TYR	121913400
116806	1499	CTNNB1	0003	HEPATOBLASTOMA, SOMATIC DESMOID TUMOR, SOMATIC, INCLUDED	CTNNB1, THR41ALA	121913412
116806	1499	CTNNB1	0004	HEPATOBLASTOMA, SOMATIC PILOMATRICOMA, SOMATIC, INCLUDED	CTNNB1, ASP32TYR	28931588
116806	1499	CTNNB1	0005	HEPATOBLASTOMA, SOMATIC	CTNNB1, GLY34VAL	
116806	1499	CTNNB1	0006	PILOMATRICOMA, SOMATIC	CTNNB1, ASP32GLY	121913396
116806	1499	CTNNB1	0007	PILOMATRICOMA, SOMATIC MEDULLOBLASTOMA, SOMATIC, INCLUDED	CTNNB1, SER33PHE	121913400
116806	1499	CTNNB1	0008	PILOMATRICOMA, SOMATIC	CTNNB1, GLY34GLU	28931589
116806	1499	CTNNB1	0009	PILOMATRICOMA, SOMATIC	CTNNB1, SER37CYS	121913403
116806	1499	CTNNB1	0010	PILOMATRICOMA, SOMATIC	CTNNB1, SER37PHE	121913403
116806	1499	CTNNB1	0011	PILOMATRICOMA, SOMATIC	CTNNB1, THR41ILE	121913413
116806	1499	CTNNB1	0012	OVARIAN CANCER, SOMATIC	CTNNB1, SER37CYS	121913403
116806	1499	CTNNB1	0013	HEPATOCELLULAR CARCINOMA, SOMATIC	CTNNB1, SER45PHE	121913409
116806	1499	CTNNB1	0014	HEPATOCELLULAR CARCINOMA, SOMATIC	CTNNB1, SER45PRO	121913407
116806	1499	CTNNB1	0016	PILOMATRICOMA, SOMATIC	CTNNB1, ASP32TYR	28931588
116806	1499	CTNNB1	0017	MENTAL RETARDATION, AUTOSOMAL DOMINANT 19	CTNNB1, 4-BP DEL, NT1272	
116806	1499	CTNNB1	0018	MENTAL RETARDATION, AUTOSOMAL DOMINANT 19	CTNNB1, ARG515TER	
116806	1499	CTNNB1	0019	MENTAL RETARDATION, AUTOSOMAL DOMINANT 19	CTNNB1, GLN309TER	
116840	1509	CTSD	0001	CEROID LIPOFUSCINOSIS, NEURONAL, 10	CTSD, PHE229ILE	121912789
116840	1509	CTSD	0002	CEROID LIPOFUSCINOSIS, NEURONAL, 10	CTSD, TRP383CYS	121912790
116840	1509	CTSD	0003	CEROID LIPOFUSCINOSIS, NEURONAL, 10	CTSD, 1-BP DUP, 764A	
116897	1050	CEBPA	0001	LEUKEMIA, ACUTE MYELOID, SOMATIC	CEBPA, 7-BP DEL, NT263	
116897	1050	CEBPA	0002	LEUKEMIA, ACUTE MYELOID, SOMATIC	CEBPA, GLU50TER	121912791
116897	1050	CEBPA	0003	LEUKEMIA, ACUTE MYELOID, SOMATIC	CEBPA, HIS84LEU	28931590
116897	1050	CEBPA	0004	LEUKEMIA, ACUTE MYELOID, SOMATIC	CEBPA, 57-BP INS, NT1137	
116897	1050	CEBPA	0005	LEUKEMIA, ACUTE MYELOID, SOMATIC	CEBPA, 27-BP INS, NT1096	
116897	1050	CEBPA	0006	LEUKEMIA, ACUTE MYELOID, SOMATIC	CEBPA, 4-BP INS, 363GGCC	
116897	1050	CEBPA	0007	LEUKEMIA, ACUTE MYELOID LEUKEMIA, ACUTE MYELOID, SOMATIC	CEBPA, 1-BP DEL, 212C	
116899	1026	CDKN1A	0001	CIP1/WAF1 TUMOR-ASSOCIATED POLYMORPHISM 1	CDKN1A, SER31ARG	1801270
116955	7555	CNBP	0001	MYOTONIC DYSTROPHY 2	ZNF9, CCTG(n) EXPANSION	193922904
117700	1356	CP	0001	ACERULOPLASMINEMIA HEMOSIDEROSIS, SYSTEMIC, DUE TO ACERULOPLASMINEMIA, INCLUDED	CP, IVSAS, G-A, -1	
117700	1356	CP	0002	ACERULOPLASMINEMIA HEMOSIDEROSIS, SYSTEMIC, DUE TO ACERULOPLASMINEMIA, INCLUDED	CP, 5-BP INS	
117700	1356	CP	0003	ACERULOPLASMINEMIA HYPOCERULOPLASMINEMIA, INCLUDED	CP, TRP858TER	121909579
117700	1356	CP	0004	ACERULOPLASMINEMIA CERULOPLASMIN BELFAST	CP, 1-BP DEL, 2389G	
117700	1356	CP	0005	ACERULOPLASMINEMIA HEMOSIDEROSIS, SYSTEMIC, DUE TO ACERULOPLASMINEMIA, INCLUDED	CP, 1-BP INS, 184A	
118190	3329	HSPD1	0001	SPASTIC PARAPLEGIA 13	HSPD1, VAL72ILE	66468541
118190	3329	HSPD1	0002	LEUKODYSTROPHY, HYPOMYELINATING, 4	HSPD1, ASP29GLY	72466451
118423	1123	CHN1	0001	DUANE RETRACTION SYNDROME 2	CHN1, LEU20PHE	121912792
118423	1123	CHN1	0002	DUANE RETRACTION SYNDROME 2	CHN1, ILE126MET	121912793
118423	1123	CHN1	0003	DUANE RETRACTION SYNDROME 2	CHN1, TYR143HIS	121912794
118423	1123	CHN1	0004	DUANE RETRACTION SYNDROME 2	CHN1, ALA223VAL	121912795
118423	1123	CHN1	0005	DUANE RETRACTION SYNDROME 2	CHN1, GLY228SER	121912796
118423	1123	CHN1	0006	DUANE RETRACTION SYNDROME 2	CHN1, PRO252GLN	121912797
118423	1123	CHN1	0007	DUANE RETRACTION SYNDROME 2	CHN1, GLU313LYS	121912798
118423	1123	CHN1	0008	DUANE RETRACTION SYNDROME 2	CHN1, PRO141LEU	
118423	1123	CHN1	0009	DUANE RETRACTION SYNDROME 2	CHN1, PRO252SER	
118425	1180	CLCN1	0001	MYOTONIA CONGENITA, AUTOSOMAL RECESSIVE	CLCN1, PHE413CYS	121912799
118425	1180	CLCN1	0002	MYOTONIA CONGENITA, AUTOSOMAL DOMINANT	CLCN1, GLY230GLU	80356700
118425	1180	CLCN1	0003	MYOTONIA CONGENITA, AUTOSOMAL RECESSIVE	CLCN1, IVSDS, G-A, +1	
118425	1180	CLCN1	0004	MYOTONIA CONGENITA, AUTOSOMAL RECESSIVE	CLCN1, ARG496SER	121912801
118425	1180	CLCN1	0005	MYOTONIA CONGENITA, AUTOSOMAL RECESSIVE	CLCN1, GLY482ARG	
118425	1180	CLCN1	0006	MYOTONIA CONGENITA, AUTOSOMAL DOMINANT	CLCN1, PRO480LEU	80356694
118425	1180	CLCN1	0007	MYOTONIA LEVIOR	CLCN1, GLN552ARG	80356696
118425	1180	CLCN1	0008	MYOTONIA CONGENITA, AUTOSOMAL DOMINANT	CLCN1, ILE290MET	80356690
118425	1180	CLCN1	0009	MYOTONIA CONGENITA, AUTOSOMAL RECESSIVE	CLCN1, 14-BP DEL	
118425	1180	CLCN1	0010	MYOTONIA CONGENITA, AUTOSOMAL RECESSIVE	CLCN1, GLU291LYS	121912805
118425	1180	CLCN1	0011	MYOTONIA CONGENITA, AUTOSOMAL RECESSIVE MYOTONIA CONGENITA, AUTOSOMAL DOMINANT, INCLUDED	CLCN1, ARG317GLN	80356702
118425	1180	CLCN1	0012	MYOTONIA CONGENITA, AUTOSOMAL RECESSIVE	CLCN1, GLY499ARG	121912807
118425	1180	CLCN1	0013	MYOTONIA CONGENITA, AUTOSOMAL RECESSIVE	CLCN1, 1-BP INS, 831G	
118425	1180	CLCN1	0014	MYOTONIA CONGENITA, AUTOSOMAL RECESSIVE	CLCN1, PRO932LEU	80356706
118425	1180	CLCN1	0015	MYOTONIA CONGENITA, AUTOSOMAL RECESSIVE MYOTONIA CONGENITA, AUTOSOMAL DOMINANT, INCLUDED	CLCN1, ARG894TER	55960271
118425	1180	CLCN1	0016	MYOTONIA CONGENITA, AUTOSOMAL DOMINANT	CLCN1, MET128VAL	80356699
118425	1180	CLCN1	0017	MYOTONIA CONGENITA, AUTOSOMAL RECESSIVE	CLCN1, ARG300TER	
118425	1180	CLCN1	0018	MYOTONIA CONGENITA, AUTOSOMAL DOMINANT	CLCN1, SER189PHE	121912810
118425	1180	CLCN1	0019	MYOTONIA CONGENITA, AUTOSOMAL DOMINANT MYOTONIA CONGENITA, AUTOSOMAL RECESSIVE, INCLUDED	CLCN1, TRP433ARG	
118425	1180	CLCN1	0020	MYOTONIA CONGENITA, AUTOSOMAL RECESSIVE	CLCN1, DUP, EX8-14	
118444	886	CCKAR	0001	CHOLECYSTOKININ A RECEPTOR POLYMORPHISM	CCKAR, GLY21ARG	104893833
118444	886	CCKAR	0002	CHOLECYSTOKININ A RECEPTOR POLYMORPHISM	CCKAR, VAL365ILE	52795588
118470	1071	CETP	0001	HYPERALPHALIPOPROTEINEMIA 1	CETP, IVS14DS, G-A, +1	
118470	1071	CETP	0002	HYPERALPHALIPOPROTEINEMIA 1	CETP, ASP442GLY	2303790
118470	1071	CETP	0003	HYPERALPHALIPOPROTEINEMIA 1	CETP, 1-BP INS, T, IVS14, +3	
118470	1071	CETP	0004	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 10	CETP, ILE405VAL	5882
118470	1071	CETP	0005	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 10	CETP, C-T	183130
118485	1583	CYP11A1	0001	ADRENAL INSUFFICIENCY, CONGENITAL, WITH 46,XY SEX REVERSAL, PARTIAL OR COMPLETE	CYP11A1, 6-BP INS	
118485	1583	CYP11A1	0002	ADRENAL INSUFFICIENCY, CONGENITAL, WITH 46,XY SEX REVERSAL, PARTIAL OR COMPLETE	CYP11A1, ARG353TRP	72547508
118485	1583	CYP11A1	0003	ADRENAL INSUFFICIENCY, CONGENITAL, WITH 46,XY SEX REVERSAL, PARTIAL OR COMPLETE	CYP11A1, ALA189VAL	121912811
118485	1583	CYP11A1	0004	ADRENAL INSUFFICIENCY, CONGENITAL, WITH 46,XY SEX REVERSAL, PARTIAL OR COMPLETE	CYP11A1, 1-BP DEL, 835A	
118485	1583	CYP11A1	0005	ADRENAL INSUFFICIENCY, CONGENITAL, WITH 46,XY SEX REVERSAL, PARTIAL OR COMPLETE	CYP11A1, ALA359VAL	121912812
118485	1583	CYP11A1	0006	ADRENAL INSUFFICIENCY, CONGENITAL, WITH 46,XY SEX REVERSAL, PARTIAL OR COMPLETE	CYP11A1, 1-BP INS, IVS3, T	
118485	1583	CYP11A1	0007	ADRENAL INSUFFICIENCY, CONGENITAL, WITH 46,XY SEX REVERSAL, PARTIAL OR COMPLETE	CYP11A1, LEU141TRP	121912813
118485	1583	CYP11A1	0008	ADRENAL INSUFFICIENCY, CONGENITAL, WITH 46,XY SEX REVERSAL, PARTIAL OR COMPLETE	CYP11A1, VAL415GLU	121912814
118485	1583	CYP11A1	0009	ADRENAL INSUFFICIENCY, CONGENITAL, WITH 46,XY SEX REVERSAL, PARTIAL OR COMPLETE	CYP11A1, LEU222PRO	
118490	1103	CHAT	0001	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH EPISODIC APNEA	CHAT, 2-BP INS, 523CC	
118490	1103	CHAT	0002	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH EPISODIC APNEA	CHAT, PRO211ALA	121912815
118490	1103	CHAT	0003	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH EPISODIC APNEA	CHAT, GLU441LYS	121912816
118490	1103	CHAT	0004	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH EPISODIC APNEA	CHAT, VAL506LEU	121912817
118490	1103	CHAT	0005	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH EPISODIC APNEA	CHAT, ARG482GLY	121912818
118490	1103	CHAT	0006	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH EPISODIC APNEA	CHAT, ARG560HIS	121912819
118490	1103	CHAT	0007	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH EPISODIC APNEA	CHAT, LEU210PRO	121912820
118490	1103	CHAT	0008	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH EPISODIC APNEA	CHAT, SER498LEU	121912821
118490	1103	CHAT	0009	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH EPISODIC APNEA	CHAT, ILE305THR	75466054
118490	1103	CHAT	0010	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH EPISODIC APNEA	CHAT, ARG420CYS	121912822
118490	1103	CHAT	0011	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH EPISODIC APNEA	CHAT, ILE1336THR	121912823
118494	1131	CHRM3	0001	ABDOMINAL MUSCLES, ABSENCE OF, WITH URINARY TRACT ABNORMALITY AND CRYPTORCHIDISM	CHRM3, 12-BP DEL/1-BP INS, NT1173	
118502	1135	CHRNA2	0001	EPILEPSY, NOCTURNAL FRONTAL LOBE, 4	CHRNA2, ILE279ASN	104894063
118503	1136	CHRNA3	0001	LUNG CANCER SUSCEPTIBILITY 2 NICOTINE DEPENDENCE, SUSCEPTIBILITY TO, INCLUDED	CHRNA3, 831C-T	1051730
118504	1137	CHRNA4	0002	EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	CHRNA4, SER252PHE	121909580
118504	1137	CHRNA4	0003	EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	CHRNA4, 3-BP INS, 776GCT	
118504	1137	CHRNA4	0004	EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	CHRNA4, SER252LEU	28931591
118504	1137	CHRNA4	0005	NICOTINE ADDICTION, PROTECTION AGAINST	CHRNA4, EX5, C-T	1044396
118504	1137	CHRNA4	0006	NICOTINE ADDICTION, PROTECTION AGAINST	CHRNA4, EX5, G-A	1044397
118505	1138	CHRNA5	0001	LUNG CANCER SUSCEPTIBILITY 2 NICOTINE DEPENDENCE, SUSCEPTIBILITY TO, INCLUDED	CHRNA5, ASP398ASN, dbSNP rs16969968	16969968
118507	1141	CHRNB2	0001	EPILEPSY, NOCTURNAL FRONTAL LOBE, 3	CHRNB2, VAL287LEU	74315291
118507	1141	CHRNB2	0002	EPILEPSY, NOCTURNAL FRONTAL LOBE, 3	CHRNB2, VAL287MET	74315291
118661	1462	VCAN	0001	WAGNER VITREORETINOPATHY	VCAN, IVS7AS, A-G, -2	80356555
118661	1462	VCAN	0002	WAGNER VITREORETINOPATHY	VCAN, IVS8DS, G-A, +1	
118661	1462	VCAN	0003	WAGNER VITREORETINOPATHY	VCAN, IVS7AS, T-C, -5	
118661	1462	VCAN	0004	WAGNER VITREORETINOPATHY	VCAN, IVS7AS, T-A, -5	
118661	1462	VCAN	0005	WAGNER VITREORETINOPATHY	VCAN, IVS7AS, G-A, -1	
118661	1462	VCAN	0006	WAGNER VITREORETINOPATHY	VCAN, IVS7AS, A-T, -2	
118661	1462	VCAN	0007	WAGNER VITREORETINOPATHY	VCAN, IVS7, T-A, +2	
118661	1462	VCAN	0008	WAGNER VITREORETINOPATHY	VCAN, IVS7, G-C, -1	
118945	1270	CNTF	0001	CILIARY NEUROTROPHIC FACTOR POLYMORPHISM	CNTF, IVS1AS, G-A, -6	
120070	1285	COL4A3	0001	ALPORT SYNDROME, AUTOSOMAL RECESSIVE	COL4A3, 5-BP DEL, NT4414	
120070	1285	COL4A3	0002	ALPORT SYNDROME, AUTOSOMAL RECESSIVE	COL4A3, ARG1481TER	121912824
120070	1285	COL4A3	0003	ALPORT SYNDROME, AUTOSOMAL RECESSIVE	COL4A3, SER1524TER	121912825
120070	1285	COL4A3	0004	ALPORT SYNDROME, AUTOSOMAL RECESSIVE	COL4A3, 5-BP DEL	
120070	1285	COL4A3	0005	ALPORT SYNDROME, AUTOSOMAL RECESSIVE	COL4A3, EX5, C-T, ARG-TER	
120070	1285	COL4A3	0006	ALPORT SYNDROME, AUTOSOMAL RECESSIVE	COL4A3, ALU INS, EX6	
120070	1285	COL4A3	0007	HEMATURIA, BENIGN FAMILIAL	COL4A3, GLY1015GLU	121912826
120070	1285	COL4A3	0008	HEMATURIA, BENIGN FAMILIAL	COL4A3, GLY985VAL	121912827
120070	1285	COL4A3	0009	ALPORT SYNDROME, AUTOSOMAL DOMINANT	COL4A3, IVS21DS, G-A, -1	
120070	1285	COL4A3	0010	ALPORT SYNDROME, AUTOSOMAL DOMINANT	COL4A3, GLY1167ARG	
120090	1284	COL4A2	0001	PORENCEPHALY 2	COL4A2, GLY1152ASP	
120090	1284	COL4A2	0002	PORENCEPHALY 2	COL4A2, GLY1037GLU	
120090	1284	COL4A2	0003	HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO	COL4A2, GLU1123GLY	
120090	1284	COL4A2	0004	HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO	COL4A2, GLN1150LYS	
120090	1284	COL4A2	0005	HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO	COL4A2, ALA1690THR	
120110	1300	COL10A1	0001	METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	COL10A1, 13-BP DEL, NT1856	
120110	1300	COL10A1	0002	METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	COL10A1, TYR598ASP	111033544
120110	1300	COL10A1	0003	METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	COL10A1, LEU614PRO	111033545
120110	1300	COL10A1	0004	METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	COL10A1, CYS591ARG	111033546
120110	1300	COL10A1	0005	METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	COL10A1, 1-BP DEL, 1856C	
120110	1300	COL10A1	0006	METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	COL10A1, 2-BP DEL, FS665TER	
120110	1300	COL10A1	0007	METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	COL10A1, 10-BP DEL, NT1867	
120110	1300	COL10A1	0008	METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	COL10A1, 2-BP DEL, NT1856	
120110	1300	COL10A1	0009	METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	COL10A1, TYR628TER	111033543
120110	1300	COL10A1	0010	METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	COL10A1, TRP651TER	111033547
120110	1300	COL10A1	0011	METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	COL10A1, TRP651ARG	111033549
120110	1300	COL10A1	0012	METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	COL10A1, GLY18ARG	111033550
120110	1300	COL10A1	0013	METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	COL10A1, GLY18GLU	111033551
120110	1300	COL10A1	0014	METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	COL10A1, SER671PRO	111033552
120110	1300	COL10A1	0015	METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	COL10A1, TYR632TER	111033548
120110	1300	COL10A1	0016	METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	COL10A1, GLY595GLU	111033553
120110	1300	COL10A1	0017	METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	COL10A1, TYR597CYS	111033554
120110	1300	COL10A1	0018	METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	COL10A1, SER600PRO	111033555
120110	1300	COL10A1	0019	METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	COL10A1, TRP611TER	111033556
120110	1300	COL10A1	0020	METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	COL10A1, TYR663TER	
120120	1294	COL7A1	0001	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE	COL7A1, MET2798LYS	121912828
120120	1294	COL7A1	0002	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL DOMINANT	COL7A1, GLY2040SER	121912829
120120	1294	COL7A1	0003	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE	COL7A1, 1-BP INS, 2470G	
120120	1294	COL7A1	0004	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE	COL7A1, 1-BP DEL, 3858G	
120120	1294	COL7A1	0005	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE	COL7A1, TYR311TER	121912830
120120	1294	COL7A1	0006	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE	COL7A1, 1-BP DEL, 5818C	
120120	1294	COL7A1	0007	EPIDERMOLYSIS BULLOSA, PRETIBIAL	COL7A1, GLY2623CYS	121912831
120120	1294	COL7A1	0008	EPIDERMOLYSIS BULLOSA DYSTROPHICA, BART TYPE	COL7A1, GLY2003ARG	121912832
120120	1294	COL7A1	0009	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE, LOCALISATA VARIANT EPIDERMOLYSIS BULLOSA PRURIGINOSA, AUTOSOMAL RECESSIVE, INCLUDED	COL7A1, IVS3DS, A-G, -2	
120120	1294	COL7A1	0010	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE, LOCALISATA VARIANT EPIDERMOLYSIS BULLOSA PRURIGINOSA, AUTOSOMAL RECESSIVE, INCLUDED	COL7A1, IVS95DS, G-A, -1	
120120	1294	COL7A1	0011	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE, LOCALISATA VARIANT	COL7A1, GLY1347ARG	121912833
120120	1294	COL7A1	0012	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE, LOCALISATA VARIANT	COL7A1, IVS70DS, G-A, -1	
120120	1294	COL7A1	0013	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE	COL7A1, IVS35DS, G-T, +1	
120120	1294	COL7A1	0014	TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN NAIL DISORDER, NONSYNDROMIC CONGENITAL, 8, INCLUDED;; EPIDERMOLYSIS BULLOSA PRURIGINOSA, AUTOSOMAL DOMINANT, INCLUDED	COL7A1, GLY2251GLU	121912834
120120	1294	COL7A1	0015	TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	COL7A1, GLY1519ASP	121912835
120120	1294	COL7A1	0016	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL DOMINANT	COL7A1, GLY2043ARG	121912836
120120	1294	COL7A1	0017	EPIDERMOLYSIS BULLOSA PRURIGINOSA, AUTOSOMAL DOMINANT	COL7A1, GLY2242ARG	121912837
120120	1294	COL7A1	0018	EPIDERMOLYSIS BULLOSA PRURIGINOSA, AUTOSOMAL RECESSIVE	COL7A1, IVS64DS, G-A, +1	
120120	1294	COL7A1	0019	EPIDERMOLYSIS BULLOSA PRURIGINOSA, AUTOSOMAL RECESSIVE	COL7A1, 1-BP DEL, 7786G	
120120	1294	COL7A1	0020	EPIDERMOLYSIS BULLOSA PRURIGINOSA, AUTOSOMAL DOMINANT	COL7A1, 16-BP DEL, NT6863	
120120	1294	COL7A1	0021	EPIDERMOLYSIS BULLOSA, PRETIBIAL, AUTOSOMAL RECESSIVE EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE, INCLUDED	COL7A1, 14-BP DEL, NT33563	
120120	1294	COL7A1	0022	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE	COL7A1, GLY2031SER	121912838
120120	1294	COL7A1	0023	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE NAIL DISORDER, NONSYNDROMIC CONGENITAL, 8, INCLUDED	COL7A1, GLY2287ARG	121912839
120120	1294	COL7A1	0024	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE NAIL DISORDER, NONSYNDROMIC CONGENITAL, 8, INCLUDED	COL7A1, GLY1595ARG	121912840
120120	1294	COL7A1	0025	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE NAIL DISORDER, NONSYNDROMIC CONGENITAL, 8, INCLUDED	COL7A1, GLY1815ARG	121912841
120120	1294	COL7A1	0026	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL DOMINANT	COL7A1, GLY2006ASP	121912842
120120	1294	COL7A1	0027	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL DOMINANT	COL7A1, GLY2015GLU	121912843
120120	1294	COL7A1	0028	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL DOMINANT	COL7A1, GLY2034ARG	121912844
120120	1294	COL7A1	0029	EPIDERMOLYSIS BULLOSA, PRETIBIAL, AUTOSOMAL RECESSIVE	COL7A1, PRO1699LEU	121912845
120120	1294	COL7A1	0030	EPIDERMOLYSIS BULLOSA, PRETIBIAL, AUTOSOMAL RECESSIVE	COL7A1, IVS2AS, G-C, -1	
120120	1294	COL7A1	0031	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL DOMINANT	COL7A1, GLY2037GLU	121912846
120120	1294	COL7A1	0032	EPIDERMOLYSIS BULLOSA PRURIGINOSA, AUTOSOMAL RECESSIVE	COL7A1, ARG1630TER	121912847
120120	1294	COL7A1	0033	EPIDERMOLYSIS BULLOSA PRURIGINOSA, AUTOSOMAL DOMINANT	COL7A1, GLY2073VAL	121912848
120120	1294	COL7A1	0034	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE	COL7A1, ARG2063TRP	121912849
120120	1294	COL7A1	0035	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL DOMINANT	COL7A1, GLY2076ASP	121912850
120120	1294	COL7A1	0036	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE	COL7A1, GLY2653ARG	121912851
120120	1294	COL7A1	0037	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE	COL7A1, ARG2471TER	121912852
120120	1294	COL7A1	0038	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE	COL7A1, GLY2749ARG	121912853
120120	1294	COL7A1	0039	TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	COL7A1, IVS35AS, G-C, -1	
120120	1294	COL7A1	0040	EPIDERMOLYSIS BULLOSA DYSTROPHICA INVERSA, AUTOSOMAL RECESSIVE EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE, INCLUDED	COL7A1, ARG109TER	121912854
120120	1294	COL7A1	0041	EPIDERMOLYSIS BULLOSA DYSTROPHICA INVERSA, AUTOSOMAL RECESSIVE	COL7A1, ARG2069CYS	121912856
120120	1294	COL7A1	0042	EPIDERMOLYSIS BULLOSA DYSTROPHICA INVERSA, AUTOSOMAL RECESSIVE	COL7A1, GLY2316ARG	
120120	1294	COL7A1	0043	EPIDERMOLYSIS BULLOSA DYSTROPHICA INVERSA, AUTOSOMAL RECESSIVE	COL7A1, GLN2827TER	
120120	1294	COL7A1	0044	TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	COL7A1, GLY1522GLU	
120120	1294	COL7A1	0045	EPIDERMOLYSIS BULLOSA DYSTROPHICA INVERSA, AUTOSOMAL RECESSIVE	COL7A1, LYS142ARG	
120130	1282	COL4A1	0001	PORENCEPHALY 1	COL4A1, GLY1236ARG	113994112
120130	1282	COL4A1	0002	PORENCEPHALY 1	COL4A1, GLY749SER	113994109
120130	1282	COL4A1	0003	BRAIN SMALL VESSEL DISEASE WITH HEMORRHAGE	COL4A1, GLY562GLU	113994107
120130	1282	COL4A1	0004	PORENCEPHALY 1	COL4A1, MET1LEU	113994103
120130	1282	COL4A1	0005	PORENCEPHALY 1	COL4A1, GLY1130ASP	113994111
120130	1282	COL4A1	0006	PORENCEPHALY 1	COL4A1, GLY1423ARG	113994113
120130	1282	COL4A1	0007	ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS	COL4A1, GLY498VAL	113994104
120130	1282	COL4A1	0008	ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS	COL4A1, GLY519ARG	113994105
120130	1282	COL4A1	0009	ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS	COL4A1, GLY528GLU	113994106
120130	1282	COL4A1	0010	BRAIN SMALL VESSEL DISEASE WITH AXENFELD-RIEGER ANOMALY	COL4A1, GLY720ASP	113994108
120130	1282	COL4A1	0011	PORENCEPHALY 1	COL4A1, GLY1580ARG	113994114
120130	1282	COL4A1	0012	ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS	COL4A1, GLY498ARG	
120130	1282	COL4A1	0013	ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS	COL4A1, GLY510ARG	
120130	1282	COL4A1	0014	ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS	COL4A1, GLY525LEU	
120130	1282	COL4A1	0015	HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO	COL4A1, PRO352LEU	
120130	1282	COL4A1	0016	HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO	COL4A1, ARG538GLY	
120131	1286	COL4A4	0001	ALPORT SYNDROME, AUTOSOMAL RECESSIVE	COL4A4, GLY1201SER	121912858
120131	1286	COL4A4	0002	ALPORT SYNDROME, AUTOSOMAL RECESSIVE	COL4A4, SER1238TER	121912859
120131	1286	COL4A4	0003	HEMATURIA, BENIGN FAMILIAL	COL4A4, GLY897GLU	121912860
120131	1286	COL4A4	0004	ALPORT SYNDROME, AUTOSOMAL RECESSIVE	COL4A4, ARG1377TER	121912861
120131	1286	COL4A4	0005	ALPORT SYNDROME, AUTOSOMAL RECESSIVE	COL4A4, CYS1641TER	121912862
120131	1286	COL4A4	0006	ALPORT SYNDROME, AUTOSOMAL RECESSIVE	COL4A4, PRO1572LEU	121912863
120131	1286	COL4A4	0007	HEMATURIA, BENIGN FAMILIAL	COL4A4, 1-BP INS, 3222A	
120131	1286	COL4A4	0008	HEMATURIA, BENIGN FAMILIAL	COL4A4, GLY960ARG	
120140	1280	COL2A1	0001	SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	COL2A1, 390-BP DEL	
120140	1280	COL2A1	0002	HYPOCHONDROGENESIS	COL2A1, GLY943SER	121912864
120140	1280	COL2A1	0003	OSTEOARTHRITIS WITH MILD CHONDRODYSPLASIA OSTEOARTHRITIS WITH MILD SPONDYLOEPIPHYSEAL DYSPLASIA, INCLUDED	COL2A1, ARG519CYS	121912865
120140	1280	COL2A1	0004	SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	COL2A1, 45-BP DUP, EX48	
120140	1280	COL2A1	0005	STICKLER SYNDROME, TYPE I	COL2A1, ARG732TER	121912866
120140	1280	COL2A1	0006	SPONDYLOEPIPHYSEAL DYSPLASIA, NAMAQUALAND TYPE	COL2A1	
120140	1280	COL2A1	0007	HYPOCHONDROGENESIS	COL2A1, GLY574SER	121912867
120140	1280	COL2A1	0008	STICKLER SYNDROME, TYPE I	COL2A1, 1-BP DEL, EX40	
120140	1280	COL2A1	0009	HYPOCHONDROGENESIS	COL2A1, GLY853GLU	121912868
120140	1280	COL2A1	0010	STICKLER SYNDROME, TYPE I	COL2A1, ARG9TER	121912869
120140	1280	COL2A1	0011	SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	COL2A1, GLY997SER	121912870
120140	1280	COL2A1	0012	KNIEST DYSPLASIA	COL2A1, 28-BP DEL	
120140	1280	COL2A1	0013	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, STRUDWICK TYPE	COL2A1, GLY154ARG	121912871
120140	1280	COL2A1	0014	STICKLER SYNDROME, TYPE I, NONSYNDROMIC OCULAR	COL2A1, GLY67ASP	121912872
120140	1280	COL2A1	0015	STICKLER SYNDROME, TYPE I	COL2A1, PRO846TER	121912873
120140	1280	COL2A1	0016	SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	COL2A1, ARG789CYS	121912874
120140	1280	COL2A1	0017	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, STRUDWICK TYPE	COL2A1, GLY709CYS	121912875
120140	1280	COL2A1	0018	CZECH DYSPLASIA	COL2A1, ARG75CYS	121912876
120140	1280	COL2A1	0019	KNIEST DYSPLASIA	COL2A1, IVS20, A-G, -2	
120140	1280	COL2A1	0020	KNIEST DYSPLASIA	COL2A1, GLY103ASP	121912877
120140	1280	COL2A1	0021	ACHONDROGENESIS, TYPE II	COL2A1, GLY769SER	121912878
120140	1280	COL2A1	0022	ACHONDROGENESIS, TYPE II	COL2A1, GLY691ARG	121912879
120140	1280	COL2A1	0023	STICKLER SYNDROME, TYPE I	COL2A1, 1-BP DEL, EX50	
120140	1280	COL2A1	0024	STICKLER SYNDROME, TYPE I	COL2A1, IVS17, A-G, -2	
120140	1280	COL2A1	0025	KNIEST DYSPLASIA	COL2A1, 1-BP DEL, IVS18, G, +1	
120140	1280	COL2A1	0026	KNIEST DYSPLASIA	COL2A1, IVS24, G-A, +5	
120140	1280	COL2A1	0027	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, STRUDWICK TYPE	COL2A1, GLY304CYS	121912880
120140	1280	COL2A1	0028	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, STRUDWICK TYPE	COL2A1, GLY292VAL	121912881
120140	1280	COL2A1	0029	EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MYOPIA AND CONDUCTIVE DEAFNESS	COL2A1, ARG704CYS	121912882
120140	1280	COL2A1	0030	SPONDYLOPERIPHERAL DYSPLASIA	COL2A1, 5-BP DUP	
120140	1280	COL2A1	0031	SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	COL2A1, GLY973ARG	121912883
120140	1280	COL2A1	0032	STICKLER SYNDROME, TYPE I	COL2A1, IVS25DS, G-A, +1	
120140	1280	COL2A1	0033	STICKLER SYNDROME, TYPE I	COL2A1, ARG365CYS	121912884
120140	1280	COL2A1	0034	STICKLER SYNDROME, TYPE I, NONSYNDROMIC OCULAR	COL2A1, LEU467PHE	121912885
120140	1280	COL2A1	0035	SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	COL2A1, THR1370MET	121912886
120140	1280	COL2A1	0036	STICKLER SYNDROME, TYPE I, NONSYNDROMIC OCULAR	COL2A1, 2-BP DEL, 4274GT	
120140	1280	COL2A1	0037	VITREORETINOPATHY WITH PHALANGEAL EPIPHYSEAL DYSPLASIA	COL2A1, GLY1105ASP	121912887
120140	1280	COL2A1	0038	ACHONDROGENESIS, TYPE II	COL2A1, GLY316ASP	121912888
120140	1280	COL2A1	0039	PLATYSPONDYLIC SKELETAL DYSPLASIA, TORRANCE TYPE SPONDYLOPERIPHERAL DYSPLASIA, INCLUDED	COL2A1, TYR1391CYS	121912889
120140	1280	COL2A1	0040	PLATYSPONDYLIC SKELETAL DYSPLASIA, TORRANCE TYPE	COL2A1, 4-BP DEL, 4413AGGG	
120140	1280	COL2A1	0041	SPONDYLOPERIPHERAL DYSPLASIA	COL2A1, 1-BP DEL, 4337G	
120140	1280	COL2A1	0042	SPONDYLOPERIPHERAL DYSPLASIA	COL2A1, CYS1438TER	121912890
120140	1280	COL2A1	0043	AVASCULAR NECROSIS OF THE FEMORAL HEAD, PRIMARY LEGG-CALVE-PERTHES DISEASE, INCLUDED	COL2A1, GLY1170SER	121912891
120140	1280	COL2A1	0044	AVASCULAR NECROSIS OF THE FEMORAL HEAD, PRIMARY	COL2A1, GLY717SER	121912892
120140	1280	COL2A1	0045	STICKLER SYNDROME, TYPE I RHEGMATOGENOUS RETINAL DETACHMENT, AUTOSOMAL DOMINANT, INCLUDED	COL2A1, ARG453TER	121912893
120140	1280	COL2A1	0046	RHEGMATOGENOUS RETINAL DETACHMENT, AUTOSOMAL DOMINANT	COL2A1, GLY118ARG	121912894
120140	1280	COL2A1	0047	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, STRUDWICK TYPE	COL2A1, ARG792GLY	121912895
120140	1280	COL2A1	0048	OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	COL2A1, IVS10AS, A-G, -2	
120140	1280	COL2A1	0049	STICKLER SYNDROME, TYPE I, NONSYNDROMIC OCULAR	COL2A1, IVS51DS, T-C, +2	
120140	1280	COL2A1	0050	STICKLER SYNDROME, TYPE I, NONSYNDROMIC OCULAR	COL2A1, TRP47TER	121912896
120140	1280	COL2A1	0051	STICKLER SYNDROME, TYPE I, NONSYNDROMIC OCULAR	COL2A1, CYS64TER	121912897
120140	1280	COL2A1	0052	STICKLER SYNDROME, TYPE I, NONSYNDROMIC OCULAR	COL2A1, CYS57TYR	121912898
120140	1280	COL2A1	0053	ACHONDROGENESIS, TYPE II	COL2A1, GLY346VAL	121912899
120140	1280	COL2A1	0054	AVASCULAR NECROSIS OF THE FEMORAL HEAD, PRIMARY	COL2A1, THR1383MET	
120150	1277	COL1A1	0001	OSTEOGENESIS IMPERFECTA, TYPE II	COL1A1, GLY97ASP	72645333
120150	1277	COL1A1	0002	OSTEOGENESIS IMPERFECTA, TYPE I	COL1A1, GLY94CYS	72645331
120150	1277	COL1A1	0003	OSTEOGENESIS IMPERFECTA, TYPE IV	COL1A1, GLY175CYS	66721653
120150	1277	COL1A1	0004	OSTEOGENESIS IMPERFECTA, TYPE II	COL1A1, GLY391ARG	72648363
120150	1277	COL1A1	0005	OSTEOGENESIS IMPERFECTA, TYPE III	COL1A1, GLY526CYS	67368147
120150	1277	COL1A1	0006	OSTEOGENESIS IMPERFECTA, TYPE II	COL1A1, GLY559ASP	72651651
120150	1277	COL1A1	0007	OSTEOGENESIS IMPERFECTA, TYPE II	COL1A1, GLY673ASP	72653137
120150	1277	COL1A1	0008	OSTEOGENESIS IMPERFECTA, TYPE II	COL1A1, GLY667ARG	72653136
120150	1277	COL1A1	0009	OSTEOGENESIS IMPERFECTA, TYPE II	COL1A1, GLY691CYS	72653143
120150	1277	COL1A1	0010	OSTEOGENESIS IMPERFECTA, TYPE II	COL1A1, GLY718CYS	72653152
120150	1277	COL1A1	0011	OSTEOGENESIS IMPERFECTA, TYPE II	COL1A1, GLY748CYS	72653154
120150	1277	COL1A1	0012	OSTEOGENESIS IMPERFECTA, TYPE IV	COL1A1, GLY832SER	72653169
120150	1277	COL1A1	0013	OSTEOGENESIS IMPERFECTA, TYPE III	COL1A1, GLY844SER	66523073
120150	1277	COL1A1	0014	OSTEOGENESIS IMPERFECTA, TYPE II	COL1A1, GLY847ARG	72653172
120150	1277	COL1A1	0015	OSTEOGENESIS IMPERFECTA, TYPE II	COL1A1, GLY883ASP	72654797
120150	1277	COL1A1	0016	OSTEOGENESIS IMPERFECTA, TYPE II	COL1A1, GLY904CYS	72656303
120150	1277	COL1A1	0017	OSTEOGENESIS IMPERFECTA, TYPE II	COL1A1, GLY913SER	72656306
120150	1277	COL1A1	0018	OSTEOGENESIS IMPERFECTA, TYPE II	COL1A1, GLY988CYS	72656324
120150	1277	COL1A1	0019	OSTEOGENESIS IMPERFECTA, TYPE II	COL1A1, GLY1009SER	72656332
120150	1277	COL1A1	0020	OSTEOGENESIS IMPERFECTA, TYPE III	COL1A1, EX22DEL	
120150	1277	COL1A1	0021	OSTEOGENESIS IMPERFECTA	COL1A1, GLY1017CYS	72656334
120150	1277	COL1A1	0022	OSTEOGENESIS IMPERFECTA	COL1A1, GLY1017CYS	
120150	1277	COL1A1	0023	OSTEOGENESIS IMPERFECTA, TYPE II	COL1A1, 9-BP DEL	
120150	1277	COL1A1	0024	OSTEOGENESIS IMPERFECTA, TYPE I	COL1A1, FS	
120150	1277	COL1A1	0025	OSTEOGENESIS IMPERFECTA, TYPE II	COL1A1, 1-BP INS, 4088T	
120150	1277	COL1A1	0026	EHLERS-DANLOS SYNDROME, TYPE VIIA	COL1A1, IVS6DS, G-A, -1	
120150	1277	COL1A1	0028	OSTEOGENESIS IMPERFECTA, TYPE I	COL1A1, GLY178CYS	72645365
120150	1277	COL1A1	0029	OSTEOGENESIS IMPERFECTA, TYPE II	COL1A1, GLY541ASP	72651646
120150	1277	COL1A1	0030	OSTEOGENESIS IMPERFECTA, TYPE III	COL1A1, GLY154ARG	72645357
120150	1277	COL1A1	0031	OSTEOGENESIS IMPERFECTA, TYPE II	COL1A1, GLY1003SER	72656330
120150	1277	COL1A1	0032	OSTEOGENESIS IMPERFECTA, TYPE II	COL1A1, GLY637VAL	66929517
120150	1277	COL1A1	0033	OSTEOGENESIS IMPERFECTA, TYPE III/IV	COL1A1, GLY415CYS	66527965
120150	1277	COL1A1	0034	OSTEOGENESIS IMPERFECTA	COL1A1, GLY85ARG	72645323
120150	1277	COL1A1	0035	OSTEOGENESIS IMPERFECTA, TYPE IIC	COL1A1, GLY1006VAL	72656331
120150	1277	COL1A1	0036	OSTEOGENESIS IMPERFECTA, TYPE IIA	COL1A1, GLY973VAL	72656321
120150	1277	COL1A1	0037	OSTEOGENESIS IMPERFECTA, TYPE IIA	COL1A1, GLY256VAL	72648333
120150	1277	COL1A1	0038	OSTEOPENIC NONFRACTURE SYNDROME	COL1A1, GLY43CYS	72667037
120150	1277	COL1A1	0039	OSTEOGENESIS IMPERFECTA, TYPE II	COL1A1, IVS14DS, G-A, +5	
120150	1277	COL1A1	0040	OSTEOGENESIS IMPERFECTA, TYPE I	COL1A1, GLY901SER	72654802
120150	1277	COL1A1	0041	OSTEOGENESIS IMPERFECTA, TYPE II	COL1A1, GLY802VAL	72653166
120150	1277	COL1A1	0042	OSTEOGENESIS IMPERFECTA, TYPE III	COL1A1, GLY352SER	67682641
120150	1277	COL1A1	0043	OSTEOGENESIS IMPERFECTA, TYPE II	COL1A1, EX15-16DUP	
120150	1277	COL1A1	0044	OSTEOGENESIS IMPERFECTA, TYPE II	COL1A1, GLY415SER	66527965
120150	1277	COL1A1	0045	OSTEOGENESIS IMPERFECTA, TYPE II	COL1A1, GLY565VAL	72651653
120150	1277	COL1A1	0046	OSTEOGENESIS IMPERFECTA, TYPE I	COL1A1, IVS26DS, G-A, +1	
120150	1277	COL1A1	0047	OSTEOGENESIS IMPERFECTA, TYPE II	COL1A1, GLY355ASP	72648356
120150	1277	COL1A1	0048	OSTEOGENESIS IMPERFECTA, TYPE III	COL1A1, GLY862SER	72653178
120150	1277	COL1A1	0049	OSTEOGENESIS IMPERFECTA, TYPE III	COL1A1, GLY661SER	72653131
120150	1277	COL1A1	0050	OSTEOGENESIS IMPERFECTA, TYPE III	COL1A1, LEU-PRO, C-TER PROPEPTIDE	
120150	1277	COL1A1	0051	BONE MINERAL DENSITY VARIATION QUANTITATIVE TRAIT LOCUS	COL1A1, IVS1, 2046G-T	1800012
120150	1277	COL1A1	0052	OSTEOGENESIS IMPERFECTA, TYPE I, MILD	COL1A1, GLY13ALA	67828806
120150	1277	COL1A1	0053	OSTEOGENESIS IMPERFECTA, TYPE II, THIN-BONE TYPE	COL1A1, TRP94CYS	72656343
120150	1277	COL1A1	0054	OSTEOGENESIS IMPERFECTA, TYPE III	COL1A1, 562-BP DEL	
120150	1277	COL1A1	0055	OSTEOGENESIS IMPERFECTA, TYPE I	COL1A1, ARG963TER	72656314
120150	1277	COL1A1	0056	OSTEOGENESIS IMPERFECTA, TYPE II	COL1A1, GLY586VAL	72651657
120150	1277	COL1A1	0057	EHLERS-DANLOS SYNDROME, TYPE VIIA	COL1A1, IVS5AS, G-A, -1	
120150	1277	COL1A1	0058	OSTEOGENESIS IMPERFECTA, TYPE IV	COL1A1, IVS8DS, G-A, +1	
120150	1277	COL1A1	0059	EHLERS-DANLOS SYNDROME, TYPE I	COL1A1, ARG134CYS	72645347
120150	1277	COL1A1	0060	OSTEOGENESIS IMPERFECTA, TYPE II	COL1A1, 9-BP DUP	
120150	1277	COL1A1	0061	OSTEOGENESIS IMPERFECTA, TYPE IV	COL1A1, 3-BP DEL, 1964GGC	
120150	1277	COL1A1	0062	OSTEOGENESIS IMPERFECTA, TYPE I OSTEOGENESIS IMPERFECTA, TYPE IV, INCLUDED	COL1A1, IVS19DS, G-C, +1	
120150	1277	COL1A1	0063	CAFFEY DISEASE PRENATAL CORTICAL HYPEROSTOSIS, LETHAL, INCLUDED	COL1A1, ARG836CYS	72653170
120150	1277	COL1A1	0064	OI/EDS COMBINED SYNDROME	COL1A1, GLY13ASP	67828806
120150	1277	COL1A1	0065	OSTEOGENESIS IMPERFECTA, TYPE III	COL1A1, GLY76GLU	72645320
120150	1277	COL1A1	0066	EHLERS-DANLOS SYNDROME, TYPE VIIA	COL1A1, IVS5AS, A-T, -2	
120150	1277	COL1A1	0067	BONE MINERAL DENSITY VARIATION QUANTITATIVE TRAIT LOCUS	COL1A1, 5-PRIME UTR, G-T, -1997	1107946
120150	1277	COL1A1	0068	BONE MINERAL DENSITY VARIATION QUANTITATIVE TRAIT LOCUS	COL1A1, 5-PRIME UTR, INDEL T, -1663	2412298
120150	1277	COL1A1	0069	OSTEOGENESIS IMPERFECTA, TYPE II	COL1A1, 1-BP DEL, 4247C	
120150	1277	COL1A1	0070	OSTEOGENESIS IMPERFECTA, TYPE II	COL1A1, ALA1387VAL	
120160	1278	COL1A2	0001	EHLERS-DANLOS SYNDROME, TYPE VIIB	COL1A2, EX6DEL	
120160	1278	COL1A2	0002	EHLERS-DANLOS SYNDROME, TYPE VIIB	COL1A2, IVS6DS, T-C, +2	
120160	1278	COL1A2	0003	EHLERS-DANLOS SYNDROME, TYPE VIIB	COL1A2, IVS6DS, G-A, -1	
120160	1278	COL1A2	0004	OSTEOGENESIS IMPERFECTA, TYPE IV	COL1A2, GLY1012ARG	72659319
120160	1278	COL1A2	0005	OSTEOGENESIS IMPERFECTA, TYPE III	COL1A2, EX1, FS	
120160	1278	COL1A2	0006	OSTEOGENESIS IMPERFECTA, MILD	COL1A2, EX11DEL	
120160	1278	COL1A2	0007	OSTEOGENESIS IMPERFECTA, TYPE II	COL1A2, DEL 7EX, CODONS 586-765	
120160	1278	COL1A2	0008	OSTEOGENESIS IMPERFECTA, TYPE II	COL1A2, GLY907ASP	121912900
120160	1278	COL1A2	0009	OSTEOGENESIS IMPERFECTA, TYPE II	COL1A2, EX33DEL	
120160	1278	COL1A2	0010	OSTEOGENESIS IMPERFECTA, TYPE II	COL1A2, GLY547ASP	121912901
120160	1278	COL1A2	0011	OSTEOGENESIS IMPERFECTA, TYPE II	COL1A2, GLY865SER	121912902
120160	1278	COL1A2	0013	OSTEOGENESIS IMPERFECTA, TYPE IV	COL1A2, GLY646CYS	121912903
120160	1278	COL1A2	0014	OSTEOGENESIS IMPERFECTA, TYPE IV	COL1A2, EX26DEL	
120160	1278	COL1A2	0015	OSTEOGENESIS IMPERFECTA, TYPE II	COL1A2, GLY976ASP	
120160	1278	COL1A2	0016	OSTEOGENESIS IMPERFECTA, TYPE II	COL1A2, GLY805ASP	121912904
120160	1278	COL1A2	0017	OSTEOGENESIS IMPERFECTA, TYPE II	COL1A2, GLY259CYS	121912905
120160	1278	COL1A2	0018	OSTEOGENESIS IMPERFECTA, TYPE II	COL1A2, EX28DEL	
120160	1278	COL1A2	0019	OSTEOGENESIS IMPERFECTA, TYPE II	COL1A2, GLY472CYS	121912906
120160	1278	COL1A2	0020	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	COL1A2, ARG618GLN	72658163
120160	1278	COL1A2	0021	EHLERS-DANLOS SYNDROME, TYPE VIIB	COL1A2, IVS6DS, G-A, +1	
120160	1278	COL1A2	0022	OSTEOGENESIS IMPERFECTA, TYPE II	COL1A2, IVS33DS, G-A, +5	
120160	1278	COL1A2	0023	OSTEOGENESIS IMPERFECTA, TYPE IV OSTEOGENESIS IMPERFECTA, TYPE III, INCLUDED	COL1A2, GLY586VAL	121912907
120160	1278	COL1A2	0025	OSTEOGENESIS IMPERFECTA, TYPE II	COL1A2, GLY694ARG	121912908
120160	1278	COL1A2	0026	OSTEOGENESIS IMPERFECTA, ATYPICAL, WITH JOINT HYPERMOBILITY	COL1A2, IVS9DS, 11-BP DEL, EX9DEL	
120160	1278	COL1A2	0027	EHLERS-DANLOS SYNDROME, TYPE VIIB	COL1A2, IVS5AS, G-C, -1	
120160	1278	COL1A2	0029	OSTEOGENESIS IMPERFECTA, TYPE II	COL1A2, GLY580ASP	121912909
120160	1278	COL1A2	0030	OSTEOPOROSIS, POSTMENOPAUSAL	COL1A2, GLY661SER	72658152
120160	1278	COL1A2	0031	OSTEOGENESIS IMPERFECTA, TYPE III	COL1A2, VAL255DEL	
120160	1278	COL1A2	0032	EHLERS-DANLOS SYNDROME, TYPE VIIB	COL1A2, IVS5AS, G-C, -1	
120160	1278	COL1A2	0033	OSTEOGENESIS IMPERFECTA, TYPE III	COL1A2, GLY859SER	72658200
120160	1278	COL1A2	0034	OSTEOGENESIS IMPERFECTA, TYPE II	COL1A2, GLY502SER	121912910
120160	1278	COL1A2	0035	OSTEOGENESIS IMPERFECTA, TYPE IV	COL1A2, 9-BP DEL, NT3418	
120160	1278	COL1A2	0036	OSTEOGENESIS IMPERFECTA, TYPE IV, WITH DENTINOGENESIS IMPERFECTA	COL1A2, IVS21DS, G-A, +5	
120160	1278	COL1A2	0037	OSTEOGENESIS IMPERFECTA, TYPE III	COL1A2, GLY1006ALA	121912911
120160	1278	COL1A2	0038	OSTEOGENESIS IMPERFECTA, TYPE III	COL1A2, GLY586VAL	
120160	1278	COL1A2	0039	OSTEOGENESIS IMPERFECTA, TYPE III	COL1A2, GLY751SER	72658176
120160	1278	COL1A2	0040	OSTEOGENESIS IMPERFECTA, TYPE IV	COL1A2, IVS26DS, A-G, +3	
120160	1278	COL1A2	0041	OSTEOGENESIS IMPERFECTA/EHLERS-DANLOS CROSSOVER SYNDROME	COL1A2, IVS9DS, G-A, +5	
120160	1278	COL1A2	0042	EHLERS-DANLOS SYNDROME, TYPE VIIB	COL1A2, IVS5AS, A-G, -2	
120160	1278	COL1A2	0043	OSTEOGENESIS IMPERFECTA/EHLERS-DANLOS CROSSOVER SYNDROME	COL1A2, 13.5-KB DUP	
120160	1278	COL1A2	0044	OSTEOGENESIS IMPERFECTA, TYPE III	COL1A2, GLY277TYR	72656402
120160	1278	COL1A2	0045	EHLERS-DANLOS SYNDROME, AUTOSOMAL RECESSIVE, CARDIAC VALVULAR FORM	COL1A2, IVS11DS, G-A, +5	
120160	1278	COL1A2	0046	EHLERS-DANLOS SYNDROME, AUTOSOMAL RECESSIVE, CARDIAC VALVULAR FORM	COL1A2, IVS24DS, G-C, +1	
120160	1278	COL1A2	0047	EHLERS-DANLOS SYNDROME, AUTOSOMAL RECESSIVE, CARDIAC VALVULAR FORM	COL1A2, IVS24, G-A, +1	
120160	1278	COL1A2	0048	EHLERS-DANLOS SYNDROME, AUTOSOMAL RECESSIVE, CARDIAC VALVULAR FORM	COL1A2, IVS1, A-G, +717	
120160	1278	COL1A2	0049	EHLERS-DANLOS/OSTEOGENESIS IMPERFECTA CROSSOVER SYNDROME	COL1A2, IVS46DS, T-C, +2	
120160	1278	COL1A2	0050	OSTEOGENESIS IMPERFECTA, TYPE IV	COL1A2, GLY379ALA	121912912
120160	1278	COL1A2	0051	EHLERS-DANLOS SYNDROME, AUTOSOMAL RECESSIVE, CARDIAC VALVULAR FORM	COL1A2, GLU1201TER	72659343
120160	1278	COL1A2	0052	EHLERS-DANLOS SYNDROME, AUTOSOMAL RECESSIVE, CARDIAC VALVULAR FORM	COL1A2, 1-BP INS, 292C	
120160	1278	COL1A2	0053	OSTEOGENESIS IMPERFECTA, TYPE II	COL1A2, GLY421ASP	
120160	1278	COL1A2	0054	OSTEOGENESIS IMPERFECTA, TYPE III	COL1A2, GLY1090ASP	
120160	1278	COL1A2	0055	OSTEOGENESIS IMPERFECTA, TYPE III	COL1A2, GLY1099ARG	72659338
120180	1281	COL3A1	0001	EHLERS-DANLOS SYNDROME, TYPE IV	COL3A1, GLY790SER	121912913
120180	1281	COL3A1	0002	EHLERS-DANLOS SYNDROME, TYPE IV, VARIANT	COL3A1, GLY619ARG	113485686
120180	1281	COL3A1	0003	EHLERS-DANLOS SYNDROME, TYPE IV	COL3A1, GLY883ASP	121912914
120180	1281	COL3A1	0004	EHLERS-DANLOS SYNDROME, TYPE IV, VARIANT	COL3A1, IVS20, G-A, +1	
120180	1281	COL3A1	0005	EHLERS-DANLOS SYNDROME, TYPE IV	COL3A1, IVS16, G-A, +1	
120180	1281	COL3A1	0006	EHLERS-DANLOS SYNDROME, TYPE IV	COL3A1, IVS42, G-A, +1	
120180	1281	COL3A1	0007	COLLAGEN TYPE III POLYMORPHISM	COL3A1, ALA531THR	1800255
120180	1281	COL3A1	0008	EHLERS-DANLOS SYNDROME, TYPE IV	COL3A1, IVS37, G-T, +5	
120180	1281	COL3A1	0009	EHLERS-DANLOS SYNDROME, TYPE IV	COL3A1, 7.5-KB DEL	
120180	1281	COL3A1	0010	EHLERS-DANLOS SYNDROME, TYPE IV	COL3A1, GLY910VAL	121912915
120180	1281	COL3A1	0011	EHLERS-DANLOS SYNDROME, TYPE IV	COL3A1, IVS25, G-T, +5	
120180	1281	COL3A1	0012	EHLERS-DANLOS SYNDROME, TYPE IV	COL3A1, IVS41, G-A, +1	
120180	1281	COL3A1	0013	EHLERS-DANLOS SYNDROME, TYPE IV	COL3A1, 27-BP DEL	
120180	1281	COL3A1	0014	EHLERS-DANLOS SYNDROME, TYPE IV	COL3A1, GLY847GLU	121912916
120180	1281	COL3A1	0015	EHLERS-DANLOS SYNDROME, TYPE IV	COL3A1, GLY1018ASP	121912917
120180	1281	COL3A1	0016	EHLERS-DANLOS SYNDROME, TYPE IV	COL3A1, GLY1006GLU	121912918
120180	1281	COL3A1	0017	EHLERS-DANLOS SYNDROME, TYPE IV	COL3A1, GLY1021GLU	112456072
120180	1281	COL3A1	0018	EHLERS-DANLOS SYNDROME, TYPE IV	COL3A1, GLY136ARG	121912919
120180	1281	COL3A1	0019	EHLERS-DANLOS SYNDROME, TYPE IV	COL3A1, IVS7, T-C, +6	
120180	1281	COL3A1	0020	EHLERS-DANLOS SYNDROME, TYPE III	COL3A1, GLY637SER	121912920
120180	1281	COL3A1	0021	EHLERS-DANLOS SYNDROME, TYPE IV	COL3A1, IVS27, G-A, +5	
120180	1281	COL3A1	0022	EHLERS-DANLOS SYNDROME, TYPE IV	COL3A1, GLY499ASP	121912921
120180	1281	COL3A1	0023	EHLERS-DANLOS SYNDROME, TYPE IV	COL3A1, GLY793VAL	121912922
120180	1281	COL3A1	0024	EHLERS-DANLOS SYNDROME, TYPE IV	COL3A1, GLY415SER	121912923
120180	1281	COL3A1	0025	EHLERS-DANLOS SYNDROME, TYPE IV	COL3A1, GLY934GLU	121912924
120180	1281	COL3A1	0026	EHLERS-DANLOS SYNDROME, TYPE IV	COL3A1, GLY571SER	121912925
120180	1281	COL3A1	0027	EHLERS-DANLOS SYNDROME, TYPE IV	COL3A1, GLY16SER	121912926
120180	1281	COL3A1	0028	EHLERS-DANLOS SYNDROME, TYPE IV	COL3A1, GLY82ASP	121912927
120180	1281	COL3A1	0029	EHLERS-DANLOS SYNDROME, TYPE IV	COL3A1, GLY373ARG	
120180	1281	COL3A1	0030	EHLERS-DANLOS SYNDROME, TYPE IV	COL3A1, GLY385GLU	121912928
120180	1281	COL3A1	0031	EHLERS-DANLOS SYNDROME, TYPE IV	COL3A1, GLY297ARG	
120180	1281	COL3A1	0032	EHLERS-DANLOS SYNDROME, TYPE IV, VARIANT	COL3A1, IVS8DS, G-A, +5	
120180	1281	COL3A1	0033	EHLERS-DANLOS SYNDROME, TYPE IV	COL3A1, GLY883VAL	
120180	1281	COL3A1	0034	EHLERS-DANLOS SYNDROME, TYPE IV, AUTOSOMAL RECESSIVE	COL3A1, 1-BP DUP, 479T	
120190	1290	COL5A2	0001	EHLERS-DANLOS SYNDROME, TYPE I	COL5A2, 7-BP DEL	
120190	1290	COL5A2	0002	EHLERS-DANLOS SYNDROME, TYPE I	COL5A2, IVS28, G-T, +1	
120190	1290	COL5A2	0003	EHLERS-DANLOS SYNDROME, TYPE II	COL5A2, GLY934ARG	121912930
120210	1297	COL9A1	0001	EPIPHYSEAL DYSPLASIA, MULTIPLE, 6	COL9A1, 1-BP INS, IVS8, T, +3	
120210	1297	COL9A1	0002	STICKLER SYNDROME, TYPE IV	COL9A1, ARG295TER	121912931
120215	1289	COL5A1	0001	EHLERS-DANLOS SYNDROME, TYPE II, ATYPICAL	COL5A1, IVS49DS, G-T, +3	
120215	1289	COL5A1	0002	EHLERS-DANLOS SYNDROME, TYPE I	COL5A1, IVS65DS, 4-BP DEL, +3 TO +6	
120215	1289	COL5A1	0003	EHLERS-DANLOS SYNDROME, TYPE I	COL5A1, CYS1181SER	80338764
120215	1289	COL5A1	0004	EHLERS-DANLOS SYNDROME, TYPE I	COL5A1, EX42DEL, SPLICE MUTATION	
120215	1289	COL5A1	0005	EHLERS-DANLOS SYNDROME, TYPE II	COL5A1, IVS64AS, T-A, -11	
120215	1289	COL5A1	0006	EHLERS-DANLOS SYNDROME, TYPE II	COL5A1, IVS32AS, T-G, -25	
120215	1289	COL5A1	0007	EHLERS-DANLOS SYNDROME, TYPE I	COL5A1, GLY1489GLU	121912932
120215	1289	COL5A1	0008	EHLERS-DANLOS SYNDROME, TYPE I	COL5A1, 1-BP DEL	
120215	1289	COL5A1	0009	EHLERS-DANLOS SYNDROME, TYPE I	COL5A1, ARG792TER	121912933
120215	1289	COL5A1	0010	EHLERS-DANLOS SYNDROME, TYPE I	COL5A1, IVS4, A-G, -2	
120215	1289	COL5A1	0011	EHLERS-DANLOS SYNDROME, TYPE I	COL5A1, 1-BP DEL, IVS55, G, -1	
120215	1289	COL5A1	0012	EHLERS-DANLOS SYNDROME, TYPE I	COL5A1, ARG1062TER	
120220	1291	COL6A1	0001	BETHLEM MYOPATHY	COL6A1, GLY286VAL	121912934
120220	1291	COL6A1	0002	BETHLEM MYOPATHY	COL6A1, IVS11AS, G-A, -1	
120220	1291	COL6A1	0003	BETHLEM MYOPATHY	COL6A1, IVS14DS, T-C, +2	
120220	1291	COL6A1	0004	BETHLEM MYOPATHY	COL6A1, GLY341ASP	121912935
120220	1291	COL6A1	0005	BETHLEM MYOPATHY	COL6A1, LYS121ARG	121912936
120220	1291	COL6A1	0006	BETHLEM MYOPATHY	COL6A1, IVS14DS, G-A, +1	
120220	1291	COL6A1	0007	ULLRICH CONGENITAL MUSCULAR DYSTROPHY, AUTOSOMAL DOMINANT	COL6A1, EX9-10DEL	
120220	1291	COL6A1	0008	BETHLEM MYOPATHY	COL6A1, IVS3DS, G-A, +1	
120220	1291	COL6A1	0009	ULLRICH CONGENITAL MUSCULAR DYSTROPHY, AUTOSOMAL RECESSIVE	COL6A1, 1-BP DEL, 856C	
120220	1291	COL6A1	0010	ULLRICH CONGENITAL MUSCULAR DYSTROPHY, AUTOSOMAL RECESSIVE	COL6A1, 1-BP DEL, 1456G	
120220	1291	COL6A1	0011	ULLRICH CONGENITAL MUSCULAR DYSTROPHY, AUTOSOMAL RECESSIVE	COL6A1, TYR659TER	121912937
120220	1291	COL6A1	0012	ULLRICH CONGENITAL MUSCULAR DYSTROPHY, AUTOSOMAL DOMINANT	COL6A1, GLY284ARG	121912938
120220	1291	COL6A1	0013	ULLRICH CONGENITAL MUSCULAR DYSTROPHY, AUTOSOMAL DOMINANT	COL6A1, GLY290ARG	121912939
120220	1291	COL6A1	0014	ULLRICH CONGENITAL MUSCULAR DYSTROPHY, DIGENIC, COL6A1/COL6A2	COL6A1, GLY281ARG	
120240	1292	COL6A2	0001	BETHLEM MYOPATHY	COL6A2, GLY250SER	121912940
120240	1292	COL6A2	0002	ULLRICH CONGENITAL MUSCULAR DYSTROPHY, AUTOSOMAL RECESSIVE	COL6A2, 1-BP INS, 1151C	
120240	1292	COL6A2	0003	ULLRICH CONGENITAL MUSCULAR DYSTROPHY, AUTOSOMAL RECESSIVE	COL6A2, IVS17, A-G, -2	
120240	1292	COL6A2	0004	ULLRICH CONGENITAL MUSCULAR DYSTROPHY, AUTOSOMAL RECESSIVE	COL6A2, IVS23, G-A, -1	
120240	1292	COL6A2	0005	BETHLEM MYOPATHY	COL6A2, ASP620ASN	
120240	1292	COL6A2	0006	ULLRICH CONGENITAL MUSCULAR DYSTROPHY, AUTOSOMAL RECESSIVE	COL6A2, 26-BP DEL, NT731	
120240	1292	COL6A2	0007	ULLRICH CONGENITAL MUSCULAR DYSTROPHY, AUTOSOMAL RECESSIVE	COL6A2, IVS12AS, A-G, -10	
120240	1292	COL6A2	0008	ULLRICH CONGENITAL MUSCULAR DYSTROPHY, AUTOSOMAL DOMINANT	COL6A2, 1.3-KB DEL	
120240	1292	COL6A2	0009	BETHLEM MYOPATHY	COL6A2, IVS10AS, A-G, -2	
120240	1292	COL6A2	0010	BETHLEM MYOPATHY	COL6A2, PRO932LEU	117725825
120240	1292	COL6A2	0011	MYOSCLEROSIS, AUTOSOMAL RECESSIVE BETHLEM MYOPATHY, AUTOSOMAL RECESSIVE	COL6A2, GLN819TER	121912942
120240	1292	COL6A2	0012	ULLRICH CONGENITAL MUSCULAR DYSTROPHY, AUTOSOMAL RECESSIVE	COL6A2, CYS777ARG	
120240	1292	COL6A2	0013	ULLRICH CONGENITAL MUSCULAR DYSTROPHY, AUTOSOMAL DOMINANT	COL6A2, GLY283ARG	
120240	1292	COL6A2	0014	ULLRICH CONGENITAL MUSCULAR DYSTROPHY, DIGENIC, COL6A1/COL6A2	COL6A2, ARG498HIS	
120240	1292	COL6A2	0015	ULLRICH CONGENITAL MUSCULAR DYSTROPHY, AUTOSOMAL RECESSIVE	COL6A2, GLU624LYS	
120240	1292	COL6A2	0016	ULLRICH CONGENITAL MUSCULAR DYSTROPHY, AUTOSOMAL RECESSIVE	COL6A2, ARG876SER	
120240	1292	COL6A2	0017	BETHLEM MYOPATHY, AUTOSOMAL RECESSIVE	COL6A2, ARG830GLN AND ARG843TRP	
120240	1292	COL6A2	0018	BETHLEM MYOPATHY, AUTOSOMAL RECESSIVE	COL6A2, ARG366TER	
120240	1292	COL6A2	0019	BETHLEM MYOPATHY, AUTOSOMAL RECESSIVE	COL6A2, ASP871ASN	
120240	1292	COL6A2	0020	ULLRICH CONGENITAL MUSCULAR DYSTROPHY, AUTOSOMAL RECESSIVE	COL6A2, 6-BP DEL, 1855	
120240	1292	COL6A2	0021	ULLRICH CONGENITAL MUSCULAR DYSTROPHY, AUTOSOMAL RECESSIVE	COL6A3, IVS23AS, G-T, -1	
120250	1293	COL6A3	0001	BETHLEM MYOPATHY	COL6A3, GLY1679GLU	121434553
120250	1293	COL6A3	0002	ULLRICH CONGENITAL MUSCULAR DYSTROPHY, AUTOSOMAL RECESSIVE	COL6A3, IVS29, A-G, +5	
120250	1293	COL6A3	0003	ULLRICH CONGENITAL MUSCULAR DYSTROPHY, AUTOSOMAL RECESSIVE	COL6A3, ARG465TER	121434554
120250	1293	COL6A3	0004	ULLRICH CONGENITAL MUSCULAR DYSTROPHY, AUTOSOMAL DOMINANT	COL6A3, IVS16DS, G-A, +1	
120250	1293	COL6A3	0005	BETHLEM MYOPATHY	COL6A3, IVS15DS, GT-TC, +1	
120250	1293	COL6A3	0006	BETHLEM MYOPATHY	COL6A3, LEU1726ARG	121434555
120252	1296	COL8A2	0001	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 1 CORNEAL DYSTROPHY, POLYMORPHOUS POSTERIOR, 2, INCLUDED	COL8A2, GLN455LYS	80358191
120252	1296	COL8A2	0003	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 1 CORNEAL DYSTROPHY, POLYMORPHOUS POSTERIOR, 2, INCLUDED	COL8A2, LEU450TRP	80358192
120260	1298	COL9A2	0001	EPIPHYSEAL DYSPLASIA, MULTIPLE, 2	COL9A2, IVS3DS, T-C, +2	
120260	1298	COL9A2	0002	EPIPHYSEAL DYSPLASIA, MULTIPLE, 2	COL9A2, IVS3DS, 186G-A	
120260	1298	COL9A2	0003	EPIPHYSEAL DYSPLASIA, MULTIPLE, 2	COL9A2, IVS3DS, G-C, +5	
120260	1298	COL9A2	0004	INTERVERTEBRAL DISC DISEASE, SUSCEPTIBILITY TO	COL9A2, GLN326TRP	137853213
120260	1298	COL9A2	0005	EPIPHYSEAL DYSPLASIA, MULTIPLE, 2	COL9A2, IVS3DS, G-C, -1	
120260	1298	COL9A2	0006	STICKLER SYNDROME V	COL9A2, 8-BP DEL, NT843	
120270	1299	COL9A3	0001	EPIPHYSEAL DYSPLASIA, MULTIPLE, 3	COL9A3, IVS2AS, A-T, -2	
120270	1299	COL9A3	0002	EPIPHYSEAL DYSPLASIA, MULTIPLE, 3, WITH MYOPATHY	COL9A3, IVS2AS, G-A, -1	
120270	1299	COL9A3	0003	INTERVERTEBRAL DISC DISEASE, SUSCEPTIBILITY TO	COL9A3, ARG103TRP	61734651
120270	1299	COL9A3	0004	EPIPHYSEAL DYSPLASIA, MULTIPLE, 3	COL9A3, IVS3DS, G-A, +5	
120280	1301	COL11A1	0001	STICKLER SYNDROME, TYPE II	COL11A1, GLY97VAL	121912943
120280	1301	COL11A1	0002	MARSHALL SYNDROME	COL11A1, 54-BP DEL	
120280	1301	COL11A1	0003	MARSHALL/STICKLER SYNDROME	COL11A1, GLY988VAL	121912944
120280	1301	COL11A1	0004	MARSHALL SYNDROME	COL11A1, 4-BP DEL, EX50/IVS50	
120280	1301	COL11A1	0005	STICKLER SYNDROME, TYPE II	COL11A1, 54-BP EX DEL, AS, AG-TG	
120280	1301	COL11A1	0006	MARSHALL SYNDROME	COL11A1, 1-BP INS, 3816T	
120280	1301	COL11A1	0007	LUMBAR DISC HERNIATION, SUSCEPTIBILITY TO	COL11A1, 4603C-T	
120280	1301	COL11A1	0008	FIBROCHONDROGENESIS	COL11A1, 1-BP DUP, 1786G	
120280	1301	COL11A1	0009	FIBROCHONDROGENESIS	COL11A1, GLY1042ARG	
120280	1301	COL11A1	0010	FIBROCHONDROGENESIS	COL11A1, GLY796ARG	
120280	1301	COL11A1	0011	FIBROCHONDROGENESIS	COL11A1, GLY1315TER	
120280	1301	COL11A1	0012	MARSHALL SYNDROME	COL11A1, IVS50, G-A, +1	
120290	1302	COL11A2	0001	STICKLER SYNDROME, TYPE III	COL11A2, IVS, G-A, +1	
120290	1302	COL11A2	0002	OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	COL11A2, GLY175ARG	121912945
120290	1302	COL11A2	0003	STICKLER SYNDROME, TYPE III	COL11A2, 27-BP DEL	
120290	1302	COL11A2	0004	WEISSENBACHER-ZWEYMULLER SYNDROME OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA, HETEROZYGOUS, INCLUDED	COL11A2, GLY955GLU	121912946
120290	1302	COL11A2	0005	DEAFNESS, AUTOSOMAL DOMINANT 13	COL11A2, ARG549CYS	121912947
120290	1302	COL11A2	0006	DEAFNESS, AUTOSOMAL DOMINANT 13	COL11A2, GLY323GLU	121912948
120290	1302	COL11A2	0007	OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	COL11A2, SER345TER	121912949
120290	1302	COL11A2	0008	STICKLER SYNDROME, TYPE III	COL11A2, ARG893TER	121912950
120290	1302	COL11A2	0009	WEISSENBACHER-ZWEYMULLER SYNDROME, AUTOSOMAL RECESSIVE	COL11A2, ARG845TER	121912951
120290	1302	COL11A2	0010	DEAFNESS, AUTOSOMAL RECESSIVE 53	COL11A2, PRO621THR	121912952
120290	1302	COL11A2	0011	OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	COL11A2, 1-BP DEL, 3962G	
120290	1302	COL11A2	0012	FIBROCHONDROGENESIS 2	COL11A2, IVS18, 1-BP INS, +3	
120290	1302	COL11A2	0013	FIBROCHONDROGENESIS 2	COL11A2, 9-BP DEL, NT2899	
120324	7373	COL14A1	0001	VARIANT OF UNKNOWN SIGNIFICANCE	COL14A1, PRO1502LEU	
120328	80781	COL18A1	0001	KNOBLOCH SYNDROME 1	COL18A1, IVS1, A-T, -2	
120328	80781	COL18A1	0002	KNOBLOCH SYNDROME 1	COL18A1, 2-BP DEL, 3514CT	
120328	80781	COL18A1	0003	KNOBLOCH SYNDROME 1	COL18A1, 1-BP INS	
120328	80781	COL18A1	0004	KNOBLOCH SYNDROME 1	COL18A1, ASP1437ASN	12483377
120328	80781	COL18A1	0005	KNOBLOCH SYNDROME 1	COL18A1, IVS36DS, A-C, +3	
120328	80781	COL18A1	0006	KNOBLOCH SYNDROME 1	COL18A1, 2-BP DEL, 3617CT	
120328	80781	COL18A1	0007	KNOBLOCH SYNDROME 1	COL18A1, 2-BP DEL	
120353	4312	MMP1	0001	PULMONARY DISEASE, CHRONIC OBSTRUCTIVE, RATE OF DECLINE OF LUNG FUNCTION IN PRETERM PREMATURE RUPTURE OF THE MEMBRANES, INCLUDED;; EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE, MODIFIER OF, INCLUDED	MMP1, 1-BP INS, -1607G	1799750
120355	4317	MMP8	0001	PRETERM PREMATURE RUPTURE OF THE MEMBRANES	MMP8, HAPLOTYPE, TGG	
120360	4313	MMP2	0001	TORG-WINCHESTER SYNDROME	MMP2, ARG101HIS	121912953
120360	4313	MMP2	0002	TORG-WINCHESTER SYNDROME	MMP2, TYR244TER	121912954
120360	4313	MMP2	0003	TORG-WINCHESTER SYNDROME	MMP2, GLU404LYS	121912955
120360	4313	MMP2	0004	TORG-WINCHESTER SYNDROME	MMP2, 3-BP DEL, 1488TGG	
120360	4313	MMP2	0005	TORG-WINCHESTER SYDNROME	MMP2, 1-BP DEL, 1357C	
120361	4318	MMP9	0001	METAPHYSEAL ANADYSPLASIA 2, AUTOSOMAL RECESSIVE	MMP9, MET1LYS	121434556
120436	4292	MLH1	0001	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2	MLH1, SER252TER	
120436	4292	MLH1	0002	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2	MLH1, SER44PHE	
120436	4292	MLH1	0003	MISMATCH REPAIR CANCER SYNDROME	MLH1, 3-BP DEL, LYS618DEL	
120436	4292	MLH1	0004	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2	MLH1, 3.5-KB DEL	
120436	4292	MLH1	0005	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2	MLH1, IVS5, G-A, -1	
120436	4292	MLH1	0006	MUIR-TORRE SYNDROME	MLH1, 370-BP DEL	
120436	4292	MLH1	0007	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2	MLH1, IVS14DS, 7-BP DEL AND 4-BP INS	
120436	4292	MLH1	0008	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2	MLH1, HIS329PRO	63750710
120436	4292	MLH1	0009	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2	MLH1, 1-BP DEL, 1784T	
120436	4292	MLH1	0010	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2 MISMATCH REPAIR CANCER SYNDROME, INCLUDED	MLH1, ARG226TER	
120436	4292	MLH1	0011	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2 MISMATCH REPAIR CANCER SYNDROME, INCLUDED	MLH1, GLY67TRP	
120436	4292	MLH1	0012	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	MLH1, LYS618ALA	35502531
120436	4292	MLH1	0013	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2	MLH1, GLU578GLY	
120436	4292	MLH1	0014	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2 MISMATCH REPAIR CANCER SYNDROME, INCLUDED	MLH1, EX16DEL	
120436	4292	MLH1	0015	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2	MLH1, HYPERMETHYLATION	
120436	4292	MLH1	0016	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2	MLH1, -42, C-T	
120436	4292	MLH1	0017	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2	MLH1, THR117MET	
120436	4292	MLH1	0018	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2	MLH1, LYS616DEL	121912962
120436	4292	MLH1	0019	COLORECTAL CANCER, SPORADIC, SUSCEPTIBILITY TO	MLH1, ASP132HIS	
120436	4292	MLH1	0020	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2 MISMATCH REPAIR CANCER SYNDROME, INCLUDED	MLH1, PRO648SER	63750899
120436	4292	MLH1	0021	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2	MLH1, SER269TER	
120436	4292	MLH1	0022	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2	MLH1, ALA681THR	63750217
120436	4292	MLH1	0023	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2	MLH1, 3-BP DEL, 213AGA	
120436	4292	MLH1	0024	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2	MLH1, EX18DEL	
120436	4292	MLH1	0025	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2	MLH1, EPIGENETICALLY SILENCED	
120436	4292	MLH1	0026	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2	MLH1, EPIGENETICALLY SILENCED INHERITED	1800734
120436	4292	MLH1	0027	MISMATCH REPAIR CANCER SYNDROME COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2, INCLUDED	MLH1, 2-BP DEL, 593AG	
120436	4292	MLH1	0028	MISMATCH REPAIR CANCER SYNDROME COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2, INCLUDED	MLH1, MET35ASN	121912965
120436	4292	MLH1	0029	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2	MLH1, GLY67GLU	
120436	4292	MLH1	0030	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2	MLH1, ARG265CYS	
120436	4292	MLH1	0031	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2	MLH1, 11.6-KB DEL	
120436	4292	MLH1	0032	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2	MLH1, IVS3DS, G-A, +5	
120436	4292	MLH1	0033	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2	MLH1, LEU622HIS	
120436	4292	MLH1	0034	MISMATCH REPAIR CANCER SYNDROME	MLH1, LEU73ARG	
120470	1630	DCC	0001	COLORECTAL CANCER, SOMATIC	DCC, PRO-HIS, 4124C-A	
120470	1630	DCC	0002	ESOPHAGEAL CARCINOMA, SOMATIC	DCC, MET168THR	121912967
120470	1630	DCC	0003	MIRROR MOVEMENTS, CONGENITAL	DCC, IVS6, G-A, +1	
120470	1630	DCC	0004	MIRROR MOVEMENTS, CONGENITAL	DCC, 1-BP INS, 571G	
120470	1630	DCC	0005	MIRROR MOVEMENTS, CONGENITAL	DCC, 2-BP DEL, 3835CT	
120550	712	C1QA	0001	C1q DEFICIENCY	C1QA, GLN186TER	121909581
120570	713	C1QB	0001	C1Q DEFICIENCY	C1QB, 150G-A	
120575	714	C1QC	0001	C1Q DEFICIENCY	C1QC, 1-BP DEL, 43C	
120575	714	C1QC	0002	C1Q DEFICIENCY	C1QC, 41C-T	
120575	714	C1QC	0003	C1Q DEFICIENCY	C1QC, 6G-A	
120580	716	C1S	0001	C1s DEFICIENCY	C1S, 4-BP DEL, NT1087	
120580	716	C1S	0002	C1s DEFICIENCY	C1S, ARG534TER	121909582
120620	1378	CR1	0001	MALARIA, SEVERE, RESISTANCE TO	CR1, 3650A-G	
120650	1380	CR2	0001	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 9	CR2, HAPLOTYPE, TGG	17615
120650	1380	CR2	0002	IMMUNODEFICIENCY, COMMON VARIABLE, 7	CR2, IVS6DS, G-C, +1	
120650	1380	CR2	0003	IMMUNODEFICIENCY, COMMON VARIABLE, 7	CR2, TRP766TER	
120700	718	C3	0001	MACULAR DEGENERATION, AGE-RELATED, 9, SUSCEPTIBILITY TO C3S/C3F POLYMORPHISM	C3, ARG102GLY	2230199
120700	718	C3	0002	C3 POLYMORPHISM, HAV 4-1 PLUS/MINUS TYPE	C3, LEU314PRO	1047286
120700	718	C3	0003	C3 DEFICIENCY	C3, 61-BP DEL, EX18	
120700	718	C3	0004	C3 DEFICIENCY	C3, 800-BP DEL	
120700	718	C3	0005	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5	C3, ARG570GLN	121909583
120700	718	C3	0006	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5	C3, ALA1072VAL	121909584
120700	718	C3	0007	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5	C3, ASP1093ASN	121909585
120700	718	C3	0008	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5	C3, TYR832TER	121909586
120700	718	C3	0009	C3 DEFICIENCY	C3, IVS38AS, A-G	
120810	720	C4A	0001	C4A DEFICIENCY	C4A, 2-BP INS, EX29	
120900	727	C5	0001	COMPLEMENT COMPONENT 5 DEFICIENCY	C5, GLN84TER	121909587
120900	727	C5	0002	COMPLEMENT COMPONENT 5 DEFICIENCY	C5, ARG1458TER	121909588
120900	727	C5	0003	COMPLEMENT COMPONENT 5 DEFICIENCY	C5, CCC-GC, NT4884	
120900	727	C5	0004	COMPLEMENT COMPONENT 5 DEFICIENCY	C5, LYS372ARG, EX10DEL	
120900	727	C5	0005	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	C5, HAPLOTYPE, C5_1	192408
120920	4179	CD46	0001	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 2	CD46, 2-BP DEL, 843AC	
120920	4179	CD46	0002	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 2	CD46, 6-BP DEL	
120920	4179	CD46	0003	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 2	CD46, SER206PRO	121909589
120920	4179	CD46	0004	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 2	CD46, IVS1AS, G-C, -1	
120920	4179	CD46	0005	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 2	CD46, ARG25TER	121909590
120920	4179	CD46	0006	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 2	CD46, CYS1TYR	121909591
120940	735	C9	0001	C9 DEFICIENCY	C9, ARG95TER	121909592
120940	735	C9	0002	C9 DEFICIENCY	C9, CYS33TER	34000044
120940	735	C9	0003	C9 DEFICIENCY	C9, CYS98GLY	121909593
120940	735	C9	0004	C9 DEFICIENCY	C9, SER406TER	121909594
120940	735	C9	0005	C9 DEFICIENCY	C9, CYS507TYR	
120950	731	C8A	0001	COMPLEMENT COMPONENT 8, ALPHA SUBUNIT, A/B POLYMORPHISM	C8A, GLN-LYS	
120950	731	C8A	0002	COMPLEMENT C8 DEFICIENCY, TYPE I	C8A, IVS2, G-T, +1	
120950	731	C8A	0003	COMPLEMENT C8 DEFICIENCY, TYPE I	C8A, ARG394TER	
120960	732	C8B	0001	COMPLEMENT C8 DEFICIENCY, TYPE II	C8B, ARG428TER	41286844
120960	732	C8B	0002	COMPLEMENT C8 DEFICIENCY, TYPE II	C8B, ARG274TER	
120960	732	C8B	0003	COMPLEMENT C8 DEFICIENCY, TYPE II	C8B, ARG121TER	
120960	732	C8B	0004	COMPLEMENT C8 DEFICIENCY, TYPE II	C8B, GLN91TER	
120960	732	C8B	0005	COMPLEMENT C8 DEFICIENCY, TYPE II	C8B, 1-BP DEL, 336C	
120960	732	C8B	0006	COMPLEMENT C8 DEFICIENCY, TYPE II	C8B, 1-BP DEL, 605C	
120960	732	C8B	0007	COMPLEMENT C8 DEFICIENCY, TYPE II	C8B, 7-BP DUP, NT1047	
121011	2706	GJB2	0001	DEAFNESS, AUTOSOMAL RECESSIVE 1A	GJB2, MET34THR	35887622
121011	2706	GJB2	0002	DEAFNESS, AUTOSOMAL RECESSIVE 1A	GJB2, TRP77TER	80338944
121011	2706	GJB2	0003	DEAFNESS, AUTOSOMAL RECESSIVE 1A	GJB2, TRP24TER	104894396
121011	2706	GJB2	0004	DEAFNESS, AUTOSOMAL RECESSIVE 1A	GJB2, TRP77ARG	104894397
121011	2706	GJB2	0005	DEAFNESS, AUTOSOMAL RECESSIVE 1A DEAFNESS, DIGENIC, GJB2/GJB6, INCLUDED	GJB2, 1-BP DEL, 35G	80338939
121011	2706	GJB2	0006	DEAFNESS, AUTOSOMAL RECESSIVE 1A	GJB2, GLU47TER	104894398
121011	2706	GJB2	0007	DEAFNESS, AUTOSOMAL RECESSIVE 1A	GJB2, GLU118DEL	
121011	2706	GJB2	0008	DEAFNESS, AUTOSOMAL RECESSIVE 1A	GJB2, ARG184PRO	80338950
121011	2706	GJB2	0009	DEAFNESS, AUTOSOMAL RECESSIVE 1A	GJB2, ARG143TRP	80338948
121011	2706	GJB2	0010	DEAFNESS, AUTOSOMAL RECESSIVE 1A	GJB2, 1-BP DEL, 167T	80338942
121011	2706	GJB2	0011	DEAFNESS, AUTOSOMAL DOMINANT 3A	GJB2, ARG75TRP	104894402
121011	2706	GJB2	0012	VOHWINKEL SYNDROME	GJB2, ASP66HIS	104894403
121011	2706	GJB2	0013	DEAFNESS, AUTOSOMAL RECESSIVE 1A	GJB2, 12-BP DEL, 1-BP INS, NT51	
121011	2706	GJB2	0014	DEAFNESS, AUTOSOMAL RECESSIVE 1A DEAFNESS, DIGENIC, GJB2/GJB3, INCLUDED	GJB2, 1-BP DEL, 235C	80338943
121011	2706	GJB2	0015	KERATODERMA, PALMOPLANTAR, WITH DEAFNESS	GJB2, GLY59ALA	104894404
121011	2706	GJB2	0016	DEAFNESS, AUTOSOMAL RECESSIVE 1A	GJB2, LEU90PRO	80338945
121011	2706	GJB2	0017	DEAFNESS, AUTOSOMAL DOMINANT 3A DEAFNESS, AUTOSOMAL RECESSIVE 1A, INCLUDED	GJB2, ARG143GLN	104894401
121011	2706	GJB2	0018	DEAFNESS, AUTOSOMAL DOMINANT 3A	GJB2, CYS202PHE	104894406
121011	2706	GJB2	0019	DEAFNESS, AUTOSOMAL DOMINANT 3A	GJB2, TRP44CYS	104894407
121011	2706	GJB2	0020	KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL DOMINANT HYSTRIX-LIKE ICHTHYOSIS WITH DEAFNESS, INCLUDED	GJB2, ASP50ASN	28931594
121011	2706	GJB2	0021	KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL DOMINANT	GJB2, GLY12ARG	104894408
121011	2706	GJB2	0022	KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL DOMINANT	GJB2, SER17PHE	28929485
121011	2706	GJB2	0023	DEAFNESS, AUTOSOMAL RECESSIVE 1A	GJB2, VAL37ILE	72474224
121011	2706	GJB2	0024	DEAFNESS, AUTOSOMAL RECESSIVE 1A	GJB2, ASP159VAL	28931592
121011	2706	GJB2	0025	DEAFNESS, AUTOSOMAL RECESSIVE 1A	GJB2, 5-BP DUP, NT280	
121011	2706	GJB2	0026	KERATODERMA, PALMOPLANTAR, WITH DEAFNESS DEAFNESS, AUTOSOMAL DOMINANT 3A, INCLUDED	GJB2, ARG75GLN	28931593
121011	2706	GJB2	0027	KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL DOMINANT	GJB2, ASP50TYR	28931594
121011	2706	GJB2	0028	DEAFNESS, AUTOSOMAL DOMINANT 3A	GJB2, ASP179ASN	28931595
121011	2706	GJB2	0029	DEAFNESS, AUTOSOMAL RECESSIVE 1A	GJB2, IVS1DS, G-A, +1	80338940
121011	2706	GJB2	0030	KNUCKLE PADS, LEUKONYCHIA, AND SENSORINEURAL DEAFNESS	GJB2, ASN54LYS	104894412
121011	2706	GJB2	0031	DEAFNESS, AUTOSOMAL DOMINANT 3A	GJB2, TRP44SER	104894413
121011	2706	GJB2	0032	DEAFNESS, AUTOSOMAL RECESSIVE 1A	GJB2, VAL84LEU	104894409
121011	2706	GJB2	0033	KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL DOMINANT DEAFNESS, AUTOSOMAL RECESSIVE 1A, INCLUDED	GJB2, GLY45GLU	72561723
121011	2706	GJB2	0034	DEAFNESS, AUTOSOMAL RECESSIVE 1A	GJB2, 14-BP DEL, NT313	
121011	2706	GJB2	0035	KNUCKLE PADS, LEUKONYCHIA, AND SENSORINEURAL DEAFNESS	GJB2, GLY59SER	104894410
121011	2706	GJB2	0036	DEAFNESS, AUTOSOMAL RECESSIVE 1A	GJB2, -3438C-T	
121011	2706	GJB2	0037	DEAFNESS, AUTOSOMAL RECESSIVE 1A	GJB2, VAL84MET	104894409
121011	2706	GJB2	0038	KERATODERMA, PALMOPLANTAR, WITH DEAFNESS	GJB2, HIS73ARG	121912968
121011	2706	GJB2	0039	DEAFNESS, AUTOSOMAL DOMINANT 3A	GJB2, ARG184GLN	
121013	2702	GJA5	0001	ATRIAL FIBRILLATION, FAMILIAL, 11	GJA5, ALA96SER	121434557
121013	2702	GJA5	0002	ATRIAL FIBRILLATION, SOMATIC	GJA5, PRO88SER	121434558
121013	2702	GJA5	0003	ATRIAL FIBRILLATION, FAMILIAL, 11	GJA5, GLN49TER	
121013	2702	GJA5	0004	ATRIAL FIBRILLATION, FAMILIAL, 11	GJA5, VAL85ILE	
121013	2702	GJA5	0005	ATRIAL FIBRILLATION, FAMILIAL, 11	GJA5, LEU221ILE	
121013	2702	GJA5	0006	ATRIAL FIBRILLATION, FAMILIAL, 11	GJA5, LEU229MET	
121014	2697	GJA1	0002	REMOVED FROM DATABASE .0003 OCULODENTODIGITAL DYSPLASIA	GJA1, TYR17SER	
121014	2697	GJA1	0004	OCULODENTODIGITAL DYSPLASIA	GJA1, SER18PRO	104893962
121014	2697	GJA1	0005	OCULODENTODIGITAL DYSPLASIA	GJA1, GLY21ARG	104893963
121014	2697	GJA1	0006	OCULODENTODIGITAL DYSPLASIA	GJA1, GLY22GLU	104893964
121014	2697	GJA1	0007	OCULODENTODIGITAL DYSPLASIA	GJA1, 3-BP DUP, 154TTT	
121014	2697	GJA1	0008	SYNDACTYLY, TYPE III	GJA1, GLY143SER	28931600
121014	2697	GJA1	0009	OCULODENTODIGITAL DYSPLASIA	GJA1, VAL96MET	28931601
121014	2697	GJA1	0010	OCULODENTODIGITAL DYSPLASIA	GJA1, 2-BP DEL, 780T-G	
121014	2697	GJA1	0011	HYPOPLASTIC LEFT HEART SYNDROME 1 ATRIOVENTRICULAR SEPTAL DEFECT 3, INCLUDED	GJA1, ARG362GLN	2227885
121014	2697	GJA1	0012	HYPOPLASTIC LEFT HEART SYNDROME ATRIOVENTRICULAR SEPTAL DEFECT 3, INCLUDED	GJA1, ARG376GLN	104893965
121014	2697	GJA1	0013	OCULODENTODIGITAL DYSPLASIA	GJA1, HIS194PRO	104893966
121014	2697	GJA1	0014	OCULODENTODIGITAL DYSPLASIA	GJA1, LEU11PRO	121912969
121014	2697	GJA1	0015	OCULODENTODIGITAL DYSPLASIA	GJA1, 2-BP DEL, 679AT	
121014	2697	GJA1	0016	OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	GJA1, ARG33TER	121912970
121014	2697	GJA1	0017	OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	GJA1, ARG76HIS	
121014	2697	GJA1	0018	OCULODENTODIGITAL DYSPLASIA	GJA1, ARG76SER	
121014	2697	GJA1	0019	OCULODENTODIGITAL DYSPLASIA	GJA1, 12-BP DEL, NT120	
121014	2697	GJA1	0020	OCULODENTODIGITAL DYSPLASIA	GJA1, LEU11PHE	
121015	2700	GJA3	0001	CATARACT 14, ZONULAR PULVERULENT	GJA3, ASN63SER	
121015	2700	GJA3	0002	CATARACT 14, ZONULAR PULVERULENT	GJA3, 1-BP INS, 1137C	
121015	2700	GJA3	0003	CATARACT 14, ZONULAR PULVERULENT	GJA3, PRO187LEU	
121015	2700	GJA3	0004	CATARACT 14, ZONULAR PULVERULENT	GJA3, ARG76HIS	
121015	2700	GJA3	0005	CATARACT 14, NUCLEAR PULVERULENT	GJA3, ASN188THR	
121015	2700	GJA3	0006	CATARACT 14, NUCLEAR PULVERULENT AND POSTERIOR POLAR	GJA3, GLY2ASP	
121015	2700	GJA3	0007	CATARACT 14, NUCLEAR CORALLIFORM	GJA3, ASN188ILE	
121015	2700	GJA3	0008	CATARACT 14, EMBRYONAL NUCLEAR	GJA3, PHE206ILE	
121015	2700	GJA3	0009	CATARACT 14, COPPOCK-LIKE	GJA3, GLY143ARG	
122500	866	SERPINA6	0001	CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	SERPINA6, LEU93HIS	113418909
122500	866	SERPINA6	0002	CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	SERPINA6, ASP367ASN	28929488
122500	866	SERPINA6	0003	CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	SERPINA6, 121G-A	
122720	1548	CYP2A6	0001	COUMARIN, POOR METABOLISM OF NICOTINE, POOR METABOLISM OF, INCLUDED;; CYP2A6, V1;; CYPA6*2	CYP2A6, LEU160HIS	1801272
122720	1548	CYP2A6	0002	LUNG CANCER, PROTECTION AGAINST CYP2A6*4A	CYP2A6, DEL	
122720	1548	CYP2A6	0003	TEGAFUR, POOR METABOLISM OF CYP2A6*11	CYP2A6, SER224PRO	111033610
122720	1548	CYP2A6	0004	NICOTINE, POOR METABOLISM OF CYP2A6*3;; CYP2A6, V2	CYP2A6, GENE CONVERSION	
122720	1548	CYP2A6	0005	COUMARIN, POOR METABOLISM OF CYP2A6*12A	CYP2A6, 10-AMINO ACID SUBSTITUTION	
123101	4488	MSX2	0001	CRANIOSYNOSTOSIS, TYPE 2	MSX2, PRO148HIS	104893895
123101	4488	MSX2	0002	PARIETAL FORAMINA 1	MSX2, 6-BP DEL, NT475	
123101	4488	MSX2	0003	PARIETAL FORAMINA 1	MSX2, ARG172HIS	104893896
123101	4488	MSX2	0004	PARIETAL FORAMINA 1	MSX2, 206-KB DEL	
123101	4488	MSX2	0005	PARIETAL FORAMINA 1	MSX2, ALA89TER	121912971
123101	4488	MSX2	0006	PARIETAL FORAMINA 1	MSX2, TRP115TER	121912972
123101	4488	MSX2	0007	PARIETAL FORAMINA WITH CLEIDOCRANIAL DYSPLASIA	MSX2, 4-BP DUP, NT505	
123101	4488	MSX2	0008	PARIETAL FORAMINA 1	MSX2, 8-BP DEL, NT548	
123580	1409	CRYAA	0001	CATARACT 9, MULTIPLE TYPES	CRYAA, ARG116CYS	74315439
123580	1409	CRYAA	0002	CATARACT 9, AUTOSOMAL RECESSIVE	CRYAA, TRP9TER	74315440
123580	1409	CRYAA	0003	CATARACT 9, NUCLEAR	CRYAA, ARG49CYS	74315441
123580	1409	CRYAA	0004	CATARACT 9, MULTIPLE TYPES, WITH MICROCORNEA	CRYAA, ARG116HIS	121912973
123590	1410	CRYAB	0001	MYOPATHY, MYOFIBRILLAR, ALPHA-B CRYSTALLIN-RELATED	CRYAB, ARG120GLY	104894201
123590	1410	CRYAB	0002	CATARACT 16, POSTERIOR POLAR	CRYAB, 1-BP DEL, 450A	
123590	1410	CRYAB	0003	MYOPATHY, MYOFIBRILLAR, ALPHA-B CRYSTALLIN-RELATED	CRYAB, 2-BP DEL, 464CT	
123590	1410	CRYAB	0004	MYOPATHY, MYOFIBRILLAR, ALPHA-B CRYSTALLIN-RELATED	CRYAB, GLN151TER	104894202
123590	1410	CRYAB	0005	MYOPATHY, MYOFIBRILLAR, FATAL INFANTILE HYPERTONIC, ALPHA-B CRYSTALLIN-RELATED	CRYAB, 1-BP DEL, 60C	
123590	1410	CRYAB	0006	CARDIOMYOPATHY, DILATED, 1II	CRYAB, ARG157HIS	
123590	1410	CRYAB	0007	CARDIOMYOPATHY, DILATED, 1II	CRYAB, GLY154SER	
123590	1410	CRYAB	0008	CATARACT 16, CONGENITAL LAMELLAR	CRYAB, ASP140ASN	
123590	1410	CRYAB	0009	CATARACT 16, POSTERIOR POLAR	CRYAB, PRO20SER	
123590	1410	CRYAB	0010	CATARACT, JUVENILE	CRYAB, ARG56TRP	
123590	1410	CRYAB	0011	MYOPATHY, MYOFIBRILLAR, 2	CRYAB, ASP109HIS	
123610	1411	CRYBA1	0001	CATARACT 10, CONGENITAL ZONULAR, WITH SUTURAL OPACITIES	CRYBA1, IVS3DS, G-A, +1	
123610	1411	CRYBA1	0002	CATARACT 10, MULTIPLE TYPES	CRYBA1, 3-BP DEL, 278GGA	
123620	1415	CRYBB2	0001	CATARACT 3, MULTIPLE TYPES	CRYBB2, GLN155TER	74315489
123620	1415	CRYBB2	0002	CATARACT 3, MULTIPLE TYPES	CRYBB2, 483C-T	
123630	1417	CRYBB3	0001	CATARACT 22, NUCLEAR, AUTOSOMAL RECESSIVE	CRYBB3, GLY165ARG	74315490
123631	1413	CRYBA4	0001	CATARACT, LAMELLAR 2	CRYBA4, PHE94SER	74315486
123631	1413	CRYBA4	0002	MICROPHTHALMIA, ISOLATED, WITH CATARACT 4	CRYBA4, LEU69PRO	74315487
123670	1419	CRYGB	0001	CATARACT, AUTOSOMAL DOMINANT, MULTIPLE TYPES	CRYGB, 1-BP DEL, 167C	
123670	1419	CRYGB	0002	CATARACT, AUTOSOMAL DOMINANT, MULTIPLE TYPES	CRYGB, 1-BP DEL, 67G	
123680	1420	CRYGC	0001	CATARACT 2, COPPOCK-LIKE	CRYGC, THR5PRO	104893618
123680	1420	CRYGC	0002	CATARACT 2, ZONULAR PULVERULENT	CRYGC, 5-BP DUP, NT226	
123680	1420	CRYGC	0003	CATARACT 2, LAMELLAR	CRYGC, ARG168TRP	28931604
123690	1421	CRYGD	0001	CATARACT 4, PUNCTATE	CRYGD, ARG14CYS	121909595
123690	1421	CRYGD	0002	CATARACT 4, CRYSTALLINE ACULEIFORM	CRYGD, ARG58HIS	121909596
123690	1421	CRYGD	0003	CATARACT 4, CRYSTALLINE	CRYGD, ARG36SER	121909597
123690	1421	CRYGD	0004	CATARACT 4, MULTIPLE TYPES	CRYGD, PRO23THR	28931605
123690	1421	CRYGD	0005	CATARACT 4, CENTRAL NUCLEAR	CRYGD, TRP156TER	121909598
123690	1421	CRYGD	0007	CATARACT 4, NONNUCLEAR POLYMORPHIC CONGENITAL	CRYGD, PRO23SER	28931605
123730	1427	CRYGS	0001	CATARACT 20, MULTIPLE TYPES	CRYGS, GLY18VAL	104893736
123740	1428	CRYM	0001	DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC	CRYM, TER315TYR	104894509
123740	1428	CRYM	0002	DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC	CRYM, LYS314THR	104894512
123810	1385	CREB1	0001	VARIANT OF UNKNOWN SIGNIFICANCE	CREB1, ASP116GLY	
123825	1259	CNGA1	0001	RETINITIS PIGMENTOSA 49	CNGA1, GLU76TER	121909599
123825	1259	CNGA1	0002	RETINITIS PIGMENTOSA 49	CNGA1, LYS139TER	121909600
123825	1259	CNGA1	0003	RETINITIS PIGMENTOSA 49	CNGA1, SER316PHE	62625014
123825	1259	CNGA1	0004	RETINITIS PIGMENTOSA 49	CNGA1, 1-BP DEL, FS655TER	
123829	1019	CDK4	0001	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 3	CDK4, ARG24CYS	11547328
123829	1019	CDK4	0002	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 3	CDK4, ARG24HIS	104894340
123841	5479	PPIB	0001	OSTEOGENESIS IMPERFECTA, TYPE IX	PPIB, 4-BP DEL, 556AAGA	
123841	5479	PPIB	0002	OSTEOGENESIS IMPERFECTA, TYPE IX	PPIB, GLN151TER	121434559
123841	5479	PPIB	0003	OSTEOGENESIS IMPERFECTA, TYPE IX	PPIB, MET9ARG	
123841	5479	PPIB	0004	OSTEOGENESIS IMPERFECTA, TYPE IX	PPIB, 4-BP DEL, 563ACAG	
123889	3588	IL10RB	0001	HEPATITIS B VIRUS, SUSCEPTIBILITY TO	IL10RB, GLU47LYS	2834167
123889	3588	IL10RB	0002	INFLAMMATORY BOWEL DISEASE 25	IL10RB, TRP159TER	121909601
123889	3588	IL10RB	0003	INFLAMMATORY BOWEL DISEASE 25	IL10RB, GLU141TER	
123890	1493	CTLA4	0001	HASHIMOTO THYROIDITIS, SUSCEPTIBILITY TO THYROID-ASSOCIATED ORBITOPATHY, SUSCEPTIBILITY TO, INCLUDED;; SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, INCLUDED;; DIABETES MELLITUS, INSULIN-DEPENDENT, SUSCEPTIBILITY TO, INCLUDED;; CELIAC DISEASE, SUSCEPTIBILITY TO, 3, INCLUDED	CTLA4, 49A-G, THR17ALA	231775
123890	1493	CTLA4	0002	GRAVES DISEASE, SUSCEPTIBILITY TO, 4 HASHIMOTO THYROIDITIS, SUSCEPTIBILITY TO, INCLUDED;; CELIAC DISEASE, SUSCEPTIBILITY TO, 3, INCLUDED	CTLA4, 60A-G, 3-PRIME UTR	3087243
123930	1555	CYP2B6	0001	EFAVIRENZ, POOR METABOLISM OF EFAVIRENZ CENTRAL NERVOUS SYSTEM TOXICITY, SUSCEPTIBILITY TO, INCLUDED	CYP2B6, GLN172HIS	
123940	3851	KRT4	0001	WHITE SPONGE NEVUS	KRT4, 3-BP DEL, ASN8	
123940	3851	KRT4	0002	WHITE SPONGE NEVUS	KRT4, 3-BP INS, GLN153	
123940	3851	KRT4	0003	WHITE SPONGE NEVUS	KRT4, GLU449LYS	62642055
123970	54205	CYCS	0001	THROMBOCYTOPENIA, AUTOSOMAL DOMINANT, 4	CYCS, GLY42SER	121918552
124010	1576	CYP3A4	0001	CYP3A4 PROMOTER POLYMORPHISM CYP3A4-V	CYP3A4, a-g PROMOTER	
124015	5447	POR	0001	ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS	POR, VAL492GLU	28931606
124015	5447	POR	0002	ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS	POR, ALA287PRO	121912974
124015	5447	POR	0003	DISORDERED STEROIDOGENESIS DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	POR, CYS569TYR	28931607
124015	5447	POR	0004	DISORDERED STEROIDOGENESIS DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	POR, VAL608PHE	72552772
124015	5447	POR	0005	ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS DISORDERED STEROIDOGENESIS DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY, INCLUDED	POR, ARG457HIS	28931608
124015	5447	POR	0006	ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS	POR, IVS6DS, G-A, +1	
124015	5447	POR	0007	DISORDERED STEROIDOGENESIS DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	POR, TYR178ASP	72552771
124015	5447	POR	0008	DISORDERED STEROIDOGENESIS DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	POR, CYS566TYR	28931607
124015	5447	POR	0009	DISORDERED STEROIDOGENESIS DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	POR, ALA284PRO	
124015	5447	POR	0011	ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS	POR, 1-BP INS, 1329C	
124015	5447	POR	0012	ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS	POR, TYR578CYS	121912975
124015	5447	POR	0013	ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS	POR, 24-BP DEL, NT1835	
124015	5447	POR	0014	ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS	POR, 15A-G	
124015	5447	POR	0015	ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS	POR, 13-BP INS, NT580	
124015	5447	POR	0016	ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS DISORDERED STEROIDOGENESIS DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY, INCLUDED	POR, GLY539ARG	121912976
124020	1557	CYP2C19	0001	MEPHENYTOIN, POOR METABOLISM OF PROGUANIL, POOR METABOLISM OF, INCLUDED;; CLOPIDOGREL, POOR METABOLISM OF, INCLUDED	CYP2C19, 681G-A	4244285
124020	1557	CYP2C19	0002	MEPHENYTOIN, POOR METABOLISM OF	CYP2C19, ARG433TRP	56337013
124020	1557	CYP2C19	0003	MEPHENYTOIN, POOR METABOLISM OF PROGUANIL, POOR METABOLISM OF, INCLUDED	CYP2C19, TRP212TER	4986893
124020	1557	CYP2C19	0004	MEPHENYTOIN, POOR METABOLISM OF	CYP2C19, MET1VAL	28399504
124030	1565	CYP2D6	0001	DEBRISOQUINE, POOR METABOLISM OF	CYP2D6, IVSDS3, G-A, +1	
124030	1565	CYP2D6	0002	DEBRISOQUINE, POOR METABOLISM OF	CYP2D6, DEL	
124030	1565	CYP2D6	0003	DEBRISOQUINE, POOR METABOLISM OF	CYP2D6, 1-BP DEL, 1795T	
124030	1565	CYP2D6	0004	DEBRISOQUINE, POOR METABOLISM OF	CYP2D6, GLY169TER	5030865
124030	1565	CYP2D6	0005	DEBRISOQUINE, POOR METABOLISM OF	CYP2D6, PRO34SER	1065852
124030	1565	CYP2D6	0006	DEBRISOQUINE, POOR METABOLISM OF	CYP2D6, 1-BP DEL, 2637A	
124030	1565	CYP2D6	0007	DEBRISOQUINE, ULTRARAPID METABOLISM OF	CYP2D6, ARG296CYS AND SER486THR	16947
124030	1565	CYP2D6	0008	CODEINE, ULTRARAPID METABOLISM OF	CYP2D6, DUP	
124040	1571	CYP2E1	0001	CYP2E1*5B ALLELE	CYP2E1, -1293G-C AND -1053C-T	2031920
124040	1571	CYP2E1	0002	CYP2E1*6 ALLELE	CYP2E1, IVS6, 7632T-A	6413432
124080	1585	CYP11B2	0001	CORTICOSTERONE METHYLOXIDASE TYPE II DEFICIENCY	CYP11B2, ARG181TRP AND VAL386ALA	61757294
124080	1585	CYP11B2	0002	CORTICOSTERONE METHYLOXIDASE TYPE I DEFICIENCY	CYP11B2, VAL386ALA AND GLU198ASP	104894072
124080	1585	CYP11B2	0003	CORTICOSTERONE METHYLOXIDASE TYPE I DEFICIENCY	CYP11B2, 5-BP DEL	
124080	1585	CYP11B2	0005	CORTICOSTERONE METHYLOXIDASE TYPE I DEFICIENCY	CYP11B2, LEU461PRO	72554627
124080	1585	CYP11B2	0006	CORTICOSTERONE METHYLOXIDASE TYPE I DEFICIENCY	CYP11B2, GLU255TER	121912977
124080	1585	CYP11B2	0007	CORTICOSTERONE METHYLOXIDASE TYPE II DEFICIENCY	CYP11B2, THR185ILE	121912978
124080	1585	CYP11B2	0009	CORTICOSTERONE METHYLOXIDASE TYPE I DEFICIENCY	CYP11B2, 6-BP DUP, CODON 143	
124080	1585	CYP11B2	0010	ALDOSTERONE TO RENIN RATIO, INCREASED	CYP11B2, -344C-T	
124080	1585	CYP11B2	0011	ALDOSTERONE TO RENIN RATIO, INCREASED	CYP11B2, IVS2 CONVERSION	
124080	1585	CYP11B2	0012	CORTICOSTERONE METHYLOXIDASE TYPE II DEFICIENCY	CYP11B2, THR498ALA	72554626
124080	1585	CYP11B2	0013	CORTICOSTERONE METHYLOXIDASE TYPE II DEFICIENCY	CYP11B2, GLU272TER	121912979
124089	1340	COX6B1	0001	CYTOCHROME c OXIDASE DEFICIENCY	COX6B1, ARG19HIS	121909602
124092	3586	IL10	0001	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO GRAFT-VERSUS-HOST DISEASE, RESISTANCE TO, INCLUDED	IL10, -592C-A	
124092	3586	IL10	0002	RHEUMATOID ARTHRITIS, PROGRESSION OF	IL10, -2849A-G	
125240	1604	CD55	0001	CROMER BLOOD GROUP SYSTEM, Inab PHENOTYPE	CD55, TRP53TER	121909603
125240	1604	CD55	0002	CROMER BLOOD GROUP SYSTEM, Inab PHENOTYPE	CD55, 26-BP DEL	
125255	1634	DCN	0001	CORNEAL DYSTROPHY, CONGENITAL STROMAL	DCN, 1-BP DEL, 967T	80338741
125270	210	ALAD	0001	PORPHYRIA, ACUTE HEPATIC	ALAD, GLY133ARG	121912980
125270	210	ALAD	0002	PORPHYRIA, ACUTE HEPATIC	ALAD, VAL275MET	121912981
125270	210	ALAD	0003	AMINOLEVULINATE DEHYDRATASE, ALAD*1/ALAD*2 POLYMORPHISM	ALAD, LYS59ASN	1800435
125270	210	ALAD	0004	PORPHYRIA, ACUTE HEPATIC	ALAD, ARG240TRP	121912982
125270	210	ALAD	0005	PORPHYRIA, ACUTE HEPATIC	ALAD, ALA274THR	121912983
125270	210	ALAD	0006	PORPHYRIA, ACUTE HEPATIC, DIGENIC	ALAD, PHE12LEU	121912984
125270	210	ALAD	0007	PORPHYRIA, ACUTE HEPATIC	ALAD, IVS3AS, C-A, -11	
125270	210	ALAD	0008	PORPHYRIA, ACUTE HEPATIC	ALAD, IVS3AS, C-T, -11	
125485	1834	DSPP	0001	DENTINOGENESIS IMPERFECTA, SHIELDS TYPE II	DSPP, GLN45TER	121912985
125485	1834	DSPP	0002	DENTINOGENESIS IMPERFECTA, SHIELDS TYPE II	DSPP, IVS3DS, G-A, +1	
125485	1834	DSPP	0003	DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 39, WITH DENTINOGENESIS IMPERFECTA 1	DSPP, PRO17THR	121912986
125485	1834	DSPP	0004	DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 39, WITH DENTINOGENESIS IMPERFECTA 1 DENTINOGENESIS IMPERFECTA, SHIELDS TYPE II, INCLUDED;; DENTINOGENESIS IMPERFECTA, SHIELDS TYPE III, INCLUDED	DSPP, VAL18PHE	121912987
125485	1834	DSPP	0005	DENTIN DYSPLASIA, TYPE II	DSPP, ASP6TYR	121912988
125485	1834	DSPP	0006	DENTINOGENESIS IMPERFECTA, SHIELDS TYPE II	DSPP, ARG68TRP	
125485	1834	DSPP	0007	DENTINOGENESIS IMPERFECTA, SHIELDS TYPE II	DSPP, ALA15VAL	121912989
125485	1834	DSPP	0008	DENTIN DYSPLASIA, TYPE II	DSPP, 1-BP DEL, 2040C	
125485	1834	DSPP	0009	DENTINOGENESIS IMPERFECTA, SHIELDS TYPE II	DSPP, 1-BP DEL, 3438C	
125505	1773	DNASE1	0001	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO	DNASE1, LYS5TER	121912990
125505	1773	DNASE1	0002	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO	DNASE1, GLN244ARG	1053874
125645	1824	DSC2	0001	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 11	DSC2, 1-BP DEL, 1430C	
125645	1824	DSC2	0002	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	DSC2, 2-BP INS, 2687GA	
125645	1824	DSC2	0003	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 11	DSC2, IVS5AS, A-G, -2	
125645	1824	DSC2	0004	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 11, WITH MILD PALMOPLANTAR KERATODERMA AND WOOLLY HAIR	DSC2, 1-BP DEL, 1841G	
125647	1832	DSP	0001	KERATOSIS PALMOPLANTARIS STRIATA II	DSP, GLN331TER	121912991
125647	1832	DSP	0002	CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR AND KERATODERMA	DSP, 1-BP DEL, 7901G	
125647	1832	DSP	0003	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 8	DSP, SER299ARG	121912992
125647	1832	DSP	0004	SKIN FRAGILITY-WOOLLY HAIR SYNDROME	DSP, ASN287LYS	121912993
125647	1832	DSP	0005	SKIN FRAGILITY-WOOLLY HAIR SYNDROME	DSP, CYS809TER	121912994
125647	1832	DSP	0006	SKIN FRAGILITY-WOOLLY HAIR SYNDROME	DSP, ARG2366CYS	28931610
125647	1832	DSP	0007	SKIN FRAGILITY-WOOLLY HAIR SYNDROME	DSP, GLN664TER	121912995
125647	1832	DSP	0008	EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC	DSP, ARG1934TER	121912996
125647	1832	DSP	0009	EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC	DSP, 6360TT DEL	
125647	1832	DSP	0010	CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR AND KERATODERMA	DSP, ARG1267TER	121912997
125647	1832	DSP	0011	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 8	DSP, VAL30MET	121912998
125647	1832	DSP	0012	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 8	DSP, ARG2834HIS	121912999
125647	1832	DSP	0013	SKIN FRAGILITY-WOOLLY HAIR SYNDROME	DSP, ARG2366HIS	
125660	1674	DES	0001	MYOPATHY, MYOFIBRILLAR, 1	DES, ALA337PRO	59962885
125660	1674	DES	0002	MYOPATHY, MYOFIBRILLAR, 1	DES, ALA360PRO	121913000
125660	1674	DES	0003	MYOPATHY, MYOFIBRILLAR, 1	DES, ASN393ILE	121913001
125660	1674	DES	0004	MYOPATHY, MYOFIBRILLAR, 1	DES, 21-BP DEL	
125660	1674	DES	0005	CARDIOMYOPATHY, DILATED, 1I	DES, ILE451MET	121913002
125660	1674	DES	0006	MYOPATHY, MYOFIBRILLAR, 1	DES, LEU345PRO	57639980
125660	1674	DES	0007	MYOPATHY, MYOFIBRILLAR, 1	DES, ARG406TRP	121913003
125660	1674	DES	0008	MYOPATHY, MYOFIBRILLAR, 1	DES, IVS3, A-G, +3	
125660	1674	DES	0009	MYOPATHY, MYOFIBRILLAR, 1	DES, IVS2, G-A, -1	
125660	1674	DES	0010	MYOPATHY, MYOFIBRILLAR, 1	DES, LEU385PRO	57955682
125660	1674	DES	0011	MYOPATHY, MYOFIBRILLAR, 1	DES, GLN389PRO	121913004
125660	1674	DES	0012	MYOPATHY, MYOFIBRILLAR, 1	DES, GLU359-ALA360-SER361 DEL	
125660	1674	DES	0013	MYOPATHY, MYOFIBRILLAR, 1	DES, ASN366DEL	58687088
125660	1674	DES	0014	MYOPATHY, MYOFIBRILLAR, 1	DES, 3-BP DEL, 720GAA	
125660	1674	DES	0015	MYOPATHY, MYOFIBRILLAR, 1	DES, THR442ILE	121913005
125660	1674	DES	0016	SCAPULOPERONEAL SYNDROME, NEUROGENIC, KAESER TYPE	DES, ARG350PRO	57965306
125660	1674	DES	0017	MYOPATHY, MYOFIBRILLAR, 1	DES, PRO419SER	
125670	1828	DSG1	0001	KERATOSIS PALMOPLANTARIS STRIATA I	DSG1, IVS2AS, G-A, -1	
125671	1829	DSG2	0001	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 10	DSG2, ARG48HIS	121913006
125671	1829	DSG2	0002	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 10	DSG2, TRP305TER	121913007
125671	1829	DSG2	0003	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 10	DSG2, ARG45GLN	121913008
125671	1829	DSG2	0004	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 10	DSG2, CYS506TYR	121913009
125671	1829	DSG2	0005	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 10	DSG2, GLY811CYS	121913010
125671	1829	DSG2	0006	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 10	DSG2, ASN266SER	121913011
125671	1829	DSG2	0007	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 10	DSG2, GLU331LYS	121913012
125671	1829	DSG2	0008	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 10	DSG2, IVS12AS, A-G, -2	
125671	1829	DSG2	0009	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 10 CARDIOMYOPATHY, DILATED, 1BB, SUSCEPTIBILITY TO, INCLUDED	DSG2, VAL55MET	121913013
125860	1728	NQO1	0001	BENZENE TOXICITY, SUSCEPTIBILITY TO LEUKEMIA, POST-CHEMOTHERAPY, SUSCEPTIBILITY TO, INCLUDED;; BREAST CANCER, POST-CHEMOTHERAPY POOR SURVIVAL IN, INCLUDED	NQO1, PRO187SER	1800566
126060	1719	DHFR	0001	MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	DHFR, LEU80PHE	
126060	1719	DHFR	0002	MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	DHFR, ASP153VAL	
126064	1723	DHODH	0001	MILLER SYNDROME	DHODH, ARG346TRP	
126064	1723	DHODH	0002	MILLER SYNDROME	DHODH, ARG135CYS	
126064	1723	DHODH	0003	MILLER SYNDROME	DHODH, GLY19GLU	
126064	1723	DHODH	0004	MILLER SYNDROME	DHODH, GLY152ARG	
126064	1723	DHODH	0005	MILLER SYNDROME	DHODH, GLY202ALA	
126064	1723	DHODH	0006	MILLER SYNDROME	DHODH, GLY202ASP	
126064	1723	DHODH	0007	MILLER SYNDROME	DHODH, ARG244TRP	
126064	1723	DHODH	0008	MILLER SYNDROME	DHODH, 1-BP DEL, 611T	
126064	1723	DHODH	0009	MILLER SYNDROME	DHODH, ARG199CYS	
126065	1591	CYP24A1	0001	HYPERCALCEMIA, INFANTILE	CYP24A1, 2-BP DEL, 1425TC	
126065	1591	CYP24A1	0002	HYPERCALCEMIA, INFANTILE	CYP24A1, 3-BP DEL, 427GAA	
126065	1591	CYP24A1	0003	HYPERCALCEMIA, INFANTILE	CYP24A1, GLU151TER	
126065	1591	CYP24A1	0004	HYPERCALCEMIA, INFANTILE	CYP24A1, ARG159GLN	
126065	1591	CYP24A1	0005	HYPERCALCEMIA, INFANTILE	CYP24A1, ARG396TRP	
126065	1591	CYP24A1	0006	HYPERCALCEMIA, INFANTILE	CYP24A1, LEU409SER	
126065	1591	CYP24A1	0007	HYPERCALCEMIA, INFANTILE	CYP24A1, GLU322LYS	
126090	5092	PCBD1	0001	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	PCBD1, GLU87TER	104894172
126090	5092	PCBD1	0002	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	PCBD1, CYS82ARG	104894177
126090	5092	PCBD1	0003	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	PCBD1, THR78ILE	121913014
126090	5092	PCBD1	0004	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	PCBD1, GLU86TER	
126090	5092	PCBD1	0005	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	PCBD1, GLN97TER	121913015
126141	1804	DPP6	0001	VENTRICULAR FIBRILLATION, PAROXYSMAL FAMILIAL, 2	DPP6, 340C-T	3807218
126340	2068	ERCC2	0001	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D TRICHOTHIODYSTROPHY, INCLUDED	ERCC2, LEU461VAL	121913016
126340	2068	ERCC2	0002	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D	ERCC2, GLN726TER	121913017
126340	2068	ERCC2	0003	TRICHOTHIODYSTROPHY	ERCC2, ALA725PRO	121913018
126340	2068	ERCC2	0004	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D	ERCC2, 4-BP DEL, NT668	
126340	2068	ERCC2	0005	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D	ERCC2, SER541ARG	121913019
126340	2068	ERCC2	0006	TRICHOTHIODYSTROPHY XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D, INCLUDED	ERCC2, ARG112HIS	121913020
126340	2068	ERCC2	0007	TRICHOTHIODYSTROPHY	ERCC2, ARG658CYS	121913021
126340	2068	ERCC2	0008	TRICHOTHIODYSTROPHY	ERCC2, GLY713ARG	121913022
126340	2068	ERCC2	0009	CEREBROOCULOFACIOSKELETAL SYNDROME 2	ERCC2, ASP681ASN	121913023
126340	2068	ERCC2	0010	CEREBROOCULOFACIOSKELETAL SYNDROME XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D, INCLUDED	ERCC2, ARG616TRP	121913024
126340	2068	ERCC2	0011	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D	ERCC2, 2-BP DEL, 1781TT	
126340	2068	ERCC2	0012	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D	ERCC2, 3-BP DEL/6-BP INS, NT1823	
126340	2068	ERCC2	0013	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D	ERCC2, LEU485PRO	121913025
126340	2068	ERCC2	0014	TRICHOTHIODYSTROPHY	ERCC2, ARG722TRP	121913026
126340	2068	ERCC2	0015	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D	ERCC2, ARG683TRP	
126375	1786	DNMT1	0001	NEUROPATHY, HEREDITARY SENSORY, TYPE IE	DNMT1, TYR495CYS	199473690
126375	1786	DNMT1	0002	NEUROPATHY, HEREDITARY SENSORY, TYPE IE	DNMT1, ASP490GLU AND PRO491TYR	199473691
126375	1786	DNMT1	0003	CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT	DNMT1, VAL606PHE	
126375	1786	DNMT1	0004	CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT	DNMT1, ALA570VAL	
126375	1786	DNMT1	0005	CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT	DNMT1, GLY605ALA	
126380	2067	ERCC1	0001	CEREBROOCULOFACIOSKELETAL SYNDROME 4	ERCC1, GLN158TER	121913027
126380	2067	ERCC1	0002	CEREBROOCULOFACIOSKELETAL SYNDROME 4	ERCC1, PHE231LEU	121913028
126391	3978	LIG1	0001	DNA LIGASE I DEFICIENCY	LIG1, GLU566LYS	121434560
126391	3978	LIG1	0002	DNA LIGASE I DEFICIENCY	LIG1, ARG771TRP	121434561
126420	7150	TOP1	0001	DNA TOPOISOMERASE I, CAMPTOTHECIN-RESISTANT	TOP1, ASP533GLY AND ASP583GLY	
126420	7150	TOP1	0002	DNA TOPOISOMERASE I, CAMPTOTHECIN-RESISTANT	TOP1, GLU418LYS	121434562
126430	7153	TOP2A	0001	DNA TOPOISOMERASE II, RESISTANCE TO INHIBITION OF, BY AMSACRINE	TOP2A, ARG486LYS	
126450	1813	DRD2	0001	MYOCLONUS-DYSTONIA SYNDROME	DRD2, VAL154ILE	104894220
126451	1814	DRD3	0001	SCHIZOPHRENIA, SUSCEPTIBILITY TO ESSENTIAL TREMOR, SUSCEPTIBILITY TO, INCLUDED	DRD3, SER9GLY	6280
126452	1815	DRD4	0001	AUTONOMIC NERVOUS SYSTEM DYSFUNCTION	DRD4, 13-BP DEL, NT235	
126452	1815	DRD4	0002	DOPAMINE RECEPTOR D4 POLYMORPHISM	DRD4, VAL194GLY	1800443
126452	1815	DRD4	0003	ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO	DRD4, 120-BP INS	
126453	1816	DRD5	0001	BLEPHAROSPASM DYSTONIA, PRIMARY CERVICAL, INCLUDED	DRD5, (CT/GT/GA)n	
126453	1816	DRD5	0002	ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO	DRD5, (CA)n MARKER	
126455	6531	SLC6A3	0001	NICOTINE DEPENDENCE, PROTECTION AGAINST SLC6A3*9	SLC6A3, 9-REPEAT VNTR	
126455	6531	SLC6A3	0002	PARKINSONISM-DYSTONIA, INFANTILE	SLC6A3, LEU368GLN	
126455	6531	SLC6A3	0003	PARKINSONISM-DYSTONIA, INFANTILE	SLC6A3, PRO395LEU	
126455	6531	SLC6A3	0004	PARKINSONISM-DYSTONIA, INFANTILE	SLC6A3, IVS9DS, G-T, +1	
126650	1811	SLC26A3	0001	DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL	SLC26A3, 3-BP DEL, VAL317DEL	121913029
126650	1811	SLC26A3	0002	DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL	SLC26A3, HIS124LEU	121913030
126650	1811	SLC26A3	0003	DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL	SLC26A3, 1-BP DEL, T344	
126650	1811	SLC26A3	0004	DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL	SLC26A3, 3.5-KB DEL	
126650	1811	SLC26A3	0005	DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL	SLC26A3, 3-BP INS, ILE676INS	121913031
126650	1811	SLC26A3	0006	DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL	SLC26A3, GLY187TER	121913032
126650	1811	SLC26A3	0007	DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL	SLC26A3, 13-BP DEL	
126650	1811	SLC26A3	0008	DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL	SLC26A3, TRP462TER	121913033
128239	1605	DAG1	0001	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9	DAG1, THR192MET	
128260	6635	SNRPE	0001	HYPOTRICHOSIS 11	SNRPE, 1A-G	
128260	6635	SNRPE	0002	HYPOTRICHOSIS 11	SNRPE, GLY45SER	
129010	1959	EGR2	0001	NEUROPATHY, CONGENITAL HYPOMYELINATING, AUTOSOMAL RECESSIVE	EGR2, ILE268ASN	104894158
129010	1959	EGR2	0002	CHARCOT-MARIE-TOOTH DISEASE, TYPE 1D	EGR2, ARG409TRP	104894159
129010	1959	EGR2	0003	NEUROPATHY, CONGENITAL HYPOMYELINATING, AUTOSOMAL DOMINANT	EGR2, SER382ARG AND ASP383TYR	
129010	1959	EGR2	0004	DEJERINE-SOTTAS NEUROPATHY, AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE, TYPE 1D, INCLUDED	EGR2, ARG359TRP	104894161
129010	1959	EGR2	0005	DEJERINE-SOTTAS NEUROPATHY, AUTOSOMAL DOMINANT	EGR2, GLU412LYS	121434563
129190	4907	NT5E	0001	CALCIFICATION OF JOINTS AND ARTERIES	NT5E, SER221TER	
129190	4907	NT5E	0002	CALCIFICATION OF JOINTS AND ARTERIES	NT5E, CYS358TYR	
129190	4907	NT5E	0003	CALCIFICATION OF JOINTS AND ARTERIES	NT5E, 1-BP DUP, 1609A	
130130	1991	ELANE	0001	CYCLIC NEUTROPENIA	ELANE, ARG191GLN	137854445
130130	1991	ELANE	0002	CYCLIC NEUTROPENIA	ELANE, LEU177PHE	137854446
130130	1991	ELANE	0003	CYCLIC NEUTROPENIA	ELANE, ALA32VAL	137854447
130130	1991	ELANE	0004	CYCLIC NEUTROPENIA	ELANE, IVS4DS, G-A, +1	
130130	1991	ELANE	0005	CYCLIC NEUTROPENIA	ELANE, IVS4DS, G-A, +5	
130130	1991	ELANE	0006	NEUTROPENIA, SEVERE CONGENITAL, 1, AUTOSOMAL DOMINANT	ELANE, PRO110LEU	137854448
130130	1991	ELANE	0007	NEUTROPENIA, SEVERE CONGENITAL, 1, AUTOSOMAL DOMINANT	ELANE, VAL72MET	137854449
130130	1991	ELANE	0008	NEUTROPENIA, SEVERE CONGENITAL, 1, AUTOSOMAL DOMINANT	ELANE, SER97LEU	137854450
130130	1991	ELANE	0009	NEUTROPENIA, SEVERE CONGENITAL, 1, AUTOSOMAL DOMINANT	ELANE, CYS42ARG	28931611
130130	1991	ELANE	0010	NEUTROPENIA, SEVERE CONGENITAL, 1, AUTOSOMAL DOMINANT	ELANE, VAL69LEU AND VAL72LEU	
130130	1991	ELANE	0011	NEUTROPENIA, SEVERE CONGENITAL, 1, AUTOSOMAL DOMINANT	ELANE, GLY185ARG	137854451
130160	2006	ELN	0001	SUPRAVALVULAR AORTIC STENOSIS	ELN, 100-KB DEL	
130160	2006	ELN	0002	SUPRAVALVULAR AORTIC STENOSIS	ELN, 30-KB DEL	
130160	2006	ELN	0003	SUPRAVALVULAR AORTIC STENOSIS	ELN, GLN442TER	137854452
130160	2006	ELN	0004	SUPRAVALVULAR AORTIC STENOSIS	ELN, ARG570TER	137854453
130160	2006	ELN	0005	SUPRAVALVULAR AORTIC STENOSIS	ELN, 1-BP DEL, 1821C	
130160	2006	ELN	0006	SUPRAVALVULAR AORTIC STENOSIS	ELN, IVS15AS, A-G, -2	
130160	2006	ELN	0007	SUPRAVALVULAR AORTIC STENOSIS	ELN, 1-BP INS, FS615TER	
130160	2006	ELN	0008	CUTIS LAXA, AUTOSOMAL DOMINANT 1	ELN, 1-BP DEL, 2012G	
130160	2006	ELN	0009	CUTIS LAXA, AUTOSOMAL DOMINANT 1	ELN, 1-BP DEL, 748A	
130160	2006	ELN	0010	CUTIS LAXA, AUTOSOMAL DOMINANT 1	ELN, 1-BP DEL, 2039C	
130160	2006	ELN	0011	SUPRAVALVULAR AORTIC STENOSIS	ELN, IVS15AS, C-G, -3	
130160	2006	ELN	0012	SUPRAVALVULAR AORTIC STENOSIS	ELN, 1-BP DEL, 1040C	
130160	2006	ELN	0013	SUPRAVALVULAR AORTIC STENOSIS	ELN, TYR150TER	137854454
130160	2006	ELN	0014	SUPRAVALVULAR AORTIC STENOSIS	ELN, LYS176TER	137854455
130160	2006	ELN	0015	SUPRAVALVULAR AORTIC STENOSIS	ELN, ARG610GLN AND 24-BP DUP, NT1034	
130160	2006	ELN	0016	CUTIS LAXA, AUTOSOMAL DOMINANT 1	ELN, EX9-33DUP	
130160	2006	ELN	0017	CUTIS LAXA, AUTOSOMAL DOMINANT 1	ELN, 25-BP DEL, NT2114	
130160	2006	ELN	0018	CUTIS LAXA, AUTOSOMAL DOMINANT 1	ELN, 1-BP DEL, 2159C	
130160	2006	ELN	0019	CUTIS LAXA, AUTOSOMAL DOMINANT 1	ELN, 1621C-T	
130160	2006	ELN	0020	SUPRAVALVULAR AORTIC STENOSIS	ELN, IVS28, G-C, +5	
130410	2109	ETFB	0001	GLUTARIC ACIDEMIA IIB	ETFB, ARG164GLN	104894677
130410	2109	ETFB	0002	GLUTARIC ACIDEMIA IIB	ETFB, 1-EX DEL, IVSDS, +1, G-C	
130410	2109	ETFB	0003	GLUTARIC ACIDEMIA IIB	ETFB, ASP128ASN	104894678
130500	2035	EPB41	0001	ELLIPTOCYTOSIS 1	EPB41, 318-BP DEL	
130500	2035	EPB41	0003	ELLIPTOCYTOSIS 1 PROTEIN 4.1(95)	EPB41, 369-BP DUP	
130500	2035	EPB41	0004	ELLIPTOCYTOSIS 1 PROTEIN 4.1(68/65)	EPB41, 240-BP DEL	
130500	2035	EPB41	0005	ELLIPTOCYTOSIS 1 PROTEIN 4.1 MADRID	EPB41, MET1ARG	121434564
130500	2035	EPB41	0006	ELLIPTOCYTOSIS 1 PROTEIN 4.1 LILLE	EPB41, MET1THR	121434564
131195	2022	ENG	0001	HEREDITARY HEMORRHAGIC TELANGIECTASIA	ENG, TYR277TER	121918400
131195	2022	ENG	0002	HEREDITARY HEMORRHAGIC TELANGIECTASIA	ENG, 39-BP DEL	
131195	2022	ENG	0003	HEREDITARY HEMORRHAGIC TELANGIECTASIA	ENG, 2-BP DEL, FS, TER	
131195	2022	ENG	0004	HEREDITARY HEMORRHAGIC TELANGIECTASIA	ENG, IVS3DS, A-G, +4	
131195	2022	ENG	0005	HEREDITARY HEMORRHAGIC TELANGIECTASIA	ENG, IVS3DS, G-A, +1, EX3DEL	
131195	2022	ENG	0006	HEREDITARY HEMORRHAGIC TELANGIECTASIA	ENG, 2T-C, MET1THR	
131195	2022	ENG	0007	HEREDITARY HEMORRHAGIC TELANGIECTASIA	ENG, GLY413VAL	121918401
131195	2022	ENG	0008	HEREDITARY HEMORRHAGIC TELANGIECTASIA	ENG, IVS1DS, G-A, +1	
131195	2022	ENG	0009	HEREDITARY HEMORRHAGIC TELANGIECTASIA	ENG, TYR120TER	121918402
131210	6401	SELE	0001	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	SELE, HIS468TYR	5368
131222	1890	TYMP	0001	MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE)	TYMP, GLU289ALA	121913036
131222	1890	TYMP	0002	MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE)	TYMP, IVS4DS, 1504T-C	
131222	1890	TYMP	0003	MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE)	TYMP, GLY145ARG	121913037
131222	1890	TYMP	0004	MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE)	TYMP, LYS222SER	
131222	1890	TYMP	0005	MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE)	TYMP, 1-BP INS, 4196C	
131222	1890	TYMP	0006	MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE)	TYMP, IVS8AS, 3867G-C	
131222	1890	TYMP	0007	MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE)	TYMP, 6-BP DEL	
131222	1890	TYMP	0008	MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE)	TYMP, GLY153SER	121913038
131222	1890	TYMP	0009	MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE)	TYMP, ARG44GLN	28931613
131222	1890	TYMP	0010	MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE)	TYMP, IVS1AS, G-C, -1	
131222	1890	TYMP	0011	MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE)	TYMP, VAL208MET	121913039
131222	1890	TYMP	0012	MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE)	TYMP, GLY311ARG	121913040
131222	1890	TYMP	0013	MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE)	TYMP, ARG202THR	121913041
131222	1890	TYMP	0014	MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE)	TYMP, LEU285PRO	121913042
131230	308	ANXA5	0001	PREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 3	ANXA5, M2 HAPLOTYPE	
131240	1906	EDN1	0001	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 7	EDN1, LYS198ASN	5370
131242	1908	EDN3	0001	WAARDENBURG SYNDROME, TYPE 4B	EDN3, 262GC-T	
131242	1908	EDN3	0002	WAARDENBURG SYNDROME TYPE 4B	EDN3, CYS159PHE	74315384
131242	1908	EDN3	0003	CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL	EDN3, 1-BP INS	
131242	1908	EDN3	0004	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 4	EDN3, ALA17THR	11570255
131242	1908	EDN3	0005	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 4	EDN3, ALA224THR	11570351
131242	1908	EDN3	0006	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 4	EDN3, 1-BP INS, 262G	
131242	1908	EDN3	0007	WAARDENBURG SYNDROME TYPE 4B	EDN3, CYS169TER	74315385
131242	1908	EDN3	0008	WAARDENBURG SYNDROME TYPE 4B	EDN3, HIS112ARG	
131242	1908	EDN3	0009	WAARDENBURG SYNDROME TYPE 4B	EDN3, ARG93GLY	
131243	1909	EDNRA	0001	MIGRAINE, RESISTANCE TO	EDNRA, -231G	
131244	1910	EDNRB	0001	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 2 WAARDENBURG SYNDROME, TYPE 4A, INCLUDED	EDNRB, TRP276CYS	104894387
131244	1910	EDNRB	0002	WAARDENBURG SYNDROME, TYPE 4A	EDNRB, ALA183GLY	104894388
131244	1910	EDNRB	0003	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 2	EDNRB, TRP275TER	104894389
131244	1910	EDNRB	0004	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 2	EDNRB, 1-BP INS, 878T	
131244	1910	EDNRB	0005	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 2	EDNRB, GLY57SER	1801710
131244	1910	EDNRB	0006	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 2	EDNRB, SER305ASN	5352
131244	1910	EDNRB	0007	WAARDENBURG SYNDROME, TYPE 4A	EDNRB, ARG253TER	104894390
131244	1910	EDNRB	0008	ABCD SYNDROME	EDNRB, ARG201TER	104894391
131244	1910	EDNRB	0009	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 2	EDNRB, LYS15TER	
131310	2020	EN2	0001	AUTISM, ASSOCIATION WITH, 10	EN2, A/G	1861972
131310	2020	EN2	0002	AUTISM, ASSOCIATION WITH, 10	EN2, C/T	
131320	2625	GATA3	0001	HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DYSPLASIA SYNDROME	GATA3, 900-KB DEL	
131320	2625	GATA3	0002	HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DYSPLASIA SYNDROME	GATA3, 250-KB DEL	
131320	2625	GATA3	0003	HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DYSPLASIA SYNDROME	GATA3, 49-BP DEL, NT465-513	
131320	2625	GATA3	0004	HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DYSPLASIA SYNDROME	GATA3, 12-BP DEL, NT946-957	
131320	2625	GATA3	0005	HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DYSPLASIA SYNDROME	GATA3, ARG277TER	104894162
131320	2625	GATA3	0006	HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DYSPLASIA SYNDROME	GATA3, TRP275ARG	104894163
131320	2625	GATA3	0007	HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DYSPLASIA SYNDROME	GATA3, 2-BP INS, 3-BP INS	
131320	2625	GATA3	0008	HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DYSPLASIA SYNDROME	GATA3, ARG367TER	104894164
131320	2625	GATA3	0009	HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DYSPLASIA SYNDROME	GATA3, 1-BP DEL, 431G	
131320	2625	GATA3	0010	HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DYSPLASIA SYNDROME	GATA3, 1-BP DEL, 478G	
131320	2625	GATA3	0011	HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DYSPLASIA SYNDROME	GATA3, IVS4, T-GCTTACTTCCC, +2	
131320	2625	GATA3	0012	HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DYSPLASIA SYNDROME	GATA3, ARG353SER	104894165
131320	2625	GATA3	0013	HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DYSPLASIA SYNDROME	GATA3, 2-BP DEL, 108GG	
131320	2625	GATA3	0014	HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DYSPLASIA SYNDROME	GATA3, CYS342TYR	
131340	5173	PDYN	0001	SPINOCEREBELLAR ATAXIA 23	PDYN, ARG138SER	
131340	5173	PDYN	0002	SPINOCEREBELLAR ATAXIA 23	PDYN, ARG215CYS	
131340	5173	PDYN	0003	SPINOCEREBELLAR ATAXIA 23	PDYN, LEU211SER	
131340	5173	PDYN	0004	SPINOCEREBELLAR ATAXIA 23	PDYN, ARG212TRP	
131370	2027	ENO3	0001	GLYCOGEN STORAGE DISEASE XIII	ENO3, GLY156ASP	121918403
131370	2027	ENO3	0002	GLYCOGEN STORAGE DISEASE XIII	ENO3, GLY374GLU	121918404
131399	8288	EPX	0001	EOSINOPHIL PEROXIDASE DEFICIENCY	EPX, ARG286HIS	121434566
131399	8288	EPX	0002	EOSINOPHIL PEROXIDASE DEFICIENCY	EPX, INS G, NT1537	
131530	1950	EGF	0001	HYPOMAGNESEMIA 4, RENAL	EGF, PRO1070LEU	121434567
131550	1956	EGFR	0001	NONSMALL CELL LUNG CANCER, RESPONSE TO TYROSINE KINASE INHIBITOR IN, SOMATIC	EGFR, 18-BP DEL, NT2240	
131550	1956	EGFR	0002	NONSMALL CELL LUNG CANCER, RESPONSE TO TYROSINE KINASE INHIBITOR IN, SOMATIC ADENOCARCINOMA OF LUNG, RESPONSE TO TYROSINE KINASE INHIBITOR IN, SOMATIC, INCLUDED	EGFR, LEU858ARG	121434568
131550	1956	EGFR	0003	NONSMALL CELL LUNG CANCER, RESPONSE TO TYROSINE KINASE INHIBITOR IN, SOMATIC	EGFR, 12-BP DEL, NT2240	
131550	1956	EGFR	0004	NONSMALL CELL LUNG CANCER, RESPONSE TO TYROSINE KINASE INHIBITOR IN, SOMATIC	EGFR, GLY719CYS	
131550	1956	EGFR	0005	NONSMALL CELL LUNG CANCER, RESPONSE TO TYROSINE KINASE INHIBITOR IN, SOMATIC	EGFR, GLY719SER	28929495
131550	1956	EGFR	0006	NONSMALL CELL LUNG CANCER, RESISTANCE TO TYROSINE KINASE INHIBITOR IN	EGFR, THR790MET	121434569
132810	2052	EPHX1	0001	LYMPHOPROLIFERATIVE DISORDERS, SUSCEPTIBILITY TO PREECLAMPSIA, SUSCEPTIBILITY TO, INCLUDED;; EMPHYSEMA, SUSCEPTIBILITY TO, INCLUDED;; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE, SUSCEPTIBILITY TO, INCLUDED	EPHX1, TYR113HIS	1051740
132810	2052	EPHX1	0002	EPOXIDE HYDROLASE POLYMORPHISM	EPHX1, HIS139ARG	2234922
132810	2052	EPHX1	0003	HYPERCHOLANEMIA, FAMILIAL	EPHX1, -4238T-A	
132810	2052	EPHX1	0004	HYPERCHOLANEMIA, FAMILIAL	EPHX1, 2557C-G	
132811	2053	EPHX2	0001	HYPERCHOLESTEROLEMIA, FAMILIAL, DUE TO LDLR DEFECT, MODIFIER OF	EPHX2, ARG287GLN	751141
133170	2056	EPO	0001	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 2	EPO, dbSNP rs1617640, G-T	1617640
133171	2057	EPOR	0001	ERYTHROCYTOSIS, FAMILIAL, 1	EPOR, TRP439TER	121918116
133171	2057	EPOR	0002	ERYTHROCYTOSIS, FAMILIAL, 1	EPOR, 1-BP INS, 5975G	
133171	2057	EPOR	0003	ERYTHROCYTOSIS, FAMILIAL, 1 ERYTHROLEUKEMIA, INCLUDED	EPOR, ASN487SER	62638745
133171	2057	EPOR	0004	ERYTHROCYTOSIS, FAMILIAL, 1	EPOR, 7-BP DEL, NT5980	
133171	2057	EPOR	0005	ERYTHROCYTOSIS, FAMILIAL, 1	EPOR, 1-BP INS, 5967T	
133171	2057	EPOR	0006	ERYTHROCYTOSIS, FAMILIAL, 1	EPOR, TYR426TER	
133171	2057	EPOR	0007	ERYTHROCYTOSIS, FAMILIAL, 1	EPOR, 5968_5975DUP	
133430	2099	ESR1	0001	ESTROGEN RECEPTOR MUTANT, TEMPERATURE-SENSITIVE	ESR1, CYS447ALA	121913043
133430	2099	ESR1	0002	ESTROGEN RESISTANCE	ESR1, ARG157TER	104893956
133430	2099	ESR1	0003	ESTROGEN RESISTANCE	ESR1, VAL364GLU	121913044
133430	2099	ESR1	0004	HDL CHOLESTEROL, AUGMENTED RESPONSE OF, TO HORMONE REPLACEMENT ATHEROSCLEROSIS, SUSCEPTIBILITY TO, INCLUDED;; MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, INCLUDED	ESR1, IVS1, T-C, -401	
133430	2099	ESR1	0005	MIGRAINE, SUSCEPTIBILITY TO	ESR1, 594G-A	
133440	1977	EIF4E	0001	AUTISM, SUSCEPTIBILITY TO, 19	EIF4E, 1-BP INS, -25C	
133510	2071	ERCC3	0001	XERODERMA PIGMENTOSUM B/COCKAYNE SYNDROME	ERCC3, IVS14AS, C-A, -6	
133510	2071	ERCC3	0002	XERODERMA PIGMENTOSUM B/COCKAYNE SYNDROME	ERCC3, PHE99SER	121913045
133510	2071	ERCC3	0003	TRICHOTHIODYSTROPHY	ERCC3, THR119PRO	121913046
133510	2071	ERCC3	0004	XERODERMA PIGMENTOSUM B/COCKAYNE SYNDROME	ERCC3, ARG425TER	121913047
133510	2071	ERCC3	0005	XERODERMA PIGMENTOSUM B/COCKAYNE SYNDROME	ERCC3, 2-BP DEL, 807TT	
133510	2071	ERCC3	0006	XERODERMA PIGMENTOSUM B/COCKAYNE SYNDROME	ERCC3, 1-BP INS	
133510	2071	ERCC3	0007	XERODERMA PIGMENTOSUM B/COCKAYNE SYNDROME	ERCC3, GLN545TER	121913048
133510	2071	ERCC3	0008	XERODERMA PIGMENTOSUM B/COCKAYNE SYNDROME	ERCC3, IVS3DS, G-A, +1	
133520	2072	ERCC4	0001	XERODERMA PIGMENTOSUM, TYPE F	ERCC4, 4-BP DEL, 2281TCTC	
133520	2072	ERCC4	0002	XERODERMA PIGMENTOSUM, TYPE F	ERCC4, ARG788TRP	121913049
133520	2072	ERCC4	0003	XFE PROGEROID SYNDROME	ERCC4, ARG153PRO	121913050
133520	2072	ERCC4	0004	FANCONI ANEMIA, COMPLEMENTATION GROUP Q	ERCC4, 5-BP DEL, 1484CTCAA	
133520	2072	ERCC4	0005	FANCONI ANEMIA, COMPLEMENTATION GROUP Q	ERCC4, ARG689SER	
133520	2072	ERCC4	0006	FANCONI ANEMIA, COMPLEMENTATION GROUP Q	ERCC4, 28-BP DUP, NT2371	
133520	2072	ERCC4	0007	FANCONI ANEMIA, COMPLEMENTATION GROUP Q	ERCC4, LEU230PRO	
133520	2072	ERCC4	0008	XERODERMA PIGMENTOSUM, TYPE F/COCKAYNE SYNDROME	ERCC4, CYS236ARG	
133520	2072	ERCC4	0009	XERODERMA PIGMENTOSUM, TYPE F/COCKAYNE SYNDROME	ERCC4, 1-BP INS, 1730A	
133520	2072	ERCC4	0010	XERODERMA PIGMENTOSUM, TYPE F/COCKAYNE SYNDROME	ERCC4, ARG589TRP	
133530	2073	ERCC5	0001	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G	ERCC5, GLU960TER	121434570
133530	2073	ERCC5	0002	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G	ERCC5, ALA792VAL	121434571
133530	2073	ERCC5	0003	XERODERMA PIGMENTOSUM GROUP G/COCKAYNE SYNDROME	ERCC5, 1-BP DEL, 2972T	
133530	2073	ERCC5	0004	XERODERMA PIGMENTOSUM GROUP G/COCKAYNE SYNDROME	ERCC5, 1-BP DEL, 2170A	
133530	2073	ERCC5	0005	XERODERMA PIGMENTOSUM GROUP G/COCKAYNE SYNDROME	ERCC5, ARG263TER	121434572
133530	2073	ERCC5	0006	XERODERMA PIGMENTOSUM GROUP G/COCKAYNE SYNDROME	ERCC5, GLN176TER	121434573
133530	2073	ERCC5	0007	XERODERMA PIGMENTOSUM GROUP G/COCKAYNE SYNDROME	ERCC5, PRO72HIS	121434574
133530	2073	ERCC5	0008	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G	ERCC5, LEU858PRO	121434575
133530	2073	ERCC5	0009	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G	ERCC5, 4-BP DEL, 1114AGGA	
133530	2073	ERCC5	0010	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G	ERCC5, 1-BP DEL, 1491A	
133530	2073	ERCC5	0011	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G	ERCC5, 1-BP DEL, 2743A	
133530	2073	ERCC5	0012	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G	ERCC5, ALA874THR	121434576
133530	2073	ERCC5	0013	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G	ERCC5, GLN136TER	121434577
133530	2073	ERCC5	0014	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G	ERCC5, ALA28ASP	
133530	2073	ERCC5	0015	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G	ERCC5, TRP968CYS	
133550	6505	SLC1A1	0001	SCHIZOPHRENIA 18 (1 family)	SLC1A1, 84-KB DEL	
134350	1675	CFD	0001	COMPLEMENT FACTOR D DEFICIENCY	CFD, SER42TER	104894667
134350	1675	CFD	0002	COMPLEMENT FACTOR D DEFICIENCY	CFD, VAL213GLY AND CYS214ARG	
134370	3075	CFH	0001	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1	CFH, ARG1215GLY	121913051
134370	3075	CFH	0002	COMPLEMENT FACTOR H DEFICIENCY	CFH, CYS536ARG	121913052
134370	3075	CFH	0003	COMPLEMENT FACTOR H DEFICIENCY	CFH, CYS959TYR	121913053
134370	3075	CFH	0004	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1	CFH, SER1191LEU	460897
134370	3075	CFH	0005	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1	CFH, 24-BP DEL	
134370	3075	CFH	0006	COMPLEMENT FACTOR H DEFICIENCY	CFH, GLU189TER	121913054
134370	3075	CFH	0007	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1	CFH, LEU1189ARG	121913055
134370	3075	CFH	0008	MACULAR DEGENERATION, AGE-RELATED, 4, SUSCEPTIBILITY TO BASAL LAMINAR DRUSEN, INCLUDED	CFH, TYR402HIS	1061170
134370	3075	CFH	0009	MACULAR DEGENERATION, AGE-RELATED, 4, SUSCEPTIBILITY TO	CFH, ILE62VAL	800292
134370	3075	CFH	0010	COMPLEMENT FACTOR H DEFICIENCY	CFH, CYS431SER	121913056
134370	3075	CFH	0011	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1	CFH, 4-BP DEL	
134370	3075	CFH	0012	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1	CFH, TYR899TER	121913057
134370	3075	CFH	0013	COMPLEMENT FACTOR H DEFICIENCY	CFH, ARG127LEU	121913058
134370	3075	CFH	0014	COMPLEMENT FACTOR H DEFICIENCY	CFH, 3-BP DEL, NT743	
134370	3075	CFH	0015	MACULAR DEGENERATION, AGE-RELATED, 4, SUSCEPTIBILITY TO	CFH,	2274700
134370	3075	CFH	0016	MACULAR DEGENERATION, AGE-RELATED, 4, SUSCEPTIBILITY TO	CFH,	1410996
134370	3075	CFH	0017	COMPLEMENT FACTOR H DEFICIENCY HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1, INCLUDED;; MACULAR DEGENERATION, AGE-RELATED, 4, SUSCEPTIBILITY TO, INCLUDED	CFH, ARG1210CYS	121913059
134370	3075	CFH	0018	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1	CFH, GLU1172TER	121913060
134370	3075	CFH	0019	BASAL LAMINAR DRUSEN	CFH, GLN408TER	121913061
134370	3075	CFH	0020	BASAL LAMINAR DRUSEN	CFH, ARG1078SER	121913062
134370	3075	CFH	0021	BASAL LAMINAR DRUSEN	CFH, 350T-G, +6	
134370	3075	CFH	0022	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1	CFH, GLU1198TER	121913063
134371	3078	CFHR1	0001	MACULAR DEGENERATION, AGE-RELATED, REDUCED RISK OF HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, INCLUDED	CFHR1, 84-KB DEL	
134570	2162	F13A1	0001	FACTOR XIII, A SUBUNIT, DEFICIENCY OF	F13A1, 2-BP DEL, 210AG	
134570	2162	F13A1	0002	FACTOR XIII, A SUBUNIT, DEFICIENCY OF	F13A1, ARG681HIS	121913064
134570	2162	F13A1	0003	FACTOR XIII, A SUBUNIT, DEFICIENCY OF	F13A1, ARG171TER	121913065
134570	2162	F13A1	0004	FACTOR XIII, A SUBUNIT, DEFICIENCY OF	F13A1, TYR441TER	121913066
134570	2162	F13A1	0005	FACTOR XIII, A SUBUNIT, DEFICIENCY OF	F13A1, ASN60LYS	121913067
134570	2162	F13A1	0006	FACTOR XIII, A SUBUNIT, DEFICIENCY OF	F13A1, GLY501ARG	121913068
134570	2162	F13A1	0007	FACTOR XIII, A SUBUNIT, DEFICIENCY OF	F13A1, GLY562ARG	121913069
134570	2162	F13A1	0008	FACTOR XIII, A SUBUNIT, DEFICIENCY OF	F13A1, VAL414PHE	121913070
134570	2162	F13A1	0009	FACTOR XIII, A SUBUNIT, DEFICIENCY OF	F13A1, ARG260HIS	121913071
134570	2162	F13A1	0010	MYOCARDIAL INFARCTION, PROTECTION AGAINST VENOUS THROMBOSIS, PROTECTION AGAINST, INCLUDED	F13A1, VAL34LEU	5985
134570	2162	F13A1	0011	FACTOR XIII, A SUBUNIT, DEFICIENCY OF	F13A1, ARG326GLN	121913072
134570	2162	F13A1	0012	FACTOR XIII, A SUBUNIT, DEFICIENCY OF	F13A1, VAL316PHE	121913073
134570	2162	F13A1	0013	FACTOR XIII, A SUBUNIT, DEFICIENCY OF	F13A1, TYR283CYS	121913074
134570	2162	F13A1	0014	FACTOR XIII, A SUBUNIT, DEFICIENCY OF	F13A1, 1-BP INS, 1286C	
134570	2162	F13A1	0015	FACTOR XIII, A SUBUNIT, DEFICIENCY OF	F13A1, IVS5AS, G-A, -1	
134570	2162	F13A1	0016	FACTOR XIII, A SUBUNIT, DEFICIENCY OF	F13A1, ARG703TRP	
134570	2162	F13A1	0017	FACTOR XIII, A SUBUNIT, DEFICIENCY OF	F13A1, ARG661TER	
134570	2162	F13A1	0018	FACTOR XIII, A SUBUNIT, DEFICIENCY OF	F13A1, MET242THR	
134570	2162	F13A1	0019	FACTOR XIII, A SUBUNIT, DEFICIENCY OF	F13A1, 4-BP DEL, 602AAAG	
134570	2162	F13A1	0020	FACTOR XIII, A SUBUNIT, DEFICIENCY OF	F13A1, IVS1, C-A, +12	
134580	2165	F13B	0001	FACTOR XIII, B SUBUNIT, DEFICIENCY OF	F13B, 1-BP DEL, IVS1AS, A, -2	
134580	2165	F13B	0002	FACTOR XIII, B SUBUNIT, DEFICIENCY OF	F13B, CYS430PHE	121913075
134580	2165	F13B	0003	VENOUS THROMBOSIS, SUSCEPTIBILITY TO	F13B, HIS95ARG	6003
134580	2165	F13B	0004	FACTOR XIII, B SUBUNIT, DEFICIENCY OF	F13B, 3-BP INS, AAC	
134580	2165	F13B	0005	FACTOR XIII, B SUBUNIT, DEFICIENCY OF	F13B, 1-BP DEL, EX9	
134637	355	FAS	0001	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IA	TNFRSF6, 1-BP DEL, 429G	
134637	355	FAS	0002	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IA	TNFRSF6, EX3DEL	
134637	355	FAS	0003	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IA	TNFRSF6, THR225PRO	121913076
134637	355	FAS	0004	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IA	TNFRSF6, IVS7AS, A-C, -2	
134637	355	FAS	0005	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IA	TNFRSF6, GLN257TER	121913077
134637	355	FAS	0006	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IA, AUTOSOMAL RECESSIVE	TNFRSF6, ARG105TRP	121913078
134637	355	FAS	0007	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IA, AUTOSOMAL RECESSIVE	TNFRSF6, TYR216CYS	121913079
134637	355	FAS	0008	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IA	TNFRSF6, ASP244VAL	28929498
134637	355	FAS	0009	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IA	TNFRSF6, ARG234PRO	121913080
134637	355	FAS	0010	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IA	TNFRSF6, THR254ILE	121913081
134637	355	FAS	0011	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IA	TNFRSF6, IVS7DS, T-A, +2	
134637	355	FAS	0012	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IA	TNFRSF6, A-T, -1	
134637	355	FAS	0013	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IA, AUTOSOMAL RECESSIVE	TNFRSF6, IVS9, 20-BP DUP	
134637	355	FAS	0014	SQUAMOUS CELL CARCINOMA, BURN SCAR-RELATED, SOMATIC	TNFRSF6, ASN239ASP	121913082
134637	355	FAS	0015	SQUAMOUS CELL CARCINOMA, BURN SCAR-RELATED, SOMATIC	TNFRSF6, ASN102SER	121913083
134637	355	FAS	0016	SQUAMOUS CELL CARCINOMA, BURN SCAR-RELATED, SOMATIC	TNFRSF6, CYS162ARG	121913084
134637	355	FAS	0017	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IA	TNFRSF6, GLY231ALA	121913085
134637	355	FAS	0018	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IA	TNFRSF6, PRO201FS, 204TER	
134637	355	FAS	0019	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IA	TNFRSF6, 1-BP INS	
134637	355	FAS	0020	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IA	TNFRSF6, ASP244TYR	121913086
134637	355	FAS	0021	LUNG CANCER, SUSCEPTIBILITY TO	TNFRSF6, -1377G-A	
134638	356	FASLG	0001	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IB	TNFSF6, 84-BP DEL, EX4	
134638	356	FASLG	0002	LUNG CANCER, SUSCEPTIBILITY TO	TNFSF6, -844T-C	
134640	2169	FABP2	0001	FATTY ACID-BINDING PROTEIN, INTESTINAL, POLYMORPHISM OF	FABP2, ALA54THR	1799883
134660	2950	GSTP1	0001	GLUTATHIONE S-TRANSFERASE PI POLYMORPHISM, TYPE A	GSTP1, ILE105 AND ALA114	
134660	2950	GSTP1	0002	GLUTATHIONE S-TRANSFERASE PI POLYMORPHISM, TYPE B	GSTP1, VAL105 AND ALA114	
134660	2950	GSTP1	0003	GLUTATHIONE S-TRANSFERASE PI POLYMORPHISM, TYPE C	GSTP1, VAL105 AND VAL114	
134770	2495	FTH1	0001	IRON OVERLOAD, AUTOSOMAL DOMINANT	FTH1, A49T	
134790	2512	FTL	0001	HYPERFERRITINEMIA WITH OR WITHOUT CATARACT	FTL, 146A-G	
134790	2512	FTL	0002	HYPERFERRITINEMIA WITH OR WITHOUT CATARACT	FTL, 147G-C	
134790	2512	FTL	0003	HYPERFERRITINEMIA WITH OR WITHOUT CATARACT	FTL, 32G-A	
134790	2512	FTL	0004	HYPERFERRITINEMIA WITH OR WITHOUT CATARACT	FTL, 18C-T AND 22T-G	
134790	2512	FTL	0005	HYPERFERRITINEMIA WITH OR WITHOUT CATARACT	FTL, 29-BP DEL	
134790	2512	FTL	0006	HYPERFERRITINEMIA WITH OR WITHOUT CATARACT	FTL, 32G-T	
134790	2512	FTL	0007	HYPERFERRITINEMIA WITH OR WITHOUT CATARACT	FTL, 39C-T	
134790	2512	FTL	0008	HYPERFERRITINEMIA WITH OR WITHOUT CATARACT	FTL, 36C-A	
134790	2512	FTL	0009	HYPERFERRITINEMIA WITH OR WITHOUT CATARACT	FTL, 51G-C	
134790	2512	FTL	0010	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3	FTL, 1-BP INS, 460A	
134790	2512	FTL	0011	HYPERFERRITINEMIA WITH OR WITHOUT CATARACT	FTL, 6-BP DEL	
134790	2512	FTL	0012	HYPERFERRITINEMIA WITH OR WITHOUT CATARACT	FTL, 32G-C	
134790	2512	FTL	0013	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3	FTL, ALA96THR	104894685
134790	2512	FTL	0014	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3	FTL, 2-BP INS, 498TC	
134790	2512	FTL	0015	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3	FTL, 16-BP DUP, NT469	
134790	2512	FTL	0016	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3	FTL, 1-BP DUP, 458A	
134790	2512	FTL	0017	HYPERFERRITINEMIA WITH OR WITHOUT CATARACT	FTL, THR30ILE	
134797	2200	FBN1	0001	MARFAN SYNDROME, SEVERE CLASSIC	FBN1, ARG1137PRO	137854456
134797	2200	FBN1	0002	MARFAN SYNDROME, MILD VARIABLE	FBN1, CYS2307SER	137854457
134797	2200	FBN1	0003	MARFAN SYNDROME	FBN1, 366-BP DEL	
134797	2200	FBN1	0004	MARFAN SYNDROME	FBN1, G8268A, TRP2756TER	
134797	2200	FBN1	0005	MARFAN SYNDROME	FBN1, CYS1249SER	137854458
134797	2200	FBN1	0006	MARFAN SYNDROME	FBN1, CYS1663ARG	137854459
134797	2200	FBN1	0007	MARFAN SYNDROME	FBN1, CYS2221SER	137854460
134797	2200	FBN1	0008	MARFAN SYNDROME	FBN1, TYR2113TER, EX51DEL	
134797	2200	FBN1	0009	MARFAN SYNDROME	FBN1, ASN2144SER	137854461
134797	2200	FBN1	0010	MARFAN SYNDROME	FBN1, ASN548ILE	137854462
134797	2200	FBN1	0011	MARFAN SYNDROME	FBN1, ASP723ALA	137854463
134797	2200	FBN1	0012	MASS SYNDROME	FBN1, 4-BP INS, NT5138	
134797	2200	FBN1	0013	MARFAN SYNDROME	FBN1, 83-BP DEL	
134797	2200	FBN1	0014	MARFAN SYNDROME	FBN1, IVS54DS, G-C, +1, 123-BP DEL	
134797	2200	FBN1	0015	ECTOPIA LENTIS 1, ISOLATED, AUTOSOMAL DOMINANT	FBN1, GLU2447LYS	137854464
134797	2200	FBN1	0016	MARFAN SYNDROME, NEONATAL	FBN1, CYS1074ARG	137854465
134797	2200	FBN1	0017	MARFAN SYNDROME	FBN1, ARG2776TER	137854466
134797	2200	FBN1	0018	MARFAN SYNDROME, ATYPICAL	FBN1, ARG122CYS	137854467
134797	2200	FBN1	0019	MARFAN SYNDROME, NEONATAL	FBN1, IVS31AS, A-T, -2	
134797	2200	FBN1	0020	MARFAN SYNDROME, NEONATAL	FBN1, IVS32DS, G-A, +1	
134797	2200	FBN1	0021	MARFAN SYNDROME, MILD	FBN1, GLY1127SER	137854468
134797	2200	FBN1	0022	MARFAN SYNDROME	FBN1, CYS1223TYR	137854469
134797	2200	FBN1	0023	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	FBN1, ARG2726TRP	61746008
134797	2200	FBN1	0025	MARFAN SYNDROME	FBN1, CYS1117TYR	137854470
134797	2200	FBN1	0026	MARFAN SYNDROME	FBN1, CYS1242TYR	137854471
134797	2200	FBN1	0027	MARFAN SYNDROME, NEONATAL	FBN1, LYS1043ARG	137854472
134797	2200	FBN1	0028	MARFAN SYNDROME, NEONATAL	FBN1, ASN1131TYR	137854473
134797	2200	FBN1	0029	MARFAN SYNDROME	FBN1, 1-BP DEL, 3192A	
134797	2200	FBN1	0030	MARFAN SYNDROME	FBN1, 6354C-T, EX51DEL, ILE2118ILE	112989722
134797	2200	FBN1	0031	MARFAN SYNDROME, CLASSIC	FBN1, CYS1265ARG	137854474
134797	2200	FBN1	0032	MARFAN SYNDROME, SUBDIAGNOSTIC VARIANT OF	FBN1, ARG1170HIS	137854475
134797	2200	FBN1	0033	MARFAN SYNDROME	FBN1, ARG529TER	137854476
134797	2200	FBN1	0034	MARFAN SYNDROME, ATYPICAL	FBN1, GLY985GLU	137854477
134797	2200	FBN1	0035	MARFAN SYNDROME	FBN1, IVS2DS, G-A, +1	
134797	2200	FBN1	0036	MARFAN SYNDROME	FBN1, GLY1013ARG	140593
134797	2200	FBN1	0037	MARFAN SYNDROME	FBN1, 33-BP INS, IVS46, G-A, +1	
134797	2200	FBN1	0038	MARFAN SYNDROME, NEONATAL	FBN1, GLU1073LYS	137854478
134797	2200	FBN1	0039	MARFAN SYNDROME	FBN1, IVS46+5G-A	
134797	2200	FBN1	0040	WEILL-MARCHESANI SYNDROME 2	FBN1, 24-BP DEL	
134797	2200	FBN1	0041	MARFAN SYNDROME	FBN1, TYR754CYS	137854479
134797	2200	FBN1	0042	MARFAN SYNDROME ECTOPIA LENTIS 1, ISOLATED, AUTOSOMAL DOMINANT, INCLUDED	FBN1, ARG240CYS	137854480
134797	2200	FBN1	0043	MARFAN SYNDROME, NEONATAL	FBN1, CYS1032TYR	137854481
134797	2200	FBN1	0044	MARFAN SYNDROME	FBN1, CYS1129TYR	137854482
134797	2200	FBN1	0045	MARFAN SYNDROME	FBN1, CYS1221TYR	137854483
134797	2200	FBN1	0046	MARFAN SYNDROME, NEONATAL	FBN1, CYS1086TYR	137854484
134797	2200	FBN1	0047	MARFAN SYNDROME, AUTOSOMAL RECESSIVE	FBN1, ARG485CYS	137854485
134797	2200	FBN1	0048	MARFAN SYNDROME	FBN1, 302.5-KB DEL	
134797	2200	FBN1	0049	MARFAN SYNDROME	FBN1, EX13-49, DEL	
134797	2200	FBN1	0050	STIFF SKIN SYNDROME	FBN1, TRP1570CYS, 4710G-T	
134797	2200	FBN1	0051	STIFF SKIN SYNDROME	FBN1, TRP1570CYS, 4710G-C	
134797	2200	FBN1	0052	STIFF SKIN SYNDROME	FBN1, CYS1564SER	
134797	2200	FBN1	0053	STIFF SKIN SYNDROME	FBN1, CYS1577GLY	
134797	2200	FBN1	0054	STIFF SKIN SYNDROME	FBN1, GLY1594ASN	
134797	2200	FBN1	0055	GELEOPHYSIC DYSPLASIA 2 ACROMICRIC DYSPLASIA, INCLUDED	FBN1, TYR1699CYS	
134797	2200	FBN1	0056	GELEOPHYSIC DYSPLASIA 2	FBN1, GLY1762SER	
134797	2200	FBN1	0057	GELEOPHYSIC DYSPLASIA 2 ACROMICRIC DYSPLASIA, INCLUDED	FBN1, ALA1728THR	
134797	2200	FBN1	0058	GELEOPHYSIC DYSPLASIA 2	FBN1, TYR1696CYS	
134797	2200	FBN1	0059	ACROMICRIC DYSPLASIA	FBN1, SER1750ARG	
134797	2200	FBN1	0060	ACROMICRIC DYSPLASIA	FBN1, TYR1700CYS	
134797	2200	FBN1	0061	ACROMICRIC DYSPLASIA	FBN1, 3-BP DUP, NT5202	
134797	2200	FBN1	0062	FNB1 POLYMORPHISM	FBN1, PRO1148ALA	
134797	2200	FBN1	0063	ECTOPIA LENTIS 1, ISOLATED, AUTOSOMAL DOMINANT	FBN1, ARG974CYS	
134797	2200	FBN1	0064	MARFAN SYNDROME	FBN1, 2-BP DEL, 8155AA	
134797	2200	FBN1	0065	MARFAN SYNDROME	FBN1, 20-BP DEL, NT8156	
134797	2200	FBN1	0066	MARFAN SYNDROME	FBN1, IVS64, G-T, +1	
134797	2200	FBN1	0067	MARFAN SYNDROME	FBN1, 7-BP DEL, NT4253	
134820	2243	FGA	0001	FIBRINOGEN LILLE 1	FGA, ASP7ASN	121909604
134820	2243	FGA	0002	FIBRINOGEN ROUEN 1	FGA, GLY12VAL	121909605
134820	2243	FGA	0003	FIBRINOGEN BERGAMO 1 FIBRINOGEN HERSHEY 2;; FIBRINOGEN HOMBURG 2;; FIBRINOGEN HOMBURG 3;; FIBRINOGEN KAWAGUCHI 1;; FIBRINOGEN LEOGAN;; FIBRINOGEN METZ 1;; FIBRINOGEN NEW ALBANY;; FIBRINOGEN OSAKA 1;; FIBRINOGEN SCHWARZACH 1;; FIBRINOGEN STONY BROOK 1;; FIBRINOGEN ZURICH 1;; FIBRINOGEN TORINO 1;; FIBRINOGEN LEDYARD;; FIBRINOGEN HERSHEY 3;; FIBRINOGEN MILANO XII, DIGENIC, INCLUDED	FGA, ARG16CYS	121909606
134820	2243	FGA	0004	FIBRINOGEN AMIENS 1 FIBRINOGEN AMIENS 2;; FIBRINOGEN BERGAMO 3;; FIBRINOGEN BERN 2;; FIBRINOGEN BICETRE 1;; FIBRINOGEN BIRMINGHAM 1;; FIBRINOGEN CHAPEL HILL 2;; FIBRINOGEN CLERMONT-FERRAND 1;; FIBRINOGEN GIESSEN 1;; FIBRINOGEN LEITCHFIELD;; FIBRINOGEN LONG BEACH 1;; FIBRINOGEN LOUISVILLE 1;; FIBRINOGEN MANCHESTER 1;; FIBRINOGEN PARIS 6;; FIBRINOGEN PETOSKEY 1;; FIBRINOGEN SEATTLE 2;; FIBRINOGEN SHEFFIELD 2;; FIBRINOGEN SYDNEY 1;; FIBRINOGEN SYDNEY 2;; FIBRINOGEN WHITE MARSH 1	FGA, ARG16HIS	121909607
134820	2243	FGA	0005	FIBRINOGEN MUNICH 1	FGA, ARG19ASN	
134820	2243	FGA	0006	FIBRINOGEN DETROIT 1	FGA, ARG19SER	
134820	2243	FGA	0007	FIBRINOGEN AARHUS 1	FGA, ARG19GLY	121909608
134820	2243	FGA	0008	FIBRINOGEN KYOTO 2	FGA, PRO18LEU	121909609
134820	2243	FGA	0009	FIBRINOGEN CARACAS-2	FGA, SER434ASN	121909610
134820	2243	FGA	0010	FIBRINOGEN LIMA	FGA, ARG141SER	
134820	2243	FGA	0011	FIBRINOGEN MARBURG DYSFIBRINOGENEMIA CAUSING BLEEDING DIATHESIS	FGA, LYS461TER	121909611
134820	2243	FGA	0012	AMYLOIDOSIS, FAMILIAL VISCERAL	FGA, ARG554LEU	78506343
134820	2243	FGA	0013	AMYLOIDOSIS, FAMILIAL VISCERAL	FGA, GLU526VAL	121909612
134820	2243	FGA	0014	FIBRINOGEN DUSART FIBRINOGEN PARIS 5	FGA, ARG554CYS	121909613
134820	2243	FGA	0015	FIBRINOGEN CANTERBURY	FGA, VAL20ASP	121909614
134820	2243	FGA	0016	AMYLOIDOSIS, FAMILIAL VISCERAL	FGA, 1-BP DEL, 4904G	
134820	2243	FGA	0018	AMYLOIDOSIS, FAMILIAL VISCERAL	FGA, 1-BP DEL, 4897T	
134820	2243	FGA	0019	AFIBRINOGENEMIA, CONGENITAL	FGA, 11-KB DEL	
134820	2243	FGA	0020	AFIBRINOGENEMIA, CONGENITAL	FGA, IVS4DS, G-T, +1	
134820	2243	FGA	0021	FIBRINOGEN NIEUWEGEIN	FGA, 1-BP INS, 453C	
134820	2243	FGA	0023	AFIBRINOGENEMIA, CONGENITAL	FGA, 1-BP INS	
134820	2243	FGA	0024	FIBRINOGEN KEOKUK	FGA, GLN328TER	121909615
134820	2243	FGA	0025	HYPODYSFIBRINOGENEMIA, CONGENITAL	FGA, IVS4DS, G-T, +1	
134820	2243	FGA	0026	VENOUS THROMBOEMBOLISM, SUSCEPTIBILITY TO	FGA, THR312ALA	6050
134830	2244	FGB	0001	FIBRINOGEN NEW YORK 1	FGB, EX2DEL	
134830	2244	FGB	0002	FIBRINOGEN CHRISTCHURCH 2 FIBRINOGEN SEATTLE 1;; FIBRINOGEN IJmuiden	FGB, ARG14CYS	121909616
134830	2244	FGB	0003	FIBRINOGEN PONTOISE 2	FGB, ALA335THR	121909617
134830	2244	FGB	0004	FIBRINOGEN BALTIMORE 2	FGB, ARG448LYS	4220
134830	2244	FGB	0005	FIBRINOGEN ISE	FGB, GLY15CYS	121909618
134830	2244	FGB	0006	FIBRINOGEN NIJMEGEN	FGB, ARG44CYS	121909616
134830	2244	FGB	0007	FIBRINOGEN NAPLES FIBRINOGEN MILANO 2;; THROMBOPHILIA, DYSFIBRINOGENEMIC	FGB, ALA68THR	121909620
134830	2244	FGB	0008	FIBRINOGEN-BETA POLYMORPHISM	FGB, PROMOTER MUTATION, -455G-A	
134830	2244	FGB	0009	AFIBRINOGENEMIA, CONGENITAL	FGB, LEU353ARG	121909621
134830	2244	FGB	0010	AFIBRINOGENEMIA, CONGENITAL	FGB, GLY400ASP	121909622
134830	2244	FGB	0011	FIBRINOGEN LONGMONT	FGB, ARG166CYS	121909623
134830	2244	FGB	0012	AFIBRINOGENEMIA, CONGENITAL	FGB, IVS6, C-T, +13	
134830	2244	FGB	0013	AFIBRINOGENEMIA, CONGENITAL	FGB, IVS7, G-T, +1	
134830	2244	FGB	0014	FIBRINOGEN, BETA-148 POLYMORPHISM	FGB, -148T-C	
134830	2244	FGB	0015	HYPOFIBRINOGENEMIA, CONGENITAL	FGB, LEU172GLN	121909624
134830	2244	FGB	0016	HYPOFIBRINOGENEMIA, CONGENITAL	FGB, ARG17TER	121909625
134850	2266	FGG	0001	FIBRINOGEN BALTIMORE 4 FIBRINOGEN MORIOKA 1;; FIBRINOGEN OSAKA 2;; FIBRINOGEN TOCHIGI 1;; FIBRINOGEN TOKYO 2	FGG, ARG275CYS	121913087
134850	2266	FGG	0002	FIBRINOGEN BERGAMO 2 FIBRINOGEN ESSEN 1;; FIBRINOGEN HAIFA 1;; FIBRINOGEN PERUGIA 1;; FIBRINOGEN SAGA 1;; FIBRINOGEN OSAKA 3	FGG, ARG275HIS	121913088
134850	2266	FGG	0003	FIBRINOGEN BALTIMORE 1	FGG, GLY292VAL	121913089
134850	2266	FGG	0004	FIBRINOGEN KYOTO 1	FGG, ASN308LYS	
134850	2266	FGG	0005	FIBRINOGEN BALTIMORE 3	FGG, ASN308ILE	121913090
134850	2266	FGG	0006	FIBRINOGEN ASAHI	FGG, MET310THR	121913091
134850	2266	FGG	0007	FIBRINOGEN VLISSINGEN 1	FGG, 6-BP DEL, ASN319DEL AND ASP320DEL	
134850	2266	FGG	0008	FIBRINOGEN NAGOYA 1	FGG, GLN329ARG	121913092
134850	2266	FGG	0009	FIBRINOGEN KYOTO 3	FGG, ASP330TYR	121913093
134850	2266	FGG	0010	FIBRINOGEN MILANO 1 THROMBOPHILIA, DYSFIBRINOGENEMIC;; FIBRINOGEN ALES	FGG, ASP330VAL	121913094
134850	2266	FGG	0011	FIBRINOGEN PARIS 1	FGG, 45-BP INS, IVS8	
134850	2266	FGG	0012	FIBRINOGEN OSLO III	FGG,	
134850	2266	FGG	0013	FIBRINOGEN OSAKA 5	FGG, ARG375GLY	75848804
134850	2266	FGG	0014	FIBRINOGEN MATSUMOTO 1	FGG, ASP364HIS	121913095
134850	2266	FGG	0015	FIBRINOGEN GIESSEN 4	FGG, ARG318GLY	
134850	2266	FGG	0016	AFIBRINOGENEMIA, CONGENITAL	FGG, IVS1DS, G-A, +5	
134850	2266	FGG	0017	AFIBRINOGENEMIA, CONGENITAL	FGG, IVS3DS, G-A, +5	
134850	2266	FGG	0018	FIBRINOGEN MILANO XII, DIGENIC	FGG, GLY165ARG	6063
134850	2266	FGG	0019	FIBRINOGEN HILLSBOROUGH	FGG, GLY309ASP	121913096
134850	2266	FGG	0021	AFIBRINOGENEMIA, CONGENITAL	FGG, IVS6AS, A-T, -320	
134934	2261	FGFR3	0001	ACHONDROPLASIA NEVUS, EPIDERMAL, SOMATIC, INCLUDED	FGFR3, GLY380ARG, 1138G-A	28931614
134934	2261	FGFR3	0002	ACHONDROPLASIA	FGFR3, GLY380ARG, 1138G-C	
134934	2261	FGFR3	0003	ACHONDROPLASIA	FGFR3, GLY375CYS	75790268
134934	2261	FGFR3	0004	THANATOPHORIC DYSPLASIA, TYPE II MULTIPLE MYELOMA, SOMATIC, INCLUDED;; SPERMATOCYTIC SEMINOMA, SOMATIC, INCLUDED	FGFR3, LYS650GLU	78311289
134934	2261	FGFR3	0005	THANATOPHORIC DYSPLASIA, TYPE I MULTIPLE MYELOMA, SOMATIC, INCLUDED;; SKELETAL DYSPLASIA WITH ACANTHOSIS NIGRICANS, INCLUDED;; NEVUS, EPIDERMAL, SOMATIC, INCLUDED;; KERATOSIS, SEBORRHEIC, SOMATIC, INCLUDED	FGFR3, ARG248CYS	121913482
134934	2261	FGFR3	0006	THANATOPHORIC DYSPLASIA, TYPE I	FGFR3, SER371CYS	121913484
134934	2261	FGFR3	0007	THANATOPHORIC DYSPLASIA, TYPE I	FGFR3, TER807GLY	
134934	2261	FGFR3	0008	THANATOPHORIC DYSPLASIA, TYPE I	FGFR3, TER807ARG	
134934	2261	FGFR3	0009	THANATOPHORIC DYSPLASIA, TYPE I	FGFR3, TER807CYS	
134934	2261	FGFR3	0010	HYPOCHONDROPLASIA	FGFR3, ASN540LYS, 1620C-A	28933068
134934	2261	FGFR3	0011	CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS	FGFR3, ALA391GLU	28931615
134934	2261	FGFR3	0012	HYPOCHONDROPLASIA	FGFR3, ASN540LYS, 1620C-G	
134934	2261	FGFR3	0013	THANATOPHORIC DYSPLASIA, TYPE I CERVICAL CANCER, SOMATIC, INCLUDED;; BLADDER CANCER, SOMATIC, INCLUDED;; KERATOSIS, SEBORRHEIC, SOMATIC, INCLUDED	FGFR3, SER249CYS	121913483
134934	2261	FGFR3	0014	MUENKE SYNDROME SAETHRE-CHOTZEN SYNDROME, INCLUDED;; BEARE-STEVENSON SYNDROME-LIKE ANOMALIES, INCLUDED	FGFR3, PRO250ARG	4647924
134934	2261	FGFR3	0015	SADDAN DYSPLASIA THANATOPHORIC DYSPLASIA, TYPE I, INCLUDED	FGFR3, LYS650MET	121913105
134934	2261	FGFR3	0016	THANATOPHORIC DYSPLASIA, TYPE I	FGFR3, TYR373CYS	121913485
134934	2261	FGFR3	0017	MULTIPLE MYELOMA, SOMATIC	FGFR3, FGFR3/IGH FUSION	
134934	2261	FGFR3	0018	HYPOCHONDROPLASIA	FGFR3, ASN540THR	
134934	2261	FGFR3	0019	HYPOCHONDROPLASIA	FGFR3, ILE538VAL	80053154
134934	2261	FGFR3	0020	HYPOCHONDROPLASIA	FGFR3, LYS650ASN, 1950G-T	28928868
134934	2261	FGFR3	0021	HYPOCHONDROPLASIA	FGFR3, LYS650ASN, 1950G-C	
134934	2261	FGFR3	0022	HYPOCHONDROPLASIA	FGFR3, LYS650GLN	
134934	2261	FGFR3	0023	HYPOCHONDROPLASIA	FGFR3, ASN540SER	77722678
134934	2261	FGFR3	0024	HYPOCHONDROPLASIA BLADDER CANCER, SOMATIC, INCLUDED	FGFR3, LYS652GLN	
134934	2261	FGFR3	0025	COLORECTAL CANCER, SOMATIC	FGFR3, GLU322LYS	121913111
134934	2261	FGFR3	0026	COLORECTAL CANCER, SOMATIC	FGFR3, 1-BP DEL, 849C	
134934	2261	FGFR3	0027	ACHONDROPLASIA	FGFR3, GLY380ARG AND LEU377ARG	
134934	2261	FGFR3	0028	LADD SYNDROME	FGFR3, ASP513ASN	121913112
134934	2261	FGFR3	0029	CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	FGFR3, ARG621HIS	121913113
134934	2261	FGFR3	0030	ACHONDROPLASIA HYPOCHONDROPLASIA, INCLUDED	FGFR3, SER279CYS	121913114
134934	2261	FGFR3	0031	HYPOCHONDROPLASIA	FGFR3, TYR278CYS	121913115
134934	2261	FGFR3	0032	HYPOCHONDROPLASIA	FGFR3, SER84LEU	121913116
134934	2261	FGFR3	0033	THANATOPHORIC DYSPLASIA, TYPE I NEVUS, EPIDERMAL, SOMATIC, INCLUDED	FGFR3, GLY370CYS	121913479
134934	2261	FGFR3	0034	THANATOPHORIC DYSPLASIA, TYPE I	FGFR3, ASN540LYS AND GLN485ARG	
134934	2261	FGFR3	0035	VARIANT OF UNKNOWN SIGNIFICANCE	FGFR3, ALA334THR	
134935	2264	FGFR4	0001	CANCER PROGRESSION AND TUMOR CELL MOTILITY	FGFR4, GLY388ARG	351855
135600	2335	FN1	0001	GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 2	FN1, TRP1925ARG	137854486
135600	2335	FN1	0002	GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 2	FN1, LEU1974ARG	137854487
135600	2335	FN1	0003	GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 2	FN1, TYR983CYS	137854488
135940	2312	FLG	0001	ICHTHYOSIS VULGARIS DERMATITIS, ATOPIC, 2, SUSCEPTIBILITY TO, INCLUDED	FLG, ARG501TER	61816761
135940	2312	FLG	0002	ICHTHYOSIS VULGARIS DERMATITIS, ATOPIC, 2, SUSCEPTIBILITY TO, INCLUDED	FLG, 4-BP DEL, 2282CAGT	
135940	2312	FLG	0003	ICHTHYOSIS VULGARIS DERMATITIS, ATOPIC, 2, SUSCEPTIBILITY TO, INCLUDED	FLG, SER2554TER	121909626
135940	2312	FLG	0004	ICHTHYOSIS VULGARIS DERMATITIS, ATOPIC, 2, SUSCEPTIBILITY TO, INCLUDED	FLG, 1-BP DEL, 3321A	
136132	2328	FMO3	0001	TRIMETHYLAMINURIA	FMO3, GLU305TER	61753344
136132	2328	FMO3	0002	TRIMETHYLAMINURIA	FMO3, VAL257MET	1736557
136132	2328	FMO3	0003	TRIMETHYLAMINURIA	FMO3, MET66ILE	72549323
136132	2328	FMO3	0004	TRIMETHYLAMINURIA	FMO3, PRO153LEU	72549326
136132	2328	FMO3	0005	TRIMETHYLAMINURIA	FMO3, ARG492TRP	72549334
136132	2328	FMO3	0006	FMO3 ACTIVITY, DECREASED	FMO3, GLY148TER	72549325
136132	2328	FMO3	0007	TRIMETHYLAMINURIA	FMO3, ARG387LEU	72549331
136132	2328	FMO3	0008	TRIMETHYLAMINURIA	FMO3, ALA52THR	72549321
136132	2328	FMO3	0009	TRIMETHYLAMINURIA	FMO3, GLU314TER	72549330
136132	2328	FMO3	0010	TRIMETHYLAMINURIA	FMO3, ASN61SER	72549322
136132	2328	FMO3	0011	TRIMETHYLAMINURIA	FMO3, MET434ILE	72549332
136132	2328	FMO3	0012	TRIMETHYLAMINURIA	FMO3, 2-EX DEL	
136132	2328	FMO3	0013	TRIMETHYLAMINURIA	FMO3, GLU32LYS	72549320
136132	2328	FMO3	0014	TRIMETHYLAMINURIA	FMO3, 1-BP DEL, 191A	
136132	2328	FMO3	0015	TRIMETHYLAMINURIA, MILD	FMO3, GLU308GLY AND GLU158LYS	2266780
136350	2260	FGFR1	0001	PFEIFFER SYNDROME JACKSON-WEISS SYNDROME, INCLUDED	FGFR1, PRO252ARG	121909627
136350	2260	FGFR1	0002	HYPOGONADOTROPIC HYPOGONADISM 2 WITH ANOSMIA, SUSCEPTIBILITY TO	FGFR1, 2-BP DEL, 1970CA	
136350	2260	FGFR1	0003	HYPOGONADOTROPIC HYPOGONADISM 2 WITH ANOSMIA, SUSCEPTIBILITY TO	FGFR1, TRP666ARG	
136350	2260	FGFR1	0004	HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA, SUSCEPTIBILITY TO	FGFR1, ARG622TER	121909628
136350	2260	FGFR1	0005	HYPOGONADOTROPIC HYPOGONADISM 2 WITH ANOSMIA, SUSCEPTIBILITY TO	FGFR1, VAL607MET	121909629
136350	2260	FGFR1	0006	HYPOGONADOTROPIC HYPOGONADISM 2 WITH ANOSMIA, SUSCEPTIBILITY TO	FGFR1, 936G-A	
136350	2260	FGFR1	0007	HYPOGONADOTROPIC HYPOGONADISM 2 WITH ANOSMIA	FGFR1, ALA167SER	121909630
136350	2260	FGFR1	0008	OSTEOGLOPHONIC DYSPLASIA	FGFR1, TYR372CYS	121909631
136350	2260	FGFR1	0009	OSTEOGLOPHONIC DYSPLASIA	FGFR1, ASN330ILE	121909632
136350	2260	FGFR1	0010	OSTEOGLOPHONIC DYSPLASIA	FGFR1, CYS379ARG	
136350	2260	FGFR1	0011	TRIGONOCEPHALY 1	FGFR1, ILE300THR	121909633
136350	2260	FGFR1	0012	OSTEOGLOPHONIC DYSPLASIA	FGFR1, CYS381ARG	121909634
136350	2260	FGFR1	0013	HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA, SUSCEPTIBILITY TO	FGFR1, GLY237SER	121909635
136350	2260	FGFR1	0014	HYPOGONADOTROPIC HYPOGONADISM 2 WITHOUT ANOSMIA, SUSCEPTIBILITY TO	FGFR1, PRO722HIS AND ASN724LYS	
136350	2260	FGFR1	0015	HYPOGONADOTROPIC HYPOGONADISM 2 WITHOUT ANOSMIA	FGFR1, GLN680TER	121909636
136350	2260	FGFR1	0016	HYPOGONADOTROPIC HYPOGONADISM 2 WITHOUT ANOSMIA, SUSCEPTIBILITY TO	FGFR1, ARG470LEU	121909637
136350	2260	FGFR1	0017	HYPOGONADOTROPIC HYPOGONADISM 2 WITH ANOSMIA, SUSCEPTIBILITY TO	FGFR1, LEU342SER	121909638
136350	2260	FGFR1	0018	HYPOGONADOTROPIC HYPOGONADISM 2 WITH ANOSMIA, SUSCEPTIBILITY TO	FGFR1, ARG609TER	121909639
136350	2260	FGFR1	0019	HYPOGONADOTROPIC HYPOGONADISM 2 WITH ANOSMIA, SUSCEPTIBILITY TO	FGFR1, 2-BP DEL, 1317TG	
136350	2260	FGFR1	0020	HYPOGONADOTROPIC HYPOGONADISM 2 WITHOUT ANOSMIA	FGFR1, GLY48SER	121909640
136350	2260	FGFR1	0021	HYPOGONADOTROPIC HYPOGONADISM 2 WITH ANOSMIA, SUSCEPTIBILITY TO	FGFR1, PRO366LEU	121909641
136350	2260	FGFR1	0022	HYPOGONADOTROPIC HYPOGONADISM 2 WITH ANOSMIA	FGFR1, PRO722SER	121909642
136350	2260	FGFR1	0023	HYPOGONADOTROPIC HYPOGONADISM 2 WITHOUT ANOSMIA	FGFR1, GLN764HIS	121909643
136350	2260	FGFR1	0024	HYPOGONADOTROPIC HYPOGONADISM 2 WITHOUT ANOSMIA, SUSCEPTIBILITY TO	FGFR1, ASP768TYR	121909644
136350	2260	FGFR1	0025	HYPOGONADOTROPIC HYPOGONADISM 2 WITHOUT ANOSMIA, SUSCEPTIBILITY TO	FGFR1, ARG250GLN	121909645
136350	2260	FGFR1	0026	HYPOGONADOTROPIC HYPOGONADISM 2 WITH ANOSMIA, SUSCEPTIBILITY TO	FGFR1, GLY348ARG	
136350	2260	FGFR1	0027	HYPOGONADOTROPIC HYPOGONADISM 2 WITH ANOSMIA, SUSCEPTIBILITY TO	FGFR1, PRO483THR	
136350	2260	FGFR1	0028	HYPOGONADOTROPIC HYPOGONADISM 2 WITH ANOSMIA, SUSCEPTIBILITY TO	FGFR1, GLU692GLY	
136350	2260	FGFR1	0029	HYPOGONADOTROPIC HYPOGONADISM 2 WITH ANOSMIA, SUSCEPTIBILITY TO	FGFR1, GLU670LYS	
136351	2322	FLT3	0001	LEUKEMIA, ACUTE MYELOID, REDUCED SURVIVAL IN	FLT3, INTERNAL TANDEM DUP, SOMATIC	
136351	2322	FLT3	0002	LEUKEMIA, ACUTE MYELOID, SOMATIC	FLT3, 6-BP INS	
136351	2322	FLT3	0003	LEUKEMIA, ACUTE MYELOID, SOMATIC LEUKEMIA, ACUTE LYMPHOBLASTIC, SOMATIC, INCLUDED	FLT3, ASP835VAL	121909646
136351	2322	FLT3	0004	LEUKEMIA, ACUTE MYELOID, SOMATIC	FLT3, ASP835HIS	121913488
136351	2322	FLT3	0005	LEUKEMIA, ACUTE MYELOID, SOMATIC	FLT3, ASP835ASN	121913488
136351	2322	FLT3	0006	LEUKEMIA, ACUTE MYELOID, SOMATIC	FLT3, ASP835GLU	
136351	2322	FLT3	0007	LEUKEMIA, ACUTE MYELOID, SOMATIC LEUKEMIA, ACUTE LYMPHOBLASTIC, SOMATIC, INCLUDED	FLT3, ASP835TYR	121913488
136351	2322	FLT3	0008	LEUKEMIA, ACUTE MYELOID, SOMATIC	FLT3, ASP835 DEL	
136351	2322	FLT3	0009	LEUKEMIA, ACUTE LYMPHOBLASTIC, SOMATIC	FLT3, 3-BP DEL, NT1777	
136352	2324	FLT4	0002	LYMPHEDEMA, HEREDITARY, IA	FLT4, GLY857ARG	
136352	2324	FLT4	0003	LYMPHEDEMA, HEREDITARY, IA	FLT4, ARG1041PRO	121909650
136352	2324	FLT4	0004	LYMPHEDEMA, HEREDITARY, IA	FLT4, LEU1044PRO	121909651
136352	2324	FLT4	0005	LYMPHEDEMA, HEREDITARY, IA	FLT4, PRO1114LEU	121909652
136352	2324	FLT4	0006	LYMPHEDEMA, HEREDITARY, I	FLT4, HIS1035ARG	121909653
136352	2324	FLT4	0007	HEMANGIOMA, CAPILLARY INFANTILE, SOMATIC	FLT4, PRO954SER	34255532
136352	2324	FLT4	0008	LYMPHEDEMA, HEREDITARY, IA	FLT4, VAL878MET	121909654
136352	2324	FLT4	0009	LYMPHEDEMA, HEREDITARY, IA	FLT4, ILE1086THR	121909655
136352	2324	FLT4	0010	LYMPHEDEMA, HEREDITARY, IA	FLT4, GLU1106LYS	121909656
136352	2324	FLT4	0011	LYMPHEDEMA, HEREDITARY, IA	FLT4, 3-BP DEL, 3323TCT	
136352	2324	FLT4	0012	LYMPHEDEMA, HEREDITARY, IA	FLT4, ALA855THR	121909657
136430	2348	FOLR1	0001	NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	FOLR1, GLN118TER	121918405
136430	2348	FOLR1	0002	NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	FOLR1, CYS175TER	121918406
136430	2348	FOLR1	0003	NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	FOLR1, 18-BP DUP, NT130	
136430	2348	FOLR1	0004	FOLATE RECEPTOR DEFICIENCY	FOLR1, SPLICE SITE MUTATION	
136435	2492	FSHR	0001	OVARIAN DYSGENESIS 1	FSHR, ALA189VAL	121909658
136435	2492	FSHR	0003	OVARIAN DYSGENESIS 1	FSHR, ILE160THR	121909659
136435	2492	FSHR	0004	OVARIAN DYSGENESIS 1	FSHR, ARG573CYS	121909660
136435	2492	FSHR	0005	OVARIAN RESPONSE TO FSH STIMULATION	FSHR, THR307ALA	6165
136435	2492	FSHR	0006	OVARIAN RESPONSE TO FSH STIMULATION OVARIAN HYPERSTIMULATION SYNDROME, MODIFIER OF SEVERITY OF, INCLUDED	FSHR, ASN680SER	6166
136435	2492	FSHR	0007	OVARIAN DYSGENESIS 1	FSHR, ALA418THR	121909661
136435	2492	FSHR	0008	OVARIAN HYPERSTIMULATION SYNDROME	FSHR, THR449ILE	28928870
136435	2492	FSHR	0009	OVARIAN HYPERSTIMULATION SYNDROME	FSHR, ASP567ASN	28928871
136435	2492	FSHR	0010	OVARIAN DYSGENESIS 1	FSHR, PRO519THR	121909662
136435	2492	FSHR	0011	OVARIAN HYPERSTIMULATION SYNDROME	FSHR, THR449ALA	121909663
136435	2492	FSHR	0012	OVARIAN HYPERSTIMULATION SYNDROME	FSHR, ILE545THR	121909664
136435	2492	FSHR	0013	OVARIAN HYPERSTIMULATION SYNDROME	FSHR, SER128TYR	121909665
136435	2492	FSHR	0014	OVARIAN DYSGENESIS 1	FSHR, PRO587HIS	
136530	2488	FSHB	0001	FOLLICLE-STIMULATING HORMONE DEFICIENCY, ISOLATED	FSHB, 2-BP DEL, FS87TER	
136530	2488	FSHB	0002	FOLLICLE-STIMULATING HORMONE DEFICIENCY, ISOLATED	FSHB, CYS51GLY	5030776
136530	2488	FSHB	0003	FOLLICLE-STIMULATING HORMONE DEFICIENCY, ISOLATED	FSHB, TYR76TER	121909666
136836	2528	FUT6	0001	FUCOSYLTRANSFERASE 6 DEFICIENCY	FUT6, GLU247LYS	17855739
136850	2271	FH	0001	FUMARASE DEFICIENCY	FH, ALA265THR	121913118
136850	2271	FH	0002	FUMARASE DEFICIENCY	FH, GLU319GLN	121913119
136850	2271	FH	0003	HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	FH, ARG58TER	121913120
136850	2271	FH	0004	HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	FH, ASN64THR	121913121
136850	2271	FH	0005	HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	FH, 2-BP DEL	
136850	2271	FH	0006	HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	FH, ARG300TER	121913122
136850	2271	FH	0007	HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	FH, ARG190HIS	121913123
136850	2271	FH	0008	HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	FH, ARG190LEU	
136850	2271	FH	0009	HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	FH, ARG58PRO	75086406
136850	2271	FH	0010	FUMARASE DEFICIENCY	FH, PRO174ARG	
136850	2271	FH	0011	FUMARASE DEFICIENCY	FH, DEL	
137060	2683	B4GALT1	0001	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IId	B4GALT1, 1-BP INS, 1031C	
137070	2521	FUS	0001	AMYOTROPHIC LATERAL SCLEROSIS 6, AUTOSOMAL RECESSIVE	FUS, HIS517GLN	121909667
137070	2521	FUS	0002	AMYOTROPHIC LATERAL SCLEROSIS 6 WITHOUT FRONTOTEMPORAL DEMENTIA	FUS, ARG521GLY	121909668
137070	2521	FUS	0003	AMYOTROPHIC LATERAL SCLEROSIS 6 WITHOUT FRONTOTEMPORAL DEMENTIA	FUS, ARG518LYS	121909669
137070	2521	FUS	0004	AMYOTROPHIC LATERAL SCLEROSIS 6 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA	FUS, ARG521CYS	
137070	2521	FUS	0005	AMYOTROPHIC LATERAL SCLEROSIS 6 WITHOUT FRONTOTEMPORAL DEMENTIA	FUS, ARG521HIS	121909671
137070	2521	FUS	0006	AMYOTROPHIC LATERAL SCLEROSIS 6 WITHOUT FRONTOTEMPORAL DEMENTIA	FUS, GLY507ASP	
137070	2521	FUS	0007	AMYOTROPHIC LATERAL SCLEROSIS 6 WITHOUT FRONTOTEMPORAL DEMENTIA TREMOR, HEREDITARY ESSENTIAL, 4, INCLUDED	FUS, ARG216CYS	
137070	2521	FUS	0008	AMYOTROPHIC LATERAL SCLEROSIS 6 WITHOUT FRONTOTEMPORAL DEMENTIA	FUS, ARG524TRP	
137070	2521	FUS	0009	AMYOTROPHIC LATERAL SCLEROSIS 6 WITHOUT FRONTOTEMPORAL DEMENTIA	FUS, ARG495TER	
137070	2521	FUS	0010	AMYOTROPHIC LATERAL SCLEROSIS 6 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA	FUS, GLY206SER	
137070	2521	FUS	0011	TREMOR, HEREDITARY ESSENTIAL, 4	FUS, GLN290TER	
137070	2521	FUS	0012	TREMOR, HEREDITARY ESSENTIAL, 4	FUS, PRO431LEU	
137140	2555	GABRA2	0001	ALCOHOLISM, SUSCEPTIBILITY TO	GABRA2,	279871
137140	2555	GABRA2	0002	ALCOHOLISM, SUSCEPTIBILITY TO	GABRA2,	279845
137140	2555	GABRA2	0003	ALCOHOLISM, SUSCEPTIBILITY TO	GABRA2,	279836
137150	18	ABAT	0001	GABA-TRANSAMINASE DEFICIENCY	ABAT, ARG220LYS	121434578
137150	18	ABAT	0002	GABA-TRANSAMINASE DEFICIENCY	ABAT, 3-PRIME DELETION	
137160	2554	GABRA1	0001	EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 5	GABRA1, ALA322ASP	121434579
137160	2554	GABRA1	0002	EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 4	GABRA1, 1-BP DEL, 975C	
137163	2563	GABRD	0001	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 5, SUSCEPTIBILITY TO	GABRD, GLU177ALA	121434580
137163	2563	GABRD	0002	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 5, SUSCEPTIBILITY TO EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 10, INCLUDED;; EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 7, INCLUDED	GABRD, ARG220HIS	41307846
137164	2566	GABRG2	0001	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 3	GABRG2, LYS289MET	121909672
137164	2566	GABRG2	0002	EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 2 FEBRILE SEIZURES, FAMILIAL, 8, INCLUDED	GABRG2, ARG43GLN	121909673
137164	2566	GABRG2	0003	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 3	GABRG2, GLN351TER	121909674
137164	2566	GABRG2	0004	EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 2 FEBRILE SEIZURES, FAMILIAL, 8, INCLUDED	GABRG2, IVS6DS, T-G, +2	
137164	2566	GABRG2	0005	FEBRILE SEIZURES, FAMILIAL, 8	GABRG2, ARG139GLY	
137167	2677	GGCX	0001	VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1	GGCX, LEU394ARG	121909675
137167	2677	GGCX	0002	VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1	GGCX, TRP501SER	28928872
137167	2677	GGCX	0003	VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1	GGCX, ARG485PRO	121909676
137167	2677	GGCX	0004	VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1	GGCX, IVS2AS, G-T	
137167	2677	GGCX	0005	PXE-LIKE DISORDER WITH MULTIPLE COAGULATION FACTOR DEFICIENCY	GGCX, PHE299SER	121909677
137167	2677	GGCX	0006	PXE-LIKE DISORDER WITH MULTIPLE COAGULATION FACTOR DEFICIENCY	GGCX, GLY558ARG	121909678
137167	2677	GGCX	0007	PXE-LIKE DISORDER WITH MULTIPLE COAGULATION FACTOR DEFICIENCY	GGCX, TRP493SER	121909679
137167	2677	GGCX	0008	PXE-LIKE DISORDER WITH MULTIPLE COAGULATION FACTOR DEFICIENCY	GGCX, GLN374TER	121909680
137167	2677	GGCX	0009	PXE-LIKE DISORDER WITH MULTIPLE COAGULATION FACTOR DEFICIENCY	GGCX, GLY537TYR	
137167	2677	GGCX	0010	PXE-LIKE DISORDER WITH MULTIPLE COAGULATION FACTOR DEFICIENCY	GGCX, ARG476CYS	121909681
137167	2677	GGCX	0011	PXE-LIKE DISORDER WITH MULTIPLE COAGULATION FACTOR DEFICIENCY	GGCX, ARG476HIS	121909682
137167	2677	GGCX	0012	PXE-LIKE DISORDER WITH MULTIPLE COAGULATION FACTOR DEFICIENCY	GGCX, VAL255MET	121909683
137167	2677	GGCX	0013	PXE-LIKE DISORDER WITH MULTIPLE COAGULATION FACTOR DEFICIENCY	GGCX, SER300PHE	121909684
137192	2562	GABRB3	0001	INSOMNIA	GABRB3, ARG192HIS	121913125
137192	2562	GABRB3	0002	EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 5	GABRB3, PRO11SER	25409
137192	2562	GABRB3	0003	EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 5	GABRB3, SER15PHE	121913126
137192	2562	GABRB3	0004	EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 5	GABRB3, GLY32ARG	71651682
137290	4070	TACSTD2	0001	GELATINOUS DROP-LIKE CORNEAL DYSTROPHY	TACSTD2, GLN118TER	80358223
137290	4070	TACSTD2	0002	GELATINOUS DROP-LIKE CORNEAL DYSTROPHY	TACSTD2, GLN207TER	80358224
137290	4070	TACSTD2	0003	GELATINOUS DROP-LIKE CORNEAL DYSTROPHY	TACSTD2, SER170TER	80358225
137290	4070	TACSTD2	0004	GELATINOUS DROP-LIKE CORNEAL DYSTROPHY	TACSTD2, 1-BP DEL, 632A	
137290	4070	TACSTD2	0005	GELATINOUS DROP-LIKE CORNEAL DYSTROPHY	TACSTD2, MET1ARG	80358226
137290	4070	TACSTD2	0006	GELATINOUS DROP-LIKE CORNEAL DYSTROPHY	TACSTD2, CYS119SER	80358227
137290	4070	TACSTD2	0007	GELATINOUS DROP-LIKE CORNEAL DYSTROPHY	TACSTD2, 12-BP DEL/1-BP INS, NT772	
137290	4070	TACSTD2	0008	GELATINOUS DROP-LIKE CORNEAL DYSTROPHY	TACSTD2, LEU186PRO	80358228
137295	2624	GATA2	0001	DENDRITIC CELL, MONOCYTE, B LYMPHOCYTE, AND NATURAL KILLER LYMPHOCYTE DEFICIENCY	GATA2, ARG398TRP	
137295	2624	GATA2	0002	DENDRITIC CELL, MONOCYTE, B LYMPHOCYTE, AND NATURAL KILLER LYMPHOCYTE DEFICIENCY MYELODYSPLASTIC SYNDROME, SUSCEPTIBILITY TO, INCLUDED;; LEUKEMIA, ACUTE MYELOID, SUSCEPTIBILITY TO, INCLUDED	GATA2, THR354MET	
137295	2624	GATA2	0003	DENDRITIC CELL, MONOCYTE, B LYMPHOCYTE, AND NATURAL KILLER LYMPHOCYTE DEFICIENCY	GATA2, PRO254LEU	
137295	2624	GATA2	0004	DENDRITIC CELL, MONOCYTE, B LYMPHOCYTE, AND NATURAL KILLER LYMPHOCYTE DEFICIENCY	GATA2, 2-KB DEL, EX3-4DEL	
137295	2624	GATA2	0005	DENDRITIC CELL, MONOCYTE, B LYMPHOCYTE, AND NATURAL KILLER LYMPHOCYTE DEFICIENCY	GATA2, 12-BP DEL, NT1083	
137295	2624	GATA2	0006	DENDRITIC CELL, MONOCYTE, B LYMPHOCYTE, AND NATURAL KILLER LYMPHOCYTE DEFICIENCY	GATA2, 1-BP DEL/2-BP INS, NT243	
137295	2624	GATA2	0007	DENDRITIC CELL, MONOCYTE, B LYMPHOCYTE, AND NATURAL KILLER LYMPHOCYTE DEFICIENCY	GATA2, 1-BP INS, 599G	
137295	2624	GATA2	0008	DENDRITIC CELL, MONOCYTE, B LYMPHOCYTE, AND NATURAL KILLER LYMPHOCYTE DEFICIENCY	GATA2, IVS4AS, G-T, -1	
137295	2624	GATA2	0009	LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	GATA2, 2-BP INS, 310CC	
137295	2624	GATA2	0010	LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	GATA2, 1-BP INS, 230C	
137295	2624	GATA2	0011	LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	GATA2, ARG337TER	
137295	2624	GATA2	0012	LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	GATA2, CYS373ARG	
137295	2624	GATA2	0013	LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	GATA2, ARG361LEU	
137295	2624	GATA2	0014	MYELODYSPLASTIC SYNDROME, SUSCEPTIBILITY TO	GATA2, 3-BP DEL, 1063ACA	
137295	2624	GATA2	0015	DENDRITIC CELL, MONOCYTE, B LYMPHOCYTE, AND NATURAL KILLER LYMPHOCYTE DEFICIENCY	GATA2, 28-BP DEL, INTRON 5	
137350	2934	GSN	0001	AMYLOIDOSIS, FAMILIAL, FINNISH TYPE AMYLOIDOSIS, MERETOJA TYPE	GSN, ASP187ASN	121909715
137350	2934	GSN	0002	AMYLOIDOSIS, FAMILIAL, FINNISH TYPE	GSN, ASP187TYR	
137780	2670	GFAP	0001	ALEXANDER DISEASE	GFAP, ARG239CYS	58064122
137780	2670	GFAP	0002	ALEXANDER DISEASE	GFAP, ARG239HIS	59565950
137780	2670	GFAP	0003	ALEXANDER DISEASE	GFAP, ARG416TRP	121909717
137780	2670	GFAP	0004	ALEXANDER DISEASE	GFAP, ARG79HIS	59285727
137780	2670	GFAP	0005	ALEXANDER DISEASE	GFAP, ARG79CYS	59793293
137780	2670	GFAP	0006	ALEXANDER DISEASE	GFAP, ARG88CYS	
137780	2670	GFAP	0007	ALEXANDER DISEASE	GFAP, ARG88SER	61622935
137780	2670	GFAP	0008	ALEXANDER DISEASE	GFAP, LEU76PHE	57120761
137780	2670	GFAP	0009	ALEXANDER DISEASE	GFAP, ASN77TYR	58732244
137780	2670	GFAP	0010	ALEXANDER DISEASE	GFAP, GLU362ASP	121909718
137780	2670	GFAP	0011	ALEXANDER DISEASE	GFAP, ARG276LEU	121909719
137780	2670	GFAP	0012	ALEXANDER DISEASE	GFAP, LEU352PRO	28932769
137780	2670	GFAP	0013	ALEXANDER DISEASE	GFAP, ASP78GLU	121909720
137960	4358	MPV17	0001	MITOCHONDRIAL DNA DEPLETION SYNDROME 6 (HEPATOCEREBRAL TYPE)	MPV17, ARG50GLN	121909721
137960	4358	MPV17	0002	MITOCHONDRIAL DNA DEPLETION SYNDROME 6 (HEPATOCEREBRAL TYPE)	MPV17, ASN166LYS	121909722
137960	4358	MPV17	0003	MITOCHONDRIAL DNA DEPLETION SYNDROME 6 (HEPATOCEREBRAL TYPE)	MPV17, ARG50TRP	121909723
137960	4358	MPV17	0004	MITOCHONDRIAL DNA DEPLETION SYNDROME 6 (HEPATOCEREBRAL TYPE)	MPV17, 26-BP DEL, NT116	
137960	4358	MPV17	0005	MITOCHONDRIAL DNA DEPLETION SYNDROME 6 (HEPATOCEREBRAL TYPE)	MPV17, TRP120TER	121909724
137960	4358	MPV17	0006	MITOCHONDRIAL DNA DEPLETION SYNDROME 6 (HEPATOCEREBRAL TYPE)	MPV17, GLY24TRP	121909725
137960	4358	MPV17	0007	MITOCHONDRIAL DNA DEPLETION SYNDROME 6 (HEPATOCEREBRAL TYPE)	MPV17, 1.5-KB DEL	
138033	2642	GCGR	0001	DIABETES MELLITUS, TYPE II	GCGR, GLY40SER	1801483
138040	2908	NR3C1	0001	GLUCOCORTICOID RESISTANCE, FAMILIAL	NR3C1, ASP641VAL	104893908
138040	2908	NR3C1	0002	GLUCOCORTICOID RESISTANCE, FAMILIAL	NR3C1, IVS6DS, 4-BP DEL	
138040	2908	NR3C1	0003	GLUCOCORTICOID RESISTANCE, CELLULAR	NR3C1, LEU753PHE	121909726
138040	2908	NR3C1	0005	REMOVED FROM DATABASE .0006 REMOVED FROM DATABASE .0007 GLUCOCORTICOID RECEPTOR POLYMORPHISM	NR3C1, ASN363SER	
138040	2908	NR3C1	0008	GLUCOCORTICOID RESISTANCE, GENERALIZED	NR3C1, ILE559ASN	104893909
138040	2908	NR3C1	0009	GLUCOCORTICOID RESISTANCE, FAMILIAL	NR3C1, ILE747MET	104893910
138040	2908	NR3C1	0010	PSEUDOHERMAPHRODITISM, FEMALE, WITH HYPOKALEMIA, DUE TO GLUCOCORTICOID RESISTANCE	NR3C1, VAL571ALA	104893911
138040	2908	NR3C1	0011	GLUCOCORTICOID RESISTANCE, RELATIVE BODY COMPOSITION, BENEFICIAL, INCLUDED	NR3C1, 198G-A, 200G-A	
138040	2908	NR3C1	0012	GLUCOCORTICOID RESISTANCE, GENERALIZED	NR3C1, LEU773PRO	104893912
138040	2908	NR3C1	0013	GLUCOCORTICOID RESISTANCE, GENERALIZED	NR3C1, ARG477HIS	104893913
138040	2908	NR3C1	0014	GLUCOCORTICOID RESISTANCE, GENERALIZED	NR3C1, GLY679SER	104893914
138040	2908	NR3C1	0015	GLUCOCORTICOID RESISTANCE, GENERALIZED	NR3C1, PHE737LEU	121909727
138079	2645	GCK	0001	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE II	GCK, GLU279TER	104894005
138079	2645	GCK	0002	DIABETES MELLITUS, NONINSULIN-DEPENDENT, LATE-ONSET	GCK, ARG186TER	104894006
138079	2645	GCK	0003	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE II	GCK, THR228MET	80356655
138079	2645	GCK	0004	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE II	GCK, GLY261ARG	104894008
138079	2645	GCK	0005	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE II	GCK, GLY299ARG	104894009
138079	2645	GCK	0006	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE II	GCK, IVS4DS, 15-BP DEL	
138079	2645	GCK	0007	DIABETES MELLITUS, GESTATIONAL	GCK, SER131PRO	104894010
138079	2645	GCK	0008	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE II	GCK, GLU265TER	104894011
138079	2645	GCK	0009	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3	GCK, VAL455MET	104894012
138079	2645	GCK	0010	DIABETES MELLITUS, PERMANENT NEONATAL MATURITY-ONSET DIABETES OF THE YOUNG, TYPE II, INCLUDED	GCK, MET210LYS	80356654
138079	2645	GCK	0011	DIABETES MELLITUS, PERMANENT NEONATAL MATURITY-ONSET DIABETES OF THE YOUNG, TYPE II, INCLUDED	GCK, THR228MET	
138079	2645	GCK	0012	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3	GCK, ALA456VAL	104894014
138079	2645	GCK	0013	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3	GCK, TYR214CYS	104894015
138079	2645	GCK	0014	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE II	GCK, ALA378THR	104894016
138079	2645	GCK	0015	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3	GCK, VAL91LEU	
138079	2645	GCK	0016	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE II	GCK, GLU339LYS	
138090	9563	H6PD	0001	CORTISONE REDUCTASE DEFICIENCY 1	H6PD, 29-BP INS, NT620	
138090	9563	H6PD	0002	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	H6PD, ARG453GLN	6688832
138090	9563	H6PD	0003	CORTISONE REDUCTASE DEFICIENCY 1	H6PD, 960G-A	
138090	9563	H6PD	0004	CORTISONE REDUCTASE DEFICIENCY 1	H6PD, GLY359ASP	
138090	9563	H6PD	0005	CORTISONE REDUCTASE DEFICIENCY 1	H6PD, TYR316TER	
138090	9563	H6PD	0006	CORTISONE REDUCTASE DEFICIENCY 1	H6PD, 1-BP DEL, 325C	
138130	2746	GLUD1	0001	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6	GLUD1, HIS454TYR	121909730
138130	2746	GLUD1	0002	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6	GLUD1, SER445LEU	121909731
138130	2746	GLUD1	0003	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6	GLUD1, SER448PRO	121909732
138130	2746	GLUD1	0004	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6	GLUD1, GLY446SER	121909733
138130	2746	GLUD1	0005	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6	GLUD1, GLY446ASP	121909734
138130	2746	GLUD1	0006	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6	GLUD1, GLU296ALA	121909735
138130	2746	GLUD1	0007	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6	GLUD1, ARG265LYS	121909736
138130	2746	GLUD1	0008	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6	GLUD1, ARG221CYS	56275071
138130	2746	GLUD1	0009	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6	GLUD1, ARG269HIS	121909737
138140	6513	SLC2A1	0001	GLUT1 DEFICIENCY SYNDROME 1	SLC2A1, DEL	
138140	6513	SLC2A1	0002	GLUT1 DEFICIENCY SYNDROME 1	SLC2A1, LYS456TER	80359829
138140	6513	SLC2A1	0003	GLUT1 DEFICIENCY SYNDROME 1	SLC2A1, TYR449TER	80359828
138140	6513	SLC2A1	0004	GLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE	SLC2A1, LYS256VAL	
138140	6513	SLC2A1	0005	GLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE	SLC2A1, ARG126LEU	
138140	6513	SLC2A1	0006	GLUT1 DEFICIENCY SYNDROME 1	SLC2A1, GLY91ASP	80359814
138140	6513	SLC2A1	0007	GLUT1 DEFICIENCY SYNDROME 1	SLC2A1, ARG126HIS	80359816
138140	6513	SLC2A1	0008	GLUT1 DEFICIENCY SYNDROME 2	SLC2A1, 12-BP DEL, NT1022	
138140	6513	SLC2A1	0009	GLUT1 DEFICIENCY SYNDROME 2	SLC2A1, GLY314SER	121909739
138140	6513	SLC2A1	0010	GLUT1 DEFICIENCY SYNDROME 2	SLC2A1, ALA275THR	121909740
138140	6513	SLC2A1	0011	GLUT1 DEFICIENCY SYNDROME 2	SLC2A1, ASN34ILE	
138140	6513	SLC2A1	0012	GLUT1 DEFICIENCY SYNDROME 2	SLC2A1, SER95ILE	
138140	6513	SLC2A1	0013	GLUT1 DEFICIENCY SYNDROME 2	SLC2A1, ARG93TRP	
138140	6513	SLC2A1	0014	GLUT1 DEFICIENCY SYNDROME 1 GLUT1 DEFICIENCY SYNDROME 2, INCLUDED;; DYSTONIA 9, INCLUDED	SLC2A1, ARG126CYS	
138140	6513	SLC2A1	0015	GLUT1 DEFICIENCY SYNDROME 2	SLC2A1, ARG91TRP	
138140	6513	SLC2A1	0016	GLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE	SLC2A1, ARG468TRP	
138140	6513	SLC2A1	0017	GLUT1 DEFICIENCY SYNDROME 2	SLC2A1, 3-BP INS, TAT	
138140	6513	SLC2A1	0018	DYSTONIA 9	SLC2A1, ARG212CYS	
138140	6513	SLC2A1	0019	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	SLC2A1, ARG232CYS	
138140	6513	SLC2A1	0020	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	SLC2A1, ARG223PRO	
138160	6514	SLC2A2	0001	DIABETES MELLITUS, NONINSULIN-DEPENDENT	SLC2A2, VAL197ILE	121909741
138160	6514	SLC2A2	0002	FANCONI-BICKEL SYNDROME	SLC2A2, 1-BP DEL	
138160	6514	SLC2A2	0003	FANCONI-BICKEL SYNDROME	SLC2A2, ARG365TER	121909742
138160	6514	SLC2A2	0004	FANCONI-BICKEL SYNDROME	SLC2A2, ARG301TER	121909743
138160	6514	SLC2A2	0005	FANCONI-BICKEL SYNDROME	SLC2A2, PRO417LEU	121909744
138160	6514	SLC2A2	0006	FANCONI-BICKEL SYNDROME	SLC2A2, TRP420TER	121909745
138160	6514	SLC2A2	0007	FANCONI-BICKEL SYNDROME	SLC2A2, 1-BP DEL, 1363G	
138160	6514	SLC2A2	0008	FANCONI-BICKEL SYNDROME	SLC2A2, 1405C-T	
138160	6514	SLC2A2	0009	FANCONI-BICKEL SYNDROME	SLC2A2, 1-BP INS, 793C	
138160	6514	SLC2A2	0010	FANCONI-BICKEL SYNDROME	SLC2A2, 1264G-A	
138160	6514	SLC2A2	0011	FANCONI-BICKEL SYNDROME	SLC2A2, 469C-T	
138160	6514	SLC2A2	0012	FANCONI-BICKEL SYNDROME	SLC2A2, VAL423GLU	28928874
138160	6514	SLC2A2	0013	FANCONI-BICKEL SYNDROME	SLC2A2, IVS2, A-G, -2	
138160	6514	SLC2A2	0014	FANCONI-BICKEL SYNDROME	SLC2A2, GLN287TER	121909746
138160	6514	SLC2A2	0015	FANCONI-BICKEL SYNDROME	SLC2A2, LEU389PRO	121909747
138180	2805	GOT1	0001	ASPARTATE AMINOTRANSFERASE, REDUCED SERUM LEVEL OF	GOT1, ASN389 DEL	
138190	6517	SLC2A4	0001	DIABETES MELLITUS, NONINSULIN-DEPENDENT	SLC2A4, VAL383ILE	121434581
138200	2875	GPT	0001	GLUTAMIC PYRUVATE TRANSAMINASE POLYMORPHISM	GPT, HIS14ASP	1063739
138244	2898	GRIK2	0001	MENTAL RETARDATION, AUTOSOMAL RECESSIVE, 6	GRIK2, DEL/INV, EX7-11	
138248	2890	GRIA1	0001	VARIANT OF UNKNOWN SIGNIFICANCE	GRIA1, ALA636THR	
138249	2902	GRIN1	0001	MENTAL RETARDATION, AUTOSOMAL DOMINANT 8	GRIN1, GLU662LYS	
138249	2902	GRIN1	0002	MENTAL RETARDATION, AUTOSOMAL DOMINANT 8	GRIN1, 3-BP DUP, SER560	
138250	5832	ALDH18A1	0001	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	ALDH18A1, ARG84GLN	121434582
138250	5832	ALDH18A1	0002	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	ALDH18A1, HIS784TYR	121434583
138250	5832	ALDH18A1	0003	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	ALDH18A1, NT1923, G-A, +1	
138252	2904	GRIN2B	0001	MENTAL RETARDATION, AUTOSOMAL DOMINANT 6	GRIN2B, IVS2DS, G-A, +1	
138252	2904	GRIN2B	0002	MENTAL RETARDATION, AUTOSOMAL DOMINANT 6	GRIN2B, 2-BP DEL, 803CA	
138252	2904	GRIN2B	0003	MENTAL RETARDATION, AUTOSOMAL DOMINANT 6	GRIN2B, ARG682CYS	
138252	2904	GRIN2B	0004	MENTAL RETARDATION, AUTOSOMAL DOMINANT 6	GRIN2B, IVS11AS, A-G, -2	
138252	2904	GRIN2B	0005	MENTAL RETARDATION, AUTOSOMAL DOMINANT 6	GRIN2B, 1-BP INS, G	
138252	2904	GRIN2B	0006	MENTAL RETARDATION, AUTOSOMAL DOMINANT 6	GRIN2B, CYS456TYR	
138252	2904	GRIN2B	0007	MENTAL RETARDATION, AUTOSOMAL DOMINANT 6	GRIN2B, NT2172, A-G, -2	
138252	2904	GRIN2B	0008	MENTAL RETARDATION, AUTOSOMAL DOMINANT 6	GRIN2B, TRP559TER	
138252	2904	GRIN2B	0009	MENTAL RETARDATION, AUTOSOMAL DOMINANT 6	GRIN2B, PRO553LEU	
138253	2903	GRIN2A	0001	EPILEPSY WITH NEURODEVELOPMENTAL DEFECTS	GRIN2A, GLN218TER	
138253	2903	GRIN2A	0002	EPILEPSY WITH NEURODEVELOPMENTAL DEFECTS	GRIN2A, ASN615LYS	
138253	2903	GRIN2A	0003	EPILEPSY WITH NEURODEVELOPMENTAL DEFECTS	GRIN2A, LEU649VAL	
138253	2903	GRIN2A	0004	EPILEPSY WITH NEURODEVELOPMENTAL DEFECTS	GRIN2A, PRO522ARG	
138290	2752	GLUL	0001	GLUTAMINE DEFICIENCY, CONGENITAL	GLUL, ARG324CYS	80358214
138290	2752	GLUL	0002	GLUTAMINE DEFICIENCY, CONGENITAL	GLUL, ARG341CYS	80358215
138290	2752	GLUL	0003	GLUTAMINE DEFICIENCY, CONGENITAL	GLUL, ARG324SER	
138292	2673	GFPT1	0001	MYASTHENIA, CONGENITAL, WITH TUBULAR AGGREGATES 1	GFPT1, ARG111CYS	
138292	2673	GFPT1	0002	MYASTHENIA, CONGENITAL, WITH TUBULAR AGGREGATES 1	GFPT1, 1-BP INS, 222A	
138292	2673	GFPT1	0003	MYASTHENIA, CONGENITAL, WITH TUBULAR AGGREGATES 1	GFPT1, TRP240TER	
138292	2673	GFPT1	0004	MYASTHENIA, CONGENITAL, WITH TUBULAR AGGREGATES 1	GFPT1, ASP348TYR	
138292	2673	GFPT1	0005	MYASTHENIA, CONGENITAL, WITH TUBULAR AGGREGATES 1	GFPT1, THR15ALA	
138292	2673	GFPT1	0006	MYASTHENIA, CONGENITAL, WITH TUBULAR AGGREGATES 1	GFPT1, 1-BP DEL, NT621	
138320	2876	GPX1	0001	GLUTATHIONE PEROXIDASE POLYMORPHISM	GPX1, PRO197LEU	1050450
138420	2819	GPD1	0001	HYPERTRIGLYCERIDEMIA, TRANSIENT INFANTILE	GPD1, IVS3AS, G-C, -1	
138430	2820	GPD2	0001	DIABETES MELLITUS, TYPE II	GPD2, PHE635SER	121918407
138470	629	CFB	0001	FACTOR B FAST-SLOW POLYMORPHISM BF*FA/S	CFB, ARG8GLN	
138470	629	CFB	0002	FACTOR B FAST-SLOW POLYMORPHISM BF*FB/S	CFB, ARG8TRP	12614
138470	629	CFB	0003	MACULAR DEGENERATION, AGE-RELATED, REDUCED RISK OF	CFB, LEU9HIS	4151667
138470	629	CFB	0004	MACULAR DEGENERATION, AGE-RELATED, REDUCED RISK OF	CFB, ARG32GLN	641153
138470	629	CFB	0005	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 4	CFB, PHE286LEU	
138470	629	CFB	0006	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 4	CFB, LYS323GLU	121909748
138491	2741	GLRA1	0001	HYPEREKPLEXIA 1, AUTOSOMAL DOMINANT	GLRA1, ARG271LEU	121918408
138491	2741	GLRA1	0002	HYPEREKPLEXIA 1, AUTOSOMAL DOMINANT	GLRA1, ARG271GLN	121918408
138491	2741	GLRA1	0003	HYPEREKPLEXIA 1, AUTOSOMAL RECESSIVE	GLRA1, ILE244ASN	121918409
138491	2741	GLRA1	0004	HYPEREKPLEXIA 1, AUTOSOMAL DOMINANT	GLRA1, TYR279CYS	121918410
138491	2741	GLRA1	0005	HYPEREKPLEXIA 1, AUTOSOMAL DOMINANT	GLRA1, GLN266HIS	121918411
138491	2741	GLRA1	0006	HYPEREKPLEXIA 1, AUTOSOMAL DOMINANT	GLRA1, LYS276GLU	121918412
138491	2741	GLRA1	0007	HYPEREKPLEXIA 1, AUTOSOMAL DOMINANT	GLRA1, PRO250THR	121918413
138491	2741	GLRA1	0008	HYPEREKPLEXIA 1, AUTOSOMAL RECESSIVE	GLRA1, 1-BP DEL, 601C	
138491	2741	GLRA1	0009	HYPEREKPLEXIA 1, AUTOSOMAL RECESSIVE	GLRA1, MET147VAL	121918414
138491	2741	GLRA1	0010	HYPEREKPLEXIA 1, AUTOSOMAL RECESSIVE	GLRA1, TYR202TER	121918415
138491	2741	GLRA1	0011	HYPEREKPLEXIA 1, AUTOSOMAL DOMINANT	GLRA1, VAL260MET	121918416
138491	2741	GLRA1	0012	HYPEREKPLEXIA 1, AUTOSOMAL RECESSIVE	GLRA1, SER231ARG	121918417
138491	2741	GLRA1	0013	HYPEREKPLEXIA 1, AUTOSOMAL RECESSIVE	GLRA1, 170-KB DEL	
138491	2741	GLRA1	0014	HYPEREKPLEXIA 1, AUTOSOMAL DOMINANT	GLRA1, SER296TER	121918418
138491	2741	GLRA1	0015	HYPEREKPLEXIA 1, AUTOSOMAL DOMINANT	GLRA1, SER267ASN	
138492	2743	GLRB	0001	HYPEREKPLEXIA 2	GLRB, GLY229ASP	121909749
138492	2743	GLRB	0002	HYPEREKPLEXIA 2	GLRB, IVS5, G-A, +5	
138492	2743	GLRB	0003	HYPEREKPLEXIA 2	GLRB, MET177ARG	
138570	2997	GYS1	0001	GLYCOGEN STORAGE DISEASE 0, MUSCLE	GYS1, ARG462TER	121434584
138571	2998	GYS2	0001	GLYCOGEN STORAGE DISEASE 0, LIVER	GYS2, ARG246TER	121918419
138571	2998	GYS2	0002	GLYCOGEN STORAGE DISEASE 0, LIVER	GYS2, IVS6, G-C, +1	
138571	2998	GYS2	0003	GLYCOGEN STORAGE DISEASE 0, LIVER	GYS2, PRO479GLN	121918420
138571	2998	GYS2	0004	GLYCOGEN STORAGE DISEASE 0, LIVER	GYS2, ALA339PRO	121918421
138571	2998	GYS2	0005	GLYCOGEN STORAGE DISEASE 0, LIVER	GYS2, MET491ARG	121918422
138571	2998	GYS2	0006	GLYCOGEN STORAGE DISEASE 0, LIVER	GYS2, ASN39SER	121918423
138571	2998	GYS2	0007	GLYCOGEN STORAGE DISEASE 0, LIVER	GYS2, SER483PRO	121918424
138571	2998	GYS2	0008	GLYCOGEN STORAGE DISEASE 0, LIVER	GYS2, HIS446ASP	121918425
138600	5004	ORM1	0001	OROSOMUCOID POLYMORPHISM ORM1*F1	ORM1, GLN20, VAL156	
138600	5004	ORM1	0002	OROSOMUCOID POLYMORPHISM ORM1*F2	ORM1, GLN20, MET156	
138600	5004	ORM1	0003	OROSOMUCOID POLYMORPHISM ORM1*S	ORM1, ARG20, VAL156	
138680	197	AHSG	0001	LEANNESS, SUSCEPTIBILITY TO	AHSG, THR230MET	4917
138680	197	AHSG	0002	LEANNESS, SUSCEPTIBILITY TO	AHSG, THR238SER	4918
138680	197	AHSG	0003	LEANNESS, SUSCEPTIBILITY TO	AHSG, 1639A-G	
138700	350	APOH	0001	APOH POLYMORPHISM	APOH, VAL247LEU	199476111
138720	2812	GP1BB	0001	MACROTHROMBOCYTOPENIA, FAMILIAL, BERNARD-SOULIER TYPE	GP1BB, TYR88CYS	121909750
138720	2812	GP1BB	0002	MACROTHROMBOCYTOPENIA, FAMILIAL, BERNARD-SOULIER TYPE	GP1BB, ALA108PRO	
138720	2812	GP1BB	0003	BERNARD SOULIER SYNDROME, TYPE B	GP1BB, TRP21TER	121909752
138720	2812	GP1BB	0004	BERNARD SOULIER SYNDROME, TYPE B	GP1BB, C-G, -133	
138750	2739	GLO1	0001	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	GLO1, ALA111GLU	4746
138850	2798	GNRHR	0001	HYPOGONADOTROPIC HYPOGONADISM 7 WITHOUT ANOSMIA FERTILE EUNUCH SYNDROME, INCLUDED	GNRHR, GLN106ARG	104893836
138850	2798	GNRHR	0002	HYPOGONADOTROPIC HYPOGONADISM 7 WITHOUT ANOSMIA	GNRHR, ARG262GLN	104893837
138850	2798	GNRHR	0003	HYPOGONADOTROPIC HYPOGONADISM 7 WITHOUT ANOSMIA	GNRHR, TYR284CYS	28933074
138850	2798	GNRHR	0004	HYPOGONADOTROPIC HYPOGONADISM 7 WITHOUT ANOSMIA	GNRHR, ALA129ASP	104893838
138850	2798	GNRHR	0005	HYPOGONADOTROPIC HYPOGONADISM 7 WITH ANOSMIA	GNRHR, SER217ARG	104893839
138850	2798	GNRHR	0006	HYPOGONADOTROPIC HYPOGONADISM 7 WITHOUT ANOSMIA	GNRHR, SER168ARG	104893840
138850	2798	GNRHR	0007	HYPOGONADOTROPIC HYPOGONADISM 7 WITHOUT ANOSMIA	GNRHR, LEU314TER	104893841
138850	2798	GNRHR	0008	HYPOGONADOTROPIC HYPOGONADISM 7 WITHOUT ANOSMIA	GNRHR, ARG139HIS	104893842
138850	2798	GNRHR	0009	HYPOGONADOTROPIC HYPOGONADISM 7 WITHOUT ANOSMIA	GNRHR, ASN10LYS	104893843
138850	2798	GNRHR	0010	HYPOGONADOTROPIC HYPOGONADISM 7 WITHOUT ANOSMIA	GNRHR, GLU90LYS	104893844
138850	2798	GNRHR	0011	HYPOGONADOTROPIC HYPOGONADISM 7 WITHOUT ANOSMIA	GNRHR, IVS1, G-A, -1	
138850	2798	GNRHR	0012	HYPOGONADOTROPIC HYPOGONADISM 7 WITHOUT ANOSMIA	GNRHR, ALA171THR	74452732
138850	2798	GNRHR	0013	HYPOGONADOTROPIC HYPOGONADISM 7 WITHOUT ANOSMIA	GNRHR, ASN10LYS AND GLN11LYS	
138850	2798	GNRHR	0014	HYPOGONADOTROPIC HYPOGONADISM 7 WITHOUT ANOSMIA	GNRHR, PRO320LEU	104893847
138945	2896	GRN	0001	FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS	GRN, IVS0, G-C, +5	
138945	2896	GRN	0002	FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS	GRN, GLN125TER	63750077
138945	2896	GRN	0003	FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS	GRN, MET1THR	63751006
138945	2896	GRN	0004	FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS	GRN, MET1ILE	63750331
138945	2896	GRN	0005	FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS	GRN, 4-BP INS, NT90	
138945	2896	GRN	0006	FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS	GRN, 4-BP DEL, NT388	
138945	2896	GRN	0007	FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS	GRN, IVS8, G-A, +1	
138945	2896	GRN	0008	FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS	GRN, ALA9ASP	63751243
138945	2896	GRN	0009	FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS	GRN, ARG493TER	63751294
138945	2896	GRN	0010	APHASIA, PRIMARY PROGRESSIVE	GRN, 1-BP DEL, 998G	
138945	2896	GRN	0011	FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS	GRN, 1-BP INS, 1145A	
138945	2896	GRN	0012	APHASIA, PRIMARY PROGRESSIVE	GRN, IVS7AS, A-G, -2	
138945	2896	GRN	0013	APHASIA, PRIMARY PROGRESSIVE	GRN, 2-BP DEL, 675CA	
138945	2896	GRN	0014	FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS	GRN, IVS6AS, A-G, -2	
138945	2896	GRN	0015	FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS APHASIA, PRIMARY PROGRESSIVE, INCLUDED;; CEROID LIPOFUSCINOSIS, NEURONAL, 11, INCLUDED	GRN, 4-BP DEL, 813CACT	
138945	2896	GRN	0016	FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS	GRN, 1-BP DEL, 102C	
138945	2896	GRN	0017	FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS	GRN, 1-BP DEL, 154A	
138945	2896	GRN	0018	FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS, SUSCEPTIBILITY TO	GRN, 78C-T, 3-PRIME UTR,	
138945	2896	GRN	0019	FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS	GRN, IVS6AS, G-A, -1	
138971	1441	CSF3R	0001	NEUTROPHILIA, HEREDITARY	CSF3R, THR617ASN	121918426
138981	1439	CSF2RB	0001	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 5	CSF2RB, 1-BP DEL, 631C	
139130	2784	GNB3	0001	GNB3 POLYMORPHISM HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, INCLUDED	GNB3, 825C-T	
139150	5921	RASA1	0001	BASAL CELL CARCINOMA, SOMATIC	RASA1, ARG398LEU	137853214
139150	5921	RASA1	0002	BASAL CELL CARCINOMA, SOMATIC	RASA1, LYS400GLY	137853215
139150	5921	RASA1	0003	BASAL CELL CARCINOMA, SOMATIC	RASA1, ILE401VAL	137853216
139150	5921	RASA1	0004	CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION PARKES WEBER SYNDROME, INCLUDED	RASA1, 2-BP DEL, 475CT	
139150	5921	RASA1	0005	CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION	RASA1, CYS540TYR	137853217
139150	5921	RASA1	0006	CAPILLARY MALFORMATION WITHOUT ARTERIOVENOUS MALFORMATION	RASA1, ARG285TER	137853218
139150	5921	RASA1	0007	CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION	RASA1, IVS3AS, G-A, -9	
139150	5921	RASA1	0008	CAPILLARY MALFORMATION WITHOUT ARTERIOVENOUS MALFORMATION	RASA1, 4-BP DUP, 2252TCAT	
139185	2619	GAS1	0001	VARIANT OF UNKNOWN SIGNIFICANCE	GAS1, THR200ARG	
139185	2619	GAS1	0002	VARIANT OF UNKNOWN SIGNIFICANCE	GAS1, GLY259GLU	
139191	2692	GHRHR	0001	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IB	GHRHR, GLU72TER	121918117
139191	2692	GHRHR	0002	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IB	GHRHR, IVS1, G-A, +1	
139191	2692	GHRHR	0003	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IB	GHRHR, LEU144HIS	121918118
139191	2692	GHRHR	0004	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IB	GHRHR, PHE242CYS	121918119
139191	2692	GHRHR	0005	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IB	GHRHR, ALA222GLU	121918120
139191	2692	GHRHR	0006	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IB	GHRHR, LYS329GLU	121918121
139191	2692	GHRHR	0007	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IB	GHRHR, -124A-C	
139200	2638	GC	0001	GC1/GC2 POLYMORPHISM	GC, THR420LYS	4588
139200	2638	GC	0002	GC1/GC2 POLYMORPHISM	GC, ASP416GLU	7041
139200	2638	GC	0003	GC1/GC2 POLYMORPHISM GRAVES DISEASE, SUSCEPTIBILITY TO, 3, INCLUDED	GC, IVS8, (TAAA)n	
139250	2688	GH1	0001	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IA	GH1, 2-BP DEL, FS132TER	
139250	2688	GH1	0002	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IA	GH1, TRP20TER	137853219
139250	2688	GH1	0003	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IA	GH1, 6.7-KB DEL	
139250	2688	GH1	0004	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IA	GH1, 1-BP DEL, 371C	
139250	2688	GH1	0005	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IB	GH1, IVS4, G-C, +1	
139250	2688	GH1	0006	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IB	GH1, IVS4, G-T, +1	
139250	2688	GH1	0007	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE II	GH1, IVS3, T-C, +6	
139250	2688	GH1	0008	KOWARSKI SYNDROME	GH1, ARG77CYS	137853220
139250	2688	GH1	0009	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE II	GH1, IVS3, G-A, +1	
139250	2688	GH1	0010	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE II	GH1, IVS3, G-C, +1	
139250	2688	GH1	0011	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE II	GH1, IVS3, G-A, +28	
139250	2688	GH1	0012	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE II	GH1, IVS3, 18-BP DEL, +28-45	
139250	2688	GH1	0013	KOWARSKI SYNDROME	GH1, ASP112GLY	137853221
139250	2688	GH1	0014	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE II	GH1, IVS3, G-A, +5	
139250	2688	GH1	0015	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IB	GH1, IVS4, G-C, +5	
139250	2688	GH1	0016	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE II	GH1, EX3, A-G, +5	
139250	2688	GH1	0017	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE II	GH1, EX3DEL	
139250	2688	GH1	0018	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE II	GH1, IVS2, A-T, -2	
139250	2688	GH1	0019	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE II	GH1, IVS3, T-C, +2	
139250	2688	GH1	0021	KOWARSKI SYNDROME	GH1, CYS53SER	137853222
139250	2688	GH1	0022	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE II	GH1, IVS3, 22-BP DEL	
139250	2688	GH1	0023	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE II	GH1, ARG183HIS	137853223
139250	2688	GH1	0024	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE II	GH1, EX3, A-C, +2	
139250	2688	GH1	0025	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE II	GH1, EX3, G-A, +1	
139265	2766	GMPR	0001	GMP REDUCTASE POLYMORPHISM	GMPR, PHE256ILE	1042391
139312	2774	GNAL	0001	DYSTONIA 25	GNAL, VAL137MET	
139312	2774	GNAL	0002	DYSTONIA 25	GNAL, SER293TER	
139312	2774	GNAL	0003	DYSTONIA 25	GNAL, GLU155LYS	
139312	2774	GNAL	0004	DYSTONIA 25	GNAL, 1-BP INS, 283T	
139312	2774	GNAL	0005	DYSTONIA 25	GNAL, 1-BP INS, 591A	
139312	2774	GNAL	0006	DYSTONIA 25	GNAL, ARG21TER	
139320	2778	GNAS	0001	PSEUDOHYPOPARATHYROIDISM, TYPE IA	GNAS, MET1VAL	137854530
139320	2778	GNAS	0002	PSEUDOHYPOPARATHYROIDISM, TYPE IA PSEUDOPSEUDOHYPOPARATHYROIDISM, INCLUDED	GNAS, IVS10DS, G-C, +1	
139320	2778	GNAS	0003	PSEUDOHYPOPARATHYROIDISM, TYPE IA PSEUDOPSEUDOHYPOPARATHYROIDISM, INCLUDED;; OSSEOUS HETEROPLASIA, PROGRESSIVE, INCLUDED	GNAS, 1-BP DEL, 725C	
139320	2778	GNAS	0005	PSEUDOHYPOPARATHYROIDISM, TYPE IA	GNAS, IVS3AS, A-G, -12	
139320	2778	GNAS	0006	PSEUDOHYPOPARATHYROIDISM, TYPE IA	GNAS, LEU99PRO	137854531
139320	2778	GNAS	0007	PSEUDOHYPOPARATHYROIDISM, TYPE IA	GNAS, CYS165ARG	137854532
139320	2778	GNAS	0008	MCCUNE-ALBRIGHT SYNDROME, SOMATIC, MOSAIC PITUITARY TUMOR, GROWTH HORMONE-SECRETING, SOMATIC, INCLUDED;; SEX CORD STROMAL TUMOR, SOMATIC, INCLUDED	GNAS, ARG201CYS	11554273
139320	2778	GNAS	0009	MCCUNE-ALBRIGHT SYNDROME, SOMATIC, MOSAIC PITUITARY TUMOR, GROWTH HORMONE-SECRETING, SOMATIC, INCLUDED;; ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA, SOMATIC, INCLUDED;; SEX CORD STROMAL TUMOR, SOMATIC, INCLUDED	GNAS, ARG201HIS	121913495
139320	2778	GNAS	0010	PITUITARY TUMOR, GROWTH HORMONE-SECRETING, SOMATIC PITUITARY ADENOMA, ACTH-SECRETING, SOMATIC, INCLUDED	GNAS, GLN227ARG	121913494
139320	2778	GNAS	0011	PSEUDOHYPOPARATHYROIDISM, TYPE IA OSSEOUS HETEROPLASIA, PROGRESSIVE, INCLUDED;; PSEUDOPSEUDOHYPOPARATHYROIDISM, INCLUDED	GNAS, 4-BP DEL, 565CTGA	
139320	2778	GNAS	0012	PITUITARY ADENOMA, ACTH-SECRETING, SOMATIC	GNAS, GLN227HIS	79709641
139320	2778	GNAS	0013	PITUITARY TUMOR, GROWTH HORMONE-SECRETING, SOMATIC POLYOSTOTIC FIBROUS DYSPLASIA, SOMATIC, MOSAIC, INCLUDED;; ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA, SOMATIC, INCLUDED	GNAS, ARG201SER	11554273
139320	2778	GNAS	0014	PSEUDOHYPOPARATHYROIDISM, TYPE IA	GNAS, SER250ARG	137854534
139320	2778	GNAS	0015	PSEUDOPSEUDOHYPOPARATHYROIDISM PSEUDOHYPOPARATHYROIDISM, TYPE IA, INCLUDED	GNAS, 38-BP DEL, EX1/IVS1 BOUNDARY	
139320	2778	GNAS	0016	PSEUDOPSEUDOHYPOPARATHYROIDISM	GNAS, ARG258TRP	137854535
139320	2778	GNAS	0017	PSEUDOPSEUDOHYPOPARATHYROIDISM	GNAS, ARG258ALA	137854536
139320	2778	GNAS	0018	PSEUDOPSEUDOHYPOPARATHYROIDISM	GNAS, GLN170ALA	
139320	2778	GNAS	0019	PSEUDOHYPOPARATHYROIDISM, TYPE IA, WITH TESTOTOXICOSIS	GNAS, ALA366SER	137854537
139320	2778	GNAS	0020	PSEUDOHYPOPARATHYROIDISM, TYPE IA	GNAS, ARG231HIS	137854538
139320	2778	GNAS	0021	MCCUNE-ALBRIGHT SYNDROME, SOMATIC, MOSAIC	GNAS, ARG201GLY	11554273
139320	2778	GNAS	0022	PSEUDOHYPOPARATHYROIDISM, TYPE IA PSEUDOPSEUDOHYPOPARATHYROIDISM, INCLUDED	GNAS, 2-BP DEL, GA, EXON 8	
139320	2778	GNAS	0023	PSEUDOHYPOPARATHYROIDISM, TYPE IA PSEUDOPSEUDOHYPOPARATHYROIDISM, INCLUDED	GNAS, 2-BP DEL, CT, EXON 4	
139320	2778	GNAS	0024	OSSEOUS HETEROPLASIA, PROGRESSIVE PSEUDOHYPOPARATHYROIDISM, TYPE IA, INCLUDED	GNAS, 1-BP DEL, 348C	
139320	2778	GNAS	0025	PSEUDOHYPOPARATHYROIDISM, TYPE IA PSEUDOPSEUDOHYPOPARATHYROIDISM, INCLUDED	GNAS, 1-BP DEL, C, EXON 1	
139320	2778	GNAS	0026	PSEUDOHYPOPARATHYROIDISM, TYPE IA	GNAS, 2-BP DEL, TG, EXON 11	
139320	2778	GNAS	0027	OSSEOUS HETEROPLASIA, PROGRESSIVE	GNAS, 2-BP DEL, 860TG	
139320	2778	GNAS	0029	PSEUDOPSEUDOHYPOPARATHYROIDISM PSEUDOHYPOPARATHYROIDISM, TYPE IA, INCLUDED	GNAS1, PRO115LEU	137854539
139320	2778	GNAS	0031	PSEUDOHYPOPARATHYROIDISM, TYPE IB	GNAS, 4.7-KB DEL	
139320	2778	GNAS	0032	PROLONGED BLEEDING TIME, BRACHYDACTYLY, AND MENTAL RETARDATION	GNAS, 36-BP DUP, ALA138ASP, PRO161ARG	
139320	2778	GNAS	0033	PSEUDOHYPOPARATHYROIDISM, TYPE IB	GNAS, 3-BP DEL, CAT, EXON 13	
139320	2778	GNAS	0034	PSEUDOHYPOPARATHYROIDISM, TYPE IA	GNAS, 1-BP INS, A, EXON 3	
139320	2778	GNAS	0035	PSEUDOHYPOPARATHYROIDISM, TYPE IA	GNAS, 12-BP INS, NT1107	
139320	2778	GNAS	0036	PSEUDOHYPOPARATHYROIDISM, TYPE IC	GNAS, TYR391TER	
139320	2778	GNAS	0037	PSEUDOHYPOPARATHYROIDISM, TYPE IB	GNAS, METHYLATION CHANGES, PATERNAL EPIGENOTYPE	
139320	2778	GNAS	0038	PSEUDOHYPOPARATHYROIDISM, TYPE IC	GNAS, LEU388ARG	
139320	2778	GNAS	0039	PSEUDOHYPOPARATHYROIDISM, TYPE IC	GNAS, GLU392TER	
139320	2778	GNAS	0040	PSEUDOHYPOPARATHYROIDISM, TYPE IC	GNAS, GLU392LYS	
139330	2779	GNAT1	0001	NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 3	GNAT1, GLY38ASP	104893740
139340	2780	GNAT2	0001	ACHROMATOPSIA 4	GNAT2, GLN79TER	121434585
139340	2780	GNAT2	0002	ACHROMATOPSIA 4	GNAT2, 4-BP INS, 842TCAG	
139340	2780	GNAT2	0003	ACHROMATOPSIA 4	GNAT2, NT285, 7-BP DEL/6-BP INS	
139340	2780	GNAT2	0004	ACHROMATOPSIA 4	GNAT2, 461+24G-A	
139350	3848	KRT1	0001	EPIDERMOLYTIC HYPERKERATOSIS	KRT1, GLU310GLN	137853224
139350	3848	KRT1	0002	EPIDERMOLYTIC HYPERKERATOSIS	KRT1, LEU160PRO	57695159
139350	3848	KRT1	0003	EPIDERMOLYTIC HYPERKERATOSIS	KRT1, TYR481CYS	58420087
139350	3848	KRT1	0004	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC	KRT1, LYS73ILE	57977969
139350	3848	KRT1	0005	ICHTHYOSIS, CYCLIC, WITH EPIDERMOLYTIC HYPERKERATOSIS	KRT1, ILE479THR	57837128
139350	3848	KRT1	0006	ICHTHYOSIS, CYCLIC, WITH EPIDERMOLYTIC HYPERKERATOSIS	KRT1, ILE479PHE	61218439
139350	3848	KRT1	0007	EPIDERMOLYTIC HYPERKERATOSIS	KRT1, VAL155ASP	57959072
139350	3848	KRT1	0008	EPIDERMOLYTIC HYPERKERATOSIS	KRT1, ASN187LYS	59429455
139350	3848	KRT1	0009	EPIDERMOLYTIC HYPERKERATOSIS	KRT1, LEU475PRO	137853225
139350	3848	KRT1	0010	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC	KRT1, IVS1, T-A, +2	
139350	3848	KRT1	0011	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC	KRT1, 24-BP DEL, NT1376	
139350	3848	KRT1	0012	KERATOSIS PALMOPLANTARIS STRIATA III	KRT1, 1-BP DEL, 1628G	
139350	3848	KRT1	0013	ICHTHYOSIS HISTRIX, CURTH-MACKLIN TYPE	KRT1, 5191GG-A	
139350	3848	KRT1	0014	PALMOPLANTAR KERATODERMA, EPIDERMOLYTIC	KRT1, IVS6, G-A, +1	
139350	3848	KRT1	0015	EPIDERMOLYTIC HYPERKERATOSIS, LATE-ONSET	KRT1, 1-BP INS, 1752G	
139360	2771	GNAI2	0001	ADRENAL CORTICAL TUMOR, SOMATIC GRANULOSA CELL TUMOR, SOMATIC, INCLUDED;; THECOMA, SOMATIC, INCLUDED	GNAI2, ARG179CYS	137853226
139360	2771	GNAI2	0002	ADRENAL CORTICAL TUMOR, SOMATIC GRANULOSA CELL TUMOR, SOMATIC, INCLUDED;; THECOMA, SOMATIC, INCLUDED	GNAI2, ARG179HIS	137853227
139360	2771	GNAI2	0003	PITUITARY ADENOMA, ACTH-SECRETING, SOMATIC	GNAI2, ARG179GLY	137853226
139360	2771	GNAI2	0004	VENTRICULAR TACHYCARDIA, SOMATIC	GNAI2, PHE200LEU	137853228
139370	2773	GNAI3	0001	AURICULOCONDYLAR SYNDROME 1	GNAI3, GLY40ARG	
140100	3240	HP	0001	HAPTOGLOBIN, ALPHA-1, FAST-SLOW POLYMORPHISM	HP, LYS53GLU	137853233
140100	3240	HP	0002	HAPTOGLOBIN, ALPHA-2	HP, 1.7-KB DUP	
140100	3240	HP	0003	ANHAPTOGLOBINEMIA HYPOHAPTOGLOBINEMIA, INCLUDED	HP, DEL	
140100	3240	HP	0004	ANHAPTOGLOBINEMIA, SUSCEPTIBILITY TO	HP, -61A-C	
140100	3240	HP	0005	ANHAPTOGLOBINEMIA, SUSCEPTIBILITY TO	HP, ILE247THR	104894517
140581	3298	HSF2	0001	VARIANT OF UNKNOWN SIGNIFICANCE	HSF2, ARG50HIS	
141250	3162	HMOX1	0001	HEME OXYGENASE 1 DEFICIENCY	HMOX1, EX2DEL	
141250	3162	HMOX1	0002	HEME OXYGENASE 1 DEFICIENCY	HMOX1, 2-BP DEL	
141250	3162	HMOX1	0003	PULMONARY DISEASE, CHRONIC OBSTRUCTIVE, SUSCEPTIBILITY TO	HMOX1, (GT)n REPEAT	
141800	3039	HBA1	0001	HEMOGLOBIN AICHI	HBA1, HIS50ARG	33967561
141800	3039	HBA1	0002	HEMOGLOBIN ALBANY-GEORGIA HEMOGLOBIN ALBANY-SUMA	HBA1, LYS11ASN	33996902
141800	3039	HBA1	0003	HEMOGLOBIN ANANTHARAJ	HBA1, LYS11GLU	33938574
141800	3039	HBA1	0004	HEMOGLOBIN ANN ARBOR	HBA1, LEU80ARG	34071856
141800	3039	HBA1	0005	HEMOGLOBIN ARYA	HBA1, ASP47ASN	34269448
141800	3039	HBA1	0006	HEMOGLOBIN ATAGO	HBA1, ASP85TYR	33915947
141800	3039	HBA1	0007	HEMOGLOBIN ATTLEBORO	HBA1, SER138PRO	34011123
141800	3039	HBA1	0008	HEMOGLOBIN AZTEC	HBA1, MET76THR	33969953
141800	3039	HBA1	0009	HEMOGLOBIN BARI	HBA1, HIS45GLN	35687532
141800	3039	HBA1	0010	HEMOGLOBIN BEIJING	HBA1, LYS16ASN	33923844
141800	3039	HBA1	0011	HEMOGLOBIN BIBBA	HBA1, LEU136PRO	34635364
141800	3039	HBA1	0012	HEMOGLOBIN BOURMEDES	HBA1, PRO37ARG	35776155
141800	3039	HBA1	0014	HEMOGLOBIN BROUSSAIS HEMOGLOBIN J (BROUSSAIS);; HEMOGLOBIN TAGAWA I	HBA1, LYS90ASN	33914470
141800	3039	HBA1	0015	HEMOGLOBIN CATONSVILLE	HBA1, INS GLU, PRO37/GLU/THR38	34667595
141800	3039	HBA1	0016	HEMOGLOBIN CHAD	HBA1, GLU23LYS	33939620
141800	3039	HBA1	0017	HEMOGLOBIN CHAPEL HILL	HBA1, ASP74GLY	33921047
141800	3039	HBA1	0018	HEMOGLOBIN CHESAPEAKE	HBA1, ARG92LEU	33991779
141800	3039	HBA1	0019	HEMOGLOBIN CHIAPAS	HBA1, PRO114ARG	33910377
141800	3039	HBA1	0020	HEMOGLOBIN CHICAGO	HBA1, LEU136MET	41364652
141800	3039	HBA1	0021	HEMOGLOBIN CHONGQING	HBA1, LEU2ARG	63750585
141800	3039	HBA1	0022	HEMOGLOBIN CONTALDO	HBA1, HIS103ARG	63750752
141800	3039	HBA1	0023	HEMOGLOBIN CORDELE	HBA1, ASP47ALA	33944368
141800	3039	HBA1	0024	HEMOGLOBIN DAGESTAN	HBA1, LYS60GLU	34259907
141800	3039	HBA1	0025	HEMOGLOBIN DALLAS	HBA1, ASN97LYS	41338947
141800	3039	HBA1	0026	HEMOGLOBIN DANESHGAH-TEHRAN	HBA1, HIS72ARG	35859529
141800	3039	HBA1	0027	HEMOGLOBIN DENMARK HILL	HBA1, PRO95ALA	33984621
141800	3039	HBA1	0028	HEMOGLOBIN DUAN	HBA1, ASP75ALA	33991223
141800	3039	HBA1	0029	HEMOGLOBIN DUNN	HBA1, ASP6ASN	33961916
141800	3039	HBA1	0030	HEMOGLOBIN ETOBICOKE	HBA1, SER84ARG	33996798
141800	3039	HBA1	0031	HEMOGLOBIN EVANSTON	HBA1, TRP14ARG	33964317
141800	3039	HBA1	0032	HEMOGLOBIN FERNDOWN	HBA1, ASP6VAL	33986902
141800	3039	HBA1	0033	HEMOGLOBIN FONTAINEBLEAU	HBA1, ALA21PRO	34324664
141800	3039	HBA1	0034	HEMOGLOBIN FORT DE FRANCE	HBA1, HIS45ARG	28928883
141800	3039	HBA1	0035	HEMOGLOBIN G (AUDHALI)	HBA1, GLU23VAL	33939421
141800	3039	HBA1	0037	HEMOGLOBIN G (FORT WORTH) HEMOGLOBIN FORT WORTH	HBA1, GLU27GLY	33964507
141800	3039	HBA1	0038	HEMOGLOBIN G (GEORGIA)	HBA1, PRO95LEU	33931314
141800	3039	HBA1	0040	HEMOGLOBIN G (NORFOLK)	HBA1, ASP85ASN	33915947
141800	3039	HBA1	0041	HEMOGLOBIN G (PEST)	HBA1, ASP74ASN	28928875
141800	3039	HBA1	0042	HEMOGLOBIN G (TAICHUNG) HEMOGLOBIN Q;; HEMOGLOBIN Q (THAILAND);; HEMOGLOBIN MAHIDOL;; HEMOGLOBIN ASABARA;; HEMOGLOBIN KURASHIKI	HBA1, ASP74HIS	28928875
141800	3039	HBA1	0043	HEMOGLOBIN G (WAIMANALO) HEMOGLOBIN AIDA	HBA1, ASP64ASN	33984024
141800	3039	HBA1	0044	HEMOGLOBIN GARDEN STATE	HBA1, ALA82ASP	34879587
141800	3039	HBA1	0045	HEMOGLOBIN GRADY HEMOGLOBIN DAKAR	HBA1, 3AA INS, 118THR-GLU-PHE119	
141800	3039	HBA1	0046	HEMOGLOBIN GUANGZHOU HEMOGLOBIN HANGZHOU	HBA1, ASP64GLY	35873730
141800	3039	HBA1	0047	HEMOGLOBIN GUIZHOU HEMOGLOBIN UTSUNOMIYA	HBA1, PRO77ARG	34019158
141800	3039	HBA1	0048	HEMOGLOBIN HANDA HEMOGLOBIN MUNAKATA	HBA1, LYS90MET	33911106
141800	3039	HBA1	0049	HEMOGLOBIN HANDSWORTH	HBA1, GLY18ARG	34504387
141800	3039	HBA1	0050	HEMOGLOBIN HARBIN	HBA1, LYS16MET	35210126
141800	3039	HBA1	0051	HEMOGLOBIN HEKINAN	HBA1, GLU27ASP	41530750
141800	3039	HBA1	0052	HEMOGLOBIN HIROSAKI	HBA1, PHE43LEU	41491146
141800	3039	HBA1	0053	HEMOGLOBIN HOBART	HBA1, HIS20ARG	33943087
141800	3039	HBA1	0054	HEMOGLOBIN HOPKINS 2	HBA1, HIS112ASP	34830032
141800	3039	HBA1	0055	HEMOGLOBIN I HEMOGLOBIN I (BURLINGTON);; HEMOGLOBIN I (PHILADELPHIA);; HEMOGLOBIN I (SKAMANIA);; HEMOGLOBIN I (TEXAS)	HBA1, LYS16GLU	41407250
141800	3039	HBA1	0057	HEMOGLOBIN IWATA	HBA1, HIS87ARG	33976776
141800	3039	HBA1	0058	HEMOGLOBIN J (ABIDJAN)	HBA1, GLY51ASP	35934411
141800	3039	HBA1	0059	HEMOGLOBIN J (ANATOLIA)	HBA1, LYS61THR	41381645
141800	3039	HBA1	0060	HEMOGLOBIN J (BIRMINGHAM) HEMOGLOBIN J (MEERUT)	HBA1, ALA120GLU	36075744
141800	3039	HBA1	0062	HEMOGLOBIN J (CAMAGUEY)	HBA1, ARG141GLY	33991910
141800	3039	HBA1	0063	HEMOGLOBIN J (CAPE TOWN)	HBA1, ARG92GLN	33991779
141800	3039	HBA1	0064	HEMOGLOBIN J (CUBUJUQUI)	HBA1, ARG141SER	33991910
141800	3039	HBA1	0065	HEMOGLOBIN J (HABANA)	HBA1, ALA71GLU	3180281
141800	3039	HBA1	0066	HEMOGLOBIN J (KUROSH)	HBA1, ALA19ASP	
141800	3039	HBA1	0067	HEMOGLOBIN J (MEDELLIN)	HBA1, GLY22ASP	34608326
141800	3039	HBA1	0068	HEMOGLOBIN J (NYANZA)	HBA1, ALA21ASP	11548605
141800	3039	HBA1	0070	HEMOGLOBIN J (PARIS 1) HEMOGLOBIN J (ALJEZUR)	HBA1, ALA12ASP	35615982
141800	3039	HBA1	0071	HEMOGLOBIN J (RAJAPPEN)	HBA1, LYS90THR	33911106
141800	3039	HBA1	0072	HEMOGLOBIN J (ROVIGO)	HBA1, ALA53ASP	34574239
141800	3039	HBA1	0074	HEMOGLOBIN J (SINGA)	HBA1, ASN78ASP	33964623
141800	3039	HBA1	0075	HEMOGLOBIN J (SINGAPORE)	HBA1, ASN78ASP AND ALA79GLY	35692096
141800	3039	HBA1	0076	HEMOGLOBIN J (TASHIKUERGAN)	HBA1, ALA19GLU	35628685
141800	3039	HBA1	0077	HEMOGLOBIN J (TONGARIKI)	HBA1, ALA115ASP	34204059
141800	3039	HBA1	0078	HEMOGLOBIN J (TORONTO)	HBA1, ALA5ASP	34090856
141800	3039	HBA1	0079	HEMOGLOBIN JACKSON	HBA1, LYS127ASN	33972894
141800	3039	HBA1	0080	HEMOGLOBIN KARACHI	HBA1, ALA5PRO	34751764
141800	3039	HBA1	0081	HEMOGLOBIN KARIYA	HBA1, LYS40GLU	34492931
141800	3039	HBA1	0082	HEMOGLOBIN KAWACHI	HBA1, PRO44ARG	33978134
141800	3039	HBA1	0083	HEMOGLOBIN KOELLIKER HEMOGLOBIN F (KOELLIKER)	HBA1, ARG141DEL	121913128
141800	3039	HBA1	0084	HEMOGLOBIN KOKURA HEMOGLOBIN BEILINSON;; HEMOGLOBIN MICHIGAN-I;; HEMOGLOBIN MICHIGAN-II;; HEMOGLOBIN L (GASLINI);; HEMOGLOBIN TAGAWA II;; HEMOGLOBIN UMI;; HEMOGLOBIN MUGINO;; HEMOGLOBIN YUKUHASHI-2	HBA1, ASP47GLY	33944368
141800	3039	HBA1	0086	HEMOGLOBIN L (PERSIAN GULF)	HBA1, GLY57ARG	35252931
141800	3039	HBA1	0087	HEMOGLOBIN LEGNANO	HBA1, ARG141LEU	33935328
141800	3039	HBA1	0088	HEMOGLOBIN LE LAMENTIN	HBA1, HIS20GLN	41525149
141800	3039	HBA1	0089	HEMOGLOBIN LILLE	HBA1, ASP74ALA	33921047
141800	3039	HBA1	0090	HEMOGLOBIN LOIRE	HBA1, ALA88SER	35239527
141800	3039	HBA1	0091	HEMOGLOBIN LUXEMBOURG	HBA1, TYR24HIS	34743106
141800	3039	HBA1	0092	HEMOGLOBIN M (BOSTON) HEMOGLOBIN GOTHENBURG;; HEMOGLOBIN M (GOTHENBURG);; HEMOGLOBIN M (OSAKA);; HEMOGLOBIN M (KISKUNHALAS)	HBA1, HIS58TYR	35213748
141800	3039	HBA1	0093	HEMOGLOBIN M (IWATE) HEMOGLOBIN M (KANKAKEE);; HEMOGLOBIN M (OLDENBURG);; HEMOGLOBIN M (SENDAI)	HBA1, HIS87TYR	28928876
141800	3039	HBA1	0095	HEMOGLOBIN MATSUE-OKI	HBA1, ASP75ASN	33977363
141800	3039	HBA1	0096	HEMOGLOBIN MEMPHIS	HBA1, GLU23GLN	33939620
141800	3039	HBA1	0097	HEMOGLOBIN MEXICO HEMOGLOBIN J;; HEMOGLOBIN J (MEXICO);; HEMOGLOBIN J (PARIS 2);; HEMOGLOBIN UPPSALA	HBA1, GLN54GLU	35317336
141800	3039	HBA1	0098	HEMOGLOBIN MILLEDGEVILLE	HBA1, PRO44LEU	33978134
141800	3039	HBA1	0099	HEMOGLOBIN MIYANO	HBA1, THR41SER	34462388
141800	3039	HBA1	0100	HEMOGLOBIN MIZUSHI	HBA1, ASP75GLY	33991223
141800	3039	HBA1	0101	HEMOGLOBIN MOABIT	HBA1, LEU86ARG	35548338
141800	3039	HBA1	0104	HEMOGLOBIN NECKER ENFANTS-MALADES	HBA1, HIS20TYR	34708054
141800	3039	HBA1	0105	HEMOGLOBIN NIGERIA	HBA1, SER81CYS	34936612
141800	3039	HBA1	0106	HEMOGLOBIN NOKO	HBA1, MET76LYS	33969953
141800	3039	HBA1	0107	HEMOGLOBIN NORFOLK HEMOGLOBIN J (NORFOLK);; HEMOGLOBIN KAGOSHIMA;; HEMOGLOBIN NISHIK	HBA1, GLY57ASP	36062788
141800	3039	HBA1	0108	HEMOGLOBIN NOUAKCHOTT	HBA1, PRO114LEU	33910377
141800	3039	HBA1	0109	HEMOGLOBIN NUNOBIKI	HBA1, ARG141CYS	33991910
141800	3039	HBA1	0110	HEMOGLOBIN O (INDONESIA) HEMOGLOBIN O (BUGINESE-X);; HEMOGLOBIN BUGINESE-X;; HEMOGLOBIN O (OLIVIERE);; HEMOGLOBIN OLIVIERE	HBA1, GLU116LYS	33987053
141800	3039	HBA1	0111	HEMOGLOBIN O (PADOVA)	HBA1, GLU30LYS	33993166
141800	3039	HBA1	0112	HEMOGLOBIN OGI HEMOGLOBIN QUEENS	HBA1, LEU34ARG	35203445
141800	3039	HBA1	0113	HEMOGLOBIN OLEANDER	HBA1, GLU116GLN	33987053
141800	3039	HBA1	0114	HEMOGLOBIN OTTAWA HEMOGLOBIN SIAM	HBA1, GLY15ARG	35816645
141800	3039	HBA1	0115	HEMOGLOBIN OWARI	HBA1, VAL121MET	35187567
141800	3039	HBA1	0116	HEMOGLOBIN PERSPOLIS	HBA1, ASP64TYR	33984024
141800	3039	HBA1	0117	HEMOGLOBIN PETAH TIKVA	HBA1, ALA110ASP	63749948
141800	3039	HBA1	0118	HEMOGLOBIN PONTOISE HEMOGLOBIN J (PONTOISE)	HBA1, ALA63ASP	34502246
141800	3039	HBA1	0119	HEMOGLOBIN PORT PHILLIP	HBA1, LEU91PRO	34684963
141800	3039	HBA1	0121	HEMOGLOBIN Q (INDIA)	HBA1, ASP64HIS	33984024
141800	3039	HBA1	0122	HEMOGLOBIN Q (IRAN)	HBA1, ASP75HIS	33977363
141800	3039	HBA1	0124	HEMOGLOBIN REIMS	HBA1, GLU23GLY	33939421
141800	3039	HBA1	0125	HEMOGLOBIN RUSS	HBA1, GLY51ARG	33960522
141800	3039	HBA1	0126	HEMOGLOBIN SASSARI	HBA1, ASP126HIS	63750950
141800	3039	HBA1	0127	HEMOGLOBIN SAVARIA	HBA1, SER49ARG	41518249
141800	3039	HBA1	0128	HEMOGLOBIN SAWARA	HBA1, ASP6ALA	33986902
141800	3039	HBA1	0130	HEMOGLOBIN SETIF	HBA1, ASP94TYR	34102339
141800	3039	HBA1	0131	HEMOGLOBIN SHAARE ZEDEK	HBA1, LYS56GLU	34182019
141800	3039	HBA1	0132	HEMOGLOBIN SHENYANG	HBA1, ALA26GLU	35477770
141800	3039	HBA1	0133	HEMOGLOBIN SHIMONOSEKI HEMOGLOBIN HIKOSHIMA	HBA1, GLN54ARG	36024711
141800	3039	HBA1	0134	HEMOGLOBIN SHUANGFENG	HBA1, GLU27LYS	34776279
141800	3039	HBA1	0135	HEMOGLOBIN SINGAPORE	HBA1, ARG141PRO	33935328
141800	3039	HBA1	0137	HEMOGLOBIN ST. CLAUDE	HBA1, LYS127THR	63751308
141800	3039	HBA1	0138	HEMOGLOBIN ST. LUKE'S	HBA1, PRO95ARG	33931314
141800	3039	HBA1	0139	HEMOGLOBIN STANLEYVILLE-II	HBA1, ASN78LYS	34440919
141800	3039	HBA1	0140	HEMOGLOBIN STRUMICA HEMOGLOBIN SERBIA	HBA1, HIS112ARG	34713708
141800	3039	HBA1	0143	HEMOGLOBIN SUNSHINE SETH	HBA1, ASP94HIS	34102339
141800	3039	HBA1	0144	HEMOGLOBIN SURESNES	HBA1, ARG141HIS	33935328
141800	3039	HBA1	0145	HEMOGLOBIN SWAN RIVER	HBA1, ASP6GLY	33986902
141800	3039	HBA1	0147	HEMOGLOBIN THAILAND	HBA1, LYS56THR	33949106
141800	3039	HBA1	0148	HEMOGLOBIN TITUSVILLE	HBA1, ASP94ASN	34102339
141800	3039	HBA1	0149	HEMOGLOBIN TOKONAME	HBA1, LYS139THR	34849179
141800	3039	HBA1	0150	HEMOGLOBIN TORINO	HBA1, PHE43VAL	35511459
141800	3039	HBA1	0151	HEMOGLOBIN TOTTORI	HBA1, GLY59VAL	28928878
141800	3039	HBA1	0152	HEMOGLOBIN TOYAMA HEINZ BODY HEMOLYTIC ANEMIA	HBA1, LEU136ARG	34635364
141800	3039	HBA1	0153	HEMOGLOBIN TWIN PEAKS	HBA1, LEU113HIS	35654345
141800	3039	HBA1	0154	HEMOGLOBIN UBE-2	HBA1, ASN68ASP	34823698
141800	3039	HBA1	0155	HEMOGLOBIN UBE-4	HBA1, GLU116ALA	35932809
141800	3039	HBA1	0156	HEMOGLOBIN WESTMEAD	HBA1, HIS122GLN	41479347
141800	3039	HBA1	0157	HEMOGLOBIN WINNIPEG	HBA1, ASP75TYR	33977363
141800	3039	HBA1	0158	HEMOGLOBIN WOODVILLE	HBA1, ASP6TYR	33961916
141800	3039	HBA1	0159	HEMOGLOBIN WUMING HEMOGLOBIN J (WENCHANG-WUMING)	HBA1, LYS11GLN	33938574
141800	3039	HBA1	0160	HEMOGLOBIN ZAMBIA	HBA1, LYS60ASN	28928887
141800	3039	HBA1	0161	HEMOGLOBIN BELLIARD	HBA1, LYS56ASN	33959483
141800	3039	HBA1	0162	HEMOGLOBIN TONOSHO	HBA1, ALA110THR	34629158
141800	3039	HBA1	0163	HEMOGLOBIN FUKUTOMI	HBA1, ASP126VAL	33957766
141800	3039	HBA1	0164	HEMOGLOBIN PORT HURON	HBA1, LYS56ARG	33949106
141800	3039	HBA1	0166	HEMOGLOBIN PAVIE	HBA1, VAL135GLU	63749809
141800	3039	HBA1	0167	HEMOGLOBIN QUESTEMBERT	HBA1, SER131PRO	35974739
141800	3039	HBA1	0168	HEMOGLOBIN THIONVILLE	HBA1, NH2 EXTENSION, VAL1GLU	
141800	3039	HBA1	0169	HEMOGLOBIN KANAGAWA	HBA1, LYS40MET	41416747
141800	3039	HBA1	0170	HEMOGLOBIN TURRIFF	HBA1, LYS99GLU	34806456
141800	3039	HBA1	0171	HEMOGLOBIN ZAIRE	HBA1, 15-BP TANDEM REPEAT	
141800	3039	HBA1	0172	HEMOGLOBIN LUTON	HBA1, HIS89LEU	33944813
141800	3039	HBA1	0173	HEMOGLOBIN OZIERI	HBA1, ALA71VAL	3180281
141800	3039	HBA1	0174	HEMOGLOBIN ADANA HEMOGLOBIN H DISEASE, NONDELETIONAL, INCLUDED	HBA1, GLY59ASP	28928878
141800	3039	HBA1	0175	HEMOGLOBIN AL-AIN ABU DHABI	HBA1, GLY18ASP	35993097
141800	3039	HBA1	0176	HEMOGLOBIN POITIERS	HBA1, HIS45ASP	33931984
141800	3039	HBA1	0178	HEMOGLOBIN CAEN	HBA1, VAL132GLY	35166834
141800	3039	HBA1	0179	HEMOGLOBIN YUDA	HBA1, ALA130ASP	41528545
141800	3039	HBA1	0180	HEMOGLOBIN CAPA	HBA1, ASP94GLY	28928879
141800	3039	HBA1	0181	HEMOGLOBIN MONTEFIORE	HBA1, ASP126TYR	33933481
141800	3039	HBA1	0182	HEMOGLOBIN ROUEN HEMOGLOBIN ETHIOPIA	HBA1, TYR140HIS	55870409
141800	3039	HBA1	0183	HEMOGLOBIN MELUSINE	HBA1, PRO114SER	34472107
141800	3039	HBA1	0184	HEMOGLOBIN TAYBE	HBA1, THR38DEL OR THR39DEL	
141800	3039	HBA1	0185	HEMOGLOBIN CEMENELUM	HBA1, ARG92TRP	34868036
141800	3039	HBA1	0186	HEMOGLOBIN RAMONA	HBA1, TYR24CYS	28928880
141800	3039	HBA1	0187	HEMOGLOBIN TATRAS	HBA1, LYS7ASN	34410516
141800	3039	HBA1	0188	HEMOGLOBIN LISBON	HBA1, GLU23ASP	36068296
141800	3039	HBA1	0189	HEMOGLOBIN ROANNE	HBA1, ASP94GLU	34814612
141800	3039	HBA1	0190	HEMOGLOBIN MALHACEN	HBA1, ALA123SER	28928881
141800	3039	HBA1	0191	HEMOGLOBIN TUNIS-BIZERTE	HBA1, LEU129PRO	35993655
141800	3039	HBA1	0193	HEMOGLOBIN BOIS GUILLAUME	HBA1, ALA65VAL	34733452
141800	3039	HBA1	0194	HEMOGLOBIN MANTES-LA-JOLIE	HBA1, ALA79THR	34586189
141800	3039	HBA1	0195	HEMOGLOBIN MOSELLA	HBA1, ALA111THR	34863047
141800	3039	HBA1	0196	HEMOGLOBIN FUCHU-I	HBA1, HIS72TYR	36104787
141800	3039	HBA1	0197	HEMOGLOBIN FUCHU-II	HBA1, ASN97HIS	41322954
141800	3039	HBA1	0198	HEMOGLOBIN GOUDA	HBA1, HIS72GLN	28928882
141800	3039	HBA1	0199	HEMOGLOBIN J (BISKRA)	HBA1, 24-BP DEL	
141800	3039	HBA1	0200	HEMOGLOBIN GODAVARI	HBA1, PRO95THR	33984621
141800	3039	HBA1	0201	HEMOGLOBIN OITA	HBA1, HIS45PRO	28928883
141800	3039	HBA1	0202	HEMOGLOBIN AGHIA SOPHIA HEMOGLOBIN H DISEASE, NONDELETIONAL, INCLUDED	HBA1, VAL62DEL	35672478
141800	3039	HBA1	0203	HEMOGLOBIN CHAROLLES	HBA1, HIS103TYR	28928884
141800	3039	HBA1	0204	HEMOGLOBIN ROUBAIX	HBA1, VAL55LEU	34068598
141800	3039	HBA1	0205	HEMOGLOBIN DOUALA	HBA1, SER3PHE	35850071
141800	3039	HBA1	0206	THALASSEMIA, ALPHA-PLUS	HBA1, 21-BP INS-DUP	
141800	3039	HBA1	0207	THALASSEMIA, ALPHA-PLUS	HBA1, 33-BP DEL	
141800	3039	HBA1	0208	HEMOGLOBIN DELFZICHT	HBA1, ASN9LYS	28928885
141800	3039	HBA1	0209	HEMOGLOBIN SARATOGA SPRINGS	HBA1, LYS40ASN	28928886
141800	3039	HBA1	0210	HEMOGLOBIN DIE	HBA1, VAL93ALA	34769782
141800	3039	HBA1	0211	HEMOGLOBIN BEZIERS	HBA1, LYS99ASN	34273731
141800	3039	HBA1	0212	HEMOGLOBIN BUFFALO	HBA1, HIS89GLN	1061009
141800	3039	HBA1	0213	HEMOGLOBIN VILLEURBANNE	HBA1, HIS89TYR	34988734
141800	3039	HBA1	0214	HEMOGLOBIN TOKYO	HBA1, HIS89PRO	33944813
141800	3039	HBA1	0215	HEMOGLOBIN TAMANO	HBA1, HIS89ARG	33944813
141800	3039	HBA1	0216	HEMOGLOBIN RICCARTON	HBA1, GLY51SER	33960522
141800	3039	HBA1	0217	HEMOGLOBIN OEGSTGEEST	HBA1, CYS104SER	35059618
141800	3039	HBA1	0218	HEMOGLOBIN LAMEN ISLAND	HBA1, 149709T-C	
141800	3039	HBA1	0219	ALPHA-THALASSEMIA	HBA1, 1-BP DEL, 354C	
141800	3039	HBA1	0220	HEMOGLOBIN AUCKLAND	HBA1, HIS87ASN	28928876
141850	3040	HBA2	0001	HEMOGLOBIN CONSTANT SPRING HEMOGLOBIN H DISEASE, NONDELETIONAL, INCLUDED	HBA2, TER142GLN	41464951
141850	3040	HBA2	0002	HEMOGLOBIN ICARIA HEMOGLOBIN H DISEASE, NONDELETIONAL, INCLUDED	HBA2, TER142LYS	41464951
141850	3040	HBA2	0003	HEMOGLOBIN KOYA DORA	HBA2, TER142SER	41321345
141850	3040	HBA2	0004	HEMOGLOBIN WAYNE	HBA2, LYS139ASN	
141850	3040	HBA2	0005	HEMOGLOBIN QUONG SZE	HBA2, LEU125PRO	41397847
141850	3040	HBA2	0006	HEMOGLOBIN EVANS	HBA2, VAL62MET	41515649
141850	3040	HBA2	0007	HEMOGLOBIN SUAN-DOK	HBA2, LEU109ARG	41479844
141850	3040	HBA2	0008	HEMOGLOBIN J (BUDA) ERYTHROCYTOSIS	HBA2, LYS61ASN	33985574
141850	3040	HBA2	0009	HEMOGLOBIN SPANISH TOWN	HBA2, GLU27VAL	33964507
141850	3040	HBA2	0010	HEMOGLOBIN J (OXFORD) HEMOGLOBIN I (INTERLAKEN);; HEMOGLOBIN N (COSENZA)	HBA2, GLY15ASP	34956202
141850	3040	HBA2	0011	HEMOGLOBIN I HEMOGLOBIN I (BURLINGTON);; HEMOGLOBIN I (PHILADELPHIA);; HEMOGLOBIN I (SKAMANIA);; HEMOGLOBIN I (TEXAS)	HBA2, LYS16GLU	41407250
141850	3040	HBA2	0012	HEMOGLOBIN L (FERRARA) HEMOGLOBIN HASHARON;; HEMOGLOBIN SINAI;; HEMOGLOBIN SEALY	HBA2, ASP47HIS	34269448
141850	3040	HBA2	0013	HEMOGLOBIN MONTGOMERY HEMOGLOBIN BIRMINGHAM (USA)	HBA2, LEU48ARG	41392146
141850	3040	HBA2	0014	HEMOGLOBIN G (BRISTOL) HEMOGLOBIN D (BALTIMORE);; HEMOGLOBIN D (ST. LOUIS);; HEMOGLOBIN D (WASHINGTON);; HEMOGLOBIN G (AZAKUOLI);; HEMOGLOBIN G (KNOXVILLE);; HEMOGLOBIN G (PHILADELPHIA);; HEMOGLOBIN KNOXVILLE-1;; HEMOGLOBIN STANLEYVILLE-I	HBA2, ASN68LYS	111033601
141850	3040	HBA2	0015	HEMOGLOBIN INKSTER	HBA2, ASP85VAL	41331747
141850	3040	HBA2	0016	HEMOGLOBIN COLUMBIA MISSOURI	HBA2, ALA88VAL	33983416
141850	3040	HBA2	0017	HEMOGLOBIN SUN PRAIRIE	HBA2, ALA130PRO	41529844
141850	3040	HBA2	0018	HEMOGLOBIN BOYLE HEIGHTS	HBA2, ASP6DEL	
141850	3040	HBA2	0019	HEMOGLOBIN DAVENPORT	HBA2, ASN78HIS	33964623
141850	3040	HBA2	0020	ALPHA-THALASSEMIA	HBA2, MET1THR	111033603
141850	3040	HBA2	0021	ALPHA-THALASSEMIA	HBA2, GLU116TER	33987053
141850	3040	HBA2	0022	HEMOGLOBIN H DISEASE, NONDELETIONAL	HBA2, MET1VAL	34220980
141850	3040	HBA2	0023	HEMOGLOBIN HANAMAKI	HBA2, LYS139GLU	41361546
141850	3040	HBA2	0024	ALPHA-THALASSEMIA-2, NONDELETIONAL HEMOGLOBIN H DISEASE, NONDELETIONAL, INCLUDED	HBA2, 3-UNT, A-G, +4	
141850	3040	HBA2	0025	HEMOGLOBIN KURDISTAN	HBA2, ASP47TYR	34269448
141850	3040	HBA2	0026	HEMOGLOBIN AGRINIO HEMOGLOBIN H DISEASE, NONDELETIONAL, INCLUDED	HBA2, LEU29PRO	41341344
141850	3040	HBA2	0027	HEMOGLOBIN PAKSE HEMOGLOBIN H DISEASE, NONDELETIONAL, INCLUDED	HBA2, TER142TYR	41412046
141850	3040	HBA2	0028	HEMOGLOBIN SEAL ROCK	HBA2, TER142GLU	41464951
141850	3040	HBA2	0029	HEMOGLOBIN ANAMOSA	HBA2, ALA111VAL	28928889
141850	3040	HBA2	0030	HEMOGLOBIN BIBBA	HBA2, LEU136PRO	41469945
141850	3040	HBA2	0031	HEMOGLOBIN SALLANCHES HEMOGLOBIN H DISEASE, NONDELETIONAL, INCLUDED	HBA2, CYS104TYR	41417548
141850	3040	HBA2	0032	ALPHA-THALASSEMIA TRAIT	HBA2, 9-BP DEL/8-BP INS	
141850	3040	HBA2	0033	HEMOGLOBIN NATAL	HBA2, TYR140TER	41507451
141850	3040	HBA2	0034	HEMOGLOBIN WATTS	HBA2, 3-BP DEL, ASP74DEL OR ASP75DEL	63750943
141850	3040	HBA2	0035	HEMOGLOBIN CONAKRY	HBA2, LEU80VAL	41466346
141850	3040	HBA2	0036	HEMOGLOBIN J (SARDEGNA)	HBA2, HIS50ASP	41461652
141850	3040	HBA2	0037	HEMOGLOBIN TARRANT	HBA2, ASP126ASN	33933481
141850	3040	HBA2	0038	HEMOGLOBIN ANTANANARIVO	HBA2, VAL1GLY	33981821
141850	3040	HBA2	0039	HEMOGLOBIN BOGHE	HBA2, HIS58GLN	41378349
141850	3040	HBA2	0040	HEMOGLOBIN TOULON	HBA2, PRO77HIS	34019158
141850	3040	HBA2	0041	HEMOGLOBIN CAMPINAS	HBA2, ALA26VAL	35477770
141850	3040	HBA2	0042	HEMOGLOBIN NIKAIA	HBA2, HIS20ASP	34708054
141850	3040	HBA2	0043	HEMOGLOBIN CLINICO-MADRID	HBA2, LYS90ARG	33911106
141850	3040	HBA2	0044	HEMOGLOBIN CLINICO-MADRID HEMOGLOBIN H DISEASE, NONDELETIONAL, INCLUDED	HBA2, IVS2AS, G-A, -1	
141850	3040	HBA2	0045	HEMOGLOBIN DARTMOUTH	HBA2, LEU66PRO	41323248
141850	3040	HBA2	0046	HEMOGLOBIN GERLAND	HBA2, VAL55ALA	63749934
141850	3040	HBA2	0047	HEMOGLOBIN MANITOBA	HBA2, SER102ARG	34098449
141850	3040	HBA2	0048	HEMOGLOBIN PARK RIDGE	HBA2, ASN9LYS	28928885
141850	3040	HBA2	0049	HEMOGLOBIN NORTON	HBA2, HIS72ASP	36104787
141850	3040	HBA2	0050	HEMOGLOBIN LOMBARD	HBA2, HIS103TYR	63750073
141850	3040	HBA2	0051	HEMOGLOBIN SAN ANTONIO	HBA2, LEU113ARG	35654345
141850	3040	HBA2	0052	HEMOGLOBIN RAMPA	HBA2, PRO95SER	33984621
141850	3040	HBA2	0053	HEMOGLOBIN MANAWATU	HBA2, PRO37LEU	35776155
141850	3040	HBA2	0054	HEMOGLOBIN G (HONOLULU) HEMOGLOBIN G (HONG KONG);; HEMOGLOBIN G (SINGAPORE);; HEMOGLOBIN G (CHINESE)	HBA2, GLU30GLN	33993166
141850	3040	HBA2	0055	HEMOGLOBIN PRATO	HBA2, ARG31SER	33977479
141850	3040	HBA2	0056	ALPHA-THALASSEMIA, DUTCH TYPE	HBA2, IVS1, A-G, -116	41457746
141850	3040	HBA2	0057	ALPHA-THALASSEMIA, ZF TYPE	HBA2, METHYLATION SILENCING DUE TO ANTISENSE TRANSCRIPT	
141850	3040	HBA2	0058	HEMOGLOBIN CHARTRES	HBA2, PHE33SER	41430445
141850	3040	HBA2	0059	HEMOGLOBIN FUKUI	HBA2, LYS139ASN	41393644
141850	3040	HBA2	0060	HEMOGLOBIN PART-DIEU	HBA2, ALA65THR	41510746
141850	3040	HBA2	0061	HEMOGLOBIN DECINES-CHARPIEU	HBA2, ALA69THR	63749997
141850	3040	HBA2	0062	HEMOGLOBIN VAL DE MARNE HEMOGLOBIN FOOTSCRAY	HBA2, SER133ARG	33960790
141850	3040	HBA2	0063	ALPHA-THALASSEMIA	HBA2, GLU23TER	33939620
141850	3040	HBA2	0064	ALPHA-PLUS-THALASSEMIA	HBA2, GLY22GLY	63751457
141850	3040	HBA2	0065	HEMOGLOBIN ZURICH ALBISRIEDEN ALPHA-PLUS-THALASSEMIA, INCLUDED	HBA2, GLY59ARG	41328049
141850	3040	HBA2	0066	HEMOGLOBIN PASSY	HBA2, SER81PRO	41484451
141850	3040	HBA2	0067	HEMOGLOBIN PLASENCIA	HBA2, LEU125ARG	41397847
141850	3040	HBA2	0068	HEMOGLOBIN KUROSAKI	HBA2, LYS7GLU	34817956
141850	3040	HBA2	0069	HEMOGLOBIN H DISEASE, NONDELETIONAL	HBA2, 1-BP DEL, 2T	63750678
141850	3040	HBA2	0070	HEMOGLOBIN AL-HAMMADI RIYADH	HBA2, ASP75VAL	33991223
141850	3040	HBA2	0071	ALPHA-THALASSEMIA, HMONG TYPE	HBA2, 1-BP DEL, 1A	
141850	3040	HBA2	0072	HEMOGLOBIN H HYDROPS FETALIS SYNDROME	HBA2, 3-BP DEL, GLU30	
141850	3040	HBA2	0073	HEMOGLOBIN H HYDROPS FETALIS SYNDROME	HBA2, GLY59ASP	
141850	3040	HBA2	0074	HEMOGLOBIN H HYDROPS FETALIS SYNDROME	HBA2, SER35PRO	
141900	3043	HBB	0001	HEMOGLOBIN AALBORG	HBB, GLY74ARG	33916541
141900	3043	HBB	0002	HEMOGLOBIN ABRUZZO	HBB, HIS143ARG	33918338
141900	3043	HBB	0003	HEMOGLOBIN AGENOGI	HBB, GLU90LYS	33913712
141900	3043	HBB	0004	HEMOGLOBIN ALABAMA	HBB, GLN39LYS	11549407
141900	3043	HBB	0005	HEMOGLOBIN ALAMO	HBB, ASN19ASP	34866629
141900	3043	HBB	0006	HEMOGLOBIN ALBERTA	HBB, GLU101GLY	33937393
141900	3043	HBB	0007	HEMOGLOBIN ALTDORF	HBB, ALA135PRO	35492035
141900	3043	HBB	0008	HEMOGLOBIN ANDREW-MINNEAPOLIS	HBB, LYS144ASN	35020585
141900	3043	HBB	0009	HEMOGLOBIN ANKARA	HBB, ALA10ASP	33947457
141900	3043	HBB	0010	HEMOGLOBIN ARLINGTON PARK	HBB, GLU6LYS AND LYS95GLU	33914359
141900	3043	HBB	0011	HEMOGLOBIN ATHENS-GEORGIA HEMOGLOBIN WACO	HBB, ARG40LYS	34831026
141900	3043	HBB	0012	HEMOGLOBIN ATLANTA	HBB, LEU75PRO	33950542
141900	3043	HBB	0013	HEMOGLOBIN ATLANTA-COVENTRY	HBB, LEU75PRO AND LEU141DEL	33950542
141900	3043	HBB	0014	HEMOGLOBIN AUSTIN	HBB, ARG40SER	33918778
141900	3043	HBB	0015	HEMOGLOBIN AVICENNA	HBB, ASP47ALA	33980484
141900	3043	HBB	0016	HEMOGLOBIN BARCELONA	HBB, ASP94HIS	33959340
141900	3043	HBB	0017	HEMOGLOBIN BAYLOR	HBB, LEU81ARG	33936967
141900	3043	HBB	0018	HEMOGLOBIN BEIRUT	HBB, VAL126ALA	33925391
141900	3043	HBB	0019	HEMOGLOBIN BELFAST	HBB, TRP15ARG	33946157
141900	3043	HBB	0020	HEMOGLOBIN BEOGRAD HEMOGLOBIN D (CAMPERDOWN)	HBB, GLU121VAL	33987957
141900	3043	HBB	0021	HEMOGLOBIN BETH ISRAEL	HBB, ASN102SER	33948057
141900	3043	HBB	0022	HEMOGLOBIN BETHESDA	HBB, TYR145HIS	33949869
141900	3043	HBB	0023	HEMOGLOBIN BICETRE	HBB, HIS63PRO	33985544
141900	3043	HBB	0024	HEMOGLOBIN BOLOGNA	HBB, LYS61MET	34974709
141900	3043	HBB	0025	HEMOGLOBIN BORAS	HBB, LEU88ARG	33940204
141900	3043	HBB	0026	HEMOGLOBIN BOUGARDIREY-MALI	HBB, GLY119VAL	33947020
141900	3043	HBB	0027	HEMOGLOBIN BREST	HBB, GLN127LYS	33971634
141900	3043	HBB	0028	HEMOGLOBIN BRIGHAM	HBB, PRO100LEU	33965000
141900	3043	HBB	0029	HEMOGLOBIN BRISBANE HEMOGLOBIN GREAT LAKES	HBB, LEU68HIS	33972593
141900	3043	HBB	0030	HEMOGLOBIN BRISTOL	HBB, VAL67MET-TO-ASP	36008922
141900	3043	HBB	0031	HEMOGLOBIN BRITISH COLUMBIA	HBB, GLU101LYS	33966487
141900	3043	HBB	0032	HEMOGLOBIN BROCKTON	HBB, ALA138PRO	33919821
141900	3043	HBB	0033	HEMOGLOBIN BRUXELLES HEINZ BODY HEMOLYTIC ANEMIA	HBB, PHE41DEL OR PHE42DEL	
141900	3043	HBB	0034	HEMOGLOBIN BRYN MAWR HEMOGLOBIN BUENOS AIRES	HBB, PHE85SER	35693898
141900	3043	HBB	0035	HEMOGLOBIN BUNBURY	HBB, ASP94ASN	33959340
141900	3043	HBB	0036	HEMOGLOBIN BURKE	HBB, GLY107ARG	35017910
141900	3043	HBB	0037	HEMOGLOBIN BUSHWICK	HBB, GLY74VAL	33976006
141900	3043	HBB	0038	HEMOGLOBIN C MALARIA, RESISTANCE TO, INCLUDED	HBB, GLU6LYS	33930165
141900	3043	HBB	0039	HEMOGLOBIN C (GEORGETOWN) HEMOGLOBIN C (HARLEM)	HBB, GLU6VAL AND ASP73ASN	334
141900	3043	HBB	0040	HEMOGLOBIN C (ZIGUINCHOR) HEMOGLOBIN ZIGUINCHOR	HBB, GLU6VAL AND PRO58ARG	334
141900	3043	HBB	0041	HEMOGLOBIN CAMDEN HEMOGLOBIN MOTOWN;; HEMOGLOBIN TOKUCHI	HBB, GLN131GLU	
141900	3043	HBB	0042	HEMOGLOBIN CAMPERDOWN	HBB, ARG104SER	33914944
141900	3043	HBB	0043	HEMOGLOBIN CARIBBEAN	HBB, LEU91ARG	33917785
141900	3043	HBB	0044	HEMOGLOBIN CASTILLA	HBB, LEU32ARG	33948578
141900	3043	HBB	0045	HEMOGLOBIN CHANDIGARH	HBB, ASP94GLY	34579351
141900	3043	HBB	0046	HEMOGLOBIN CHEMILLY	HBB, ASP99VAL	33971048
141900	3043	HBB	0047	HEMOGLOBIN CHEVERLY	HBB, PHE45SER	33978338
141900	3043	HBB	0048	HEMOGLOBIN CHICO	HBB, LYS66THR	35939489
141900	3043	HBB	0049	HEMOGLOBIN CHRISTCHURCH	HBB, PHE71SER	34362537
141900	3043	HBB	0050	HEMOGLOBIN CITY OF HOPE	HBB, GLY69SER	33947415
141900	3043	HBB	0051	HEMOGLOBIN COCHIN-PORT ROYAL	HBB, HIS146ARG	33954264
141900	3043	HBB	0052	HEMOGLOBIN COCODY	HBB, ASP21ASN	33950093
141900	3043	HBB	0053	HEMOGLOBIN COLLINGWOOD	HBB, VAL60ALA	33931779
141900	3043	HBB	0054	HEMOGLOBIN CONNECTICUT	HBB, ASP21GLY	33977536
141900	3043	HBB	0055	HEMOGLOBIN COVENTRY	HBB, LEU141DEL	
141900	3043	HBB	0056	HEMOGLOBIN COWTOWN	HBB, HIS146LEU	33954264
141900	3043	HBB	0057	HEMOGLOBIN CRANSTON	HBB, 2-BP INS, CODON 144	35660883
141900	3043	HBB	0058	HEMOGLOBIN CRETE	HBB, ALA129PRO	34139813
141900	3043	HBB	0059	HEMOGLOBIN CRETEIL	HBB, SER89ASN	33917628
141900	3043	HBB	0060	HEMOGLOBIN D (BUSHMAN)	HBB, GLY16ARG	63751285
141900	3043	HBB	0061	HEMOGLOBIN D (GRANADA)	HBB, GLU22VAL	33936254
141900	3043	HBB	0062	HEMOGLOBIN D (IBADAN)	HBB, THR87LYS	33993568
141900	3043	HBB	0063	HEMOGLOBIN D (IRAN)	HBB, GLU22GLN	33959855
141900	3043	HBB	0064	HEMOGLOBIN D (OULED RABAH)	HBB, ASN19LYS	63750840
141900	3043	HBB	0065	HEMOGLOBIN D (PUNJAB) HEMOGLOBIN D (CHICAGO);; HEMOGLOBIN D (LOS ANGELES);; HEMOGLOBIN D (NORTH CAROLINA);; HEMOGLOBIN D (PORTUGAL);; HEMOGLOBIN OAK RIDGE	HBB, GLU121GLN	33946267
141900	3043	HBB	0066	HEMOGLOBIN DEER LODGE	HBB, HIS2ARG	33983205
141900	3043	HBB	0067	HEMOGLOBIN DETROIT	HBB, LYS95ASN	36038739
141900	3043	HBB	0068	HEMOGLOBIN DJELFA	HBB, VAL98ALA	33985510
141900	3043	HBB	0069	HEMOGLOBIN DOHA	HBB, NH2 EXTENSION, VAL1GLU	33949930
141900	3043	HBB	0070	HEMOGLOBIN DUARTE	HBB, ALA62PRO	34933455
141900	3043	HBB	0071	HEMOGLOBIN E BETA-PLUS-THALASSEMIA;; BETA-E-THALASSEMIA;; MALARIA, RESISTANCE TO, INCLUDED	HBB, GLU26LYS	33950507
141900	3043	HBB	0072	HEMOGLOBIN E (SASKATOON)	HBB, GLU22LYS	33959855
141900	3043	HBB	0073	HEMOGLOBIN EDMONTON	HBB, THR50LYS	
141900	3043	HBB	0074	HEMOGLOBIN EXTREMADURA	HBB, VAL133LEU	34095019
141900	3043	HBB	0075	HEMOGLOBIN FANNIN-LUBBOCK	HBB, VAL111LEU AND GLY119ASP	
141900	3043	HBB	0076	HEMOGLOBIN FREIBURG HEMOGLOBIN M (FREIBURG)	HBB, VAL23DEL	34160180
141900	3043	HBB	0077	HEMOGLOBIN FUKUOKA	HBB, HIS2TYR	35906307
141900	3043	HBB	0078	HEMOGLOBIN FUKUYAMA	HBB, HIS77TYR	33991294
141900	3043	HBB	0079	HEMOGLOBIN G (ACCRA)	HBB, ASP79ASN	33990858
141900	3043	HBB	0080	HEMOGLOBIN G (COPENHAGEN)	HBB, ASP47ASN	33932070
141900	3043	HBB	0081	HEMOGLOBIN G (COUSHATTA) HEMOGLOBIN G (SASKATOON);; HEMOGLOBIN G (HSIN-CHU);; HEMOGLOBIN G (TAEGU)	HBB, GLU22ALA	33936254
141900	3043	HBB	0082	HEMOGLOBIN G (FERRARA)	HBB, ASN57LYS	35278874
141900	3043	HBB	0083	HEMOGLOBIN G (GALVESTON) HEMOGLOBIN G (PORT ARTHUR);; HEMOGLOBIN G (TEXAS)	HBB, GLU43ALA	35262412
141900	3043	HBB	0084	HEMOGLOBIN G (HSI-TSOU)	HBB, ASP79GLY	34173382
141900	3043	HBB	0085	HEMOGLOBIN G (MAKASSAR)	HBB, GLU6ALA	334
141900	3043	HBB	0086	HEMOGLOBIN G (SAN JOSE)	HBB, GLU7GLY	34387455
141900	3043	HBB	0087	HEMOGLOBIN G (SZUHU) HEMOGLOBIN GIFU	HBB, ASN80LYS	35890380
141900	3043	HBB	0088	HEMOGLOBIN G (TAIPEI)	HBB, GLU22GLY	33936254
141900	3043	HBB	0089	HEMOGLOBIN G (TAIWAN-AMI)	HBB, GLY25ARG	34404985
141900	3043	HBB	0090	HEMOGLOBIN GAINESVILLE-GA	HBB, GLY46ARG	34743882
141900	3043	HBB	0091	HEMOGLOBIN GAVELLO	HBB, ASP47GLY	33980484
141900	3043	HBB	0092	HEMOGLOBIN GEELONG HEMOGLOBIN JINAN	HBB, ASN139ASP	33910475
141900	3043	HBB	0093	HEMOGLOBIN GENOVA HEMOGLOBIN HYOGO	HBB, LEU28PRO	33916412
141900	3043	HBB	0094	HEMOGLOBIN GRANGE-BLANCHE	HBB, ALA27VAL	33954632
141900	3043	HBB	0095	HEMOGLOBIN GUN HILL	HBB, 15-BP DEL	34210688
141900	3043	HBB	0096	HEMOGLOBIN HACETTEPE HEMOGLOBIN COMPLUTENSE	HBB, GLN127GLU	33971634
141900	3043	HBB	0097	HEMOGLOBIN HAFNIA	HBB, HIS116GLN	35209776
141900	3043	HBB	0098	HEMOGLOBIN HAMADAN	HBB, GLY56ARG	33935983
141900	3043	HBB	0099	HEMOGLOBIN HAMILTON	HBB, VAL11ILE	33974228
141900	3043	HBB	0100	HEMOGLOBIN HAMMERSMITH HEMOGLOBIN CHIBA;; HEINZ BODY HEMOLYTIC ANEMIA	HBB, PHE42SER	34378160
141900	3043	HBB	0101	HEMOGLOBIN HAZEBROUCK	HBB, THR38PRO	34571024
141900	3043	HBB	0102	HEMOGLOBIN HEATHROW	HBB, PHE103LEU	35067717
141900	3043	HBB	0103	HEMOGLOBIN HELSINKI	HBB, LYS82MET	33987903
141900	3043	HBB	0104	HEMOGLOBIN HENRI MONDOR	HBB, GLU26VAL	33915112
141900	3043	HBB	0105	HEMOGLOBIN HIJIYAMA	HBB, LYS120GLU	33924134
141900	3043	HBB	0106	HEMOGLOBIN HIKARI	HBB, LYS61ASN	34446260
141900	3043	HBB	0107	HEMOGLOBIN HIMEJI	HBB, ALA140ASP	33927093
141900	3043	HBB	0108	HEMOGLOBIN HINSDALE	HBB, ASN139LYS	34240441
141900	3043	HBB	0109	HEMOGLOBIN HIROSE	HBB, TRP37SER	33991059
141900	3043	HBB	0110	HEMOGLOBIN HIROSHIMA	HBB, HIS146ASP	33961444
141900	3043	HBB	0111	HEMOGLOBIN HOFU	HBB, VAL126GLU	33925391
141900	3043	HBB	0112	HEMOGLOBIN HOPE	HBB, GLY136ASP	33949486
141900	3043	HBB	0113	HEMOGLOBIN HOSHIDA HEMOGLOBIN CHAYA	HBB, GLU43GLN	33922842
141900	3043	HBB	0114	HEMOGLOBIN HOTEL-DIEU	HBB, ASP99GLY	33971048
141900	3043	HBB	0115	HEMOGLOBIN I (HIGH WYCOMBE)	HBB, LYS59GLU	33969400
141900	3043	HBB	0116	HEMOGLOBIN I (TOULOUSE) HEMOGLOBIN TOULOUSE	HBB, LYS66GLU	34165323
141900	3043	HBB	0117	HEMOGLOBIN INDIANAPOLIS HEINZ BODY HEMOLYTIC ANEMIA	HBB, CYS112ARG	35849199
141900	3043	HBB	0118	HEMOGLOBIN ISTANBUL HEMOGLOBIN SAINT ETIENNE	HBB, HIS92GLN	34083951
141900	3043	HBB	0119	HEMOGLOBIN J (ALTGELD GARDENS)	HBB, HIS92ASP	33924775
141900	3043	HBB	0120	HEMOGLOBIN J (AMIENS)	HBB, LYS17ASN	36006214
141900	3043	HBB	0121	HEMOGLOBIN J (ANTAKYA)	HBB, LYS65MET	33932548
141900	3043	HBB	0122	HEMOGLOBIN J (AUCKLAND)	HBB, GLY25ASP	35474880
141900	3043	HBB	0123	HEMOGLOBIN J (BALTIMORE) HEMOGLOBIN J (IRELAND);; HEMOGLOBIN J (TRINIDAD);; HEMOGLOBIN J (GEORGIA);; HEMOGLOBIN N (NEW HAVEN 2)	HBB, GLY16ASP	33962676
141900	3043	HBB	0124	HEMOGLOBIN J (BANGKOK) HEMOGLOBIN J (KORAT);; HEMOGLOBIN J (MANADO);; HEMOGLOBIN J (MEINUNG)	HBB, GLY56ASP	34439278
141900	3043	HBB	0125	HEMOGLOBIN J (CAIRO)	HBB, LYS65GLN	35353749
141900	3043	HBB	0126	HEMOGLOBIN J (CALABRIA) HEMOGLOBIN J (COSENZA);; HEMOGLOBIN J (BARI)	HBB, GLY64ASP	33922018
141900	3043	HBB	0127	HEMOGLOBIN J (CHICAGO)	HBB, ALA76ASP	33985847
141900	3043	HBB	0128	HEMOGLOBIN J (CORDOBA)	HBB, LYS95MET	35204496
141900	3043	HBB	0129	HEMOGLOBIN J (DALOA)	HBB, ASN57ASP	33988732
141900	3043	HBB	0130	HEMOGLOBIN J (GUANTANAMO)	HBB, ALA128ASP	33957286
141900	3043	HBB	0131	HEMOGLOBIN J (IRAN)	HBB, HIS77ASP	33991294
141900	3043	HBB	0132	HEMOGLOBIN J (KAOHSIUNG) HEMOGLOBIN J (HONOLULU)	HBB, LYS59THR	35537181
141900	3043	HBB	0133	HEMOGLOBIN J (LENS)	HBB, ALA13ASP	35203747
141900	3043	HBB	0134	HEMOGLOBIN J (LOME)	HBB, LYS59ASN	34621955
141900	3043	HBB	0135	HEMOGLOBIN J (LUHE)	HBB, LYS8GLN	33926764
141900	3043	HBB	0136	HEMOGLOBIN J (RAMBAM) HEMOGLOBIN J (CAMBRIDGE)	HBB, GLY69ASP	34718174
141900	3043	HBB	0137	HEMOGLOBIN J (SICILIA)	HBB, LYS65ASN	35747961
141900	3043	HBB	0138	HEMOGLOBIN J (TAICHUNG)	HBB, ALA129ASP	111645889
141900	3043	HBB	0139	HEMOGLOBIN JIANGHUA	HBB, LYS120ILE	34303736
141900	3043	HBB	0140	HEMOGLOBIN JOHNSTOWN	HBB, VAL109LEU	33969677
141900	3043	HBB	0141	HEMOGLOBIN K (CAMEROON)	HBB, ALA129GLU OR ALA129ASP	
141900	3043	HBB	0142	HEMOGLOBIN K (IBADAN)	HBB, GLY46GLU	35303218
141900	3043	HBB	0143	HEMOGLOBIN K (WOOLWICH)	HBB, LYS132GLN	33910209
141900	3043	HBB	0144	HEMOGLOBIN KAIROUAN HEMOGLOBIN MONROE	HBB, ARG30THR	33960103
141900	3043	HBB	0145	HEMOGLOBIN KANSAS HEMOGLOBIN REISSMANN ET AL.	HBB, ASN102THR	33948057
141900	3043	HBB	0146	HEMOGLOBIN KEMPSEY	HBB, ASP99ASN	33954595
141900	3043	HBB	0147	HEMOGLOBIN KENITRA	HBB, GLY69ARG	33947415
141900	3043	HBB	0148	HEMOGLOBIN KHARTOUM	HBB, PRO124ARG	33983276
141900	3043	HBB	0149	HEMOGLOBIN KNOSSOS BETA-PLUS-THALASSEMIA;; BETA-KNOSSOS-THALASSEMIA	HBB, ALA27SER	35424040
141900	3043	HBB	0150	HEMOGLOBIN KOFU	HBB, THR84ILE	35914488
141900	3043	HBB	0151	HEMOGLOBIN KOLN HEMOGLOBIN UBE-1;; HEMOGLOBIN SAN FRANCISCO (PACIFIC);; HEINZ BODY HEMOLYTIC ANEMIA	HBB, VAL98MET	33933298
141900	3043	HBB	0152	HEMOGLOBIN KORIYAMA	HBB, 15-BP INS	
141900	3043	HBB	0153	HEMOGLOBIN KORLE-BU	HBB, ASP73ASN	33945705
141900	3043	HBB	0154	HEMOGLOBIN LA DESIRADE	HBB, ALA129VAL	111645889
141900	3043	HBB	0155	HEMOGLOBIN LAS PALMAS	HBB, SER49PHE	33960931
141900	3043	HBB	0156	HEMOGLOBIN LEIDEN	HBB, GLU6DEL OR GLU7DEL	63750928
141900	3043	HBB	0157	HEMOGLOBIN LINCOLN PARK HBB/HBD ANTI-LEPORE	HBB, HBB/HBD FUSION, HBD137DEL	34218295
141900	3043	HBB	0158	HEMOGLOBIN LINKOPING HEMOGLOBIN MEILAHTI	HBB, PRO36THR	33948615
141900	3043	HBB	0159	HEMOGLOBIN LITTLE ROCK	HBB, HIS143GLN	36020563
141900	3043	HBB	0160	HEMOGLOBIN LOUISVILLE HEMOGLOBIN BUCURESTI	HBB, PHE42LEU	33924146
141900	3043	HBB	0161	HEMOGLOBIN LUFKIN	HBB, GLY29ASP	35685286
141900	3043	HBB	0162	HEMOGLOBIN LYON	HBB, LYS17DEL AND VAL18DEL	63749958
141900	3043	HBB	0163	HEMOGLOBIN M (MILWAUKEE 1)	HBB, VAL67GLU	33918343
141900	3043	HBB	0164	HEMOGLOBIN M (MILWAUKEE 2) HEMOGLOBIN M (HYDE PARK);; HEMOGLOBIN M (AKITA)	HBB, HIS92TYR	33924775
141900	3043	HBB	0165	HEMOGLOBIN M (SASKATOON) HEMOGLOBIN M (ARHUS);; HEMOGLOBIN M (CHICAGO);; HEMOGLOBIN M (EMORY);; HEMOGLOBIN M (ERLANGEN);; HEMOGLOBIN M (HAMBURG);; HEMOGLOBIN M (HIDA);; HEMOGLOBIN M (HORLEIN-WEBER);; HEMOGLOBIN M (KURUME);; HEMOGLOBIN M (LEIPZIG);; HEMOGLOBIN M (NOVI SAD);; HEMOGLOBIN M (RADOM)	HBB, HIS63TYR	33922873
141900	3043	HBB	0166	HEMOGLOBIN MACHIDA	HBB, GLU6GLN	33930165
141900	3043	HBB	0167	HEMOGLOBIN MADRID	HBB, ALA115PRO	34945623
141900	3043	HBB	0168	HEMOGLOBIN MALAY BETA-PLUS-THALASSEMIA;; BETA-MALAY-THALASSEMIA	HBB, ASN19SER	33972047
141900	3043	HBB	0169	HEMOGLOBIN MALMO	HBB, HIS97GLN	34515413
141900	3043	HBB	0170	HEMOGLOBIN MAPUTO	HBB, ASP47TYR	33932070
141900	3043	HBB	0171	HEMOGLOBIN MARSEILLE HEMOGLOBIN LONG ISLAND	HBB, NH2 EXTENSION, HIS2PRO	33983205
141900	3043	HBB	0172	HEMOGLOBIN MASUDA	HBB, LEU114MET AND GLY119ASP	33917394
141900	3043	HBB	0173	HEMOGLOBIN MATERA	HBB, MET55LYS	35094013
141900	3043	HBB	0174	HEMOGLOBIN MEQUON	HBB, PHE41TYR	33926796
141900	3043	HBB	0175	HEMOGLOBIN MCKEES ROCKS	HBB, TYR145TER	35291591
141900	3043	HBB	0176	HEMOGLOBIN MINNEAPOLIS-LAOS	HBB, PHE118TYR	33928092
141900	3043	HBB	0177	HEMOGLOBIN MISSISSIPPI HEMOGLOBIN MS	HBB, SER44CYS	34868397
141900	3043	HBB	0178	HEMOGLOBIN MITO	HBB, LYS144GLU	33964352
141900	3043	HBB	0179	HEMOGLOBIN MIYADA HBB/HBD ANTI-LEPORE	HBB, HBB/HBD FUSION	
141900	3043	HBB	0180	HEMOGLOBIN MIYASHIRO	HBB, VAL23GLY	33945546
141900	3043	HBB	0181	HEMOGLOBIN MIZUHO	HBB, LEU68PRO	33972593
141900	3043	HBB	0182	HEMOGLOBIN MIZUNAMI	HBB, PHE83SER	1803195
141900	3043	HBB	0183	HEMOGLOBIN MOBILE	HBB, ASP73VAL	33967755
141900	3043	HBB	0184	HEMOGLOBIN MORIGUCHI	HBB, HIS97TYR	33950993
141900	3043	HBB	0185	HEMOGLOBIN MOSCVA	HBB, GLY24ASP	33968721
141900	3043	HBB	0186	HEMOGLOBIN MOZHAISK	HBB, HIS92ARG	33974325
141900	3043	HBB	0187	HEMOGLOBIN N, BETA TYPE	HBB, LYS95ASP	
141900	3043	HBB	0188	HEMOGLOBIN N (BALTIMORE) HEMOGLOBIN N (JENKINS);; HEMOGLOBIN JENKINS;; HEMOGLOBIN HOPKINS 1;; HEMOGLOBIN KENWOOD	HBB, LYS95GLU	33914359
141900	3043	HBB	0189	HEMOGLOBIN N (MEMPHIS)	HBB, LYS95GLX	
141900	3043	HBB	0190	HEMOGLOBIN N (SEATTLE)	HBB, LYS61GLU	33995148
141900	3043	HBB	0191	HEMOGLOBIN N (TIMONE)	HBB, LYS8GLU	33926764
141900	3043	HBB	0192	HEMOGLOBIN NAGASAKI	HBB, LYS17GLU	33986703
141900	3043	HBB	0193	HEMOGLOBIN NAGOYA	HBB, HIS97PRO	33951978
141900	3043	HBB	0194	HEMOGLOBIN NEVERS	HBB, TYR130SER	33937535
141900	3043	HBB	0195	HEMOGLOBIN NEW MEXICO	HBB, PRO100ARG	33965000
141900	3043	HBB	0196	HEMOGLOBIN NEW YORK HEMOGLOBIN KAOHSIUNG	HBB, VAL113GLU	34484056
141900	3043	HBB	0197	HEMOGLOBIN NEWCASTLE	HBB, HIS92PRO	33974325
141900	3043	HBB	0198	HEMOGLOBIN NITEROI	HBB, PHE42DEL, GLU43DEL, SER44DEL	35637840
141900	3043	HBB	0199	HEMOGLOBIN NORTH CHICAGO	HBB, PRO36SER	33948615
141900	3043	HBB	0200	HEMOGLOBIN NORTH SHORE HEMOGLOBIN NORTH SHORE-CARACAS	HBB, VAL134GLU	33966761
141900	3043	HBB	0201	HEMOGLOBIN NOTTINGHAM	HBB, VAL98GLY	33985510
141900	3043	HBB	0202	HEMOGLOBIN O (ARAB) HEMOGLOBIN EGYPT	HBB, GLU121LYS	33946267
141900	3043	HBB	0203	HEMOGLOBIN OCHO RIOS	HBB, ASP52ALA	33919924
141900	3043	HBB	0204	HEMOGLOBIN OHIO	HBB, ALA142ASP	33921821
141900	3043	HBB	0205	HEMOGLOBIN OKALOOSA	HBB, LEU48ARG	33952850
141900	3043	HBB	0206	HEMOGLOBIN OKAYAMA	HBB, HIS2GLN	713040
141900	3043	HBB	0207	HEMOGLOBIN OKAZAKI	HBB, CYS93ARG	33972927
141900	3043	HBB	0208	HEMOGLOBIN OLMSTED	HBB, LEU141ARG	35854892
141900	3043	HBB	0209	HEMOGLOBIN OLOMOUC	HBB, ALA86ASP	35819837
141900	3043	HBB	0210	HEMOGLOBIN OLYMPIA	HBB, VAL20MET	35890959
141900	3043	HBB	0211	HEMOGLOBIN OSLER HEMOGLOBIN NANCY;; HEMOGLOBIN FORT GORDON	HBB, TYR145ASN-TO-ASP	33949869
141900	3043	HBB	0212	HEMOGLOBIN OSU CHRISTIANSBORG	HBB, ASP52ASN	33961886
141900	3043	HBB	0213	HEMOGLOBIN P HEMOGLOBIN P (GALVESTON)	HBB, HIS117ARG	33935673
141900	3043	HBB	0214	HEMOGLOBIN P (CONGO) HBB/HBD ANTI-LEPORE	HBB, HBB/HBD FUSION	
141900	3043	HBB	0215	HEMOGLOBIN P (NILOTIC) HBB/HBD ANTI-LEPORE	HBB, HBB/HBD FUSION	
141900	3043	HBB	0216	HEMOGLOBIN PALMERSTON NORTH	HBB, VAL23PHE	33929459
141900	3043	HBB	0217	HEMOGLOBIN PASADENA	HBB, LEU75ARG	33950542
141900	3043	HBB	0218	HEMOGLOBIN PERTH HEMOGLOBIN ABRAHAM LINCOLN;; HEMOGLOBIN KOBE	HBB, LEU32PRO	33920173
141900	3043	HBB	0219	HEMOGLOBIN PETERBOROUGH	HBB, VAL111PHE	33957964
141900	3043	HBB	0220	HEMOGLOBIN PHILLY	HBB, TYR35PHE	35857380
141900	3043	HBB	0221	HEMOGLOBIN PIERRE-BENITE	HBB, GLU90ASP	35002698
141900	3043	HBB	0222	HEMOGLOBIN PITIE-SALPETRIERE	HBB, VAL34PHE	1141387
141900	3043	HBB	0223	HEMOGLOBIN POISSY	HBB, GLY56ARG AND ALA86PRO	33935983
141900	3043	HBB	0224	HEMOGLOBIN PORTO ALEGRE	HBB, SER9CYS	33918131
141900	3043	HBB	0225	HEMOGLOBIN POTOMAC	HBB, GLU101ASP	35209591
141900	3043	HBB	0226	HEMOGLOBIN PRESBYTERIAN	HBB, ASN108LYS	34933751
141900	3043	HBB	0227	HEMOGLOBIN PROVIDENCE	HBB, LYS82ASX	33991993
141900	3043	HBB	0228	HEMOGLOBIN PYRGOS	HBB, GLY83ASP	1803195
141900	3043	HBB	0229	HEMOGLOBIN QUIN-HAI	HBB, LEU78ARG	34870172
141900	3043	HBB	0230	HEMOGLOBIN RADCLIFFE	HBB, ASP99ALA	33971048
141900	3043	HBB	0231	HEMOGLOBIN RAHERE	HBB, LYS82THR	33987903
141900	3043	HBB	0232	HEMOGLOBIN RAINIER	HBB, TYR145CYS	35117167
141900	3043	HBB	0233	HEMOGLOBIN RALEIGH	HBB, VAL1ALA	33949930
141900	3043	HBB	0234	HEMOGLOBIN RANDWICK	HBB, TRP15GLY	33946157
141900	3043	HBB	0235	HEMOGLOBIN REGINA	HBB, LEU96VAL	34665886
141900	3043	HBB	0236	HEMOGLOBIN RICHMOND	HBB, ASN102LYS	34227486
141900	3043	HBB	0237	HEMOGLOBIN RIO GRANDE	HBB, LYS8THR	33932981
141900	3043	HBB	0238	HEMOGLOBIN RIVERDALE-BRONX	HBB, GLY24ARG	33972975
141900	3043	HBB	0239	HEMOGLOBIN RIYADH HEMOGLOBIN KARATSU	HBB, LYS120ASN	34726542
141900	3043	HBB	0240	HEMOGLOBIN ROSEAU-POINTE A PITRE	HBB, GLU90GLY	35068498
141900	3043	HBB	0241	HEMOGLOBIN ROTHSCHILD	HBB, TRP37ARG	33994623
141900	3043	HBB	0242	HEMOGLOBIN RUSH	HBB, GLU101GLN	33966487
141900	3043	HBB	0243	HEMOGLOBIN S SICKLE CELL ANEMIA, INCLUDED;; MALARIA, RESISTANCE TO, INCLUDED	HBB, GLU6VAL	334
141900	3043	HBB	0244	HEMOGLOBIN S (ANTILLES)	HBB, GLU6VAL AND VAL23ILE	334
141900	3043	HBB	0245	HEMOGLOBIN S (OMAN) HEMOGLOBIN S/O (ARAB)	HBB, GLU6VAL AND GLU121LYS	334
141900	3043	HBB	0246	HEMOGLOBIN S (PROVIDENCE)	HBB, GLU6VAL AND LYS82ASX	334
141900	3043	HBB	0247	HEMOGLOBIN S (TRAVIS)	HBB, GLU6VAL AND ALA142VAL	334
141900	3043	HBB	0248	HEMOGLOBIN SABINE	HBB, LEU91PRO	33917785
141900	3043	HBB	0249	HEMOGLOBIN SAINT JACQUES	HBB, ALA140THR	34980264
141900	3043	HBB	0250	HEMOGLOBIN SAITAMA	HBB, HIS117PRO	33935673
141900	3043	HBB	0251	HEMOGLOBIN SAKI	HBB, LEU14PRO	33935445
141900	3043	HBB	0252	HEMOGLOBIN SAN DIEGO	HBB, VAL109MET	33969677
141900	3043	HBB	0253	HEMOGLOBIN SANTA ANA	HBB, LEU88PRO	33940204
141900	3043	HBB	0254	HEMOGLOBIN SAVANNAH	HBB, GLY24VAL	33968721
141900	3043	HBB	0255	HEMOGLOBIN SAVERNE	HBB, 1-BP DEL, HIS143PRO, FS	63749858
141900	3043	HBB	0256	HEMOGLOBIN SEATTLE	HBB, ALA70ASP	33946401
141900	3043	HBB	0257	HEMOGLOBIN SENDAGI HEMOGLOBIN WARSAW	HBB, PHE42VAL	33924146
141900	3043	HBB	0258	HEMOGLOBIN SHANGHAI	HBB, GLN131PRO	33950778
141900	3043	HBB	0259	HEMOGLOBIN SHELBY HEMOGLOBIN LESLIE;; HEMOGLOBIN DEACONESS	HBB, GLN131LYS	33910209
141900	3043	HBB	0260	HEMOGLOBIN SHEPHERDS BUSH	HBB, GLY74ASP	33976006
141900	3043	HBB	0261	HEMOGLOBIN SHERWOOD FOREST	HBB, ARG104THR	33911434
141900	3043	HBB	0262	HEMOGLOBIN SHOWA-YAKUSHIJI BETA-PLUS-THALASSEMIA;; BETA-SHOWA-YAKUSHIJI THALASSEMIA	HBB, LEU110PRO	35256489
141900	3043	HBB	0263	HEMOGLOBIN SIRIRAJ HEMOGLOBIN G (HONAN)	HBB, GLU7LYS	34948328
141900	3043	HBB	0264	HEMOGLOBIN SOGN	HBB, LEU14ARG	33935445
141900	3043	HBB	0265	HEMOGLOBIN SOUTHAMPTON HEMOGLOBIN CASPER	HBB, LEU106PRO	33941844
141900	3043	HBB	0266	HEMOGLOBIN SOUTH FLORIDA	HBB, NH2 EXTENSION, VAL1MET, METi RETAINED	33958358
141900	3043	HBB	0267	HEMOGLOBIN ST. ANTOINE	HBB, GLY74DEL AND LEU75DEL	63750968
141900	3043	HBB	0268	HEMOGLOBIN ST. LOUIS HEINZ BODY HEMOLYTIC ANEMIA	HBB, LEU28GLN	33916412
141900	3043	HBB	0269	HEMOGLOBIN ST. MANDE	HBB, ASN102TYR	33927739
141900	3043	HBB	0270	HEMOGLOBIN STANMORE	HBB, VAL111ALA	35871407
141900	3043	HBB	0271	HEMOGLOBIN STRASBOURG	HBB, VAL23ASP	33945546
141900	3043	HBB	0272	HEMOGLOBIN SUMMER HILL	HBB, ASP52HIS	33961886
141900	3043	HBB	0273	HEMOGLOBIN SUNNYBROOK	HBB, PRO36ARG	33993004
141900	3043	HBB	0274	HEMOGLOBIN SYDNEY	HBB, VAL67ALA	33918343
141900	3043	HBB	0275	HEMOGLOBIN SYRACUSE	HBB, HIS143PRO	33918338
141900	3043	HBB	0276	HEMOGLOBIN T (CAMBODIA)	HBB, GLU26LYS AND GLU121GLN	33950507
141900	3043	HBB	0277	HEMOGLOBIN TA-LI	HBB, GLY83CYS	33930385
141900	3043	HBB	0278	HEMOGLOBIN TACOMA HEINZ BODY HEMOLYTIC ANEMIA	HBB, ARG30SER	1135071
141900	3043	HBB	0279	HEMOGLOBIN TAK	HBB, +8 RESIDUES	33999427
141900	3043	HBB	0280	HEMOGLOBIN TAKAMATSU	HBB, LYS120GLN	33924134
141900	3043	HBB	0281	HEMOGLOBIN TAMPA	HBB, ASP79TYR	33990858
141900	3043	HBB	0282	HEMOGLOBIN TIANSHUI	HBB, GLN39ARG	35973315
141900	3043	HBB	0283	HEMOGLOBIN TILBURG	HBB, ASP73GLY	33967755
141900	3043	HBB	0284	HEMOGLOBIN TOCHIGI	HBB, GLY56DEL, ASN57DEL, PRO58DEL, LYS59DEL	63751103
141900	3043	HBB	0285	HEMOGLOBIN TOURS	HBB, THR87DEL	
141900	3043	HBB	0286	HEMOGLOBIN TOYOAKE	HBB, ALA142PRO	33931806
141900	3043	HBB	0287	HEMOGLOBIN TUBINGEN	HBB, LEU106GLN	33941844
141900	3043	HBB	0288	HEMOGLOBIN TUNIS	HBB, PRO124SER	35461710
141900	3043	HBB	0289	HEMOGLOBIN TY GARD	HBB, PRO124GLN	33983276
141900	3043	HBB	0290	HEMOGLOBIN VAASA	HBB, GLN39GLU	11549407
141900	3043	HBB	0291	HEMOGLOBIN VANCOUVER	HBB, ASP73TYR	33945705
141900	3043	HBB	0292	HEMOGLOBIN VANDERBILT	HBB, SER89ARG	35351128
141900	3043	HBB	0293	HEMOGLOBIN VICKSBURG	HBB, LEU75DEL	35452098
141900	3043	HBB	0294	HEMOGLOBIN VILLEJUIF	HBB, THR123ILE	33935383
141900	3043	HBB	0295	HEMOGLOBIN VOLGA HEMOGLOBIN DRENTHE	HBB, ALA27ASP	33954632
141900	3043	HBB	0296	HEMOGLOBIN WARWICKSHIRE	HBB, PRO5ARG	34769005
141900	3043	HBB	0297	HEMOGLOBIN WIEN	HBB, TYR130ASP	35834416
141900	3043	HBB	0298	HEMOGLOBIN WILLAMETTE	HBB, PRO51ARG	33969727
141900	3043	HBB	0299	HEMOGLOBIN WINDSOR	HBB, VAL11ASP	35140348
141900	3043	HBB	0300	HEMOGLOBIN WOOD	HBB, HIS97LEU	33951978
141900	3043	HBB	0301	HEMOGLOBIN YAKIMA	HBB, ASP99HIS	33954595
141900	3043	HBB	0302	HEMOGLOBIN YAMAGATA	HBB, LYS132ASN	33946775
141900	3043	HBB	0303	HEMOGLOBIN YATSUSHIRO	HBB, VAL60LEU	33990253
141900	3043	HBB	0304	HEMOGLOBIN YOKOHAMA	HBB, LEU31PRO	33920173
141900	3043	HBB	0305	HEMOGLOBIN YORK	HBB, HIS146PRO	33954264
141900	3043	HBB	0306	HEMOGLOBIN YOSHIZUKA	HBB, ASN108ASP	33958637
141900	3043	HBB	0307	HEMOGLOBIN YPSILANTI	HBB, ASP99TYR	33954595
141900	3043	HBB	0308	HEMOGLOBIN YUKUHASHI HEMOGLOBIN DHOFAR	HBB, PRO58ARG	33991472
141900	3043	HBB	0309	HEMOGLOBIN YUSA	HBB, ASP21TYR	33950093
141900	3043	HBB	0310	HEMOGLOBIN ZURICH	HBB, HIS63ARG	33985544
141900	3043	HBB	0311	BETA-ZERO-THALASSEMIA	HBB, LYS17TER	33986703
141900	3043	HBB	0312	BETA-ZERO-THALASSEMIA	HBB, GLN39TER	11549407
141900	3043	HBB	0313	BETA-ZERO-THALASSEMIA	HBB, TRP15TER	34716011
141900	3043	HBB	0314	BETA-THALASSEMIA, DOMINANT INCLUSION BODY TYPE	HBB, GLU121TER	33946267
141900	3043	HBB	0315	BETA-ZERO-THALASSEMIA	HBB, TRP37TER	33974936
141900	3043	HBB	0316	BETA-ZERO-THALASSEMIA	HBB, GLU43TER	33922842
141900	3043	HBB	0317	BETA-ZERO-THALASSEMIA	HBB, LYS61TER	33995148
141900	3043	HBB	0318	BETA-ZERO-THALASSEMIA	HBB, TYR35TER	33982568
141900	3043	HBB	0319	HEMOGLOBIN HOUSTON BETA-PLUS-THALASSEMIA, DOMINANT;; BETA-HOUSTON-THALASSEMIA	HBB, GLN127PRO	33910569
141900	3043	HBB	0320	BETA-PLUS-THALASSEMIA	HBB, GLN127PRO AND ALA128DEL	34502690
141900	3043	HBB	0321	BETA-PLUS-THALASSEMIA HEMOGLOBIN CAGLIARI	HBB, VAL60GLU	33931779
141900	3043	HBB	0322	BETA-ZERO-THALASSEMIA	HBB, LYS8FS	35497102
141900	3043	HBB	0323	BETA-ZERO-THALASSEMIA	HBB, GLY16FS	
141900	3043	HBB	0324	BETA-ZERO-THALASSEMIA	HBB, SER44FS	
141900	3043	HBB	0325	BETA-ZERO-THALASSEMIA	HBB, 1-BP INS, G, CODONS 8/9	
141900	3043	HBB	0326	BETA-ZERO-THALASSEMIA	HBB, 4-BP DEL, 41/42CTTT	
141900	3043	HBB	0327	BETA-ZERO-THALASSEMIA	HBB, GLU6FS	
141900	3043	HBB	0328	BETA-ZERO-THALASSEMIA	HBB, PHE71FS	33969853
141900	3043	HBB	0329	BETA-ZERO-THALASSEMIA	HBB, LEU106FS	35225141
141900	3043	HBB	0330	BETA-ZERO-THALASSEMIA	HBB, ALA76FS	
141900	3043	HBB	0331	BETA-ZERO-THALASSEMIA	HBB, TRP37FS	
141900	3043	HBB	0332	BETA-ZERO-THALASSEMIA	HBB, PRO5FS	
141900	3043	HBB	0333	BETA-ZERO-THALASSEMIA	HBB, VAL11FS	
141900	3043	HBB	0334	BETA-ZERO-THALASSEMIA	HBB, TYR35FS	
141900	3043	HBB	0335	BETA-ZERO-THALASSEMIA HEMOGLOBIN GENEVA	HBB, ASP114FS	41443947
141900	3043	HBB	0336	BETA-ZERO-THALASSEMIA	HBB, LEU14FS	35383398
141900	3043	HBB	0337	BETA-ZERO-THALASSEMIA	HBB, TRP37FS	63750099
141900	3043	HBB	0338	BETA-ZERO-THALASSEMIA	HBB, ASP94FS	
141900	3043	HBB	0339	BETA-ZERO-THALASSEMIA	HBB, GLY64FS	
141900	3043	HBB	0340	BETA-ZERO-THALASSEMIA	HBB, VAL109FS	
141900	3043	HBB	0341	BETA-ZERO-THALASSEMIA	HBB, PRO36FS	63750532
141900	3043	HBB	0342	BETA-ZERO-THALASSEMIA	HBB, ALA27FS	35532010
141900	3043	HBB	0343	BETA-ZERO-THALASSEMIA	HBB, PHE71FS	33969853
141900	3043	HBB	0344	BETA-ZERO-THALASSEMIA	HBB, MET1ARG	33941849
141900	3043	HBB	0345	BETA-ZERO-THALASSEMIA BETA-THALASSEMIA, LERMONTOV TYPE	HBB, MET1THR	33941849
141900	3043	HBB	0346	BETA-ZERO-THALASSEMIA	HBB, IVS1, G-A, +1	33971440
141900	3043	HBB	0347	BETA-ZERO-THALASSEMIA	HBB, IVS1, G-T, +1	33971440
141900	3043	HBB	0348	BETA-ZERO-THALASSEMIA	HBB, IVS2, G-A, +1	
141900	3043	HBB	0349	BETA-ZERO-THALASSEMIA	HBB, IVS1, T-G, +2	33956879
141900	3043	HBB	0350	BETA-ZERO-THALASSEMIA	HBB, IVS2, T-C, +2	33956879
141900	3043	HBB	0351	BETA-ZERO-THALASSEMIA	HBB, IVS1, 17-BP DEL	63750915
141900	3043	HBB	0352	BETA-ZERO-THALASSEMIA	HBB, IVS1, 25-BP DEL	63750223
141900	3043	HBB	0353	BETA-ZERO-THALASSEMIA	HBB, IVS2, A-G, -2	33914668
141900	3043	HBB	0354	BETA-ZERO-THALASSEMIA	HBB, IVS2, A-C, -2	33914668
141900	3043	HBB	0355	BETA-ZERO-THALASSEMIA	HBB, IVS1, 44-BP, SS DEL	63751076
141900	3043	HBB	0356	BETA-ZERO-THALASSEMIA	HBB, IVS1, G-A, -1	33943001
141900	3043	HBB	0357	BETA-PLUS-THALASSEMIA	HBB, IVS1, G-C, +5	33915217
141900	3043	HBB	0358	BETA-PLUS-THALASSEMIA	HBB, IVS1, G-T, +5	33915217
141900	3043	HBB	0359	BETA-PLUS-THALASSEMIA	HBB, IVS1, G-A, +5	33915217
141900	3043	HBB	0360	BETA-PLUS-THALASSEMIA	HBB, IVS1, T-C, +6	
141900	3043	HBB	0361	BETA-PLUS-THALASSEMIA	HBB, IVS2, C-A, -3	33913413
141900	3043	HBB	0362	BETA-PLUS-THALASSEMIA	HBB, IVS1, T-G, -3	34527846
141900	3043	HBB	0363	BETA-PLUS-THALASSEMIA	HBB, IVS1, C-A, -8	
141900	3043	HBB	0364	BETA-PLUS-THALASSEMIA	HBB, IVS1, G-A, +110	
141900	3043	HBB	0365	BETA-ZERO-THALASSEMIA	HBB, IVS1, T-G, +16	
141900	3043	HBB	0366	BETA-PLUS-THALASSEMIA	HBB, IVS2, T-G, +705	35328027
141900	3043	HBB	0367	BETA-PLUS-THALASSEMIA	HBB, IVS2, C-G, +745	
141900	3043	HBB	0368	BETA-ZERO-THALASSEMIA	HBB, IVS2, C-T, +654	
141900	3043	HBB	0369	BETA-PLUS-THALASSEMIA	HBB, GGT24GGA AND GLY24GLY	33951465
141900	3043	HBB	0370	BETA-PLUS-THALASSEMIA	HBB, -101C-T	63751208
141900	3043	HBB	0371	BETA-PLUS-THALASSEMIA	HBB, -92C-T	34883338
141900	3043	HBB	0372	BETA-PLUS-THALASSEMIA	HBB, -88C-T	33944208
141900	3043	HBB	0373	BETA-PLUS-THALASSEMIA	HBB, -88C-A	33944208
141900	3043	HBB	0374	BETA-PLUS-THALASSEMIA	HBB, -87C-G	33941377
141900	3043	HBB	0375	BETA-PLUS-THALASSEMIA	HBB, -86C-G	
141900	3043	HBB	0376	BETA-PLUS-THALASSEMIA	HBB, -31A-G	33981098
141900	3043	HBB	0377	BETA-PLUS-THALASSEMIA	HBB, -30T-A	33980857
141900	3043	HBB	0378	BETA-PLUS-THALASSEMIA	HBB, -30T-C	33980857
141900	3043	HBB	0379	BETA-PLUS-THALASSEMIA	HBB, -29A-G	34598529
141900	3043	HBB	0380	BETA-PLUS-THALASSEMIA	HBB, -28A-C	33931746
141900	3043	HBB	0381	BETA-PLUS-THALASSEMIA	HBB, -28A-G	33931746
141900	3043	HBB	0382	BETA-PLUS-THALASSEMIA	HBB, 3-UNT, T-C, +3	33978907
141900	3043	HBB	0383	BETA-PLUS-THALASSEMIA	HBB, 3-UNT, A-G, +6	33985472
141900	3043	HBB	0384	BETA-PLUS-THALASSEMIA	HBB, 3-UNT, A DEL, +4	
141900	3043	HBB	0385	BETA-PLUS-THALASSEMIA	HBB, 3-UNT, G INS, +4	
141900	3043	HBB	0386	BETA-PLUS-THALASSEMIA	HBB, 3-UNT, A-G, +5	63750954
141900	3043	HBB	0387	BETA-PLUS-THALASSEMIA	HBB, CAP, A-C	34305195
141900	3043	HBB	0389	HEMOGLOBIN BIRMINGHAM	HBB, 9-BP DEL	34383403
141900	3043	HBB	0390	HEMOGLOBIN GALICIA	HBB, 3-BP DEL	63750837
141900	3043	HBB	0391	HEMOGLOBIN SOUTH MILWAUKEE	HBB, LEU105PHE	34022507
141900	3043	HBB	0392	BETA-ZERO-THALASSEMIA	HBB, IVS1, T-A, +2	33956879
141900	3043	HBB	0393	HEMOGLOBIN DHONBURI HEMOGLOBIN NEAPOLIS	HBB, VAL126GLY	33925391
141900	3043	HBB	0394	HEMOGLOBIN IOWA	HBB, GLY119ALA	33947020
141900	3043	HBB	0395	BETA-THALASSEMIA	HBB, 1-BP INS, A, CODON 47	35894115
141900	3043	HBB	0396	HEMOGLOBIN CALAIS	HBB, ALA76PRO	35286210
141900	3043	HBB	0397	HEMOGLOBIN ZENGCHENG	HBB, LEU114MET	33917394
141900	3043	HBB	0398	HEMOGLOBIN TERRE HAUTE BETA-PLUS-THALASSEMIA	HBB, LEU106ARG	33941844
141900	3043	HBB	0399	BETA-PLUS-THALASSEMIA	HBB, 3-UNT, A-G, +4	63751128
141900	3043	HBB	0400	HEMOGLOBIN VALLETTA	HBB, THR87PRO	35553496
141900	3043	HBB	0401	HEMOGLOBIN JACKSONVILLE	HBB, VAL54ASP	34037627
141900	3043	HBB	0402	HEMOGLOBIN CHESTERFIELD	HBB, LEU28ARG	33916412
141900	3043	HBB	0403	HEMOGLOBIN QUEBEC-CHORI HEMOGLOBIN CHORI	HBB, THR87ILE	33993568
141900	3043	HBB	0404	HEMOGLOBIN REDONDO HEMOGLOBIN ISEHARA	HBB, HIS92ASN-TO-ASP	33924775
141900	3043	HBB	0405	HEMOGLOBIN COIMBRA	HBB, ASP99GLU	34013622
141900	3043	HBB	0406	BETA-PLUS-THALASSEMIA	HBB, C-A, -32	34500389
141900	3043	HBB	0407	HEMOGLOBIN CLEVELAND	HBB, CYS93ARG AND GLU121GLN	33972927
141900	3043	HBB	0408	HEMOGLOBIN GRENOBLE	HBB, PRO51SER AND ASP52ASN	33961886
141900	3043	HBB	0409	HEMOGLOBIN KODAIRA	HBB, HIS146GLN	33985739
141900	3043	HBB	0410	HEMOGLOBIN MONTREAL	HBB, 9-BP DEL AND 12-BP INS	
141900	3043	HBB	0411	HEMOGLOBIN NIKOSIA	HBB, LYS17GLN	33986703
141900	3043	HBB	0412	HEMOGLOBIN ST. FRANCIS	HBB, GLU121GLY	33987957
141900	3043	HBB	0413	HEMOGLOBIN YAHATA	HBB, CYS112TYR	33932908
141900	3043	HBB	0414	HEMOGLOBIN RANCHO MIRAGE	HBB, HIS143ASP	33929415
141900	3043	HBB	0415	BETA-ZERO-THALASSEMIA	HBB, GLU90TER	33913712
141900	3043	HBB	0416	BETA-ZERO-THALASSEMIA	HBB, IVS2AS, -3, C-G	33913413
141900	3043	HBB	0417	BETA-PLUS-THALASSEMIA	HBB, 3-NT, 5-BP DEL, AATAAA-A	35949130
141900	3043	HBB	0418	BETA-ZERO-THALASSEMIA	HBB, IVS1AS, G-C, -1	33943001
141900	3043	HBB	0419	BETA-ZERO-THALASSEMIA	HBB, 1-BP DEL, GTG-TG	63750475
141900	3043	HBB	0420	HEMOGLOBIN MUSCAT	HBB, LEU32VAL	34314652
141900	3043	HBB	0421	HEMOGLOBIN BAB-SAADOUN	HBB, LEU48PRO	33952850
141900	3043	HBB	0422	HEMOGLOBIN MANHATTAN	HBB, 1-BP DEL, -G, CODON 109	63751201
141900	3043	HBB	0423	BETA-ZERO-THALASSEMIA	HBB, IVS2, G-C, -1	33952266
141900	3043	HBB	0424	BETA-THALASSEMIA INTERMEDIA HEMOGLOBIN BRESCIA;; HEMOGLOBIN DURHAM-N.C.	HBB, LEU114PRO	36015961
141900	3043	HBB	0425	BETA-PLUS-THALASSEMIA	HBB, C-T, -90	34999973
141900	3043	HBB	0426	BETA-THALASSEMIA INTERMEDIA, DOMINANT	HBB, IVS2DS, 2-BP DEL, AG	34750035
141900	3043	HBB	0427	HEMOGLOBIN DUINO	HBB, HIS92PRO AND ARG104SER	33974325
141900	3043	HBB	0428	HEMOGLOBIN BADEN	HBB, VAL18MET	35802118
141900	3043	HBB	0429	HEMOGLOBIN GRAZ	HBB, HIS2LEU	33983205
141900	3043	HBB	0430	BETA-ZERO-THALASSEMIA	HBB, MET1ILE	33930702
141900	3043	HBB	0431	HEMOGLOBIN KARLSKOGA	HBB, ASP21HIS	33950093
141900	3043	HBB	0432	HEMOGLOBIN MUSKEGON	HBB, GLY83ARG	33930385
141900	3043	HBB	0433	HEMOGLOBIN TIGRAYE	HBB, ASP79HIS	33990858
141900	3043	HBB	0435	HEMOGLOBIN SARREBOURG	HBB, GLN131ARG	33950778
141900	3043	HBB	0436	HEMOGLOBIN SAINT NAZAIRE	HBB, PHE103ILE	33921589
141900	3043	HBB	0437	HEMOGLOBIN HRADEC KRALOVE HEMOGLOBIN HK	HBB, ALA115ASP	35485099
141900	3043	HBB	0438	HEMOGLOBIN MANUKAU	HBB, VAL67GLY	33918343
141900	3043	HBB	0439	HEMOGLOBIN VILLAVERDE	HBB, SER89THR	33917628
141900	3043	HBB	0440	HEMOGLOBIN HOWICK	HBB, TRP37GLY	33994623
141900	3043	HBB	0441	HEMOGLOBIN DENVER	HBB, PHE41SER	33926796
141900	3043	HBB	0442	HEMOGLOBIN BECKMAN	HBB, ALA135GLU	35669628
141900	3043	HBB	0443	HEMOGLOBIN KOREA	HBB, VAL33DEL OR VAL34DEL	35699671
141900	3043	HBB	0445	HEMOGLOBIN D (NEATH)	HBB, GLU121ALA	33987957
141900	3043	HBB	0446	HEMOGLOBIN WASHTENAW	HBB, VAL11PHE	33974228
141900	3043	HBB	0447	HEMOGLOBIN ALESHA	HBB, VAL67MET	36008922
141900	3043	HBB	0448	HEMOGLOBIN DIEPPE	HBB, GLN127ARG	33910569
141900	3043	HBB	0449	HEMOGLOBIN HIGASHITOCHIGI HEMOGLOBIN HT	HBB, GLY24DEL OR GLY25DEL	63749918
141900	3043	HBB	0450	HEMOGLOBIN TROLLHAETTAN	HBB, VAL20GLU	33918474
141900	3043	HBB	0451	HEMOGLOBIN TYNE	HBB, PRO5SER	33912272
141900	3043	HBB	0452	HEMOGLOBIN MEDICINE LAKE	HBB, VAL98MET AND LEU32GLN	
141900	3043	HBB	0453	HEMOGLOBIN YAIZU	HBB, ASP79ASN	33990858
141900	3043	HBB	0454	BETA-ZERO-THALASSEMIA	HBB, IVS2AS, G-A, -1	33952266
141900	3043	HBB	0455	HEMOGLOBIN HAKKARI	HBB, LEU31ARG	
141900	3043	HBB	0457	HEMOGLOBIN PUTTELANGE	HBB, ALA140VAL	33927093
141900	3043	HBB	0458	HEMOGLOBIN ARTA	HBB, PHE45CYS	33978338
141900	3043	HBB	0459	HEMOGLOBIN AURORA	HBB, ASN139TYR	33910475
141900	3043	HBB	0460	HEMOGLOBIN NAKANO	HBB, LYS8MET	33932981
141900	3043	HBB	0461	HEMOGLOBIN HINWIL	HBB, THR38ASN	34703513
141900	3043	HBB	0462	HEMOGLOBIN DEBROUSSE	HBB, LEU96PRO	36081208
141900	3043	HBB	0463	BETA-THALASSEMIA	HBB, 2-BP DEL, CC, CODONS 38-39	
141900	3043	HBB	0464	HEMOGLOBIN TSURUMAI	HBB, LYS82GLN	33940051
141900	3043	HBB	0465	HEMOGLOBIN J (EUROPA)	HBB, ALA62ASP	34151786
141900	3043	HBB	0466	HB AUBENAS	HBB, GLU26GLY	33915112
141900	3043	HBB	0467	HB CAMPERDOWN	HBB, ARG104SER	
141900	3043	HBB	0468	BETA-THALASSEMIA, DOMINANT	HBB, 3-BP INS, CGG, CODON 30	35348864
141900	3043	HBB	0469	HEMOGLOBIN COSTA RICA	HBB, HIS77ARG	33952543
141900	3043	HBB	0470	BETA-THALASSEMIA, ASHKENAZI JEWISH TYPE	HBB, 1-BP INS, CODON 20/21, FS	
141900	3043	HBB	0471	HB NIIGATA	HBB, VAL1LEU	33958358
141900	3043	HBB	0472	BETA-ZERO-THALASSEMIA	HBB, 5-BP DEL AND 1-BP INS	63751218
141900	3043	HBB	0473	HB GAMBARA	HBB, LYS82GLU	33940051
141900	3043	HBB	0474	BETA-ZERO-THALASSEMIA	HBB, IVS1AS, A-G, -2	
141900	3043	HBB	0475	BETA-ZERO-THALASSEMIA	HBB, 1-BP INS, T, CODON 26	35477349
141900	3043	HBB	0476	HEMOGLOBIN SILVER SPRINGS	HBB, GLN131HIS	34188626
141900	3043	HBB	0477	HEMOGLOBIN BURTON-UPON-TRENT HEMOGLOBIN OLD DOMINION	HBB, HIS143TYR	33929415
141900	3043	HBB	0478	HEMOGLOBIN RIO CLARO	HBB, VAL34MET	1141370
141900	3043	HBB	0479	HEMOGLOBIN NIJKERK	HBB, 4-BP DEL/1-BP INS, CODONS 138/139, GCTA/T	
141900	3043	HBB	0480	HEMOGLOBIN CHILE	HBB, LEU28MET	33958088
141900	3043	HBB	0481	HEMOGLOBIN TENDE	HBB, PRO124LEU	33983276
141900	3043	HBB	0482	HEMOGLOBIN LA ROCHE-SUR-YON	HBB, LEU81HIS	33936967
141900	3043	HBB	0483	HEMOGLOBIN IRAQ-HALABJA	HBB, ALA10VAL	33947457
141900	3043	HBB	0484	HEMOGLOBIN LUCKNOW	HBB, LYS8ARG	33932981
141900	3043	HBB	0485	HEMOGLOBIN SAGAMI	HBB, ASN139THR	34407387
141900	3043	HBB	0486	HEMOGLOBIN HARROW	HBB, PHE118CYS	33928092
141900	3043	HBB	0487	HEMOGLOBIN BRIE COMTE ROBERT	HBB, PRO36ALA	33948615
141900	3043	HBB	0488	HEMOGLOBIN BARBIZON	HBB, LYS144MET	33996892
141900	3043	HBB	0489	HEMOGLOBIN BOLOGNA-ST. ORSOLA	HBB, HIS146TYR	33961444
141900	3043	HBB	0490	HEMOGLOBIN VILA REAL	HBB, PRO36HIS	33993004
141900	3043	HBB	0491	HEMOGLOBIN SAALE	HBB, THR84ALA	35960772
141900	3043	HBB	0492	HEMOGLOBIN BUSHEY	HBB, PHE122LEU	33973589
141900	3043	HBB	0493	HEMOGLOBIN CASABLANCA	HBB, LYS65MET AND PHE122LEU	33973589
141900	3043	HBB	0494	HEMOGLOBIN TSUKUMI	HBB, HIS117TYR	33935527
141900	3043	HBB	0495	HEMOGLOBIN ERNZ	HBB, THR123ASN	33935383
141900	3043	HBB	0496	HEMOGLOBIN RENERT	HBB, VAL133ALA	35825479
141900	3043	HBB	0497	HEMOGLOBIN WATFORD	HBB, VAL1GLY	33949930
141900	3043	HBB	0498	HEMOGLOBIN YAOUNDE	HBB, VAL134ALA	33966761
141900	3043	HBB	0499	HEMOGLOBIN SITIA	HBB, ALA128VAL	33957286
141900	3043	HBB	0500	HEMOGLOBIN MONT SAINT-AIGNAN	HBB, ALA128PRO	34139813
141900	3043	HBB	0501	HEMOGLOBIN 'T LANGE LAND	HBB, GLY136ARG	33984863
141900	3043	HBB	0502	HEMOGLOBIN D (AGRI)	HBB, SER9TYR AND GLU121GLN	33918131
141900	3043	HBB	0503	HEMOGLOBIN ANTALYA	HBB, 9-BP DEL/INS	
141900	3043	HBB	0504	HEMOGLOBIN LIMASSOL	HBB, LYS8ASN	35198910
141900	3043	HBB	0505	THALASSEMIA INTERMEDIA	HBB, DEL, SOMATIC	34533941
141900	3043	HBB	0506	HEMOGLOBIN CANTERBURY	HBB, CYS112PHE	33932908
141900	3043	HBB	0507	HEMOGLOBIN O (TIBESTI)	HBB, GLU121LYS, VAL11ILE	33974228
141900	3043	HBB	0508	HEMOGLOBIN MOLFETTA	HBB, VAL126LEU	35658323
141900	3043	HBB	0509	BETA-THALASSEMIA, DOMINANT	HBB, 1-BP DEL	
141900	3043	HBB	0510	HEMOGLOBIN KODAIRA II	HBB, HIS146GLN	33985739
141900	3043	HBB	0511	HEMOGLOBIN ILMENAU	HBB, PHE41CYS	33926796
141900	3043	HBB	0512	HEMOGLOBIN AUBAGNE	HBB, GLY64ALA	33922018
141900	3043	HBB	0513	HEMOGLOBIN COLIMA	HBB, SER49CYS	33960931
141900	3043	HBB	0514	HEMOGLOBIN POCOS DE CALDAS	HBB, LYS61GLN	33995148
141900	3043	HBB	0515	HEMOGLOBIN TRENTO	HBB, 1-BP DEL, 144A	63751425
141900	3043	HBB	0516	HEMOGLOBIN SANTANDER	HBB, VAL34ASP	1135101
141900	3043	HBB	0517	HEMOGLOBIN BUZEN	HBB, ALA138THR	33919821
141900	3043	HBB	0518	HEMOGLOBIN SANTA CLARA	HBB, HIS97ASN	33950993
141900	3043	HBB	0519	HEMOGLOBIN SPARTA	HBB, PHE103VAL	33921589
141900	3043	HBB	0520	BETA-THALASSEMIA, DOMINANT INCLUSION BODY TYPE	HBB, INS/DEL, EX3	
141900	3043	HBB	0521	HEMOGLOBIN S (CAMEROON)	HBB, GLU6VAL AND GLU90LYS	334
141900	3043	HBB	0522	HEMOGLOBIN CARDARELLI	HBB, ALA86PRO	33952147
141900	3043	HBB	0523	HEMOGLOBIN JAMAICA PLAIN	HBB, GLU6VAL AND LEU68PHE	334
141900	3043	HBB	0524	HEMOGLOBIN ROCKFORD	HBB, LEU68PHE	33961459
141900	3043	HBB	0525	HEMOGLOBIN TRIPOLI	HBB, GLU26ALA	33915112
141900	3043	HBB	0526	HEMOGLOBIN TIZI-OUZOU	HBB, GLY29SER	33974277
141900	3043	HBB	0527	BETA-PLUS-THALASSEMIA	HBB, 3-UNT, T-A, +3	
141900	3043	HBB	0528	BETA-PLUS-THALASSEMIA	HBB, 2-BP INS, 25TA	
141900	3043	HBB	0529	BETA-PLUS-THALASSEMIA	HBB, 1-BP DEL, C	
141900	3043	HBB	0530	BETA-PLUS-THALASSEMIA	HBB, -101C-G	
141900	3043	HBB	0531	HEMOGLOBIN HOKUSETSU	HBB, ASP52GLY	33919924
141900	3043	HBB	0532	HEMOGLOBIN KOCHI	HBB, LEU141VAL, LYS144TER	33970699
141900	3043	HBB	0533	HEMOGLOBIN ZOETERWOUDE	HBB, VAL23ALA	33945546
141900	3043	HBB	0534	HEMOGLOBIN BREM-SUR-MER	HBB, SER9TYR	33918131
141900	3043	HBB	0535	HEMOGLOBIN GELDROP ST. ANNA	HBB, ASP94TYR	33959340
141900	3043	HBB	0536	HEMOGLOBIN MARINEO	HBB, ALA70VAL	33946401
141900	3043	HBB	0537	HEMOGLOBIN LA CORUNA	HBB, THR38ILE	
141900	3043	HBB	0538	HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN DELTA/BETA THALESSEMIA, INCLUDED	HBB, 106-KB DEL	
142000	3045	HBD	0001	HEMOGLOBIN A(2)-PRIME HEMOGLOBIN B(2)	HBD, GLY16ARG	34012192
142000	3045	HBD	0002	HEMOGLOBIN A(2) ADRIA	HBD, PRO51ARG	34489183
142000	3045	HBD	0003	HEMOGLOBIN A(2) BABINGA	HBD, GLY136ASP	35849348
142000	3045	HBD	0004	HEMOGLOBIN A(2) CANADA	HBD, ASP99ASN	35329985
142000	3045	HBD	0005	HEMOGLOBIN A(2) COBURG	HBD, ARG116HIS	34536353
142000	3045	HBD	0006	HEMOGLOBIN A(2) FITZROY	HBD, ALA142ASP	35848600
142000	3045	HBD	0007	HEMOGLOBIN A(2) FLATBUSH HEMOGLOBIN FLATBUSH (GEORGIA)	HBD, ALA22GLU	35395083
142000	3045	HBD	0008	HEMOGLOBIN A(2) HONAI	HBD, GLU90VAL	34420481
142000	3045	HBD	0009	HEMOGLOBIN A(2) INDONESIA	HBD, GLY69ARG	35913713
142000	3045	HBD	0010	HEMOGLOBIN A(2) MANZANARES	HBD, GLU121VAL	35790721
142000	3045	HBD	0011	HEMOGLOBIN A(2) MELBOURNE	HBD, GLU43LYS	35166721
142000	3045	HBD	0012	HEMOGLOBIN A(2) NYU HEMOGLOBIN NYU	HBD, ASN12LYS	34313675
142000	3045	HBD	0013	HEMOGLOBIN A(2) ROOSEVELT	HBD, VAL20GLU	34093840
142000	3045	HBD	0014	HEMOGLOBIN A(2) SPHAKIA	HBD, HIS2ARG	35433207
142000	3045	HBD	0015	HEMOGLOBIN A(2) VICTORIA	HBD, GLY24ASP	34460332
142000	3045	HBD	0016	HEMOGLOBIN A(2) WRENS	HBD, VAL98MET	28933076
142000	3045	HBD	0017	HEMOGLOBIN A(2) YOKOSHIMA	HBD, GLY25ASP	34389944
142000	3045	HBD	0018	HEMOGLOBIN A(2) ZAGREB	HBD, GLN125GLU	36078803
142000	3045	HBD	0019	HEMOGLOBIN LEPORE (BALTIMORE)	HBD50/HBB86 FUSION	41495351
142000	3045	HBD	0020	HEMOGLOBIN LEPORE (BOSTON) HEMOGLOBIN LEPORE (WASHINGTON);; HEMOGLOBIN LEPORE (AUGUSTA);; HEMOGLOBIN PYLOS	HBD87/HBB116 FUSION	
142000	3045	HBD	0021	HEMOGLOBIN LEPORE (HOLLANDIA)	HBD22/HBB50 FUSION	
142000	3045	HBD	0022	HEMOGLOBIN PARCHMAN	HBD1-12/HBB22-50/HBD87-146 FUSION	
142000	3045	HBD	0023	DELTA-ZERO-THALASSEMIA, KNOSSOS TYPE	HBD, 1-BP DEL, AAG59AG, FS60TER	34224604
142000	3045	HBD	0024	HEMOGLOBIN A(2) CORFU HEMOGLOBIN A(2) TROODOS	HBD, ARG116CYS	33971270
142000	3045	HBD	0025	HEMOGLOBIN A(2) PARKVILLE	HBD, ASP47VAL	34977235
142000	3045	HBD	0026	DELTA-THALASSEMIA	HBD, G-A, +69	35324967
142000	3045	HBD	0027	HEMOGLOBIN A(2) NIIGATA	HBD, VAL1ALA	34991152
142000	3045	HBD	0028	DELTA-THALASSEMIA HEMOGLOBIN A(2) YIALOUSA	HBD, ALA27SER	35152987
142000	3045	HBD	0029	DELTA-THALASSEMIA	HBD, ARG30THR	35654785
142000	3045	HBD	0030	DELTA-THALASSEMIA	HBD, T-C, -77	34975911
142000	3045	HBD	0031	HEMOGLOBIN A(2) PELENDRI	HBD, LEU141PRO	33956485
142000	3045	HBD	0032	DELTA-THALASSEMIA	HBD, IVS2AS, A-G, -2	
142000	3045	HBD	0033	DELTA-THALASSEMIA HEMOGLOBIN A(2) GROVETOWN	HBD, LEU75VAL	34430836
142000	3045	HBD	0034	HEMOGLOBIN A(2) PUGLIA	HBD, GLU26ASP	34289459
142000	3045	HBD	0035	DELTA-0-THALASSEMIA	HBD, TRP37TER	35887507
142000	3045	HBD	0036	HEMOGLOBIN A(2) SANT' ANTIOCO	HBD, CYS93GLY	28933077
142000	3045	HBD	0037	HEMOGLOBIN A(2) AGRINIO	HBD, GLU43GLY	36084266
142000	3045	HBD	0038	HEMOGLOBIN A(2) MONREALE	HBD, HIS146ARG	34149886
142000	3045	HBD	0039	HEMOGLOBIN A(2) METAPONTO	HBD, PRO37HIS	34383555
142000	3045	HBD	0040	HEMOGLOBIN A(2) CAMPANIA	HBD, ASN58LYS	35666685
142000	3045	HBD	0041	HEMOGLOBIN A(2) LUCANIA	HBD, LEU89VAL	34933313
142000	3045	HBD	0042	HEMOGLOBIN A(2) CAPRI	HBD, ARG105SER	34390965
142000	3045	HBD	0043	DELTA-THALASSEMIA	HBD, IVS2, T-A, +6	63750345
142000	3045	HBD	0044	DELTA-THALASSEMIA	HBD, -126A-T	35661168
142000	3045	HBD	0045	HEMOGLOBIN A(2) NINIVE	HBD, VAL133ALA	34802738
142000	3045	HBD	0046	DELTA-PLUS-THALASSEMIA	HBD, -31A-G	35518301
142200	3047	HBG1	0001	HBG1 POLYMORPHISM	HBG1, ILE75THR	1061234
142200	3047	HBG1	0002	HEMOGLOBIN F (BASKENT)	HBG1, ALA128THR	41330850
142200	3047	HBG1	0003	HEMOGLOBIN F (BEECH ISLAND)	HBG1, ALA53ASP	35746147
142200	3047	HBG1	0004	HEMOGLOBIN F (BONAIRE)	HBG1, GLN39ARG	35977759
142200	3047	HBG1	0005	HEMOGLOBIN F (CALLUNA)	HBG1, THR12ARG	33992775
142200	3047	HBG1	0006	HEMOGLOBIN F (COBB)	HBG1, TRP37GLY	35700518
142200	3047	HBG1	0007	HEMOGLOBIN F (DAMMAM)	HBG1, ASP79ASN	34435255
142200	3047	HBG1	0008	HEMOGLOBIN F (DICKINSON)	HBG1, HIS97ARG	34127117
142200	3047	HBG1	0009	HEMOGLOBIN F (FOREST PARK)	HBG1, ASP73ASN	33965337
142200	3047	HBG1	0010	HEMOGLOBIN F (FUKUYAMA)	HBG1, ASP43ASN	41475844
142200	3047	HBG1	0011	HEMOGLOBIN F (IWATA)	HBG1, GLY72ARG	34049890
142200	3047	HBG1	0012	HEMOGLOBIN F (IZUMI)	HBG1, GLU6GLY	34432567
142200	3047	HBG1	0013	HEMOGLOBIN F (JAMAICA)	HBG1, LYS61GLU	34747494
142200	3047	HBG1	0014	HEMOGLOBIN F (KOTOBUKI)	HBG1, GLU6GLY	34263826
142200	3047	HBG1	0015	HEMOGLOBIN F (KUALA LUMPUR)	HBG1, ASP22GLY	33970907
142200	3047	HBG1	0016	HEMOGLOBIN F (PENDERGRASS)	HBG1, PRO36ARG	41404150
142200	3047	HBG1	0017	HEMOGLOBIN F (PORDENONE)	HBG1, GLU6GLN	33924825
142200	3047	HBG1	0018	HEMOGLOBIN F (SARDINIA)	HBG1, ILE75THR	1061234
142200	3047	HBG1	0019	HEMOGLOBIN F (SIENA) HEMOGLOBIN F (HULL)	HBG1, GLU121LYS	34647752
142200	3047	HBG1	0020	HEMOGLOBIN F (TEXAS I)	HBG1, GLU5LYS	34427034
142200	3047	HBG1	0021	HEMOGLOBIN F (VICTORIA JUBILEE)	HBG1, ASP80TYR	33947112
142200	3047	HBG1	0022	HEMOGLOBIN F (XINJIANG)	HBG1, GLY25ARG	35957832
142200	3047	HBG1	0023	HEMOGLOBIN F (XIN-SU)	HBG1, ASP73HIS	33965337
142200	3047	HBG1	0024	HEMOGLOBIN F (YAMAGUCHI)	HBG1, ASP80ASN	33947112
142200	3047	HBG1	0025	HEMOGLOBIN KENYA	HBG1, 1-81/HBD, 86-146	
142200	3047	HBG1	0026	HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN SARDINIAN HPFH;; GREEK HPFH	HBG1, G-A, -117	35378915
142200	3047	HBG1	0027	HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN	HBG1, C-T, -196	35983258
142200	3047	HBG1	0028	HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN BRITISH HPFH	HBG1, T-C, -198	35710727
142200	3047	HBG1	0029	HEMOGLOBIN F (JIANGSU)	HBG1, VAL134MET	35849660
142200	3047	HBG1	0030	HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN	HBG1, C-G, -195	35321913
142200	3047	HBG1	0031	HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN	HBG1, C-T, -114	34809449
142200	3047	HBG1	0032	HEMOGLOBIN F (CHARLOTTE)	HBG1, ILE75THR AND ALA136GLY	56205611
142200	3047	HBG1	0033	HEMOGLOBIN F (WOODSTOCK)	HBG1, ARG40LYS	33974602
142200	3047	HBG1	0034	FETAL HEMOGLOBIN, A-GAMMA TYPE, REDUCTION IN	HBG1, 4-BP DEL, -222 TO -225	
142200	3047	HBG1	0035	HEMOGLOBIN F (MACEDONIA-I)	HBG1, HIS2GLN	35315638
142200	3047	HBG1	0036	HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN	HBG1, C-T, -158	
142200	3047	HBG1	0037	HEMOGLOBIN F (PORTO TORRES)	HBG1, ALA136SER, ILE75THR	1061234
142250	3048	HBG2	0001	HEMOGLOBIN F (ALBAICIN)	HBG2, LYS8GLX	35521813
142250	3048	HBG2	0002	HEMOGLOBIN F (AUCKLAND)	HBG2, ASP7ASN	34501593
142250	3048	HBG2	0003	HEMOGLOBIN F (CALTECH)	HBG2, LYS120GLN	34703519
142250	3048	HBG2	0004	HEMOGLOBIN F (CARLTON)	HBG2, GLU121LYS	34647752
142250	3048	HBG2	0005	HEMOGLOBIN F (CLARKE)	HBG2, LYS65ASN	34019507
142250	3048	HBG2	0006	HEMOGLOBIN F (COLUMBUS-GA)	HBG2, ASP94ASN	35812514
142250	3048	HBG2	0007	HEMOGLOBIN F (FUCHU)	HBG2, GLU21GLN	33955330
142250	3048	HBG2	0009	HEMOGLOBIN F (KENNESTONE)	HBG2, HIS77ARG	34150306
142250	3048	HBG2	0010	HEMOGLOBIN F (KINGSTON)	HBG2, MET55ARG	34915311
142250	3048	HBG2	0011	HEMOGLOBIN F (LA GRANGE)	HBG2, GLU101LYS	34876238
142250	3048	HBG2	0012	HEMOGLOBIN F (LODZ)	HBG2, SER44ARG	34017450
142250	3048	HBG2	0013	HEMOGLOBIN F (MALAYSIA)	HBG2, GLY1CYS	36006195
142250	3048	HBG2	0014	HEMOGLOBIN F (MALTA)	HBG2, HIS117ARG	36049074
142250	3048	HBG2	0015	HEMOGLOBIN F (MARIETTA)	HBG2, ASP80ASN	33947112
142250	3048	HBG2	0016	HEMOGLOBIN F (MEINOHAMA)	HBG2, GLU5GLY	34263826
142250	3048	HBG2	0017	HEMOGLOBIN F (MELBOURNE)	HBG2, GLY16ARG	34907654
142250	3048	HBG2	0018	HEMOGLOBIN F (MINOO)	HBG2, GLY72ARG	34049890
142250	3048	HBG2	0019	HEMOGLOBIN F (OAKLAND)	HBG2, GLU26LYS	35654328
142250	3048	HBG2	0020	HEMOGLOBIN F (POOLE)	HBG2, TRP130GLY	35826780
142250	3048	HBG2	0021	HEMOGLOBIN F (PORT ROYAL)	HBG2, GLU125ALA	34997902
142250	3048	HBG2	0022	HEMOGLOBIN F (SHANGHAI)	HBG2, LYS66ARG	35481866
142250	3048	HBG2	0023	HEMOGLOBIN F (TOKYO)	HBG2, VAL34ILE	35885783
142250	3048	HBG2	0024	HEMOGLOBIN F (URUMQI)	HBG2, ASP22GLY	33970907
142250	3048	HBG2	0025	CYANOSIS, TRANSIENT NEONATAL	HBG2, HIS63TYR	34474104
142250	3048	HBG2	0026	HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN	HBG2, C-G, -202	35617911
142250	3048	HBG2	0027	HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN	HBG2, T-C, -175	63750654
142250	3048	HBG2	0028	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	HBG2, C-T, -158	7482144
142250	3048	HBG2	0029	HEMOGLOBIN F (GRANADA)	HBG2, ASP22VAL	33970907
142250	3048	HBG2	0030	HEMOGLOBIN F (AUSTELL)	HBG2, ARG40LYS	33974602
142250	3048	HBG2	0031	HEMOGLOBIN F (BROOKLYN)	HBG2, LYS66GLN	34264694
142250	3048	HBG2	0032	HEMOGLOBIN F (ONODA)	HBG2, HIS146TYR	34807671
142250	3048	HBG2	0034	CYANOSIS, TRANSIENT NEONATEL	HBG2, HIS92TYR	35103459
142250	3048	HBG2	0035	HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN	HBG2, C-T, -114	34809449
142250	3048	HBG2	0036	HEMOGLOBIN F (CATALONIA)	HBG2, TRP15ARG	34438981
142250	3048	HBG2	0037	HEMOGLOBIN F (COSENZA)	HBG2, GLY25GLU	35687396
142250	3048	HBG2	0038	HEMOGLOBIN F (SACROMONTE)	HBG2, LYS59GLN	28933078
142250	3048	HBG2	0039	HEMOGLOBIN F (WAYNESBORO)	HBG2, ILE75THR	1061234
142250	3048	HBG2	0040	HEMOGLOBIN F (MACEDONIA II)	HBG2, LYS104ASN	35717854
142250	3048	HBG2	0041	CYANOSIS, TRANSIENT NEONATAL	HBG2, PHE41SER	34878913
142250	3048	HBG2	0042	HEMOGLOBIN F (EMIRATES)	HBG2, LYS59GLU	28933078
142250	3048	HBG2	0043	HEMOGLOBIN F (SACROMONTE)	HBG2, LYS59GLN	
142250	3048	HBG2	0044	HEMOGLOBIN F (VELETA)	HBG2, ARG40GLY	34532478
142250	3048	HBG2	0045	HEMOGLOBIN F (LESVOS)	HBG2, ILE75THR	
142250	3048	HBG2	0046	HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN	HBG2, C-A, -114	34809449
142250	3048	HBG2	0047	HEMOGLOBIN F (CALABRIA)	HBG2, PHE118LEU	35020253
142250	3048	HBG2	0048	HEMOGLOBIN F (CLAMART)	HBG2, LYS17ASN	35621390
142250	3048	HBG2	0049	HEMOGLOBIN F (OULED RABAH)	HBG2, ASN19LYS	34018799
142250	3048	HBG2	0050	CYANOSIS, TRANSIENT NEONATAL	HBG2, HIS63LEU	
142250	3048	HBG2	0051	CYANOSIS, TRANSIENT NEONATAL	HBG2, VAL67MET	
142250	3048	HBG2	0052	HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN	HBG2, T-G, -567	
142360	3053	SERPIND1	0001	HEPARIN COFACTOR II DEFICIENCY	HCF2, ARG189HIS	5907
142360	3053	SERPIND1	0002	HEPARIN COFACTOR II DEFICIENCY	HCF2, 1-BP INS, T, EXON 2	
142360	3053	SERPIND1	0003	THROMBOPHILIA DUE TO HEPARIN COFACTOR II DEFICIENCY	HCF2, 2-BP DEL, 12896TT	
142360	3053	SERPIND1	0004	THROMBOPHILIA DUE TO HEPARIN COFACTOR II DEFICIENCY	HCF2, PRO443LEU	121912420
142409	3082	HGF	0001	DEAFNESS, AUTOSOMAL RECESSIVE 39	HGF, SER165SER	137853235
142409	3082	HGF	0002	DEAFNESS, AUTOSOMAL RECESSIVE 39	HGF, 3-BP DEL, 1986TGA	
142409	3082	HGF	0003	DEAFNESS, AUTOSOMAL RECESSIVE 39	HGF, 10-BP DEL, NT482+1991	
142410	6927	HNF1A	0001	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3 HEPATIC ADENOMA, SOMATIC, INCLUDED;; RENAL CELL CARCINOMA, CLEAR CELL, INCLUDED;; DIABETES MELLITUS, INSULIN-DEPENDENT, 20, INCLUDED	HNF1A, 1-BP INS, 872C	
142410	6927	HNF1A	0002	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3	HNF1A, PRO447LEU	137853236
142410	6927	HNF1A	0003	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3	HNF1A, 1-BP DEL	
142410	6927	HNF1A	0004	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3	HNF1A, TYR122CYS	137853237
142410	6927	HNF1A	0005	DIABETES MELLITUS, INSULIN-DEPENDENT, 20	HNF1A, ARG272HIS	137853238
142410	6927	HNF1A	0006	DIABETES MELLITUS, INSULIN-DEPENDENT, 20	HNF1A, ARG583GLY	137853239
142410	6927	HNF1A	0007	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3	HNF1A, A-C, -58	
142410	6927	HNF1A	0008	DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO	HNF1A, GLY319SER	137853240
142410	6927	HNF1A	0009	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3	HNF1A, THR620ILE	137853241
142410	6927	HNF1A	0010	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3	HNF1A, 1-BP DEL, -119G	
142410	6927	HNF1A	0011	INSULIN RESISTANCE, SUSCEPTIBILITY TO SERUM HDL CHOLESTEROL LEVEL, MODIFIER OF, INCLUDED	HNF1A, ILE27LEU	1169288
142410	6927	HNF1A	0012	DIABETES MELLITUS, INSULIN-DEPENDENT, 20	HNF1A, 1-BP DEL, 142G	
142410	6927	HNF1A	0013	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3	HNF1A, GLY574SER	1169305
142410	6927	HNF1A	0014	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3	HNF1A, ARG583GLN	137853242
142410	6927	HNF1A	0015	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3	HNF1A, PRO112LEU	137853243
142410	6927	HNF1A	0016	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3	HNF1A, ARG131TRP	137853244
142410	6927	HNF1A	0017	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3	HNF1A, 4-BP DEL	
142410	6927	HNF1A	0018	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3	HNF1A, IVS3, G-A, -1	
142410	6927	HNF1A	0019	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3	HNF1A, ALA276ASP	137853245
142410	6927	HNF1A	0020	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3	HNF1A, 2-BP DEL, AG	
142410	6927	HNF1A	0021	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3	HNF1A, SER531THR	137853246
142410	6927	HNF1A	0022	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3 RENAL CELL CARCINOMA, CLEAR CELL, INCLUDED;; RENAL CELL CARCINOMA, CHROMOPHOBE, INCLUDED	HNF1A, GLY92ASP	137853247
142461	3339	HSPG2	0001	SCHWARTZ-JAMPEL SYNDROME, TYPE 1	HSPG2, IVS64DS, A-G, +4	
142461	3339	HSPG2	0002	SCHWARTZ-JAMPEL SYNDROME, TYPE 1	HSPG2, CYS1532TYR	137853248
142461	3339	HSPG2	0003	DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE	HSPG2, 89-BP DUP, EX34	
142461	3339	HSPG2	0004	DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE	HSPG2, 7086G-A, +5	
142461	3339	HSPG2	0005	DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE	HSPG2, 10328C-T	
142461	3339	HSPG2	0006	SCHWARTZ-JAMPEL SYNDROME, TYPE 1	HSPG2, IVS56DS, A-G, +4	
142461	3339	HSPG2	0007	SCHWARTZ-JAMPEL SYNDROME, TYPE 1	HSPG2, EX60/61 FUS	
142461	3339	HSPG2	0008	SCHWARTZ-JAMPEL SYNDROME, TYPE 1	HSPG2, 8544G-A	
142461	3339	HSPG2	0009	SCHWARTZ-JAMPEL SYNDROME, TYPE 1	HSPG2, 9-BP DEL	
142461	3339	HSPG2	0010	SCHWARTZ-JAMPEL SYNDROME, TYPE 1	HSPG2, 7,108-BP DEL	
142600	3098	HK1	0001	HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO HEXOKINASE DEFICIENCY	HK1, 96-BP DEL	
142600	3098	HK1	0002	HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO HEXOKINASE DEFICIENCY	HK1, LEU529SER	137853249
142600	3098	HK1	0003	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE	HK1, -3818-195G-C, AltT2 EXON	
142640	3273	HRG	0001	THROMBOPHILIA DUE TO HISTIDINE-RICH GLYCOPROTEIN DEFICIENCY	HRG, GLY85GLU	121918122
142702	3347	HTN3	0001	HIS2*1/HIS2*2 POLYMORPHISM	HTN3, TYR28TER AND ARG22GLN	
142704	3067	HDC	0001	GILLES DE LA TOURETTE SYNDROME	HDC, TRP317TER	
142800	3105	HLA-A	0001	HYPERSENSITIVITY SYNDROME, CARBAMAZEPINE-INDUCED, SUSCEPTIBILITY TO	HLA-A, HLA-A*3101	
142810	3035	HARS	0001	USHER SYNDROME, TYPE IIIB	HARS, TYR454SER	
142810	3035	HARS	0002	VARIANT OF UNKNOWN SIGNIFICANCE	HARS, ARG137GLN	
142830	3106	HLA-B	0001	ANKYLOSING SPONDYLITIS, SUSCEPTIBILITY TO, 1 SYNOVITIS, CHRONIC, SUSCEPTIBILITY TO, INCLUDED	HLA-B, HLA-B27	
142830	3106	HLA-B	0002	SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO STEVENS-JOHNSON SYNDROME, SUSCEPTIBILITY TO, INCLUDED;; TOXIC EPIDERMAL NECROLYSIS, SUSCEPTIBILITY TO, INCLUDED	HLA-B, HLA-B*1502	
142830	3106	HLA-B	0003	ABACAVIR HYPERSENSITIVITY, SUSCEPTIBILITY TO DRUG-INDUCED LIVER INJURY DUE TO FLUCLOXACILLIN, INCLUDED	HLA-B, HLA-B*5701	
142830	3106	HLA-B	0004	SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO STEVENS-JOHNSON SYNDROME, SUSCEPTIBILITY TO, INCLUDED;; TOXIC EPIDERMAL NECROLYSIS, SUSCEPTIBILITY TO, INCLUDED	HLA-B, HLA-B*5801	
142840	3107	HLA-C	0001	PSORIASIS SUSCEPTIBILITY 1	HLA-C, HLA-Cw6	
142840	3107	HLA-C	0002	HIV-1 VIREMIA, SUSCEPTIBILITY TO	HLA-C, -35C-T	
142857	3123	HLA-DRB1	0001	SARCOIDOSIS, SUSCEPTIBILITY TO, 1	HLA-DRB1, HLA-DRB1*1101	
142857	3123	HLA-DRB1	0002	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 1	HLA-DRB1, DRB1*1501	
142858	3115	HLA-DPB1	0001	BERYLLIUM DISEASE, CHRONIC, SUSCEPTIBILITY TO	HLA-DPB1, LYS69GLU	
142910	3156	HMGCR	0001	STATINS, ATTENUATED CHOLESTEROL LOWERING BY	HMGCR, HAPLOTYPE, HAP7	
142910	3156	HMGCR	0002	LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 3	HMGCR, 300A-T	
142955	3198	HOXA1	0001	BOSLEY-SALIH-ALORAINY SYNDROME	HOXA1, 1-BP INS, 175G	
142955	3198	HOXA1	0002	BOSLEY-SALIH-ALORAINY SYNDROME	HOXA1, TYR28TER	104894017
142955	3198	HOXA1	0003	ATHABASKAN BRAINSTEM DYSGENESIS SYNDROME	HOXA1, ARG26TER	104894018
142955	3198	HOXA1	0004	BOSLEY-SALIH-ALORAINY SYNDROME	HOXA1, 1-BP DEL, 185G	
142958	3207	HOXA11	0001	RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA	HOXA11, 1-BP DEL	
142959	3209	HOXA13	0001	HAND-FOOT-GENITAL SYNDROME	HOXA13, TRP369TER	104894019
142959	3209	HOXA13	0002	HAND-FOOT-GENITAL SYNDROME	HOXA13, 407A-C	
142959	3209	HOXA13	0003	HAND-FOOT-GENITAL SYNDROME	HOXA13, 24-BP INS, 8-ALA EXP	
142959	3209	HOXA13	0004	HAND-FOOT-GENITAL SYNDROME	HOXA13, ASN51HIS	121912542
142959	3209	HOXA13	0005	GUTTMACHER SYNDROME	HOXA13, GLN50LEU, 2-BP DEL, -79GC	
142959	3209	HOXA13	0006	HAND-FOOT-GENITAL SYNDROME	HOXA13, 18-BP INS, 6-ALA EXP	
142959	3209	HOXA13	0007	HAND-FOOT-GENITAL SYNDROME	HOXA13, 27-BP INS, 9-ALA EXP	
142959	3209	HOXA13	0008	HAND-FOOT-GENITAL SYNDROME	HOXA13, 42-BP INS, 14-ALA EXP	193922947
142968	3211	HOXB1	0001	FACIAL PARESIS, HEREDITARY CONGENITAL, 3	HOXB1, ARG207CYS	
142976	3229	HOXC13	0001	ECTODERMAL DYSPLASIA 9, HAIR/NAIL TYPE	HOXC13, TYR130TER	
142976	3229	HOXC13	0002	ECTODERMAL DYSPLASIA 9, HAIR/NAIL TYPE	HOXC13, 27.6-KB DEL	
142976	3229	HOXC13	0003	ECTODERMAL DYSPLASIA 9, HAIR/NAIL TYPE	HOXC13, 1-BP DEL, 355C	
142981	3233	HOXD4	0001	LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO	HOXD4, GLU81VAL	104893636
142983	4487	MSX1	0001	TOOTH AGENESIS, SELECTIVE, 1	MSX1, ARG31PRO	121913129
142983	4487	MSX1	0002	TOOTH AGENESIS, SELECTIVE, WITH OR WITHOUT OROFACIAL CLEFT	MSX1, SER105TER	104893852
142983	4487	MSX1	0003	WITKOP SYNDROME	MSX1, SER202TER	104893853
142983	4487	MSX1	0004	OROFACIAL CLEFT 5	MSX1, GLU78VAL	28928890
142983	4487	MSX1	0005	OROFACIAL CLEFT 5	MSX1, GLY116GLU	28933081
142983	4487	MSX1	0006	TOOTH AGENESIS, SELECTIVE, 1	MSX1, GLN187TER	104893850
142983	4487	MSX1	0007	OROFACIAL CLEFT 5	MSX1, PRO147GLN	104893854
142983	4487	MSX1	0008	TOOTH AGENESIS, SELECTIVE, 1	MSX1, MET6LYS	121913130
142983	4487	MSX1	0009	TOOTH AGENESIS, SELECTIVE, 1	MSX1, 1-BP DUP, 62G	
142984	3236	HOXD10	0001	VERTICAL TALUS, CONGENITAL CHARCOT-MARIE-TOOTH DISEASE, FOOT DEFORMITY OF, INCLUDED	HOXD10, MET319LYS	104893634
142989	3239	HOXD13	0001	SYNPOLYDACTYLY 1	HOXD13, 27-BP DUP	193922939
142989	3239	HOXD13	0002	SYNPOLYDACTYLY WITH FOOT ANOMALIES	HOXD13, 14-BP DEL, NT323	
142989	3239	HOXD13	0003	SYNPOLYDACTYLY WITH FOOT ANOMALIES	HOXD13, 1-BP DEL, 834G	
142989	3239	HOXD13	0004	BRACHYDACTYLY, TYPE E BRACHYDACTYLY, TYPE D, INCLUDED	HOXD13, ILE314LEU	28928891
142989	3239	HOXD13	0005	BRACHYDACTYLY, TYPE E BRACHYDACTYLY, TYPE D, INCLUDED	HOXD13, SER308CYS	28928892
142989	3239	HOXD13	0006	SYNPOLYDACTYLY WITH FOOT ANOMALIES	HOXD13, IVS1AS, 1-BP DEL, A, -2	
142989	3239	HOXD13	0007	SYNPOLYDACTYLY 1	HOXD13, ARG298TRP	28933082
142989	3239	HOXD13	0008	SYNDACTYLY, TYPE V	HOXD13, 21-BP DUP	
142989	3239	HOXD13	0009	SYNDACTYLY, TYPE V	HOXD13, GLN317ARG	104893635
142989	3239	HOXD13	0010	BRACHYDACTYLY-SYNDACTYLY SYNDROME	HOXD13, 21-BP DEL	
142989	3239	HOXD13	0011	SYNPOLYDACTYLY 1	HOXD13, GLY220VAL	121912541
142989	3239	HOXD13	0012	VACTERL ASSOCIATION	HOXD13, 21-BP DEL, NT163	
142992	3166	HMX1	0001	OCULOAURICULAR SYNDROME	HMX1, 26-BP DEL, NT215	
142993	338917	VSX2	0001	MICROPHTHALMIA, CATARACTS, AND IRIS ABNORMALITIES	CHX10, ARG200GLN	121912543
142993	338917	VSX2	0002	MICROPHTHALMIA, CATARACTS, AND IRIS ABNORMALITIES MICROPHTHALMIA, ISOLATED 2, INCLUDED	CHX10, ARG200PRO	
142993	338917	VSX2	0003	MICROPHTHALMIA, ISOLATED 2	CHX10, ARG227TRP	121912545
142993	338917	VSX2	0004	MICROPHTHALMIA, ISOLATED 2	CHX10, 4-KB DEL, EXON 3	
142993	338917	VSX2	0005	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 3	CHX10, IVS1, G-A, -1	
142994	3110	MNX1	0001	CURRARINO SYNDROME	MNX1, 1-BP DEL, 652A	
142994	3110	MNX1	0002	CURRARINO SYNDROME	MNX1, GLU261TER	121912546
142994	3110	MNX1	0003	CURRARINO SYNDROME	MNX1, 1-BP DEL, 414C	
142994	3110	MNX1	0004	CURRARINO SYNDROME	MNX1, TYR166TER	121912547
142994	3110	MNX1	0005	CURRARINO SYNDROME	MNX1, 1-BP INS, 125C	
142994	3110	MNX1	0006	CURRARINO SYNDROME	MNX1, IVS2, A-G, -2	
142994	3110	MNX1	0007	CURRARINO SYNDROME	MNX1, IVS2, G-A, +1	
142994	3110	MNX1	0008	CURRARINO SYNDROME	MNX1, THR248SER	121912548
142994	3110	MNX1	0009	CURRARINO SYNDROME	MNX1, 24-BP DEL/2-BP INS, NT577	
142994	3110	MNX1	0010	CURRARINO SYNDROME	MNX1, GLU283TER	121912549
143450	3032	HADHB	0001	TRIFUNCTIONAL PROTEIN DEFICIENCY	HADHB, ASP263GLY	121913131
143450	3032	HADHB	0002	TRIFUNCTIONAL PROTEIN DEFICIENCY	HADHB, ARG61HIS	121913132
143450	3032	HADHB	0003	TRIFUNCTIONAL PROTEIN DEFICIENCY	HADHB, ARG247HIS	121913133
143450	3032	HADHB	0004	TRIFUNCTIONAL PROTEIN DEFICIENCY	HADHB, ARG411LYS	121913134
143450	3032	HADHB	0005	TRIFUNCTIONAL PROTEIN DEFICIENCY	HADHB, 1-BP INS, 36-BP DEL	
143450	3032	HADHB	0006	TRIFUNCTIONAL PROTEIN DEFICIENCY	HADHB, VAL422GLY	
146661	3575	IL7R	0001	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	IL7R, THR66ILE	1494558
146661	3575	IL7R	0002	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	IL7R, ILE138VAL	1494555
146661	3575	IL7R	0003	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	IL7R, IVS4, G-A, -1	
146661	3575	IL7R	0004	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	IL7R, TRP217TER	104893893
146661	3575	IL7R	0005	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	IL7R, PRO132SER	104893894
146690	3614	IMPDH1	0001	RETINITIS PIGMENTOSA 10	IMPDH1, ASP226ASN	121912550
146690	3614	IMPDH1	0002	RETINITIS PIGMENTOSA 10	IMPDH1, VAL268ILE	121912551
146690	3614	IMPDH1	0003	RETINITIS PIGMENTOSA 10	IMPDH1, ARG224PRO	121912552
146690	3614	IMPDH1	0004	LEBER CONGENITAL AMAUROSIS 11	IMPDH1, ARG105TRP	121912553
146690	3614	IMPDH1	0005	LEBER CONGENITAL AMAUROSIS 11	IMPDH1, ASN198LYS	121912554
146691	3615	IMPDH2	0001	IMPDH2 ENZYME ACTIVITY, VARIATION IN	IMPDH2, LEU263PHE	121434586
146738	3640	INSL3	0001	CRYPTORCHIDISM	INSL3, ASN86LYS	121912555
146738	3640	INSL3	0002	CRYPTORCHIDISM	INSL3, PRO69LEU	104894697
146738	3640	INSL3	0003	CRYPTORCHIDISM	INSL3, ARG102CYS	104894698
146738	3640	INSL3	0004	CRYPTORCHIDISM	INSL3, ARG102HIS	121912556
146738	3640	INSL3	0005	CRYPTORCHIDISM	INSL3, ARG49TER	
146740	2214	FCGR3A	0002	VIRAL INFECTIONS, RECURRENT, SUSCEPTIBILITY TO	FCGR3A, LEU48HIS	10127939
146760	2209	FCGR1A	0001	IgG RECEPTOR I, PHAGOCYTIC, FAMILIAL DEFICIENCY OF CD64 DEFICIENCY, FAMILIAL	FCGR1A, ARG92TER	74315310
146770	3543	IGLL1	0001	AGAMMAGLOBULINEMIA 2, AUTOSOMAL RECESSIVE (1 family)	IGLL1, GLN22TER	74315491
146770	3543	IGLL1	0002	AGAMMAGLOBULINEMIA 2, AUTOSOMAL RECESSIVE (1 family)	IGLL1, PRO142LEU	1064422
146790	2212	FCGR2A	0001	LUPUS NEPHRITIS, SUSCEPTIBILITY TO PSEUDOMONAS AERUGINOSA, SUSCEPTIBILITY TO CHRONIC INFECTION BY, IN CYSTIC FIBROSIS, INCLUDED	FCGR2A, ARG131HIS	1801274
146920	103	ADAR	0001	DYSCHROMATOSIS SYMMETRICA HEREDITARIA	ADAR, ARG474TER	121912421
146920	103	ADAR	0002	DYSCHROMATOSIS SYMMETRICA HEREDITARIA	ADAR, LEU923PRO	28936680
146920	103	ADAR	0003	DYSCHROMATOSIS SYMMETRICA HEREDITARIA	ADAR, LYS952TER	121912422
146920	103	ADAR	0004	DYSCHROMATOSIS SYMMETRICA HEREDITARIA	ADAR, PHE1165SER	28936681
146920	103	ADAR	0005	DYSCHROMATOSIS SYMMETRICA HEREDITARIA	ADAR, GLN693TER	121912423
146920	103	ADAR	0006	DYSCHROMATOSIS SYMMETRICA HEREDITARIA	ADAR, 2-BP DEL, 941CT	
146920	103	ADAR	0007	AICARDI-GOUTIERES SYNDROME 6	ADAR, PRO193ALA	
146920	103	ADAR	0008	AICARDI-GOUTIERES SYNDROME 6	ADAR, ARG892HIS	
146920	103	ADAR	0009	AICARDI-GOUTIERES SYNDROME 6	ADAR, ALA870THR	
146920	103	ADAR	0010	AICARDI-GOUTIERES SYNDROME 6	ADAR, ASP1113HIS	
146920	103	ADAR	0011	DYSCHROMATOSIS SYMMETRICA HEREDITARIA AICARDI-GOUTIERES SYNDROME 6, INCLUDED	ADAR, GLY1007ARG	
146920	103	ADAR	0012	AICARDI-GOUTIERES SYNDROME 6	ADAR, TYR1112PHE	
146920	103	ADAR	0013	AICARDI-GOUTIERES SYNDROME 6	ADAR, LYS999ASN	
146920	103	ADAR	0014	AICARDI-GOUTIERES SYNDROME 6	ADAR, ILE872THR	
146920	103	ADAR	0015	AICARDI-GOUTIERES SYNDROME 6	ADAR, 5-BP DEL, NT1076	
146929	3577	CXCR1	0001	ACQUIRED IMMUNODEFICIENCY SYNDROME, SLOW PROGRESSION TO	IL8RA, HAPLOTYPE Ha	16858811
146933	3587	IL10RA	0001	INFLAMMATORY BOWEL DISEASE 28	IL10RA, GLY141ARG	137853579
146933	3587	IL10RA	0002	INFLAMMATORY BOWEL DISEASE 28	IL10RA, THR84ILE	137853580
146933	3587	IL10RA	0003	INFLAMMATORY BOWEL DISEASE 28	IL10RA, ARG262CYS	
146933	3587	IL10RA	0004	INFLAMMATORY BOWEL DISEASE 28	IL10RA, THR84ILE	
146933	3587	IL10RA	0005	INFLAMMATORY BOWEL DISEASE 28	IL10RA, ARG101TRP	
147020	3507	IGHM	0001	AGAMMAGLOBULINEMIA 1	IGHM, 75-KB DEL	
147020	3507	IGHM	0002	AGAMMAGLOBULINEMIA 1	IGHM, IVS4AS, G-A, -1	
147020	3507	IGHM	0003	AGAMMAGLOBULINEMIA 1	IGHM, CYS412GLY	
147020	3507	IGHM	0004	AGAMMAGLOBULINEMIA 1	IGHM, 2-BP DEL, AA	
147020	3507	IGHM	0005	AGAMMAGLOBULINEMIA 1	IGHM, TRP258TER	
147110	3501	IGHG2	0001	IgG2 DEFICIENCY, SELECTIVE	IGHG2, 1793G INS	
147138	2206	MS4A2	0001	ATOPIC ASTHMA, SUSCEPTIBILITY TO	MS4A2, GLU237GLY	569108
147183	3516	RBPJ	0001	ADAMS-OLIVER SYNDROME 3	RBPJ, GLU63GLY	
147183	3516	RBPJ	0002	ADAMS-OLIVER SYNDROME 3	RBPJ, LYS169GLU	
147200	3514	IGKC	0001	IMMUNOGLOBULIN KAPPA LIGHT CHAIN POLYMORPHISM Inv1	IGKC, LEU191/VAL153	
147200	3514	IGKC	0002	IMMUNOGLOBULIN KAPPA LIGHT CHAIN POLYMORPHISM Inv2	IGKC, ALA153/LEU191	
147200	3514	IGKC	0003	IMMUNOGLOBULIN KAPPA LIGHT CHAIN POLYMORPHISM Inv3	IGKC, VAL191/ALA153	
147200	3514	IGKC	0004	IMMUNOGLOBULIN KAPPA LIGHT CHAIN DEFICIENCY	IGKC, TRP148ARG	
147200	3514	IGKC	0005	IMMUNOGLOBULIN KAPPA LIGHT CHAIN DEFICIENCY	IGKC, CYS194GLY	
147245	974	CD79B	0001	AGAMMAGLOBULINEMIA 6	CD79B, GLY137SER	121912424
147245	974	CD79B	0002	AGAMMAGLOBULINEMIA 6	CD79B, GLN80TER	
147265	3708	ITPR1	0001	SPINOCEREBELLAR ATAXIA 15	ITPR1, EX1-48DEL	
147265	3708	ITPR1	0002	SPINOCEREBELLAR ATAXIA 15	ITPR1, PRO1059LEU	121912425
147265	3708	ITPR1	0003	SPINOCEREBELLAR ATAXIA 29	ITPR1, VAL1553MET	
147265	3708	ITPR1	0004	SPINOCEREBELLAR ATAXIA 29	ITPR1, ASN602ASP	
147270	3697	ITIH1	0001	INTER-ALPHA-TRYPSIN INHIBITOR, HEAVY CHAIN 1 POLYMORPHISM	ITIH1, GLU551 AND GLN561	
147270	3697	ITIH1	0002	INTER-ALPHA-TRYPSIN INHIBITOR, HEAVY CHAIN 1 POLYMORPHISM	ITIH1, VAL551 AND ARG561	
147270	3697	ITIH1	0003	INTER-ALPHA-TRYPSIN INHIBITOR, HEAVY CHAIN 1 POLYMORPHISM	ITIH1, GLU551 AND ARG561	
147280	3482	IGF2R	0001	HEPATOCELLULAR CARCINOMA, SOMATIC	IGF2R, GLY1449VAL	121434587
147280	3482	IGF2R	0002	HEPATOCELLULAR CARCINOMA, SOMATIC	IGF2R, GLY1464GLU	121434588
147370	3480	IGF1R	0001	INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO	IGF1R, ARG108GLN	121912426
147370	3480	IGF1R	0002	INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO	IGF1R, LYS115ASN	121912427
147370	3480	IGF1R	0003	INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO	IGF1R, ARG59TER	121912428
147370	3480	IGF1R	0004	INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO	IGF1R, ARG709GLN	121912429
147370	3480	IGF1R	0005	INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO	IGF1R, ARG481GLN	33958176
147440	3479	IGF1	0001	INSULIN-LIKE GROWTH FACTOR I DEFICIENCY	IGF1, EX4,5 DEL	
147440	3479	IGF1	0002	INSULIN-LIKE GROWTH FACTOR I DEFICIENCY	IGF1, MUTATION IN POLYADENYLATION SIGNAL, T-A	
147440	3479	IGF1	0003	INSULIN-LIKE GROWTH FACTOR I DEFICIENCY	IGF1, VAL44MET	121912430
147450	6647	SOD1	0001	AMYOTROPHIC LATERAL SCLEROSIS 1	SOD1, GLY37ARG	121912431
147450	6647	SOD1	0002	AMYOTROPHIC LATERAL SCLEROSIS 1	SOD1, LEU38VAL	121912432
147450	6647	SOD1	0003	AMYOTROPHIC LATERAL SCLEROSIS 1	SOD1, GLY41SER	121912433
147450	6647	SOD1	0004	AMYOTROPHIC LATERAL SCLEROSIS 1	SOD1, GLY41ASP	121912434
147450	6647	SOD1	0005	AMYOTROPHIC LATERAL SCLEROSIS 1	SOD1, HIS43ARG	121912435
147450	6647	SOD1	0006	AMYOTROPHIC LATERAL SCLEROSIS 1	SOD1, GLY85ARG	121912436
147450	6647	SOD1	0007	AMYOTROPHIC LATERAL SCLEROSIS 1	SOD1, GLY93CYS	121912437
147450	6647	SOD1	0008	AMYOTROPHIC LATERAL SCLEROSIS 1	SOD1, GLY93ALA	121912438
147450	6647	SOD1	0009	AMYOTROPHIC LATERAL SCLEROSIS 1	SOD1, GLU100GLY	121912439
147450	6647	SOD1	0010	AMYOTROPHIC LATERAL SCLEROSIS 1	SOD1, LEU106VAL	121912440
147450	6647	SOD1	0011	AMYOTROPHIC LATERAL SCLEROSIS 1	SOD1, ILE113THR	74315452
147450	6647	SOD1	0012	AMYOTROPHIC LATERAL SCLEROSIS 1	SOD1, ALA4VAL	121912442
147450	6647	SOD1	0013	AMYOTROPHIC LATERAL SCLEROSIS 1	SOD1, HIS46ARG	121912443
147450	6647	SOD1	0014	AMYOTROPHIC LATERAL SCLEROSIS 1	SOD1, ALA4THR	121912444
147450	6647	SOD1	0015	AMYOTROPHIC LATERAL SCLEROSIS 1 AMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL RECESSIVE, INCLUDED	SOD1, ASP90ALA	80265967
147450	6647	SOD1	0016	AMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL RECESSIVE	SOD1, ILE104PHE	121912445
147450	6647	SOD1	0017	AMYOTROPHIC LATERAL SCLEROSIS 1	SOD1, LEU144SER	121912446
147450	6647	SOD1	0018	AMYOTROPHIC LATERAL SCLEROSIS 1	SOD1, ALA145THR	121912447
147450	6647	SOD1	0019	AMYOTROPHIC LATERAL SCLEROSIS 1	SOD1, IVS4AS, T-G, -10	
147450	6647	SOD1	0020	AMYOTROPHIC LATERAL SCLEROSIS 1	SOD1, CYS6PHE	121912448
147450	6647	SOD1	0021	AMYOTROPHIC LATERAL SCLEROSIS 1	SOD1, THR151ILE	121912449
147450	6647	SOD1	0022	AMYOTROPHIC LATERAL SCLEROSIS 1	SOD1, GLU21LYS	121912450
147450	6647	SOD1	0023	AMYOTROPHIC LATERAL SCLEROSIS 1	SOD1, SER134ASN	121912451
147450	6647	SOD1	0024	AMYOTROPHIC LATERAL SCLEROSIS 1	SOD1, LEU84VAL	121912452
147450	6647	SOD1	0025	AMYOTROPHIC LATERAL SCLEROSIS 1	SOD1, GLY16SER	121912453
147450	6647	SOD1	0026	AMYOTROPHIC LATERAL SCLEROSIS 1	SOD1, LEU126TER	121912454
147450	6647	SOD1	0027	AMYOTROPHIC LATERAL SCLEROSIS 1	SOD1, IVS4AS, A-G, -11	
147450	6647	SOD1	0028	AMYOTROPHIC LATERAL SCLEROSIS 1	SOD1, GLY72SER	121912455
147450	6647	SOD1	0029	AMYOTROPHIC LATERAL SCLEROSIS 1	SOD1, GLY12ARG	121912456
147450	6647	SOD1	0030	AMYOTROPHIC LATERAL SCLEROSIS 1	SOD1, PHE45CYS	121912457
147450	6647	SOD1	0031	AMYOTROPHIC LATERAL SCLEROSIS 1	SOD1, HIS80ALA	121912458
147450	6647	SOD1	0032	AMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL RECESSIVE	SOD1, ASP96ASN	121912459
147450	6647	SOD1	0033	AMYOTROPHIC LATERAL SCLEROSIS 1	SOD1, GLY93ARG	
147450	6647	SOD1	0034	AMYOTROPHIC LATERAL SCLEROSIS 1	SOD1, 6-BP DEL, GGACCA	
147450	6647	SOD1	0035	AMYOTROPHIC LATERAL SCLEROSIS 1	SOD1, IVS4AS, C-G, -304	
147460	6648	SOD2	0001	SUPEROXIDE DISMUTASE 2 POLYMORPHISM MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 6, INCLUDED	SOD2, ALA16VAL	4880
147470	3481	IGF2	0001	INSULIN-LIKE GROWTH FACTOR II POLYMORPHISM	IGF2, 6815A-T	
147470	3481	IGF2	0002	INSULIN-LIKE GROWTH FACTOR II POLYMORPHISM	IGF2, 1156C-T	
147470	3481	IGF2	0003	INSULIN-LIKE GROWTH FACTOR II POLYMORPHISM	IGF2, 1926C-G	
147520	3704	ITPA	0001	INOSINE TRIPHOSPHATASE DEFICIENCY	ITPA, PRO32THR	1127354
147520	3704	ITPA	0002	INOSINE TRIPHOSPHATASE DEFICIENCY	ITPA, IVS2, A-C, +21	
147545	3667	IRS1	0001	DIABETES MELLITUS, TYPE II	IRS1, 3-BP DEL, GLY723	
147545	3667	IRS1	0002	INSULIN RESISTANCE, SUSCEPTIBILITY TO CORONARY ARTERY DISEASE, SUSCEPTIBILITY TO, INCLUDED	IRS1, GLY972ARG	
147545	3667	IRS1	0003	DIABETES MELLITUS, TYPE II	IRS1, THR608ARG	
147556	3655	ITGA6	0001	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, WITH PYLORIC ATRESIA	ITGA6, 1-BP DEL, 791C	
147557	3691	ITGB4	0001	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, WITH PYLORIC ATRESIA	ITGB4, 1-BP INS, 3801T	
147557	3691	ITGB4	0002	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, WITH PYLORIC ATRESIA	ITGB4, 1-BP DEL, 1150G	
147557	3691	ITGB4	0003	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, WITH PYLORIC ATRESIA	ITGB4, LEU156PRO	121912461
147557	3691	ITGB4	0004	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, WITH PYLORIC ATRESIA	ITGB4, ARG554TER	121912462
147557	3691	ITGB4	0005	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, WITH PYLORIC ATRESIA	ITGB4, CYS61TYR	80338755
147557	3691	ITGB4	0006	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, WITH PYLORIC ATRESIA	ITGB4, CYS562ARG	121912463
147557	3691	ITGB4	0007	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, WITH PYLORIC ATRESIA	ITGB4, IVS30DS, G-A, +1	
147557	3691	ITGB4	0008	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, WITH PYLORIC ATRESIA	ITGB4, TRP1478TER	121912464
147557	3691	ITGB4	0009	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, WITH PYLORIC ATRESIA	ITGB4, CYS38ARG	121912465
147557	3691	ITGB4	0010	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, WITH PYLORIC ATRESIA	ITGB4, 1-BP DEL, 4776G	
147557	3691	ITGB4	0011	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, WITH PYLORIC ATRESIA	ITGB4, IVS31DS, T-A, -19	
147557	3691	ITGB4	0012	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE	ITGB4, GLY931ASP	121912466
147557	3691	ITGB4	0013	EPIDERMOLYSIS BULLOSA SIMPLEX, LOCALIZED	ITGB4, 2-BP DEL, 4733CT	
147557	3691	ITGB4	0014	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, WITH PYLORIC ATRESIA	ITGB4, ARG1281TRP	121912467
147557	3691	ITGB4	0015	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, WITH PYLORIC ATRESIA	ITGB4, ARG1225HIS	121912468
147557	3691	ITGB4	0016	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, WITH PYLORIC ATRESIA AND APLASIA CUTIS CONGENITA	ITGB4, 2,279-BP DEL	
147569	3460	IFNGR2	0001	ATYPICAL MYCOBACTERIAL INFECTION, FAMILIAL DISSEMINATED	IFNGR2, 2-BP DEL, 278AG	
147569	3460	IFNGR2	0002	ATYPICAL MYCOBACTERIAL INFECTION, FAMILIAL DISSEMINATED	IFNGR2, THR168ASN	74315444
147569	3460	IFNGR2	0003	ATYPICAL MYCOBACTERIAL INFECTION, FAMILIAL DISSEMINATED	IFNGR2, 7-BP DEL, NT663	
147569	3460	IFNGR2	0004	ATYPICAL MYCOBACTERIAL INFECTION, FAMILIAL DISSEMINATED	IFNGR2, 6-BP DUP, NT382	
147570	3458	IFNG	0001	TSC2 ANGIOMYOLIPOMAS, RENAL, MODIFIER OF APLASTIC ANEMIA, SUSCEPTIBILITY TO, INCLUDED	IFNG, NT1349, 12 CA REPEATS	
147570	3458	IFNG	0002	MYCOBACTERIUM TUBERCULOSIS, PROTECTION AGAINST	IFNG, +874A-T	
147570	3458	IFNG	0003	ACQUIRED IMMUNODEFICIENCY SYNDROME, RAPID PROGRESSION TO	IFNG, -179G-T	
147570	3458	IFNG	0004	HEPATITIS C VIRUS INFECTION, RESPONSE TO THERAPY OF	IFNG, -764C-G	2069707
147575	3659	IRF1	0001	GASTRIC CANCER, SOMATIC	IRF1, MET8LEU	121912469
147575	3659	IRF1	0002	NONSMALL CELL LUNG CANCER	IRF1, TRP11ARG	121912470
147620	3569	IL6	0001	RHEUMATOID ARTHRITIS, SYSTEMIC JUVENILE, SUSCEPTIBILITY TO KAPOSI SARCOMA, SUSCEPTIBILITY TO, INCLUDED;; DIABETES MELLITUS, INSULIN-DEPENDENT, SUSCEPTIBILITY TO, INCLUDED;; DIABETES MELLITUS, NONINSULIN-DEPENDENT, SUSCEPTIBILITY TO, INCLUDED;; CROHN DISEASE-ASSOCIATED GROWTH FAILURE, SUSCEPTIBILITY TO, INCLUDED;; INTRACRANIAL HEMORRHAGE IN BRAIN CEREBROVASCULAR MALFORMATIONS, SUSCEPTIBILITY TO, INCLUDED	IL6, -174G-C	
147620	3569	IL6	0002	INTERLEUKIN 6 POLYMORPHISM	IL6, -597G-A	
147650	3418	IDH2	0001	D-2-HYDROXYGLUTARIC ACIDURIA 2	IDH2, ARG140GLN	
147650	3418	IDH2	0002	D-2-HYDROXYGLUTARIC ACIDURIA 2	IDH2, ARG140GLY	
147670	3643	INSR	0001	DIABETES MELLITUS, INSULIN-RESISTANT, WITH ACANTHOSIS NIGRICANS	INSR, GLY996VAL	121913135
147670	3643	INSR	0002	DONOHUE SYNDROME	INSR, LYS460GLU	121913136
147670	3643	INSR	0003	DONOHUE SYNDROME	INSR, GLU672TER	121913137
147670	3643	INSR	0004	DIABETES MELLITUS, INSULIN-RESISTANT, WITH ACANTHOSIS NIGRICANS	INSR, ARG735SER	121913138
147670	3643	INSR	0005	DIABETES MELLITUS, INSULIN-RESISTANT, WITH ACANTHOSIS NIGRICANS	INSR, TRP?SER	
147670	3643	INSR	0006	DIABETES MELLITUS, INSULIN-RESISTANT, WITH ACANTHOSIS NIGRICANS	INSR, EX17, ALU	
147670	3643	INSR	0007	DONOHUE SYNDROME	INSR, EX14, CODON 897	
147670	3643	INSR	0008	DIABETES MELLITUS, INSULIN-RESISTANT, WITH ACANTHOSIS NIGRICANS INSULIN RESISTANCE, INCLUDED	INSR, ALA1134THR	121913139
147670	3643	INSR	0009	DIABETES MELLITUS, INSULIN-RESISTANT, WITH ACANTHOSIS NIGRICANS	INSR, TRP1200SER	121913140
147670	3643	INSR	0010	DONOHUE SYNDROME	INSR, LEU233PRO	121913141
147670	3643	INSR	0011	DIABETES MELLITUS, INSULIN-RESISTANT	INSR, PHE382VAL	121913142
147670	3643	INSR	0012	RABSON-MENDENHALL SYNDROME	INSR, ASN15LYS	121913143
147670	3643	INSR	0013	RABSON-MENDENHALL SYNDROME	INSR, ARG1000TER	121913144
147670	3643	INSR	0014	DONOHUE SYNDROME	INSR, HIS209ARG	121913145
147670	3643	INSR	0015	DIABETES MELLITUS, INSULIN-RESISTANT, WITH ACANTHOSIS NIGRICANS	INSR, TRP133TER	121913146
147670	3643	INSR	0016	DIABETES MELLITUS, INSULIN-RESISTANT, WITH ACANTHOSIS NIGRICANS	INSR, ASN462SER	121913147
147670	3643	INSR	0017	DIABETES MELLITUS, INSULIN-RESISTANT, WITH ACANTHOSIS NIGRICANS	INSR, EX14DEL	
147670	3643	INSR	0018	DIABETES MELLITUS, INSULIN-RESISTANT, WITH ACANTHOSIS NIGRICANS	INSR, ARG981GLN	121913148
147670	3643	INSR	0019	DIABETES MELLITUS, INSULIN-RESISTANT, WITH ACANTHOSIS NIGRICANS	INSR, ARG988TER	121913144
147670	3643	INSR	0020	DONOHUE SYNDROME	INSR, GLY31ARG	52836744
147670	3643	INSR	0021	DIABETES MELLITUS, NONINSULIN-DEPENDENT	INSR, ARG1152GLN	121913150
147670	3643	INSR	0022	DONOHUE SYNDROME	INSR, ARG372TER	121913151
147670	3643	INSR	0023	DONOHUE SYNDROME	INSR, VAL28ALA	121913152
147670	3643	INSR	0024	DONOHUE SYNDROME	INSR, GLY366ARG	
147670	3643	INSR	0025	DONOHUE SYNDROME	INSR, ARG86PRO	121913153
147670	3643	INSR	0026	DIABETES MELLITUS, INSULIN-RESISTANT, WITH ACANTHOSIS NIGRICANS	INSR, ALA1135GLU	121913154
147670	3643	INSR	0027	DONOHUE SYNDROME	INSR, LYS121TER	121913155
147670	3643	INSR	0028	DONOHUE SYNDROME	INSR, DEL	
147670	3643	INSR	0029	DIABETES MELLITUS, NONINSULIN-DEPENDENT	INSR, VAL985MET	1799816
147670	3643	INSR	0030	DIABETES MELLITUS, INSULIN-RESISTANT, WITH ACANTHOSIS NIGRICANS	INSR, ARG1174GLN	121913156
147670	3643	INSR	0031	INSULIN RESISTANCE	INSR, MET1153ILE	121913157
147670	3643	INSR	0032	DONOHUE SYNDROME	INSR, TRP412SER	121913158
147670	3643	INSR	0033	DONOHUE SYNDROME	INSR, ILE119MET	121913159
147670	3643	INSR	0034	RABSON-MENDENHALL SYNDROME	INSR, IVS4AS, A-G, -2	
147670	3643	INSR	0035	RABSON-MENDENHALL SYNDROME	INSR, 8-BP DEL	
147670	3643	INSR	0036	DONOHUE SYNDROME	INSR, ASN431ASP	121913160
147670	3643	INSR	0037	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5	INSR, ARG1174GLN	
147679	3557	IL1RN	0001	GASTRIC CANCER SUSCEPTIBILITY AFTER H. PYLORI INFECTION MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 4, INCLUDED	IL1RN, IVS2, 86-BP DUP	
147679	3557	IL1RN	0002	OSTEOMYELITIS, STERILE MULTIFOCAL, WITH PERIOSTITIS AND PUSTULOSIS	IL1RN, GLU77TER	121913161
147679	3557	IL1RN	0003	OSTEOMYELITIS, STERILE MULTIFOCAL, WITH PERIOSTITIS AND PUSTULOSIS	IL1RN, GLN54TER	121913162
147679	3557	IL1RN	0004	OSTEOMYELITIS, STERILE MULTIFOCAL, WITH PERIOSTITIS AND PUSTULOSIS	IL1RN, 2-BP DEL, 156CA	
147679	3557	IL1RN	0005	OSTEOMYELITIS, STERILE MULTIFOCAL, WITH PERIOSTITIS AND PUSTULOSIS	IL1RN, 175-KB DEL	
147683	3596	IL13	0001	ASTHMA, SUSCEPTIBILITY TO	IL13, -1112C-T	
147683	3596	IL13	0002	ASTHMA, SUSCEPTIBILITY TO ALLERGIC RHINITIS, SUSCEPTIBILITY TO	IL13, ARG130GLN	20541
147720	3553	IL1B	0001	GASTRIC CANCER SUSCEPTIBILITY AFTER H. PYLORI INFECTION	IL1B, -31C-T	
147730	3559	IL2RA	0001	INTERLEUKIN 2 RECEPTOR, ALPHA, DEFICIENCY OF	IL2RA, 4-BP DEL, NT60	
147730	3559	IL2RA	0002	DIABETES MELLITUS, INSULIN-DEPENDENT, 10	IL2RA, C-A	
147730	3559	IL2RA	0003	DIABETES MELLITUS, INSULIN-DEPENDENT, 10	IL2RA, T-A	11594656
147781	3566	IL4R	0001	ATOPY, SUSCEPTIBILITY TO	IL4R, GLN576ARG	1801275
147781	3566	IL4R	0002	ASTHMA, ATOPIC ACQUIRED IMMUNODEFICIENCY SYNDROME, SLOW PROGRESSION TO, INCLUDED	IL4R, ILE50VAL	1805010
147781	3566	IL4R	0003	ATOPY, RESISTANCE TO ASTHMA, SUSCEPTIBILITY TO	IL4R, SER503PRO	1805015
147796	3717	JAK2	0001	POLYCYTHEMIA VERA, SOMATIC THROMBOCYTHEMIA 3, SOMATIC, INCLUDED;; MYELOFIBROSIS, SOMATIC, INCLUDED;; ERYTHROCYTOSIS, SOMATIC, INCLUDED;; LEUKEMIA, ACUTE MYELOGENOUS, SOMATIC, INCLUDED;; BUDD-CHIARI SYNDROME, SUSCEPTIBILITY TO, SOMATIC, INCLUDED	JAK2, VAL617PHE	77375493
147796	3717	JAK2	0002	LEUKEMIA, ACUTE MYELOGENOUS, SOMATIC	JAK2, LYS607ASN	121912472
147796	3717	JAK2	0003	ERYTHROCYTOSIS, JAK2-RELATED, SOMATIC	JAK2, LYS539LEU	121912473
147796	3717	JAK2	0004	THROMBOCYTHEMIA 3	JAK2, VAL617ILE	
147840	3383	ICAM1	0001	MALARIA, CEREBRAL, SUSCEPTIBILITY TO	ICAM1, LYS29MET	5491
147880	3570	IL6R	0001	SOLUBLE INTERLEUKIN-6 RECEPTOR, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS INTERLEUKIN 6, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS, INCLUDED	IL6R, ASP358ALA	2228145
147910	3816	KLK1	0001	KALLIKREIN, DECREASED URINARY ACTIVITY OF	KLKR, ARG53HIS	5515
148040	3852	KRT5	0001	EPIDERMOLYSIS BULLOSA SIMPLEX, DOWLING-MEARA TYPE	KRT5, GLU475GLY	61348633
148040	3852	KRT5	0002	EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED	KRT5, LEU462PRO	57599352
148040	3852	KRT5	0003	EPIDERMOLYSIS BULLOSA SIMPLEX, LOCALIZED	KRT5, ILE161SER	58058996
148040	3852	KRT5	0004	EPIDERMOLYSIS BULLOSA SIMPLEX, LOCALIZED	KRT5, MET327THR	58072617
148040	3852	KRT5	0005	EPIDERMOLYSIS BULLOSA SIMPLEX, LOCALIZED	KRT5, ASN329LYS	59730172
148040	3852	KRT5	0006	EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED	KRT5, LYS173ASN	58163069
148040	3852	KRT5	0007	EPIDERMOLYSIS BULLOSA SIMPLEX, LOCALIZED	KRT5, ASN193LYS	60586163
148040	3852	KRT5	0008	EPIDERMOLYSIS BULLOSA SIMPLEX, DOWLING-MEARA TYPE	KRT5, LEU174PHE	57890479
148040	3852	KRT5	0009	EPIDERMOLYSIS BULLOSA SIMPLEX WITH MOTTLED PIGMENTATION	KRT5, PRO25LEU	57499817
148040	3852	KRT5	0010	EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED	KRT5, VAL7ALA	121912474
148040	3852	KRT5	0011	EPIDERMOLYSIS BULLOSA SIMPLEX, DOWLING-MEARA TYPE	KRT5, IVS1DS, G-A, +1	
148040	3852	KRT5	0012	EPIDERMOLYSIS BULLOSA SIMPLEX, DOWLING-MEARA TYPE	KRT5, SER181PRO	60715293
148040	3852	KRT5	0013	EPIDERMOLYSIS BULLOSA SIMPLEX, LOCALIZED	KRT5, 1-BP DEL, 1635G	
148040	3852	KRT5	0014	EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED	KRT5, VAL186LEU	121912475
148040	3852	KRT5	0015	EPIDERMOLYSIS BULLOSA SIMPLEX, DOWLING-MEARA TYPE, WITH SEVERE PALMOPLANTAR KERATODERMA	KRT5, GLU477TER	
148040	3852	KRT5	0016	EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED, WITH SEVERE PALMOPLANTAR KERATOSIS	KRT5, LYS472TER	57348201
148040	3852	KRT5	0017	EPIDERMOLYSIS BULLOSA SIMPLEX WITH MIGRATORY CIRCINATE ERYTHEMA	KRT5, 1-BP DEL, 1649G	
148040	3852	KRT5	0018	DOWLING-DEGOS DISEASE	KRT5, 1-BP DUP, 418A	
148040	3852	KRT5	0019	DOWLING-DEGOS DISEASE	KRT5, SER5TER	58751565
148040	3852	KRT5	0020	EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE EPIDERMOLYSIS BULLOSA SIMPLEX, LOCALIZED, INCLUDED	KRT5, GLU170LYS	59115483
148040	3852	KRT5	0021	EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE	KRT5, GLU418LYS	121912476
148041	3853	KRT6A	0001	PACHYONYCHIA CONGENITA, TYPE 1	KRT6A, 3-BP DEL, ASN8	
148041	3853	KRT6A	0002	PACHYONYCHIA CONGENITA, TYPE 1	KRT6A, PHE174VAL	28933087
148041	3853	KRT6A	0003	PACHYONYCHIA CONGENITA, TYPE 1	KRT6A, GLU472LYS	60554162
148041	3853	KRT6A	0004	PACHYONYCHIA CONGENITA, TYPE 1	KRT6A, LEU469ARG	57052654
148042	3854	KRT6B	0001	PACHYONYCHIA CONGENITA, TYPE 2	KRT6B, GLU472LYS	60627726
148043	3850	KRT3	0001	MEESMANN CORNEAL DYSTROPHY	KRT3, GLU509LYS	57872071
148060	3856	KRT8	0001	CIRRHOSIS, CRYPTOGENIC CIRRHOSIS, NONCRYPTOGENIC, SUSCEPTIBILITY TO, INCLUDED	KRT8, GLY61CYS	11554495
148060	3856	KRT8	0002	CIRRHOSIS, CRYPTOGENIC	KRT8, TYR53HIS	57749775
148065	3860	KRT13	0001	WHITE SPONGE NEVUS	KRT13, LEU15PRO	60440396
148066	3861	KRT14	0001	EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED	KRT14, LEU384PRO	59629244
148066	3861	KRT14	0002	EPIDERMOLYSIS BULLOSA SIMPLEX, DOWLING-MEARA TYPE	KRT14, ARG125CYS	60399023
148066	3861	KRT14	0003	EPIDERMOLYSIS BULLOSA SIMPLEX, DOWLING-MEARA TYPE	KRT14, ARG125HIS	58330629
148066	3861	KRT14	0004	EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE	KRT14, GLU144ALA	57121345
148066	3861	KRT14	0005	EPIDERMOLYSIS BULLOSA SIMPLEX, LOCALIZED	KRT14, 3-BP DEL, GLU375DEL	
148066	3861	KRT14	0006	EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE	KRT14, TYR204TER	60725382
148066	3861	KRT14	0007	EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED	KRT14, MET272ARG	61371557
148066	3861	KRT14	0008	EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE	KRT14, IVS1AS, A-C, -2	
148066	3861	KRT14	0009	EPIDERMOLYSIS BULLOSA SIMPLEX, DOWLING-MEARA TYPE	KRT14, MET119THR	28928893
148066	3861	KRT14	0010	EPIDERMOLYSIS BULLOSA SIMPLEX, LOCALIZED EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE, INCLUDED	KRT14, MET119ILE	57358989
148066	3861	KRT14	0011	EPIDERMOLYSIS BULLOSA SIMPLEX, DOWLING-MEARA TYPE	KRT14, TYR415HIS	58380626
148066	3861	KRT14	0012	EPIDERMOLYSIS BULLOSA SIMPLEX, DOWLING-MEARA TYPE	KRT14, LEU419GLN	57364972
148066	3861	KRT14	0013	EPIDERMOLYSIS BULLOSA SIMPLEX, DOWLING-MEARA TYPE	KRT14, GLU422LYS	58762773
148066	3861	KRT14	0014	EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE	KRT14, 1-BP DEL, 92T	
148066	3861	KRT14	0015	NAEGELI-FRANCESCHETTI-JADASSOHN SYNDROME	KRT14, 1-BP DEL, 17G	
148066	3861	KRT14	0016	DERMATOPATHIA PIGMENTOSA RETICULARIS	KRT14, CYS18TER	60831116
148066	3861	KRT14	0017	EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE	KRT14, 2-BP DEL, NT313	
148066	3861	KRT14	0018	EPIDERMOLYSIS BULLOSA SIMPLEX, DOWLING-MEARA TYPE	KRT14, ASN123SER	60171927
148067	3868	KRT16	0001	PACHYONYCHIA CONGENITA, TYPE 1	KRT16, LEU132PRO	60944949
148067	3868	KRT16	0002	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL	KRT16, ARG127CYS	59856285
148067	3868	KRT16	0003	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL	KRT16, ASN125SER	60723330
148067	3868	KRT16	0004	PACHYONYCHIA CONGENITA, TYPE 1	KRT16, 3-BP DEL, NT388	
148067	3868	KRT16	0005	PACHYONYCHIA CONGENITA, TYPE 1	KRT16, ARG127PRO	57424749
148067	3868	KRT16	0006	PACHYONYCHIA CONGENITA, TYPE 1	KRT16, GLN122PRO	59349773
148067	3868	KRT16	0007	PACHYONYCHIA CONGENITA, TYPE 1	KRT16, LEU124ARG	58293603
148067	3868	KRT16	0008	PACHYONYCHIA CONGENITA TARDA, TYPE 1	KRT16, LYS354ASN	59328451
148067	3868	KRT16	0009	PACHYONYCHIA CONGENITA, TYPE 1	KRT16, MET121THR	28928894
148067	3868	KRT16	0010	PACHYONYCHIA CONGENITA, TYPE 1	KRT16, LEU128GLN	28928895
148067	3868	KRT16	0011	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL	KRT16, 23-BP DEL, NT1244 AND 1-BP DEL, 1270G	
148069	3872	KRT17	0001	PACHYONYCHIA CONGENITA, TYPE 2	KRT17, ASN92ASP	28928896
148069	3872	KRT17	0002	PACHYONYCHIA CONGENITA, TYPE 2	KRT17, ASN92SER	59151893
148069	3872	KRT17	0003	PACHYONYCHIA CONGENITA, TYPE 2	KRT17, TYR98ASP	28933088
148069	3872	KRT17	0004	STEATOCYSTOMA MULTIPLEX	KRT17, ASN92HIS	28928896
148069	3872	KRT17	0005	STEATOCYSTOMA MULTIPLEX PACHYONYCHIA CONGENITA, TYPE 2, INCLUDED	KRT17, ARG94HIS	28928897
148069	3872	KRT17	0006	STEATOCYSTOMA MULTIPLEX PACHYONYCHIA CONGENITA, TYPE 2, INCLUDED	KRT17, ARG94CYS	58730926
148069	3872	KRT17	0007	PACHYONYCHIA CONGENITA, TYPE 2	KRT17, MET88THR	28928898
148069	3872	KRT17	0008	PACHYONYCHIA CONGENITA, TYPE 2	KRT17, 15-BP DEL, NT279	
148069	3872	KRT17	0009	PACHYONYCHIA CONGENITA, TYPE 2	KRT17, ARG94PRO	28928897
148069	3872	KRT17	0010	PACHYONYCHIA CONGENITA, TYPE 2	KRT17, LEU95GLN	28928899
148069	3872	KRT17	0011	PACHYONYCHIA CONGENITA, TYPE 2	KRT17, LEU95PRO	28928899
148069	3872	KRT17	0012	PACHYONYCHIA CONGENITA, TYPE 2	KRT17, SER97DEL	121912478
148069	3872	KRT17	0013	PACHYONYCHIA CONGENITA, TYPE 2	KRT17,LEU99PRO	28933089
148069	3872	KRT17	0014	PACHYONYCHIA CONGENITA, TYPE 2	KRT17, VAL102MET	59977263
148070	3875	KRT18	0001	CIRRHOSIS, CRYPTOGENIC CIRRHOSIS, NONCRYPTOGENIC, SUSCEPTIBILITY TO, INCLUDED	KRT18, HIS127LEU	57758506
148080	3858	KRT10	0001	EPIDERMOLYTIC HYPERKERATOSIS	KRT10, ARG10HIS	
148080	3858	KRT10	0002	EPIDERMOLYTIC HYPERKERATOSIS	KRT10, LEU15SER	60118264
148080	3858	KRT10	0003	EPIDERMOLYTIC HYPERKERATOSIS	KRT10, ARG156HIS	58075662
148080	3858	KRT10	0004	EPIDERMOLYTIC HYPERKERATOSIS	KRT10, ARG10CYS	
148080	3858	KRT10	0005	EPIDERMOLYTIC HYPERKERATOSIS	KRT10, ARG10LEU	
148080	3858	KRT10	0007	EPIDERMOLYTIC HYPERKERATOSIS	KRT10, ASN8HIS	57784225
148080	3858	KRT10	0008	EPIDERMOLYTIC HYPERKERATOSIS	KRT10, TYR14ASP	58414354
148080	3858	KRT10	0009	EPIDERMOLYTIC HYPERKERATOSIS	KRT10, LEU103GLN	58026994
148080	3858	KRT10	0010	EPIDERMOLYTIC HYPERKERATOSIS	KRT10, ARG156CYS	58852768
148080	3858	KRT10	0011	EPIDERMOLYTIC HYPERKERATOSIS	KRT10, MET150ARG	58901407
148080	3858	KRT10	0012	EPIDERMOLYTIC HYPERKERATOSIS	KRT10, LYS439GLU	61434181
148080	3858	KRT10	0013	EPIDERMOLYTIC HYPERKERATOSIS	KRT10, MET150THR	
148080	3858	KRT10	0014	ICHTHYOSIS, CYCLIC, WITH EPIDERMOLYTIC HYPERKERATOSIS	KRT10, ARG83GLU	59075499
148080	3858	KRT10	0015	ICHTHYOSIS WITH CONFETTI	KRT10, IVS6AS, A-G, -2	
148080	3858	KRT10	0016	ICHTHYOSIS WITH CONFETTI	KRT10, IVS6DS, +2, G-A	
148080	3858	KRT10	0017	ICHTHYOSIS WITH CONFETTI	KRT10, 1-BP INS, 1450C	
148080	3858	KRT10	0018	ICHTHYOSIS WITH CONFETTI	KRT10, 2-BP DEL, 1560CG	
148080	3858	KRT10	0019	EPIDERMOLYTIC HYPERKERATOSIS	KRT10, GLN434TER	
148080	3858	KRT10	0020	EPIDERMOLYTIC HYPERKERATOSIS	KRT10, CYS427TER	
148080	3858	KRT10	0021	EPIDERMOLYTIC HYPERKERATOSIS	KRT10, 1-BP INS, 1325C	
148080	3858	KRT10	0022	EPIDERMOLYTIC HYPERKERATOSIS	KRT10, IVS5DS, G-A, +5	
148760	3832	KIF11	0001	MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION	KIF11, ARG387TER	
148760	3832	KIF11	0002	MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION	KIF11, 2-BP DEL, 1039CT	
148760	3832	KIF11	0003	MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION	KIF11, ARG944CYS	
148760	3832	KIF11	0004	MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION	KIF11, 1-BP DEL, 1592A	
148760	3832	KIF11	0005	MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION	KIF11, IVS18, T-C, +2	
148760	3832	KIF11	0006	MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION	KIF11, SER235CYS	
150000	3939	LDHA	0001	GLYCOGEN STORAGE DISEASE XI	LDHA, 20-BP DEL, EX6	
150000	3939	LDHA	0002	GLYCOGEN STORAGE DISEASE XI	LDHA, GLU328TER	121912479
150100	3945	LDHB	0001	LACTATE DEHYDROGENASE B DEFICIENCY	LDHB, ARG173HIS	118203895
150100	3945	LDHB	0002	LACTATE DEHYDROGENASE B DEFICIENCY	LDHB, SER131ARG	118203896
150100	3945	LDHB	0003	LACTATE DEHYDROGENASE B DEFICIENCY	LDHB, LYS6GLU	118203897
150100	3945	LDHB	0004	LACTATE DEHYDROGENASE B DEFICIENCY	LDHB, TRP323ARG	
150240	3912	LAMB1	0001	LISSENCEPHALY 5	LAMB1, 14-BP DEL/41-BP INS, NT3145	
150240	3912	LAMB1	0002	LISSENCEPHALY 5	LAMB1, IVS16DS, G-T, +1	
150292	3918	LAMC2	0001	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ TYPE	LAMC2, IVS8AS, G-A, -1	
150292	3918	LAMC2	0002	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ TYPE	LAMC2, ARG95TER	80356683
150292	3918	LAMC2	0003	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ TYPE	LAMC2, TYR355TER	118203899
150292	3918	LAMC2	0004	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ TYPE	LAMC2, CYS553TER	118203900
150292	3918	LAMC2	0005	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ TYPE	LAMC2, 7-BP DEL, NT2137	
150292	3918	LAMC2	0006	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE	LAMC2, ARG245TER	118203901
150292	3918	LAMC2	0007	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE	LAMC2, IVS3, G-A, -1	
150292	3918	LAMC2	0008	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE	LAMC2, 1-BP INS, 3511A	
150310	3914	LAMB3	0001	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ TYPE EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE, INCLUDED	LAMB3, ARG635TER	80356682
150310	3914	LAMB3	0002	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE	LAMB3, ARG-TER, EX3	
150310	3914	LAMB3	0003	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ TYPE EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE, INCLUDED	LAMB3, ARG42TER	80356680
150310	3914	LAMB3	0005	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE	LAMB3, 1-BP DEL, 904T	
150310	3914	LAMB3	0006	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE	LAMB3, GLU210LYS	121912482
150310	3914	LAMB3	0007	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ TYPE	LAMB3, GLN166TER	121912483
150310	3914	LAMB3	0008	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ TYPE	LAMB3, TRP610TER	121912484
150310	3914	LAMB3	0009	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ TYPE	LAMB3, GLN936TER	121912485
150310	3914	LAMB3	0010	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE	LAMB3, 5-BP DEL, NT1438	
150310	3914	LAMB3	0011	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ TYPE	LAMB3, 2-BP DEL, NT1587	
150310	3914	LAMB3	0012	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE, SOMATIC MOSAIC REVERTANT	LAMB3, IVS7, G-A, +42	
150310	3914	LAMB3	0013	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE, SOMATIC MOSAIC REVERTANT	LAMB3, GLY199ALA	121912486
150310	3914	LAMB3	0014	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE, SOMATIC MOSAIC REVERTANT	LAMB3, IVS6, T-C, -3	
150310	3914	LAMB3	0015	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE, SOMATIC MOSAIC REVERTANT	LAMB3, LYS207GLN	121912487
150310	3914	LAMB3	0016	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE, SOMATIC MOSAIC REVERTANT	LAMB3, IVS7, G-A, -1	
150325	3913	LAMB2	0001	PIERSON SYNDROME	LAMB2, 1-BP DEL, 3015G	
150325	3913	LAMB2	0002	PIERSON SYNDROME	LAMB2, ARG246TRP	121912488
150325	3913	LAMB2	0003	PIERSON SYNDROME	LAMB2, 1-BP INS, 5259A	
150325	3913	LAMB2	0004	PIERSON SYNDROME	LAMB2, TYR689TER	121912489
150325	3913	LAMB2	0005	PIERSON SYNDROME	LAMB2, CYS374TER	121912490
150325	3913	LAMB2	0006	NEPHROTIC SYNDROME, TYPE 5, WITHOUT OCULAR ABNORMALITIES	LAMB2, ARG246GLN	121912491
150325	3913	LAMB2	0007	NEPHROTIC SYNDROME, TYPE 5, WITH OCULAR ABNORMALITIES	LAMB2, ASN1380LYS AND LEU1393PHE	
150325	3913	LAMB2	0008	NEPHROTIC SYNDROME, TYPE 5, WITH OCULAR ABNORMALITIES	LAMB2, CYS321ARG	121912492
150325	3913	LAMB2	0009	NEPHROTIC SYNDROME, TYPE 5, WITH OCULAR ABNORMALITIES	LAMB2, 1-BP DEL, 1478G	
150325	3913	LAMB2	0010	NEPHROTIC SYNDROME, TYPE 5, WITH OCULAR ABNORMALITIES	LAMB2, 1-BP DEL, 4804C	
150325	3913	LAMB2	0011	NEPHROTIC SYNDROME, TYPE 5, WITH OCULAR ABNORMALITIES	LAMB2, HIS147ARG	
150330	4000	LMNA	0001	EMERY-DREIFUSS MUSCULAR DYSTROPHY, AUTOSOMAL DOMINANT	LMNA, GLN6TER	61046466
150330	4000	LMNA	0002	EMERY-DREIFUSS MUSCULAR DYSTROPHY, AUTOSOMAL DOMINANT	LMNA, ARG453TRP	58932704
150330	4000	LMNA	0003	EMERY-DREIFUSS MUSCULAR DYSTROPHY, AUTOSOMAL DOMINANT LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2, INCLUDED	LMNA, ARG527PRO	57520892
150330	4000	LMNA	0004	EMERY-DREIFUSS MUSCULAR DYSTROPHY, AUTOSOMAL DOMINANT	LMNA, LEU530PRO	60934003
150330	4000	LMNA	0005	CARDIOMYOPATHY, DILATED, 1A LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2, INCLUDED	LMNA, ARG60GLY	28928900
150330	4000	LMNA	0006	CARDIOMYOPATHY, DILATED, 1A	LMNA, LEU85ARG	28933090
150330	4000	LMNA	0007	CARDIOMYOPATHY, DILATED, 1A	LMNA, ASN195LYS	28933091
150330	4000	LMNA	0008	CARDIOMYOPATHY, DILATED, 1A	LMNA, GLU203GLY	28933092
150330	4000	LMNA	0009	CARDIOMYOPATHY, DILATED, 1A	LMNA, ARG571SER	80338938
150330	4000	LMNA	0010	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	LMNA, ARG482GLN	11575937
150330	4000	LMNA	0011	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	LMNA, ARG482TRP	57920071
150330	4000	LMNA	0012	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	LMNA, ARG482LEU	11575937
150330	4000	LMNA	0013	CARDIOMYOPATHY, DILATED, 1A EMERY-DREIFUSS MUSCULAR DYSTROPHY, AUTOSOMAL DOMINANT, INCLUDED	LMNA, 1-BP DEL, 959T	
150330	4000	LMNA	0014	EMERY-DREIFUSS MUSCULAR DYSTROPHY, ATYPICAL, AUTOSOMAL RECESSIVE	LMNA, HIS222TYR	28928901
150330	4000	LMNA	0015	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	LMNA, GLY465ASP	61282106
150330	4000	LMNA	0016	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	LMNA, ARG582HIS	57830985
150330	4000	LMNA	0017	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1B CARDIOMYOPATHY, DILATED, 1A, INCLUDED	LMNA, ARG377HIS	61672878
150330	4000	LMNA	0018	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1B	LMNA, 3-BP DEL, EXON 3	
150330	4000	LMNA	0019	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1B	LMNA, IVS9, G-C, +5	
150330	4000	LMNA	0020	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B1	LMNA, ARG298CYS	59885338
150330	4000	LMNA	0021	MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY, ATYPICAL, INCLUDED	LMNA, ARG527HIS	57520892
150330	4000	LMNA	0022	HUTCHINSON-GILFORD PROGERIA SYNDROME RESTRICTIVE DERMOPATHY, LETHAL, INCLUDED	LMNA, GLY608GLY	58596362
150330	4000	LMNA	0023	HUTCHINSON-GILFORD PROGERIA SYNDROME	LMNA, GLY608SER	61064130
150330	4000	LMNA	0024	HUTCHINSON-GILFORD PROGERIA SYNDROME, ATYPICAL	LMNA, GLU145LYS	60310264
150330	4000	LMNA	0025	MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY, ATYPICAL	LMNA, ARG471CYS	28928902
150330	4000	LMNA	0026	MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	LMNA, ARG527CYS	57318642
150330	4000	LMNA	0027	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2 HUTCHINSON-GILFORD PROGERIA SYNDROME, CHILDHOOD-ONSET, INCLUDED	LMNA, ARG133LEU	60864230
150330	4000	LMNA	0028	CARDIOMYOPATHY, DILATED, 1A	LMNA, GLU161LYS	28933093
150330	4000	LMNA	0029	CARDIOMYOPATHY, DILATED, 1A	LMNA, 1-BP INS, 28A	
150330	4000	LMNA	0030	CARDIOMYOPATHY, DILATED, WITH HYPERGONADOTRIPIC HYPOGONADISM	LMNA, ALA57PRO	28928903
150330	4000	LMNA	0031	HUTCHINSON-GILFORD PROGERIA SYNDROME, CHILDHOOD-ONSET	LMNA, LEU140ARG	60652225
150330	4000	LMNA	0032	EMERY-DREIFUSS MUSCULAR DYSTROPHY, AUTOSOMAL DOMINANT	LMNA, ARG133PRO	60864230
150330	4000	LMNA	0033	MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	LMNA, LYS542ASN	56673169
150330	4000	LMNA	0034	MUSCULAR DYSTROPHY, CONGENITAL, LMNA-RELATED	LMNA, SER143PHE	58912633
150330	4000	LMNA	0035	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1B	LMNA, TYR259TER	58048078
150330	4000	LMNA	0036	RESTRICTIVE DERMOPATHY, LETHAL HUTCHINSON-GILFORD PROGERIA SYNDROME, INCLUDED	LMNA, IVS11, G-A, +1	
150330	4000	LMNA	0037	MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	LMNA, ALA529VAL	60580541
150330	4000	LMNA	0038	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1B	LMNA, GLN493TER	56699480
150330	4000	LMNA	0039	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	LMNA, IVS8, G-C, +5	
150330	4000	LMNA	0040	HUTCHINSON-GILFORD PROGERIA SYNDROME	LMNA, VAL607VAL	59886214
150330	4000	LMNA	0041	CARDIOMYOPATHY, DILATED, 1A MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY, ATYPICAL, INCLUDED;; LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2, INCLUDED	LMNA, SER573LEU	60890628
150330	4000	LMNA	0042	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	LMNA, ASP230ASN	61214927
150330	4000	LMNA	0043	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	LMNA, ARG399CYS	58672172
150330	4000	LMNA	0044	MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY, ATYPICAL	LMNA, VAL440MET	121912493
150330	4000	LMNA	0045	HEART-HAND SYNDROME, SLOVENIAN TYPE	LMNA, IVS9AS, T-G, -12	
150330	4000	LMNA	0046	MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	LMNA, ALA529THR	121912494
150330	4000	LMNA	0047	MUSCULAR DYSTROPHY, CONGENITAL, LMNA-RELATED	LMNA, LEU380SER	121912495
150330	4000	LMNA	0048	MUSCULAR DYSTROPHY, CONGENITAL, LMNA-RELATED	LMNA, ARG249TRP	121912496
150330	4000	LMNA	0049	EMERY-DREIFUSS MUSCULAR DYSTROPHY, AUTOSOMAL DOMINANT MUSCULAR DYSTROPHY, CONGENITAL, LMNA-RELATED, INCLUDED;; MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1B, INCLUDED	LMNA, GLU358LYS	60458016
150330	4000	LMNA	0050	MUSCULAR DYSTROPHY, CONGENITAL, LMNA-RELATED	LMNA, 3-BP DEL, 94AAG	
150330	4000	LMNA	0051	VARIANT OF UNKNOWN SIGNIFICANCE	LMNA, ARG644CYS	
150330	4000	LMNA	0052	CARDIOMYOPATHY, DILATED, WITH HYPERGONADOTRIPIC HYPOGONADISM	LMNA, LEU59ARG	
150330	4000	LMNA	0053	CARDIOMYOPATHY, DILATED, 1A	LMNA, ARG541GLY	
150340	4001	LMNB1	0001	LEUKODYSTROPHY, ADULT-ONSET, AUTOSOMAL DOMINANT	LMNB1, DUP	
150341	84823	LMNB2	0001	LIPODYSTROPHY, PARTIAL, ACQUIRED, SUSCEPTIBILITY TO	LMNB2, IVS1AS, C-T, -6	
150341	84823	LMNB2	0002	LIPODYSTROPHY, PARTIAL, ACQUIRED, SUSCEPTIBILITY TO	LMNB2, ARG215GLN	121912497
150341	84823	LMNB2	0003	LIPODYSTROPHY, PARTIAL, ACQUIRED, SUSCEPTIBILITY TO	LMNB2, ALA407THR	
150571	3957	LGALS2	0001	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO	LGALS2, 3279C-T	
151385	861	RUNX1	0001	PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY	RUNX1, IVS3AS, G-T, -1	
151385	861	RUNX1	0002	PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY	RUNX1, ARG201GLN	74315450
151385	861	RUNX1	0003	PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY	RUNX1, LYS83GLU	121912498
151385	861	RUNX1	0004	PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY	RUNX1, 1-BP DEL, IVS4, +3, A	
151385	861	RUNX1	0005	PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY	RUNX1, TYR260TER	121912499
151385	861	RUNX1	0006	PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY	RUNX1, ALA107PRO	74315451
151385	861	RUNX1	0008	TRANSIENT MYELOPROLIFERATIVE DISORDER OF DOWN SYNDROME LEUKEMIA, ACUTE MYELOID, M0 SUBTYPE, INCLUDED	RUNX1, HIS58ASN	121912500
151385	861	RUNX1	0009	PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY	RUNX1, 8-BP DEL, NT442	
151385	861	RUNX1	0010	PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY	RUNX1, ALA129GLU	
151443	3977	LIFR	0001	STUVE-WIEDEMANN/SCHWARTZ-JAMPEL TYPE 2 SYNDROME	LIFR, 1-BP INS, 653T	
151443	3977	LIFR	0002	STUVE-WIEDEMANN/SCHWARTZ-JAMPEL TYPE 2 SYNDROME	LIFR, ARG597TER	121912501
151443	3977	LIFR	0003	STUVE-WIEDEMANN/SCHWARTZ-JAMPEL TYPE 2 SYNDROME	LIFR, 1-BP INS, 2011T	
151443	3977	LIFR	0004	STUVE-WIEDEMANN/SCHWARTZ-JAMPEL TYPE 2 SYNDROME	LIFR, 4-BP DEL, 167TAAC	
151460	5788	PTPRC	0001	HEPATITIS C VIRUS, SUSCEPTIBILITY TO	PTPRC, 77C-G	
151460	5788	PTPRC	0002	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	PTPRC, IVS13DS, G-A, +1	
151460	5788	PTPRC	0003	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	PTPRC, 6-BP DEL, NT1168	
151670	3990	LIPC	0001	HEPATIC LIPASE DEFICIENCY	LIPC, THR383MET	113298164
151670	3990	LIPC	0002	HEPATIC LIPASE DEFICIENCY	LIPC, SER267PHE	121912502
151670	3990	LIPC	0003	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 12	LIPC, -514C-T	
151670	3990	LIPC	0004	DIABETES MELLITUS, NONINSULIN-DEPENDENT, SUSCEPTIBILITY TO HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 12, INCLUDED	LIPC, -250G-A	
151670	3990	LIPC	0005	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 12	LIPC, INTRON 1 HAPLOTYPE, TA	12594375
151670	3990	LIPC	0006	HEPATIC LIPASE DEFICIENCY	LIPC, ALA174THR	
152200	4018	LPA	0001	APOLIPOPROTEIN(a), TYPE C POLYMORPHISM	LPA, -773A, +93C, +121A	
152200	4018	LPA	0002	APOLIPOPROTEIN(a), TYPE D POLYMORPHISM	LPA, -773G, +93T, +121G	
152200	4018	LPA	0003	LIPOPROTEIN(a) DEFICIENCY, CONGENITAL	LPA, IVS K4 TYPE 8 DS, G-A, +1	
152200	4018	LPA	0004	LIPOPROTEIN(a) DEFICIENCY, CONGENITAL	LPA, ARG21TER	121912503
152390	240	ALOX5	0001	ASTHMA, DIMINISHED RESPONSE TO ANTILEUKOTRIENE TREATMENT IN ATHEROSCLEROSIS, SUSCEPTIBILITY TO	ALOX5, VARIANT PROMOTER SP1 BINDING	
152424	387281	-	0001	THALASSEMIA, GAMMA-DELTA-BETA	LCRB, 30-KB DEL	
152427	3757	KCNH2	0001	LONG QT SYNDROME 2	KCNH2, ALA561VAL	121912504
152427	3757	KCNH2	0002	LONG QT SYNDROME 2	KCNH2, ASN470ASP	121912505
152427	3757	KCNH2	0003	LONG QT SYNDROME 2	KCNH2, IVS3, G-C, +1	
152427	3757	KCNH2	0004	LONG QT SYNDROME 2	KCNH2, ILE593ARG	28928904
152427	3757	KCNH2	0005	LONG QT SYNDROME 2	KCNH2, VAL822MET	121912506
152427	3757	KCNH2	0006	LONG QT SYNDROME 2	KCNH2, 27-BP DEL	
152427	3757	KCNH2	0007	LONG QT SYNDROME 2	KCNH2, 1-BP DEL	
152427	3757	KCNH2	0008	LONG QT SYNDROME 2	KCNH2, GLY628SER	121912507
152427	3757	KCNH2	0009	LONG QT SYNDROME 2	KCNH2, ARG582CYS	121912508
152427	3757	KCNH2	0010	LONG QT SYNDROME 2	KCNH2, GLY572ARG	9333649
152427	3757	KCNH2	0011	LONG QT SYNDROME, BRADYCARDIA-INDUCED	KCNH2, ALA490THR	28928905
152427	3757	KCNH2	0012	LONG QT SYNDROME 2	KCNH2, TRP1001TER	121912509
152427	3757	KCNH2	0013	LONG QT SYNDROME 2	KCNH2, SER818LEU	121912510
152427	3757	KCNH2	0014	LONG QT SYNDROME 2, ACQUIRED, SUSCEPTIBILITY TO	KCNH2, ARG784TRP	12720441
152427	3757	KCNH2	0015	LONG QT SYNDROME 2	KCNH2, THR65PRO	121912511
152427	3757	KCNH2	0016	LONG QT SYNDROME 2	KCNH2, ARG752GLN	121912512
152427	3757	KCNH2	0017	SHORT QT SYNDROME 1	KCNH2, ASN588LYS	104894021
152427	3757	KCNH2	0018	SHORT QT SYNDROME 1	KCNH2, ASN588LYS	104894021
152427	3757	KCNH2	0019	LONG QT SYNDROME 1/2, DIGENIC	KCNH2, IVS10, G-A, +1	
152427	3757	KCNH2	0020	LONG QT SYNDROME 2 LONG QT SYNDROME 1/2, DIGENIC, INCLUDED	KCNH2, 1-BP INS, 2775G	
152427	3757	KCNH2	0021	LONG QT SYNDROME 2 LONG QT SYNDROME 2/5, DIGENIC, INCLUDED	KCNH2, ASN861ILE	121912513
152427	3757	KCNH2	0022	LONG QT SYNDROME 1/2, DIGENIC	KCNH2, ARG948CYS	121912514
152427	3757	KCNH2	0023	LONG QT SYNDROME 2/3, DIGENIC	KCNH2, ARG100GLY	121912515
152427	3757	KCNH2	0024	LONG QT SYNDROME 2 LONG QT SYNDROME 2/9, DIGENIC, INCLUDED	KCNH2, ARG913VAL	77331749
152427	3757	KCNH2	0025	LONG QT SYNDROME 2	KCNH2, ALA558PRO	121912516
152427	3757	KCNH2	0026	LONG QT SYNDROME 2	KCNH2, ALA614VAL	
152427	3757	KCNH2	0027	LONG QT SYNDROME 2	KCNH2, TYR611HIS	
152445	4014	LOR	0001	VOHWINKEL SYNDROME WITH ICHTHYOSIS	LOR, 1-BP INS, 730G	
152445	4014	LOR	0002	VOHWINKEL SYNDROME WITH ICHTHYOSIS	LOR, 1-BP INS, 709C	
152760	2796	GNRH1	0001	HYPOGONADOTROPIC HYPOGONADISM 12 WITH ANOSMIA	GNRH1, 1-BP INS, 18A	
152780	3972	LHB	0001	HYPOGONADISM, MALE	LHB, GLN54ARG	5030773
152780	3972	LHB	0002	LUTEINIZING HORMONE POLYMORPHISM	LHB, TRP8ARG AND ILE15THR	1800447
152780	3972	LHB	0003	INFERTILITY, MALE AND FEMALE	LHB, GLY102SER	5030774
152780	3972	LHB	0004	HYPOGONADISM, MALE	LHB, GLY36ASP	121912517
152790	3973	LHCGR	0001	PRECOCIOUS PUBERTY, MALE-LIMITED	LHCGR, ASP578GLY	121912518
152790	3973	LHCGR	0002	PRECOCIOUS PUBERTY, MALE-LIMITED	LHCGR, MET575ILE	121912519
152790	3973	LHCGR	0003	PRECOCIOUS PUBERTY, MALE-LIMITED	LHCGR, ASP582GLY	
152790	3973	LHCGR	0004	LEYDIG CELL HYPOPLASIA, TYPE I LUTEINIZING HORMONE RESISTANCE, FEMALE, INCLUDED	LHCGR, ALA593PRO	121912520
152790	3973	LHCGR	0005	PRECOCIOUS PUBERTY, MALE-LIMITED	LHCGR, THR577ILE	121912521
152790	3973	LHCGR	0006	PRECOCIOUS PUBERTY, MALE-LIMITED	LHCGR, ALA572VAL	121912522
152790	3973	LHCGR	0007	LEYDIG CELL HYPOPLASIA, TYPE I	LHCGR, CYS545TER	121912523
152790	3973	LHCGR	0008	LEYDIG CELL HYPOPLASIA, TYPE I LUTEINIZING HORMONE RESISTANCE, FEMALE, INCLUDED	LHCGR, ARG554TER	121912524
152790	3973	LHCGR	0009	LEYDIG HYPOPLASIA, TYPE I	LHCGR, SER616TYR	121912525
152790	3973	LHCGR	0010	PRECOCIOUS PUBERTY, MALE-LIMITED	LHCGR, MET398THR	121912526
152790	3973	LHCGR	0011	PRECOCIOUS PUBERTY, MALE-LIMITED	LHCGR, ASP578GLY	
152790	3973	LHCGR	0012	LEYDIG CELL HYPOPLASIA, TYPE II	LHCGR, ARG133CYS	121912527
152790	3973	LHCGR	0013	PRECOCIOUS PUBERTY, MALE-LIMITED	LHCGR, ALA373VAL	121912528
152790	3973	LHCGR	0014	LEYDIG CELL HYPOPLASIA, TYPE I LUTEINIZING HORMONE RESISTANCE, FEMALE, INCLUDED	LHCGR, GLU354LYS	121912529
152790	3973	LHCGR	0015	LEYDIG CELL HYPOPLASIA, TYPE I LUTEINIZING HORMONE RESISTANCE, FEMALE, INCLUDED	LHCGR, 6-BP DEL, NT1822	
152790	3973	LHCGR	0016	LEYDIG CELL HYPOPLASIA, TYPE II	LHCGR, ILE625LYS	121912530
152790	3973	LHCGR	0017	LUTEINIZING HORMONE/CHORIOGONADOTROPIN RECEPTOR, LQ VARIANT LUTEINIZING HORMONE/CHORIOGONADOTROPIN RECEPTOR, LQ VARIANT, INCLUDED	LHCGR, LEU-GLN INS, CODON 19-20	
152790	3973	LHCGR	0018	PRECOCIOUS PUBERTY, MALE-LIMITED	LHCGR, ILE542LEU	121912531
152790	3973	LHCGR	0019	LEYDIG CELL ADENOMA, SOMATIC, WITH MALE-LIMITED PRECOCIOUS PUBERTY	LHCGR, ASP578HIS	121912532
152790	3973	LHCGR	0020	LEYDIG CELL HYPOPLASIA, TYPE II	LHCGR, EX10DEL	
152790	3973	LHCGR	0021	LEYDIG CELL HYPOPLASIA, TYPE I	LHCGR, 33-BP INS, NT54	
152790	3973	LHCGR	0022	PRECOCIOUS PUBERTY, MALE-LIMITED	LHCGR, LEU368PRO	121912533
152790	3973	LHCGR	0023	PRECOCIOUS PUBERTY, MALE-LIMITED	LHCGR, ALA568VAL	121912534
152790	3973	LHCGR	0024	PRECOCIOUS PUBERTY, MALE-LIMITED	LHCGR, LEU457ARG	121912535
152790	3973	LHCGR	0025	LEYDIG CELL HYPOPLASIA, TYPE I	LHCGR, CYS343SER	121912536
152790	3973	LHCGR	0026	LEYDIG CELL HYPOPLASIA, TYPE I	LHCGR, CYS543ARG	121912537
152790	3973	LHCGR	0027	LEYDIG CELL HYPOPLASIA, TYPE I	LHCGR, LEU502PRO	121912538
152790	3973	LHCGR	0028	LEYDIG CELL HYPOPLASIA, TYPE I	LHCGR, VAL144PHE	121912539
152790	3973	LHCGR	0029	PRECOCIOUS PUBERTY, MALE-LIMITED	LHCGR, ASP564GLY	121912540
153245	51176	LEF1	0001	SEBACEOUS TUMORS, SOMATIC	LEF1, GLU45LYS AND SER61PRO	
153440	4049	LTA	0001	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO	LTA, THR26ASN	1041981
153440	4049	LTA	0002	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO, INCLUDED	LTA, 252A-G	
153440	4049	LTA	0003	LEPROSY, EARLY-ONSET, SUSCEPTIBILITY TO	LTA, 80A-C	2239704
153450	4069	LYZ	0001	AMYLOIDOSIS, FAMILIAL VISCERAL	LYZ, ILE56THR	121913547
153450	4069	LYZ	0002	AMYLOIDOSIS, FAMILIAL VISCERAL	LYZ, ASP67HIS	121913548
153450	4069	LYZ	0003	AMYLOIDOSIS, FAMILIAL VISCERAL	LYZ, TRP64ARG, T-C	
153450	4069	LYZ	0004	AMYLOIDOSIS, FAMILIAL VISCERAL	LYZ, PHE57ILE	121913549
153450	4069	LYZ	0005	AMYLOIDOSIS, FAMILIAL VISCERAL	LYZ, TRP64ARG, T-A	
153454	5351	PLOD1	0001	EHLERS-DANLOS SYNDROME, TYPE VI	PLOD1, ARG319TER	121913550
153454	5351	PLOD1	0002	EHLERS-DANLOS SYNDROME, TYPE VI	PLOD1, 8.9-KB DUP	
153454	5351	PLOD1	0003	EHLERS-DANLOS SYNDROME, TYPE VI	PLOD1, GLY678ARG	121913551
153454	5351	PLOD1	0004	EHLERS-DANLOS SYNDROME, TYPE VI	PLOD1, 3-BP DEL, GLU532DEL	
153454	5351	PLOD1	0005	EHLERS-DANLOS SYNDROME, TYPE VI	PLOD1, 1-BP DEL, IVS15, A, -2	
153454	5351	PLOD1	0006	EHLERS-DANLOS SYNDROME, TYPE VI	PLOD1, 3-KB DEL, EX17DEL	
153454	5351	PLOD1	0007	EHLERS-DANLOS SYNDROME, TYPE VI	PLOD1, TYR511TER	121913552
153454	5351	PLOD1	0008	EHLERS-DANLOS SYNDROME, TYPE VI	PLOD1, IVS5, G-A, +1	
153454	5351	PLOD1	0009	EHLERS-DANLOS SYNDROME, TYPE VI	PLOD1, TRP612CYS	121913553
153454	5351	PLOD1	0010	EHLERS-DANLOS SYNDROME, TYPE VI	PLOD1, ARG670TER	121913554
153455	4015	LOX	0001	LYSYL OXIDASE POLYMORPHISM	LOX, ARG158GLN	1800449
153456	4016	LOXL1	0001	EXFOLIATION SYNDROME, SUSCEPTIBILITY TO	LOXL1, ARG141LEU	1048661
153456	4016	LOXL1	0002	EXFOLIATION SYNDROME, SUSCEPTIBILITY TO	LOXL1, GLY153ASP	3825942
153456	4016	LOXL1	0003	EXFOLIATION SYNDROME, SUSCEPTIBILITY TO	LOXL1, IVS1, C-T	2165241
153620	4282	MIF	0001	RHEUMATOID ARTHRITIS, SYSTEMIC JUVENILE, SUSCEPTIBILITY TO	MIF, -173G-C	
153622	4481	MSR1	0001	PROSTATE CANCER BARRETT ESOPHAGUS/ESOPHAGEAL ADENOCARCINOMA, INCLUDED	MSR1, ARG293TER	41341748
153622	4481	MSR1	0002	PROSTATE CANCER	MSR1, ASP174TYR	72552387
153622	4481	MSR1	0003	BARRETT ESOPHAGUS/ESOPHAGEAL ADENOCARCINOMA	MSR1, LEU254VAL	
154045	3982	LIM2	0001	CATARACT 19, CORTICAL PULVERULENT, AUTOSOMAL RECESSIVE	LIM2, PHE105VAL	121913555
154050	4284	MIP	0001	CATARACT 15, MULTIPLE TYPES	MIP, THR138ARG	
154050	4284	MIP	0002	CATARACT 15, LAMELLAR WITH SUTURAL OPACITIES	MIP, GLU134GLY	
154050	4284	MIP	0003	CATARACT 15, MULTIPLE TYPES	MIP, 1-BP DEL, 3223G	
154235	4117	MAK	0001	RETINITIS PIGMENTOSA 62	MAK, 353-BP ALU INS, EX9	
154235	4117	MAK	0002	RETINITIS PIGMENTOSA 62	MAK, GLY240TER	
154235	4117	MAK	0003	RETINITIS PIGMENTOSA 62	MAK, ASN130HIS	
154235	4117	MAK	0004	RETINITIS PIGMENTOSA 62	MAK, GLY13SER	
154235	4117	MAK	0005	RETINITIS PIGMENTOSA 62	MAK, ARG166HIS	
154270	4200	ME2	0001	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO ME2, HAPLOTYPE (dbSNP rs674351, dbSNP rs584087, dbSNP rs585344, dbSNP rs608781, dbSNP rs642698, dbSNP rs674210, dbSNP rs645088,	dbSNP rs649224, dbSNP rs654136)	674351
154545	4153	MBL2	0001	MANNOSE-BINDING PROTEIN DEFICIENCY	MBL2, GLY54ASP	1800450
154545	4153	MBL2	0002	MANNOSE-BINDING PROTEIN DEFICIENCY	MBL2, GLY57GLU	1800451
154545	4153	MBL2	0003	MANNOSE-BINDING PROTEIN DEFICIENCY	MBL2, ARG52CYS	5030737
154550	4351	MPI	0001	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib	MPI, ARG219GLN	104894489
154550	4351	MPI	0002	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib	MPI, SER102LEU	104894494
154550	4351	MPI	0003	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib	MPI, MET138THR	104894495
154550	4351	MPI	0004	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib	MPI, 1-BP INS, 166C	
154550	4351	MPI	0005	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib	MPI, ARG295HIS	28928906
154870	4256	MGP	0001	KEUTEL SYNDROME	MGP, 1-BP DEL, 69G	
154870	4256	MGP	0002	KEUTEL SYNDROME	MGP, IVS1, A-G, -2	
154870	4256	MGP	0003	KEUTEL SYNDROME	MGP, 113T-A	
154870	4256	MGP	0004	KEUTEL SYNDROME	MGP, IVS2, G-A, +1	
154950	4149	MAX	0001	PHEOCHROMOCYTOMA, SUSCEPTIBILITY TO	MAX, MET1VAL	
154950	4149	MAX	0002	PHEOCHROMOCYTOMA, SUSCEPTIBILITY TO	MAX, ARG75TER	
154950	4149	MAX	0003	PHEOCHROMOCYTOMA, SUSCEPTIBILITY TO	MAX, IVS4DS, G-A, +1	
154950	4149	MAX	0004	PHEOCHROMOCYTOMA, SUSCEPTIBILITY TO	MAX, ARG33TER	
154950	4149	MAX	0005	PHEOCHROMOCYTOMA, SUSCEPTIBILITY TO	MAX, 1-BP DEL, 185A	
155540	4159	MC3R	0001	OBESITY, SUSCEPTIBILITY TO	MC3R, ILE183ASN	74315393
155540	4159	MC3R	0002	OBESITY, SUSCEPTIBILITY TO	MC3R, ILE335SER	121913556
155541	4160	MC4R	0001	OBESITY	MC4R, 4-BP DEL, NT631	
155541	4160	MC4R	0002	OBESITY	MC4R, 4-BP INS, NT732	
155541	4160	MC4R	0003	OBESITY	MC4R, TYR35TER	13447324
155541	4160	MC4R	0004	OBESITY	MC4R, ASP37VAL	13447325
155541	4160	MC4R	0005	OBESITY	MC4R, VAL50MET	
155541	4160	MC4R	0006	OBESITY	MC4R, SER58CYS	
155541	4160	MC4R	0007	OBESITY	MC4R, ILE102SER	
155541	4160	MC4R	0008	OBESITY	MC4R, ILE170VAL	
155541	4160	MC4R	0009	OBESITY	MC4R, ASN274SER	
155541	4160	MC4R	0010	OBESITY	MC4R, 1-BP INS, 112A	
155541	4160	MC4R	0011	OBESITY	MC4R, 4-BP DEL, 211CTCT	
155541	4160	MC4R	0012	OBESITY	MC4R, 2-BP INS, 279GT	
155541	4160	MC4R	0013	OBESITY	MC4R, ILE125LYS	
155541	4160	MC4R	0014	OBESITY	MC4R, CYS271TYR	
155541	4160	MC4R	0015	OBESITY	MC4R, ALA175THR	
155541	4160	MC4R	0016	OBESITY	MC4R, ILE316SER	
155541	4160	MC4R	0017	OBESITY	MC4R, TYR287TER	
155541	4160	MC4R	0018	OBESITY	MC4R, ASN97ASP	
155541	4160	MC4R	0019	OBESITY	MC4R, ASN62SER	
155541	4160	MC4R	0020	OBESITY	MC4R, 15-BP DEL	
155541	4160	MC4R	0021	OBESITY	MC4R, SER127LEU	13447331
155541	4160	MC4R	0022	OBESITY	MC4R, 2-BP DEL, 750GA	
155541	4160	MC4R	0023	OBESITY	MC4R, ALA219VAL	
155555	4157	MC1R	0001	SKIN/HAIR/EYE PIGMENTATION 2, RED HAIR/FAIR SKIN	MC1R, ASP294HIS	1805009
155555	4157	MC1R	0002	SKIN/HAIR/EYE PIGMENTATION 2, RED HAIR/FAIR SKIN SKIN/HAIR/EYE PIGMENTATION 2, BLOND HAIR/FAIR SKIN, INCLUDED	MC1R, VAL92MET	2228479
155555	4157	MC1R	0003	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 5	MC1R, ASP84GLU	1805006
155555	4157	MC1R	0004	SKIN/HAIR/EYE PIGMENTATION 2, RED HAIR/FAIR SKIN INCREASED ANALGESIA FROM KAPPA-OPIOID RECEPTOR AGONIST, FEMALE-SPECIFIC, INCLUDED;; OCULOCUTANEOUS ALBINISM, TYPE II, MODIFIER OF, INCLUDED;; PARKINSON DISEASE, LATE-ONSET, SUSCEPTIBILITY TO, INCLUDED	MC1R, ARG151CYS	1805007
155555	4157	MC1R	0005	SKIN/HAIR/EYE PIGMENTATION 2, RED HAIR/FAIR SKIN INCREASED ANALGESIA FROM KAPPA-OPIOID RECEPTOR AGONIST, FEMALE-SPECIFIC, INCLUDED;; OCULOCUTANEOUS ALBINISM, TYPE II, MODIFIER OF, INCLUDED	MC1R, ARG160TRP	1805008
155555	4157	MC1R	0006	SKIN/HAIR/EYE PIGMENTATION 2, BLOND HAIR/FAIR SKIN	MC1R, VAL60LEU	1805005
155555	4157	MC1R	0007	UV-INDUCED SKIN DAMAGE, SUSCEPTIBILITY TO	MC1R, 3-BP DEL, 439TTC	
155555	4157	MC1R	0008	UV-INDUCED SKIN DAMAGE, SUSCEPTIBILITY TO	MC1R, THR157ILE	104894524
155555	4157	MC1R	0009	UV-INDUCED SKIN DAMAGE, SUSCEPTIBILITY TO	MC1R, PRO159THR	104894523
155760	176	ACAN	0001	SPONDYLOEPIPHYSEAL DYSPLASIA, KIMBERLEY TYPE	ACAN, 1-BP INS	
155760	176	ACAN	0002	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE	ACAN, ASP2267ASN	121913568
155760	176	ACAN	0003	OSTEOCHONDRITIS DISSECANS, SHORT STATURE, AND EARLY-ONSET OSTEOARTHRITIS	ACAN, VAL2303MET	
156225	3908	LAMA2	0001	MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT	LAMA2, IVS30, A-T, -2	
156225	3908	LAMA2	0002	MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT	LAMA2, GLN1241TER	121913569
156225	3908	LAMA2	0003	MUSCULAR DYSTROPHY, CONGENITAL, DUE TO PARTIAL LAMA2 DEFICIENCY	LAMA2, IVS25, T-C, +2	
156225	3908	LAMA2	0004	MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT	LAMA2, LEU2564PRO	121913570
156225	3908	LAMA2	0005	MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT	LAMA2, ARG3085TER	121913571
156225	3908	LAMA2	0006	MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT	LAMA2, 1-BP DEL, 8314A	
156225	3908	LAMA2	0007	MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT	LAMA2, 2-BP DEL, 2098AG	
156225	3908	LAMA2	0008	MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT	LAMA2, ARG2578TER	121913572
156225	3908	LAMA2	0009	MUSCULAR DYSTROPHY, CONGENITAL, DUE TO PARTIAL LAMA2 DEFICIENCY	LAMA2, CYS862ARG	121913573
156225	3908	LAMA2	0010	MUSCULAR DYSTROPHY, CONGENITAL, DUE TO PARTIAL LAMA2 DEFICIENCY	LAMA2, CYS527TYR	121913574
156225	3908	LAMA2	0011	MUSCULAR DYSTROPHY, CONGENITAL, DUE TO PARTIAL LAMA2 DEFICIENCY	LAMA2, ARG1549TER	121913575
156225	3908	LAMA2	0012	MUSCULAR DYSTROPHY, CONGENITAL, DUE TO PARTIAL LAMA2 DEFICIENCY	LAMA2, ARG2383TER	121913576
156225	3908	LAMA2	0013	MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT	LAMA2, CYS967TER	121913577
156225	3908	LAMA2	0014	MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT	LAMA, 1-BP DEL, 825C	
156225	3908	LAMA2	0015	MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT	LAMA2, 5-KB DEL	
156540	4507	MTAP	0001	DIAPHYSEAL MEDULLARY STENOSIS WITH MALIGNANT FIBROUS HISTIOCYTOMA	MTAP, 885A-G, ARG100ARG	
156540	4507	MTAP	0002	DIAPHYSEAL MEDULLARY STENOSIS WITH MALIGNANT FIBROUS HISTIOCYTOMA	MTAP, IVS9AS, A-G, -2	
156570	4548	MTR	0001	METHYLCOBALAMIN DEFICIENCY, cblG TYPE	MTR, PRO1173LEU	121913578
156570	4548	MTR	0002	METHYLCOBALAMIN DEFICIENCY, cblG TYPE	MTR, 3-BP DEL	
156570	4548	MTR	0003	METHYLCOBALAMIN DEFICIENCY, cblG TYPE	MTR, HIS920ASP	121913579
156570	4548	MTR	0004	METHYLCOBALAMIN DEFICIENCY, cblG TYPE	MTR, IVS, AS, A-G, -166	
156570	4548	MTR	0005	METHYLCOBALAMIN DEFICIENCY, cblG TYPE	MTR, 2-BP DEL, 2112TC	
156570	4548	MTR	0006	METHYLCOBALAMIN DEFICIENCY, cblG TYPE	MTR, IVS6AS, G-A, LYS203	
156570	4548	MTR	0007	METHYLCOBALAMIN DEFICIENCY, cblG TYPE	MTR, 1-BP INS, 3378A	
156570	4548	MTR	0008	NEURAL TUBE DEFECTS, FOLATE-SENSITIVE, SUSCEPTIBILITY TO	MTR, 2756A-G	
156570	4548	MTR	0009	METHYLCOBALAMIN DEFICIENCY, cblG TYPE	MTR, ARG585TER	121913580
156570	4548	MTR	0010	METHYLCOBALAMIN DEFICIENCY, cblG TYPE	MTR, GLU1204TER	121913581
156570	4548	MTR	0011	METHYLCOBALAMIN DEFICIENCY, cblG TYPE	MTR, ALA410PRO	121913582
156845	4286	MITF	0001	WAARDENBURG SYNDROME, TYPE 2A	MITF, IVS1DS, G-A, +1	
156845	4286	MITF	0002	WAARDENBURG SYNDROME, TYPE 2A	MITF, IVS4AS, A-C, -2	
156845	4286	MITF	0003	TIETZ ALBINISM-DEAFNESS SYNDROME	MITF, 3-BP DEL, ARG217DEL	
156845	4286	MITF	0004	WAARDENBURG SYNDROME, TYPE 2A	MITF, SER250PRO	104893744
156845	4286	MITF	0005	WAARDENBURG SYNDROME, TYPE 2A	MITF, 1-BP DEL	
156845	4286	MITF	0006	TIETZ ALBINISM-DEAFNESS SYNDROME	MITF, ASN210LYS	104893745
156845	4286	MITF	0007	WAARDENBURG SYNDROME, TYPE 2A	MITF, ARG214TER	104893746
156845	4286	MITF	0008	WAARDENBURG SYNDROME, TYPE 2A	MITF, SER298PRO	104893747
156845	4286	MITF	0009	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 8	MITF, GLU318LYS	
157140	4137	MAPT	0001	DEMENTIA, FRONTOTEMPORAL, WITH PARKINSONISM SUPRANUCLEAR PALSY, PROGRESSIVE, 1, INCLUDED	MAPT, PRO301LEU	63751273
157140	4137	MAPT	0002	DEMENTIA, FRONTOTEMPORAL, WITH PARKINSONISM	MAPT, GLY272VAL	63750376
157140	4137	MAPT	0003	DEMENTIA, FRONTOTEMPORAL	MAPT, ARG406TRP	63750424
157140	4137	MAPT	0004	DEMENTIA, FRONTOTEMPORAL, WITH PARKINSONISM	MAPT, IVS10, C-U, +14	
157140	4137	MAPT	0005	DEMENTIA, FRONTOTEMPORAL, WITH PARKINSONISM	MAPT, IVS10, A-G, +13	
157140	4137	MAPT	0006	DEMENTIA, FRONTOTEMPORAL, WITH PARKINSONISM	MAPT, IVS10, C-T, +16	
157140	4137	MAPT	0007	DEMENTIA, FRONTOTEMPORAL, WITH PARKINSONISM	MAPT, IVS10, G-A, +1	
157140	4137	MAPT	0008	DEMENTIA, FRONTOTEMPORAL, WITH PARKINSONISM	MAPT, VAL337MET	63750570
157140	4137	MAPT	0009	DEMENTIA, FRONTOTEMPORAL, WITH PARKINSONISM	MAPT, ASN279LYS	63750756
157140	4137	MAPT	0010	DEMENTIA, FRONTOTEMPORAL, WITH PARKINSONISM	MAPT, SER305ASN	63751165
157140	4137	MAPT	0011	PICK DISEASE	MAPT, GLY389ARG	63750512
157140	4137	MAPT	0012	DEMENTIA, FRONTOTEMPORAL, WITH PARKINSONISM	MAPT, PRO301SER	63751438
157140	4137	MAPT	0013	DEMENTIA, FRONTOTEMPORAL	MAPT, ASN296ASN	63750912
157140	4137	MAPT	0014	DEMENTIA, FRONTOTEMPORAL, WITH PARKINSONISM	MAPT, GLU342VAL	63750711
157140	4137	MAPT	0015	PICK DISEASE	MAPT, LYS257THR	63750129
157140	4137	MAPT	0016	PICK DISEASE	MAPT, LYS369ILE	63751264
157140	4137	MAPT	0017	DEMENTIA, FRONTOTEMPORAL, WITH PARKINSONISM	MAPT, ARG5HIS	63750959
157140	4137	MAPT	0018	PICK DISEASE	MAPT, SER320PHE	63750635
157140	4137	MAPT	0019	SUPRANUCLEAR PALSY, PROGRESSIVE, 1	MAPT, ARG5LEU	63750959
157140	4137	MAPT	0020	DEMENTIA, FRONTOTEMPORAL, WITH PARKINSONISM	MAPT, IVS10, T-C, +11	
157140	4137	MAPT	0021	SUPRANUCLEAR PALSY, PROGRESSIVE, 1, ATYPICAL PARKINSON DISEASE, LATE-ONSET, SUSCEPTIBILITY TO, INCLUDED	MAPT, ASN296DEL	199422218
157140	4137	MAPT	0022	DEMENTIA, FRONTOTEMPORAL	MAPT, LEU266VAL	63750349
157140	4137	MAPT	0023	SUPRANUCLEAR PALSY, PROGRESSIVE, 1	MAPT, SER352LEU	63750425
157140	4137	MAPT	0024	DEMENTIA, FRONTOTEMPORAL, WITH PARKINSONISM	MAPT, LYS317MET	63750092
157140	4137	MAPT	0025	SUPRANUCLEAR PALSY, PROGRESSIVE, 1	MAPT, GLY303VAL	63751391
157145	4477	MSMB	0001	PROSTATE CANCER, HEREDITARY, 13	MSMB, -2C-T	10993994
157147	4547	MTTP	0001	ABETALIPOPROTEINEMIA	MTP, 1-BP DEL, 215C	
157147	4547	MTTP	0002	ABETALIPOPROTEINEMIA	MTP, ARG215TER	199422219
157147	4547	MTTP	0003	ABETALIPOPROTEINEMIA	MTP, IVS, G-A, +5	
157147	4547	MTTP	0004	ABETALIPOPROTEINEMIA	MTP, IVS9AS, G-A, -1	
157147	4547	MTTP	0005	ABETALIPOPROTEINEMIA	MTP, ARG540HIS	199422220
157147	4547	MTTP	0006	ABETALIPOPROTEINEMIA	MTP, EXON 10 DEL	
157147	4547	MTTP	0007	ABETALIPOPROTEINEMIA	MTP, ASN780TYR	199422221
157147	4547	MTTP	0008	ABETALIPOPROTEINEMIA	MTP, SER590ILE	199422222
157147	4547	MTTP	0009	METABOLIC SYNDROME, PROTECTION AGAINST	MTP, ILE128THR	3816873
157147	4547	MTTP	0010	ABETALIPOPROTEINEMIA	MTP, GLY865TER	146064714
157655	4719	NDUFS1	0001	MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFS1, 3-BP DEL, 664CAT	
157655	4719	NDUFS1	0002	MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFS1, ASP252GLY	199422224
157655	4719	NDUFS1	0003	MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFS1, ARG241TRP	199422225
157655	4719	NDUFS1	0004	MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFS1, LEU231VAL	199422226
157655	4719	NDUFS1	0005	MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFS1, THR595ALA	
157655	4719	NDUFS1	0006	MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFS1, ASP619ASN	
157655	4719	NDUFS1	0007	MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFS1, ARG557TER	
157655	4719	NDUFS1	0008	MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFS1, ARG408CYS	
157660	6023	RMRP	0001	CARTILAGE-HAIR HYPOPLASIA METAPHYSEAL DYSPLASIA WITHOUT HYPOTRICHOSIS, INCLUDED	RMRP, 70A-G	199476103
157660	6023	RMRP	0002	CARTILAGE-HAIR HYPOPLASIA	RMRP, 262G-T	
157660	6023	RMRP	0003	CARTILAGE-HAIR HYPOPLASIA	RMRP, 10-BP DUP, NT-13	
157660	6023	RMRP	0004	CARTILAGE-HAIR HYPOPLASIA	RMRP, 15-BP DUP, NT-10	
157660	6023	RMRP	0005	CARTILAGE-HAIR HYPOPLASIA	RMRP, 2-BP DUP, 98TG	
157660	6023	RMRP	0006	CARTILAGE-HAIR HYPOPLASIA	RMRP, 6-BP INS, NT-6	
157660	6023	RMRP	0007	CARTILAGE-HAIR HYPOPLASIA	RMRP, 18-BP DUP, NT-3	
157660	6023	RMRP	0008	CARTILAGE-HAIR HYPOPLASIA	RMRP, 193G-A	
157660	6023	RMRP	0009	METAPHYSEAL DYSPLASIA WITHOUT HYPOTRICHOSIS	RMRP, 195C-T, 238C-T, 12-BP DUP	
157660	6023	RMRP	0010	METAPHYSEAL DYSPLASIA WITHOUT HYPOTRICHOSIS	RMRP, 238C-T	
157660	6023	RMRP	0011	METAPHYSEAL DYSPLASIA WITHOUT HYPOTRICHOSIS	RMRP, 12-BP DUP	
157660	6023	RMRP	0012	METAPHYSEAL DYSPLASIA WITHOUT HYPOTRICHOSIS	RMRP, 17-BP INS, NT-20	
157660	6023	RMRP	0013	METAPHYSEAL DYSPLASIA WITHOUT HYPOTRICHOSIS	RMRP, 218A-G	
157660	6023	RMRP	0014	CARTILAGE-HAIR HYPOPLASIA	RMRP, 17-BP DUP, NT3	
157660	6023	RMRP	0015	CARTILAGE-HAIR HYPOPLASIA	RMRP, 182G-A	
157660	6023	RMRP	0016	CARTILAGE-HAIR HYPOPLASIA	RMRP, 1-BP INS, 195T	
157660	6023	RMRP	0017	CARTILAGE-HAIR HYPOPLASIA	RMRP, 63C-T	
157660	6023	RMRP	0018	ANAUXETIC DYSPLASIA	RMRP, 14-BP INS, NT111	
157660	6023	RMRP	0019	ANAUXETIC DYSPLASIA	RMRP, 14G-A	
157660	6023	RMRP	0020	ANAUXETIC DYSPLASIA	RMRP, AG-GC, NT90	
157660	6023	RMRP	0021	ANAUXETIC DYSPLASIA	RMRP, 254C-G	
157660	6023	RMRP	0022	ANAUXETIC DYSPLASIA	RMRP, 10-BP DEL, NT254	
158105	6347	CCL2	0001	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO	CCL2, -2136A-T	
158105	6347	CCL2	0002	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO	CCL2, 767C-G	
158105	6347	CCL2	0003	SPINA BIFIDA, SUSCEPTIBILITY TO CORONARY ARTERY DISEASE, MODIFIER OF, INCLUDED;; CORONARY ARTERY DISEASE, DEVELOPMENT OF, IN HIV, INCLUDED;; MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO, INCLUDED	CCL2, -2518A-G	1024611
158340	4582	MUC1	0001	MEDULLARY CYSTIC KIDNEY DISEASE 1	MUC1, 1-BP INS, CYTOSINE IN VNTR	
158375	4589	MUC7	0001	ASTHMA, PROTECTION AGAINST	MUC7, 69-BP DUP, VARIABLE REPEATS	
158378	6575	SLC20A2	0001	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 3	SLC20A2, GLY498ARG	
158378	6575	SLC20A2	0002	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 3	SLC20A2, SER601TRP	
158378	6575	SLC20A2	0003	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 3	SLC20A2, SER601LEU	
158378	6575	SLC20A2	0004	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 3	SLC20A2, GLU575LYS	
158378	6575	SLC20A2	0005	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 3	SLC20A2, THR595MET	
159350	4163	MCC	0001	COLORECTAL CANCER, SOMATIC	MCC, ALA698VAL	121917731
159350	4163	MCC	0002	COLORECTAL CANCER, SOMATIC	MCC, ARG506GLN	121917732
159440	4359	MPZ	0001	CHARCOT-MARIE-TOOTH DISEASE, TYPE 1B	MPZ, LYS96GLU	121913583
159440	4359	MPZ	0002	CHARCOT-MARIE-TOOTH DISEASE, TYPE 1B	MPZ, ASP90GLU	121913584
159440	4359	MPZ	0003	CHARCOT-MARIE-TOOTH DISEASE, TYPE 1B	MPZ, 3-BP DEL, SER34DEL	
159440	4359	MPZ	0004	DEJERINE-SOTTAS SYNDROME, AUTOSOMAL DOMINANT	MPZ, SER63CYS	121913585
159440	4359	MPZ	0005	DEJERINE-SOTTAS SYNDROME, AUTOSOMAL DOMINANT	MPZ, GLY167ARG	121913586
159440	4359	MPZ	0006	CHARCOT-MARIE-TOOTH DISEASE, TYPE 1B	MPZ, THR216GLU-ARG	
159440	4359	MPZ	0007	CHARCOT-MARIE-TOOTH DISEASE, TYPE 1B	MPZ, ILE135THR	121913587
159440	4359	MPZ	0008	CHARCOT-MARIE-TOOTH DISEASE, TYPE 1B	MPZ, GLY137SER	121913588
159440	4359	MPZ	0009	CHARCOT-MARIE-TOOTH DISEASE, TYPE 1B	MPZ, ARG98PRO	121913589
159440	4359	MPZ	0010	CHARCOT-MARIE-TOOTH DISEASE, TYPE 1B	MPZ, ARG98CYS	121913590
159440	4359	MPZ	0011	CHARCOT-MARIE-TOOTH DISEASE, TYPE 1B	MPZ, ARG98HIS	
159440	4359	MPZ	0012	CHARCOT-MARIE-TOOTH DISEASE, TYPE 1B	MPZ, SER63PHE	
159440	4359	MPZ	0013	NEUROPATHY, CONGENITAL HYPOMYELINATING, AUTOSOMAL DOMINANT	MPZ, GLN186TER	121913593
159440	4359	MPZ	0014	CHARCOT-MARIE-TOOTH DISEASE, TYPE 1B	MPZ, HIS81ARG	121913594
159440	4359	MPZ	0015	DEJERINE-SOTTAS SYNDROME, SPORADIC	MPZ, ILE85THR, ASN87HIS, ASP99ASN	
159440	4359	MPZ	0016	CHARCOT-MARIE-TOOTH DISEASE, TYPE 2J CHARCOT-MARIE-TOOTH DISEASE, TYPE 1B, INCLUDED	MPZ, THR124MET	121913595
159440	4359	MPZ	0017	CHARCOT-MARIE-TOOTH DISEASE, TYPE 2I	MPZ, ILE89ASN, VAL92MET, ILE162MET	
159440	4359	MPZ	0018	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE D	MPZ, ASP6TYR	121913596
159440	4359	MPZ	0019	CHARCOT-MARIE-TOOTH DISEASE, TYPE 2J	MPZ, ASP75VAL	121913597
159440	4359	MPZ	0020	CHARCOT-MARIE-TOOTH DISEASE, TYPE 2I	MPZ, SER44PHE	121913598
159440	4359	MPZ	0021	ROUSSY-LEVY SYNDROME	MPZ, ASN131LYS	121913599
159440	4359	MPZ	0022	CHARCOT-MARIE-TOOTH DISEASE, TYPE 1B	MPZ, GLY74GLU	121913600
159440	4359	MPZ	0023	CHARCOT-MARIE-TOOTH DISEASE, TYPE 1B, WITH FOCALLY FOLDED MYELIN SHEATHS	MPZ, SER49LEU	121913601
159440	4359	MPZ	0024	CHARCOT-MARIE-TOOTH DISEASE, TYPE 1B, WITH FOCALLY FOLDED MYELIN SHEATHS	MPZ, ILE62PHE	121913602
159440	4359	MPZ	0025	DEJERINE-SOTTAS SYNDROME, AUTOSOMAL RECESSIVE	MPZ, 1-BP DEL	
159440	4359	MPZ	0026	CHARCOT-MARIE-TOOTH DISEASE, TYPE 1B	MPZ, TYR145SER	121913603
159440	4359	MPZ	0027	NEUROPATHY, CONGENITAL HYPOMYELINATING, AUTOSOMAL DOMINANT	MPZ, 3-BP DEL/1-BP INS, NT550	
159440	4359	MPZ	0028	CHARCOT-MARIE-TOOTH DISEASE, TYPE 2I	MPZ, ASP60HIS	121913604
159440	4359	MPZ	0029	CHARCOT-MARIE-TOOTH DISEASE, TYPE 2I	MPZ, ILE62MET	121913605
159440	4359	MPZ	0030	CHARCOT-MARIE-TOOTH DISEASE, TYPE 2J	MPZ, GLU97VAL	121913606
159440	4359	MPZ	0031	NEUROPATHY, CONGENITAL HYPOMYELINATING, AUTOSOMAL DOMINANT	MPZ, THR124LYS	
159440	4359	MPZ	0032	CHARCOT-MARIE-TOOTH DISEASE, TYPE 1B	MPZ, IVS4DS, T-G, +2	
159440	4359	MPZ	0033	CHARCOT-MARIE-TOOTH DISEASE, TYPE 1B	MPZ, GLY123SER	121913608
159440	4359	MPZ	0034	CHARCOT-MARIE-TOOTH DISEASE, TYPE 2J	MPZ, PRO105THR	121913609
159440	4359	MPZ	0035	CHARCOT-MARIE-TOOTH DISEASE, TYPE 1B	MPZ, VAL102VAL	
159440	4359	MPZ	0036	CHARCOT-MARIE-TOOTH DISEASE, TYPE 1B	MPZ, ASP195TYR	
159465	4340	MOG	0001	NARCOLEPSY 7	MOG, SER133CYS	
159530	4352	MPL	0001	AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL	MPL, GLN186TER	121913610
159530	4352	MPL	0002	AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL	MPL, 1-BP DEL, 1499T	
159530	4352	MPL	0003	AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL	MPL, ARG257CYS	121913611
159530	4352	MPL	0004	AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL	MPL, PRO635LEU	121913612
159530	4352	MPL	0005	AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL	MPL, ARG102PRO	28928907
159530	4352	MPL	0006	AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL	MPL, TRP491TER	121913613
159530	4352	MPL	0007	AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL	MPL, IVS10AS, G-T, -1	
159530	4352	MPL	0008	AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL	MPL, PRO275THR	28928908
159530	4352	MPL	0009	THROMBOCYTHEMIA 2, SUSCEPTIBILITY TO	MPL, LYS39ASN	17292650
159530	4352	MPL	0010	THROMBOCYTHEMIA 2	MPL, SER505ASN	121913614
159530	4352	MPL	0011	MYELOFIBROSIS WITH MYELOID METAPLASIA, SOMATIC THROMBOCYTHEMIA 2, SOMATIC, INCLUDED	MPL, TRP515LEU	121913615
159530	4352	MPL	0012	MYELOFIBROSIS WITH MYELOID METAPLASIA, SOMATIC	MPL, TRP515LYS	121913616
159555	4297	KMT2A	0001	HAIRY ELBOWS, SHORT STATURE, FACIAL DYSMORPHISM, AND DEVELOPMENTAL DELAY	MLL, 4-BP DEL, NT8806	
159555	4297	KMT2A	0002	HAIRY ELBOWS, SHORT STATURE, FACIAL DYSMORPHISM, AND DEVELOPMENTAL DELAY	MLL, 1-BP DEL, NT8267	
159555	4297	KMT2A	0003	HAIRY ELBOWS, SHORT STATURE, FACIAL DYSMORPHISM, AND DEVELOPMENTAL DELAY	MLL, 1-BP DEL, NT6913	
159555	4297	KMT2A	0004	HAIRY ELBOWS, SHORT STATURE, FACIAL DYSMORPHISM, AND DEVELOPMENTAL DELAY	MLL, ARG2382TER	
159555	4297	KMT2A	0005	HAIRY ELBOWS, SHORT STATURE, FACIAL DYSMORPHISM, AND DEVELOPMENTAL DELAY	MLL, 1-BP DUP, NT4599	
159991	4618	MYF6	0001	MYOPATHY, CENTRONUCLEAR, 3	MYF6, ALA112SER	28928909
160710	4624	MYH6	0001	MYOSIN, CARDIAC, HEAVY CHAIN VARIANT	MYH6, MYH6/MYH7 HYBRID	
160710	4624	MYH6	0002	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 14	MYH6, ARG795GLN	
160710	4624	MYH6	0003	ATRIAL SEPTAL DEFECT 3	MYH6, ILE820ASN	
160710	4624	MYH6	0004	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 14	MYH6, GLN1065HIS	
160710	4624	MYH6	0005	CARDIOMYOPATHY, DILATED, 1EE	MYH6, PRO830LEU	
160710	4624	MYH6	0006	CARDIOMYOPATHY, DILATED, 1EE	MYH6, ALA1004SER	
160710	4624	MYH6	0007	CARDIOMYOPATHY, DILATED, 1EE	MYH6, GLU1457LYS	
160710	4624	MYH6	0008	SICK SINUS SYNDROME 3, SUSCEPTIBILITY TO	MYH6, ARG721TRP	
160720	4621	MYH3	0001	ARTHROGRYPOSIS, DISTAL, TYPE 2A	MYH3, ARG672HIS	121913617
160720	4621	MYH3	0002	ARTHROGRYPOSIS, DISTAL, TYPE 2A	MYH3, ARG672CYS	121913618
160720	4621	MYH3	0003	ARTHROGRYPOSIS, DISTAL, TYPE 2A ARTHROGRYPOSIS, DISTAL, TYPE 2B, INCLUDED	MYH3, THR178ILE	121913619
160720	4621	MYH3	0004	ARTHROGRYPOSIS, DISTAL, TYPE 2A	MYH3, VAL825ASP	121913620
160720	4621	MYH3	0005	ARTHROGRYPOSIS, DISTAL, TYPE 2B	MYH3, 3-BP DEL, 2590CTC	
160720	4621	MYH3	0006	ARTHROGRYPOSIS, DISTAL, TYPE 2B	MYH3, GLU375LYS	121913621
160720	4621	MYH3	0007	ARTHROGRYPOSIS, DISTAL, TYPE 2B	MYH3, ASP462GLY	121913622
160720	4621	MYH3	0008	ARTHROGRYPOSIS, DISTAL, TYPE 2B	MYH3, ALA234THR	121913623
160740	4620	MYH2	0001	INCLUSION BODY MYOPATHY 3	MYH2, GLU706LYS	121434589
160741	4626	MYH8	0001	CARNEY COMPLEX VARIANT TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME, INCLUDED	MYH8, ARG674GLN	121434590
160745	4629	MYH11	0001	AORTIC ANEURYSM, FAMILIAL THORACIC 4	MYH11, IVS32, G-T, +1, ARG1758GLN	
160745	4629	MYH11	0002	AORTIC ANEURYSM, FAMILIAL THORACIC 4	MYH11, 72-BP DEL	
160745	4629	MYH11	0003	AORTIC ANEURYSM, FAMILIAL THORACIC 4	MYH11, LEU1264PRO	
160745	4629	MYH11	0004	AORTIC ANEURYSM, FAMILIAL THORACIC 4	MYH11, ARG1275LEU	
160745	4629	MYH11	0005	AORTIC ANEURYSM, FAMILIAL THORACIC 4	MYH11, ARG712GLN	
160760	4625	MYH7	0001	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1	MYH7, ARG403GLN	121913624
160760	4625	MYH7	0002	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1	MYH7, ARG249GLN	3218713
160760	4625	MYH7	0003	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1	MYH7, ARG453CYS	121913625
160760	4625	MYH7	0004	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1	MYH7, GLY584ARG	121913626
160760	4625	MYH7	0005	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1	MYH7, VAL606MET	121913627
160760	4625	MYH7	0006	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1	MYH7, GLU924LYS	121913628
160760	4625	MYH7	0007	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1	MYH7, GLU949LYS	121913629
160760	4625	MYH7	0008	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1	MYH7, ARG723CYS	121913630
160760	4625	MYH7	0009	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1	MYH7, 2.4-KB DEL	
160760	4625	MYH7	0010	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1	MYH7, LEU908VAL	121913631
160760	4625	MYH7	0011	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1	MYH7, GLY741ARG	121913632
160760	4625	MYH7	0012	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1	MYH7, GLY256GLU	121913633
160760	4625	MYH7	0013	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1	MYH7, ASP778GLY	121913634
160760	4625	MYH7	0014	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1	MYH7, ARG403LEU	
160760	4625	MYH7	0015	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1	MYH7, ARG403TRP	3218714
160760	4625	MYH7	0016	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1	MYH7, PHE513CYS	121913636
160760	4625	MYH7	0017	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1	MYH7, ARG719TRP	121913637
160760	4625	MYH7	0018	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1	MYH7, GLY716ARG	121913638
160760	4625	MYH7	0019	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1	MYH7, GLU935LYS	121913639
160760	4625	MYH7	0020	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1	MYH7, MET349THR	121913640
160760	4625	MYH7	0021	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1	MYH7, ARG719GLN	121913641
160760	4625	MYH7	0022	CARDIOMYOPATHY, DILATED, 1S	MYH7, SER532PRO	121913642
160760	4625	MYH7	0023	CARDIOMYOPATHY, DILATED, 1S	MYH7, PHE764LEU	121913643
160760	4625	MYH7	0024	CARDIOMYOPATHY, HYPERTROPHIC, MIDVENTRICULAR, DIGENIC	MYH7, GLU743ASP	
160760	4625	MYH7	0025	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1	MYH7, ALA728VAL	121913644
160760	4625	MYH7	0026	CARDIOMYOPATHY, DILATED, 1S	MYH7, ALA223THR	121913645
160760	4625	MYH7	0027	CARDIOMYOPATHY, DILATED, 1S	MYH7, SER642LEU	121913646
160760	4625	MYH7	0028	MYOPATHY, MYOSIN STORAGE SCAPULOPERONEAL MYOPATHY, MYH7-RELATED, INCLUDED	MYH7, ARG1845TRP	28933098
160760	4625	MYH7	0029	LAING DISTAL MYOPATHY	MYH7, ARG1500PRO	121913647
160760	4625	MYH7	0030	LAING DISTAL MYOPATHY	MYH7, LYS1617DEL	121913648
160760	4625	MYH7	0031	MYOPATHY, MYOSIN STORAGE	MYH7, HIS1904LEU	121913649
160760	4625	MYH7	0032	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1	MYH7, ARG1712TRP	121913650
160760	4625	MYH7	0033	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1	MYH7, GLU483LYS	121913651
160760	4625	MYH7	0034	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1	MYH7, ARG870HIS	36211715
160760	4625	MYH7	0035	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1 MYOPATHY, MYOSIN STORAGE, INCLUDED	MYH7, GLU1883LYS	121913652
160760	4625	MYH7	0036	LAING DISTAL MYOPATHY	MYH7, THR441MET	121913653
160760	4625	MYH7	0037	MYOPATHY, MYOSIN STORAGE CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1, INCLUDED;; LEFT VENTRICULAR NONCOMPACTION 5, INCLUDED	MYH7, LEU1793PRO	121913654
160760	4625	MYH7	0038	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1	MYH7, GLU497ASP	
160760	4625	MYH7	0039	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1	MYH7, ASP906GLY	
160760	4625	MYH7	0040	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1 LEFT VENTRICULAR NONCOMPACTION 5, INCLUDED	MYH7, ARG243HIS	
160760	4625	MYH7	0041	LEFT VENTRICULAR NONCOMPACTION 5	MYH7, IVS8DS, G-A, +1	
160760	4625	MYH7	0042	LEFT VENTRICULAR NONCOMPACTION 5	MYH7, ALA1766THR	
160760	4625	MYH7	0043	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1	MYH7, ARG453SER	
160760	4625	MYH7	0044	LAING DISTAL MYOPATHY	MYH7, 3-BP DEL, AAG	
160775	4627	MYH9	0001	MAY-HEGGLIN ANOMALY FECHTNER SYNDROME, INCLUDED;; SEBASTIAN SYNDROME, INCLUDED	MYH9, ARG1933TER	80338835
160775	4627	MYH9	0002	MAY-HEGGLIN ANOMALY FECHTNER SYNDROME, INCLUDED	MYH9, GLU1841LYS	80338834
160775	4627	MYH9	0003	SEBASTIAN SYNDROME	MYH9, ARG1165CYS	80338829
160775	4627	MYH9	0004	MAY-HEGGLIN ANOMALY	MYH9, ASN93LYS	121913655
160775	4627	MYH9	0005	FECHTNER SYNDROME	MYH9, ASP1424HIS	80338831
160775	4627	MYH9	0006	FECHTNER SYNDROME EPSTEIN SYNDROME, INCLUDED;; SEBASTIAN SYNDROME, INCLUDED;; MAY-HEGGLIN ANOMALY, INCLUDED	MYH9, ARG702CYS	80338826
160775	4627	MYH9	0007	MAY-HEGGLIN ANOMALY FECHTNER SYNDROME, INCLUDED	MYH9, THR1155ILE	121913656
160775	4627	MYH9	0008	DEAFNESS, AUTOSOMAL DOMINANT 17	MYH9, ARG705HIS	80338828
160775	4627	MYH9	0009	FECHTNER SYNDROME EPSTEIN SYNDROME, INCLUDED	MYH9, ARG702HIS	80338827
160775	4627	MYH9	0010	MAY-HEGGLIN ANOMALY FECHTNER SYNDROME, INCLUDED;; MACROTHROMBOCYTOPENIA AND PROGRESSIVE SENSORINEURAL DEAFNESS, INCLUDED;; SEBASTIAN SYNDROME, INCLUDED	MYH9, ASP1424ASN	80338831
160775	4627	MYH9	0011	MAY-HEGGLIN ANOMALY	MYH9, 1-BP DEL, 5818G	
160775	4627	MYH9	0012	EPSTEIN SYNDROME	MYH9, SER96LEU	121913657
160775	4627	MYH9	0013	MAY-HEGGLIN ANOMALY SEBASTIAN SYNDROME, INCLUDED	MYH9, 21-BP DEL	
160775	4627	MYH9	0014	MAY-HEGGLIN ANOMALY	MYH9, 21-BP DUP	
160775	4627	MYH9	0015	MACROTHROMBOCYTOPENIA AND PROGRESSIVE SENSORINEURAL DEAFNESS	MYH9, 18-BP DEL, NT228	
160777	4644	MYO5A	0002	GRISCELLI SYNDROME, TYPE 1	MYO5A, 2332C-T	
160777	4644	MYO5A	0003	GRISCELLI SYNDROME, TYPE 1	MYO5A, 47-BP INS, NT4634	
160777	4644	MYO5A	0004	GRISCELLI SYNDROME, TYPE 3	MYO5A, F-EXON DEL	
160781	4633	MYL2	0001	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 10	MYL2, ALA13THR	104894363
160781	4633	MYL2	0002	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 10	MYL2, GLU22LYS	104894368
160781	4633	MYL2	0003	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 10	MYL2, PRO94ARG	121913658
160781	4633	MYL2	0004	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 10	MYL2, ARG58GLN	104894369
160781	4633	MYL2	0005	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 10	MYL2, PHE18LEU	104894370
160790	4634	MYL3	0001	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 8	MYL3, MET149VAL	104893748
160790	4634	MYL3	0002	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 8	MYL3, ARG154HIS	104893749
160790	4634	MYL3	0003	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 8	MYL3, GLU143LYS	104893750
160794	4604	MYBPC1	0001	ARTHROGRYPOSIS, DISTAL, TYPE 1B	MYBPC1, TRP236ARG	
160794	4604	MYBPC1	0002	ARTHROGRYPOSIS, DISTAL, TYPE 1B	MYBPC1, TRP236ARG	
160794	4604	MYBPC1	0003	LETHAL CONGENITAL CONTRACTURE SYNDROME 4	MYBPC1, ARG318TER	
161015	4723	NDUFV1	0001	MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFV1, THR423MET	121913659
161015	4723	NDUFV1	0002	MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFV1, 175C-T	
161015	4723	NDUFV1	0003	MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFV1, ALA341VAL	121913660
161015	4723	NDUFV1	0004	MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFV1, GLU214LYS	121913661
161015	4723	NDUFV1	0005	MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFV1, IVS8DS, A-C, +4	
161561	3593	IL12B	0001	BCG AND SALMONELLA INFECTION, DISSEMINATED	IL12B, 4.4-KB DEL	
161561	3593	IL12B	0002	BCG AND SALMONELLA INFECTION, DISSEMINATED	IL12B, 1-BP INS, 315A	
161561	3593	IL12B	0003	ASTHMA, SEVERE, SUSCEPTIBILITY TO	IL12B, 4237G-A	
161650	4703	NEB	0001	NEMALINE MYOPATHY 2	NEB, 1-BP DEL, G, EX165	
161650	4703	NEB	0002	NEMALINE MYOPATHY 2	NEB, 4-BP INS, EX172	
161650	4703	NEB	0003	NEMALINE MYOPATHY 2	NEB, 2-BP DEL, AG, EX172	
161650	4703	NEB	0004	NEMALINE MYOPATHY 2	NEB, 2-BP DEL, GA, EX181	
161650	4703	NEB	0005	NEMALINE MYOPATHY 2	NEB, GLU6636TER	121913662
161650	4703	NEB	0006	NEMALINE MYOPATHY 2	NEB, IVS163DS, G-C	
161650	4703	NEB	0007	NEMALINE MYOPATHY 2	NEB, 2,502-BP DEL, EX55 DEL	80358246
162030	4803	NGF	0001	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE V	NGFB, ARG211TRP	11466112
162030	4803	NGF	0002	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE V	NGFB, 680C-A AND 2-BP DEL, 681GG	
162080	4901	NRL	0001	RETINITIS PIGMENTOSA 27	NRL, SER50THR	104894459
162080	4901	NRL	0002	RETINAL DEGENERATION, AUTOSOMAL RECESSIVE, CLUMPED PIGMENT TYPE	NRL, 1-BP INS, 224C	
162080	4901	NRL	0003	RETINAL DEGENERATION, AUTOSOMAL RECESSIVE, CLUMPED PIGMENT TYPE	NRL, LEU160PRO	104894463
162080	4901	NRL	0004	RETINITIS PIGMENTOSA 27	NRL, MET96THR	
162150	5122	PCSK1	0001	PROPROTEIN CONVERTASE 1/3 DEFICIENCY	PCSK1, GLY483ARG	137852821
162150	5122	PCSK1	0002	PROPROTEIN CONVERTASE 1/3 DEFICIENCY	PCSK1, IVS5DS, A-C, +4	
162150	5122	PCSK1	0003	PROPROTEIN CONVERTASE 1/3 DEFICIENCY	PCSK1, GLU250TER	137852822
162150	5122	PCSK1	0004	PROPROTEIN CONVERTASE 1/3 DEFICIENCY	PCSK1, ALA213DEL	137852823
162150	5122	PCSK1	0005	OBESITY, SUSCEPTIBILITY TO	PCSK1, ASN221ASP	6232
162150	5122	PCSK1	0006	PROPROTEIN CONVERTASE 1/3 DEFICIENCY	PCSK1, SER307LEU	137852824
162230	4744	NEFH	0001	AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO	NEFH, 42-BP DEL, NT1989	
162280	4747	NEFL	0001	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E	NEFL, GLN333PRO	59443585
162280	4747	NEFL	0002	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E	NEFL, PRO22SER	28928910
162280	4747	NEFL	0003	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E CHARCOT-MARIE-TOOTH DISEASE, TYPE 1F, INCLUDED	NEFL, PRO8ARG	61491953
162280	4747	NEFL	0004	CHARCOT-MARIE-TOOTH DISEASE, TYPE 1F	NEFL, 3-BP DEL, 1581GAG	
162280	4747	NEFL	0005	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E	NEFL, 13-BP DUP/INS, NT61	
162280	4747	NEFL	0006	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E	NEFL, LEU94PRO	62636505
162280	4747	NEFL	0007	CHARCOT-MARIE-TOOTH DISEASE, TYPE 1F	NEFL, GLU140TER	121913663
162280	4747	NEFL	0008	CHARCOT-MARIE-TOOTH DISEASE, TYPE 1F	NEFL, GLU210TER	
162330	6866	TAC3	0001	HYPOGONADOTROPIC HYPOGONADISM 10 WITHOUT ANOSMIA	TAC3, MET90THR	121918123
162332	6870	TACR3	0001	HYPOGONADOTROPIC HYPOGONADISM 11 WITHOUT ANOSMIA	TACR3, GLY93ASP	121918124
162332	6870	TACR3	0002	HYPOGONADOTROPIC HYPOGONADISM 11 WITHOUT ANOSMIA	TACR3, PRO353SER	121918125
162640	4852	NPY	0001	NEUROPEPTIDE Y POLYMORPHISM	NPY, LEU7PRO	16139
162643	7852	CXCR4	0001	WHIM SYNDROME MYELOKATHEXIS, ISOLATED, INCLUDED	CXCR4, ARG334TER	104893624
162643	7852	CXCR4	0002	WHIM SYNDROME	CXCR4, 2-BP DEL, 1016CT	
162643	7852	CXCR4	0003	WHIM SYNDROME	CXCR4, GLU343TER	104893625
162643	7852	CXCR4	0004	WHIM SYNDROME	CXCR4, SER338TER	104893626
162662	4909	NTF4	0001	GLAUCOMA 1, OPEN ANGLE, O	NTF4, ALA88VAL	61732310
162662	4909	NTF4	0002	GLAUCOMA 1, OPEN ANGLE, O	NTF4, ARG206TRP	121918427
162662	4909	NTF4	0003	GLAUCOMA 1, OPEN ANGLE, O	NTF4, ARG206GLN	121918428
163729	4846	NOS3	0001	CORONARY ARTERY SPASM 1, SUSCEPTIBILITY TO ALZHEIMER DISEASE, LATE-ONSET, SUSCEPTIBILITY TO, INCLUDED;; HYPERTENSION, PREGNANCY-INDUCED, SUSCEPTIBILITY TO, INCLUDED;; HYPERTENSION RESISTANT TO CONVENTIONAL THERAPY, INCLUDED;; ISCHEMIC HEART DISEASE, SUSCEPTIBILITY TO, INCLUDED;; ISCHEMIC STROKE, SUSCEPTIBILITY TO, INCLUDED	NOS3, GLU298ASP	1799983
163729	4846	NOS3	0002	CORONARY ARTERY SPASM 1, SUSCEPTIBILITY TO	NOS3, -786T-C	
163730	4843	NOS2	0001	MALARIA, RESISTANCE TO	NOS2A, -1173C-T	
163730	4843	NOS2	0002	MALARIA, SEVERE, RESISTANCE TO	NOS2A, -969G-C	
163731	4842	NOS1	0001	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	NOS1, -84G-A	41279104
163890	6622	SNCA	0001	PARKINSON DISEASE 1, AUTOSOMAL DOMINANT	SNCA, ALA53THR	104893877
163890	6622	SNCA	0002	PARKINSON DISEASE 1, AUTOSOMAL DOMINANT	SNCA, ALA30PRO	104893878
163890	6622	SNCA	0003	PARKINSON DISEASE 4, AUTOSOMAL DOMINANT	SNCA, TRIPLICATION	
163890	6622	SNCA	0004	DEMENTIA, LEWY BODY	SNCA, GLU46LYS	104893875
163890	6622	SNCA	0005	PARKINSON DISEASE 1, AUTOSOMAL DOMINANT DEMENTIA, LEWY BODY, INCLUDED	SNCA, DUPLICATION	
163970	6530	SLC6A2	0001	ORTHOSTATIC INTOLERANCE	SLC6A2, ALA457PRO	121918126
164005	4784	NFIX	0001	SOTOS SYNDROME 2	NFIX, GLN190TER	
164005	4784	NFIX	0002	MARSHALL-SMITH SYNDROME	NFIX, 2-BP DEL, 1011TC	
164005	4784	NFIX	0003	MARSHALL-SMITH SYNDROME	NFIX, 1-BP INS, 1037T	
164005	4784	NFIX	0004	MARSHALL-SMITH SYNDROME	NFIX, 5-BP DEL, NT1008	
164005	4784	NFIX	0005	MARSHALL-SMITH SYNDROME	NFIX, 1-BP INS, 1048C	
164005	4784	NFIX	0006	MARSHALL-SMITH SYNDROME	NFIX, 1-BP DEL, 1243G	
164005	4784	NFIX	0007	MARSHALL-SMITH SYNDROME	NFIX, 1-BP INS, 994T	
164005	4784	NFIX	0008	MARSHALL-SMITH SYNDROME	NFIX, 1-BP INS, 959C	
164005	4784	NFIX	0009	MARSHALL-SMITH SYNDROME	NFIX, IVS6DS, G-A, +1	
164005	4784	NFIX	0010	MARSHALL-SMITH SYNDROME	NFIX, IVS6DS, G-T, +1	
164005	4784	NFIX	0011	SOTOS SYNDROME 2	NFIX, LEU60PRO	
164005	4784	NFIX	0012	SOTOS SYNDROME 2	NFIX, ARG121PRO	
164008	4792	NFKBIA	0001	ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH T-CELL IMMUNODEFICIENCY, AUTOSOMAL DOMINANT	NFKBIA, SER32ILE	28933100
164008	4792	NFKBIA	0002	ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH T-CELL IMMUNODEFICIENCY, AUTOSOMAL DOMINANT	NFKBIA, TRP11TER	121913664
164008	4792	NFKBIA	0003	ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH T-CELL IMMUNODEFICIENCY, AUTOSOMAL DOMINANT	NFKBIA, GLU14TER	121913665
164010	5119	CHMP1A	0001	PONTOCEREBELLAR HYPOPLASIA, TYPE 8	CHMP1A, GLN30TER	
164010	5119	CHMP1A	0002	PONTOCEREBELLAR HYPOPLASIA, TYPE 8	CHMP1A, IVS2AS, G-A, -13	
164015	9782	MATR3	0001	MYOPATHY, DISTAL, 2	MATR3, SER85CYS	121434591
164040	4869	NPM1	0001	LEUKEMIA, ACUTE MYELOID	NPM1, 4-BP DUP, 956TCTG	
164040	4869	NPM1	0002	LEUKEMIA, ACUTE MYELOID	NPM1, 4-BP INS, 960CATG	
164040	4869	NPM1	0003	LEUKEMIA, ACUTE MYELOID	NPM1, 4-BP INS, 960CGTG	
164040	4869	NPM1	0004	LEUKEMIA, ACUTE MYELOID	NPM1, 4-BP INS, 960CCTG	
164050	4860	PNP	0001	NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	PNP, GLU89LYS	104894453
164050	4860	PNP	0002	NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	PNP, ALA174PRO	104894454
164050	4860	PNP	0003	NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	PNP, ASP128GLY	104894450
164050	4860	PNP	0004	NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	PNP, ARG234PRO	104894451
164050	4860	PNP	0005	NUCLEOSIDE PHOSPHORYLASE POLYMORPHISM	PNP, SER51GLY	1049564
164050	4860	PNP	0006	NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	PNP, TYR192CYS	104894452
164050	4860	PNP	0007	NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	NP, 1-BP DEL	
164050	4860	PNP	0008	NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	PNP, ARG24TER	104894455
164050	4860	PNP	0009	NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	PNP, ARG58TER	104894460
164050	4860	PNP	0010	NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	PNP, IVS3DS, G-A, +1	
164160	3952	LEP	0001	LEPTIN DEFICIENCY	LEP, 1-BP DEL, FS147TER	
164160	3952	LEP	0002	LEPTIN DEFICIENCY	LEP, ARG105TRP	104894023
164350	4938	OAS1	0001	DIABETES MELLITUS, TYPE 1, SUSCEPTIBILITY TO	OAS1, IVS6, G-A, -1	
164350	4938	OAS1	0002	DIABETES MELLITUS, TYPE 1, SUSCEPTIBILITY TO	OAS1, SER162GLY	1131454
164360	498	ATP5A1	0001	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4 (1 family)	ATP5A1, ARG329CYS	
164730	207	AKT1	0001	BREAST CANCER, SOMATIC COLORECTAL CANCER, SOMATIC, INCLUDED;; OVARIAN CANCER, SOMATIC, INCLUDED;; PROTEUS SYNDROME, SOMATIC, INCLUDED	AKT1, GLU17LYS	121434592
164730	207	AKT1	0002	COWDEN DISEASE 6	AKT1, ARG25CYS	
164730	207	AKT1	0003	COWDEN DISEASE 6	AKT1, THR435PRO	
164731	208	AKT2	0001	DIABETES MELLITUS, TYPE II	AKT2, ARG274HIS	121434593
164731	208	AKT2	0002	HYPOINSULINEMIC HYPOGLYCEMIA AND HEMIHYPERTROPHY	AKT2, GLU17LYS	
164757	673	BRAF	0001	MELANOMA, MALIGNANT, SOMATIC COLORECTAL CANCER, SOMATIC, INCLUDED;; THYROID CARCINOMA, PAPILLARY, SOMATIC, INCLUDED;; NONSEMINOMATOUS GERM CELL TUMORS, SOMATIC, INCLUDED;; ASTROCYTOMA, LOW-GRADE, SOMATIC, INCLUDED	BRAF, VAL600GLU	113488022
164757	673	BRAF	0002	COLON CANCER, SOMATIC	BRAF, ARG462ILE	180177032
164757	673	BRAF	0003	COLORECTAL CANCER, SOMATIC	BRAF, ILE463SER	180177033
164757	673	BRAF	0004	COLORECTAL CANCER, SOMATIC	BRAF, GLY464GLU	121913348
164757	673	BRAF	0005	COLORECTAL CANCER, SOMATIC THYROID CARCINOMA, FOLLICULAR, SOMATIC, INCLUDED	BRAF, LYS601GLU	121913364
164757	673	BRAF	0006	ADENOCARCINOMA OF LUNG, SOMATIC	BRAF, GLY466VAL	121913351
164757	673	BRAF	0007	ADENOCARCINOMA OF LUNG, SOMATIC	BRAF, LEU597ARG	121913366
164757	673	BRAF	0008	NONSMALL CELL LUNG CANCER, SOMATIC	BRAF, LEU597VAL	121913369
164757	673	BRAF	0009	LYMPHOMA, NON-HODGKIN, SOMATIC	BRAF, GLY469ARG	121913357
164757	673	BRAF	0010	LYMPHOMA, NON-HODGKIN, SOMATIC	BRAF, GLY469ALA	121913355
164757	673	BRAF	0011	LYMPHOMA, NON-HODGKIN, SOMATIC	BRAF, ASP594GLY	121913338
164757	673	BRAF	0012	CARDIOFACIOCUTANEOUS SYNDROME 1	BRAF, ALA246PRO	180177034
164757	673	BRAF	0013	CARDIOFACIOCUTANEOUS SYNDROME 1	BRAF, GLN257ARG	180177035
164757	673	BRAF	0014	CARDIOFACIOCUTANEOUS SYNDROME 1	BRAF, GLY469GLU	121913355
164757	673	BRAF	0015	CARDIOFACIOCUTANEOUS SYNDROME 1	BRAF, LEU485PHE	180177036
164757	673	BRAF	0016	CARDIOFACIOCUTANEOUS SYNDROME 1	BRAF, LYS499GLU	180177037
164757	673	BRAF	0017	CARDIOFACIOCUTANEOUS SYNDROME 1	BRAF, GLU501LYS	180177038
164757	673	BRAF	0018	CARDIOFACIOCUTANEOUS SYNDROME 1	BRAF, GLU501GLY	180177039
164757	673	BRAF	0019	CARDIOFACIOCUTANEOUS SYNDROME 1	BRAF, ASN581ASP	180177040
164757	673	BRAF	0020	CARDIOFACIOCUTANEOUS SYNDROME 1	BRAF, GLY534ARG	180177041
164757	673	BRAF	0021	CARDIOFACIOCUTANEOUS SYNDROME 1	BRAF, ASP638GLU	180177042
164757	673	BRAF	0022	NOONAN SYNDROME 7	BRAF, THR241MET	
164757	673	BRAF	0023	NOONAN SYNDROME 7	BRAF, THR241ARG	
164757	673	BRAF	0024	CARDIOFACIOCUTANEOUS SYNDROME 1 LEOPARD SYNDROME 3, INCLUDED	BRAF, THR241PRO	
164757	673	BRAF	0025	NOONAN SYNDROME 7	BRAF, TRP531CYS	
164757	673	BRAF	0026	NOONAN SYNDROME 7	BRAF, LEU597VAL	
164760	5894	RAF1	0001	NOONAN SYNDROME 5 LEOPARD SYNDROME 2, INCLUDED	RAF1, SER257LEU	80338796
164760	5894	RAF1	0002	NOONAN SYNDROME 5	RAF1, PRO261SER	121434594
164760	5894	RAF1	0003	NOONAN SYNDROME 5	RAF1, THR491ARG	80338799
164760	5894	RAF1	0004	LEOPARD SYNDROME 2 NOONAN SYNDROME 5, INCLUDED	RAF1, LEU613VAL	80338797
164761	5979	RET	0001	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA	RET, CYS618GLY	76262710
164761	5979	RET	0002	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA	RET, GLU378ASP, LEU379VAL, CYS380ARG	
164761	5979	RET	0003	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA PHEOCHROMOCYTOMA, INCLUDED	RET, CYS634GLY	
164761	5979	RET	0004	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA PHEOCHROMOCYTOMA, INCLUDED	RET, CYS634TYR	75996173
164761	5979	RET	0005	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA PHEOCHROMOCYTOMA, INCLUDED	RET, CYS634SER	
164761	5979	RET	0006	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA THYROID CARCINOMA, FAMILIAL MEDULLARY, INCLUDED;; PHEOCHROMOCYTOMA, INCLUDED	RET, CYS634PHE	
164761	5979	RET	0007	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA	RET, CYS611TRP	80069458
164761	5979	RET	0008	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA THYROID CARCINOMA, FAMILIAL MEDULLARY, INCLUDED	RET, CYS618SER	79781594
164761	5979	RET	0009	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA	RET, CYS620ARG	77316810
164761	5979	RET	0010	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA	RET, CYS620TYR	77503355
164761	5979	RET	0011	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA PHEOCHROMOCYTOMA, INCLUDED	RET, CYS634ARG	75076352
164761	5979	RET	0012	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA PHEOCHROMOCYTOMA, INCLUDED	RET, CYS634TRP	77709286
164761	5979	RET	0013	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB THYROID CARCINOMA, SPORADIC MEDULLARY, INCLUDED;; PHEOCHROMOCYTOMA, SOMATIC, INCLUDED;; RENAL AGENESIS, INCLUDED	RET, MET918THR	74799832
164761	5979	RET	0014	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1	RET, 1-BP DEL, G1120	
164761	5979	RET	0015	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1	RET, SER765PRO	75075748
164761	5979	RET	0016	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1	RET, ARG897GLN	76087194
164761	5979	RET	0017	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1	RET, ARG972GLY	76534745
164761	5979	RET	0018	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1	RET, SER32LEU	76764689
164761	5979	RET	0019	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1	RET, PRO64LEU	77596424
164761	5979	RET	0020	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1	RET, GLU136TER	79014735
164761	5979	RET	0021	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1	RET, ARG180TER	76449634
164761	5979	RET	0022	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1	RET, ARG330GLN	80236571
164761	5979	RET	0023	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1	RET, PHE393LEU	78098482
164761	5979	RET	0024	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA	RET, CYS620PHE	77503355
164761	5979	RET	0025	THYROID CARCINOMA, FAMILIAL MEDULLARY	RET, CYS618ARG	76262710
164761	5979	RET	0026	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA, WITHOUT PHEOCHROMOCYTOMA	RET, 12-BP DUP	
164761	5979	RET	0027	THYROID CARCINOMA, FAMILIAL MEDULLARY	RET, GLU768ASP	78014899
164761	5979	RET	0028	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1	RET, ARG313GLN	77702891
164761	5979	RET	0029	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA, WITH HIRSCHSPRUNG DISEASE	RET, CYS609TYR	77939446
164761	5979	RET	0032	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA, WITH HIRSCHSPRUNG DISEASE	RET, CYS620TRP	79890926
164761	5979	RET	0033	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA THYROID CARCINOMA, FAMILIAL MEDULLARY, INCLUDED	RET, LEU790PHE	75030001
164761	5979	RET	0034	THYROID CARCINOMA, FAMILIAL MEDULLARY PHEOCHROMOCYTOMA, INCLUDED	RET, TYR791PHE	77724903
164761	5979	RET	0035	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1	RET, ARG231HIS	79661516
164761	5979	RET	0036	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1	RET, ARG982CYS	17158558
164761	5979	RET	0037	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1	RET, ILE647ILE, 1941C-T	75225191
164761	5979	RET	0038	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1	RET, ALA45ALA	1800858
164761	5979	RET	0039	THYROID CARCINOMA, FAMILIAL MEDULLARY	RET, 9-BP DUP, EX8	
164761	5979	RET	0040	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA	RET, ALA640GLY	78935588
164761	5979	RET	0041	THYROID CARCINOMA, FAMILIAL MEDULLARY	RET, CYS620SER	77503355
164761	5979	RET	0042	THYROID CARCINOMA, FAMILIAL MEDULLARY	RET, CYS609ARG	77558292
164761	5979	RET	0043	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB	RET, VAL804MET, SER904CYS	79658334
164761	5979	RET	0044	THYROID CARCINOMA, FAMILIAL MEDULLARY	RET, VAL804LEU	
164761	5979	RET	0045	CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL	RET, ARG114HIS	76397662
164761	5979	RET	0046	CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL, WITH HIRSCHSPRUNG DISEASE	RET, PRO1039LEU	79853121
164761	5979	RET	0047	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA	RET, VAL648ILE	77711105
164761	5979	RET	0048	THYROID CARCINOMA, FAMILIAL MEDULLARY	RET, GLY533CYS	75873440
164761	5979	RET	0049	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA THYROID CARCINOMA, FAMILIAL MEDULLARY, INCLUDED	RET, SER891ALA	75234356
164761	5979	RET	0050	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1	RET, IVS1, C-T, +9.7 KB	2435357
164761	5979	RET	0051	THYROID CARCINOMA, FAMILIAL MEDULLARY	RET, ARG912PRO	78347871
164761	5979	RET	0052	HIRSCHSPRUNG DISEASE, PROTECTION AGAINST	RET, 128496T-C	3026785
164761	5979	RET	0053	RENAL AGENESIS	RET, VAL778ILE	75686697
164761	5979	RET	0054	RENAL AGENESIS	RET, PRO198THR	76736111
164770	1436	CSF1R	0001	LEUKOENCEPHALOPATHY, DIFFUSE HEREDITARY, WITH SPHEROIDS	CSF1R, MET875THR	
164770	1436	CSF1R	0002	LEUKOENCEPHALOPATHY, DIFFUSE HEREDITARY, WITH SPHEROIDS	CSF1R, GLU633LYS	
164770	1436	CSF1R	0003	LEUKOENCEPHALOPATHY, DIFFUSE HEREDITARY, WITH SPHEROIDS	CSF1R, IVS12AS, A-G, -2	
164770	1436	CSF1R	0004	LEUKOENCEPHALOPATHY, DIFFUSE HEREDITARY, WITH SPHEROIDS	CSF1R, ILE794THR	
164770	1436	CSF1R	0005	LEUKOENCEPHALOPATHY, DIFFUSE HEREDITARY, WITH SPHEROIDS	CSF1R, ASP837TYR	
164780	6497	SKI	0001	SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME	SKI, GLY116GLU	
164780	6497	SKI	0002	SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME	SKI, LEU32VAL	
164780	6497	SKI	0003	SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME	SKI, GLY34ASP	
164780	6497	SKI	0004	SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME	SKI, GLY34SER	
164780	6497	SKI	0005	SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME	SKI, GLY34CYS	
164780	6497	SKI	0006	SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME	SKI, 9-BP DEL, NT283	
164780	6497	SKI	0007	SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME	SKI, GLY34VAL	
164780	6497	SKI	0008	SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME	SKI, 12-BP DEL, NT280	
164780	6497	SKI	0009	SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME	SKI, PRO35GLN	
164780	6497	SKI	0010	SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME	SKI, PRO35SER	
164785	4193	MDM2	0001	ACCELERATED TUMOR FORMATION, SUSCEPTIBILITY TO	MDM2, -410T-G,	2279244
164790	4893	NRAS	0001	RECTAL CANCER, SOMATIC	NRAS, GLY13ARG	121434595
164790	4893	NRAS	0002	THYROID CARCINOMA, FOLLICULAR, SOMATIC EPIDERMAL NEVUS, SOMATIC, INCLUDED	NRAS, GLN61ARG	11554290
164790	4893	NRAS	0003	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IV JUVENILE MYELOMONOCYTIC LEUKEMIA, INCLUDED;; NOONAN SYNDROME 6, INCLUDED	NRAS, GLY13ASP	121434596
164790	4893	NRAS	0004	NOONAN SYNDROME 6	NRAS, THR50ILE	
164790	4893	NRAS	0005	NOONAN SYNDROME 6	NRAS, GLY60GLU	
164790	4893	NRAS	0006	EPIDERMAL NEVUS, SOMATIC	NRAS, PRO34LEU	
164790	4893	NRAS	0007	EPIDERMAL NEVUS, SOMATIC	NRAS, GLY12ASP	
164820	7471	WNT1	0001	OSTEOGENESIS IMPERFECTA, TYPE XV OSTEOPOROSIS, EARLY-ONSET, SUSCEPTIBILITY TO, INCLUDED	WNT1, 1-BP DUP, 859C	
164820	7471	WNT1	0002	OSTEOGENESIS IMPERFECTA, TYPE XV	WNT1, IVS4DS, A-G, +4	
164820	7471	WNT1	0003	OSTEOGENESIS IMPERFECTA, TYPE XV	WNT1, GLU189TER	
164820	7471	WNT1	0004	OSTEOGENESIS IMPERFECTA, TYPE XV	WNT1, SER295TER	
164820	7471	WNT1	0005	OSTEOGENESIS IMPERFECTA, TYPE XV	WNT1, 4-BP INS, 946AACA	
164820	7471	WNT1	0006	OSTEOGENESIS IMPERFECTA, TYPE XV	WNT1, VAL355PHE	
164820	7471	WNT1	0007	OSTEOPOROSIS, EARLY-ONSET, SUSCEPTIBILITY TO	WNT1, ARG235TRP	
164820	7471	WNT1	0008	OSTEOGENESIS IMPERFECTA, TYPE XV	WNT1, SER295TER	
164820	7471	WNT1	0009	OSTEOPOROSIS, EARLY-ONSET, SUSCEPTIBILITY TO	WNT1, CYS218GLY	
164840	4613	MYCN	0001	FEINGOLD SYNDROME	MYCN, ARG393HIS	104893646
164840	4613	MYCN	0002	FEINGOLD SYNDROME	MYCN, ARG393SER	104893647
164840	4613	MYCN	0003	FEINGOLD SYNDROME	MYCN, ARG394HIS	104893648
164840	4613	MYCN	0004	FEINGOLD SYNDROME	MYCN, GLU73TER	113994115
164840	4613	MYCN	0005	FEINGOLD SYNDROME	MYCN, 1-BP DUP, 626C	
164840	4613	MYCN	0006	FEINGOLD SYNDROME	MYCN, ARG382HIS	121913666
164840	4613	MYCN	0007	FEINGOLD SYNDROME	MYCN, TRP77TER	121913667
164860	4233	MET	0001	RENAL CELL CARCINOMA, PAPILLARY, 1	MET, MET1149THR	121913668
164860	4233	MET	0002	RENAL CELL CARCINOMA, PAPILLARY, 1	MET, VAL1206LEU	121913669
164860	4233	MET	0003	RENAL CELL CARCINOMA, PAPILLARY, 1	MET, VAL1238ILE	121913670
164860	4233	MET	0004	RENAL CELL CARCINOMA, PAPILLARY, 1	MET, ASP1246ASN	121913671
164860	4233	MET	0005	RENAL CELL CARCINOMA, PAPILLARY, 1	MET, TYR1248CYS	121913246
164860	4233	MET	0006	RENAL CELL CARCINOMA, PAPILLARY, 1, SOMATIC	MET, LEU1213VAL	121913673
164860	4233	MET	0007	RENAL CELL CARCINOMA, PAPILLARY, 1	MET, HIS1112ARG	121913243
164860	4233	MET	0008	HEPATOCELLULAR CARCINOMA, CHILDHOOD TYPE, SOMATIC	MET, THR1191ILE	121913675
164860	4233	MET	0009	HEPATOCELLULAR CARCINOMA, CHILDHOOD TYPE, SOMATIC	MET, MET1268ILE	121913676
164860	4233	MET	0010	HEPATOCELLULAR CARCINOMA, CHILDHOOD TYPE, SOMATIC	MET, LYS1262ARG	121913677
164860	4233	MET	0011	AUTISM, ASSOCIATION WITH, 9	MET, -20G-C	1858830
164870	2064	ERBB2	0001	ERBB2 POLYMORPHISM	ERBB2, VAL655ILE	1136201
164870	2064	ERBB2	0002	ERBB2 POLYMORPHISM	ERBB2, VAL654ILE	1801201
164870	2064	ERBB2	0003	ADENOCARCINOMA OF LUNG, SOMATIC	ERBB2, INS/DUP, NT2322	
164870	2064	ERBB2	0004	ADENOCARCINOMA OF LUNG, SOMATIC	ERBB2, 9-BP INS, NT2335	
164870	2064	ERBB2	0005	ADENOCARCINOMA OF LUNG, SOMATIC	ERBB2, LEU755PRO	121913469
164870	2064	ERBB2	0006	GLIOBLASTOMA, SOMATIC	ERBB2, GLU914LYS	28933368
164870	2064	ERBB2	0007	GASTRIC CANCER, SOMATIC	ERBB2, GLY776SER	28933369
164870	2064	ERBB2	0008	OVARIAN CANCER, SOMATIC	ERBB2, ASN857SER	28933370
164874	2290	FOXG1	0001	RETT SYNDROME, CONGENITAL VARIANT	FOXG1, TRP255TER	121913678
164874	2290	FOXG1	0002	RETT SYNDROME, CONGENITAL VARIANT	FOXG1, 1-BP DEL, 969C	
164874	2290	FOXG1	0003	RETT SYNDROME, CONGENITAL VARIANT	FOXG1, TYR208TER	
164874	2290	FOXG1	0004	RETT SYNDROME, CONGENITAL VARIANT	FOXG1, PHE215LEU	
164874	2290	FOXG1	0005	RETT SYNDROME, CONGENITAL VARIANT	FOXG1, TRP308TER	
164874	2290	FOXG1	0006	RETT SYNDROME, CONGENITAL VARIANT	FOXG1, TRP400TER	
164874	2290	FOXG1	0007	RETT SYNDROME, CONGENITAL VARIANT	FOXG1, 1-BP DUP, 460G	
164920	3815	KIT	0001	PIEBALDISM	KIT, GLY664ARG	121913679
164920	3815	KIT	0002	PIEBALDISM	KIT, DEL	
164920	3815	KIT	0003	PIEBALDISM	KIT, PHE584LEU	
164920	3815	KIT	0004	PIEBALDISM	KIT, 2-BP DEL, FS647TER	
164920	3815	KIT	0005	PIEBALDISM	KIT, 1-BP DUP, FS578TER	
164920	3815	KIT	0006	PIEBALDISM	KIT, GLU583LYS	121913680
164920	3815	KIT	0007	PIEBALDISM	KIT, 1-BP DEL, FS104TER	
164920	3815	KIT	0008	PIEBALDISM	KIT, IVS12DS, G-A, +1	
164920	3815	KIT	0009	MAST CELL LEUKEMIA MASTOCYTOSIS WITH ASSOCIATED HEMATOLOGIC DISORDER, INCLUDED;; MASTOCYTOSIS, ADULT SPORADIC, INCLUDED	KIT, ASP816VAL	121913507
164920	3815	KIT	0010	MAST CELL DISEASE, SYSTEMIC	KIT, ASP820GLY	121913682
164920	3815	KIT	0011	GASTROINTESTINAL STROMAL TUMOR, SOMATIC	KIT, 6-BP DEL	
164920	3815	KIT	0012	GASTROINTESTINAL STROMAL TUMOR, SOMATIC	KIT, 15-BP DEL	
164920	3815	KIT	0013	GASTROINTESTINAL STROMAL TUMOR, SOMATIC	KIT, 15-BP DEL/LYS550ILE	
164920	3815	KIT	0014	GASTROINTESTINAL STROMAL TUMOR, SOMATIC	KIT, VAL559ASP	121913517
164920	3815	KIT	0015	GASTROINTESTINAL STROMAL TUMOR, SOMATIC	KIT, 27-BP DEL	
164920	3815	KIT	0016	PIEBALDISM WITH SENSORINEURAL DEAFNESS	KIT, ARG796GLY	121913684
164920	3815	KIT	0017	GASTROINTESTINAL STROMAL TUMOR, FAMILIAL	KIT, VAL559DEL	121913685
164920	3815	KIT	0018	LEUKEMIA, ACUTE MYELOID	KIT, ASP816TYR	121913506
164920	3815	KIT	0019	PIEBALDISM	KIT, THR847PRO	121913687
164920	3815	KIT	0020	MASTOCYTOSIS, SPORADIC, CHILDHOOD-ONSET	KIT, GLU839LYS	121913509
164920	3815	KIT	0021	GERM CELL TUMOR, SOMATIC	KIT, ASP816HIS	121913506
164920	3815	KIT	0022	PIEBALDISM	KIT, PHE584CYS	28933371
164920	3815	KIT	0023	GASTROINTESTINAL STROMAL TUMOR, FAMILIAL	KIT, VAL559ALA	121913517
164920	3815	KIT	0024	GASTROINTESTINAL STROMAL TUMOR, FAMILIAL	KIT, LYS642GLU	121913512
164920	3815	KIT	0025	PIEBALDISM, PROGRESSIVE	KIT, VAL620ALA	
164950	2248	FGF3	0001	DEAFNESS, CONGENITAL, WITH INNER EAR AGENESIS, MICROTIA, AND MICRODONTIA	FGF3, SER156PRO	121917703
164950	2248	FGF3	0002	DEAFNESS, CONGENITAL, WITH INNER EAR AGENESIS, MICROTIA, AND MICRODONTIA	FGF3, ARG104TER	121917704
164950	2248	FGF3	0003	DEAFNESS, CONGENITAL, WITH INNER EAR AGENESIS, MICROTIA, AND MICRODONTIA	FGF3, 1-BP DEL, 616G	
164950	2248	FGF3	0004	DEAFNESS, CONGENITAL, WITH INNER EAR AGENESIS, MICROTIA, AND MICRODONTIA	FGF3, GLY66CYS	121917705
164950	2248	FGF3	0005	DEAFNESS, CONGENITAL, WITH INNER EAR AGENESIS, MICROTIA, AND MICRODONTIA	FGF3, LEU6PRO	121917706
164950	2248	FGF3	0006	DEAFNESS, CONGENITAL, WITH INNER EAR AGENESIS, MICROTIA, AND MICRODONTIA	FGF3, 1-BP DEL, 254T	
164950	2248	FGF3	0007	DEAFNESS, CONGENITAL, WITH INNER EAR AGENESIS, MICROTIA, AND MICRODONTIA	FGF3, TYR49CYS	
164950	2248	FGF3	0008	DEAFNESS, CONGENITAL, WITH INNER EAR AGENESIS, MICROTIA, AND MICRODONTIA	FGF3, TYR106CYS	
164950	2248	FGF3	0009	DEAFNESS, CONGENITAL, WITH INNER EAR AGENESIS, MICROTIA, AND MICRODONTIA	FGF3, 2-BP DEL, 457TG	
164975	7474	WNT5A	0001	ROBINOW SYNDROME, AUTOSOMAL DOMINANT	WNT5A, CYS182ARG	
164975	7474	WNT5A	0002	ROBINOW SYNDROME, AUTOSOMAL DOMINANT	WNT5A, CYS83SER	
165230	2736	GLI2	0001	HOLOPROSENCEPHALY 9	GLI2, 1-BP DEL, NT2274	
165230	2736	GLI2	0002	HOLOPROSENCEPHALY 9	GLI2, TRP113TER	121917707
165230	2736	GLI2	0003	HOLOPROSENCEPHALY 9	GLI2, ARG151GLY	121917708
165230	2736	GLI2	0004	HOLOPROSENCEPHALY 9	GLI2, SER1555PRO	
165230	2736	GLI2	0005	HOLOPROSENCEPHALY 9	GLI2, 2-BP DEL, 864CC	
165230	2736	GLI2	0006	HOLOPROSENCEPHALY 9	GLI2, GLU629LYS	
165230	2736	GLI2	0007	HOLOPROSENCEPHALY 9	GLI2, ASP1520ASN	
165240	2737	GLI3	0001	GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	GLI3, DEL	
165240	2737	GLI3	0002	PALLISTER-HALL SYNDROME	GLI3, 1-BP DEL, 2023G	116840744
165240	2737	GLI3	0003	PALLISTER-HALL SYNDROME	GLI3, 1-BP DEL, 2012G	116840743
165240	2737	GLI3	0004	POSTAXIAL POLYDACTYLY, TYPE A1	GLI3, CODON 764, FS	
165240	2737	GLI3	0005	PREAXIAL POLYDACTYLY, TYPE IV	GLI3, 1-BP INS, 3647C	
165240	2737	GLI3	0006	PALLISTER-HALL SYNDROME	GLI3, GLU1147TER	116840768
165240	2737	GLI3	0007	POSTAXIAL POLYDACTYLY, TYPE A1/B	GLI3, 1-BP DEL, 3707G	
165240	2737	GLI3	0008	POSTAXIAL POLYDACTYLY, TYPE A1/B	GLI3, ARG643TER	121917709
165240	2737	GLI3	0009	POSTAXIAL POLYDACTYLY, TYPE A1/B	GLI3, GLY727ARG	121917710
165240	2737	GLI3	0010	GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	GLI3, GLU543TER	121917711
165240	2737	GLI3	0011	PALLISTER-HALL SYNDROME	GLI3, 72-BP INS mtDNA, EX14	
165240	2737	GLI3	0012	GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	GLI3, ARG625TRP	121917712
165240	2737	GLI3	0013	GREIG CEPHALOPOLYSYNDACTYLY SYNDROME, SEVERE	GLI3, ALA934PRO	
165240	2737	GLI3	0014	GREIG CEPHALOPOLYSYNDACTYLY SYNDROME PREAXIAL POLYDACTYLY, TYPE IV, INCLUDED	GLI3, ARG290TER	121917713
165240	2737	GLI3	0015	POSTAXIAL POLYDACTYLY, TYPE B	GLI3, 1-BP DEL, 2372C	
165240	2737	GLI3	0016	GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	GLI3, ARG792TER	121917714
165240	2737	GLI3	0017	PALLISTER-HALL SYNDROME	GLI3, 19-BP DEL, NT2188	116840754
165240	2737	GLI3	0018	GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	GLI3, GLN496TER	121917715
165240	2737	GLI3	0019	GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	GLI3, PRO707SER	121917716
165240	2737	GLI3	0020	GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	GLI3, 4-BP DEL, 4542CCAC	
165240	2737	GLI3	0021	GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	GLI3, 1-BP DEL, 1018A	
165240	2737	GLI3	0022	POSTAXIAL POLYDACTYLY, TYPE A1/B	GLI3, 2-BP DEL, 1615GA	
165330	7473	WNT3	0001	TETRAAMELIA, AUTOSOMAL RECESSIVE	WNT3, GLN83TER	104894653
165360	867	CBL	0001	NOONAN SYNDROME-LIKE DISORDER WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	CBL, GLN367PRO	
165360	867	CBL	0002	NOONAN SYNDROME-LIKE DISORDER WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	CBL, LYS382GLU	
165360	867	CBL	0003	NOONAN SYNDROME-LIKE DISORDER WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	CBL, ASP390TYR	
165360	867	CBL	0004	NOONAN SYNDROME-LIKE DISORDER WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	CBL, ARG420GLN	
165360	867	CBL	0005	NOONAN SYNDROME-LIKE DISORDER WITH JUVENILE MYELOMONOCYTIC LEUKEMIA	CBL, TYR371HIS	
165360	867	CBL	0006	NOONAN SYNDROME-LIKE DISORDER WITH JUVENILE MYELOMONOCYTIC LEUKEMIA	CBL, IVS8AS, A-G, -2	
165360	867	CBL	0007	NOONAN SYNDROME-LIKE DISORDER WITH JUVENILE MYELOMONOCYTIC LEUKEMIA	CBL, CYS384ARG	
165360	867	CBL	0008	NOONAN SYNDROME-LIKE DISORDER WITH JUVENILE MYELOMONOCYTIC LEUKEMIA	CBL, CYS396ARG	
165360	867	CBL	0009	NOONAN SYNDROME-LIKE DISORDER WITH JUVENILE MYELOMONOCYTIC LEUKEMIA	CBL, TYR371CYS	
165640	4953	ODC1	0001	COLONIC ADENOMA RECURRENCE, REDUCED RISK OF	ODC, IVS1 +316G/A	
167409	5076	PAX2	0001	PAPILLORENAL SYNDROME	PAX2, 1-BP DEL, NT1104	77777862
167409	5076	PAX2	0002	PAPILLORENAL SYNDROME RENAL HYPOPLASIA, ISOLATED, INCLUDED	PAX2, 1-BP INS, 619G	77453353
167409	5076	PAX2	0003	PAPILLORENAL SYNDROME	PAX2, 22-BP DEL, NT674	76675173
167409	5076	PAX2	0005	RENAL HYPOPLASIA, ISOLATED	PAX2, 6-BP DEL	
167409	5076	PAX2	0006	PAPILLORENAL SYNDROME	PAX2, GLY76SER	79555199
167409	5076	PAX2	0007	PAPILLORENAL SYNDROME	PAX2, 6-BP DUP, NT768	80356379
167409	5076	PAX2	0008	PAPILLORENAL SYNDROME	PAX2, 1-BP DEL, G, EX2	75462234
167409	5076	PAX2	0009	PAPILLORENAL SYNDROME	PAX2, 2-BP INS, 619GG	77453353
167409	5076	PAX2	0010	RENAL HYPOPLASIA, ISOLATED	PAX2, 1566C-A	
167409	5076	PAX2	0011	PAPILLORENAL SYNDROME	PAX2, 1318C-T	
167409	5076	PAX2	0012	PAPILLORENAL SYNDROME WITH MACULAR ABNORMALITIES	PAX2, ARG71THR	104894170
167413	5078	PAX4	0001	DIABETES MELLITUS, TYPE 2	PAX4, ARG121TRP	114202595
167413	5078	PAX4	0002	DIABETES MELLITUS, KETOSIS-PRONE, SUSCEPTIBILITY TO	PAX4, ARG133TRP	2233578
167413	5078	PAX4	0003	DIABETES MELLITUS, KETOSIS-PRONE, SUSCEPTIBILITY TO	PAX4, ARG37TRP	35155575
167413	5078	PAX4	0004	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 9	PAX4, ARG64TRP	121917718
167413	5078	PAX4	0005	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 9	PAX4, IVS7, G-A, -1	
167415	7849	PAX8	0001	PAX8 POLYMORPHISM	PAX8, PHE329LEU	3188996
167415	7849	PAX8	0002	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	PAX8, ARG108TER	104893655
167415	7849	PAX8	0003	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	PAX8, ARG31HIS	104893657
167415	7849	PAX8	0004	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	PAX8, LEU62ARG	104893658
167415	7849	PAX8	0005	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	PAX8, CYS57TYR	104893659
167415	7849	PAX8	0006	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	PAX8, SER54GLY	104893660
167415	7849	PAX8	0007	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	PAX8, GLN40PRO	104893656
167415	7849	PAX8	0008	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	PAX8, SER48PHE	121917719
167416	5083	PAX9	0001	TOOTH AGENESIS, SELECTIVE, 3	PAX9, 1-BP INS, 219G	
167416	5083	PAX9	0002	TOOTH AGENESIS, SELECTIVE, 3	PAX9, LYS114TER	104894467
167416	5083	PAX9	0003	TOOTH AGENESIS, SELECTIVE, 3	PAX9, DEL	
167416	5083	PAX9	0004	TOOTH AGENESIS, SELECTIVE, 3	PAX9, LYS91GLU	28933373
167416	5083	PAX9	0005	TOOTH AGENESIS, SELECTIVE, 3	PAX9, LEU21PRO	28933970
167416	5083	PAX9	0006	TOOTH AGENESIS, SELECTIVE, 3	PAX9, 288-BP INS	
167416	5083	PAX9	0007	TOOTH AGENESIS, SELECTIVE, 3	PAX9, ARG28PRO	28933971
167416	5083	PAX9	0008	TOOTH AGENESIS, SELECTIVE, 3	PAX9, ARG26TRP	28933972
167416	5083	PAX9	0009	TOOTH AGENESIS, SELECTIVE, 3	PAX9, ILE87PHE	104894468
167416	5083	PAX9	0010	TOOTH AGENESIS, SELECTIVE, 3	PAX9, 1-BP INS, 793C	
167416	5083	PAX9	0011	TOOTH AGENESIS, SELECTIVE, 3	PAX9, 1A-G	
167416	5083	PAX9	0012	TOOTH AGENESIS, SELECTIVE, 3	PAX9, 3-BP DEL, 24-BP INS, NT619	
167416	5083	PAX9	0013	TOOTH AGENESIS, SELECTIVE, 3	PAX9, GLY51SER	104894469
167416	5083	PAX9	0014	TOOTH AGENESIS, SELECTIVE, 3	PAX9, 1-BP INS, 190G	
167416	5083	PAX9	0015	TOOTH AGENESIS, SELECTIVE, 3	PAX9, ARG47TRP	
167420	5396	PRRX1	0001	AGNATHIA-OTOCEPHALY COMPLEX	PRRX1, PHE113SER	
167420	5396	PRRX1	0002	AGNATHIA-OTOCEPHALY COMPLEX	PRRX1, ALA231PRO	
167420	5396	PRRX1	0003	AGNATHIA-OTOCEPHALY COMPLEX	PRRX1, 1-BP DEL, 267A	
167420	5396	PRRX1	0004	AGNATHIA-OTOCEPHALY COMPLEX	PRRX1, 4-BP DUP, 266AAAA	
167790	6690	SPINK1	0001	PANCREATITIS, CHRONIC, SUSCEPTIBILITY TO TROPICAL CALCIFIC PANCREATITIS, INCLUDED;; FIBROCALCULOUS PANCREATIC DIABETES, SUSCEPTIBILITY TO, INCLUDED	SPINK1, ASN34SER	17107315
167790	6690	SPINK1	0002	PANCREATITIS, CHRONIC	SPINK1, MET1THR	104893938
167790	6690	SPINK1	0003	PANCREATITIS, CHRONIC	SPINK1, -215G-A	
167790	6690	SPINK1	0004	TROPICAL CALCIFIC PANCREATITIS	SPINK1, -215G-T	
167790	6690	SPINK1	0005	PANCREATITIS, CHRONIC	SPINK1, LEU14PRO	104893939
167790	6690	SPINK1	0006	PANCREATITIS, CHRONIC	SPINK1, LEU14ARG	104893939
167790	6690	SPINK1	0007	PANCREATITIS, CHRONIC	SPINK1, 1.3-KB DEL	
168450	5741	PTH	0001	HYPOPARATHYROIDISM, FAMILIAL ISOLATED	PTH, CYS18ARG	104894271
168450	5741	PTH	0002	HYPOPARATHYROIDISM, FAMILIAL ISOLATED	PTH, IVS2DS, G-C, +1, EX2DEL	
168450	5741	PTH	0003	HYPOPARATHYROIDISM, FAMILIAL ISOLATED	PTH, SER23PRO	104894272
168450	5741	PTH	0004	HYPERPARATHYROIDISM, PRIMARY	PTH, ARG83TER	6256
168461	595	CCND1	0001	COLORECTAL CANCER, SUSCEPTIBILITY TO VON HIPPEL-LINDAU DISEASE, MODIFIER OF, INCLUDED	CCND1, 870G-A	
168468	5745	PTH1R	0001	METAPHYSEAL CHONDRODYSPLASIA, MURK JANSEN TYPE	PTH1R, HIS223ARG	121434597
168468	5745	PTH1R	0002	METAPHYSEAL CHONDRODYSPLASIA, MURK JANSEN TYPE	PTH1R, THR410PRO	121434598
168468	5745	PTH1R	0003	CHONDRODYSPLASIA, BLOMSTRAND TYPE	PTH1R, ARG383GLN, 33-BP DEL	
168468	5745	PTH1R	0004	CHONDRODYSPLASIA, BLOMSTRAND TYPE	PTH1R, PRO132LEU	121434599
168468	5745	PTH1R	0005	CHONDRODYSPLASIA, BLOMSTRAND TYPE	PTH1R, 1-BP DEL, 1122G	
168468	5745	PTH1R	0006	METAPHYSEAL CHONDRODYSPLASIA, MURK JANSEN TYPE	PTH1R, ILE458ARG	121434600
168468	5745	PTH1R	0008	METAPHYSEAL CHONDRODYSPLASIA, MURK JANSEN TYPE	PTH1R, THR410ARG	121434602
168468	5745	PTH1R	0009	EIKEN SYNDROME	PTH1R, ARG485TER	121434603
168468	5745	PTH1R	0010	CHONDRODYSPLASIA, BLOMSTRAND TYPE	PTH1R, ARG104TER	121434604
168468	5745	PTH1R	0011	CHONDRODYSPLASIA, BLOMSTRAND TYPE	PTH1R, IVSM4, C-T, +27	
168468	5745	PTH1R	0012	FAILURE OF TOOTH ERUPTION, PRIMARY	PTH1R, IVS11AS, C-G, -3	
168468	5745	PTH1R	0013	FAILURE OF TOOTH ERUPTION, PRIMARY	PTH1R, IVS8DS, G-A, +1	
168468	5745	PTH1R	0014	FAILURE OF TOOTH ERUPTION, PRIMARY	PTH1R, GLU155TER	121434605
168470	5744	PTHLH	0001	BRACHYDACTYLY, TYPE E2	PTHLH, LEU60PRO	
168470	5744	PTHLH	0002	BRACHYDACTYLY, TYPE E2	PTHLH, LEU44PRO	
168470	5744	PTHLH	0003	BRACHYDACTYLY, TYPE E2	PTHLH, TER178TRP	
168470	5744	PTHLH	0004	BRACHYDACTYLY, TYPE E2	PTHLH, LYS120TER	
168820	5444	PON1	0001	PON1 ENZYME ACTIVITY, VARIATION IN CORONARY ARTERY DISEASE, SUSCEPTIBILITY TO, INCLUDED;; CORONARY ARTERY SPASM 2, SUSCEPTIBILITY TO, INCLUDED	PON1, GLN192ARG	662
168820	5444	PON1	0002	PON1 ENZYME ACTIVITY, VARIATION IN CORONARY ARTERY DISEASE, SUSCEPTIBILITY TO, INCLUDED;; MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 5, INCLUDED	PON1, LEU55MET	854560
168820	5444	PON1	0003	PON1 ENZYME ACTIVITY, VARIATION IN	PON1, -108C-T	
168840	5544	PRB3	0001	PRB3S(CYS)	PRB3, ARG15CYS	71455367
168840	5544	PRB3	0002	PRB3M(NULL)	PRB3, 1-BP INS	
170260	6890	TAP1	0001	PEPTIDE TRANSPORTER PSF1 POLYMORPHISM	TAP1, ILE333VAL	1057141
170260	6890	TAP1	0002	PEPTIDE TRANSPORTER PSF1 POLYMORPHISM	TAP1, ASP637GLY	1135216
170260	6890	TAP1	0003	TAP1 DEFICIENCY, SOMATIC	TAP1, ARG659GLN	121917702
170260	6890	TAP1	0004	BARE LYMPHOCYTE SYNDROME, TYPE I	TAP1, IVS1, G-A, -1	
170261	6891	TAP2	0001	PEPTIDE TRANSPORTER PSF2 POLYMORPHISM	TAP2, ILE379VAL	1800454
170261	6891	TAP2	0002	PEPTIDE TRANSPORTER PSF2 POLYMORPHISM	TAP2, ALA665THR	241447
170261	6891	TAP2	0003	PEPTIDE TRANSPORTER PSF2 POLYMORPHISM	TAP2, GLN687TER	241448
170261	6891	TAP2	0004	BARE LYMPHOCYTE SYNDROME, TYPE I	TAP2, ARG253TER	
170261	6891	TAP2	0005	BARE LYMPHOCYTE SYNDROME, TYPE I	TAP2, 1-BP DEL	
170280	5551	PRF1	0001	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	PRF1, 1-BP DEL, 50T	
170280	5551	PRF1	0002	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2 LYMPHOMA, NON-HODGKIN, INCLUDED	PRF1, TRP374TER	104894176
170280	5551	PRF1	0003	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	PRF1, GLN64TER	104894180
170280	5551	PRF1	0004	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	PRF1, ARG225TRP	28933973
170280	5551	PRF1	0005	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	PRF1, GLY429GLU	104894181
170280	5551	PRF1	0006	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	PRF1, PRO345LEU	28933374
170280	5551	PRF1	0007	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	PRF1, CYS279TYR	104894182
170280	5551	PRF1	0008	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	PRF1, VAL183GLY	104894183
170280	5551	PRF1	0009	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2 LYMPHOMA, NON-HODGKIN, INCLUDED	PRF1, ASN252SER	28933375
170280	5551	PRF1	0010	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	PRF1, THR435MET	28933376
170280	5551	PRF1	0011	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2, SUSCEPTIBILITY TO LYMPHOMA, NON-HODGKIN, SUSCEPTIBILITY TO, INCLUDED;; APLASTIC ANEMIA, SUSCEPTIBILITY TO, INCLUDED	PRF1, ALA91VAL	35947132
170280	5551	PRF1	0012	APLASTIC ANEMIA	PRF1, SER388ILE	193302875
170280	5551	PRF1	0013	APLASTIC ANEMIA	PRF1, ARG4HIS	35418374
170280	5551	PRF1	0014	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	PRF1, 2-BP DEL, 1090CT	
170280	5551	PRF1	0015	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	PRF1, 1-BP DEL, 207A	
170280	5551	PRF1	0016	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	PRF1, GLN416TER	193302876
170290	5346	PLIN1	0001	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 4	PLIN1, IVS8AS, G-T, -1	
170290	5346	PLIN1	0002	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 4	PLIN1, 2-BP DEL, 1191AG	
170710	5630	PRPH	0001	AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO	PRPH, 1-BP DEL, 228C	
170710	5630	PRPH	0002	AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO	PRPH, ASP141TYR	58599399
170993	5828	PEX2	0001	PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER) PEROXISOME BIOGENESIS DISORDER 5B, INCLUDED	PEX2, ARG118TER	61752123
170993	5828	PEX2	0002	PEROXISOME BIOGENESIS DISORDER 5B	PEX2, GLU55LYS	61752119
170995	5825	ABCD3	0001	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	ABCD3, IVS L-1, DS, G-A, +1, 23-BP INS	
170995	5825	ABCD3	0002	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	ABCD3, GLY17ASP	121917999
170998	5465	PPARA	0001	HYPERAPOBETALIPOPROTEINEMIA, SUSCEPTIBILITY TO	PPARA, LEU162VAL	1800206
171050	5243	ABCB1	0001	COLCHICINE RESISTANCE	ABCB1, GLY185VAL	1128501
171050	5243	ABCB1	0002	MDR1 POLYMORPHISM	ABCB1, 3435C-T	1045642
171050	5243	ABCB1	0003	INFLAMMATORY BOWEL DISEASE 13, SUSCEPTIBILITY TO	ABCB1, ALA893SER/THR	
171060	5244	ABCB4	0001	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 3	ABCB4, 7-BP DEL	
171060	5244	ABCB4	0002	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 3 CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 3, INCLUDED	ABCB4, ARG957TER	121918440
171060	5244	ABCB4	0003	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 3 CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 3, INCLUDED	ABCB4, 1-BP DEL, 1712T	
171060	5244	ABCB4	0004	CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 3	ABCB4, ALA546ASP	121918441
171060	5244	ABCB4	0005	GALLBLADDER DISEASE 1 CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 3, INCLUDED	ABCB4, SER320PHE	72552778
171060	5244	ABCB4	0006	GALLBLADDER DISEASE 1	ABCB4, THR175VAL	58238559
171060	5244	ABCB4	0007	GALLBLADDER DISEASE 1	ABCB4, PRO1161SER	121918442
171060	5244	ABCB4	0008	GALLBLADDER DISEASE 1 CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 3, INCLUDED	ABCB4, 1-BP INS, 1327A	
171060	5244	ABCB4	0009	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 3	ABCB4, 1-BP INS, 2169G	
171060	5244	ABCB4	0010	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 3	ABCB4, TYR403HIS	121918443
171060	5244	ABCB4	0011	CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 3	ABCB4, ARG144TER	72552780
171060	5244	ABCB4	0012	CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 3 GALLBLADDER DISEASE 1, INCLUDED	ABCB4, ARG590GLN	45575636
171060	5244	ABCB4	0013	GALLBLADDER DISEASE 1	ABCB4, ARG545GLY	
171500	52	ACP1	0001	ACID PHOSPHATASE 1, SOLUBLE, A/B POLYMORPHISM OF	ACP1, ARG105GLN	79716074
171640	54	ACP5	0001	SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION	ACP5, THR89ILE	
171640	54	ACP5	0002	SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION	ACP5, GLN223TER	
171640	54	ACP5	0003	SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION	ACP5, MET264LYS	
171640	54	ACP5	0004	SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION	ACP5, GLY215ARG	
171640	54	ACP5	0005	SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION	ACP5, GLY109ARG	
171640	54	ACP5	0006	SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION	ACP5, 3-BP DEL, 831CTA	
171640	54	ACP5	0007	SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION	ACP5, LEU201PRO	
171760	249	ALPL	0001	HYPOPHOSPHATASIA, INFANTILE	ALPL, ALA162THR	121918000
171760	249	ALPL	0002	HYPOPHOSPHATASIA, INFANTILE	ALPL, ARG54CYS	121918001
171760	249	ALPL	0003	HYPOPHOSPHATASIA, INFANTILE HYPOPHOSPHATASIA, CHILDHOOD, INCLUDED;; HYPOPHOSPHATASIA, ADULT, INCLUDED	ALPL, ASP277ALA	121918002
171760	249	ALPL	0004	HYPOPHOSPHATASIA, INFANTILE	ALPL, ARG54PRO	121918003
171760	249	ALPL	0005	HYPOPHOSPHATASIA, INFANTILE	ALPL, GLN190PRO	121918004
171760	249	ALPL	0006	HYPOPHOSPHATASIA, INFANTILE	ALPL, ALA16VAL	121918005
171760	249	ALPL	0007	HYPOPHOSPHATASIA, INFANTILE	ALPL, TYR419HIS	121918006
171760	249	ALPL	0008	HYPOPHOSPHATASIA, INFANTILE HYPOPHOSPHATASIA, CHILDHOOD, INCLUDED;; HYPOPHOSPHATASIA, ADULT	ALPL, GLU174LYS	121918007
171760	249	ALPL	0009	HYPOPHOSPHATASIA, INFANTILE HYPOPHOSPHATASIA, ADULT, INCLUDED	ALPL, ASP378VAL	121918008
171760	249	ALPL	0010	HYPOPHOSPHATASIA, INFANTILE	ALPL, GLY317ASP	121918009
171760	249	ALPL	0011	HYPOPHOSPHATASIA, INFANTILE	ALPL, PHE310LEU	121918010
171760	249	ALPL	0012	HYPOPHOSPHATASIA, INFANTILE	ALPL, 1-BP DEL, 1735T	
171760	249	ALPL	0013	HYPOPHOSPHATASIA, CHILDHOOD	ALPL, ARG119HIS	121918011
171760	249	ALPL	0014	HYPOPHOSPHATASIA, CHILDHOOD	ALPL, GLY145VAL	121918012
171760	249	ALPL	0015	HYPOPHOSPHATASIA, CHILDHOOD HYPOPHOSPHATASIA, ADULT, INCLUDED;; ODONTOHYPOPHOSPHATASIA, INCLUDED	ALPL, ALA99THR	121918013
171760	249	ALPL	0016	HYPOPHOSPHATASIA, INFANTILE	ALPL, IVS6DS, G-A, +1	
171760	249	ALPL	0017	HYPOPHOSPHATASIA, INFANTILE	ALPL, ASN400SER	121918014
171760	249	ALPL	0018	ODONTOHYPOPHOSPHATASIA	ALPL, PRO91LEU	121918015
171760	249	ALPL	0019	HYPOPHOSPHATASIA, INFANTILE	ALPL, GLY439ARG	121918016
171760	249	ALPL	0020	HYPOPHOSPHATASIA, INFANTILE	ALPL, GLU281LYS	121918017
171760	249	ALPL	0021	HYPOPHOSPHATASIA, CHILDHOOD ODONTOHYPOPHOSPHATASIA, INCLUDED	ALPL, GLY232VAL	121918018
171760	249	ALPL	0022	HYPOPHOSPHATASIA, INFANTILE HYPOPHOSPHATASIA, CHILDHOOD, INCLUDED	ALPL, ALA176THR	121918019
171760	249	ALPL	0023	HYPOPHOSPHATASIA, INFANTILE HYPOPHOSPHATASIA, CHILDHOOD, INCLUDED	ALPL, ARG272CYS	121918020
171800	250	ALPP	0001	ALKALINE PHOSPHATASE, PLACENTAL, ALLELE-1 POLYMORPHISM ALPP*1	ALPP, MULTIPLE CHANGES	
171800	250	ALPP	0002	ALKALINE PHOSPHATASE, PLACENTAL, ALLELE-3 POLYMORPHISM ALPP*3	ALPP, MULTIPLE CHANGES	
171833	5295	PIK3R1	0001	AGAMMAGLOBULINEMIA 7, AUTOSOMAL RECESSIVE (1 family)	PIK3R1, TRP298TER	
171834	5290	PIK3CA	0001	BREAST CANCER, SOMATIC OVARIAN CANCER, EPITHELIAL, SOMATIC, INCLUDED;; COLORECTAL CANCER, SOMATIC, INCLUDED;; GASTRIC CANCER, SOMATIC, INCLUDED;; HEPATOCELLULAR CARCINOMA, SOMATIC, INCLUDED;; NONSMALL CELL LUNG CANCER, SOMATIC, INCLUDED;; KERATOSIS, SEBORRHEIC, SOMATIC, INCLUDED;; CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI, SOMATIC, INCLUDED	PIK3CA, HIS1047ARG	121913279
171834	5290	PIK3CA	0002	BREAST CANCER, SOMATIC CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI, SOMATIC, INCLUDED	PIK3CA, HIS1047LEU	121913279
171834	5290	PIK3CA	0003	BREAST CANCER, SOMATIC OVARIAN CANCER, EPITHELIAL, SOMATIC, INCLUDED;; COLORECTAL CANCER, SOMATIC, INCLUDED;; GASTRIC CANCER, SOMATIC, INCLUDED;; NONSMALL CELL LUNG CANCER, SOMATIC, INCLUDED;; KERATOSIS, SEBORRHEIC, SOMATIC, INCLUDED;; MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME, SOMATIC, INCLUDED	PIK3CA, GLU545LYS	104886003
171834	5290	PIK3CA	0004	COLORECTAL CANCER, SOMATIC NEVUS, EPIDERMAL, SOMATIC, INCLUDED	PIK3CA, GLU545GLY	121913274
171834	5290	PIK3CA	0005	OVARIAN CANCER, EPITHELIAL, SOMATIC COLORECTAL CANCER, SOMATIC, INCLUDED	PIK3CA, GLN546LYS	121913286
171834	5290	PIK3CA	0006	BREAST CANCER, SOMATIC	PIK3CA, GLN546GLU	
171834	5290	PIK3CA	0007	HEPATOCELLULAR CARCINOMA, SOMATIC GASTRIC CANCER, SOMATIC, INCLUDED	PIK3CA, 1-BP INS, 3204A	
171834	5290	PIK3CA	0008	HEPATOCELLULAR CARCINOMA, SOMATIC	PIK3CA, GLU545ALA	121913274
171834	5290	PIK3CA	0009	CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI, SOMATIC	PIK3CA, GLU542LYS	
171834	5290	PIK3CA	0010	CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI, SOMATIC	PIK3CA, CYS420ARG	
171834	5290	PIK3CA	0011	MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME, SOMATIC	PIK3CA, GLY914ARG	
171834	5290	PIK3CA	0012	MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME, SOMATIC	PIK3CA, CYS378TYR	
171834	5290	PIK3CA	0013	MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME, SOMATIC	PIK3CA, HIS1047TYR	
171834	5290	PIK3CA	0014	MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME, SOMATIC MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME, SOMATIC, INCLUDED	PIK3CA, GLU453DEL	
171834	5290	PIK3CA	0015	COWDEN DISEASE 5	PIK3CA, GLY118ASP	
171834	5290	PIK3CA	0016	COWDEN DISEASE 5	PIK3CA, GLU135LYS	
171834	5290	PIK3CA	0017	COWDEN DISEASE 5	PIK3CA, GLU218LYS	
171834	5290	PIK3CA	0018	COWDEN DISEASE 5	PIK3CA, VAL356ILE	
171834	5290	PIK3CA	0019	COWDEN DISEASE 5	PIK3CA, ARG382LYS	
171834	5290	PIK3CA	0020	COWDEN DISEASE 5 PIK3CA, GLU545ALA AND 2-BP DEL/1-BP INS, NT1658	SER553fsTHR7	
171834	5290	PIK3CA	0021	COWDEN DISEASE 5	PIK3CA, LEU632TER	
171900	5236	PGM1	0001	GLYCOGEN STORAGE DISEASE XIV	PGM1, THR115ALA	121918371
171900	5236	PGM1	0002	GLYCOGEN STORAGE DISEASE XIV	PGM1, IVS7DS, G-C, -1	
171900	5236	PGM1	0003	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE It	PGM1, GLY121ARG	
171900	5236	PGM1	0004	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE It	PGM1, ARG503TER	
172400	2821	GPI	0001	HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASE DEFICIENCY	GPI, GLY158SER	137853582
172400	2821	GPI	0002	HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASE DEFICIENCY	GPI, ARG346HIS	137853583
172400	2821	GPI	0003	HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASE DEFICIENCY	GPI, ILE524THR	137853584
172400	2821	GPI	0004	HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASE DEFICIENCY	GPI, ASP539ASN	137853585
172400	2821	GPI	0005	HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASE DEFICIENCY	GPI, THR224MET	61754634
172400	2821	GPI	0006	HEMOLYTIC ANEMIA, NONSPHEROCYTIC, AND NEUROLOGIC DEFICITS, DUE TO GLUCOSE PHOSPHATE ISOMERASE DEFICIENCY	GPI, HIS20PRO	137853586
172400	2821	GPI	0007	HEMOLYTIC ANEMIA, NONSPHEROCYTIC, AND NEUROLOGIC DEFICITS, DUE TO GLUCOSE PHOSPHATE ISOMERASE DEFICIENCY	GPI, LEU339PRO	137853587
172400	2821	GPI	0008	HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASE DEFICIENCY	GPI, GLN343ARG	
172400	2821	GPI	0009	HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASE DEFICIENCY	GPI, THR5ILE	
172400	2821	GPI	0010	HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASE DEFICIENCY	GPI, THR375ARG	
172400	2821	GPI	0011	HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASE DEFICIENCY	GPI, ASP539ASN	
172405	5350	PLN	0001	CARDIOMYOPATHY, DILATED, 1P	PLN, ARG9CYS	111033559
172405	5350	PLN	0002	CARDIOMYOPATHY, DILATED, 1P CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC 18, INCLUDED	PLN, LEU39TER	111033560
172405	5350	PLN	0003	CARDIOMYOPATHY, DILATED, 1P	PLN, 3-BP DEL, 39AGA	
172405	5350	PLN	0004	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 18	PLN, -77A-G	
172405	5350	PLN	0005	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 18	PLN, -42C-G	
172405	5350	PLN	0006	CARDIOMYOPATHY, DILATED, 1P	PLN, -36A-C	
172411	5320	PLA2G2A	0001	COLORECTAL CANCER	PLA2G2A, 2-BP DEL, NT1119	
172425	5360	PLTP	0001	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 9	PLTP, C-T	3843763
172460	4522	MTHFD1	0001	SPINA BIFIDA, FOLATE-SENSITIVE, SUSCEPTIBILITY TO	MTHFD1, ARG293HIS	34181110
172460	4522	MTHFD1	0002	NEURAL TUBE DEFECTS, FOLATE-SENSITIVE, SUSCEPTIBILITY TO	MTHFD1, ARG653GLN	2236225
172471	5261	PHKG2	0001	GLYCOGEN STORAGE DISEASE IXc	PHKG2, 1-BP INS	
172471	5261	PHKG2	0002	GLYCOGEN STORAGE DISEASE IXc	PHKG2, GLY189GLU	137853588
172471	5261	PHKG2	0003	GLYCOGEN STORAGE DISEASE IXc	PHKG2, VAL106GLU	137853589
172471	5261	PHKG2	0004	GLYCOGEN STORAGE DISEASE IXc	PHKG2, ARG44TER	137853590
172471	5261	PHKG2	0005	GLYCOGEN STORAGE DISEASE IXc	PHKG2, 1-BP DEL, 277C	
172471	5261	PHKG2	0006	GLYCOGEN STORAGE DISEASE IXc	PHKG2, HIS144TYR	137853591
172471	5261	PHKG2	0007	GLYCOGEN STORAGE DISEASE IXc	PHKG2, LEU225ARG	137853592
172480	5723	PSPH	0001	PHOSPHOSERINE PHOSPHATASE DEFICIENCY	PSPH, ASP32ASN	104894035
172480	5723	PSPH	0002	PHOSPHOSERINE PHOSPHATASE DEFICIENCY	PSPH, MET52THR	104894036
172490	5257	PHKB	0001	GLYCOGEN STORAGE DISEASE IXb	PHKB, 1-BP INS	
172490	5257	PHKB	0002	GLYCOGEN STORAGE DISEASE IXb	PHKB, GLN656TER	34667348
172490	5257	PHKB	0003	GLYCOGEN STORAGE DISEASE IXb	PHKB, TYR418TER	121918021
172490	5257	PHKB	0004	GLYCOGEN STORAGE DISEASE IXb	PHKB, TYR974HIS AND GLU975TER	
172490	5257	PHKB	0005	GLYCOGEN STORAGE DISEASE IXb	PHKB, ALA117PRO	121918022
172490	5257	PHKB	0006	GLYCOGEN STORAGE DISEASE IXb	PHKB, IVS4AS, A-G, -2	
172860	5176	SERPINF1	0001	OSTEOGENESIS IMPERFECTA, TYPE VI	SERPINF1, TYR232TER	
172860	5176	SERPINF1	0002	OSTEOGENESIS IMPERFECTA, TYPE VI	SERPINF1, 2-BP DUP, 324CT	
172860	5176	SERPINF1	0003	OSTEOGENESIS IMPERFECTA, TYPE VI	SERPINF1, GLN378TER	
172860	5176	SERPINF1	0004	OSTEOGENESIS IMPERFECTA, TYPE VI	SERPINF1, 2-BP DEL, NT1118	
172860	5176	SERPINF1	0005	OSTEOGENESIS IMPERFECTA, TYPE VI	SERPINF1, -9+2DUP	
172860	5176	SERPINF1	0006	OSTEOGENESIS IMPERFECTA, TYPE VI	SERPINF1, 1-BP DEL, 653T	
173110	5449	POU1F1	0001	PITUITARY HORMONE DEFICIENCY, COMBINED, 1	POU1F1, ARG172TER	104893754
173110	5449	POU1F1	0002	PITUITARY HORMONE DEFICIENCY, COMBINED, 1	POU1F1, ARG271TRP	104893755
173110	5449	POU1F1	0003	PITUITARY HORMONE DEFICIENCY, COMBINED, 1	POU1F1, ALA158PRO	104893756
173110	5449	POU1F1	0004	PITUITARY HORMONE DEFICIENCY, COMBINED, 1	POU1F1, PRO24LEU	104893757
173110	5449	POU1F1	0005	PITUITARY HORMONE DEFICIENCY, COMBINED, 1	POU1F1, ARG143GLN	104893759
173110	5449	POU1F1	0006	PITUITARY HORMONE DEFICIENCY, COMBINED, 1	POU1F1, GLU250TER	104893760
173110	5449	POU1F1	0007	PITUITARY HORMONE DEFICIENCY, COMBINED, 1	POU1F1, PHE135CYS	104893761
173110	5449	POU1F1	0008	PITUITARY HORMONE DEFICIENCY, COMBINED, 1	POU1F1, PRO239SER	104893762
173110	5449	POU1F1	0009	PITUITARY HORMONE DEFICIENCY, COMBINED, 1	POU1F1, 1-BP DEL, 747A	
173110	5449	POU1F1	0010	PITUITARY HORMONE DEFICIENCY, COMBINED, 1	POU1F1, TRP193ARG	104893758
173110	5449	POU1F1	0011	PITUITARY HORMONE DEFICIENCY, COMBINED, 1	POU1F1, LYS145TER	104893763
173110	5449	POU1F1	0012	PITUITARY HORMONE DEFICIENCY, COMBINED, 1	POU1F1, GLU230LYS	104893764
173110	5449	POU1F1	0013	PITUITARY HORMONE DEFICIENCY, COMBINED, 1	POU1F1, ARG172GLN	104893765
173110	5449	POU1F1	0014	PITUITARY HORMONE DEFICIENCY, COMBINED, 1	POU1F1, 1-BP INS, 778A	
173110	5449	POU1F1	0015	PITUITARY HORMONE DEFICIENCY, COMBINED, 1	POU1F1, SER179ARG	104893766
173321	5269	SERPINB6	0001	DEAFNESS, AUTOSOMAL RECESSIVE 91	SERPINB6, GLU245TER	
173325	3728	JUP	0001	NAXOS DISEASE	JUP, 2-BP DEL, 2157TG	113994177
173325	3728	JUP	0002	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 12	JUP, 3-BP INS, 118GCA	113994176
173335	5167	ENPP1	0001	DIABETES MELLITUS, NONINSULIN-DEPENDENT, SUSCEPTIBILITY TO OBESITY, SUSCEPTIBILITY TO, INCLUDED	ENPP1, IVS20AS, 1-BP DEL, T, -11	
173335	5167	ENPP1	0002	ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1	ENPP1, GLU893TER	121918023
173335	5167	ENPP1	0003	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	ENPP1, ARG774CYS	28933977
173335	5167	ENPP1	0004	ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1	ENPP1, 11-BP DEL, NT1072	
173335	5167	ENPP1	0005	ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1	ENPP1, LEU579PHE	121918024
173335	5167	ENPP1	0006	INSULIN RESISTANCE, SUSCEPTIBILITY TO DIABETES MELLITUS, NONINSULIN-DEPENDENT, SUSCEPTIBILITY TO, INCLUDED;; OBESITY, SUSCEPTIBILITY TO, INCLUDED	ENPP1, LYS121GLN	1044498
173335	5167	ENPP1	0007	OBESITY, SUSCEPTIBILITY TO	ENPP1, A-G1044TGA	
173335	5167	ENPP1	0008	ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1	ENPP1, GLY342VAL	121918025
173335	5167	ENPP1	0009	ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1	ENPP1, TYR371PHE	121918026
173335	5167	ENPP1	0010	HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 2	ENPP1, EX24-25DEL	
173335	5167	ENPP1	0011	HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 2 ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1, INCLUDED	ENPP1, GLY266VAL	121908248
173335	5167	ENPP1	0012	HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 2	ENPP1, 1-BP INS, 2248A	
173335	5167	ENPP1	0013	HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 2	ENPP1, TYR901SER	121908249
173335	5167	ENPP1	0014	ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1	ENPP1, TYR261TER	
173335	5167	ENPP1	0015	ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1	ENPP1, 2-BP DEL, 878AA	
173335	5167	ENPP1	0016	ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1	ENPP1, PRO305THR	
173335	5167	ENPP1	0017	ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1	ENPP1, ASP538HIS	
173335	5167	ENPP1	0018	ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1	ENPP1, IVS7, G-A, +1	
173335	5167	ENPP1	0019	ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1	ENPP1, GLY586ARG	
173350	5340	PLG	0001	DYSPLASMINOGENEMIA	PLG, ALA601THR	121918027
173350	5340	PLG	0002	DYSPLASMINOGENEMIA	PLG, VAL355PHE	121918028
173350	5340	PLG	0003	DYSPLASMINOGENEMIA	PLG, SER572PRO	121918029
173350	5340	PLG	0004	PLASMINOGEN DEFICIENCY, TYPE I	PLG, ARG216HIS	121918030
173350	5340	PLG	0005	PLASMINOGEN DEFICIENCY, TYPE I	PLG, TRP597TER	121918031
173350	5340	PLG	0006	PLASMINOGEN DEFICIENCY, TYPE I	PLG, GLU460TER	121918032
173350	5340	PLG	0007	DYSPLASMINOGENEMIA	PLG, GLY732ARG	121918033
173350	5340	PLG	0008	PLASMINOGEN DEFICIENCY, TYPE I	PLG, LYS212DEL	121918034
173350	5340	PLG	0009	PLASMINOGEN DEFICIENCY, TYPE I	PLG, 1-BP DEL, IVS17, G, +1	
173350	5340	PLG	0010	PLASMINOGEN DEFICIENCY, TYPE I	PLG, LYS19GLU	73015965
173360	5054	SERPINE1	0001	PLASMINOGEN ACTIVATOR INHIBITOR-1 DEFICIENCY	SERPINE1, 2-BP INS, 4977TA	
173360	5054	SERPINE1	0002	TRANSCRIPTION OF PLASMINOGEN ACTIVATOR INHIBITOR, MODULATOR OF	SEPINE1, 1-BP DEL/INS, 4G/5G	
173360	5054	SERPINE1	0003	PLASMINOGEN ACTIVATOR INHIBITOR-1 DEFICIENCY	SERPINE1, ALA15THR	6092
173410	5159	PDGFRB	0001	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4	PDGFRB, LEU658PRO	
173410	5159	PDGFRB	0002	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4	PDGFRB, ARG987TRP	
173410	5159	PDGFRB	0003	MYOFIBROMATOSIS, INFANTILE, 1	PDGFRB, ARG561CYS	
173410	5159	PDGFRB	0004	MYOFIBROMATOSIS, INFANTILE, 1	PDGFRB, PRO660THR	
173445	5175	PECAM1	0001	PLATELET-ENDOTHELIAL CELL ADHESION MOLECULE 1 POLYMORPHISM	PECAM1, LEU125VAL	
173470	3690	ITGB3	0001	GLANZMANN THROMBASTHENIA	ITGB3, ARG214GLN	121918444
173470	3690	ITGB3	0002	GLANZMANN THROMBASTHENIA	ITGB3, ASP119TYR	121918445
173470	3690	ITGB3	0003	GLANZMANN THROMBASTHENIA	ITGB3, ARG214TRP	121918446
173470	3690	ITGB3	0004	GLANZMANN THROMBASTHENIA	ITGB3, SER752PRO	121918447
173470	3690	ITGB3	0005	PEN(a)/PEN(b) ALLOANTIGEN POLYMORPHISM THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE, INCLUDED;; POSTTRANSFUSION PURPURA, INCLUDED	ITGB3, ARG143GLN	5917
173470	3690	ITGB3	0006	PL(A1)/(A2) ALLOANTIGEN POLYMORPHISM THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE, INCLUDED;; POSTTRANSFUSION PURPURA, INCLUDED;; MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, INCLUDED;; AUTISM, ASSOCIATION WITH, 7, INCLUDED;; FRACTURE, HIP, SUSCEPTIBILITY TO, INCLUDED	ITGB3, LEU33PRO	5918
173470	3690	ITGB3	0007	Mo ALLOANTIGEN POLYMORPHISM THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE, INCLUDED	ITGB3, PRO407ALA	121918448
173470	3690	ITGB3	0008	GLANZMANN THROMBASTHENIA	ITGB3, IVSiDS, G-T, EXiDEL	
173470	3690	ITGB3	0009	Ca/Tu ALLOANTIGEN POLYMORPHISM THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE, INCLUDED	ITGB3, ARG489GLN	13306487
173470	3690	ITGB3	0010	GLANZMANN THROMBASTHENIA	ITGB3, CYS374TYR	121918449
173470	3690	ITGB3	0011	GLANZMANN THROMBASTHENIA	ITGB3, 11.2-KB DEL	
173470	3690	ITGB3	0012	GLANZMANN THROMBASTHENIA	ITGB3, ARG724TER	121918450
173470	3690	ITGB3	0013	GLANZMANN THROMBASTHENIA	ITGB3, GLU616TER	121918451
173470	3690	ITGB3	0014	GLANZMANN THROMBASTHENIA	ITGB3, 11-BP DEL, EX12	
173470	3690	ITGB3	0015	GLANZMANN THROMBASTHENIA	ITGB3, LEU117TRP	121918452
173470	3690	ITGB3	0016	GLANZMANN THROMBASTHENIA	ITGB3, LYS253MET	
173470	3690	ITGB3	0017	GLANZMANN THROMBASTHENIA	ITGB3, GLY221ASP	
173470	3690	ITGB3	0018	BLEEDING DISORDER, PLATELET-TYPE, 16	ITGB3, ASP723HIS	
173470	3690	ITGB3	0019	BLEEDING DISORDER, PLATELET-TYPE, 16	ITGB3, IVS13DS, G-C, +1	
173470	3690	ITGB3	0020	BLEEDING DISORDER, PLATELET-TYPE, 16	ITGB3, LEU718PRO	
173490	5156	PDGFRA	0001	GASTROINTESTINAL STROMAL TUMOR, SOMATIC	PDGFRA, ASP842VAL	121908585
173490	5156	PDGFRA	0002	GASTROINTESTINAL STROMAL TUMOR, SOMATIC	PDGFRA, 4-CODON DEL, 842DIMH	
173490	5156	PDGFRA	0003	GASTROINTESTINAL STROMAL TUMOR, SOMATIC	PDGFRA, 4-CODON DEL, 845HDSN	
173490	5156	PDGFRA	0004	GASTROINTESTINAL STROMAL TUMOR, SOMATIC GASTROINTESTINAL STROMAL TUMOR, FAMILIAL, INCLUDED	PDGFRA, VAL561ASP	121908586
173490	5156	PDGFRA	0005	GASTROINTESTINAL STROMAL TUMOR, SOMATIC	PDGFRA, 2-CODON INS, 561ER	
173490	5156	PDGFRA	0006	GASTROINTESTINAL STROMAL TUMOR, SOMATIC	PDGFRA, 5-CODON DEL, 560RVIES	
173490	5156	PDGFRA	0007	GASTROINTESTINAL STROMAL TUMOR, SOMATIC	PDGFRA, 6-CODON DEL, 566SPDGHE	
173490	5156	PDGFRA	0008	HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC, RESISTANT TO IMATINIB	PDGFRA, THR674ILE	121908587
173490	5156	PDGFRA	0009	GASTROINTESTINAL STROMAL TUMOR, FAMILIAL	PDGFRA, ASP846TYR	121908588
173490	5156	PDGFRA	0010	GASTROINTESTINAL STROMAL TUMOR, FAMILIAL	PDGFRA, TYR555CYS	121908589
173490	5156	PDGFRA	0011	VARIANT OF UNKNOWN SIGNIFICANCE	PDGFRA, ALA401ASP	
173490	5156	PDGFRA	0012	VARIANT OF UNKNOWN SIGNIFICANCE	PDGFRA, VAL544ALA	
173490	5156	PDGFRA	0013	VARIANT OF UNKNOWN SIGNIFICANCE	PDGFRA, THR1052MET	
173510	948	CD36	0001	PLATELET GLYCOPROTEIN IV DEFICIENCY	CD36, PRO90SER	75326924
173510	948	CD36	0002	PLATELET GLYCOPROTEIN IV DEFICIENCY MALARIA, CEREBRAL, SUSCEPTIBILITY TO, INCLUDED	CD36, T1264G	
173510	948	CD36	0003	PLATELET GLYCOPROTEIN IV DEFICIENCY MALARIA, CEREBRAL, SUSCEPTIBILITY TO, INCLUDED	CD36, G1439C, 1-BP DEL, 1444A	
173510	948	CD36	0004	PLATELET GLYCOPROTEIN IV DEFICIENCY MALARIA, CEREBRAL, RESISTANCE TO, INCLUDED	CD36, IVS3 (TG)12	
173510	948	CD36	0005	PLATELET GLYCOPROTEIN IV DEFICIENCY	CD36, 1-BP INS, 1159A	
173510	948	CD36	0006	PLATELET GLYCOPROTEIN IV DEFICIENCY	CD36, PHE253LEU	
173510	948	CD36	0007	PLATELET GLYCOPROTEIN IV DEFICIENCY	CD36, ILE413LEU	121918035
173510	948	CD36	0008	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 7	CD36, HAPLOTYPE, AAGIC	
173515	2815	GP9	0001	BERNARD-SOULIER SYNDROME, TYPE C	GP9, ASN45SER	5030764
173515	2815	GP9	0002	BERNARD-SOULIER SYNDROME, TYPE C	GP9, ASP21GLY	121918036
173515	2815	GP9	0003	BERNARD-SOULIER SYNDROME, TYPE C	GP9, PHE55SER	121918037
173515	2815	GP9	0004	BERNARD-SOULIER SYNDROME, TYPE C	GP9, LEU40PRO	28933377
173515	2815	GP9	0005	BERNARD-SOULIER SYNDROME, TYPE C	GP9, CYS8ARG	28933378
173515	2815	GP9	0006	BERNARD-SOULIER SYNDROME, TYPE C	GP9, LEU7PRO	121918038
173610	6403	SELP	0001	SELECTIN P POLYMORPHISM	SELP, THR715PRO	6136
173610	6403	SELP	0002	ATOPY, SUSCEPTIBILITY TO	SELP, VAL640LEU	6133
173880	5284	PIGR	0001	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	PIGR, ALA580VAL	291102
173910	5311	PKD2	0001	POLYCYSTIC KIDNEY DISEASE 2	PKD2, TRP380TER	121918039
173910	5311	PKD2	0002	POLYCYSTIC KIDNEY DISEASE 2	PKD2, ARG742TER	121918040
173910	5311	PKD2	0003	POLYCYSTIC KIDNEY DISEASE 2	PKD2, GLN405TER	121918041
173910	5311	PKD2	0004	POLYCYSTIC KIDNEY DISEASE 2	PKD2, 1-BP INS, 693C	
173910	5311	PKD2	0005	POLYCYSTIC KIDNEY DISEASE 2	PKD2, ARG464TER	121918042
173910	5311	PKD2	0006	POLYCYSTIC KIDNEY DISEASE 2	PKD2, 1-BP INS, 2160A	
173910	5311	PKD2	0007	POLYCYSTIC KIDNEY DISEASE 2	PKD2, 1-BP INS, 197-203C	
173910	5311	PKD2	0008	POLYCYSTIC KIDNEY DISEASE 2	PKD2, ASP511VAL	121918043
173910	5311	PKD2	0009	POLYCYSTIC KIDNEY DISEASE 2	PKD2, 2-BP DEL/1-BP INS, NT1934	
173910	5311	PKD2	0010	POLYCYSTIC KIDNEY DISEASE 2	PKD2, EX3DUP	
173910	5311	PKD2	0011	POLYCYSTIC KIDNEY DISEASE 2	PKD2, 3-BP INS, 305GAG	
174761	5424	POLD1	0001	COLORECTAL CANCER, SUSCEPTIBILITY TO, 10	POLD1, SER478ASN	
174761	5424	POLD1	0002	COLORECTAL CANCER, SUSCEPTIBILITY TO, 10	POLD1, PRO327LEU	
174762	5426	POLE	0001	COLORECTAL CANCER, SUSCEPTIBILITY TO, 12	POLE, LEU424VAL	
174762	5426	POLE	0002	FACIAL DYSMORPHISM, IMMUNODEFICIENCY, LIVEDO, AND SHORT STATURE	POLE, IVS34DS, A-G, +3	
174763	5428	POLG	0001	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 1	POLG, TYR955CYS	113994099
174763	5428	POLG	0002	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS, INCLUDED;; SPINOCEREBELLAR ATAXIA WITH EPILEPSY, INCLUDED;; MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE), INCLUDED	POLG, ALA467THR	113994095
174763	5428	POLG	0003	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE	POLG, LEU304ARG	121918044
174763	5428	POLG	0004	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE	POLG, ARG3PRO	121918045
174763	5428	POLG	0005	SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS	POLG, ARG627TRP	121918046
174763	5428	POLG	0006	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, DIGENIC, INCLUDED;; MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE), INCLUDED;; MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE), INCLUDED	POLG, GLY848SER	113994098
174763	5428	POLG	0007	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE), INCLUDED	POLG, THR251ILE	113994094
174763	5428	POLG	0008	MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	POLG, GLU873TER	121918047
174763	5428	POLG	0009	SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS	POLG, HIS932TYR	121918048
174763	5428	POLG	0010	SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS	POLG, GLY1051ARG	121918049
174763	5428	POLG	0011	MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE) PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE, INCLUDED	POLG, PRO587LEU	113994096
174763	5428	POLG	0012	MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE)	POLG, ASN864SER	121918050
174763	5428	POLG	0013	SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS SPINOCEREBELLAR ATAXIA WITH EPILEPSY, INCLUDED;; MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE), INCLUDED	POLG, TRP748SER	113994097
174763	5428	POLG	0014	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 1	POLG, ALA957SER	121918051
174763	5428	POLG	0015	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 1	POLG, TYR831CYS	41549716
174763	5428	POLG	0016	SPINOCEREBELLAR ATAXIA WITH EPILEPSY	POLG, GLN497HIS	121918052
174763	5428	POLG	0017	MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	POLG, TRP1020TER	
174763	5428	POLG	0018	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE	POLG, ARG853TRP	121918053
174763	5428	POLG	0019	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE	POLG, GLY737ARG	121918054
174763	5428	POLG	0020	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 1	POLG, SER511ASN	121918055
174763	5428	POLG	0021	MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE)	POLG, ARG227TRP	121918056
174763	5428	POLG	0022	MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE) MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE), INCLUDED	POLG, PRO1073LEU	
176260	3736	KCNA1	0001	EPISODIC ATAXIA, TYPE 1	KCNA1, VAL408ALA	104894352
176260	3736	KCNA1	0002	EPISODIC ATAXIA, TYPE 1	KCNA1, ARG239SER	104894348
176260	3736	KCNA1	0003	EPISODIC ATAXIA, TYPE 1	KCNA1, VAL174PHE	104894349
176260	3736	KCNA1	0004	EPISODIC ATAXIA, TYPE 1	KCNA1, PHE249ILE	104894356
176260	3736	KCNA1	0005	EPISODIC ATAXIA, TYPE 1	KCNA1, PHE184CYS	104894357
176260	3736	KCNA1	0006	EPISODIC ATAXIA, TYPE 1	KCNA1, GLU325ASP	104894353
176260	3736	KCNA1	0007	EPISODIC ATAXIA, TYPE 1	KCNA1, THR226ALA	104894354
176260	3736	KCNA1	0008	EPISODIC ATAXIA, TYPE 1	KCNA1, VAL404ILE	104894355
176260	3736	KCNA1	0009	EPISODIC ATAXIA, TYPE 1	KCNA1, ILE177ASN	
176260	3736	KCNA1	0010	MYOKYMIA 1	KCNA1, ALA242PRO	28933381
176260	3736	KCNA1	0011	MYOKYMIA 1	KCNA1, PRO244HIS	28933382
176260	3736	KCNA1	0012	EPISODIC ATAXIA, TYPE 1	KCNA1, ARG417TER	104894358
176260	3736	KCNA1	0013	EPISODIC ATAXIA, TYPE 1	KCNA1, THR226ARG	28933383
176260	3736	KCNA1	0014	MYOKYMIA 1	KCNA1, THR226LYS	28933383
176260	3736	KCNA1	0015	MYOKYMIA 1 WITH HYPOMAGNESEMIA	KCNA1, ASN255ASP	121918067
176261	3753	KCNE1	0001	JERVELL AND LANGE-NIELSEN SYNDROME 2	KCNE1, THR59PRO AND LEU60PRO	
176261	3753	KCNE1	0002	JERVELL AND LANGE-NIELSEN SYNDROME 2	KCNE1, THR7ILE	28933384
176261	3753	KCNE1	0003	JERVELL AND LANGE-NIELSEN SYNDROME 2 LONG QT SYNDROME 5, INCLUDED	KCNE1, ASP76ASN	74315445
176261	3753	KCNE1	0004	LONG QT SYNDROME 5	KCNE1, SER74LEU	74315446
176261	3753	KCNE1	0005	LONG QT SYNDROME 5, ACQUIRED, SUSCEPTIBILITY TO LONG QT SYNDROME 2/5, DIGENIC, INCLUDED	KCNE1, ASP85ASN	1805128
176264	3748	KCNC3	0001	SPINOCEREBELLAR ATAXIA 13	KCNC3, ARG420HIS	104894699
176264	3748	KCNC3	0002	SPINOCEREBELLAR ATAXIA 13	KCNC3, PHE448LEU	104894700
176267	3741	KCNA5	0001	ATRIAL FIBRILLATION, FAMILIAL, 7	KCNA5, GLU375TER	121908590
176267	3741	KCNA5	0002	ATRIAL FIBRILLATION, FAMILIAL, 7	KCNA5, THR527MET	121908591
176267	3741	KCNA5	0003	ATRIAL FIBRILLATION, FAMILIAL, 7	KCNA5, ALA576VAL	121908592
176267	3741	KCNA5	0004	ATRIAL FIBRILLATION, FAMILIAL, 7	KCNA5, GLU610LYS	121908593
176300	7276	TTR	0001	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	TTR, VAL30MET	28933979
176300	7276	TTR	0002	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	TTR, PHE33ILE	121918068
176300	7276	TTR	0003	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	TTR, LEU58HIS	121918069
176300	7276	TTR	0004	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	TTR, THR60ALA	121918070
176300	7276	TTR	0005	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	TTR, SER77TYR	121918071
176300	7276	TTR	0006	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	TTR, ILE84SER	121918072
176300	7276	TTR	0007	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	TTR, LEU111MET	121918073
176300	7276	TTR	0008	TRANSTHYRETIN POLYMORPHISM	TTR, TYR116VAL	
176300	7276	TTR	0009	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	TTR, VAL122ILE	76992529
176300	7276	TTR	0010	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	TTR, HIS90ASN	121918074
176300	7276	TTR	0011	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	TTR, TYR114CYS	121918075
176300	7276	TTR	0012	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	TTR, GLU42GLY	11541796
176300	7276	TTR	0013	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	TTR, SER50ARG	121918076
176300	7276	TTR	0014	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	TTR, VAL30ALA	79977247
176300	7276	TTR	0015	DYSTRANSTHYRETINEMIC EUTHYROIDAL HYPERTHYROXINEMIA	TTR, ALA109THR	
176300	7276	TTR	0016	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	TTR, ALA36PRO	121918077
176300	7276	TTR	0018	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED, MODIFIER OF	TTR, THR119MET	28933981
176300	7276	TTR	0019	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	TTR, LEU58ARG	121918069
176300	7276	TTR	0020	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	TTR, GLY47ARG, G-C	
176300	7276	TTR	0021	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	TTR, ALA45THR	104894664
176300	7276	TTR	0022	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	TTR, LEU55PRO	121918079
176300	7276	TTR	0023	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	TTR, SER50ILE	121918080
176300	7276	TTR	0024	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	TTR, VAL30LEU	28933979
176300	7276	TTR	0025	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	TTR, THR49ALA	121918081
176300	7276	TTR	0026	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	TTR, GLU89GLN	121918082
176300	7276	TTR	0027	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	TTR, LYS70ASN	
176300	7276	TTR	0028	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	TTR, CYS10ARG	121918083
176300	7276	TTR	0029	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	TTR, VAL71ALA	121918084
176300	7276	TTR	0030	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	TTR, ILE68LEU	121918085
176300	7276	TTR	0031	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	TTR, GLU61LYS	121918086
176300	7276	TTR	0032	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	TTR, ALA97GLY	121918087
176300	7276	TTR	0033	CARPAL TUNNEL SYNDROME, FAMILIAL	TTR, TYR114HIS	121918088
176300	7276	TTR	0034	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	TTR, ILE107VAL	121918089
176300	7276	TTR	0035	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	TTR, GLY47ALA	121918090
176300	7276	TTR	0036	TRANSTHYRETIN POLYMORPHISM	TTR, GLY6SER	1800458
176300	7276	TTR	0037	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	TTR, PHE64LEU	121918091
176300	7276	TTR	0038	DYSTRANSTHYRETINEMIC EUTHYROIDAL HYPERTHYROXINEMIA	TTR, ALA109VAL	121918092
176300	7276	TTR	0039	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	TTR, VAL20ILE	121918093
176300	7276	TTR	0040	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	TTR, PHE33LEU	121918068
176300	7276	TTR	0041	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	TTR, LEU12PRO	121918094
176300	7276	TTR	0042	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	TTR, ARG104HIS	121918095
176300	7276	TTR	0043	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	TTR, GLY47ARG, G-A	
176300	7276	TTR	0044	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	TTR, VAL122DEL	121918096
176300	7276	TTR	0045	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	TTR, PHE44SER	104894665
176300	7276	TTR	0046	AMYLOIDOSIS, LEPTOMENINGEAL, TRANSTHYRETIN-RELATED	TTR, GLY53GLU	121918097
176300	7276	TTR	0047	AMYLOIDOSIS, LEPTOMENINGEAL, TRANSTHYRETIN-RELATED	TTR, ASP18GLY	121918098
176300	7276	TTR	0048	AMYLOIDOSIS, LEPTOMENINGEAL, TRANSTHYRETIN-RELATED	TTR, PHE64SER	104894665
176300	7276	TTR	0049	AMYLOIDOSIS, LEPTOMENINGEAL, TRANSTHYRETIN-RELATED	TTR, VAL30GLY	79977247
176300	7276	TTR	0050	AMYLOIDOSIS, LEPTOMENINGEAL, TRANSTHYRETIN-RELATED	TTR, TYR69HIS	121918100
176300	7276	TTR	0051	AMYLOIDOSIS, LEPTOMENINGEAL, TRANSTHYRETIN-RELATED	TTR, ALA25THR	
176300	7276	TTR	0052	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	TTR, ALA97SER	
176610	5216	PFN1	0001	AMYOTROPHIC LATERAL SCLEROSIS 18	PFN1, CYS71GLY	
176610	5216	PFN1	0002	AMYOTROPHIC LATERAL SCLEROSIS 18	PFN1, MET114THR	
176610	5216	PFN1	0003	AMYOTROPHIC LATERAL SCLEROSIS 18	PFN1, GLY118VAL	
176610	5216	PFN1	0004	AMYOTROPHIC LATERAL SCLEROSIS 18	PFN1, GLU117GLY	
176640	5621	PRNP	0001	CREUTZFELDT-JAKOB DISEASE GERSTMANN-STRAUSSLER DISEASE, INCLUDED;; HUNTINGTON DISEASE-LIKE 1, INCLUDED	PRNP, EXTRA OCTAPEPTIDE CODING REPEATS	193922906
176640	5621	PRNP	0002	GERSTMANN-STRAUSSLER DISEASE	PRNP, PRO102LEU	74315401
176640	5621	PRNP	0004	GERSTMANN-STRAUSSLER DISEASE	PRNP, ALA117VAL	74315402
176640	5621	PRNP	0005	PRION DISEASE, SUSCEPTIBILITY TO ALZHEIMER DISEASE, EARLY-ONSET, SUSCEPTIBILITY TO, INCLUDED;; APHASIA, PRIMARY PROGRESSIVE, SUSCEPTIBILITY TO, INCLUDED	PRNP, MET129VAL	1799990
176640	5621	PRNP	0006	CREUTZFELDT-JAKOB DISEASE FATAL FAMILIAL INSOMNIA, INCLUDED	PRNP, GLU200LYS	28933385
176640	5621	PRNP	0007	CREUTZFELDT-JAKOB DISEASE FATAL FAMILIAL INSOMNIA, INCLUDED	PRNP, ASP178ASN AND MET129VAL	1799990
176640	5621	PRNP	0009	REMOVED FROM DATABASE .0010 FATAL FAMILIAL INSOMNIA CREUTZFELDT-JAKOB DISEASE, INCLUDED	PRNP, ASP178ASN AND MET129	
176640	5621	PRNP	0011	GERSTMANN-STRAUSSLER DISEASE	PRNP, PHE198SER	74315405
176640	5621	PRNP	0012	GERSTMANN-STRAUSSLER DISEASE	PRNP, GLN217ARG	74315406
176640	5621	PRNP	0014	CREUTZFELDT-JAKOB DISEASE	PRNP, VAL210ILE	74315407
176640	5621	PRNP	0015	GERSTMANN-STRAUSSLER DISEASE	PRNP, PRO105LEU	11538758
176640	5621	PRNP	0016	CREUTZFELDT-JAKOB DISEASE	PRNP, VAL180ILE	74315408
176640	5621	PRNP	0017	CREUTZFELDT-JAKOB DISEASE DEMENTIA, LEWY BODY, INCLUDED	PRNP, MET232ARG	74315409
176640	5621	PRNP	0018	SPONGIFORM ENCEPHALOPATHY WITH NEUROPSYCHIATRIC FEATURES EPILEPSY, FOCAL, DUE TO CORTICAL MALFORMATION, SUSCEPTIBILITY TO, INCLUDED	PRNP, ASN171SER	16990018
176640	5621	PRNP	0019	CREUTZFELDT-JAKOB DISEASE, PROTECTION AGAINST	PRNP, GLU219LYS	1800014
176640	5621	PRNP	0021	GERSTMANN-STRAUSSLER DISEASE	PRNP, GLY131VAL	74315410
176640	5621	PRNP	0022	SPONGIFORM ENCEPHALOPATHY WITH NEUROPSYCHIATRIC FEATURES	PRNP, THR183ALA	74315411
176640	5621	PRNP	0023	CREUTZFELDT-JAKOB DISEASE	PRNP, ARG208HIS	74315412
176640	5621	PRNP	0024	GERSTMANN-STRAUSSLER DISEASE SPONGIFORM ENCEPHALOPATHY WITH NEUROPSYCHIATRIC FEATURES, INCLUDED	PRNP, HIS187ARG	74315413
176640	5621	PRNP	0025	SPONGIFORM ENCEPHALOPATHY WITH NEUROPSYCHIATRIC FEATURES	PRNP, PRO105THR	74315414
176640	5621	PRNP	0026	GERSTMANN-STRAUSSLER DISEASE	PRNP, ALA133VAL	74315415
176640	5621	PRNP	0027	GERSTMANN-STRAUSSLER DISEASE	PRNP, PRO105SER	74315414
176640	5621	PRNP	0028	KURU, PROTECTION AGAINST	PRNP, GLY127VAL	
176705	5245	PHB	0001	BREAST CANCER, SUSCEPTIBILITY TO	PHB, 729C-T, 3-PRIME UTR	121918372
176730	3630	INS	0001	INSULIN CHICAGO	INS, PHE25LEU	
176730	3630	INS	0002	INSULIN LOS ANGELES	INS, PHE24SER	80356668
176730	3630	INS	0003	HYPERPROINSULINEMIA, FAMILIAL PROINSULIN PROVIDENCE	INS, HIS10ASP	121918101
176730	3630	INS	0004	HYPERPROINSULINEMIA, FAMILIAL	INS, ARG65HIS	28933985
176730	3630	INS	0005	INSULIN WAKAYAMA DIABETES MELLITUS WITH HYPERINSULINEMIA	INS, VAL3LEU	121918102
176730	3630	INS	0006	HYPERPROINSULINEMIA, FAMILIAL PROINSULIN KYOTO	INS, ARG65LEU	28933985
176730	3630	INS	0007	HYPERPROINSULINEMIA, FAMILIAL	INS, ARG65PRO	28933985
176730	3630	INS	0008	DIABETES MELLITUS, PERMANENT NEONATAL	INS, GLY32SER	80356664
176730	3630	INS	0009	DIABETES MELLITUS, PERMANENT NEONATAL	INS, CYS43GLY	80356666
176730	3630	INS	0010	DIABETES MELLITUS, PERMANENT NEONATAL	INS, ARG89CYS	80356669
176730	3630	INS	0011	DIABETES MELLITUS, PERMANENT NEONATAL	INS, CYS96TYR	80356671
176730	3630	INS	0012	DIABETES MELLITUS, PERMANENT NEONATAL	INS, ALA24ASP	80356663
176730	3630	INS	0013	DIABETES MELLITUS, PERMANENT NEONATAL	INS, PHE48CYS	80356668
176730	3630	INS	0014	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 10	INS, ARG6CYS	121908278
176730	3630	INS	0015	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 10	INS, ARG46GLN	121908260
176730	3630	INS	0016	DIABETES MELLITUS, INSULIN-DEPENDENT, 2	INS, ARG55CYS	121908261
176797	7704	ZBTB16	0001	SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	ZBTB16, MET617VAL	121434606
176801	5660	PSAP	0001	METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	PSAP, THR217ILE	121918103
176801	5660	PSAP	0002	METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	PSAP, IVS4AS, C-A	
176801	5660	PSAP	0003	METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	PSAP, CYS241SER	121918104
176801	5660	PSAP	0004	GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY	PSAP, CYS385PHE	121918105
176801	5660	PSAP	0005	COMBINED SAPOSIN DEFICIENCY GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY, INCLUDED	PSAP, MET1LEU	121918106
176801	5660	PSAP	0006	METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	PSAP, IVS5AS, G-T, -1	
176801	5660	PSAP	0007	METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	PSAP, ASN215HIS	121918107
176801	5660	PSAP	0008	COMBINED SAPOSIN DEFICIENCY	PSAP, 1-BP DEL, 803G	
176801	5660	PSAP	0009	KRABBE DISEASE, ATYPICAL, DUE TO SAPOSIN A DEFICIENCY	PSAP, 3-BP DEL, 207TGT	
176801	5660	PSAP	0010	GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY	PSAP, CYS382GLY	121918108
176801	5660	PSAP	0011	GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY	PSAP, GLN430TER	121918109
176801	5660	PSAP	0012	GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY	PSAP, LEU349PRO	121918110
176801	5660	PSAP	0013	COMBINED SAPOSIN DEFICIENCY	PSAP, IVS9AS, A-G, -2	
176801	5660	PSAP	0014	METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	PSAP, IVS5AS, A-G, -2	
176801	5660	PSAP	0015	METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	PSAP, 2-BP DEL, 828GA	
176804	5732	PTGER2	0001	ASTHMA, ASPIRIN-INDUCED, SUSCEPTIBILITY TO	PTGER2, G-A POLYMORPHISM	
176830	5443	POMC	0001	PROOPIOMELANOCORTIN DEFICIENCY	POMC, GLU79TER	121918111
176830	5443	POMC	0002	PROOPIOMELANOCORTIN DEFICIENCY	POMC, 1-BP DEL, 7133C	
176830	5443	POMC	0003	PROOPIOMELANOCORTIN DEFICIENCY	POMC, 3804C-A	
176830	5443	POMC	0004	OBESITY, EARLY-ONSET, SUSCEPTIBILITY TO	POMC, ARG236GLY	28932472
176830	5443	POMC	0005	PROOPIOMELANOCORTIN DEFICIENCY	POMC, 2-BP INS, 7100GG	
176830	5443	POMC	0006	PROOPIOMELANOCORTIN DEFICIENCY	POMC, LYS25TER	121918112
176830	5443	POMC	0007	PROOPIOMELANOCORTIN DEFICIENCY	POMC, 1-BP DEL, NT6996	
176872	5604	MAP2K1	0001	CARDIOFACIOCUTANEOUS SYNDROME 3	MAP2K1, PHE53SER	121908594
176872	5604	MAP2K1	0002	CARDIOFACIOCUTANEOUS SYNDROME 3	MAP2K1, TYR130CYS	121908595
176872	5604	MAP2K1	0003	CARDIOFACIOCUTANEOUS SYNDROME 3	MAP2K1, GLY128VAL	121908596
176876	5781	PTPN11	0001	NOONAN SYNDROME 1	PTPN11, ALA72SER	121918453
176876	5781	PTPN11	0002	NOONAN SYNDROME 1	PTPN11, ALA72GLY	121918454
176876	5781	PTPN11	0003	NOONAN SYNDROME 1	PTPN11, ASN308ASP	28933386
176876	5781	PTPN11	0004	NOONAN SYNDROME 1	PTPN11, ASN308SER	121918455
176876	5781	PTPN11	0005	LEOPARD SYNDROME	PTPN11, TYR279CYS	121918456
176876	5781	PTPN11	0006	LEOPARD SYNDROME	PTPN11, THR468MET	121918457
176876	5781	PTPN11	0007	NOONAN SYNDROME 1	PTPN11, SER502THR	121918458
176876	5781	PTPN11	0008	NOONAN SYNDROME 1	PTPN11, TYR63CYS	121918459
176876	5781	PTPN11	0009	NOONAN SYNDROME 1	PTPN11, TYR62ASP	121918460
176876	5781	PTPN11	0010	NOONAN SYNDROME 1	PTPN11, ASP61GLY	121918461
176876	5781	PTPN11	0011	NOONAN SYNDROME 1	PTPN11, THR73ILE	121918462
176876	5781	PTPN11	0012	NOONAN SYNDROME 1	PTPN11, PHE285SER	121918463
176876	5781	PTPN11	0014	LEUKEMIA, JUVENILE MYELOMONOCYTIC, SOMATIC	PTPN11, GLU76LYS	121918464
176876	5781	PTPN11	0015	LEUKEMIA, JUVENILE MYELOMONOCYTIC, SOMATIC	PTPN11, GLU76VAL	
176876	5781	PTPN11	0016	LEUKEMIA, JUVENILE MYELOMONOCYTIC, SOMATIC	PTPN11, GLU76GLY	
176876	5781	PTPN11	0017	LEUKEMIA, JUVENILE MYELOMONOCYTIC, SOMATIC	PTPN11, GLU76ALA	121918465
176876	5781	PTPN11	0018	NOONAN SYNDROME	PTPN11, GLN79ARG	121918466
176876	5781	PTPN11	0019	NOONAN SYNDROME	PTPN11, THR411MET	121918467
176876	5781	PTPN11	0020	LEOPARD SYNDROME	PTPN11, ALA461THR	121918468
176876	5781	PTPN11	0021	LEOPARD SYNDROME	PTPN11, GLY464ALA	121918469
176876	5781	PTPN11	0022	LEOPARD SYNDROME	PTPN11, GLN510PRO	121918470
176876	5781	PTPN11	0023	NOONAN SYNDROME	PTPN11, GLN510ARG	
176876	5781	PTPN11	0024	NOONAN SYNDROME	PTPN11, 3-BP DEL, 181GTG	121918471
176876	5781	PTPN11	0025	METACHONDROMATOSIS	PTPN11, 11-BP DEL, NT514	
176876	5781	PTPN11	0026	METACHONDROMATOSIS	PTPN11, ARG138TER	
176876	5781	PTPN11	0027	NOONAN SYNDROME	PTPN11, THR2ILE	
176876	5781	PTPN11	0028	METACHONDROMATOSIS	PTPN11, 5-BP DEL, NT409	
176876	5781	PTPN11	0029	METACHONDROMATOSIS	PTPN11, 11-BP DEL/24-BP INS, NT458	
176876	5781	PTPN11	0030	METACHONDROMATOSIS	PTPN11, 2-BP DEL, NT353	
176876	5781	PTPN11	0031	METACHONDROMATOSIS	PTPN11, GLN506TER	
176876	5781	PTPN11	0032	METACHONDROMATOSIS	PTPN11, 1-BP DEL, NT1315	
176876	5781	PTPN11	0033	METACHONDROMATOSIS	PTPN11, IVS5AS, A-C, -2	
176876	5781	PTPN11	0034	METACHONDROMATOSIS	PTPN11, LYS99TER	
176876	5781	PTPN11	0035	METACHONDROMATOSIS	PTPN11, IVS9AS, G-T, -1	
176876	5781	PTPN11	0036	METACHONDROMATOSIS	PTPN11, 15-KB DEL	
176880	5627	PROS1	0001	PROTEIN S HEERLEN	PROS1, SER460PRO	121918472
176880	5627	PROS1	0002	THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL DOMINANT	PROS1, ASN217SER	121918473
176880	5627	PROS1	0003	THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL DOMINANT	PROS1, LYS155GLU	121918474
176880	5627	PROS1	0004	THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL DOMINANT	PROS1, IVS10DS, G-A, +5	
176880	5627	PROS1	0005	THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL DOMINANT	PROS1, TER636TYR, 649TER	
176880	5627	PROS1	0006	THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL DOMINANT	PROS1, IVS11AS, A-G, -9	
176880	5627	PROS1	0007	THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL DOMINANT	PROS1, GLN238TER	121918475
176880	5627	PROS1	0008	THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL DOMINANT	PROS1, ARG520GLY	121918476
176880	5627	PROS1	0009	THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL DOMINANT	PROS1, ARG355CYS	
176880	5627	PROS1	0010	THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL RECESSIVE	PROS1, 1-BP INS, 146A	
176880	5627	PROS1	0011	THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL RECESSIVE	PROS1, ARG410TER	
176880	5627	PROS1	0012	THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL RECESSIVE	PROS1, TYR234CYS	
176885	5770	PTPN1	0001	INSULIN RESISTANCE, SUSCEPTIBILITY TO	PTPN1, 1-BP INS, g.1484G, 3-PRIME UTR	
176895	8858	PROZ	0001	PROTEIN Z DEFICIENCY	PROZ, GLU30GLN	
176930	2147	F2	0001	PROTHROMBIN TYPE 3	F2, GLU157LYS	62623459
176930	2147	F2	0002	DYSPROTHROMBINEMIA	F2, ARG271CYS	121918477
176930	2147	F2	0003	DYSPROTHROMBINEMIA	F2, ARG418TRP	121918478
176930	2147	F2	0004	DYSPROTHROMBINEMIA	F2, ARG382CYS	121918479
176930	2147	F2	0005	DYSPROTHROMBINEMIA	F2, GLY558VAL	121918480
176930	2147	F2	0006	DYSPROTHROMBINEMIA	F2, MET337THR	121918481
176930	2147	F2	0007	DYSPROTHROMBINEMIA PROTHROMBIN HIMI-II	F2, ARG388HIS	121918482
176930	2147	F2	0008	HYPOPROTHROMBINEMIA	F2, 1-BP INS, 4177T	
176930	2147	F2	0009	THROMBOPHILIA DUE TO THROMBIN DEFECT STROKE, ISCHEMIC, SUSCEPTIBILITY TO, INCLUDED;; PREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 2, INCLUDED	F2, 20210G-A	
176930	2147	F2	0010	DYSPROTHROMBINEMIA	F2, GLU300LYS	121918483
176930	2147	F2	0011	DYSPROTHROMBINEMIA	F2, GLU309LYS	121918484
176930	2147	F2	0012	DYSPROTHROMBINEMIA	F2, ARG382HIS	121918485
176930	2147	F2	0013	DYSPROTHROMBINEMIA	F2, ASP552GLU	121918486
176930	2147	F2	0014	HYPOPROTHROMBINEMIA	F2, TYR44CYS	
176930	2147	F2	0015	THROMBOPHILIA DUE TO THROMBIN DEFECT	F2, ARG596LEU	
176941	7297	TYK2	0001	TYROSINE KINASE 2 DEFICIENCY	TYK2, 4-BP DEL, 550GCTT	
176943	2263	FGFR2	0001	CROUZON SYNDROME PFEIFFER SYNDROME, INCLUDED	FGFR2, CYS342TYR	121918487
176943	2263	FGFR2	0002	CROUZON SYNDROME PFEIFFER SYNDROME, INCLUDED;; JACKSON-WEISS SYNDROME, INCLUDED;; ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS, INCLUDED	FGFR2, CYS342ARG	
176943	2263	FGFR2	0003	CROUZON SYNDROME JACKSON-WEISS SYNDROME, INCLUDED;; ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS, INCLUDED	FGFR2, CYS342SER	121918488
176943	2263	FGFR2	0004	CROUZON SYNDROME	FGFR2, TYR340HIS	121918489
176943	2263	FGFR2	0005	CROUZON SYNDROME	FGFR2, SER354CYS	121918490
176943	2263	FGFR2	0006	CROUZON SYNDROME CRANIOSYNOSTOSIS, NONCLASSIFIABLE AUTOSOMAL DOMINANT, INCLUDED;; SCAPHOCEPHALY AND AXENFELD-RIEGER ANOMALY, INCLUDED	FGFR2, ALA344ALA	121918491
176943	2263	FGFR2	0007	JACKSON-WEISS SYNDROME CROUZON SYNDROME, INCLUDED	FGFR2, ALA344GLY	121918492
176943	2263	FGFR2	0008	CROUZON SYNDROME	FGFR2, TYR328CYS	121918493
176943	2263	FGFR2	0009	CROUZON SYNDROME	FGFR2, SER347CYS	121918494
176943	2263	FGFR2	0010	APERT SYNDROME ENDOMETRIAL CANCER, SOMATIC, INCLUDED	FGFR2, SER252TRP	79184941
176943	2263	FGFR2	0011	APERT SYNDROME	FGFR2, PRO253ARG	77543610
176943	2263	FGFR2	0012	PFEIFFER SYNDROME	FGFR2, THR341PRO	121918495
176943	2263	FGFR2	0013	CROUZON SYNDROME	FGFR2, CYS342TRP	121918496
176943	2263	FGFR2	0014	CROUZON SYNDROME JACKSON-WEISS SYNDROME, INCLUDED	FGFR2, GLN289PRO	121918497
176943	2263	FGFR2	0015	BEARE-STEVENSON CUTIS GYRATA SYNDROME ENDOMETRIAL CANCER, SOMATIC, INCLUDED	FGFR2, TYR375CYS	121913478
176943	2263	FGFR2	0016	BEARE-STEVENSON CUTIS GYRATA SYNDROME	FGFR2, SER372CYS	121913477
176943	2263	FGFR2	0017	APERT SYNDROME	FGFR2, SER252PHE	121918498
176943	2263	FGFR2	0018	PFEIFFER SYNDROME VARIANT	FGFR2, SER252PHE AND PRO253SER	
176943	2263	FGFR2	0019	PFEIFFER SYNDROME	FGFR2, TRP290CYS	121918499
176943	2263	FGFR2	0020	CROUZON SYNDROME	FGFR2, LYS292GLU	121918500
176943	2263	FGFR2	0021	CROUZON SYNDROME	FGFR2, TRP290ARG	121918501
176943	2263	FGFR2	0022	CROUZON SYNDROME	FGFR2, TRP290GLY	
176943	2263	FGFR2	0023	SAETHRE-CHOTZEN SYNDROME	FGFR2, VAL-VAL DEL	
176943	2263	FGFR2	0024	PFEIFFER SYNDROME, TYPE III ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS, INCLUDED	FGFR2, SER351CYS	121918502
176943	2263	FGFR2	0025	APERT SYNDROME	FGFR2, ALU INS	
176943	2263	FGFR2	0027	PFEIFFER SYNDROME	FGFR2, ASP273DEL	121918503
176943	2263	FGFR2	0028	CRANIOSYNOSTOSIS, NONSYNDROMIC UNICORONAL	FGFR2, ALA315SER	121918504
176943	2263	FGFR2	0029	PFEIFFER SYNDROME GASTRIC CANCER, SOMATIC, INCLUDED	FGFR2, SER267PRO	121918505
176943	2263	FGFR2	0030	PFEIFFER SYNDROME	FGFR2, IVSAS, G-A, -1	
176943	2263	FGFR2	0031	PFEIFFER SYNDROME	FGFR2, 10-BP DEL/3-BP INS, NT952	
176943	2263	FGFR2	0032	PFEIFFER SYNDROME CRANIOFACIAL-SKELETAL-DERMATOLOGIC DYSPLASIA, INCLUDED	FGFR2, TRP290CYS, 870G-T	
176943	2263	FGFR2	0033	PFEIFFER SYNDROME	FGFR2, GLU565ALA	121918506
176943	2263	FGFR2	0034	CROUZON SYNDROME SCAPHOCEPHALY, MAXILLARY RETRUSION, AND MENTAL RETARDATION, INCLUDED	FGFR2, LYS526GLU	121918507
176943	2263	FGFR2	0035	LADD SYNDROME	FGFR2, ALA648THR	121918508
176943	2263	FGFR2	0036	LADD SYNDROME	FGFR2, 3-BP DEL, 1947AGA	
176943	2263	FGFR2	0037	LADD SYNDROME	FGFR2, ALA628THR	121918509
176943	2263	FGFR2	0038	PFEIFFER SYNDROME CROUZON SYNDROME, INCLUDED	FGFR2, IVSDS, A-G, +3	
176943	2263	FGFR2	0039	PFEIFFER SYNDROME	FGFR2, ASP321ALA	121918510
176943	2263	FGFR2	0040	BEARE-STEVENSON CUTIS GYRATA SYNDROME	FGFR2, 63-BP DEL, NT1506	
176943	2263	FGFR2	0041	CROUZON SYNDROME	FGFR2, ALA337PRO	
176943	2263	FGFR2	0042	VARIANT OF UNKNOWN SIGNIFICANCE	FGFR2, ALA337THR	
176943	2263	FGFR2	0043	BENT BONE DYSPLASIA SYNDROME	FGFR2, MET391ARG	
176943	2263	FGFR2	0044	BENT BONE DYSPLASIA SYNDROME	FGFR2, TYR381ASP	
176946	1969	EPHA2	0001	CATARACT 6, POSTERIOR POLAR	EPHA2, GLY948TRP	137853199
176946	1969	EPHA2	0002	CATARACT 6, POSTERIOR POLAR	EPHA2, THR940ILE	137853200
176946	1969	EPHA2	0003	CATARACT 6, POSTERIOR POLAR	EPHA2, 2-BP DEL, 2915TG	
176946	1969	EPHA2	0004	CATARACT 6, CONGENITAL TOTAL	EPHA2, IVS16, G-A, -9	
176946	1969	EPHA2	0005	CATARACT 6, AGE-RELATED CORTICAL	EPHA2, ARG721GLN	116506614
176947	7535	ZAP70	0001	SELECTIVE T-CELL DEFECT	ZAP70, IVS, G-A, -11	
176947	7535	ZAP70	0002	SELECTIVE T-CELL DEFECT	ZAP70, IVS, G-A, -9	
176947	7535	ZAP70	0003	SELECTIVE T-CELL DEFECT	ZAP70, SER518ARG	104893674
176947	7535	ZAP70	0004	SELECTIVE T-CELL DEFECT	ZAP70, 13-BP DEL, NT1719	
176947	7535	ZAP70	0005	SELECTIVE T-CELL DEFECT	ZAP70, ARG465HIS	137853201
176980	5582	PRKCG	0001	SPINOCEREBELLAR ATAXIA 14	PRKCG, HIS101TYR	121918511
176980	5582	PRKCG	0002	SPINOCEREBELLAR ATAXIA 14	PRKCG, SER119PRO	121918512
176980	5582	PRKCG	0003	SPINOCEREBELLAR ATAXIA 14	PRKCG, GLY128ASP	121918513
176980	5582	PRKCG	0004	SPINOCEREBELLAR ATAXIA 14	PRKCG, GLY118ASP	121918514
176980	5582	PRKCG	0005	SPINOCEREBELLAR ATAXIA 14	PRKCG, GLN127ARG	121918515
176980	5582	PRKCG	0006	SPINOCEREBELLAR ATAXIA 14	PRKCG, PHE643LEU	121918516
176980	5582	PRKCG	0007	SPINOCEREBELLAR ATAXIA 14	PRKCG, SER361GLY	121918517
176980	5582	PRKCG	0008	SPINOCEREBELLAR ATAXIA 14	PRKCG, HIS101GLN	121918518
176980	5582	PRKCG	0009	SPINOCEREBELLAR ATAXIA 14	PRKCG, 102-BP DEL	
176980	5582	PRKCG	0010	SPINOCEREBELLAR ATAXIA 14	PRKCG, 1,717-BP DEL	
176980	5582	PRKCG	0011	SPINOCEREBELLAR ATAXIA 14	PRKCG, ASP480TYR	
177046	5696	PSMB8	0001	AUTOINFLAMMATION, LIPODYSTROPHY, AND DERMATOSIS SYNDROME	PSMB8, THR75MET	
177046	5696	PSMB8	0002	AUTOINFLAMMATION, LIPODYSTROPHY, AND DERMATOSIS SYNDROME	PSMB8, GLY197VAL	
177046	5696	PSMB8	0003	AUTOINFLAMMATION, LIPODYSTROPHY, AND DERMATOSIS SYNDROME	PSMB8, GLY201VAL	
177046	5696	PSMB8	0004	AUTOINFLAMMATION, LIPODYSTROPHY, AND DERMATOSIS SYNDROME	PSMB8, CYS135TER	
177060	5589	PRKCSH	0001	POLYCYSTIC LIVER DISEASE	PRKCSH, IVS16, A-G, -2	
177060	5589	PRKCSH	0002	POLYCYSTIC LIVER DISEASE	PRKCSH, IVS4, G-C, +1	
177060	5589	PRKCSH	0003	POLYCYSTIC LIVER DISEASE	PRKCSH, 2-BP DEL, IVS16GT, +1	
177060	5589	PRKCSH	0004	POLYCYSTIC LIVER DISEASE	PRKCSH, GLN413TER	121918519
177060	5589	PRKCSH	0005	POLYCYSTIC LIVER DISEASE	PRKCSH, TYR422TER	121918520
177060	5589	PRKCSH	0006	POLYCYSTIC LIVER DISEASE	PRKCSH, 1-BP INS, 216A	
177070	2038	EPB42	0001	SPHEROCYTOSIS, TYPE 5, DUE TO PROTEIN 4.2-NIPPON	EPB42, ALA142THR	104894487
177070	2038	EPB42	0002	SPHEROCYTOSIS, TYPE 5, DUE TO PROTEIN 4.2-LISBOA	EPB42, 1-BP DEL, 264G	
177070	2038	EPB42	0003	SPHEROCYTOSIS, TYPE 5, DUE TO PROTEIN 4.2-TOZEUR	EPB42, ARG310GLN	121917734
177070	2038	EPB42	0004	SPHEROCYTOSIS, TYPE 5, DUE TO PROTEIN 4.2-NOTAME	EPB42, IVS6DS, G-A, +1	
177070	2038	EPB42	0005	SPHEROCYTOSIS, TYPE 5, DUE TO PROTEIN 4.2-HAMMERSMITH	EPB42, 41-BP DEL, NT1709	
177075	4094	MAF	0001	CATARACT 21, MULTIPLE TYPES, WITH OR WITHOUT MICROCORNEA	MAF, ARG288PRO	121917735
177075	4094	MAF	0002	CATARACT 21, CERULEAN, WITH OR WITHOUT MICROCORNEA	MAF, LYS297ARG	121917736
177400	590	BCHE	0001	APNEA, POSTANESTHETIC, DUE TO BCHE, ATYPICAL-1 BCHE, DIBUCAINE-RESISTANT I;; CHE*70G;; BCHE*70G	BCHE, ASP70GLY	1799807
177400	590	BCHE	0002	BCHE, SILENT 1 BCHE ANN ARBOR;; CHE*FS117;; BCHE*FS117	BCHE, 1-BP INS, FS129TER	
177400	590	BCHE	0003	BCHE, FLUORIDE 1 BCHE, FLUORIDE-RESISTANT I;; CHE*243M;; BCHE*243M	BCHE, THR243MET	28933389
177400	590	BCHE	0004	BCHE, FLUORIDE 2 BCHE, FLUORIDE-RESISTANT II;; CHE*390V;; BCHE*390V	BCHE, GLY390VAL	28933390
177400	590	BCHE	0005	BCHE, K VARIANT BCHE, QUANTITATIVE K POLYMORPHISM;; CHE*539T;; BCHE*539T	BCHE, ALA539THR	1803274
177400	590	BCHE	0006	BCHE, J VARIANT BCHE, QUANTITATIVE J VARIANT	BCHE, GLU497VAL	121918556
177400	590	BCHE	0007	BCHE, H VARIANT BCHE, QUANTITATIVE H VARIANT	BCHE, VAL142MET	
177400	590	BCHE	0008		BCHE NEWFOUNDLAND	
177400	590	BCHE	0009		BCHE CYNTHIANA	
177400	590	BCHE	0010		BCHE JOHANNESBURG	
177400	590	BCHE	0011	BUTYRYLCHOLINESTERASE DEFICIENCY	BCHE, ALU INS, EX2	
177400	590	BCHE	0012	BUTYRYLCHOLINESTERASE DEFICIENCY, FLUORIDE-RESISTANT, JAPANESE TYPE	BCHE, LEU330ILE	121918557
177400	590	BCHE	0013	BUTYRYLCHOLINESTERASE DEFICIENCY	BCHE, TYR128CYS	121918558
177400	590	BCHE	0014	BUTYRYLCHOLINESTERASE DEFICIENCY	BCHE, LEU335PRO	104893684
177400	590	BCHE	0015	BUTYRYLCHOLINESTERASE DEFICIENCY BCHE*FS126	BCHE, 2-BP DEL, 376CA	
177400	590	BCHE	0016	BUTYRYLCHOLINESTERASE DEFICIENCY	BCHE, GLY115ASP AND IVS3AS, T-C, -14	
178620	6440	SFTPC	0001	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 2	SFTPC, IVS4DS, G-A, +1	
178620	6440	SFTPC	0002	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 2	SFTPC, ILE73THR	
178620	6440	SFTPC	0003	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 2	SFTPC, ARG167GLN	34957318
178620	6440	SFTPC	0004	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 2	SFTPC, LEU188GLN	
178620	6440	SFTPC	0005	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 2	SFTPC, IVS4DS, G-T, +1	
178620	6440	SFTPC	0006	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 2	SFTPC, ALA116ASP	121918559
178620	6440	SFTPC	0007	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 2	SFTPC, GLU66LYS	
178620	6440	SFTPC	0008	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 2	SFTPC, LEU194PRO	121918560
178630	653509	SFTPA1	0001	PULMONARY FIBROSIS, IDIOPATHIC, SUSCEPTIBILITY TO	SFTPA1, ARG219TRP	4253527
178640	6439	SFTPB	0001	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1	SFTPB, 2-BP INS, 375C-GAA	
178640	6439	SFTPB	0002	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1	SFTPB, 1-BP DEL, 1553T	
178640	6439	SFTPB	0003	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1	SFTPB, 1-BP DEL, 457C	
178640	6439	SFTPB	0004	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1	SFTPB, ARG236CYS	137853202
178640	6439	SFTPB	0005	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1	SFTPB, 479G-T	
178642	729238	SFTPA2	0001	PULMONARY FIBROSIS, IDIOPATHIC	SFTPA2, GLY231VAL	121917737
178642	729238	SFTPA2	0002	PULMONARY FIBROSIS, IDIOPATHIC	SFTPA2, PHE198SER	121917738
179035	5831	PYCR1	0001	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB	PYCR1, ARG266GLN	121918374
179035	5831	PYCR1	0002	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB	PYCR1, GLY206TRP	121918375
179035	5831	PYCR1	0003	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB	PYCR1, 22-BP DEL, NT617	
179035	5831	PYCR1	0004	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB	PYCR1, ARG266GLN	121918374
179035	5831	PYCR1	0005	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB	PYCR1, 3-BP DEL, NT797+2	
179035	5831	PYCR1	0006	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB	PYCR1, 1-BP DEL, 11G	
179035	5831	PYCR1	0007	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB	PYCR1, ARG119GLY	121918376
179035	5831	PYCR1	0008	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB	PYCR1, ARG119HIS	121918377
179035	5831	PYCR1	0009	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIB	PYCR1, ARG251HIS	121918378
179035	5831	PYCR1	0010	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIB	PYCR1, ALA257THR	
179035	5831	PYCR1	0011	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIB	PYCR1, 1-BP DEL, 345C	
179035	5831	PYCR1	0012	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIB	PYCR1, GLY248GLU	
179060	5162	PDHB	0001	PYRUVATE DEHYDROGENASE E1-BETA DEFICIENCY	PDHB, TYR132CYS	28935769
179060	5162	PDHB	0002	PYRUVATE DEHYDROGENASE E1-BETA DEFICIENCY	PDHB, PRO344SER	28933391
179410	5962	RDX	0001	DEAFNESS, AUTOSOMAL RECESSIVE, 24	RDX, ASP578ASN	121918379
179410	5962	RDX	0002	DEAFNESS, AUTOSOMAL RECESSIVE, 24	RDX, 1-BP INS, 1404G	
179410	5962	RDX	0003	DEAFNESS, AUTOSOMAL RECESSIVE, 24	RDX, GLN155TER	121918380
179410	5962	RDX	0004	DEAFNESS, AUTOSOMAL RECESSIVE, 24	RDX, IVS7DS, G-A, +1	
179605	5961	PRPH2	0001	RETINITIS PIGMENTOSA 7	PRPH2, CYS118DEL	121918561
179605	5961	PRPH2	0002	RETINITIS PIGMENTOSA 7	PRPH2, PRO219DEL	121918562
179605	5961	PRPH2	0003	RETINITIS PIGMENTOSA 7	PRPH2, PRO216LEU	61755806
179605	5961	PRPH2	0004	RETINITIS PIGMENTOSA 7, DIGENIC	PRPH2, LEU185PRO	121918563
179605	5961	PRPH2	0005	RETINITIS PUNCTATA ALBESCENS, AUTOSOMAL DOMINANT	PRPH2, 2-BP DEL	
179605	5961	PRPH2	0006	CHOROIDAL DYSTROPHY, CENTRAL AREOLAR 2	PRPH2, ARG172GLN	61755793
179605	5961	PRPH2	0007	CHOROIDAL DYSTROPHY, CENTRAL AREOLAR 2	PRPH2, ARG172TRP	61755792
179605	5961	PRPH2	0008	VITELLIFORM MACULAR DYSTROPHY, ADULT-ONSET	PRPH2, TYR258TER	121918564
179605	5961	PRPH2	0009	MACULAR DYSTROPHY, PATTERNED	PRPH2, GLY167ASP	61755789
179605	5961	PRPH2	0010	MACULAR DYSTROPHY, PATTERNED	PRPH2, 2-BP DEL, 1137TG	
179605	5961	PRPH2	0011	RETINITIS PIGMENTOSA 7, WITH BULL'S-EYE MACULOPATHY	PRPH2, ASN244LYS	61755816
179605	5961	PRPH2	0012	FOVEOMACULAR DYSTROPHY, ADULT-ONSET, WITH CHOROIDAL NEOVASCULARIZATION	PRPH2, PRO210ARG	61755798
179605	5961	PRPH2	0013	MACULAR DYSTROPHY, PATTERNED	PRPH2, 4-BP INS, CODON 140	
179605	5961	PRPH2	0014	VITELLIFORM MACULAR DYSTROPHY, ADULT-ONSET	PRPH2, MET1THR	121918565
179605	5961	PRPH2	0015	VITELLIFORM MACULAR DYSTROPHY, ADULT-ONSET	PRPH2, TRP316TER	121918566
179605	5961	PRPH2	0016	FOVEOMACULAR DYSTROPHY, ADULT-ONSET, WITH CHOROIDAL NEOVASCULARIZATION	PRPH2, 1-BP DEL, 112G	
179605	5961	PRPH2	0017	RETINITIS PIGMENTOSA 7 MACULAR DYSTROPHY, PATTERNED, INCLUDED;; FUNDUS FLAVIMACULATUS, INCLUDED	PRPH2, 3-BP DEL	
179605	5961	PRPH2	0018	FUNDUS FLAVIMACULATUS	PRPH2, ARG46TER	61755771
179605	5961	PRPH2	0019	RETINITIS PIGMENTOSA 7	PRPH2, 1-BP DEL, 1160T	
179605	5961	PRPH2	0020	RETINITIS PIGMENTOSA 7	PRPH2, ASP173VAL	61755794
179605	5961	PRPH2	0021	CHOROIDAL DYSTROPHY, CENTRAL AREOLAR 2	PRPH2, ARG195LEU	121918567
179605	5961	PRPH2	0022	CHOROIDAL DYSTROPHY, CENTRAL AREOLAR 2	PRPH2, ARG142TRP	61755783
179615	5896	RAG1	0001	SEVERE COMBINED IMMUNODEFICIENCY, B CELL-NEGATIVE	RAG1, GLU722LYS	28933392
179615	5896	RAG1	0002	SEVERE COMBINED IMMUNODEFICIENCY, B CELL-NEGATIVE	RAG1, GLU774TER	104894282
179615	5896	RAG1	0003	SEVERE COMBINED IMMUNODEFICIENCY, B CELL-NEGATIVE	RAG1, TYR938TER	104894283
179615	5896	RAG1	0004	RECOMBINATION ACTIVATING GENE 1 POLYMORPHISM	RAG1, ALA156VAL	1801203
179615	5896	RAG1	0005	OMENN SYNDROME	RAG1, ARG561HIS	104894284
179615	5896	RAG1	0006	OMENN SYNDROME	RAG1, ARG396CYS	104894289
179615	5896	RAG1	0007	OMENN SYNDROME	RAG1, TYR912CYS	104894290
179615	5896	RAG1	0008	OMENN SYNDROME	RAG1, ARG396HIS	104894291
179615	5896	RAG1	0009	OMENN SYNDROME	RAG1, ASP429GLY	104894292
179615	5896	RAG1	0010	OMENN SYNDROME SEVERE COMBINED IMMUNODEFICIENCY, B CELL-NEGATIVE, INCLUDED	RAG1, ARG561CYS	104894285
179615	5896	RAG1	0011	OMENN SYNDROME	RAG1, ARG737HIS	104894286
179615	5896	RAG1	0012	OMENN SYNDROME	RAG1, 13-BP DEL, NT1723	
179615	5896	RAG1	0013	OMENN SYNDROME ALPHA/BETA T-CELL LYMPHOPENIA WITH GAMMA/DELTA T-CELL EXPANSION, SEVERE CYTOMEGALOVIRUS INFECTION, AND AUTOIMMUNITY, INCLUDED	RAG1, 2-BP DEL, 368AA	
179615	5896	RAG1	0014	OMENN SYNDROME	RAG1, 1-BP DEL, 887A	
179615	5896	RAG1	0015	OMENN SYNDROME SEVERE COMBINED IMMUNODEFICIENCY, B CELL-NEGATIVE, INCLUDED;; ALPHA/BETA T-CELL LYMPHOPENIA WITH GAMMA/DELTA T-CELL EXPANSION, SEVERE CYTOMEGALOVIRUS INFECTION, AND AUTOIMMUNITY, INCLUDED	RAG1, 1-BP DEL, 631T	
179615	5896	RAG1	0016	ALPHA/BETA T-CELL LYMPHOPENIA WITH GAMMA/DELTA T-CELL EXPANSION, SEVERE CYTOMEGALOVIRUS INFECTION, AND AUTOIMMUNITY	RAG1, ARG841TRP	104894287
179615	5896	RAG1	0017	ALPHA/BETA T-CELL LYMPHOPENIA WITH GAMMA/DELTA T-CELL EXPANSION, SEVERE CYTOMEGALOVIRUS INFECTION, AND AUTOIMMUNITY	RAG1, GLN981PRO	104894288
179615	5896	RAG1	0018	COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS	RAG1, ARG314TRP	121918568
179615	5896	RAG1	0019	COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS	RAG1, ARG507TRP AND ARG737HIS	104894298
179615	5896	RAG1	0020	COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS	RAG1, ARG778GLN	121918569
179615	5896	RAG1	0021	COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS	RAG1, ARG975TRP	121918570
179615	5896	RAG1	0022	OMENN SYNDROME	RAG1, CYS328TYR	121918571
179615	5896	RAG1	0023	SEVERE COMBINED IMMUNODEFICIENCY, B CELL-NEGATIVE	RAG1, ARG776TRP	121918572
179615	5896	RAG1	0024	COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS	RAG1, TRP522CYS	
179615	5896	RAG1	0025	COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS	RAG1, 1-BP DEL, 1621C	
179616	5897	RAG2	0001	SEVERE COMBINED IMMUNODEFICIENCY, B CELL-NEGATIVE	RAG2, CYS476TYR	121918573
179616	5897	RAG2	0002	SEVERE COMBINED IMMUNODEFICIENCY, B CELL-NEGATIVE OMENN SYNDROME, INCLUDED	RAG2, ARG229GLN	
179616	5897	RAG2	0003	OMENN SYNDROME	RAG2, CYS41TRP	
179616	5897	RAG2	0004	OMENN SYNDROME	RAG2, MET285ARG	
179616	5897	RAG2	0005	OMENN SYNDROME	RAG2, GLY95ARG	36001797
179616	5897	RAG2	0006	SEVERE COMBINED IMMUNODEFICIENCY, B CELL-NEGATIVE	RAG2, 3-BP DEL, NT2018	
179616	5897	RAG2	0007	SEVERE COMBINED IMMUNODEFICIENCY, B CELL-NEGATIVE	RAG2, TRP215ILE	35691292
179616	5897	RAG2	0008	SEVERE COMBINED IMMUNODEFICIENCY, B CELL-NEGATIVE OMENN SYNDROME, INCLUDED	RAG2, ARG39GLY	
179616	5897	RAG2	0009	COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS	RAG2, THR77ASN	121918574
179616	5897	RAG2	0010	COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS	RAG2, GLY451ALA	121918575
179617	5888	RAD51	0001	BREAST CANCER, FAMILIAL	RAD51, ARG150GLN	121917739
179617	5888	RAD51	0002	BREAST CANCER, SUSCEPTIBILITY TO, IN BRCA1 AND BRCA2 CARRIERS	RAD51, 135G-C	
179617	5888	RAD51	0003	MIRROR MOVEMENTS 2, SUSCEPTIBILITY TO	RAD51, ARG254TER	
179617	5888	RAD51	0004	MIRROR MOVEMENTS 2	RAD51, 1-BP DUP, 855A	
179820	5972	REN	0001	HYPERPRORENINEMIA, FAMILIAL	REN, ARG387TER	121917740
179820	5972	REN	0002	RENAL TUBULAR DYSGENESIS	REN, ARG49TER	121917741
179820	5972	REN	0003	RENAL TUBULAR DYSGENESIS	REN, ARG230LYS	121917742
179820	5972	REN	0004	HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 2	REN, 3-BP DEL, 45GCT	
179820	5972	REN	0005	HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 2	REN, LEU16ARG	121917743
179820	5972	REN	0006	RENAL TUBULAR DYSGENESIS	REN, ARG43TER	
179820	5972	REN	0007	RENAL TUBULAR DYSGENESIS	REN, SER135TYR	
180040	343035	RD3	0001	LEBER CONGENITAL AMAUROSIS 12	RD3, IVS2DS, G-A, +1	
180069	6121	RPE65	0001	LEBER CONGENITAL AMAUROSIS 2	RPE65, 1-BP DEL, 1067A	
180069	6121	RPE65	0002	LEBER CONGENITAL AMAUROSIS 2	RPE65, ARG234TER	
180069	6121	RPE65	0003	RETINITIS PIGMENTOSA 20	RPE65, PRO363THR	121917744
180069	6121	RPE65	0004	RETINITIS PIGMENTOSA 20	RPE65, LEU341SER	
180069	6121	RPE65	0005	RETINITIS PIGMENTOSA 20	RPE65, ALA132THR	
180069	6121	RPE65	0006	RETINITIS PIGMENTOSA 20	RPE65, ARG91TRP	
180069	6121	RPE65	0007	RETINITIS PIGMENTOSA 20	RPE65, VAL452GLY	
180069	6121	RPE65	0008	RETINITIS PIGMENTOSA 20 LEBER CONGENITAL AMAUROSIS 2, INCLUDED	RPE65, ARG515TRP	121917745
180069	6121	RPE65	0009	RETINITIS PIGMENTOSA 20 LEBER CONGENITAL AMAUROSIS 2, INCLUDED	RPE65, TYR368HIS	
180069	6121	RPE65	0010	RETINITIS PIGMENTOSA 20 LEBER CONGENITAL AMAUROSIS 2, INCLUDED	RPE65, IVS1, G-A, +5	
180069	6121	RPE65	0011	LEBER CONGENITAL AMAUROSIS 2	RPE65, LYS303TER	
180069	6121	RPE65	0012	LEBER CONGENITAL AMAUROSIS 2	RPE65, TYR431CYS	
180071	5145	PDE6A	0001	RETINITIS PIGMENTOSA 43	PDE6A, TYR583TER	121918576
180071	5145	PDE6A	0002	RETINITIS PIGMENTOSA 43	PDE6A, SER344ARG	121918577
180071	5145	PDE6A	0003	RETINITIS PIGMENTOSA 43	PDE6A, TRP561TER	121918578
180071	5145	PDE6A	0004	RETINITIS PIGMENTOSA 43	PDE6A, VAL685MET	
180072	5158	PDE6B	0001	RETINITIS PIGMENTOSA 40	PDE6B, GLN298TER	121918579
180072	5158	PDE6B	0002	RETINITIS PIGMENTOSA 40	PDE6B, ARG531TER	121918580
180072	5158	PDE6B	0003	RETINITIS PIGMENTOSA 40	PDE6B, 1-BP DEL, NT17981	
180072	5158	PDE6B	0004	RETINITIS PIGMENTOSA 40	PDE6B, HIS557TYR	121918581
180072	5158	PDE6B	0005	NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 2	PDE6B, HIS258ASN	121918582
180072	5158	PDE6B	0006	RETINITIS PIGMENTOSA 40	PDE6B, 71-BP DUP	
180072	5158	PDE6B	0007	RETINITIS PIGMENTOSA 40	PDE6B, TRP807ARG	121918583
180073	5148	PDE6G	0001	RETINITIS PIGMENTOSA 57	PDE6G, IVS3DS, G-T, +1	
180090	6017	RLBP1	0001	FUNDUS ALBIPUNCTATUS RETINITIS PUNCTATA ALBESCENS, INCLUDED	RLBP1, ARG150GLN	137853290
180090	6017	RLBP1	0002	NEWFOUNDLAND ROD-CONE DYSTROPHY	RLBP1, IVS3, T-C, +2	
180090	6017	RLBP1	0003	NEWFOUNDLAND ROD-CONE DYSTROPHY RETINITIS PUNCTATA ALBESCENS, INCLUDED	RLBP1, 324G-A	
180090	6017	RLBP1	0004	BOTHNIA RETINAL DYSTROPHY RETINITIS PUNCTATA ALBESCENS, INCLUDED	RLBP1, ARG234TRP	28933990
180090	6017	RLBP1	0005	RETINITIS PUNCTATA ALBESCENS	RLBP1, MET225LYS	137853291
180250	5950	RBP4	0001	RETINAL DYSTROPHY, IRIS COLOBOMA, AND COMEDOGENIC ACNE SYNDROME	RBP4, ILE41ASN	121918584
180250	5950	RBP4	0002	RETINAL DYSTROPHY, IRIS COLOBOMA, AND COMEDOGENIC ACNE SYNDROME	RBP4, GLY75ASP	121918585
180250	5950	RBP4	0003	RETINAL DYSTROPHY, IRIS COLOBOMA, AND COMEDOGENIC ACNE SYNDROME	RBP4, IVS2, G-A, +1	
180290	5949	RBP3	0001	RETINITIS PIGMENTOSA 66 (1 family)	RBP3, ASP1080ASN	
180297	6005	RHAG	0001	RH-NULL HEMOLYTIC ANEMIA, REGULATOR TYPE	RHAG, CCTC-TO-GA, NT154	
180297	6005	RHAG	0002	RH-NULL HEMOLYTIC ANEMIA, REGULATOR TYPE	RHAG, 1-BP DEL, 1086A	
180297	6005	RHAG	0003	RH-NULL HEMOLYTIC ANEMIA, REGULATOR TYPE	RHAG, SER79ASN	121918586
180297	6005	RHAG	0004	RH-NULL HEMOLYTIC ANEMIA, REGULATOR TYPE	RHAG, GLY279GLU	121918587
180297	6005	RHAG	0005	RH-NULL HEMOLYTIC ANEMIA, REGULATOR TYPE	RHAG, IVS1, G-A, +1	
180297	6005	RHAG	0006	RH-NULL HEMOLYTIC ANEMIA, REGULATOR TYPE	RHAG, IVS6, G-A, -1	
180297	6005	RHAG	0007	RH-MOD SYNDROME	RHAG, MET1ILE	121918588
180297	6005	RHAG	0008	RH-NULL HEMOLYTIC ANEMIA, REGULATOR TYPE	RHAG, IVS7, G-A, +1	
180297	6005	RHAG	0009	RH-NULL HEMOLYTIC ANEMIA, REGULATOR TYPE	RHAG, VAL270ILE AND GLY280ARG	16879498
180297	6005	RHAG	0010	RH-NULL HEMOLYTIC ANEMIA, REGULATOR TYPE	RHAG, GLY380VAL	121918589
180380	6010	RHO	0001	RETINITIS PIGMENTOSA 4	RHO, PRO23HIS	104893768
180380	6010	RHO	0002	RETINITIS PIGMENTOSA 4	RHO, PRO347LEU	29001566
180380	6010	RHO	0003	RETINITIS PIGMENTOSA 4	RHO, PRO347SER	29001637
180380	6010	RHO	0004	RETINITIS PIGMENTOSA 4	RHO, THR58ARG	28933394
180380	6010	RHO	0005	RETINITIS PIGMENTOSA 4	RHO, 3-BP DEL	
180380	6010	RHO	0006	RETINITIS PIGMENTOSA 4	RHO, THR17MET	104893769
180380	6010	RHO	0007	RETINITIS PIGMENTOSA 4	RHO, PHE45LEU	104893770
180380	6010	RHO	0008	RETINITIS PIGMENTOSA 4	RHO, VAL87ASP	104893771
180380	6010	RHO	0009	RETINITIS PIGMENTOSA 4	RHO, GLY89ASP	104893772
180380	6010	RHO	0010	RETINITIS PIGMENTOSA 4	RHO, GLY106TRP	104893773
180380	6010	RHO	0011	RETINITIS PIGMENTOSA 4	RHO, ARG135LEU	104893774
180380	6010	RHO	0012	RETINITIS PIGMENTOSA 4 RETINITIS PUNCTATA ALBESCENS, INCLUDED	RHO, ARG135TRP	104893775
180380	6010	RHO	0013	RETINITIS PIGMENTOSA 4	RHO, TYR178CYS	104893776
180380	6010	RHO	0014	RETINITIS PIGMENTOSA 4	RHO, ASP190GLY	104893777
180380	6010	RHO	0015	RETINITIS PIGMENTOSA 4	RHO, GLN344TER	104893778
180380	6010	RHO	0016	RETINITIS PIGMENTOSA 4	RHO, LYS296GLU	29001653
180380	6010	RHO	0017	RETINITIS PIGMENTOSA 4	RHO, ASP190ASN	104893779
180380	6010	RHO	0018	RETINITIS PIGMENTOSA 4	RHO, HIS211PRO	28933993
180380	6010	RHO	0019	RETINITIS PIGMENTOSA 4	RHO, 12-BP DEL, EX1	
180380	6010	RHO	0020	RETINITIS PIGMENTOSA 4	RHO, PRO347ARG	29001566
180380	6010	RHO	0021	RETINITIS PIGMENTOSA 4	RHO, GLY182SER	104893780
180380	6010	RHO	0022	RETINITIS PIGMENTOSA 4	RHO, PRO267LEU	104893781
180380	6010	RHO	0023	RETINITIS PIGMENTOSA 4, AUTOSOMAL RECESSIVE	RHO, GLU249TER	104893783
180380	6010	RHO	0024	RETINITIS PIGMENTOSA 4	RHO, PRO53ARG	28933395
180380	6010	RHO	0025	RETINITIS PIGMENTOSA 4	RHO, GLY106ARG	104893773
180380	6010	RHO	0026	RETINITIS PIGMENTOSA 4	RHO, IVS4, G-T, +1	
180380	6010	RHO	0027	RETINITIS PIGMENTOSA 4	RHO, ASP190TYR	104893779
180380	6010	RHO	0028	RETINITIS PIGMENTOSA 4	RHO, ARG207MET	104893782
180380	6010	RHO	0029	RETINITIS PIGMENTOSA 4	RHO, ASN15SER	104893786
180380	6010	RHO	0030	RETINITIS PIGMENTOSA 4	RHO, MET207ARG	104893782
180380	6010	RHO	0031	NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 1	RHO, ALA292GLU	104893789
180380	6010	RHO	0032	NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 1	RHO, GLY90ASP	104893790
180380	6010	RHO	0033	RETINITIS PIGMENTOSA 4, AUTOSOMAL RECESSIVE	RHO, GLU150LYS	104893791
180380	6010	RHO	0034	RETINITIS PIGMENTOSA 4	RHO, GLY51ARG	104893792
180380	6010	RHO	0035	RETINITIS PIGMENTOSA 4	RHO, CYS110TYR	104893787
180380	6010	RHO	0036	RETINITIS PIGMENTOSA 4	RHO, GLY114ASP	104893788
180380	6010	RHO	0037	RETINITIS PIGMENTOSA 4	RHO, ALA164GLU	104893793
180380	6010	RHO	0038	RETINITIS PIGMENTOSA 4	RHO, PRO171SER	104893794
180380	6010	RHO	0039	RETINITIS PIGMENTOSA 4	RHO, CYS264DEL	121918590
180380	6010	RHO	0040	RETINITIS PIGMENTOSA 4	RHO, VAL345LEU	104893795
180380	6010	RHO	0041	RETINITIS PIGMENTOSA 4	RHO, PRO347GLN	29001566
180380	6010	RHO	0042	NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 1	RHO, THR94ILE	104893796
180380	6010	RHO	0043	RETINITIS PIGMENTOSA 4	RHO, PRO23ALA	104893797
180380	6010	RHO	0044	RETINITIS PIGMENTOSA 4	RHO, VAL345MET	104893795
180380	6010	RHO	0045	RETINITIS PIGMENTOSA 4, AUTOSOMAL RECESSIVE	RHO, TYR161TER	
180381	6011	GRK1	0001	OGUCHI DISEASE 2	GRK1, EX5DEL	
180381	6011	GRK1	0002	OGUCHI DISEASE 2	GRK1, VAL380ASP	
180381	6011	GRK1	0003	OGUCHI DISEASE 2	GRK1, 4-BP DEL	
180381	6011	GRK1	0004	OGUCHI DISEASE 2	GRK1, PRO391HIS	
180430	22934	RPIA	0001	RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY	RPIA, 1-BP DEL, 540G	
180430	22934	RPIA	0002	RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY	RPI, ALA61VAL	121918591
180435	6041	RNASEL	0001	PROSTATE CANCER, HEREDITARY, 1	RNASEL, GLU265TER	74315364
180435	6041	RNASEL	0002	PROSTATE CANCER, HEREDITARY, 1	RNASEL, MET1ILE	74315365
180435	6041	RNASEL	0003	PROSTATE CANCER, SUSCEPTIBILITY TO	RNASEL, ARG462GLN	486907
180468	6165	RPL35A	0001	DIAMOND-BLACKFAN ANEMIA 5	RPL35A, VAL33ILE	116840808
180468	6165	RPL35A	0002	DIAMOND-BLACKFAN ANEMIA 5	RPL35A, 3-BP DEL, LEU27DEL	116840807
180468	6165	RPL35A	0003	DIAMOND-BLACKFAN ANEMIA 5	RPL35A, ARG102TER	116840809
180472	6218	RPS17	0001	DIAMOND-BLACKFAN ANEMIA 4	RPS17, MET1ARG	116840811
180472	6218	RPS17	0002	DIAMOND-BLACKFAN ANEMIA 4	RPS17, 2-BP DEL, 200GA	116840812
180721	6094	ROM1	0001	RETINITIS PIGMENTOSA 7, DIGENIC	ROM1, 1-BP INS, 80G	
180721	6094	ROM1	0002	RETINITIS PIGMENTOSA 7, DIGENIC	ROM1, 1-BP INS, 114G	
180901	6261	RYR1	0001	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1	RYR1, ARG614CYS	118192172
180901	6261	RYR1	0002	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1	RYR1, ARG248GLY	1801086
180901	6261	RYR1	0003	CENTRAL CORE DISEASE	RYR1, ARG2435HIS	28933396
180901	6261	RYR1	0004	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1 CENTRAL CORE DISEASE, INCLUDED	RYR1, ARG163CYS	118192161
180901	6261	RYR1	0005	CENTRAL CORE DISEASE	RYR1, ILE403MET	118192116
180901	6261	RYR1	0006	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1	RYR1, GLY341ARG	121918592
180901	6261	RYR1	0007	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1	RYR1, GLY2434ARG	121918593
180901	6261	RYR1	0008	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1	RYR1, ARG2458CYS	28933397
180901	6261	RYR1	0009	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1	RYR1, ARG2458HIS	121918594
180901	6261	RYR1	0010	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1	RYR1, ARG2163CYS	118192175
180901	6261	RYR1	0011	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1 CENTRAL CORE DISEASE, INCLUDED	RYR1, ARG2163HIS	118192163
180901	6261	RYR1	0012	CENTRAL CORE DISEASE MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1, INCLUDED	RYR1, ILE4898THR	118192170
180901	6261	RYR1	0013	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1	RYR1, VAL2168MET	118192176
180901	6261	RYR1	0014	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1	RYR1, THR2206MET	118192177
180901	6261	RYR1	0015	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1	RYR1, THR4826ILE	121918595
180901	6261	RYR1	0016	CENTRAL CORE DISEASE MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1, INCLUDED	RYR1, TYR4796CYS	118192167
180901	6261	RYR1	0017	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1	RYR1, GLU2347DEL	121918596
180901	6261	RYR1	0018	CENTRAL CORE DISEASE	RYR1, 9-BP DEL, NT12640	118192165
180901	6261	RYR1	0019	CENTRAL CORE DISEASE NEUROMUSCULAR DISEASE, CONGENITAL, WITH UNIFORM TYPE 1 FIBER, INCLUDED	RYR1, ARG4861HIS	63749869
180901	6261	RYR1	0021	CENTRAL CORE DISEASE, AUTOSOMAL RECESSIVE	RYR1, PRO3527SER	118192164
180901	6261	RYR1	0022	CENTRAL CORE DISEASE, AUTOSOMAL RECESSIVE MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA, INCLUDED	RYR1, VAL4849ILE	118192168
180901	6261	RYR1	0023	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1	RYR1, ARG2676TRP AND THR2787SER	35180584
180901	6261	RYR1	0024	CENTRAL CORE DISEASE	RYR1, 18-BP DEL, NT14588	118192169
180901	6261	RYR1	0025	MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	RYR1, 119-BP INS	
180901	6261	RYR1	0026	MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	RYR1, ARG109TRP	118192173
180901	6261	RYR1	0027	MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	RYR1, MET2423LYS	118192174
180901	6261	RYR1	0028	MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	RYR1, IVS99AS, A-T, -2	
180901	6261	RYR1	0029	MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	RYR1, SER3450PHE	
180901	6261	RYR1	0030	CENTRAL CORE DISEASE	RYR1, THR4637ALA	118192166
180901	6261	RYR1	0031	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1 CENTRAL CORE DISEASE, INCLUDED	RYR1, TYR522SER	118192162
180901	6261	RYR1	0032	MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	RYR1, 4-BP INS, 1742ATCA	
180901	6261	RYR1	0033	NEUROMUSCULAR DISEASE, CONGENITAL, WITH UNIFORM TYPE 1 FIBER CENTRAL CORE DISEASE, INCLUDED	RYR1, 2-BP DEL/2-BP INS, NT14761	118192171
180901	6261	RYR1	0034	NEUROMUSCULAR DISEASE, CONGENITAL, WITH UNIFORM TYPE 1 FIBER	RYR1, 20-BP DEL, NT13013	
180901	6261	RYR1	0035	MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	RYR1, 2-BP DEL, 5726AG AND MET3081THR	
180901	6261	RYR1	0036	MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	RYR1, IVS68AS, C-G, -6 AND VAL4842MET	
180901	6261	RYR1	0037	MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	RYR1, 2-BP DEL, 8342TA AND HIS3981TYR	
180901	6261	RYR1	0038	KING-DENBOROUGH SYNDROME	RYR1, LYS33GLU	
180902	6262	RYR2	0001	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1	RYR2, SER2246LEU	121918597
180902	6262	RYR2	0002	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1	RYR2, ARG2474SER	121918598
180902	6262	RYR2	0003	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1	RYR2, ASN4104LYS	121918599
180902	6262	RYR2	0004	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1	RYR2, ARG4497CYS	121918600
180902	6262	RYR2	0005	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 2	RYR2, ASN2386ILE	121918601
180902	6262	RYR2	0006	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 2	RYR2, LEU433PRO	121918602
180902	6262	RYR2	0007	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1	RYR2, PRO2328SER	121918603
180902	6262	RYR2	0008	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1	RYR2, VAL4653PHE	121918604
180902	6262	RYR2	0009	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1	RYR2, GLN4201ARG	121918605
180902	6262	RYR2	0010	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1	RYR2, ALA4860GLY	121918606
180902	6262	RYR2	0011	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND DILATED CARDIOMYOPATHY	RYR2, 1.1-KB DEL, EX3	
180960	191	AHCY	0001	HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	AHCY, TRP112TER	121918607
180960	191	AHCY	0002	HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	AHCY, TYR143CYS	121918608
181031	6295	SAG	0001	OGUCHI DISEASE 1 RETINITIS PIGMENTOSA 47, INCLUDED	SAG, 1-BP DEL, 1147A	
181031	6295	SAG	0002	OGUCHI DISEASE 1	SAG, ARG193TER	
181031	6295	SAG	0003	OGUCHI DISEASE 1	SAG, ASN309TER	
181031	6295	SAG	0004	OGUCHI DISEASE 1	SAG, ARG292TER	
181031	6295	SAG	0005	OGUCHI DISEASE 1	SAG, GLU306TER	
181590	6491	STIL	0001	MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE	STIL, GLN1239TER	121918609
181590	6491	STIL	0002	MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE	STIL, 1-BP DEL, 3655G	199422207
181590	6491	STIL	0003	MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE	STIL, IVS16DS, G-A, +1	199422206
182100	2524	FUT2	0001	SECRETOR/NONSECRETOR POLYMORPHISM NORWALK VIRUS INFECTION, RESISTANCE TO, INCLUDED;; VITAMIN B12 PLASMA LEVEL QUANTITATIVE TRAIT LOCUS 1, INCLUDED	FUT2, TRP143TER	601338
182100	2524	FUT2	0002	SECRETOR/NONSECRETOR POLYMORPHISM, JAPANESE TYPE	FUT2, ILE129PHE	1047781
182100	2524	FUT2	0003	BOMBAY PHENOTYPE, CLASSIC	FUT2, DEL	
182125	6697	SPR	0001	DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	SPR, GLN119TER	121917746
182125	6697	SPR	0002	DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	SPR, 5-BP DEL, NT1397	
182125	6697	SPR	0003	DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	SPR, ARG150GLY	104893665
182125	6697	SPR	0004	DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	SPR, -13G-A	
182125	6697	SPR	0005	DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	SPR, PRO163LEU	104893666
182125	6697	SPR	0006	DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	SPR, LYS251TER	121917747
182125	6697	SPR	0007	DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	SPR, GLY102CYS	
182125	6697	SPR	0008	DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	SPR, IVS2AS, A-G, -2	
182135	3356	HTR2A	0001	SCHIZOPHRENIA, SUSCEPTIBILITY TO	HTR2A, 102T-C	
182135	3356	HTR2A	0002	OBSESSIVE-COMPULSIVE DISORDER, SUSCEPTIBILITY TO	HTR2A, -1438G-A	
182135	3356	HTR2A	0003	MAJOR DEPRESSIVE DISORDER, RESPONSE TO CITALOPRAM THERAPY IN	HTR2A, IVS2, A-G	7997012
182138	6532	SLC6A4	0001	SEROTONIN TRANSPORTER ACTIVITY, INCREASED/DECREASED	SLC6A4, 44-BP INS/DEL	
182138	6532	SLC6A4	0002	OBSESSIVE-COMPULSIVE DISORDER, SUSCEPTIBILITY TO	SLC6A4, ILE425VAL	28914832
182309	6569	SLC34A1	0001	NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 1	SLC34A1, ALA48PHE	121918610
182309	6569	SLC34A1	0002	NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 1	SLC34A1, VAL147MET	121918611
182309	6569	SLC34A1	0003	FANCONI RENOTUBULAR SYNDROME 2	SLC34A1, 21-BP DUP, NT2061	
182340	477	ATP1A2	0001	MIGRAINE, FAMILIAL HEMIPLEGIC, 2	ATP1A2, LEU764PRO	28933398
182340	477	ATP1A2	0002	MIGRAINE, FAMILIAL HEMIPLEGIC, 2	ATP1A2, TRP887ARG	28933399
182340	477	ATP1A2	0003	MIGRAINE, FAMILIAL HEMIPLEGIC, 2	ATP1A2, MET731THR	28933400
182340	477	ATP1A2	0004	MIGRAINE, FAMILIAL HEMIPLEGIC, 2	ATP1A2, ARG689GLN	28933401
182340	477	ATP1A2	0005	ALTERNATING HEMIPLEGIA OF CHILDHOOD 1	ATP1A2, THR378ASN	28934002
182340	477	ATP1A2	0006	MIGRAINE, FAMILIAL HEMIPLEGIC, 2	ATP1A2, GLY301ARG	121918612
182340	477	ATP1A2	0007	MIGRAINE, FAMILIAL HEMIPLEGIC, 2	ATP1A2, THR345ALA	121918613
182340	477	ATP1A2	0008	MIGRAINE, FAMILIAL HEMIPLEGIC, 2	ATP1A2, ASP718ASN	121918614
182340	477	ATP1A2	0009	MIGRAINE, FAMILIAL HEMIPLEGIC, 2	ATP1A2, PRO979LEU	121918615
182340	477	ATP1A2	0010	MIGRAINE, FAMILIAL BASILAR	ATP1A2, ARG548HIS	121918616
182340	477	ATP1A2	0011	MIGRAINE, FAMILIAL HEMIPLEGIC, 2	ATP1A2, ILE286THR	121918617
182340	477	ATP1A2	0012	MIGRAINE, FAMILIAL HEMIPLEGIC, 2	ATP1A2, THR415MET	121918618
182340	477	ATP1A2	0013	MIGRAINE, FAMILIAL HEMIPLEGIC, 2	ATP1A2, ARG65TRP	121918619
182340	477	ATP1A2	0014	MIGRAINE, FAMILIAL HEMIPLEGIC, 2	ATP1A2, THR376MET	121918620
182350	478	ATP1A3	0001	DYSTONIA 12	ATP1A3, THR613MET	80356534
182350	478	ATP1A3	0002	DYSTONIA 12	ATP1A3, ILE274THR	80356532
182350	478	ATP1A3	0003	DYSTONIA 12	ATP1A3, GLU277LYS	80356533
182350	478	ATP1A3	0004	DYSTONIA 12	ATP1A3, ILE758SER	80356535
182350	478	ATP1A3	0005	DYSTONIA 12	ATP1A3, PHE780LEU	80356536
182350	478	ATP1A3	0006	DYSTONIA 12	ATP1A3, ASP801TYR	80356537
182350	478	ATP1A3	0007	DYSTONIA 12	ATP1A3, ASP923ASN	
182350	478	ATP1A3	0008	DYSTONIA 12	ATP1A3, 3-BP DUP, 3191TAC	
182350	478	ATP1A3	0009	ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	ATP1A3, ASP801ASN	
182350	478	ATP1A3	0010	ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	ATP1A3, GLU815LYS	
182350	478	ATP1A3	0011	ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	ATP1A3, SER811PRO	
182350	478	ATP1A3	0012	ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	ATP1A3, GLY947ARG	
182380	6523	SLC5A1	0001	GLUCOSE/GALACTOSE MALABSORPTION	SLC5A1, ASP28ASN	121912668
182380	6523	SLC5A1	0002	GLUCOSE/GALACTOSE MALABSORPTION	SLC5A1, ASP28GLY	121912669
182381	6524	SLC5A2	0001	RENAL GLUCOSURIA	SLC5A2, TRP440TER	121918621
182381	6524	SLC5A2	0002	RENAL GLUCOSURIA	SLC5A2, ASN654SER	61742739
182381	6524	SLC5A2	0003	RENAL GLUCOSURIA	SLC5A2, GLN167FS186TER	
182381	6524	SLC5A2	0004	RENAL GLUCOSURIA	SLC5A2, IVS1AS, C-A, -16	
182381	6524	SLC5A2	0005	RENAL GLUCOSURIA	SLC5A2, ARG479GLY	
182381	6524	SLC5A2	0006	RENAL GLUCOSURIA, AUTOSOMAL DOMINANT	SLC5A2, PHE98LEU	
182389	6323	SCN1A	0001	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2	SCN1A, ARG1648HIS	121918622
182389	6323	SCN1A	0002	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2	SCN1A, THR875MET	121918623
182389	6323	SCN1A	0003	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2	SCN1A, ASP188VAL	121917953
182389	6323	SCN1A	0004	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2	SCN1A, VAL1353LEU	121917954
182389	6323	SCN1A	0005	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2	SCN1A, ILE1656MET	121917955
182389	6323	SCN1A	0006	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2	SCN1A, TRP1204ARG	121917930
182389	6323	SCN1A	0007	DRAVET SYNDROME	SCN1A, 2-BP DEL, 657AG	
182389	6323	SCN1A	0008	DRAVET SYNDROME	SCN1A, ARG222TER	121918624
182389	6323	SCN1A	0009	DRAVET SYNDROME	SCN1A, LEU986PHE	121918625
182389	6323	SCN1A	0010	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2	SCN1A, LYS1270THR	121918626
182389	6323	SCN1A	0011	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2	SCN1A, VAL1428ALA	121918627
182389	6323	SCN1A	0012	MIGRAINE, FAMILIAL HEMIPLEGIC, 3	SCN1A, GLN1489LYS	121918628
182389	6323	SCN1A	0013	DRAVET SYNDROME GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2, INCLUDED	SCN1A, THR1709ILE	121918629
182389	6323	SCN1A	0014	DRAVET SYNDROME GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2, INCLUDED	SCN1A, VAL1611PHE	121918630
182389	6323	SCN1A	0015	FEBRILE SEIZURES, FAMILIAL, 3A	SCN1A, MET145THR	121918631
182389	6323	SCN1A	0016	FEBRILE SEIZURES, FAMILIAL, 3A, SUSCEPTIBILITY TO	SCN1A, IVS5N+5G-A	3812718
182389	6323	SCN1A	0017	DRAVET SYNDROME GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2, INCLUDED	SCN1A, 1-BP DEL, 2528G	
182389	6323	SCN1A	0018	DRAVET SYNDROME	SCN1A, DEL EX21-26	
182389	6323	SCN1A	0019	DRAVET SYNDROME	SCN1A, 6.5-KB DEL	
182389	6323	SCN1A	0020	DRAVET SYNDROME	SCN1A, 1-BP DEL, 3608A	
182389	6323	SCN1A	0021	MIGRAINE, FAMILIAL HEMIPLEGIC, 3	SCN1A, PHE1499LEU	121918632
182389	6323	SCN1A	0022	MIGRAINE, FAMILIAL HEMIPLEGIC, 3	SCN1A, GLN1489HIS	121918633
182389	6323	SCN1A	0023	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6	SCN1A, ALA1669GLU	
182389	6323	SCN1A	0024	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6	SCN1A, ARG862GLY	
182390	6326	SCN2A	0001	SEIZURES, BENIGN FAMILIAL INFANTILE, 3	SCN2A, ARG188TRP	121917748
182390	6326	SCN2A	0002	SEIZURES, BENIGN FAMILIAL INFANTILE, 3	SCN2A, LEU1330PHE	121917749
182390	6326	SCN2A	0003	SEIZURES, BENIGN FAMILIAL INFANTILE, 3	SCN2A, LEU1563VAL	121917750
182390	6326	SCN2A	0004	SEIZURES, BENIGN FAMILIAL INFANTILE, 3	SCN2A, VAL892ILE	121917751
182390	6326	SCN2A	0005	SEIZURES, BENIGN FAMILIAL INFANTILE, 3	SCN2A, ARG223GLN	121917752
182390	6326	SCN2A	0006	SEIZURES, BENIGN FAMILIAL INFANTILE, 3	SCN2A, ARG1319GLN	121917753
182390	6326	SCN2A	0007	SEIZURES, BENIGN FAMILIAL INFANTILE, 3	SCN2A, LEU1003ILE	121917754
182390	6326	SCN2A	0008	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11	SCN2A, ARG102TER	
182390	6326	SCN2A	0009	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11	SCN2A, GLU1211LYS	
182390	6326	SCN2A	0010	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11	SCN2A, ILE1473MET	
182390	6326	SCN2A	0011	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11, MILD	SCN2A, ALA263VAL	
182390	6326	SCN2A	0012	SEIZURES, BENIGN FAMILIAL INFANTILE, 3	SCN2A, MET252VAL	
182455	6755	SSTR5	0001	SOMATOSTATIN ANALOG, RESISTANCE TO	SSTR5, ARG240TRP	
182530	6654	SOS1	0001	FIBROMATOSIS, GINGIVAL, 1	SOS1, 1-BP INS	
182530	6654	SOS1	0002	NOONAN SYNDROME 4	SOS1, THR266LYS	137852812
182530	6654	SOS1	0003	NOONAN SYNDROME 4	SOS1, MET269ARG	137852813
182530	6654	SOS1	0004	NOONAN SYNDROME 4	SOS1, ARG552GLY	137852814
182530	6654	SOS1	0005	NOONAN SYNDROME 4	SOS1, ARG552SER	
182530	6654	SOS1	0006	NOONAN SYNDROME 4	SOS1, TRP432ARG	
182810	6709	SPTAN1	0001	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	SPTAN1, 3-BP DEL, 6619GAG	
182810	6709	SPTAN1	0002	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	SPTAN1, 6-BP DUP, NT6923	
182810	6709	SPTAN1	0003	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	SPTAN1, 3-BP DEL, NT6605	
182810	6709	SPTAN1	0004	VARIANT OF UNKNOWN SIGNIFICANCE	SPTAN1, ARG566PRO	
182860	6708	SPTA1	0001	ELLIPTOCYTOSIS 2	SPTA1, LEU260PRO	121918634
182860	6708	SPTA1	0002	ELLIPTOCYTOSIS 2	SPTA1, GLN471PRO	121918635
182860	6708	SPTA1	0003	ELLIPTOCYTOSIS 2	SPTA1, 3-BP INS, LEU154DUP	
182860	6708	SPTA1	0004	ELLIPTOCYTOSIS 2	SPTA1, SER261PRO	121918636
182860	6708	SPTA1	0005	PYROPOIKILOCYTOSIS, HEREDITARY ELLIPTOCYTOSIS 2, INCLUDED	SPTA1, ARG45SER	121918637
182860	6708	SPTA1	0006	ELLIPTOCYTOSIS 2	SPTA1, GLY46VAL	121918638
182860	6708	SPTA1	0007	ELLIPTOCYTOSIS 2	SPTA1, LEU48PHE	121918639
182860	6708	SPTA1	0009	SPHEROCYTOSIS, TYPE 3, AUTOSOMAL RECESSIVE	SPTA1, ALA970ASP	35948326
182860	6708	SPTA1	0010	ELLIPTOCYTOSIS 2	SPTA1, ARG41TRP	121918640
182860	6708	SPTA1	0011	ELLIPTOCYTOSIS 2	SPTA1, ARG28LEU	
182860	6708	SPTA1	0012	ELLIPTOCYTOSIS 2 PYROPOIKILOCYTOSIS, HEREDITARY, INCLUDED	SPTA1, ARG28SER	121918642
182860	6708	SPTA1	0013	ELLIPTOCYTOSIS 2 PYROPOIKILOCYTOSIS, HEREDITARY, INCLUDED	SPTA1, ARG28CYS	
182860	6708	SPTA1	0014	ELLIPTOCYTOSIS 2 PYROPOIKILOCYTOSIS, HEREDITARY, INCLUDED	SPTA1, ARG28HIS	121918641
182860	6708	SPTA1	0016	PYROPOIKILOCYTOSIS, HEREDITARY ELLIPTOCYTOSIS 2, INCLUDED	SPTA1, LEU207PRO	121918643
182860	6708	SPTA1	0017	PYROPOIKILOCYTOSIS, HEREDITARY	SPTA1, LYS48ARG	121918644
182860	6708	SPTA1	0018	ELLIPTOCYTOSIS 2	SPTA1, ASP791GLU	7418956
182860	6708	SPTA1	0019	ELLIPTOCYTOSIS 2	SPTA1, IVS17, G-A, -1	
182860	6708	SPTA1	0020	ELLIPTOCYTOSIS 2 PYROPOIKILOCYTOSIS, INCLUDED	SPTA1, EX5DEL, SVA RETROTRANSPOSON INS	
182860	6708	SPTA1	0021	PYROPOIKILOCYTOSIS, HEREDITARY ELLIPTOCYTOSIS 2, INCLUDED	SPTA1, IVS19, T-G, -13	
182860	6708	SPTA1	0022	SPHEROCYTOSIS, TYPE 3, DUE TO SPECTRIN PRAGUE	SPTA1, IVS36, A-G, -1	
182860	6708	SPTA1	0023	SPHEROCYTOSIS, TYPE 3, DUE TO SPECTRIN LEPRA	SPTA1, IVS30, C-T, -99	
182860	6708	SPTA1	0024	PYROPOIKILOCYTOSIS, HEREDITARY	SPTA1, IVS22DS, G-A, +5	
182870	6710	SPTB	0001	SPECTRIN SAINT CHAMOND	SPTB, BETA-IV DOMAIN	
182870	6710	SPTB	0002	SPECTRIN TLEMCEN	SPTB, BETA-IV DOMAIN	
182870	6710	SPTB	0003	ELLIPTOCYTOSIS 3	SPTB, ALA2053PRO	121918645
182870	6710	SPTB	0004	ELLIPTOCYTOSIS 3 SPECTRIN ROUEN	SPTB, EXON Y DEL	
182870	6710	SPTB	0005	ELLIPTOCYTOSIS 3	SPTB, 2-BP INS, FS2077TER	
182870	6710	SPTB	0006	ELLIPTOCYTOSIS 3	SPTB, 1-BP DEL, FS2075TER	
182870	6710	SPTB	0007	SPHEROCYTOSIS, TYPE 2, AUTOSOMAL DOMINANT SPECTRIN KISSIMMEE	SPTB, TRP202ARG	121918646
182870	6710	SPTB	0008	PYROPOIKILOCYTOSIS, HEREDITARY ELLIPTOCYTOSIS 3, INCLUDED	SPTB, ALA2018GLY	121918647
182870	6710	SPTB	0009	SPECTRIN PROVIDENCE	SPTB, SER2019PRO	121918648
182870	6710	SPTB	0010	SPHEROCYTOSIS, TYPE 2, AUTOSOMAL DOMINANT SPECTRIN DURHAM	SPTB, EX22-23 DEL	
182870	6710	SPTB	0011	ANEMIA, NEONATAL HEMOLYTIC, FATAL AND NEAR-FATAL	SPTB, LEU2025ARG	121918649
182870	6710	SPTB	0012	ELLIPTOCYTOSIS 3 DUE TO SPECTRIN COSENZA	SPTB, ARG2064PRO	121918650
182870	6710	SPTB	0013	ELLIPTOCYTOSIS 3 DUE TO SPECTRIN PROMISSAO	SPTB, MET1VAL	121918651
182870	6710	SPTB	0014	SPHEROCYTOSIS, TYPE 2, AUTOSOMAL DOMINANT SPECTRIN S-TA BARBARA	SPTB, 1-BP DEL	
182870	6710	SPTB	0015	SPHEROCYTOSIS, TYPE 2, AUTOSOMAL DOMINANT	SPTB, ARG1756TER	
184429	6657	SOX2	0001	MICROPHTHALMIA, SYNDROMIC 3	SOX2, GLN177TER	104893799
184429	6657	SOX2	0002	MICROPHTHALMIA, SYNDROMIC 3	SOX2, GLU93TER	104893800
184429	6657	SOX2	0003	MICROPHTHALMIA, SYNDROMIC 3	SOX2, SER83TER	104893801
184429	6657	SOX2	0004	MICROPHTHALMIA, SYNDROMIC 3	SOX2, LEU97PRO	104893802
184429	6657	SOX2	0005	MICROPHTHALMIA, SYNDROMIC 3	SOX2, GLN155TER	104893803
184429	6657	SOX2	0006	MICROPHTHALMIA, SYNDROMIC 3	SOX2, DEL	
184429	6657	SOX2	0007	MICROPHTHALMIA, SYNDROMIC 3	SOX2, GLN55TER	104893804
184429	6657	SOX2	0008	MICROPHTHALMIA, SYNDROMIC 3	SOX2, ARG74PRO	104893805
184429	6657	SOX2	0009	MICROPHTHALMIA, SYNDROMIC 3	SOX2, ASN46LYS	104893806
184429	6657	SOX2	0010	MICROPHTHALMIA, SYNDROMIC 3	SOX2, 20-BP DEL, NT70	
184429	6657	SOX2	0011	MICROPHTHALMIA, SYNDROMIC 3	SOX2, 1-BP INS, 60G	
184429	6657	SOX2	0012	OPTIC NERVE HYPOPLASIA AND ABNORMALITIES OF THE CENTRAL NERVOUS SYSTEM	SOX2, GLY130ALA	121918652
184429	6657	SOX2	0013	OPTIC NERVE HYPOPLASIA AND ABNORMALITIES OF THE CENTRAL NERVOUS SYSTEM	SOX2, ALA191THR	104893808
184429	6657	SOX2	0014	MICROPHTHALMIA, SYNDROMIC 3	SOX2, 17-BP DEL, NT70	
184429	6657	SOX2	0015	MICROPHTHALMIA, SYNDROMIC 3	SOX2, 1-BP DEL, 551C	
184429	6657	SOX2	0016	MICROPHTHALMIA, SYNDROMIC 3	SOX2, 2-BP INS, 59GG	
184429	6657	SOX2	0017	MICROPHTHALMIA, SYNDROMIC 3	SOX2, LEU82TER	
184429	6657	SOX2	0018	MICROPHTHALMIA, SYNDROMIC 3	SOX2, PHE48TER	
184429	6657	SOX2	0019	MICROPHTHALMIA, SYNDROMIC 3	SOX2, 1-BP DEL, 837C	
184600	1475	CSTA	0001	EXFOLIATIVE ICHTHYOSIS, AUTOSOMAL RECESSIVE, ICHTHYOSIS BULLOSA OF SIEMENS-LIKE	CSTA, IVS1, A-T, -2	
184600	1475	CSTA	0002	EXFOLIATIVE ICHTHYOSIS, AUTOSOMAL RECESSIVE, ICHTHYOSIS BULLOSA OF SIEMENS-LIKE	CSTA, GLN86TER	
184745	4254	KITLG	0001	SKIN/HAIR/EYE PIGMENTATION 7, BLOND/BROWN HAIR	KITLG, C/T	12821256
184745	4254	KITLG	0002	SKIN/HAIR/EYE PIGMENTATION 7, DARK/LIGHT SKIN	KITLG, -326A-G, 5-PRIME UTR	642742
184745	4254	KITLG	0003	HYPERPIGMENTATION, FAMILIAL PROGRESSIVE, 2	KITLG, ASN36SER	121918653
184755	6342	SCP2	0001	LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY	SCP2, 1-BP INS, 545A	
184757	2516	NR5A1	0001	46,XY SEX REVERSAL 3	NR5A1, GLY35GLU	121918654
184757	2516	NR5A1	0002	ADRENOCORTICAL INSUFFICIENCY	NR5A1, ARG255LEU	104894118
184757	2516	NR5A1	0003	46,XY SEX REVERSAL 3	NR5A1, ARG92GLN	104894119
184757	2516	NR5A1	0004	46,XY SEX REVERSAL 3	NR5A1, 8-BP DEL, NT1058	
184757	2516	NR5A1	0005	46,XY SEX REVERSAL 3	NR5A1, CYS16TER	104894123
184757	2516	NR5A1	0006	46,XY SEX REVERSAL 3	NR5A1, 1-BP DEL, 18C	
184757	2516	NR5A1	0007	46,XY SEX REVERSAL 3	NR5A1, VAL15MET	104894124
184757	2516	NR5A1	0008	46,XY SEX REVERSAL 3	NR5A1, MET78ILE	
184757	2516	NR5A1	0009	46,XY SEX REVERSAL 3	NR5A1, GLY91SER	104894126
184757	2516	NR5A1	0010	46,XY SEX REVERSAL 3	NR5A1, LEU437GLN	104894120
184757	2516	NR5A1	0011	46,XY SEX REVERSAL 3 PREMATURE OVARIAN FAILURE 7, INCLUDED	NR5A1, 1-BP DEL, 666C	
184757	2516	NR5A1	0012	46,XY SEX REVERSAL 3 PREMATURE OVARIAN FAILURE 7, INCLUDED	NR5A1, ASP293ASN	121918655
184757	2516	NR5A1	0013	46,XY SEX REVERSAL 3 PREMATURE OVARIAN FAILURE 7, INCLUDED	NR5A1, MET1ILE	121918656
184757	2516	NR5A1	0014	46,XY SEX REVERSAL 3 PREMATURE OVARIAN FAILURE 7, INCLUDED	NR5A1, 1-BP DEL, 390G	
184757	2516	NR5A1	0015	PREMATURE OVARIAN FAILURE 7	NR5A1, 9-BP DEL, NT691	
184757	2516	NR5A1	0016	PREMATURE OVARIAN FAILURE 7 SPERMATOGENIC FAILURE 8, INCLUDED	NR5A1, GLY123ALA AND PRO129LEU	
184757	2516	NR5A1	0017	SPERMATOGENIC FAILURE 8	NR5A1, PRO131LEU	
184757	2516	NR5A1	0018	SPERMATOGENIC FAILURE 8	NR5A1, GLY212SER	
185250	4314	MMP3	0001	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 6	MMP3, -1171 5A/6A	
185470	6390	SDHB	0001	PARAGANGLIOMAS 4	SDHB, ARG90TER	74315366
185470	6390	SDHB	0002	PARAGANGLIOMAS 4	SDHB, PRO197ARG	74315367
185470	6390	SDHB	0003	PHEOCHROMOCYTOMA	SDHB, 1-BP DEL, 725C	
185470	6390	SDHB	0004	PARAGANGLIOMAS 4 PHEOCHROMOCYTOMA, INCLUDED;; GASTROINTESTINAL STROMAL TUMOR, INCLUDED	SDHB, ARG242HIS	74315368
185470	6390	SDHB	0005	PARAGANGLIOMAS 4 PHEOCHROMOCYTOMA, INCLUDED	SDHB, 4-BP DEL, 847NT	
185470	6390	SDHB	0006	PARAGANGLIOMAS 4 PHEOCHROMOCYTOMA, INCLUDED	SDHB, ARG27TER	74315369
185470	6390	SDHB	0007	PARAGANGLIOMAS 4	SDHB, 1.0-KB DEL, EX1	
185470	6390	SDHB	0008	PHEOCHROMOCYTOMA	SDHB, ARG46GLY	74315370
185470	6390	SDHB	0009	PHEOCHROMOCYTOMA	SDHB, CYS101TYR	74315371
185470	6390	SDHB	0010	PARAGANGLIOMAS 4	SDHB, HIS132PRO	74315372
185470	6390	SDHB	0011	PHEOCHROMOCYTOMA	SDHB, SER100PHE	121917755
185470	6390	SDHB	0012	PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA	SDHB, IVS1DS, G-T, +1	
185470	6390	SDHB	0013	PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA	SDHB, IVS4DS, G-C, +1	
185470	6390	SDHB	0014	COWDEN DISEASE 2	SDHB, ALA3GLY	11203289
185470	6390	SDHB	0015	COWDEN DISEASE 2	SDHB, SER163PRO	33927012
185470	6390	SDHB	0016	PARAGANGLIOMAS 4	SDHB, VAL140PHE	
185470	6390	SDHB	0017	PARAGANGLIOMAS 4	SDHB, 15.69-KB DEL, EX1	
185470	6390	SDHB	0018	PARAGANGLIOMAS 4	SDHB, 20.3-KB DEL, EX1	
185470	6390	SDHB	0019	PARAGANGLIOMAS 4	SDHB, IVS4DS, G-A, +1	
185470	6390	SDHB	0020	VARIANT OF UNKNOWN SIGNIFICANCE	SDHB, ASP48VAL	
185490	6649	SOD3	0001	SUPEROXIDE DISMUTASE, ELEVATED EXTRACELLULAR	SOD3, ARG213GLY	1799895
185535	4072	EPCAM	0001	DIARRHEA 5, WITH TUFTING ENTEROPATHY, CONGENITAL	EPCAM, IVS4, G-A, +1	
185535	4072	EPCAM	0002	DIARRHEA 5, WITH TUFTING ENTEROPATHY, CONGENITAL	EPCAM, IVS3, G-A, -1	
185535	4072	EPCAM	0003	DIARRHEA 5, WITH TUFTING ENTEROPATHY, CONGENITAL	EPCAM, CYS66TYR	
185535	4072	EPCAM	0004	DIARRHEA 5, WITH TUFTING ENTEROPATHY, CONGENITAL	EPCAM, 1-BP INS, 498C	
185535	4072	EPCAM	0005	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 8	EPCAM, 5-KB DEL	
185535	4072	EPCAM	0006	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 8	EPCAM, 22.8-KB DEL	
185535	4072	EPCAM	0007	DIARRHEA 5, WITH TUFTING ENTEROPATHY, CONGENITAL	EPCAM, ARG138TER	
185620	6834	SURF1	0001	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX IV DEFICIENCY	SURF1, 765C-T	
185620	6834	SURF1	0002	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX IV DEFICIENCY	SURF1, IVS4, T-C, +2	
185620	6834	SURF1	0003	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX IV DEFICIENCY	SURF1, 2-BP INS/10-BP DEL, NT326	
185620	6834	SURF1	0004	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX IV DEFICIENCY	SURF1, 2-BP DEL, 855CT	
185620	6834	SURF1	0005	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX IV DEFICIENCY	SURF1, 1-BP INS, 882T	
185620	6834	SURF1	0006	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX IV DEFICIENCY	SURF1, GLN251TER	121918657
185620	6834	SURF1	0007	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX IV DEFICIENCY	SURF1, 1-BP INS, 868T	
185620	6834	SURF1	0008	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX IV DEFICIENCY	SURF1, IVS5DS, T-G, +2	
185620	6834	SURF1	0009	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX IV DEFICIENCY	SURF1, 2-BP DEL, 550AG	
185620	6834	SURF1	0010	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX IV DEFICIENCY	SURF1, TYR274ASP	121918658
185620	6834	SURF1	0011	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX IV DEFICIENCY MITOCHONDRIAL COMPLEX IV DEFICIENCY	SURF1, 2-BP DEL, 790AG	
185620	6834	SURF1	0012	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX IV DEFICIENCY	SURF1, GLY124GLU	28933402
185620	6834	SURF1	0013	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX IV DEFICIENCY	SURF1, 4-BP INS, 572CCCT	
185620	6834	SURF1	0014	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX IV DEFICIENCY	SURF1, 2-BP DEL, 845CT	
185620	6834	SURF1	0015	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX IV DEFICIENCY	SURF1, TRP227ARG	
186357	9672	SDC3	0001	OBESITY, ASSOCIATION WITH	SDC3, THR271ILE	2282440
186357	9672	SDC3	0002	OBESITY, ASSOCIATION WITH	SDC3, VAL150ILE	2491132
186711	939	CD27	0001	LYMPHOPROLIFERATIVE SYNDROME 2	CD27, TRP8TER	
186711	939	CD27	0002	LYMPHOPROLIFERATIVE SYNDROME 2	CD27, CYS53TYR	
186740	917	CD3G	0001	IMMUNODEFICIENCY DUE TO DEFECT IN CD3-GAMMA	CD3G, MET1VAL	104894199
186740	917	CD3G	0002	IMMUNODEFICIENCY DUE TO DEFECT IN CD3-GAMMA	CD3G, 17-BP DEL	
186780	919	CD247	0001	IMMUNODEFICIENCY DUE TO DEFECT IN CD3-ZETA	CD247, GLN70TER	74315290
186780	919	CD247	0002	IMMUNODEFICIENCY DUE TO DEFECT IN CD3-ZETA, SOMATIC	CD3Z, GLN70TRP	193922739
186780	919	CD247	0003	IMMUNODEFICIENCY DUE TO DEFECT IN CD3-ZETA, SOMATIC	CD3Z, GLN70LEU	193922740
186780	919	CD247	0004	IMMUNODEFICIENCY DUE TO DEFECT IN CD3-ZETA, SOMATIC	CD3Z, GLN70TYR	193922741
186790	915	CD3D	0001	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	CD3D, ARG68TER	111033580
186790	915	CD3D	0002	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	CD3D, CYS93TER	111033581
186830	916	CD3E	0001	IMMUNODEFICIENCY DUE TO DEFECT IN CD3-EPSILON	CD3E, IVS7DS, T-C, +2	
186830	916	CD3E	0002	IMMUNODEFICIENCY DUE TO DEFECT IN CD3-EPSILON	CD3E, TRP59TER	121918659
186830	916	CD3E	0003	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	CD3E, 2-BP DEL, NT128	
186845	975	CD81	0001	IMMUNODEFICIENCY, COMMON VARIABLE, 6	CD81, IVS6DS, G-A, +1	
186910	925	CD8A	0001	CD8 DEFICIENCY, FAMILIAL	CD8A, GLY90SER	121918660
186940	920	CD4	0001	OKT4 EPITOPE DEFICIENCY	CD4, ARG240TRP	
186973	3702	ITK	0001	LYMPHOPROLIFERATIVE SYNDROME 1	ITK, ARG335TRP	121908191
187011	6352	CCL5	0001	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, DELAYED DISEASE PROGRESSION WITH INFECTION BY	CCL5, -28C-G	
187011	6352	CCL5	0002	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RAPID DISEASE PROGRESSION WITH INFECTION BY	CCL5, 168923, T/C	
187270	7015	TERT	0001	BONE MARROW FAILURE, TELOMERE-RELATED, 1	TERT, ALA202THR	121918661
187270	7015	TERT	0002	BONE MARROW FAILURE, TELOMERE-RELATED, 1 DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 4, INCLUDED	TERT, HIS412TYR	34094720
187270	7015	TERT	0003	BONE MARROW FAILURE, TELOMERE-RELATED, 1	TERT, VAL694MET	121918662
187270	7015	TERT	0004	BONE MARROW FAILURE, TELOMERE-RELATED, 1	TERT, TYR772CYS	121918663
187270	7015	TERT	0005	BONE MARROW FAILURE, TELOMERE-RELATED, 1	TERT, VAL1090MET	121918664
187270	7015	TERT	0006	CORONARY ARTERY DISEASE, SUSCEPTIBILITY TO	TERT, -1327T-C	
187270	7015	TERT	0007	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 2	TERT, LYS902ASN	121918665
187270	7015	TERT	0008	PULMONARY FIBROSIS, TELOMERE-RELATED, 1	TERT, ARG865HIS	121918666
187270	7015	TERT	0009	PULMONARY FIBROSIS, TELOMERE-RELATED, 1	TERT, 1-BP DEL, 2240T	199422300
187270	7015	TERT	0010	PULMONARY FIBROSIS, TELOMERE-RELATED, 1	TERT, IVS1DS, G-A, +1	199422309
187270	7015	TERT	0011	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 2	TERT, ARG631GLN	
187270	7015	TERT	0012	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 4	TERT, ARG811CYS	
187270	7015	TERT	0013	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 4	TERT, ARG901TRP	
187270	7015	TERT	0014	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 4	TERT, PRO704SER	
187270	7015	TERT	0015	PULMONARY FIBROSIS, TELOMERE-RELATED, 1	TERT, LEU55GLN	
187270	7015	TERT	0016	PULMONARY FIBROSIS, TELOMERE-RELATED, 1	TERT, IVS9AS, A-C, -2	
187270	7015	TERT	0017	PULMONARY FIBROSIS, TELOMERE-RELATED, 1	TERT, VAL791ILE AND VAL867MET	
187270	7015	TERT	0018	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 1	TERT, VAL170MET	
187270	7015	TERT	0019	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 1	TERT, ALA716THR	
187270	7015	TERT	0020	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 1	TERT, LYS902ARG	
187270	7015	TERT	0021	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 1	TERT, PRO923LEU	
187270	7015	TERT	0022	LEUKEMIA, ACUTE MYELOID, SUSCEPTIBILITY TO	TERT, ALA1062THR	
187270	7015	TERT	0023	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 9	TERT, -57, T-G	
187395	6997	TDGF1	0001	FOREBRAIN DEFECTS	TDGF1, PRO125LEU	121909501
187680	7172	TPMT	0001	THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	TPMT, ALA80PRO	1800462
187680	7172	TPMT	0002	THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	TPMT, ALA154THR AND TYR240CYS	1800460
187680	7172	TPMT	0003	THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	TPMT, IVS9AS, G-A, -1	
187680	7172	TPMT	0004	THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	TPMT, ALA154THR	1800460
187680	7172	TPMT	0005	THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	TPMT, TYR240CYS	1142345
187680	7172	TPMT	0006	THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	TPMT, ARG215HIS	56161402
187680	7172	TPMT	0007	THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	TPMT, ALA167GLY	74423290
188040	7056	THBD	0001	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	THBD, ASP468TYR	41348347
188040	7056	THBD	0002	THROMBOPHILIA DUE TO THROMBOMODULIN DEFECT	THBD, ALA25THR	
188040	7056	THBD	0003	THROMBOPHILIA DUE TO THROMBOMODULIN DEFECT	THBD, 1-BP INS, 1689T	
188040	7056	THBD	0004	THROMBOPHILIA DUE TO THROMBOMODULIN DEFECT	THBD, -33G-A	
188040	7056	THBD	0005	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 6	THBD, ALA43THR	1800576
188040	7056	THBD	0006	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 6	THBD, ASP53GLY	121918667
188040	7056	THBD	0007	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 6	THBD, PRO495SER	1800578
188040	7056	THBD	0008	VARIANT OF UNKNOWN SIGNIFICANCE	THBD, ALA455VAL	
188040	7056	THBD	0009	THROMBOPHILIA DUE TO THROMBOMODULIN DEFECT	THBD, ARG385SER	
188061	7058	THBS2	0001	LUMBAR DISC HERNIATION, SUSCEPTIBILITY TO	THBS2, IVS10, C-T, -8	9406328
188070	6915	TBXA2R	0001	BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO	TBXA2R, ARG60LEU	34377097
188070	6915	TBXA2R	0002	BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO	TBXA2R, ASP304ASN	
188070	6915	TBXA2R	0003	BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO	TBXA2R, VAL241GLY	
188250	7084	TK2	0001	MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	TK2, HIS121ASN	137854429
188250	7084	TK2	0002	MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	TK2, ILE212ASN	137854430
188250	7084	TK2	0003	MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	TK2, THR108MET	137854431
188250	7084	TK2	0004	MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	TK2, ILE53MET	137854432
188250	7084	TK2	0005	MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	TK2, 8-BP DUP	
188250	7084	TK2	0006	MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	TK2, ARG90CYS	
188380	7112	TMPO	0001	CARDIOMYOPATHY, DILATED, 1T	TMPO, ARG690CYS	17028450
188450	7038	TG	0001	THYROID DYSHORMONOGENESIS 3	TG, IVS3, C-G, -3	
188450	7038	TG	0002	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	TG, GLN870HIS	2229843
188450	7038	TG	0003	THYROID DYSHORMONOGENESIS 3	TG, ARG1511TER	121912646
188450	7038	TG	0004	THYROID DYSHORMONOGENESIS 3	TG, 138-BP DEL, NT5590 TG, IVS30, +1, G-T	
188450	7038	TG	0005	THYROID DYSHORMONOGENESIS 3	TG, CYS1245ARG	121912647
188450	7038	TG	0006	THYROID DYSHORMONOGENESIS 3	TG, CYS1977SER	2076739
188450	7038	TG	0007	THYROID DYSHORMONOGENESIS 3	TG, ARG277TER	121912648
188450	7038	TG	0008	AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3	TG, ARG1980TRP	2076740
188450	7038	TG	0009	AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3	TG, SER734ALA	180223
188450	7038	TG	0010	AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3	TG, MET1027VAL	853326
188450	7038	TG	0011	THYROID DYSHORMONOGENESIS 3	TG, 1-BP DEL, 1143C	
188450	7038	TG	0012	THYROID DYSHORMONOGENESIS 3	TG, ARG2223HIS	2069566
188450	7038	TG	0013	THYROID DYSHORMONOGENESIS 3	TG, IVS34, G-C, -1	
188450	7038	TG	0014	THYROID DYSHORMONOGENESIS 3	TG, CYS1058ARG	137854433
188450	7038	TG	0015	THYROID DYSHORMONOGENESIS 3	TG, GLY2356ARG	137854434
188450	7038	TG	0016	THYROID DYSHORMONOGENESIS 3	TG, CYS1897TYR	121912649
188450	7038	TG	0017	THYROID DYSHORMONOGENESIS 3	TG, ARG2336GLN	121912650
188450	7038	TG	0018	THYROID DYSHORMONOGENESIS 3	TG, IVS5DS, G-A, +1	
188450	7038	TG	0019	AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3	TG, -1623, A-G, dbSNP rs180195	
188540	7252	TSHB	0001	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	TSHB, GLY29ARG	121918668
188540	7252	TSHB	0002	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	TSHB, GLU12TER	121918669
188540	7252	TSHB	0003	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	TSHB, 1-BP DEL, 313T	
188540	7252	TSHB	0004	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	TSHB, GLN49TER	121918670
188540	7252	TSHB	0005	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	TSHB, IVS2, G-A, +5	
188545	7201	TRHR	0001	THYROTROPIN-RELEASING HORMONE RESISTANCE, GENERALIZED	TRHR, 9-BP DEL AND ALA118THR	
188545	7201	TRHR	0002	THYROTROPIN-RELEASING HORMONE RESISTANCE, GENERALIZED	TRHR, ARG17TER	
188545	7201	TRHR	0003	THYROTROPIN-RELEASING HORMONE RESISTANCE, GENERALIZED	TRHR, ARG17TER	
188826	7078	TIMP3	0001	SORSBY FUNDUS DYSTROPHY	TIMP3, SER181CYS	137853298
188826	7078	TIMP3	0002	SORSBY FUNDUS DYSTROPHY	TIMP3, TYR168CYS	137853299
188826	7078	TIMP3	0003	SORSBY FUNDUS DYSTROPHY	TIMP3, SER156CYS	137853300
188826	7078	TIMP3	0004	SORSBY FUNDUS DYSTROPHY, LAVIA TYPE	TIMP3, GLY166CYS	137853301
188826	7078	TIMP3	0005	SORSBY FUNDUS DYSTROPHY	TIMP3, GLU139TER	137853302
188830	5573	PRKAR1A	0001	CARNEY COMPLEX, TYPE 1	PRKAR1A, 2-BP DEL, 578TG	
188830	5573	PRKAR1A	0002	CARNEY COMPLEX, TYPE 1	PRKAR1A, 889GG-CT	
188830	5573	PRKAR1A	0003	CARNEY COMPLEX, TYPE 1	PRKAR1A, IVS8DS, A-G, +3	
188830	5573	PRKAR1A	0004	MYXOMA, INTRACARDIAC	PRKAR1A, 4-BP DEL, 617TTAT	
188830	5573	PRKAR1A	0005	CARNEY COMPLEX, TYPE 1	PRKAR1A, 1-BP DEL, 710G	
188830	5573	PRKAR1A	0006	CARNEY COMPLEX, TYPE 1	PRKAR1A, 2-BP DEL, 845TC	
188830	5573	PRKAR1A	0007	CARNEY COMPLEX, TYPE 1	PRKAR1A, 2-BP DEL, 576TG	
188830	5573	PRKAR1A	0008	CARNEY COMPLEX, TYPE 1	PRKAR1A, 88AG	
188830	5573	PRKAR1A	0009	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	PRKAR1A, 102G-A	
188830	5573	PRKAR1A	0010	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	PRKAR1A, 16-BP DEL	
188830	5573	PRKAR1A	0011	CARNEY COMPLEX, TYPE 1	PRKAR1A, IVS6DS, G-T, +1	
188830	5573	PRKAR1A	0012	ADRENOCORTICAL TUMOR, SOMATIC	PRKAR1A, IVS9AS, G-A, -1	
188830	5573	PRKAR1A	0013	CARNEY COMPLEX, TYPE 1	PRKAR1A, ARG74CYS	137853303
188830	5573	PRKAR1A	0014	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1 CARNEY COMPLEX, INCLUDED	PRKAR1A, IVS6, 6-BP DEL	
188830	5573	PRKAR1A	0015	ACRODYSOSTOSIS 1, WITH HORMONE RESISTANCE	PRKAR1A, ARG368TER	
188830	5573	PRKAR1A	0016	ACRODYSOSTOSIS 1, WITH HORMONE RESISTANCE	PRKAR1A, TYR373HIS	
188830	5573	PRKAR1A	0017	ACRODYSOSTOSIS 1, WITHOUT HORMONE RESISTANCE	PRKAR1A, ARG335PRO	
188830	5573	PRKAR1A	0018	ACRODYSOSTOSIS 1, WITH HORMONE RESISTANCE	PRKAR1A, ILE327THR	
188840	7273	TTN	0001	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 9	TTN, ARG740LEU	
188840	7273	TTN	0002	CARDIOMYOPATHY, DILATED, 1G	TTN, 2-BP INS, 43628AT	
188840	7273	TTN	0003	CARDIOMYOPATHY, DILATED, 1G	TTN, TRP930ARG	
188840	7273	TTN	0004	TIBIAL MUSCULAR DYSTROPHY, TARDIVE MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2J, INCLUDED	TTN, 11-BP DEL/INS	
188840	7273	TTN	0005	TIBIAL MUSCULAR DYSTROPHY, TARDIVE	TTN, LEU34315PRO	
188840	7273	TTN	0006	TIBIAL MUSCULAR DYSTROPHY, TARDIVE	TTN, 293329T-A	
188840	7273	TTN	0007	CARDIOMYOPATHY, DILATED, 1G	TTN, ALA743VAL	
188840	7273	TTN	0008	CARDIOMYOPATHY, DILATED, 1G	TTN, VAL54MET	
188840	7273	TTN	0009	CARDIOMYOPATHY, DILATED, 1G	TTN, GLN4053TER	
188840	7273	TTN	0010	CARDIOMYOPATHY, DILATED, 1G	TTN, SER4465ASN	
188840	7273	TTN	0011	HEREDITARY MYOPATHY WITH EARLY RESPIRATORY FAILURE	TTN, ARG279TRP	
188840	7273	TTN	0012	MYOPATHY, EARLY-ONSET, WITH FATAL CARDIOMYOPATHY	TTN, 1-BP DEL, 291394A	199469666
188840	7273	TTN	0013	MYOPATHY, EARLY-ONSET, WITH FATAL CARDIOMYOPATHY	TTN, 8-BP DEL, NT289385	199469665
189907	6928	HNF1B	0001	RENAL CYSTS AND DIABETES SYNDROME	HNF1B, ARG177TER	1800575
189907	6928	HNF1B	0002	RENAL CYSTS AND DIABETES SYNDROME	HNF1B, 75-BP DEL, NT409	
189907	6928	HNF1B	0003	RENAL CYSTS AND DIABETES SYNDROME	HNF1B, 5-BP DEL	
189907	6928	HNF1B	0004	RENAL CYSTS AND DIABETES SYNDROME	HNF1B, GLU101TER	121918671
189907	6928	HNF1B	0005	RENAL CYSTS AND DIABETES SYNDROME	HNF1B, 1-BP DEL	
189907	6928	HNF1B	0006	RENAL CYSTS AND DIABETES SYNDROME	HNF1B, ARG276TER	121918672
189907	6928	HNF1B	0007	DIABETES MELLITUS, NONINSULIN-DEPENDENT	HNF1B, SER465ARG	121918673
189907	6928	HNF1B	0008	RENAL CYSTS AND DIABETES SYNDROME	HNF1B, 1-BP INS, 1055A	
189907	6928	HNF1B	0009	RENAL CYSTS AND DIABETES SYNDROME	HNF1B, IVS2DS, G-A, +1	
189907	6928	HNF1B	0010	RENAL CYSTS AND DIABETES SYNDROME	HNF1B, IVS2DS, G-T, +1	
189907	6928	HNF1B	0011	RENAL CYSTS AND DIABETES SYNDROME	HNF1B, SER148TRP	121918674
189907	6928	HNF1B	0013	RENAL CYSTS AND DIABETES SYNDROME	HNF1B, EX5DUP	
189907	6928	HNF1B	0014	RENAL CYSTS AND DIABETES SYNDROME	HNF1B, ARG165HIS	121918675
189907	6928	HNF1B	0015	RENAL CELL CARCINOMA, CHROMOPHOBE	HNF1B, 1-BP DEL, 46C	
189907	6928	HNF1B	0016	REMOVED FROM DATABASE *FIELD* SA Menzel et al. (1998); Nishigori et al. (1998) *FIELD* RF 1. Abbott, C.; Piaggio, G.; Ammendola, R.; Solomon, E.; Povey, S.; Gounari, F.; De Simone, V.; Cortese, R.: Mapping of the gene TCF2 for the transcription factor LFB3 to human chromosome 17 by polymerase	chain reaction. Genomics 8: 165-167, 1990.	
189909	6935	ZEB1	0001	CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 3	ZEB1, 2-BP DEL, 2916TG	
189909	6935	ZEB1	0002	CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 3	ZEB1, 1350C-T	
189909	6935	ZEB1	0003	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 6	ZEB1, ASN78THR	80194531
189909	6935	ZEB1	0004	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 6	ZEB1, GLN840PRO	
189967	7003	TEAD1	0001	SVEINSSON CHOREORETINAL ATROPHY	TEAD1, TYR421HIS	11567847
189980	25	ABL1	0001	LEUKEMIA, PHILADELPHIA CHROMOSOME-POSITIVE, RESISTANT TO IMATINIB	ABL1, THR315ILE	121913459
189980	25	ABL1	0002	LEUKEMIA, PHILADELPHIA CHROMOSOME-POSITIVE, RESISTANT TO IMATINIB	ABL1, GLU255VAL	121913449
189980	25	ABL1	0003	LEUKEMIA, PHILADELPHIA CHROMOSOME-POSITIVE, RESISTANT TO IMATINIB	ABL1, GLU255LYS	121913448
189980	25	ABL1	0004	LEUKEMIA, PHILADELPHIA CHROMOSOME-POSITIVE, RESISTANT TO IMATINIB	ABL1, TYR253HIS	121913461
189980	25	ABL1	0005	CHRONIC MYELOID LEUKEMIA, RESISTANT TO IMATINIB	ABL1, PHE311LEU	137853304
189980	25	ABL1	0006	CHRONIC MYELOID LEUKEMIA, RESISTANT TO IMATINIB	ABL1, MET351THR	121913457
190000	7018	TF	0001	TRANSFERRIN VARIANT D1	TF, GLY277ASP	121918676
190000	7018	TF	0002	TRANSFERRIN VARIANT CHI	TF, HIS300ARG	41295774
190000	7018	TF	0003	TRANSFERRIN VARIANT B2	TF, GLY652GLU	121918677
190000	7018	TF	0004	TRANSFERRIN VARIANT C1/C2 ALZHEIMER DISEASE, SUSCEPTIBILITY TO, INCLUDED	TF, PRO570SER	1049296
190000	7018	TF	0005	TRANSFERRIN VARIANT Bv	TF, LYS627GLU	121918678
190000	7018	TF	0006	ATRANSFERRINEMIA	TF, 10-BP DEL AND 9-BP DUP	
190000	7018	TF	0007	ATRANSFERRINEMIA	TF, ALA477PRO	121918679
190000	7018	TF	0008	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	TF, GLY277SER	1799899
190000	7018	TF	0009	ATRANSFERRINEMIA	TF, GLU375LYS	121918680
190000	7018	TF	0010	ATRANSFERRINEMIA	TF, ASP77ASN	121918681
190020	3265	HRAS	0001	BLADDER CANCER, SOMATIC COSTELLO SYNDROME, INCLUDED;; MYOPATHY, CONGENITAL, WITH EXCESS OF MUSCLE SPINDLES, INCLUDED;; EPIDERMAL NEVUS, SOMATIC, INCLUDED	HRAS, GLY12VAL	
190020	3265	HRAS	0002	THYROID CARCINOMA, FOLLICULAR, SOMATIC SPERMATOCYTIC SEMINOMA, SOMATIC, INCLUDED	HRAS, GLN61LYS	28933406
190020	3265	HRAS	0003	COSTELLO SYNDROME MYOPATHY, CONGENITAL, WITH EXCESS OF MUSCLE SPINDLES, INCLUDED;; EPIDERMAL NEVUS WITH UROTHELIAL CANCER, SOMATIC, INCLUDED;; NEVUS SEBACEOUS, SOMATIC, INCLUDED	HRAS, GLY12SER	104894229
190020	3265	HRAS	0004	COSTELLO SYNDROME	HRAS, GLY12ALA	104894230
190020	3265	HRAS	0005	COSTELLO SYNDROME	HRAS, GLY13ASP	104894226
190020	3265	HRAS	0006	COSTELLO SYNDROME	HRAS, LYS117ARG	104894227
190020	3265	HRAS	0007	COSTELLO SYNDROME	HRAS, GLY13CYS	104894228
190020	3265	HRAS	0008	COSTELLO SYNDROME	HRAS, ALA146THR	104894231
190020	3265	HRAS	0009	MYOPATHY, CONGENITAL, WITH EXCESS OF MUSCLE SPINDLES	HRAS, GLU63LYS	121917756
190020	3265	HRAS	0010	MYOPATHY, CONGENITAL, WITH EXCESS OF MUSCLE SPINDLES	HRAS, GLN22LYS	121917757
190020	3265	HRAS	0011	COSTELLO SYNDROME	HRAS, THR58ILE	121917758
190020	3265	HRAS	0012	COSTELLO SYNDROME	HRAS, ALA146VAL	121917759
190020	3265	HRAS	0013	COSTELLO SYNDROME, SEVERE NEVUS SEBACEOUS, SOMATIC, INCLUDED	HRAS, GLY12ASP	104894230
190020	3265	HRAS	0014	COSTELLO SYNDROME NEVUS SEBACEOUS, SOMATIC, INCLUDED;; EPIDERMAL NEVUS, SOMATIC, INCLUDED	HRAS, GLY12CYS	104894229
190020	3265	HRAS	0015	COSTELLO SYNDROME	HRAS, 3-BP DUP, 110AGG	
190020	3265	HRAS	0016	COSTELLO SYNDROME	HRAS, 3-BP DUP, 108AGA	
190020	3265	HRAS	0017	NEVUS SEBACEOUS, SOMATIC SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME, SOMATIC MOSAIC, INCLUDED;; EPIDERMAL NEVUS, SOMATIC, INCLUDED	HRAS, GLY13ARG	
190040	5155	PDGFB	0001	MENINGIOMA	PDGFB, 135-BP DEL, IVS5	
190040	5155	PDGFB	0002	DERMATOFIBROSARCOMA PROTUBERANS	PDGFB, PDGFB/COL1A1 FUSION	
190070	3845	KRAS	0001	LUNG CANCER, SOMATIC	KRAS, GLY12CYS	121913530
190070	3845	KRAS	0002	LUNG CANCER, SQUAMOUS CELL, SOMATIC BLADDER CANCER, SOMATIC, INCLUDED	KRAS, GLY12ARG	121913530
190070	3845	KRAS	0003	BREAST ADENOCARCINOMA, SOMATIC	KRAS, GLY13ASP	112445441
190070	3845	KRAS	0004	BLADDER CANCER, TRANSITIONAL CELL, SOMATIC	KRAS, ALA59THR	121913528
190070	3845	KRAS	0005	PANCREATIC CARCINOMA, SOMATIC GASTRIC CANCER, SOMATIC, INCLUDED;; EPIDERMAL NEVUS, SOMATIC, INCLUDED;; NEVUS SEBACEOUS, SOMATIC, INCLUDED;; SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME, SOMATIC MOSAIC, INCLUDED	KRAS, GLY12ASP	121913529
190070	3845	KRAS	0006	PANCREATIC CARCINOMA, SOMATIC NEVUS SEBACEOUS, SOMATIC, INCLUDED	KRAS, GLY12VAL	121913529
190070	3845	KRAS	0007	GASTRIC CANCER, SOMATIC	KRAS, GLY12SER	121913530
190070	3845	KRAS	0008	LEUKEMIA, ACUTE MYELOGENOUS	KRAS, 3-BP INS, GLY11INS	
190070	3845	KRAS	0009	CARDIOFACIOCUTANEOUS SYNDROME 2	KRAS, GLY60ARG	104894359
190070	3845	KRAS	0010	CARDIOFACIOCUTANEOUS SYNDROME 2 NOONAN SYNDROME 3, INCLUDED	KRAS, ASP153VAL	104894360
190070	3845	KRAS	0011	NOONAN SYNDROME 3	KRAS, THR58ILE	104894364
190070	3845	KRAS	0012	NOONAN SYNDROME 3	KRAS, VAL14ILE	104894365
190070	3845	KRAS	0013	CARDIOFACIOCUTANEOUS SYNDROME 2	KRAS, PRO34ARG	104894366
190070	3845	KRAS	0014	NOONAN SYNDROME 3	KRAS, VAL152GLY	104894367
190070	3845	KRAS	0015	NOONAN SYNDROME 3	KRAS, ASP153VAL	
190070	3845	KRAS	0016	PILOCYTIC ASTROCYTOMA, SOMATIC	KRAS, GLY13ARG	121913535
190070	3845	KRAS	0017	CARDIOFACIOCUTANEOUS SYNDROME 2	KRAS, LYS5ASN	104894361
190070	3845	KRAS	0018	CARDIOFACIOCUTANEOUS SYNDROME 2	KRAS, PHE156LEU	104894362
190070	3845	KRAS	0019	NOONAN SYNDROME 3	KRAS, LYS5GLU	193929331
190070	3845	KRAS	0020	NOONAN SYNDROME 3	KRAS, GLY60SER	104894359
190070	3845	KRAS	0021	CARDIOFACIOCUTANEOUS SYNDROME 2	KRAS, TYR71HIS	
190070	3845	KRAS	0022	CARDIOFACIOCUTANEOUS SYNDROME 2	KRAS, LYS147GLU	
190080	4609	MYC	0001	BURKITT LYMPHOMA	MYC, PRO57SER	28933407
190080	4609	MYC	0002	BURKITT LYMPHOMA	MYC, ASN86THR	121918683
190080	4609	MYC	0003	BURKITT LYMPHOMA	MYC, GLU39ASP	121918684
190080	4609	MYC	0004	BURKITT LYMPHOMA	MYC, PRO59ALA	121918685
190090	6714	SRC	0001	COLON CANCER, ADVANCED	SRC, GLN531TER	121913314
190120	7067	THRA	0001	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS 6	THRA, GLU403TER	
190120	7067	THRA	0002	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS 6	THRA, 1-BP INS, 1190T	
190151	2065	ERBB3	0001	LETHAL CONGENITAL CONTRACTURE SYNDROME 2	ERBB3, IVS10, A-G, -8	
190160	7068	THRB	0001	THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	THRB, GLY345ARG	
190160	7068	THRB	0002	THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	THRB, PRO453HIS	121918687
190160	7068	THRB	0003	THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL RECESSIVE	THRB, EX4-10DEL	
190160	7068	THRB	0004	THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	THRB, GLN340HIS	121918688
190160	7068	THRB	0005	THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL RECESSIVE	THRB, THR337DEL	121918689
190160	7068	THRB	0006	THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	THRB, ALA317THR	121918690
190160	7068	THRB	0007	THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	THRB, GLY332ARG	28999969
190160	7068	THRB	0008	THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	THRB, GLY345VAL	28999970
190160	7068	THRB	0009	THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	THRB, GLY347GLU	28999971
190160	7068	THRB	0010	THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	THRB, MET442VAL	121918691
190160	7068	THRB	0011	THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	THRB, 1-BP INS, 1627C	
190160	7068	THRB	0012	THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	THRB, PRO453THR	28933408
190160	7068	THRB	0013	THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	THRB, LYS443GLU	121918692
190160	7068	THRB	0014	THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	THRB, GLY345SER	121918686
190160	7068	THRB	0015	THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	THRB, ARG320HIS	121918693
190160	7068	THRB	0017	THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	THRB, ALA234THR	121918694
190160	7068	THRB	0018	THYROID HORMONE RESISTANCE, SELECTIVE PITUITARY	THRB, ARG316HIS	121918695
190160	7068	THRB	0019	THYROID HORMONE RESISTANCE, SELECTIVE PITUITARY	THRB, LEU325PHE	
190160	7068	THRB	0021	THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	THRB, ARG320CYS	121918696
190160	7068	THRB	0023	THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT THYROID HORMONE RESISTANCE, SELECTIVE PITUITARY, INCLUDED	THRB, ARG338TRP	121918697
190160	7068	THRB	0024	THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	THRB, ARG438HIS	121918698
190160	7068	THRB	0026	THYROID HORMONE RESISTANCE, GENERALIZED	THRB, MET310THR	121918699
190160	7068	THRB	0027	THYROID HORMONE RESISTANCE, GENERALIZED	THRB, ASP322HIS	121918700
190160	7068	THRB	0029	THYROID HORMONE RESISTANCE, GENERALIZED	THRB, GLY345ASP	
190160	7068	THRB	0030	THYROID HORMONE RESISTANCE, GENERALIZED	THRB, LEU450HIS	121918701
190160	7068	THRB	0031	THYROID HORMONE RESISTANCE, GENERALIZED	THRB, 1-BP INS, 1644C	
190160	7068	THRB	0032	THYROID HORMONE RESISTANCE, GENERALIZED	THRB, PHE459CYS	121918702
190160	7068	THRB	0033	THYROID HORMONE RESISTANCE, SELECTIVE PITUITARY	THRB, ARG320LEU	
190160	7068	THRB	0034	THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	THRB, CYS446ARG	121918703
190160	7068	THRB	0035	THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL RECESSIVE	THRB, VAL458ALA	121918704
190160	7068	THRB	0036	THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	THRB, CYS434TER	121918705
190160	7068	THRB	0037	THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	THRB, ARG243GLN	121918706
190160	7068	THRB	0038	THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	THRB, ARG243TRP	121918707
190160	7068	THRB	0039	THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	THRB, ARG383HIS	121918708
190160	7068	THRB	0040	THYROID HORMONE RESISTANCE, SELECTIVE PITUITARY	THRB, THR337ALA	121918709
190160	7068	THRB	0041	THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	THRB, 1-BP DEL, CODON 438, C	
190160	7068	THRB	0042	THYROID HORMONE RESISTANCE, SELECTIVE PITUITARY	THRB, 1-BP INS, 1590T	
190180	7040	TGFB1	0001	CAMURATI-ENGELMANN DISEASE	TGFB1, CYS225ARG	104894719
190180	7040	TGFB1	0002	CAMURATI-ENGELMANN DISEASE	TGFB1, ARG218HIS	104894720
190180	7040	TGFB1	0003	CAMURATI-ENGELMANN DISEASE	TGFB1, ARG218CYS	104894721
190180	7040	TGFB1	0004	CAMURATI-ENGELMANN DISEASE	TGFB1, TYR81HIS	111033611
190180	7040	TGFB1	0005	CAMURATI-ENGELMANN DISEASE	TGFB1, CYS223ARG	104894722
190180	7040	TGFB1	0006	CAMURATI-ENGELMANN DISEASE	TGFB1, CYS223GLY	104894722
190180	7040	TGFB1	0007	CYSTIC FIBROSIS LUNG DISEASE, MODIFIER OF BREAST CANCER, INVASIVE, SUSCEPTIBILITY TO, INCLUDED	TGFB1, LEU10PRO	
190181	7046	TGFBR1	0001	LOEYS-DIETZ SYNDROME, TYPE 1A	TGFBR1, MET318ARG	121918710
190181	7046	TGFBR1	0002	LOEYS-DIETZ SYNDROME, TYPE 1A	TGFBR1, ASP400GLY	121918711
190181	7046	TGFBR1	0003	LOEYS-DIETZ SYNDROME, TYPE 1A	TGFBR1, THR200ILE	121918712
190181	7046	TGFBR1	0004	LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ SYNDROME, TYPE 2A, INCLUDED	TGFBR1, ARG487PRO	113605875
190181	7046	TGFBR1	0005	LOEYS-DIETZ SYNDROME, TYPE 1A	TGFBR1, SER241LEU	111854391
190181	7046	TGFBR1	0006	LOEYS-DIETZ SYNDROME, TYPE 2A	TGFBR1, ARG487GLN	113605875
190181	7046	TGFBR1	0007	LOEYS-DIETZ SYNDROME, TYPE 2A	TGFBR1, ARG487TRP	111426349
190181	7046	TGFBR1	0008	LOEYS-DIETZ SYNDROME, TYPE 2A	TGFBR1, GLY174VAL	121918713
190181	7046	TGFBR1	0009	MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA, SUSCEPTIBILITY TO	TGFBR1, ASN45SER	
190181	7046	TGFBR1	0010	MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA, SUSCEPTIBILITY TO	TGFBR1, GLY52ARG	
190181	7046	TGFBR1	0011	MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA, SUSCEPTIBILITY TO	TGFBR1, IVS4AS, A-C, -2	
190181	7046	TGFBR1	0012	MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA, SUSCEPTIBILITY TO	TGFBR1, ARG414TER	
190182	7048	TGFBR2	0001	COLON CANCER, HEREDITARY NONPOLYPOSIS, TYPE 6, SOMATIC	TGFBR2, 2-BP INS, 1931GT	
190182	7048	TGFBR2	0002	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 6	TGFBR2, THR315MET	34833812
190182	7048	TGFBR2	0003	ESOPHAGEAL CANCER, SOMATIC	TGFBR2, GLU526GLN	121918714
190182	7048	TGFBR2	0004	LOEYS-DIETZ SYNDROME, TYPE 2B	TGFBR2, GLN508GLN	121918715
190182	7048	TGFBR2	0005	LOEYS-DIETZ SYNDROME, TYPE 2B LOEYS-DIETZ SYNDROME, TYPE 1B, INCLUDED	TGFBR2, LEU308PRO	28934568
190182	7048	TGFBR2	0006	LOEYS-DIETZ SYNDROME, TYPE 2B	TGFBR2, SER449PHE	104893807
190182	7048	TGFBR2	0007	LOEYS-DIETZ SYNDROME, TYPE 2B	TGFBR2, ARG537CYS	104893809
190182	7048	TGFBR2	0008	LOEYS-DIETZ SYNDROME, TYPE 1B	TGFBR2, TYR336ASN	104893812
190182	7048	TGFBR2	0009	LOEYS-DIETZ SYNDROME, TYPE 1B	TGFBR2, ALA355PRO	104893813
190182	7048	TGFBR2	0010	LOEYS-DIETZ SYNDROME, TYPE 1B	TGFBR2, GLY357TRP	104893814
190182	7048	TGFBR2	0011	LOEYS-DIETZ SYNDROME, TYPE 1B COLON CANCER, HEREDITARY NONPOLYPOSIS, TYPE 6, SOMATIC, INCLUDED	TGFBR2, ARG528HIS	104893815
190182	7048	TGFBR2	0012	LOEYS-DIETZ SYNDROME, TYPE 1B	TGFBR2, ARG528CYS	104893810
190182	7048	TGFBR2	0013	LOEYS-DIETZ SYNDROME, TYPE 1B	TGFBR2, IVS1, A-G, -2	
190182	7048	TGFBR2	0014	LOEYS-DIETZ SYNDROME, TYPE 2B	TGFBR2, ARG460CYS	104893811
190182	7048	TGFBR2	0015	LOEYS-DIETZ SYNDROME, TYPE 2B	TGFBR2, ARG460HIS	104893816
190182	7048	TGFBR2	0016	LOEYS-DIETZ SYNDROME, TYPE 1B	TGFBR2, IVS5AS, -2A-G	
190182	7048	TGFBR2	0017	LOEYS-DIETZ SYNDROME, TYPE 2B	TGFBR2, MET425VAL	104893817
190182	7048	TGFBR2	0018	LOEYS-DIETZ SYNDROME, TYPE 2B	TGFBR2, PRO427LEU	104893818
190182	7048	TGFBR2	0019	LOEYS-DIETZ SYNDROME, TYPE 1B	TGFBR2, ARG495TER	104893819
190195	7051	TGM1	0001	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1	TGM1, 1-BP DEL, 4640T	
190195	7051	TGM1	0002	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1, WITH OR WITHOUT BATHING SUIT DISTRIBUTION	TGM1, IVS5, A-G, -2	
190195	7051	TGM1	0003	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1	TGM1, SER42TYR	41295338
190195	7051	TGM1	0004	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1	TGM1, ARG142CYS	121918716
190195	7051	TGM1	0005	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1	TGM1, ARG323GLN	121918717
190195	7051	TGM1	0006	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1	TGM1, ARG141HIS	121918718
190195	7051	TGM1	0007	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1, WITH OR WITHOUT BATHING SUIT DISTRIBUTION	TGM1, ARG142HIS	121918719
190195	7051	TGM1	0008	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1	TGM1, VAL378LEU	121918720
190195	7051	TGM1	0009	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1	TGM1, ARG395LEU	121918721
190195	7051	TGM1	0010	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1, WITH BATHING SUIT DISTRIBUTION	TGM1, VAL382MET	121918722
190195	7051	TGM1	0011	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1	TGM1, ARG388HIS	121918723
190195	7051	TGM1	0012	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1	TGM1, 1-BP DEL, 9008A	
190195	7051	TGM1	0013	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1	TGM1, ASP490GLY	121918724
190195	7051	TGM1	0014	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1	TGM1, GLY278ARG	121918725
190195	7051	TGM1	0015	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1	TGM1, GLY392ASP	121918726
190195	7051	TGM1	0016	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1	TGM1, ARG142PR0	
190195	7051	TGM1	0017	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1	TGM1, ARG286GLN	121918727
190195	7051	TGM1	0018	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1	TGM1, VAL518MET	35312232
190195	7051	TGM1	0019	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1	TGM1, SER160CYS	121918728
190195	7051	TGM1	0020	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1	TGM1, GLY94ASP	121918729
190195	7051	TGM1	0021	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1, WITH BATHING SUIT DISTRIBUTION	TGM1, ASN288THR	121918730
190195	7051	TGM1	0022	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1, WITH BATHING SUIT DISTRIBUTION	TGM1, ARG306TRP	121918731
190195	7051	TGM1	0023	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1	TGM1, GLY217SER	121918732
190195	7051	TGM1	0024	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1	TGM1, 5-BP DEL, NT1303	
190195	7051	TGM1	0025	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1	TGM1, GLN582TER	
190195	7051	TGM1	0026	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1	TGM1, -86C-T	
190195	7051	TGM1	0027	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1	TGM1, ASP101VAL	
190195	7051	TGM1	0028	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1	TGM1, LEU204GLN	
190195	7051	TGM1	0029	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1, WITH BATHING SUIT DISTRIBUTION	TGM1, TYR276ASN	
190195	7051	TGM1	0030	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1, WITH BATHING SUIT DISTRIBUTION	TGM1, ARG126CYS	
190195	7051	TGM1	0031	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1, WITH BATHING SUIT DISTRIBUTION	TGM1, ARG315CYS	
190195	7051	TGM1	0032	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1, WITH BATHING SUIT DISTRIBUTION	TGM1, ARG315HIS	
190195	7051	TGM1	0033	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1, WITH OR WITHOUT BATHING SUIT DISTRIBUTION	TGM1, ARG315LEU	
190195	7051	TGM1	0034	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1	TGM1, VAL359MET	
190195	7051	TGM1	0035	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1	TGM1, ARG396HIS	
190195	7051	TGM1	0036	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1	TGM1, 7-BP DEL, NT1922	
190195	7051	TGM1	0037	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1	TGM1, 1-BP INS, 1331A	
190195	7051	TGM1	0038	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1, WITH OR WITHOUT BATHING SUIT DISTRIBUTION	TGM1, ARG670TER	
190195	7051	TGM1	0039	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1	TGM1, 5-BP DEL, NT1223	
190198	4851	NOTCH1	0001	AORTIC VALVE DISEASE 1	NOTCH1, ARG1108TER	41309764
190198	4851	NOTCH1	0002	AORTIC VALVE DISEASE 1	NOTCH1, 1-BP DEL, NT4515	
190220	7042	TGFB2	0001	LOEYS-DIETZ SYNDROME, TYPE 4	TGFB2, PRO366HIS	
190220	7042	TGFB2	0002	LOEYS-DIETZ SYNDROME, TYPE 4	TGFB2, 15-BP DEL, NT294	
190220	7042	TGFB2	0003	LOEYS-DIETZ SYNDROME, TYPE 4	TGFB2, 5-BP DEL, 1021TACAA	
190220	7042	TGFB2	0004	LOEYS-DIETZ SYNDROME, TYPE 4	TGFB2, CYS229TER	
190230	7043	TGFB3	0001	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA 1	TGFB3, -36G-A, 5-PRIME UTR	
190230	7043	TGFB3	0002	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA 1	TGFB3, 1723C-T, 3-PRIME UTR	
190315	6576	SLC25A1	0001	COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA	SLC25A1, ARG282GLY	
190315	6576	SLC25A1	0002	COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA	SLC25A1, ARG282CYS	
190315	6576	SLC25A1	0003	COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA	SLC25A1, ARG282HIS	
190315	6576	SLC25A1	0004	COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA	SLC25A1, GLY130ASP	
190315	6576	SLC25A1	0005	COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA	SLC25A1, 821C-T	
190315	6576	SLC25A1	0006	COMBINED D-2- AND L-2 -HYDROXYGLUTARIC ACIDURIA	SLC25A1, 10-BP DEL, NT517	
190450	7167	TPI1	0001	TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	TPI1, GLU104ASP	121964845
190450	7167	TPI1	0002	TRIOSEPHOSPHATE ISOMERASE MANCHESTER TPI-MANCHESTER	TPI1, GLY122ARG	121964846
190450	7167	TPI1	0003	TRIOSEPHOSPHATE ISOMERASE DEFICIENCY TPI-HUNGARY	TPI1, PHE240LEU	121964847
190450	7167	TPI1	0004	TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	TPI1, CYS41TYR	121964848
190450	7167	TPI1	0005	TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	TPI1, ILE170VAL	121964849
190450	7167	TPI1	0006	TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	TPI1, GLU145TER	121964850
190990	7169	TPM2	0001	ARTHROGRYPOSIS, DISTAL, TYPE 1	TPM2, ARG91GLY	104894127
190990	7169	TPM2	0002	NEMALINE MYOPATHY 4	TPM2, GLN147PRO	104894128
190990	7169	TPM2	0003	NEMALINE MYOPATHY 4	TPM2, GLU117LYS	104894129
190990	7169	TPM2	0004	ARTHROGRYPOSIS, DISTAL, TYPE 2B	TPM2, ARG133TRP	137853305
190990	7169	TPM2	0005	NEMALINE MYOPATHY 4	TPM2, GLU41LYS	137853306
190990	7169	TPM2	0006	CAP MYOPATHY, TPM2-RELATED	TPM2, 3-BP DEL, 415GAG	
190990	7169	TPM2	0007	CAP MYOPATHY, TPM2-RELATED	TPM2, 3-BP DEL, 384GAA	
190990	7169	TPM2	0008	CAP MYOPATHY, TPM2-RELATED	TPM2, ASN202LYS	137853307
191010	7168	TPM1	0001	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 3	TPM1, GLU180GLY	104894502
191010	7168	TPM1	0002	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 3	TPM1, ASP175ASN	104894503
191010	7168	TPM1	0003	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 3	TPM1, VAL95ALA	104894504
191010	7168	TPM1	0004	CARDIOMYOPATHY, DILATED, 1Y	TPM1, GLU54LYS	104894505
191010	7168	TPM1	0005	CARDIOMYOPATHY, DILATED, 1Y	TPM1, GLU40LYS	104894501
191030	7170	TPM3	0001	NEMALINE MYOPATHY 1	TPM3, MET9ARG	80358247
191030	7170	TPM3	0002	NEMALINE MYOPATHY 1	TPM3, TER286SER	199474720
191030	7170	TPM3	0003	NEMALINE MYOPATHY 1	TPM3, IVS9sk, G-A, -1	113605263
191030	7170	TPM3	0004	NEMALINE MYOPATHY 1	TPM3, GLN32TER	80358248
191030	7170	TPM3	0005	NEMALINE MYOPATHY 1 MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, INCLUDED;; CAP MYOPATHY, TPM3-RELATED, INCLUDED	TPM3, ARG168HIS	121964852
191030	7170	TPM3	0006	NEMALINE MYOPATHY 1	TPM3, 1-BP DEL, 913A	199474719
191030	7170	TPM3	0007	MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION	TPM3, LEU100MET	121964853
191030	7170	TPM3	0008	MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION	TPM3, ARG168GLY	121964854
191030	7170	TPM3	0009	MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION CAP MYOPATHY, TPM3-RELATED, INCLUDED	TPM3, ARG168CYS	
191040	7134	TNNC1	0001	CARDIOMYOPATHY, DILATED, 1Z	TNNC1, GLY159ASP	104893823
191040	7134	TNNC1	0002	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 13	TNNC1, LEU29GLN	
191040	7134	TNNC1	0003	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 13	TNNC1, ALA8VAL	
191040	7134	TNNC1	0004	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 13	TNNC1, CYS84TYR	
191040	7134	TNNC1	0005	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 13	TNNC1, ASP145GLU	
191040	7134	TNNC1	0006	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 13	TNNC1, ALA31SER	
191041	7138	TNNT1	0001	NEMALINE MYOPATHY, 5	TNNT1, GLU180TER	80358249
191043	7136	TNNI2	0001	ARTHROGRYPOSIS, DISTAL, TYPE 2B	TNNI2, ARG174GLN	104894311
191043	7136	TNNI2	0002	ARTHROGRYPOSIS, DISTAL, TYPE 2B	TNNI2, ARG156TER	104894312
191043	7136	TNNI2	0003	ARTHROGRYPOSIS, DISTAL, TYPE 2B	TNNI2, 3-BP DEL, 523AAG	
191043	7136	TNNI2	0004	ARTHROGRYPOSIS, DISTAL, TYPE 2B	TNNI2, 3-BP DEL, 526AAG	199474801
191043	7136	TNNI2	0005	ARTHROGRYPOSIS, DISTAL, TYPE 2B	TNNI2, 3-BP DEL, 496GAG	199474800
191044	7137	TNNI3	0001	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 7	TNNI3, ARG145GLY	104894724
191044	7137	TNNI3	0002	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 7	TNNI3, LYS206GLN	104894725
191044	7137	TNNI3	0003	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 7	TNNI3, PRO82SER	77615401
191044	7137	TNNI3	0004	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 7	TNNI3, ASP196ASN	104894727
191044	7137	TNNI3	0005	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 7 CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1, INCLUDED	TNNI3, ASP190GLY	104894728
191044	7137	TNNI3	0006	CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1	TNNI3, ARG192HIS	104894729
191044	7137	TNNI3	0007	CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1	TNNI3, LYS178GLU	104894730
191044	7137	TNNI3	0008	CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1	TNNI3, ARG145TRP	104894724
191044	7137	TNNI3	0009	CARDIOMYOPATHY, DILATED, 2A	TNNI3, A2V	
191044	7137	TNNI3	0010	CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1	TNNI3, LEU144GLN	121917760
191044	7137	TNNI3	0011	CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1	TNNI3, ALA171THR	121917761
191044	7137	TNNI3	0012	CARDIOMYOPATHY, DILATED, 1FF	TNNI3, LYS36GLN	
191044	7137	TNNI3	0013	CARDIOMYOPATHY, DILATED, 1FF	TNNI3, ASN185LYS	
191044	7137	TNNI3	0014	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 7	TNNI3, GLY203SER	
191044	7137	TNNI3	0015	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 7	TNNI3, 3-BP DEL, LYS183	
191044	7137	TNNI3	0016	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 7	TNNI3, ARG21CYS	
191045	7139	TNNT2	0001	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 2 CARDIOMYOPATHY, DILATED, 1D, INCLUDED;; CARDIOMYOPATHY, FAMILIAL, RESTRICTIVE, 3, INCLUDED	TNNT2, ILE79ASN	121964855
191045	7139	TNNT2	0002	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 2	TNNT2, ARG92GLN	121964856
191045	7139	TNNT2	0003	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 2	TNNT2, IVS15, G-A, +1	
191045	7139	TNNT2	0004	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 2	TNNT2, ARG278CYS	121964857
191045	7139	TNNT2	0005	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 2	TNNT2, PHE110ILE	121964858
191045	7139	TNNT2	0006	CARDIOMYOPATHY, DILATED, 1D	TNNT2, LYS210DEL	121964859
191045	7139	TNNT2	0007	CARDIOMYOPATHY, DILATED, 1D	TNNT2, ARG141TRP	74315379
191045	7139	TNNT2	0008	CARDIOMYOPATHY, DILATED, 1D LEFT VENTRICULAR NONCOMPACTION 6, INCLUDED	TNNT2, ARG131TRP	74315379
191045	7139	TNNT2	0009	CARDIOMYOPATHY, DILATED, 1D	TNNT2, ARG205LEU	121964860
191045	7139	TNNT2	0010	CARDIOMYOPATHY, DILATED, 1D	TNNT2, ASP270ASN	121964861
191045	7139	TNNT2	0011	CARDIOMYOPATHY, FAMILIAL, RESTRICTIVE, 3	TNNT2, 3-BP DEL, 285GGA	
191092	7249	TSC2	0001	TUBEROUS SCLEROSIS 2	TSC2, 1-BP DEL, 5110A	
191092	7249	TSC2	0002	TUBEROUS SCLEROSIS 2	TSC2, 1-BP DEL, 4590C	
191092	7249	TSC2	0003	TUBEROUS SCLEROSIS 2	TSC2, LYS12TER	45512692
191092	7249	TSC2	0004	TUBEROUS SCLEROSIS 2	TSC2, 4-BP INS, 2077TACT	
191092	7249	TSC2	0005	TUBEROUS SCLEROSIS 2	TSC2, ARG505TER	45517179
191092	7249	TSC2	0006	TUBEROUS SCLEROSIS 2 LYMPHANGIOLEIOMYOMATOSIS, SOMATIC, INCLUDED	TSC2, ARG611GLN	28934872
191092	7249	TSC2	0007	TUBEROUS SCLEROSIS 2	TSC2, LEU717ARG	45517214
191092	7249	TSC2	0008	TUBEROUS SCLEROSIS 2	TSC2, GLN478TER	121964862
191092	7249	TSC2	0009	TUBEROUS SCLEROSIS 2	TSC2, PRO1675LEU	45483392
191092	7249	TSC2	0010	LYMPHANGIOLEIOMYOMATOSIS, SOMATIC	TSC2, GLU366TER	45517148
191092	7249	TSC2	0011	TUBEROUS SCLEROSIS 2	TSC2, GLN1503PRO	45516293
191092	7249	TSC2	0012	TUBEROUS SCLEROSIS 2	TSC2, 18-BP DEL, NT5256	
191092	7249	TSC2	0013	TUBEROUS SCLEROSIS 2	TSC2, ARG905GLN	45517259
191092	7249	TSC2	0014	TUBEROUS SCLEROSIS 2	TSC2, ARG905TRP	45517258
191092	7249	TSC2	0015	TUBEROUS SCLEROSIS 2	TSC2, ARG905GLY	45517258
191092	7249	TSC2	0016	TUBEROUS SCLEROSIS 2	TSC2, 4-BP DEL, IVS20, +1	
191092	7249	TSC2	0017	TUBEROUS SCLEROSIS 2	TSC2, TRP441TER	45515894
191160	7124	TNF	0001	TNF RECEPTOR BINDING, ALTERED	TNF, LEU29SER	
191160	7124	TNF	0002	TNF RECEPTOR BINDING, ALTERED	TNF, ARG32TRP	
191160	7124	TNF	0003	MALARIA, CEREBRAL, SUSCEPTIBILITY TO	TNF, -376G-A	
191160	7124	TNF	0004	SEPTIC SHOCK, SUSCEPTIBILITY TO ASTHMA, SUSCEPTIBILITY TO, INCLUDED;; HUMAN IMMUNODEFICIENCY VIRUS DEMENTIA, SUSCEPTIBILITY TO, INCLUDED;; MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, INCLUDED;; PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO, INCLUDED;; SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, INCLUDED;; MALARIA, CEREBRAL, SUSCEPTIBILITY TO, INCLUDED	TNF, -308G-A	
191160	7124	TNF	0005	VASCULAR DEMENTIA, SUSCEPTIBILITY TO ALZHEIMER DISEASE, SUSCEPTIBILITY TO, INCLUDED	TNF, -850C-T	1799724
191160	7124	TNF	0006	ALZHEIMER DISEASE, PROTECTION AGAINST	TNF, -863C-A	
191170	7157	TP53	0001	LI-FRAUMENI SYNDROME 1	TP53, ARG248TRP	121912651
191170	7157	TP53	0002	LI-FRAUMENI SYNDROME 1	TP53, GLU258LYS	121912652
191170	7157	TP53	0003	LI-FRAUMENI SYNDROME 1	TP53, GLY245CYS	
191170	7157	TP53	0004	LI-FRAUMENI SYNDROME 1	TP53, 1-BP DEL, T, CODON 184	121912653
191170	7157	TP53	0005	CODON 72 POLYMORPHISM, (dbSNP rs1042522)	TP53, PRO72ARG	1042522
191170	7157	TP53	0006	HEPATOCELLULAR CARCINOMA, SOMATIC CERVICAL CANCER, SOMATIC, INCLUDED	TP53, ARG249SER	28934571
191170	7157	TP53	0007	HEPATOCELLULAR CARCINOMA, SOMATIC	TP53, VAL157PHE	121912654
191170	7157	TP53	0008	LI-FRAUMENI-LIKE SYNDROME	TP53, CYS242TYR	121912655
191170	7157	TP53	0009	LI-FRAUMENI SYNDROME 1	TP53, GLY245ASP	121912656
191170	7157	TP53	0010	LI-FRAUMENI SYNDROME 1	TP53, ARG248GLN	11540652
191170	7157	TP53	0011	LI-FRAUMENI SYNDROME 1	TP53, MET133THR	28934873
191170	7157	TP53	0012	LI-FRAUMENI SYNDROME 1	TP53, VAL272LEU	121912657
191170	7157	TP53	0013	HEPATOBLASTOMA OSTEOSARCOMA, INCLUDED	TP53, SER241PHE	28934573
191170	7157	TP53	0014	LI-FRAUMENI SYNDROME 1	TP53, 1-BP INS, 151C	
191170	7157	TP53	0015	LI-FRAUMENI SYNDROME 1	TP53, 2-BP DEL, CODONS 209-210	
191170	7157	TP53	0016	LI-FRAUMENI-LIKE SYNDROME	TP53, 1-BP INS, CODONS 71-72	
191170	7157	TP53	0017	LI-FRAUMENI-LIKE SYNDROME	TP53, LYS120TER	121912658
191170	7157	TP53	0018	LI-FRAUMENI-LIKE SYNDROME	TP53, ARG282TRP	28934574
191170	7157	TP53	0019	LI-FRAUMENI-LIKE SYNDROME	TP53, GLY245SER	28934575
191170	7157	TP53	0020	LI-FRAUMENI SYNDROME 1 THYROID CARCINOMA, ANAPLASTIC, SOMATIC, INCLUDED	TP53, ARG273HIS	28934576
191170	7157	TP53	0021	NON-HODGKIN LYMPHOMA COLON CANCER, INCLUDED	TP53, GLY325VAL	121912659
191170	7157	TP53	0023	REMOVED FROM DATABASE .0024 NASOPHARYNGEAL CARCINOMA, SOMATIC	TP53, ARG280THR	
191170	7157	TP53	0025	BREAST CANCER, SOMATIC	TP53, PRO151THR	28934874
191170	7157	TP53	0026	BREAST CANCER, SOMATIC	TP53, PRO151SER	28934874
191170	7157	TP53	0027	PANCREATIC CANCER, SOMATIC	TP53, LEU35PHE	121912661
191170	7157	TP53	0028	LI-FRAUMENI-LIKE SYNDROME	TP53, LEU257GLN	28934577
191170	7157	TP53	0029	LI-FRAUMENI SYNDROME 1	TP53, 1-BP DEL, CODON 257	
191170	7157	TP53	0030	LI-FRAUMENI SYNDROME 1	TP53, ARG175HIS	28934578
191170	7157	TP53	0031	LI-FRAUMENI SYNDROME 1	TP53, LEU344PRO	121912662
191170	7157	TP53	0032	LI-FRAUMENI SYNDROME 1	TP53, ALA138PRO	28934875
191170	7157	TP53	0033	LI-FRAUMENI SYNDROME 1	TP53, 1-BP DEL, CODON 178	
191170	7157	TP53	0034	LI-FRAUMENI SYNDROME 1	TP53, LYS292ILE	121912663
191170	7157	TP53	0035	ADRENOCORTICAL CARCINOMA, PEDIATRIC	TP53, ARG337HIS	121912664
191170	7157	TP53	0036	CHOROID PLEXUS PAPILLOMA OSTEOSARCOMA, INCLUDED	TP53, 7-BP INS, NT13160	
191170	7157	TP53	0037	LI-FRAUMENI SYNDROME 1	TP53, 11-BP DEL/5-BP INS	
191170	7157	TP53	0038	COLORECTAL CANCER	TP53, ALA189VAL	121912665
191170	7157	TP53	0039	LI-FRAUMENI SYNDROME 1	TP53, TYR220SER	121912666
191170	7157	TP53	0040	ADRENOCORTICAL CARCINOMA, PEDIATRIC CHOROID PLEXUS CARCINOMA, INCLUDED	TP53, GLU285VAL	121912667
191170	7157	TP53	0041	BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 7	TP53, A-C, 3-PRIME UTR	
191170	7157	TP53	0042	GLIOMA SUSCEPTIBILITY 1	TP53, ARG181LEU	
191190	7132	TNFRSF1A	0001	PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT	TNFRSF1A, CYS33TYR	104895218
191190	7132	TNFRSF1A	0002	PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT	TNFRSF1A, THR50MET	104895219
191190	7132	TNFRSF1A	0003	PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT	TNFRSF1A, CYS30ARG	104895217
191190	7132	TNFRSF1A	0004	PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT	TNFRSF1A, CYS52PHE	104895220
191190	7132	TNFRSF1A	0005	PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT	TNFRSF1A, CYS88ARG	104895221
191190	7132	TNFRSF1A	0006	PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT	TNFRSF1A, CYS88TYR	104895222
191190	7132	TNFRSF1A	0007	PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT	TNFRSF1A, ARG92PRO	4149584
191190	7132	TNFRSF1A	0008	PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT	TNFRSF1A, CYS30SER	104895223
191190	7132	TNFRSF1A	0009	PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT	TNFRSF1A, CYS33GLY	104895225
191190	7132	TNFRSF1A	0010	PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT	TNFRSF1A, 3-BP DEL, NT211	
191190	7132	TNFRSF1A	0011	PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT	TNFRSF1A, CYS70SER	104895228
191190	7132	TNFRSF1A	0012	PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT	TNFRSF1A, CYS55ALA	
191190	7132	TNFRSF1A	0013	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 5	TNFRSF1A, IVS6, A-G	
191290	7054	TH	0001	SEGAWA SYNDROME, AUTOSOMAL RECESSIVE	TH, GLN412LYS	121917762
191290	7054	TH	0002	SEGAWA SYNDROME, AUTOSOMAL RECESSIVE	TH, LEU236PRO	121917763
191290	7054	TH	0003	SEGAWA SYNDROME, AUTOSOMAL RECESSIVE	TH, ARG233HIS	80338892
191290	7054	TH	0004	SEGAWA SYNDROME, AUTOSOMAL RECESSIVE	TH, ARG337HIS	28934580
191290	7054	TH	0005	SEGAWA SYNDROME, AUTOSOMAL RECESSIVE	TH, THR494MET	45471299
191290	7054	TH	0006	SEGAWA SYNDROME, AUTOSOMAL RECESSIVE	TH, THR276PRO	28934581
191290	7054	TH	0007	SEGAWA SYNDROME, AUTOSOMAL RECESSIVE	TH, THR314MET	121917764
191290	7054	TH	0008	EXTRAPYRAMIDAL MOVEMENT DISORDER	TH, IVS11AS, T-A, -24	
191290	7054	TH	0009	SEGAWA SYNDROME, AUTOSOMAL RECESSIVE	TH, 1-BP DEL, 291C	
191290	7054	TH	0010	SEGAWA SYNDROME, AUTOSOMAL RECESSIVE	TH, -70G-A	
191290	7054	TH	0011	SEGAWA SYNDROME, AUTOSOMAL RECESSIVE	TH, CYS359PHE	121917765
191290	7054	TH	0012	SEGAWA SYNDROME, AUTOSOMAL RECESSIVE	TH, ARG202HIS	
191305	640	BLK	0001	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 11	BLK, ALA71THR	
191305	640	BLK	0002	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 11	BLK, CHR8:11,459,364, T-G	
191305	640	BLK	0003	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 11	BLK, CHR8:11,468,050, C-T	
191305	640	BLK	0004	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 11	BLK, CHR8:11,369,157, G-A	
191305	640	BLK	0005	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 11	BLK, CHR8:11,459,531, G-T	
191306	3791	KDR	0001	HEMANGIOMA, CAPILLARY INFANTILE, SOMATIC	KDR, PRO1147SER	121917766
191306	3791	KDR	0002	HEMANGIOMA, CAPILLARY INFANTILE, SUSCEPTIBILITY TO	KDR, CYS482ARG	34231037
191311	4921	DDR2	0001	SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	DDR2, ARG752CYS	121964863
191311	4921	DDR2	0002	SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	DDR2, ILE726ARG	121964864
191311	4921	DDR2	0003	SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	DDR2, THR713ILE	121964865
191311	4921	DDR2	0004	SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	DDR2, IVS17, G-A, +1	
191315	4914	NTRK1	0001	INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS	NTRK1, 1-BP DEL, 1726C	
191315	4914	NTRK1	0002	INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS	NTRK1, IVSDS, A-C, +3	
191315	4914	NTRK1	0003	INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS	NTRK1, GLY571ARG	121964866
191315	4914	NTRK1	0004	INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS	NTRK1, ARG774PRO	35669708
191315	4914	NTRK1	0005	INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS	NTRK1, GLN9TER, HIS598TYR, AND GLY607VAL	6339
191315	4914	NTRK1	0006	INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS	NTRK1, IVS4, G-C, -1 AND ARG85SER	
191315	4914	NTRK1	0007	INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS	NTRK1, IVS7AS, T-A, -33	
191315	4914	NTRK1	0008	THYROID CARCINOMA, FAMILIAL MEDULLARY	NTRK1, TYR604HIS	6336
191315	4914	NTRK1	0009	THYROID CARCINOMA, FAMILIAL MEDULLARY	NTRK1, VAL613GLY	6339
191315	4914	NTRK1	0010	INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS	NTRK1, 1-BP INS, 1926T	
191315	4914	NTRK1	0011	INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS	NTRK1, PRO689LEU	121964868
191315	4914	NTRK1	0012	INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS	NTRK1, TYR359CYS	121964869
191315	4914	NTRK1	0013	INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS	NTRK1, MET581VAL	121964870
191315	4914	NTRK1	0014	INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS	NTRK1, 2-BP DEL, 207TG	
191329	7385	UQCRC2	0001	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5	UQCRC2, ARG183TRP	
191330	7381	UQCRB	0001	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3	UQCRB, 4-BP DEL, NT338	
191342	7345	UCHL1	0001	PARKINSON DISEASE 5, AUTOSOMAL DOMINANT	UCHL1, ILE93MET	121917767
191342	7345	UCHL1	0002	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	UCHL1, SER18TYR	5030732
191350	1798	DPAGT1	0001	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij	DPAGT1, TYR170CYS	28934876
191350	1798	DPAGT1	0002	MYASTHENIC SYNDROME, CONGENITAL, WITH TUBULAR AGGREGATES 2	DPAGT1, VAL117ILE	
191350	1798	DPAGT1	0003	MYASTHENIC SYNDROME, CONGENITAL, WITH TUBULAR AGGREGATES 2	DPAGT1, MET108ILE	
191350	1798	DPAGT1	0004	MYASTHENIC SYNDROME, CONGENITAL, WITH TUBULAR AGGREGATES 2	DPAGT1, 1-BP DUP, NT699	
191350	1798	DPAGT1	0005	MYASTHENIC SYNDROME, CONGENITAL, WITH TUBULAR AGGREGATES 2	DPAGT1, LEU120MET	
191350	1798	DPAGT1	0006	MYASTHENIC SYNDROME, CONGENITAL, WITH TUBULAR AGGREGATES 2	DPAGT1, VAL264GLY	
191350	1798	DPAGT1	0007	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij	DPAGT1, ILE69ASN	
191350	1798	DPAGT1	0008	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij	DPAGT1, IVS1DS, G-A, +5	
191523	7391	USF1	0001	HYPERLIPIDEMIA, FAMILIAL COMBINED, SUSCEPTIBILITY TO	USF1, USF1S1	3737787
191523	7391	USF1	0002	HYPERLIPIDEMIA, FAMILIAL COMBINED, SUSCEPTIBILITY TO	USF1, USF1S2	2073658
191525	7374	UNG	0001	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 5	UNG, 1-BP DEL, 462C	
191525	7374	UNG	0002	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 5	UNG, 2-BP DEL, 639TA	
191525	7374	UNG	0003	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 5	UNG, PHE251SER	104894380
191525	7374	UNG	0004	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 5	UNG, 2-BP DEL, 497AT	
191740	54658	UGT1A1	0001	CRIGLER-NAJJAR SYNDROME, TYPE I	UGT1A1, 13-BP DEL, EX2	
191740	54658	UGT1A1	0002	CRIGLER-NAJJAR SYNDROME, TYPE I	UGT1A1, SER376PHE	
191740	54658	UGT1A1	0003	CRIGLER-NAJJAR SYNDROME, TYPE I	UGT1A1, GLN331TER	111033539
191740	54658	UGT1A1	0004	CRIGLER-NAJJAR SYNDROME, TYPE I GILBERT SYNDROME, INCLUDED	UGT1A1, ARG341TER	72551349
191740	54658	UGT1A1	0005	CRIGLER-NAJJAR SYNDROME, TYPE II	UGT1A1, GLN331ARG	72551348
191740	54658	UGT1A1	0006	CRIGLER-NAJJAR SYNDROME, TYPE I	UGT1A1, PHE170DEL	
191740	54658	UGT1A1	0008	CRIGLER-NAJJAR SYNDROME, TYPE I	UGT1A1, GLY309GLU	
191740	54658	UGT1A1	0009	CRIGLER-NAJJAR SYNDROME, TYPE I	UGT1A1, CYS1TER	
191740	54658	UGT1A1	0010	GILBERT SYNDROME CRIGLER-NAJJAR SYNDROME, TYPE II, INCLUDED	UGT1A1, PRO229GLN	35350960
191740	54658	UGT1A1	0011	GILBERT SYNDROME CRIGLER-NAJJAR SYNDROME, TYPE II, INCLUDED;; HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL, INCLUDED;; BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1, INCLUDED	UGT1A1, 2-BP INS, TA, TATAA ELEMENT	
191740	54658	UGT1A1	0012	CRIGLER-NAJJAR SYNDROME, TYPE I	UGT1A1, 1-BP INS, 470T	
191740	54658	UGT1A1	0013	CRIGLER-NAJJAR SYNDROME, TYPE I	UGT1A1, IVS1DS, G-C, +1	
191740	54658	UGT1A1	0014	CRIGLER-NAJJAR SYNDROME, TYPE I	UGT1A1, 145C-T	
191740	54658	UGT1A1	0015	CRIGLER-NAJJAR SYNDROME, TYPE I	UGT1A1, IVSAS3, A-G, -2	
191740	54658	UGT1A1	0016	GILBERT SYNDROME HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL, INCLUDED;; BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1, INCLUDED	UGT1A1, GLY71ARG	4148323
191740	54658	UGT1A1	0017	HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL CRIGLER-NAJJAR SYNDROME, TYPE II, INCLUDED	UGT1A1, TYR486ASP	34993780
191740	54658	UGT1A1	0018	HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL	UGT1A1, C-A, -1353	
191740	54658	UGT1A1	0019	CRIGLER-NAJJAR SYNDROME, TYPE I	UGT1A1, GLN357ARG	72551351
191740	54658	UGT1A1	0020	CRIGLER-NAJJAR SYNDROME, TYPE II	UGT1A1, 1-BP DEL, 1223A	
191740	54658	UGT1A1	0021	CRIGLER-NAJJAR SYNDROME, TYPE II	UGT1A1, LEU175GLN	72551341
191740	54658	UGT1A1	0022	CRIGLER-NAJJAR SYNDROME, TYPE II GILBERT SYNDROME, INCLUDED	UGT1A1, ASN400ASP	
191740	54658	UGT1A1	0023	CRIGLER-NAJJAR SYNDROME, TYPE II	UGT1A1, LEU15ARG	111033541
191740	54658	UGT1A1	0024	GILBERT SYNDROME, SUSCEPTIBILITY TO	UGT1A1, -3263T-G	
191740	54658	UGT1A1	0025	BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1	UGT1A1, G-T,	6742078
191840	5328	PLAU	0001	ALZHEIMER DISEASE, LATE-ONSET, SUSCEPTIBILITY TO	PLAU, PRO141LEU	2227564
191840	5328	PLAU	0002	QUEBEC PLATELET DISORDER	PLAU, 78-BP DUP	
191845	7369	UMOD	0001	HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 1	UMOD, 27-BP DEL, NT1966	
191845	7369	UMOD	0002	HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 1	UMOD, CYS148TYR	28934582
191845	7369	UMOD	0003	HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 1	UMOD, CYS217ARG	28934583
191845	7369	UMOD	0004	MEDULLARY CYSTIC KIDNEY DISEASE 2	UMOD, GLY103CYS	28934584
191845	7369	UMOD	0005	HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 1	UMOD, CYS77TYR	121917768
191845	7369	UMOD	0006	HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 1	UMOD, CYS126ARG	121917769
191845	7369	UMOD	0007	HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 1	UMOD, ASN128SER	121917770
191845	7369	UMOD	0008	HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 1	UMOD, CYS255TYR	121917771
191845	7369	UMOD	0009	HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 1	UMOD, CYS300GLY	121917772
191845	7369	UMOD	0010	GLOMERULOCYSTIC KIDNEY DISEASE WITH HYPERURICEMIA AND ISOSTHENURIA	UMOD, CYS315ARG	121917773
191845	7369	UMOD	0011	HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 1	UMOD, VAL273PHE	121917774
191845	7369	UMOD	0012	HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 1	UMOD, CYS217GLY	
192020	7356	SCGB1A1	0001	ASTHMA, SUSCEPTIBILITY TO	SCGB1A1, A38G	
192090	999	CDH1	0001	ENDOMETRIAL CARCINOMA, SOMATIC	CDH1, LEU711VAL	121964871
192090	999	CDH1	0002	ENDOMETRIAL CARCINOMA, SOMATIC GASTRIC CANCER, HEREDITARY DIFFUSE, INCLUDED	CDH1, ALA617THR	33935154
192090	999	CDH1	0003	OVARIAN CANCER, SOMATIC	CDH1, SER838GLY	121964872
192090	999	CDH1	0004	BREAST CANCER, SOMATIC	CDH1, GLU261TER	121964873
192090	999	CDH1	0005	GASTRIC CANCER, HEREDITARY DIFFUSE	CDH1, 1008G-T	
192090	999	CDH1	0006	GASTRIC CANCER, HEREDITARY DIFFUSE	CDH1, 1-BP INS, 2382C	
192090	999	CDH1	0007	GASTRIC CANCER, HEREDITARY DIFFUSE	CDH1, GLN699TER	121964874
192090	999	CDH1	0008	GASTRIC CANCER, HEREDITARY DIFFUSE	CDH1, IVS1AS, A-G, -2	
192090	999	CDH1	0009	GASTRIC CANCER, HEREDITARY DIFFUSE	CDH1, TRP20TER	121964875
192090	999	CDH1	0011	GASTRIC CANCER, HEREDITARY DIFFUSE	CDH1, GLU24TER	121964876
192090	999	CDH1	0012	GASTRIC CANCER, HEREDITARY DIFFUSE	CDH1, ARG598TER	121964877
192090	999	CDH1	0013	GASTRIC CANCER, HEREDITARY DIFFUSE	CDH1, 1-BP INS, 1711G	
192090	999	CDH1	0014	GASTRIC CANCER, HEREDITARY DIFFUSE	CDH1, 1-BP INS, 1588C	
192090	999	CDH1	0015	GASTRIC CANCER, HEREDITARY DIFFUSE	CDH1, ALA634VAL	121964878
192090	999	CDH1	0016	GASTRIC CANCER, HEREDITARY DIFFUSE	CDH1, THR340ALA	116093741
192090	999	CDH1	0017	GASTRIC CANCER, HEREDITARY DIFFUSE	CDH1, VAL832MET	35572355
192090	999	CDH1	0018	PROSTATE CANCER, SUSCEPTIBILITY TO	CDH1, -160C-A	16260
192090	999	CDH1	0019	GASTRIC CANCER, HEREDITARY DIFFUSE, AND CLEFT LIP WITH OR WITHOUT CLEFT PALATE	CDH1, IVS4DS, T-A, +2	
192090	999	CDH1	0020	GASTRIC CANCER, HEREDITARY DIFFUSE, AND CLEFT LIP WITH OR WITHOUT CLEFT PALATE	CDH1, 1137G-A	
192090	999	CDH1	0021	BREAST CANCER	CDH1, 1-BP INS, 517A	
192090	999	CDH1	0022	GASTRIC CANCER, HEREDITARY DIFFUSE	CDH1, 193.6-KB DEL, EX1-2	
192090	999	CDH1	0023	GASTRIC CANCER, HEREDITARY DIFFUSE	CDH1, 828-BP DEL/3-BP INS, EX16	
192132	525	ATP6V1B1	0001	RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE DEAFNESS	ATP6V1B1, ARG31TER	121964879
192132	525	ATP6V1B1	0002	RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE DEAFNESS	ATP6V1B1, 1-BP DEL	
192132	525	ATP6V1B1	0003	RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE DEAFNESS	ATP6V1B1, IVS6DS, G-A, +1	
192132	525	ATP6V1B1	0004	RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE DEAFNESS	ATP6V1B1, LEU81PRO	121964880
192132	525	ATP6V1B1	0005	RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE DEAFNESS	ATP6V1B1, GLY78ARG	121964881
192132	525	ATP6V1B1	0006	RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE DEAFNESS	ATP6V1B1, IVS12DS, G-C, +1	
192240	7422	VEGFA	0001	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 1	VEGFA, -634G-C,	2010963
192240	7422	VEGFA	0002	ATHEROSCLEROSIS, SUSCEPTIBILITY TO ALZHEIMER DISEASE, SUSCEPTIBILITY TO, INCLUDED;; AMYOTROPHIC LATERAL SCLEROSIS IN MALES, SUSCEPTIBILITY TO, INCLUDED	VEGFA, -2578C-A,	699947
192340	551	AVP	0001	DIABETES INSIPIDUS, NEUROHYPOPHYSEAL	AVP, GLY57SER	121964882
192340	551	AVP	0002	DIABETES INSIPIDUS, NEUROHYPOPHYSEAL	AVP, GLY17VAL	121964883
192340	551	AVP	0003	DIABETES INSIPIDUS, NEUROHYPOPHYSEAL	AVP, ALA-1THR	
192340	551	AVP	0004	DIABETES INSIPIDUS, NEUROHYPOPHYSEAL	AVP, 3-BP DEL, NT1824	
192340	551	AVP	0005	DIABETES INSIPIDUS, NEUROHYPOPHYSEAL	AVP, CYS67TER	121964884
192340	551	AVP	0006	DIABETES INSIPIDUS, NEUROHYPOPHYSEAL	AVP, GLY62TRP	121964885
192340	551	AVP	0007	DIABETES INSIPIDUS, NEUROHYPOPHYSEAL	AVP, 1-BP DEL, 227G	
192340	551	AVP	0008	DIABETES INSIPIDUS, NEUROHYPOPHYSEAL	AVP, GLY65VAL	121964886
192340	551	AVP	0009	DIABETES INSIPIDUS, NEUROHYPOPHYSEAL	AVP, ALA-1VAL	
192340	551	AVP	0010	DIABETES INSIPIDUS, NEUROHYPOPHYSEAL	AVP, GLY23VAL	121964887
192340	551	AVP	0011	DIABETES INSIPIDUS, NEUROHYPOPHYSEAL	AVP, GLY23ARG	121964888
192340	551	AVP	0012	DIABETES INSIPIDUS, NEUROHYPOPHYSEAL	AVP, GLU82TER	121964889
192340	551	AVP	0014	DIABETES INSIPIDUS, NEUROHYPOPHYSEAL	AVP, SER56PHE	121964890
192340	551	AVP	0015	DIABETES INSIPIDUS, NEUROHYPOPHYSEAL	AVP, CYS61TYR	121964891
192340	551	AVP	0016	DIABETES INSIPIDUS, NEUROHYPOPHYSEAL, AUTOSOMAL RECESSIVE	AVP, PRO7LEU	121964892
192340	551	AVP	0017	DIABETES INSIPIDUS, NEUROHYPOPHYSEAL	AVP, CYS116GLY	74315383
192340	551	AVP	0018	DIABETES INSIPIDUS, NEUROHYPOPHYSEAL	AVP, TYR2HIS	121964893
192340	551	AVP	0019	DIABETES INSIPIDUS, NEUROHYPOPHYSEAL	AVP, VAL67ALA	28934878
192340	551	AVP	0020	DIABETES INSIPIDUS, NEUROHYPOPHYSEAL	AVP, 3-BP DEL, PHE3DEL	
192977	7436	VLDLR	0001	CEREBELLAR ATAXIA, CONGENITAL, AND MENTAL RETARDATION, AUTOSOMAL RECESSIVE	VLDLR, DEL	
192977	7436	VLDLR	0002	CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH QUADRUPEDAL LOCOMOTION 1	VLDLR, ARG257TER	80338907
192977	7436	VLDLR	0003	CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH QUADRUPEDAL LOCOMOTION 1	VLDLR, 1-BP DEL, 2339T	80338906
192977	7436	VLDLR	0004	CEREBELLAR ATAXIA, CONGENITAL, AND MENTAL RETARDATION, AUTOSOMAL RECESSIVE	VLDLR, ARG448TER	
193060	7431	VIM	0001	CATARACT, PULVERULENT, AUTOSOMAL DOMINANT	VIM, GLU151LYS	121917775
193065	7414	VCL	0001	CARDIOMYOPATHY, DILATED, 1W	VCL, 3-BP DEL, 2862GTT	
193065	7414	VCL	0002	CARDIOMYOPATHY, DILATED, 1W CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 15	VCL, ARG975TRP	121917776
193065	7414	VCL	0003	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 15	VCL, LEU277MET	71579353
194355	7494	XBP1	0001	MAJOR AFFECTIVE DISORDER 7, SUSCEPTIBILITY TO	XBP1, -116C-G	
194648	7700	ZNF141	0001	POLYDACTYLY, POSTAXIAL, TYPE A6 (1 family)	ZNF141, THR474ILE	
209901	582	BBS1	0001	BARDET-BIEDL SYNDROME 1	BBS1, MET390ARG	113624356
209901	582	BBS1	0002	BARDET-BIEDL SYNDROME 1	BBS1, GLU549TER	121917777
209901	582	BBS1	0003	BARDET-BIEDL SYNDROME 1	BBS1, IVS4, G-A, +1	
209901	582	BBS1	0004	BARDET-BIEDL SYNDROME 1	BBS1, 1-BP DEL, 851A	
209901	582	BBS1	0005	BARDET-BIEDL SYNDROME 1	BBS1, LEU518PRO	121917778
209901	582	BBS1	0006	BARDET-BIEDL SYNDROME 7	BBS1, GLU234LYS	35520756
209901	582	BBS1	0007	BARDET-BIEDL SYNDROME 1	BBS1, 1-BP DEL, 1650C	
211100	2523	FUT1	0001	BOMBAY PHENOTYPE	FUT1, TYR316TER	104894686
211100	2523	FUT1	0002	PARA-BOMBAY PHENOTYPE	FUT1, LEU164HIS	104894687
211100	2523	FUT1	0003	PARA-BOMBAY PHENOTYPE	FUT1, GLN276TER	104894688
211100	2523	FUT1	0004	BOMBAY PHENOTYPE	FUT1, LEU242ARG	28934588
217030	3426	CFI	0001	COMPLEMENT FACTOR I DEFICIENCY	CFI, HIS400LEU	121964912
217030	3426	CFI	0002	COMPLEMENT FACTOR I DEFICIENCY	CFI, IVS5DS G-A, -1	
217030	3426	CFI	0003	COMPLEMENT FACTOR I DEFICIENCY	CFI, 2-BP INS, 1205AT	
217030	3426	CFI	0004	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 3	CFI, ARG456TER	121964913
217030	3426	CFI	0005	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 3	CFI, ASP506VAL	121964914
217030	3426	CFI	0006	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 3	CFI, TRP528TER	121964915
217030	3426	CFI	0007	COMPLEMENT FACTOR I DEFICIENCY	CFI, GLY243ASP	121964916
217030	3426	CFI	0008	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 3	CFI, ARG317TRP	121964917
217030	3426	CFI	0009	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 3	CFI, ASP519ASN	121964918
217050	729	C6	0001	C6 A/B POLYMORPHISM	C6, GLU98ALA	121917779
217050	729	C6	0002	C6 DEFICIENCY, SUBTOTAL	C6, IVS15DS, T-C, +2	
217050	729	C6	0003	C6 DEFICIENCY	C6, 1-BP DEL, 879G	
217050	729	C6	0004	C6 DEFICIENCY	C6, 1-BP DEL, 1195C	
217050	729	C6	0005	C6 DEFICIENCY	C6, 1-BP DEL, 1936G	
217050	729	C6	0006	C6 DEFICIENCY	C6, 1-BP DEL, 291C	
217070	730	C7	0001	C7 DEFICIENCY	C7, CYS728TER	121964919
217070	730	C7	0002	C7 DEFICIENCY	C7, 2-BP DEL, 2137TG	
217070	730	C7	0003	C7 DEFICIENCY C7 AND C6 DEFICIENCY, COMBINED SUBTOTAL	C7, ARG499SER	121964920
217070	730	C7	0004	C7 DEFICIENCY	C7, IVS1, G-A, -1	
217070	730	C7	0005	C7 DEFICIENCY	C7, EXON 7-8 DEL	
217070	730	C7	0006	C7 DEFICIENCY	C7, GLY357ARG	121964921
217070	730	C7	0007	C7 DEFICIENCY	C7, 1-BP DEL, 1309A	
217070	730	C7	0008	C7 DEFICIENCY	C7, 2-BP DEL, 1922AG	
217070	730	C7	0009	C7 DEFICIENCY	C7, CYS464TER	121964922
217070	730	C7	0010	C7 DEFICIENCY	C7, 11-BP DEL, NT631	
229000	3818	KLKB1	0001	PREKALLIKREIN DEFICIENCY	KLKB1, ARG94TER	121964949
229000	3818	KLKB1	0002	PREKALLIKREIN DEFICIENCY	KLKB1, TRP383TER	121964950
229000	3818	KLKB1	0003	PREKALLIKREIN DEFICIENCY	KLKB1, CYS529TYR	121964951
229000	3818	KLKB1	0004	PREKALLIKREIN DEFICIENCY	KLKB1, GLY104ARG	121964952
229000	3818	KLKB1	0005	PREKALLIKREIN DEFICIENCY	KLKB1, ASN124SER	3733402
231675	2110	ETFDH	0001	GLUTARIC ACIDEMIA IIC	ETFDH, MET1THR	121964953
231675	2110	ETFDH	0002	GLUTARIC ACIDEMIA IIC	ETFDH, 1-BP DEL, 36A	
231675	2110	ETFDH	0003	GLUTARIC ACIDEMIA IIC	ETFDH, ALA84THR	121964954
231675	2110	ETFDH	0004	GLUTARIC ACIDEMIA IIC	ETFDH, ARG175LEU	121964955
231675	2110	ETFDH	0005	GLUTARIC ACIDEMIA IIC	ETFDH, LEU127HIS	121964956
231675	2110	ETFDH	0006	GLUTARIC ACIDEMIA IIC	ETFDH, ARG175HIS	
231675	2110	ETFDH	0007	GLUTARIC ACIDEMIA IIC, LATE-ONSET	ETFDH, LEU377PRO	
231675	2110	ETFDH	0008	GLUTARIC ACIDEMIA IIC, LATE-ONSET	ETFDH, PRO483LEU	
232000	5095	PCCA	0001	PROPIONIC ACIDEMIA	PCCA, 4-BP DEL, 1824IVS, +3	
232000	5095	PCCA	0002	PROPIONIC ACIDEMIA	PCCA, 9-BP DEL, 1771IVS, -2	
232000	5095	PCCA	0003	PROPIONIC ACIDEMIA	PCCA, 2-BP INS, 1824IVS, +3	
232000	5095	PCCA	0004	PROPIONIC ACIDEMIA	PCCA, ARG288TER	121964957
232000	5095	PCCA	0005	PROPIONIC ACIDEMIA	PCCA, MET348LYS	121964958
232000	5095	PCCA	0006	PROPIONIC ACIDEMIA	PCCA, IVS14, A-G, -1416	
232050	5096	PCCB	0001	PROPIONIC ACIDEMIA	PCCB, ARG412TRP	121964959
232050	5096	PCCB	0002	PROPIONIC ACIDEMIA	PCCB, 8-BP DEL, NT3	
232050	5096	PCCB	0003	PROPIONIC ACIDEMIA	PCCB, 12-BP INS, 14-BP DEL, NT1218	
232050	5096	PCCB	0004	PROPIONIC ACIDEMIA	PCCB, 1-BP INS, 1170T	
232050	5096	PCCB	0005	PROPIONIC ACIDEMIA	PCCB, GLU168LYS	121964960
232050	5096	PCCB	0006	PROPIONIC ACIDEMIA	PCCB, THR428ILE	111033542
232050	5096	PCCB	0007	PROPIONIC ACIDEMIA	PCCB, 3-BP INS, 1540CCC	
232050	5096	PCCB	0008	PROPIONIC ACIDEMIA	PCCB, TYR435CYS	121964961
232050	5096	PCCB	0009	PROPIONIC ACIDEMIA	PCCB, IVS6, A-G, +462	
238300	2731	GLDC	0001	GLYCINE ENCEPHALOPATHY	GLDC, SER564ILE	121964974
238300	2731	GLDC	0002	GLYCINE ENCEPHALOPATHY	GLDC, PHE756DEL	121964975
238300	2731	GLDC	0003	GLYCINE ENCEPHALOPATHY	GLDC, 30-KB DEL	
238300	2731	GLDC	0004	GLYCINE ENCEPHALOPATHY	GLDC, ARG515SER	121964976
238300	2731	GLDC	0005	GLYCINE ENCEPHALOPATHY	GLDC, GLY761ARG	
238300	2731	GLDC	0006	GLYCINE ENCEPHALOPATHY	GLDC, ALA802VAL	121964977
238300	2731	GLDC	0007	GLYCINE ENCEPHALOPATHY	GLDC, MET1THR	121964978
238300	2731	GLDC	0008	GLYCINE ENCEPHALOPATHY	GLDC, ALA389VAL	121964979
238300	2731	GLDC	0009	GLYCINE ENCEPHALOPATHY	GLDC, ARG739HIS	121964980
238300	2731	GLDC	0010	GLYCINE ENCEPHALOPATHY	GLDC, 2607C-A	
238310	275	AMT	0001	GLYCINE ENCEPHALOPATHY	AMT, GLY269ASP	121964981
238310	275	AMT	0002	GLYCINE ENCEPHALOPATHY	AMT, GLY47ARG	121964982
238310	275	AMT	0003	GLYCINE ENCEPHALOPATHY	AMT, HIS42ARG	121964983
238310	275	AMT	0004	GLYCINE ENCEPHALOPATHY	AMT, 1-BP DEL, 183C	
238310	275	AMT	0005	GLYCINE ENCEPHALOPATHY	AMT, ASP276HIS	121964984
238310	275	AMT	0006	GLYCINE ENCEPHALOPATHY	AMT, ARG320HIS	121964985
238310	275	AMT	0007	GLYCINE ENCEPHALOPATHY	AMT, GLN192TER	121964986
238310	275	AMT	0008	GLYCINE ENCEPHALOPATHY	AMT, IVS7, G-A, -1	
238330	2653	GCSH	0001	GLYCINE ENCEPHALOPATHY	GCSH, COMPLEX REARRANGEMENT	
238331	1738	DLD	0001	DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	DLD, LYS72GLU	121964987
238331	1738	DLD	0002	DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	DLD, PRO488LEU	121964988
238331	1738	DLD	0003	DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	DLD, 1-BP INS, 105A	
238331	1738	DLD	0004	DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	DLD, ARG495GLY	121964989
238331	1738	DLD	0006	DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	DLD, GLY229CYS	121964990
238331	1738	DLD	0007	DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	DLD, ILE393THR	121964991
238331	1738	DLD	0008	DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	DLD, IVS9, G-A, +1	
238331	1738	DLD	0009	DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	DLD, GLU375LYS	121964992
238331	1738	DLD	0010	DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	DLD, MET361VAL	121964993
238331	1738	DLD	0011	DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	DLD, ASP479VAL	
238331	1738	DLD	0012	DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	DLD, ARG482GLY	
238331	1738	DLD	0013	DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	DLD, ILE47THR	
243305	27130	INVS	0001	NEPHRONOPHTHISIS 2	INVS, ARG603TER	121964994
243305	27130	INVS	0002	NEPHRONOPHTHISIS 2	INVS, LEU493SER	121964995
243305	27130	INVS	0003	NEPHRONOPHTHISIS 2	INVS, ARG907TER	
243305	27130	INVS	0004	NEPHRONOPHTHISIS 2	INVS, ARG899TER	
243305	27130	INVS	0005	NEPHRONOPHTHISIS 2	INVS, 1-BP DEL, 1453C	
248610	1629	DBT	0001	MAPLE SYRUP URINE DISEASE, CLASSIC, TYPE II	DBT, 124-BP DEL	
248610	1629	DBT	0002	MAPLE SYRUP URINE DISEASE, THIAMINE-RESPONSIVE, TYPE II	DBT, PHE215CYS	121964999
248610	1629	DBT	0003	MAPLE SYRUP URINE DISEASE, THIAMINE-RESPONSIVE, TYPE II	DBT, 17-BP INS	
248610	1629	DBT	0004	MAPLE SYRUP URINE DISEASE, CLASSIC, TYPE II	DBT, 78-BP DEL	
248610	1629	DBT	0005	MAPLE SYRUP URINE DISEASE, INTERMEDIATE, TYPE II	DBT, 126-BP INS	
248610	1629	DBT	0006	MAPLE SYRUP URINE DISEASE, INTERMEDIATE, TYPE II	DBT, TER422LEU	121965000
248610	1629	DBT	0007	MAPLE SYRUP URINE DISEASE, INTERMEDIATE, TYPE II	DBT, ILE37MET	121965001
248610	1629	DBT	0008	MAPLE SYRUP URINE DISEASE, INTERMEDIATE, TYPE II	DBT, GLY323SER	12021720
248610	1629	DBT	0009	MAPLE SYRUP URINE DISEASE, CLASSIC, TYPE II	DBT, 2-BP DEL, 88AT	
248610	1629	DBT	0010	MAPLE SYRUP URINE DISEASE, CLASSIC, TYPE II	DBT, 4.7-KB DEL	
248610	1629	DBT	0011	MAPLE SYRUP URINE DISEASE, THIAMINE-RESPONSIVE, TYPE II	DBT, HIS391ARG	121965002
248610	1629	DBT	0012	MAPLE SYRUP URINE DISEASE, CLASSIC, TYPE II	DBT, SER133TER	121965003
248611	594	BCKDHB	0001	MAPLE SYRUP URINE DISEASE, CLASSIC, TYPE IB	BCKDHB, 11-BP DEL	
248611	594	BCKDHB	0002	MAPLE SYRUP URINE DISEASE, CLASSIC, TYPE IB	BCKDHB, ARG183PRO	79761867
248611	594	BCKDHB	0003	MAPLE SYRUP URINE DISEASE, CLASSIC, TYPE IB	BCKDHB, HIS156TYR	121965004
248611	594	BCKDHB	0004	MAPLE SYRUP URINE DISEASE, CLASSIC, TYPE IB	BCKHDB, VAL69GLY	121965005
248611	594	BCKDHB	0005	MAPLE SYRUP URINE DISEASE, CLASSIC, TYPE IB	BCKHDB, 4-BP DEL, IVS9	
248611	594	BCKDHB	0006	MAPLE SYRUP URINE DISEASE, CLASSIC, TYPE IB	BCKHDB, 8-BP INS, NT1109	
251170	4598	MVK	0001	MEVALONIC ACIDURIA	MVK, ASN301THR	121917789
251170	4598	MVK	0002	HYPER-IgD SYNDROME	MVK, VAL377ILE	28934897
251170	4598	MVK	0003	HYPER-IgD SYNDROME MEVALONIC ACIDURIA, INCLUDED	MVK, HIS20PRO	104895295
251170	4598	MVK	0004	HYPER-IgD SYNDROME MEVALONIC ACIDURIA, INCLUDED	MVK, ILE268THR	104895304
251170	4598	MVK	0005	HYPER-IgD SYNDROME	MVK, PRO165LEU	121917790
251170	4598	MVK	0006	MEVALONIC ACIDURIA	MVK, ALA334THR	104895317
251170	4598	MVK	0007	MEVALONIC ACIDURIA	MVK, VAL310MET	104895319
251170	4598	MVK	0008	MEVALONIC ACIDURIA	MVK, 19-BP DEL	
251170	4598	MVK	0009	POROKERATOSIS 3, DISSEMINATED SUPERFICIAL ACTINIC TYPE	MVK, LEU255PRO	
251170	4598	MVK	0010	HYPER-IgD SYNDROME MEVALONIC ACIDURIA, INCLUDED;; POROKERATOSIS 3, DISSEMINATED SUPERFICIAL ACTINIC TYPE, INCLUDED	MVK, GLY202ARG	
251170	4598	MVK	0011	HYPER-IgD SYNDROME	MVK, PRO167LEU	
251170	4598	MVK	0012	MEVALONIC ACIDURIA INCLUDED	MVK, 1-BP INS, 417C	
251170	4598	MVK	0013	POROKERATOSIS 3, DISSEMINATED SUPERFICIAL ACTINIC TYPE	MVK, LEU41PRO	
251170	4598	MVK	0014	POROKERATOSIS 3, DISSEMINATED SUPERFICIAL ACTINIC TYPE	MVK, IVS10DS, T-C, +2	
251170	4598	MVK	0015	POROKERATOSIS 3, DISSEMINATED SUPERFICIAL ACTINIC TYPE	MVK, PHE364SER	
252800	3425	IDUA	0001	HURLER SYNDROME	IDUA, TRP402TER	121965019
252800	3425	IDUA	0002	HURLER SYNDROME	IDUA, GLN70TER	121965020
252800	3425	IDUA	0003	HURLER SYNDROME	IDUA, PRO533ARG	121965021
252800	3425	IDUA	0004	SCHEIE SYNDROME	IDUA, IVS5AS, G-A, -7	
252800	3425	IDUA	0005	HURLER SYNDROME	IDUA, GLY409ARG AND TER654CYS	11934801
252800	3425	IDUA	0006	HURLER SYNDROME	IDUA, TYR64TER	121965022
252800	3425	IDUA	0007	HURLER SYNDROME	IDUA, GLN310TER	121965023
252800	3425	IDUA	0008	HURLER SYNDROME	IDUA, THR366PRO	121965024
252800	3425	IDUA	0009	HURLER SYNDROME	IDUA, 1-BP DEL, 1702G	
252800	3425	IDUA	0010	HURLER SYNDROME	IDUA, ARG621TER	121965025
252800	3425	IDUA	0011	SCHEIE SYNDROME	IDUA, ARG492PRO	121965026
252800	3425	IDUA	0012	HURLER-SCHEIE SYNDROME	IDUA, LEU490PRO	121965027
252800	3425	IDUA	0013	HURLER-SCHEIE SYNDROME	IDUA, TER654GLY	121965028
252800	3425	IDUA	0014	HURLER SYNDROME	IDUA, 5-BP INS, NT704	
252800	3425	IDUA	0015	HURLER-SCHEIE SYNDROME	IDUA, ARG89GLN	121965029
252800	3425	IDUA	0016	IDUA PSEUDODEFICIENCY	IDUA, ALA300THR	121965030
252800	3425	IDUA	0017	HURLER-SCHEIE SYNDROME	IDUA, ARG619GLY	121965031
252800	3425	IDUA	0018	HURLER-SCHEIE SYNDROME	IDUA, THR364MET	121965032
252800	3425	IDUA	0019	HURLER-SCHEIE SYNDROME	IDUA, IVS2AS, C-G, -3	
252800	3425	IDUA	0020	HURLER-SCHEIE SYNDROME HURLER SYNDROME, INCLUDED	IDUA, LEU346ARG	121965033
264900	2160	F11	0001	FACTOR XI DEFICIENCY	F11, IVS14DS, G-A, +1	
264900	2160	F11	0002	FACTOR XI DEFICIENCY	F11, GLU117TER	121965063
264900	2160	F11	0003	FACTOR XI DEFICIENCY	F11, PHE283LEU	121965064
264900	2160	F11	0004	FACTOR XI DEFICIENCY	F11, IVS9AS, A-G, -2	
264900	2160	F11	0005	FACTOR XI DEFICIENCY	F11, IVS5DS, G-C, +5	
264900	2160	F11	0006	FACTOR XI DEFICIENCY	F11, PHE442VAL	121965065
264900	2160	F11	0007	FACTOR XI DEFICIENCY	F11, CYS128TER	121965066
264900	2160	F11	0008	FACTOR XI DEFICIENCY	F11, THR386ASN	121965067
264900	2160	F11	0009	FACTOR XI DEFICIENCY	F11, ARG308CYS	28934608
264900	2160	F11	0010	FACTOR XI DEFICIENCY	F11, ALA412VAL	121965068
264900	2160	F11	0011	FACTOR XI DEFICIENCY	F11, SER576ARG	28934609
264900	2160	F11	0012	FACTOR XI DEFICIENCY	F11, CYS38ARG	121965069
264900	2160	F11	0013	FACTOR XI DEFICIENCY	F11, LYS252ILE	121965070
264900	2160	F11	0014	FACTOR XI DEFICIENCY	F11, GLY400VAL	121965071
264900	2160	F11	0015	FACTOR XI DEFICIENCY	F11, TRP569SER	121965072
264900	2160	F11	0016	FACTOR XI DEFICIENCY	F11, DEL	
274180	6916	TBXAS1	0001	GHOSAL HEMATODIAPHYSEAL SYNDROME	TBXAS1, LEU488PRO	199422114
274180	6916	TBXAS1	0002	GHOSAL HEMATODIAPHYSEAL SYNDROME	TBXAS1, LEU83PRO	140005285
274180	6916	TBXAS1	0003	GHOSAL HEMATODIAPHYSEAL SYNDROME	TBXAS1, GLY482TRP	199422116
274180	6916	TBXAS1	0004	GHOSAL HEMATODIAPHYSEAL SYNDROME	TBXAS1, ARG413GLU	199422117
276000	5644	PRSS1	0001	PANCREATITIS, HEREDITARY	PRSS1, ARG122HIS, 365G-A	111033565
276000	5644	PRSS1	0002	PANCREATITIS, HEREDITARY	PRSS1, ASN29ILE	111033566
276000	5644	PRSS1	0003	PANCREATITIS, HEREDITARY	PRSS1, LYS23ARG	111033567
276000	5644	PRSS1	0005	PANCREATITIS, HEREDITARY	PRSS1, 3-BP DEL	
276000	5644	PRSS1	0006	PANCREATITIS, HEREDITARY	PRSS1, GLU79LYS	111033564
276000	5644	PRSS1	0007	PANCREATITIS, HEREDITARY	PRSS1, ASN54SER	144422014
276000	5644	PRSS1	0008	PANCREATITIS, HEREDITARY	PRSS1, ARG122HIS, 365GC-AT	
276000	5644	PRSS1	0009	PANCREATITIS, HEREDITARY	PRSS1, ARG122CYS	111033568
276000	5644	PRSS1	0010	PANCREATITIS, HEREDITARY	PRSS1, TRIPLICATION	
276000	5644	PRSS1	0011	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	PRSS1, ALA121THR	199422123
276000	5644	PRSS1	0012	PANCREATITIS, HEREDITARY	PRSS1, ARG116CYS	
276903	4647	MYO7A	0001	USHER SYNDROME, TYPE IB	MYO7A, ARG150TER	121965079
276903	4647	MYO7A	0002	USHER SYNDROME, TYPE IB	MYO7A, GLN234TER	41298133
276903	4647	MYO7A	0003	USHER SYNDROME, TYPE IB	MYO7A, 6-BP DEL, EX3	
276903	4647	MYO7A	0004	USHER SYNDROME, TYPE IB	MYO7A, ARG212HIS	28934610
276903	4647	MYO7A	0005	USHER SYNDROME, TYPE IB	MYO7A, ARG212CYS	121965080
276903	4647	MYO7A	0006	USHER SYNDROME, TYPE IB	MYO7A, ARG302HIS	41298135
276903	4647	MYO7A	0007	DEAFNESS, AUTOSOMAL RECESSIVE 2	MYO7A, ARG244PRO	121965081
276903	4647	MYO7A	0008	DEAFNESS, AUTOSOMAL RECESSIVE 2	MYO7A, IVS3AS, A-G, -2	
276903	4647	MYO7A	0009	DEAFNESS, AUTOSOMAL RECESSIVE 2	MYO7A, 1-BP INS, EX28	
276903	4647	MYO7A	0010	DEAFNESS, AUTOSOMAL RECESSIVE 2 USHER SYNDROME, TYPE IB, INCLUDED	MYO7A, MET599ILE	121965082
276903	4647	MYO7A	0011	DEAFNESS, AUTOSOMAL DOMINANT 11	MYO7A, 9-BP DEL, EX22	
276903	4647	MYO7A	0012	USHER SYNDROME, TYPE IB	MYO7A, CYS628TER	121965083
276903	4647	MYO7A	0013	USHER SYNDROME, TYPE IB	MYO7A, CYS31TER	35689081
276903	4647	MYO7A	0014	VARIANT OF UNKNOWN SIGNIFICANCE	MYO7A, 1-BP DEL AND LEU1087PRO	
276903	4647	MYO7A	0015	DEAFNESS, AUTOSOMAL DOMINANT 11	MYO7A, ASN458ILE	121965084
276903	4647	MYO7A	0016	USHER SYNDROME, TYPE IB	MYO7A, ARG666TER	121965085
276903	4647	MYO7A	0017	USHER SYNDROME, TYPE IB	MYO7A, IVS27AS, G-C, -1	
276903	4647	MYO7A	0018	DEAFNESS, AUTOSOMAL RECESSIVE 2	MYO7A, 3-BP DEL, 5146GAG	
276903	4647	MYO7A	0019	DEAFNESS, AUTOSOMAL DOMINANT 11	MYO7A, ASP218ASN	
276903	4647	MYO7A	0020	DEAFNESS, AUTOSOMAL DOMINANT 11	MYO7A, GLY671SER	
276903	4647	MYO7A	0021	DEAFNESS, AUTOSOMAL RECESSIVE 2	MYO7A, ARG395HIS	
300005	4204	MECP2	0001	RETT SYNDROME, ZAPPELLA VARIANT RETT SYNDROME, INCLUDED	MECP2, ARG133CYS	28934904
300005	4204	MECP2	0002	RETT SYNDROME	MECP2, PHE155SER	28934905
300005	4204	MECP2	0003	RETT SYNDROME ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATION, INCLUDED	MECP2, 1-BP DEL, 806G	
300005	4204	MECP2	0004	RETT SYNDROME	MECP2, 44-BP DEL, NT1152	
300005	4204	MECP2	0005	RETT SYNDROME	MECP2, ARG270TER	61750240
300005	4204	MECP2	0006	RETT SYNDROME	MECP2, IVS2, A-G, -2	
300005	4204	MECP2	0007	RETT SYNDROME ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATION, INCLUDED	MECP2, THR158MET	28934906
300005	4204	MECP2	0008	RETT SYNDROME	MECP2, ARG106TRP	28934907
300005	4204	MECP2	0009	MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	MECP2, GLU406TER	61753965
300005	4204	MECP2	0010	RETT SYNDROME	MECP2, 2-BP DEL, 211CC	
300005	4204	MECP2	0011	RETT SYNDROME AUTISM, SUSCEPTIBILITY TO, X-LINKED 3, INCLUDED	MECP2, ARG294TER	61751362
300005	4204	MECP2	0012	RETT SYNDROME, ZAPPELLA VARIANT AUTISM, SUSCEPTIBILITY TO, X-LINKED 3, INCLUDED	MECP2, 41-BP DEL, NT1157	
300005	4204	MECP2	0013	RETT SYNDROME	MECP2, 41-BP DEL, NT1159	
300005	4204	MECP2	0014	RETT SYNDROME, ZAPPELLA VARIANT	MECP2, 44-BP DEL, NT1159	
300005	4204	MECP2	0015	MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	MECP2, ALA140VAL	28934908
300005	4204	MECP2	0016	RETT SYNDROME	MECP2, ARG306CYS	28935468
300005	4204	MECP2	0017	MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	MECP2, GLU137GLY	61748392
300005	4204	MECP2	0018	RETT SYNDROME	MECP2, 1-BP DEL, 76C	
300005	4204	MECP2	0019	RETT SYNDROME	MECP2, 14-BP DUP, NT766	
300005	4204	MECP2	0020	RETT SYNDROME	MECP2, ARG168TER	61748421
300005	4204	MECP2	0021	RETT SYNDROME	MECP2, ARG255TER	61749721
300005	4204	MECP2	0022	MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	MECP2, 240-BP DEL, NT1161	
300005	4204	MECP2	0023	ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATION	MECP2, GLY428SER	61753971
300005	4204	MECP2	0024	RETT SYNDROME, ATYPICAL	MECP2, 52-BP DEL	
300005	4204	MECP2	0025	RETT SYNDROME, ATYPICAL	MECP2, TYR141TER	61748396
300005	4204	MECP2	0026	RETT SYNDROME	MECP2, GLU455TER	104894864
300005	4204	MECP2	0027	RETT SYNDROME	MECP2, LEU100VAL	28935168
300005	4204	MECP2	0028	RETT SYNDROME	MECP2, 11-BP DEL, EX1	
300005	4204	MECP2	0029	RETT SYNDROME	MECP2, 5-BP DUP, EX1	
300005	4204	MECP2	0030	LUBS X-LINKED MENTAL RETARDATION SYNDROME	MECP2, DUP	
300005	4204	MECP2	0031	RETT SYNDROME	MECP2, 1-BP DEL AND 2-BP INS	
300005	4204	MECP2	0032	RETT SYNDROME ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATION, INCLUDED	MECP2, 2-BP DEL, 488GG	
300005	4204	MECP2	0033	MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	MECP2, PRO225LEU	61749715
300005	4204	MECP2	0034	ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATION	MECP2, 32-BP DEL, NT1154	
300005	4204	MECP2	0035	MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	MECP2, PRO322SER	61751449
300005	4204	MECP2	0036	RETT SYNDROME, ZAPPELLA VARIANT	MECP2, PRO152ALA	179363900
300005	4204	MECP2	0037	RETT SYNDROME	MECP2, ALA2VAL	179363901
300005	4204	MECP2	0038	RETT SYNDROME	MECP2, 1-BP DEL, 710G	
300008	1184	CLCN5	0001	DENT DISEASE 1 PROTEINURIA, LOW MOLECULAR WEIGHT, WITH HYPERCALCIURIA AND NEPHROCALCINOSIS, INCLUDED	CLCN5, TRP279TER	
300008	1184	CLCN5	0002	DENT DISEASE 1	CLCN5, ARG648TER	
300008	1184	CLCN5	0003	DENT DISEASE 1	CLCN5, LEU200ARG	
300008	1184	CLCN5	0004	DENT DISEASE 1	CLCN5, SER520PRO	
300008	1184	CLCN5	0005	NEPHROLITHIASIS, X-LINKED RECESSIVE	CLCN5, ARG704TER	
300008	1184	CLCN5	0006	NEPHROLITHIASIS, X-LINKED RECESSIVE	CLCN5, GLY506GLU	
300008	1184	CLCN5	0007	HYPOPHOSPHATEMIC RICKETS, X-LINKED RECESSIVE	CLCN5, SER244LEU	
300008	1184	CLCN5	0008	PROTEINURIA, LOW MOLECULAR WEIGHT, WITH HYPERCALCIURIA AND NEPHROCALCINOSIS	CLCN5, TRP343TER	151340627
300008	1184	CLCN5	0009	PROTEINURIA, LOW MOLECULAR WEIGHT, WITH HYPERCALCIURIA AND NEPHROCALCINOSIS	CLCN5, 1-BP DEL, 2085C	
300008	1184	CLCN5	0010	PROTEINURIA, LOW MOLECULAR WEIGHT, WITH HYPERCALCIURIA AND NEPHROCALCINOSIS	CLCN5, ARG280PRO	
300008	1184	CLCN5	0011	NEPHROLITHIASIS, X-LINKED RECESSIVE	CLCN5, GLY57VAL	
300008	1184	CLCN5	0012	DENT DISEASE 1	CLCN5, ALU INS, EX11	
300008	1184	CLCN5	0013	DENT DISEASE 1	CLCN5, GLY260VAL	
300008	1184	CLCN5	0014	DENT DISEASE 1	CLCN5, IVS8DS, G-T, +1	
300011	538	ATP7A	0001	MENKES DISEASE, MILD	ATP7A, IVSXDS, A-T, +3	
300011	538	ATP7A	0002	OCCIPITAL HORN SYNDROME	ATP7A, IVSAS, 2642A-G, -2	
300011	538	ATP7A	0003	OCCIPITAL HORN SYNDROME	ATP7A, SER637LEU	
300011	538	ATP7A	0004	OCCIPITAL HORN SYNDROME	ATP7A, 8-BP DEL, NT1552	
300011	538	ATP7A	0005	MENKES DISEASE	ATP7A, ARG980TER	72554649
300011	538	ATP7A	0006	OCCIPITAL HORN SYNDROME	ATP7A, IVS6DS, T-A, +6	
300011	538	ATP7A	0007	MENKES DISEASE	ATP7A, IVS6DS, G-A, +1	
300011	538	ATP7A	0008	OCCIPITAL HORN SYNDROME	ATP7A, 1-BP DEL, 4497G	
300011	538	ATP7A	0009	MENKES DISEASE	ATP7A, GLY1019ASP	72554652
300011	538	ATP7A	0010	MENKES DISEASE, COPPER-REPLACEMENT RESPONSIVE	ATP7A, EX8 DEL	
300011	538	ATP7A	0011	MENKES DISEASE	ATP7A, 8-BP DEL, NT408	
300011	538	ATP7A	0012	MENKES DISEASE	ATP7A, EX3-4 DEL	
300011	538	ATP7A	0013	OCCIPITAL HORN SYNDROME	ATP7A, ASN1304SER	
300011	538	ATP7A	0014	MENKES DISEASE	ATP7A, ARG201TER	
300011	538	ATP7A	0015	SPINAL MUSCULAR ATROPHY, DISTAL, X-LINKED 3	ATP7A, THR994ILE	
300011	538	ATP7A	0016	SPINAL MUSCULAR ATROPHY, DISTAL, X-LINKED 3	ATP7A, PRO1386SER	
300013	8260	NAA10	0001	OGDEN SYNDROME	NAA10, SER37PRO	
300014	492	ATP2B3	0001	SPINOCEREBELLAR ATAXIA, X-LINKED 1	ATP2B3, GLY1107ASP	
300017	2316	FLNA	0001	HETEROTOPIA, PERIVENTRICULAR NODULAR, X-LINKED DOMINANT	FLNA, GLN182TER	137853310
300017	2316	FLNA	0002	HETEROTOPIA, PERIVENTRICULAR NODULAR, X-LINKED DOMINANT	FLNA, IVS4DS, T-C, +2	
300017	2316	FLNA	0003	HETEROTOPIA, PERIVENTRICULAR NODULAR, X-LINKED DOMINANT	FLNA, IVS3AS, C-G, -3	
300017	2316	FLNA	0004	HETEROTOPIA, PERIVENTRICULAR NODULAR, X-LINKED DOMINANT	FLNA, IVS2DS, G-A, +1	
300017	2316	FLNA	0005	HETEROTOPIA, PERIVENTRICULAR NODULAR, X-LINKED DOMINANT	FLNA, 5-BP DEL, NT287	
300017	2316	FLNA	0006	HETEROTOPIA, PERIVENTRICULAR NODULAR, X-LINKED DOMINANT	FLNA, LEU656PHE	137853311
300017	2316	FLNA	0007	HETEROTOPIA, PERIVENTRICULAR NODULAR, X-LINKED DOMINANT	FLNA, 5915C-G	
300017	2316	FLNA	0008	HETEROTOPIA, PERIVENTRICULAR NODULAR, X-LINKED DOMINANT	FLNA, GLU82VAL	28935169
300017	2316	FLNA	0009	OTOPALATODIGITAL SYNDROME, TYPE I	FLNA, PRO207LEU	28935469
300017	2316	FLNA	0010	OTOPALATODIGITAL SYNDROME, TYPE II	FLNA, GLU254LYS	28935470
300017	2316	FLNA	0011	FRONTOMETAPHYSEAL DYSPLASIA	FLNA, ASP1159ALA	28935471
300017	2316	FLNA	0012	MELNICK-NEEDLES SYNDROME	FLNA, ALA1188THR	28935472
300017	2316	FLNA	0013	MELNICK-NEEDLES SYNDROME	FLNA, SER1199LEU	28935473
300017	2316	FLNA	0014	HETEROTOPIA, PERIVENTRICULAR NODULAR, X-LINKED, WITH FRONTOMETAPHYSEAL DYSPLASIA	FLNA, 7315C-A	
300017	2316	FLNA	0015	FRONTOMETAPHYSEAL DYSPLASIA	FLNA, SER1186LEU	137853312
300017	2316	FLNA	0016	OTOPALATODIGITAL SPECTRUM DISORDER	FLNA, 9-BP DEL, NT4904	
300017	2316	FLNA	0017	HETEROTOPIA, PERIVENTRICULAR, EHLERS-DANLOS VARIANT	FLNA, 1-BP DEL, 2762G	
300017	2316	FLNA	0018	HETEROTOPIA, PERIVENTRICULAR, EHLERS-DANLOS VARIANT	FLNA, 1-BP DEL, 4147G	
300017	2316	FLNA	0019	HETEROTOPIA, PERIVENTRICULAR, EHLERS-DANLOS VARIANT	FLNA, ALA39GLY	137853313
300017	2316	FLNA	0020	OTOPALATODIGITAL SYNDROME, TYPE I	FLNA, ASP203TYR	137853314
300017	2316	FLNA	0021	HETEROTOPIA, PERIVENTRICULAR, EHLERS-DANLOS VARIANT	FLNA, ALA128VAL	137853315
300017	2316	FLNA	0022	OTOPALATODIGITAL SPECTRUM DISORDER	FLNA, GLY1728CYS	137853316
300017	2316	FLNA	0024	HETEROTOPIA, PERIVENTRICULAR NODULAR, X-LINKED DOMINANT	FLNA, 1923C-T	
300017	2316	FLNA	0025	INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	FLNA, 2-BP DEL, 65AC	80338840
300017	2316	FLNA	0026	OTOPALATODIGITAL SYNDROME, TYPE I OTOPALATODIGITAL SYNDROME, TYPE II, INCLUDED	FLNA, ARG196TRP	137853317
300017	2316	FLNA	0027	OTOPALATODIGITAL SYNDROME, TYPE II	FLNA, CYS210PHE	137853318
300017	2316	FLNA	0028	FG SYNDROME 2	FLNA, PRO1291LEU	137853319
300017	2316	FLNA	0029	TERMINAL OSSEOUS DYSPLASIA	FLNA, 5217G-A, 48-BP DEL	
300017	2316	FLNA	0030	CARDIAC VALVULAR DYSPLASIA, X-LINKED	FLNA, PRO637GLN	
300017	2316	FLNA	0031	CARDIAC VALVULAR DYSPLASIA, X-LINKED	FLNA, GLY288ARG	
300017	2316	FLNA	0032	CARDIAC VALVULAR DYSPLASIA, X-LINKED	FLNA, VAL711ASP	
300017	2316	FLNA	0033	CARDIAC VALVULAR DYSPLASIA, X-LINKED	FLNA, 1,944-BP DEL	
300017	2316	FLNA	0034	HETEROTOPIA, PERIVENTRICULAR NODULAR, X-LINKED DOMINANT	FLNA, TRP2632TER	
300017	2316	FLNA	0035	CONGENITAL SHORT BOWEL SYNDROME	FLNA, 2-BP DEL, 16TC	
300019	3054	HCFC1	0001	MENTAL RETARDATION, X-LINKED 3	HCFC1, 455A-G	
300019	3054	HCFC1	0002	MENTAL RETARDATION, X-LINKED 3	HCFC1, SER225ASN	
300032	546	ATRX	0001	ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED	ATRX, HIS750ARG	122445093
300032	546	ATRX	0002	ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED	ATRX, CYS755ARG	122445094
300032	546	ATRX	0003	ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED	ATRX, LYS792ASN	122445095
300032	546	ATRX	0004	ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED	ATRX, ASN1002SER	45439799
300032	546	ATRX	0005	ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED	ATRX, ASP1177VAL	122445096
300032	546	ATRX	0006	ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED	ATRX, TYR1226HIS	122445097
300032	546	ATRX	0007	ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED	ATRX, TYR1305CYS	122445098
300032	546	ATRX	0008	ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED	ATRX, ARG1528TER	122445099
300032	546	ATRX	0009	ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED	ATRX, GLU1530TER	122445100
300032	546	ATRX	0010	ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED	ATRX, IVSAS, T-A, -10	
300032	546	ATRX	0011	MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED	ATRX, ARG1272GLN	122445101
300032	546	ATRX	0012	MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED	ATRX, PRO852SER	122445102
300032	546	ATRX	0013	ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED	ATRX, 751A-G	
300032	546	ATRX	0014	ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED	ATRX, PRO73ALA	122445103
300032	546	ATRX	0015	ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED	ATRX, ARG129CYS	
300032	546	ATRX	0016	ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED	ATRX, ARG1742LYS	122445104
300032	546	ATRX	0017	MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED	ATRX, IVS34, A-G, -2	
300032	546	ATRX	0018	ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED	ATRX, ARG246CYS	122445105
300032	546	ATRX	0019	ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED	ATRX, THR1621MET	122445106
300032	546	ATRX	0020	ALPHA-THALASSEMIA MYELODYSPLASIA SYNDROME, SOMATIC	ATRX, IVS1DS, G-A, +1	
300032	546	ATRX	0021	ALPHA-THALASSEMIA MYELODYSPLASIA SYNDROME, SOMATIC	ATRX, SER79TER	122445107
300032	546	ATRX	0022	MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED	ATRX, ARG37TER	122445108
300032	546	ATRX	0023	MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED	ATRX, LEU409SER	122445109
300032	546	ATRX	0024	MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED	ATRX, ILE2052THR	122445110
300032	546	ATRX	0025	MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED	ATRX, CYS220TYR	122445111
300032	546	ATRX	0026	MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED	ATRX, ARG2271GLY	122445112
300034	186	AGTR2	0001	MENTAL RETARDATION, X-LINKED 88	AGTR2, GLY21VAL	
300034	186	AGTR2	0002	MENTAL RETARDATION, X-LINKED 88	AGTR2, 1-BP DEL, 395T	
300034	186	AGTR2	0003	MENTAL RETARDATION, X-LINKED 88	AGTR2, ARG324GLN	35474657
300034	186	AGTR2	0004	MENTAL RETARDATION, X-LINKED 88	AGTR2, ILE337VAL	
300034	186	AGTR2	0006	MENTAL RETARDATION, X-LINKED 88	AGTR2, ILE53PHE	
300035	1947	EFNB1	0001	CRANIOFRONTONASAL SYNDROME	EFNB1, EX2-5DEL	
300035	1947	EFNB1	0002	CRANIOFRONTONASAL SYNDROME	EFNB1, THR111ILE	104894796
300035	1947	EFNB1	0003	CRANIOFRONTONASAL SYNDROME	EFNB1, PRO54LEU	104894801
300035	1947	EFNB1	0004	CRANIOFRONTONASAL SYNDROME	EFNB1, GLY151SER	28936069
300035	1947	EFNB1	0005	CRANIOFRONTONASAL SYNDROME	EFNB1, GLY151VAL	28936070
300035	1947	EFNB1	0006	CRANIOFRONTONASAL SYNDROME	EFNB1, MET158VAL	28936071
300035	1947	EFNB1	0007	CRANIOFRONTONASAL SYNDROME	EFNB1, MET158ILE	28935170
300035	1947	EFNB1	0008	CRANIOFRONTONASAL SYNDROME	EFNB1, TRP37GLY	104894802
300035	1947	EFNB1	0009	CRANIOFRONTONASAL SYNDROME	EFNB1, TRP37TER	104894803
300035	1947	EFNB1	0010	CRANIOFRONTONASAL SYNDROME	EFNB1, ARG66TER	104894804
300036	6535	SLC6A8	0001	CREATINE DEFICIENCY SYNDROME, X-LINKED	SLC6A8, ARG514TER	122453113
300036	6535	SLC6A8	0002	CREATINE DEFICIENCY SYNDROME, X-LINKED	SLC6A8, GLY381ARG	122453114
300036	6535	SLC6A8	0003	CREATINE DEFICIENCY SYNDROME, X-LINKED	SLC6A8, 3-BP DEL, 1221TTC	80338740
300036	6535	SLC6A8	0004	CREATINE DEFICIENCY SYNDROME, X-LINKED	SLC6A8, 1-BP INS, 950A	
300036	6535	SLC6A8	0005	CREATINE DEFICIENCY SYNDROME, X-LINKED	SLC6A8, GLY87ARG	122453115
300036	6535	SLC6A8	0006	CREATINE DEFICIENCY SYNDROME, X-LINKED	SLC6A8, IVS1AS, A-G, -2	
300036	6535	SLC6A8	0007	CREATINE DEFICIENCY SYNDROME, X-LINKED	SLC6A8, CYS337TRP	122453116
300036	6535	SLC6A8	0008	CREATINE DEFICIENCY SYNDROME, X-LINKED	SLC6A8, GLY132VAL	122453117
300036	6535	SLC6A8	0009	CREATINE DEFICIENCY SYNDROME, X-LINKED	SLC6A8, CYS491TRP	122453118
300036	6535	SLC6A8	0010	CREATINE DEFICIENCY SYNDROME, X-LINKED	SLC6A8, 3-BP DEL, 1006AAC	
300037	2719	GPC3	0001	SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	GPC3, 13-BP DEL, NT391	
300037	2719	GPC3	0002	SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	GPC3, EX7DEL	
300037	2719	GPC3	0003	SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	GPC3, TRP296ARG	104894854
300037	2719	GPC3	0004	SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	GPC3, IVS5, G-T, +1	
300037	2719	GPC3	0005	SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	GPC3, ARG199TER	104894855
300037	2719	GPC3	0006	WILMS TUMOR, SOMATIC	GPC3, HIS558TYR	122453119
300037	2719	GPC3	0007	WILMS TUMOR, SOMATIC	GPC3, ALA1902THR	122453120
300037	2719	GPC3	0008	SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	GPC3, EX6DEL	
300037	2719	GPC3	0009	SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	GPC3, IVS2, G-A, +1	
300037	2719	GPC3	0010	SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	GPC3, ARG387TER	122453121
300037	2719	GPC3	0011	SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	GPC3, GLY556ARG	
300039	5456	POU3F4	0001	DEAFNESS, X-LINKED 2	POU3F4, LEU298TER	
300039	5456	POU3F4	0002	DEAFNESS, X-LINKED 2	POU3F4, ASP215TER	
300039	5456	POU3F4	0003	DEAFNESS, X-LINKED 2	POU3F4, LYS202TER	104894920
300039	5456	POU3F4	0004	DEAFNESS, X-LINKED 2	POU3F4, LEU317TRP	104894921
300039	5456	POU3F4	0005	DEAFNESS, X-LINKED 2	POU3F4, LYS334GLU	104894922
300039	5456	POU3F4	0006	DEAFNESS, X-LINKED 2	POU3F4, 4-BP DEL	
300039	5456	POU3F4	0007	DEAFNESS, X-LINKED 2	POU3F4, C935T, ALA-VAL	
300039	5456	POU3F4	0008	DEAFNESS, X-LINKED 2	POU3F4, ARG330SER	104894923
300039	5456	POU3F4	0009	DEAFNESS, X-LINKED 2	POU3F4, ARG323GLY	104894924
300039	5456	POU3F4	0010	DEAFNESS, X-LINKED 2	POU3F4, 1-BP DEL, 1069A	
300039	5456	POU3F4	0011	DEAFNESS, X-LINKED 2	POU3F4, 1-BP DUP, 950T	
300040	8243	SMC1A	0001	CORNELIA DE LANGE SYNDROME 2	SMC1A, 3-BP DEL, 2493CCA	
300040	8243	SMC1A	0002	CORNELIA DE LANGE SYNDROME 2	SMC1A, GLU493ALA	122454122
300040	8243	SMC1A	0003	CORNELIA DE LANGE SYNDROME 2	SMC1A, 15-BP DEL, NT173	
300040	8243	SMC1A	0004	CORNELIA DE LANGE SYNDROME 2	SMC1A, ARG496HIS	122454123
300040	8243	SMC1A	0005	CORNELIA DE LANGE SYNDROME 2	SMC1A, ILE784THR	
300040	8243	SMC1A	0006	CORNELIA DE LANGE SYNDROME 2	SMC1A, 8.152-KB DEL	
300056	3052	HCCS	0001	MICROPHTHALMIA, SYNDROMIC, 7	HCCS, 8.6-KB DEL	
300056	3052	HCCS	0002	MICROPHTHALMIA, SYNDROMIC, 7	HCCS, ARG197TER	
300056	3052	HCCS	0003	MICROPHTHALMIA, SYNDROMIC, 7	HCCS, ARG217CYS	
300075	6197	RPS6KA3	0001	COFFIN-LOWRY SYNDROME	RPS6KA3, 187-BP DEL, NT406	
300075	6197	RPS6KA3	0002	COFFIN-LOWRY SYNDROME	RPS6KA3, GLY75VAL	122454124
300075	6197	RPS6KA3	0003	COFFIN-LOWRY SYNDROME	RPS6KA3, SER227ALA	122454125
300075	6197	RPS6KA3	0004	COFFIN-LOWRY SYNDROME	RPS6KA3, VAL82PHE	122454126
300075	6197	RPS6KA3	0005	COFFIN-LOWRY SYNDROME	RPS6KA3, IVS4AS, G-C, -1	
300075	6197	RPS6KA3	0006	COFFIN-LOWRY SYNDROME	RPS6KA3, ARG114TRP	122454127
300075	6197	RPS6KA3	0007	COFFIN-LOWRY SYNDROME	RPS6KA3, 2-BP DEL, 451AG	
300075	6197	RPS6KA3	0008	COFFIN-LOWRY SYNDROME	RPS6KA3, GLN689TER	122454128
300075	6197	RPS6KA3	0009	COFFIN-LOWRY SYNDROME	RPS6KA3, ARG729GLN	28935171
300075	6197	RPS6KA3	0010	MENTAL RETARDATION, X-LINKED 19	RPS6KA3, ARG383TRP	122454129
300075	6197	RPS6KA3	0011	COFFIN-LOWRY SYNDROME, MILD	RPS6KA3, ILE189LYS	122454130
300075	6197	RPS6KA3	0012	COFFIN-LOWRY SYNDROME	RPS6KA3, IVS6, A-G, +3	
300075	6197	RPS6KA3	0013	COFFIN-LOWRY SYNDROME	RPS6KA3, IVS5, A-G, -11	
300075	6197	RPS6KA3	0014	COFFIN-LOWRY SYNDROME	RPS6KA3, 1-BP DEL, 2144C	
300075	6197	RPS6KA3	0015	COFFIN-LOWRY SYNDROME	RPS6KA3, IVS12, A-G, -2	
300075	6197	RPS6KA3	0016	COFFIN-LOWRY SYNDROME	RPS6KA3, IVS3, L1 INS, -8	
300075	6197	RPS6KA3	0017	COFFIN-LOWRY SYNDROME	RPS6KA3, PHE268SER	122454131
300075	6197	RPS6KA3	0018	COFFIN-LOWRY SYNDROME	RPS6KA3, 3-BP DEL, 1428TAT	
300075	6197	RPS6KA3	0019	COFFIN-LOWRY SYNDROME	RPS6KA3, DUP EXONS 17-20, NT1959	
300075	6197	RPS6KA3	0020	MENTAL RETARDATION, X-LINKED 19	RPS6KA3, 3-BP DEL, 454GGA	
300075	6197	RPS6KA3	0021	MENTAL RETARDATION, X-LINKED 19	RPS6KA3, THR115SER	
300078	4694	NDUFA1	0001	MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFA1, GLY8ARG	104894884
300078	4694	NDUFA1	0002	MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFA1, ARG37SER	104894885
300078	4694	NDUFA1	0003	MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFA1, GLY32ARG	
300079	331	XIAP	0001	LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2	XIAP, 1-BP DEL, 291C	
300079	331	XIAP	0002	LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2	XIAP, GLU118TER	104894764
300079	331	XIAP	0003	LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2	XIAP, 2606-BP DEL	
300079	331	XIAP	0004	LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2	XIAP, CYS203TYR	
300080	8241	RBM10	0001	TARP SYNDROME	RBM10, 1-BP INS, 1893A	
300080	8241	RBM10	0002	TARP SYNDROME	RBM10, TRP412TER	
300095	6567	SLC16A2	0001	ALLAN-HERNDON-DUDLEY SYNDROME	SLC16A2, LEU512PRO	104894931
300095	6567	SLC16A2	0002	ALLAN-HERNDON-DUDLEY SYNDROME	SLC16A2, 1-BP DEL, 1212T	
300095	6567	SLC16A2	0003	ALLAN-HERNDON-DUDLEY SYNDROME	SLC16A2, ALA224VAL	104894936
300095	6567	SLC16A2	0004	ALLAN-HERNDON-DUDLEY SYNDROME	SLC16A2, EX1DEL	
300095	6567	SLC16A2	0005	ALLAN-HERNDON-DUDLEY SYNDROME	SLC16A2, LEU397PRO	122455132
300095	6567	SLC16A2	0006	ALLAN-HERNDON-DUDLEY SYNDROME	SLC16A2, 2.4-KB DEL	
300095	6567	SLC16A2	0007	ALLAN-HERNDON-DUDLEY SYNDROME	SLC16A2, LEU568PRO	104894938
300095	6567	SLC16A2	0008	ALLAN-HERNDON-DUDLEY SYNDROME	SLC16A2, LEU434TRP	104894939
300095	6567	SLC16A2	0009	ALLAN-HERNDON-DUDLEY SYNDROME	SLC16A2, SER448TER	104894940
300095	6567	SLC16A2	0010	ALLAN-HERNDON-DUDLEY SYNDROME	SLC16A2, PHE230 DEL	113994164
300095	6567	SLC16A2	0011	ALLAN-HERNDON-DUDLEY SYNDROME	SLC16A2, 1-BP DEL, 1834C	113994166
300096	7102	TSPAN7	0001	MENTAL RETARDATION, X-LINKED 58	TSPAN7, GLY218TER	104894950
300096	7102	TSPAN7	0002	MENTAL RETARDATION, X-LINKED 58	TSPAN7, PRO172HIS	104894951
300096	7102	TSPAN7	0003	MENTAL RETARDATION, X-LINKED 58	TSPAN7, 2-BP DEL, 564GT	
300104	2664	GDI1	0001	MENTAL RETARDATION, X-LINKED 41	GDI1, LEU92PRO	121434607
300104	2664	GDI1	0002	MENTAL RETARDATION, X-LINKED 41	GDI1, ARG70TER	121434608
300104	2664	GDI1	0003	MENTAL RETARDATION, X-LINKED 41	GDI1, ARG423PRO	121434609
300104	2664	GDI1	0004	MENTAL RETARDATION, X-LINKED 41	GDI1, 2-BP DEL, 1185AG	
300105	6611	SMS	0001	MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	SMS, IVS4AS, G-A, +5	
300105	6611	SMS	0002	MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	SMS, GLY56SER	121434610
300105	6611	SMS	0003	MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	SMS, VAL132GLY	
300108	1730	DIAPH2	0001	PREMATURE OVARIAN FAILURE 2A	DIAPH2, INTRONIC BREAKPOINT	
300110	778	CACNA1F	0001	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A	CACNA1F, GLY369ASP	122456133
300110	778	CACNA1F	0002	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A	CACNA1F, ARG958TER	122456134
300110	778	CACNA1F	0003	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A	CACNA1F, 1-BP INS, 991C	
300110	778	CACNA1F	0004	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A	CACNA1F, ARG830TER	122456135
300110	778	CACNA1F	0005	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A	CACNA1F, 1-BP DEL, 4548C	
300110	778	CACNA1F	0006	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A, SEVERE	CACNA1F, ILE745THR	122456136
300110	778	CACNA1F	0007	CONE-ROD DYSTROPHY, X-LINKED, 3	CACNA1F, 5-BP DEL/3-BP INS	
300110	778	CACNA1F	0008	ALAND ISLAND EYE DISEASE	CACNA1F, 425-BP DEL	
300120	10046	MAMLD1	0001	HYPOSPADIAS 2, X-LINKED	MAMLD1, GLU124TER	121909493
300120	10046	MAMLD1	0002	HYPOSPADIAS 2, X-LINKED	MAMLD1, GLN197TER	121909494
300120	10046	MAMLD1	0003	HYPOSPADIAS 2, X-LINKED	MAMLD1, ARG653TER	121909495
300121	1641	DCX	0001	LISSENCEPHALY, X-LINKED, 1 SUBCORTICAL LAMINAR HETEROTOPIA, X-LINKED, INCLUDED	DCX, ASP62ASN	104894779
300121	1641	DCX	0002	LISSENCEPHALY, X-LINKED, 1 SUBCORTICAL LAMINAR HETEROTOPIA, X-LINKED, INCLUDED	DCX, ARG192TRP	104894780
300121	1641	DCX	0003	LISSENCEPHALY, X-LINKED, 1 SUBCORTICAL LAMINAR HETEROTOPIA, X-LINKED, INCLUDED	DCX, TYR125HIS	104894781
300121	1641	DCX	0004	SUBCORTICAL LAMINAR HETEROTOPIA, X-LINKED	DCX, IVS4, G-A, +1	
300121	1641	DCX	0005	LISSENCEPHALY, X-LINKED, 1 SUBCORTICAL LAMINAR HETEROTOPIA, X-LINKED, INCLUDED	DCX, ARG59LEU	122457137
300121	1641	DCX	0006	LISSENCEPHALY, X-LINKED, 1 SUBCORTICAL LAMINAR HETEROTOPIA, X-LINKED, INCLUDED	DCX, THR203ARG	104894782
300121	1641	DCX	0007	LISSENCEPHALY, X-LINKED, 1 SUBCORTICAL LAMINAR HETEROTOPIA, X-LINKED, INCLUDED	DCX, SER47ARG	104894783
300121	1641	DCX	0008	SUBCORTICAL LAMINAR HETEROTOPIA, X-LINKED	DCX, 2-BP INS, 36AG	
300121	1641	DCX	0009	SUBCORTICAL LAMINAR HETEROTOPIA, X-LINKED	DCX, 2-BP DEL, 684CT	
300121	1641	DCX	0010	SUBCORTICAL LAMINAR HETEROTOPIA, X-LINKED	DCX, 2-BP DEL, 691CT	
300121	1641	DCX	0011	SUBCORTICAL LAMINAR HETEROTOPIA, X-LINKED	DCX, ARG78HIS	104894784
300121	1641	DCX	0012	SUBCORTICAL LAMINAR HETEROTOPIA, X-LINKED	DCX, ARG89GLY	104894785
300121	1641	DCX	0013	LISSENCEPHALY, X-LINKED, 1 SUBCORTICAL LAMINAR HETEROTOPIA, X-LINKED, INCLUDED	DCX, ARG196HIS	56030372
300121	1641	DCX	0014	LISSENCEPHALY, X-LINKED, 1 SUBCORTICAL LAMINAR HETEROTOPIA, X-LINKED, INCLUDED	DCX, ALA71SER	104894786
300126	1736	DKC1	0001	DYSKERATOSIS CONGENITA, X-LINKED	DKC1, PHE36VAL	121912293
300126	1736	DKC1	0002	DYSKERATOSIS CONGENITA, X-LINKED	DKC1, LEU37DEL	137854489
300126	1736	DKC1	0003	DYSKERATOSIS CONGENITA, X-LINKED	DKC1, PRO40ARG	121912292
300126	1736	DKC1	0004	DYSKERATOSIS CONGENITA, X-LINKED	DKC1, LEU72TYR	137854490
300126	1736	DKC1	0005	DYSKERATOSIS CONGENITA, X-LINKED	DKC1, GLY402GLU	121912295
300126	1736	DKC1	0006	DYSKERATOSIS CONGENITA, X-LINKED HOYERAAL-HREIDARSSON SYNDROME, INCLUDED	DKC1, ALA353VAL	121912288
300126	1736	DKC1	0007	DYSKERATOSIS CONGENITA, X-LINKED	DKC1, 2-KB DEL	
300126	1736	DKC1	0008	DYSKERATOSIS CONGENITA, X-LINKED	DKC1, -141C-G	
300126	1736	DKC1	0009	DYSKERATOSIS CONGENITA, X-LINKED	DKC1, IVS1, C-G, +592	
300126	1736	DKC1	0010	HOYERAAL-HREIDARSSON SYNDROME DYSKERATOSIS CONGENITA, X-LINKED, INCLUDED	DKC1, THR49MET	121912304
300126	1736	DKC1	0011	HOYERAAL-HREIDARSSON SYNDROME	DKC1, SER121GLY	121912305
300126	1736	DKC1	0012	HOYERAAL-HREIDARSSON SYNDROME	DKC1, ILE38THR	28936072
300126	1736	DKC1	0013	DYSKERATOSIS CONGENITA, X-LINKED	DKC1, GLN31LYS	137854491
300126	1736	DKC1	0014	DYSKERATOSIS CONGENITA, X-LINKED	DKC1, THR357ALA	137854492
300126	1736	DKC1	0015	HOYERAAL-HREIDARSSON SYNDROME	DKC1, IVS12DS, G-A, +1	
300127	4983	OPHN1	0001	MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	OPHN1, 1-BP DEL, NT1578	
300127	4983	OPHN1	0002	MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	OPHN1, 8-BP DUP	
300127	4983	OPHN1	0003	MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	OPHN1, GLN62TER	137854493
300127	4983	OPHN1	0004	MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	OPHN1, 17.6-KB DEL	
300127	4983	OPHN1	0005	MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	OPHN1, 2-BP DEL, NT642	
300127	4983	OPHN1	0006	MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	OPHN1, 68-KB DEL	
300128	7403	KDM6A	0001	KABUKI SYNDROME 2	KDM6A, EX5-9DEL	
300128	7403	KDM6A	0002	KABUKI SYNDROME 2	KDM6A, TRP1239TER	
300128	7403	KDM6A	0003	KABUKI SYNDROME 2	KDM6A, ARG519TER	
300128	7403	KDM6A	0004	KABUKI SYNDROME 2	KDM6A, 3-BP DEL, 3354TCT	
300135	22	ABCB7	0001	ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	ABCB7, ILE400MET	72554634
300135	22	ABCB7	0002	ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	ABCB7, GLU433LYS	80356714
300135	22	ABCB7	0003	ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	ABCB7, VAL411LEU	80356713
300137	3547	IGSF1	0001	HYPOTHYROIDISM, CENTRAL, AND TESTICULAR ENLARGEMENT	IGSF1, 27-BP DEL, NT2137	
300137	3547	IGSF1	0002	HYPOTHYROIDISM, CENTRAL, AND TESTICULAR ENLARGEMENT	IGSF1, TRP977TER	
300137	3547	IGSF1	0003	HYPOTHYROIDISM, CENTRAL, AND TESTICULAR ENLARGEMENT	IGSF1, 1-BP DEL, 2248G	
300137	3547	IGSF1	0004	HYPOTHYROIDISM, CENTRAL, AND TESTICULAR ENLARGEMENT	IGSF1, SER863PHE	
300137	3547	IGSF1	0005	HYPOTHYROIDISM, CENTRAL, AND TESTICULAR ENLARGEMENT	IGSF1, 1-BP DUP, 3596T	
300138	1193	CLIC2	0001	MENTAL RETARDATION, X-LINKED, SYNDROMIC 32	CLIC2, HIS101GLN	
300139	3476	IGBP1	0001	CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA, AND MICROGNATHIA	IGBP1, -57delT and -55T-A, 5-PRIME UTR	
300142	5063	PAK3	0001	MENTAL RETARDATION, X-LINKED 30	PAK3, ARG419TER	121434611
300142	5063	PAK3	0002	MENTAL RETARDATION, X-LINKED 30	PAK3, ARG67CYS	121434612
300142	5063	PAK3	0003	MENTAL RETARDATION, X-LINKED 30	PAK3, ALA365GLU	121434613
300142	5063	PAK3	0004	MENTAL RETARDATION, X-LINKED 30	PAK3, TRP446SER	121434614
300142	5063	PAK3	0005	MENTAL RETARDATION, X-LINKED 30	PAK3, IVS6DS, A-G, +4	
300144	2747	GLUD2	0001	PARKINSON DISEASE, AGE OF ONSET, MODIFIER	GLUD2, SER445ALA	
300145	7512	XPNPEP2	0001	ANGIOEDEMA INDUCED BY ACE INHIBITORS, SUSCEPTIBILITY TO	XPNPEP2, -2399C/A	3788853
300157	2182	ACSL4	0001	MENTAL RETARDATION, X-LINKED 63	ACSL4, ARG529SER	122458138
300157	2182	ACSL4	0002	MENTAL RETARDATION, X-LINKED 63	ACSL4, IVS10, A-G, -2	
300157	2182	ACSL4	0003	MENTAL RETARDATION, X-LINKED 68	ACSL4, PRO375LEU	122458139
300163	2273	FHL1	0001	SCAPULOPERONEAL MYOPATHY, X-LINKED DOMINANT	FHL1, TRP122SER	122458140
300163	2273	FHL1	0002	MYOPATHY, X-LINKED, WITH POSTURAL MUSCLE ATROPHY	FHL1, CYS224TRP	122458141
300163	2273	FHL1	0003	MYOPATHY, X-LINKED, WITH POSTURAL MUSCLE ATROPHY SCAPULOPERONEAL MYOPATHY, X-LINKED DOMINANT, INCLUDED	FHL1, 3-BP INS, 381ATC	
300163	2273	FHL1	0004	MYOPATHY, REDUCING BODY, X-LINKED, SEVERE EARLY-ONSET	FHL1, HIS123TYR	122458142
300163	2273	FHL1	0005	MYOPATHY, REDUCING BODY, X-LINKED, SEVERE EARLY-ONSET	FHL1, CYS132PHE	122458143
300163	2273	FHL1	0006	MYOPATHY, REDUCING BODY, X-LINKED, CHILDHOOD-ONSET	FHL1, CYS153ARG	122458144
300163	2273	FHL1	0007	MYOPATHY, REDUCING BODY, X-LINKED, CHILDHOOD-ONSET	FHL1, CYS153TYR	122458145
300163	2273	FHL1	0008	MYOPATHY, REDUCING BODY, X-LINKED, SEVERE EARLY-ONSET	FHL1, CYS150TYR	122459146
300163	2273	FHL1	0009	MYOPATHY, REDUCING BODY, X-LINKED, CHILDHOOD-ONSET	FHL1, CYS104ARG	122459147
300163	2273	FHL1	0010	EMERY-DREIFUSS MUSCULAR DYSTROPHY 6	FHL1, TER281GLU	122459148
300163	2273	FHL1	0011	EMERY-DREIFUSS MUSCULAR DYSTROPHY 6	FHL1, CYS209ARG	122459149
300163	2273	FHL1	0012	EMERY-DREIFUSS MUSCULAR DYSTROPHY 6	FHL1, 1-BP INS, NT817	
300163	2273	FHL1	0013	MYOPATHY, X-LINKED, WITH POSTURAL MUSCLE ATROPHY	FHL1, VAL280MET	
300163	2273	FHL1	0014	MYOPATHY, X-LINKED, WITH POSTURAL MUSCLE ATROPHY	FHL1, IVS4DS, G-A, +1	
300163	2273	FHL1	0015	MYOPATHY, REDUCING BODY, X-LINKED, SEVERE EARLY-ONSET	FHL1, HIS123LEU	
300163	2273	FHL1	0016	MYOPATHY, REDUCING BODY, X-LINKED, SEVERE EARLY-ONSET	FHL1, HIS123GLN	
300163	2273	FHL1	0017	MYOPATHY, REDUCING BODY, X-LINKED, CHILDHOOD-ONSET	FHL1, 9-BP DEL, NT451	
300169	9131	AIFM1	0001	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6	AIFM1, 3-BP DEL, 601AGA	
300169	9131	AIFM1	0002	COWCHOCK SYNDROME	AIFM1, GLU493VAL	
300170	8481	OFD1	0001	OROFACIODIGITAL SYNDROME I	OFD1, SER434ARG	122460150
300170	8481	OFD1	0002	OROFACIODIGITAL SYNDROME I	OFD1, 1-BP DEL, 312G	
300170	8481	OFD1	0003	OROFACIODIGITAL SYNDROME I	OFD1, 19-BP DEL, NT294	
300170	8481	OFD1	0004	OROFACIODIGITAL SYNDROME I	OFD1, IVS5AS, T-G, -10	
300170	8481	OFD1	0005	OROFACIODIGITAL SYNDROME I	OFD1, 2-BP INS, 1887AT	
300170	8481	OFD1	0006	OROFACIODIGITAL SYNDROME I	OFD1, 4,094-BP DEL, 14-BP DEL	
300170	8481	OFD1	0007	SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2	OFD1, 4-BP DUP, 2122AAGA	
300170	8481	OFD1	0008	JOUBERT SYNDROME 10	OFD1, 7-BP DEL, NT2841	
300170	8481	OFD1	0009	JOUBERT SYNDROME 10	OFD1, 1-BP DEL, 2767G	
300170	8481	OFD1	0010	JOUBERT SYNDROME 10	OFD1, 18-BP DEL, EX 8	
300172	8573	CASK	0001	MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA	CASK, ARG639TER	137852815
300172	8573	CASK	0002	MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA	CASK, 915G-A, EX9	
300172	8573	CASK	0003	FG SYNDROME 4	CASK, ARG28LEU	137852816
300172	8573	CASK	0004	MENTAL RETARDATION, X-LINKED, WITH NYSTAGMUS	CASK, TYR268HIS	137852817
300172	8573	CASK	0005	MENTAL RETARDATION, X-LINKED, WITH NYSTAGMUS	CASK, ASP710GLY	137852818
300172	8573	CASK	0006	MENTAL RETARDATION, X-LINKED, WITH NYSTAGMUS	CASK, TRP914ARG	137852819
300172	8573	CASK	0007	MENTAL RETARDATION, X-LINKED, WITHOUT NYSTAGMUS	CASK, PRO396SER	137852820
300172	8573	CASK	0008	MENTAL RETARDATION, X-LINKED, WITH NYSTAGMUS	CASK, TYR728CYS	
300172	8573	CASK	0009	MENTAL RETARDATION, X-LINKED, WITH NYSTAGMUS	CASK, IVS25AS, A-T, -2	
300172	8573	CASK	0010	MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA	CASK, ARG106TER	
300172	8573	CASK	0011	MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA	CASK, 100-KB DEL	
300172	8573	CASK	0012	MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA	CASK, GLN547TER	
300180	415	ARSE	0001	CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	ARSE, ARG12SER	122460151
300180	415	ARSE	0002	CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	ARSE, GLY117ARG	122460152
300180	415	ARSE	0003	CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	ARSE, ARG111PRO	122460153
300180	415	ARSE	0004	CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	ARSE, GLY137VAL	80338711
300180	415	ARSE	0005	CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	ARSE, GLY245ARG	122460154
300180	415	ARSE	0006	CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	ARSE, CYS492TYR	122460155
300180	415	ARSE	0007	CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	ARSE, PRO578SER	28935474
300180	415	ARSE	0008	CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	ARSE, TRP581TER	80338714
300188	9968	MED12	0001	OPITZ-KAVEGGIA SYNDROME	MED12, ARG961TRP	80338758
300188	9968	MED12	0002	LUJAN-FRYNS SYNDROME	MED12, ASN1007SER	80338759
300188	9968	MED12	0003	OHDO SYNDROME, X-LINKED	MED12, ARG1148HIS	
300188	9968	MED12	0004	OHDO SYNDROME, X-LINKED	MED12, SER1165PRO	
300188	9968	MED12	0005	OHDO SYNDROME, X-LINKED	MED12, HIS1729ASN	
300189	1741	DLG3	0001	MENTAL RETARDATION, X-LINKED 90	DLG3, IVS6DS, G-A, +5	
300189	1741	DLG3	0002	MENTAL RETARDATION, X-LINKED 90	DLG3, IVS8DS, G-A, +1	
300189	1741	DLG3	0003	MENTAL RETARDATION, X-LINKED 90	DLG3, 1-BP INS, 1325C	
300189	1741	DLG3	0004	MENTAL RETARDATION, X-LINKED 90	DLG3, SER458TER	
300202	6399	TRAPPC2	0001	SPONDYLOEPIPHYSEAL DYSPLASIA TARDA	SEDL, 2-BP DEL, 53TT	
300202	6399	TRAPPC2	0002	SPONDYLOEPIPHYSEAL DYSPLASIA TARDA	SEDL, 2-BP DEL, 191TG	
300202	6399	TRAPPC2	0003	SPONDYLOEPIPHYSEAL DYSPLASIA TARDA	SEDL, 2-BP DEL, 157AT	
300202	6399	TRAPPC2	0004	SPONDYLOEPIPHYSEAL DYSPLASIA TARDA	SEDL, 5-BP DEL, NT267	
300202	6399	TRAPPC2	0005	SPONDYLOEPIPHYSEAL DYSPLASIA TARDA	SEDL, 5-BP DEL, NT271	
300202	6399	TRAPPC2	0006	SPONDYLOEPIPHYSEAL DYSPLASIA TARDA	SEDL, IVS3DS, G-A, +5	
300202	6399	TRAPPC2	0007	SPONDYLOEPIPHYSEAL DYSPLASIA TARDA	SEDL, PHE83SER	104894948
300202	6399	TRAPPC2	0008	SPONDYLOEPIPHYSEAL DYSPLASIA TARDA	SEDL, GLN131TER	122460156
300202	6399	TRAPPC2	0009	SPONDYLOEPIPHYSEAL DYSPLASIA TARDA	SEDL, SER110TER	104894949
300202	6399	TRAPPC2	0010	SPONDYLOEPIPHYSEAL DYSPLASIA TARDA	SEDL, IVS4, T-C, +4	
300202	6399	TRAPPC2	0011	SPONDYLOEPIPHYSEAL DYSPLASIA TARDA	SEDL, 1-BP DEL, 613A	
300203	6792	CDKL5	0001	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2	CDKL5, 1-BP DEL, 183T	
300203	6792	CDKL5	0002	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2	CDKL5, IVSAS13, G-A, -1	
300203	6792	CDKL5	0003	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2	CDKL5, CYS152PHE	122460157
300203	6792	CDKL5	0004	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2	CDKL5, ARG175SER	61749700
300203	6792	CDKL5	0005	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2	CDKL5, 4-BP DEL, 166GAAA	
300203	6792	CDKL5	0006	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2	CDKL5, 2-BP DEL, 2636CT	
300203	6792	CDKL5	0007	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2	CDKL5, GLN834TER	122460158
300203	6792	CDKL5	0008	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2	CDKL5, IVS6AS, G-T, -1	
300203	6792	CDKL5	0009	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2	CDKL5, ALA40VAL	122460159
300203	6792	CDKL5	0010	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2	CDKL5, ILE72THR	62641235
300203	6792	CDKL5	0011	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2	CDKL5, THR288ILE	
300203	6792	CDKL5	0012	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2	CDKL5, CYS291TYR	
300203	6792	CDKL5	0013	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2	CDKL5, 2-BP INS, 903GA	
300203	6792	CDKL5	0014	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2	CDKL5, ARG178PRO	
300205	10682	EBP	0001	CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT	EBP, TRP29TER	104894798
300205	10682	EBP	0002	CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT	EBP, ARG63TER	104894799
300205	10682	EBP	0003	CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT	EBP, GLU80LYS	104894800
300205	10682	EBP	0005	CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT	EBP, IVS3, G-T, +1	
300205	10682	EBP	0007	CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT	EBP, 1-BP DEL, 390A	
300205	10682	EBP	0008	CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT	EBP, 1-BP INS, 586A	
300205	10682	EBP	0009	CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT	EBP, TRP129TER	104894792
300205	10682	EBP	0010	CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT	EBP, GLN175TER	104894793
300205	10682	EBP	0011	CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT	EBP, TRP196TER	104894794
300205	10682	EBP	0012	CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT	EBP, ARG147HIS	28935174
300205	10682	EBP	0013	CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT, ATYPICAL	EBP, LEU18PRO	104894795
300206	11141	IL1RAPL1	0001	MENTAL RETARDATION, X-LINKED 21	IL1RAPL1, TYR459TER	122461160
300206	11141	IL1RAPL1	0002	MENTAL RETARDATION, X-LINKED 21	IL1RAPL1, TRP487TER	122461161
300206	11141	IL1RAPL1	0003	MENTAL RETARDATION, X-LINKED 21	IL1RAPL1, EX2-5DEL	
300206	11141	IL1RAPL1	0004	MENTAL RETARDATION, X-LINKED 21	IL1RAPL1, 730-KB DEL, EX3-7	
300226	23676	SMPX	0001	DEAFNESS, X-LINKED 4	SMPX, GLY59TER	
300226	23676	SMPX	0002	DEAFNESS, X-LINKED 4	SMPX, GLU37TER	
300226	23676	SMPX	0003	DEAFNESS, X-LINKED 4	SMPX, GLU72TER	
300226	23676	SMPX	0004	DEAFNESS, X-LINKED 4	SMPX, 1-BP DEL, 130G	
300226	23676	SMPX	0005	DEAFNESS, X-LINKED 4	SMPX, 1-BP DEL, 99C	
300231	10479	SLC9A6	0001	MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	SLC9A6, 6-BP DEL, NT764	
300231	10479	SLC9A6	0002	MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	SLC9A6, ARG468TER	122461162
300231	10479	SLC9A6	0003	MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	SLC9A6, IVS3, AA-CC	
300231	10479	SLC9A6	0004	MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	SLC9A6, 2-BP DEL	
300231	10479	SLC9A6	0005	MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	SLC9A6, 9-BP DEL, NT1012	
300247	9210	BMP15	0001	OVARIAN DYSGENESIS 2	BMP15, TYR235CYS	104894765
300247	9210	BMP15	0002	PREMATURE OVARIAN FAILURE 4	BMP15, ARG76CYS	104894766
300247	9210	BMP15	0003	PREMATURE OVARIAN FAILURE 4	BMP15, ALA180THR	104894767
300247	9210	BMP15	0004	PREMATURE OVARIAN FAILURE 4	BMP15, GLU211TER	137853320
300247	9210	BMP15	0005	PREMATURE OVARIAN FAILURE 4	BMP15, ARG68TRP	104894763
300247	9210	BMP15	0006	PREMATURE OVARIAN FAILURE 4	BMP15, ALA180THR	
300248	8517	IKBKG	0001	INCONTINENTIA PIGMENTI, TYPE II	IKBKG, EXON 4-10 DEL	
300248	8517	IKBKG	0002	ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH IMMUNODEFICIENCY, OSTEOPETROSIS, AND LYMPHEDEMA	IKBKG, TER420TRP	
300248	8517	IKBKG	0003	INCONTINENTIA PIGMENTI, TYPE II	IKBKG, 10-BP INS, NT127	
300248	8517	IKBKG	0004	INCONTINENTIA PIGMENTI, TYPE II	IKBKG, 1-BP INS, 1110C	
300248	8517	IKBKG	0005	INCONTINENTIA PIGMENTI, TYPE II	IKBKG, MET407VAL	137853322
300248	8517	IKBKG	0006	INCONTINENTIA PIGMENTI, TYPE II	IKBKG, PRO62TER	137853323
300248	8517	IKBKG	0007	ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH IMMUNE DEFICIENCY	IKBKG, GLU391TER	137853324
300248	8517	IKBKG	0008	ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH IMMUNE DEFICIENCY INCONTINENTIA PIGMENTI, TYPE II, ATYPICAL, INCLUDED	IKBKG, 1-BP DUP, 1167C	
300248	8517	IKBKG	0009	ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH IMMUNE DEFICIENCY HYPER-IgM IMMUNODEFICIENCY, X-LINKED, WITH HYPOHIDROTIC ECTODERMAL DYSPLASIA, INCLUDED	IKBKG, CYS417ARG	137853325
300248	8517	IKBKG	0010	ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH IMMUNE DEFICIENCY	IKBKG, CYS417PHE	137853326
300248	8517	IKBKG	0011	HYPER-IgM IMMUNODEFICIENCY, X-LINKED, WITH HYPOHIDROTIC ECTODERMAL DYSPLASIA ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH IMMUNE DEFICIENCY, INCLUDED	IKBKG, ASP406VAL	137853327
300248	8517	IKBKG	0012	INCONTINENTIA PIGMENTI, TYPE II, ATYPICAL	IKBKG, 13-BP DUP, NT1166	
300248	8517	IKBKG	0013	ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH IMMUNE DEFICIENCY	IKBKG, 4.4-KB DUP	
300248	8517	IKBKG	0014	ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH IMMUNE DEFICIENCY	IKBKG, LEU153ARG	137853328
300248	8517	IKBKG	0015	ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH IMMUNE DEFICIENCY	IKBKG, GLN403TER	137853329
300248	8517	IKBKG	0016	ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH IMMUNE DEFICIENCY	IKBKG, IVS6DS, G-A, +5	
300248	8517	IKBKG	0017	ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH IMMUNE DEFICIENCY	IKBKG, 1-BP INS, 1409A	
300248	8517	IKBKG	0018	IMMUNODEFICIENCY, ISOLATED	IKBKG, IVS8, -1, G-A	
300248	8517	IKBKG	0019	IMMUNODEFICIENCY, ISOLATED	IKBKG, 1-BP INS, 110C	
300248	8517	IKBKG	0020	ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH IMMUNE DEFICIENCY	IKBKG, ALA288GLY	137853330
300248	8517	IKBKG	0021	MYCOBACTERIAL DISEASE, SUSCEPTIBILITY TO, X-LINKED, 1	IKBKG, GLU315ALA	137853331
300248	8517	IKBKG	0022	MYCOBACTERIAL DISEASE, SUSCEPTIBILITY TO, X-LINKED, 1	IKBKG, ARG319GLN	137853332
300248	8517	IKBKG	0023	INVASIVE PNEUMOCOCCAL DISEASE, RECURRENT ISOLATED, 2	IKBKG, 518C-G, ARG173GLY	
300256	3028	HSD17B10	0001	17-@BETA-HYDROXYSTEROID DEHYDROGENASE X DEFICIENCY	HSD17B10, ARG130CYS	28935475
300256	3028	HSD17B10	0002	17-@BETA-HYDROXYSTEROID DEHYDROGENASE X DEFICIENCY	HSD17B10, LEU122VAL	28935476
300256	3028	HSD17B10	0003	17-@BETA-HYDROXYSTEROID DEHYDROGENASE X DEFICIENCY	HSD17B10, ASN247SER	122461163
300256	3028	HSD17B10	0004	MENTAL RETARDATION, X-LINKED, SYNDROMIC 10	HSD17B10, ARG192ARG	122462164
300256	3028	HSD17B10	0005	17-@BETA-HYDROXYSTEROID DEHYDROGENASE X DEFICIENCY	HSD17B10, GLU249GLN	62626305
300264	29978	UBQLN2	0001	AMYOTROPHIC LATERAL SCLEROSIS 15, WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA	UBQLN2, PRO497HIS	
300264	29978	UBQLN2	0002	AMYOTROPHIC LATERAL SCLEROSIS 15, WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA	UBQLN2, PRO497SER	
300264	29978	UBQLN2	0003	AMYOTROPHIC LATERAL SCLEROSIS 15, WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA	UBQLN2, PRO506THR	
300264	29978	UBQLN2	0004	AMYOTROPHIC LATERAL SCLEROSIS 15, WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA	UBQLN2, PRO509SER	
300264	29978	UBQLN2	0005	AMYOTROPHIC LATERAL SCLEROSIS 15, WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA	UBQLN2, PRO525SER	
300265	7547	ZIC3	0001	HETEROTAXY, VISCERAL, 1, X-LINKED	ZIC3, THR325MET	122462165
300265	7547	ZIC3	0002	HETEROTAXY, VISCERAL, 1, X-LINKED	ZIC3, CYS270TER	122462166
300265	7547	ZIC3	0003	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 1, X-LINKED	ZIC3, 1741A-T, LYS-TER	
300265	7547	ZIC3	0004	HETEROTAXY, VISCERAL, 1, X-LINKED	ZIC3, GLN249TER	104894960
300265	7547	ZIC3	0005	HETEROTAXY, VISCERAL, 1, X-LINKED	ZIC3, CYS253SER	122463167
300265	7547	ZIC3	0006	HETEROTAXY, VISCERAL, 1, X-LINKED	ZIC3, LYS405GLU	104894962
300265	7547	ZIC3	0007	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 1, X-LINKED	ZIC3, PRO217ALA	104894963
300265	7547	ZIC3	0008	HETEROTAXY, VISCERAL, 1, X-LINKED	ZIC3, 2-BP INS, 1507TT	
300265	7547	ZIC3	0009	HETEROTAXY, VISCERAL, 1, X-LINKED	ZIC3, TRP255GLY	122463168
300265	7547	ZIC3	0010	VACTERL ASSOCIATION, X-LINKED	ZIC3, 6-BP INS	
300267	9459	ARHGEF6	0001	MENTAL RETARDATION, X-LINKED 46	ARHGEF6, IVS1AS, T-C, -11	
300269	55869	HDAC8	0001	WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME	HDAC8, IVS1DS, G-A, +5	
300269	55869	HDAC8	0002	CORNELIA DE LANGE SYNDROME 5	HDAC8, ARG164TER	
300269	55869	HDAC8	0003	CORNELIA DE LANGE SYNDROME 5	HDAC8, HIS180ARG	
300269	55869	HDAC8	0004	CORNELIA DE LANGE SYNDROME 5	HDAC8, THR311MET	
300269	55869	HDAC8	0005	CORNELIA DE LANGE SYNDROME 5	HDAC8, GLY320ARG	
300269	55869	HDAC8	0006	CORNELIA DE LANGE SYNDROME 5	HDAC8, HIS334ARG	
300275	50814	NSDHL	0001	CHILD SYNDROME	NSDHL, ALA105VAL	104894909
300275	50814	NSDHL	0002	CHILD SYNDROME	NSDHL, GLY205SER	104894901
300275	50814	NSDHL	0003	CHILD SYNDROME	NSDHL, GLN210TER	104894902
300275	50814	NSDHL	0004	CHILD SYNDROME	NSDHL, ARG88TER	104894903
300275	50814	NSDHL	0005	CHILD SYNDROME	NSDHL, ALA182PRO	104894904
300275	50814	NSDHL	0006	CHILD SYNDROME	NSDHL, GLU151TER	104894905
300275	50814	NSDHL	0007	CK SYNDROME	NSDHL, 1-BP DUP, 1098T	121909834
300275	50814	NSDHL	0008	CK SYNDROME	NSDHL, 3-BP DEL, 696GAA	121909833
300276	60401	EDA2R	0001	VARIANT OF UNKNOWN SIGNIFICANCE	XEDAR, 1-BP DEL, 252G	
300278	60506	NYX	0001	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1A	NYX, 24-BP DEL	
300278	60506	NYX	0002	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1A	NYX, TRP350TER	62637037
300278	60506	NYX	0003	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1A	NYX, CYS35TER	62637021
300278	60506	NYX	0004	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1A	NYX, ALA187LYS	62637027
300278	60506	NYX	0005	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1A	NYX, ARG94PRO	104894910
300278	60506	NYX	0006	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1A	NYX, ILE101THR	104894911
300292	50943	FOXP3	0001	IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED	FOXP3, ARG397TRP	28935477
300292	50943	FOXP3	0002	IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED	FOXP3, 20-BP DEL, 3-BP INS, NT1290	
300292	50943	FOXP3	0003	IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED	FOXP3, PHE371CYS	122467169
300292	50943	FOXP3	0004	IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED	FOXP3, ALA384THR	122467170
300292	50943	FOXP3	0005	IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED	FOXP3, 2-BP DEL, 1481CT	
300292	50943	FOXP3	0006	IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED	FOXP3, IVS9DS, A-G, +4	
300292	50943	FOXP3	0007	IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED	FOXP3, GLU203DEL	122467171
300292	50943	FOXP3	0008	IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED	FOXP3, 1-BP DEL	
300292	50943	FOXP3	0009	IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED	FOXP3, PHE373ALA	122467172
300292	50943	FOXP3	0010	IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED	FOXP3, PHE324LYS	122467173
300292	50943	FOXP3	0011	IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED	FOXP3, 543C-T	
300292	50943	FOXP3	0012	IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED	FOXP3, MET1ILE	122467174
300292	50943	FOXP3	0013	IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED	FOXP3, PRO367LEU	122467175
300294	51360	MBTPS2	0001	IFAP SYNDROME	MBTPS2, HIS277LEU	122468176
300294	51360	MBTPS2	0002	IFAP SYNDROME	MBTPS2, MET87ILE	122468177
300294	51360	MBTPS2	0003	IFAP SYNDROME WITH BRESHECK SYNDROME	MBTPS2, ARG429HIS	122468178
300294	51360	MBTPS2	0004	IFAP SYNDROME WITH BRESHECK SYNDROME	MBTPS2, PHE475SER	122468179
300294	51360	MBTPS2	0005	IFAP SYNDROME	MBTPS2, TRP226LEU	122468180
300294	51360	MBTPS2	0006	KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, X-LINKED	MBTPS2, ARG508SER	
300298	65109	UPF3B	0001	MENTAL RETARDATION, X-LINKED, SYNDROMIC 14	UPF3B, 4-BP DEL, 674GAAA	
300298	65109	UPF3B	0002	MENTAL RETARDATION, X-LINKED, SYNDROMIC 14	UPF3B, 2-BP DEL, 867AG	
300298	65109	UPF3B	0003	MENTAL RETARDATION, X-LINKED, SYNDROMIC 14	UPF3B, ARG430TER	122468181
300298	65109	UPF3B	0004	MENTAL RETARDATION, X-LINKED, SYNDROMIC 14	UPF3B, TYR160ASP	122468182
300300	695	BTK	0001	AGAMMAGLOBULINEMIA, X-LINKED	BTK, ARG525GLN	128620183
300300	695	BTK	0002	AGAMMAGLOBULINEMIA, X-LINKED	BTK, LYS430GLU	128620184
300300	695	BTK	0003	HYPOAGAMMAGLOBULINEMIA, X-LINKED	BTK, TYR361CYS	28935478
300300	695	BTK	0004	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE III	BTK, IVS17DS, G-A, +5	
300300	695	BTK	0005	AGAMMAGLOBULINEMIA, X-LINKED	BTK, ARG28HIS	128620185
300300	695	BTK	0006	AGAMMAGLOBULINEMIA, X-LINKED	BTK, MET1THR	128620186
300300	695	BTK	0007	HYPOGAMMAGLOBULINEMIA, X-LINKED	BTK, ALA-ASP, 1952C-A	
300300	695	BTK	0008	AGAMMAGLOBULINEMIA, X-LINKED	BTK, ARG13TER	128620187
300300	695	BTK	0009	AGAMMAGLOBULINEMIA, X-LINKED	BTK, GLN15TER	128620188
300300	695	BTK	0010	AGAMMAGLOBULINEMIA, X-LINKED	BTK, THR33PRO	128620189
300300	695	BTK	0011	AGAMMAGLOBULINEMIA, X-LINKED	BTK, 4-BP DEL, CODON 76, GAAA	
300300	695	BTK	0012	AGAMMAGLOBULINEMIA, X-LINKED	BTK, 2-BP DEL, IVS2DS, +3AA	
300300	695	BTK	0013	AGAMMAGLOBULINEMIA, X-LINKED	BTK, IVS4AS, G-C, -1	
300300	695	BTK	0014	AGAMMAGLOBULINEMIA, X-LINKED	BTK, 21-BP INS, NT442	
300300	695	BTK	0015	AGAMMAGLOBULINEMIA, X-LINKED	BTK, VAL113ASP	128621190
300300	695	BTK	0016	AGAMMAGLOBULINEMIA, X-LINKED	BTK, 1-BP DEL, CODON 130, A	
300300	695	BTK	0017	AGAMMAGLOBULINEMIA, X-LINKED	BTK, 1-BP INS, CODON 186, A	
300300	695	BTK	0018	AGAMMAGLOBULINEMIA, X-LINKED	BTK, 8-BP INS, NT721	
300300	695	BTK	0019	AGAMMAGLOBULINEMIA, X-LINKED	BTK, 1-BP DEL, CODON 218, A	
300300	695	BTK	0020	AGAMMAGLOBULINEMIA, X-LINKED	BTK, GLU240TER	128621191
300300	695	BTK	0021	AGAMMAGLOBULINEMIA, X-LINKED	BTK, TRP252TER	128621192
300300	695	BTK	0022	AGAMMAGLOBULINEMIA, X-LINKED	BTK, ARG255TER	128621193
300300	695	BTK	0023	AGAMMAGLOBULINEMIA, X-LINKED	BTK, IVS9DS, G-A, +1	
300300	695	BTK	0024	AGAMMAGLOBULINEMIA, X-LINKED	BTK, 1-BP DEL/3-BP INS, CODON 261	
300300	695	BTK	0025	AGAMMAGLOBULINEMIA, X-LINKED	BTK, ARG288TRP	128621194
300300	695	BTK	0026	AGAMMAGLOBULINEMIA, X-LINKED	BTK, ARG307GLY	128621195
300300	695	BTK	0027	AGAMMAGLOBULINEMIA, X-LINKED	BTK, TYR334SER	128621196
300300	695	BTK	0028	AGAMMAGLOBULINEMIA, X-LINKED	BTK, 1-BP DEL, IVS11DS, +1G	
300300	695	BTK	0029	AGAMMAGLOBULINEMIA, X-LINKED	BTK, IVS12AS, A-T, -2	
300300	695	BTK	0030	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE III	BTK, TYR375TER	128621197
300300	695	BTK	0031	AGAMMAGLOBULINEMIA, X-LINKED	BTK, 16-BP INS, NT1263	
300300	695	BTK	0032	AGAMMAGLOBULINEMIA, X-LINKED	BTK, LEU408PRO	128621198
300300	695	BTK	0033	AGAMMAGLOBULINEMIA, X-LINKED	BTK, TYR425TER	128621199
300300	695	BTK	0034	AGAMMAGLOBULINEMIA, X-LINKED	BTK, CYS502TER	41310709
300300	695	BTK	0035	AGAMMAGLOBULINEMIA, X-LINKED	BTK, CYS506ARG	128621200
300300	695	BTK	0036	AGAMMAGLOBULINEMIA, X-LINKED	BTK, ARG520TER	128621201
300300	695	BTK	0037	AGAMMAGLOBULINEMIA, X-LINKED	BTK, ARG520GLN	128621202
300300	695	BTK	0038	AGAMMAGLOBULINEMIA, X-LINKED	BTK, 1-BP DEL, 1720A	
300300	695	BTK	0039	AGAMMAGLOBULINEMIA, X-LINKED	BTK, 4-BP DEL, CODON 527, GTTT	
300300	695	BTK	0040	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE III	BTK, LEU542PRO	128621203
300300	695	BTK	0041	AGAMMAGLOBULINEMIA, X-LINKED	BTK, IVS16DS, G-T, +1	
300300	695	BTK	0042	AGAMMAGLOBULINEMIA, X-LINKED	BTK, ARG562TRP	128621204
300300	695	BTK	0043	AGAMMAGLOBULINEMIA, X-LINKED	BTK, TYR581ARG	128621205
300300	695	BTK	0044	AGAMMAGLOBULINEMIA, X-LINKED	BTK, GLU589GLY	128621206
300300	695	BTK	0045	AGAMMAGLOBULINEMIA, X-LINKED	BTK, TYR591TER	128621207
300300	695	BTK	0046	AGAMMAGLOBULINEMIA, X-LINKED	BTK, ALA607ASP	128621208
300300	695	BTK	0047	AGAMMAGLOBULINEMIA, X-LINKED	BTK, GLY613ASP	128621209
300300	695	BTK	0048	AGAMMAGLOBULINEMIA, X-LINKED	BTK, MET630LYS	128621210
300300	695	BTK	0049	AGAMMAGLOBULINEMIA, X-LINKED	BTK, GLU636TER	128622211
300300	695	BTK	0050	AGAMMAGLOBULINEMIA, X-LINKED	BTK, 6-BP INS, NT2041	
300300	695	BTK	0051	AGAMMAGLOBULINEMIA, X-LINKED	BTK, LEU652PRO	128622212
300300	695	BTK	0052	AGAMMAGLOBULINEMIA, X-LINKED	BTK, 26-BP INS, NT2019	
300300	695	BTK	0053	AGAMMAGLOBULINEMIA, X-LINKED	BTK, ARG562PRO	104894770
300300	695	BTK	0054	AGAMMAGLOBULINEMIA, X-LINKED	BTK, 2-BP DEL, 54TG	
300300	695	BTK	0055	AGAMMAGLOBULINEMIA, X-LINKED	BTK, IVS1DS, G-A, +5	
300300	695	BTK	0056	AGAMMAGLOBULINEMIA, X-LINKED	BTK, 6.1-KB DEL	
300304	8450	CUL4B	0001	MENTAL RETARDATION, X-LINKED, WITH SHORT STATURE, HYPOGONADISM, AND ABNORMAL GAIT	CUL4B, ARG572CYS	121434615
300304	8450	CUL4B	0002	MENTAL RETARDATION, X-LINKED, WITH SHORT STATURE, HYPOGONADISM, AND ABNORMAL GAIT	CUL4B, ARG388TER	121434616
300304	8450	CUL4B	0003	MENTAL RETARDATION, X-LINKED, WITH SHORT STATURE, HYPOGONADISM, AND ABNORMAL GAIT	CUL4B, IVS6, A-G, -2	
300307	50945	TBX22	0001	CLEFT PALATE WITH ANKYLOGLOSSIA	TBX22, IVS6, G-C, +1	
300307	50945	TBX22	0002	CLEFT PALATE WITH ANKYLOGLOSSIA	TBX22, THR260MET	104894943
300307	50945	TBX22	0003	CLEFT PALATE WITH ANKYLOGLOSSIA	TBX22, GLY118CYS	104894944
300307	50945	TBX22	0004	CLEFT PALATE WITH ANKYLOGLOSSIA	TBX22, IVS4DS, G-A, +1	
300307	50945	TBX22	0005	CLEFT PALATE WITH ANKYLOGLOSSIA	TBX22, 1-BP DEL, 671C	
300307	50945	TBX22	0006	CLEFT PALATE WITH ANKYLOGLOSSIA	TBX22, GLU56TER	104894945
300307	50945	TBX22	0007	CLEFT PALATE WITH ANKYLOGLOSSIA	TBX22, LEU214PRO	104894946
300307	50945	TBX22	0008	CLEFT PALATE WITH ANKYLOGLOSSIA	TBX22, 3-BP DUP, 583GCT	
300307	50945	TBX22	0009	CLEFT PALATE WITH ANKYLOGLOSSIA	TBX22, ASN264TYR	28935177
300307	50945	TBX22	0010	CLEFT PALATE, X-LINKED	TBX22, 1-BP DEL, 1252G	
300307	50945	TBX22	0011	ABRUZZO-ERICKSON SYNDROME (1 family)	TBX22, IVS3AS, T-A, -5	
300336	54413	NLGN3	0001	AUTISM, SUSCEPTIBILITY TO, X-LINKED 1 ASPERGER SYNDROME, SUSCEPTIBILITY TO, X-LINKED 1, INCLUDED	NLGN3, ARG451CYS	
300350	91851	CHRDL1	0001	MEGALOCORNEA	CHRDL1, 1-BP DEL, 872G	
300350	91851	CHRDL1	0002	MEGALOCORNEA	CHRDL1, CYS261PHE	
300350	91851	CHRDL1	0003	MEGALOCORNEA	CHRDL1, IVS4, T-G, +2	
300350	91851	CHRDL1	0004	MEGALOCORNEA	CHRDL1, 2-BP DEL, 101AG	
300350	91851	CHRDL1	0005	MEGALOCORNEA	CHRDL1, ARG218TER	
300356	1678	TIMM8A	0001	MOHR-TRANEBJAERG SYNDROME	TIMM8A, 1-BP DEL, 151T	
300356	1678	TIMM8A	0002	MOHR-TRANEBJAERG SYNDROME	TIMM8A, 10-BP DEL, FS61TER	
300356	1678	TIMM8A	0003	JENSEN SYNDROME	TIMM8A, GLU24TER	111033631
300356	1678	TIMM8A	0004	MOHR-TRANEBJAERG SYNDROME	TIMM8A, CYS66TRP	80356560
300356	1678	TIMM8A	0005	MOHR-TRANEBJAERG SYNDROME	TIMM8A, 1-BP DEL, 108G	
300356	1678	TIMM8A	0006	MOHR-TRANEBJAERG SYNDROME	TIMM8A, DEL	
300356	1678	TIMM8A	0007	MOHR-TRANEBJAERG SYNDROME	TIMM8A, ARG80TER	1054894
300356	1678	TIMM8A	0008	MOHR-TRANEBJAERG SYNDROME	TIMM8A, IVS1, A-C, -23	
300356	1678	TIMM8A	0009	MOHR-TRANEBJAERG SYNDROME	TIMM8A, 1-BP DEL, 127T	
300371	215	ABCD1	0001	ADRENOLEUKODYSTROPHY	ABCD1, GLU291LYS	128624213
300371	215	ABCD1	0002	ADRENOLEUKODYSTROPHY	ABCD1, PRO484ARG	128624214
300371	215	ABCD1	0003	ADRENOLEUKODYSTROPHY	ABCD1, IVS6AS, A-G, -2	
300371	215	ABCD1	0004	ADRENOLEUKODYSTROPHY	ABCD1, IVS8AS, G-A, -10, 8-BP INS	
300371	215	ABCD1	0005	ADRENOMYELONEUROPATHY	ABCD1, ARG389GLY	128624215
300371	215	ABCD1	0006	ADRENOLEUKODYSTROPHY	ABCD1, ASN148SER	128624216
300371	215	ABCD1	0007	ADRENOLEUKODYSTROPHY	ABCD1, TYR174ASP	128624217
300371	215	ABCD1	0008	ADRENOLEUKODYSTROPHY	ABCD1, GLY266ARG	128624218
300371	215	ABCD1	0009	ADRENOLEUKODYSTROPHY	ABCD1, ARG401GLN	128624219
300371	215	ABCD1	0010	ADRENOLEUKODYSTROPHY	ABCD1, ARG418TRP	128624220
300371	215	ABCD1	0011	ADRENOMYELONEUROPATHY	ABCD1, ARG464TER	128624221
300371	215	ABCD1	0012	ADRENOLEUKODYSTROPHY	ABCD1, 2-BP DEL, 1801AG	
300371	215	ABCD1	0013	ADRENOLEUKODYSTROPHY	ABCD1, GLU477TER	128624222
300371	215	ABCD1	0014	ADRENOLEUKODYSTROPHY	ABCD1, SER515PHE	128624223
300371	215	ABCD1	0015	ADRENOLEUKODYSTROPHY	ABCD1, 1-BP DEL, 1937C	
300371	215	ABCD1	0016	ADRENOMYELONEUROPATHY	ABCD1, ARG518TRP	128624224
300371	215	ABCD1	0017	ADRENOMYELONEUROPATHY	ABCD1, IVS6DS, G-A, +1	
300371	215	ABCD1	0018	ADRENOLEUKODYSTROPHY	ABCD1, 2-BP DEL, 2177TA	
300371	215	ABCD1	0019	ADDISON DISEASE	ABCD1, SER606LEU	128624225
300371	215	ABCD1	0020	ADDISON DISEASE	ABCD1, 1-BP DEL, 2204G	
300371	215	ABCD1	0021	ADRENOMYELONEUROPATHY	ABCD1, ARG617HIS	11146842
300371	215	ABCD1	0022	ADRENOLEUKODYSTROPHY	ABCD1, ARG617CYS	4010613
300371	215	ABCD1	0023	ADRENOLEUKODYSTROPHY	ABCD1, 3-BP DEL, 1258GAG, GLU291DEL	
300371	215	ABCD1	0024	ADRENOLEUKODYSTROPHY	ABCD1, IVS8DS, G-A, +1	
300371	215	ABCD1	0025	ADRENOLEUKODYSTROPHY	ABCD1, IVS1DS, G-A, -1	
300371	215	ABCD1	0026	ADRENOMYELONEUROPATHY	ABCD1, 26-BP DEL, NT369	
300377	1756	DMD	0001	DUCHENNE MUSCULAR DYSTROPHY	DMD, GLU1157TER	128625226
300377	1756	DMD	0002	BECKER MUSCULAR DYSTROPHY, ATYPICAL	DMD, PROMOTER DEL	
300377	1756	DMD	0003	DUCHENNE MUSCULAR DYSTROPHY	DMD, GLU931TER	128625227
300377	1756	DMD	0004	DUCHENNE MUSCULAR DYSTROPHY	DMD, GLN1851TER	128625228
300377	1756	DMD	0005	DUCHENNE MUSCULAR DYSTROPHY	DMD, ARG2982TER	128625229
300377	1756	DMD	0006	DUCHENNE MUSCULAR DYSTROPHY	DMD, IVS68, T-A, +2	
300377	1756	DMD	0007	DUCHENNE MUSCULAR DYSTROPHY	DMD, ARG3370TER	104894787
300377	1756	DMD	0008	DUCHENNE MUSCULAR DYSTROPHY	DMD, EX73-76DEL	
300377	1756	DMD	0009	DUCHENNE MUSCULAR DYSTROPHY	DMD, 1-BP DEL, 10662T	
300377	1756	DMD	0010	DUCHENNE MUSCULAR DYSTROPHY	DMD, 1-BP INS, EX12	
300377	1756	DMD	0011	DUCHENNE MUSCULAR DYSTROPHY	DMD, AG-T, EX48	
300377	1756	DMD	0012	DUCHENNE MUSCULAR DYSTROPHY	DMD, EX21DEL	
300377	1756	DMD	0013	DUCHENNE MUSCULAR DYSTROPHY	DMD, EX18DEL	
300377	1756	DMD	0014	DUCHENNE MUSCULAR DYSTROPHY	DMD, GLN2319TER	128625230
300377	1756	DMD	0015	DUCHENNE MUSCULAR DYSTROPHY	DMD, ARG768TER, C-T, NT2510	
300377	1756	DMD	0016	DUCHENNE MUSCULAR DYSTROPHY	DMD, 1-BP DEL, 2568C	
300377	1756	DMD	0017	DUCHENNE MUSCULAR DYSTROPHY	DMD, GLU772TER, G-T, NT2522	
300377	1756	DMD	0018	BECKER MUSCULAR DYSTROPHY	DMD, IVS19, A-C, +3	
300377	1756	DMD	0019	BECKER MUSCULAR DYSTROPHY	DMD, IVS57, G-C, -1	
300377	1756	DMD	0020	DUCHENNE MUSCULAR DYSTROPHY	DMD, LEU54ARG	128626231
300377	1756	DMD	0021	CARDIOMYOPATHY, DILATED, 3B	DMD, EX1DEL	
300377	1756	DMD	0022	DUCHENNE MUSCULAR DYSTROPHY	DMD, IVS26, T-G, +2	
300377	1756	DMD	0023	DUCHENNE MUSCULAR DYSTROPHY	DMD, GLN673TER	128626232
300377	1756	DMD	0024	DUCHENNE MUSCULAR DYSTROPHY	DMD, 1-BP DEL, 10334C AND IVS69, G-T, +1	
300377	1756	DMD	0025	CARDIOMYOPATHY, DILATED, 3B	DMD, IVS1, G-T, +1	
300377	1756	DMD	0026	DUCHENNE MUSCULAR DYSTROPHY, MENTAL RETARDATION, AND ABSENCE OF ERG B-WAVE	DMD, CYS3340TYR	104894788
300377	1756	DMD	0027	BECKER MUSCULAR DYSTROPHY	DMD, IVS2, G-T, -1	
300377	1756	DMD	0028	INTERMEDIATE MUSCULAR DYSTROPHY	DMD, 2-BP DEL, 382AG	
300377	1756	DMD	0029	DUCHENNE MUSCULAR DYSTROPHY	DMD, GLN60TER	128626233
300377	1756	DMD	0030	DUCHENNE MUSCULAR DYSTROPHY	DMD, 1-BP INS, 402A	
300377	1756	DMD	0031	DUCHENNE MUSCULAR DYSTROPHY	DMD, GLN85TER	128626234
300377	1756	DMD	0032	DUCHENNE MUSCULAR DYSTROPHY	DMD, ARG145TER	128626235
300377	1756	DMD	0033	BECKER MUSCULAR DYSTROPHY	DMD, ALA168ASP	128626236
300377	1756	DMD	0034	DUCHENNE MUSCULAR DYSTROPHY	DMD, 1-BP DEL, 724C	
300377	1756	DMD	0035	BECKER MUSCULAR DYSTROPHY	DMD, TYR231ASN	128626237
300377	1756	DMD	0036	DUCHENNE MUSCULAR DYSTROPHY	DMD, GLN242TER	128626238
300377	1756	DMD	0037	DUCHENNE MUSCULAR DYSTROPHY	DMD, GLU250TER	128626239
300377	1756	DMD	0038	DUCHENNE MUSCULAR DYSTROPHY	DMD, 11-BP DEL, NT989	
300377	1756	DMD	0039	DUCHENNE MUSCULAR DYSTROPHY	DMD, 1-BP INS, NT1554	
300377	1756	DMD	0040	INTERMEDIATE MUSCULAR DYSTROPHY	DMD, GLY480TER	128626240
300377	1756	DMD	0041	DUCHENNE MUSCULAR DYSTROPHY	DMD, GLN497TER	128626241
300377	1756	DMD	0042	BECKER MUSCULAR DYSTROPHY	BMD, IVS13, G-T, -1	
300377	1756	DMD	0043	DUCHENNE MUSCULAR DYSTROPHY	DMD, TRP651TER	128626242
300377	1756	DMD	0044	DUCHENNE MUSCULAR DYSTROPHY	DMD, LYS770TER	128626243
300377	1756	DMD	0045	DUCHENNE MUSCULAR DYSTROPHY	DMD, LYS773GLU	128626244
300377	1756	DMD	0046	DUCHENNE MUSCULAR DYSTROPHY	DMD, 52-BP DEL	
300377	1756	DMD	0047	DUCHENNE MUSCULAR DYSTROPHY	DMD, 1-BP INS, NT2928	
300377	1756	DMD	0048	DUCHENNE MUSCULAR DYSTROPHY	DMD, GLN1041TER	128626245
300377	1756	DMD	0049	DUCHENNE MUSCULAR DYSTROPHY	DMD, TRP1063TER	128626246
300377	1756	DMD	0050	DUCHENNE MUSCULAR DYSTROPHY	DMD, GLN1405TER	128626247
300377	1756	DMD	0051	DUCHENNE MUSCULAR DYSTROPHY	DMD, GLN1472TER	128626248
300377	1756	DMD	0052	DUCHENNE MUSCULAR DYSTROPHY	DMD, ARG1967TER	128626249
300377	1756	DMD	0053	DUCHENNE MUSCULAR DYSTROPHY	DMD, 1-BP DEL, 6408C	
300377	1756	DMD	0054	DUCHENNE MUSCULAR DYSTROPHY	DMD, ARG2098TER	128626250
300377	1756	DMD	0055	DUCHENNE MUSCULAR DYSTROPHY	DMD, GLN2125TER	128626251
300377	1756	DMD	0056	DUCHENNE MUSCULAR DYSTROPHY	DMD, 17-BP DEL, NT6982	
300377	1756	DMD	0057	DUCHENNE MUSCULAR DYSTROPHY	DMD, GLN2264TER	128626252
300377	1756	DMD	0058	DUCHENNE MUSCULAR DYSTROPHY	DMD, 1-BP INS, 7188A	
300377	1756	DMD	0059	DUCHENNE MUSCULAR DYSTROPHY	DMD, IVS47, G-A, +1, EX48DEL	
300377	1756	DMD	0060	DUCHENNE MUSCULAR DYSTROPHY	DMD, GLU2468TER	128626253
300377	1756	DMD	0061	DUCHENNE MUSCULAR DYSTROPHY	DMD, GLU2910VAL	41305353
300377	1756	DMD	0062	DUCHENNE MUSCULAR DYSTROPHY	DMD, ASN2912ASP	1800278
300377	1756	DMD	0063	BECKER MUSCULAR DYSTROPHY	DMD, HIS2921ARG	1800279
300377	1756	DMD	0064	DUCHENNE MUSCULAR DYSTROPHY	DMD, SER3066TER	128626254
300377	1756	DMD	0065	DUCHENNE MUSCULAR DYSTROPHY	DMD, 4-BP DEL, NT9679	
300377	1756	DMD	0066	DUCHENNE MUSCULAR DYSTROPHY	DMD, IVS65, G-A, +1	
300377	1756	DMD	0067	DUCHENNE MUSCULAR DYSTROPHY	DMD, ARG3381TER	104894790
300377	1756	DMD	0068	INTERMEDIATE MUSCULAR DYSTROPHY	DMD, IVS70, G-A, +1	
300377	1756	DMD	0069	DUCHENNE MUSCULAR DYSTROPHY	DMD, IVS70, G-T, +5	
300377	1756	DMD	0070	BECKER MUSCULAR DYSTROPHY	DMD, ALA3421VAL	104894791
300377	1756	DMD	0071	BECKER MUSCULAR DYSTROPHY	DMD, 1-BP DEL, 10683C	
300377	1756	DMD	0072	DUCHENNE MUSCULAR DYSTROPHY	DMD, 8-BP DEL, 1-BP INS, NT10692	
300377	1756	DMD	0073	CARDIOMYOPATHY, DILATED, 3B	DMD, THR279ALA	128627255
300377	1756	DMD	0074	BECKER MUSCULAR DYSTROPHY	DMD, GLU1211TER, 3839G-T	
300377	1756	DMD	0075	CARDIOMYOPATHY, DILATED, 3B	DMD, ALU INS	
300377	1756	DMD	0076	DUCHENNE MUSCULAR DYSTROPHY	DMD, ARG3190TER	104894797
300377	1756	DMD	0077	BECKER MUSCULAR DYSTROPHY	DMD, ARG1314TER	5030730
300377	1756	DMD	0078	DUCHENNE MUSCULAR DYSTROPHY	DMD, 1-BP DEL, 377A	
300377	1756	DMD	0079	DUCHENNE MUSCULAR DYSTROPHY	DMD, 16-BP DEL	
300377	1756	DMD	0080	BECKER MUSCULAR DYSTROPHY	DMD, IVS62, A-G, -285	
300377	1756	DMD	0081	BECKER MUSCULAR DYSTROPHY	DMD, IVS25, A-G, +2036	
300377	1756	DMD	0082	DUCHENNE MUSCULAR DYSTROPHY	DMD, ARG2905TER	128627256
300377	1756	DMD	0083	BECKER MUSCULAR DYSTROPHY, ATYPICAL	DMD, IVS2, T-A, +5591	
300377	1756	DMD	0084	DUCHENNE MUSCULAR DYSTROPHY	DMD, TYR1995TER	128627257
300377	1756	DMD	0085	BECKER MUSCULAR DYSTROPHY, ATYPICAL	DMD, EX45-47DEL	
300377	1756	DMD	0086	BECKER MUSCULAR DYSTROPHY	DMD, TRP3TER	
300382	170302	ARX	0001	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1	ARX, (GCG)10+7	193922944
300382	170302	ARX	0002	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1 PARTINGTON SYNDROME, INCLUDED;; MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED, INCLUDED	ARX, 24-BP DUP, NT428	193922945
300382	170302	ARX	0003	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1	ARX, PRO353LEU	104894743
300382	170302	ARX	0004	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1	ARX, 1,517-BP DEL	
300382	170302	ARX	0005	LISSENCEPHALY, X-LINKED, 2	ARX, 32-BP DEL, NT420	
300382	170302	ARX	0006	LISSENCEPHALY, X-LINKED, 2	ARX, 1-BP DEL, 790C	
300382	170302	ARX	0007	LISSENCEPHALY, X-LINKED, 2	ARX, ARG332HIS	111033612
300382	170302	ARX	0008	LISSENCEPHALY, X-LINKED, 2	ARX, GLN373TER	104894740
300382	170302	ARX	0009	LISSENCEPHALY, X-LINKED, 2	ARX, 1-BP INS, 1188C	
300382	170302	ARX	0010	LISSENCEPHALY, X-LINKED, 2	ARX, EX1-2DEL	
300382	170302	ARX	0011	LISSENCEPHALY, X-LINKED, 2	ARX, 1-BP DEL, 1372G	
300382	170302	ARX	0012	LISSENCEPHALY, X-LINKED, 2	ARX, LEU343GLN	104894741
300382	170302	ARX	0013	MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	ARX, LEU33PRO	28936077
300382	170302	ARX	0014	MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	ARX, GLY286SER	28935479
300382	170302	ARX	0015	CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA	ARX, THR333ASN	104894745
300382	170302	ARX	0016	HYDRANENCEPHALY WITH ABNORMAL GENITALIA	ARX, GLU369TER	104894746
300382	170302	ARX	0017	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1	ARX, 33-BP DUP	
300382	170302	ARX	0018	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	ARX, 24-BP DEL, NT441	
300382	170302	ARX	0019	LISSENCEPHALY, X-LINKED, 2	ARX, 1-BP DEL, 617G	
300382	170302	ARX	0020	LISSENCEPHALY, X-LINKED, 2	ARX, GLU78TER	
300382	170302	ARX	0021	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1	ARX, 1-BP DEL, 1465G	
300382	170302	ARX	0022	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1	ARX, 27-BP DUP, NT430	
300382	170302	ARX	0023	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1	ARX, TYR27TER	
300382	170302	ARX	0024	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1	ARX, LEU535GLN	
300383	5199	CFP	0001	PROPERDIN DEFICIENCY, TYPE I	CFP, ARG134TER	132630258
300383	5199	CFP	0002	PROPERDIN DEFICIENCY, TYPE II	CFP, ARG73TRP	132630259
300383	5199	CFP	0003	PROPERDIN DEFICIENCY, TYPE I	CFP, GLY271VAL	28935480
300383	5199	CFP	0004	PROPERDIN DEFICIENCY, TYPE I	CFP, SER179TER	132630260
300383	5199	CFP	0005	PROPERDIN DEFICIENCY, TYPE III	CFP, TYR387ASP	132630261
300384	2010	EMD	0001	EMERY-DREIFUSS MUSCULAR DYSTROPHY, X-LINKED	EMD, 2-BP DEL, NT564	
300384	2010	EMD	0002	EMERY-DREIFUSS MUSCULAR DYSTROPHY, X-LINKED	EMD, MET1VAL	
300384	2010	EMD	0003	EMERY-DREIFUSS MUSCULAR DYSTROPHY, X-LINKED	EMD, 29-BP DEL, NT113	
300384	2010	EMD	0004	EMERY-DREIFUSS MUSCULAR DYSTROPHY, X-LINKED	EMD, 2-BP INS, NT198	
300384	2010	EMD	0005	EMERY-DREIFUSS MUSCULAR DYSTROPHY, X-LINKED	EMD, IVSAS, A-G, -3, 214-BP INS	
300384	2010	EMD	0006	EMERY-DREIFUSS MUSCULAR DYSTROPHY, X-LINKED	EMD, GLN43TER	132630262
300384	2010	EMD	0007	EMERY-DREIFUSS MUSCULAR DYSTROPHY, X-LINKED	EMD, 1-BP DEL, FS236TER	
300384	2010	EMD	0008	EMERY-DREIFUSS MUSCULAR DYSTROPHY, X-LINKED	EMD, PRO183HIS	104894805
300384	2010	EMD	0009	EMERY-DREIFUSS MUSCULAR DYSTROPHY, X-LINKED	EMD, PRO183THR	104894806
300384	2010	EMD	0010	EMERY-DREIFUSS MUSCULAR DYSTROPHY, X-LINKED	EMD, 5-BP DEL, NT631	
300386	959	CD40LG	0001	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 1	CD40LG, ALA235PRO	104894771
300386	959	CD40LG	0002	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 1	CD40LG, SER128ARG AND GLU129GLY	104894772
300386	959	CD40LG	0003	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 1	CD40LG, GLY227VAL	104894768
300386	959	CD40LG	0004	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 1	CD40LG, LEU155PRO	104894769
300386	959	CD40LG	0005	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 1	CD40LG, THR211ASP	
300386	959	CD40LG	0006	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 1	CD40LG, MET36ARG	104894774
300386	959	CD40LG	0007	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 1	CD40LG, TRP140TER	104894775
300386	959	CD40LG	0008	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 1	CD40LG, TRP140GLY	104894777
300386	959	CD40LG	0009	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 1	CD40LG, 63-BP DEL	
300386	959	CD40LG	0010	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 1	CD40LG, 8-BP DEL	
300386	959	CD40LG	0011	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 1	CD40LG, 10-BP DEL	
300386	959	CD40LG	0012	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 1	CD40LG, ALA123GLU	104894778
300386	959	CD40LG	0013	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 1	CD40LG, 1-BP INS, TTT-TTTT, FS84TER	
300386	959	CD40LG	0014	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 1	CD40LG, ALU INS, EX1	
300390	1121	CHM	0001	CHOROIDEREMIA, SALLA TYPE	CHM, EXON C, DS, INS T	
300390	1121	CHM	0002	CHOROIDEREMIA	CHM, SER116TER	132630263
300390	1121	CHM	0003	CHOROIDEREMIA	CHM, SER158TER	132630264
300390	1121	CHM	0004	CHOROIDEREMIA	CHM, GLU154TER	132630265
300390	1121	CHM	0005	CHOROIDEREMIA	CHM, 1-BP DEL, GGA146GA, FS159TER	
300390	1121	CHM	0006	CHOROIDEREMIA	CHM, 4-BP DEL, FS198TER	
300390	1121	CHM	0007	CHOROIDEREMIA	CHM, CYS162TER	
300390	1121	CHM	0008	CHOROIDEREMIA	CHM, ARG294TER	132630266
300390	1121	CHM	0009	CHOROIDEREMIA	CHM, CYS500TER	132630267
300390	1121	CHM	0010	CHOROIDEREMIA	CHM, L1 INS	
300390	1121	CHM	0011	CHOROIDEREMIA	CHM, HIS507ARG	
300391	265	AMELX	0001	AMELOGENESIS IMPERFECTA, TYPE 1E	AMELX, 5-KB DEL	
300391	265	AMELX	0002	AMELOGENESIS IMPERFECTA, TYPE 1E	AMELX, 1-BP DEL, 155C	
300391	265	AMELX	0003	AMELOGENESIS IMPERFECTA, TYPE 1E	AMELX, 9-BP DEL	
300391	265	AMELX	0004	AMELOGENESIS IMPERFECTA, TYPE 1E	AMELX, 1-BP DEL, 473C	
300391	265	AMELX	0005	AMELOGENESIS IMPERFECTA, TYPE 1E	AMELX, THR51ILE	104894733
300391	265	AMELX	0006	AMELOGENESIS IMPERFECTA, TYPE 1E	AMELX, GLU191TER	104894734
300391	265	AMELX	0007	AMELOGENESIS IMPERFECTA, TYPE 1E	AMELX, PRO70THR	104894736
300391	265	AMELX	0008	AMELOGENESIS IMPERFECTA, TYPE 1E	AMELX, 1-BP DEL, 541C	
300391	265	AMELX	0009	AMELOGENESIS IMPERFECTA, TYPE 1E	AMELX, 1-BP DEL, 420C	
300391	265	AMELX	0010	AMELOGENESIS IMPERFECTA, TYPE 1E	AMELX, MET1THR	104894737
300391	265	AMELX	0011	AMELOGENESIS IMPERFECTA, TYPE 1E	AMELX, TRP4SER	104894738
300391	265	AMELX	0012	AMELOGENESIS IMPERFECTA, TYPE 1E, WITH SNOW-CAPPED TEETH	AMELX, 96-KB DEL	
300391	265	AMELX	0013	AMELOGENESIS IMPERFECTA, TYPE 1E, WITH SNOW-CAPPED TEETH	AMELX, 53-KB DEL	
300392	7454	WAS	0001	WISKOTT-ALDRICH SYNDROME	WAS, 1-BP DEL, 211T	
300392	7454	WAS	0002	WISKOTT-ALDRICH SYNDROME	WAS, ARG86LEU	132630268
300392	7454	WAS	0003	WISKOTT-ALDRICH SYNDROME	WAS, ARG86HIS	132630268
300392	7454	WAS	0004	THROMBOCYTOPENIA, X-LINKED, 1	WAS, ALA56VAL	132630269
300392	7454	WAS	0005	THROMBOCYTOPENIA, X-LINKED, 1	WAS, ALA236GLU	132630270
300392	7454	WAS	0006	THROMBOCYTOPENIA, X-LINKED, 1	WAS, 1-BP INS, 512C	
300392	7454	WAS	0007	WISKOTT-ALDRICH SYNDROME	WAS, ARG34TER	132630271
300392	7454	WAS	0008	WISKOTT-ALDRICH SYNDROME	WAS, 6-BP INS, NT434	
300392	7454	WAS	0009	WISKOTT-ALDRICH SYNDROME, ATTENUATED	WAS, SER82PRO	132630272
300392	7454	WAS	0010	THROMBOCYTOPENIA, X-LINKED, 1	WAS, THR45MET	132630273
300392	7454	WAS	0011	WISKOTT-ALDRICH SYNDROME	WAS, 1-BP DEL, 1127G	
300392	7454	WAS	0012	NEUTROPENIA, SEVERE CONGENITAL, X-LINKED	WAS, LEU270PRO	132630274
300392	7454	WAS	0013	THROMBOCYTOPENIA, X-LINKED, INTERMITTENT	WAS, PRO58ARG	132630275
300392	7454	WAS	0014	THROMBOCYTOPENIA, X-LINKED, INTERMITTENT	WAS, ILE481ASN	132630276
300392	7454	WAS	0015	WISKOTT-ALDRICH SYNDROME	WAS, 15,800-BP DEL	
300392	7454	WAS	0016	WISKOTT-ALDRICH SYNDROME THROMBOCYTOPENIA, X-LINKED, 1, INCLUDED	WAS, IVS6DS, G-A, +5	
300392	7454	WAS	0017	WISKOTT-ALDRICH SYNDROME	WAS, IVS6AS, G-A, -1	
300392	7454	WAS	0018	WISKOTT-ALDRICH SYNDROME	WAS, IVS6DS, T-G, +2	
300392	7454	WAS	0019	WISKOTT-ALDRICH SYNDROME	WAS, 1-BP DEL, 11G	
300392	7454	WAS	0020	WISKOTT-ALDRICH SYNDROME, SOMATIC	WAS, 1A-T	
300392	7454	WAS	0021	WISKOTT-ALDRICH SYNDROME	WAS, 2-BP DEL, 73AC	
300392	7454	WAS	0022	WISKOTT-ALDRICH SYNDROME	WAS, 1-BP DEL, 758A	
300392	7454	WAS	0023	WISKOTT-ALDRICH SYNDROME	WAS, 1-BP DEL, CODON 241, C	
300392	7454	WAS	0024	NEUTROPENIA, SEVERE CONGENITAL, X-LINKED	WAS, SER272PRO	
300392	7454	WAS	0025	NEUTROPENIA, SEVERE CONGENITAL, X-LINKED	WAS, ILE294THR	
300394	6901	TAZ	0001	BARTH SYNDROME	TAZ, IVS2, G-A, -1	
300394	6901	TAZ	0002	BARTH SYNDROME	TAZ, TYR51TER	104894941
300394	6901	TAZ	0003	BARTH SYNDROME	TAZ, IVS2, G-C, -1	
300394	6901	TAZ	0004	BARTH SYNDROME	TAZ, 1-BP INS	
300394	6901	TAZ	0005	BARTH SYNDROME	TAZ, 1-BP DEL	
300394	6901	TAZ	0006	BARTH SYNDROME	TAZ, GLY197ARG	132630277
300394	6901	TAZ	0007	BARTH SYNDROME	TAZ, IVS1, G-C, +5	
300394	6901	TAZ	0008	BARTH SYNDROME	TAZ, IVS3, G-A, +110	
300394	6901	TAZ	0009	BARTH SYNDROME	TAZ, CYS118ARG	104894937
300394	6901	TAZ	0010	BARTH SYNDROME	TAZ, IVS1, A-G, -2	
300394	6901	TAZ	0011	BARTH SYNDROME	TAZ, ARG94SER	104894942
300394	6901	TAZ	0012	BARTH SYNDROME	TAZ, 4-BP DEL, AGTG	
300394	6901	TAZ	0013	BARTH SYNDROME	TAZ, IVS8AS, G-C, -1	
300394	6901	TAZ	0014	BARTH SYNDROME	TAZ, GLY240ARG	
300401	5354	PLP1	0001	PELIZAEUS-MERZBACHER DISEASE	PLP1, PRO215SER	132630278
300401	5354	PLP1	0002	PELIZAEUS-MERZBACHER DISEASE	PLP1, TRP162ARG	132630279
300401	5354	PLP1	0003	PELIZAEUS-MERZBACHER DISEASE	PLP1, PRO14LEU	11543022
300401	5354	PLP1	0004	PELIZAEUS-MERZBACHER DISEASE	PLP1, THR155ILE	132630280
300401	5354	PLP1	0005	PELIZAEUS-MERZBACHER DISEASE	PLP1, VAL218PHE	132630281
300401	5354	PLP1	0006	PELIZAEUS-MERZBACHER DISEASE	PLP1, DEL	
300401	5354	PLP1	0007	PELIZAEUS-MERZBACHER DISEASE	PLP1, THR181PRO	132630282
300401	5354	PLP1	0008	PELIZAEUS-MERZBACHER DISEASE	PLP1, LEU223PRO	132630283
300401	5354	PLP1	0009	PELIZAEUS-MERZBACHER DISEASE	PLP1, ASP202HIS	132630284
300401	5354	PLP1	0010	PELIZAEUS-MERZBACHER DISEASE	PLP1, GLY73ARG	132630285
300401	5354	PLP1	0011	PELIZAEUS-MERZBACHER DISEASE, CONNATAL	PLP1, GLY220CYS	132630286
300401	5354	PLP1	0012	SPASTIC PARAPLEGIA 2	PLP1, HIS139TYR	132630287
300401	5354	PLP1	0013	SPASTIC PARAPLEGIA 2	PLP1, ILE186THR	132630288
300401	5354	PLP1	0014	PELIZAEUS-MERZBACHER DISEASE	PLP1, THR42ILE	132630289
300401	5354	PLP1	0015	PELIZAEUS-MERZBACHER DISEASE, MILD	PLP1, MET1ILE	132630290
300401	5354	PLP1	0016	PELIZAEUS-MERZBACHER DISEASE, MILD	PLP1, -34C-T, 5-PRIME UTR	
300401	5354	PLP1	0017	SPASTIC PARAPLEGIA 2	PLP1, PHE236SER	132630291
300401	5354	PLP1	0018	PELIZAEUS-MERZBACHER DISEASE, ATYPICAL	PLP1, TRP144TER	132630292
300401	5354	PLP1	0019	PELIZAEUS-MERZBACHER DISEASE, CONNATAL	PLP1, ALA242VAL	132630293
300401	5354	PLP1	0020	SPASTIC PARAPLEGIA 2	PLP1, SER169PHE	132630294
300401	5354	PLP1	0021	PELIZAEUS-MERZBACHER DISEASE	PLP1, DUP	
300401	5354	PLP1	0022	PELIZAEUS-MERZBACHER DISEASE	PLP1, IVS6DS, G-T, +3	
300401	5354	PLP1	0023	PELIZAEUS-MERZBACHER DISEASE	PLP1, IVS3DS, T-C, +2	
300401	5354	PLP1	0024	PELIZAEUS-MERZBACHER DISEASE	PLP1, IVS3DS, A-G, +4	
300401	5354	PLP1	0025	PELIZAEUS-MERZBACHER DISEASE, ATYPICAL	PLP1, IVS3, 19-BP DEL, +28	
300401	5354	PLP1	0026	SPASTIC PARAPLEGIA 2	PLP1, ARG137TRP	132630295
300401	5354	PLP1	0027	PELIZAEUS-MERZBACHER DISEASE	PLP1, ASP57TYR	132630296
300405	282808	RAB40AL	0001	MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	RAB40AL, ASP59GLY	
300414	84295	PHF6	0001	BORJESON-FORSSMAN-LEHMANN SYNDROME	PHF6, ARG342TER	132630297
300414	84295	PHF6	0002	BORJESON-FORSSMAN-LEHMANN SYNDROME	PHF6, CYS99PHE	132630298
300414	84295	PHF6	0003	BORJESON-FORSSMAN-LEHMANN SYNDROME	PHF6, LYS234GLU	104894917
300414	84295	PHF6	0004	BORJESON-FORSSMAN-LEHMANN SYNDROME	PHF6, CYS45TYR	132630299
300414	84295	PHF6	0005	BORJESON-FORSSMAN-LEHMANN SYNDROME	PHF6, HIS229ARG	104894918
300414	84295	PHF6	0006	BORJESON-FORSSMAN-LEHMANN SYNDROME	PHF6, MET1TYR	132630300
300414	84295	PHF6	0007	BORJESON-FORSSMAN-LEHMANN SYNDROME	PHF6, ARG257GLY	104894919
300414	84295	PHF6	0008	BORJESON-FORSSMAN-LEHMANN SYNDROME	PHF6, LYS8TER	132630301
300414	84295	PHF6	0009	BORJESON-FORSSMAN-LEHMANN SYNDROME	PHF6, IVS2AS, A-G, -8	
300414	84295	PHF6	0010	BORJESON-FORSSMAN-LEHMANN SYNDROME	PHF6, 1-BP INS, 27A	
300415	4534	MTM1	0001	MYOTUBULAR MYOPATHY, X-LINKED	MTM1, ASN207SER	132630302
300415	4534	MTM1	0002	MYOTUBULAR MYOPATHY, X-LINKED	MTM1, TYR415CYS	132630303
300415	4534	MTM1	0003	MYOTUBULAR MYOPATHY, X-LINKED	MTM1, ARG69CYS	132630304
300415	4534	MTM1	0004	MYOTUBULAR MYOPATHY, X-LINKED	MTM1, IVS8, G-A, -1	
300415	4534	MTM1	0005	MYOTUBULAR MYOPATHY, X-LINKED	MTM1, 4-BP DEL, NT195	
300415	4534	MTM1	0006	MYOTUBULAR MYOPATHY, X-LINKED	MTM1, IVS11, A-G, -10	
300415	4534	MTM1	0007	MYOTUBULAR MYOPATHY, X-LINKED	MTM1, ARG241CYS	132630305
300415	4534	MTM1	0008	MYOTUBULAR MYOPATHY, X-LINKED	MTM1, ARG224TER	132630306
300415	4534	MTM1	0009	MYOTUBULAR MYOPATHY, X-LINKED	MTM1, 1-BP DEL, 605T	
300415	4534	MTM1	0010	MYOTUBULAR MYOPATHY, X-LINKED	MTM1, GLU157LYS	132630307
300427	57502	NLGN4X	0001	AUTISM, SUSCEPTIBILITY TO, X-LINKED 2 ASPERGER SYNDROME, SUSCEPTIBILITY TO, X-LINKED 2, INCLUDED	NLGN4, 1-BP INS, 1186T	
300427	57502	NLGN4X	0002	MENTAL RETARDATION, X-LINKED AUTISM, SUSCEPTIBILITY TO, X-LINKED 2, INCLUDED	NLGN4, 2-BP DEL, 1253AG	
300427	57502	NLGN4X	0003	AUTISM, SUSCEPTIBILITY TO, X-LINKED 2 MENTAL RETARDATION, X-LINKED, INCLUDED	NLGN4, 757-KB DEL	
300429	23229	ARHGEF9	0001	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 8	ARHGEF9, GLY55ALA	121918361
300429	23229	ARHGEF9	0002	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 8	ARHGEF9, GLN2TER	
300451	1896	EDA	0001	ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC/HAIR/TOOTH TYPE, X-LINKED	EDA, TYR61HIS	132630308
300451	1896	EDA	0002	ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC/HAIR/TOOTH TYPE, X-LINKED	EDA, ARG69LEU	132630309
300451	1896	EDA	0003	ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC/HAIR/TOOTH TYPE, X-LINKED	EDA, GLN23TER	132630310
300451	1896	EDA	0004	ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC/HAIR/TOOTH TYPE, X-LINKED	EDA, GLU63LYS	132630311
300451	1896	EDA	0005	ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC/HAIR/TOOTH TYPE, X-LINKED	EDA, ARG155CYS	132630312
300451	1896	EDA	0006	ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC/HAIR/TOOTH TYPE, X-LINKED	EDA, ARG156CYS	132630313
300451	1896	EDA	0007	ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC/HAIR/TOOTH TYPE, X-LINKED	EDA, ARG156HIS	132630314
300451	1896	EDA	0008	ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC/HAIR/TOOTH TYPE, X-LINKED	EDA, PRO209LEU	132630315
300451	1896	EDA	0009	ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC/HAIR/TOOTH TYPE, X-LINKED	EDA, GLY224ALA	132630316
300451	1896	EDA	0010	ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC/HAIR/TOOTH TYPE, X-LINKED	EDA, ALA349THR	132630317
300451	1896	EDA	0011	ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC/HAIR/TOOTH TYPE, X-LINKED	EDA, TYR61TER	132630318
300451	1896	EDA	0012	ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC/HAIR/TOOTH TYPE, X-LINKED	EDA, 36-BP DEL, EX5	
300451	1896	EDA	0013	ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC/HAIR/TOOTH TYPE, X-LINKED	EDA, 1-BP DEL, EX6	
300451	1896	EDA	0014	TOOTH AGENESIS, SELECTIVE, X-LINKED, 1	EDA, ARG65GLY	132630319
300451	1896	EDA	0015	TOOTH AGENESIS, SELECTIVE, X-LINKED, 1	EDA, GLN358GLU	132630320
300451	1896	EDA	0016	ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC/HAIR/TOOTH TYPE, X-LINKED	EDA, 1-BP INS, 573T	
300451	1896	EDA	0017	ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC/HAIR/TOOTH TYPE, X-LINKED	EDA, 2-BP INS, 913TA	
300451	1896	EDA	0018	TOOTH AGENESIS, SELECTIVE, X-LINKED, 1	EDA, THR338MET	132630321
300451	1896	EDA	0019	ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC/HAIR/TOOTH TYPE, X-LINKED	EDA, ARG276CYS	
300457	4810	NHS	0001	NANCE-HORAN SYNDROME	NHS, 1-BP INS, 2387C	
300457	4810	NHS	0002	NANCE-HORAN SYNDROME	NHS, 1-BP DEL, 3459C	
300457	4810	NHS	0003	NANCE-HORAN SYNDROME	NHS, ARG378TER	132630322
300457	4810	NHS	0004	NANCE-HORAN SYNDROME	NHS, 1-BP INS, 718G	
300457	4810	NHS	0005	NANCE-HORAN SYNDROME	NHS, GLN39TER	104894881
300457	4810	NHS	0006	NANCE-HORAN SYNDROME	NHS, IVS3AS, A-G, -2	
300457	4810	NHS	0007	CATARACT, CONGENITAL, X-LINKED	NHS, 500-KB TRIPLICATION	
300457	4810	NHS	0008	CATARACT, CONGENITAL, X-LINKED	NHS, 4.8-KB DEL	
300460	57526	PCDH19	0001	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9	PCDH19, 1-BP INS, 1091C	
300460	57526	PCDH19	0002	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9	PCDH19, VAL441GLU	132630323
300460	57526	PCDH19	0003	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9	PCDH19, GLN85TER	132630324
300460	57526	PCDH19	0004	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9	PCDH19, SER671TER	132630325
300460	57526	PCDH19	0005	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9	PCDH19, 1-BP INS, 2030T	
300460	57526	PCDH19	0006	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9	PCDH19, GLU48TER	132630326
300460	57526	PCDH19	0007	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9	PCDH19, 5-BP DUP, NT1036	
300460	57526	PCDH19	0008	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9	PCDH19, ASN557LYS	
300461	5009	OTC	0001	ORNITHINE TRANSCARBAMYLASE DEFICIENCY	OTC, DEL	
300461	5009	OTC	0002	ORNITHINE TRANSCARBAMYLASE DEFICIENCY	OTC, ARG109GLN	68026851
300461	5009	OTC	0003	ORNITHINE TRANSCARBAMYLASE DEFICIENCY	OTC, ARG109TER	67960011
300461	5009	OTC	0004	ORNITHINE TRANSCARBAMYLASE DEFICIENCY	OTC, LEU111PRO	
300461	5009	OTC	0005	ORNITHINE TRANSCARBAMYLASE DEFICIENCY	OTC, GLN216GLU	
300461	5009	OTC	0006	ORNITHINE TRANSCARBAMYLASE DEFICIENCY	OTC, GLU154TER	
300461	5009	OTC	0007	ORNITHINE TRANSCARBAMYLASE DEFICIENCY	OTC, LEU45PRO	
300461	5009	OTC	0008	ORNITHINE TRANSCARBAMYLASE DEFICIENCY	OTC, ARG26GLN	
300461	5009	OTC	0009	ORNITHINE TRANSCARBAMYLASE POLYMORPHISM	OTC, LYS46ARG	1800321
300461	5009	OTC	0010	ORNITHINE TRANSCARBAMYLASE DEFICIENCY	OTC, ARG245TRP	
300461	5009	OTC	0011	ORNITHINE TRANSCARBAMYLASE DEFICIENCY	OTC, GT-GC, INTRON 7	
300461	5009	OTC	0012	ORNITHINE TRANSCARBAMYLASE DEFICIENCY	OTC, GTA-GTG, INTRON 7	
300461	5009	OTC	0013	ORNITHINE TRANSCARBAMYLASE DEFICIENCY	OTC, IVS4, A-T, -2	
300461	5009	OTC	0014	ORNITHINE TRANSCARBAMYLASE DEFICIENCY	OTC, ARG277TRP	
300461	5009	OTC	0015	ORNITHINE TRANSCARBAMYLASE DEFICIENCY	OTC, PRO225LEU	
300461	5009	OTC	0016	ORNITHINE TRANSCARBAMYLASE DEFICIENCY	OTC, GLU87LYS	
300461	5009	OTC	0017	ORNITHINE TRANSCARBAMYLASE DEFICIENCY	OTC, GLY50TER	
300461	5009	OTC	0018	ORNITHINE TRANSCARBAMYLASE DEFICIENCY	OTC, GLY162ARG	
300461	5009	OTC	0019	ORNITHINE TRANSCARBAMYLASE DEFICIENCY	OTC, 1-BP DEL, 403G	
300461	5009	OTC	0020	ORNITHINE TRANSCARBAMYLASE DEFICIENCY	OTC, IVS2, G-A, -1	
300461	5009	OTC	0021	ORNITHINE TRANSCARBAMYLASE DEFICIENCY	OTC, GLY47GLU	72554331
300461	5009	OTC	0022	ORNITHINE TRANSCARBAMYLASE DEFICIENCY	OTC, ARG62THR	72554345
300461	5009	OTC	0023	ORNITHINE TRANSCARBAMYLASE DEFICIENCY	OTC, LEU272PHE	72558465
300461	5009	OTC	0024	ORNITHINE TRANSCARBAMYLASE DEFICIENCY	OTC, TYR313ASP	66469337
300461	5009	OTC	0025	ORNITHINE TRANSCARBAMYLASE DEFICIENCY	OTC, ARG129HIS	66656800
300461	5009	OTC	0026	ORNITHINE TRANSCARBAMYLASE DEFICIENCY	OTC, LEU148PHE	
300461	5009	OTC	0027	ORNITHINE TRANSCARBAMYLASE DEFICIENCY	OTC, MET206ARG	
300461	5009	OTC	0028	ORNITHINE TRANSCARBAMYLASE DEFICIENCY	OTC, ARG40CYS	
300461	5009	OTC	0029	ORNITHINE TRANSCARBAMYLASE DEFICIENCY	OTC, ARG40HIS	
300463	10084	PQBP1	0001	RENPENNING SYNDROME	PQBP1, 2-BP INS, 3900AG	
300463	10084	PQBP1	0002	RENPENNING SYNDROME	PQBP1, 4-BP DEL, 3896AGAG	
300463	10084	PQBP1	0003	RENPENNING SYNDROME	PQBP1, 2-BP DEL, 3898AG	
300463	10084	PQBP1	0004	RENPENNING SYNDROME	PQBP1, 1-BP INS, 641C	
300463	10084	PQBP1	0005	RENPENNING SYNDROME	PQBP1, 23-BP DEL, NT547	
300463	10084	PQBP1	0006	RENPENNING SYNDROME	PQBP1, 21-BP DEL, NT334	
300463	10084	PQBP1	0007	RENPENNING SYNDROME	PQBP1, TYR65CYS	
300473	190	NR0B1	0001	ADRENAL HYPOPLASIA, CONGENITAL	NR0B1, GLN283TER	104894890
300473	190	NR0B1	0002	ADRENAL HYPOPLASIA, CONGENITAL	NR0B1, TRP369TER	104894886
300473	190	NR0B1	0003	ADRENAL HYPOPLASIA, CONGENITAL	NR0B1, LEU263TER	104894887
300473	190	NR0B1	0004	ADRENAL HYPOPLASIA, CONGENITAL	NR0B1, ARG267PRO	104894888
300473	190	NR0B1	0005	ADRENAL HYPOPLASIA, CONGENITAL	NR0B1, TRP235TER	104894889
300473	190	NR0B1	0006	ADRENAL HYPOPLASIA, CONGENITAL	NR0B1, TRP171TER	104894891
300473	190	NR0B1	0007	ADRENAL HYPOPLASIA, CONGENITAL	NR0B1, 1-BP DEL	
300473	190	NR0B1	0008	ADRENAL HYPOPLASIA, CONGENITAL	NR0B1, ASN440ILE	28935481
300473	190	NR0B1	0009	ADRENAL HYPOPLASIA, CONGENITAL	NR0B1, GLN395TER	104894894
300473	190	NR0B1	0010	ADRENAL HYPOPLASIA, CONGENITAL	NR0B1, TYR271TER	104894895
300473	190	NR0B1	0011	ADRENAL HYPOPLASIA, CONGENITAL	NR0B1, TYR91TER	104894892
300473	190	NR0B1	0012	ADRENAL HYPOPLASIA, CONGENITAL	NR0B1, 2-BP DEL, 1610AG, AND 1-BP INS	
300473	190	NR0B1	0013	ADRENAL HYPOPLASIA, CONGENITAL	NR0B1, 1-BP DEL, 1169C	
300473	190	NR0B1	0014	46,XY SEX REVERSAL 2	NR0B1, DUP	
300473	190	NR0B1	0015	ADRENAL HYPOPLASIA, CONGENITAL	NR0B1, 2-BP DEL, 388AG	
300473	190	NR0B1	0016	ADRENAL HYPOPLASIA, CONGENITAL	NR0B1, LYS382ASN	104894896
300473	190	NR0B1	0017	ADRENAL HYPOPLASIA, CONGENITAL	NR0B1, TRP291CYS	28935482
300473	190	NR0B1	0018	ADRENAL HYPOPLASIA, CONGENITAL	NR0B1, DEL	
300473	190	NR0B1	0019	ADRENAL HYPOPLASIA, CONGENITAL	NR0B1, 4-BP DEL, NT1464	
300473	190	NR0B1	0020	ADRENAL HYPOPLASIA, CONGENITAL	NR0B1, ILE439SER	104894897
300473	190	NR0B1	0021	ADRENAL HYPOPLASIA, CONGENITAL	NR0B1, TYR197TER	104894898
300473	190	NR0B1	0022	ADRENAL HYPOPLASIA, CONGENITAL	NR0B1, 1-BP DEL, 501A	
300473	190	NR0B1	0023	ADRENAL HYPOPLASIA, CONGENITAL	NR0B1, LEU381HIS	104894899
300473	190	NR0B1	0024	ADRENAL HYPOPLASIA, CONGENITAL, WITH PRECOCIOUS PUBERTY	NR0B1, 1-BP INS, 430G	
300473	190	NR0B1	0025	ADRENAL HYPOPLASIA, CONGENITAL	NR0B1, TYR380ASP	104894900
300473	190	NR0B1	0026	ADRENAL INSUFFICIENCY, PROGRESSIVE, AND HYPOGONADOTROPIC HYPOGONADISM	NR0B1, 2.2-KB DEL/27-BP INS	
300473	190	NR0B1	0027	ADRENAL HYPOPLASIA, CONGENITAL	NR0B1, TYR399TER	104894906
300473	190	NR0B1	0028	ADRENAL HYPOPLASIA, CONGENITAL	NR0B1, LEU297PRO	104894907
300473	190	NR0B1	0029	ADRENAL HYPOPLASIA, CONGENITAL	NR0B1, GLN37TER	104894908
300473	190	NR0B1	0030	MINERALOCORTICOID DEFICIENCY, ISOLATED	NR0B1, TRP105CYS	132630327
300474	2710	GK	0001	GLYCEROL KINASE DEFICIENCY, ISOLATED	GK, IVS6AS, G-C, -1	
300474	2710	GK	0002	GLYCEROL KINASE DEFICIENCY, ISOLATED	GK, EX17DEL	
300474	2710	GK	0003	GLYCEROL KINASE DEFICIENCY, ISOLATED	GK, ASP440VAL	132630328
300474	2710	GK	0004	GLYCEROL KINASE DEFICIENCY, ISOLATED	GK, 20-KB DEL	
300474	2710	GK	0005	GLYCEROL KINASE DEFICIENCY, ISOLATED	GK, ARG413TER	132630329
300474	2710	GK	0006	GLYCEROL KINASE DEFICIENCY, ISOLATED	GK, TRP503ARG	132630330
300474	2710	GK	0007	GLYCEROL KINASE DEFICIENCY, ISOLATED	GK, ALU INS, IVS4	
300474	2710	GK	0008	HYPERGLYCEROLEMIA	GK, ASN288ASP	132630331
300481	1536	CYBB	0001	GRANULOMATOUS DISEASE, CHRONIC, X-LINKED, VARIANT	CYBB, PRO415HIS	137854585
300481	1536	CYBB	0002	GRANULOMATOUS DISEASE, CHRONIC, X-LINKED, VARIANT	CYBB, GLY389ALA	137854586
300481	1536	CYBB	0003	GRANULOMATOUS DISEASE, CHRONIC, X-LINKED	CYBB, HIS209TYR	137854587
300481	1536	CYBB	0004	GRANULOMATOUS DISEASE, CHRONIC, X-LINKED	CYBB, ARG73TER	137854588
300481	1536	CYBB	0005	GRANULOMATOUS DISEASE, CHRONIC, X-LINKED, VARIANT	CYBB, CYS244SER	137854589
300481	1536	CYBB	0006	GRANULOMATOUS DISEASE, CHRONIC, X-LINKED, VARIANT	CYBB, ALA156THR	137854590
300481	1536	CYBB	0007	GRANULOMATOUS DISEASE, CHRONIC, X-LINKED, VARIANT	CYBB, HIS101ARG	137854591
300481	1536	CYBB	0008	GRANULOMATOUS DISEASE, CHRONIC, X-LINKED	CYBB, EX12DEL	
300481	1536	CYBB	0009	GRANULOMATOUS DISEASE, CHRONIC, X-LINKED	CYBB, ARG226TER	137854592
300481	1536	CYBB	0010	GRANULOMATOUS DISEASE, CHRONIC, X-LINKED	CYBB, IVS3, G-A, +5	
300481	1536	CYBB	0011	GRANULOMATOUS DISEASE, CHRONIC, X-LINKED	CYBB, ASP500GLY	137854593
300481	1536	CYBB	0012	GRANULOMATOUS DISEASE, CHRONIC, X-LINKED, VARIANT	CYBB, HIS101TYR	137854594
300481	1536	CYBB	0013	GRANULOMATOUS DISEASE, CHRONIC, X-LINKED	CYBB, 250GCG-GCA	
300481	1536	CYBB	0014	GRANULOMATOUS DISEASE, CHRONIC, X-LINKED	CYBB, IN5, L1 INS	
300481	1536	CYBB	0015	GRANULOMATOUS DISEASE, CHRONIC, X-LINKED	CYBB, 252G-A	
300481	1536	CYBB	0016	GRANULOMATOUS DISEASE, CHRONIC, X-LINKED, VARIANT	CYBB, HIS303ASN	137854595
300481	1536	CYBB	0017	GRANULOMATOUS DISEASE, CHRONIC, X-LINKED	CYBB, PRO304ARG	137854596
300481	1536	CYBB	0018	GRANULOMATOUS DISEASE, CHRONIC, X-LINKED	CYBB, IVS5, G-T, +978	
300481	1536	CYBB	0019	GRANULOMATOUS DISEASE, CHRONIC, X-LINKED	CYBB, EX4, L1 INS	
300481	1536	CYBB	0020	GRANULOMATOUS DISEASE, CHRONIC, X-LINKED	CYBB, IVS1, T-C, +6	
300481	1536	CYBB	0021	GRANULOMATOUS DISEASE, CHRONIC, X-LINKED, SOMATIC MOSAIC	CYBB, 90CCG-GGT	
300481	1536	CYBB	0022	ATYPICAL MYCOBACTERIOSIS, FAMILIAL, X-LINKED 2	CYBB, GLU231PRO	
300481	1536	CYBB	0023	ATYPICAL MYCOBACTERIOSIS, FAMILIAL, X-LINKED 2	CYBB, THR178PRO	
300485	54880	BCOR	0001	MICROPHTHALMIA, SYNDROMIC 2	BCOR, PRO85LEU	121434618
300485	54880	BCOR	0002	MICROPHTHALMIA, SYNDROMIC 2	BCOR, IVS8AS, G-T, -1	
300485	54880	BCOR	0003	MICROPHTHALMIA, SYNDROMIC 2	BCOR, ARG976TER	121434619
300485	54880	BCOR	0004	MICROPHTHALMIA, SYNDROMIC 2	BCOR, 1-BP DEL, 3881A	
300485	54880	BCOR	0005	MICROPHTHALMIA, SYNDROMIC 2	BCOR, EX9-15DEL	
300485	54880	BCOR	0006	MICROPHTHALMIA, SYNDROMIC 2	BCOR, 2-BP DEL, 2488AG	
300485	54880	BCOR	0007	MICROPHTHALMIA, SYNDROMIC 2	BCOR, 1-BP DEL, 3286G	
300485	54880	BCOR	0008	MICROPHTHALMIA, SYNDROMIC 2	BCOR, 60-KB DEL	
300485	54880	BCOR	0009	MICROPHTHALMIA, SYNDROMIC 2	BCOR, 1-BP DEL, 1315C	
300490	4068	SH2D1A	0001	LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1	SH2D1A, ARG55TER	111033623
300490	4068	SH2D1A	0002	LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1	SH2D1A, GLN58TER	111033628
300490	4068	SH2D1A	0003	LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1	SH2D1A, 159-BP DEL	
300490	4068	SH2D1A	0004	LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1	SH2D1A, ARG32THR	111033624
300490	4068	SH2D1A	0005	LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1	SH2D1A, IVS2AS, G-T, -1	
300490	4068	SH2D1A	0006	LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1	SH2D1A, TER129ARG	111033625
300490	4068	SH2D1A	0007	LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1	SH2D1A, PRO101LEU	111033626
300490	4068	SH2D1A	0008	LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1	SH2D1A, THR68ILE	111033627
300490	4068	SH2D1A	0009	LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1	SH2D1A, -10C-T	
300490	4068	SH2D1A	0010	LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1	SH2D1A, EX1DEL	
300490	4068	SH2D1A	0011	LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1	SH2D1A, MET1ILE	111033629
300490	4068	SH2D1A	0012	LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1	SH2D1A, 163C-T	
300490	4068	SH2D1A	0013	LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1	SH2D1A, ARG55LEU	111033630
300499	24140	FTSJ1	0001	MENTAL RETARDATION, X-LINKED 44	FTSJ1, EX9DEL	
300499	24140	FTSJ1	0002	MENTAL RETARDATION, X-LINKED 44	FTSJ1, 196C-T	
300499	24140	FTSJ1	0003	MENTAL RETARDATION, X-LINKED 44	FTSJ1, IVS2, G DEL, +1	
300499	24140	FTSJ1	0004	MENTAL RETARDATION, X-LINKED 9	FTSJ1, IVS3AS, A-G, -2	
300502	5160	PDHA1	0001	PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY	PDHA1, 4-BP DEL	
300502	5160	PDHA1	0002	PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY	PDHA1, 7-BP DEL	
300502	5160	PDHA1	0003	PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY	PDHA1, ARG378HIS	137853250
300502	5160	PDHA1	0004	PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY	PDHA1, LYS313DEL	137853251
300502	5160	PDHA1	0005	PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY	PDHA1, 2-BP DEL	
300502	5160	PDHA1	0006	PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY	PDHA1, 20-BP DEL, EX11DEL	
300502	5160	PDHA1	0007	PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY	PDHA1, 21-BP INS	
300502	5160	PDHA1	0008	PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY	PDHA1, ARG234GLY	
300502	5160	PDHA1	0009	PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY	PDHA1, ARG302CYS	137853252
300502	5160	PDHA1	0010	PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY	PDHA1, 4-BP INS, 1251ACTA	
300502	5160	PDHA1	0011	LEIGH SYNDROME, X-LINKED	PDHA1, ASP258ALA	137853253
300502	5160	PDHA1	0012	PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY	PDHA1, PHE205LEU	137853254
300502	5160	PDHA1	0013	PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY	PDHA1, TYR243ASN	137853255
300502	5160	PDHA1	0014	PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY	PDHA1, ASP315ASN	137853256
300502	5160	PDHA1	0015	PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY	PDHA1, MET282LEU	2229137
300502	5160	PDHA1	0016	PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY	PDHA1, 1-BP INS, FS141TER	
300502	5160	PDHA1	0017	PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY	PDHA1, ARG10PRO	137853257
300502	5160	PDHA1	0018	PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY	PDHA1, 13-BP INS, EX10	
300502	5160	PDHA1	0019	PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY	PDHA1, 36-BP INS	
300502	5160	PDHA1	0020	PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY	PDHA1, ARG288HIS	137853258
300502	5160	PDHA1	0021	PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY	PDHA1, 12-BP INS, EX11	
300502	5160	PDHA1	0022	LEIGH SYNDROME, X-LINKED	PDHA1, ARG263GLY	137853259
300502	5160	PDHA1	0023	PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY	PDHA1, LEU216PHE	
300515	2187	FANCB	0001	FANCONI ANEMIA, COMPLEMENTATION GROUP B	FANCB, 1-BP INS, 1838T	
300515	2187	FANCB	0002	FANCONI ANEMIA, COMPLEMENTATION GROUP B	FANCB, 3314-BP DEL	
300515	2187	FANCB	0003	FANCONI ANEMIA, COMPLEMENTATION GROUP B	FANCB, 1-BP DEL, 1650T	
300515	2187	FANCB	0004	FANCONI ANEMIA, COMPLEMENTATION GROUP B	FANCB, 1-BP INS, 811T	
300515	2187	FANCB	0005	FANCONI ANEMIA, COMPLEMENTATION GROUP B	FANCB, IVS7DS, G-A, +5	
300515	2187	FANCB	0006	FANCONI ANEMIA, COMPLEMENTATION GROUP B	FANCB, LEU717TER	
300515	2187	FANCB	0007	FANCONI ANEMIA, COMPLEMENTATION GROUP B	FANCB, 2-BP DEL, 1857AG	
300522	23096	IQSEC2	0001	MENTAL RETARDATION, X-LINKED 1	IQSEC2, ARG863TRP	
300522	23096	IQSEC2	0002	MENTAL RETARDATION, X-LINKED 18	IQSEC2, GLN801PRO	
300522	23096	IQSEC2	0003	MENTAL RETARDATION, X-LINKED 1	IQSEC2, ARG758GLN	
300522	23096	IQSEC2	0004	MENTAL RETARDATION, X-LINKED 1	IQSEC2, ARG359CYS	
300526	11152	WDR45	0001	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5	WDR45, 1-BP DEL, NT1007	
300526	11152	WDR45	0002	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5	WDR45, ARG234TER	
300526	11152	WDR45	0003	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5	WDR45, 516G-C	
300526	11152	WDR45	0004	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5	WDR45, 1-BP DUP, 437A	
300526	11152	WDR45	0005	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5	WDR45, GLN213TER	
300535	4952	OCRL	0001	LOWE OCULOCEREBRORENAL SYNDROME	OCRL, 112-BP DEL	
300535	4952	OCRL	0002	LOWE OCULOCEREBRORENAL SYNDROME	OCRL, ARG-TER	
300535	4952	OCRL	0003	LOWE OCULOCEREBRORENAL SYNDROME	OCRL, ARG577GLN	137853260
300535	4952	OCRL	0004	LOWE OCULOCEREBRORENAL SYNDROME	OCRL, HIS601GLN	137853261
300535	4952	OCRL	0005	DENT DISEASE 2	OCRL, TYR462CYS	137853262
300535	4952	OCRL	0006	DENT DISEASE 2	OCRL, ARG301CYS	137853263
300535	4952	OCRL	0007	DENT DISEASE 2	OCRL, ARG476TRP	
300535	4952	OCRL	0008	DENT DISEASE 2	OCRL, ILE526THR	
300535	4952	OCRL	0009	DENT DISEASE 2	OCRL, 2-BP DEL, 166TT	
300538	554	AVPR2	0001	DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	AVPR2, 1-BP DEL, 733G	
300538	554	AVPR2	0002	DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	AVPR2, ALA132ASP	104894747
300538	554	AVPR2	0003	DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	AVPR2, GLY185CYS	104894748
300538	554	AVPR2	0004	DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	AVPR2, TYR205CYS	104894749
300538	554	AVPR2	0005	DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	AVPR2, ARG203CYS	104894750
300538	554	AVPR2	0006	DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	AVPR2, ARG113TRP	28935496
300538	554	AVPR2	0007	DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	AVPR2, 1-BP INS	
300538	554	AVPR2	0008	DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	AVPR2, TRP71TER	104894751
300538	554	AVPR2	0009	DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	AVPR2, TYR280CYS	104894752
300538	554	AVPR2	0010	DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	AVPR2, ARG337TER	104894753
300538	554	AVPR2	0011	DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	AVPR2, ASP85ASN	104894754
300538	554	AVPR2	0012	DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	AVPR2, GLY201ASP	104894755
300538	554	AVPR2	0013	DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	AVPR2, 1-BP INS, 804G	
300538	554	AVPR2	0014	DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	AVPR2, 1-BP DEL, 102G	
300538	554	AVPR2	0015	DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	AVPR2, ARG137HIS	104894756
300538	554	AVPR2	0016	DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	AVPR2, ARG181CYS	104894757
300538	554	AVPR2	0017	DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	AVPR2, PHE105VAL	104894758
300538	554	AVPR2	0018	DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	AVPR2, ILE46LYS	104894759
300538	554	AVPR2	0020	DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	AVPR2, ARG104CYS	104894760
300538	554	AVPR2	0021	NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS	AVPR2, ARG137CYS	104894761
300538	554	AVPR2	0022	NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS	AVPR2, ARG137LEU	104894756
300546	2245	FGD1	0001	AARSKOG-SCOTT SYNDROME	FGD1, 1-BP INS, 2122G	
300546	2245	FGD1	0002	AARSKOG-SCOTT SYNDROME	FGD1, ARG610GLN	28935497
300546	2245	FGD1	0003	AARSKOG-SCOTT SYNDROME	FGD1, ARG522HIS	137853264
300546	2245	FGD1	0004	AARSKOG-SCOTT SYNDROME	FGD1, EX9-12DEL	
300546	2245	FGD1	0005	MENTAL RETARDATION, X-LINKED, SYNDROMIC 16	FGD1, PRO312LEU	28935498
300546	2245	FGD1	0006	AARSKOG-SCOTT SYNDROME	FGD1, 1-BP INS, 528C	
300546	2245	FGD1	0007	AARSKOG-SCOTT SYNDROME WITH ATTENTION DEFICIT-HYPERACTIVITY DISORDER	FGD1, ARG408GLN	137853265
300546	2245	FGD1	0008	AARSKOG-SCOTT SYNDROME	FGD1, 1-BP DEL, 2189A	
300546	2245	FGD1	0009	AARSKOG-SCOTT SYNDROME WITH ATTENTION DEFICIT-HYPERACTIVITY DISORDER	FGD1, ARG433LEU	137853266
300546	2245	FGD1	0010	AARSKOG-SCOTT SYNDROME	FGD1, 1-BP INS, 945C	
300546	2245	FGD1	0011	AARSKOG-SCOTT SYNDROME	FGD1, MET466VAL	137853267
300546	2245	FGD1	0012	AARSKOG-SCOTT SYNDROME	FGD1, ARG656TER	
300550	5251	PHEX	0001	HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT	PHEX, 2-BP DEL, 675TC	
300550	5251	PHEX	0002	HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT	PHEX, IVS1AS, G-A, -1	
300550	5251	PHEX	0003	HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT	PHEX, IVS1AS, G-C, -1	
300550	5251	PHEX	0004	HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT	PHEX, LEU274TER	137853268
300550	5251	PHEX	0005	HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT	PHEX, CYS82TYR	137853269
300550	5251	PHEX	0006	HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT	PHEX, PHE249SER AND MET250ILE	
300550	5251	PHEX	0007	HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT	PHEX, LEU555PRO	137853270
300550	5251	PHEX	0008	HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT	PHEX, A-G, NT-429	
300550	5251	PHEX	0009	HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT	PHEX, IVS7, +1268, G-T	
300550	5251	PHEX	0010	HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT	PHEX, ARG567TER	137853271
300550	5251	PHEX	0011	HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT	PHEX, IVS4, T-C, +6	
300552	4281	MID1	0001	OPITZ SYNDROME, X-LINKED	MID1, 3-BP DEL, MET438	
300552	4281	MID1	0002	OPITZ SYNDROME, X-LINKED	MID1, 24-BP DUP	
300552	4281	MID1	0003	OPITZ SYNDROME, X-LINKED	MID1, 1-BP INS	
300552	4281	MID1	0004	OPITZ SYNDROME, X-LINKED	MID1, LEU626PRO	28934611
300552	4281	MID1	0005	OPITZ SYNDROME, X-LINKED	MID1, GLU115TER	104894865
300552	4281	MID1	0006	OPITZ SYNDROME, X-LINKED	MID1, EX1 DUP	
300552	4281	MID1	0007	OPITZ SYNDROME, X-LINKED	MID1, LEU295PRO	104894866
300552	4281	MID1	0008	OPITZ SYNDROME, X-LINKED	MID1, 2-BP DEL, 1545GA	
300552	4281	MID1	0009	OPITZ SYNDROME, X-LINKED	MID1, GLU238TER	
300553	254065	BRWD3	0001	MENTAL RETARDATION, X-LINKED 93	BRWD3, IVS29, G-T, +1	
300553	254065	BRWD3	0002	MENTAL RETARDATION, X-LINKED 93	BRWD3, 1-BP INS, 946A	
300553	254065	BRWD3	0003	MENTAL RETARDATION, X-LINKED 93	BRWD3, LYS1596GLU	137853272
300556	10159	ATP6AP2	0001	MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE	ATP6AP2, ASP107ASP	121918521
300560	23133	PHF8	0001	SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME	PHF8, 12-BP DEL	
300560	23133	PHF8	0002	SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME	PHF8, ARG211TER	121918522
300560	23133	PHF8	0003	SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME	PHF8, LYS177TER	121918523
300560	23133	PHF8	0004	SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME	PHF8, PHE279SER	121918524
300573	641339	ZNF674	0001	MENTAL RETARDATION, X-LINKED 92	ZNF674, GLU118TER	121918362
300579	57477	SHROOM4	0001	STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME	SHROOM4, SER1089LEU	121434620
300603	79983	POF1B	0001	PREMATURE OVARIAN FAILURE 2B	POF1B, ARG329GLN	75398746
300611	29071	C1GALT1C1	0001	TN POLYAGGLUTINATION SYNDROME, SOMATIC	C1GALT1C1, ARG68TER	137853598
300611	29071	C1GALT1C1	0002	TN POLYAGGLUTINATION SYNDROME, SOMATIC	C1GALT1C1, ASP131GLU	17261572
300611	29071	C1GALT1C1	0003	TN POLYAGGLUTINATION SYNDROME, SOMATIC	C1GALT1C1, GLU152LYS	137853599
300611	29071	C1GALT1C1	0004	TN POLYAGGLUTINATION SYNDROME, SOMATIC	C1GALT1C1, SER193PRO	
300611	29071	C1GALT1C1	0005	TN POLYAGGLUTINATION SYNDROME, SOMATIC	C1GALT1C1, MET1ILE	
300628	90167	FRMD7	0001	NYSTAGMUS 1, CONGENITAL, X-LINKED	FRMD7, GLN201TER	137852207
300628	90167	FRMD7	0002	NYSTAGMUS 1, CONGENITAL, X-LINKED NYSTAGMUS, INFANTILE PERIODIC ALTERNATING, X-LINKED, INCLUDED	FRMD7, ARG335TER	137852208
300628	90167	FRMD7	0003	NYSTAGMUS 1, CONGENITAL, X-LINKED	FRMD7, IVS3DS, T-G, +2	
300628	90167	FRMD7	0004	NYSTAGMUS 1, CONGENITAL, X-LINKED	FRMD7, VAL84VAL	137852209
300628	90167	FRMD7	0005	NYSTAGMUS 1, CONGENITAL, X-LINKED NYSTAGMUS, INFANTILE PERIODIC ALTERNATING, X-LINKED, INCLUDED	FRMD7, GLY24ARG	137852210
300628	90167	FRMD7	0006	NYSTAGMUS 1, CONGENITAL, X-LINKED	FRMD7, 3-BP DEL, 41AGA	
300628	90167	FRMD7	0007	NYSTAGMUS 1, CONGENITAL, X-LINKED	FRMD7, LEU142ARG	137852211
300628	90167	FRMD7	0008	NYSTAGMUS 1, CONGENITAL, X-LINKED	FRMD7, ARG229GLY	137852212
300628	90167	FRMD7	0009	NYSTAGMUS 1, CONGENITAL, X-LINKED	FRMD7, 2-BP DEL, 1274TG	
300628	90167	FRMD7	0010	NYSTAGMUS 1, CONGENITAL, X-LINKED NYSTAGMUS, INFANTILE PERIODIC ALTERNATING, X-LINKED, INCLUDED	FRMD7, LEU231VAL	
300628	90167	FRMD7	0011	NYSTAGMUS 1, CONGENITAL, X-LINKED NYSTAGMUS, INFANTILE PERIODIC ALTERNATING, X-LINKED, INCLUDED	FRMD7, CYS271TYR	
300628	90167	FRMD7	0012	NYSTAGMUS, INFANTILE PERIODIC ALTERNATING, X-LINKED	FRMD7, IVS11, G-A, +5	
300629	8905	AP1S2	0001	MENTAL RETARDATION, X-LINKED 59	AP1S2, GLN36TER	104894739
300629	8905	AP1S2	0002	MENTAL RETARDATION, X-LINKED 59	AP1S2, ARG52TER	104894735
300629	8905	AP1S2	0003	MENTAL RETARDATION, X-LINKED 59	AP1S2, 4-BP DEL, NT180	
300629	8905	AP1S2	0004	MENTAL RETARDATION, X-LINKED 59	AP1S2, IVS3DS, G-A, +5	
300629	8905	AP1S2	0005	MENTAL RETARDATION, X-LINKED 59	AP1S2, GLN66TER	137852213
300642	27286	SRPX2	0001	ROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, X-LINKED	SRPX2, ASN327SER	121918363
300642	27286	SRPX2	0002	ROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, X-LINKED	SRPX2, TYR72SER	121918364
300644	2717	GLA	0001	FABRY DISEASE	GLA, ARG356TRP	104894827
300644	2717	GLA	0002	FABRY DISEASE	GLA, EX3DEL	
300644	2717	GLA	0003	FABRY DISEASE, CARDIAC VARIANT FABRY DISEASE, INCLUDED	GLA, ARG301GLN	104894828
300644	2717	GLA	0004	FABRY DISEASE	GLA, TRP44TER	104894829
300644	2717	GLA	0005	FABRY DISEASE, CARDIAC VARIANT	GLA, MET296VAL	104894830
300644	2717	GLA	0006	FABRY DISEASE	GLA, EX4DEL	
300644	2717	GLA	0007	FABRY DISEASE	GLA, IVS6DS, G-T, +1	
300644	2717	GLA	0008	FABRY DISEASE, CARDIAC VARIANT	GLA, GLN279GLU	28935485
300644	2717	GLA	0009	FABRY DISEASE	GLA, PRO40SER	104894831
300644	2717	GLA	0010	FABRY DISEASE	GLA, GLY328ARG	104894832
300644	2717	GLA	0011	FABRY DISEASE	GLA, GLU66GLN AND ARG112CYS	104894833
300644	2717	GLA	0012	FABRY DISEASE	GLA, ASN34SER	104894835
300644	2717	GLA	0013	FABRY DISEASE	GLA, CYS56GLY	104894836
300644	2717	GLA	0014	FABRY DISEASE	GLA, PRO146SER	104894837
300644	2717	GLA	0015	FABRY DISEASE	GLA, ALA156THR	28935195
300644	2717	GLA	0016	FABRY DISEASE	GLA, TRP162ARG	28935196
300644	2717	GLA	0017	FABRY DISEASE	GLA, CYS202TRP	104894838
300644	2717	GLA	0018	FABRY DISEASE	GLA, ASN215SER	28935197
300644	2717	GLA	0019	FABRY DISEASE	GLA, ARG227GLN	104894840
300644	2717	GLA	0020	FABRY DISEASE	GLA, ARG227TER	104894841
300644	2717	GLA	0021	FABRY DISEASE	GLA, ASP264VAL	28935486
300644	2717	GLA	0022	FABRY DISEASE	GLA, ASP266VAL	28935487
300644	2717	GLA	0023	FABRY DISEASE	GLA, VAL269ALA	28935488
300644	2717	GLA	0024	FABRY DISEASE	GLA, TRP287TER	104894839
300644	2717	GLA	0025	FABRY DISEASE	GLA, SER297PHE	28935489
300644	2717	GLA	0026	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	GLA, ASP313TYR	28935490
300644	2717	GLA	0027	FABRY DISEASE	GLA, GLN327LYS	28935491
300644	2717	GLA	0028	FABRY DISEASE	GLA, GLY328ALA	28935492
300644	2717	GLA	0029	FABRY DISEASE	GLA, TRP340TER	104894842
300644	2717	GLA	0030	FABRY DISEASE	GLA, ARG342GLN	28935493
300644	2717	GLA	0031	FABRY DISEASE	GLA, ARG342TER	104894843
300644	2717	GLA	0032	FABRY DISEASE	GLA, GLY361ARG	28935494
300644	2717	GLA	0033	FABRY DISEASE	GLA, GLU398TER	104894844
300644	2717	GLA	0034	FABRY DISEASE	GLA, IVSDS, GT-GG, +2	
300644	2717	GLA	0035	FABRY DISEASE	GLA, IVS5AS, DEL -2,-3	
300644	2717	GLA	0036	FABRY DISEASE	GLA, ALA143THR	104894845
300644	2717	GLA	0037	FABRY DISEASE	GLA, 13-BP DEL, NT125	
300644	2717	GLA	0038	FABRY DISEASE	GLA, 1-BP DEL, NT716	
300644	2717	GLA	0039	FABRY DISEASE	GLA, 2-BP DEL, NT773	
300644	2717	GLA	0040	FABRY DISEASE	GLA, 5-BP INS, NT954	
300644	2717	GLA	0041	FABRY DISEASE	GLA, 11-BP DEL, NT1016	
300644	2717	GLA	0042	FABRY DISEASE	GLA, 1-BP INS, NT1040	
300644	2717	GLA	0043	FABRY DISEASE	GLA, 53-BP DEL, NT1123	
300644	2717	GLA	0044	FABRY DISEASE	GLA, 2-BP DEL, NT1176	
300644	2717	GLA	0045	FABRY DISEASE	GLA, 3-BP DEL, 1208AAG	
300644	2717	GLA	0046	FABRY DISEASE	GLA, EX1-2DEL	
300644	2717	GLA	0047	FABRY DISEASE	GLA, EX3-4DEL	
300644	2717	GLA	0048	FABRY DISEASE	GLA, EX3-7DEL	
300644	2717	GLA	0049	FABRY DISEASE	GLA, EX6-7DEL	
300644	2717	GLA	0050	FABRY DISEASE	GLA, EX2-6DUP	
300644	2717	GLA	0051	FABRY DISEASE, CARDIAC VARIANT	GLA, MET296ILE	104894846
300644	2717	GLA	0052	FABRY DISEASE, CARDIAC VARIANT	GLA, ALA20PRO	104894847
300644	2717	GLA	0053	FABRY DISEASE	GLA, 3-BP DEL, PHE383DEL	
300644	2717	GLA	0054	FABRY DISEASE	GLA, SER65THR	104894848
300644	2717	GLA	0055	FABRY DISEASE	GLA, TYR365TER	104894849
300644	2717	GLA	0056	FABRY DISEASE, CARDIAC VARIANT	GLA, IVS4, G-A, -4	199473684
300644	2717	GLA	0057	FABRY DISEASE	GLA, ALA143PRO	104894845
300644	2717	GLA	0058	FABRY DISEASE	GLA, TYR222TER	104894851
300644	2717	GLA	0059	FABRY DISEASE	GLA, THR410ALA	104894852
300644	2717	GLA	0060	FABRY DISEASE	GLA, 2-BP DEL, 1277AA	
300644	2717	GLA	0061	FABRY DISEASE	GLA, 4-BP DEL, 1284ACTT	
300644	2717	GLA	0062	FABRY DISEASE	GLA, ASN272SER	28935495
300646	51114	ZDHHC9	0001	MENTAL RETARDATION, X-LINKED, SYNDROMIC, RAYMOND TYPE	ZDHHC9, 4-BP DUP, 172CGCT	
300646	51114	ZDHHC9	0002	MENTAL RETARDATION, X-LINKED, SYNDROMIC, RAYMOND TYPE	ZDHHC9, 167+5G-C	
300646	51114	ZDHHC9	0003	MENTAL RETARDATION, X-LINKED, SYNDROMIC, RAYMOND TYPE	ZDHHC9, ARG148TRP	137852214
300646	51114	ZDHHC9	0004	MENTAL RETARDATION, X-LINKED, SYNDROMIC, RAYMOND TYPE	ZDHHC9, PRO150SER	137852215
300647	139285	AMER1	0001	OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	FAM123B, 1-BP DEL, 671C	
300647	139285	AMER1	0002	OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	FAM123B, 1-BP INS, 780A	
300647	139285	AMER1	0003	OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	FAM123B, DEL	
300647	139285	AMER1	0004	OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	FAM123B, ARG353TER	137852216
300647	139285	AMER1	0005	OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	FAM123B, ARG358TER	137852217
300647	139285	AMER1	0006	OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	FAM123B, CYS143TER	
300647	139285	AMER1	0007	OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	FAM123B, 1-BP DEL, 1267C	
300647	139285	AMER1	0008	OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	FAM123B, GLN271TER	
300651	64840	PORCN	0001	FOCAL DERMAL HYPOPLASIA	PORCN, 13-BP DUP, NT1059	
300651	64840	PORCN	0002	FOCAL DERMAL HYPOPLASIA	PORCN, 178G-A, GLY60ARG	
300651	64840	PORCN	0003	FOCAL DERMAL HYPOPLASIA	PORCN, ARG124TER	137852218
300651	64840	PORCN	0004	FOCAL DERMAL HYPOPLASIA	PORCN, TRP74TER	137852219
300651	64840	PORCN	0005	FOCAL DERMAL HYPOPLASIA	PORCN, ARG365GLN	
300658	4693	NDP	0001	NORRIE DISEASE	NDP, ARG90PRO	104894867
300658	4693	NDP	0002	NORRIE DISEASE	NDP, SER75CYS	104894868
300658	4693	NDP	0003	NORRIE DISEASE	NDP, VAL60GLU	104894869
300658	4693	NDP	0004	NORRIE DISEASE	NDP, TYR44CYS	104894870
300658	4693	NDP	0005	NORRIE DISEASE	NDP, CYS96TYR	104894871
300658	4693	NDP	0006	EXUDATIVE VITREORETINOPATHY 2, X-LINKED	NDP, LEU124PHE	28933684
300658	4693	NDP	0007	NORRIE DISEASE	NDP, CYS69SER	104894872
300658	4693	NDP	0008	NORRIE DISEASE	NDP, CYS128TER	104894873
300658	4693	NDP	0009	NORRIE DISEASE	NDP, MET1VAL	28933685
300658	4693	NDP	0010	EXUDATIVE VITREORETINOPATHY 2, X-LINKED	NDP, ARG121TRP	104894878
300658	4693	NDP	0011	NORRIE DISEASE	NDP, LEU13ARG	104894879
300658	4693	NDP	0012	NORRIE DISEASE	NDP, LEU61PHE	104894880
300658	4693	NDP	0013	EXUDATIVE VITREORETINOPATHY, X-LINKED	NDP, HIS42ARG	104894874
300658	4693	NDP	0014	NORRIE DISEASE	NDP, 1-BP DEL	
300658	4693	NDP	0015	NORRIE DISEASE	NDP, ALA105THR	104894875
300658	4693	NDP	0016	EXUDATIVE VITREORETINOPATHY 2, X-LINKED	NDP, CYS110GLY	104894876
300658	4693	NDP	0017	EXUDATIVE VITREORETINOPATHY 2, X-LINKED	NDP, ARG121LEU	137852220
300658	4693	NDP	0018	NORRIE DISEASE	NDP, CYS96TRP	104894877
300658	4693	NDP	0019	NORRIE DISEASE	NDP, VAL45GLU	137852221
300658	4693	NDP	0020	NORRIE DISEASE	NDP, SER73TER	104894882
300658	4693	NDP	0021	NORRIE DISEASE	NDP, SER101PHE	104894883
300697	10075	HUWE1	0001	MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE	HUWE1, ARG4013TRP	121918525
300697	10075	HUWE1	0002	MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE	HUWE1, ARG2981HIS	121918526
300697	10075	HUWE1	0003	MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE	HUWE1, ARG4187CYS	121918527
300708	92002	FAM58A	0001	STAR SYNDROME	FAM58A, 40-KB DEL	
300708	92002	FAM58A	0002	STAR SYNDROME	FAM58A, 4249-BP DEL	
300708	92002	FAM58A	0003	STAR SYNDROME	FAM58A, IVS4, G-A, +1	
300708	92002	FAM58A	0004	STAR SYNDROME	FAM58A, 1-BP DUP	
300708	92002	FAM58A	0005	STAR SYNDROME	FAM58A, IVS4, G-A, -1	
300715	84061	MAGT1	0001	MENTAL RETARDATION, X-LINKED 95	MAGT1, VAL311GLY	137852222
300715	84061	MAGT1	0002	IMMUNODEFICIENCY, X-LINKED, WITH MAGNESIUM DEFECT, EPSTEIN-BARR VIRUS INFECTION, AND NEOPLASIA	MAGT1, IVS7AS, 10-BP DEL, -6	
300715	84061	MAGT1	0003	IMMUNODEFICIENCY, X-LINKED, WITH MAGNESIUM DEFECT, EPSTEIN-BARR VIRUS INFECTION, AND NEOPLASIA	MAGT1, ARG137TER	
300746	2158	F9	0001	HEMOPHILIA B LEYDEN	F9, -20T-A	
300746	2158	F9	0002	HEMOPHILIA B LEYDEN	F9, -6G-A	
300746	2158	F9	0003	HEMOPHILIA B LEYDEN	F9, -6G-C	
300746	2158	F9	0004	HEMOPHILIA B LEYDEN	F9, 1-BP DEL, +13A	
300746	2158	F9	0005	FACTOR IX POLYMORPHISM	F9, ILE-40PHE	
300746	2158	F9	0006	FACTOR IX POLYMORPHISM	F9, IVS1, 192A-G	
300746	2158	F9	0007	HEMOPHILIA B	F9, ARG-4TRP	
300746	2158	F9	0008	HEMOPHILIA B	F9, ARG-4GLN	
300746	2158	F9	0009	HEMOPHILIA B	F9, ARG-1SER	
300746	2158	F9	0010	HEMOPHILIA B	F9, GLU7ASP	
300746	2158	F9	0011	HEMOPHILIA B	F9, GLN11TER	137852223
300746	2158	F9	0012	HEMOPHILIA B	F9, CYS18ARG	137852224
300746	2158	F9	0013	HEMOPHILIA B	F9, GLU27LYS	137852225
300746	2158	F9	0014	HEMOPHILIA B	F9, GLU27VAL	137852226
300746	2158	F9	0015	HEMOPHILIA B	F9, ARG29TER	137852227
300746	2158	F9	0016	HEMOPHILIA B	F9, ARG29GLN	137852228
300746	2158	F9	0017	HEMOPHILIA B	F9, GLU33ASP	137852229
300746	2158	F9	0018	HEMOPHILIA B	F9, IVS3DS, T-G	
300746	2158	F9	0019	HEMOPHILIA B	F9, ASP47GLY	137852230
300746	2158	F9	0020	HEMOPHILIA B	F9, GLN50PRO	137852231
300746	2158	F9	0021	HEMOPHILIA B	F9, PRO55ALA	137852232
300746	2158	F9	0022	HEMOPHILIA B	F9, GLY60SER	137852233
300746	2158	F9	0023	HEMOPHILIA B	F9, ASP64GLY	137852234
300746	2158	F9	0024	HEMOPHILIA B	F9, GLY114ALA	137852235
300746	2158	F9	0025	HEMOPHILIA B	F9, ASN120TYR	137852236
300746	2158	F9	0026	HEMOPHILIA B	F9, ARG145CYS	137852237
300746	2158	F9	0027	HEMOPHILIA B	F9, ARG145HIS	137852238
300746	2158	F9	0028	DEEP VENOUS THROMBOSIS, PROTECTION AGAINST	F9, THR148ALA	6048
300746	2158	F9	0029	HEMOPHILIA B	F9, GLN173TER	137852239
300746	2158	F9	0030	HEMOPHILIA B	F9, ARG180TRP	137852240
300746	2158	F9	0031	HEMOPHILIA B(M)	F9, ARG180GLN	137852241
300746	2158	F9	0032	HEMOPHILIA B	F9, VAL181PHE	137852242
300746	2158	F9	0033	HEMOPHILIA B	F9, VAL182PHE	137852243
300746	2158	F9	0034	HEMOPHILIA B(M)	F9, VAL182LEU	137852243
300746	2158	F9	0035	HEMOPHILIA B	F9, GLN191TER	137852244
300746	2158	F9	0036	HEMOPHILIA B	F9, GLN191LEU	137852245
300746	2158	F9	0037	HEMOPHILIA B	F9, TRP194TER	
300746	2158	F9	0038	HEMOPHILIA B	F9, IVS6DS, G-T	
300746	2158	F9	0039	HEMOPHILIA B	F9, TRP215TER	
300746	2158	F9	0040	HEMOPHILIA B	F9, CYS222TRP	137852246
300746	2158	F9	0041	FACTOR IX, DNA POLYMORPHISM	F9, VAL227VAL	1800455
300746	2158	F9	0042	HEMOPHILIA B	F9, ALA233THR	137852247
300746	2158	F9	0043	HEMOPHILIA B	F9, IVS7AS, G-A	
300746	2158	F9	0044	HEMOPHILIA B	F9, ARG248TER	137852248
300746	2158	F9	0045	HEMOPHILIA B	F9, ARG248GLN	137852249
300746	2158	F9	0046	HEMOPHILIA B	F9, ARG252TER	137852250
300746	2158	F9	0047	HEMOPHILIA B	F9, ASN260SER	137852251
300746	2158	F9	0048	HEMOPHILIA B	F9, PRO287LEU	137852252
300746	2158	F9	0049	HEMOPHILIA B	F9, ALA291PRO	137852253
300746	2158	F9	0050	HEMOPHILIA B	F9, THR296MET	137852254
300746	2158	F9	0051	HEMOPHILIA B	F9, VAL307ALA	137852255
300746	2158	F9	0052	HEMOPHILIA B	F9, GLY309VAL	137852256
300746	2158	F9	0053	HEMOPHILIA B	F9, TRP310TER	
300746	2158	F9	0054	HEMOPHILIA B	F9, GLY311ARG	137852257
300746	2158	F9	0055	HEMOPHILIA B	F9, ARG333TER	137852258
300746	2158	F9	0056	HEMOPHILIA B	F9, ARG333GLN	137852259
300746	2158	F9	0057	HEMOPHILIA B	F9, CYS336ARG	137852260
300746	2158	F9	0058	HEMOPHILIA B	F9, ARG338TER	137852261
300746	2158	F9	0060	HEMOPHILIA B	F9, MET348VAL	137852262
300746	2158	F9	0061	HEMOPHILIA B	F9, SER360LEU	137852263
300746	2158	F9	0062	HEMOPHILIA B	F9, GLY363VAL	137852264
300746	2158	F9	0063	HEMOPHILIA B	F9, GLY367ARG	
300746	2158	F9	0064	HEMOPHILIA B	F9, PRO368THR	137852265
300746	2158	F9	0065	HEMOPHILIA B	F9, PHE378LEU	
300746	2158	F9	0066	HEMOPHILIA B	F9, ALA390GLU	137852266
300746	2158	F9	0067	HEMOPHILIA B	F9, ALA390VAL	137852266
300746	2158	F9	0068	HEMOPHILIA B	F9, GLY396ARG	137852267
300746	2158	F9	0069	HEMOPHILIA B	F9, ILE397THR	137852268
300746	2158	F9	0070	HEMOPHILIA B	F9, TRP407ARG	137852269
300746	2158	F9	0071	HEMOPHILIA B	F9, LYS411TER	137852270
300746	2158	F9	0072	HEMOPHILIA B	F9, EX1-8DEL	
300746	2158	F9	0073	HEMOPHILIA B	F9, EX1DEL	
300746	2158	F9	0074	HEMOPHILIA B	F9, EX1-3DEL	
300746	2158	F9	0075	HEMOPHILIA B	F9, EX2-8DEL	
300746	2158	F9	0076	HEMOPHILIA B	F9, EX4-5DEL	
300746	2158	F9	0077	HEMOPHILIA B	F9, EX4DEL	
300746	2158	F9	0078	HEMOPHILIA B	F9, EX4INS	
300746	2158	F9	0079	HEMOPHILIA B	F9, EX5-8DEL	
300746	2158	F9	0080	HEMOPHILIA B	F9, EX51INS	
300746	2158	F9	0081	HEMOPHILIA B	F9, EX7DEL	
300746	2158	F9	0082	HEMOPHILIA B	F9, 1-BP DEL, ASP85FS	
300746	2158	F9	0083	HEMOPHILIA B	F9, VAL328PHE	137852271
300746	2158	F9	0084	HEMOPHILIA B	F9, ARG116TER	137852272
300746	2158	F9	0085	FACTOR IX POLYMORPHISM	F9, HIS257TYR	1801202
300746	2158	F9	0086	HEMOPHILIA B	F9, CYS350SER	137852273
300746	2158	F9	0087	HEMOPHILIA B	F9, ASP64ASN	137852274
300746	2158	F9	0088	HEMOPHILIA B LEYDEN	F9, +8T-C	
300746	2158	F9	0089	HEMOPHILIA B LEYDEN	F9, -5A-T	
300746	2158	F9	0090	HEMOPHILIA B LEYDEN	F9, +13A-G	
300746	2158	F9	0091	HEMOPHILIA B	F9, GLY311GLU	137852275
300746	2158	F9	0092	HEMOPHILIA B	F9, IVS4, 4442-BP DEL	
300746	2158	F9	0093	HEMOPHILIA B	F9, SER365ILE	137852276
300746	2158	F9	0094	HEMOPHILIA B	F9, SER365GLY	137852277
300746	2158	F9	0095	HEMOPHILIA B	F9, ASP364HIS	137852278
300746	2158	F9	0096	HEMOPHILIA B	F9, GLU245VAL	137852279
300746	2158	F9	0097	HEMOPHILIA B BRANDENBURG	F9, -26G-C	
300746	2158	F9	0098	HEMOPHILIA B	F9, ALU INSERTION, EX5	
300746	2158	F9	0099	HEMOPHILIA B	HEMB, ILE-30ASN	
300746	2158	F9	0100	HEMOPHILIA B	HEMB, CYS-19ARG	
300746	2158	F9	0101	HEMOPHILIA B	F9, VAL373GLU	137852280
300746	2158	F9	0102	WARFARIN SENSITIVITY	F9, ALA-10THR	
300746	2158	F9	0103	WARFARIN SENSITIVITY	F9, ALA-10VAL	
300746	2158	F9	0104	HEMOPHILIA B	F9, ALA351PRO	137852281
300746	2158	F9	0105	HEMOPHILIA B	F9, 17747G-A	
300746	2158	F9	0106	HEMOPHILIA B	F9, 17747G-C	
300746	2158	F9	0107	HEMOPHILIA B	F9, IVS3DS, T-C, +2	
300746	2158	F9	0108	HEMOPHILIA B	F9, ILE344THR	137852282
300746	2158	F9	0109	HEMOPHILIA B	F9, CYS206SER	
300746	2158	F9	0110	HEMOPHILIA B	F9, 2-BP DEL	
300746	2158	F9	0111	HEMOPHILIA B	F9, ARG338PRO	137852283
300746	2158	F9	0112	THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT	F9, ARG338LEU	137852283
300746	2158	F9	0113	HEMOPHILIA B	F9, IVS3, A-G, -3	
300747	412	STS	0001	ICHTHYOSIS, X-LINKED	STS, TRP372ARG	137853165
300747	412	STS	0002	ICHTHYOSIS, X-LINKED	STS, CYS446TYR	137853166
300747	412	STS	0003	ICHTHYOSIS, X-LINKED	STS, SER341LEU	137853167
300747	412	STS	0004	ICHTHYOSIS, X-LINKED	STS, TRP372PRO	137853168
300747	412	STS	0005	ICHTHYOSIS, X-LINKED	STS, HIS444ARG	137853169
300747	412	STS	0006	ICHTHYOSIS, X-LINKED	STS, IVS8DS, G-T, +1	
300757	6102	RP2	0001	RETINITIS PIGMENTOSA 2	RP2, SER6DEL	137852284
300757	6102	RP2	0002	RETINITIS PIGMENTOSA 2	RP2, GLN26TER	104894925
300757	6102	RP2	0003	RETINITIS PIGMENTOSA 2	RP2, ARG118HIS	28933687
300757	6102	RP2	0004	RETINITIS PIGMENTOSA 2	RP2, TYR151TER	104894926
300757	6102	RP2	0005	RETINITIS PIGMENTOSA 2	RP2, 1-BP DEL	
300757	6102	RP2	0006	RETINITIS PIGMENTOSA 2	RP2, ARG118LEU	28933687
300757	6102	RP2	0007	RETINITIS PIGMENTOSA 2	RP2, 1-BP INS, 303T	
300757	6102	RP2	0008	RETINITIS PIGMENTOSA 2	RP2, ARG120TER	104894927
300774	116442	RAB39B	0001	MENTAL RETARDATION, X-LINKED 72	RAB39B, IVS1DS, G-A, +1	
300774	116442	RAB39B	0002	MENTAL RETARDATION, X-LINKED 72	RAB39B, TYR7TER	
300776	79868	ALG13	0001	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Is; CDG1S	ALG13, LYS94GLU	
300777	55217	TMLHE	0001	EPSILON-TRIMETHYLLYSINE HYDROXYLASE DEFICIENCY	TMLHE, EX2DEL	
300798	5256	PHKA2	0001	GLYCOGEN STORAGE DISEASE, TYPE IXa1	PHKA2, GLN1009TER	137852285
300798	5256	PHKA2	0002	GLYCOGEN STORAGE DISEASE, TYPE IXa1	PHKA2, GLN766TER	137852286
300798	5256	PHKA2	0003	GLYCOGEN STORAGE DISEASE, TYPE IXa1	PHKA2, IVS7DS, G-T, +1	
300798	5256	PHKA2	0004	GLYCOGEN STORAGE DISEASE, TYPE IXa1	PHKA2, SER1049TER	137852287
300798	5256	PHKA2	0005	GLYCOGEN STORAGE DISEASE, TYPE IXa1	PHKA2, PRO1205LEU	137852288
300798	5256	PHKA2	0006	GLYCOGEN STORAGE DISEASE, TYPE IXa1	PHKA2, 3-BP DEL, 419TCT	
300798	5256	PHKA2	0007	GLYCOGEN STORAGE DISEASE, TYPE IXa1	PHKA2, ASP299GLY	137852289
300798	5256	PHKA2	0008	GLYCOGEN STORAGE DISEASE, TYPE IXa2	PHKA2, ARG186HIS	137852290
300798	5256	PHKA2	0009	GLYCOGEN STORAGE DISEASE, TYPE IXa2	PHKA2, HIS132PRO	137852291
300798	5256	PHKA2	0010	GLYCOGEN STORAGE DISEASE, TYPE IXa2	PHKA2, HIS132TYR	137852292
300798	5256	PHKA2	0011	GLYCOGEN STORAGE DISEASE, TYPE IXa2	PHKA2, THR1114ILE	137852293
300798	5256	PHKA2	0012	GLYCOGEN STORAGE DISEASE, TYPE IXa2	PHKA2, ARG556CYS	137852294
300798	5256	PHKA2	0013	GLYCOGEN STORAGE DISEASE, TYPE IXa2	PHKA2, 3-BP DEL, NT750	
300798	5256	PHKA2	0014	GLYCOGEN STORAGE DISEASE, TYPE IXa2	PHKA2, 6-BP INS, NT3331	
300798	5256	PHKA2	0015	GLYCOGEN STORAGE DISEASE, TYPE IXa2	PHKA2, LYS189GLU	137852295
300806	2334	AFF2	0001	MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH FRAGILE SITE FRAXE	AFF2, (GCC)n EXPANSION	193922937
300806	2334	AFF2	0002	MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH FRAGILE SITE FRAXE	AFF2, 121- to 145-KB DEL	
300808	4935	GPR143	0001	ALBINISM, OCULAR, TYPE I	GPR143, 2-BP INS, NT992	
300808	4935	GPR143	0002	ALBINISM, OCULAR, TYPE I	GPR143, 17-BP DEL	
300808	4935	GPR143	0003	ALBINISM, OCULAR, TYPE I	GPR143, TRP133ARG	137852296
300808	4935	GPR143	0004	ALBINISM, OCULAR, TYPE I	GPR143, SER152ASN	58933950
300808	4935	GPR143	0005	ALBINISM, OCULAR, TYPE I	GPR143, THR232LYS	137852297
300808	4935	GPR143	0006	ALBINISM, OCULAR, TYPE I	GPR143, TRP133ARG	137852296
300808	4935	GPR143	0007	ALBINISM, OCULAR, TYPE I	GPR143, 420G-A	
300808	4935	GPR143	0008	ALBINISM, OCULAR, TYPE I	GPR143, GLY35ASP	62635018
300808	4935	GPR143	0009	NYSTAGMUS, 6, CONGENITAL, X-LINKED	GPR143, SER89PHE	137852298
300808	4935	GPR143	0010	ALBINISM, OCULAR, TYPE I	GPR143, 14-BP DEL, NT816	
300808	4935	GPR143	0011	NYSTAGMUS 6, CONGENITAL, X-LINKED	GPR143, 37-BP DEL	
300808	4935	GPR143	0012	NYSTAGMUS 6, CONGENITAL, X-LINKED	GPR143, 19-BP DUP	
300808	4935	GPR143	0013	OCULAR ALBINISM, TYPE I	GPR143, EX1-2DEL	
300821	2652	OPN1MW	0001	DEUTERANOMALY COLORBLINDNESS, DEUTAN	OPN1MW, CYS203ARG	104894914
300821	2652	OPN1MW	0002	BLUE CONE MONOCHROMACY	OPN1MW AND OPN1LW, CYS203ARG	
300821	2652	OPN1MW	0003	COLORBLINDNESS, DEUTAN	OPN1MW, ASN94LYS	104894915
300821	2652	OPN1MW	0004	COLORBLINDNESS, DEUTAN	OPN1MW, ARG330GLN	104894916
300821	2652	OPN1MW	0005	COLORBLINDNESS, DEUTAN	OPN1MW, -71A-C	
300821	2652	OPN1MW	0006	CONE DYSTROPHY 5, X-LINKED	OPN1MW, TRP177ARG	
300822	5956	OPN1LW	0001	BLUE CONE MONOCHROMACY	OPN1LW, ARG247TER	
300822	5956	OPN1LW	0002	RED CONE POLYMORPHISM	OPN1LW, SER180ALA	
300822	5956	OPN1LW	0003	BLUE CONE MONOCHROMACY	OPN1LW AND OPN1MW, CYS203ARG	
300822	5956	OPN1LW	0004	COLORBLINDNESS, PROTAN	RCP, GLY338GLU	
300822	5956	OPN1LW	0005	BLUE CONE MONOCHROMACY	OPN1LW, EX2DEL	
300823	3423	IDS	0001	MUCOPOLYSACCHARIDOSIS TYPE II	IDS, ARG443TER	199422227
300823	3423	IDS	0002	MUCOPOLYSACCHARIDOSIS TYPE II	IDS, SER333LEU	104894853
300823	3423	IDS	0003	MUCOPOLYSACCHARIDOSIS TYPE II	IDS, TRP502SER	199422228
300823	3423	IDS	0004	MUCOPOLYSACCHARIDOSIS TYPE II	IDS, PRO160ARG	104894856
300823	3423	IDS	0005	MUCOPOLYSACCHARIDOSIS TYPE II	IDS, ARG172TER	104894860
300823	3423	IDS	0006	MUCOPOLYSACCHARIDOSIS TYPE II	IDS, 60-BP DEL, NT1244	
300823	3423	IDS	0007	MUCOPOLYSACCHARIDOSIS TYPE II	IDS, DEL	
300823	3423	IDS	0008	MUCOPOLYSACCHARIDOSIS TYPE II	IDS, CYS422GLY	199422229
300823	3423	IDS	0009	MUCOPOLYSACCHARIDOSIS TYPE II	IDS, LYS135ARG	104894861
300823	3423	IDS	0010	MUCOPOLYSACCHARIDOSIS TYPE II	IDS, TRP475TER	199422230
300823	3423	IDS	0011	MUCOPOLYSACCHARIDOSIS TYPE II	IDS, 2-BP DEL, CODON 170	
300823	3423	IDS	0012	MUCOPOLYSACCHARIDOSIS TYPE II, MILD FORM	IDS, ARG468TRP	199422231
300823	3423	IDS	0013	MUCOPOLYSACCHARIDOSIS TYPE II, SEVERE FORM	IDS, ARG468GLN	113993946
300823	3423	IDS	0014	MUCOPOLYSACCHARIDOSIS TYPE II, MILD FORM	IDS, 78-BP INS	
300823	3423	IDS	0015	MUCOPOLYSACCHARIDOSIS TYPE II, SEVERE FORM	IDS, ARG468LEU	113993946
300823	3423	IDS	0016	MUCOPOLYSACCHARIDOSIS TYPE II	IDS, 3-BP DEL, 473TCC	
300823	3423	IDS	0017	MUCOPOLYSACCHARIDOSIS TYPE II	IDS, GLY489ALA, MET488ILE	
300836	3730	KAL1	0001	HYPOGONADOTROPIC HYPOGONADISM 1 WITH ANOSMIA	KAL1, 3,300-BP DEL	
300836	3730	KAL1	0002	HYPOGONADOTROPIC HYPOGONADISM 1 WITH ANOSMIA	KAL1, TRP237TER	
300836	3730	KAL1	0003	HYPOGONADOTROPIC HYPOGONADISM 1 WITH ANOSMIA	KAL1, ARG257TER	
300836	3730	KAL1	0004	HYPOGONADOTROPIC HYPOGONADISM 1 WITH ANOSMIA	KAL1, TRP258TER	
300836	3730	KAL1	0005	HYPOGONADOTROPIC HYPOGONADISM 1 WITH ANOSMIA	KAL1, 1-BP DEL, PRO277FS	
300836	3730	KAL1	0006	HYPOGONADOTROPIC HYPOGONADISM 1 WITH ANOSMIA	KAL1, EX3-5DEL	
300836	3730	KAL1	0007	HYPOGONADOTROPIC HYPOGONADISM 1 WITH ANOSMIA	KAL1, GLU514LYS	
300836	3730	KAL1	0008	HYPOGONADOTROPIC HYPOGONADISM 1 WITH ANOSMIA	KAL1, EX5DEL	
300836	3730	KAL1	0009	HYPOGONADOTROPIC HYPOGONADISM 1 WITH ANOSMIA	KAL1, 11-BP DUP, NT158	
300836	3730	KAL1	0010	HYPOGONADOTROPIC HYPOGONADISM 1 WITH ANOSMIA	KAL1, ARG262TER	
300836	3730	KAL1	0011	HYPOGONADOTROPIC HYPOGONADISM 1 WITH ANOSMIA	KAL1, EX3-13 DEL	
300836	3730	KAL1	0012	HYPOGONADOTROPIC HYPOGONADISM 1 WITH ANOSMIA	KAL1, SER396LEU	
300836	3730	KAL1	0013	HYPOGONADOTROPIC HYPOGONADISM 1 WITH ANOSMIA	KAL1, EX3-6 DEL	
300836	3730	KAL1	0014	HYPOGONADOTROPIC HYPOGONADISM 1 WITH ANOSMIA	KAL1, IVS7, G-A, +1	
300839	6247	RS1	0001	RETINOSCHISIS 1, X-LINKED, JUVENILE	RS1, TRP96ARG	
300839	6247	RS1	0002	RETINOSCHISIS 1, X-LINKED, JUVENILE	RS1, ARG102TRP	
300839	6247	RS1	0003	RETINOSCHISIS 1, X-LINKED, JUVENILE	RS1, GLU72LYS	
300839	6247	RS1	0004	RETINOSCHISIS 1, X-LINKED, JUVENILE	RS1, GLU72ASP	
300839	6247	RS1	0005	RETINOSCHISIS 1, X-LINKED, JUVENILE	RS1, GLY74VAL	
300839	6247	RS1	0006	RETINOSCHISIS 1, X-LINKED, JUVENILE	RS1, GLY109ARG	
300839	6247	RS1	0007	RETINOSCHISIS 1, X-LINKED, JUVENILE	RS1, LEU13PRO	
300839	6247	RS1	0008	RETINOSCHISIS 1, X-LINKED, JUVENILE	RS1, CYS223ARG	
300839	6247	RS1	0009	RETINOSCHISIS 1, X-LINKED, JUVENILE	RS1, 4-BP INS	
300839	6247	RS1	0010	RETINOSCHISIS 1, X-LINKED, JUVENILE	RS1, PRO203LEU	
300839	6247	RS1	0011	RETINOSCHISIS 1, X-LINKED, JUVENILE	RS1, ARG102GLN	
300841	2157	F8	0001	HEMOPHILIA A	F8, ARG2307TER	
300841	2157	F8	0002	HEMOPHILIA A	F8, ARG2209TER	
300841	2157	F8	0003	HEMOPHILIA A	F8, EX26DEL	
300841	2157	F8	0004	HEMOPHILIA A	F8, ARG2116TER	
300841	2157	F8	0005	HEMOPHILIA A	F8, EX6DEL	
300841	2157	F8	0006	HEMOPHILIA A	F8, EX14DEL	
300841	2157	F8	0007	HEMOPHILIA A	F8, EX24-25DEL	
300841	2157	F8	0008	HEMOPHILIA A	F8, EX23-25DEL	
300841	2157	F8	0009	HEMOPHILIA A	F8, EX22DEL	
300841	2157	F8	0010	HEMOPHILIA A	F8, EX26DEL	
300841	2157	F8	0011	HEMOPHILIA A	F8, EX1DEL	
300841	2157	F8	0012	HEMOPHILIA A	F8, ARG2147TER	
300841	2157	F8	0013	HEMOPHILIA A	F8, NEW SPLICE DONOR, IVS4	
300841	2157	F8	0014	HEMOPHILIA A	F8, ARG2209GLN	
300841	2157	F8	0015	HEMOPHILIA A	F8, GLU272GLY	
300841	2157	F8	0016	HEMOPHILIA A	F8, EX2-3DEL	
300841	2157	F8	0017	HEMOPHILIA A	F8, EX3-13DEL	
300841	2157	F8	0018	HEMOPHILIA A	F8, EX4-25DEL	
300841	2157	F8	0019	HEMOPHILIA A	F8, EX7-14DEL	
300841	2157	F8	0020	FACTOR VIII POLYMORPHISM	F8, LINE INS, IVS10	
300841	2157	F8	0021	HEMOPHILIA A	F8, EX26DEL	
300841	2157	F8	0022	HEMOPHILIA A	F8, LINE INS, EX14	
300841	2157	F8	0023	HEMOPHILIA A	F8, EX15DEL	
300841	2157	F8	0024	HEMOPHILIA A	F8, 2-BP DEL, EX8	
300841	2157	F8	0025	HEMOPHILIA A	F8, ARG2307LEU	
300841	2157	F8	0026	HEMOPHILIA A	F8, ARG1941GLN	
300841	2157	F8	0027	FACTOR VIII (OKAYAMA)	F8, ARG372HIS	
300841	2157	F8	0028	HEMOPHILIA A	F8, GLU1686TER	
300841	2157	F8	0029	HEMOPHILIA A	F8, EX14DEL	
300841	2157	F8	0030	HEMOPHILIA A FACTOR VIII (EAST HARTFORD)	F8, ARG1689CYS	
300841	2157	F8	0031	HEMOPHILIA A	F8, TYR1680PHE	
300841	2157	F8	0032	HEMOPHILIA A	F8, TYR1709CYS	
300841	2157	F8	0033	HEMOPHILIA A	F8, EX11-18DEL	
300841	2157	F8	0034	HEMOPHILIA A	F8, ARG1941TER	
300841	2157	F8	0035	HEMOPHILIA A	F8, EX3DEL	
300841	2157	F8	0036	FACTOR VIII POLYMORPHISM	F8, 7-KB DEL, IVS1	
300841	2157	F8	0037	HEMOPHILIA A	F8, EX1-5DEL	
300841	2157	F8	0038	HEMOPHILIA A	F8, EX1-22DEL	
300841	2157	F8	0039	HEMOPHILIA A	F8, EX26DEL	
300841	2157	F8	0040	HEMOPHILIA A	F8, EX1-26DEL	
300841	2157	F8	0041	HEMOPHILIA A	F8, ARG372CYS	
300841	2157	F8	0042	HEMOPHILIA A	F8, ARG2307GLN	
300841	2157	F8	0043	HEMOPHILIA A	F8, LEU2166SER	
300841	2157	F8	0044	HEMOPHILIA A	F8, ARG2116PRO	
300841	2157	F8	0045	HEMOPHILIA A	F8, SER170LEU	
300841	2157	F8	0046	HEMOPHILIA A	F8, EX15-18DEL	
300841	2157	F8	0047	HEMOPHILIA A	F8, EX14DEL	
300841	2157	F8	0048	HEMOPHILIA A	F8, EX23-25DEL	
300841	2157	F8	0049	HEMOPHILIA A	F8, EX14DEL	
300841	2157	F8	0050	HEMOPHILIA A	F8, EX7-9DEL	
300841	2157	F8	0051	HEMOPHILIA A	F8, EX5DEL	
300841	2157	F8	0052	HEMOPHILIA A	F8, EX5DEL	
300841	2157	F8	0053	HEMOPHILIA A	F8, EX5DEL	
300841	2157	F8	0054	HEMOPHILIA A	F8, EX5-6 DEL	
300841	2157	F8	0055	HEMOPHILIA A	F8, ARG336TER	
300841	2157	F8	0057	HEMOPHILIA A	F8, ASN1922ASP	
300841	2157	F8	0058	HEMOPHILIA A	F8, CYS329ARG	
300841	2157	F8	0059	HEMOPHILIA A	F8, VAL326LEU	
300841	2157	F8	0060	HEMOPHILIA A	F8, 4-BP DEL, FS	
300841	2157	F8	0061	HEMOPHILIA A	F8, EX13DUP	
300841	2157	F8	0062	HEMOPHILIA A	F8, ARG427TER	
300841	2157	F8	0063	HEMOPHILIA A	F8, GLU1704LYS	
300841	2157	F8	0064	HEMOPHILIA A	F8, PRO2300SER	
300841	2157	F8	0065	HEMOPHILIA A	F8, MET1772THR	
300841	2157	F8	0066	HEMOPHILIA A	F8, ILE566THR	
300841	2157	F8	0067	HEMOPHILIA A, SEVERE	F8, IVS22 INV	
300841	2157	F8	0068	HEMOPHILIA A	F8, IVS6DS, A-G, +3, 186-BP DEL, EX5-6 DEL	
300841	2157	F8	0069	HEMOPHILIA A	F8, ARG-5TER	
300841	2157	F8	0070	HEMOPHILIA A	F8, LEU7ARG	
300841	2157	F8	0071	HEMOPHILIA A	F8, GLU11VAL	
300841	2157	F8	0072	HEMOPHILIA A	F8, 89-BP DEL, FS	
300841	2157	F8	0073	HEMOPHILIA A	F8, GLY22CYS	
300841	2157	F8	0074	HEMOPHILIA A	F8, 10-BP INS, FS	
300841	2157	F8	0075	HEMOPHILIA A	F8, 2-BP DEL, FS	
300841	2157	F8	0076	HEMOPHILIA A	F8, 4-BP DEL, FS	
300841	2157	F8	0077	HEMOPHILIA A	F8, 2-BP DEL, FS	
300841	2157	F8	0078	HEMOPHILIA A	F8, 23-BP DEL, FS	
300841	2157	F8	0079	HEMOPHILIA A	F8, IVS4AS, A-G, -2	
300841	2157	F8	0080	HEMOPHILIA A	F8, GLY70ASP	
300841	2157	F8	0081	HEMOPHILIA A	F8, GLY73VAL	
300841	2157	F8	0082	HEMOPHILIA A	F8, VAL80ASP	
300841	2157	F8	0083	HEMOPHILIA A	F8, VAL85ASP	
300841	2157	F8	0084	HEMOPHILIA A	F8, LYS89THR	
300841	2157	F8	0085	HEMOPHILIA A	F8, MET91VAL	
300841	2157	F8	0086	HEMOPHILIA A	F8, LEU98ARG	
300841	2157	F8	0087	HEMOPHILIA A	F8, GLY111ARG	
300841	2157	F8	0088	HEMOPHILIA A	F8, GLU113ASP	
300841	2157	F8	0089	HEMOPHILIA A	F8, TYR114CYS	
300841	2157	F8	0090	HEMOPHILIA A	F8, ASP116GLY	
300841	2157	F8	0091	HEMOPHILIA A	F8, TYR118ILE	
300841	2157	F8	0092	HEMOPHILIA A	F8, GLY145VAL	
300841	2157	F8	0093	HEMOPHILIA A	F8, PRO146SER	
300841	2157	F8	0094	HEMOPHILIA A	F8, VAL162MET	
300841	2157	F8	0095	HEMOPHILIA A	F8, LYS166THR	
300841	2157	F8	0096	HEMOPHILIA A	F8, ASP203VAL	
300841	2157	F8	0097	HEMOPHILIA A	F8, GLY205TRP	
300841	2157	F8	0098	HEMOPHILIA A	F8, 2-BP DEL, FS	
300841	2157	F8	0099	HEMOPHILIA A	F8, IVS5AS, A-G, -2	
300841	2157	F8	0100	HEMOPHILIA A	F8, IVS6DS, A-G, +3	
300841	2157	F8	0101	HEMOPHILIA A	F8, IVS6AS, G-C, -1	
300841	2157	F8	0102	HEMOPHILIA A	F8, GLY247GLN	
300841	2157	F8	0103	HEMOPHILIA A	F8, TRP255TER	
300841	2157	F8	0104	HEMOPHILIA A	F8, GLY259ARG	
300841	2157	F8	0105	HEMOPHILIA A	F8, 1-BP DEL, FS	
300841	2157	F8	0106	HEMOPHILIA A	F8, VAL266GLY	
300841	2157	F8	0107	HEMOPHILIA A	F8, THR275ILE	
300841	2157	F8	0108	HEMOPHILIA A	F8, ASN280ILE	
300841	2157	F8	0109	HEMOPHILIA A	F8, ARG282HIS	
300841	2157	F8	0110	HEMOPHILIA A	F8, ARG282LEU	
300841	2157	F8	0111	HEMOPHILIA A	F8, 1-BP DEL, FS	
300841	2157	F8	0112	HEMOPHILIA A	F8, SER289LEU	
300841	2157	F8	0113	HEMOPHILIA A	F8, PHE293SER	
300841	2157	F8	0114	HEMOPHILIA A	F8, THR295ALA	
300841	2157	F8	0115	HEMOPHILIA A	F8, 1-BP DEL, FS	
300841	2157	F8	0116	HEMOPHILIA A	F8, LEU308PRO	
300841	2157	F8	0117	HEMOPHILIA A	F8, TRP323TER	
300841	2157	F8	0118	HEMOPHILIA A	F8, CYS329TYR	
300841	2157	F8	0119	HEMOPHILIA A	F8, CYS329SER	
300841	2157	F8	0120	HEMOPHILIA A	F8, 2-BP DEL, FS	
300841	2157	F8	0121	HEMOPHILIA A	F8, SER373TER	
300841	2157	F8	0122	HEMOPHILIA A	F8, SER373LEU	
300841	2157	F8	0123	HEMOPHILIA A	F8, SER373PRO	
300841	2157	F8	0124	HEMOPHILIA A	F8, 2-BP DEL, FS	
300841	2157	F8	0125	HEMOPHILIA A	F8, ILE386SER	
300841	2157	F8	0126	HEMOPHILIA A	F8, GLU390GLY	
300841	2157	F8	0127	HEMOPHILIA A	F8, LEU412PHE	
300841	2157	F8	0128	HEMOPHILIA A	F8, 1-BP DEL, FS	
300841	2157	F8	0129	HEMOPHILIA A	F8, LYS425ARG	
300841	2157	F8	0130	HEMOPHILIA A	F8, TYR431ASN	
300841	2157	F8	0131	HEMOPHILIA A	F8, TYR473HIS	
300841	2157	F8	0132	HEMOPHILIA A	F8, TYR473CYS	
300841	2157	F8	0133	HEMOPHILIA A	F8, ILE475THR	
300841	2157	F8	0134	HEMOPHILIA A	F8, GLY479ARG	
300841	2157	F8	0135	HEMOPHILIA A	F8, 11-BP DEL, FS	
300841	2157	F8	0136	HEMOPHILIA A	F8, IVS10AS, G-T, +1	
300841	2157	F8	0137	HEMOPHILIA A	F8, 1-BP INS, FS	
300841	2157	F8	0138	HEMOPHILIA A	F8, ASP525ASN	
300841	2157	F8	0139	HEMOPHILIA A	F8, ARG527TRP	
300841	2157	F8	0140	HEMOPHILIA A	F8, ARG531CYS	
300841	2157	F8	0141	HEMOPHILIA A	F8, ARG531GLY	
300841	2157	F8	0142	HEMOPHILIA A	F8, ARG531HIS	
300841	2157	F8	0143	HEMOPHILIA A	F8, SER535GLY	
300841	2157	F8	0144	HEMOPHILIA A	F8, ASP542GLY	
300841	2157	F8	0145	HEMOPHILIA A	F8, GLU557TER	
300841	2157	F8	0146	HEMOPHILIA A	F8, SER558PHE	
300841	2157	F8	0147	HEMOPHILIA A	F8, GLN565LYS	
300841	2157	F8	0148	HEMOPHILIA A	F8, SER577PRO	
300841	2157	F8	0149	HEMOPHILIA A	F8, ARG583TER	
300841	2157	F8	0150	HEMOPHILIA A	F8, SER584ILE	
300841	2157	F8	0151	HEMOPHILIA A	F8, TRP585CYS	
300841	2157	F8	0152	HEMOPHILIA A	F8, TYR586SER	
300841	2157	F8	0153	HEMOPHILIA A	F8, ARG593CYS	
300841	2157	F8	0154	HEMOPHILIA A	F8, ASN612SER	
300841	2157	F8	0155	HEMOPHILIA A	F8, IVS12DS, G-A, +5	
300841	2157	F8	0156	HEMOPHILIA A	F8, VAL634ALA	
300841	2157	F8	0157	HEMOPHILIA A	F8, VAL634MET	
300841	2157	F8	0158	HEMOPHILIA A	F8, TYR636TER	
300841	2157	F8	0159	HEMOPHILIA A	F8, ALA644VAL	
300841	2157	F8	0160	HEMOPHILIA A	F8, 3-BP DEL, PHE652DEL	
300841	2157	F8	0161	HEMOPHILIA A	F8, PHE658LEU	
300841	2157	F8	0162	HEMOPHILIA A	F8, ARG698TRP	
300841	2157	F8	0163	HEMOPHILIA A	F8, ALA704THR	
300841	2157	F8	0164	HEMOPHILIA A	F8, GLU720LYS	
300841	2157	F8	0165	HEMOPHILIA A	F8, ARG795TER	
300841	2157	F8	0166	HEMOPHILIA A	F8, 1-BP INS, FS	
300841	2157	F8	0167	HEMOPHILIA A	F8, 2-BP DEL, FS	
300841	2157	F8	0168	HEMOPHILIA A	F8, GLU1038LYS	
300841	2157	F8	0169	HEMOPHILIA A	F8, 2-BP DEL, FS	
300841	2157	F8	0170	HEMOPHILIA A	F8, 1-BP DEL, FS	
300841	2157	F8	0171	HEMOPHILIA A	F8, 1-BP DEL, FS	
300841	2157	F8	0172	HEMOPHILIA A	F8, 2-BP, INS, FS	
300841	2157	F8	0173	HEMOPHILIA A	F8, 4-BP DEL, FS	
300841	2157	F8	0174	HEMOPHILIA A	F8, 1-BP INS, A, CODON 1414	
300841	2157	F8	0175	HEMOPHILIA A	F8, 5-BP DEL, FS	
300841	2157	F8	0176	HEMOPHILIA A	F8, 4-BP DEL, FS	
300841	2157	F8	0177	HEMOPHILIA A	F8, 1-BP INS, A	
300841	2157	F8	0178	HEMOPHILIA A	F8, 1-BP DEL, FS	
300841	2157	F8	0179	HEMOPHILIA A	F8, 2-BP DEL, GA	
300841	2157	F8	0180	HEMOPHILIA A	F8, 1-BP INS, FS	
300841	2157	F8	0181	HEMOPHILIA A	F8, 1-BP DEL, FS	
300841	2157	F8	0182	HEMOPHILIA A	F8, GLU161TER	
300841	2157	F8	0183	HEMOPHILIA A	F8, ARG1689HIS	
300841	2157	F8	0184	HEMOPHILIA A	F8, ARG1696TER	
300841	2157	F8	0185	HEMOPHILIA A	F8, ARG1696GLY	
300841	2157	F8	0186	HEMOPHILIA A	F8, IVS14AS, A-G, -2	
300841	2157	F8	0187	HEMOPHILIA A	F8, GLY1750ARG	
300841	2157	F8	0188	HEMOPHILIA A	F8, LEU1756VAL	
300841	2157	F8	0189	HEMOPHILIA A	F8, LEU1756PHE	
300841	2157	F8	0190	HEMOPHILIA A	F8, GLY1760GLU	
300841	2157	F8	0191	HEMOPHILIA A	F8, ARG1781HIS	
300841	2157	F8	0192	HEMOPHILIA A	F8, ARG1781CYS	
300841	2157	F8	0193	HEMOPHILIA A	F8, ARG1781GLY	
300841	2157	F8	0194	HEMOPHILIA A	F8, SER1784TYR	
300841	2157	F8	0195	HEMOPHILIA A	F8, LEU1789PHE	
300841	2157	F8	0196	HEMOPHILIA A	F8, GLN1796TER	
300841	2157	F8	0197	HEMOPHILIA A	F8, MET1823ILE	
300841	2157	F8	0198	HEMOPHILIA A	F8, PRO1825SER	
300841	2157	F8	0199	HEMOPHILIA A	F8, THR1826PRO	
300841	2157	F8	0200	HEMOPHILIA A	F8, LYS1827TER	
300841	2157	F8	0201	HEMOPHILIA A	F8, ALA1834VAL	
300841	2157	F8	0202	HEMOPHILIA A	F8, IVS16DS, G-A, -1	
300841	2157	F8	0203	HEMOPHILIA A	F8, ASP1846ASN	
300841	2157	F8	0204	HEMOPHILIA A	F8, ASP1846TYR	
300841	2157	F8	0205	HEMOPHILIA A	F8, HIS1848ARG	
300841	2157	F8	0206	HEMOPHILIA A	F8, PRO1854ARG	
300841	2157	F8	0207	HEMOPHILIA A	F8, 1-BP INS, FS	
300841	2157	F8	0208	HEMOPHILIA A	F8, GLN1874TER	
300841	2157	F8	0209	HEMOPHILIA A	F8, GLU1885LYS	
300841	2157	F8	0210	HEMOPHILIA A	F8, 1-BP INS, FS	
300841	2157	F8	0211	HEMOPHILIA A	F8, ASN1922SER	
300841	2157	F8	0212	HEMOPHILIA A	F8, ARG1941LEU	
300841	2157	F8	0213	HEMOPHILIA A	F8, TRP1942TER	
300841	2157	F8	0214	HEMOPHILIA A	F8, GLY1948ASP	
300841	2157	F8	0215	HEMOPHILIA A	F8, GLY1960VAL	
300841	2157	F8	0216	HEMOPHILIA A	F8, HIS1961TYR	
300841	2157	F8	0217	HEMOPHILIA A	F8, ARG1966TER	
300841	2157	F8	0218	HEMOPHILIA A	F8, 1-BP DEL, FS	
300841	2157	F8	0219	HEMOPHILIA A	F8, 1-BP DEL, FS	
300841	2157	F8	0220	HEMOPHILIA A	F8, GLU1987TER, EX19 DEL	
300841	2157	F8	0221	HEMOPHILIA A	F8, ARG1997TRP	
300841	2157	F8	0222	HEMOPHILIA A	F8, ASN2019SER	
300841	2157	F8	0223	HEMOPHILIA A	F8, TRP2046ARG	
300841	2157	F8	0224	HEMOPHILIA A	F8, SER2069PHE	
300841	2157	F8	0225	HEMOPHILIA A	F8, ASP2074GLY	
300841	2157	F8	0226	HEMOPHILIA A	F8, PHE2101LEU	
300841	2157	F8	0227	HEMOPHILIA A	F8, CYS2105TYR	
300841	2157	F8	0228	HEMOPHILIA A	F8, SER2119TYR	
300841	2157	F8	0229	HEMOPHILIA A	F8, 2-BP DEL, FS	
300841	2157	F8	0230	HEMOPHILIA A	F8, 2-BP DEL, FS	
300841	2157	F8	0231	HEMOPHILIA A	F8, ARG2150HIS	
300841	2157	F8	0232	HEMOPHILIA A	F8, PRO2153GLN	
300841	2157	F8	0233	HEMOPHILIA A	F8, THR2154ILE	
300841	2157	F8	0234	HEMOPHILIA A	F8, ARG2159CYS	
300841	2157	F8	0235	HEMOPHILIA A	F8, ARG2159LEU	
300841	2157	F8	0236	HEMOPHILIA A	F8, ARG2159HIS	
300841	2157	F8	0237	HEMOPHILIA A	F8, ARG2163HIS	
300841	2157	F8	0238	HEMOPHILIA A	F8, ARG2163CYS	
300841	2157	F8	0239	HEMOPHILIA A	F8, ALA2192PRO	
300841	2157	F8	0240	HEMOPHILIA A	F8, 3-BP DEL, PRO220 DEL	
300841	2157	F8	0241	HEMOPHILIA A	F8, ARG2209LEU	
300841	2157	F8	0242	HEMOPHILIA A	F8, ARG2209GLY	
300841	2157	F8	0243	HEMOPHILIA A	F8, 1-BP DEL, FS	
300841	2157	F8	0244	HEMOPHILIA A	F8, TRP2229CYS	
300841	2157	F8	0245	HEMOPHILIA A	F8, GLN2246ARG	
300841	2157	F8	0246	HEMOPHILIA A	F8, 2-BP DEL, FS	
300841	2157	F8	0247	HEMOPHILIA A	F8, GLN2270TER	
300841	2157	F8	0248	HEMOPHILIA A	F8, 5-BP DEL, FS	
300841	2157	F8	0249	HEMOPHILIA A	F8, PRO2300LEU	
300841	2157	F8	0250	HEMOPHILIA A	F8, ARG2304CYS	
300841	2157	F8	0251	HEMOPHILIA A	F8, ARG2304HIS	
300841	2157	F8	0252	HEMOPHILIA A	F8, EX1-6DEL	
300841	2157	F8	0253	HEMOPHILIA A	F8, EX2-4DEL	
300841	2157	F8	0254	HEMOPHILIA A	F8, EX3-5DEL	
300841	2157	F8	0255	HEMOPHILIA A	F8, EX4-10DEL	
300841	2157	F8	0256	HEMOPHILIA A	F8, EX5-13DEL	
300841	2157	F8	0257	HEMOPHILIA A	F8, EX10DEL	
300841	2157	F8	0258	HEMOPHILIA A	F8, EX14-21DEL	
300841	2157	F8	0259	HEMOPHILIA A	F8, EX14-22DEL	
300841	2157	F8	0260	HEMOPHILIA A	F8, EX15-22DEL	
300841	2157	F8	0261	HEMOPHILIA A	F8, EX16-26DEL	
300841	2157	F8	0262	HEMOPHILIA A	F8, EX18-19DEL	
300841	2157	F8	0263	HEMOPHILIA A	F8, EX16DEL	
300841	2157	F8	0264	HEMOPHILIA A	F8, EX19-21DEL	
300841	2157	F8	0265	HEMOPHILIA A	F8, EX23-24DEL	
300841	2157	F8	0266	HEMOPHILIA A	F8, EX23-26DEL	
300841	2157	F8	0267	HEMOPHILIA A	F8, 1-BP DEL	
300841	2157	F8	0268	HEMOPHILIA A	F8, CYS179GLY	
300841	2157	F8	0269	HEMOPHILIA A	F8, TYR16CYS	
300841	2157	F8	0270	HEMOPHILIA A	F8, ALU INS	
300885	1349	COX7B	0001	APLASIA CUTIS CONGENITA, RETICULOLINEAR, WITH MICROCEPHALY, FACIAL DYSMORPHISM, AND OTHER CONGENITAL ANOMALIES	COX7B, 1-BP DEL, 196C	
300885	1349	COX7B	0002	APLASIA CUTIS CONGENITA, RETICULOLINEAR, WITH MICROCEPHALY, FACIAL DYSMORPHISM, AND OTHER CONGENITAL ANOMALIES	COX7B, IVS1AS, A-G, -2	
300885	1349	COX7B	0003	APLASIA CUTIS CONGENITA, RETICULOLINEAR, WITH MICROCEPHALY, FACIAL DYSMORPHISM, AND OTHER CONGENITAL ANOMALIES	COX7B, GLN19TER	
300897	55906	ZC4H2	0001	WIEACKER-WOLFF SYNDROME	ZC4H2, VAL63LEU	
300897	55906	ZC4H2	0002	WIEACKER-WOLFF SYNDROME	ZC4H2, ARG198GLN	
300897	55906	ZC4H2	0003	WIEACKER-WOLFF SYNDROME	ZC4H2, PRO201SER	
300897	55906	ZC4H2	0004	WIEACKER-WOLFF SYNDROME	ZC4H2, ARG213TRP	
301300	212	ALAS2	0001	ANEMIA, HEREDITARY SIDEROBLASTIC	ALAS2, ILE471ASN	137852299
301300	212	ALAS2	0002	ANEMIA, HEREDITARY SIDEROBLASTIC	ALAS2, THR388SER	137852300
301300	212	ALAS2	0003	ANEMIA, HEREDITARY SIDEROBLASTIC	ALAS2, PHE165LEU	137852301
301300	212	ALAS2	0004	ANEMIA, HEREDITARY SIDEROBLASTIC	ALAS2, GLY291SER	137852302
301300	212	ALAS2	0005	ANEMIA, HEREDITARY SIDEROBLASTIC, LATE-ONSET	ALAS2, LYS299GLN	137852303
301300	212	ALAS2	0006	ANEMIA, HEREDITARY SIDEROBLASTIC, LATE-ONSET	ALAS2, ALA172THR	137852304
301300	212	ALAS2	0007	ANEMIA, HEREDITARY SIDEROBLASTIC, PYRIDOXINE REFRACTORY	ALAS2, ASP190VAL	28935484
301300	212	ALAS2	0008	ANEMIA, HEREDITARY SIDEROBLASTIC	ALAS2, ARG411CYS	137852305
301300	212	ALAS2	0009	ANEMIA, HEREDITARY SIDEROBLASTIC	ALAS2, SER568GLY	137852306
301300	212	ALAS2	0010	ANEMIA, HEREDITARY SIDEROBLASTIC	ALAS2, CYS395TYR	137852307
301300	212	ALAS2	0011	ANEMIA, HEREDITARY SIDEROBLASTIC	ALAS2, ASP159TYR	137852308
301300	212	ALAS2	0012	ANEMIA, HEREDITARY SIDEROBLASTIC	ALAS2, ASP159ASN	137852308
301300	212	ALAS2	0013	ANEMIA, HEREDITARY SIDEROBLASTIC	ALAS2, -206C-G	
301300	212	ALAS2	0014	ANEMIA, HEREDITARY SIDEROBLASTIC	ALAS2, HIS524ASP	137852309
301300	212	ALAS2	0015	PROTOPORPHYRIA, ERYTHROPOIETIC, X-LINKED DOMINANT	ALAS2, 4-BP DEL, 1706AGTG	
301300	212	ALAS2	0016	PROTOPORPHYRIA, ERYTHROPOIETIC, X-LINKED DOMINANT	ALAS2, 2-BP DEL, 1699AT	
301300	212	ALAS2	0017	ANEMIA, HEREDITARY SIDEROBLASTIC	ALAS2, TYR199HIS	137852310
301300	212	ALAS2	0018	ANEMIA, HEREDITARY SIDEROBLASTIC	ALAS2, ARG452CYS	137852311
303630	1287	COL4A5	0001	ALPORT SYNDROME, X-LINKED	COL4A5, EX5-10DEL	
303630	1287	COL4A5	0002	ALPORT SYNDROME, X-LINKED	COL4A5, CYS108SER	104886287
303630	1287	COL4A5	0003	ALPORT SYNDROME, X-LINKED	COL4A5, 10-15-KB INS, 40-KB DEL	
303630	1287	COL4A5	0004	ALPORT SYNDROME, X-LINKED	COL4A5, 450-KB DEL	
303630	1287	COL4A5	0005	ALPORT SYNDROME, X-LINKED	COL4A5, 38-KB DEL	
303630	1287	COL4A5	0006	ALPORT SYNDROME, X-LINKED	COL4A5, GLY1143ASP	104886229
303630	1287	COL4A5	0007	ALPORT SYNDROME, X-LINKED	COL4A5, GLY325ARG	104886088
303630	1287	COL4A5	0008	ALPORT SYNDROME, X-LINKED	COL4A5, 3-PRIME AND PARTIAL 5-PRIME DELETION	
303630	1287	COL4A5	0009	ALPORT SYNDROME, X-LINKED	COL4A5, TRP1538SER	
303630	1287	COL4A5	0010	ALPORT SYNDROME, X-LINKED	COL4A5, GLY521CYS	104886121
303630	1287	COL4A5	0011	ALPORT SYNDROME, X-LINKED	COL4A5, GLY325GLU	104886091
303630	1287	COL4A5	0012	ALPORT SYNDROME, X-LINKED	COL4A5, GLY289VAL AND ARG1421CYS	
303630	1287	COL4A5	0013	ALPORT SYNDROME, X-LINKED	COL4A5, GLY54ASP	104886043
303630	1287	COL4A5	0014	ALPORT SYNDROME, X-LINKED	COL4A5, LEU1649ARG	104886303
303630	1287	COL4A5	0015	ALPORT SYNDROME, X-LINKED	COL4A5, ARG1677GLN	104886308
303631	1288	COL4A6	0001	LEIOMYOMATOSIS, DIFFUSE, WITH ALPORT SYNDROME	COL4A6, DEL	
304040	2705	GJB1	0001	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1	GJB1, ARG142TRP	104894810
304040	2705	GJB1	0002	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1	GJB1, PRO172SER	104894811
304040	2705	GJB1	0003	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1	GJB1, VAL139MET	104894812
304040	2705	GJB1	0004	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1	GJB1, TRP133ARG	104894813
304040	2705	GJB1	0005	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1	GJB1, ARG220TER	104894814
304040	2705	GJB1	0006	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1	GJB1, ILE30ASN	104894817
304040	2705	GJB1	0007	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1	GJB1, LEU156ARG	104894818
304040	2705	GJB1	0008	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1	GJB1, TYR65CYS	104894819
304040	2705	GJB1	0009	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1	GJB1, VAL13LEU	104894820
304040	2705	GJB1	0010	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1	GJB1, 1-BP DEL	
304040	2705	GJB1	0011	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1	GJB1, VAL95MET	104894821
304040	2705	GJB1	0012	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1	GJB1, ASN205SER	104894822
304040	2705	GJB1	0013	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1	GJB1, 367G-T	
304040	2705	GJB1	0014	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1	GJB1, SER85CYS	104894823
304040	2705	GJB1	0015	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1	GJB1, -528T-G	
304040	2705	GJB1	0016	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1	GJB1, THR55ILE	104894824
304040	2705	GJB1	0017	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1	GJB1, 21-BP DUP	
304040	2705	GJB1	0018	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1	GJB1, 3-BP DEL, 304GAG	
304040	2705	GJB1	0019	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1	GJB1, -526G-C	
304040	2705	GJB1	0020	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1	GJB1, PHE235CYS	104894825
304040	2705	GJB1	0021	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1 DEJERINE-SOTTAS NEUROPATHY, INCLUDED	GJB1, VAL136ALA	104894826
305371	2623	GATA1	0001	THROMBOCYTOPENIA, X-LINKED, WITH DYSERYTHROPOIETIC ANEMIA	GATA1, VAL205MET	104894815
305371	2623	GATA1	0002	THROMBOCYTOPENIA, X-LINKED, WITHOUT DYSERYTHROPOIETIC ANEMIA	GATA1, ASP218GLY	104894816
305371	2623	GATA1	0003	THROMBOCYTOPENIA, X-LINKED, WITHOUT DYSERYTHROPOIETIC ANEMIA	GATA1, GLY208SER	137852312
305371	2623	GATA1	0004	LEUKEMIA, MEGAKARYOBLASTIC, OF DOWN SYNDROME, SOMATIC	GATA1, 4-BP INS	
305371	2623	GATA1	0005	THROMBOCYTOPENIA, X-LINKED, WITH DYSERYTHROPOIETIC ANEMIA	GATA1, ASP218TYR	104894808
305371	2623	GATA1	0006	THROMBOCYTOPENIA WITH BETA-THALASSEMIA, X-LINKED	GATA1, ARG216GLN	104894809
305371	2623	GATA1	0007	LEUKEMIA, MEGAKARYOBLASTIC, SOMATIC	GATA1, 20-BP DUP	
305371	2623	GATA1	0008	ANEMIA, X-LINKED, WITH OR WITHOUT NEUTROPENIA AND/OR PLATELET ABNORMALITIES	GATA1, 332G-C	
305371	2623	GATA1	0009	ANEMIA, X-LINKED, WITH OR WITHOUT NEUTROPENIA AND/OR PLATELET ABNORMALITIES	GATA1, 1-BP DEL, 332G	
305371	2623	GATA1	0010	THROMBOCYTOPENIA WITH BETA-THALASSEMIA, X-LINKED	GATA1, ARG216TRP	
305900	2539	G6PD	0001	G6PD A+	G6PD, ASN126ASP	1050829
305900	2539	G6PD	0002	G6PD A- G6PD MATERA;; G6PD BETICA;; G6PD CASTILLA;; G6PD DISTRITO FEDERAL;; G6PD TEPIC	G6PD, VAL68MET, ASN126ASP	1050828
305900	2539	G6PD	0003	G6PD CHATHAM	G6PD, ALA335THR	5030869
305900	2539	G6PD	0004	G6PD ILESHA	G6PD, GLU156LYS	137852313
305900	2539	G6PD	0005	G6PD MAHIDOL	G6PD, GLY163SER	137852314
305900	2539	G6PD	0006	G6PD MEDITERRANEAN G6PD SASSARI;; G6PD CAGLIARI	G6PD, SER188PHE	5030868
305900	2539	G6PD	0007	G6PD METAPONTO	G6PD, ASP58ASN	137852315
305900	2539	G6PD	0008	G6PD PORTICI	G6PD, ARG393HIS	137852316
305900	2539	G6PD	0009	G6PD SANTIAGO DE CUBA	G6PD, GLY447ARG	137852317
305900	2539	G6PD	0010	G6PD SEATTLE-LIKE G6PD MODENA	G6PD, ASP282HIS	137852318
305900	2539	G6PD	0011	G6PD HARILAOU	G6PD, PHE216LEU	137852319
305900	2539	G6PD	0012	G6PD IOWA G6PD IOWA CITY;; G6PD SPRINGFIELD;; G6PD WALTER REED	G6PD, LYS386GLU	137852320
305900	2539	G6PD	0013	G6PD BEVERLY HILLS	G6PD, ARG387HIS	137852321
305900	2539	G6PD	0014	G6PD TOMAH	G6PD, CYS385ARG	137852322
305900	2539	G6PD	0015	G6PD RIVERSIDE	G6PD, GLY410CYS	137852323
305900	2539	G6PD	0016	G6PD MONTALBANO	G6PD, ARG285HIS	74575103
305900	2539	G6PD	0017	G6PD RFLP	G6PD, NT1116, G-A	
305900	2539	G6PD	0018	G6PD RFLP	G6PD, NT1311, C-T	
305900	2539	G6PD	0019	G6PD RFLP	G6PD, EX6, -60, C-G	
305900	2539	G6PD	0020	G6PD ANDALUS	G6PD, ARG454HIS	137852324
305900	2539	G6PD	0021	G6PD CANTON G6PD GIFU;; G6PD AGRIGENTO;; G6PD TAIWAN-HAKKA	G6PD, ARG459LEU	72554665
305900	2539	G6PD	0022	G6PD PUERTO LIMON	G6PD, GLU398LYS	137852325
305900	2539	G6PD	0023	G6PD SANTAMARIA	G6PD, ASP181VAL, ASN126ASP	5030872
305900	2539	G6PD	0024	G6PD GASTONIA G6PD MARION;; G6PD MINNESOTA	G6PD, VAL213LEU	137852326
305900	2539	G6PD	0025	G6PD NASHVILLE G6PD ANAHEIM	G6PD, ARG393HIS	
305900	2539	G6PD	0026	G6PD VIANGCHAN G6PD JAMMU	G6PD, VAL291MET	137852327
305900	2539	G6PD	0027	G6PD A-	G6PD, ARG227LEU	137852328
305900	2539	G6PD	0028	G6PD A-	G6PD, LEU323PRO	76723693
305900	2539	G6PD	0029	G6PD KAIPING G6PD ANANT;; G6PD DHON;; G6PD PETRICH-LIKE;; G6PD SAPPORO-LIKE	G6PD, ARG463HIS	72554664
305900	2539	G6PD	0030	G6PD LOMA LINDA	G6PD, ASN363LYS	137852329
305900	2539	G6PD	0031	G6PD COIMBRA	G6PD, ARG198CYS	137852330
305900	2539	G6PD	0032	CHRONIC GRANULOMA AND HEMOLYTIC ANEMIA	G6PD, SER106CYS, ARG182TRP, ARG198CYS	
305900	2539	G6PD	0033	G6PD TAIWAN-HAKKA 2	G6PD, ASN165ASP	137852331
305900	2539	G6PD	0034	G6PD SANTIAGO ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY	G6PD, ARG198PRO	137852332
305900	2539	G6PD	0035	G6PD MEXICO CITY	G6PD, ARG227GLN	137852328
305900	2539	G6PD	0036	G6PD IERAPETRA	G6PD, PRO353SER	137852333
305900	2539	G6PD	0037	G6PD GUADALAJARA ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY	G6PD, ARG387CYS	137852334
305900	2539	G6PD	0038	G6PD ALHAMBRA ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY	G6PD, VAL394LEU	137852335
305900	2539	G6PD	0039	G6PD JAPAN ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY	G6PD, GLY410ASP	137852336
305900	2539	G6PD	0040	G6PD PAWNEE ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY	G6PD, ARG439PRO	137852337
305900	2539	G6PD	0041	G6PD SUNDERLAND ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY	G6PD, ILE35DEL	137852338
305900	2539	G6PD	0042	G6PD KERALA-KALYAN G6PD KERALA;; G6PD KALYAN	G6PD, GLU317LYS	137852339
305900	2539	G6PD	0043	G6PD AURES	G6PD, ILE48THR	76645461
305900	2539	G6PD	0044	G6PD GAOHE	G6PD, HIS32ARG	137852340
305900	2539	G6PD	0045	G6PD QUING YUAN	G6PD, GLY131VAL	137852341
305900	2539	G6PD	0046	G6PD MAHIDOL-LIKE	G6PD, LEU342PHE	137852342
305900	2539	G6PD	0047	G6PD ORISSA	G6PD, ALA44GLY	78478128
305900	2539	G6PD	0048	G6PD NANKANG	G6PD, PHE173LEU	137852343
305900	2539	G6PD	0049	G6PD MALAGA	G6PD, ASP181VAL	5030872
305900	2539	G6PD	0050	G6PD NEAPOLIS	G6PD, PRO467ARG	137852344
305900	2539	G6PD	0051	G6PD SERRES	G6PD, ALA361VAL	137852345
305900	2539	G6PD	0052	G6PD NARA	G6PD, 24-BP DEL, NT953	
305900	2539	G6PD	0053	G6PD AVEIRO ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY	G6PD, CYS269TYR	137852346
305900	2539	G6PD	0054	G6PD ASAHI	G6PD, VAL68MET	1050828
305900	2539	G6PD	0055	G6PD REHOVOT	G6PD, TYR322HIS	137852347
305900	2539	G6PD	0056	G6PD AMSTERDAM	G6PD, 3-BP DEL, 180TCT	
305900	2539	G6PD	0057	G6PD ZURICH	G6PD, IVS10AS, A-G, -2	
305900	2539	G6PD	0058	G6PD VARNSDORF	G6PD, IVS10AS, 2-BP DEL, AG, -2	
305900	2539	G6PD	0059	G6PD COSENZA	G6PD, ARG459PRO	72554665
305900	2539	G6PD	0060	G6PD SPLIT	G6PD, PRO481ARG	137852348
305900	2539	G6PD	0061	G6PD NAMORU	G6PD, HIS70TYR	137852349
305900	2539	G6PD	0062	G6PD NILGIRI	G6PD, ARG198HIS	137852332
305915	2892	GRIA3	0001	MENTAL RETARDATION, X-LINKED 94	GRIA3, GLY833ARG	137852350
305915	2892	GRIA3	0002	MENTAL RETARDATION, X-LINKED 94	GRIA3, ARG631SER	137852351
305915	2892	GRIA3	0003	MENTAL RETARDATION, X-LINKED 94	GRIA3, MET706THR	137852352
305915	2892	GRIA3	0004	MENTAL RETARDATION, X-LINKED 94	GRIA3, 0.4-MB DEL	
306250	1438	CSF2RA	0001	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 4	CSF2RA, EX5-13 DEL	
306250	1438	CSF2RA	0002	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 4	CSF2RA, GLY174ARG	137852353
308000	3251	HPRT1	0001	GOUT, HPRT-RELATED HPRT ANN ARBOR	HPRT, ILE132MET	137852477
308000	3251	HPRT1	0002	GOUT, HPRT-RELATED HPRT ARLINGTON	HPRT, ASP80VAL	137852478
308000	3251	HPRT1	0003	GOUT, HPRT-RELATED HPRT ASHVILLE	HPRT, ASP201GLY	137852479
308000	3251	HPRT1	0004	LESCH-NYHAN SYNDROME HPRT CHICAGO	HPRT, 1-BP INS, 56T	
308000	3251	HPRT1	0005	LESCH-NYHAN SYNDROME HPRT CONNERSVILLE	HPRT, EX8DEL	
308000	3251	HPRT1	0006	LESCH-NYHAN SYNDROME HPRT DETROIT	HPRT, LEU41PRO	137852480
308000	3251	HPRT1	0007	LESCH-NYHAN SYNDROME HPRT EVANSVILLE	HPRT, 24AA+	
308000	3251	HPRT1	0008	LESCH-NYHAN SYNDROME HPRT FLINT	HPRT, PHE74LEU	137852481
308000	3251	HPRT1	0009	LESCH-NYHAN SYNDROME HPRT KINSTON	HPRT, ASP194ASN AND ASP193ASN	
308000	3251	HPRT1	0010	GOUT, HPRT-RELATED HPRT LONDON	HPRT, SER110LEU	137852482
308000	3251	HPRT1	0011	LESCH-NYHAN SYNDROME HPRT MICHIGAN	HPRT, 3-BP DEL, VAL179DEL	
308000	3251	HPRT1	0012	LESCH-NYHAN SYNDROME HPRT MIDLAND	HPRT, VAL130ASP	137852483
308000	3251	HPRT1	0013	GOUT, HPRT-RELATED HPRT MILWAUKEE	HPRT, ALA161SER	137852484
308000	3251	HPRT1	0014	GOUT, HPRT-RELATED HPRT MUNICH	HPRT, SER104ARG	137852485
308000	3251	HPRT1	0015	LESCH-NYHAN SYNDROME HPRT NEW BRITON	HPRT, PHE199VAL	137852486
308000	3251	HPRT1	0016	LESCH-NYHAN SYNDROME HPRT NEW HAVEN	HPRT, GLY70GLU	137852487
308000	3251	HPRT1	0017	LESCH-NYHAN SYNDROME HPRT YALE	HPRT, GLY71ARG	137852488
308000	3251	HPRT1	0018	LESCH-NYHAN SYNDROME	HPRT, GLN108TER	137852489
308000	3251	HPRT1	0019	LESCH-NYHAN SYNDROME	HPRT, HIS203ASP	137852490
308000	3251	HPRT1	0020	LESCH-NYHAN SYNDROME	HPRT, ARG44LYS	137852491
308000	3251	HPRT1	0021	LESCH-NYHAN SYNDROME	HPRT, ASP176TYR	137852492
308000	3251	HPRT1	0024	LESCH-NYHAN SYNDROME	HPRT, 2-BP DEL, GT	
308000	3251	HPRT1	0026	LESCH-NYHAN SYNDROME	HPRT, 1-BP DEL, TTA-TA	
308000	3251	HPRT1	0027	LESCH-NYHAN SYNDROME	HPRT, 1-BP DEL, TTG-TG	
308000	3251	HPRT1	0028	LESCH-NYHAN SYNDROME	HPRT, 40-BP DEL	
308000	3251	HPRT1	0029	LESCH-NYHAN SYNDROME	HPRT, IVS8DS, G-A, +5	
308000	3251	HPRT1	0030	LESCH-NYHAN SYNDROME	HPRT, IVS8AS, ATAG-TTTG	
308000	3251	HPRT1	0031	LESCH-NYHAN SYNDROME	HPRT, IVS7DS, G-A, +5	
308000	3251	HPRT1	0032	LESCH-NYHAN SYNDROME	HPRT, IVS1AS, A-T, -2	
308000	3251	HPRT1	0033	LESCH-NYHAN SYNDROME	HPRT, PRO176LEU	137852493
308000	3251	HPRT1	0034	GOUT, HPRT-RELATED HPRT TORONTO	HPRT, ARG51GLY	137852494
308000	3251	HPRT1	0035	LESCH-NYHAN SYNDROME HPRT FUJIMI	HPRT, ARG51TER	137852494
308000	3251	HPRT1	0036	LESCH-NYHAN SYNDROME, NEUROLOGIC VARIANT HPRT MONTREAL	HPRT, MET56THR	137852495
308000	3251	HPRT1	0037	LESCH-NYHAN SYNDROME	HPRT, MET143LYS	137852496
308000	3251	HPRT1	0038	LESCH-NYHAN SYNDROME	HPRT, ARG170TER	137852497
308000	3251	HPRT1	0039	GOUT, HPRT-RELATED	HPRT, 13-BP DEL, 5-PRIME UTR	
308000	3251	HPRT1	0040	LESCH-NYHAN SYNDROME	HPRT, EX2DEL	
308000	3251	HPRT1	0041	LESCH-NYHAN SYNDROME	HPRT, EX4-9DEL	
308000	3251	HPRT1	0042	LESCH-NYHAN SYNDROME	HPRT, EX6-9DEL	
308000	3251	HPRT1	0043	LESCH-NYHAN SYNDROME	HPRT, EX9DEL	
308000	3251	HPRT1	0044	LESCH-NYHAN SYNDROME	HPRT, DEL	
308000	3251	HPRT1	0045	LESCH-NYHAN SYNDROME	HPRT,1-BP INS, 207G	
308000	3251	HPRT1	0046	LESCH-NYHAN SYNDROME	HPRT, INV/DEL, EX6-9	
308000	3251	HPRT1	0047	LESCH-NYHAN SYNDROME	HPRT, EX2-3DUP, IVS1DEL	
308000	3251	HPRT1	0048	GOUT, HPRT-RELATED HPRT BRISBANE	HPRT, THR168ILE	137852498
308000	3251	HPRT1	0049	HPRT DEFICIENCY, PARTIAL HPRT URANGAN	HPRT, GLY16SER	137852499
308000	3251	HPRT1	0050	HPRT DEFICIENCY, PARTIAL HPRT TOOWONG	HPRT, GLY58ARG	137852500
308000	3251	HPRT1	0051	HPRT DEFICIENCY, PARTIAL HPRT SWAN	HPRT, LEU78VAL	137852501
308000	3251	HPRT1	0052	LESCH-NYHAN SYNDROME HPRT CHERMSIDE	HPRT, EX6DEL	
308000	3251	HPRT1	0053	LESCH-NYHAN SYNDROME HPRT COORPAROO	HPRT, 1-BP INS, 14823T	
308000	3251	HPRT1	0054	GOUT, HPRT-RELATED HPRT EDINBURGH	HPRT, ASP52GLY	137852502
308000	3251	HPRT1	0055	LESCH-NYHAN SYNDROME HPRT TOKYO	HPRT, GLY140ASP	137852503
308000	3251	HPRT1	0056	GOUT, HPRT-RELATED HPRT MOOSE JAW	HPRT, ASP194GLU	137852504
308000	3251	HPRT1	0057	LESCH-NYHAN SYNDROME HPRT PARIS	HPRT, TYR153TER	137852505
308000	3251	HPRT1	0058	LESCH-NYHAN SYNDROME	HPRT, 2969-BP DEL, NT970	
308000	3251	HPRT1	0059	HPRT DEFICIENCY, PARTIAL	HPRT, LEU65PHE	137852506
308000	3251	HPRT1	0060	LESCH-NYHAN SYNDROME, NEUROLOGIC VARIANT GOUT, HPRT-RELATED, INCLUDED	HPRT, ARG48HIS	
308380	3561	IL2RG	0001	SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED	IL2RG, LYS97TER	137852507
308380	3561	IL2RG	0002	SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED	IL2RG, ARG267TER	137852508
308380	3561	IL2RG	0003	SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED	IL2RG, SER286TER	137852509
308380	3561	IL2RG	0004	SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED	IL2RG, CYS62TER	111033619
308380	3561	IL2RG	0005	SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED	IL2RG, GLY114ASP	111033620
308380	3561	IL2RG	0006	SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED	IL2RG, IVS3DS, G-A, +1	
308380	3561	IL2RG	0007	SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED	IL2RG, ILE153ASN	111033621
308380	3561	IL2RG	0008	COMBINED IMMUNODEFICIENCY, X-LINKED	IL2RG, LEU271GLN	137852510
308380	3561	IL2RG	0009	SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED	IL2RG, 9-BP DUP, GLN-HIS-TRP INS	
308380	3561	IL2RG	0010	SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED	IL2RG, CYS115ARG	111033622
308380	3561	IL2RG	0011	SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED	IL2RG, ARG285GLN	111033617
308380	3561	IL2RG	0012	COMBINED IMMUNODEFICIENCY, X-LINKED	IL2RG, ARG222CYS	111033618
308380	3561	IL2RG	0013	SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED	IL2RG, LEU151PRO	137852511
308840	3897	L1CAM	0001	HYDROCEPHALUS, X-LINKED	L1CAM, IVS18AS, A-C, -19	
308840	3897	L1CAM	0002	HYDROCEPHALUS, X-LINKED	L1CAM, CYS264TYR	137852518
308840	3897	L1CAM	0003	HYDROCEPHALUS, X-LINKED	L1CAM, 1.3-KB DUP	
308840	3897	L1CAM	0004	MASA SYNDROME	L1CAM, HIS210GLN	28933683
308840	3897	L1CAM	0005	MASA SYNDROME	L1CAM, ASP598ASN	137852519
308840	3897	L1CAM	0006	HYDROCEPHALUS, X-LINKED	L1CAM, GLY452ARG	137852520
308840	3897	L1CAM	0007	HYDROCEPHALUS, X-LINKED	L1CAM, ARG184GLN	137852521
308840	3897	L1CAM	0008	MASA SYNDROME	L1CAM, 2-BP DEL, EX26	
308840	3897	L1CAM	0009	HYDROCEPHALUS, X-LINKED MASA SYNDROME, INCLUDED	L1CAM, SER1194LEU	137852522
308840	3897	L1CAM	0010	CRASH SYNDROME	L1CAM, ILE179SER	137852523
308840	3897	L1CAM	0011	CRASH SYNDROME	L1CAM, GLY370ARG	137852524
308840	3897	L1CAM	0012	HYDROCEPHALUS, X-LINKED, WITH HIRSCHSPRUNG DISEASE	L1CAM, 2-BP DEL, EX18	
308840	3897	L1CAM	0013	HYDROCEPHALUS, X-LINKED	L1CAM, 924C-T	
308840	3897	L1CAM	0014	HYDROCEPHALUS, X-LINKED, WITH HIRSCHSPRUNG DISEASE	L1CAM, VAL752MET	137852525
308840	3897	L1CAM	0015	HYDROCEPHALUS, X-LINKED, WITH HIRSCHSPRUNG DISEASE	L1CAM, IVS15DS, G-A, +5	
308840	3897	L1CAM	0016	HYDROCEPHALUS, X-LINKED, WITH CONGENITAL IDIOPATHIC INTESTINAL PSEUDOOBSTRUCTION	L1CAM, GLN974TER	
308840	3897	L1CAM	0017	HYDROCEPHALUS, X-LINKED CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED, INCLUDED	L1CAM, PRO240LEU	137852526
308840	3897	L1CAM	0018	HYDROCEPHALUS, X-LINKED	L1CAM, IVS26AS, G-C, -1	
309060	3920	LAMP2	0001	DANON DISEASE	LAMP2, 2-BP DEL, 1097AA	
309060	3920	LAMP2	0002	DANON DISEASE	LAMP2, LEU113TER	137852527
309060	3920	LAMP2	0003	DANON DISEASE	LAMP2, IVS6, G-C, +5	
309060	3920	LAMP2	0004	DANON DISEASE	LAMP2, 1-BP INS, 974A	
309060	3920	LAMP2	0005	DANON DISEASE	LAMP2, IVS5, G-A, +1	
309060	3920	LAMP2	0006	DANON DISEASE	LAMP2, 1-BP DEL, 14G	
309060	3920	LAMP2	0007	DANON DISEASE	LAMP2, 1-BP INS, 883T	
309060	3920	LAMP2	0008	DANON DISEASE	LAMP2, 7-BP DEL	
309060	3920	LAMP2	0009	DANON DISEASE	LAMP2, GLN174TER	104894857
309060	3920	LAMP2	0010	DANON DISEASE	LAMP2, VAL310ILE	104894858
309060	3920	LAMP2	0011	DANON DISEASE	LAMP2, TRP321ARG	104894859
309060	3920	LAMP2	0012	DANON DISEASE	LAMP2, 1-BP DEL, 1219A	
309550	2332	FMR1	0001	FRAGILE X MENTAL RETARDATION SYNDROME	FMR1, ILE304ASN	121434622
309550	2332	FMR1	0002	FRAGILE X MENTAL RETARDATION SYNDROME	FMR1, 1-BP DEL, 373A	
309550	2332	FMR1	0003	FRAGILE X MENTAL RETARDATION SYNDROME	FMR1, IVS2AS1, G-T, -1 AND G-A, +1	
309550	2332	FMR1	0004	FRAGILE X MENTAL RETARDATION SYNDROME FRAGILE X TREMOR/ATAXIA SYNDROME, INCLUDED;; PREMATURE OVARIAN FAILURE 1, INCLUDED	FMR1, (CGG)n EXPANSION	193922936
309550	2332	FMR1	0005	FRAGILE X MENTAL RETARDATION SYNDROME	FMR1, SER27TER	
309850	4128	MAOA	0001	BRUNNER SYNDROME	MAOA, GLN296TER	72554632
309850	4128	MAOA	0002	ANTISOCIAL BEHAVIOR FOLLOWING CHILDHOOD MALTREATMENT, SUSCEPTIBILITY TO AUTISM, SEVERE, INCLUDED	MAOA, PROMOTER POLYMORPHISM, 30-BP REPEAT	
311770	5277	PIGA	0001	PAROXYSMAL NOCTURNAL HEMOGLOBINURIA	PIGA, 1-BP DEL, T, IVSDS, SOMATIC	
311770	5277	PIGA	0002	PAROXYSMAL NOCTURNAL HEMOGLOBINURIA	PIGA, TYR98TER, SOMATIC	199422232
311770	5277	PIGA	0003	PAROXYSMAL NOCTURNAL HEMOGLOBINURIA	PIGA, 1-BP INS, 460A, SOMATIC	
311770	5277	PIGA	0004	PAROXYSMAL NOCTURNAL HEMOGLOBINURIA	PIGA, 1-BP DEL, 1114C, SOMATIC	
311770	5277	PIGA	0005	PAROXYSMAL NOCTURNAL HEMOGLOBINURIA	PIGA, GLN55TER, SOMATIC	199422233
311770	5277	PIGA	0006	PAROXYSMAL NOCTURNAL HEMOGLOBINURIA	PIGA, 2-BP INS, 334GT, SOMATIC	
311770	5277	PIGA	0007	PAROXYSMAL NOCTURNAL HEMOGLOBINURIA	PIGA, 1-BP DEL, 516C, SOMATIC	
311770	5277	PIGA	0008	PAROXYSMAL NOCTURNAL HEMOGLOBINURIA	PIGA, 2-BP DEL, 1408CT, SOMATIC	
311770	5277	PIGA	0009	PAROXYSMAL NOCTURNAL HEMOGLOBINURIA	PIGA, IVS5DS, G-A, +1, SOMATIC	
311770	5277	PIGA	0010	PAROXYSMAL NOCTURNAL HEMOGLOBINURIA	PIGA, 2-BP INS/32-BP DUP, SOMATIC	
311770	5277	PIGA	0011	MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2	PIGA, ARG412TER	
311800	5230	PGK1	0001	PHOSPHOGLYCERATE KINASE 1 DEFICIENCY, MUNCHEN	PGK1, ASP268ASN	137852528
311800	5230	PGK1	0002	PHOSPHOGLYCERATE KINASE 1 DEFICIENCY, UPPSALA	PGK1, ARG206PRO	137852529
311800	5230	PGK1	0003	PHOSPHOGLYCERATE KINASE 1 DEFICIENCY, TOKYO	PGK1, VAL266MET	
311800	5230	PGK1	0004	PHOSPHOGLYCERATE KINASE 1, PGK II	PGK1, THR352ASN	137852530
311800	5230	PGK1	0005	PHOSPHOGLYCERATE KINASE 1 DEFICIENCY, MATSUE	PGK1, LEU88PRO	137852531
311800	5230	PGK1	0006	PHOSPHOGLYCERATE KINASE 1 DEFICIENCY, SHIZUOKA	PGK1, GLY157VAL	137852532
311800	5230	PGK1	0007	PHOSPHOGLYCERATE KINASE 1 DEFICIENCY, MICHIGAN	PGK1, CYS315ARG	137852533
311800	5230	PGK1	0008	PHOSPHOGLYCERATE KINASE 1 DEFICIENCY, ALABAMA	PGK1, 3-BP DEL, LYS191DEL	
311800	5230	PGK1	0009	PHOSPHOGLYCERATE KINASE 1 DEFICIENCY, HAMAMATSU	PGK1, ILE252THR	137852534
311800	5230	PGK1	0010	PHOSPHOGLYCERATE KINASE 1 DEFICIENCY, HERLEV	PGK1, ASP285VAL	137852535
311800	5230	PGK1	0011	PHOSPHOGLYCERATE KINASE 1 DEFICIENCY, BARCELONA	PGK1, ILE46ASN	137852536
311800	5230	PGK1	0012	PHOSPHOGLYCERATE KINASE 1 DEFICIENCY, MURCIA	PGK1, SER319ASN	137852537
311800	5230	PGK1	0013	PHOSPHOGLYCERATE KINASE 1 DEFICIENCY, AMIENS	PGK1, ASP164VAL	137852538
311800	5230	PGK1	0014	PHOSPHOGLYCERATE KINASE 1 DEFICIENCY, FUKUROI	PGK1, IVS7DS, G-A, +5	
311800	5230	PGK1	0015	PHOSPHOGLYCERATE KINASE 1 DEFICIENCY, AFULA	PGK1, THR378PRO	137852539
311850	5631	PRPS1	0001	PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	PRPS1, ASN113SER	137852540
311850	5631	PRPS1	0002	PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	PRPS1, ASP182HIS	137852541
311850	5631	PRPS1	0003	PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	PRPS1, ASP51HIS	137852542
311850	5631	PRPS1	0005	PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	PRPS1, LEU128ILE	137852543
311850	5631	PRPS1	0007	PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	PRPS1, ALA189VAL	137852544
311850	5631	PRPS1	0008	PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	PRPS1, HIS192GLN	137852545
311850	5631	PRPS1	0009	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	PRPS1, GLU43ASP	80338731
311850	5631	PRPS1	0010	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	PRPS1, MET115THR	80338732
311850	5631	PRPS1	0011	ARTS SYNDROME	PRPS1, LEU152PRO	80338676
311850	5631	PRPS1	0012	ARTS SYNDROME	PRPS1, GLN133PRO	80338675
311850	5631	PRPS1	0013	DEAFNESS, X-LINKED 1	PRPS1, ASP65ASN	180177151
311850	5631	PRPS1	0014	DEAFNESS, X-LINKED 1	PRPS1, ALA87THR	180177152
311850	5631	PRPS1	0015	DEAFNESS, X-LINKED 1	PRPS1, GLY306ARG	180177154
311850	5631	PRPS1	0016	DEAFNESS, X-LINKED 1	PRPS1, ILE290THR	180177153
311850	5631	PRPS1	0017	ARTS SYNDROME AND PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	PRPS1, VAL142LEU	
311870	5255	PHKA1	0001	GLYCOGEN STORAGE DISEASE, TYPE IXd	PHKA1, GLU1112TER	137852546
311870	5255	PHKA1	0002	GLYCOGEN STORAGE DISEASE, TYPE IXd	PHKA1, IVSL, G-C, +1	
311870	5255	PHKA1	0003	GLYCOGEN STORAGE DISEASE, TYPE IXd	PHKA1, ASP299VAL	137852547
311870	5255	PHKA1	0004	GLYCOGEN STORAGE DISEASE, TYPE IXd	PHKA1, 1-BP DEL, 695C	
311870	5255	PHKA1	0005	GLYCOGEN STORAGE DISEASE, TYPE IXd	PHKA1, GLY223ARG	137852548
312173	6134	RPL10	0001	AUTISM, SUSCEPTIBILITY TO, X-LINKED 5	RPL10, LEU206MET	
312173	6134	RPL10	0002	AUTISM, SUSCEPTIBILITY TO, X-LINKED 5	RPL10, HIS213GLN	
312180	7319	UBE2A	0001	MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE	UBE2A, GLN128TER	104894952
312180	7319	UBE2A	0002	MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE	UBE2A, GLY23ARG	
312180	7319	UBE2A	0003	MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE	UBE2A, ARG11GLN	
312610	6103	RPGR	0001	RETINITIS PIGMENTOSA 3	RPGR, PHE130CYS	62638644
312610	6103	RPGR	0002	RETINITIS PIGMENTOSA 3	RPGR, PRO235SER	62638651
312610	6103	RPGR	0003	RETINITIS PIGMENTOSA 3	RPGR, GLY275SER	62642057
312610	6103	RPGR	0004	RETINITIS PIGMENTOSA 3	RPGR, 4-BP DEL, NT1433	
312610	6103	RPGR	0005	RETINITIS PIGMENTOSA 3	RPGR, IVS10DS, A-G, +3	
312610	6103	RPGR	0006	RETINITIS PIGMENTOSA 3	RPGR, GLY60VAL	62638634
312610	6103	RPGR	0007	RETINITIS PIGMENTOSA 3	RPGR, 2-BP DEL, NT1571	
312610	6103	RPGR	0008	RETINITIS PIGMENTOSA 3	RPGR, EX15ADEL	
312610	6103	RPGR	0009	RETINITIS PIGMENTOSA 3	RPGR, THR99ASN	62638637
312610	6103	RPGR	0010	RETINITIS PIGMENTOSA 3	RPGR, 2-BP DEL, 673AG	
312610	6103	RPGR	0011	RETINITIS PIGMENTOSA 3	RPGR, 2-BP DEL, 652AG	
312610	6103	RPGR	0012	RETINITIS PIGMENTOSA 3	RPGR, GLU299TER	137852549
312610	6103	RPGR	0013	RETINITIS PIGMENTOSA 3	RPGR, 1-BP INS, 173A	
312610	6103	RPGR	0014	CONE DYSTROPHY, X-LINKED, 1	RPGR, 2-BP DEL, 1343GG	
312610	6103	RPGR	0015	CONE DYSTROPHY, X-LINKED, 1	RPGR, 2-BP DEL, 1339AG	
312610	6103	RPGR	0016	RETINITIS PIGMENTOSA, X-LINKED, AND SINORESPIRATORY INFECTIONS, WITH OR WITHOUT DEAFNESS	RPGR, IVS5, G-T, +1	
312610	6103	RPGR	0017	MACULAR DEGENERATION, X-LINKED ATROPHIC	RPGR, IVS15, G-T, +1164	
312610	6103	RPGR	0018	CONE DYSTROPHY, X-LINKED, 1	RPGR, 15-BP DEL, NT694	
312610	6103	RPGR	0019	RETINITIS PIGMENTOSA, X-LINKED, AND SINORESPIRATORY INFECTIONS, WITH DEAFNESS	RPGR, 2-BP DEL, 845TG	
312610	6103	RPGR	0020	RETINITIS PIGMENTOSA, X-LINKED, AND SINORESPIRATORY INFECTIONS, WITH DEAFNESS	RPGR, GLY173ARG	137852550
312610	6103	RPGR	0021	CONE DYSTROPHY, X-LINKED, 1	RPGR, GLU364ASP, GLU365TER	
312610	6103	RPGR	0022	CONE DYSTROPHY, X-LINKED, 1	RPGR, GLY392TER	137852551
312610	6103	RPGR	0023	RETINITIS PIGMENTOSA, X-LINKED, AND SINORESPIRATORY INFECTIONS, WITH DEAFNESS	RPGR, 57-BP DEL, NT631	
312610	6103	RPGR	0024	RETINITIS PIGMENTOSA 3	RPGR, 912G-T	
312610	6103	RPGR	0025	RETINITIS PIGMENTOSA 3	RPGR, IVS9AS, G-A, -55	
312861	3358	HTR2C	0001	SEROTONIN 5-HT-2C RECEPTOR POLYMORPHISM	HTR2C, CYS23SER	6318
312865	6473	SHOX	0001	SHORT STATURE, IDIOPATHIC, X-LINKED	SHOX, ARG195TER	137852552
312865	6473	SHOX	0002	LERI-WEILL DYSCHONDROSTEOSIS	SHOX, TYR199TER	137852553
312865	6473	SHOX	0003	LANGER MESOMELIC DYSPLASIA LERI-WEILL DYSCHONDROSTEOSIS, INCLUDED	SHOX, DEL	
312865	6473	SHOX	0004	LERI-WEILL DYSCHONDROSTEOSIS	SHOX, LEU132VAL	137852554
312865	6473	SHOX	0005	LERI-WEILL DYSCHONDROSTEOSIS	SHOX, ARG153LEU	137852555
312865	6473	SHOX	0006	LERI-WEILL DYSCHONDROSTEOSIS	SHOX, 1-BP DEL, 1272G	
312865	6473	SHOX	0007	LERI-WEILL DYSCHONDROSTEOSIS	SHOX, ARG173CYS	137852556
312865	6473	SHOX	0008	LANGER MESOMELIC DYSPLASIA LERI-WEILL DYSCHONDROSTEOSIS, INCLUDED	SHOX, ARG168TRP	137852557
312865	6473	SHOX	0009	LANGER MESOMELIC DYSPLASIA	SHOX, 1-BP INS, 723C	
312865	6473	SHOX	0010	LANGER MESOMELIC DYSPLASIA	SHOX, 2-BP INS, 350AG	
312865	6473	SHOX	0011	LERI-WEILL DYSCHONDROSTEOSIS	SHOX, GLU102TER	137852558
312865	6473	SHOX	0012	LERI-WEILL DYSCHONDROSTEOSIS	SHOX, TER293ARG	137852559
312865	6473	SHOX	0013	LANGER MESOMELIC DYSPLASIA LERI-WEILL DYSCHONDROSTEOSIS, INCLUDED	SHOX, 1.1-MB DEL	
312865	6473	SHOX	0014	LERI-WEILL DYSCHONDROSTEOSIS LANGER MESOMELIC DYSPLASIA, INCLUDED	SHOX, ALA170PRO	
312865	6473	SHOX	0015	LERI-WEILL DYSCHONDROSTEOSIS	SHOX, ALA170ASP	
313430	6658	SOX3	0001	MENTAL RETARDATION, X-LINKED, WITH ISOLATED GROWTH HORMONE DEFICIENCY	SOX3, 33-BP DUP, NT711-743	
313430	6658	SOX3	0002	PANHYPOPITUITARISM, X-LINKED	SOX3, DUP	
313430	6658	SOX3	0003	PANHYPOPITUITARISM, X-LINKED	SOX3, 21-BP DUP	
313440	6853	SYN1	0001	EPILEPSY, X-LINKED, WITH VARIABLE LEARNING DISABILITIES AND BEHAVIOR DISORDERS	SYN1, TRP356TER	137852560
313440	6853	SYN1	0002	EPILEPSY, X-LINKED, WITH VARIABLE LEARNING DISABILITIES AND BEHAVIOR DISORDERS	SYN1, GLN555TER	
313440	6853	SYN1	0003	EPILEPSY, X-LINKED, WITH VARIABLE LEARNING DISABILITIES AND BEHAVIOR DISORDERS	SYN1, ALA550THR	
313440	6853	SYN1	0004	EPILEPSY, X-LINKED, WITH VARIABLE LEARNING DISABILITIES AND BEHAVIOR DISORDERS	SYN1, THR567ALA	
313475	6855	SYP	0001	MENTAL RETARDATION, X-LINKED 96	SYP, 1-BP INS, 274A	
313475	6855	SYP	0002	MENTAL RETARDATION, X-LINKED 96	SYP, 2-BP DEL/INS	
313475	6855	SYP	0003	MENTAL RETARDATION, X-LINKED 96	SYP, 4-BP DEL, 829GACT	
313475	6855	SYP	0004	MENTAL RETARDATION, X-LINKED 96	SYP, GLY217ARG	137852561
313650	6872	TAF1	0001	DYSTONIA-PARKINSONISM, X-LINKED	TAF1, SVA RETROTRANSPOSON INSERTION	
313700	367	AR	0001	ANDROGEN INSENSITIVITY, COMPLETE	AR, PARTIAL DEL	
313700	367	AR	0002	ANDROGEN INSENSITIVITY, COMPLETE	AR, PARTIAL DEL	
313700	367	AR	0003	ANDROGEN INSENSITIVITY, COMPLETE	AR, ARG773CYS	137852562
313700	367	AR	0004	ANDROGEN INSENSITIVITY, COMPLETE	AR, TRP717TER	137852563
313700	367	AR	0005	ANDROGEN INSENSITIVITY, COMPLETE	AR, VAL866MET	137852564
313700	367	AR	0006	ANDROGEN INSENSITIVITY, COMPLETE	AR, TRP794TER	137852565
313700	367	AR	0007	ANDROGEN INSENSITIVITY, COMPLETE	AR, LYS588TER	137852566
313700	367	AR	0008	ANDROGEN INSENSITIVITY, PARTIAL	AR, TYR761CYS	137852567
313700	367	AR	0009	ANDROGEN INSENSITIVITY, COMPLETE	AR, LYS882TER	137852568
313700	367	AR	0010	ANDROGEN INSENSITIVITY, COMPLETE	AR, ARG772CYS	
313700	367	AR	0011	ANDROGEN INSENSITIVITY, PARTIAL	AR, ALA771THR	137852569
313700	367	AR	0012	ANDROGEN INSENSITIVITY, COMPLETE	AR, MET786VAL	137852570
313700	367	AR	0013	PROSTATE CANCER	AR, VAL730MET	137852571
313700	367	AR	0014	SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	AR, (CAG)n EXPANSION	193922933
313700	367	AR	0015	ANDROGEN INSENSITIVITY, COMPLETE	AR, ARG773HIS	137852572
313700	367	AR	0016	ANDROGEN INSENSITIVITY, PARTIAL, WITH OR WITHOUT BREAST CANCER	AR, ARG607GLN	137852573
313700	367	AR	0017	ANDROGEN INSENSITIVITY, COMPLETE	AR, VAL865MET	
313700	367	AR	0018	ANDROGEN INSENSITIVITY, PARTIAL	AR, VAL865LEU	137852564
313700	367	AR	0019	ANDROGEN INSENSITIVITY, PARTIAL	AR, ARG855HIS	9332971
313700	367	AR	0020	HYPOSPADIAS 1, X-LINKED	AR, ILE869MET	137852574
313700	367	AR	0021	ANDROGEN INSENSITIVITY, COMPLETE	AR, GLN60TER	137852575
313700	367	AR	0022	ANDROGEN INSENSITIVITY, COMPLETE	AR, 5-KB DEL, EX E	
313700	367	AR	0023	ANDROGEN INSENSITIVITY, COMPLETE	AR, 5-KB DEL, EX F,G	
313700	367	AR	0024	ANDROGEN INSENSITIVITY, PARTIAL, WITH BREAST CANCER	AR, ARG608LYS	137852576
313700	367	AR	0025	ANDROGEN INSENSITIVITY, PARTIAL	AR, ARG839HIS	9332969
313700	367	AR	0026	ANDROGEN INSENSITIVITY, PARTIAL	AR, ARG839CYS	137852577
313700	367	AR	0027	PROSTATE CANCER	AR, THR877ALA	137852578
313700	367	AR	0028	ANDROGEN INSENSITIVITY, COMPLETE	AR, LEU676PRO	137852579
313700	367	AR	0029	PROSTATE CANCER	AR, THR877SER	137852580
313700	367	AR	0030	PROSTATE CANCER	AR, HIS874TYR	137852581
313700	367	AR	0031	PROSTATE CANCER	AR, GLN902ARG	137852582
313700	367	AR	0032	PROSTATE CANCER	AR, ALA721THR	137852583
313700	367	AR	0033	PROSTATE CANCER	AR, SER647ASN	137852584
313700	367	AR	0034	ANDROGEN INSENSITIVITY, COMPLETE	AR, LEU707ARG	137852585
313700	367	AR	0035	ANDROGEN INSENSITIVITY, COMPLETE	AR, CYS579PHE	137852586
313700	367	AR	0036	ANDROGEN INSENSITIVITY, COMPLETE	AR, PHE582TYR	137852587
313700	367	AR	0037	HYPOSPADIAS 1, X-LINKED	AR, PRO546SER	137852588
313700	367	AR	0038	ANDROGEN INSENSITIVITY, PARTIAL	AR, GLU2LYS	104894742
313700	367	AR	0039	ANDROGEN INSENSITIVITY, COMPLETE	AR, MET780ILE	137852589
313700	367	AR	0040	ANDROGEN INSENSITIVITY, PARTIAL	AR, ARG846HIS	
313700	367	AR	0041	ANDROGEN INSENSITIVITY, PARTIAL	AR, IVS2AS, T-A, -11	
313700	367	AR	0042	ANDROGEN INSENSITIVITY, PARTIAL	AR, LEU172TER	137852590
313700	367	AR	0043	ANDROGEN INSENSITIVITY, PARTIAL	AR, GLN798GLU	137852591
313700	367	AR	0044	ANDROGEN INSENSITIVITY, PARTIAL	AR, MET807THR	137852592
313700	367	AR	0045	ANDROGEN INSENSITIVITY, COMPLETE	AR, 1-BP INS, 179A	
313700	367	AR	0046	ANDROGEN INSENSITIVITY, COMPLETE	AR, 2-BP DEL, 180GC	
313700	367	AR	0047	PROSTATE CANCER SUSCEPTIBILITY	AR, ARG726LEU	137852593
313700	367	AR	0048	ANDROGEN INSENSITIVITY SYNDROME	AR, SER888SER	137852594
313700	367	AR	0049	ANDROGEN INSENSITIVITY, PARTIAL	AR, IVS6, G-T, +5	
313700	367	AR	0050	ANDROGEN INSENSITIVITY SYNDROME	AR, LEU712PHE	137852595
313700	367	AR	0051	ANDROGEN INSENSITIVITY SYNDROME	AR, GLY577ARG	137852596
313700	367	AR	0052	ANDROGEN INSENSITIVITY SYNDROME	AR, SER865PRO	137852597
313700	367	AR	0053	ANDROGEN INSENSITIVITY SYNDROME	AR, PHE856LEU	137852598
313700	367	AR	0054	ANDROGEN INSENSITIVITY SYNDROME	AR, ARG840CYS	
313700	367	AR	0055	ANDROGEN INSENSITIVITY, COMPLETE	AR, HIS689PRO	137852599
313700	367	AR	0056	ANDROGEN INSENSITIVITY, PARTIAL ANDROGEN INSENSITIVITY, COMPLETE, INCLUDED	AR, GLY743VAL	137852600
313700	367	AR	0057	ANDROGEN INSENSITIVITY, COMPLETE	AR, GLY743GLU	137852600
313700	367	AR	0058	ANDROGEN INSENSITIVITY, COMPLETE	AR, INS/DEL, EX5	
313700	367	AR	0059	ANDROGEN INSENSITIVITY, PARTIAL	AR, SER740CYS	137852601
313700	367	AR	0060	ANDROGEN INSENSITIVITY, PARTIAL	AR, ALA645ASP, SHORT POLYGLYCINE REPEAT, LONG POLYGLUTAMINE REPEAT	1800053
314200	6906	SERPINA7	0001	THYROXINE-BINDING GLOBULIN DEFICIENCY, COMPLETE COMPLETE DEFICIENCY 5	TBG, LEU227PRO	28937312
314200	6906	SERPINA7	0002	THYROXINE-BINDING GLOBULIN, VARIANT A TBG-A;; TBG-ABORIGINE	TBG, ALA191THR	2234036
314200	6906	SERPINA7	0003	THYROXINE-BINDING GLOBULIN, VARIANT P TBG-P	TBG, LEU283PHE	1804495
314200	6906	SERPINA7	0004	THYROXINE-BINDING GLOBULIN, SLOW TBG-S	TBG, ASP171ASN	1050086
314200	6906	SERPINA7	0005	THYROXINE-BINDING GLOBULIN DEFICIENCY, PARTIAL, QUEBEC TYPE THYROXINE-BINDING GLOBULIN, QUEBEC;; TBG-QUEBEC	TBG, HIS331TYR	72554659
314200	6906	SERPINA7	0006	THYROXINE-BINDING GLOBULIN DEFICIENCY, PARTIAL, MONTREAL TYPE THYROXINE-BINDING GLOBULIN, MONTREAL;; TBG-MONTREAL	TBG, ALA113PRO	28933688
314200	6906	SERPINA7	0007	THYROXINE-BINDING GLOBULIN DEFICIENCY, COMPLETE COMPLETE DEFICIENCY 6	TBG, 1-BP DEL, GTT165GT	
314200	6906	SERPINA7	0008	THYROXINE-BINDING GLOBULIN DEFICIENCY, PARTIAL, GARY TYPE THYROXINE-BINDING GLOBULIN, GARY;; TBG-GARY	TBG, ILE96ASN	28933689
314200	6906	SERPINA7	0009	THYROXINE-BINDING GLOBULIN DEFICIENCY, COMPLETE, JAPANESE TYPE TBG-CDJ	TBG, 1-BP DEL, FS374TER	
314200	6906	SERPINA7	0010	THYROXINE-BINDING GLOBULIN, CHICAGO TBG-CHICAGO	TBG, TYR309PHE	61754490
314200	6906	SERPINA7	0011	THYROXINE-BINDING GLOBULIN EXCESS	TBG, AMP	
314200	6906	SERPINA7	0012	THYROXINE-BINDING GLOBULIN DEFICIENCY, PARTIAL, JAPANESE TYPE TBG-PDJ	TBG, PRO363LEU	72554658
314200	6906	SERPINA7	0013	THYROXINE-BINDING GLOBULIN DEFICIENCY, COMPLETE, BUFFALO TYPE THYROXINE-BINDING GLOBULIN, BUFFALO;; TBG-BUFFALO	TBG, TRP280TER	121909496
314200	6906	SERPINA7	0014	THYROXINE-BINDING GLOBULIN DEFICIENCY, COMPLETE, KANKAKEE TYPE TBG-CD KANKAKEE	TBG, IVS2AS, A-G, -2	
314200	6906	SERPINA7	0015	THYROXINE-BINDING GLOBULIN DEFICIENCY, COMPLETE, NEGEV TYPE TBG-CD NEGEV	TBG, 1-BP DEL, CODON 38, T	
314200	6906	SERPINA7	0016	THYROXINE-BINDING GLOBULIN DEFICIENCY, COMPLETE	TBG, 19-BP DEL, EX4	
314200	6906	SERPINA7	0017	THYROXINE-BINDING GLOBULIN DEFICIENCY, COMPLETE	TBG, 1-BP DEL, 2690G	
314200	6906	SERPINA7	0018	THYROXINE-BINDING GLOBULIN DEFICIENCY, COMPLETE	TBG, 1-BP DEL, 3358G	
314200	6906	SERPINA7	0019	THYROXINE-BINDING GLOBULIN DEFICIENCY, COMPLETE, JACKSON TYPE TBG-JACKSON	TBG, IVS4DS, G-A, +5	
314370	7317	UBA1	0001	SPINAL MUSCULAR ATROPHY, X-LINKED 2	UBE1, MET539ILE	80356545
314370	7317	UBA1	0002	SPINAL MUSCULAR ATROPHY, X-LINKED 2	UBE1, SER547GLY	80356546
314370	7317	UBA1	0003	SPINAL MUSCULAR ATROPHY, X-LINKED 2	UBE1, ASN577ASN	80356547
314375	7355	SLC35A2	0001	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm, SOMATIC MOSAIC	SLC35A2, c.15_91+48delinsA	
314375	7355	SLC35A2	0002	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm, SOMATIC MOSAIC	SLC35A2, VAL331ILE	
314375	7355	SLC35A2	0003	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm	SLC35A2, MET1?	
314670	7503	XIST	0001	X INACTIVATION, FAMILIAL SKEWED, 1	XIST, C-G, -43	
314690	8242	KDM5C	0001	MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE	KDM5C, LEU731PHE	199422234
314690	8242	KDM5C	0002	MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE	KDM5C, 1-BP INS, 202C	
314690	8242	KDM5C	0003	MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE	KDM5C, ALA388PRO	199422235
314690	8242	KDM5C	0004	MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE	KDM5C, ARG694TER	199422236
314690	8242	KDM5C	0005	MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE	KDM5C, SER451ARG	199422237
314690	8242	KDM5C	0006	MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE	KDM5C, ARG766TRP	199422238
314690	8242	KDM5C	0007	MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE	KDM5C, ALA77THR	199422239
314690	8242	KDM5C	0008	MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE	KDM5C, CYS724TER	
314690	8242	KDM5C	0009	MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE	KDM5C, PRO554THR	
314850	7504	XK	0001	MCLEOD SYNDROME	XK, IVS2DS, G-A, +1	
314850	7504	XK	0002	MCLEOD SYNDROME	XK, IVS2AS, G-A, -1	
314850	7504	XK	0003	MCLEOD SYNDROME	XK, 1-BP DEL	
314850	7504	XK	0004	MCLEOD SYNDROME	XK, 1-BP DEL, 1095T	
314850	7504	XK	0005	MCLEOD SYNDROME	XK, CYS294ARG	28933690
314850	7504	XK	0006	MCLEOD SYNDROME	XK, 13-BP DEL	
314850	7504	XK	0007	MCLEOD SYNDROME	XK, TRP314TER	104894953
314850	7504	XK	0008	MCLEOD SYNDROME	XK, GLN299TER	104894954
314990	7552	ZNF711	0001	MENTAL RETARDATION, X-LINKED 97	ZNF711, 2-BP DEL, 2157TG	
314990	7552	ZNF711	0002	MENTAL RETARDATION, X-LINKED 97	ZNF711, ARG525TER	199422240
314995	7592	ZNF41	0001	MENTAL RETARDATION, X-LINKED 89	ZNF41, PRO111LEU	104894955
314995	7592	ZNF41	0002	MENTAL RETARDATION, X-LINKED 89	ZNF41, IVS2AS, A-C, -42	
314998	347344	ZNF81	0001	MENTAL RETARDATION, X-LINKED 45	ZNF81, SER179ASN	28933691
400005	8287	USP9Y	0001	AZOOSPERMIA, NONOBSTRUCTIVE, Y-LINKED	USP9Y, IVS7DS, 4-BP DEL	
400005	8287	USP9Y	0002	HYPOSPERMATOGENESIS, NONOBSTRUCTIVE, Y-LINKED	USP9Y, DEL	
480000	6736	SRY	0001	46,XY SEX REVERSAL 1	SRY, 4-BP DEL, NT773	
480000	6736	SRY	0003	46,XY SEX REVERSAL 1	SRY, PHE109SER	104894956
480000	6736	SRY	0004	46,XY SEX REVERSAL 1	SRY, VAL60LEU	104894957
480000	6736	SRY	0005	46,XY SEX REVERSAL 1	SRY, GLN93TER	104894958
480000	6736	SRY	0006	46,XY SEX REVERSAL 1 46,XY TRUE HERMAPHRODITISM, INCLUDED	SRY, ILE90MET	104894959
480000	6736	SRY	0007	46,XY SEX REVERSAL 1	SRY, LYS106ILE	104894964
480000	6736	SRY	0008	46,XY SEX REVERSAL 1	SRY, 1-BP DEL, 734A	
480000	6736	SRY	0009	46,XY SEX REVERSAL 1	SRY, ALA113THR	104894966
480000	6736	SRY	0010	46,XY SEX REVERSAL 1	SRY, TRP107TER	104894967
480000	6736	SRY	0011	46,XY SEX REVERSAL 1	SRY, ILE68THR	104894968
480000	6736	SRY	0012	46,XY SEX REVERSAL 1	SRY, MET64ILE	104894969
480000	6736	SRY	0013	46,XY SEX REVERSAL 1	SRY, TRP70TER	104894965
480000	6736	SRY	0015	46,XY SEX REVERSAL 1	SRY, LYS92TER	104894970
480000	6736	SRY	0016	46,XY SEX REVERSAL 1	SRY, GLY95ARG	104894974
480000	6736	SRY	0018	46,XY SEX REVERSAL 1	SRY, TYR4TER	104894975
480000	6736	SRY	0019	46,XY SEX REVERSAL 1	SRY, ARG133TRP	104894976
480000	6736	SRY	0020	46,XY SEX REVERSAL 1	SRY, GLN2TER	104894977
480000	6736	SRY	0021	46,XY SEX REVERSAL 1	SRY, SER18ASN	104894971
480000	6736	SRY	0022	46,XY SEX REVERSAL 1	SRY, GLY95GLU	104894972
480000	6736	SRY	0023	46,XY SEX REVERSAL 1	SRY, TYR127PHE	104894973
516000	-	-	0001	LEBER OPTIC ATROPHY MITOCHONDRIAL COMPLEX I DEFICIENCY, INCLUDED	MTND1, LHON3460G-A	199476118
516000	-	-	0002	LEBER OPTIC ATROPHY	MTND1, LHON4160C	199476119
516000	-	-	0003	LEBER OPTIC ATROPHY NADH-DEHYDROGENASE SUBUNIT 1, MITOCHONDRIAL, MUTATION IN	MTND1, LHON4216C	1599988
516000	-	-	0004	LEBER OPTIC ATROPHY	MTND1, LHON3394C	41460449
516000	-	-	0005	ALZHEIMER DISEASE PARKINSON DISEASE, INCLUDED	MTND1, ADPD3397G	199476120
516000	-	-	0006	LEBER OPTIC ATROPHY	MTND1, LHON4136G	199476121
516000	-	-	0007	COLORECTAL CANCER SUDDEN INFANT DEATH SYNDROME, INCLUDED	MTND1, 3308T-C, MET1THR	28358582
516000	-	-	0008	SUDDEN INFANT DEATH SYNDROME	MTND1, 3308T-G, MET1TER	28358582
516000	-	-	0009	MITOCHONDRIAL COMPLEX I DEFICIENCY	MTND1, 7-BP INV	
516000	-	-	0010	LEBER OPTIC ATROPHY	MTND1, LHON4171A	28616230
516000	-	-	0011	DYSTONIA, ADULT-ONSET	MTND1, 3796A-G	28357970
516000	-	-	0012	MELAS SYNDROME LEBER OPTIC ATROPHY AND DYSTONIA, INCLUDED	MTND1, 3697G-A	199476122
516000	-	-	0013	MELAS SYNDROME	MTND1, 3946G-A	199476123
516000	-	-	0014	MELAS SYNDROME	MTND1, 3949T-C	199476124
516000	-	-	0015	LEBER OPTIC ATROPHY	MTND1, LHON3733G-A	199476125
516000	-	-	0016	DEAFNESS, NONSYNDROMIC SENSORINEURAL, MITOCHONDRIAL	MTND1, 3388C-A	
516001	-	-	0001	LEBER OPTIC ATROPHY	MTND2, LHON4917G	28357980
516001	-	-	0002	LEBER OPTIC ATROPHY	MTND2, LHON5244A	199476115
516001	-	-	0003	LEBER OPTIC ATROPHY	MTND2, LHON4640A	
516001	-	-	0004	MITOCHONDRIAL COMPLEX I DEFICIENCY	MTND2, 2-BP DEL, 5132AA	199476116
516001	-	-	0005	MITOCHONDRIAL COMPLEX I DEFICIENCY	MTND2, TRP114TER	
516001	-	-	0006	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY	MTND2, LEU71PRO	
516002	-	-	0001	MITOCHONDRIAL COMPLEX I DEFICIENCY	MTND3, SER45PRO	
516002	-	-	0002	PARKINSON DISEASE, RESISTANCE TO	MTND3, 10398A-G	2853826
516002	-	-	0003	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY MITOCHONDRIAL COMPLEX I DEFICIENCY, INCLUDED	MTND3, 10158T-C	199476117
516002	-	-	0004	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY LEBER OPTIC ATROPHY AND DYSTONIA, INCLUDED	MTND3, 10197G-A, ALA47THR	
516003	-	-	0001	LEBER OPTIC ATROPHY	MTND4, LHON11778A	199476112
516003	-	-	0002	MELAS SYNDROME	MTND4, MELAS11084G	199476113
516003	-	-	0003	LEBER OPTIC ATROPHY AND DYSTONIA	MTND4, VAL312ILE	
516003	-	-	0004	MITOCHONDRIAL COMPLEX I DEFICIENCY	MTND4, 11777C-A	28384199
516004	-	-	0001	COLORECTAL CANCER	MTND4L, CYS32ARG	
516004	-	-	0002	LEBER OPTIC ATROPHY	MTND4L, 10663T-C	199476114
516005	-	-	0001	LEBER OPTIC ATROPHY	MTND5, LHON13708A	
516005	-	-	0002	LEBER OPTIC ATROPHY	MTND5, LHON13730A	
516005	-	-	0003	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY	MTND5, 12706T-C, PHE124LEU	
516005	-	-	0004	MELAS SYNDROME	MTND5, 12770A-G, GLU145GLY	
516005	-	-	0005	MELAS SYNDROME LEBER OPTIC ATROPHY, INCLUDED;; LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY, INCLUDED	MTND5, 13045A-C, MET237LEU	
516005	-	-	0006	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY MELAS SYNDROME, INCLUDED	MTND5, 13084A-T, SER250CYS	
516005	-	-	0007	MELAS SYNDROME LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY, INCLUDED	MTND5, 13513G-A, ASP393ASN	
516005	-	-	0008	MELAS SYNDROME MERRF SYNDROME, INCLUDED;; LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY, INCLUDED	MTND5, 13042G-A, ALA236THR	
516005	-	-	0009	LEBER OPTIC ATROPHY	MTND5, 12848C-T, ALA171VAL	
516005	-	-	0010	PARKINSON DISEASE 6, MODIFIER OF	MTND5, 12397A-G	
516005	-	-	0011	LEBER OPTIC ATROPHY	MTND5, 12338T-C, MET1THR	
516006	-	-	0001	LEBER OPTIC ATROPHY	MTND6, LHON14484C	199476104
516006	-	-	0002	LEBER OPTIC ATROPHY AND DYSTONIA LEBER OPTIC ATROPHY, INCLUDED;; LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY, INCLUDED	MTND6, LDYT14459A	199476105
516006	-	-	0003	LEBER OPTIC ATROPHY AND DYSTONIA	MTND6, LDYT14596A	
516006	-	-	0004	LEBER OPTIC ATROPHY	MTND6, LHON14495G	199476106
516006	-	-	0005	MELAS SYNDROME	MTND6, MELAS14453A	199476107
516006	-	-	0006	LEBER OPTIC ATROPHY	MTND6, LHON14482A	199476108
516006	-	-	0007	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY STRIATAL NECROSIS, BILATERAL, WITH DYSTONIA, INCLUDED	MTND6, 14487T-C	199476109
516006	-	-	0008	PARKINSON DISEASE 6, MODIFIER OF	MTND6, 14319T-C	199476110
516020	-	-	0001	LEBER OPTIC ATROPHY	MTCYB, LHON15257A	
516020	-	-	0002	LEBER OPTIC ATROPHY	MTCYB, LHON15812A	
516020	-	-	0003	COLORECTAL CANCER	MTCYB, 14985G-A, ARG80HIS	
516020	-	-	0004	COLORECTAL CANCER	MTCYB, 15572T-C, PHE276LEU	
516020	-	-	0005	EXERCISE INTOLERANCE	MTCYB, 15615G-A, GLY290ASP	
516020	-	-	0006	EXERCISE INTOLERANCE	MTCYB, 14846G-A, GLY34SER	
516020	-	-	0007	ENCEPHALOMYOPATHY, MITOCHONDRIAL	MTCYB, 15242G-A, GLY166TER	
516020	-	-	0008	EXERCISE INTOLERANCE	MTCYB, 15150G-A, TRP135TER	
516020	-	-	0009	EXERCISE INTOLERANCE	MTCYB, 15197T-C, SER151PRO	
516020	-	-	0010	MULTISYSTEM DISORDER	MTCYB, 15579A-G, TYR278CYS	
516020	-	-	0011	CARDIOMYOPATHY, INFANTILE HISTIOCYTOID	MTCYB, 15498G-A, GLY251ASP	
516020	-	-	0012	EXERCISE INTOLERANCE, CARDIOMYOPATHY, AND SEPTOOPTIC DYSPLASIA	MTCYB, 14849T-C, SER35PRO	
516020	-	-	0013	PARKINSONISM/MELAS OVERLAP SYNDROME	MTCYB, 4-BP DEL, 14787TTAA	
516020	-	-	0014	OBESITY, SUSCEPTIBILITY TO	MTCYB, 15497G-A, GLY251SER	
516030	-	-	0001	LEBER OPTIC ATROPHY DEAFNESS, AMINOGLYCOSIDE-INDUCED, INCLUDED;; DEAFNESS, NONSYNDROMIC SENSORINEURAL, MITOCHONDRIAL, INCLUDED	MTCO1, LHON7444A	
516030	-	-	0002	SIDEROBLASTIC ANEMIA, ACQUIRED IDIOPATHIC	MTCO1, AISA6742C	199476126
516030	-	-	0003	SIDEROBLASTIC ANEMIA, ACQUIRED IDIOPATHIC	MTCO1, AISA6721C	199476127
516030	-	-	0004	CYTOCHROME c OXIDASE DEFICIENCY	MTCO1, COX6480A	199476128
516030	-	-	0005	COLORECTAL CANCER	MTCO1, GLY121TER	
516030	-	-	0006	CYTOCHROME c OXIDASE DEFICIENCY	MTCO1, 6930G-A	28679680
516030	-	-	0007	MYOGLOBINURIA, RECURRENT	MTCO1, 5920G-A	199476129
516030	-	-	0008	CYTOCHROME c OXIDASE I DEFICIENCY	MTCO1, LEU196ILE	
516030	-	-	0009	CYTOCHROME c OXIDASE I DEFICIENCY	MTCO1, SER142PHE	
516030	-	-	0010	COLORECTAL CANCER	MTCO1, GLY125ASP	
516030	-	-	0011	COLORECTAL CANCER	MTCO1, SER458PRO	
516040	-	-	0001	CYTOCHROME c OXIDASE DEFICIENCY	MTCO2, 7587T-C	199474825
516040	-	-	0002	COLORECTAL CANCER	MTCO2, 8009G-A, VAL142MET	199474826
516040	-	-	0003	CYTOCHROME c OXIDASE DEFICIENCY	MTCO2, 7671T-A	199474827
516040	-	-	0004	CYTOCHROME c OXIDASE DEFICIENCY	MTCO2, 2-BP DEL, 8042AT	199474828
516040	-	-	0005	CYTOCHROME c OXIDASE DEFICIENCY	MTCO2, 7896G-A	199474829
516050	-	-	0001	LEBER OPTIC ATROPHY	MTCO3, LHON9438A	
516050	-	-	0002	LEBER OPTIC ATROPHY	MTCO3, LHON9804A	
516050	-	-	0003	MITOCHONDRIAL COMPLEX IV DEFICIENCY MITOCHONDRIAL COMPLEX IV DEFICIENCY WITH RECURRENT MYOGLOBINURIA	MTCO3, 15-BP DEL	
516050	-	-	0004	MITOCHONDRIAL COMPLEX IV DEFICIENCY	MTCO3, 9952G-A, TRP-TER	
516050	-	-	0005	MITOCHONDRIAL COMPLEX IV DEFICIENCY	MTCO3, 1-BP INS, 9537C	
516050	-	-	0006	MITOCHONDRIAL COMPLEX IV DEFICIENCY	MTCO3, 9379G-A, TRP58TER	
516050	-	-	0007	SEIZURES AND LACTIC ACIDOSIS	MTCO3, 2-BP DEL, 9205TA	
516060	-	-	0001	LEIGH SYNDROME NARP SYNDROME, INCLUDED	MTATP6, 8993T-G, LEU156ARG	199476133
516060	-	-	0002	LEIGH SYNDROME ATAXIA AND POLYNEUROPATHY, ADULT-ONSET, INCLUDED	MTATP6, 8993T-C, LEU156PRO	199476133
516060	-	-	0003	LEBER OPTIC ATROPHY	MTATP6, 9101T-C, ILE192THR	199476134
516060	-	-	0005	BILATERAL STRIATAL NECROSIS, INFANTILE, MITOCHONDRIAL LEIGH SYNDROME, INCLUDED	MTATP6, 9176T-C	199476135
516060	-	-	0006	BILATERAL STRIATAL NECROSIS, INFANTILE, MITOCHONDRIAL	MTATP6, 8851T-C	199476136
516060	-	-	0007	SEIZURES AND LACTIC ACIDOSIS	MTATP6, 2-BP DEL, 9205TA	199476137
516060	-	-	0008	LEIGH SYNDROME	MTATP6, 9185T-C, LEU220PRO	199476138
516060	-	-	0009	NARP SYNDROME	MTATP6, 1-BP INS, 8618T	199476139
516060	-	-	0010	CARDIOMYOPATHY, INFANTILE HYPERTROPHIC	MTATP6, MET1THR	
516060	-	-	0011	LEIGH SYNDROME	MTATP6, 9176T-G, LEU217ARG	
516070	-	-	0001	BRAIN PSEUDOATROPHY, REVERSIBLE, VALPROATE-INDUCED, SUSCEPTIBILITY TO	MTATP8, 8393C-T	
516070	-	-	0002	CARDIOMYOPATHY, APICAL HYPERTROPHIC, AND NEUROPATHY	MTATP8, TRP55TER	
516070	-	-	0003	CARDIOMYOPATHY, INFANTILE HYPERTROPHIC	MTATP8, TRP55ARG	
561000	-	-	0001	DEAFNESS, AMINOGLYCOSIDE-INDUCED DEAFNESS, NONSYNDROMIC SENSORINEURAL, MITOCHONDRIAL, INCLUDED;; CARDIOMYOPATHY, RESTRICTIVE, INCLUDED	MTRNR1, 1555A-G	
561000	-	-	0002	DEAFNESS, AMINOGLYCOSIDE-INDUCED	MTRNR1, 1-BP DEL, 961T, C INS	
561000	-	-	0003	DEAFNESS, AMINOGLYCOSIDE-INDUCED DEAFNESS, NONSYNDROMIC SENSORINEURAL, MITOCHONDRIAL, INCLUDED;; AUDITORY NEUROPATHY, INCLUDED	MTRNR1, 1095T-C	
561000	-	-	0004	DEAFNESS, AMINOGLYCOSIDE-INDUCED DEAFNESS, NONSYNDROMIC SENSORINEURAL, MITOCHONDRIAL, INCLUDED	MTRNR1, 1494C-T	
561000	-	-	0005	DEAFNESS, NONSYNDROMIC SENSORINEURAL, MITOCHONDRIAL	MTRNR1, 961T-G	
561000	-	-	0006	DEAFNESS, NONSYNDROMIC SENSORINEURAL, MITOCHONDRIAL	MTRNR1, 1291T-C	
561000	-	-	0007	DEAFNESS, NONSYNDROMIC SENSORINEURAL, MITOCHONDRIAL DEAFNESS, AMINOGLYCOSIDE-INDUCED, INCLUDED	MTRNR1, 827A-G	
561010	-	-	0001	CHLORAMPHENICOL RESISTANCE	MTRNR2, T2991C	199474823
561010	-	-	0002	CHLORAMPHENICOL RESISTANCE	MTRNR2, C2939A	199474824
590000	-	-	0001	MYOTONIC DYSTROPHY-LIKE MYOPATHY	MTTA, 5650G-A	
590000	-	-	0002	MITOCHONDRIAL MYOPATHY	MTTA, 5591G-A	
590005	-	-	0001	ENCEPHALOMYOPATHY, MITOCHONDRIAL	MTTR, 10438A-G	
590005	-	-	0002	ENCEPHALOMYOPATHY, MITOCHONDRIAL	MTTR, 10450A-G	
590010	-	-	0001	OPHTHALMOPLEGIA, ISOLATED	MTTN, 5703G-A	199476130
590010	-	-	0002	OPHTHALMOPLEGIA, ISOLATED	MTTN, 5692A-G	199476131
590010	-	-	0003	MITOCHONDRIAL COMPLEX I DEFICIENCY MITOCHONDRIAL COMPLEX IV DEFICIENCY, INCLUDED	MTTN, 5728A-G	199476132
590015	-	-	0001	MITOCHONDRIAL MYOPATHY, ISOLATED	MTTD, 7526A-G	
590020	-	-	0001	MELAS SYNDROME	MTTC, 5814A-G	
590020	-	-	0002	DYSTONIA, MITOCHONDRIAL	MTTC, 5816A-G	
590025	-	-	0001	MYOPATHY, MITOCHONDRIAL, WITH DIABETES MELLITUS DIABETES AND DEAFNESS, MATERNALLY INHERITED, INCLUDED	MTTE, 14709T-C	
590025	-	-	0002	MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT	MTTE, 14674T-C	
590025	-	-	0003	MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT	MTTE, 14674T-G	
590030	-	-	0001	MYOPATHY	MTTQ, 1-BP INS, 4366A	199476140
590030	-	-	0002	SENSORINEURAL DEAFNESS AND MIGRAINE	MTTQ, 4336A-G	
590030	-	-	0003	MELAS SYNDROME	MTTQ, 4332G-A	199476141
590035	-	-	0001	CARDIOMYOPATHY, HYPERTROPHIC	MTTG, 9997T-C	
590035	-	-	0002	EXERCISE INTOLERANCE	MTTG, 10010T-C	
590035	-	-	0003	SUDDEN DEATH	MTTG, 10044A-G	41362547
590040	-	-	0001	CARDIOMYOPATHY, IDIOPATHIC DILATED, MITOCHONDRIAL CARDIOMYOPATHY, HYPERTROPHIC, MITOCHONDRIAL, INCLUDED	MTTH, 12192G-A	3134560
590040	-	-	0002	PIGMENTARY RETINOPATHY AND SENSORINEURAL DEAFNESS	MTTH, 12183G-A	
590040	-	-	0003	MERRF/MELAS OVERLAP SYNDROME	MTTH, 12147G-A	
590040	-	-	0004	DEAFNESS, NONSYNDROMIC SENSORINEURAL, MITOCHONDRIAL	MTTH, 12201T-C	
590045	-	-	0001	CARDIOMYOPATHY, FATAL INFANTILE	MTTI, 4317A-G	
590045	-	-	0002	CARDIOMYOPATHY, FATAL	MTTI, 4269A-G	
590045	-	-	0003	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC DEAFNESS, NONSYNDROMIC SENSORINEURAL, MITOCHONDRIAL, INCLUDED	MTTI, 4295A-G	
590045	-	-	0004	MULTISYSTEM DISORDER	MTTI, 4284G-A	
590045	-	-	0005	ENCEPHALOPATHY, FAMILIAL PROGRESSIVE NECROTIZING	MTTI, 4290T-C	
590045	-	-	0006	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC	MTTI, 4300A-G	
590045	-	-	0007	HYPERTENSION, HYPERCHOLESTEROLEMIA, AND HYPOMAGNESEMIA, MITOCHONDRIAL	MTTI, 4291T-C	
590050	-	-	0001	MELAS SYNDROME DIABETES AND DEAFNESS, MATERNALLY INHERITED, INCLUDED;; MUSCLE STIFFNESS, PAINFUL, INCLUDED;; 3-@METHYLGLUTACONIC ACIDURIA, INCLUDED;; MACULOPATHY, AGE-RELATED, INCLUDED;; CYCLIC VOMITING SYNDROME, INCLUDED;; MITOCHONDRIAL COMPLEX IV DEFICIENCY, INCLUDED;; MERRF/MELAS OVERLAP SYNDROME, INCLUDED	MTTL1, 3243A-G	199474657
590050	-	-	0002	MELAS SYNDROME	MTTL1, 3271T-C	199474658
590050	-	-	0003	MERRF SYNDROME DIABETES MELLITUS, NONINSULIN-DEPENDENT, MATERNALLY TRANSMITTED	MTTL1, 3256C-T	199474659
590050	-	-	0004	CARDIOMYOPATHY WITH OR WITHOUT SKELETAL MYOPATHY	MTTL1, 3303C-T	199474660
590050	-	-	0005	ENCEPHALOMYOPATHY, MITOCHONDRIAL	MTTL1, 3252T-C	199474661
590050	-	-	0006	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, PROXIMAL MYOPATHY, AND SUDDEN DEATH	MTTL1, 3251A-G	199474662
590050	-	-	0007	CARDIOMYOPATHY WITH OR WITHOUT SKELETAL MYOPATHY	MTTL1, 3260A-G	199474663
590050	-	-	0008	SKELETAL MYOPATHY, RESPONSIVE TO RIBOFLAVIN	MTTL1, 3250T-C	199474664
590050	-	-	0009	SUDDEN INFANT DEATH SYNDROME	MTTL1, 3290T-C	199474665
590050	-	-	0010	NEUROPSYCHIATRIC DISORDER AND EARLY-ONSET CATARACT	MTTL1, 3274A-G	199474666
590050	-	-	0011	KEARNS-SAYRE SYNDROME	MTTL1, 3249G-A	199474667
590050	-	-	0012	MYELODYSPLASTIC SYNDROME, SOMATIC	MTTL1, 3242G-A	199474668
590055	-	-	0001	ENCEPHALOMYOPATHY, MITOCHONDRIAL	MTTL2, 12315G-A	
590055	-	-	0002	MYOPATHY, MITOCHONDRIAL	MTTL2, 12320A-G	
590055	-	-	0003	CARDIOMYOPATHY, MITOCHONDRIAL	MTTL2, 12297T-C	
590060	-	-	0001	MERRF SYNDROME LEIGH SYNDROME, INCLUDED;; PARKINSON DISEASE, MITOCHONDRIAL, INCLUDED	MTTK, 8344A-G	
590060	-	-	0002	MERRF SYNDROME MERRF/MELAS OVERLAP SYNDROME	MTTK, 8356T-C	
590060	-	-	0003	CARDIOMYOPATHY AND DEAFNESS	MTTK, 8363G-A	
590060	-	-	0004	MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY SYNDROME	MTTK, 8313G-A	
590060	-	-	0005	DIABETES AND DEAFNESS, MATERNALLY INHERITED	MTTK, 8296A-G	
590060	-	-	0006	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MYOCLONUS	MTTK, 8342G-A	
590060	-	-	0007	MERRF SYNDROME	MTTK, 8361G-A	
590065	-	-	0001	MYOPATHY, MITOCHONDRIAL	MTTM, 4409T-C	
590070	-	-	0001	MELAS SYNDROME	MTTF, 583G-A	
590070	-	-	0002	MERRF SYNDROME	MTTF, 611G-A	
590070	-	-	0003	MYOPATHY, MITOCHONDRIAL, LATE-ONSET	MTTF, 622G-A	
590070	-	-	0004	EPILEPSY, MITOCHONDRIAL	MTTF, 616T-C	
590070	-	-	0005	EPILEPSY, MITOCHONDRIAL	MTTF, 616T-G	
590070	-	-	0006	ENCEPHALOPATHY, MITOCHONDRIAL	MTTF, 586G-A	
590070	-	-	0007	NEPHROPATHY, TUBULOINTERSTITIAL	MTTF, 608A-G	
590075	-	-	0001	MYOPATHY	MTTP, UGG-TO-UGA ANTICODON MUTATION	199474699
590075	-	-	0002	PARKINSON DISEASE, SUSCEPTIBILITY TO	MTTP, 15965T-C	199474700
590075	-	-	0003	MERFF SYNDROME	MTTP, 15967G-A	199474701
590080	-	-	0001	MERRF/MELAS OVERLAP SYNDROME MITOCHONDRIAL CYTOCHROME c OXIDASE DEFICIENCY	MTTS1, 7512T-C	199474817
590080	-	-	0002	KERATODERMA, PALMOPLANTAR, WITH DEAFNESS DEAFNESS, NONSYNDROMIC SENSORINEURAL, MITOCHONDRIAL, INCLUDED	MTTS1, 7445A-G	199474818
590080	-	-	0003	MITOCHONDRIAL CYTOCHROME c OXIDASE DEFICIENCY DEAFNESS, SENSORINEURAL, WITH NEUROLOGIC FEATURES, INCLUDED;; DEAFNESS, NONSYNDROMIC SENSORINEURAL, MITOCHONDRIAL, INCLUDED	MTTS1, 1-BP INS, 7472C	199474819
590080	-	-	0004	DEAFNESS, NONSYNDROMIC SENSORINEURAL, MITOCHONDRIAL	MTTS1, 7510T-C	199474820
590080	-	-	0005	DEAFNESS, NONSYNDROMIC SENSORINEURAL, MITOCHONDRIAL	MTTS1, 7511T-C	199474821
590080	-	-	0006	DEAFNESS, AMINOGLYCOSIDE-INDUCED	MTTS1, 7444G-A	199474822
590080	-	-	0007	DEAFNESS, NONSYNDROMIC SENSORINEURAL, MITOCHONDRIAL	MTTS1, 7445A-C	199474818
590080	-	-	0008	EXERCISE INTOLERANCE, MUSCLE PAIN, AND LACTIC ACIDEMIA	MTTS1, 7497G-A	
590080	-	-	0009	DEAFNESS, NONSYNDROMIC SENSORINEURAL, MITOCHONDRIAL	MTTS1, 7505T-C	
590085	-	-	0001	CEREBELLAR ATAXIA, CATARACT, AND DIABETES MELLITUS RETINITIS PIGMENTOSA-DEAFNESS SYNDROME, INCLUDED;; RP21, INCLUDED	MTTS2, 12258C-A	
590085	-	-	0002	MERRF/MELAS OVERLAP SYNDROME	MTTS2, 12207G-A	
590090	-	-	0001	PARKINSON DISEASE, SUSCEPTIBILITY TO	MTTT, 15950G-A	
590090	-	-	0002	VARIANT OF UNKNOWN SIGNIFICANCE	MTTT, 15923A-G	
590095	-	-	0001	ENCEPHALOPATHY, MITOCHONDRIAL	MTTW, 5549G-A	199474671
590095	-	-	0002	ENCEPHALOPATHY, MITOCHONDRIAL LEIGH SYNDROME, INCLUDED	MTTW, 1-BP INS, 5537T	199474672
590095	-	-	0003	MYOPATHY, MITOCHONDRIAL	MTTW, 5521G-A	199474673
590095	-	-	0004	NEUROGASTROINTESTINAL SYNDROME, MITOCHONDRIAL	MTTW, 5532G-A	199474674
590095	-	-	0005	ENCEPHALOCARDIOMYOPATHY, MITOCHONDRIAL	MTTW, 5545C-T	
590095	-	-	0006	ENCEPHALOMYOPATHY, MITOCHONDRIAL	MTTW, 5556G-A	
590100	-	-	0001	EXERCISE INTOLERANCE AND COMPLEX III DEFICIENCY, SOMATIC	MTTY, 5874A-G	
590100	-	-	0002	CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MYOPATHY, SOMATIC	MTTY, 1-BP DEL, 5885T	
590100	-	-	0003	CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MYOPATHY, SOMATIC	MTTY, 5877G-A	
590100	-	-	0004	FOCAL SEGMENTAL GLOMERULOSCLEROSIS AND DILATED CARDIOMYOPATHY	MTTY, 5843A-G	
590105	-	-	0001	ATAXIA, PROGRESSIVE SEIZURES, MENTAL DETERIORATION, AND HEARING LOSS	MTTV, 1606A-G	199476143
590105	-	-	0002	NEONATAL DEATH LEIGH SYNDROME	MTTV, 1624C-T	199476144
600003	783	CACNB2	0001	BRUGADA SYNDROME 4	CACNB2, SER481LEU	
600005	4261	CIITA	0001	BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP A	MHC2TA, IVSDS, G-A, 72-BP DEL	
600005	4261	CIITA	0002	BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP A	MHC2TA, GLU381TER	137852602
600005	4261	CIITA	0003	BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP A	MHC2TA, IVS, G-A, +1	
600005	4261	CIITA	0004	BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP A	MHC2TA, 2178G-A	
600005	4261	CIITA	0005	BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP A	MHC2TA, 81-BP DEL, NT3003	
600005	4261	CIITA	0006	BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP A	MHC2TA, 3-BP DEL, 3193CAT	
600005	4261	CIITA	0007	RHEUMATOID ARTHRITIS, SUSCEPTIBILITY TO	MHC2TA, -168A-G	3087456
600014	6595	SMARCA2	0001	NICOLAIDES-BARAITSER SYNDROME	SMARCA2, ARG1213TRP	
600014	6595	SMARCA2	0002	NICOLAIDES-BARAITSER SYNDROME	SMARCA2, GLY1202CYS	
600014	6595	SMARCA2	0003	NICOLAIDES-BARAITSER SYNDROME	SMARCA2, ARG1159GLN	
600014	6595	SMARCA2	0004	NICOLAIDES-BARAITSER SYNDROME	SMARCA2, ASP1158VAL	
600014	6595	SMARCA2	0005	NICOLAIDES-BARAITSER SYNDROME	SMARCA2, ARG1159GLY	
600014	6595	SMARCA2	0006	NICOLAIDES-BARAITSER SYNDROME	SMARCA2, GLY881VAL	
600014	6595	SMARCA2	0007	NICOLAIDES-BARAITSER SYNDROME	SMARCA2, ARG1162HIS	
600014	6595	SMARCA2	0008	NICOLAIDES-BARAITSER SYNDROME	SMARCA2, ARG1159LEU	
600014	6595	SMARCA2	0009	NICOLAIDES-BARAITSER SYNDROME	SMARCA2, PRO883LEU	
600014	6595	SMARCA2	0010	NICOLAIDES-BARAITSER SYNDROME	SMARCA2, ALA1201VAL	
600014	6595	SMARCA2	0011	NICOLAIDES-BARAITSER SYNDROME	SMARCA2, HIS939TYR	
600014	6595	SMARCA2	0012	NICOLAIDES-BARAITSER SYNDROME	SMARCA2, GLY752ALA	
600014	6595	SMARCA2	0013	NICOLAIDES-BARAITSER SYNDROME	SMARCA2, 55-KB DEL	
600014	6595	SMARCA2	0014	NICOLAIDES-BARAITSER SYNDROME	SMARCA2, GLY1132ASP	
600016	1272	CNTN1	0001	MYOPATHY, CONGENITAL, COMPTON-NORTH	CNTN1, 1-BP DUP, 871T	
600018	4988	OPRM1	0001	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	OPRM1, 118A-G, ASN40ASP	
600020	4601	MXI1	0001	PROSTATE CANCER	MXI1, 1-BP DEL, A, CODON 140 OR 141	
600020	4601	MXI1	0002	PROSTATE CANCER	MXI1, SPLICE DONOR SITE, GT-GC	
600020	4601	MXI1	0003	PROSTATE CANCER	MXI1, GLU152ALA	137852603
600020	4601	MXI1	0004	NEUROFIBROSARCOMA	MXI1, ALA54VAL	137852604
600024	3930	LBR	0001	PELGER-HUET ANOMALY	LBR, 6-BP DEL, IVS12AS, -5-10	
600024	3930	LBR	0002	PELGER-HUET ANOMALY	LBR, IVS2AS, A-G, -2	
600024	3930	LBR	0003	HYDROPS-ECTOPIC CALCIFICATION-MOTH-EATEN SKELETAL DYSPLASIA	LBR, 7-BP SUB, NT1599	
600024	3930	LBR	0004	PELGER-HUET ANOMALY	LBR, PRO119LEU	137852605
600024	3930	LBR	0005	PELGER-HUET ANOMALY	LBR, IVS11AS, A-G, -9	
600024	3930	LBR	0006	PELGER-HUET ANOMALY	LBR, PRO569ARG	137852606
600024	3930	LBR	0007	REYNOLDS SYNDROME	LBR, ARG372CYS	
600028	1749	DLX5	0001	SPLIT-HAND/FOOT MALFORMATION 1 WITH SENSORINEURAL HEARING LOSS	DLX5, GLN178PRO	
600031	1118	CHIT1	0001	CHITOTRIOSIDASE DEFICIENCY	CHIT1, 24-BP DUP	
600031	1118	CHIT1	0002	CHITOTRIOSIDASE DEFICIENCY	CHIT1, GLY354ARG, LEU385LEU, AND 4-BP DEL	9943208
600031	1118	CHIT1	0003	CHITOTRIOSIDASE DEFICIENCY	CHIT1, GLU74LYS	137852607
600031	1118	CHIT1	0004	CHITOTRIOSIDASE DEFICIENCY	CHIT1, GLY102SER	2297950
600035	2018	EMX2	0001	SCHIZENCEPHALY	EMX2, 1-BP INS	
600035	2018	EMX2	0002	SCHIZENCEPHALY	EMX2, IVS1AS, G-A, -1	
600035	2018	EMX2	0003	SCHIZENCEPHALY	EMX2, IVS1AS, G-T, -4	
600035	2018	EMX2	0004	SCHIZENCEPHALY	EMX2, G-T, EXON 2, NT1	
600037	5015	OTX2	0001	MICROPHTHALMIA, SYNDROMIC 5	OTX2, 2-BP INS, 464GC	
600037	5015	OTX2	0002	MICROPHTHALMIA, SYNDROMIC 5	OTX2, ARG89GLY	104894464
600037	5015	OTX2	0003	MICROPHTHALMIA, SYNDROMIC 5	OTX2, 1-BP DEL, 81C	
600037	5015	OTX2	0004	MICROPHTHALMIA, SYNDROMIC 5	OTX2, TYR179TER	104894465
600037	5015	OTX2	0005	MICROPHTHALMIA, SYNDROMIC 5	OTX2, 1-BP INS, 402C	
600037	5015	OTX2	0006	PITUITARY HORMONE DEFICIENCY, COMBINED 6	OTX2, ASN233SER	
600037	5015	OTX2	0007	MICROPHTHALMIA, SYNDROMIC 5	OTX2, 2-BP INS, 576CT	
600037	5015	OTX2	0008	RETINAL DYSTROPHY, EARLY-ONSET, AND PITUITARY DYSFUNCTION	OTX2, SER138TER	
600037	5015	OTX2	0009	MICROPHTHALMIA, SYNDROMIC 5	OTX2, 16-BP DEL, NT221	
600037	5015	OTX2	0010	MICROPHTHALMIA, SYNDROMIC 5	OTX2, GLY188TER	
600037	5015	OTX2	0011	MICROPHTHALMIA, SYNDROMIC 5	OTX2, ARG90SER	
600040	581	BAX	0001	COLORECTAL CANCER, SOMATIC	BAX, 1-BP INS, FS	
600040	581	BAX	0002	COLORECTAL CANCER, SOMATIC	BAX, 1-BP DEL, FS	
600040	581	BAX	0003	LEUKEMIA, T-CELL ACUTE LYMPHOBLASTIC, SOMATIC	BAX, GLY67ARG	
600040	581	BAX	0004	LEUKEMIA, T-CELL ACUTE LYMPHOBLASTIC, SOMATIC	BAX, 7-BP DEL, 114-121G	
600044	7066	THPO	0001	THROMBOCYTHEMIA 1	THPO, IVS3, G-C, +1	
600044	7066	THPO	0002	THROMBOCYTHEMIA 1	THPO, 1-BP DEL, 3252G	
600044	7066	THPO	0003	THROMBOCYTHEMIA 1	THPO, 516G-T	
600046	19	ABCA1	0001	TANGIER DISEASE	ABCA1, CYS1417ARG	137854494
600046	19	ABCA1	0002	TANGIER DISEASE	ABCA1, IVS24DS, G-C	
600046	19	ABCA1	0003	TANGIER DISEASE	ABCA1, GLN537ARG	2853578
600046	19	ABCA1	0004	HIGH DENSITY LIPOPROTEIN DEFICIENCY, TYPE 2	ABCA1, 3-BP DEL	
600046	19	ABCA1	0005	TANGIER DISEASE	ABCA1, 1-BP DEL, 1764G	
600046	19	ABCA1	0006	TANGIER DISEASE	ABCA1, ASN875SER	
600046	19	ABCA1	0007	TANGIER DISEASE	ABCA1, ALA877VAL	137854495
600046	19	ABCA1	0008	TANGIER DISEASE	ABCA1, TRP530SER	137854496
600046	19	ABCA1	0009	TANGIER DISEASE	ABCA1, 1-BP DEL, 1764G	
600046	19	ABCA1	0010	TANGIER DISEASE	ABCA1, 110-BP INS/14-BP DEL	
600046	19	ABCA1	0011	TANGIER DISEASE	ABCA1, 2-BP DEL, 3283TC	
600046	19	ABCA1	0012	TANGIER DISEASE	ABCA1, 1-BP DEL, 2665C	
600046	19	ABCA1	0013	TANGIER DISEASE	ABCA1, SER1446LEU	137854497
600046	19	ABCA1	0014	TANGIER DISEASE	ABCA1, ASN935SER	28937313
600046	19	ABCA1	0015	TANGIER DISEASE	ABCA1, ASN935HIS	28937314
600046	19	ABCA1	0016	TANGIER DISEASE	ABCA1, INT12-14 DEL, INT16-31 DEL	
600046	19	ABCA1	0017	TANGIER DISEASE, VARIANT	ABCA1, ARG1680TRP	137854498
600046	19	ABCA1	0018	HIGH DENSITY LIPOPROTEIN DEFICIENCY	ABCA1, ASP1099TYR	28933692
600046	19	ABCA1	0019	HIGH DENSITY LIPOPROTEIN DEFICIENCY	ABCA1, PHE2009SER	137854499
600046	19	ABCA1	0020	TANGIER DISEASE	ABCA1, ASP1229ASN	137854500
600046	19	ABCA1	0021	TANGIER DISEASE	ABCA1, ARG2021TRP	137854501
600046	19	ABCA1	0022	HIGH DENSITY LIPOPROTEIN DEFICIENCY	ABCA1, 4-BP DEL, 3787CGCC	
600046	19	ABCA1	0023	TANGIER DISEASE	ABCA1, TYR573TER	137854502
600046	19	ABCA1	0024	CORONARY HEART DISEASE IN FAMILIAL HYPERCHOLESTEROLEMIA, PROTECTION AGAINST	ABCA1, ARG219LYS	2230806
600046	19	ABCA1	0025	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 13	ABCA1, 74A-G	3890182
600053	1261	CNGA3	0001	ROD MONOCHROMACY	CNGA3, PRO163LEU	104893612
600053	1261	CNGA3	0002	ROD MONOCHROMACY	CNGA3, ARG283TRP	104893613
600053	1261	CNGA3	0003	ROD MONOCHROMACY	CNGA3, ARG283GLN	104893614
600053	1261	CNGA3	0004	ROD MONOCHROMACY	CNGA3, GLY557ARG	104893615
600053	1261	CNGA3	0005	ROD MONOCHROMACY	CNGA3, THR291ARG	104893616
600053	1261	CNGA3	0006	ROD MONOCHROMACY	CNGA3, PHE547LEU	104893617
600053	1261	CNGA3	0007	ROD MONOCHROMACY	CNGA3, ARG411TRP	137852608
600053	1261	CNGA3	0008	ROD MONOCHROMACY	CNGA3, VAL529MET	104893619
600053	1261	CNGA3	0009	ROD MONOCHROMACY	CNGA3, ARG277CYS	104893620
600053	1261	CNGA3	0010	ROD MONOCHROMACY	CNGA3, ARG436TRP	104893621
600065	3689	ITGB2	0001	LEUKOCYTE ADHESION DEFICIENCY	ITGB2, ARG593CYS	137852609
600065	3689	ITGB2	0002	LEUKOCYTE ADHESION DEFICIENCY	ITGB2, LYS196THR	137852610
600065	3689	ITGB2	0003	LEUKOCYTE ADHESION DEFICIENCY	ITGB2, LEU149PRO	137852611
600065	3689	ITGB2	0004	LEUKOCYTE ADHESION DEFICIENCY	ITGB2, GLY169ARG	137852612
600065	3689	ITGB2	0005	LEUKOCYTE ADHESION DEFICIENCY	ITGB2, INITIATION MUTATION	
600065	3689	ITGB2	0006	LEUKOCYTE ADHESION DEFICIENCY	ITGB2, ARG586TRP	5030672
600065	3689	ITGB2	0007	LEUKOCYTE ADHESION DEFICIENCY	ITGB2, IVS?AS, -12, 12-BP INS	
600065	3689	ITGB2	0008	LEUKOCYTE ADHESION DEFICIENCY	ITGB2, ASN351SER	137852613
600065	3689	ITGB2	0009	LEUKOCYTE ADHESION DEFICIENCY	ITGB2, PRO178LEU	137852614
600065	3689	ITGB2	0010	LEUKOCYTE ADHESION DEFICIENCY	ITGB2, ASP128ASN	137852615
600065	3689	ITGB2	0011	LEUKOCYTE ADHESION DEFICIENCY	ITGB2, IVSDS, G-A, +1	
600065	3689	ITGB2	0012	LEUKOCYTE ADHESION DEFICIENCY	ITGB2, GLY284SER	137852616
600065	3689	ITGB2	0013	LEUKOCYTE ADHESION DEFICIENCY	ITGB2, SER138PRO	137852617
600065	3689	ITGB2	0014	LEUKOCYTE ADHESION DEFICIENCY	ITGB2, GLY273ARG	137852618
600065	3689	ITGB2	0015	LEUKOCYTE ADHESION DEFICIENCY	ITGB2, IVS4AS, 169-BP DEL, -37	
600073	4036	LRP2	0001	DONNAI-BARROW SYNDROME	LRP2, TYR2522HIS	80338747
600073	4036	LRP2	0002	DONNAI-BARROW SYNDROME	LRP2, 2-BP DEL, 9484GT	
600073	4036	LRP2	0003	DONNAI-BARROW SYNDROME	LRP2, IVS18AS, G-A, -1	80338746
600073	4036	LRP2	0004	DONNAI-BARROW SYNDROME	LRP2, 4-BP DEL, 8516TTTA	
600073	4036	LRP2	0005	DONNAI-BARROW SYNDROME	LRP2, IVS44DS, G-A, +1	80338748
600073	4036	LRP2	0006	DONNAI-BARROW SYNDROME	LRP2, ARG3399TER	80338752
600073	4036	LRP2	0007	DONNAI-BARROW SYNDROME	LRP2, IVS11DS, T-G, +2	80338745
600073	4036	LRP2	0008	DONNAI-BARROW SYNDROME	LRP2, ARG365TER	80338744
600073	4036	LRP2	0009	DONNAI-BARROW SYNDROME	LRP2, 1-BP DEL, NT12437	
600073	4036	LRP2	0010	DONNAI-BARROW SYNDROME	LRP2, ASP2054ASN	
600075	6908	TBP	0001	SPINOCEREBELLAR ATAXIA 17 PARKINSON DISEASE, LATE-ONSET, SUSCEPTIBILITY TO, INCLUDED	TBP, (CAG)n EXPANSION	193922935
600079	5782	PTPN12	0001	COLON CANCER	PTPN1, LYS61ARG	121434623
600098	22800	RRAS2	0001	OVARIAN CANCER, SOMATIC	RRAS2, LEU72GLN	113954997
600108	4322	MMP13	0001	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MISSOURI TYPE	MMP13, PHE56SER	121909497
600108	4322	MMP13	0002	METAPHYSEAL ANADYSPLASIA 1, AUTOSOMAL DOMINANT	MMP13, PHE55SER	121909498
600108	4322	MMP13	0003	METAPHYSEAL ANADYSPLASIA 1, AUTOSOMAL DOMINANT	MMP13, MET72THR	121909499
600108	4322	MMP13	0004	METAPHYSEAL ANADYSPLASIA 1, AUTOSOMAL RECESSIVE	MMP13, HIS213ASN	121909500
600111	6507	SLC1A3	0001	EPISODIC ATAXIA, TYPE 6	SLC1A3, PRO290ARG	137852619
600111	6507	SLC1A3	0002	EPISODIC ATAXIA, TYPE 6	SLC1A3, CYS186SER	137852620
600112	1778	DYNC1H1	0001	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O	DYNC1H1, HIS306ARG	
600112	1778	DYNC1H1	0002	MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	DYNC1H1, HIS3822PRO	
600112	1778	DYNC1H1	0003	MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	DYNC1H1, GLU1518LYS	
600112	1778	DYNC1H1	0004	SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY, AUTOSOMAL DOMINANT	DYNC1H1, ILE584LEU	
600112	1778	DYNC1H1	0005	SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY, AUTOSOMAL DOMINANT	DYNC1H1, LYS671GLU	
600112	1778	DYNC1H1	0006	SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY, AUTOSOMAL DOMINANT	DYNC1H1, TYR970CYS	
600119	6442	SGCA	0001	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2D	SGCA, ARG98HIS	137852621
600119	6442	SGCA	0002	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2D	SGCA, VAL175ALA	137852622
600119	6442	SGCA	0003	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2D	SGCA, ARG77CYS	28933693
600119	6442	SGCA	0004	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2D	SGCA, 15-BP INS, GLU137GLY	
600119	6442	SGCA	0005	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2D	SGCA, ARG284CYS	137852623
600119	6442	SGCA	0006	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2D	SGCA, TYR134TER	
600119	6442	SGCA	0007	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2D	SGCA, ARG192TER	
600129	5144	PDE4D	0001	ACRODYSOSTOSIS 2	PDE4D, PRO225THR	
600129	5144	PDE4D	0002	ACRODYSOSTOSIS 2	PDE4D, PHE226SER	
600129	5144	PDE4D	0003	ACRODYSOSTOSIS 2	PDE4D, SER190ALA	
600129	5144	PDE4D	0004	ACRODYSOSTOSIS 2	PDE4D, THR587PRO	
600129	5144	PDE4D	0005	ACRODYSOSTOSIS 2	PDE4D, GLN228GLU	
600129	5144	PDE4D	0006	ACRODYSOSTOSIS 2	PDE4D, GLU590ALA	
600129	5144	PDE4D	0007	ACRODYSOSTOSIS 2	PDE4D, GLY673ASP	
600129	5144	PDE4D	0008	ACRODYSOSTOSIS 2	PDE4D, ALA243VAL	
600133	3910	LAMA4	0001	CARDIOMYOPATHY, DILATED, 1JJ	LAMA4, ARG1073TER	
600133	3910	LAMA4	0002	CARDIOMYOPATHY, DILATED, 1JJ	LAMA4, PRO943LEU	
600140	1387	CREBBP	0001	RUBINSTEIN-TAYBI SYNDROME 1	CREBBP, GLN136TER	121434624
600140	1387	CREBBP	0002	RUBINSTEIN-TAYBI SYNDROME 1	CREBBP, GLN357TER	121434625
600140	1387	CREBBP	0003	RUBINSTEIN-TAYBI SYNDROME 1	CREBBP, ARG1378PRO	121434626
600140	1387	CREBBP	0004	RUBINSTEIN-TAYBI SYNDROME 1	CREBBP, 2-BP DEL, NT5222	
600140	1387	CREBBP	0005	RUBINSTEIN-TAYBI SYNDROME 1, INCOMPLETE	CREBBP, TYR1175CYS	28937315
600140	1387	CREBBP	0006	RUBINSTEIN-TAYBI SYNDROME 1	CREBBP, GLU1278LYS	
600140	1387	CREBBP	0007	RUBINSTEIN-TAYBI SYNDROME 1	CREBBP, IVS21, A-T, -2	
600140	1387	CREBBP	0008	RUBINSTEIN-TAYBI SYNDROME 1, INCOMPLETE	CREBBP, THR910ALA	
600147	4222	MEOX1	0001	KLIPPEL-FEIL SYNDROME 2	MEOX1, 1-BP DEL, 94G	
600147	4222	MEOX1	0002	KLIPPEL-FEIL SYNDROME 2	MEOX1, ARG222TER	
600150	3778	KCNMA1	0001	GENERALIZED EPILEPSY AND PAROXYSMAL DYSKINESIA	KCNMA1, ASP434GLY	137853333
600160	1029	CDKN2A	0001	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2	CDKN2A, GLY259SER	137854597
600160	1029	CDKN2A	0002	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2	CDKN2A, ARG232TER	121913388
600160	1029	CDKN2A	0003	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2 p16-LEIDEN;; MELANOMA-PANCREATIC CANCER SYNDROME, INCLUDED;; OROLARYNGEAL CANCER, MULTIPLE, INCLUDED	CDKN2A, 19-BP DEL, NT225	
600160	1029	CDKN2A	0004	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2	CDKN2A, 6-BP DEL, NT363	
600160	1029	CDKN2A	0005	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2 MELANOMA-PANCREATIC CANCER SYNDROME, INCLUDED	CDKN2A, GLY101TRP	104894094
600160	1029	CDKN2A	0006	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO , 2	CDKN2A, 3-BP DUP, ARG105INS	
600160	1029	CDKN2A	0007	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2	CDKN2A, MET53ILE	104894095
600160	1029	CDKN2A	0008	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2	CDKN2A, ARG24PRO	104894097
600160	1029	CDKN2A	0009	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2	CDKN2A, 24-BP DUP	
600160	1029	CDKN2A	0010	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2	CDKN2A, -34G-T	
600160	1029	CDKN2A	0012	MELANOMA AND NEURAL SYSTEM TUMOR SYNDROME	CDKN2A, EXON 1-BETA DEL	
600160	1029	CDKN2A	0013	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2	CDKN2A, VAL126ASP	104894098
600160	1029	CDKN2A	0014	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2	CDKN2A, IVS2, A-G, -105	
600160	1029	CDKN2A	0015	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2	CDKN2A, GLY122ARG	113798404
600160	1029	CDKN2A	0016	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2	CDKN2A, VAL59GLY	104894099
600160	1029	CDKN2A	0017	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2	CDKN2A, LEU113LEU AND PRO114SER	
600160	1029	CDKN2A	0018	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2	CDKN2A, SER56ILE	104894109
600160	1029	CDKN2A	0019	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2	CDKN2A, GLY89ASP	137854599
600160	1029	CDKN2A	0020	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2	CDKN2A, IVS1BDS, A-G, +1	
600160	1029	CDKN2A	0021	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2	CDKN2A, ARG54HIS	
600160	1029	CDKN2A	0022	MELANOMA-PANCREATIC CANCER SYNDROME	CDKN2A, 5-BP DUP, NT19	
600163	6331	SCN5A	0001	LONG QT SYNDROME 3	SCN5A, 9-BP DEL, NT4661	
600163	6331	SCN5A	0002	LONG QT SYNDROME 3	SCN5A, ARG1644HIS	28937316
600163	6331	SCN5A	0003	LONG QT SYNDROME 3	SCN5A, ASN1325SER	28937317
600163	6331	SCN5A	0004	BRUGADA SYNDROME 1	SCN5A, ARG1232TRP AND THR1620MET	
600163	6331	SCN5A	0005	BRUGADA SYNDROME 1	SCN5A, IVS7DS, 2-BP INS	
600163	6331	SCN5A	0006	BRUGADA SYNDROME 1	SCN5A, 1-BP DEL, VAL1398TER	
600163	6331	SCN5A	0007	LONG QT SYNDROME 3 LONG QT SYNDROME 3/6, DIGENIC, INCLUDED	SCN5A, ARG1623GLN	137854600
600163	6331	SCN5A	0008	LONG QT SYNDROME 3 BRUGADA SYNDROME 1, INCLUDED;; SINUS NODE DISEASE, INCLUDED	SCN5A, GLU1784LYS	137854601
600163	6331	SCN5A	0009	PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA	SCN5A, IVS22DS, T-C, +2	
600163	6331	SCN5A	0010	HEART BLOCK, NONPROGRESSIVE	SCN5A, 1-BP DEL, 5280G	
600163	6331	SCN5A	0011	BRUGADA SYNDROME 1	SCN5A, ARG1512TRP	137854602
600163	6331	SCN5A	0012	BRUGADA SYNDROME 1	SCN5A, ALA1924THR	137854603
600163	6331	SCN5A	0013	LONG QT SYNDROME 3 BRUGADA SYNDROME 1, INCLUDED	SCN5A, 3-BP INS, 5537TGA	
600163	6331	SCN5A	0014	VENTRICULAR FIBRILLATION, PAROXYSMAL FAMILIAL	SCN5A, SER1710LEU	137854604
600163	6331	SCN5A	0015	LONG QT SYNDROME 3	SCN5A, SER941ASN	137854605
600163	6331	SCN5A	0016	CARDIAC CONDUCTION DEFECT, NONPROGRESSIVE	SCN5A, GLY514CYS	137854606
600163	6331	SCN5A	0017	PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA	SCN5A, ASP1595ASN	137854607
600163	6331	SCN5A	0018	PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA	SCN5A, GLN298SER	137854608
600163	6331	SCN5A	0019	LONG QT SYNDROME 3	SCN5A, ALA997SER	137854609
600163	6331	SCN5A	0020	LONG QT SYNDROME 3	SCN5A, ARG1826HIS	137854610
600163	6331	SCN5A	0021	BRUGADA SYNDROME 1	SCN5A, ARG367HIS	28937318
600163	6331	SCN5A	0022	BRUGADA SYNDROME 1	SCN5A, ALA735VAL	137854611
600163	6331	SCN5A	0023	BRUGADA SYNDROME 1 LONG QT SYNDROME 3, ACQUIRED, SUSCEPTIBILITY TO, INCLUDED	SCN5A, ARG1193GLN	41261344
600163	6331	SCN5A	0024	LONG QT SYNDROME 3, ACQUIRED, SUSCEPTIBILITY TO SUDDEN INFANT DEATH SYNDROME, INCLUDED	SCN5A, SER1103TYR	7626962
600163	6331	SCN5A	0025	SICK SINUS SYNDROME 1, AUTOSOMAL RECESSIVE	SCN5A, PRO1298LEU	28937319
600163	6331	SCN5A	0026	SICK SINUS SYNDROME 1, AUTOSOMAL RECESSIVE BRUGADA SYNDROME 1, INCLUDED;; CARDIAC CONDUCTION DEFECT, NONSPECIFIC, INCLUDED	SCN5A, GLY1408ARG	137854612
600163	6331	SCN5A	0027	SICK SINUS SYNDROME 1, AUTOSOMAL RECESSIVE	SCN5A, THR220ILE	45620037
600163	6331	SCN5A	0028	SICK SINUS SYNDROME 1, AUTOSOMAL RECESSIVE	SCN5A, ARG1623TER	137854613
600163	6331	SCN5A	0029	LONG QT SYNDROME 3	SCN5A, TYR1795CYS	137854614
600163	6331	SCN5A	0030	BRUGADA SYNDROME 1	SCN5A, TYR1795HIS	137854615
600163	6331	SCN5A	0031	PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA	SCN5A, THR512ILE AND HIS558ARG	1805124
600163	6331	SCN5A	0032	BRUGADA SYNDROME 1	SCN5A, GLY1262SER	137854616
600163	6331	SCN5A	0033	BRUGADA SYNDROME 1 ATRIAL FIBRILLATION, FAMILIAL, 10, INCLUDED	SCN5A, GLU1053LYS	137854617
600163	6331	SCN5A	0034	CARDIOMYOPATHY, DILATED, 1E ATRIAL STANDSTILL, INCLUDED;; ATRIAL FIBRILLATION, FAMILIAL, 10, INCLUDED	SCN5A, ASP1275ASN	137854618
600163	6331	SCN5A	0035	LONG QT SYNDROME 2/3, DIGENIC	SCN5A, ASP1819ASN	137854619
600163	6331	SCN5A	0036	BRUGADA SYNDROME 1	SCN5A, TRP1421TER	137854620
600163	6331	SCN5A	0037	CARDIOMYOPATHY, DILATED, 1E	SCN5A, THR220ILE	45620037
600163	6331	SCN5A	0038	CARDIOMYOPATHY, DILATED, 1E	SCN5A, 2-BP INS, NT2550	
600163	6331	SCN5A	0039	CARDIOMYOPATHY, DILATED, 1E	SCN5A, ASP1595HIS	137854607
600163	6331	SCN5A	0040	BRUGADA SYNDROME	SCN5A, VAL232ILE and LEU1308PHE	45471994
600163	6331	SCN5A	0041	ATRIAL FIBRILLATION, FAMILIAL, 10	SCN5A, ASN1986LYS	
600163	6331	SCN5A	0042	ATRIAL FIBRILLATION, FAMILIAL, 10	SCN5A, HIS445ASP	
600163	6331	SCN5A	0043	ATRIAL FIBRILLATION, FAMILIAL, 10	SCN5A, ASN470LYS	
600163	6331	SCN5A	0044	ATRIAL FIBRILLATION, FAMILIAL, 10	SCN5A, GLU428LYS	
600163	6331	SCN5A	0045	ATRIAL FIBRILLATION, FAMILIAL, 10	SCN5A, GLU655LYS	
600163	6331	SCN5A	0046	CARDIOMYOPATHY, DILATED, 1E	SCN5A, ARG222GLN	
600163	6331	SCN5A	0047	CARDIOMYOPATHY, DILATED, 1E	SCN5A, ILE1835THR	
600170	360	AQP3	0001	GIL BLOOD GROUP	AQP3, IVS5, G-A, +1	
600173	3718	JAK3	0001	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-NEGATIVE	JAK3, TYR100CYS	137852624
600173	3718	JAK3	0002	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-NEGATIVE	JAK3, 151-BP DEL	
600173	3718	JAK3	0003	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-NEGATIVE	JAK3, 1-BP INS, 1172G	
600173	3718	JAK3	0004	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-NEGATIVE	JAK3, CYS565TER	137852625
600173	3718	JAK3	0005	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-NEGATIVE	JAK3, ARG445TER	137852626
600173	3718	JAK3	0006	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-NEGATIVE	JAK3, ASP169GLU	
600173	3718	JAK3	0007	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-NEGATIVE	JAK3, ALA58DEL	137852627
600179	3000	GUCY2D	0001	LEBER CONGENITAL AMAUROSIS 1	GUCY2D, PHE565SER	61749755
600179	3000	GUCY2D	0002	LEBER CONGENITAL AMAUROSIS 1	GUCY2D, 1-BP DEL, 460C	
600179	3000	GUCY2D	0003	LEBER CONGENITAL AMAUROSIS 1	GUCY2D, 1-BP DEL, 693C	
600179	3000	GUCY2D	0004	LEBER CONGENITAL AMAUROSIS 1	GUCY2D, ALA52SER	61749665
600179	3000	GUCY2D	0005	CONE-ROD DYSTROPHY 6	GUCY2D, GLU837ASP AND ARG838SER	28933695
600179	3000	GUCY2D	0006	CONE-ROD DYSTROPHY 6	GUCY2D, ARG838CYS	61750172
600179	3000	GUCY2D	0007	CONE-ROD DYSTROPHY 6	GUCY2D, GLU837ASP, ARG838CYS, AND THR839MET	61750172
600179	3000	GUCY2D	0008	CONE-ROD DYSTROPHY 6	GUCY2D, ARG838HIS	61750173
600179	3000	GUCY2D	0009	LEBER CONGENITAL AMAUROSIS 1	GUCY2D, 1-BP DEL, 2943G	
600179	3000	GUCY2D	0010	CONE-ROD DYSTROPHY 6	GUCY2D, ILE949THR	
600185	675	BRCA2	0001	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2	BRCA2, 6-BP DEL, PHE-TER	
600185	675	BRCA2	0002	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2	BRCA2, 2-BP DEL, 6503TT	
600185	675	BRCA2	0003	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2	BRCA2, 2-BP DEL	
600185	675	BRCA2	0004	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2	BRCA2, 2-BP DEL	
600185	675	BRCA2	0005	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2	BRCA2, 1-BP DEL	
600185	675	BRCA2	0006	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2	BRCA2, 4-BP DEL	
600185	675	BRCA2	0007	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2	BRCA2, 1-BP DEL, 8525C	
600185	675	BRCA2	0008	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2	BRCA2, 3-BP DEL, THR1302DEL	
600185	675	BRCA2	0009	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2 PANCREATIC CANCER, SUSCEPTIBILITY TO, 2, INCLUDED;; FANCONI ANEMIA, COMPLEMENTATION GROUP D1, INCLUDED	BRCA2, 1-BP DEL, 6174T	
600185	675	BRCA2	0010	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2	BRCA2, 5-BP DEL, NT999	
600185	675	BRCA2	0011	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2	BRCA2, 1-BP INS, 3295A	
600185	675	BRCA2	0012	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2	BRCA2, 2-BP DEL, 8765AG	
600185	675	BRCA2	0013	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2	BRCA2, ASN372HIS	144848
600185	675	BRCA2	0014	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2	BRCA2, IVS23AS, A-G, -2	
600185	675	BRCA2	0015	PROSTATE CANCER	BRCA2, 1-BP DEL, 6051A	
600185	675	BRCA2	0016	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2	BRCA2, 4-BP DEL, NT3034	
600185	675	BRCA2	0017	FANCONI ANEMIA, COMPLEMENTATION GROUP D1	BRCA2, IVS19, G-A, -1	
600185	675	BRCA2	0018	FANCONI ANEMIA, COMPLEMENTATION GROUP D1	BRCA2, 2-BP INS, 7691AT	
600185	675	BRCA2	0019	FANCONI ANEMIA, COMPLEMENTATION GROUP D1	BRCA2, 1-BP INS, 9900A	
600185	675	BRCA2	0020	FANCONI ANEMIA, COMPLEMENTATION GROUP D1	BRCA2, 7235G-A	
600185	675	BRCA2	0021	FANCONI ANEMIA, COMPLEMENTATION GROUP D1	BRCA2, 5837TC-AG	
600185	675	BRCA2	0022	FANCONI ANEMIA, COMPLEMENTATION GROUP D1	BRCA2, 8415 G-T	
600185	675	BRCA2	0023	FANCONI ANEMIA, COMPLEMENTATION GROUP D1	BRCA2, 8732C-A	
600185	675	BRCA2	0025	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	BRCA2, THR2722ARG	80359062
600185	675	BRCA2	0026	PROSTATE CANCER	BRCA2, 1-BP INS, 2558A	
600185	675	BRCA2	0027	FANCONI ANEMIA, COMPLEMENTATION GROUP D1 WILMS TUMOR, INCLUDED;; GLIOMA SUSCEPTIBILITY 3, INCLUDED;; MEDULLOBLASTOMA, INCLUDED;; PRE-B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA, INCLUDED	BRCA2, 2-BP DEL, 886GT	
600185	675	BRCA2	0028	FANCONI ANEMIA, COMPLEMENTATION GROUP D1	BRCA2, LEU2740TER	80359070
600185	675	BRCA2	0029	FANCONI ANEMIA, COMPLEMENTATION GROUP D1	BRCA2, GLU1550TER	80358695
600185	675	BRCA2	0030	FANCONI ANEMIA, COMPLEMENTATION GROUP D1	BRCA2, LEU2510PRO	80358979
600185	675	BRCA2	0031	WILMS TUMOR GLIOMA SUSCEPTIBILITY 3, INCLUDED;; MEDULLOBLASTOMA, INCLUDED;; PRE-B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA, INCLUDED	BRCA2, SER1882TER	80358785
600185	675	BRCA2	0032	FANCONI ANEMIA, COMPLEMENTATION GROUP D1	BRCA2, GLN3066TER	80359180
600185	675	BRCA2	0033	FANCONI ANEMIA, COMPLEMENTATION GROUP D1	BRCA2, IVS7DS, G-A, +1	
600185	675	BRCA2	0034	FANCONI ANEMIA, COMPLEMENTATION GROUP D1	BRCA2, IVS7DS, T-G, +2	
600194	3849	KRT2	0001	ICHTHYOSIS BULLOSA OF SIEMENS	KRT2, GLU493ASP	137852628
600194	3849	KRT2	0002	ICHTHYOSIS BULLOSA OF SIEMENS ICHTHYOSIS EXFOLIATIVA, INCLUDED	KRT2, GLU493LYS	137852629
600194	3849	KRT2	0003	ICHTHYOSIS BULLOSA OF SIEMENS	KRT2, GLN187PRO	57510142
600194	3849	KRT2	0004	ICHTHYOSIS BULLOSA OF SIEMENS	KRT2, THR485PRO	137852630
600194	3849	KRT2	0005	ICHTHYOSIS BULLOSA OF SIEMENS	KRT2, ASN192TYR	137852631
600194	3849	KRT2	0006	ICHTHYOSIS BULLOSA OF SIEMENS	KRT2, GLU482LYS	56829062
600194	3849	KRT2	0007	ICHTHYOSIS BULLOSA OF SIEMENS	KRT2, ASN192ASP	137852631
600194	3849	KRT2	0008	ICHTHYOSIS BULLOSA OF SIEMENS	KRT2, ASN192LYS	137852632
600201	434	ASIP	0001	SKIN/HAIR/EYE PIGMENTATION 9, DARK/LIGHT HAIR SKIN/HAIR/EYE PIGMENTATION 9, BROWN/NONBROWN EYES, INCLUDED	ASIP, 8818A-G	6058017
600211	860	RUNX2	0001	CLEIDOCRANIAL DYSPLASIA	RUNX2, 16-BP INS	
600211	860	RUNX2	0002	CLEIDOCRANIAL DYSPLASIA	RUNX2, TRP283TER	104893988
600211	860	RUNX2	0003	CLEIDOCRANIAL DYSPLASIA, FORME FRUSTE, WITH BRACHYDACTYLY	RUNX2, ALA REPEAT EXPANSION	193922946
600211	860	RUNX2	0004	CLEIDOCRANIAL DYSPLASIA	RUNX2, MET175ARG	104893989
600211	860	RUNX2	0005	CLEIDOCRANIAL DYSPLASIA	RUNX2, SER191ASN	104893990
600211	860	RUNX2	0006	CLEIDOCRANIAL DYSPLASIA, FORME FRUSTE	RUNX2, 1-BP INS, 1380C	
600211	860	RUNX2	0007	CLEIDOCRANIAL DYSPLASIA, SEVERE, WITH OSTEOPOROSIS AND SCOLIOSIS	RUNX2, 1-BP INS, 1206C	
600211	860	RUNX2	0008	CLEIDOCRANIAL DYSPLASIA	RUNX2, ARG225GLN	104893991
600211	860	RUNX2	0009	CLEIDOCRANIAL DYSPLASIA	RUNX2, ARG225TRP	104893992
600211	860	RUNX2	0010	CLEIDOCRANIAL DYSPLASIA CLEIDOCRANIAL DYSPLASIA, FORME FRUSTE, DENTAL ANOMALIES ONLY, INCLUDED	RUNX2, THR200ALA	104893993
600211	860	RUNX2	0011	CLEIDOCRANIAL DYSPLASIA	RUNX2, TER522SER	104893994
600211	860	RUNX2	0012	CLEIDOCRANIAL DYSPLASIA	RUNX2, ARG169PRO	104893995
600211	860	RUNX2	0013	CLEIDOCRANIAL DYSPLASIA	RUNX2, 1-BP INS, 1228C	
600211	860	RUNX2	0014	METAPHYSEAL DYSPLASIA AND MAXILLARY HYPOPLASIA WITH OR WITHOUT BRACHYDACTYLY	RUNX2, 105-KB DUP, EX3-5	
600220	5336	PLCG2	0001	FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3	PLCG2, 5.9-KB DEL	
600220	5336	PLCG2	0002	FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3	PLCG2, 8.2-KB DEL	
600220	5336	PLCG2	0003	FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3	PLCG2, 4.8-KB DEL	
600220	5336	PLCG2	0004	AUTOINFLAMMATION, ANTIBODY DEFICIENCY, AND IMMUNE DYSREGULATION, PLCG2-ASSOCIATED	PLCG2, SER707TYR	
600221	7010	TEK	0001	VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	TEK, ARG849TRP	80338908
600221	7010	TEK	0002	VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	TEK, TYR897SER	80338909
600221	7010	TEK	0003	VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	TEK, TYR897CYS	
600221	7010	TEK	0004	VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	TEK, ARG915HIS	
600225	2643	GCH1	0001	DYSTONIA, DOPA-RESPONSIVE	GCH1, ARG88TRP	104894433
600225	2643	GCH1	0002	DYSTONIA, DOPA-RESPONSIVE	GCH1, ASP134VAL	104894437
600225	2643	GCH1	0003	DYSTONIA, DOPA-RESPONSIVE	GCH1, 2-BP INS	
600225	2643	GCH1	0004	DYSTONIA, DOPA-RESPONSIVE	GCH1, GLY201GLU	104894438
600225	2643	GCH1	0005	DYSTONIA, DOPA-RESPONSIVE	GCH1, IVS1, A-G, -2	
600225	2643	GCH1	0006	DYSTONIA, DOPA-RESPONSIVE	GCH1, IVS2, A-G, -2	
600225	2643	GCH1	0007	DYSTONIA, DOPA-RESPONSIVE	GCH1, MET1ILE	104894439
600225	2643	GCH1	0008	DYSTONIA, DOPA-RESPONSIVE	GCH1, HIS144PRO	104894440
600225	2643	GCH1	0009	DYSTONIA, DOPA-RESPONSIVE	GCH1, IVS2, G-C, +1	
600225	2643	GCH1	0010	DYSTONIA, DOPA-RESPONSIVE, WITH OR WITHOUT HYPERPHENYLALANINEMIA, AUTOSOMAL RECESSIVE	GCH1, 1-BP DEL, 351A	
600225	2643	GCH1	0011	DYSTONIA, DOPA-RESPONSIVE, WITH OR WITHOUT HYPERPHENYLALANINEMIA, AUTOSOMAL RECESSIVE	GCH1, MET221THR	104894434
600225	2643	GCH1	0012	DYSTONIA, DOPA-RESPONSIVE, WITH OR WITHOUT HYPERPHENYLALANINEMIA, AUTOSOMAL RECESSIVE	GCH1, GLY108ASP	104894435
600225	2643	GCH1	0013	DYSTONIA, DOPA-RESPONSIVE DYSTONIA, DOPA-RESPONSIVE, WITH OR WITHOUT HYPERPHENYLALANINEMIA, AUTOSOMAL RECESSIVE, INCLUDED	GCH1, LYS224ARG	41298442
600225	2643	GCH1	0014	DYSTONIA, DOPA-RESPONSIVE	GCH1, ALA196SER	104894436
600225	2643	GCH1	0015	DYSTONIA, DOPA-RESPONSIVE	GCH1, ILE135LYS	104894441
600225	2643	GCH1	0016	DYSTONIA, DOPA-RESPONSIVE, WITH OR WITHOUT HYPERPHENYLALANINEMIA, AUTOSOMAL RECESSIVE	GCH1, ARG249SER	104894442
600225	2643	GCH1	0017	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B	GCH1, MET211ILE	104894443
600225	2643	GCH1	0018	DYSTONIA, DOPA-RESPONSIVE	GCH1, GLN48TER	104894444
600225	2643	GCH1	0019	DYSTONIA, DOPA-RESPONSIVE	GCH1, IVS5, G-A, +1	
600225	2643	GCH1	0020	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B	GCH1, ARG184HIS	104894445
600225	2643	GCH1	0021	DYSTONIA, DOPA-RESPONSIVE	GCH1, DEL	
600225	2643	GCH1	0022	DYSTONIA, DOPA-RESPONSIVE, WITH OR WITHOUT HYPERPHENYLALANINEMIA, AUTOSOMAL RECESSIVE	GCH1, PRO199ALA	137852633
600228	6337	SCNN1A	0001	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE	SCNN1A, 2-BP DEL, FS144TER	
600228	6337	SCNN1A	0002	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE	SCNN1A, ARG508TER	137852634
600228	6337	SCNN1A	0003	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE	SCNN1A, 1-BP DEL, 1449C	
600228	6337	SCNN1A	0004	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE	SCNN1A, 1-BP DEL, 729A	
600228	6337	SCNN1A	0005	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE	SCNN1A, SER562LEU	137852635
600228	6337	SCNN1A	0006	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 2	SCNN1A, VAL114ILE	61759861
600228	6337	SCNN1A	0007	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 2	SCNN1A, TRP493ARG	5742912
600228	6337	SCNN1A	0008	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 2	SCNN1A, ARG81CYS	61759860
600234	3158	HMGCS2	0001	MITOCHONDRIAL HMG-CoA SYNTHASE DEFICIENCY	HMGCS2, PHE174LEU	137852636
600234	3158	HMGCS2	0002	MITOCHONDRIAL HMG-CoA SYNTHASE DEFICIENCY	HMGCS2, ARG424TER	137852637
600234	3158	HMGCS2	0003	MITOCHONDRIAL HMG-CoA SYNTHASE DEFICIENCY	HMGCS2, GLY212ARG	137852638
600234	3158	HMGCS2	0004	MITOCHONDRIAL HMG-CoA SYNTHASE DEFICIENCY	HMGCS2, ARG500HIS	137852639
600234	3158	HMGCS2	0005	MITOCHONDRIAL HMG-CoA SYNTHASE DEFICIENCY	HMGCS2, VAL54MET	28937320
600234	3158	HMGCS2	0006	MITOCHONDRIAL HMG-CoA SYNTHASE DEFICIENCY	HMGCS2, TYR167CYS	137852640
600235	6324	SCN1B	0001	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1	SCN1B, CYS121TRP	104894718
600235	6324	SCN1B	0002	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1	SCN1B, IVS2AS, A-C, -2	
600235	6324	SCN1B	0003	BRUGADA SYNDROME 5	SCN1B, 536G-A, TRP179TER	
600235	6324	SCN1B	0004	CARDIAC CONDUCTION DEFECT, NONSPECIFIC	SCN1B, GLU87GLN	121434627
600235	6324	SCN1B	0005	CARDIAC CONDUCTION DEFECT, NONSPECIFIC	SCN1B, 537G-A, TRP179TER	
600244	5133	PDCD1	0001	SYSTEMIC LUPUS ERYTHEMATOSUS, ASSOCIATION WITH SUSCEPTIBILITY TO, 2 MULTIPLE SCLEROSIS, DISEASE PROGRESSION, MODIFIER OF	PDCD1, 7146G-A	
600258	5378	PMS1	0001	REMOVED FROM DATABASE *FIELD* SA Dietz et al. (1993) *FIELD* RF 1. Adams, M. D.; Kelley, J. M.; Gocayne, J. D.; Dubnick, M.; Polymeropoulos, M. H.; Xiao, H.; Merril, C. R.; Wu, A.; Olde, B.; Moreno, R. F.; Kerlavage, A. R.; McCombie, W. R.; Venter, J. C.: Complementary DNA sequencing: expressed sequence tags and human genome project. Science 252: 1651-1656,	1991.	121434628
600259	5395	PMS2	0001	MISMATCH REPAIR CANCER SYNDROME	PMS2, ARG134TER	63750871
600259	5395	PMS2	0002	MISMATCH REPAIR CANCER SYNDROME	PMS2, 1-BP DEL, 1221G	
600259	5395	PMS2	0003	MISMATCH REPAIR CANCER SYNDROME	PMS2, 4-BP DEL, 2361CTTC	
600259	5395	PMS2	0004	MISMATCH REPAIR CANCER SYNDROME	PMS2, ARG802TER	63751466
600259	5395	PMS2	0005	MISMATCH REPAIR CANCER SYNDROME	PMS2, 2-BP DEL, 2184TC	
600259	5395	PMS2	0006	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4	PMS2, 3-BP DEL, LYS412DEL	
600259	5395	PMS2	0007	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4	PMS2, 1-BP DEL, 1021A	
600259	5395	PMS2	0008	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4	PMS2, 2-BP INS, NT1144	
600259	5395	PMS2	0009	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4	PMS2, ARG628TER	63750451
600259	5395	PMS2	0010	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4	PMS2, 1-BP DEL, 856G	
600259	5395	PMS2	0011	MISMATCH REPAIR CANCER SYNDROME	PMS2, LYS577FS	
600259	5395	PMS2	0012	MISMATCH REPAIR CANCER SYNDROME	PMS2, SER46ILE	121434629
600259	5395	PMS2	0013	MISMATCH REPAIR CANCER SYNDROME	PMS2, 20-BP INS, NT1169	
600259	5395	PMS2	0014	MISMATCH REPAIR CANCER SYNDROME	PMS2, 1-BP DEL, 182A	
600259	5395	PMS2	0015	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4	PMS2, 6-BP DEL/11-BP INS, NT736	
600259	5395	PMS2	0016	MISMATCH REPAIR CANCER SYNDROME	PMS2, CYS73TER	121434630
600259	5395	PMS2	0017	MISMATCH REPAIR CANCER SYNDROME	PMS2, 1-BP INS, 1306A	
600259	5395	PMS2	0018	MISMATCH REPAIR CANCER SYNDROME	PMS2, EX11-EX14 DEL/18-BP INS	
600266	6556	SLC11A1	0001	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO INFECTION BY	SLC11A1, 274C-T	
600266	6556	SLC11A1	0002	BURULI ULCER, SUSCEPTIBILITY TO	SLC11A1, ASP543ASN	17235409
600271	1825	DSC3	0001	HYPOTRICHOSIS AND RECURRENT SKIN VESICLES	DSC3, LEU710TER	137852782
600275	4853	NOTCH2	0001	ALAGILLE SYNDROME 2	NOTCH2, IVS33AS, G-A, -1	
600275	4853	NOTCH2	0002	ALAGILLE SYNDROME 2	NOTCH2, CYS444TYR	111033632
600275	4853	NOTCH2	0003	HAJDU-CHENEY SYNDROME	NOTCH2, 1-BP DEL, 6272T	
600275	4853	NOTCH2	0004	HAJDU-CHENEY SYNDROME	NOTCH2, 1-BP DEL, 6460T	
600275	4853	NOTCH2	0005	HAJDU-CHENEY SYNDROME	NOTCH2, GLN2208TER	
600275	4853	NOTCH2	0006	HAJDU-CHENEY SYNDROME	NOTCH2, TYR2373TER	
600275	4853	NOTCH2	0007	HAJDU-CHENEY SYNDROME	NOTCH2, GLN2317TER	
600275	4853	NOTCH2	0008	HAJDU-CHENEY SYNDROME	NOTCH2, GLU2299TER	
600275	4853	NOTCH2	0009	HAJDU-CHENEY SYNDROME	NOTCH2, GLN2389TER	
600276	4854	NOTCH3	0001	CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY	NOTCH3, TRP71CYS	28937321
600276	4854	NOTCH3	0002	CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY	NOTCH3, ARG169CYS	28933696
600276	4854	NOTCH3	0003	CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY	NOTCH3, ARG182CYS	28933697
600276	4854	NOTCH3	0004	CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY	NOTCH3, ALA-THR	
600276	4854	NOTCH3	0005	CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY	NOTCH3, 45-BP DEL	
600276	4854	NOTCH3	0006	CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY	NOTCH3, CYS455ARG	28933698
600276	4854	NOTCH3	0007	CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY	NOTCH3, ARG332CYS	137852641
600276	4854	NOTCH3	0008	CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY	NOTCH3, ARG133CYS	137852642
600276	4854	NOTCH3	0009	CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY	NOTCH3, IVS15AS, G-T, -1	
600276	4854	NOTCH3	0010	CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY	NOTCH3, ALA1020PRO	35769976
600276	4854	NOTCH3	0011	CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY	NOTCH3, CYS428SER	
600276	4854	NOTCH3	0012	MYOFIBROMATOSIS, INFANTILE, 2 (1 family)	NOTCH3, LEU1519PRO	
600279	5824	PEX19	0001	PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	PEX19, 1-BP INS, 764A	
600279	5824	PEX19	0002	PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	PEX19, 1-BP DEL, 320A	
600281	3172	HNF4A	0001	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 1	HNF4A, GLN268TER	137853334
600281	3172	HNF4A	0002	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 1	HNF4A, ARG154TER	137853335
600281	3172	HNF4A	0003	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 1	HNF4A, ARG127TRP	137853336
600281	3172	HNF4A	0004	NONINSULIN-DEPENDENT DIABETES MELLITUS	HNF4A, VAL393ILE	137853337
600281	3172	HNF4A	0005	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 1	HNF4A, 1-BP DEL, PHE75T	
600281	3172	HNF4A	0006	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 1	HNF4A, IVS5, DEL A, -2	
600281	3172	HNF4A	0007	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 1	HNF4A, MET364ARG	137853338
600287	2617	GARS	0001	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2D	GARS, GLY240ARG	137852643
600287	2617	GARS	0002	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE V	GARS, LEU129PRO	137852644
600287	2617	GARS	0003	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2D NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE V, INCLUDED	GARS, GLU71GLY	137852645
600287	2617	GARS	0004	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE V	GARS, GLY526ARG	137852646
600287	2617	GARS	0005	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2D NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE V, INCLUDED	GARS, ASP500ASN	137852647
600287	2617	GARS	0006	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2D	GARS, PRO244LEU	137852648
600293	111	ADCY5	0001	DYSKINESIA, FAMILIAL, WITH FACIAL MYOKYMIA	ADCY5, ALA726THR	
600301	36	ACADSB	0001	2-@METHYLBUTYRYL-CoA DEHYDROGENASE DEFICIENCY	ACADSB, 1228G-A, EX10DEL	
600301	36	ACADSB	0002	2-@METHYLBUTYRYL-CoA DEHYDROGENASE DEFICIENCY	ACADSB, LEU222PHE	137852649
600301	36	ACADSB	0003	2-@METHYLBUTYRYL-CoA DEHYDROGENASE DEFICIENCY	ACADSB, IVS3DS, A-G, +3	
600301	36	ACADSB	0004	2-@METHYLBUTYRYL-CoA DEHYDROGENASE DEFICIENCY	ACADSB, THR148ILE	58639322
600301	36	ACADSB	0005	2-@METHYLBUTYRYL-CoA DEHYDROGENASE DEFICIENCY	ACADSB, GLU387LYS	
600310	1311	COMP	0001	PSEUDOACHONDROPLASIA	COMP, ASP472TYR	137852650
600310	1311	COMP	0002	PSEUDOACHONDROPLASIA	COMP, CYS468TYR	137852651
600310	1311	COMP	0003	PSEUDOACHONDROPLASIA	COMP, 3-BP DEL, 459TCA, SER459DEL	
600310	1311	COMP	0004	PSEUDOACHONDROPLASIA	COMP, 3-BP DEL, (GAC)4	
600310	1311	COMP	0005	EPIPHYSEAL DYSPLASIA, MULTIPLE, 1, SEVERE	COMP, ASP342TYR	137852652
600310	1311	COMP	0006	PSEUDOACHONDROPLASIA	COMP, CYS328ARG	137852653
600310	1311	COMP	0008	EPIPHYSEAL DYSPLASIA, MULTIPLE, 1, MILD	COMP, ASN523LYS	137852654
600310	1311	COMP	0009	EPIPHYSEAL DYSPLASIA, MULTIPLE, 1, SEVERE	COMP, ASN453SER	28936668
600310	1311	COMP	0010	PSEUDOACHONDROAPLASIA	COMP, ASP473GLY	28936669
600310	1311	COMP	0011	PSEUDOACHONDROPLASIA	COMP, 6-BP INS, (GAC)7	193922900
600310	1311	COMP	0012	EPIPHYSEAL DYSPLASIA, MULTIPLE, 1	COMP, 3-BP INS, (GAC)6	
600310	1311	COMP	0013	PSEUDOACHONDROPLASIA, SEVERE	COMP, GLY719ASP	137852655
600310	1311	COMP	0014	PSEUDOACHONDROPLASIA	COMP, CYS348ARG	137852656
600310	1311	COMP	0015	PSEUDOACHONDROPLASIA	COMP, EX9DEL	
600310	1311	COMP	0016	EPIPHYSEAL DYSPLASIA, MULTIPLE, 1, MILD	COMP, 1-BP INS, 2223C	
600310	1311	COMP	0017	EPIPHYSEAL DYSPLASIA, MULTIPLE, 1	COMP, ARG718TRP	28936368
600310	1311	COMP	0018	PSEUDOACHONDROPLASIA	COMP, 3-BP DEL, (GAC)2	
600342	5995	RGR	0001	RETINITIS PIGMENTOSA 44	RGR, SER66ARG	104894187
600342	5995	RGR	0002	RETINITIS PIGMENTOSA 44	RGR, 1-BP INS	
600354	6606	SMN1	0001	SPINAL MUSCULAR ATROPHY, TYPE I	SMN1, 11-BP DUP, 801-811	
600354	6606	SMN1	0002	SPINAL MUSCULAR ATROPHY, TYPE II SPINAL MUSCULAR ATROPHY, TYPE III, INCLUDED	SMN1, THR274ILE	76871093
600354	6606	SMN1	0003	SPINAL MUSCULAR ATROPHY, TYPE III	SMN1, SER262ILE	75660264
600354	6606	SMN1	0004	SPINAL MUSCULAR ATROPHY, TYPE I	SMN1, TYR272CYS	104893922
600354	6606	SMN1	0005	SPINAL MUSCULAR ATROPHY, TYPE I	SMN1, GLY279VAL	76163360
600354	6606	SMN1	0006	SPINAL MUSCULAR ATROPHY, TYPE II SPINAL MUSCULAR ATROPHY, TYPE III, INCLUDED	SMN1, ALA2GLY	75030631
600354	6606	SMN1	0007	SPINAL MUSCULAR ATROPHY, TYPE II SPINAL MUSCULAR ATROPHY, TYPE III, INCLUDED	SMN1, EX8DEL	
600354	6606	SMN1	0008	SPINAL MUSCULAR ATROPHY, TYPE III	SMN1, IVS7DS, T-G, +6	
600354	6606	SMN1	0009	SPINAL MUSCULAR ATROPHY, TYPE I	SMN1, 5-BP DEL, 425	
600354	6606	SMN1	0010	SPINAL MUSCULAR ATROPHY, TYPE II SPINAL MUSCULAR ATROPHY, TYPE III, INCLUDED	SMN1, TRP102TER	77804083
600354	6606	SMN1	0011	SPINAL MUSCULAR ATROPHY, TYPE I SPINAL MUSCULAR ATROPHY, TYPE II, INCLUDED;; SPINAL MUSCULAR ATROPHY, TYPE III, INCLUDED;; SPINAL MUSCULAR ATROPHY, TYPE IV, INCLUDED	SMN1, 4-BP DEL, 399AGAG	
600354	6606	SMN1	0012	SPINAL MUSCULAR ATROPHY, TYPE II	SMN1, ASP30ASN	104893930
600354	6606	SMN1	0013	SPINAL MUSCULAR ATROPHY, TYPE III	SMN1, ASP44VAL	104893931
600354	6606	SMN1	0014	SPINAL MUSCULAR ATROPHY, TYPE III	SMN1, GLY95ARG	104893927
600354	6606	SMN1	0015	SPINAL MUSCULAR ATROPHY, TYPE I SPINAL MUSCULAR ATROPHY, TYPE II, INCLUDED	SMN1, ALA111GLY	104893935
600354	6606	SMN1	0016	SPINAL MUSCULAR ATROPHY, TYPE III	SMN1, SER262GLY	104893932
600354	6606	SMN1	0017	SPINAL MUSCULAR ATROPHY, TYPE I	SMN1, ILE116PHE	104893933
600354	6606	SMN1	0018	SPINAL MUSCULAR ATROPHY, TYPE I	SMN1, GLN136GLU	104893934
600354	6606	SMN1	0019	SPINAL MUSCULAR ATROPHY, TYPE III	SMN1, TYR130CYS	
600354	6606	SMN1	0020	SPINAL MUSCULAR ATROPHY, TYPE III	SMN1, TYR130HIS	
600354	6606	SMN1	0021	SPINAL MUSCULAR ATROPHY, TYPE III	SMN1, DEL	
600359	3758	KCNJ1	0001	BARTTER SYNDROME, ANTENATAL, TYPE 2	KCNJ1, TYR60TER	104894244
600359	3758	KCNJ1	0002	BARTTER SYNDROME, ANTENATAL, TYPE 2	KCNJ1, 1-BP INS, CODON 15	
600359	3758	KCNJ1	0003	BARTTER SYNDROME, ANTENATAL, TYPE 2	KCNJ1, SER200ARG	104894245
600359	3758	KCNJ1	0004	BARTTER SYNDROME, ANTENATAL, TYPE 2	KCNJ1, TRP58TER	
600359	3758	KCNJ1	0005	BARTTER SYNDROME, ANTENATAL, TYPE 2	KCNJ1, ALA195VAL	104894246
600359	3758	KCNJ1	0006	BARTTER SYNDROME, ANTENATAL, TYPE 2	KCNJ1, MET338THR	59172778
600359	3758	KCNJ1	0007	BARTTER SYNDROME, ANTENATAL, TYPE 2	KCNJ1, ALA198THR	104894253
600359	3758	KCNJ1	0008	BARTTER SYNDROME, ANTENATAL, TYPE 2	KCNJ1, GLY167GLU	104894254
600359	3758	KCNJ1	0009	BARTTER SYNDROME, ANTENATAL, TYPE 2	KCNJ1, ASP108HIS	104894250
600359	3758	KCNJ1	0010	BARTTER SYNDROME, ANTENATAL, TYPE 2	KCNJ1, LYS124ASN	104894251
600364	2978	GUCA1A	0001	CONE DYSTROPHY 3 CONE-ROD DYSTROPHY 14, INCLUDED	GUCA1A, TYR99CYS	104893967
600364	2978	GUCA1A	0002	CONE DYSTROPHY 3	GUCA1A, PRO50LEU	104893968
600364	2978	GUCA1A	0003	CONE-ROD DYSTROPHY 14 CONE DYSTROPHY 3, INCLUDED	GUCA1A, LEU151PHE	121434631
600370	5250	SLC25A3	0001	MITOCHONDRIAL PHOSPHATE CARRIER DEFICIENCY	SLC25A3, GLY72GLU	104894375
600374	585	BBS4	0001	BARDET-BIEDL SYNDROME 4	BBS4, ARG295PRO	121434632
600374	585	BBS4	0002	BARDET-BIEDL SYNDROME 4	BBS4, EX3-4 DEL	113994189
600374	585	BBS4	0003	BARDET-BIEDL SYNDROME 4	BBS4, IVS3, A-G, -2	113994192
600374	585	BBS4	0004	BARDET-BIEDL SYNDROME 4	BBS4, ALA364GLU	28938468
600375	7516	XRCC2	0001	VARIANT OF UNKNOWN SIGNIFICANCE	XRCC2, ARG215TER	
600414	5830	PEX5	0001	PEROXISOME BIOGENESIS DISORDER 2B	PEX5, ASN489LYS	61752138
600414	5830	PEX5	0002	PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER)	PEX5, ARG390TER	61752137
600415	7274	TTPA	0001	ATAXIA, FRIEDREICH-LIKE, WITH ISOLATED VITAMIN E DEFICIENCY	TTPA, 1-BP DEL	
600415	7274	TTPA	0002	ATAXIA AND RETINITIS PIGMENTOSA WITH ISOLATED VITAMIN E DEFICIENCY	TTPA, HIS101GLN	
600415	7274	TTPA	0003	ATAXIA, FRIEDREICH-LIKE, WITH ISOLATED VITAMIN E DEFICIENCY	TTPA, 1-BP DEL, 485T	
600415	7274	TTPA	0004	ATAXIA, FRIEDREICH-LIKE, WITH ISOLATED VITAMIN E DEFICIENCY	TTPA, 2-BP INS, 513TT	
600415	7274	TTPA	0005	ATAXIA, FRIEDREICH-LIKE, WITH ISOLATED VITAMIN E DEFICIENCY	TTPA, ARG192HIS	
600415	7274	TTPA	0006	ATAXIA, FRIEDREICH-LIKE, WITH ISOLATED VITAMIN E DEFICIENCY	TTPA, ARG134TER	
600415	7274	TTPA	0007	ATAXIA, FRIEDREICH-LIKE, WITH ISOLATED VITAMIN E DEFICIENCY	TTPA, 552G-A	
600423	1889	ECE1	0001	HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	ECE1, ARG742CYS	3026906
600423	1889	ECE1	0002	HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO	ECE1, -338C-A	
600423	1889	ECE1	0003	HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO	ECE1, -839T-G	
600429	2651	GCNT2	0001	CATARACT 13 WITH ADULT i PHENOTYPE	GCNT2, GLY348GLU	56141211
600429	2651	GCNT2	0002	CATARACT 13 WITH ADULT i PHENOTYPE	GCNT2, ARG383HIS	55940927
600429	2651	GCNT2	0003	CATARACT 13 WITH ADULT i PHENOTYPE	GCNT2, DEL	
600429	2651	GCNT2	0004	ADULT i PHENOTYPE	GCNT2, ALA169THR	56106312
600429	2651	GCNT2	0005	ADULT i PHENOTYPE	GCNT2, ARG228GLN	55795227
600450	1646	AKR1C2	0001	46,XY SEX REVERSAL 8	AKR1C2, ILE79VAL	
600450	1646	AKR1C2	0002	46,XY SEX REVERSAL 8	AKR1C2, HIS90GLN	
600450	1646	AKR1C2	0003	46,XY SEX REVERSAL 8	AKR1C2, ASN300THR	
600450	1646	AKR1C2	0004	46,XY SEX REVERSAL 8	AKR1C2, HIS222GLN	
600451	1109	AKR1C4	0001	46,XY SEX REVERSAL 8, MODIFIER OF	AKR1C4, IVS1, -106G-T	
600456	4915	NTRK2	0001	OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY	NTRK2, TYR722CYS	121434633
600463	220	ALDH1A3	0001	MICROPHTHALMIA, ISOLATED 8	ALDH1A3, ARG89CYS	
600463	220	ALDH1A3	0002	MICROPHTHALMIA, ISOLATED 8	ALDH1A3, ALA493PRO	
600463	220	ALDH1A3	0003	MICROPHTHALMIA, ISOLATED 8	ALDH1A3, IVSDS, G-T, +1	
600478	6499	SKIV2L	0001	TRICHOHEPATOENTERIC SYNDROME 2	SKIV2L, TRP283TER	
600478	6499	SKIV2L	0002	TRICHOHEPATOENTERIC SYNDROME 2	SKIV2L, VAL341GLY	
600478	6499	SKIV2L	0003	TRICHOHEPATOENTERIC SYNDROME 2	SKIV2L, 1-BP INS, 1635A	
600483	2253	FGF8	0001	HYPOGONADOTROPIC HYPOGONADISM 6 WITHOUT ANOSMIA	FGF8, HIS14ASN	137852659
600483	2253	FGF8	0002	HYPOGONADOTROPIC HYPOGONADISM 6 WITH ANOSMIA	FGF8, PRO26LEU	137852660
600483	2253	FGF8	0003	HYPOGONADOTROPIC HYPOGONADISM 6 WITHOUT ANOSMIA	FGF8, PHE40LEU	137852661
600483	2253	FGF8	0004	HYPOGONADOTROPIC HYPOGONADISM 6 WITHOUT ANOSMIA	FGF8, LYS100GLU	137852662
600483	2253	FGF8	0005	HYPOGONADOTROPIC HYPOGONADISM 6 WITH OR WITHOUT ANOSMIA	FGF8, ARG127GLY	137852663
600483	2253	FGF8	0006	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	FGF8, THR229MET	137852664
600495	1981	EIF4G1	0001	PARKINSON DISEASE 18	EIF4G1, ARG1205HIS	
600495	1981	EIF4G1	0002	PARKINSON DISEASE 18	EIF4G1, ALA502VAL	
600502	3508	IGHMBP2	0001	DISTAL SPINAL MUSCULAR ATROPHY, AUTOSOMAL RECESSIVE, 1	IGHMBP2, GLU514LYS	137852665
600502	3508	IGHMBP2	0002	DISTAL SPINAL MUSCULAR ATROPHY, AUTOSOMAL RECESSIVE, 1	IGHMBP2, HIS213ARG	137852666
600502	3508	IGHMBP2	0003	DISTAL SPINAL MUSCULAR ATROPHY, AUTOSOMAL RECESSIVE, 1	IGHMBP2, VAL580ILE	137852667
600502	3508	IGHMBP2	0004	DISTAL SPINAL MUSCULAR ATROPHY, AUTOSOMAL RECESSIVE, 1	IGHMBP2, GLN41TER	137852668
600502	3508	IGHMBP2	0005	DISTAL SPINAL MUSCULAR ATROPHY, AUTOSOMAL RECESSIVE, 1	IGHMBP2, 1-BP DEL, 675T	
600502	3508	IGHMBP2	0006	DISTAL SPINAL MUSCULAR ATROPHY, AUTOSOMAL RECESSIVE, 1	IGHMBP2, LEU236TER	137852669
600502	3508	IGHMBP2	0007	DISTAL SPINAL MUSCULAR ATROPHY, AUTOSOMAL RECESSIVE, 1	IGHMBP2, IVS13, G-T, +1	
600502	3508	IGHMBP2	0008	DISTAL SPINAL MUSCULAR ATROPHY, AUTOSOMAL RECESSIVE, 1	IGHMBP2, PHE369LEU	137852670
600502	3508	IGHMBP2	0009	DISTAL SPINAL MUSCULAR ATROPHY, AUTOSOMAL RECESSIVE, 1	IGHMBP2, 18.5-KB DEL, EX3-7	
600509	6833	ABCC8	0001	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1	ABCC8, IVS, G-A, -1, EXON CHI DEL	
600509	6833	ABCC8	0002	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1	ABCC8, IVS32, G-A, -9, EXON ALPHA DEL	151344623
600509	6833	ABCC8	0003	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1	ABCC8, GLY716VAL	72559723
600509	6833	ABCC8	0004	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1	ABCC8, IVS, G-A, -1	
600509	6833	ABCC8	0005	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1	ABCC8, BRANCH POINT, A-G, -20	
600509	6833	ABCC8	0006	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1	ABCC8, 3-BP DEL, PHE1388DEL	
600509	6833	ABCC8	0007	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1	ABCC8, EX35, G-A	
600509	6833	ABCC8	0008	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1	ABCC8, ARG1353PRO	28936370
600509	6833	ABCC8	0009	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1	ABCC8, ARG1421CYS	28938469
600509	6833	ABCC8	0010	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1	ABCC8, ARG1494TRP	28936371
600509	6833	ABCC8	0011	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1	ABCC8, GLU1506LYS	137852671
600509	6833	ABCC8	0012	LEUCINE-SENSITIVE HYPOGLYCEMIA OF INFANCY	ABCC8, ARG1353HIS	28936370
600509	6833	ABCC8	0013	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1	ABCC8, VAL187ASP	137852672
600509	6833	ABCC8	0014	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1	ABCC8, 3-BP DEL, SER1387DEL	
600509	6833	ABCC8	0015	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1	ABCC8, -64C-G	
600509	6833	ABCC8	0016	DIABETES MELLITUS, PERMANENT NEONATAL, WITH NEUROLOGIC FEATURES	ABCC8, PHE132LEU	80356637
600509	6833	ABCC8	0017	DIABETES MELLITUS, PERMANENT NEONATAL	ABCC8, LEU213ARG	80356642
600509	6833	ABCC8	0018	DIABETES MELLITUS, PERMANENT NEONATAL	ABCC8, ILE1424VAL	80356653
600509	6833	ABCC8	0019	DIABETES MELLITUS, TRANSIENT NEONATAL, 2 DIABETES MELLITUS, NONINSULIN-DEPENDENT, INCLUDED	ABCC8, ARG1379CYS	137852673
600509	6833	ABCC8	0020	DIABETES MELLITUS, TRANSIENT NEONATAL, 2 DIABETES MELLITUS, NONINSULIN-DEPENDENT, INCLUDED	ABCC8, LEU582VAL	137852674
600509	6833	ABCC8	0021	DIABETES MELLITUS, PERMANENT NEONATAL	ABCC8, ASN72SER	80356634
600509	6833	ABCC8	0022	DIABETES MELLITUS, PERMANENT NEONATAL	ABCC8, GLU382LYS	80356651
600509	6833	ABCC8	0023	DIABETES MELLITUS, PERMANENT NEONATAL	ABCC8, ALA1185GLU	137852675
600509	6833	ABCC8	0024	DIABETES MELLITUS, PERMANENT NEONATAL	ABCC8, 134C-T, PRO45LEU	
600509	6833	ABCC8	0025	DIABETES MELLITUS, PERMANENT NEONATAL	ABCC8, GLY1401ARG	137852676
600509	6833	ABCC8	0026	DIABETES MELLITUS, PERMANENT NEONATAL	ABCC8, 257T-G, VAL86GLY	
600509	6833	ABCC8	0027	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1	ABCC8, EX13DEL	
600509	6833	ABCC8	0028	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1	ABCC8, 1-BP DUP, 512T	
600509	6833	ABCC8	0029	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1	ABCC8, IVS8, A-G, -1013	
600514	5649	RELN	0001	LISSENCEPHALY SYNDROME, NORMAN-ROBERTS TYPE	RELN, IVS37AS, G-A, -1	
600514	5649	RELN	0002	LISSENCEPHALY SYNDROME, NORMAN-ROBERTS TYPE	RELN, 148-BP DEL	
600515	64805	P2RY12	0001	BLEEDING DISORDER, PLATELET-TYPE, 8	P2RY12, 2-BP DEL, CA, CODON 240	
600515	64805	P2RY12	0002	BLEEDING DISORDER, PLATELET-TYPE, 8	P2RY12, ARG256GLN	
600515	64805	P2RY12	0003	BLEEDING DISORDER, PLATELET-TYPE, 8	P2RY12, ARG265TRP	
600521	5648	MASP1	0001	3MC SYNDROME 1	MASP1, HIS497TYR	
600521	5648	MASP1	0002	3MC SYNDROME 1	MASP1, CYS630ARG	
600521	5648	MASP1	0003	3MC SYNDROME 1	MASP1, GLY666GLU	
600521	5648	MASP1	0004	3MC SYNDROME 1	MASP1, GLY687ARG	
600521	5648	MASP1	0005	3MC SYNDROME 1	MASP1, TRP290TER	
600522	5321	PLA2G4A	0001	PHOSPHOLIPASE A2, GROUP IV A, DEFICIENCY OF	PLA2G4A, SER111PRO	121434634
600522	5321	PLA2G4A	0002	PHOSPHOLIPASE A2, GROUP IV A, DEFICIENCY OF	PLA2G4A, ARG485HIS	121434635
600523	4891	SLC11A2	0001	ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD	SLC11A2, GLU399ASP	121918365
600523	4891	SLC11A2	0002	ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD	SLC11A2, 3-BP DEL, 310CTT	
600523	4891	SLC11A2	0003	ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD	SLC11A2, ARG416CYS	121918366
600523	4891	SLC11A2	0004	ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD	SLC11A2, 3-BP DEL, 428GTG	
600523	4891	SLC11A2	0005	ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD	SLC11A2, GLY212VAL	121918367
600525	1747	DLX3	0001	TRICHODENTOOSSEOUS SYNDROME	DLX3, 4-BP DEL, NT3198	
600525	1747	DLX3	0002	AMELOGENESIS IMPERFECTA, TYPE IV TRICHODENTOOSSEOUS SYNDROME, INCLUDED	DLX3, 2-BP DEL, 560CT	
600528	1374	CPT1A	0001	CARNITINE PALMITOYLTRANSFERASE IA DEFICIENCY	CPT1A, ASP454GLY	80356778
600528	1374	CPT1A	0002	CARNITINE PALMITOYLTRANSFERASE IA DEFICIENCY	CPT1A, GLU360GLY	80356787
600528	1374	CPT1A	0003	CARNITINE PALMITOYLTRANSFERASE IA DEFICIENCY	CPT1A, GLN100TER	80356774
600528	1374	CPT1A	0004	CARNITINE PALMITOYLTRANSFERASE IA DEFICIENCY	CPT1A, ALA414VAL	80356790
600528	1374	CPT1A	0005	CARNITINE PALMITOYLTRANSFERASE IA DEFICIENCY	CPT1A, TYR498CYS	80356791
600528	1374	CPT1A	0006	CARNITINE PALMITOYLTRANSFERASE IA DEFICIENCY	CPT1A, 153-BP DEL	
600528	1374	CPT1A	0007	CARNITINE PALMITOYLTRANSFERASE IA DEFICIENCY	CPT1A, 113-BP INS	
600528	1374	CPT1A	0008	CARNITINE PALMITOYLTRANSFERASE IA DEFICIENCY	CPT1A, 8-KB DEL	80356797
600528	1374	CPT1A	0009	CARNITINE PALMITOYLTRANSFERASE IA DEFICIENCY	CPT1A, GLY709GLU	28936374
600528	1374	CPT1A	0010	CARNITINE PALMITOYLTRANSFERASE IA DEFICIENCY	CPT1A, 1-BP DEL, 948G	
600528	1374	CPT1A	0011	CARNITINE PALMITOYLTRANSFERASE IA DEFICIENCY	CPT1A, GLY710GLU	80356780
600529	549	AUH	0001	3-@METHYLGLUTACONIC ACIDURIA, TYPE I	AUH, ARG197TER	121434636
600529	549	AUH	0002	3-@METHYLGLUTACONIC ACIDURIA, TYPE I	AUH, IVS8AS, G-A, -1	
600529	549	AUH	0003	3-@METHYLGLUTACONIC ACIDURIA, TYPE I	AUH, 1-BP DEL, 80G	
600529	549	AUH	0004	3-@METHYLGLUTACONIC ACIDURIA, TYPE I	AUH, IVS1AS, A-G, -2	
600529	549	AUH	0005	3-@METHYLGLUTACONIC ACIDURIA, TYPE I	AUH, IVS9AS, A-G, -2	
600529	549	AUH	0006	3-@METHYLGLUTACONIC ACIDURIA, TYPE I	AUH, GLY187SER	
600529	549	AUH	0007	3-@METHYLGLUTACONIC ACIDURIA, TYPE I	AUH, GLY217ASP	
600529	549	AUH	0008	3-@METHYLGLUTACONIC ACIDURIA, TYPE I	AUH, LYS331TER	
600532	4729	NDUFV2	0001	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	NDUFV2, ALA29VAL	906807
600532	4729	NDUFV2	0002	MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFV2, 4-BP DEL, NT5	
600533	57216	VANGL2	0001	NEURAL TUBE DEFECT	VANGL2, ARG353CYS	
600533	57216	VANGL2	0002	NEURAL TUBE DEFECT	VANGL2, PHE437SER	
600536	3679	ITGA7	0001	MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	ITGA7, IVSAS, A-G, -2	
600536	3679	ITGA7	0002	MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	ITGA7, IVSDS, T-C, +2	
600536	3679	ITGA7	0003	MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	ITGA7, 1-BP DEL, 1204G	
600555	6772	STAT1	0001	ATYPICAL MYCOBACTERIAL INFECTION, FAMILIAL DISSEMINATED	STAT1, LEU706SER	137852677
600555	6772	STAT1	0002	MYCOBACTERIAL AND VIRAL INFECTIONS, SUSCEPTIBILITY TO, AUTOSOMAL RECESSIVE	STAT1, 2-BP DEL, 1757AG	
600555	6772	STAT1	0003	MYCOBACTERIAL AND VIRAL INFECTIONS, SUSCEPTIBILITY TO, AUTOSOMAL RECESSIVE	STAT1, LEU600PRO	137852678
600555	6772	STAT1	0004	ATYPICAL MYCOBACTERIAL INFECTION, FAMILIAL DISSEMINATED	STAT1, GLN463HIS	137852679
600555	6772	STAT1	0005	ATYPICAL MYCOBACTERIAL INFECTION, FAMILIAL DISSEMINATED	STAT1, GLU320GLN	137852680
600555	6772	STAT1	0006	MYCOBACTERIAL AND VIRAL INFECTIONS, SUSCEPTIBILITY TO, AUTOSOMAL RECESSIVE	STAT1, 1-BP INS, 1928A	
600555	6772	STAT1	0007	MYCOBACTERIAL AND VIRAL INFECTIONS, SUSCEPTIBILITY TO, AUTOSOMAL RECESSIVE	STAT1, LYS201ASN	
600555	6772	STAT1	0008	CANDIDIASIS, FAMILIAL, 7	STAT1, ARG274TRP	
600555	6772	STAT1	0009	CANDIDIASIS, FAMILIAL, 7	STAT1, ALA267VAL	
600555	6772	STAT1	0010	CANDIDIASIS, FAMILIAL, 7	STAT1, ARG274GLN	
600555	6772	STAT1	0011	CANDIDIASIS, FAMILIAL, 7	STAT1, LYS286ILE	
600555	6772	STAT1	0012	CANDIDIASIS, FAMILIAL, 7	STAT1, MET202VAL	
600555	6772	STAT1	0013	CANDIDIASIS, FAMILIAL, 7	STAT1, CYS174ARG	
600555	6772	STAT1	0014	CANDIDIASIS, FAMILIAL, 7	STAT1, ASP165GLY	
600555	6772	STAT1	0015	CANDIDIASIS, FAMILIAL, 7	STAT1, THR288ALA	
600555	6772	STAT1	0016	CANDIDIASIS, FAMILIAL, 7	STAT1, TYR170ASN	
600555	6772	STAT1	0017	CANDIDIASIS, FAMILIAL, 7	STAT1, ASP165HIS	
600555	6772	STAT1	0018	CANDIDIASIS, FAMILIAL, 7	STAT1, MET202ILE	
600555	6772	STAT1	0019	CANDIDIASIS, FAMILIAL, 7	STAT1, GLN271PRO	
600558	6775	STAT4	0001	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 11; SLEB11	STAT4, G-T	
600564	3700	ITIH4	0001	HYPERCHOLESTEROLEMIA, SUSCEPTIBILITY TO	ITIH4, IVS17, +8, C-T	
600565	9378	NRXN1	0001	PITT-HOPKINS-LIKE SYNDROME 2	NRXN1, 180-KB DEL, EX1-4	
600565	9378	NRXN1	0002	PITT-HOPKINS-LIKE SYNDROME 2	NRXN1, SER979TER	
600565	9378	NRXN1	0003	SCHIZOPHRENIA, SUSCEPTIBILITY TO, 17	NRXN1, 4-BP INS, 4205ACGG	
600565	9378	NRXN1	0004	PITT-HOPKINS-LIKE SYNDROME 2	NRXN1, 79-KB DEL	
600565	9378	NRXN1	0005	PITT-HOPKINS-LIKE SYNDROME 2	NRXN1, 287-KB DEL	
600570	1181	CLCN2	0001	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	CLCN2, 1-BP INS, 597G	
600570	1181	CLCN2	0002	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	CLCN2, IVS2, 11-BP DEL	
600570	1181	CLCN2	0003	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	CLCN2, GLY715GLU	137852681
600570	1181	CLCN2	0004	EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 8	CLCN2, ARG235GLN	71318369
600570	1181	CLCN2	0005	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 11	CLCN2, ARG577GLN	137852682
600576	2626	GATA4	0001	ATRIAL SEPTAL DEFECT 2	GATA4, GLY296SER	104894073
600576	2626	GATA4	0002	ATRIAL SEPTAL DEFECT 2	GATA4, 1-BP DEL, 1075G	
600576	2626	GATA4	0003	ATRIAL SEPTAL DEFECT 2	GATA4, SER52PHE	104894074
600576	2626	GATA4	0004	ATRIAL SEPTAL DEFECT 2	GATA4, GLN316GLU	56298569
600576	2626	GATA4	0005	ATRIAL SEPTAL DEFECT 2 TETRALOGY OF FALLOT, INCLUDED	GATA4, ASP425ASN	56208331
600576	2626	GATA4	0006	ATRIAL SEPTAL DEFECT 2	GATA4, GLY296CYS	
600576	2626	GATA4	0007	ATRIOVENTRICULAR SEPTAL DEFECT 4 VENTRICULAR SEPTAL DEFECT 1, INCLUDED;; TETRALOGY OF FALLOT, INCLUDED	GATA4, PRO163SER	
600576	2626	GATA4	0008	ATRIOVENTRICULAR SEPTAL DEFECT 4	GATA4, ALA346VAL	
600576	2626	GATA4	0009	VENTRICULAR SEPTAL DEFECT 1	GATA4, GLU359LYS	
600576	2626	GATA4	0010	VENTRICULAR SEPTAL DEFECT 1	GATA4, ALA442VAL	
600576	2626	GATA4	0011	TETRALOGY OF FALLOT	GATA4, PRO407GLN	
600576	2626	GATA4	0012	TETRALOGY OF FALLOT	GATA4, 3-BP INS, 354GCC	
600576	2626	GATA4	0013	VENTRICULAR SEPTAL DEFECT 1	GATA4, PRO407GLN	
600576	2626	GATA4	0014	VENTRICULAR SEPTAL DEFECT 1	GATA4, GLY296ARG	
600576	2626	GATA4	0015	VENTRICULAR SEPTAL DEFECT 1	GATA4, ARG43TRP	
600576	2626	GATA4	0016	ATRIAL SEPTAL DEFECT 2	GATA4, THR280MET	
600576	2626	GATA4	0017	ATRIAL SEPTAL DEFECT 2	GATA4, MET310VAL	
600577	8022	LHX3	0001	PITUITARY HORMONE DEFICIENCY, COMBINED, 3	LHX3, TYR116CYS	104894117
600577	8022	LHX3	0002	PITUITARY HORMONE DEFICIENCY, COMBINED, 3	LHX3, 23-BP DEL	
600577	8022	LHX3	0003	PITUITARY HORMONE DEFICIENCY, COMBINED, 3	LHX3, 1-BP DEL, 159T	
600577	8022	LHX3	0004	PITUITARY HORMONE DEFICIENCY, COMBINED, 3	LHX3, ALA210VAL	137854503
600577	8022	LHX3	0005	PITUITARY HORMONE DEFICIENCY, COMBINED, 3	LHX3, GLU173TER	137854504
600577	8022	LHX3	0006	PITUITARY HORMONE DEFICIENCY, COMBINED, 3	LHX3, DEL	
600577	8022	LHX3	0007	PITUITARY HORMONE DEFICIENCY, COMBINED, 3	LHX3, TRP224TER	137854505
600577	8022	LHX3	0008	PITUITARY HORMONE DEFICIENCY, COMBINED, 3	LHX3, 3,088-BP DEL	
600577	8022	LHX3	0009	PITUITARY HORMONE DEFICIENCY, COMBINED, 3	LHX3, LYS50TER	137854506
600579	5800	PTPRO	0001	NEPHROTIC SYNDROME, TYPE 6	PTPRO, IVS16DS, G-T, +1	
600579	5800	PTPRO	0002	NEPHROTIC SYNDROME, TYPE 6	PTPRO, IVS19DS, G-A, +1	
600584	1482	NKX2-5	0001	ATRIAL SEPTAL DEFECT 7 WITH OR WITHOUT ATRIOVENTRICULAR CONDUCTION DEFECTS	NKX2-5, THR178MET	104893900
600584	1482	NKX2-5	0002	ATRIAL SEPTAL DEFECT 7 WITH OR WITHOUT ATRIOVENTRICULAR CONDUCTION DEFECTS	NKX2-5, GLN170TER	104893901
600584	1482	NKX2-5	0003	ATRIAL SEPTAL DEFECT 7 WITH OR WITHOUT ATRIOVENTRICULAR CONDUCTION DEFECTS	NKX2-5, GLN198TER	104893903
600584	1482	NKX2-5	0004	TETRALOGY OF FALLOT INTERRUPTED AORTIC ARCH, INCLUDED;; TRUNCUS ARTERIOSUS, INCLUDED;; HYPOPLASTIC LEFT HEART SYNDROME 2, INCLUDED;; HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 5, INCLUDED	NKX2-5, ARG25CYS	28936670
600584	1482	NKX2-5	0005	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	NKX2-5, IVS1DS, G-T, +1	
600584	1482	NKX2-5	0006	TETRALOGY OF FALLOT	NKX2-5, GLU21GLN	104893904
600584	1482	NKX2-5	0007	TETRALOGY OF FALLOT	NKX2-5, ARG216CYS	104893905
600584	1482	NKX2-5	0008	TETRALOGY OF FALLOT	NKX2-5, ALA219VAL	104893902
600584	1482	NKX2-5	0009	ATRIAL SEPTAL DEFECT 7 WITH OR WITHOUT ATRIOVENTRICULAR CONDUCTION DEFECTS	NKX2-5, 7-BP DEL	
600584	1482	NKX2-5	0010	ATRIAL SEPTAL DEFECT 7 WITH OR WITHOUT ATRIOVENTRICULAR CONDUCTION DEFECTS	NKX2-5, 2-BP DEL, 223CG	
600584	1482	NKX2-5	0011	ATRIAL SEPTAL DEFECT 7 WITH OR WITHOUT ATRIOVENTRICULAR CONDUCTION DEFECTS, SOMATIC ATRIOVENTRICULAR SEPTAL DEFECT, SOMATIC, INCLUDED	NKX2-5, ASP299GLY	137852683
600584	1482	NKX2-5	0012	ATRIAL SEPTAL DEFECT 7 WITH OR WITHOUT ATRIOVENTRICULAR CONDUCTION DEFECTS	NKX2-5, 1-BP DEL, 262G	
600584	1482	NKX2-5	0013	ATRIAL SEPTAL DEFECT 7 WITH OR WITHOUT ATRIOVENTRICULAR CONDUCTION DEFECTS	NKX2-5, ARG190CYS	104893906
600584	1482	NKX2-5	0014	ATRIAL SEPTAL DEFECT 7 WITH OR WITHOUT ATRIOVENTRICULAR CONDUCTION DEFECTS	NKX2-5, TYR256TER	104893907
600584	1482	NKX2-5	0015	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 5	NKX2-5, ALA119SER	137852684
600584	1482	NKX2-5	0016	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 5	NKX2-5, ARG161PRO	137852685
600584	1482	NKX2-5	0017	ATRIOVENTRICULAR SEPTAL DEFECT, SOMATIC	NKX2-5, LYS183GLU	137852686
600584	1482	NKX2-5	0018	ATRIAL SEPTAL DEFECT 7 WITH OR WITHOUT ATRIOVENTRICULAR CONDUCTION DEFECTS	NKX2-5, LYS15ILE	
600584	1482	NKX2-5	0019	ATRIAL SEPTAL DEFECT 7 WITH OR WITHOUT ATRIOVENTRICULAR CONDUCTION DEFECTS	NKX2-5, ALA127GLU	
600584	1482	NKX2-5	0020	DOUBLE-OUTLET RIGHT VENTRICLE	NKX2-5, 3-BP DEL, 871AAC	
600584	1482	NKX2-5	0021	VENTRICULAR SEPTAL DEFECT 3	NKX2-5, PRO283GLN	
600584	1482	NKX2-5	0022	VENTRICULAR SEPTAL DEFECT 3	NKX2-5, PRO59ALA	
600584	1482	NKX2-5	0023	VENTRICULAR SEPTAL DEFECT 3	NKX2-5, PRO257ALA	
600584	1482	NKX2-5	0024	ASPLENIA, ISOLATED CONGENITAL	NKX2-5, PRO236HIS	
600599	10661	KLF1	0001	BLOOD GROUP--LUTHERAN INHIBITOR	KLF1, 1-BP DUP, 954G	
600599	10661	KLF1	0002	BLOOD GROUP--LUTHERAN INHIBITOR	KLF1, 1-BP DEL, 569C	
600599	10661	KLF1	0003	BLOOD GROUP--LUTHERAN INHIBITOR	KLF1, LYS292TER	137852687
600599	10661	KLF1	0004	BLOOD GROUP--LUTHERAN INHIBITOR	KLF1, HIS299TYR	137852688
600599	10661	KLF1	0005	HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN, KLF1-RELATED	KLF1, LYS288TER	
600599	10661	KLF1	0006	ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE IV	KLF1, GLU325LYS	
600599	10661	KLF1	0007	BLOOD GROUP--LUTHERAN INHIBITOR	KLF1, LEU326ARG	
600599	10661	KLF1	0008	BLOOD GROUP--LUTHERAN INHIBITOR	KLF1, HIS357GLN	
600599	10661	KLF1	0009	BLOOD GROUP--LUTHERAN INHIBITOR	KLF1, TYR197TER	
600617	6770	STAR	0001	LIPOID CONGENITAL ADRENAL HYPERPLASIA	STAR, IVS4AS, T-A, -11	
600617	6770	STAR	0002	LIPOID CONGENITAL ADRENAL HYPERPLASIA	STAR, GLN258TER	104894085
600617	6770	STAR	0003	LIPOID CONGENITAL ADRENAL HYPERPLASIA	STAR, ARG182LEU	104894086
600617	6770	STAR	0004	LIPOID CONGENITAL ADRENAL HYPERPLASIA	STAR, 1-BP DEL, 261T	
600617	6770	STAR	0005	LIPOID CONGENITAL ADRENAL HYPERPLASIA	STAR, IVS2, 1-BP INS, T, +3	
600617	6770	STAR	0006	LIPOID CONGENITAL ADRENAL HYPERPLASIA	STAR, TRP250TER	104894087
600617	6770	STAR	0007	LIPOID CONGENITAL ADRENAL HYPERPLASIA	STAR, ARG217THR	137852689
600617	6770	STAR	0008	LIPOID CONGENITAL ADRENAL HYPERPLASIA	STAR, ARG218VAL	137852690
600617	6770	STAR	0009	LIPOID CONGENITAL ADRENAL HYPERPLASIA	STAR, IVS1, G-T, +1	
600617	6770	STAR	0010	LIPOID CONGENITAL ADRENAL HYPERPLASIA	STAR, ARG182HIS	104894086
600617	6770	STAR	0011	LIPOID CONGENITAL ADRENAL HYPERPLASIA	STAR, VAL187MET	104894089
600617	6770	STAR	0012	LIPOID CONGENITAL ADRENAL HYPERPLASIA	STAR, ARG188CYS	104894090
600617	6770	STAR	0013	LIPOID CONGENITAL ADRENAL HYPERPLASIA	STAR, 2-BP DEL, 201CT	
600617	6770	STAR	0014	LIPOID CONGENITAL ADRENAL HYPERPLASIA	STAR, ARG193TER	
600618	2120	ETV6	0001	LEUKEMIA, ACUTE MYELOID, SOMATIC	ETV6, GLU76TER	121434637
600618	2120	ETV6	0002	LEUKEMIA, ACUTE MYELOID, SOMATIC	ETV6, 3-BP INS, 1307GGG	
600632	4978	OPCML	0001	OVARIAN CANCER, SOMATIC	OPCML, PRO95ARG	137852691
600635	7080	NKX2-1	0001	CHOREA, BENIGN HEREDITARY	NKX2-1, 1.2-MB DEL	
600635	7080	NKX2-1	0002	CHOREA, BENIGN HEREDITARY	NKX2-1, ARG243SER	28936671
600635	7080	NKX2-1	0003	CHOREA, BENIGN HEREDITARY	NKX2-1, TRP238LEU	28936672
600635	7080	NKX2-1	0004	CHOREA, BENIGN HEREDITARY	NKX2-1, 1-BP DEL, 908G	
600635	7080	NKX2-1	0005	CHOREOATHETOSIS, CONGENITAL HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESS	NKX2-1, VAL45PHE	137852692
600635	7080	NKX2-1	0006	CHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM	NKX2-1, 2-BP INS, 2595GG	
600635	7080	NKX2-1	0007	CHOREA, BENIGN HEREDITARY	NKX2-1, IVS2AS, A-T, -2	
600635	7080	NKX2-1	0008	CHOREOATHETOSIS, CONGENITAL HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESS	NKX2-1, GLU175TER	137852693
600635	7080	NKX2-1	0009	CHOREA, BENIGN HEREDITARY	NKX2-1, GLN249TER	137852694
600635	7080	NKX2-1	0010	CHOREOATHETOSIS, CONGENITAL HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESS	NKX2-1, 1-BP INS, 255G	
600635	7080	NKX2-1	0011	CHOREOATHETOSIS, CONGENITAL HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESS	NKX2-1, IVS2AS, A-G, -2	
600644	5818	PVRL1	0001	CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME OROFACIAL CLEFT 7, INCLUDED	PVRL1, TRP185TER	104894281
600644	5818	PVRL1	0002	CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME	PVRL1, 1-BP DEL	
600644	5818	PVRL1	0003	CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME	PVRL1, 1-BP DUP	
600650	1376	CPT2	0001	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LATE-ONSET, INCLUDED	CPT2, ARG631CYS	74315293
600650	1376	CPT2	0002	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LATE-ONSET	CPT2, SER113LEU	74315294
600650	1376	CPT2	0003	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LATE-ONSET CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE, INCLUDED	CPT2, PRO50HIS	28936375
600650	1376	CPT2	0004	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LATE-ONSET	CPT2, ASP553ASN	28936376
600650	1376	CPT2	0005	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LATE-ONSET, INCLUDED	CPT2, TYR628SER	28936673
600650	1376	CPT2	0006	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	CPT2, GLU174LYS	28936674
600650	1376	CPT2	0007	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LATE-ONSET, INCLUDED	CPT2, PHE383TYR	74315295
600650	1376	CPT2	0008	MYOPATHY, VARIABLE	CPT2, ARG503CYS	74315296
600650	1376	CPT2	0009	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LATE-ONSET CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL, INCLUDED;; CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE, INCLUDED	CPT2, 2-BP DEL, 1237AG AND PHE448LEU	74315297
600650	1376	CPT2	0010	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL	CPT2, 1-BP INS, 534T/25-BP DEL, NT534	
600650	1376	CPT2	0011	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL	CPT2, IVS2AS, G-A, -1	
600650	1376	CPT2	0012	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL	CPT2, 11-BP DUP	
600650	1376	CPT2	0013	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL	CPT2, PRO227LEU	74315298
600650	1376	CPT2	0014	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL	CPT2, 3-BP DEL, 109AGC AND 5-BP INS, 109GCAGC	
600650	1376	CPT2	0015	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LATE-ONSET	CPT2, GLU454TER	74315299
600650	1376	CPT2	0016	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LATE-ONSET	CPT2, ASP213GLY	74315300
600650	1376	CPT2	0017	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	CPT2, TYR120CYS	121918528
600650	1376	CPT2	0018	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4	CPT2, PHE352CYS AND VAL368ILE	
600660	4205	MEF2A	0001	CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 1	MEF2A, 21-BP DEL	
600660	4205	MEF2A	0002	CORONARY ARTERY DISEASE/MYOCARDIAL INFARCTION	MEF2A, PRO279LEU	121918529
600660	4205	MEF2A	0003	CORONARY ARTERY DISEASE/MYOCARDIAL INFARCTION	MEF2A, ASN263SER	121918530
600660	4205	MEF2A	0004	CORONARY ARTERY DISEASE/MYOCARDIAL INFARCTION	MEF2A, GLY283ASP	121918531
600662	4208	MEF2C	0001	MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	MEF2C, SER228TER	
600662	4208	MEF2C	0002	MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	MEF2C, LEU38GLN	
600662	4208	MEF2C	0003	MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	MEF2C, 1-BP DUP, 99T	
600662	4208	MEF2C	0004	MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	MEF2C, GLY27ALA	
600662	4208	MEF2C	0005	MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	MEF2C, 1-BP DEL, 457A	
600664	1147	CHUK	0001	COCOON SYNDROME	CHUK, GLN422TER	
600675	7517	XRCC3	0001	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 6	XRCC3, THR241MET	861539
600675	7517	XRCC3	0002	BREAST CANCER, SUSCEPTIBILITY TO	XRCC3, IVS5, A-G, -14	
600678	2956	MSH6	0001	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 5	MSH6, 1-BP DEL, LEU222TER	
600678	2956	MSH6	0003	REMOVED FROM DATABASE .0004 COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 5	MSH6, 1-BP DEL, FS570TER	
600678	2956	MSH6	0005	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 5	MSH6, 1-BP DEL, 594T	
600678	2956	MSH6	0006	COLON CANCER, HEREDITARY NONPOLYPOSIS, TYPE 5	MSH6, VAL878ALA	2020912
600678	2956	MSH6	0007	COLON CANCER, HEREDITARY NONPOLYPOSIS, TYPE 5	MSH6, 1-BP INS, 650T	
600678	2956	MSH6	0008	COLON CANCER, HEREDITARY NONPOLYPOSIS, TYPE 5	MSH6, 2-BP DEL, 3052CT	
600678	2956	MSH6	0009	COLON CANCER, HEREDITARY NONPOLYPOSIS, TYPE 5	MSH6, 2-BP DEL, 3311TT	
600678	2956	MSH6	0010	COLON CANCER, HEREDITARY NONPOLYPOSIS, TYPE 5	MSH6, 13-BP DEL	
600678	2956	MSH6	0011	COLON CANCER, HEREDITARY NONPOLYPOSIS, TYPE 5	MSH6, 4.9-KB DUP	
600678	2956	MSH6	0012	MISMATCH REPAIR CANCER SYNDROME COLON CANCER, HEREDITARY NONPOLYPOSIS, TYPE 5, INCLUDED	MSH6, TRP1024TER	
600678	2956	MSH6	0013	MISMATCH REPAIR CANCER SYNDROME	MSH6, 3-BP DEL, NT3609	
600678	2956	MSH6	0014	MISMATCH REPAIR CANCER SYNDROME	MSH6, 3-BP DEL, 3386GTG	
600678	2956	MSH6	0015	MISMATCH REPAIR CANCER SYNDROME	MSH6, 1-BP INS, 3436T	
600678	2956	MSH6	0016	MISMATCH REPAIR CANCER SYNDROME	MSH6, 1-BP INS, 1596T	
600678	2956	MSH6	0017	MISMATCH REPAIR CANCER SYNDROME	MSH6, 1-BP DEL, 3261C	
600681	3759	KCNJ2	0001	ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	KCNJ2, ASP71VAL	104894575
600681	3759	KCNJ2	0002	ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	KCNJ2, ARG218TRP	104894578
600681	3759	KCNJ2	0003	ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	KCNJ2, GLY300VAL	104894579
600681	3759	KCNJ2	0004	ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	KCNJ2, 12-BP DEL, NT513	
600681	3759	KCNJ2	0005	ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	KCNJ2, 6-BP DEL, NT1167	
600681	3759	KCNJ2	0006	ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	KCNJ2, ARG67TRP	104894580
600681	3759	KCNJ2	0007	ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	KCNJ2, PRO186LEU	104894581
600681	3759	KCNJ2	0008	ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	KCNJ2, VAL302MET	104894582
600681	3759	KCNJ2	0009	ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	KCNJ2, ASN216HIS	104894583
600681	3759	KCNJ2	0010	SHORT QT SYNDROME 3	KCNJ2, ASP172ASN	104894584
600681	3759	KCNJ2	0011	ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	KCNJ2, THR75ARG	104894585
600681	3759	KCNJ2	0012	ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	KCNJ2, CYS54PHE	
600681	3759	KCNJ2	0013	ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	KCNJ2, THR305PRO	
600681	3759	KCNJ2	0014	ATRIAL FIBRILLATION, FAMILIAL, 9	KCNJ2, VAL93ILE	
600682	6566	SLC16A1	0001	ERYTHROCYTE LACTATE TRANSPORTER DEFECT	SLC16A1, LYS204GLU	80358222
600682	6566	SLC16A1	0002	ERYTHROCYTE LACTATE TRANSPORTER DEFECT	SLC16A1, GLY472ARG	72552271
600682	6566	SLC16A1	0003	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7	SLC16A1, 163G-A, 5-PRIME UTR	
600682	6566	SLC16A1	0004	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7	SLC16A1, 25-BP INS, NT-24	
600692	7140	TNNT3	0001	ARTHROGRYPOSIS, DISTAL, TYPE 2B	TNNT3, ARG63HIS	121434638
600701	3159	HMGA1	0001	DIABETES MELLITUS, NONINSULIN-DEPENDENT, SUSCEPTIBILITY TO	HMGA1, 1-BP INS, IVS5, -13	
600702	6334	SCN8A	0001	COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA	SCN8A, 2-BP DEL, 5157CT	
600702	6334	SCN8A	0002	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	SCN8A, ASN1768ASP	
600713	3290	HSD11B1	0001	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE HSD11B1, 1-BP INS, 83557A AND 83597T-G (dbSNP rs45487298 AND dbSNP	rs12086634)	
600713	3290	HSD11B1	0002	CORTISONE REDUCTASE DEFICIENCY 2	HSD11B1, ARG137CYS	
600713	3290	HSD11B1	0003	CORTISONE REDUCTASE DEFICIENCY 2	HSD11B1, LYS187ASN	
600716	26191	PTPN22	0001	DIABETES MELLITUS, INSULIN-DEPENDENT, SUSCEPTIBILITY TO RHEUMATOID ARTHRITIS, SUSCEPTIBILITY TO, INCLUDED;; SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, INCLUDED;; HASHIMOTO THYROIDITIS, SUSCEPTIBILITY TO, INCLUDED;; ADDISON DISEASE, SUSCEPTIBILITY TO, INCLUDED	PTPN22, ARG620TRP	2476601
600716	26191	PTPN22	0002	DIABETES MELLITUS, INSULIN-DEPENDENT, SUSCEPTIBILITY TO	PTPN22, -1123, C-G	2488457
600722	5538	PPT1	0001	CEROID LIPOFUSCINOSIS, NEURONAL, 1	PPT1, ARG122TRP	137852695
600722	5538	PPT1	0002	CEROID LIPOFUSCINOSIS, NEURONAL, 1	PPT1, THR75PRO	137852696
600722	5538	PPT1	0003	CEROID LIPOFUSCINOSIS, NEURONAL, 1	PPT1, ASP79GLY	137852697
600722	5538	PPT1	0004	CEROID LIPOFUSCINOSIS, NEURONAL, 1	PPT1, LEU219GLN	137852698
600722	5538	PPT1	0005	CEROID LIPOFUSCINOSIS, NEURONAL, 1	PPT1, LEU10TER	137852699
600722	5538	PPT1	0006	CEROID LIPOFUSCINOSIS, NEURONAL, 1	PPT1, ARG151TER	137852700
600722	5538	PPT1	0007	CEROID LIPOFUSCINOSIS, NEURONAL, 1	PPT1, 1-BP INS, 169A	
600722	5538	PPT1	0008	CEROID LIPOFUSCINOSIS, NEURONAL, 1	PPT1, 451C-T	
600722	5538	PPT1	0009	CEROID LIPOFUSCINOSIS, NEURONAL, 1	PPT1, GLY108ARG	137852701
600722	5538	PPT1	0010	CEROID LIPOFUSCINOSIS, NEURONAL, 1	PPT1, CYS45TYR	137852702
600724	1258	CNGB1	0001	RETINITIS PIGMENTOSA 45	CNGB1, GLY993VAL	121918532
600724	1258	CNGB1	0002	RETINITIS PIGMENTOSA 45	CNGB1, IVS32, G-A, +1	
600725	6469	SHH	0001	HOLOPROSENCEPHALY 3	SHH, GLY31ARG	28936675
600725	6469	SHH	0002	HOLOPROSENCEPHALY 3	SHH, GLN100TER	104894044
600725	6469	SHH	0003	HOLOPROSENCEPHALY 3	SHH, LYS105TER	104894045
600725	6469	SHH	0004	HOLOPROSENCEPHALY 3	SHH, TRP117GLY	104894040
600725	6469	SHH	0005	HOLOPROSENCEPHALY 3	SHH, TRP117ARG	104894040
600725	6469	SHH	0006	HOLOPROSENCEPHALY 3	SHH, VAL224GLU	104894042
600725	6469	SHH	0007	HOLOPROSENCEPHALY 3	SHH, ALA226THR	104894043
600725	6469	SHH	0008	HOLOPROSENCEPHALY 3	SHH, 21-BP DEL	
600725	6469	SHH	0009	HOLOPROSENCEPHALY 3	SHH, GLU284TER	104894046
600725	6469	SHH	0010	HOLOPROSENCEPHALY 3	SHH, ALA384THR	137853341
600725	6469	SHH	0011	HOLOPROSENCEPHALY 3 SCHIZENCEPHALY, INCLUDED	SHH, GLY290ASP	104894047
600725	6469	SHH	0012	HOLOPROSENCEPHALY 3	SHH, PRO424ALA	104894048
600725	6469	SHH	0013	HOLOPROSENCEPHALY 3	SHH, 9-BP DEL, NT1283	
600725	6469	SHH	0014	SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR	SHH, ILE111PHE	104894049
600725	6469	SHH	0015	HOLOPROSENCEPHALY 3	SHH, ASP88VAL	104894050
600725	6469	SHH	0016	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 5	SHH, 24-BP DEL, NT1353	
600725	6469	SHH	0017	HOLOPROSENCEPHALY 3	SHH, GLU256TER	104894051
600725	6469	SHH	0018	SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR	SHH, VAL332ALA	104894052
600725	6469	SHH	0019	HOLOPROSENCEPHALY 3 SINGLE CENTRAL MAXILLARY INCISOR, INCLUDED	SHH, TRP128TER	104894053
600725	6469	SHH	0020	HOLOPROSENCEPHALY 3	SHH, ASN115LYS	
600726	3549	IHH	0001	BRACHYDACTYLY, TYPE A1	IHH, GLU95LYS	
600726	3549	IHH	0002	BRACHYDACTYLY, TYPE A1	IHH, GLU131LYS	
600726	3549	IHH	0003	BRACHYDACTYLY, TYPE A1	IHH, ASP100GLU	
600726	3549	IHH	0004	BRACHYDACTYLY, TYPE A1	IHH, ASP100ASN	
600726	3549	IHH	0005	ACROCAPITOFEMORAL DYSPLASIA	IHH, PRO46LEU	
600726	3549	IHH	0006	ACROCAPITOFEMORAL DYSPLASIA	IHH, VAL190ALA	
600726	3549	IHH	0007	BRACHYDACTYLY, TYPE A1	IHH, GLU95GLY	
600726	3549	IHH	0008	BRACHYDACTYLY, TYPE A1	IHH, THR154ILE	
600726	3549	IHH	0009	BRACHYDACTYLY, TYPE A1	IHH, 3-BP DEL, 283GAG	
600726	3549	IHH	0010	BRACHYDACTYLY, TYPE A1	IHH, ARG128GLN	
600726	3549	IHH	0011	BRACHYDACTYLY, TYPE A1	IHH, THR130ASN	
600733	3651	PDX1	0001	PANCREATIC AGENESIS MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 4, INCLUDED	PDX1, 1-BP DEL, 188C	
600733	3651	PDX1	0002	DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO	PDX1, ASP76ASN	137852783
600733	3651	PDX1	0003	DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO	PDX1, GLN59LEU	137852784
600733	3651	PDX1	0004	DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO	PDX1, 3-BP INS, 243CCG	
600733	3651	PDX1	0005	DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO	PDX1, CYS18ARG	137852785
600733	3651	PDX1	0006	DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO	PDX1, ARG197HIS	137852786
600733	3651	PDX1	0007	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE IV	PDX1, GLU224LYS	137852787
600733	3651	PDX1	0008	PANCREATIC AGENESIS DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO, INCLUDED	PDX1, GLU164ASP	80356661
600733	3651	PDX1	0009	PANCREATIC AGENESIS	PDX1, GLU178LYS	80356662
600733	3651	PDX1	0010	PANCREATIC AGENESIS	PDX1, GLU178GLY	
600734	3762	KCNJ5	0001	LONG QT SYNDROME 13	KCNJ5, GLY387ARG	
600734	3762	KCNJ5	0002	HYPERALDOSTERONISM, FAMILIAL, TYPE III	KCNJ5, THR158ALA	
600749	1053	CEBPE	0001	SPECIFIC GRANULE DEFICIENCY	CEBPE, 5-BP DEL, NT224	
600749	1053	CEBPE	0002	SPECIFIC GRANULE DEFICIENCY	CEBPE, 1-BP INS, 1113A	
600759	5664	PSEN2	0001	ALZHEIMER DISEASE, FAMILIAL, 4	PSEN2, ASN141ILE	63750215
600759	5664	PSEN2	0002	ALZHEIMER DISEASE, FAMILIAL, 4	PSEN2, MET239VAL	28936379
600759	5664	PSEN2	0003	ALZHEIMER DISEASE, FAMILIAL, 4	PSEN2, ASP439ALA	63750110
600759	5664	PSEN2	0004	ALZHEIMER DISEASE, FAMILIAL, 4	PSEN2, THR430MET	63750666
600759	5664	PSEN2	0005	ALZHEIMER DISEASE, FAMILIAL, 4	PSEN2, THR122PRO	63749851
600759	5664	PSEN2	0006	ALZHEIMER DISEASE, FAMILIAL, 4	PSEN2, MET239ILE	63749884
600759	5664	PSEN2	0007	ALZHEIMER DISEASE, FAMILIAL, 4	PSEN2, THR122ARG	
600759	5664	PSEN2	0008	CARDIOMYOPATHY, DILATED, 1V ALZHEIMER DISEASE, FAMILIAL, 4, INCLUDED	PSEN2, SER130LEU	63750197
600759	5664	PSEN2	0009	ALZHEIMER DISEASE, FAMILIAL, 4	PSEN2, ALA85VAL	63750048
600760	6338	SCNN1B	0001	LIDDLE SYNDROME	SCNN1B, ARG564TER	137852704
600760	6338	SCNN1B	0002	LIDDLE SYNDROME	SCNN1B, PRO616LEU	137852705
600760	6338	SCNN1B	0003	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE	SCNN1B, GLY37SER	137852706
600760	6338	SCNN1B	0004	LIDDLE SYNDROME	SCNN1B, TYR618HIS	137852707
600760	6338	SCNN1B	0005	LIDDLE SYNDROME	SCNN1B, 1-BP INS, 592C	
600760	6338	SCNN1B	0006	LIDDLE SYNDROME	SCNN1B, 32-BP DEL	
600760	6338	SCNN1B	0007	LIDDLE SYNDROME	SCNN1B, PRO615SER	137852708
600760	6338	SCNN1B	0008	LIDDLE SYNDROME	SCNN1B, PRO616ARG	137852705
600760	6338	SCNN1B	0009	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1	SCNN1B, PRO267LEU	137852709
600760	6338	SCNN1B	0010	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1	SCNN1B, IVS12AS, A-G, -2	
600760	6338	SCNN1B	0011	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1	SCNN1B, GLY294SER	72654338
600760	6338	SCNN1B	0012	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1	SCNN1B, GLU539LYS	137852710
600760	6338	SCNN1B	0013	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1	SCNN1B, PRO369THR	137852711
600760	6338	SCNN1B	0014	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1	SCNN1B, ASN288SER	137852712
600760	6338	SCNN1B	0015	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1	SCNN1B, SER82CYS	35731153
600761	6340	SCNN1G	0001	LIDDLE SYNDROME	SCNN1G, TRP574TER	137853342
600761	6340	SCNN1G	0002	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE	SCNN1G, IVSAAS, G-A, -1	
600761	6340	SCNN1G	0003	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE	SCNN1G, 1-BP DEL, 1627G	
600761	6340	SCNN1G	0004	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE	SCNN1G, IVS11, G-A, -1	
600761	6340	SCNN1G	0005	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 3	SCNN1G, GLY183SER	5736
600761	6340	SCNN1G	0006	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 3	SCNN1G, GLU197LYS	5738
600770	727897	MUC5B	0001	PULMONARY FIBROSIS, IDIOPATHIC, SUSCEPTIBILITY TO	MUC5B, 1241221G-T	
600778	1027	CDKN1B	0001	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV	CDKN1B, TRP76TER	
600781	5697	PYY	0001	OBESITY, SUSCEPTIBILITY TO	PYY, GLN62PRO	
600783	23438	HARS2	0001	PERRAULT SYNDROME 2	HARS2, LEU200VAL	
600783	23438	HARS2	0002	PERRAULT SYNDROME 2	HARS2, VAL368LEU	
600797	8660	IRS2	0001	DIABETES, TYPE II, SUSCEPTIBILITY TO	IRS2, GLY1057ASP	1805097
600797	8660	IRS2	0002	DIABETES, TYPE II, SUSCEPTIBILITY TO	IRS2, LEU647VAL	137852740
600799	659	BMPR2	0001	PULMONARY HYPERTENSION, PRIMARY, 1	BMPR2, 1-BP DEL, 2579T	
600799	659	BMPR2	0002	PULMONARY HYPERTENSION, PRIMARY, 1	BMPR2, ARG899TER	137852741
600799	659	BMPR2	0003	PULMONARY HYPERTENSION, PRIMARY, 1	BMPR2, SER73TER	137852742
600799	659	BMPR2	0004	PULMONARY HYPERTENSION, PRIMARY, 1	BMPR2, 1-BP DEL, 355A	
600799	659	BMPR2	0005	PULMONARY HYPERTENSION, PRIMARY, 1	BMPR2, CYS118TRP	137852743
600799	659	BMPR2	0006	PULMONARY HYPERTENSION, PRIMARY, 1	BMPR2, CYS347TYR	137852744
600799	659	BMPR2	0007	PULMONARY HYPERTENSION, PRIMARY, 1	BMPR2, ASP485GLY	137852745
600799	659	BMPR2	0008	PULMONARY HYPERTENSION, PRIMARY, 1	BMPR2, ARG491TRP	137852746
600799	659	BMPR2	0009	PULMONARY HYPERTENSION, PRIMARY, 1	BMPR2, 5-BP DEL, NT1099	
600799	659	BMPR2	0011	PULMONARY HYPERTENSION, PRIMARY, 1	BMPR2, CYS169TER	137852747
600799	659	BMPR2	0012	PULMONARY HYPERTENSION, PRIMARY, 1	BMPR2, ARG873TER	137852748
600799	659	BMPR2	0013	PULMONARY HYPERTENSION, PRIMARY, 1	BMPR2, ARG491GLN	137852749
600799	659	BMPR2	0014	PULMONARY HYPERTENSION, PRIMARY, 1	BMPR2, 2-BP DEL, 1-BP INS, NT690	
600799	659	BMPR2	0015	PULMONARY HYPERTENSION, PRIMARY, 1	BMPR2, CYS123ARG	137852750
600799	659	BMPR2	0016	PULMONARY HYPERTENSION, PRIMARY, 1	BMPR2, CYS123SER	137852750
600799	659	BMPR2	0017	PULMONARY HYPERTENSION, PRIMARY, 1	BMPR2, ARG332TER	137852751
600799	659	BMPR2	0018	PULMONARY HYPERTENSION, PRIMARY, 1	BMPR2, ARG899PRO	137852752
600799	659	BMPR2	0019	PULMONARY HYPERTENSION, PRIMARY, 1 PULMONARY HYPERTENSION, PRIMARY, DEXFENFLURAMINE-ASSOCIATED, INCLUDED	BMPR2, ARG211TER	137852753
600799	659	BMPR2	0020	PULMONARY HYPERTENSION, PRIMARY, FENFLURAMINE-ASSOCIATED	BMPR2, GLY182ASP	137852754
600799	659	BMPR2	0021	PULMONARY HYPERTENSION, PRIMARY, 1 PULMONARY VENOOCCLUSIVE DISEASE, INCLUDED	BMPR2, 1-BP DEL, 44C	
600799	659	BMPR2	0022	PULMONARY VENOOCCLUSIVE DISEASE	BMPR2, TYR40TER	137852755
600799	659	BMPR2	0023	PULMONARY HYPERTENSION, PRIMARY, 1 PULMONARY VENOOCCLUSIVE DISEASE, INCLUDED	BMPR2, EX2DEL	
600799	659	BMPR2	0024	PULMONARY HYPERTENSION, PRIMARY, 1	BMPR2, EX10DEL	
600799	659	BMPR2	0025	PULMONARY HYPERTENSION, PRIMARY, 1	BMPR2, EX1-13DEL	
600799	659	BMPR2	0026	PULMONARY HYPERTENSION, PRIMARY, 1, WITH HEREDITARY HEMORRHAGIC TELANGIECTASIA	BMPR2, GLN433TER	137852756
600799	659	BMPR2	0027	PULMONARY VENOOCCLUSIVE DISEASE	BMPR2, ASN202TYR	
600799	659	BMPR2	0028	PULMONARY VENOOCCLUSIVE DISEASE	BMPR2, GLU195TER	
600804	4544	MTNR1B	0001	DIABETES MELLITUS, TYPE 2, SUSCEPTIBILITY TO	MTNR1B, ALA42PRO	
600804	4544	MTNR1B	0002	DIABETES MELLITUS, TYPE 2, SUSCEPTIBILITY TO	MTNR1B, LEU60ARG	
600804	4544	MTNR1B	0003	DIABETES MELLITUS, TYPE 2, SUSCEPTIBILITY TO	MTNR1B, PRO95LEU	
600804	4544	MTNR1B	0004	DIABETES MELLITUS, TYPE 2, SUSCEPTIBILITY TO	MTNR1B, TYR308SER	
600805	3909	LAMA3	0001	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ TYPE	LAMA3, 1-BP DEL, 300G	
600805	3909	LAMA3	0002	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ TYPE	LAMA3, ARG650TER	137852757
600805	3909	LAMA3	0003	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE	LAMA3, GLN1368TER	137852758
600805	3909	LAMA3	0004	LARYNGOONYCHOCUTANEOUS SYNDROME	LAMA3, 1-BP INS, 151G	
600810	5332	PLCB4	0001	AURICULOCONDYLAR SYNDROME 2	PLCB4, TYR623CYS	
600810	5332	PLCB4	0002	AURICULOCONDYLAR SYNDROME 2	PLCB4, ASN329SER	
600810	5332	PLCB4	0003	AURICULOCONDYLAR SYNDROME 2	PLCB4, ARG621HIS	
600810	5332	PLCB4	0004	AURICULOCONDYLAR SYNDROME 2	PLCB4, ARG621CYS	
600810	5332	PLCB4	0005	AURICULOCONDYLAR SYNDROME 2	PLCB4, ASN650HIS	
600811	1643	DDB2	0001	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP E, DDB-NEGATIVE FORM	DDB2, LYS244GLU	121434639
600811	1643	DDB2	0002	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP E, DDB-NEGATIVE FORM	DDB2, ARG273HIS	121434640
600811	1643	DDB2	0003	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP E, DDB-NEGATIVE FORM	DDB2, ARG313TER	121434641
600811	1643	DDB2	0004	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP E, DDB-NEGATIVE FORM	DDB2, ASP307TYR	121434642
600814	4361	MRE11A	0001	ATAXIA-TELANGIECTASIA-LIKE DISORDER	MRE11A, ARG633TER	137852759
600814	4361	MRE11A	0002	ATAXIA-TELANGIECTASIA-LIKE DISORDER	MRE11A, ASN117SER	137852760
600814	4361	MRE11A	0003	ATAXIA-TELANGIECTASIA-LIKE DISORDER	MRE11A, ARG571TER	137852761
600814	4361	MRE11A	0004	ATAXIA-TELANGIECTASIA-LIKE DISORDER	MRE11A, THR481LYS	137852762
600814	4361	MRE11A	0005	ATAXIA-TELANGIECTASIA-LIKE DISORDER	MRE11A, TRP210CYS	137852763
600824	8048	CSRP3	0001	CARDIOMYOPATHY, DILATED, 1M	CSRP3, TRP4ARG	45550635
600824	8048	CSRP3	0002	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 12	CSRP3, CYS58GLY	104894204
600824	8048	CSRP3	0003	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 12	CSRP3, LEU44PRO	104894205
600824	8048	CSRP3	0004	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 12	CSRP3, SER54ARG AND GLU55GLY	
600824	8048	CSRP3	0005	CARDIOMYOPATHY, DILATED, 1M	CSRP3, LYS69ARG	137852764
600824	8048	CSRP3	0006	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 12	CSRP3, SER46ARG	137852765
600827	5146	PDE6C	0001	CONE DYSTROPHY 4	PDE6C, ARG29TRP	121918537
600827	5146	PDE6C	0002	ACHROMATOPISIA 5	PDE6C, TYR323ASN	121918538
600827	5146	PDE6C	0003	ACHROMATOPISIA 5	PDE6C, 2-BP DUP, 257AG	
600827	5146	PDE6C	0004	ACHROMATOPISIA 5	PDE6C, 5-BP DEL, 2367+1GTAAG	
600827	5146	PDE6C	0005	ACHROMATOPISIA 5	PDE6C, MET455VAL	121918539
600827	5146	PDE6C	0006	ACHROMATOPISIA 5	PDE6C, EXON 2, 633G-C	
600827	5146	PDE6C	0007	ACHROMATOPISIA 5	PDE6C, IVS1, -12T-A	
600827	5146	PDE6C	0008	ACHROMATOPISIA 5	PDE6C, IVS11, -2A-G	
600827	5146	PDE6C	0009	ACHROMATOPISIA 5	PDE6C, HIS602LEU	
600827	5146	PDE6C	0010	ACHROMATOPISIA 5	PDE6C, GLU790LYS	
600827	5146	PDE6C	0011	ACHROMATOPISIA 5	PDE6C, ARG276TER	
600827	5146	PDE6C	0012	ACHROMATOPISIA 5	PDE6C, TYR819TER	
600827	5146	PDE6C	0013	ACHROMATOPISIA 5	PDE6C, 1-BP INS, 1682A	
600829	3636	INPPL1	0001	OPSISMODYSPLASIA	INPPL1, PRO659LEU	
600829	3636	INPPL1	0002	OPSISMODYSPLASIA	INPPL1, SER182TER	
600829	3636	INPPL1	0003	OPSISMODYSPLASIA	INPPL1, 1-BP DEL, NT768	
600829	3636	INPPL1	0004	OPSISMODYSPLASIA	INPPL1, IVS21, G-A, +1	
600829	3636	INPPL1	0005	OPSISMODYSPLASIA	INPPL1, PRO659SER	
600829	3636	INPPL1	0006	OPSISMODYSPLASIA	INPPL1, 4-BP DEL, NT276	
600829	3636	INPPL1	0007	OPSISMODYSPLASIA	INPPL1, ARG401TRP	
600829	3636	INPPL1	0008	OPSISMODYSPLASIA	INPPL1, PHE722ILE	
600829	3636	INPPL1	0009	OPSISMODYSPLASIA	INPPL1, 27-BP DEL, NT94	
600835	6387	CXCL12	0001	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO	CXCL12, 801G-A, 3-PRIME UTR	
600837	2668	GDNF	0001	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 3 CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL, INCLUDED;; PHEOCHROMOCYTOMA, MODIFIER OF, INCLUDED	GDNF, ARG93TRP	36119840
600837	2668	GDNF	0002	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 3	GDNF, ASP150ASN	76466003
600837	2668	GDNF	0003	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 3	GDNF, THR154SER	104893891
600837	2668	GDNF	0004	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 3	GDNF, ILE211MET	121918536
600838	8456	FOXN1	0001	T-CELL IMMUNODEFICIENCY, CONGENITAL ALOPECIA, AND NAIL DYSTROPHY	FOXN1, ARG255TER	104894562
600839	6557	SLC12A1	0001	BARTTER SYNDROME, ANTENATAL, TYPE 1	SLC12A1, ASP648ASN	137853157
600839	6557	SLC12A1	0002	BARTTER SYNDROME, ANTENATAL, TYPE 1	SLC12A1, VAL272PHE	137853158
600839	6557	SLC12A1	0003	BARTTER SYNDROME, ANTENATAL, TYPE 1	SLC12A1, TRP625TER	137853159
600839	6557	SLC12A1	0004	BARTTER SYNDROME, ANTENATAL, TYPE 1	SLC12A1, IVS5DS, A-G, +4	
600839	6557	SLC12A1	0005	BARTTER SYNDROME, ANTENATAL, TYPE 1	SLC12A1, 1-BP DEL, 2095G	
600842	2646	GCKR	0001	FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 5	GCKR, PRO446LEU	1260326
600845	5023	P2RX1	0001	BLEEDING DISORDER DUE TO P2RX1 DEFECT, SOMATIC	P2RX1, 3-BP DEL, 1051CTG	
600855	1859	DYRK1A	0001	MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	DYRK1A, 52-KB DEL	
600855	1859	DYRK1A	0002	MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	DYRK1A, 2-BP DEL, AT	
600855	1859	DYRK1A	0003	MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	DYRK1A, 1098, G-A, +1	
600855	1859	DYRK1A	0004	MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	DYRK1A, 1-BP DEL, C	
600855	1859	DYRK1A	0005	MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	DYRK1A, 2-BP DEL, 290CT	
600856	1028	CDKN1C	0001	BECKWITH-WIEDEMANN SYNDROME	CDKN1C, GLU47TER	137852766
600856	1028	CDKN1C	0002	BECKWITH-WIEDEMANN SYNDROME	CDKN1C, 1-BP DEL/2-BP INS, 1086T-AG	
600856	1028	CDKN1C	0003	BECKWITH-WIEDEMANN SYNDROME	CDKN1C, 570CT-G	
600856	1028	CDKN1C	0004	BECKWITH-WIEDEMANN SYNDROME	CDKN1C, SER247TER	104894200
600856	1028	CDKN1C	0005	BECKWITH-WIEDEMANN SYNDROME	CDKN1C, SER282TER, 845C-G	
600856	1028	CDKN1C	0006	BECKWITH-WIEDEMANN SYNDROME	CDKN1C, SER282TER, 845C-A	
600856	1028	CDKN1C	0007	INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, AND GENITAL ANOMALIES	CDKN1C, PHE276VAL	
600856	1028	CDKN1C	0008	INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, AND GENITAL ANOMALIES	CDKN1C, PHE276SER	
600856	1028	CDKN1C	0009	INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, AND GENITAL ANOMALIES	CDKN1C, ARG279PRO	
600856	1028	CDKN1C	0010	INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, AND GENITAL ANOMALIES	CDKN1C, ASP274ASN	
600856	1028	CDKN1C	0011	INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, AND GENITAL ANOMALIES	CDKN1C, LYS278GLU	
600857	6389	SDHA	0001	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX II DEFICIENCY	SDHA, ARG554TRP	9809219
600857	6389	SDHA	0002	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX II DEFICIENCY	SDHA, ALA524VAL	137852767
600857	6389	SDHA	0003	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX II DEFICIENCY	SDHA, MET1LEU	1061517
600857	6389	SDHA	0004	MITOCHONDRIAL COMPLEX II DEFICIENCY LEIGH SYNDROME, INCLUDED;; CARDIOMYOPATHY, DILATED, 1GG, INCLUDED	SDHA, GLY555GLU	137852768
600857	6389	SDHA	0005	PARAGANGLIOMAS 5	SDHA, ARG589TRP	
600857	6389	SDHA	0006	MITOCHONDRIAL COMPLEX II DEFICIENCY	SDHA, THR508ILE	
600857	6389	SDHA	0007	MITOCHONDRIAL COMPLEX II DEFICIENCY	SDHA, SER509LEU	
600864	1453	CSNK1D	0001	ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2	CSNK1D, THR44ALA	104894561
600864	1453	CSNK1D	0002	ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2	CSNK1D, HIS46ARG	
600871	2672	GFI1	0001	NEUTROPENIA, SEVERE CONGENITAL, 2, AUTOSOMAL DOMINANT	GFI1, ASN382SER	28936381
600871	2672	GFI1	0002	NEUTROPENIA, NONIMMUNE CHRONIC IDIOPATHIC, OF ADULTS	GFI1, LYS403ARG	28936382
600887	4437	MSH3	0001	ENDOMETRIAL CANCER	MSH3, 1-BP DEL, NT1148	
600890	3030	HADHA	0001	LCHAD DEFICIENCY LCHAD DEFICIENCY WITH MATERNAL ACUTE FATTY LIVER OF PREGNANCY, INCLUDED	HADHA, GLU510GLN	137852769
600890	3030	HADHA	0002	LCHAD DEFICIENCY	HADHA, GLN342TER	137852770
600890	3030	HADHA	0003	TRIFUNCTIONAL PROTEIN DEFICIENCY	HADHA, IVS3, G-A, +1	
600890	3030	HADHA	0004	TRIFUNCTIONAL PROTEIN DEFICIENCY	HADHA, IVS3, A-G, +3	
600890	3030	HADHA	0005	TRIFUNCTIONAL PROTEIN DEFICIENCY	HADHA, ARG524TER	137852771
600890	3030	HADHA	0006	LCHAD DEFICIENCY	HADHA, 1-BP INS, 2129C	
600890	3030	HADHA	0007	LCHAD DEFICIENCY	HADHA, LEU342PRO	137852772
600890	3030	HADHA	0008	TRIFUNCTIONAL PROTEIN DEFICIENCY WITH MYOPATHY AND NEUROPATHY	HADHA, VAL246ASP	137852773
600890	3030	HADHA	0009	TRIFUNCTIONAL PROTEIN DEFICIENCY WITH MYOPATHY AND NEUROPATHY	HADHA, ILE269ASN	137852774
600890	3030	HADHA	0010	TRIFUNCTIONAL PROTEIN DEFICIENCY WITH MYOPATHY AND NEUROPATHY	HADHA, ARG255TER	137852775
600897	2703	GJA8	0001	CATARACT 1, ZONULAR PULVERULENT	GJA8, PRO88SER	80358200
600897	2703	GJA8	0002	CATARACT 1, ZONULAR PULVERULENT	GJA8, GLU48LYS	80358201
600897	2703	GJA8	0003	CATARACT 1, ZONULAR PULVERULENT	GJA8, ILE247MET	80358202
600897	2703	GJA8	0004	CATARACT 1, NUCLEAR PROGRESSIVE	GJA8, ARG23THR	80358203
600897	2703	GJA8	0005	CATARACT 1 WITH MICROCORNEA	GJA8, VAL44GLU	80358204
600897	2703	GJA8	0006	CATARACT 1 WITH MICROCORNEA	GJA8, ARG198GLN	80358205
600897	2703	GJA8	0007	CATARACT 1, MULTIPLE TYPES	GJA8, ASP47ASN	121434643
600900	6443	SGCB	0001	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2E	SGCB, THR151ARG	28936383
600900	6443	SGCB	0002	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2E	SGCB, TYR184TER	104893868
600900	6443	SGCB	0003	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2E	SGCB, 8-BP DUP, NT383	
600900	6443	SGCB	0004	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2E	SGCB, 2-BP DEL, NT465	
600900	6443	SGCB	0005	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2E	SGCB, ARG91PRO	104893869
600900	6443	SGCB	0006	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2E	SGCB, LEU108ARG	104893870
600900	6443	SGCB	0007	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2E	SGCB, MET100LYS	104893871
600900	6443	SGCB	0008	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2E	SGCB, ARG91LEU	104893869
600900	6443	SGCB	0009	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2E	SGCB, 4-BP DEL, 243+3GAGT	
600917	5506	PPP1R3A	0001	INSULIN RESISTANCE, SUSCEPTIBILITY TO	PPP1R3, ASP905TYR	1799999
600917	5506	PPP1R3A	0002	GLYCEMIA VARIATION	PPP1R3, 5-BP INS/DEL, 3-PRIME UTR	
600917	5506	PPP1R3A	0003	INSULIN RESISTANCE, SEVERE, DIGENIC DIABETES MELLITUS, TYPE II, DIGENIC	PPP1R3A, 2-BP DEL, 1985AG	
600921	2254	FGF9	0001	MULTIPLE SYNOSTOSES SYNDROME 3	FGF9, SER99ASN	121918322
600922	4638	MYLK	0001	AORTIC ANEURYSM, FAMILIAL THORACIC 7	MYLK, SER1759PRO	
600922	4638	MYLK	0002	AORTIC ANEURYSM, FAMILIAL THORACIC 7	MYLK, ARG1480TER	
600923	5498	PPOX	0001	VARIEGATE PORPHYRIA	PPOX, 1-BP INS, 1022G	
600923	5498	PPOX	0002	VARIEGATE PORPHYRIA	PPOX, GLY232ARG	121918323
600923	5498	PPOX	0003	VARIEGATE PORPHYRIA	PPOX, ARG59TRP	121918324
600923	5498	PPOX	0004	VARIEGATE PORPHYRIA	PPOX, ARG168CYS	121918325
600923	5498	PPOX	0005	VARIEGATE PORPHYRIA	PPOX, HIS20PRO	121918326
600923	5498	PPOX	0006	VARIEGATE PORPHYRIA	PPOX, ARG168HIS	41270025
600923	5498	PPOX	0007	VARIEGATE PORPHYRIA, HOMOZYGOUS	PPOX, ASP349ALA	
600923	5498	PPOX	0008	VARIEGATE PORPHYRIA	PPOX, 2-BP DEL, 537AT	
600923	5498	PPOX	0009	VARIEGATE PORPHYRIA	PPOX, 5-BP DEL, NT1239	
600923	5498	PPOX	0010	VARIEGATE PORPHYRIA, HOMOZYGOUS	PPOX, 12-BP INS, NT657	
600923	5498	PPOX	0011	VARIEGATE PORPHYRIA, HOMOZYGOUS	PPOX, IVS 11-1 GA	
600923	5498	PPOX	0012	VARIEGATE PORPHYRIA, HOMOZYGOUS	PPOX, ILE12THR	28936677
600923	5498	PPOX	0013	VARIEGATE PORPHYRIA, HOMOZYGOUS	PPOX, PRO256ARG	12735723
600924	2671	GFER	0001	MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT, HEARING LOSS, AND DEVELOPMENTAL DELAY	GFER, ARG194HIS	121908192
600925	5795	PTPRJ	0001	COLON CANCER, SOMATIC	PTPRJ, ARG214CYS	121434507
600925	5795	PTPRJ	0002	COLON CANCER, SOMATIC	PTPRJ, GLN276PRO	1566734
600929	1414	CRYBB1	0001	CATARACT 17, PULVERULENT	CRYBB1, GLY220TER	74315488
600929	1414	CRYBB1	0002	CATARACT 17, CONGENITAL NUCLEAR, AUTOSOMAL RECESSIVE	CRYBB1, 1-BP DEL, 168G	
600937	3767	KCNJ11	0001	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2	KCNJ11, LEU147PRO	28936678
600937	3767	KCNJ11	0002	DIABETES MELLITUS, PERMANENT NEONATAL DIABETES MELLITUS, PERMANENT NEONATAL, WITH NEUROLOGIC FEATURES, INCLUDED;; DIABETES MELLITUS, TRANSIENT NEONATAL, 3, INCLUDED	KCNJ11, ARG201HIS	80356624
600937	3767	KCNJ11	0003	DIABETES MELLITUS, PERMANENT NEONATAL, WITH NEUROLOGIC FEATURES DIABETES MELLITUS, PERMANENT NEONATAL, INCLUDED	KCNJ11, VAL59MET	80356616
600937	3767	KCNJ11	0004	DIABETES MELLITUS, PERMANENT NEONATAL DIABETES MELLITUS, PERMANENT NEONATAL, WITH NEUROLOGIC FEATURES, INCLUDED	KCNJ11, ARG201CYS	80356625
600937	3767	KCNJ11	0005	DIABETES MELLITUS, PERMANENT NEONATAL, WITH NEUROLOGIC FEATURES	KCNJ11, VAL59GLY	80356617
600937	3767	KCNJ11	0006	DIABETES MELLITUS, PERMANENT NEONATAL	KCNJ11, ARG50PRO	80356611
600937	3767	KCNJ11	0007	DIABETES MELLITUS, PERMANENT NEONATAL	KCNJ11, LYS170ARG	80356621
600937	3767	KCNJ11	0008	DIABETES MELLITUS, PERMANENT NEONATAL	KCNJ11, LYS170ASN	80356622
600937	3767	KCNJ11	0009	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2	KCNJ11, TYR12TER	104894236
600937	3767	KCNJ11	0010	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2	KCNJ11, 88G-T, PROMOTER REGION	
600937	3767	KCNJ11	0011	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2	KCNJ11, PRO254LEU	104894237
600937	3767	KCNJ11	0012	DIABETES MELLITUS, TRANSIENT NEONATAL, 3 DIABETES MELLITUS, TYPE II, AUTOSOMAL DOMINANT, INCLUDED	KCNJ11, CYS42ARG	80356610
600937	3767	KCNJ11	0013	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2	KCNJ11, HIS259ARG	104894248
600937	3767	KCNJ11	0014	DIABETES MELLITUS, NONINSULIN-DEPENDENT, SUSCEPTIBILITY TO EXERCISE STRESS RESPONSE, IMPAIRED, ASSOCIATION WITH, INCLUDED	KCNJ11, GLU23LYS	5219
600937	3767	KCNJ11	0015	DIABETES MELLITUS, PERMANENT NEONATAL, WITH NEUROLOGIC FEATURES	KCNJ11, CYS166PHE	80356618
600937	3767	KCNJ11	0016	DIABETES MELLITUS, PERMANENT NEONATAL, WITH NEUROLOGIC FEATURES	KCNJ11, ILE167LEU	80356620
600937	3767	KCNJ11	0017	DIABETES MELLITUS, TRANSIENT NEONATAL, 3	KCNJ11, GLY53SER	80356613
600937	3767	KCNJ11	0018	DIABETES MELLITUS, TRANSIENT NEONATAL, 3	KCNJ11, GLY53ARG	80356613
600937	3767	KCNJ11	0019	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2	KCNJ11, ARG301HIS	74339576
600937	3767	KCNJ11	0020	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2	KCNJ11, GLY156ARG	
600937	3767	KCNJ11	0021	DIABETES MELLITUS, PERMANENT NEONATAL, WITH NEUROLOGIC FEATURES	KCNJ11, GLY53ASP	80356615
600937	3767	KCNJ11	0022	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2	KCNJ11, GLU282LYS	
600937	3767	KCNJ11	0023	DIABETES MELLITUS, PERMANENT NEONATAL, WITH NEUROLOGIC FEATURES	KCNJ11, PHE60TYR	
600939	3590	IL11RA	0001	CRANIOSYNOSTOSIS AND DENTAL ANOMALIES	IL11RA, ARG296TRP	
600939	3590	IL11RA	0002	CRANIOSYNOSTOSIS AND DENTAL ANOMALIES	IL11RA, PRO221ARG	
600939	3590	IL11RA	0003	CRANIOSYNOSTOSIS AND DENTAL ANOMALIES	IL11RA, SER245CYS	
600939	3590	IL11RA	0004	CRANIOSYNOSTOSIS AND DENTAL ANOMALIES	IL11RA, GLN159TER	
600939	3590	IL11RA	0005	CRANIOSYNOSTOSIS AND DENTAL ANOMALIES	IL11RA, 9-BP DUP, NT916	
600943	871	SERPINH1	0001	PRETERM PREMATURE RUPTURE OF THE MEMBRANES	SERPINH1, -656C-T	
600943	871	SERPINH1	0002	OSTEOGENESIS IMPERFECTA, TYPE X	SERPINH1, LEU78PRO	
600946	2690	GHR	0001	LARON SYNDROME	GHR, EX4,6DEL	
600946	2690	GHR	0002	LARON SYNDROME	GHR, PHE96SER	121909357
600946	2690	GHR	0003	LARON SYNDROME	GHR, ARG43TER	121909358
600946	2690	GHR	0004	LARON SYNDROME	GHR, CYS38TER	121909359
600946	2690	GHR	0005	LARON SYNDROME	GHR, GAA180GAG	121909360
600946	2690	GHR	0006	SHORT STATURE, IDIOPATHIC, AUTOSOMAL	GHR, GLU44LYS	121909361
600946	2690	GHR	0007	SHORT STATURE, IDIOPATHIC, AUTOSOMAL	GHR, ARG161CYS	121909362
600946	2690	GHR	0008	SHORT STATURE, IDIOPATHIC, AUTOSOMAL	GHR, GLU224ASP	45588036
600946	2690	GHR	0009	LARON SYNDROME	GHR, ARG217TER	121909363
600946	2690	GHR	0010	LARON SYNDROME	GHR, IVS4DS, G-A, +1	
600946	2690	GHR	0011	LARON SYNDROME	GHR, 2-BP DEL, FS51TER	
600946	2690	GHR	0012	LARON SYNDROME	GHR, IVS6AS, G-T, -1	
600946	2690	GHR	0013	LARON SYNDROME	GHR, 2-BP DEL, FS234TER	
600946	2690	GHR	0014	LARON SYNDROME WITH ELEVATED SERUM GH-BINDING PROTEIN	GHR, IVS8DS, G-C, -1, EX8DEL	
600946	2690	GHR	0015	SHORT STATURE, IDIOPATHIC, AUTOSOMAL	GHR, IVS8AS, G-C, -1	
600946	2690	GHR	0016	LARON SYNDROME WITH UNDETECTABLE SERUM GH-BINDING PROTEIN	GHR, GLU224TER	121909364
600946	2690	GHR	0017	LARON SYNDROME WITH UNDETECTABLE SERUM GH-BINDING PROTEIN	GHR, 1-BP DEL, FS330TER	
600946	2690	GHR	0018	LARON SYNDROME WITH ELEVATED SERUM GH-BINDING PROTEIN	GHR, IVS9DS, G-A, +1	
600946	2690	GHR	0019	LARON SYNDROME WITH UNDETECTABLE SERUM GH-BINDING PROTEIN	GHR, PRO131GLN	121909365
600946	2690	GHR	0020	SHORT STATURE, IDIOPATHIC, AUTOSOMAL	GHR, VAL144ILE	6413484
600946	2690	GHR	0021	LARON SYNDROME	GHR, ASP152HIS	121909366
600946	2690	GHR	0022	LARON SYNDROME	GHR, ILE153THR	121909367
600946	2690	GHR	0023	LARON SYNDROME	GHR, GLN154PRO	121909368
600946	2690	GHR	0024	LARON SYNDROME	GHR, VAL155GLY	121909369
600946	2690	GHR	0025	LARON SYNDROME	GHR, PSEUDOEXON(-1)A-G	
600946	2690	GHR	0026	LARON SYNDROME	GHR, 22-BP DEL	
600946	2690	GHR	0027	LARON SYNDROME	GHR, TRP16TER	121909370
600946	2690	GHR	0028	HYPERCHOLESTEROLEMIA, FAMILIAL, MODIFICATION OF	GHR, LEU526ILE	6180
600946	2690	GHR	0029	LARON SYNDROME	GHR, CYS83TER	121909371
600946	2690	GHR	0030	LARON SYNDROME	GHR, 1-BP DEL, 1776G	
600946	2690	GHR	0031	INCREASED RESPONSIVENESS TO GROWTH HORMONE	GHR, EX3DEL	
600946	2690	GHR	0032	LARON SYNDROME	GHR, CYS94SER	121909372
600946	2690	GHR	0033	LARON SYNDROME	GHR, HIS150GLN	121909373
600950	15	AANAT	0001	DELAYED SLEEP PHASE SYNDROME, SUSCEPTIBILITY TO	AANAT, ALA129THR	28936679
600956	269	AMHR2	0001	PERSISTENT MULLERIAN DUCT SYNDROME, TYPE II	AMHR2, IVS2DS, G-T, +1	
600956	269	AMHR2	0002	PERSISTENT MULLERIAN DUCT SYNDROME, TYPE II	AMHR2, 27-BP DEL, NT6331	
600956	269	AMHR2	0003	PERSISTENT MULLERIAN DUCT SYNDROME, TYPE II	AMHR2, 1-BP DEL, 1692A	
600956	269	AMHR2	0004	PERSISTENT MULLERIAN DUCT SYNDROME, TYPE II	AMHR2, ARG406GLN	137853104
600957	268	AMH	0001	PERSISTENT MULLERIAN DUCT SYNDROME, TYPE I ANTI-MULLERIAN HORMONE BRUXELLES	AMH, GLU358TER	
600957	268	AMH	0002	PERSISTENT MULLERIAN DUCT SYNDROME, TYPE I	AMH, 14-BP DEL, EX2	
600957	268	AMH	0003	PERSISTENT MULLERIAN DUCT SYNDROME, TYPE I	AMH, ARG191TER	104894666
600957	268	AMH	0004	PERSISTENT MULLERIAN DUCT SYNDROME, TYPE I	AMH, EXON 5, 23-BP DUP	
600958	4607	MYBPC3	0001	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4	MYBPC3, IVS, G-C, +5	
600958	4607	MYBPC3	0002	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4	MYBPC3, 18-BP DUP	
600958	4607	MYBPC3	0003	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4	MYBPC3, IVS, A-G	
600958	4607	MYBPC3	0004	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4	MYBPC3, IVS, G-A, +1	
600958	4607	MYBPC3	0005	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4	MYBPC3, IVS7, G-A, +5	
600958	4607	MYBPC3	0006	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4	MYBPC3, GLU542GLN	121909374
600958	4607	MYBPC3	0007	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4	MYBPC3, IVS23, G-A, +1	
600958	4607	MYBPC3	0008	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4	MYBPC3, BRANCH POINT, IVS23, A-G, TGAT-TGGT	
600958	4607	MYBPC3	0009	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4	MYBPC3, 5-BP DEL, EX25	
600958	4607	MYBPC3	0010	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4	MYBPC3, 12-BP DUP/4-BP DEL, EX33	
600958	4607	MYBPC3	0011	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4	MYBPC3, 1-BP INS, 2405G	
600958	4607	MYBPC3	0012	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4	MYBPC3, THR59ALA	121909375
600958	4607	MYBPC3	0013	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	MYBPC3, ASN948THR	121909376
600958	4607	MYBPC3	0014	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4	MYBPC3, GLU1096TER	121909377
600958	4607	MYBPC3	0015	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4	MYBPC3, ARG820GLN	2856655
600958	4607	MYBPC3	0016	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4	MYBPC3, IVS13AS, G-A, -19	
600958	4607	MYBPC3	0017	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4	MYBPC3, IVS9, G-C, -1	
600958	4607	MYBPC3	0018	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4	MYBPC3, VAL1125MET	121909378
600958	4607	MYBPC3	0019	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4, SUSCEPTIBILITY TO	MYBPC3, IVS32, 25-BP DEL	
600958	4607	MYBPC3	0020	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4	MYBPC3, IVS30DS, T-G, +2	
600958	4607	MYBPC3	0021	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4	MYBPC3, ARG745GLY	
600958	4607	MYBPC3	0022	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4	MYBPC3, PRO873HIS	
600958	4607	MYBPC3	0023	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4	MYBPC3, ARG943TER	
600963	147912	SIX5	0001	BRANCHIOOTORENAL SYNDROME 2	SIX5, ALA158THR	80356461
600963	147912	SIX5	0002	BRANCHIOOTORENAL SYNDROME 2	SIX5, ALA296THR	80356462
600963	147912	SIX5	0003	BRANCHIOOTORENAL SYNDROME 2	SIX5, GLY365ARG	80356463
600963	147912	SIX5	0004	BRANCHIOOTORENAL SYNDROME 2	SIX5, THR552MET	80356464
600968	6559	SLC12A3	0001	GITELMAN SYNDROME	SLC12A3, LEU850PRO	121909379
600968	6559	SLC12A3	0002	GITELMAN SYNDROME	SLC12A3, CYS421ARG	28936387
600968	6559	SLC12A3	0003	GITELMAN SYNDROME	SLC12A3, ARG209TRP	28936388
600968	6559	SLC12A3	0004	GITELMAN SYNDROME	SLC12A3, IVS15AS, G-T, -1	
600968	6559	SLC12A3	0005	GITELMAN SYNDROME	SLC12A3, ARG655HIS	121909380
600968	6559	SLC12A3	0006	GITELMAN SYNDROME	SLC12A3, ARG653LEU	
600968	6559	SLC12A3	0007	GITELMAN SYNDROME	SLC12A3, IVS23DS, G-T, +1	
600968	6559	SLC12A3	0008	GITELMAN SYNDROME	SLC12A3, ALA588VAL	121909382
600968	6559	SLC12A3	0009	GITELMAN SYNDROME	SLC12A3, PRO349LEU	121909383
600968	6559	SLC12A3	0010	GITELMAN SYNDROME	SLC12A3, 3-BP DEL	
600968	6559	SLC12A3	0011	GITELMAN SYNDROME	SLC12A3, GLY630VAL	121909384
600968	6559	SLC12A3	0012	GITELMAN SYNDROME	SLC12A3, LEU623PRO	121909385
600968	6559	SLC12A3	0013	GITELMAN SYNDROME	SLC12A3, THR163MET AND ARG871HIS	
600968	6559	SLC12A3	0014	GITELMAN SYNDROME	SLC12A3, 2-BP DEL, 2881AG	
600970	4646	MYO6	0001	DEAFNESS, AUTOSOMAL DOMINANT 22	MYO6, CYS442TYR	121912557
600970	4646	MYO6	0002	DEAFNESS, AUTOSOMAL RECESSIVE 37	MYO6, 1-BP INS, 36T	
600970	4646	MYO6	0003	DEAFNESS, AUTOSOMAL RECESSIVE 37	MYO6, ARG1166TER	121912558
600970	4646	MYO6	0004	DEAFNESS, AUTOSOMAL RECESSIVE 37	MYO6, GLU216VAL	121912559
600970	4646	MYO6	0005	DEAFNESS, SENSORINEURAL, WITH HYPERTROPHIC CARDIOMYOPATHY	MYO6, HIS246ARG	121912560
600970	4646	MYO6	0006	DEAFNESS, AUTOSOMAL DOMINANT 22	MYO6, ARG849TER	121912561
600970	4646	MYO6	0007	DEAFNESS, AUTOSOMAL DOMINANT 22	MYO6, IVS23, T-G, +2321	
600980	1758	DMP1	0001	HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 1	DMP1, 1-BP DEL, 362C	
600980	1758	DMP1	0002	HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 1	DMP1, IVS2, G-C, -1	
600980	1758	DMP1	0003	HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 1	DMP1, MET1VAL	104893834
600980	1758	DMP1	0004	HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 1	DMP1, 7-BP DEL, NT1484	
600982	4214	MAP3K1	0001	46,XY SEX REVERSAL 6	MAP3K1, IVS2AS, T-A, -8	
600982	4214	MAP3K1	0002	46,XY SEX REVERSAL 6	MAP3K1, GLY616ARG	
600982	4214	MAP3K1	0003	46,XY SEX REVERSAL 6	MAP3K1, LEU189PRO	
600982	4214	MAP3K1	0004	46,XY SEX REVERSAL 6	MAP3K1, LEU189ARG	
600983	4306	NR3C2	0001	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT	NR3C2, 1-BP DEL, 1226G	
600983	4306	NR3C2	0002	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT	NR3C2, 1-BP DEL, 1597T	
600983	4306	NR3C2	0003	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT	NR3C2, ARG537TER	121912562
600983	4306	NR3C2	0004	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT	NR3C2, IVS5, 1-BP DEL, A, +3	
600983	4306	NR3C2	0005	HYPERTENSION, EARLY-ONSET, AUTOSOMAL DOMINANT, WITH EXACERBATION IN PREGNANCY	NR3C2, SER810LEU	41511344
600983	4306	NR3C2	0006	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT	NR3C2, 1-BP INS, 2871C	
600983	4306	NR3C2	0007	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT	NR3C2, LEU924PRO	121912563
600983	4306	NR3C2	0008	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT	NR3C2, 1-BP INS, 1354T	
600983	4306	NR3C2	0009	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT	NR3C2, 8-BP DEL, NT537	
600983	4306	NR3C2	0010	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT	NR3C2, CYS645TER	121912564
600983	4306	NR3C2	0011	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT	NR3C2, GLN776ARG	121912565
600983	4306	NR3C2	0012	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT	NR3C2, GLY633ARG	121912566
600983	4306	NR3C2	0013	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT	NR3C2, LEU979PRO	121912567
600983	4306	NR3C2	0014	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT	NR3C2, SER163TER	121912568
600983	4306	NR3C2	0015	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT	NR3C2, ARG947TER	121912569
600983	4306	NR3C2	0016	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT	NR3C1, CYS436TER	121912570
600983	4306	NR3C2	0017	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT	NR3C1, ARG673TER	121912571
600983	4306	NR3C2	0018	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT	NR3C1, SER675TER	121912572
600983	4306	NR3C2	0019	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT	NR3C1, SER181LEU	121912573
600983	4306	NR3C2	0020	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT	NR3C1, GLU972GLY	121912574
600985	7148	TNXB	0001	EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY EHLERS-DANLOS SYNDROME, HYPERMOBILITY TYPE, INCLUDED	TNXB, 30-KB DEL	
600985	7148	TNXB	0002	EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY EHLERS-DANLOS SYNDROME, HYPERMOBILITY TYPE, INCLUDED	TNXB, 2-BP DEL, 56063AA	
600985	7148	TNXB	0003	EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY	TNXB, 2-BP INS, 44906GT	
600985	7148	TNXB	0004	EHLERS-DANLOS SYNDROME, HYPERMOBILITY TYPE	TNXB, VAL1195MET	121912575
600993	4089	SMAD4	0001	PANCREATIC CARCINOMA, SOMATIC	SMAD4, GLY358TER	121912576
600993	4089	SMAD4	0002	PANCREATIC CARCINOMA, SOMATIC	SMAD4, TYR412TER	121912577
600993	4089	SMAD4	0003	PANCREATIC CARCINOMA, SOMATIC	SMAD4, ASP493HIS	121912578
600993	4089	SMAD4	0004	PANCREATIC CARCINOMA, SOMATIC	SMAD4, ARG515TER	121912579
600993	4089	SMAD4	0005	JUVENILE POLYPOSIS SYNDROME	SMAD4, 4-BP DEL, NT1372	
600993	4089	SMAD4	0006	JUVENILE POLYPOSIS SYNDROME	SMAD4, 2-BP DEL	
600993	4089	SMAD4	0007	JUVENILE POLYPOSIS SYNDROME JUVENILE POLYPOSIS OF STOMACH, INCLUDED;; JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME, INCLUDED	SMAD4, 1-BP INS	
600993	4089	SMAD4	0008	JUVENILE POLYPOSIS SYNDROME JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME, INCLUDED	SMAD4, ARG361CYS	80338963
600993	4089	SMAD4	0009	JUVENILE POLYPOSIS SYNDROME	SMAD4, 2-BP DEL, 959AC	
600993	4089	SMAD4	0010	JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME	SMAD4, GLY386ASP	121912580
600993	4089	SMAD4	0011	JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME	SMAD4, GLY352ARG	121912581
600993	4089	SMAD4	0012	JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME	SMAD4, 14-BP DEL, NT1612	
600993	4089	SMAD4	0013	JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME	SMAD4, 2-BP DEL/1-BP INS, 1596CC/T	
600993	4089	SMAD4	0014	JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME	SMAD4, ARG445TER	
600993	4089	SMAD4	0015	MYHRE SYNDROME	SMAD4, ILE500THR	
600993	4089	SMAD4	0016	MYHRE SYNDROME	SMAD4, ILE500VAL	
600993	4089	SMAD4	0017	MYHRE SYNDROME	SMAD4, ILE500MET	
600997	2048	EPHB2	0001	PROSTATE CANCER, PROGRESSION AND METASTASIS OF	EPHB2, GLN723TER	121912582
600997	2048	EPHB2	0002	PROSTATE CANCER, PROGRESSION AND METASTASIS OF	EPHB2, ALA279SER	35882952
600997	2048	EPHB2	0003	PROSTATE CANCER, PROGRESSION AND METASTASIS OF	EPHB2, ASP679ASN	28936395
600997	2048	EPHB2	0004	PROSTATE CANCER, SUSCEPTIBILITY TO, IN AFRICAN AMERICANS	EPHB2, LYS1019TER	76826147
600998	2776	GNAQ	0001	STURGE-WEBER SYNDROME, SOMATIC, MOSAIC CAPILLARY MALFORMATIONS, CONGENITAL, 1, SOMATIC, MOSAIC, INCLUDED	GNAQ, ARG183GLN	
601002	2937	GSS	0001	GLUTATHIONE SYNTHETASE DEFICIENCY	GSS, ARG164GLN	121909307
601002	2937	GSS	0002	GLUTATHIONE SYNTHETASE DEFICIENCY	GSS, 1-BP DEL, NT3/4G	
601002	2937	GSS	0003	GLUTATHIONE SYNTHETASE DEFICIENCY	GSS, ARG267TRP	121909308
601002	2937	GSS	0004	GLUTATHIONE SYNTHETASE DEFICIENCY	GSS, ARG283CYS	121909309
601002	2937	GSS	0005	GLUTATHIONE SYNTHETASE DEFICIENCY	GSS, ARG125CYS	28936396
601002	2937	GSS	0006	GLUTATHIONE SYNTHETASE DEFICIENCY	GSS, PRO314LEU AND 6-BP DEL, NT1137	75863437
601002	2937	GSS	0007	GLUTATHIONE SYNTHETASE DEFICIENCY OF ERYTHROCYTES, HEMOLYTIC ANEMIA DUE TO	GSS, ASP219GLY	28938472
601007	3953	LEPR	0001	LEPTIN RECEPTOR POLYMORPHISM	LEPR, GLN223ARG	
601007	3953	LEPR	0002	LEPTIN RECEPTOR DEFICIENCY	LEPR, IVS16, G-A, +1	
601007	3953	LEPR	0004	LEPTIN RECEPTOR POLYMORPHISM	LEPR, LYS109ARG	1137100
601007	3953	LEPR	0005	LEPTIN RECEPTOR POLYMORPHISM	LEPR, LYS656ASN	
601011	773	CACNA1A	0001	MIGRAINE, FAMILIAL HEMIPLEGIC, 1	CACNA1A, ARG192GLN	121908211
601011	773	CACNA1A	0002	MIGRAINE, FAMILIAL HEMIPLEGIC, 1 MIGRAINE, FAMILIAL HEMIPLEGIC 1, WITH PROGRESSIVE CEREBELLAR ATAXIA, INCLUDED;; MIGRAINE, SPORADIC HEMIPLEGIC, WITH PROGRESSIVE CEREBELLAR ATAXIA, INCLUDED	CACNA1A, THR666MET	121908212
601011	773	CACNA1A	0003	MIGRAINE, FAMILIAL HEMIPLEGIC, 1	CACNA1A, VAL714ALA	121908213
601011	773	CACNA1A	0004	MIGRAINE, FAMILIAL HEMIPLEGIC, 1	CACNA1A, ILE1811LEU	121908214
601011	773	CACNA1A	0005	EPISODIC ATAXIA, TYPE 2	CACNA1A, 1-BP DEL, 4073C	
601011	773	CACNA1A	0006	EPISODIC ATAXIA, TYPE 2	CACNA1A, IVS24DS, G-A, +1	
601011	773	CACNA1A	0007	SPINOCEREBELLAR ATAXIA 6	CACNA1A, (CAG)n EXPANSION	193922932
601011	773	CACNA1A	0008	EPISODIC ATAXIA, TYPE 2	CACNA1A, (CAG)n EXPANSION	
601011	773	CACNA1A	0009	SPINOCEREBELLAR ATAXIA 6 EPISODIC ATAXIA, TYPE 2, INCLUDED	CACNA1A, GLY293ARG	121908215
601011	773	CACNA1A	0010	MIGRAINE, FAMILIAL HEMIPLEGIC 1, WITH PROGRESSIVE CEREBELLAR ATAXIA MIGRAINE, FAMILIAL HEMIPLEGIC, 1, INCLUDED	CACNA1A, ASP715GLU	
601011	773	CACNA1A	0011	EPISODIC ATAXIA, TYPE 2	CACNA1A, ARG1666HIS	121908216
601011	773	CACNA1A	0012	EPISODIC ATAXIA, TYPE 2	CACNA1A, PHE1491SER	121908233
601011	773	CACNA1A	0013	MIGRAINE, FAMILIAL HEMIPLEGIC, 1	CACNA1A, TYR1385CYS	121908219
601011	773	CACNA1A	0014	EPISODIC ATAXIA, TYPE 2	CACNA1A, GLU1757LYS	121908226
601011	773	CACNA1A	0015	EPISODIC ATAXIA, TYPE 2	CACNA1A, 1-BP INS, 3091G	
601011	773	CACNA1A	0016	EPISODIC ATAXIA, TYPE 2	CACNA1A, 1-BP DEL, 5123G	
601011	773	CACNA1A	0017	MIGRAINE, FAMILIAL HEMIPLEGIC 1, WITH PROGRESSIVE CEREBELLAR ATAXIA	CACNA1A, SER218LEU	121908225
601011	773	CACNA1A	0018	MIGRAINE, FAMILIAL HEMIPLEGIC, 1 MIGRAINE, FAMILIAL HEMIPLEGIC 1, WITH PROGRESSIVE CEREBELLAR ATAXIA, INCLUDED;; MIGRAINE, SPORADIC HEMIPLEGIC, INCLUDED;; SPINOCEREBELLAR ATAXIA 6, INCLUDED	CACNA1A, ARG583GLN	121908217
601011	773	CACNA1A	0019	MIGRAINE, FAMILIAL HEMIPLEGIC, 1	CACNA1A, VAL1457LEU	121908237
601011	773	CACNA1A	0020	EPISODIC ATAXIA, TYPE 2	CACNA1A, ARG1281TER	121909323
601011	773	CACNA1A	0021	EPISODIC ATAXIA, TYPE 2	CACNA1A, ARG1549TER	121909324
601011	773	CACNA1A	0022	EPISODIC ATAXIA, TYPE 2	CACNA1A, PHE1406CYS	121908227
601011	773	CACNA1A	0023	EPISODIC ATAXIA, TYPE 2, AND EPILEPSY	CACNA1A, ARG1820TER	
601011	773	CACNA1A	0024	MIGRAINE, FAMILIAL HEMIPLEGIC, 1 SPINOCEREBELLAR ATAXIA 6, INCLUDED	CACNA1A, ILE1710THR	121909326
601011	773	CACNA1A	0025	EPISODIC ATAXIA, TYPE 2	CACNA1A, CYS287TYR	121908236
601011	773	CACNA1A	0026	EPISODIC ATAXIA, TYPE 2	CACNA1A, 39.5-KB DEL	
601011	773	CACNA1A	0027	MIGRAINE, FAMILIAL HEMIPLEGIC, 1	CACNA1A, ARG1347GLN	121908230
601011	773	CACNA1A	0028	EPISODIC ATAXIA, TYPE 2	CACNA1A, 146.1-KB DEL	
601011	773	CACNA1A	0029	EPISODIC ATAXIA, TYPE 2	CACNA1A, 35.7-KB DEL	
601011	773	CACNA1A	0030	EPISODIC ATAXIA, TYPE 2	CACNA1A, 35.7-KB DUP	
601011	773	CACNA1A	0031	EPISODIC ATAXIA, TYPE 2	CACNA1A, 7.4-KB DEL	
601011	773	CACNA1A	0032	EPISODIC ATAXIA, TYPE 2	CACNA1A, 86.1-KB DEL	
601011	773	CACNA1A	0033	EPISODIC ATAXIA, TYPE 2	CACNA1A, 18.2-Kb DEL	
601011	773	CACNA1A	0034	MIGRAINE, FAMILIAL HEMIPLEGIC, 1	CACNA1A, 18.2-Kb DEL	
601015	10577	NPC2	0001	NIEMANN-PICK DISEASE, TYPE C2	NPC2, GLU20TER	80358260
601015	10577	NPC2	0002	NIEMANN-PICK DISEASE, TYPE C2	NPC2, 1-BP DEL, 111A	
601015	10577	NPC2	0003	NIEMANN-PICK DISEASE, TYPE C2	NPC2, IVS2, G-A, +5	80358268
601015	10577	NPC2	0004	NIEMANN-PICK DISEASE, TYPE C2	NPC2, GLU118TER	80358266
601015	10577	NPC2	0005	NIEMANN-PICK DISEASE, TYPE C2	NPC2, 1-BP DEL, 27G	
601015	10577	NPC2	0006	NIEMANN-PICK DISEASE, TYPE C2	NPC2, SER67PRO	11694
601015	10577	NPC2	0007	NIEMANN-PICK DISEASE, TYPE C2	NPC2, VAL39MET	80358261
601015	10577	NPC2	0008	NIEMANN-PICK DISEASE, TYPE C2	NPC2, IVS1DS, T-C, +2	
601015	10577	NPC2	0009	NIEMANN-PICK DISEASE, TYPE C2	NPC2, GLN146TER	104894457
601015	10577	NPC2	0010	NIEMANN-PICK DISEASE, TYPE C2	NPC2, PRO120SER	104894458
601017	6640	SNTA1	0001	LONG QT SYNDROME 12	SNTA1, ALA390VAL	121434500
601022	4795	NFKBIL1	0001	RHEUMATOID ARTHRITIS, SUSCEPTIBILITY TO	NFKBIL1, -62T-A	
601023	7415	VCP	0001	INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE AND FRONTOTEMPORAL DEMENTIA AMYOTROPHIC LATERAL SCLEROSIS 14 WITHOUT FRONTOTEMPORAL DEMENTIA, INCLUDED	VCP, ARG155HIS	121909329
601023	7415	VCP	0002	INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE AND FRONTOTEMPORAL DEMENTIA	VCP, ARG155CYS	121909330
601023	7415	VCP	0003	INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE AND FRONTOTEMPORAL DEMENTIA	VCP, ALA232GLU	121909331
601023	7415	VCP	0004	INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE AND FRONTOTEMPORAL DEMENTIA	VCP, ARG95GLY	121909332
601023	7415	VCP	0005	INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE AND FRONTOTEMPORAL DEMENTIA	VCP, ARG155PRO	
601023	7415	VCP	0006	INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE AND FRONTOTEMPORAL DEMENTIA AMYOTROPHIC LATERAL SCLEROSIS 14 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA, INCLUDED	VCP, ARG191GLN	121909334
601023	7415	VCP	0007	INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE AND FRONTOTEMPORAL DEMENTIA	VCP, ARG159HIS	121909335
601023	7415	VCP	0008	AMYOTROPHIC LATERAL SCLEROSIS 14 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA	VCP, ARG159GLY	
601023	7415	VCP	0009	AMYOTROPHIC LATERAL SCLEROSIS 14 WITHOUT FRONTOTEMPORAL DEMENTIA	VCP, ASP592ASN	
601040	949	SCARB1	0001	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6	SCARB1, PRO297SER	
601040	949	SCARB1	0002	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6	SCARB1, THR175ALA	
601040	949	SCARB1	0003	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6	SCARB1, SER112PHE	
601047	857	CAV1	0001	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3	CAV1, GLU38TER	121434501
601065	16	AARS	0001	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2N	AARS, ARG329HIS	
601065	16	AARS	0002	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2N	AARS, ASN71TYR	
601089	2294	FOXF1	0001	ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS	FOXF1, TYR50TER	121909336
601089	2294	FOXF1	0002	ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS	FOXF1, TER355ARG	121909337
601089	2294	FOXF1	0003	ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS	FOXF1, 1-BP DUP, 775T	
601089	2294	FOXF1	0004	ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS	FOXF1, 2-BP DEL, 956TT	
601090	2296	FOXC1	0001	RIEGER ANOMALY IRIS HYPOPLASIA WITH GLAUCOMA, INCLUDED	FOXC1, 11-BP DEL	
601090	2296	FOXC1	0002	RIEGER ANOMALY	FOXC1, SER131LEU	104893957
601090	2296	FOXC1	0003	AXENFELD ANOMALY	FOXC1, ILE126MET	104893958
601090	2296	FOXC1	0004	RIEGER ANOMALY AXENFELD ANOMALY, INCLUDED;; AXENFELD-RIEGER SYNDROME, TYPE 3, INCLUDED;; PETERS ANOMALY, INCLUDED	FOXC1, PHE112SER	104893951
601090	2296	FOXC1	0005	AXENFELD-RIEGER SYNDROME, TYPE 3	FOXC1, GLN23TER	104893952
601090	2296	FOXC1	0006	IRIS HYPOPLASIA WITH GLAUCOMA PETERS ANOMALY, INCLUDED;; IRIDOGONIODYSGENESIS, TYPE 1, INCLUDED	FOXC1, DUP	
601090	2296	FOXC1	0007	AXENFELD ANOMALY	FOXC1, 22-BP INS, NT26	
601090	2296	FOXC1	0008	AXENFELD-RIEGER SYNDROME, TYPE 3	FOXC1, SER82THR	104893953
601090	2296	FOXC1	0009	AXENFELD-RIEGER ANOMALY	FOXC1, ILE87MET	104893954
601090	2296	FOXC1	0010	AXENFELD-RIEGER SYNDROME, TYPE 3	FOXC1, LEU130PHE	121909338
601090	2296	FOXC1	0011	AXENFELD-RIEGER SYNDROME, TYPE 3 PETERS ANOMALY, INCLUDED	FOXC1, GLN120TER	121909339
601090	2296	FOXC1	0012	IRIDOGONIODYSGENESIS, TYPE 1	FOXC1, PRO297SER	
601093	2299	FOXI1	0001	DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT, DIGENIC	FOXI1, GLY258GLU	121909340
601093	2299	FOXI1	0002	DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT PENDRED SYNDROME, INCLUDED	FOXI1, ARG267GLN	121909341
601094	2301	FOXE3	0001	ANTERIOR SEGMENT MESENCHYMAL DYSGENESIS	FOXE3, 1-BP INS, 943G	
601094	2301	FOXE3	0002	APHAKIA, CONGENITAL PRIMARY	FOXE3, CYS240TER	80358194
601094	2301	FOXE3	0003	ANTERIOR SEGMENT MESENCHYMAL DYSGENESIS	FOXE3, TER320LEU	
601097	5376	PMP22	0001	CHARCOT-MARIE-TOOTH DISEASE, TYPE 1A ROUSSY-LEVY SYNDROME, INCLUDED	PMP22, 1.4-MB DUP	
601097	5376	PMP22	0002	CHARCOT-MARIE-TOOTH DISEASE, TYPE 1A	PMP22, LEU16PRO	104894617
601097	5376	PMP22	0003	CHARCOT-MARIE-TOOTH DISEASE, TYPE 1A	PMP22, SER79CYS	104894618
601097	5376	PMP22	0004	NEUROPATHY, HEREDITARY, WITH LIABILITY TO PRESSURE PALSIES POLYNEUROPATHY, INFLAMMATORY DEMYELINATING, INCLUDED;; DEJERINE-SOTTAS SYNDROME, AUTOSOMAL RECESSIVE, INCLUDED	PMP22, 1.1- to 1.5-MB DEL	
601097	5376	PMP22	0005	CHARCOT-MARIE-TOOTH DISEASE, TYPE 1A, AUTOSOMAL RECESSIVE NEUROPATHY, HEREDITARY, WITH LIABILITY TO PRESSURE PALSIES, INCLUDED	PMP22, THR118MET	104894619
601097	5376	PMP22	0006	DEJERINE-SOTTAS SYNDROME, AUTOSOMAL DOMINANT	PMP22, MET69LYS	104894620
601097	5376	PMP22	0007	DEJERINE-SOTTAS SYNDROME, AUTOSOMAL DOMINANT	PMP22, SER72LEU	104894621
601097	5376	PMP22	0008	DEJERINE-SOTTAS SYNDROME, AUTOSOMAL DOMINANT	PMP22, HIS12GLN	104894622
601097	5376	PMP22	0009	NEUROPATHY, HEREDITARY, WITH LIABILITY TO PRESSURE PALSIES	PMP22, 2-BP DEL, 207TC	
601097	5376	PMP22	0010	CHARCOT-MARIE-TOOTH DISEASE AND DEAFNESS	PMP22, ALA67PRO	104894623
601097	5376	PMP22	0011	NEUROPATHY, HEREDITARY, WITH LIABILITY TO PRESSURE PALSIES	PMP22, 1-BP INS, 325G	
601097	5376	PMP22	0012	DEJERINE-SOTTAS SYNDROME, AUTOSOMAL DOMINANT	PMP22, 2-BP DEL, 426CT	
601097	5376	PMP22	0013	DEJERINE-SOTTAS SYNDROME, AUTOSOMAL DOMINANT	PMP22, GLY150CYS	104894624
601097	5376	PMP22	0014	CHARCOT-MARIE-TOOTH DISEASE AND DEAFNESS	PMP22, TRP28ARG	104894626
601097	5376	PMP22	0015	CHARCOT-MARIE-TOOTH DISEASE AND DEAFNESS	PMP22, 12-BP DEL	
601097	5376	PMP22	0016	CHARCOT-MARIE-TOOTH DISEASE, TYPE 1A, WITH FOCALLY FOLDED MYELIN SHEATHS	PMP22, ASP37VAL	104894627
601097	5376	PMP22	0017	NEUROPATHY, HEREDITARY, WITH LIABILITY TO PRESSURE PALSIES	PMP22, ALA67THR	104894623
601097	5376	PMP22	0018	DEJERINE-SOTTAS SYNDROME, AUTOSOMAL RECESSIVE	PMP22, ARG157TRP	28936682
601097	5376	PMP22	0019	NEUROPATHY, HEREDITARY, WITH LIABILITY TO PRESSURE PALSIES CHARCOT-MARIE-TOOTH DISEASE, TYPE 1A, INCLUDED	PMP22, SER22PHE	104894625
601097	5376	PMP22	0020	DEJERINE-SOTTAS SYNDROME, AUTOSOMAL RECESSIVE NEUROPATHY, HEREDITARY, WITH LIABILITY TO PRESSURE PALSIES, INCLUDED	PMP22, DEL, EX2-3	
601097	5376	PMP22	0021	CHARCOT-MARIE-TOOTH DISEASE, TYPE 1A	PMP22, 1-BP DEL, 281G	
601105	1513	CTSK	0001	PYCNODYSOSTOSIS	CTSK, TER330TRP	74315301
601105	1513	CTSK	0002	PYCNODYSOSTOSIS	CTSK, GLY146ARG	74315302
601105	1513	CTSK	0003	PYCNODYSOSTOSIS	CTSK, ARG241TER	74315303
601105	1513	CTSK	0004	PYCNODYSOSTOSIS	CTSK, ALA277VAL	74315304
601105	1513	CTSK	0005	PYCNODYSOSTOSIS	CTSK, GLY79GLU	74315305
601105	1513	CTSK	0006	PYCNODYSOSTOSIS	CTSK, LYS52TER	74315306
601105	1513	CTSK	0007	PYCNODYSOSTOSIS	CTSK, LEU309PRO	29001685
601107	1244	ABCC2	0001	DUBIN-JOHNSON SYNDROME	ABCC2, ARG768TRP	56199535
601107	1244	ABCC2	0002	DUBIN-JOHNSON SYNDROME	ABCC2, 168-BP DEL, NT2272	
601107	1244	ABCC2	0003	DUBIN-JOHNSON SYNDROME	ABCC2, 147-BP DEL, NT1669	
601107	1244	ABCC2	0004	DUBIN-JOHNSON SYNDROME	ABCC2, IVS18DS, T-C, +2	
601107	1244	ABCC2	0005	DUBIN-JOHNSON SYNDROME	ABCC2, GLN1382ARG	72558202
601107	1244	ABCC2	0006	DUBIN-JOHNSON SYNDROME	ABCC2, 67-BP DEL, IVSDS, T-C, +2	
601107	1244	ABCC2	0007	DUBIN-JOHNSON SYNDROME	ABCC2, ILE1173PHE	72558201
601107	1244	ABCC2	0008	DUBIN-JOHNSON SYNDROME	ABCC2, ARG1150HIS	72558200
601107	1244	ABCC2	0009	DUBIN-JOHNSON SYNDROME	ABCC2, ARG1066TER	
601129	1558	CYP2C8	0001	RHABDOMYOLYSIS, CERIVASTATIN-INDUCED	CYP2C8, 1-BP DEL, 475A DEL	
601130	1559	CYP2C9	0001	TOLBUTAMIDE POOR METABOLIZER WARFARIN SENSITIVITY, INCLUDED;; PHENYTOIN POOR METABOLIZER, INCLUDED;; GLIPIZIDE POOR METABOLIZER, INCLUDED	CYP2C9, ILE359LEU	1057910
601130	1559	CYP2C9	0002	WARFARIN SENSITIVITY	CYP2C9, ARG144CYS	1799853
601130	1559	CYP2C9	0003	WARFARIN SENSITIVITY	CYP2C9, LEU208VAL	72558191
601143	1639	DCTN1	0001	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIB	DCTN1, GLY59SER	121909342
601143	1639	DCTN1	0002	AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO	DCTN1, THR1249ILE	72466496
601143	1639	DCTN1	0003	AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO	DCTN1, MET571THR	121909343
601143	1639	DCTN1	0004	AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO	DCTN1, ARG785TRP	121909344
601143	1639	DCTN1	0005	AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO	DCTN1, ARG1101LYS	121909345
601143	1639	DCTN1	0006	PERRY SYNDROME	DCTN1, GLY71ARG	72466485
601143	1639	DCTN1	0007	PERRY SYNDROME	DCTN1, GLN74PRO	72466487
601145	1476	CSTB	0001	MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	CSTB, IVS1, G-C, -1	
601145	1476	CSTB	0002	MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	CSTB, ARG68TER	74315442
601145	1476	CSTB	0003	MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	CSTB, (CCCCGCCCCGCG)n EXPANSION, 12-MER EXPANSION, PROMOTER REGION	193922905
601145	1476	CSTB	0004	MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	CSTB, GLY4ARG	74315443
601145	1476	CSTB	0005	MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	CSTB, 2-BP DEL, 2404TC	
601145	1476	CSTB	0006	MYCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	CSTB, GLN71PRO	121909346
601146	8200	GDF5	0001	ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE	GDF5, 22-BP DUP	
601146	8200	GDF5	0002	BRACHYDACTYLY, TYPE C	GDF5, ARG301TER	74315386
601146	8200	GDF5	0003	CHONDRODYSPLASIA, GREBE TYPE	GDF5, CYS400TYR	74315387
601146	8200	GDF5	0004	CHONDRODYSPLASIA, GREBE TYPE	GDF5, 1-BP INS, 297C	
601146	8200	GDF5	0005	FIBULAR HYPOPLASIA AND COMPLEX BRACHYDACTYLY BRACHYDACTYLY, TYPE A2, INCLUDED	GDF5, LEU441PRO	28936683
601146	8200	GDF5	0006	BRACHYDACTYLY, TYPE C	GDF5, 23-BP INS, NT811	
601146	8200	GDF5	0007	CHONDRODYSPLASIA, GREBE TYPE	GDF5, 1-BP DEL, 1144G	
601146	8200	GDF5	0008	BRACHYDACTYLY, TYPE C	GDF5, MET173VAL	28936397
601146	8200	GDF5	0009	BRACHYDACTYLY, TYPE C	GDF5, 1-BP INS, 206G	
601146	8200	GDF5	0011	SYMPHALANGISM, PROXIMAL, 1B MULTIPLE SYNOSTOSES SYNDROME 2, INCLUDED	GDF5, ARG438LEU	74315388
601146	8200	GDF5	0012	FIBULAR HYPOPLASIA AND COMPLEX BRACHYDACTYLY	GDF5, 3-BP DEL, 1309TTG, SER439THR, AND HIS440LEU	
601146	8200	GDF5	0013	MULTIPLE SYNOSTOSES SYNDROME 2	GDF5, SER475ASN	121909347
601146	8200	GDF5	0014	SYMPHALANGISM, PROXIMAL, 1B	GDF5, GLU491LYS	74315389
601146	8200	GDF5	0015	OSTEOARTHRITIS SUSCEPTIBILITY 5	GDF5, +104T/C	143383
601146	8200	GDF5	0016	BRACHYDACTYLY, TYPE C	GDF5, TYR487TER	121909348
601146	8200	GDF5	0017	SYMPHALANGISM, PROXIMAL, 1B	GDF5, LEU373ARG	121909349
601146	8200	GDF5	0018	FIBULAR HYPOPLASIA AND COMPLEX BRACHYDACTYLY	GDF5, ARG378GLN	121909350
601146	8200	GDF5	0019	FIBULAR HYPOPLASIA AND COMPLEX BRACHYDACTYLY	GDF5, PRO436THR	121909351
601146	8200	GDF5	0020	BRACHYDACTYLY, TYPE A1, C	GDF5, ARG399CYS	
601146	8200	GDF5	0021	BRACHYDACTYLY, TYPE A2	GDF5, ARG380GLN	
601147	392255	GDF6	0001	KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT MICROPHTHALMIA, ISOLATED 4, INCLUDED	GDF6, ALA249GLU	121909352
601147	392255	GDF6	0002	KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT	GDF6, LEU289PRO	63751220
601147	392255	GDF6	0003	KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT	GDF6, LYS242ARG	121909353
601147	392255	GDF6	0004	KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT	GDF6, GLY42VAL	121909354
601147	392255	GDF6	0005	MICROPHTHALMIA, ISOLATED 4	GDF6, GLN253LEU	121909355
601147	392255	GDF6	0006	MICROPHTHALMIA, ISOLATED 4	GDF6, PRO327HIS	121909356
601147	392255	GDF6	0007	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6	GDF6, ALA199THR	
601150	1663	DDX11	0001	WARSAW BREAKAGE SYNDROME	DDX11, IVS22, T-C, +2	
601150	1663	DDX11	0002	WARSAW BREAKAGE SYNDROME	DDX11, 3-BP DEL, 2689AAG	
601150	1663	DDX11	0003	WARSAW BREAKAGE SYNDROME	DDX11, ARG263GLN	
601156	6356	CCL11	0001	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO	CCL11, -1385G-A	
601156	6356	CCL11	0002	ASTHMA, SUSCEPTIBILITY TO	CCL11, (GAAGGA)n	
601176	2730	GCLM	0001	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO	GCLM, -588C-T	
601181	5903	RANBP2	0001	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3	RANBP2, THR585MET	121434502
601181	5903	RANBP2	0002	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3	RANBP2, THR653ILE	121434503
601181	5903	RANBP2	0003	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3	RANBP2, ILE656VAL	121434504
601190	5149	PDE6H	0001	RETINAL CONE DYSTROPHY 3A	PDE6H, -29G-C, 5-PRIME UTR	
601190	5149	PDE6H	0002	ACHROMATOPSIA 6	PDE6H, SER12TER	
601192	5322	PLA2G5	0001	FLECK RETINA, FAMILIAL BENIGN	PLA2G5, GLY45CYS	
601192	5322	PLA2G5	0002	FLECK RETINA, FAMILIAL BENIGN	PLA2G5, TRP62TER	
601192	5322	PLA2G5	0003	FLECK RETINA, FAMILIAL BENIGN	PLA2G5, GLY49SER	
601192	5322	PLA2G5	0004	FLECK RETINA, FAMILIAL BENIGN	PLA2G5, ARG53TER	
601192	5322	PLA2G5	0005	FLECK RETINA, FAMILIAL BENIGN	PLA2G5, 1-BP DEL, 383A	
601194	7096	TLR1	0001	LEPROSY, PROTECTION AGAINST	TLR1, ILE602SER	5743618
601194	7096	TLR1	0002	LEPROSY, SUSCEPTIBILITY TO, 5	TLR1, ASN248SER	4833095
601199	846	CASR	0001	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL	CASR, ARG796TRP	121909258
601199	846	CASR	0002	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL HYPERPARATHYROIDISM, NEONATAL SEVERE, INCLUDED	CASR, GLU298LYS	121909259
601199	846	CASR	0003	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL HYPERPARATHYROIDISM, NEONATAL SEVERE, INCLUDED	CASR, ARG185GLN	104893689
601199	846	CASR	0004	HYPOPARATHYROIDISM, FAMILIAL ISOLATED	CASR, GLU128ALA	121909260
601199	846	CASR	0005	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL HYPERPARATHYROIDISM, NEONATAL SEVERE, INCLUDED	CASR, ALU INS, CODON 877	
601199	846	CASR	0006	HYPERPARATHYROIDISM, NEONATAL SEVERE PRIMARY	CASR, ARG227LEU	28936684
601199	846	CASR	0007	HYPERPARATHYROIDISM, NEONATAL SEVERE PRIMARY	CASR, CYS582TYR	104893690
601199	846	CASR	0008	HYPERPARATHYROIDISM, NEONATAL SEVERE PRIMARY	CASR, 2-BP DEL/1-BP INS, CCC747TC	
601199	846	CASR	0009	HYPOPARATHYROIDISM, FAMILIAL ISOLATED	CASR, GLU681HIS	121909261
601199	846	CASR	0010	HYPOPARATHYROIDISM, FAMILIAL ISOLATED	CASR, ALA116THR	104893691
601199	846	CASR	0011	HYPOPARATHYROIDISM, FAMILIAL ISOLATED	CASR, PHE806SER	104893693
601199	846	CASR	0012	HYPOPARATHYROIDISM, FAMILIAL ISOLATED	CASR, THR151MET	104893694
601199	846	CASR	0013	HYPOPARATHYROIDISM, FAMILIAL ISOLATED HYPOPARATHYROIDISM, SPORADIC, INCLUDED	CASR, ASN118LYS	104893695
601199	846	CASR	0014	HYPOPARATHYROIDISM, FAMILIAL ISOLATED	CASR, PHE128LEU	104893696
601199	846	CASR	0016	HYPOPARATHYROIDISM, FAMILIAL ISOLATED	CASR, GLU191LYS	104893697
601199	846	CASR	0017	HYPOPARATHYROIDISM, FAMILIAL ISOLATED	CASR, PHE612SER	104893698
601199	846	CASR	0019	HYPOPARATHYROIDISM, SPORADIC	CASR, LEU773ARG	104893699
601199	846	CASR	0020	HYPERPARATHYROIDISM, NEONATAL SEVERE PRIMARY	CASR, GLY670GLU	104893700
601199	846	CASR	0021	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL	CASR, PRO40ALA	121909262
601199	846	CASR	0022	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL	CASR, ARG228GLN	
601199	846	CASR	0023	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL	CASR, THR139MET	121909263
601199	846	CASR	0024	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL	CASR, GLY144GLU	121909264
601199	846	CASR	0025	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL	CASR, ARG63MET	121909265
601199	846	CASR	0026	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL	CASR, ARG67CYS	121909266
601199	846	CASR	0027	HYPOPARATHYROIDISM, FAMILIAL ISOLATED	CASR, PHE788CYS	104893701
601199	846	CASR	0028	HYPOCALCEMIA, AUTOSOMAL DOMINANT	CASR, LYS47ASN	104893702
601199	846	CASR	0029	HYPOPARATHYROIDISM, FAMILIAL	CASR, LEU616VAL	104893703
601199	846	CASR	0030	HYPOPARATHYROIDISM, FAMILIAL ISOLATED	CASR, 543-BP DEL, NT2682	
601199	846	CASR	0031	HYPERCALCIURIC HYPERCALCEMIA	CASR, PHE881LEU	104893704
601199	846	CASR	0032	HYPOCALCIURIC HYPERCALCEMIA HYPERPARATHYROIDISM, NEONATAL SEVERE PRIMARY, INCLUDED	CASR, ARG648TER	104893705
601199	846	CASR	0033	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL HYPERPARATHYROIDISM, NEONATAL SEVERE PRIMARY, INCLUDED	CASR, IVS2AS, G-T, -1	
601199	846	CASR	0034	HYPOCALCEMIA, AUTOSOMAL DOMINANT, WITH BARTTER SYNDROME HYPOPARATHYROIDISM, FAMILIAL ISOLATED, INCLUDED	CASR, ALA843GLU	104893706
601199	846	CASR	0035	HYPOCALCEMIA, AUTOSOMAL DOMINANT, WITH BARTTER SYNDROME	CASR, CYS141TRP	121909267
601199	846	CASR	0036	HYPERPARATHYROIDISM, NEONATAL SEVERE PRIMARY	CASR, ARG185TER	104893707
601199	846	CASR	0037	HYPERCALCIURIC HYPOCALCEMIA, FAMILIAL	CASR, LEU125PRO	104893708
601199	846	CASR	0038	HYPOPARATHYROIDISM, FAMILIAL ISOLATED	CASR, SER820PHE	104893710
601199	846	CASR	0039	HYPOPARATHYROIDISM, FAMILIAL ISOLATED	CASR, PHE788LEU	104893711
601199	846	CASR	0040	CALCIUM, SERUM LEVEL OF	CASR, ALA986SER	1801725
601199	846	CASR	0041	HYPOPARATHYROIDISM, FAMILIAL ISOLATED	CASR, GLU604LYS	104893712
601199	846	CASR	0042	HYPERPARATHYROIDISM, NEONATAL SEVERE PRIMARY	CASR, GLY94TER	104893709
601199	846	CASR	0043	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL	CASR, ARG465GLN	104893716
601199	846	CASR	0044	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL	CASR, LEU13PRO	104893717
601199	846	CASR	0045	HYPOPARATHYROIDISM, FAMILIAL ISOLATED	CASR, LEU727GLN	104893718
601199	846	CASR	0046	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL	CASR, PHE180CYS	121909268
601199	846	CASR	0047	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL	CASR, CYS582PHE	104893690
601199	846	CASR	0048	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL	CASR, GLY553ARG	104893719
601199	846	CASR	0049	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL	CASR, ARG227GLN	28936684
601199	846	CASR	0050	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 8	CASR, ARG898GLN	121909269
601205	6495	SIX1	0001	BRANCHIOOTIC SYNDROME 3	SIX1, TYR129CYS	104894478
601205	6495	SIX1	0002	BRANCHIOOTIC SYNDROME 3	SIX1, ARG110TRP	80356459
601205	6495	SIX1	0003	DEAFNESS, AUTOSOMAL DOMINANT 23	SIX1, 3-BP DEL, 397GGA	80356460
601205	6495	SIX1	0004	BRANCHIOOTIC SYNDROME 3	SIX1, TRP122ARG	121909770
601215	545	ATR	0001	SECKEL SYNDROME 1	ATR, 2101A-G	
601215	545	ATR	0002	CUTANEOUS TELANGIECTASIA AND CANCER SYNDROME, FAMILIAL	ATR, GLN2144ARG	
601215	545	ATR	0003	SECKEL SYNDROME 1	ATR, ASP1879TYR	
601239	1837	DTNA	0001	LEFT VENTRICULAR NONCOMPACTION 1	DTNA, PRO121LEU	104894654
601240	2593	GAMT	0001	GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	GAMT, IVS2DS, G-A, -1	
601240	2593	GAMT	0002	GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	GAMT, 13-BP DUP, NT309	80338736
601240	2593	GAMT	0003	GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	GAMT, TRP20SER	80338734
601240	2593	GAMT	0004	GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	GAMT, CYS169TYR	121909272
601240	2593	GAMT	0005	GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	GAMT, MET50LEU	104894694
601248	274	BIN1	0001	MYOPATHY, CENTRONUCLEAR, AUTOSOMAL RECESSIVE	BIN1, LYS35ASN	121909273
601248	274	BIN1	0002	MYOPATHY, CENTRONUCLEAR, AUTOSOMAL RECESSIVE	BIN1, ASP151ASN	121909274
601248	274	BIN1	0003	MYOPATHY, CENTRONUCLEAR, AUTOSOMAL RECESSIVE	BIN1, LYS575TER	121909275
601248	274	BIN1	0004	MYOPATHY, CENTRONUCLEAR, AUTOSOMAL RECESSIVE	BIN1, ARG154GLN	
601253	859	CAV3	0001	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1C RIPPLING MUSCLE DISEASE 2, INCLUDED	CAV3, PRO105LEU	116840805
601253	859	CAV3	0002	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1C	CAV3, 9-BP DEL, NT186	116840800
601253	859	CAV3	0003	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1C, AUTOSOMAL RECESSIVE	CAV3, GLY56SER	72546667
601253	859	CAV3	0004	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1C	CAV3, CYS72TRP	116840776
601253	859	CAV3	0005	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1C RIPPLING MUSCLE DISEASE 2, INCLUDED;; CREATINE PHOSPHOKINASE, ELEVATED SERUM, INCLUDED	CAV3, ALA46THR	116840789
601253	859	CAV3	0006	RIPPLING MUSCLE DISEASE 2	CAV3, ALA46VAL	116840773
601253	859	CAV3	0007	RIPPLING MUSCLE DISEASE 2 CREATINE PHOSPHOKINASE, ELEVATED SERUM, INCLUDED;; MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1C, INCLUDED;; MYOPATHY, DISTAL, TATEYAMA TYPE, INCLUDED	CAV3, ARG27GLN	116840778
601253	859	CAV3	0008	RIPPLING MUSCLE DISEASE 2 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1C, INCLUDED	CAV3, ASP28GLU	116840782
601253	859	CAV3	0009	RIPPLING MUSCLE DISEASE 2	CAV3, LEU87PRO	28936685
601253	859	CAV3	0010	RIPPLING MUSCLE DISEASE 2, AUTOSOMAL RECESSIVE	CAV3, ALA93THR	28936686
601253	859	CAV3	0011	CREATINE PHOSPHOKINASE, ELEVATED SERUM RIPPLING MUSCLE DISEASE 2, INCLUDED;; MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1C, INCLUDED	CAV3, 3-BP DEL, PHE98DEL	116840802
601253	859	CAV3	0012	CREATINE PHOSPHOKINASE, ELEVATED SERUM	CAV3, PRO29LEU	116840786
601253	859	CAV3	0013	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC	CAV3, THR64SER	116840799
601253	859	CAV3	0014	MYOPATHY, DISTAL, TATEYAMA TYPE	CAV3, ASN33LYS	1008642
601253	859	CAV3	0015	RIPPLING MUSCLE DISEASE 2	CAV3, GLU47LYS	116840793
601253	859	CAV3	0016	LONG QT SYNDROME 9	CAV3, SER141ARG	104893713
601253	859	CAV3	0017	LONG QT SYNDROME 9, ACQUIRED, SUSCEPTIBILITY TO	CAV3, PHE97CYS	104893714
601253	859	CAV3	0018	LONG QT SYNDROME 9 LONG QT SYNDROME 2/9, DIGENIC, INCLUDED	CAV3, THR78MET	72546668
601253	859	CAV3	0019	LONG QT SYNDROME 9	CAV3, ALA85THR	104893715
601253	859	CAV3	0020	LONG QT SYNDROME 9	CAV3, VAL14LEU	121909281
601253	859	CAV3	0021	LONG QT SYNDROME 9	CAV3, LEU79ARG	121909282
601255	547	KIF1A	0001	SPASTIC PARAPLEGIA 30, AUTOSOMAL RECESSIVE	KIF1A, ALA255VAL	
601255	547	KIF1A	0002	NEUROPATHY, HEREDITARY SENSORY, TYPE IIC	KIF1A, 1-BP DEL, 2840T	
601255	547	KIF1A	0003	NEUROPATHY, HEREDITARY SENSORY, TYPE IIC	KIF1A, 1-BP DUP, 5271C	
601255	547	KIF1A	0004	MENTAL RETARDATION, AUTOSOMAL DOMINANT 9	KIF1A, THR99MET	
601255	547	KIF1A	0005	SPASTIC PARAPLEGIA 30, AUTOSOMAL RECESSIVE	KIF1A, ARG350GLY	
601263	5605	MAP2K2	0001	CARDIOFACIOCUTANEOUS SYNDROME 4	MAP2K2, PHE57CYS	121434497
601263	5605	MAP2K2	0002	CARDIOFACIOCUTANEOUS SYNDROME 4	MAP2K2, PHE57VAL	121434498
601263	5605	MAP2K2	0003	CARDIOFACIOCUTANEOUS SYNDROME 4	MAP2K2, TYR134HIS	121434499
601263	5605	MAP2K2	0004	CARDIOFACIOCUTANEOUS SYNDROME 4	MAP2K2, PRO128GLN	
601263	5605	MAP2K2	0005	CARDIOFACIOCUTANEOUS SYNDROME 4	MAP2K2, GLY132ASP	
601265	4838	NODAL	0001	HETEROTAXY, VISCERAL, 5, AUTOSOMAL	NODAL, ARG183GLN	104894169
601265	4838	NODAL	0002	HETEROTAXY, VISCERAL, 5, AUTOSOMAL	NODAL, GLY260ARG	121909283
601265	4838	NODAL	0003	HETEROTAXY, VISCERAL, 5, AUTOSOMAL	NODAL, 9-BP INSERTION/24-BP DELETION, NT700	
601265	4838	NODAL	0004	HETEROTAXY, VISCERAL, 5, AUTOSOMAL	NODAL, IVS2DS, G-A, +1	
601267	729230	CCR2	0001	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO	CCR2, VAL64ILE	1799864
601282	5339	PLEC	0001	EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY	PLEC1, 8-BP DUP	
601282	5339	PLEC	0002	EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY	PLEC1, 9-BP DEL, EX22	
601282	5339	PLEC	0003	EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY	PLEC1, 1-BP DEL, 5866C	
601282	5339	PLEC	0004	EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY	PLEC1, 8-BP DEL, EX32	
601282	5339	PLEC	0005	EPIDERMOLYSIS BULLOSA SIMPLEX, OGNA TYPE	PLEC1, ARG2110TRP	80338756
601282	5339	PLEC	0006	EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	PLEC1, 14-BP DEL, NT2727	
601282	5339	PLEC	0007	EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	PLEC1, GLN305TER	137853160
601282	5339	PLEC	0008	EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	PLEC1, 1344G-A	
601282	5339	PLEC	0009	EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	PLEC1, ARG3029TER	137853161
601282	5339	PLEC	0010	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2Q	PLEC1, 9-BP DEL, EXON 1F	
601282	5339	PLEC	0011	EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY	PLEC1, 1-BP DUP, 12043G	
601282	5339	PLEC	0012	EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY	PLEC1, GLN2057TER	
601282	5339	PLEC	0013	EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY	PLEC1, ARG2319TER	
601284	94	ACVRL1	0001	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2 PULMONARY ARTERIAL HYPERTENSION, HEREDITARY HEMORRHAGIC TELANGIECTASIA-RELATED, INCLUDED	ACVRL1, ARG411GLN	121909284
601284	94	ACVRL1	0002	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2	ACVRL1, MET376ARG	28936399
601284	94	ACVRL1	0003	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2	ACVRL1, 3-BP DEL, 696CCT	
601284	94	ACVRL1	0004	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2	ACVRL1, TRP150CYS	121909285
601284	94	ACVRL1	0005	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2	ACVRL1, GLY48GLU, ALA49PRO	
601284	94	ACVRL1	0006	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2	ACVRL1, ILE398ASN	121909286
601284	94	ACVRL1	0007	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2 PULMONARY ARTERIAL HYPERTENSION, HEREDITARY HEMORRHAGIC TELANGIECTASIA-RELATED, INCLUDED	ACVRL1, ARG374TRP	28936401
601284	94	ACVRL1	0008	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2 PULMONARY ARTERIAL HYPERTENSION, HEREDITARY HEMORRHAGIC TELANGIECTASIA-RELATED, INCLUDED	ACVRL1, 3-BP DEL, 759GAC	
601284	94	ACVRL1	0009	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2 PULMONARY ARTERIAL HYPERTENSION, HEREDITARY HEMORRHAGIC TELANGIECTASIA-RELATED, INCLUDED	ACVRL1, ARG411TRP	121909287
601284	94	ACVRL1	0010	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2 PULMONARY ARTERIAL HYPERTENSION, HEREDITARY HEMORRHAGIC TELANGIECTASIA-RELATED, INCLUDED	ACVRL1, ARG484TRP	121909288
601284	94	ACVRL1	0011	PULMONARY ARTERIAL HYPERTENSION, HEREDITARY HEMORRHAGIC TELANGIECTASIA-RELATED	ACVRL1, GLY211ASP	28936687
601284	94	ACVRL1	0012	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2 PULMONARY ARTERIAL HYPERTENSION, HEREDITARY HEMORRHAGIC TELANGIECTASIA-RELATED, INCLUDED	ACVRL1, CYS344TYR	28936688
601284	94	ACVRL1	0013	PULMONARY ARTERIAL HYPERTENSION, HEREDITARY HEMORRHAGIC TELANGIECTASIA-RELATED	ACVRL1, TRP399SER	121909289
601284	94	ACVRL1	0014	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE II	ACVRL1, 1-BP INS, 1113G	
601284	94	ACVRL1	0015	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE II	ACVRL1, ARG411PRO	
601295	6555	SLC10A2	0001	BILE ACID MALABSORPTION, PRIMARY	SLC10A2, LEU243PRO AND THR262MET	72547505
601295	6555	SLC10A2	0002	BILE ACID MALABSORPTION, PRIMARY	SLC10A2, IVS3DS, AAg-CTt	
601296	4593	MUSK	0001	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	MUSK, VAL790MET	199476083
601296	4593	MUSK	0002	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	MUSK, 1-BP INS, 220C	
601296	4593	MUSK	0003	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	MUSK, PRO344ARG	
601299	657	BMPR1A	0001	JUVENILE POLYPOSIS SYNDROME	BMPR1A, 4-BP DEL, 44TGTT	
601299	657	BMPR1A	0002	JUVENILE POLYPOSIS SYNDROME	BMPR1A, GLN239TER	199476084
601299	657	BMPR1A	0003	JUVENILE POLYPOSIS SYNDROME	BMPR1A, TRP271TER	199476085
601299	657	BMPR1A	0004	JUVENILE POLYPOSIS SYNDROME	BMPR1A, 1-BP DEL, 961C	
601299	657	BMPR1A	0005	JUVENILE POLYPOSIS SYNDROME	BMPR1A, ALA338ASP	199476086
601299	657	BMPR1A	0006	JUVENILE POLYPOSIS SYNDROME	BMPR1A, CYS124ARG	199476087
601299	657	BMPR1A	0007	JUVENILE POLYPOSIS SYNDROME	BMPR1A, CYS376TYR	199476088
601299	657	BMPR1A	0008	JUVENILE POLYPOSIS SYNDROME	BMPR1A, MET470THR	199476089
601299	657	BMPR1A	0009	POLYPOSIS SYNDROME, HEREDITARY MIXED, 2	BMPR1A, 11-BP DEL, CODON 42	
601299	657	BMPR1A	0010	JUVENILE POLYPOSIS OF INFANCY	BMPR1A, DEL	
601300	91	ACVR1B	0001	PANCREATIC CARCINOMA, SOMATIC	ACVR1B, 5-BP DEL	
601300	91	ACVR1B	0002	PANCREATIC CARCINOMA, SOMATIC	ACVR1B, 657-BP DEL	
601309	5727	PTCH1	0001	BASAL CELL NEVUS SYNDROME	PTCH1, 9-BP INS, CODON 815, PRO-ASN-ILE INS	
601309	5727	PTCH1	0002	BASAL CELL NEVUS SYNDROME	PTCH1, 11-BP DEL, NT2442	
601309	5727	PTCH1	0003	BASAL CELL NEVUS SYNDROME	PTCH1, GLN210TER	199476090
601309	5727	PTCH1	0004	BASAL CELL NEVUS SYNDROME	PTCH1, 37-BP DEL, NT808	
601309	5727	PTCH1	0005	BASAL CELL NEVUS SYNDROME	PTCH1, 1148G-A	
601309	5727	PTCH1	0006	BASAL CELL NEVUS SYNDROME	PTCH1, 2-BP INS, 2047CT	
601309	5727	PTCH1	0007	BASAL CELL NEVUS SYNDROME	PTCH1, 1-BP INS, 2000C	
601309	5727	PTCH1	0008	BASAL CELL NEVUS SYNDROME	PTCH1, 1-BP DEL, 2583C	
601309	5727	PTCH1	0009	BASAL CELL CARCINOMA, SOMATIC	PTCH1, PRO-SER, 451C-T	
601309	5727	PTCH1	0010	BASAL CELL CARCINOMA, SOMATIC	PTCH1, 3340A-T	
601309	5727	PTCH1	0011	HOLOPROSENCEPHALY 7	PTCH1, ALA393THR	199476091
601309	5727	PTCH1	0012	HOLOPROSENCEPHALY 7	PTCH1, THR728MET	115556836
601309	5727	PTCH1	0013	HOLOPROSENCEPHALY 7	PTCH1, SER827GLY	199476092
601309	5727	PTCH1	0014	HOLOPROSENCEPHALY 7	PTCH1, THR1052MET	138911275
601309	5727	PTCH1	0015	HOLOPROSENCEPHALY 7	PTCH1, VAL908GLY	199476093
601309	5727	PTCH1	0016	BASAL CELL NEVUS SYNDROME	PTCH1, 1-BP INS, 1247T	
601309	5727	PTCH1	0017	BASAL CELL NEVUS SYNDROME	PTCH1, TRP129TER	
601313	5310	PKD1	0001	POLYCYSTIC KIDNEY DISEASE 1	PKD1, IVSDS, G-C, +1	
601313	5310	PKD1	0002	POLYCYSTIC KIDNEY DISEASE 1	PKD1, GLN1273TER	199476094
601313	5310	PKD1	0003	POLYCYSTIC KIDNEY DISEASE 1	PKD1, 15-BP DEL	
601313	5310	PKD1	0004	POLYCYSTIC KIDNEY DISEASE 1	PKD1, ARG4227TER	199476095
601313	5310	PKD1	0005	POLYCYSTIC KIDNEY DISEASE 1	PKD1, GLN3837TER	199476096
601313	5310	PKD1	0006	POLYCYSTIC KIDNEY DISEASE 1	PKD1, CYS4086TER	199476097
601313	5310	PKD1	0007	POLYCYSTIC KIDNEY DISEASE 1	PKD1, TYR3818TER	199476098
601313	5310	PKD1	0008	POLYCYSTIC KIDNEY DISEASE 1	PKD1, 12036G-A	
601313	5310	PKD1	0009	POLYCYSTIC KIDNEY DISEASE 1	PKD1, 28-BP DEL, NT6434	
601313	5310	PKD1	0010	POLYCYSTIC KIDNEY DISEASE 1	PKD1, IVS14, G-A, -1	
601313	5310	PKD1	0011	POLYCYSTIC KIDNEY DISEASE 1	PKD1, ARG324LEU	199476099
601313	5310	PKD1	0012	POLYCYSTIC KIDNEY DISEASE 1	PKD1, LEU845SER	199476100
601313	5310	PKD1	0013	POLYCYSTIC KIDNEY DISEASE 1	PKD1, GLN1922TER	199476101
601313	5310	PKD1	0014	POLYCYSTIC KIDNEY DISEASE 1, SEVERE	PKD1, 2-BP DEL, 5224AG	
601313	5310	PKD1	0015	POLYCYSTIC KIDNEY DISEASE 1, SEVERE	PKD1, TRP4139TER	199476102
601313	5310	PKD1	0016	POLYCYSTIC KIDNEY DISEASE 1	PKD1, GLY2579DEL, 8-BP DEL	
601314	3094	HINT1	0001	NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE	HINT1, ARG37PRO	
601314	3094	HINT1	0002	NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE	HINT1, CYS84ARG	
601314	3094	HINT1	0003	NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE	HINT1, GLY89VAL	
601314	3094	HINT1	0004	NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE	HINT1, HIS112ASN	
601314	3094	HINT1	0005	NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE	HINT1, HIS51ARG	
601314	3094	HINT1	0006	NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE	HINT1, GLN62TER	
601314	3094	HINT1	0007	NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE	HINT1, GLY93ASP	
601330	2984	GUCY2C	0001	DIARRHEA 6	GUCY2C, SER840ILE	
601330	2984	GUCY2C	0002	MECONIUM ILEUS	GUCY2C, ASP387GLY	
601330	2984	GUCY2C	0003	MECONIUM ILEUS	GUCY2C, 1-BP INS, 2270A	
601336	7841	MOGS	0001	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIb	GCS1, ARG486THR	121909291
601336	7841	MOGS	0002	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIb	GCS1, PHE652LEU	121909292
601373	1234	CCR5	0001	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO WEST NILE VIRUS, SUSCEPTIBILITY TO, INCLUDED;; HEPATITIS C VIRUS, RESISTANCE TO, INCLUDED;; MULTIPLE SCLEROSIS, DISEASE PROGRESSION, MODIFIER OF, INCLUDED	CCR5, 32-BP DEL, NT794	
601373	1234	CCR5	0002	CCR5 POLYMORPHISM, ORIENTAL 1	CCR5, 1-BP DEL	
601373	1234	CCR5	0003	CCR5 POLYMORPHISM, ORIENTAL 2	CCR5, ARG223GLN	1800452
601373	1234	CCR5	0004	CCR5 POLYMORPHISM, AFRICAN-AMERICAN	CCR5, ALA335VAL	1800944
601373	1234	CCR5	0005	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO	CCR5, CYS101TER	1800560
601373	1234	CCR5	0006	ACQUIRED IMMUNODEFICIENCY SYNDROME, DELAYED PROGRESSION TO	CCR5, 59029G-A	
601373	1234	CCR5	0007	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, INCREASED PERINATAL TRANSMISSION OF	CCR5, 59356C-T	
601373	1234	CCR5	0008	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO	CCR5, ARG60SER	1800940
601373	1234	CCR5	0009	CCR5 PROMOTER POLYMORPHISM HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO	CCR5, 2459A-G	
601385	7991	TUSC3	0001	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 7	TUSC3, 1-BP INS, 787C	
601385	7991	TUSC3	0002	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 7	TUSC3, GLN55TER	
601387	7251	TSG101	0001	BREAST CANCER	TSG101, VAL-ALA, 1162T-C	
601397	6862	T	0001	NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO	T, IVS7DS, T-C, +79	
601405	11330	CTRC	0001	PANCREATITIS, CHRONIC, SUSCEPTIBILITY TO	CTRC, ARG254TRP	121909293
601405	11330	CTRC	0002	PANCREATITIS, CHRONIC, SUSCEPTIBILITY TO	CTRC, 24-BP DEL, NT738	
601405	11330	CTRC	0003	PANCREATITIS, CHRONIC, SUSCEPTIBILITY TO	CTRC, TRP55TER	121909294
601411	6444	SGCD	0001	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2F	SGCD, 1-BP DEL, 656C	
601411	6444	SGCD	0002	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2F	SGCD, ARG165TER	121909295
601411	6444	SGCD	0003	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2F	SGCD, TRP30TER	121909296
601411	6444	SGCD	0004	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2F	SGCD, GLU262LYS	121909297
601411	6444	SGCD	0005	CARDIOMYOPATHY, DILATED, 1L	SGCD, 3-BP DEL, 710AGA/711GAA	
601411	6444	SGCD	0006	CARDIOMYOPATHY, DILATED, 1L MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2F, DIGENIC, INCLUDED	SGCD, SER151ALA	121909298
601411	6444	SGCD	0007	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2F	SGCD, ALA131PRO	
601421	3735	KARS	0001	CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE, B	KARS, LEU133HIS	
601421	3735	KARS	0002	CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE, B	KARS, 2-BP INS, 524TT	
601424	5019	OXCT1	0001	SUCCINYL-CoA:3-OXOACID CoA TRANSFERASE DEFICIENCY	OXCT1, SER283TER	121909299
601424	5019	OXCT1	0002	SUCCINYL-CoA:3-OXOACID CoA TRANSFERASE DEFICIENCY	OXCT1, CYS456PHE	121909300
601424	5019	OXCT1	0003	SUCCINYL-CoA:3-OXOACID CoA TRANSFERASE DEFICIENCY	OXCT1, THR58MET, VAL133GLU	75134564
601424	5019	OXCT1	0004	SUCCINYL-CoA:3-OXOACID CoA TRANSFERASE DEFICIENCY	OXCT1, GLY324GLU	121909301
601424	5019	OXCT1	0005	SUCCINYL-CoA:3-OXOACID CoA TRANSFERASE DEFICIENCY	OXCT1, GLY219GLU	121909302
601424	5019	OXCT1	0006	SUCCINYL-CoA:3-OXOACID CoA TRANSFERASE DEFICIENCY	OXCT1, VAL221MET	121909303
601424	5019	OXCT1	0007	SUCCINYL-CoA:3-OXOACID CoA TRANSFERASE DEFICIENCY	OXCT1, IVS13DS, G-A, +5	
601428	100151683	RNU4ATAC	0001	MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	RNU4ATAC, 51G-A	
601428	100151683	RNU4ATAC	0002	MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	RNU4ATAC, 55G-A	
601428	100151683	RNU4ATAC	0003	MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	RNU4ATAC, 30G-A	
601428	100151683	RNU4ATAC	0004	MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	RNU4ATAC, 111G-A	
601428	100151683	RNU4ATAC	0005	MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	RNU4ATAC, 50G-C	
601428	100151683	RNU4ATAC	0006	MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	RNU4ATAC, 53C-G	
601428	100151683	RNU4ATAC	0007	MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	RNU4ATAC, 50G-A	
601428	100151683	RNU4ATAC	0008	MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	RNU4ATAC, 66G-C	
601428	100151683	RNU4ATAC	0009	MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	RNU4ATAC, 124G-A	
601439	10060	ABCC9	0001	CARDIOMYOPATHY, DILATED, 1O	ABCC9, 3-BP DEL, 4-BP INS, EX38	
601439	10060	ABCC9	0002	CARDIOMYOPATHY, DILATED, 1O	ABCC9, ALA1513THR	121909304
601439	10060	ABCC9	0003	ATRIAL FIBRILLATION, FAMILIAL, 12	ABCC9, THR1547ILE	
601439	10060	ABCC9	0004	HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	ABCC9, ARG1154TRP	
601439	10060	ABCC9	0005	HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	ABCC9, ARG1154GLN	
601439	10060	ABCC9	0006	HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	ABCC9, CYS1043TYR	
601439	10060	ABCC9	0007	HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	ABCC9, ALA478VAL	
601439	10060	ABCC9	0008	HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	ABCC9, ARG1116HIS	
601439	10060	ABCC9	0009	HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	ABCC9, ARG1116CYS	
601439	10060	ABCC9	0010	HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	ABCC9, SER1020PRO	
601439	10060	ABCC9	0011	HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	ABCC9, HIS60TYR	
601440	8526	DGKE	0001	NEPHROTIC SYNDROME, TYPE 7	DGKE, GLN43TER	
601440	8526	DGKE	0002	NEPHROTIC SYNDROME, TYPE 7	DGKE, 1-BP DEL, 610A	
601440	8526	DGKE	0003	NEPHROTIC SYNDROME, TYPE 7	DGKE, IVS5AS, A-G, -2	
601440	8526	DGKE	0004	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 7	DGKE, TRP322TER	
601440	8526	DGKE	0005	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 7	DGKE, 1-BP INS, 486A	
601440	8526	DGKE	0006	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 7	DGKE, ARG63PRO	
601440	8526	DGKE	0007	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 7	DGKE, SER11TER	
601440	8526	DGKE	0008	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 7	DGKE, ARG273PRO	
601443	1073	CFL2	0001	NEMALINE MYOPATHY 7	CFL2, ALA35THR	80358250
601460	6578	SLCO2A1	0001	HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 2	SLCO2A1, IVS1AS, G-A, -1	
601460	6578	SLCO2A1	0002	HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 2	SLCO2A1, GLY255GLU	
601460	6578	SLCO2A1	0003	HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 2	SLCO2A1, 1-BP DEL, 1634A	
601460	6578	SLCO2A1	0004	HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 2	SLCO2A1, GLY222ARG	
601460	6578	SLCO2A1	0005	HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 2	SLCO2A1, IVS7, G-A, +1	
601460	6578	SLCO2A1	0006	HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 2	SLCO2A1, 1-BP INS, 830T	
601460	6578	SLCO2A1	0007	VARIANT OF UNKNOWN SIGNIFICANCE	SLCO2A1, ARG252TER	
601460	6578	SLCO2A1	0008	HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 2	SLCO2A1, CYS420PHE	
601460	6578	SLCO2A1	0009	HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 2	SLCO2A1, ILE85PHE	
601460	6578	SLCO2A1	0010	HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 2	SLCO2A1, GLY104TER	
601465	1716	DGUOK	0001	MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	DGUOK, 1-BP DEL, 204A	
601465	1716	DGUOK	0002	MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	DGUOK, ARG105TER	104893630
601465	1716	DGUOK	0003	MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	DGUOK, 4-BP DUP, 763GATT	
601465	1716	DGUOK	0004	MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	DGUOK, 2-BP DEL, 609GT	
601465	1716	DGUOK	0005	MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	DGUOK, ARG142LYS	104893631
601465	1716	DGUOK	0006	MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	DGUOK, GLU227LYS	104893632
601465	1716	DGUOK	0007	MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	DGUOK, ASP255TYR	104893633
601470	1524	CX3CR1	0001	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RAPID PROGRESSION TO AIDS CORONARY ARTERY DISEASE, RESISTANCE TO, INCLUDED;; MACULAR DEGENERATION, AGE-RELATED, 12, SUSCEPTIBILITY TO, INCLUDED	CX3CR1, VAL249ILE/THR280MET	3732379
601478	4640	MYO1A	0001	DEAFNESS, AUTOSOMAL DOMINANT 48	MYO1A, ARG93TER	121909305
601478	4640	MYO1A	0002	DEAFNESS, AUTOSOMAL DOMINANT 48	MYO1A, 3-BP INS, 349CTT	
601478	4640	MYO1A	0003	DEAFNESS, AUTOSOMAL DOMINANT 48	MYO1A, VAL306MET	55679042
601478	4640	MYO1A	0004	DEAFNESS, AUTOSOMAL DOMINANT 48	MYO1A, GLU385ASP	61753849
601478	4640	MYO1A	0005	DEAFNESS, AUTOSOMAL DOMINANT 48	MYO1A, GLY662GLU	33962952
601478	4640	MYO1A	0006	DEAFNESS, AUTOSOMAL DOMINANT 48	MYO1A, SER910PRO	121909306
601479	4643	MYO1E	0001	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 6	MYO1E, ALA159PRO	
601479	4643	MYO1E	0002	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 6	MYO1E, TYR695TER	
601486	1618	DAZL	0001	SPERMATOGENIC FAILURE, SUSCEPTIBILITY TO	DAZL, THR54ALA	121918346
601487	5468	PPARG	0001	OBESITY, SEVERE	PPARG, PRO115GLN	1800571
601487	5468	PPARG	0002	DIABETES MELLITUS, NONINSULIN-DEPENDENT, MODIFIER OF OBESITY, MODIFIER OF, INCLUDED;; BODY MASS INDEX, MODIFIER OF, INCLUDED;; INTIMAL MEDIAL THICKNESS OF INTERNAL CAROTID ARTERY, MODIFIER OF, INCLUDED	PPARG2, PRO12ALA	1801282
601487	5468	PPARG	0003	COLON CANCER, SOMATIC	PPARG, 1-BP DEL, 472A	
601487	5468	PPARG	0004	COLON CANCER, SOMATIC	PPARG, GLN286PRO	121909242
601487	5468	PPARG	0005	COLON CANCER, SOMATIC	PPARG, LYS319TER	121909243
601487	5468	PPARG	0006	COLON CANCER, SOMATIC	PPARG, ARG288HIS	28936407
601487	5468	PPARG	0007	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3	PPARG, PRO467LEU	121909244
601487	5468	PPARG	0008	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3	PPARG, VAL290MET	72551362
601487	5468	PPARG	0009	PPARG POLYMORPHISM C/T	PPARG, 161C-T	
601487	5468	PPARG	0010	RECLASSIFIED - PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA POLYMORPHISM	PPARG, HIS449HIS	3856806
601487	5468	PPARG	0011	INSULIN RESISTANCE, DIGENIC DIABETES MELLITUS, TYPE II, DIGENIC, INCLUDED	PPARG, 3-BP DEL/1-BP INS, NT553	
601487	5468	PPARG	0012	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3	PPARG, PHE388LEU	72551363
601487	5468	PPARG	0013	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3	PPARG, ARG425CYS	72551364
601487	5468	PPARG	0014	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3	PPARG, CYS190SER	121909245
601487	5468	PPARG	0015	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3	PPARG, ARG194TRP	121909246
601488	4689	NCF4	0001	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE III	NCF4, 10-BP DUP, NT3957	
601488	4689	NCF4	0002	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE III	NCF4, ARG105GLN	
601489	3483	IGFALS	0001	ACID-LABILE SUBUNIT DEFICIENCY	IGFALS, 1-BP DEL, 1338G	
601489	3483	IGFALS	0002	ACID-LABILE SUBUNIT DEFICIENCY	IGFALS, CYS540ARG	121909247
601489	3483	IGFALS	0003	ACID-LABILE SUBUNIT DEFICIENCY	IGFALS, 9-BP DUP	
601498	5190	PEX6	0001	PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	PEX6, IVSAS, G-A, -1, 8-BP DEL	
601498	5190	PEX6	0002	PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	PEX6, 20-BP DEL, 1-BP INS	
601498	5190	PEX6	0003	PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	PEX6, 1-BP INS, NT511	
601498	5190	PEX6	0004	PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	PEX6, IVS3DS, G-A, +1	
601498	5190	PEX6	0005	PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	PEX6, IVS7, G-A, +1	
601498	5190	PEX6	0006	PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	PEX6, 1-BP DEL, 1301C	
601498	5190	PEX6	0007	PEROXISOME BIOGENESIS DISORDER 4B	PEX6, 264-BP DEL, NT619	
601498	5190	PEX6	0008	PEROXISOME BIOGENESIS DISORDER 4B	PEX6, 269-BP DEL AND 21-BP INS	
601498	5190	PEX6	0009	PEROXISOME BIOGENESIS DISORDER 4B	PEX6, LEU534PRO	
601500	6608	SMO	0001	BASAL CELL CARCINOMA, SPORADIC	SMOH, TRP535LEU	121918347
601500	6608	SMO	0002	BASAL CELL CARCINOMA, SPORADIC	SMOH, ARG562GLN	121918348
601501	55737	VPS35	0001	PARKINSON DISEASE 17	VPS35, ASP620ASN	
601515	2259	FGF14	0001	SPINOCEREBELLAR ATAXIA 27	FGF14, PHE145SER	104894393
601515	2259	FGF14	0002	SPINOCEREBELLAR ATAXIA 27	FGF14, 1-BP DEL, 487A	
601517	6311	ATXN2	0001	SPINOCEREBELLAR ATAXIA 2 PARKINSON DISEASE, LATE-ONSET, SUSCEPTIBILITY TO, INCLUDED	ATXN2, (CAG)n EXPANSION, LONG	193922927
601517	6311	ATXN2	0002	AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 13	ATXN2, (CAG)n EXPANSION, INTERMEDIATE	
601525	1116	CHI3L1	0001	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 7	CHI3L1, -131C-G	4950928
601527	8092	ALX1	0001	FRONTONASAL DYSPLASIA 3	ALX1, IVS2DS, G-A, +1	
601530	8878	SQSTM1	0001	PAGET DISEASE OF BONE	SQSTM1, PRO392LEU	104893941
601530	8878	SQSTM1	0002	PAGET DISEASE OF BONE	SQSTM1, 1-BP INS, 1224T	
601530	8878	SQSTM1	0003	PAGET DISEASE OF BONE	SQSTM1, IVS7, G-A, +1	
601538	5626	PROP1	0001	PITUITARY HORMONE DEFICIENCY, COMBINED, 2	PROP1, ARG120CYS	
601538	5626	PROP1	0002	PITUITARY HORMONE DEFICIENCY, COMBINED, 2	PROP1, 2-BP DEL, 301AG	
601538	5626	PROP1	0003	PITUITARY HORMONE DEFICIENCY, COMBINED, 2	PROP1, PHE117ILE	
601538	5626	PROP1	0004	PITUITARY HORMONE DEFICIENCY, COMBINED, 2	PROP1, 2-BP DEL, 149GA	
601538	5626	PROP1	0005	PITUITARY HORMONE DEFICIENCY, COMBINED, 2	PROP1, 2-BP DEL, 296GA	
601538	5626	PROP1	0006	PITUITARY HORMONE DEFICIENCY, COMBINED, 2	PROP1, PHE88SER	
601538	5626	PROP1	0007	PITUITARY HORMONE DEFICIENCY, COMBINED, 2	PROP1, 13-BP DEL, NT112	
601538	5626	PROP1	0008	PITUITARY HORMONE DEFICIENCY, COMBINED, 2	PROP1, 1-BP DEL, 150A	
601538	5626	PROP1	0009	PITUITARY HORMONE DEFICIENCY, COMBINED, 2	PROP1, ARG73HIS	
601538	5626	PROP1	0010	PITUITARY HORMONE DEFICIENCY, COMBINED, 2	PROP1, ARG73CYS	
601538	5626	PROP1	0011	PITUITARY HORMONE DEFICIENCY, COMBINED, 2	PROP1, ARG99TER	
601538	5626	PROP1	0012	PITUITARY HORMONE DEFICIENCY, COMBINED, 2	PROP1, ARG99GLU	137853100
601538	5626	PROP1	0013	PITUITARY HORMONE DEFICIENCY, COMBINED, 2	PROP1, TRP194TER	
601542	5308	PITX2	0001	AXENFELD-RIEGER SYNDROME, TYPE 1	PITX2, LEU54GLN	104893857
601542	5308	PITX2	0002	AXENFELD-RIEGER SYNDROME, TYPE 1	PITX2, IVS3DS, G-C, +5	
601542	5308	PITX2	0003	AXENFELD-RIEGER SYNDROME, TYPE 1	PITX2, THR68PRO	104893858
601542	5308	PITX2	0004	AXENFELD-RIEGER SYNDROME, TYPE 1	PITX2, IVS3AS, A-G, -11	
601542	5308	PITX2	0005	AXENFELD-RIEGER SYNDROME, TYPE 1	PITX2, ARG91PRO	104893859
601542	5308	PITX2	0006	AXENFELD-RIEGER SYNDROME, TYPE 1	PITX2, TRP133TER	104893860
601542	5308	PITX2	0007	IRIDOGONIODYSGENESIS, TYPE 2	PITX2, ARG46TRP	121909248
601542	5308	PITX2	0008	IRIDOGONIODYSGENESIS, TYPE 2	PITX2, ARG70HIS	
601542	5308	PITX2	0009	PETERS ANOMALY	PITX2, IVS3AS, A-T, -2	
601542	5308	PITX2	0010	AXENFELD-RIEGER SYNDROME, TYPE 1	PITX2, VAL45LEU	121909249
601542	5308	PITX2	0011	AXENFELD-RIEGER SYNDROME, TYPE 1	PITX2, 21-BP DUP, NT713	
601542	5308	PITX2	0012	RING DERMOID OF CORNEA	PITX2, ARG62HIS	104893862
601542	5308	PITX2	0013	AXENFELD-RIEGER SYNDROME, TYPE 1	PITX2, LYS88GLU	
601545	5048	PAFAH1B1	0001	LISSENCEPHALY 1	PAFAH1B1, HIS149ARG	121434482
601545	5048	PAFAH1B1	0002	LISSENCEPHALY 1	PAFAH1B1, ARG273TER	121434483
601545	5048	PAFAH1B1	0003	LISSENCEPHALY 1	PAFAH1B1, 22-BP DEL	
601545	5048	PAFAH1B1	0004	SUBCORTICAL LAMINAR HETEROTOPIA	PAFAH1B1, SER169PRO	121434484
601545	5048	PAFAH1B1	0005	LISSENCEPHALY 1	PAFAH1B1, ASP317HIS	121434485
601545	5048	PAFAH1B1	0006	LISSENCEPHALY 1	PAFAH1B1, PHE31SER	121434486
601545	5048	PAFAH1B1	0007	LISSENCEPHALY 1	PAFAH1B1, GLY162SER	121434487
601545	5048	PAFAH1B1	0008	SUBCORTICAL LAMINAR HETEROTOPIA	PAFAH1B1, ARG241PRO	121434488
601545	5048	PAFAH1B1	0009	SUBCORTICAL LAMINAR HETEROTOPIA LISSENCEPHALY 1	PAFAH1B1, ARG8TER	121434489
601545	5048	PAFAH1B1	0010	LISSENCEPHALY 1	PAFAH1B1, HIS277PRO	121434490
601548	2202	EFEMP1	0001	MALATTIA LEVENTINESE DOYNE HONEYCOMB RETINAL DYSTROPHY, INCLUDED	EFEMP1, ARG345TRP	121434491
601556	6310	ATXN1	0001	SPINOCEREBELLAR ATAXIA 1	ATXN1, (CAG)n EXPANSION	193922926
601564	5645	PRSS2	0001	PANCREATITIS, CHRONIC, PROTECTION AGAINST	PRSS2, GLY191ARG	111033569
601566	3621	ING1	0001	SQUAMOUS CELL CARCINOMA, HEAD AND NECK, SOMATIC	ING1, CYS215SER	121909250
601566	3621	ING1	0002	SQUAMOUS CELL CARCINOMA, HEAD AND NECK, SOMATIC	ING1, ASN216SER	121909251
601566	3621	ING1	0003	SQUAMOUS CELL CARCINOMA, HEAD AND NECK, SOMATIC	ING1, ALA192ASP	121909252
601567	3998	LMAN1	0001	FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 1, MIDDLE EASTERN JEWISH TYPE	LMAN1, 1-BP INS, 86G	
601567	3998	LMAN1	0002	FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 1, SEPHARDIC JEWISH TYPE	LMAN1, IVS383DS, T-C, +2	
601567	3998	LMAN1	0003	FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 1	LMAN1, 1-BP DEL, 795C	
601567	3998	LMAN1	0004	FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 1	LMAN1, 1-BP DEL, 1356C	
601567	3998	LMAN1	0005	FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 1	LMAN1, MET1THR	121909253
601570	7476	WNT7A	0001	ULNA AND FIBULA, ABSENCE OF, WITH SEVERE LIMB DEFICIENCY	WNT7A, ARG292CYS	104893835
601570	7476	WNT7A	0002	FUHRMANN SYNDROME	WNT7A, ALA109THR	104893832
601570	7476	WNT7A	0003	ULNA AND FIBULA, ABSENCE OF, WITH SEVERE LIMB DEFICIENCY	WNT7A, GLY204SER	
601570	7476	WNT7A	0004	ULNA AND FIBULA, ABSENCE OF, WITH SEVERE LIMB DEFICIENCY	WNT7A, ARG222TRP	
601570	7476	WNT7A	0005	ULNA AND FIBULA, ABSENCE OF, WITH SEVERE LIMB DEFICIENCY	WNT7A, GLU72LYS	
601573	2146	EZH2	0001	WEAVER SYNDROME	EZH2, 3-BP DEL, NT457	
601573	2146	EZH2	0002	WEAVER SYNDROME	EZH2, HIS694TYR	
601573	2146	EZH2	0003	WEAVER SYNDROME	EZH2, PRO132SER	
601592	5913	RAPSN	0001	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	RAPSN, ASN88LYS	104894299
601592	5913	RAPSN	0002	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	RAPSN, LEU14PRO	104894300
601592	5913	RAPSN	0003	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	RAPSN, 5-BP INS	
601592	5913	RAPSN	0004	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	RAPSN, 1-BP INS, 46C	
601592	5913	RAPSN	0005	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	RAPSN, TYR269TER	104894301
601592	5913	RAPSN	0006	MYASTHENIC SYNDROME, CONGENITAL, WITH FACIAL DYSMORPHISM, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	RAPSN, -38A-G	
601592	5913	RAPSN	0007	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	RAPSN, LEU283PRO	104894293
601592	5913	RAPSN	0008	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	RAPSN, IVS1AS, C-A, -15	
601592	5913	RAPSN	0009	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	RAPSN, ARG164CYS	104894294
601592	5913	RAPSN	0010	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	RAPSN, VAL45MET	121909254
601592	5913	RAPSN	0011	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	RAPSN, GLU162LYS	121909255
601592	5913	RAPSN	0012	FETAL AKINESIA DEFORMATION SEQUENCE	RAPSN, 2-BP DEL, 1177AA	
601592	5913	RAPSN	0013	FETAL AKINESIA DEFORMATION SEQUENCE	RAPSN, PHE139SER	121909256
601592	5913	RAPSN	0014	FETAL AKINESIA DEFORMATION SEQUENCE	RAPSN, ALA189VAL	121909257
601593	580	BARD1	0001	BREAST CANCER, SUSCEPTIBILITY TO	BARD1, CYS557SER	28997576
601601	7021	TFAP2B	0001	CHAR SYNDROME	TFAP2B, ALA264ASP	80338914
601601	7021	TFAP2B	0002	CHAR SYNDROME	TFAP2B, ARG289CYS	80338917
601601	7021	TFAP2B	0003	CHAR SYNDROME	TFAP2B, ARG225CYS	80338912
601601	7021	TFAP2B	0004	CHAR SYNDROME	TFAP2B, ARG225SER	80338912
601601	7021	TFAP2B	0005	CHAR SYNDROME	TFAP2B, ARG274GLN	80338915
601601	7021	TFAP2B	0006	CHAR SYNDROME	TFAP2B, PRO62ARG	80338910
601604	3594	IL12RB1	0001	MYCOBACTERIAL AND SALMONELLA INFECTIONS, SUSCEPTIBILITY TO	IL12RB1, GLN32TER	121434492
601604	3594	IL12RB1	0002	MYCOBACTERIAL AND SALMONELLA INFECTIONS, SUSCEPTIBILITY TO	IL12RB1, GLN376TER	121434493
601604	3594	IL12RB1	0003	MYCOBACTERIAL AND SALMONELLA INFECTIONS, SUSCEPTIBILITY TO	IL12RB1, 409-549DEL	
601604	3594	IL12RB1	0004	MYCOBACTERIAL AND SALMONELLA INFECTIONS, SUSCEPTIBILITY TO	IL12RB1, ARG213TRP	121434494
601604	3594	IL12RB1	0005	MYCOBACTERIAL AND SALMONELLA INFECTIONS, SUSCEPTIBILITY TO	IL12RB1, 12,165-BP DEL	
601604	3594	IL12RB1	0006	MYCOBACTERIAL AND SALMONELLA INFECTIONS, SUSCEPTIBILITY TO MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO INFECTION BY	IL12RB1, IVS9DS, G-C, +1	
601604	3594	IL12RB1	0007	MYCOBACTERIAL INFECTIONS, SUSCEPTIBILITY TO	IL12RB1, CYS198ARG	121434495
601607	6598	SMARCB1	0001	MALIGNANT RHABDOID TUMOR, SOMATIC	SMARCB1, 1-BP DEL	
601607	6598	SMARCB1	0002	MALIGNANT RHABDOID TUMOR, SOMATIC	SMARCB1, 19-BP DEL	
601607	6598	SMARCB1	0003	RHABDOID TUMOR PREDISPOSITION SYNDROME 1	SMARCB1, 1-BP DEL, 591G	
601607	6598	SMARCB1	0004	RHABDOID TUMOR PREDISPOSITION SYNDROME 1	SMARCB1, IVS7DS, G-A, +1	
601607	6598	SMARCB1	0005	SCHWANNOMATOSIS	SMARCB1, GLN12TER	74315513
601607	6598	SMARCB1	0006	SCHWANNOMATOSIS, SOMATIC	SMARCB1, GLN182TER	121434496
601607	6598	SMARCB1	0007	SCHWANNOMATOSIS	SMARCB1, 14-BP DEL/4-BP INS, NT203	
601607	6598	SMARCB1	0008	SCHWANNOMATOSIS	SMARCB1, 7-BP DEL, NT233	
601607	6598	SMARCB1	0009	SCHWANNOMATOSIS RHABDOID TUMOR PREDISPOSITION SYNDROME 1, INCLUDED	SMARCB1, 2,631-BP DUP	
601607	6598	SMARCB1	0010	SCHWANNOMATOSIS	SMARCB1, GLU31VAL	
601607	6598	SMARCB1	0011	SCHWANNOMATOSIS	SMARCB1, PRO48LEU	
601607	6598	SMARCB1	0012	MENTAL RETARDATION, AUTOSOMAL DOMINANT 15	SMARCB1, LYS364DEL	
601607	6598	SMARCB1	0013	MENTAL RETARDATION, AUTOSOMAL DOMINANT 15	SMARCB1, ARG377HIS	
601609	3033	HADH	0001	3-@HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY	HADH, ALA28THR	137853101
601609	3033	HADH	0002	3-@HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY	HADH, ASP45GLU	137853102
601609	3033	HADH	0003	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4	HADH, PRO258LEU	137853103
601609	3033	HADH	0004	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4	HADH, 6-BP DEL	
601609	3033	HADH	0005	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4	HADH, ARG236TER	
601609	3033	HADH	0006	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4	HADH, EX1DEL	
601609	3033	HADH	0007	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4	HADH, IVS5, G-T, +471	
601615	21	ABCA3	0001	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 3	ABCA3, TRP1142TER	121909181
601615	21	ABCA3	0002	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 3	ABCA3, LEU101PRO	121909182
601615	21	ABCA3	0003	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 3	ABCA3, LEU1553PRO	121909183
601615	21	ABCA3	0004	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 3	ABCA3, GLN1591PRO	28936691
601615	21	ABCA3	0005	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 3	ABCA3, ASN568ASP	121909184
601615	21	ABCA3	0006	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 3	ABCA3, 4909, G-A, +1	
601615	21	ABCA3	0007	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 3	ABCA3, LEU326PRO	121909185
601617	5959	RDH5	0001	FUNDUS ALBIPUNCTATUS, AUTOSOMAL RECESSIVE	RDH5, GLY238TRP	62638191
601617	5959	RDH5	0002	FUNDUS ALBIPUNCTATUS, AUTOSOMAL RECESSIVE	RDH5, SER73PHE	62638185
601617	5959	RDH5	0003	FUNDUS ALBIPUNCTATUS, AUTOSOMAL RECESSIVE	RDH5, ARG280HIS	62638193
601617	5959	RDH5	0004	FUNDUS ALBIPUNCTATUS, AUTOSOMAL RECESSIVE	RDH5, ALA294PRO	111033593
601617	5959	RDH5	0005	FUNDUS ALBIPUNCTATUS, AUTOSOMAL RECESSIVE	RDH5, VAL177GLY	104894373
601617	5959	RDH5	0006	FUNDUS ALBIPUNCTATUS, AUTOSOMAL RECESSIVE	RDH5, TYR281HIS	62638194
601617	5959	RDH5	0007	FUNDUS ALBIPUNCTATUS, AUTOSOMAL RECESSIVE	RDH5, LEU310GLY/VAL	
601617	5959	RDH5	0008	FUNDUS ALBIPUNCTATUS, AUTOSOMAL RECESSIVE	RDH5, ARG157TRP	104894374
601618	54345	SOX18	0001	HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME	SOX18, ALA104PRO	28936692
601618	54345	SOX18	0002	HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME	SOX18, TRP95ARG	28936693
601618	54345	SOX18	0003	HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME	SOX18, CYS240TER	74315430
601620	6910	TBX5	0001	HOLT-ORAM SYNDROME	TBX5, 1491C-T	
601620	6910	TBX5	0002	HOLT-ORAM SYNDROME	TBX5, GLU69TER	104894377
601620	6910	TBX5	0003	HOLT-ORAM SYNDROME	TBX5, ARG237GLN	104894378
601620	6910	TBX5	0004	HOLT-ORAM SYNDROME	TBX5, GLY80ARG	104894381
601620	6910	TBX5	0005	HOLT-ORAM SYNDROME	TBX5, ARG237TRP	104894382
601620	6910	TBX5	0006	HOLT-ORAM SYNDROME	TBX5, 1-BP DEL, 416C	
601620	6910	TBX5	0007	HOLT-ORAM SYNDROME	TBX5, GLN49LYS	104894383
601620	6910	TBX5	0008	HOLT-ORAM SYNDROME	TBX5, ILE54THR	104894384
601620	6910	TBX5	0009	HOLT-ORAM SYNDROME	TBX5, TYR136TER	104894379
601621	6926	TBX3	0001	ULNAR-MAMMARY SYNDROME	TBX3, 1-BP DEL, 227T	
601621	6926	TBX3	0002	ULNAR-MAMMARY SYNDROME	TBX3, IVS2DS, G-C, +1	
601621	6926	TBX3	0003	ULNAR-MAMMARY SYNDROME	TBX3, LYS273TER	104894376
601621	6926	TBX3	0004	ULNAR-MAMMARY SYNDROME	TBX3, 1-BP INS, 88A	
601621	6926	TBX3	0005	ULNAR-MAMMARY SYNDROME	TBX3, GLN331TER	
601622	7291	TWIST1	0001	SAETHRE-CHOTZEN SYNDROME	TWIST1, TYR103TER	104894054
601622	7291	TWIST1	0002	SAETHRE-CHOTZEN SYNDROME	TWIST1, GLN119PRO	104894057
601622	7291	TWIST1	0003	SAETHRE-CHOTZEN SYNDROME	TWIST1, TYR107TER	104894054
601622	7291	TWIST1	0004	SAETHRE-CHOTZEN SYNDROME	TWIST1, SER127TER	121909187
601622	7291	TWIST1	0005	SAETHRE-CHOTZEN SYNDROME	TWIST1, GLU130TER	121909188
601622	7291	TWIST1	0006	SAETHRE-CHOTZEN SYNDROME	TWIST1, LEU135PRO	121909189
601622	7291	TWIST1	0007	SAETHRE-CHOTZEN SYNDROME	TWIST1, 21-BP DUP	
601622	7291	TWIST1	0008	SAETHRE-CHOTZEN SYNDROME	TWIST1, GLU181TER	104894058
601622	7291	TWIST1	0009	ROBINOW-SORAUF SYNDROME	TWIST1, 1-BP INS, 460A	
601622	7291	TWIST1	0010	SAETHRE-CHOTZEN SYNDROME	TWIST1, ILE156VAL	104894059
601622	7291	TWIST1	0011	SAETHRE-CHOTZEN SYNDROME WITH EYELID ANOMALIES	TWIST1, GLN28TER	104894055
601622	7291	TWIST1	0012	ROBINOW-SORAUF SYNDROME	TWIST1, GLN71TER	104894065
601622	7291	TWIST1	0013	CRANIOSYNOSTOSIS, TYPE 1	TWIST1, ALA186THR	121909190
601622	7291	TWIST1	0014	CRANIOSYNOSTOSIS, TYPE 1	TWIST1, SER188LEU	121909191
601623	7337	UBE3A	0001	ANGELMAN SYNDROME	UBE3A, 5-BP DUP	
601623	7337	UBE3A	0002	ANGELMAN SYNDROME	UBE3A, IVS9, A-G, -8	
601623	7337	UBE3A	0003	ANGELMAN SYNDROME	UBE3A, 2-BP DEL, 1344GT	
601623	7337	UBE3A	0004	ANGELMAN SYNDROME	UBE3A, ARG417TER	111033594
601623	7337	UBE3A	0005	ANGELMAN SYNDROME	UBE3A, TRP768TER	111033595
601623	7337	UBE3A	0006	ANGELMAN SYNDROME	UBE3A, THR106PRO	111033596
601623	7337	UBE3A	0007	ANGELMAN SYNDROME	UBE3A, ILE130THR	111033597
601623	7337	UBE3A	0008	ANGELMAN SYNDROME	UBE3A, 4-BP DEL, 3093AAGA	
601623	7337	UBE3A	0009	ANGELMAN SYNDROME	UBE3A, 2-BP DEL, 1930AG	
601623	7337	UBE3A	0010	ANGELMAN SYNDROME	UBE3A, 4-BP DUP, EX10, GAGG	
601623	7337	UBE3A	0011	ANGELMAN SYNDROME	UBE3A, 15-BP DEL/7-BP INS, NT3240	
601627	6607	SMN2	0001	SPINAL MUSCULAR ATROPHY, MODIFIER OF	SMN2, GLY287ARG	121909192
601652	4653	MYOC	0001	GLAUCOMA 1, OPEN ANGLE, A	MYOC, TYR437HIS	74315328
601652	4653	MYOC	0002	GLAUCOMA 1, OPEN ANGLE, A	MYOC, GLY357VAL	121909193
601652	4653	MYOC	0003	GLAUCOMA 1, OPEN ANGLE, A	MYOC, GLN368TER	74315329
601652	4653	MYOC	0004	GLAUCOMA 1, OPEN ANGLE, A	MYOC, PRO370LEU	74315330
601652	4653	MYOC	0005	GLAUCOMA 1, OPEN ANGLE, A	MYOC, ILE477SER	74315331
601652	4653	MYOC	0006	GLAUCOMA 1, OPEN ANGLE, A	MYOC, ASN480LYS	74315332
601652	4653	MYOC	0008	GLAUCOMA 1, OPEN ANGLE, A	MYOC, GLY367ARG	74315334
601652	4653	MYOC	0009	GLAUCOMA 1, OPEN ANGLE, A	MYOC, GLN337ARG	74315335
601652	4653	MYOC	0010	GLAUCOMA 1, OPEN ANGLE, A	MYOC, LYS423GLU	74315336
601652	4653	MYOC	0011	GLAUCOMA 1, OPEN ANGLE, A, AUTOSOMAL RECESSIVE	MYOC, ARG46TER	74315337
601652	4653	MYOC	0012	GLAUCOMA 1, OPEN ANGLE, A	MYOC, CYS433ARG	74315338
601652	4653	MYOC	0013	GLAUCOMA 1, OPEN ANGLE, A, DIGENIC	MYOC, GLY399VAL	28936694
601652	4653	MYOC	0014	GLAUCOMA 1, OPEN ANGLE, A GLAUCOMA 3, PRIMARY CONGENITAL, A, DIGENIC, INCLUDED	MYOC, GLN48HIS	74315339
601652	4653	MYOC	0015	GLAUCOMA 1, OPEN ANGLE, A	MYOC, CYS245TYR	74315340
601652	4653	MYOC	0016	GLAUCOMA 1, OPEN ANGLE, A	MYOC, GLY252ARG	74315341
601652	4653	MYOC	0017	GLAUCOMA 1, OPEN ANGLE, A	MYOC, ASP380HIS	74315331
601652	4653	MYOC	0018	GLAUCOMA 1, OPEN ANGLE, A	MYOC, ILE477ASN	
601653	2138	EYA1	0001	BRANCHIOOTORENAL SYNDROME 1	EYA1, ARG275TER	121909195
601653	2138	EYA1	0002	BRANCHIOOTORENAL SYNDROME 1	EYA1, 1-BP DEL AND 2-BP INS, 1251T-CC	
601653	2138	EYA1	0003	BRANCHIOOTIC SYNDROME 1	EYA1, 2-BP INS, 870GT	
601653	2138	EYA1	0004	BRANCHIOOTIC SYNDROME 1	EYA1, 8-BP DEL, NT297	
601653	2138	EYA1	0005	BRANCHIOOTORENAL SYNDROME 1	EYA1, ALU INS, EX10	
601653	2138	EYA1	0006	BRANCHIOOTORENAL SYNDROME 1	EYA1, 4-BP DEL, NT1501	
601653	2138	EYA1	0007	BRANCHIOOTORENAL SYNDROME 1	EYA1, ARG407GLN	121909196
601653	2138	EYA1	0008	ANTERIOR SEGMENT ANOMALIES AND CATARACT	EYA1, ARG514GLY	121909197
601653	2138	EYA1	0009	ANTERIOR SEGMENT ANOMALIES	EYA1, GLU330LYS	121909198
601653	2138	EYA1	0010	BRANCHIOOTORENAL SYNDROME WITH CATARACT	EYA1, GLY393SER	121909199
601653	2138	EYA1	0011	BRANCHIOOTORENAL SYNDROME 1	EYA1, 1-BP INS, 387T	
601653	2138	EYA1	0012	BRANCHIOOTORENAL SYNDROME 1	EYA1, SER454PRO	121909200
601653	2138	EYA1	0013	BRANCHIOOTORENAL SYNDROME 1	EYA1, LEU472ARG	121909201
601653	2138	EYA1	0014	OTOFACIOCERVICAL SYNDROME	EYA1, IVS6DS, G-A, +1	
601653	2138	EYA1	0015	BRANCHIOOTIC SYNDROME 1 BRANCHIOOTORENAL SYNDROME 1, INCLUDED	EYA1, ARG328TER	121909202
601653	2138	EYA1	0016	BRANCHIOOTIC SYNDROME 1	EYA1, 7-BP DEL, NT1402	
601653	2138	EYA1	0017	BRANCHIOOTORENAL SYNDROME 1	EYA1, IVS8DS, G-A, +5	
601656	2627	GATA6	0001	PERSISTENT TRUNCUS ARTERIOSUS	GATA6, 2-BP DEL, 1456GA	
601656	2627	GATA6	0002	PERSISTENT TRUNCUS ARTERIOSUS	GATA6, ASN466HIS	
601656	2627	GATA6	0003	TETRALOGY OF FALLOT	GATA6, LEU198VAL	
601656	2627	GATA6	0004	ATRIOVENTRICULAR SEPTAL DEFECT 5	GATA6, ALA178VAL	
601656	2627	GATA6	0005	ATRIAL SEPTAL DEFECT 9 TETRALOGY OF FALLOT, INCLUDED	GATA6, SER184ASN	
601656	2627	GATA6	0006	PANCREATIC AGENESIS AND CONGENITAL CARDIAC DEFECTS	GATA6, THR452ALA	
601656	2627	GATA6	0007	PANCREATIC AGENESIS AND CONGENITAL CARDIAC DEFECTS	GATA6, 8-BP DEL, NT1448	
601656	2627	GATA6	0008	PANCREATIC AGENESIS AND CONGENITAL CARDIAC DEFECTS	GATA6, ARG456CYS	
601656	2627	GATA6	0009	PANCREATIC AGENESIS AND CONGENITAL CARDIAC DEFECTS	GATA6, ARG456HIS	
601656	2627	GATA6	0010	PANCREATIC AGENESIS AND CONGENITAL CARDIAC DEFECTS	GATA6, ASN466ASP	
601656	2627	GATA6	0011	PANCREATIC AGENESIS AND CONGENITAL CARDIAC DEFECTS	GATA6, ALA467THR	
601656	2627	GATA6	0012	PANCREATIC AGENESIS AND CONGENITAL CARDIAC DEFECTS	GATA6, 2-BP DEL, 1504AA	
601664	23020	SNRNP200	0001	RETINITIS PIGMENTOSA 33	SNRNP200, SER1087LEU	
601664	23020	SNRNP200	0002	RETINITIS PIGMENTOSA 33	SNRNP200, ARG1090LEU	
601664	23020	SNRNP200	0003	RETINITIS PIGMENTOSA 33	SNRNP200, GLN885GLU	
601687	3859	KRT12	0001	MEESMANN CORNEAL DYSTROPHY	KRT12, ARG135THR	57218384
601687	3859	KRT12	0002	MEESMANN CORNEAL DYSTROPHY	KRT12, VAL143LEU	58343600
601687	3859	KRT12	0003	MEESMANN CORNEAL DYSTROPHY	KRT12, ARG135GLY	58410481
601687	3859	KRT12	0004	MEESMANN CORNEAL DYSTROPHY	KRT12, ARG135ILE	57218384
601687	3859	KRT12	0005	MEESMANN CORNEAL DYSTROPHY	KRT12, TYR429ASP	58162394
601687	3859	KRT12	0006	MEESMANN CORNEAL DYSTROPHY	KRT12, LEU140ARG	58918655
601687	3859	KRT12	0007	MEESMANN CORNEAL DYSTROPHY	KRT12, MET129THR	28936695
601688	3248	HPGD	0001	CRANIOOSTEOARTHROPATHY	HPGD, ALA140PRO	121434480
601688	3248	HPGD	0002	HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1	HPGD, 10-BP DEL/2-BP INS, NT232	
601688	3248	HPGD	0003	HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1	HPGD, 2-BP DEL, 175CT	
601688	3248	HPGD	0004	DIGITAL CLUBBING, ISOLATED CONGENITAL	HPGD, SER193PRO	121434481
601690	7941	PLA2G7	0001	PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE DEFICIENCY	PLA2G7, VAL279PHE	76863441
601690	7941	PLA2G7	0002	ASTHMA AND ATOPY, SUSCEPTIBILITY TO	PLA2G7, ILE198THR	1805018
601690	7941	PLA2G7	0003	ASTHMA AND ATOPY, SUSCEPTIBILITY TO	PLA2G7, ALA379VAL	1051931
601691	24	ABCA4	0001	STARGARDT DISEASE 1 CONE-ROD DYSTROPHY 3, INCLUDED	ABCA4, GLY863ALA	76157638
601691	24	ABCA4	0002	STARGARDT DISEASE 1	ABCA4, VAL931MET	58331765
601691	24	ABCA4	0003	STARGARDT DISEASE 1	ABCA4, ALA1028VAL	121909204
601691	24	ABCA4	0004	STARGARDT DISEASE 1 CONE-ROD DYSTROPHY 3, INCLUDED	ABCA4, LEU2027PHE	61751408
601691	24	ABCA4	0005	STARGARDT DISEASE 1	ABCA4, VAL2050LEU	41292677
601691	24	ABCA4	0006	MACULAR DEGENERATION, AGE-RELATED, 2, SUSCEPTIBILITY TO	ABCA4, ASP2177ASN	1800555
601691	24	ABCA4	0007	MACULAR DEGENERATION, AGE-RELATED, 2, SUSCEPTIBILITY TO STARGARDT DISEASE 1, INCLUDED;; CONE-ROD DYSTROPHY 3, INCLUDED	ABCA4, GLY1961GLU	1800553
601691	24	ABCA4	0008	RETINITIS PIGMENTOSA 19	ABCA4, 1-BP DEL, 1847A	
601691	24	ABCA4	0009	RETINITIS PIGMENTOSA 19 CONE-ROD DYSTROPHY 3, INCLUDED	ABCA4, IVS30, G-T, +1	
601691	24	ABCA4	0010	CONE-ROD DYSTROPHY 3	ABCA4, IVS40, G-A, +5	
601691	24	ABCA4	0011	STARGARDT DISEASE 1	ABCA4, TRP855TER	61749438
601691	24	ABCA4	0012	STARGARDT DISEASE 1	ABCA4, GLU1036LYS	61750061
601691	24	ABCA4	0013	STARGARDT DISEASE 1	ABCA4, 2-BP INS, 3211GT	
601691	24	ABCA4	0014	FUNDUS FLAVIMACULATUS	ABCA4, LEU1970PHE	28938473
601691	24	ABCA4	0015	FUNDUS FLAVIMACULATUS	ABCA4, LEU1971ARG	61753034
601691	24	ABCA4	0016	STARGARDT DISEASE 1 MACULAR DEGENERATION, AGE-RELATED, 2, SUSCEPTIBILITY TO, INCLUDED;; CONE-ROD DYSTROPHY 3, INCLUDED	ABCA4, ALA1038VAL	61751374
601691	24	ABCA4	0017	STARGARDT DISEASE 1 RETINITIS PIGMENTOSA 19, INCLUDED	ABCA4, IVS13, G-A, -1	
601691	24	ABCA4	0018	STARGARDT DISEASE 1	ABCA4, TYR340ASP	61748548
601691	24	ABCA4	0019	STARGARDT DISEASE 1	ABCA4, IVS5AS, A-G, -2	
601691	24	ABCA4	0020	STARGARDT DISEASE 1	ABCA4, ARG212CYS	61750200
601691	24	ABCA4	0021	STARGARDT DISEASE 1	ABCA4, ARG18TRP	121909205
601691	24	ABCA4	0022	STARGARDT DISEASE 1	ABCA4, ARG572GLN	61748559
601691	24	ABCA4	0023	STARGARDT DISEASE 1 CONE-ROD DYSTROPHY 3, INCLUDED	ABCA4, LEU541PRO AND ALA1038VAL	
601691	24	ABCA4	0024	CONE-ROD DYSTROPHY 3	ABCA4, 2-BP DEL, 2617CT	
601691	24	ABCA4	0025	CONE-ROD DYSTROPHY 3	ABCA4, LEU1201ARG	61750126
601691	24	ABCA4	0026	STARGARDT DISEASE MACULAR DEGENERATION, AGE-RELATED, 2, SUSCEPTIBILITY TO, INCLUDED	ABCA4, PRO1380LEU	61750130
601691	24	ABCA4	0027	CONE-ROD DYSTROPHY 3	ABCA4, 1-BP DEL, 2888G	
601691	24	ABCA4	0028	RETINAL DYSTROPHY, EARLY-ONSET SEVERE	ABCA4, 1-BP DEL, 1225A	
601691	24	ABCA4	0029	RETINAL DYSTROPHY, EARLY-ONSET SEVERE	ABCA4, ARG2030TER	61751383
601691	24	ABCA4	0030	CONE-ROD DYSTROPHY 3	ABCA4, IVS39, T-C, -10	
601691	24	ABCA4	0031	CONE-ROD DYSTROPHY 3 STARGARDT DISEASE 1, INCLUDED	ABCA4, ALA1762ASP	121909206
601691	24	ABCA4	0032	CONE-ROD DYSTROPHY 3	ABCA4, 15-BP DEL, NT3539	
601691	24	ABCA4	0033	FUNDUS FLAVIMACULATUS STARGARDT DISEASE 1, INCLUDED;; CONE-ROD DYSTROPHY 3, INCLUDED	ABCA4, LEU1940PRO	61753033
601691	24	ABCA4	0034	STARGARDT DISEASE 1	ABCA4, PRO1780ALA	121909207
601691	24	ABCA4	0035	MACULAR DEGENERATION, AGE-RELATED, 2, SUSCEPTIBILITY TO STARGARDT DISEASE 1	ABCA4, ARG943GLN	1801581
601691	24	ABCA4	0036	STARGARDT DISEASE 1	ABCA4, TRP821ARG	
601691	24	ABCA4	0037	STARGARDT DISEASE 1	ABCA4, GLU1122LYS	
601692	7045	TGFBI	0001	CORNEAL DYSTROPHY, GROENOUW TYPE I	TGFBI, ARG555TRP	121909208
601692	7045	TGFBI	0002	CORNEAL DYSTROPHY, THIEL-BEHNKE TYPE	TGFBI, ARG555GLN	121909209
601692	7045	TGFBI	0003	CORNEAL DYSTROPHY, LATTICE TYPE I	TGFBI, ARG124CYS	121909210
601692	7045	TGFBI	0004	CORNEAL DYSTROPHY, AVELLINO TYPE	TGFBI, ARG124HIS	121909211
601692	7045	TGFBI	0005	CORNEAL DYSTROPHY, LATTICE TYPE IIIA	TGFBI, PRO501THR	121909212
601692	7045	TGFBI	0006	CORNEAL DYSTROPHY, REIS-BUCKLERS TYPE	TGFBI, 3-BP DEL	
601692	7045	TGFBI	0007	CORNEAL DYSTROPHY, REIS-BUCKLERS TYPE	TGFBI, ARG124LEU	
601692	7045	TGFBI	0008	CORNEAL DYSTROPHY, GROENOUW TYPE I	TGFBI, ARG124SER	
601692	7045	TGFBI	0009	CORNEAL DYSTROPHY, LATTICE TYPE I	TGFBI, ALA546ASP, PRO551GLN	
601692	7045	TGFBI	0010	CORNEAL DYSTROPHY, LATTICE TYPE IIIA	TGFBI, PHE540SER	121909214
601692	7045	TGFBI	0011	CORNEAL DYSTROPHY, REIS-BUCKLERS TYPE	TGFBI, GLY623ASP	121909215
601692	7045	TGFBI	0012	CORNEAL DYSTROPHY, EPITHELIAL BASEMENT MEMBRANE	TGFBI, LEU509ARG	121909216
601692	7045	TGFBI	0013	CORNEAL DYSTROPHY, EPITHELIAL BASEMENT MEMBRANE	TGFBI, ARG666SER	121909217
601693	7351	UCP2	0001	OBESITY, SUSCEPTIBILITY TO	UCP2, -866G-A	659366
601699	5740	PTGIS	0001	HYPERTENSION, ESSENTIAL	PTGIS, IVS9, T-C, +2	
601717	6813	STXBP2	0001	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL 5	STXBP2, PRO477LEU	121918540
601717	6813	STXBP2	0002	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL 5	STXBP2, 3-BP DEL, 693GAT	
601717	6813	STXBP2	0003	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL 5	STXBP2, IVS14AS, G-C, -1	
601717	6813	STXBP2	0004	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL 5	STXBP2, LEU209PRO	121918541
601717	6813	STXBP2	0005	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL 5	STXBP2, 1-BP DEL, 260T	
601717	6813	STXBP2	0006	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL 5	STXBP2, 1-BP DEL, 706G	
601717	6813	STXBP2	0007	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL 5	STXBP2, GLY541SER	
601719	9496	TBX4	0001	SMALL PATELLA SYNDROME	TBX4, GLY248VAL	28938474
601719	9496	TBX4	0002	SMALL PATELLA SYNDROME	TBX4, GLN62TER	104894648
601719	9496	TBX4	0003	SMALL PATELLA SYNDROME	TBX4, GLN531ARG	28936696
601724	4760	NEUROD1	0001	DIABETES MELLITUS, TYPE II	NEUROD1, ARG111LEU	104893649
601724	4760	NEUROD1	0002	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE VI	NEUROD1, 206+C	
601728	5728	PTEN	0001	COWDEN DISEASE 1	PTEN, GLY129GLU	121909218
601728	5728	PTEN	0002	COWDEN DISEASE 1 BANNAYAN-RILEY-RUVALCABA SYNDROME, INCLUDED	PTEN, ARG233TER	121909219
601728	5728	PTEN	0003	LHERMITTE-DUCLOS DISEASE	PTEN, GLU157TER	121909220
601728	5728	PTEN	0004	BANNAYAN-RILEY-RUVALCABA SYNDROME	PTEN, SER170ARG	121909221
601728	5728	PTEN	0005	COWDEN DISEASE 1	PTEN, HIS123ARG	121909222
601728	5728	PTEN	0006	COWDEN DISEASE 1	PTEN, CYS124ARG	121909223
601728	5728	PTEN	0007	COWDEN DISEASE 1 BANNAYAN-RILEY-RUVALCABA SYNDROME, INCLUDED;; MACROCEPHALY/AUTISM SYNDROME, INCLUDED	PTEN, ARG130TER	121909224
601728	5728	PTEN	0008	ENDOMETRIAL CARCINOMA	PTEN, IVS4, G-A, +1	
601728	5728	PTEN	0009	COWDEN DISEASE 1	PTEN, IVS6, T-G, +2	
601728	5728	PTEN	0010	COWDEN DISEASE 1	PTEN, 1-BP DEL, 696A	
601728	5728	PTEN	0011	COWDEN DISEASE 1	PTEN, MET35ARG	121909225
601728	5728	PTEN	0012	COWDEN DISEASE 1	PTEN, LEU70PRO	121909226
601728	5728	PTEN	0013	BANNAYAN-RILEY-RUVALCABA SYNDROME	PTEN, 1-BP DEL, 1390C	
601728	5728	PTEN	0014	BANNAYAN-RILEY-RUVALCABA SYNDROME	PTEN, TYR178TER	104894184
601728	5728	PTEN	0015	BANNAYAN-RILEY-RUVALCABA SYNDROME	PTEN, GLN214TER	121909227
601728	5728	PTEN	0016	BANNAYAN-RILEY-RUVALCABA SYNDROME	PTEN, GLU256TER	121909228
601728	5728	PTEN	0017	COWDEN DISEASE 1	PTEN, ARG130GLN	121909229
601728	5728	PTEN	0018	PROSTATE CANCER, SOMATIC	PTEN, 5-BP DEL, NT761	
601728	5728	PTEN	0019	PROSTATE CANCER, SOMATIC	PTEN, 564T-A	
601728	5728	PTEN	0020	LHERMITTE-DUCLOS DISEASE	PTEN, LEU112PRO	121909230
601728	5728	PTEN	0021	BANNAYAN-RILEY-RUVALCABA SYNDROME COWDEN DISEASE 1, INCLUDED;; PROTEUS-LIKE SYNDROME, INCLUDED	PTEN, ARG335TER	121909231
601728	5728	PTEN	0022	COWDEN DISEASE 1	PTEN, 1-BP INS, A	
601728	5728	PTEN	0023	COWDEN DISEASE 1	PTEN, CYS124SER	
601728	5728	PTEN	0024	MALIGNANT MELANOMA, SOMATIC	PTEN, CYS211TER	121909232
601728	5728	PTEN	0025	MALIGNANT MELANOMA, SOMATIC	PTEN, ASP19ASN	121909233
601728	5728	PTEN	0026	MALIGNANT MELANOMA, SOMATIC	PTEN, VAL217ILE	121909234
601728	5728	PTEN	0027	COWDEN DISEASE 1	PTEN, 1-BP DEL, 802G	
601728	5728	PTEN	0028	COWDEN DISEASE 1	PTEN, 5-BP DEL, NT347	
601728	5728	PTEN	0029	GLIOMA SUSCEPTIBILITY 2 MENINGIOMA, INCLUDED	PTEN, ARG234GLN	121909235
601728	5728	PTEN	0030	VATER ASSOCIATION WITH MACROCEPHALY AND VENTRICULOMEGALY	PTEN, HIS861ASP	121909236
601728	5728	PTEN	0031	SQUAMOUS CELL CARCINOMA, HEAD AND NECK, SOMATIC	PTEN, ALA121GLY	121909237
601728	5728	PTEN	0032	PROTEUS-LIKE SYNDROME PTEN HAMARTOMA TUMOR SYNDROME, INCLUDED	PTEN, 1-BP DEL, 507C	
601728	5728	PTEN	0033	COWDEN DISEASE 1	PTEN, -764A-G	
601728	5728	PTEN	0034	COWDEN DISEASE 1	PTEN, -861G-T	
601728	5728	PTEN	0035	BANNAYAN-RILEY-RUVALCABA SYNDROME	PTEN, DEL	
601728	5728	PTEN	0036	PTEN HAMARTOMA TUMOR SYNDROME WITH GRANULAR CELL TUMOR	PTEN, 1-BP DEL, 179G	
601728	5728	PTEN	0037	MACROCEPHALY/AUTISM SYNDROME	PTEN, HIS93ARG	121909238
601728	5728	PTEN	0038	MACROCEPHALY/AUTISM SYNDROME	PTEN, ASP252GLY	121909239
601728	5728	PTEN	0039	MACROCEPHALY/AUTISM SYNDROME	PTEN, PHE241SER	121909240
601728	5728	PTEN	0040	MACROCEPHALY/AUTISM SYNDROME	PTEN, 1-BP INS, 519T	
601728	5728	PTEN	0041	PTEN HAMARTOMA TUMOR SYNDROME	PTEN, GLY132VAL	121909241
601728	5728	PTEN	0042	MACROCEPHALY/AUTISM SYNDROME	PTEN, THR167ASN	
601728	5728	PTEN	0043	MACROCEPHALY/AUTISM SYNDROME	PTEN, THR131ILE	
601728	5728	PTEN	0044	MACROCEPHALY/AUTISM SYNDROME	PTEN, 1-BP INS, A	
601731	471	ATIC	0001	AICA-RIBOSIDURIA DUE TO ATIC DEFICIENCY	ATIC, LYS426ARG	121434478
601731	471	ATIC	0002	AICA-RIBOSIDURIA DUE TO ATIC DEFICIENCY	ATIC, 125-129DUP, 130-132DEL	
601743	9180	OSMR	0001	AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 1	OSMR, ILE691THR	63750567
601743	9180	OSMR	0002	AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 1	OSMR, GLY618ALA	63750560
601743	9180	OSMR	0003	AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 1	OSMR, ASP647VAL	
601743	9180	OSMR	0004	AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 1	OSMR, PRO694LEU	
601743	9180	OSMR	0005	AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 1	OSMR, LYS697THR	
601749	11146	GLMN	0001	GLOMUVENOUS MALFORMATIONS	GLMN, 8.4-KB DEL, 2-BP GG INS	
601749	11146	GLMN	0002	GLOMUVENOUS MALFORMATIONS	GLMN, 5-BP DEL, 980CAGAA	
601749	11146	GLMN	0003	GLOMUVENOUS MALFORMATIONS	GLMN, 5-BP DEL, 157AAGAA	
601749	11146	GLMN	0004	GLOMUVENOUS MALFORMATIONS	GLMN, ASN394 DEL	
601756	2591	GALNT3	0001	TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL	GALNT3, IVS7, G-A, +1	
601756	2591	GALNT3	0002	TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL	GALNT3, ARG162TER	137853086
601756	2591	GALNT3	0003	TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL	GALNT3, IVS7DS, G-A, +5	
601756	2591	GALNT3	0004	TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL	GALNT3, IVS1AS, A-T, -2	
601756	2591	GALNT3	0005	TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL	GALNT3, GLN592TER	137853087
601756	2591	GALNT3	0006	TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL	GALNT3, TYR322TER	137853088
601756	2591	GALNT3	0007	TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL	GALNT3, GLN481TER	137853089
601756	2591	GALNT3	0008	TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL	GALNT3, THR272LYS	137853090
601756	2591	GALNT3	0009	TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL	GALNT3, THR359LYS	137853091
601756	2591	GALNT3	0010	TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL	GALNT3, 1-BP INS, 803C	
601756	2591	GALNT3	0011	TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL	GALNT3, IVS8, G-A, +1	
601756	2591	GALNT3	0012	TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL	GALNT3, 1-BP DEL, 677C	
601756	2591	GALNT3	0013	TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL	GALNT3, CYS574GLY	
601757	5191	PEX7	0001	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1	PEX7, LEU292TER	1805137
601757	5191	PEX7	0002	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1 PEROXISOME BIOGENESIS DISORDER 9B, INCLUDED	PEX7, ALA218VAL	121909151
601757	5191	PEX7	0003	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1	PEX7, GLY217ARG	121909152
601757	5191	PEX7	0004	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1	PEX7, ARG232TER	121909153
601757	5191	PEX7	0005	PEROXISOME BIOGENESIS DISORDER 9B	PEX7, 8-BP DUP, NT45	
601757	5191	PEX7	0006	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1	PEX7, IVS9, G-C, +1	
601757	5191	PEX7	0007	PEROXISOME BIOGENESIS DISORDER 9B	PEX7, TYR115TER	121909154
601757	5191	PEX7	0008	PEROXISOME BIOGENESIS DISORDER 9B	PEX7, IVS3, A-G, -10	
601757	5191	PEX7	0009	PEROXISOME BIOGENESIS DISORDER 9B	PEX7, TYR40TER	61753238
601757	5191	PEX7	0010	PEROXISOME BIOGENESIS DISORDER 9B	PEX7, 7-BP DUP, NT12	
601757	5191	PEX7	0011	PEROXISOME BIOGENESIS DISORDER 9B	PEX7, THR14PRO	61753233
601758	5193	PEX12	0001	PEROXISOMAL BIOGENESIS DISORDER 3A (ZELLWEGER)	PEX12, 4-BP INS, 733GCCT	
601758	5193	PEX12	0002	PEROXISOMAL BIOGENESIS DISORDER 3A (ZELLWEGER)	PEX12, 1-BP INS, 744T	
601758	5193	PEX12	0003	PEROXISOMAL BIOGENESIS DISORDER 3A (ZELLWEGER)	PEX12, 4-BP DEL, 684TAGT	
601758	5193	PEX12	0004	PEROXISOMAL BIOGENESIS DISORDER 3A (ZELLWEGER)	PEX12, LYS231TER	104894616
601758	5193	PEX12	0005	PEROXISOMAL BIOGENESIS DISORDER 3A (ZELLWEGER) PEROXISOMAL BIOGENESIS DISORDER 3B, INCLUDED	PEX12, ARG180TER	61752103
601758	5193	PEX12	0006	PEROXISOMAL BIOGENESIS DISORDER 3B	PEX12, SER320PHE	28936697
601758	5193	PEX12	0007	PEROXISOMAL BIOGENESIS DISORDER 3B	PEX12, 2-BP DEL, 26CA	
601758	5193	PEX12	0008	PEROXISOMAL BIOGENESIS DISORDER 3B	PEX12, IVS1DS, G-T, +1	
601758	5193	PEX12	0009	PEROXISOMAL BIOGENESIS DISORDER 3B	PEX12, ARG91SER	28936698
601758	5193	PEX12	0010	PEROXISOMAL BIOGENESIS DISORDER 3B	PEX12, LEU317PHE	61752112
601762	843	CASP10	0001	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IIA	CASP10, LEU285PHE	17860403
601762	843	CASP10	0003	NON-HODGKIN LYMPHOMA, SOMATIC	CASP10, ALA414VAL	28936699
601762	843	CASP10	0004	NON-HODGKIN LYMPHOMA, SOMATIC GASTRIC CANCER, SOMATIC, INCLUDED	CASP10, GLN257TER	121909775
601762	843	CASP10	0005	NON-HODGKIN LYMPHOMA, SOMATIC	CASP10, 1-BP INS, 1042A	
601762	843	CASP10	0006	GASTRIC CANCER, SOMATIC	CASP10, MET147THR	121909776
601762	843	CASP10	0007	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IIA	CASP10, ILE406LEU	80358239
601763	841	CASP8	0001	CASPASE 8 DEFICIENCY	CASP8, ARG248TRP	17860424
601763	841	CASP8	0002	HEPATOCELLULAR CARCINOMA, SOMATIC	CASP8, 2-BP DEL, 1225TG	
601763	841	CASP8	0003	BREAST CANCER, PROTECTION AGAINST	CASP8, ASP302HIS	1045485
601763	841	CASP8	0004	LUNG CANCER, PROTECTION AGAINST	CASP8, 6-BP DEL, NT-652	3834129
601769	7421	VDR	0001	VITAMIN D-DEPENDENT RICKETS, TYPE 2A	VDR, GLY33ASP	121909790
601769	7421	VDR	0002	VITAMIN D-DEPENDENT RICKETS, TYPE 2A	VDR, ARG73GLN	121909791
601769	7421	VDR	0003	VITAMIN D-DEPENDENT RICKETS, TYPE 2A	VDR, TYR292TER	121909792
601769	7421	VDR	0004	VITAMIN D-DEPENDENT RICKETS, TYPE 2A	VDR, ARG77GLN	121909793
601769	7421	VDR	0005	VITAMIN D-DEPENDENT RICKETS, TYPE 2A	VDR, ARG47GLN	121909794
601769	7421	VDR	0006	VITAMIN D-DEPENDENT RICKETS, TYPE 2A	VDR, GLN149TER	121909795
601769	7421	VDR	0007	VITAMIN D-DEPENDENT RICKETS, TYPE 2A	VDR, ARG271LEU	121909796
601769	7421	VDR	0008	VITAMIN D-DEPENDENT RICKETS, TYPE 2A	VDR, GLY46ASP	121909797
601769	7421	VDR	0009	VITAMIN D-DEPENDENT RICKETS, TYPE 2A	VDR, HIS305GLN	121909798
601769	7421	VDR	0010	VITAMIN D-DEPENDENT RICKETS, TYPE 2A	VDR, ILE314SER	121909799
601769	7421	VDR	0011	VITAMIN D-DEPENDENT RICKETS, TYPE 2A	VDR, ARG391CYS	121909800
601769	7421	VDR	0012	VITAMIN D-DEPENDENT RICKETS, TYPE 2A	VDR, ARG30TER	121909801
601769	7421	VDR	0013	VITAMIN D-DEPENDENT RICKETS, TYPE 2A	VDR, 1-BP DEL, 366C	
601769	7421	VDR	0014	VITAMIN D-DEPENDENT RICKETS, TYPE 2A	VDR, GLU329LYS	121909802
601769	7421	VDR	0015	VITAMIN D-DEPENDENT RICKETS, TYPE 2A	VDR, VAL346MET	
601771	1545	CYP1B1	0001	GLAUCOMA 3, PRIMARY CONGENITAL, A	CYP1B1, 13-BP DEL, NT1410	
601771	1545	CYP1B1	0002	GLAUCOMA 3, PRIMARY CONGENITAL, A	CYP1B1, 1-BP INS, 1209C	
601771	1545	CYP1B1	0003	GLAUCOMA 3, PRIMARY CONGENITAL, A	CYP1B1, GLY61GLU	28936700
601771	1545	CYP1B1	0004	GLAUCOMA 3, PRIMARY CONGENITAL, A	CYP1B1, 10-BP DUP, NT1546	
601771	1545	CYP1B1	0005	GLAUCOMA, PRIMARY CONGENITAL, A	CYP1B1, GLY365TRP	55771538
601771	1545	CYP1B1	0006	GLAUCOMA 3, PRIMARY CONGENITAL, A	CYP1B1, ARG469TRP	28936701
601771	1545	CYP1B1	0007	GLAUCOMA 3, PRIMARY CONGENITAL, A	CYP1B1, ASP374ASN	104893622
601771	1545	CYP1B1	0008	GLAUCOMA 3, PRIMARY CONGENITAL, A	CYP1B1, LYS387GLU	55989760
601771	1545	CYP1B1	0009	PETERS ANOMALY	CYP1B1, MET1THR	72549389
601771	1545	CYP1B1	0010	PETERS ANOMALY	CYP1B1, TRP57TER	72549387
601771	1545	CYP1B1	0011	GLAUCOMA 3, PRIMARY CONGENITAL, A	CYP1B1, 1-BP DEL, 4339G	
601771	1545	CYP1B1	0012	GLAUCOMA, EARLY-ONSET, DIGENIC GLAUCOMA 3, PRIMARY CONGENITAL, A, INCLUDED	CYP1B1, ARG368HIS	79204362
601771	1545	CYP1B1	0013	GLAUCOMA 3, PRIMARY CONGENITAL, A GLAUCOMA, PRIMARY OPEN ANGLE, ADULT-ONSET, INCLUDED	CYP1B1, GLY232ARG	
601771	1545	CYP1B1	0014	GLAUCOMA 3, PRIMARY CONGENITAL, A GLAUCOMA, PRIMARY OPEN ANGLE, ADULT-ONSET, INCLUDED	CYP1B1, GLU387LYS	55989760
601771	1545	CYP1B1	0015	GLAUCOMA, PRIMARY OPEN ANGLE, JUVENILE-ONSET GLAUCOMA 3, PRIMARY CONGENITAL, A, INCLUDED	CYP1B1, 1-BP DEL, 3979A	
601771	1545	CYP1B1	0016	GLAUCOMA, PRIMARY OPEN ANGLE, JUVENILE-ONSET GLAUCOMA 3, PRIMARY CONGENITAL, A, INCLUDED	CYP1B1, ASN423TYR	104893629
601771	1545	CYP1B1	0017	GLAUCOMA, PRIMARY OPEN ANGLE, ADULT-ONSET	CYP1B1, TYR81ASN	9282671
601771	1545	CYP1B1	0018	GLAUCOMA 3, PRIMARY CONGENITAL A	CYP1B1, PHE261LEU	
601771	1545	CYP1B1	0019	GLAUCOMA, PRIMARY OPEN ANGLE, JUVENILE-ONSET	CYP1B1, PRO52LEU	
601785	5373	PMM2	0001	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia	PMM2, ARG141HIS	28936415
601785	5373	PMM2	0002	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia	PMM2, ASN216ILE	78290141
601785	5373	PMM2	0003	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia	PMM2, VAL129MET	104894525
601785	5373	PMM2	0004	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia	PMM2, ARG162TRP	104894526
601785	5373	PMM2	0005	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia	PMM2, ASP65TYR	104894527
601785	5373	PMM2	0006	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia	PMM2, PHE119LEU	80338701
601785	5373	PMM2	0007	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia	PMM2, ASP188GLY	80338704
601785	5373	PMM2	0008	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia	PMM2, GLY117ARG	104894530
601785	5373	PMM2	0009	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia	PMM2, ASP223GLU	104894531
601785	5373	PMM2	0010	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia	PMM2, 357C-A	
601785	5373	PMM2	0011	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia	PMM2, THR237ARG	80338708
601785	5373	PMM2	0012	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia	PMM2, CYS241SER	80338709
601785	5373	PMM2	0013	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia	PMM2, ILE132THR	80338702
601785	5373	PMM2	0014	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia	PMM2, VAL231MET	80338707
601785	5373	PMM2	0015	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia	PMM2, CYS9TYR	104894532
601785	5373	PMM2	0016	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia	PMM2, LEU32ARG	104894533
601785	5373	PMM2	0017	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia	PMM2, THR226SER	80338706
601785	5373	PMM2	0018	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia	PMM2, PRO113LEU	80338700
601785	5373	PMM2	0019	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia	PMM2, IVS7, C-T	
601785	5373	PMM2	0020	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia	PMM2, VAL44ALA	104894534
601785	5373	PMM2	0021	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia	PMM2, 28-KB DEL	
601785	5373	PMM2	0022	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia	PMM2, IVS3AS, G-C, -1	
601785	5373	PMM2	0023	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia	PMM2, TYR106PHE	
601788	2660	MSTN	0001	MUSCLE HYPERTROPHY	MSTN, IVS1, G-A, +5	
601789	5194	PEX13	0001	PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	PEX13, TRP234TER	104893661
601789	5194	PEX13	0002	PEROXISOME BIOGENESIS DISORDER 11B	PEX13, ILE326THR	61752115
601789	5194	PEX13	0003	PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	PEX13, 147-KB DEL	
601789	5194	PEX13	0004	PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	PEX13, 14-BP DEL, EXON 2	
601791	5195	PEX14	0001	PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	PEX14, GLN185TER	61752116
601791	5195	PEX14	0002	PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	PEX14, 41-KB DEL	
601802	8820	HESX1	0001	SEPTOOPTIC DYSPLASIA	HESX1, ARG160CYS	28936702
601802	8820	HESX1	0002	SEPTOOPTIC DYSPLASIA, MILD	HESX1, SER170LEU	28936703
601802	8820	HESX1	0003	GROWTH HORMONE DEFICIENCY WITH PITUITARY ANOMALIES	HESX1, THR181ALA	28936704
601802	8820	HESX1	0004	SEPTOOPTIC DYSPLASIA	HESX1, 2-BP INS, 306AG	
601802	8820	HESX1	0005	PITUITARY HORMONE DEFICIENCY, COMBINED, 5	HESX1, ILE26THR	28936416
601802	8820	HESX1	0006	SEPTOOPTIC DYSPLASIA	HESX1, 1-BP DEL, 1684G	
601802	8820	HESX1	0007	PITUITARY HORMONE DEFICIENCY, COMBINED, 5	HESX1, 2-BP DEL, 449AC	
601802	8820	HESX1	0008	PITUITARY HORMONE DEFICIENCY, COMBINED, 5	HESX1, IVS2, T-C, +2	
601802	8820	HESX1	0009	GROWTH HORMONE DEFICIENCY WITH PITUITARY ANOMALIES	HESX1, GLU149LYS	104893742
601802	8820	HESX1	0010	PITUITARY HORMONE DEFICIENCY, COMBINED, 5	HESX1, GLN6HIS	121909173
601806	4175	MCM6	0001	LACTASE PERSISTENCE	MCM6, IVS13, C/T	4988235
601806	4175	MCM6	0002	LACTASE PERSISTENCE	MCM6, IVS9, G/A	182549
601806	4175	MCM6	0003	LACTASE PERSISTENCE	MCM6, IVS13, G/C	
601806	4175	MCM6	0004	LACTASE PERSISTENCE	MCM6, IVS13, T/G	
601806	4175	MCM6	0005	LACTASE PERSISTENCE	MCM6, IVS13, C/G	
601806	4175	MCM6	0006	LACTATE PERSISTENCE	MCM6, EX17, T/C	
601810	1763	DNA2	0001	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 6	DNA2, ARG284HIS	
601810	1763	DNA2	0002	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 6	DNA2, LYS313GLU	
601810	1763	DNA2	0003	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 6	DNA2, VAL723ILE	
601814	486	FXYD2	0001	HYPOMAGNESEMIA 2, RENAL	FXYD2, GLY41ARG	28938168
601825	374291	NDUFS7	0001	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFS7, VAL122MET	104894705
601825	374291	NDUFS7	0002	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFS7, ARG145HIS	121434479
601825	374291	NDUFS7	0003	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFS7, IVS1AS, C-G, -1167	
601828	4929	NR4A2	0001	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	NR4A2, 1-BP DEL, -291T	
601828	4929	NR4A2	0002	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	NR4A2, -245T-G	
601837	3981	LIG4	0001	LIG4 SYNDROME	LIG4, ARG580TER	104894418
601837	3981	LIG4	0002	LIG4 SYNDROME	LIG4, ARG814TER	104894419
601837	3981	LIG4	0003	LIG4 SYNDROME	LIG4, GLY469GLU	104894420
601837	3981	LIG4	0004	LIG4 SYNDROME	LIG4, ARG278HIS	104894421
601837	3981	LIG4	0005	MULTIPLE MYELOMA, RESISTANCE TO	LIG4, ALA3VAL	1805389
601837	3981	LIG4	0006	MULTIPLE MYELOMA, RESISTANCE TO	LIG4, THR9ILE	1805388
601837	3981	LIG4	0007	SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION	LIG4, 3-BP DEL, 5333CAA	
601843	6528	SLC5A5	0001	THYROID DYSHORMONOGENESIS 1	SLC5A5, THR354PRO	121909174
601843	6528	SLC5A5	0002	THYROID DYSHORMONOGENESIS 1	SLC5A5, CYS272TER	121909175
601843	6528	SLC5A5	0003	THYROID DYSHORMONOGENESIS 1	SLC5A5, GLN267GLU	121909176
601843	6528	SLC5A5	0004	THYROID DYSHORMONOGENESIS 1	SLC5A5, TYR531TER	121909177
601843	6528	SLC5A5	0005	THYROID DYSHORMONOGENESIS 1	SLC5A5, GLY93ARG	121909178
601843	6528	SLC5A5	0006	THYROID DYSHORMONOGENESIS 1	SLC5A5, GLY543GLU	121909179
601843	6528	SLC5A5	0007	THYROID DYSHORMONOGENESIS 1	SLC5A5, GLY395ARG	121909180
601843	6528	SLC5A5	0008	THYROID DYSHORMONOGENESIS 1	SLC5A5, EX3-7DEL	
601844	65266	WNK4	0001	PSEUDOHYPOALDOSTERONISM, TYPE IIB	WNK4, GLN565GLU	137853092
601844	65266	WNK4	0002	PSEUDOHYPOALDOSTERONISM, TYPE IIB	WNK4, GLU562LYS	137853093
601844	65266	WNK4	0003	PSEUDOHYPOALDOSTERONISM, TYPE IIB	WNK4, ASP564ALA	137853094
601844	65266	WNK4	0004	PSEUDOHYPOALDOSTERONISM, TYPE IIB	WNK4, ARG1185CYS	137853095
601860	3295	HSD17B4	0001	D-BIFUNCTIONAL PROTEIN DEFICIENCY	HSD17B4, 52-BP DEL	
601860	3295	HSD17B4	0002	D-BIFUNCTIONAL PROTEIN DEFICIENCY	HSD17B4, 237-BP DEL	
601860	3295	HSD17B4	0003	D-BIFUNCTIONAL PROTEIN DEFICIENCY	HSD17B4, GLY16SER	137853096
601860	3295	HSD17B4	0004	D-BIFUNCTIONAL PROTEIN DEFICIENCY	HSD17B4, ASN457TYR	137853097
601860	3295	HSD17B4	0005	D-BIFUNCTIONAL PROTEIN DEFICIENCY	HSD17B4, ARG106PRO	25640
601860	3295	HSD17B4	0006	D-BIFUNCTIONAL PROTEIN DEFICIENCY	HSD17B4, 138-BP DEL	
601860	3295	HSD17B4	0007	D-BIFUNCTIONAL PROTEIN DEFICIENCY	HSD17B4, 2-BP DEL, 422AG	
601860	3295	HSD17B4	0008	PERRAULT SYNDROME 1	HSD17B4, TYR217CYS	
601860	3295	HSD17B4	0009	PERRAULT SYNDROME 1	HSD17B4, TYR568TER	
601861	5994	RFXAP	0001	BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP D	RFXAP, 1-BP INS, 413G	
601861	5994	RFXAP	0002	BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP D	RFXAP, 1-BP INS, 505G	
601861	5994	RFXAP	0003	BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP D	RFXAP, 1-BP DEL, 484G	
601861	5994	RFXAP	0004	BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP D	RFXAP, GLN53TER	137853098
601863	5993	RFX5	0001	BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP C	RFX5, IVS2DS, G-A, +5	
601863	5993	RFX5	0002	BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP C	RFX5, 1032C-T	
601863	5993	RFX5	0003	BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP C	RFX5, IVS4AS, G-A, -1	
601863	5993	RFX5	0004	BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP C	RFX5, 4-BP DEL, IVS-AS, G-A, -1	
601863	5993	RFX5	0005	BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP E	RFX5, ARG149GLN	137853099
601865	5352	PLOD2	0001	BRUCK SYNDROME 2	PLOD2, THR608ILE	121434459
601865	5352	PLOD2	0002	BRUCK SYNDROME 2	PLOD2, GLY601VAL	121434460
601865	5352	PLOD2	0003	BRUCK SYNDROME 2	PLOD2, ARG598HIS	121434461
601865	5352	PLOD2	0004	BRUCK SYNDROME 2	PLOD2, 1-BP DUP, 1559C	
601877	7044	LEFTY2	0001	LEFT-RIGHT AXIS MALFORMATIONS	LEFTY2, ARG314TER	121909125
601877	7044	LEFTY2	0002	LEFT-RIGHT AXIS MALFORMATIONS	LEFTY2, SER342LYS	121909126
601881	30062	RAX	0001	MICROPHTHALMIA, ISOLATED 3	RAX, GLN147TER	104894663
601881	30062	RAX	0002	MICROPHTHALMIA, ISOLATED 3	RAX, ARG192GLU	121909127
601881	30062	RAX	0003	MICROPHTHALMIA, ISOLATED 3	RAX, 1-BP DEL, 664T	
601881	30062	RAX	0004	MICROPHTHALMIA, ISOLATED 3	RAX, TYR303TER	121909128
601896	7187	TRAF3	0001	HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 3	TRAF3, ARG118TRP	
601898	2693	GHSR	0001	SHORT STATURE, IDIOPATHIC, AUTOSOMAL	GHSR, ALA204GLU	
601898	2693	GHSR	0002	SHORT STATURE, IDIOPATHIC, AUTOSOMAL	GHSR, TRP2TER	
601898	2693	GHSR	0003	SHORT STATURE, IDIOPATHIC, AUTOSOMAL	GHSR, ARG237TRP	
601902	4998	ORC1	0001	MEIER-GORLIN SYNDROME 1	ORC1, GLU127GLY	
601902	4998	ORC1	0002	MEIER-GORLIN SYNDROME 1	ORC1, PHE89SER	
601902	4998	ORC1	0003	MEIER-GORLIN SYNDROME 1	ORC1, ARG105GLN	
601902	4998	ORC1	0004	MEIER-GORLIN SYNDROME 1	ORC1, ARG720GLN	
601902	4998	ORC1	0005	MEIER-GORLIN SYNDROME 1	ORC1, 2-BP DEL/1-BP INS, NT2000	
601902	4998	ORC1	0006	MEIER-GORLIN SYNDROME 1	ORC1, IVS9, G-A, -2	
601902	4998	ORC1	0007	MEIER-GORLIN SYNDROME 1	ORC1, ARG666TRP	
601903	7367	UGT2B17	0001	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12	UGT2B17, 150-KB DEL	
601906	7480	WNT10B	0001	SPLIT-HAND/FOOT MALFORMATION 6	WNT10B, ARG332TRP	34201045
601906	7480	WNT10B	0002	SPLIT-HAND/FOOT MALFORMATION 6	WNT10B, 4-BP DUP, 458AGCA	
601912	7341	SUMO1	0001	OROFACIAL CLEFT 10	SUMO1, DEL	
601920	182	JAG1	0001	ALAGILLE SYNDROME 1	JAG1, 2-BP DEL, 3098GT	
601920	182	JAG1	0002	ALAGILLE SYNDROME 1	JAG1, IVS23DS, G-C, +1	
601920	182	JAG1	0003	ALAGILLE SYNDROME 1	JAG1, 2-BP DEL, 1104AG	
601920	182	JAG1	0004	ALAGILLE SYNDROME 1	JAG1, 1-BP DEL, 2066C	
601920	182	JAG1	0005	ALAGILLE SYNDROME 1	JAG1, ARG184CYS	121918350
601920	182	JAG1	0006	ALAGILLE SYNDROME 1	JAG1, ARG184HIS	121918351
601920	182	JAG1	0007	ALAGILLE SYNDROME 1	JAG1, 5-BP DEL	
601920	182	JAG1	0008	ALAGILLE SYNDROME 1	JAG1, 1-BP INS, 1618C	
601920	182	JAG1	0009	ALAGILLE SYNDROME 1	JAG1, 1-BP INS, 684G	
601920	182	JAG1	0010	TETRALOGY OF FALLOT	JAG1, GLY274ASP	28939668
601920	182	JAG1	0011	ALAGILLE SYNDROME 1	JAG1, LEU37SER	121918352
601920	182	JAG1	0012	DEAFNESS, CONGENITAL HEART DEFECTS, AND POSTERIOR EMBRYOTOXON	JAG1, CYS234TYR	121918353
601920	182	JAG1	0013	ALAGILLE SYNDROME 1	JAG1, 2-BP DEL, 1485CT	
601920	182	JAG1	0014	ALAGILLE SYNDROME 1	JAG1, 1329, T-G, +2	
601925	396	ARHGDIA	0001	NEPHROTIC SYNDROME, TYPE 8 (1 family)	ARHGDIA, 3-BP DEL, 553GAC	
601928	3892	KRT86	0001	MONILETHRIX	KRT86, GLU413LYS	121909129
601928	3892	KRT86	0002	MONILETHRIX	KRT86, GLU413ASP	121909130
601928	3892	KRT86	0003	MONILETHRIX	KRT86, GLU402LYS	60687604
601928	3892	KRT86	0004	MONILETHRIX	KRT86, ASN114ASP	
601928	3892	KRT86	0005	MONILETHRIX	KRT86, GLU402GLN	60687604
601928	3892	KRT86	0006	MONILETHRIX	KRT86, ALA118GLU	
601949	785	CACNB4	0001	EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 6	CACNB4, ARG482TER	1805032
601949	785	CACNB4	0002	EPILEPSY, GENERALIZED IDIOPATHIC, SUSCEPTIBILITY TO, 9 EPISODIC ATAXIA, TYPE 5, INCLUDED	CACNB4, CYS104PHE	1805031
601962	6892	TAPBP	0001	BARE LYMPHOCYTE SYNDROME, TYPE I	TAPBP, 7.4-KB DEL	
601975	5317	PKP1	0001	ECTODERMAL DYSPLASIA/SKIN FRAGILITY SYNDROME	PKP1, GLN304TER	121918354
601975	5317	PKP1	0002	ECTODERMAL DYSPLASIA/SKIN FRAGILITY SYNDROME	PKP1, 28-BP DUP, NT1132	
601975	5317	PKP1	0003	ECTODERMAL DYSPLASIA/SKIN FRAGILITY SYNDROME	PKP1, IVS6, A-T, -2	
601978	10280	SIGMAR1	0001	AMYOTROPHIC LATERAL SCLEROSIS 16, JUVENILE	SIGMAR1, GLU102GLN	
601982	4968	OGG1	0001	RENAL CELL CARCINOMA, CLEAR CELL, SOMATIC	OGG1, ARG46GLN	104893751
602023	1188	CLCNKB	0001	BARTTER SYNDROME, TYPE 3	CLCNKB, PRO124LEU	121909131
602023	1188	CLCNKB	0002	BARTTER SYNDROME, TYPE 3	CLCNKB, ALA204THR	121909132
602023	1188	CLCNKB	0003	BARTTER SYNDROME, TYPE 3	CLCNKB, ARG438CYS	121909133
602023	1188	CLCNKB	0004	BARTTER SYNDROME, TYPE 3	CLCNKB, ALA349ASP	121909134
602023	1188	CLCNKB	0005	BARTTER SYNDROME, TYPE 3	CLCNKB, TYR432HIS	121909135
602023	1188	CLCNKB	0006	BARTTER SYNDROME, TYPE 3	CLCNKB, DEL	
602023	1188	CLCNKB	0007	BARTTER SYNDROME, TYPE 3	CLCNKB, IVS7, A-G, -2	
602023	1188	CLCNKB	0008	BARTTER SYNDROME, TYPE 4B	CLCNKB, DEL	
602023	1188	CLCNKB	0009	BARTTER SYNDROME, TYPE 3, WITH HYPOCALCIURIA	CLCNKB, TRP610TER	121909136
602023	1188	CLCNKB	0010	BARTTER SYNDROME, TYPE 3, WITH HYPOCALCIURIA	CLCNKB, IVS2AS, G-C, -1	
602023	1188	CLCNKB	0011	BARTTER SYNDROME, TYPE 4B	CLCNKB, IVS17DS, G-A, +1	
602024	1187	CLCNKA	0001	BARTTER SYNDROME, TYPE 4B	CLCNKA, CYS80TRP	121909137
602024	1187	CLCNKA	0002	BARTTER SYNDROME, TYPE 4B	CLCNKA, GLN260TER	121909138
602026	5264	PHYH	0001	REFSUM DISEASE, ADULT, 1	PHYH, ARG275TRP	104894178
602026	5264	PHYH	0002	REFSUM DISEASE, ADULT, 1	PHYH, IVS2AS, A-G, -2	
602026	5264	PHYH	0003	REFSUM DISEASE, ADULT, 1	PHYH, 1-BP DEL, 164T	
602026	5264	PHYH	0004	REFSUM DISEASE, ADULT, 1	PHYH, ASN269HIS	104894179
602026	5264	PHYH	0005	REFSUM DISEASE, ADULT, 1	PHYH, 3-BP INS, 576GCC	
602026	5264	PHYH	0006	RECLASSIFIED - PHYTANOYL-CoA HYDROXYLASE POLYMORPHISM (dbSNP rs28938169)	PHYH, PRO29SER	28938169
602026	5264	PHYH	0007	REFSUM DISEASE, ADULT, 1	PHYH, GLN176LYS	28939672
602026	5264	PHYH	0008	REFSUM DISEASE, ADULT, 1	PHYH, GLY204SER	104894173
602026	5264	PHYH	0009	REFSUM DISEASE, ADULT, 1	PHYH, ARG275GLN	104894174
602044	7352	UCP3	0001	UCP3 POLYMORPHISM G/A OBESITY, SEVERE, AND TYPE II DIABETES	UCP3, 304G-A, VAL102ILE	2229707
602044	7352	UCP3	0002	OBESITY, SEVERE, AND TYPE II DIABETES	UCP3, ARG143TER	104894319
602044	7352	UCP3	0003	UCP3 POLYMORPHISM, EXON 6 SPLICE DONOR JUNCTION OBESITY, SEVERE	UCP3, IVS6, G-A, +1	
602044	7352	UCP3	0004	OBESITY, SEVERE, AND TYPE II DIABETES	UCP3, ARG70TRP	17848368
602049	5880	RAC2	0001	NEUTROPHIL IMMUNODEFICIENCY SYNDROME	RAC2, ASP57ASN	74315507
602053	1316	KLF6	0001	PROSTATE CANCER, SOMATIC	KLF6, SER116PRO	121909139
602053	1316	KLF6	0002	PROSTATE CANCER, SOMATIC	KLF6, SER137TER	121909140
602053	1316	KLF6	0003	PROSTATE CANCER, SOMATIC	KLF6, ALA123ASP	121909141
602053	1316	KLF6	0004	PROSTATE CANCER, SOMATIC	KLF6, TRP64ARG	121909142
602053	1316	KLF6	0005	PROSTATE CANCER, SOMATIC	KLF6, LEU169PRO	121909143
602053	1316	KLF6	0006	GASTRIC CANCER, SOMATIC	KLF6, SER155ARG	121909144
602054	6899	TBX1	0001	CONOTRUNCAL ANOMALY FACE SYNDROME/VELOCARDIOFACIAL SYNDROME	TBX1, PHE148TYR	28939675
602054	6899	TBX1	0002	DIGEORGE SYNDROME	TBX1, GLY310SER	41298838
602054	6899	TBX1	0003	CONOTRUNCAL ANOMALY FACE SYNDROME/VELOCARDIOFACIAL SYNDROME	TBX1, 1-BP DEL, 1223C	
602054	6899	TBX1	0004	VELOCARDIOFACIAL SYNDROME	TBX1, 23-BP DEL, NT1320	
602054	6899	TBX1	0005	VELOCARDIOFACIAL SYNDROME	TBX1, HIS194GLN	74315522
602054	6899	TBX1	0006	TETRALOGY OF FALLOT	TBX1, 30-BP DUP, NT1399	
602063	6888	TALDO1	0001	TRANSALDOLASE DEFICIENCY	TALDO1, SER171DEL	137853085
602090	4054	LTBP3	0001	TOOTH AGENESIS, SELECTIVE, 6	LTBP3, TYR744TER	121909145
602091	4053	LTBP2	0001	GLAUCOMA 3, PRIMARY CONGENITAL, D MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA, INCLUDED	LTBP2, ARG299TER	121918355
602091	4053	LTBP2	0002	GLAUCOMA 3, PRIMARY CONGENITAL, D	LTBP2, 1-BP DEL, 412G	
602091	4053	LTBP2	0003	GLAUCOMA 3, PRIMARY CONGENITAL, D	LTBP2, 14-BP DEL, NT1243	
602091	4053	LTBP2	0004	GLAUCOMA 3, PRIMARY CONGENITAL, D	LTBP2, GLN111TER	121918356
602091	4053	LTBP2	0005	MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA	LTBP2, 1-BP INS, 5446C	
602091	4053	LTBP2	0006	GLAUCOMA 3, PRIMARY CONGENITAL, D	LTBP2, 1-BP DEL, 1415C	
602091	4053	LTBP2	0007	GLAUCOMA 3, PRIMARY CONGENITAL, D	LTBP2, 1-BP DEL, 5376C	
602091	4053	LTBP2	0008	MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA	LTBP2, 1-BP INS, 1796C	
602091	4053	LTBP2	0009	MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA	LTBP2, 1-BP DEL, 1012T	
602091	4053	LTBP2	0010	MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA	LTBP2, GLN1619TER	
602091	4053	LTBP2	0011	MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA	LTBP2, CYS1438TYR	
602091	4053	LTBP2	0012	WEILL-MARCHESANI SYNDROME 3	LTBP2, VAL1177MET	
602104	6452	SH3BP2	0001	CHERUBISM	SH3BP2, PRO418LEU	121909146
602104	6452	SH3BP2	0002	CHERUBISM	SH3BP2, PRO418ARG	
602104	6452	SH3BP2	0003	CHERUBISM	SH3BP2, PRO418HIS	
602104	6452	SH3BP2	0004	CHERUBISM	SH3BP2, ARG415PRO	121909149
602104	6452	SH3BP2	0005	CHERUBISM	SH3BP2, ARG415GLN	
602104	6452	SH3BP2	0006	CHERUBISM	SH3BP2, GLY420ARG	28938170
602104	6452	SH3BP2	0007	CHERUBISM	SH3BP2, GLY420GLU	28938171
602109	4148	MATN3	0001	EPIPHYSEAL DYSPLASIA, MULTIPLE, 5	MATN3, VAL194ASP	104893645
602109	4148	MATN3	0002	EPIPHYSEAL DYSPLASIA, MULTIPLE, 5	MATN3, ARG121TRP	104893637
602109	4148	MATN3	0003	OSTEOARTHRITIS SUSCEPTIBILITY 2	MATN3, THR303MET	77245812
602109	4148	MATN3	0004	EPIPHYSEAL DYSPLASIA, MULTIPLE, 5	MATN3, ALA219ASP	28939677
602109	4148	MATN3	0005	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MATN3-RELATED	MATN3, CYS304SER	104893639
602109	4148	MATN3	0006	EPIPHYSEAL DYSPLASIA, MULTIPLE, 5	MATN3, ARG70HIS	104893640
602109	4148	MATN3	0007	EPIPHYSEAL DYSPLASIA, MULTIPLE, 5	MATN3, ALA128PRO	104893641
602113	8085	KMT2D	0001	KABUKI SYNDROME 1	MLL2, ARG5179HIS	
602113	8085	KMT2D	0002	KABUKI SYNDROME 1	MLL2, LYS4527TER	
602113	8085	KMT2D	0003	KABUKI SYNDROME 1	MLL2, ARG5454TER	
602113	8085	KMT2D	0004	KABUKI SYNDROME 1	MLL2, THR5464MET	
602115	2255	FGF10	0001	APLASIA OF LACRIMAL AND SALIVARY GLANDS	FGF10, ARG193TER	104893884
602115	2255	FGF10	0002	APLASIA OF LACRIMAL AND SALIVARY GLANDS	FGF10, 53-KB DEL	
602115	2255	FGF10	0003	LADD SYNDROME	FGF10, CYS106PHE	104893885
602115	2255	FGF10	0004	LADD SYNDROME	FGF10, ILE156ARG	104893886
602115	2255	FGF10	0005	APLASIA OF LACRIMAL AND SALIVARY GLANDS LADD SYNDROME, INCLUDED	FGF10, LYS137TER	104893887
602115	2255	FGF10	0006	APLASIA OF LACRIMAL AND SALIVARY GLANDS	FGF10, ARG80SER	104893888
602115	2255	FGF10	0007	APLASIA OF LACRIMAL AND SALIVARY GLANDS	FGF10, GLY138GLU	104893889
602121	1729	DIAPH1	0001	DEAFNESS, AUTOSOMAL DOMINANT 1	DIAPH1, IVS17DS, G-T, +1	
602122	6731	SRP72	0001	BONE MARROW FAILURE, FAMILIAL	SRP72, 2-BP DEL, NT1064	
602122	6731	SRP72	0002	BONE MARROW FAILURE, FAMILIAL	SRP72, ARG207HIS	
602123	818	CAMK2G	0001	VARIANT OF UNKNOWN SIGNIFICANCE	CAMK2G, ARG292PRO	
602125	1352	COX10	0001	MITOCHONDRIAL COMPLEX IV DEFICIENCY ENCEPHALOPATHY, PROGRESSIVE MITOCHONDRIAL, WITH PROXIMAL RENAL TUBULOPATHY DUE TO MITOCHONDRIAL COMPLEX IV DEFICIENCY	COX10, ASN204LYS	104894560
602125	1352	COX10	0002	MITOCHONDRIAL COMPLEX IV DEFICIENCY	COX10, THR196LYS	104894555
602125	1352	COX10	0003	MITOCHONDRIAL COMPLEX IV DEFICIENCY	COX10, PRO225LEU	104894556
602125	1352	COX10	0004	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX IV DEFICIENCY	COX10, ASP336VAL	104894557
602125	1352	COX10	0005	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX IV DEFICIENCY	COX10, ASP336GLY	104894557
602125	1352	COX10	0006	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX IV DEFICIENCY	COX10, T-C	
602129	4650	MYO9B	0001	CELIAC DISEASE, SUSCEPTIBILITY TO, 4	MYO9B, IVS28, G-A	2305764
602136	5189	PEX1	0001	PEROXISOME BIOGENESIS DISORDER 1B PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER), INCLUDED	PEX1, GLY843ASP	61750420
602136	5189	PEX1	0002	PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER) PEROXISOME BIOGENESIS DISORDER 1B, INCLUDED	PEX1, LEU664PRO	121434455
602136	5189	PEX1	0003	PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER) PEROXISOME BIOGENESIS DISORDER 1B, INCLUDED	PEX1, 171-BP DEL	
602136	5189	PEX1	0004	PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	PEX1, 1-BP INS, 2097T	
602136	5189	PEX1	0005	PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER) PEROXISOME BIOGENESIS DISORDER 1B, INCLUDED	PEX1, 1-BP DEL, 2916A	
602137	4695	NDUFA2	0001	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFA2, IVS2DS, G-A, +5	
602141	4728	NDUFS8	0001	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFS8, PRO79LEU	28939679
602141	4728	NDUFS8	0002	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFS8, ARG102HIS	
602141	4728	NDUFS8	0003	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFS8, PRO85LEU	
602141	4728	NDUFS8	0004	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFS8, ARG138HIS	
602141	4728	NDUFS8	0005	MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFS8, ARG77TRP	
602141	4728	NDUFS8	0006	MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFS8, ALA159ASP	
602141	4728	NDUFS8	0007	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFS8, GLU63GLN	
602142	5333	PLCD1	0001	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 3	PLCD1, ARG437TER	
602142	5333	PLCD1	0002	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 3	PLCD1, 10-BP DEL, NT1792	
602142	5333	PLCD1	0003	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 3	PLCD1, ALA574THR	
602142	5333	PLCD1	0004	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 3	PLCD1, CYS209ARG	
602146	89884	LHX4	0001	PITUITARY HORMONE DEFICIENCY, COMBINED, 4	LHX4, IVS4, G-C, -1	
602146	89884	LHX4	0002	PITUITARY HORMONE DEFICIENCY, COMBINED, 4	LHX4, ALA210PRO	121912641
602146	89884	LHX4	0003	PITUITARY HORMONE DEFICIENCY, COMBINED, 4	LHX4, ARG84CYS	121912642
602146	89884	LHX4	0004	PITUITARY HORMONE DEFICIENCY, COMBINED, 4	LHX4, LEU190ARG	121912643
602146	89884	LHX4	0005	PITUITARY HORMONE DEFICIENCY, COMBINED, 4	LHX4, PRO366THR	121912644
602146	89884	LHX4	0006	PITUITARY HORMONE DEFICIENCY, COMBINED, 4	LHX4, 1-BP INS, 293C	
602149	5307	PITX1	0001	CLUBFOOT, CONGENITAL, WITH OR WITHOUT DEFICIENCY OF LONG BONES AND/OR MIRROR-IMAGE POLYDACTYLY	PITX1, GLU130LYS	121909109
602149	5307	PITX1	0002	CLUBFOOT, CONGENITAL, WITH OR WITHOUT DEFICIENCY OF LONG BONES AND/OR MIRROR-IMAGE POLYDACTYLY	PITX1, 35-BP DEL, NT765	
602150	6591	SNAI2	0001	WAARDENBURG SYNDROME, TYPE IID	SNAI2, DEL	
602150	6591	SNAI2	0002	PIEBALDISM	SNAI2, DEL	
602153	3887	KRT81	0001	MONILETHRIX	KRT81, GLU413LYS	57419521
602153	3887	KRT81	0002	MONILETHRIX	KRT81, GLU402LYS	56821304
602167	2103	ESRRB	0001	DEAFNESS, AUTOSOMAL RECESSIVE 35	ESRRB, 7-BP DUP, NT1018	
602167	2103	ESRRB	0002	DEAFNESS, AUTOSOMAL RECESSIVE 35	ESRRB, ALA110VAL	121909110
602167	2103	ESRRB	0003	DEAFNESS, AUTOSOMAL RECESSIVE 35	ESRRB, VAL342LEU	121909111
602168	7443	VRK1	0001	PONTOCEREBELLAR HYPOPLASIA, TYPE 1A	VRK1, ARG358TER	137853063
602168	7443	VRK1	0002	PONTOCEREBELLAR HYPOPLASIA, TYPE 1A	VRK1, ARG133CYS	
602170	4615	MYD88	0001	MYD88 DEFICIENCY	MYD88, 3-BP DEL, 160GAG	
602170	4615	MYD88	0002	MYD88 DEFICIENCY	MYD88, ARG196CYS	137853064
602170	4615	MYD88	0003	MYD88 DEFICIENCY	MYD88, LEU93PRO	137853065
602170	4615	MYD88	0004	MACROGLOBULINEMIA, WALDENSTROM, SOMATIC	MYD88, LEU265PRO	
602183	579	NKX3-2	0001	SPONDYLO-MEGAEPIPHYSEAL-METAPHYSEAL DYSPLASIA	NKX3-2, 1-BP DUP, 337G	
602183	579	NKX3-2	0002	SPONDYLO-MEGAEPIPHYSEAL-METAPHYSEAL DYSPLASIA	NKX3-2, 2-BP DEL/1-BP INS, 336GG/T	
602183	579	NKX3-2	0003	SPONDYLO-MEGAEPIPHYSEAL-METAPHYSEAL DYSPLASIA	NKX3-2, 7-BP DEL, NT104	
602194	5654	HTRA1	0001	MACULAR DEGENERATION, AGE-RELATED, 7, SUSCEPTIBILITY TO MACULAR DEGENERATION, AGE-RELATED, NEOVASCULAR TYPE, SUSCEPTIBILITY TO, INCLUDED	HTRA1, -512G-A	11200638
602194	5654	HTRA1	0002	CEREBRAL AUTOSOMAL RECESSIVE ARTERIOPATHY WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY	HTRA1, ARG370TER	113993971
602194	5654	HTRA1	0003	CEREBRAL AUTOSOMAL RECESSIVE ARTERIOPATHY WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY	HTRA1, ARG302TER	113993970
602194	5654	HTRA1	0004	CEREBRAL AUTOSOMAL RECESSIVE ARTERIOPATHY WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY	HTRA1, VAL297MET	113993969
602194	5654	HTRA1	0005	CEREBRAL AUTOSOMAL RECESSIVE ARTERIOPATHY WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY	HTRA1, ALA252THR	113993968
602194	5654	HTRA1	0006	CEREBRAL AUTOSOMAL RECESSIVE ARTERIOPATHY WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY	HTRA1, GLY295ARG	
602195	3315	HSPB1	0001	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB	HSPB1, SER135PHE	28939680
602195	3315	HSPB1	0002	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F, INCLUDED	HSPB1, ARG127TRP	29001571
602195	3315	HSPB1	0003	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB	HSPB1, THR151ILE	28937568
602195	3315	HSPB1	0004	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB	HSPB1, PRO182LEU	28937569
602195	3315	HSPB1	0005	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F	HSPB1, ARG136TRP	28939681
602195	3315	HSPB1	0006	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB	HSPB1, PRO182SER	104894020
602195	3315	HSPB1	0007	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB	HSPB1, ARG140GLY	121909112
602195	3315	HSPB1	0008	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB, AUTOSOMAL RECESSIVE	HSPB1, LEU99MET	121909113
602201	1893	ECM1	0001	LIPOID PROTEINOSIS OF URBACH AND WIETHE	ECM1, 1-BP DEL, 1019A	
602201	1893	ECM1	0002	LIPOID PROTEINOSIS OF URBACH AND WIETHE	ECM1, GLN346TER	121909114
602201	1893	ECM1	0003	LIPOID PROTEINOSIS OF URBACH AND WIETHE	ECM1, 1163-BP DEL	
602201	1893	ECM1	0004	LIPOID PROTEINOSIS OF URBACH AND WIETHE	ECM1, 1-BP DEL, 507T	
602201	1893	ECM1	0005	LIPOID PROTEINOSIS OF URBACH AND WIETHE	ECM1, ARG53TER	121909115
602201	1893	ECM1	0006	LIPOID PROTEINOSIS OF URBACH AND WIETHE	ECM1, PHE167ILE	121909116
602201	1893	ECM1	0007	LIPOID PROTEINOSIS OF URBACH AND WIETHE	ECM1, TRP160TER	
602202	1650	DDOST	0001	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ir	DDOST, 22-BP DEL, NT1265	
602202	1650	DDOST	0002	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ir	DDOST, GLY217ASP	
602207	22931	RAB18	0001	WARBURG MICRO SYNDROME 3	RAB18, LEU24GLN	
602207	22931	RAB18	0002	WARBURG MICRO SYNDROME 3	RAB18, EX2DEL	
602207	22931	RAB18	0003	WARBURG MICRO SYNDROME 3	RAB18, 3-BP DEL, NT277	
602207	22931	RAB18	0004	WARBURG MICRO SYNDROME 3	RAB18, TER207GLN	
602208	3766	KCNJ10	0001	SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	KCNJ10, ARG65PRO	137853066
602208	3766	KCNJ10	0002	SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	KCNJ10, ARG199TER	137853067
602208	3766	KCNJ10	0003	SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	KCNJ10, CYS140ARG	137853068
602208	3766	KCNJ10	0004	SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	KCNJ10, THR164ILE	137853069
602208	3766	KCNJ10	0005	SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	KCNJ10, ALA167VAL	137853070
602208	3766	KCNJ10	0006	SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	KCNJ10, ARG297CYS	137853071
602208	3766	KCNJ10	0007	SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	KCNJ10, GLY77ARG	137853072
602208	3766	KCNJ10	0008	DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT, DIGENIC	KCNJ10, ARG194HIS	137853073
602208	3766	KCNJ10	0009	DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT, DIGENIC	KCNJ10, ARG348CYS	137853074
602208	3766	KCNJ10	0010	SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	KCNJ10, ARG65CYS	
602208	3766	KCNJ10	0011	SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	KCNJ10, PHE75LEU	
602208	3766	KCNJ10	0012	SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	KCNJ10, 1-BP DEL, 775G	
602208	3766	KCNJ10	0013	SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	KCNJ10, ARG175GLN	
602216	6794	STK11	0001	PEUTZ-JEGHERS SYNDROME	STK11, DEL EX4-5/INV EX4-7	
602216	6794	STK11	0002	PEUTZ-JEGHERS SYNDROME	STK11, TYR253TER	137853075
602216	6794	STK11	0003	PEUTZ-JEGHERS SYNDROME	STK11, 1-BP DEL, 843G	
602216	6794	STK11	0004	PEUTZ-JEGHERS SYNDROME	STK11, 4-BP DEL, 716GGTC	
602216	6794	STK11	0005	PEUTZ-JEGHERS SYNDROME	STK11, IVS3, G-A, -1	
602216	6794	STK11	0006	PEUTZ-JEGHERS SYNDROME	STK11, LYS84TER	137853076
602216	6794	STK11	0007	PEUTZ-JEGHERS SYNDROME	STK11, 2-BP DEL, NT277	
602216	6794	STK11	0008	PEUTZ-JEGHERS SYNDROME	STK11, LEU67PRO	137853077
602216	6794	STK11	0009	PEUTZ-JEGHERS SYNDROME	STK11, 9-BP DEL	
602216	6794	STK11	0010	PEUTZ-JEGHERS SYNDROME	STK11, GLU57TER	137854584
602216	6794	STK11	0011	TESTICULAR TUMOR, SOMATIC	STK11, GLY163ASP	137853078
602216	6794	STK11	0012	PEUTZ-JEGHERS SYNDROME	STK11, 1-BP DEL, 1407C	
602216	6794	STK11	0013	MELANOMA, MALIGNANT, SOMATIC	STK11, ASP194TYR	121913315
602216	6794	STK11	0014	PEUTZ-JEGHERS SYNDROME	STK11, 1-BP INS, 535T	
602216	6794	STK11	0015	PANCREATIC CANCER, SOMATIC	STK11, TYR36TER	137853079
602216	6794	STK11	0016	PANCREATIC CANCER, SOMATIC	STK11, 1-BP DEL, CODON 217	
602216	6794	STK11	0017	PANCREATIC CANCER, SOMATIC	STK11, 1-BP DEL, CODON 312	
602216	6794	STK11	0018	MELANOMA, MALIGNANT, SOMATIC	STK11, GLU170TER	121913323
602216	6794	STK11	0019	MELANOMA, MALIGNANT, SOMATIC	STK11, TYR49ASP	137853080
602216	6794	STK11	0020	MELANOMA, MALIGNANT, SOMATIC	STK11, GLY135ARG	137853081
602216	6794	STK11	0021	PEUTZ-JEGHERS SYNDROME	STK11, TRP239CYS	137853082
602216	6794	STK11	0022	PEUTZ-JEGHERS SYNDROME	STK11, 1-BP DEL, 890G	
602216	6794	STK11	0023	PEUTZ-JEGHERS SYNDROME	STK11, TYR246TER	137853083
602216	6794	STK11	0024	PEUTZ-JEGHERS SYNDROME	STK11, PHE354LEU	
602218	6299	SALL1	0001	TOWNES-BROCKS SYNDROME	SALL1, 1-BP DEL, 1268C	
602218	6299	SALL1	0002	TOWNES-BROCKS SYNDROME	SALL1, 1115C-A, SER372TER	104894535
602218	6299	SALL1	0003	TOWNES-BROCKS SYNDROME	SALL1, ARG276TER	104894537
602218	6299	SALL1	0004	TOWNES-BROCKS SYNDROME	SALL1, 1115C-G, SER372TER	
602218	6299	SALL1	0005	TOWNES-BROCKS SYNDROME	SALL1, 2-BP DEL, NT1277	
602218	6299	SALL1	0006	TOWNES-BROCKS SYNDROME	SALL1, 2-BP DEL, 1347CA	
602218	6299	SALL1	0007	TOWNES-BROCKS-BRANCHIOOTORENAL-LIKE SYNDROME	SALL1, 1-BP DEL, 1819G	
602218	6299	SALL1	0008	TOWNES-BROCKS SYNDROME	SALL1, 2-BP DEL, 792GC	
602218	6299	SALL1	0009	TOWNES-BROCKS-BRANCHIOOTORENAL-LIKE SYNDROME	SALL1, GLN323TER	104894538
602218	6299	SALL1	0010	TOWNES-BROCKS SYNDROME HEMIFACIAL MICROSOMIA, INCLUDED	SALL1, LEU419TER	137853084
602218	6299	SALL1	0011	TOWNES-BROCKS SYNDROME	SALL1, 1-BP DEL, 995C	
602218	6299	SALL1	0012	TOWNES-BROCKS SYNDROME	SALL1, 2-BP DEL, 3414AT	
602225	1406	CRX	0001	CONE-ROD DYSTROPHY 2	CRX, GLU80ALA	104894671
602225	1406	CRX	0002	CONE-ROD DYSTROPHY 2	CRX, 1-BP DEL, 502G	
602225	1406	CRX	0003	LEBER CONGENITAL AMAUROSIS 7	CRX, 2-BP DEL, GLU168	
602225	1406	CRX	0004	LEBER CONGENITAL AMAUROSIS 7	CRX, 1-BP DEL, GLY217	
602225	1406	CRX	0005	CONE-ROD DYSTROPHY 2	CRX, ARG41TRP	104894672
602225	1406	CRX	0006	CONE-ROD DYSTROPHY 2	CRX, ARG41GLN	61748436
602225	1406	CRX	0007	LEBER CONGENITAL AMAUROSIS 7	CRX, ARG90TRP	104894673
602225	1406	CRX	0008	LEBER CONGENITAL AMAUROSIS 7	CRX, 1-BP DEL, 520G	
602225	1406	CRX	0009	CONE-ROD DYSTROPHY 2	CRX, 1-BP DEL, 615C	
602225	1406	CRX	0010	CONE-ROD DYSTROPHY 2	CRX, 3-BP DEL/2-BP INS, NT816	
602228	6934	TCF7L2	0001	DIABETES MELLITUS, NONINSULIN-DEPENDENT, SUSCEPTIBILITY TO	TCF7L2, IVS3, C-T	7903146
602228	6934	TCF7L2	0002	DIABETES MELLITUS, NONINSULIN-DEPENDENT, SUSCEPTIBILITY TO	TCF7L2, IVS4, G-T	12255372
602228	6934	TCF7L2	0003	DIABETES MELLITUS, NONINSULIN-DEPENDENT, SUSCEPTIBILITY TO	TCF7L2, IVS3, G-C	11196205
602229	6663	SOX10	0001	WAARDENBURG SYNDROME, TYPE 4C	SOX10, GLU189TER	74315514
602229	6663	SOX10	0002	WAARDENBURG SYNDROME, TYPE 4C	SOX10, TYR83TER	73415876
602229	6663	SOX10	0003	WAARDENBURG SYNDROME, TYPE 4C	SOX10, 6-BP INS, NT482	
602229	6663	SOX10	0004	WAARDENBURG SYNDROME, TYPE 4C	SOX10, 2-BP DEL, 1076GA	
602229	6663	SOX10	0005	WAARDENBURG SYNDROME, TYPE 2E, WITHOUT NEUROLOGIC INVOLVEMENT	SOX10, SER135THR	74315515
602229	6663	SOX10	0006	PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE	SOX10, TYR313TER	74315516
602229	6663	SOX10	0007	PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE	SOX10, SER251TER	74315518
602229	6663	SOX10	0008	PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE	SOX10, 12-BP DEL, EXON 5	
602229	6663	SOX10	0009	WAARDENBURG SYNDROME, TYPE 4C	SOX10, TYR207TER	
602229	6663	SOX10	0010	WAARDENBURG SYNDROME, TYPE 4C WAARDENBURG SYNDROME, TYPE 2E, WITH NEUROLOGIC INVOLVEMENT, INCLUDED	SOX10, GLN377TER	74315520
602229	6663	SOX10	0011	PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE	SOX10, GLN250TER	74315521
602229	6663	SOX10	0012	WAARDENBURG SYNDROME, TYPE 4C	SOX10, 1128-BP DEL/3-BP INS	
602229	6663	SOX10	0013	WAARDENBURG SYNDROME, TYPE 2E, WITHOUT NEUROLOGIC INVOLVEMENT	SOX10, 253-BP DEL	
602229	6663	SOX10	0014	WAARDENBURG SYNDROME, TYPE 2E, WITHOUT NEUROLOGIC INVOLVEMENT	SOX10, 1,777-BP DEL	
602229	6663	SOX10	0015	WAARDENBURG SYNDROME, TYPE 2E, WITHOUT NEUROLOGIC INVOLVEMENT	SOX10, 1-BP DEL, 506C	
602229	6663	SOX10	0016	WAARDENBURG SYNDROME, TYPE 4C	SOX10, ALA157VAL	121909117
602229	6663	SOX10	0017	WAARDENBURG SYNDROME, TYPE 2E, WITH NEUROLOGIC INVOLVEMENT	SOX10, IVS4AS, A-C, -2	
602229	6663	SOX10	0018	WAARDENBURG SYNDROME, TYPE 2E, WITH NEUROLOGIC INVOLVEMENT	SOX10, GLN174PRO	
602229	6663	SOX10	0019	PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE	SOX10, 1-BP DEL, 795G	
602229	6663	SOX10	0020	PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE	SOX10, 1-BP DEL, 915G	
602229	6663	SOX10	0021	WAARDENBURG SYNDROME, TYPE 2E, WITHOUT NEUROLOGIC INVOLVEMENT	SOX10, 2-BP DEL, 743AG	
602229	6663	SOX10	0022	WAARDENBURG SYNDROME, TYPE 2E, WITHOUT NEUROLOGIC INVOLVEMENT	SOX10, 1-BP DEL, 113G	
602232	3786	KCNQ3	0001	SEIZURES, BENIGN FAMILIAL NEONATAL, 2	KCNQ3, GLY263VAL	118192250
602235	3785	KCNQ2	0001	SEIZURES, BENIGN FAMILIAL NEONATAL, 1	KCNQ2, TYR284CYS	28939683
602235	3785	KCNQ2	0002	SEIZURES, BENIGN FAMILIAL NEONATAL, 1	KCNQ2, ALA306THR	74315390
602235	3785	KCNQ2	0003	SEIZURES, BENIGN FAMILIAL NEONATAL, 1	KCNQ2, 5-BP INS	118192231
602235	3785	KCNQ2	0004	SEIZURES, BENIGN FAMILIAL NEONATAL, 1	KCNQ2, 1-BP DEL, 1846T	
602235	3785	KCNQ2	0005	SEIZURES, BENIGN FAMILIAL NEONATAL, 1	KCNQ2, ARG214TRP	28939684
602235	3785	KCNQ2	0006	SEIZURES, BENIGN FAMILIAL NEONATAL, 1, AND/OR MYOKYMIA	KCNQ2, ARG207TRP	74315391
602235	3785	KCNQ2	0007	SEIZURES, BENIGN FAMILIAL NEONATAL, 1 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7, INCLUDED	KCNQ2, LYS526ASN	
602235	3785	KCNQ2	0008	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	KCNQ2, SER247TRP	74315392
602235	3785	KCNQ2	0009	SEIZURES, BENIGN FAMILIAL NEONATAL, 1 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7, INCLUDED	KCNQ2, 10-BP DEL/1-BP INS, NT761	
602235	3785	KCNQ2	0010	SEIZURES, BENIGN FAMILIAL NEONATAL, 1	KCNQ2, 1-BP DEL, 2127T	118192244
602235	3785	KCNQ2	0011	SEIZURES, BENIGN FAMILIAL NEONATAL, 1, AND/OR MYOKYMIA	KCNQ2, ARG207GLN	118192200
602235	3785	KCNQ2	0012	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	KCNQ2, ARG213GLN	
602235	3785	KCNQ2	0013	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	KCNQ2, MET546VAL	
602235	3785	KCNQ2	0014	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	KCNQ2, GLY290ASP	
602242	1175	AP2S1	0001	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	AP2S1, ARG15CYS	
602242	1175	AP2S1	0002	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	AP2S1, ARG15LEU	
602242	1175	AP2S1	0003	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	AP2S1, ARG15HIS	
602243	977	CD151	0001	NEPHROPATHY WITH PRETIBIAL EPIDERMOLYSIS BULLOSA AND DEAFNESS	CD151, 1-BP INS, G383	
602244	1776	DNASE1L3	0001	SYSTEMIC LUPUS ERYTHEMATOSUS 16	DNASE1L3, 1-BP DEL, 643T	
602257	950	SCARB2	0001	EPILEPSY, PROGRESSIVE MYOCLONIC 4, WITH RENAL FAILURE	SCARB2, IVS10DS, G-T, +1	
602257	950	SCARB2	0002	EPILEPSY, PROGRESSIVE MYOCLONIC 4, WITH RENAL FAILURE	SCARB2, 2-BP INS, 435AG	
602257	950	SCARB2	0003	EPILEPSY, PROGRESSIVE MYOCLONIC 4, WITH OR WITHOUT RENAL FAILURE	SCARB2, GLN288TER	121909118
602257	950	SCARB2	0004	EPILEPSY, PROGRESSIVE MYOCLONIC 4, WITH RENAL FAILURE	SCARB2, TRP178TER	121909119
602257	950	SCARB2	0005	EPILEPSY, PROGRESSIVE MYOCLONIC 4, WITHOUT RENAL FAILURE	SCARB2, IVS8AS, A-C, -2	
602257	950	SCARB2	0006	EPILEPSY, PROGRESSIVE MYOCLONIC 4, WITHOUT RENAL FAILURE	SCARB2, 1-BP DEL, 1258	
602257	950	SCARB2	0007	EPILEPSY, PROGRESSIVE MYOCLONIC 4, WITHOUT RENAL FAILURE	SCARB2, 1-BP INS, 1187T	
602272	6925	TCF4	0001	PITT-HOPKINS SYNDROME	TCF4, ARG576TRP	121909120
602272	6925	TCF4	0002	PITT-HOPKINS SYNDROME	TCF4, ARG576GLN	121909121
602272	6925	TCF4	0003	PITT-HOPKINS SYNDROME	TCF4, ARG358TER	121909122
602272	6925	TCF4	0004	PITT-HOPKINS SYNDROME	TCF4, IVS9AS, G-C, -1	
602272	6925	TCF4	0005	PITT-HOPKINS SYNDROME	TCF4, ARG574PRO	121909123
602272	6925	TCF4	0006	PITT-HOPKINS SYNDROME	TCF4, 1-BP DEL, 908C	
602275	2979	GUCA1B	0001	RETINITIS PIGMENTOSA 48	GUCA1B, GLY157ARG	121909124
602279	8106	PABPN1	0001	OCULOPHARYNGEAL MUSCULAR DYSTROPHY	PABPN1, (GCG)n EXPANSION, (GCG)8-13	193922941
602279	8106	PABPN1	0002	OCULOPHARYNGEAL MUSCULAR DYSTROPHY	PABPN1, (GCG)n EXPANSION, (GCG)7	
602279	8106	PABPN1	0003	OCULOPHARYNGEAL MUSCULAR DYSTROPHY	PABPN1, GLY12ALA	104894466
602280	7287	TULP1	0001	RETINITIS PIGMENTOSA 14	TULP1, ARG420PRO	121909073
602280	7287	TULP1	0002	RETINITIS PIGMENTOSA 14	TULP1, PHE491LEU	121909074
602280	7287	TULP1	0003	RETINITIS PIGMENTOSA 14	TULP1, ILE459LYS	121909075
602280	7287	TULP1	0004	RETINITIS PIGMENTOSA 14 LEBER CONGENITAL AMAUROSIS 15, INCLUDED	TULP1, IVS2DS, G-A, +1	
602280	7287	TULP1	0005	RETINITIS PIGMENTOSA 14	TULP1, IVS14DS, G-A, +1	
602280	7287	TULP1	0006	RETINITIS PIGMENTOSA 14	TULP1, PHE382SER	121909076
602280	7287	TULP1	0007	RETINITIS PIGMENTOSA 14	TULP1, ARG482TRP	121909077
602280	7287	TULP1	0008	RETINITIS PIGMENTOSA 14	TULP1, 11-BP DEL, NT1511	
602280	7287	TULP1	0009	RETINITIS PIGMENTOSA, JUVENILE, TULP1-RELATED	TULP1, IVS7, T-C, +2	
602280	7287	TULP1	0010	LEBER CONGENITAL AMAUROSIS 15	TULP1, GLU402TER	
602280	7287	TULP1	0011	LEBER CONGENITAL AMAUROSIS 15	TULP1, ARG400TRP	
602280	7287	TULP1	0012	LEBER CONGENITAL AMAUROSIS 15	TULP1, GLY368TRP	
602280	7287	TULP1	0013	LEBER CONGENITAL AMAUROSIS 15	TULP1, 6-BP DUP, NT1593	
602286	6309	SC5D	0001	LATHOSTEROLOSIS	SC5DL, ARG29GLN	104894295
602286	6309	SC5D	0002	LATHOSTEROLOSIS	SC5DL, GLY211ASP	104894296
602286	6309	SC5D	0003	LATHOSTEROLOSIS	SC5DL, TYR46SER	104894297
602290	22954	TRIM32	0001	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2H	TRIM32, ASP487ASN	111033570
602290	22954	TRIM32	0002	BARDET-BIEDL SYNDROME 11	TRIM32, PRO130SER	111033571
602290	22954	TRIM32	0003	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2H	TRIM32, 1-BP DEL, 1559C	
602290	22954	TRIM32	0004	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2H	TRIM32, ARG394HIS	121434447
602296	9179	AP4M1	0001	SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE	AP4M1, IVS14DS, G-T, +1	
602296	9179	AP4M1	0002	SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE	AP4M1, GLU193LYS	
602298	7879	RAB7A	0001	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B	RAB7, LEU129PHE	121909078
602298	7879	RAB7A	0002	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B	RAB7, VAL162MET	121909079
602298	7879	RAB7A	0003	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B	RAB7, ASN161THR	121909080
602298	7879	RAB7A	0004	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B	RAB7, LYS157ASN	121909081
602302	55806	HR	0001	ALOPECIA UNIVERSALIS CONGENITA	HR, THR1022ALA	7014851
602302	55806	HR	0002	ALOPECIA UNIVERSALIS CONGENITA	HR, VAL1136ASP	121434448
602302	55806	HR	0003	ALOPECIA UNIVERSALIS CONGENITA	HR, IVS12, G-A, +1	
602302	55806	HR	0005	ATRICHIA WITH PAPULAR LESIONS	HR, 1-BP DEL, 2147C	
602302	55806	HR	0006	ATRICHIA WITH PAPULAR LESIONS	HR, 1-BP DEL, 3434C	
602302	55806	HR	0007	ATRICHIA WITH PAPULAR LESIONS	HR, ARG613TER	121434449
602302	55806	HR	0008	ATRICHIA WITH PAPULAR LESIONS	HR, 1-BP DEL, 1256C	
602302	55806	HR	0009	ATRICHIA WITH PAPULAR LESIONS	HR, 21-BP DEL, NT1261	
602302	55806	HR	0010	ATRICHIA WITH PAPULAR LESIONS	HR, 2-BP DEL, 2847AG	
602302	55806	HR	0011	ATRICHIA WITH PAPULAR LESIONS	HR, GLN1176TER	121434450
602302	55806	HR	0012	ALOPECIA UNIVERSALIS CONGENITA	HR, ASP1012ASN	121434451
602302	55806	HR	0013	HYPOTRICHOSIS 4	HR, -320T-C	
602302	55806	HR	0014	HYPOTRICHOSIS 4	HR, UPSTREAM ORF2, GLN3TER	
602302	55806	HR	0015	HYPOTRICHOSIS 4	HR, UPSTREAM ORF2, PRO25ALA	
602302	55806	HR	0016	HYPOTRICHOSIS 4	HR, UPSTREAM ORF2, TER35TRP	
602311	181	AGRP	0001	OBESITY, LATE-ONSET LEANNESS, INHERITED	AGRP, ALA67THR	5030980
602322	7012	TERC	0001	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 1	TERC, 821-BP DEL	
602322	7012	TERC	0002	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 1	TERC, 408C-G	199422284
602322	7012	TERC	0003	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 1	TERC, 107/8GC-AG	
602322	7012	TERC	0004	BONE MARROW FAILURE, TELOMERE-RELATED, 2	TERC, 58G-A	113487931
602322	7012	TERC	0005	BONE MARROW FAILURE, TELOMERE-RELATED, 2	TERC, 72C-G	199422265
602322	7012	TERC	0006	BONE MARROW FAILURE, TELOMERE-RELATED, 2	TERC, 4-BP DEL, 110GACT	199422270
602322	7012	TERC	0007	BONE MARROW FAILURE, TELOMERE-RELATED, 2	TERC, 116C-T	199422272
602322	7012	TERC	0008	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 2	TERC, 204C-G	199422277
602322	7012	TERC	0009	PULMONARY FIBROSIS AND BONE MARROW FAILURE, TELOMERE-RELATED, 2	TERC, 98G-A	199422268
602322	7012	TERC	0010	PULMONARY FIBROSIS, TELOMERE-RELATED, 2	TERC, 325G-T	
602322	7012	TERC	0011	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 1	TERC, 4-BP DEL, NT54	
602322	7012	TERC	0012	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 2	TERC, 143G-A	
602322	7012	TERC	0013	BONE MARROW FAILURE, TELOMERE-RELATED, 2	TERC, 212C-G	
602337	4920	ROR2	0001	BRACHYDACTYLY, TYPE B1	ROR2, TYR755TER	121909082
602337	4920	ROR2	0002	BRACHYDACTYLY, TYPE B1	ROR2, TRP749TER	104894121
602337	4920	ROR2	0003	BRACHYDACTYLY, TYPE B1	ROR2, 1-BP DEL, 2249G	
602337	4920	ROR2	0004	ROBINOW SYNDROME, AUTOSOMAL RECESSIVE	ROR2, GLN502TER	121909083
602337	4920	ROR2	0005	ROBINOW SYNDROME, AUTOSOMAL RECESSIVE	ROR2, ARG184CYS	121909084
602337	4920	ROR2	0006	ROBINOW SYNDROME, AUTOSOMAL RECESSIVE	ROR2, TRP720TER	121909085
602337	4920	ROR2	0007	ROBINOW SYNDROME, AUTOSOMAL RECESSIVE	ROR2, ARG205TER	121909086
602337	4920	ROR2	0008	BRACHYDACTYLY, TYPE B1 ROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH APLASIA/HYPOPLASIA OF PHALANGES AND METACARPALS/METATARSALS	ROR2, 5-BP DEL, 1321CGGCG	
602337	4920	ROR2	0009	BRACHYDACTYLY, TYPE B1	ROR2, 2247G-A, TRP749TER	
602337	4920	ROR2	0010	ROBINOW SYNDROME, AUTOSOMAL RECESSIVE	ROR2, 7-BP DEL, NT1937	
602337	4920	ROR2	0011	ROBINOW SYNDROME, AUTOSOMAL RECESSIVE	ROR2, ARG119TER	121909087
602337	4920	ROR2	0012	ROBINOW SYNDROME, AUTOSOMAL RECESSIVE	ROR2, EX6,7DEL	
602337	4920	ROR2	0013	BRACHYDACTYLY, TYPE B1	ROR2, 1-BP INS, 1366C	
602337	4920	ROR2	0014	BRACHYDACTYLY, TYPE B1	ROR2, 1-BP DEL, 2243C	
602337	4920	ROR2	0015	ROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH BRACHY-SYN-POLYDACTYLY	ROR2, ARG441TER	
602357	7456	WIPF1	0001	WISKOTT-ALDRICH SYNDROME 2	WIPF1, SER434TER	
602358	3060	HCRT	0001	NARCOLEPSY 1	HCRT, LEU16ARG	104894574
602360	2628	GATM	0001	ARGININE:GLYCINE AMIDINOTRANSFERASE DEFICIENCY	GATM, TRP149TER	80338737
602365	1075	CTSC	0001	PAPILLON-LEFEVRE SYNDROME	CTSC, ARG210TER	104894206
602365	1075	CTSC	0002	PAPILLON-LEFEVRE SYNDROME	CTSC, IVS3, G-A, -1	
602365	1075	CTSC	0003	PAPILLON-LEFEVRE SYNDROME	CTSC, GLN252LEU	104894207
602365	1075	CTSC	0004	PAPILLON-LEFEVRE SYNDROME	CTSC, GLU286TER	
602365	1075	CTSC	0005	PAPILLON-LEFEVRE SYNDROME	CTSC, 1-BP DEL, 2692A	
602365	1075	CTSC	0006	HAIM-MUNK SYNDROME	CTSC, GLN286ARG	104894208
602365	1075	CTSC	0007	PAPILLON-LEFEVRE SYNDROME	CTSC, GLN286TER	104894209
602365	1075	CTSC	0008	PAPILLON-LEFEVRE SYNDROME	CTSC, TRP39SER	104894210
602365	1075	CTSC	0009	PAPILLON-LEFEVRE SYNDROME	CTSC, GLY301SER	104894214
602365	1075	CTSC	0010	PAPILLON-LEFEVRE SYNDROME	CTSC, TRP429CYS	104894215
602365	1075	CTSC	0011	PAPILLON-LEFEVRE SYNDROME	CTSC, HIS127PRO	104894216
602365	1075	CTSC	0012	PERIODONTITIS, AGGRESSIVE, 1	CTSC, TYR412CYS	28937571
602365	1075	CTSC	0013	PERIODONTITIS, AGGRESSIVE, 1	CTSC, TYR347CYS	104894211
602366	3611	ILK	0001	VARIANT OF UNKNOWN SIGNIFICANCE	ILK, ALA262VAL	
602376	3455	IFNAR2	0001	HEPATITIS B VIRUS, SUSCEPTIBILITY TO	IFNAR2, SER8PHE	2229207
602378	1785	DNM2	0001	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE B	DNM2, 9-BP DEL, NT1652	
602378	1785	DNM2	0002	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE B, WITH NEUTROPENIA	DNM2, LYS558GLU	121909088
602378	1785	DNM2	0003	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE B, WITH NEUTROPENIA	DNM2, LYS558 DEL	
602378	1785	DNM2	0004	MYOPATHY, CENTRONUCLEAR, 1	DNM2, ARG369GLN	121909089
602378	1785	DNM2	0005	MYOPATHY, CENTRONUCLEAR, 1	DNM2, ARG369TRP	121909090
602378	1785	DNM2	0006	MYOPATHY, CENTRONUCLEAR, 1	DNM2, ARG465TRP	121909091
602378	1785	DNM2	0007	MYOPATHY, CENTRONUCLEAR, 1	DNM2, GLU368LYS	121909092
602378	1785	DNM2	0008	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2M	DNM2, GLY533CYS	121909093
602378	1785	DNM2	0009	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2M	DNM2, LEU566HIS	121909094
602378	1785	DNM2	0010	MYOPATHY, CENTRONUCLEAR, 1	DNM2, SER619LEU	121909095
602378	1785	DNM2	0011	MYOPATHY, CENTRONUCLEAR, 1	DNM2, SER619TRP	
602378	1785	DNM2	0012	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2M	DNM2, GLY358ARG	
602389	7284	TUFM	0001	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4	TUFM, ARG339GLN	121434452
602397	5205	ATP8B1	0001	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 1	ATP8B1, GLY308VAL	111033609
602397	5205	ATP8B1	0002	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 1	ATP8B1, GLY892ARG	121909098
602397	5205	ATP8B1	0003	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 1	ATP8B1, LEU288SER	121909099
602397	5205	ATP8B1	0004	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 1	ATP8B1, 2097T-C, +2	
602397	5205	ATP8B1	0005	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 1	ATP8B1, 1.4-KB DEL	
602397	5205	ATP8B1	0006	CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC 1 CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 1, INCLUDED	ATP8B1, ILE661THR	121909100
602397	5205	ATP8B1	0007	CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC 1	ATP8B1, 9-BP DEL, NT2384	
602397	5205	ATP8B1	0008	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 1	ATP8B1, ASP554ASN	121909101
602397	5205	ATP8B1	0009	CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC 1	ATP8B1, IVS23AS, C-A, -3	
602397	5205	ATP8B1	0010	CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1	ATP8B1, ASP70ASN	34719006
602397	5205	ATP8B1	0011	CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1	ATP8B1, ARG867CYS	121909103
602397	5205	ATP8B1	0012	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 1	ATP8B1, THR456MET	121909104
602397	5205	ATP8B1	0013	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 1	ATP8B1, ARG602TER	121909105
602402	2303	FOXC2	0001	LYMPHEDEMA-DISTICHIASIS SYNDROME	FOXC2, TYR99TER	104894516
602402	2303	FOXC2	0002	LYMPHEDEMA-DISTICHIASIS SYNDROME	FOXC2, 4-BP DUP, NT1093	
602402	2303	FOXC2	0003	LYMPHEDEMA-DISTICHIASIS SYNDROME	FOXC2, 11-BP DEL, NT290	
602402	2303	FOXC2	0004	LYMPHEDEMA-DISTICHIASIS SYNDROME	FOXC2, 1-BP DEL, 1331A	
602402	2303	FOXC2	0005	LYMPHEDEMA-DISTICHIASIS SYNDROME	FOXC2, 1-BP INS, 209T	
602402	2303	FOXC2	0006	LYMPHEDEMA-DISTICHIASIS SYNDROME	FOXC2, 2-BP INS, 201CT	
602402	2303	FOXC2	0007	LYMPHEDEMA-DISTICHIASIS SYNDROME	FOXC2, 1-BP INS, 589C	
602402	2303	FOXC2	0008	LYMPHEDEMA-DISTICHIASIS SYNDROME	FOXC2, 1-BP DEL, 505A	
602402	2303	FOXC2	0009	LYMPHEDEMA-DISTICHIASIS SYNDROME	FOXC2, 8-BP DEL, NT914	
602402	2303	FOXC2	0010	LYMPHEDEMA-DISTICHIASIS SYNDROME WITH RENAL DISEASE AND DIABETES MELLITUS	FOXC2, 1-BP INS, 1006A	
602402	2303	FOXC2	0011	LYMPHEDEMA-DISTICHIASIS SYNDROME	FOXC2, 5-BP INS/79-BP DEL, NT602	
602402	2303	FOXC2	0012	LYMPHEDEMA-DISTICHIASIS SYNDROME	FOXC2, SER125LEU	121909106
602402	2303	FOXC2	0013	LYMPHEDEMA-DISTICHIASIS SYNDROME	FOXC2, ARG121HIS	121909107
602403	642	BLMH	0001	BLEOMYCIN HYDROLASE POLYMORPHISM	BLMH, ILE443VAL	1050565
602412	6229	RPS24	0001	DIAMOND-BLACKFAN ANEMIA 3	RPS24, GLN106TER	104894188
602412	6229	RPS24	0002	DIAMOND-BLACKFAN ANEMIA 3	RPS24, ARG16TER	104894189
602412	6229	RPS24	0003	DIAMOND-BLACKFAN ANEMIA 3	RPS24, DEL/INS	116840806
602413	6391	SDHC	0001	PARAGANGLIOMAS 3	SDHC, 958G-A	
602413	6391	SDHC	0002	PARAGANGLIOMAS 3	SDHC, IVS5, G-T, +1	
602413	6391	SDHC	0003	PARAGANGLIOMAS 3	SDHC, 8,372-BP DEL	
602413	6391	SDHC	0004	PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA GASTROINTESTINAL STROMAL TUMOR, INCLUDED	SDHC, IVS5DS, G-A, +1	
602421	1080	CFTR	0001	CYSTIC FIBROSIS BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1, MODIFIER OF, INCLUDED	CFTR, PHE508DEL	
602421	1080	CFTR	0002	CYSTIC FIBROSIS	CFTR, ILE507DEL	
602421	1080	CFTR	0003	CYSTIC FIBROSIS	CFTR, GLN493TER	77101217
602421	1080	CFTR	0004	CYSTIC FIBROSIS	CFTR, ASP110HIS	113993958
602421	1080	CFTR	0005	CYSTIC FIBROSIS VAS DEFERENS, CONGENITAL BILATERAL ABSENCE OF, INCLUDED	CFTR, ARG117HIS	78655421
602421	1080	CFTR	0006	CYSTIC FIBROSIS	CFTR, ARG347PRO	77932196
602421	1080	CFTR	0007	CYSTIC FIBROSIS	CFTR, ALA455GLU	74551128
602421	1080	CFTR	0008	CYSTIC FIBROSIS	CFTR, IVS10, G-A, -1	76713772
602421	1080	CFTR	0009	CYSTIC FIBROSIS	CFTR, GLY542TER	113993959
602421	1080	CFTR	0010	CYSTIC FIBROSIS	CFTR, SER549ASN	121908755
602421	1080	CFTR	0011	CYSTIC FIBROSIS	CFTR, SER549ILE	121908755
602421	1080	CFTR	0012	CYSTIC FIBROSIS	CFTR, SER549ARG	121908757
602421	1080	CFTR	0013	CYSTIC FIBROSIS	CFTR, GLY551ASP	75527207
602421	1080	CFTR	0014	CYSTIC FIBROSIS	CFTR, ARG553TER	74597325
602421	1080	CFTR	0015	CYSTIC FIBROSIS	CFTR, ALA559THR	75549581
602421	1080	CFTR	0016	CYSTIC FIBROSIS	CFTR, ARG560THR	80055610
602421	1080	CFTR	0017	CYSTIC FIBROSIS	CFTR, TYR563ASN	121909006
602421	1080	CFTR	0018	CYSTIC FIBROSIS	CFTR, PRO574HIS	121908758
602421	1080	CFTR	0019	CYSTIC FIBROSIS	CFTR, 2-BP INS, 2566AT	
602421	1080	CFTR	0020	CYSTIC FIBROSIS	CFTR, 1-BP DEL, 3659C	
602421	1080	CFTR	0021	CYSTIC FIBROSIS	CFTR, SER1255TER	76649725
602421	1080	CFTR	0022	CYSTIC FIBROSIS	CFTR, TRP1282TER	77010898
602421	1080	CFTR	0023	CFTR POLYMORPHISM	CFTR, MET470VAL	213950
602421	1080	CFTR	0024	CFTR POLYMORPHISM	CFTR, ILE506VAL	1800091
602421	1080	CFTR	0025	CFTR POLYMORPHISM	CFTR, PHE508CYS	74571530
602421	1080	CFTR	0026	CYSTIC FIBROSIS	CFTR, TRP846TER	
602421	1080	CFTR	0027	CYSTIC FIBROSIS	CFTR, TYR913CYS	121909008
602421	1080	CFTR	0028	CYSTIC FIBROSIS	CFTR, GLY458VAL	121909009
602421	1080	CFTR	0029	CYSTIC FIBROSIS	CFTR, TRP1316TER	121909010
602421	1080	CFTR	0030	CYSTIC FIBROSIS	CFTR, 2-BP INS, 1154TC	
602421	1080	CFTR	0031	CYSTIC FIBROSIS	CFTR, 1-BP DEL, 1213T	
602421	1080	CFTR	0032	CYSTIC FIBROSIS	CFTR, ASN1303LYS	80034486
602421	1080	CFTR	0033	CYSTIC FIBROSIS	CFTR, ARG1162TER	74767530
602421	1080	CFTR	0034	CYSTIC FIBROSIS	CFTR, ARG334TRP	121909011
602421	1080	CFTR	0035	CYSTIC FIBROSIS	CFTR, 2-BP DEL, 1677TA	121908776
602421	1080	CFTR	0036	CYSTIC FIBROSIS	CFTR, ARG851TER	121909012
602421	1080	CFTR	0037	CYSTIC FIBROSIS	CFTR, GLY551SER	121909013
602421	1080	CFTR	0038	CYSTIC FIBROSIS	CFTR, GLY85GLU	75961395
602421	1080	CFTR	0039	CYSTIC FIBROSIS	CFTR, ARG1158TER	79850223
602421	1080	CFTR	0040	CYSTIC FIBROSIS	CFTR, IVS19, A-G, +4	
602421	1080	CFTR	0041	CYSTIC FIBROSIS	CFTR, 22-BP DEL	
602421	1080	CFTR	0042	CYSTIC FIBROSIS	CFTR, 1-BP DEL, 556A	
602421	1080	CFTR	0043	CYSTIC FIBROSIS	CFTR, 1-BP DEL, 557T	
602421	1080	CFTR	0044	CYSTIC FIBROSIS	CFTR, 84-BP DEL, NT1949	121908777
602421	1080	CFTR	0045	CYSTIC FIBROSIS	CFTR, 1-BP INS, 2869G	121908788
602421	1080	CFTR	0046	CYSTIC FIBROSIS	CFTR, VAL520PHE	77646904
602421	1080	CFTR	0047	CYSTIC FIBROSIS	CFTR, CYS524TER	121908754
602421	1080	CFTR	0048	CYSTIC FIBROSIS	CFTR, GLN1291HIS	121909015
602421	1080	CFTR	0049	CYSTIC FIBROSIS	CFTR, PHE311LEU	121909016
602421	1080	CFTR	0050	CYSTIC FIBROSIS	CFTR, 2-BP DEL, NT1221	
602421	1080	CFTR	0051	CYSTIC FIBROSIS	CFTR, SER492PHE	121909017
602421	1080	CFTR	0052	CYSTIC FIBROSIS	CFTR, ARG560LYS	80055610
602421	1080	CFTR	0053	CYSTIC FIBROSIS	CFTR, GLU827TER	121909018
602421	1080	CFTR	0054	CYSTIC FIBROSIS	CFTR, ARG1066HIS	121909019
602421	1080	CFTR	0055	CYSTIC FIBROSIS	CFTR, ALA1067THR	121909020
602421	1080	CFTR	0056	CYSTIC FIBROSIS	CFTR, IVS20, G-A, +1	
602421	1080	CFTR	0057	CYSTIC FIBROSIS	CFTR, 5-BP DUP, NT3320	
602421	1080	CFTR	0058	CYSTIC FIBROSIS	CFTR, ARG1066CYS	78194216
602421	1080	CFTR	0059	CYSTIC FIBROSIS	CFTR, 1-BP DEL, 1078T	121908744
602421	1080	CFTR	0060	VAS DEFERENS, CONGENITAL BILATERAL ABSENCE OF	CFTR, ASP1270ASN	11971167
602421	1080	CFTR	0061	VAS DEFERENS, CONGENITAL BILATERAL ABSENCE OF	CFTR, GLY576ALA	1800098
602421	1080	CFTR	0062	CYSTIC FIBROSIS	CFTR, 3849+10KB, C-T	75039782
602421	1080	CFTR	0063	CYSTIC FIBROSIS	CFTR, ARG1283MET	77902683
602421	1080	CFTR	0064	CYSTIC FIBROSIS	CFTR, IVS12, G-A, +1	
602421	1080	CFTR	0065	CYSTIC FIBROSIS	CFTR, GLN359LYS AND THR360LYS	75053309
602421	1080	CFTR	0066	CYSTIC FIBROSIS	CFTR, IVS6, 12-BP DEL	
602421	1080	CFTR	0067	CYSTIC FIBROSIS	CFTR, ARG347LEU	77932196
602421	1080	CFTR	0068	CYSTIC FIBROSIS	CFTR, ALA349VAL	121909021
602421	1080	CFTR	0069	CYSTIC FIBROSIS	CFTR, ALA534GLU	121909022
602421	1080	CFTR	0070	CYSTIC FIBROSIS	CFTR, LYS716TER	121909023
602421	1080	CFTR	0071	CYSTIC FIBROSIS	CFTR, IVS13, G-A, +1	
602421	1080	CFTR	0072	CYSTIC FIBROSIS	CFTR, GLN1238TER	121908766
602421	1080	CFTR	0073	CYSTIC FIBROSIS	CFTR, IVS19, G-A, -1	
602421	1080	CFTR	0074	CYSTIC FIBROSIS	CFTR, 1-BP INS, 3898C	
602421	1080	CFTR	0075	CYSTIC FIBROSIS	CFTR, TRP57TER	121909025
602421	1080	CFTR	0076	CYSTIC FIBROSIS	CFTR, GLN1313TER	121909026
602421	1080	CFTR	0077	CYSTIC FIBROSIS	CFTR, GLU92LYS	121908751
602421	1080	CFTR	0078	CYSTIC FIBROSIS	CFTR, ARG347HIS	77932196
602421	1080	CFTR	0079	CYSTIC FIBROSIS	CFTR, GLY91ARG	121908750
602421	1080	CFTR	0080	CYSTIC FIBROSIS	CFTR, PHE1286SER	121909028
602421	1080	CFTR	0081	CYSTIC FIBROSIS	CFTR, 1-BP INS, 2307A	121908787
602421	1080	CFTR	0082	CYSTIC FIBROSIS	CFTR, GLU92TER	121908751
602421	1080	CFTR	0083	CYSTIC FIBROSIS	CFTR, GLY480CYS	79282516
602421	1080	CFTR	0084	CYSTIC FIBROSIS	CFTR, LEU206TRP	121908752
602421	1080	CFTR	0085	CYSTIC FIBROSIS	CFTR, 18-BP DEL, NT591	
602421	1080	CFTR	0086	VAS DEFERENS, CONGENITAL BILATERAL ABSENCE OF BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1, MODIFIER OF	CFTR, IVS8AS, 5T VARIANT	
602421	1080	CFTR	0087	CYSTIC FIBROSIS	CFTR, THR338ILE	77409459
602421	1080	CFTR	0088	CYSTIC FIBROSIS	CFTR, TRP1089TER	78802634
602421	1080	CFTR	0089	CYSTIC FIBROSIS	CFTR, 4-BP DEL, NT4010	
602421	1080	CFTR	0090	CYSTIC FIBROSIS	CFTR, ILE556VAL	75789129
602421	1080	CFTR	0091	CYSTIC FIBROSIS	CFTR, TYR109CYS	121909031
602421	1080	CFTR	0092	CYSTIC FIBROSIS	CFTR, ARG352GLN	121908753
602421	1080	CFTR	0093	CYSTIC FIBROSIS	CFTR, IVS3, A-G, +4	
602421	1080	CFTR	0094	CYSTIC FIBROSIS	CFTR, GLN524HIS	
602421	1080	CFTR	0095	CYSTIC FIBROSIS	CFTR, GLY542TER	
602421	1080	CFTR	0096	CYSTIC FIBROSIS	CFTR, GLN552TER	76554633
602421	1080	CFTR	0097	CYSTIC FIBROSIS	CFTR, ASP648VAL	121909033
602421	1080	CFTR	0098	CYSTIC FIBROSIS	CFTR, LYS710TER	75115087
602421	1080	CFTR	0099	CYSTIC FIBROSIS	CFTR, GLN890TER	79633941
602421	1080	CFTR	0100	CFTR POLYMORPHISM	CFTR, SER912LEU	121909034
602421	1080	CFTR	0101	CYSTIC FIBROSIS	CFTR, 2-BP DEL, 936TA	121908773
602421	1080	CFTR	0102	CYSTIC FIBROSIS	CFTR, HIS949TYR	121909035
602421	1080	CFTR	0103	CYSTIC FIBROSIS	CFTR, LEU1065PRO	121909036
602421	1080	CFTR	0104	CYSTIC FIBROSIS	CFTR, GLN1071PRO	121909037
602421	1080	CFTR	0105	CYSTIC FIBROSIS	CFTR, HIS1085ARG	79635528
602421	1080	CFTR	0106	CYSTIC FIBROSIS	CFTR, TYR1092TER	121908761
602421	1080	CFTR	0107	CYSTIC FIBROSIS	CFTR, TRP1204TER	121908764
602421	1080	CFTR	0108	CYSTIC FIBROSIS	CFTR, 1-BP DEL, 1215G	
602421	1080	CFTR	0109	CYSTIC FIBROSIS	CFTR, THR1220ILE	1800123
602421	1080	CFTR	0110	CYSTIC FIBROSIS	CFTR, ILE1234VAL	75389940
602421	1080	CFTR	0111	CYSTIC FIBROSIS	CFTR, GLY1249GLU	121909040
602421	1080	CFTR	0112	CYSTIC FIBROSIS	CFTR, SER1251ASN	74503330
602421	1080	CFTR	0113	CYSTIC FIBROSIS	CFTR, SER1255PRO	121909041
602421	1080	CFTR	0114	CYSTIC FIBROSIS	CFTR, ASN1303HIS	121909042
602421	1080	CFTR	0115	CYSTIC FIBROSIS	CFTR, 2-BP DEL, 1609CA	121908775
602421	1080	CFTR	0116	CYSTIC FIBROSIS	CFTR, 1-BP DEL, 2423G	
602421	1080	CFTR	0117	CYSTIC FIBROSIS	CFTR, 1-BP DEL, 3293A	
602421	1080	CFTR	0118	CYSTIC FIBROSIS	CFTR, 4-BP INS, NT3667	
602421	1080	CFTR	0119	SWEAT CHLORIDE ELEVATION WITHOUT CYSTIC FIBROSIS	CFTR, SER1455TER	121909043
602421	1080	CFTR	0120	CYSTIC FIBROSIS	CFTR, IVS16, G-A, +1	
602421	1080	CFTR	0121	CYSTIC FIBROSIS	CFTR, ARG553GLN	121909044
602421	1080	CFTR	0122	CYSTIC FIBROSIS	CFTR, -102T-A	
602421	1080	CFTR	0123	CYSTIC FIBROSIS	CFTR, 21-KB DEL	
602421	1080	CFTR	0124	PANCREATITIS, IDIOPATHIC, SUSCEPTIBILITY TO HYPERTRYPSINEMIA, NEONATAL, SUSCEPTIBILITY TO, INCLUDED	CFTR, LEU997PHE	1800111
602421	1080	CFTR	0125	CYSTIC FIBROSIS	CFTR, 1-BP INS, 3622T	
602421	1080	CFTR	0126	CYSTIC FIBROSIS	CFTR, 3601, T-C, -20	
602421	1080	CFTR	0127	CYSTIC FIBROSIS	CFTR, 1-BP DEL, 3876A	121908784
602421	1080	CFTR	0128	CYSTIC FIBROSIS	CFTR, 2-BP DEL, 394TT	121908769
602421	1080	CFTR	0129	CYSTIC FIBROSIS	CFTR, HIS1282TER	
602421	1080	CFTR	0130	CYSTIC FIBROSIS	CFTR, ALA445GLU	
602421	1080	CFTR	0131	CYSTIC FIBROSIS	CFTR, GLU7TER	121909045
602421	1080	CFTR	0132	CYSTIC FIBROSIS	CFTR, 1-BP INS, 989A	
602421	1080	CFTR	0133	CYSTIC FIBROSIS	CFTR, GLN1352HIS	113857788
602421	1080	CFTR	0134	CYSTIC FIBROSIS	CFTR, GLU217GLY	121909046
602421	1080	CFTR	0135	CYSTIC FIBROSIS	CFTR, GLY1244VAL AND SER912LEU	
602421	1080	CFTR	0136	CYSTIC FIBROSIS	CFTR, ALA561GLU	121909047
602421	1080	CFTR	0137	CYSTIC FIBROSIS	CFTR, MET1101LYS	
602431	6092	ROBO2	0001	VESICOURETERAL REFLUX 2	ROBO2, ILE945THR	
602431	6092	ROBO2	0002	VESICOURETERAL REFLUX 2	ROBO2, ALA1236THR	
602432	10133	OPTN	0001	GLAUCOMA 1, OPEN ANGLE, E	OPTN, GLU50LYS	28939688
602432	10133	OPTN	0002	GLAUCOMA 1, OPEN ANGLE, E	OPTN, 2-BP INS, 691AG	
602432	10133	OPTN	0003	GLAUCOMA 1, OPEN ANGLE, E	OPTN, ARG545GLN	75654767
602432	10133	OPTN	0004	GLAUCOMA, NORMAL TENSION, SUSCEPTIBILITY TO GLAUCOMA 1, OPEN ANGLE, E, INCLUDED	OPTN, MET98LYS	11258194
602432	10133	OPTN	0005	AMYOTROPHIC LATERAL SCLEROSIS 12	OPTN, DEL EXON 5	
602432	10133	OPTN	0006	AMYOTROPHIC LATERAL SCLEROSIS 12	OPTN, GLN398TER	
602432	10133	OPTN	0007	AMYOTROPHIC LATERAL SCLEROSIS 12	OPTN, GLU478GLY	
602438	3299	HSF4	0001	CATARACT 5, LAMELLAR	HSF4, LEU115PRO	121909048
602438	3299	HSF4	0002	CATARACT 5, MULTIPLE TYPES	HSF4, ARG120CYS	28937573
602438	3299	HSF4	0003	CATARACT 5, LAMELLAR	HSF4, ALA20ASP	121909049
602438	3299	HSF4	0004	CATARACT 5, LAMELLAR	HSF4, ILE87VAL	121909050
602441	1154	CISH	0001	TUBERCULOSIS, SUSCEPTIBILITY TO MALARIA, SUSCEPTIBILITY TO, INCLUDED;; BACTEREMIA, SUSCEPTIBILITY TO, 2, INCLUDED	CISH, -292, A-T	414171
602445	5274	SERPINI1	0001	ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES	SERPINI1, SER49PRO	121909051
602445	5274	SERPINI1	0002	ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES	SERPINI1, SER52ARG	
602445	5274	SERPINI1	0003	ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES	SERPINI1, HIS338ARG	121909052
602445	5274	SERPINI1	0004	ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES	SERPINI1, GLY392GLU	121909053
602445	5274	SERPINI1	0005	ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES	SERPINI1, GLY392ARG	121909054
602447	5445	PON2	0001	PARAOXONASE 2 POLYMORPHISM	PON2, CYS311SER	7493
602447	5445	PON2	0002	PARAOXONASE 2 POLYMORPHISM	PON2, ALA148GLY	12026
602452	699	BUB1	0001	COLORECTAL CANCER WITH CHROMOSOMAL INSTABILITY	BUB1, 197-BP DEL	
602452	699	BUB1	0002	COLORECTAL CANCER WITH CHROMOSOMAL INSTABILITY	BUB1, SER492TYR	121909055
602457	8772	FADD	0001	INFECTIONS, RECURRENT, ASSOCIATED WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	FADD, CYS105TRP	
602458	6272	SORT1	0001	LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6	SORT1-TBS1, dbSNP rs12740374	12740374
602460	5459	POU4F3	0001	DEAFNESS, AUTOSOMAL DOMINANT 15	POU4F3, 8-BP DEL, EX2	
602460	5459	POU4F3	0002	DEAFNESS, AUTOSOMAL DOMINANT 15	POU4F3, LEU298PHE	121909056
602460	5459	POU4F3	0003	DEAFNESS, AUTOSOMAL DOMINANT 15	POU4F3, LEU223PRO	121909057
602498	10342	TFG	0001	HEREDITARY MOTOR AND SENSORY NEUROPATHY, PROXIMAL TYPE	TFG, PRO285LEU	
602529	7846	TUBA1A	0001	LISSENCEPHALY 3	TUBA1A, ARG264CYS	137853043
602529	7846	TUBA1A	0002	LISSENCEPHALY 3	TUBA1A, ARG402HIS	137853044
602529	7846	TUBA1A	0003	LISSENCEPHALY 3	TUBA1A, ILE188LEU	137853045
602529	7846	TUBA1A	0004	LISSENCEPHALY 3	TUBA1A, PRO263THR	137853046
602529	7846	TUBA1A	0005	LISSENCEPHALY 3	TUBA1A, SER419LEU	137853047
602529	7846	TUBA1A	0006	LISSENCEPHALY 3	TUBA1A, LEU397PRO	137853048
602529	7846	TUBA1A	0007	LISSENCEPHALY 3	TUBA1A, ARG422CYS	137853049
602529	7846	TUBA1A	0008	LISSENCEPHALY 3	TUBA1A, ARG422HIS	137853050
602529	7846	TUBA1A	0009	LISSENCEPHALY 3	TUBA1A, ILE5LEU	
602533	11315	PARK7	0001	PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET	PARK7, 14-KB DEL	
602533	11315	PARK7	0002	PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET	PARK7, LEU166PRO	28938172
602533	11315	PARK7	0003	PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET	PARK7, MET26ILE	74315351
602533	11315	PARK7	0004	PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET	PARK7, ASP149ALA	74315352
602533	11315	PARK7	0005	PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET	PARK7, GLU64ASP	74315353
602533	11315	PARK7	0006	PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET	PARK7, GLU163LYS AND 18-BP DUP	74315354
602533	11315	PARK7	0007	PARKINSON DISEASE, AUTOSOMAL RECESSIVE EARLY-ONSET, DIGENIC, PINK1/DJ1	PARK7, ALA39SER	137853051
602536	22930	RAB3GAP1	0001	WARBURG MICRO SYNDROME 1	RAB3GAP1, 1-BP DEL, 2801C	
602536	22930	RAB3GAP1	0002	WARBURG MICRO SYNDROME 1	RAB3GAP1, IVS7AS, A-G, -2	
602536	22930	RAB3GAP1	0003	WARBURG MICRO SYNDROME 1	RAB3GAP1, IVS8DS, G-A, +1	
602536	22930	RAB3GAP1	0004	WARBURG MICRO SYNDROME 1	RAB3GAP1, ARG671TER	137853052
602536	22930	RAB3GAP1	0005	WARBURG MICRO SYNDROME 1	RAB3GAP1, TRP578TER	137853053
602536	22930	RAB3GAP1	0006	WARBURG MICRO SYNDROME 1	RAB3GAP1, TYR470TER	
602536	22930	RAB3GAP1	0007	WARBURG MICRO SYNDROME 1	RAB3GAP1, 7-BP DEL/6-BP INS, NT264	
602537	726	CAPN5	0001	VITREORETINOPATHY, NEOVASCULAR INFLAMMATORY	CAPN5, ARG243LEU	
602537	726	CAPN5	0002	VITREORETINOPATHY, NEOVASCULAR INFLAMMATORY	CAPN5, LEU244PRO	
602544	5071	PARK2	0001	PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE	PARK2, EX3-7DEL	
602544	5071	PARK2	0002	PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE	PARK2, EX4DEL	
602544	5071	PARK2	0003	PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE	PARK2, THR240ARG	137853054
602544	5071	PARK2	0004	PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE	PARK2, GLN311TER	137853055
602544	5071	PARK2	0005	PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE	PARK2, EX3DEL	
602544	5071	PARK2	0006	PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE	PARK2, EX8-9DEL	
602544	5071	PARK2	0007	PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE	PARK2, TRP453TER	137853056
602544	5071	PARK2	0008	PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE	PARK2, LYS161ASN	137853057
602544	5071	PARK2	0009	PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE	PARK2, 1-BP DEL, 202A	
602544	5071	PARK2	0010	PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE	PARK2, EX7DEL	
602544	5071	PARK2	0011	PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE	PARK2, ALA82GLU	55774500
602544	5071	PARK2	0012	PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE	PARK2, CYS212TYR	137853058
602544	5071	PARK2	0013	PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE	PARK2, VAL56GLU	137853059
602544	5071	PARK2	0014	PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE	PARK2, 1-BP DEL, 255A	
602544	5071	PARK2	0015	ADENOCARCINOMA OF LUNG, SOMATIC	PARK2, EX2DEL	
602544	5071	PARK2	0016	OVARIAN CANCER, SOMATIC	PARK2, DEL	
602544	5071	PARK2	0017	PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE	PARK2, ARG275TRP	34424986
602544	5071	PARK2	0018	PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE	PARK2, LYS211ASN	137853060
602544	5071	PARK2	0019	PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE	PARK2, 1-BP DEL, 1072T	
602544	5071	PARK2	0020	PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE	PARK2, IVS1DS, G-T, +1	
602544	5071	PARK2	0021	PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE	PARK2, THR240MET	137853054
602544	5071	PARK2	0022	PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE	PARK2, EX5-6 DEL	
602544	5071	PARK2	0023	PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE	PARK2, CYS431PHE	
602568	4552	MTRR	0001	HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA DUE TO DEFECT IN COBALAMIN METABOLISM, cblE COMPLEMENTATION TYPE	MTRR, 4-BP DEL, NT1675	
602568	4552	MTRR	0002	HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA DUE TO DEFECT IN COBALAMIN METABOLISM, cblE COMPLEMENTATION TYPE	MTRR, 3-BP DEL, 1726TTG	
602568	4552	MTRR	0003	NEURAL TUBE DEFECTS, FOLATE-SENSITIVE, SUSCEPTIBILITY TO DOWN SYNDROME, SUSCEPTIBILITY TO, INCLUDED	MTRR, ILE22MET	1801394
602568	4552	MTRR	0004	HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA DUE TO DEFECT IN COBALAMIN METABOLISM, cblE COMPLEMENTATION TYPE	MTRR, GLY487ARG	137853061
602568	4552	MTRR	0005	HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA DUE TO DEFECT IN COBALAMIN METABOLISM, cblE COMPLEMENTATION TYPE	MTRR, 2-BP INS, 1623TA	
602568	4552	MTRR	0006	HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA DUE TO DEFECT IN COBALAMIN METABOLISM, cblE COMPLEMENTATION TYPE	MTRR, 140-BP INS, NT903	
602568	4552	MTRR	0007	HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA DUE TO DEFECT IN COBALAMIN METABOLISM, cblE COMPLEMENTATION TYPE	MTRR, SER454LEU	137853062
602569	6620	SNCB	0001	DEMENTIA, LEWY BODY	SNCB, VAL70MET	104893936
602569	6620	SNCB	0002	DEMENTIA, LEWY BODY	SNCB, PRO123HIS	104893937
602574	7007	TECTA	0001	DEAFNESS, AUTOSOMAL DOMINANT 12	TECTA, LEU1820THR AND GLY1824ASP	
602574	7007	TECTA	0002	DEAFNESS, AUTOSOMAL DOMINANT 12	TECTA, TYR1870CYS	121909058
602574	7007	TECTA	0003	DEAFNESS, NEUROSENSORY AUTOSOMAL RECESSIVE 21	TECTA, IVS9DS, G-A, +1	
602574	7007	TECTA	0004	DEAFNESS, AUTOSOMAL DOMINANT 12	TECTA, CYS1057SER	121909059
602574	7007	TECTA	0005	DEAFNESS, AUTOSOMAL DOMINANT 12	TECTA, CYS1619SER	121909060
602574	7007	TECTA	0006	DEAFNESS, NEUROSENSORY AUTOSOMAL RECESSIVE 21	TECTA, 1-BP INS, 649C	
602574	7007	TECTA	0007	DEAFNESS, NEUROSENSORY AUTOSOMAL RECESSIVE 21	TECTA, 1-BP DEL, 6037G	
602574	7007	TECTA	0008	DEAFNESS, AUTOSOMAL DOMINANT 12	TECTA, CYS1837GLY	121909061
602574	7007	TECTA	0009	DEAFNESS, AUTOSOMAL DOMINANT 12	TECTA, ARG2021HIS	121909062
602574	7007	TECTA	0010	DEAFNESS, AUTOSOMAL DOMINANT 12	TECTA, ARG1890CYS	121909063
602574	7007	TECTA	0011	DEAFNESS, AUTOSOMAL DOMINANT 12	TECTA, CYS1837ARG	
602574	7007	TECTA	0012	DEAFNESS, AUTOSOMAL DOMINANT 12	TECTA, 5331G-A	
602575	4010	LMX1B	0001	NAIL-PATELLA SYNDROME	LMX1B, ASN246LYS	121909486
602575	4010	LMX1B	0002	NAIL-PATELLA SYNDROME	LMX1B, ARG198TER	121909487
602575	4010	LMX1B	0003	NAIL-PATELLA SYNDROME	LMX1B, 1-BP INS, 713A	
602575	4010	LMX1B	0004	NAIL-PATELLA SYNDROME	LMX1B, CYS95PHE	121909488
602575	4010	LMX1B	0005	NAIL-PATELLA SYNDROME	LMX1B, 2-BP DEL, 233TG	
602575	4010	LMX1B	0006	NAIL-PATELLA SYNDROME	LMX1B, GLN59TER	121909489
602575	4010	LMX1B	0007	NAIL-PATELLA SYNDROME	LMX1B, ARG208TER	121909490
602575	4010	LMX1B	0008	NAIL-PATELLA SYNDROME	LMX1B, ARG200GLN	121909491
602575	4010	LMX1B	0009	NAIL-PATELLA SYNDROME	LMX1B, 672, G-A, +1	
602575	4010	LMX1B	0010	NAIL-PATELLA SYNDROME	LMX1B, 672, G-T, +1	
602575	4010	LMX1B	0011	NAIL-PATELLA SYNDROME	LMX1B, ARG226TER	121909492
602575	4010	LMX1B	0012	NAIL-PATELLA SYNDROME	LMX1B, 17-BP DEL	
602575	4010	LMX1B	0013	NAIL-PATELLA SYNDROME	LMX1B, DEL	
602576	3955	LFNG	0001	SPONDYLOCOSTAL DYSOSTOSIS 3, AUTOSOMAL RECESSIVE	LFNG, PHE188LEU	104894024
602593	1041	CDSN	0001	HYPOTRICHOSIS 2	CDSN, GLN215TER	
602593	1041	CDSN	0002	HYPOTRICHOSIS 2	CDSN, GLN200TER	
602593	1041	CDSN	0003	PEELING SKIN SYNDROME	CDSN, LYS59TER	
602600	7804	LRP8	0001	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, 1	LRP8, ARG952GLN	5174
602601	4973	OLR1	0002	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO	LOX1, LYS167ASN	11053646
602601	4973	OLR1	0003	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO	LOX1, 1852C-T, 3-PRIME UTR	1060286
602606	9607	CARTPT	0001	OBESITY, SUSCEPTIBILITY TO	CART, LEU34PHE	121909065
602616	4247	MGAT2	0001	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa	MGAT2, SER290PHE	104894446
602616	4247	MGAT2	0002	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa	MGAT2, HIS262ARG	104894447
602616	4247	MGAT2	0003	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa	MGAT2, ASN318ASP	104894448
602616	4247	MGAT2	0004	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa	MGAT2, CYS339TER	104894449
602616	4247	MGAT2	0005	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa	MGAT2, LYS237ASN	
602617	2304	FOXE1	0001	HYPOTHYROIDISM, ATHYROIDAL, WITH SPIKY HAIR AND CLEFT PALATE	FOXE1, ALA65VAL	104894110
602617	2304	FOXE1	0002	HYPOTHYROIDISM, ATHYROIDAL, WITH SPIKY HAIR AND CLEFT PALATE	FOXE1, SER57ASN	28937575
602617	2304	FOXE1	0003	HYPOTHYROIDISM, THYROIDAL, WITH SPIKY HAIR AND CLEFT PALATE	FOXE1, ARG102CYS	104894111
602623	2289	FKBP5	0001	MAJOR DEPRESSIVE DISORDER, INCREASED RECURRENCE OF DEPRESSIVE EPISODES IN, SUSCEPTIBILITY TO ANTIDEPRESSANT DRUG TREATMENT, ACCELERATED RESPONSE TO, INCLUDED	FKBP5, IVS2, C-T	1360780
602627	990	CDC6	0001	MEIER-GORLIN SYNDROME 5	CDC6, THR323ARG	
602630	7050	TGIF1	0001	HOLOPROSENCEPHALY 4	TGIF, SER28CYS	121909066
602630	7050	TGIF1	0002	HOLOPROSENCEPHALY 4	TGIF, PRO63ARG	121909067
602630	7050	TGIF1	0003	HOLOPROSENCEPHALY 4	TGIF, THR151ALA	121909068
602630	7050	TGIF1	0004	HOLOPROSENCEPHALY 4	TGIF, SER162PHE	121909069
602630	7050	TGIF1	0005	HOLOPROSENCEPHALY 4	TGIF, TYR59TER	121909070
602630	7050	TGIF1	0006	HOLOPROSENCEPHALY 4	TGIF, GLN107LEU	28939693
602631	5002	SLC22A18	0001	BREAST CANCER, SOMATIC	SLC22A1L, 111-BP INS	
602631	5002	SLC22A18	0002	RHABDOMYOSARCOMA, SOMATIC	SLC22A1L, 688G-A	
602631	5002	SLC22A18	0003	LUNG CANCER, SOMATIC	SLC22A1L, SER233PHE	121909071
602638	4173	MCM4	0001	NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	MCM4, IVS1AS, A-G, -2	
602642	8600	TNFSF11	0001	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 2	TNFSF11, 5-BP DEL, IVS7+4	
602642	8600	TNFSF11	0002	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 2	TNFSF11, MET199LYS	121909072
602642	8600	TNFSF11	0003	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 2	TNFSF11, 2-BP DEL, 828CG	
602643	4982	TNFRSF11B	0001	PAGET DISEASE, JUVENILE	TNFRSF11B, 100-KB DEL	
602643	4982	TNFRSF11B	0002	PAGET DISEASE, JUVENILE	TNFRSF11B, 3-BP DEL, 182GAC	
602643	4982	TNFRSF11B	0003	PAGET DISEASE, JUVENILE	TNFRSF11B, CYS87TYR	104894091
602643	4982	TNFRSF11B	0004	PAGET DISEASE, JUVENILE	TNFRSF11B, PHE117LEU	104894092
602643	4982	TNFRSF11B	0005	PAGET DISEASE, JUVENILE	TNFRSF11B, 3-BP DEL AND 2-BP INS	
602661	10381	TUBB3	0001	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULAR INVOLVEMENT	TUBB3, ARG262CYS	
602661	10381	TUBB3	0002	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULAR INVOLVEMENT	TUBB3, ALA302THR	
602661	10381	TUBB3	0003	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULAR INVOLVEMENT	TUBB3, ASP417HIS	
602661	10381	TUBB3	0004	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULAR INVOLVEMENT	TUBB3, ASP417ASN	
602661	10381	TUBB3	0005	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULAR INVOLVEMENT	TUBB3, GLU410LYS	
602661	10381	TUBB3	0006	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS	TUBB3, THR178MET	
602661	10381	TUBB3	0007	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS	TUBB3, GLU205LYS	
602661	10381	TUBB3	0008	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS	TUBB3, ALA302VAL	
602661	10381	TUBB3	0009	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS	TUBB3, MET323VAL	
602662	10382	TUBB4A	0001	DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT (1 family)	TUBB4A, ARG2GLY	
602662	10382	TUBB4A	0002	LEUKODYSTROPHY, HYPOMYELINATING, 6	TUBB4A, ASP249ASN	
602666	51168	MYO15A	0001	DEAFNESS, AUTOSOMAL RECESSIVE 3	MYO15A, ILE892PHE	121908965
602666	51168	MYO15A	0002	DEAFNESS, AUTOSOMAL RECESSIVE 3	MYO15A, ASN890TYR	121908966
602666	51168	MYO15A	0003	DEAFNESS, AUTOSOMAL RECESSIVE 3	MYO15A, LYS1300TER	121908967
602666	51168	MYO15A	0004	DEAFNESS, AUTOSOMAL RECESSIVE 3	MYO15A, GLN1229TER	121908968
602666	51168	MYO15A	0005	DEAFNESS, AUTOSOMAL RECESSIVE 3	MYO15A, IVS4DS, G-T, +1	
602666	51168	MYO15A	0006	DEAFNESS, AUTOSOMAL RECESSIVE 3	MYO15A, GLN2716HIS	121908969
602666	51168	MYO15A	0007	DEAFNESS, WITH SMITH-MAGENIS SYNDROME	MYO15A, THR2205ILE	121908970
602666	51168	MYO15A	0008	DEAFNESS, AUTOSOMAL RECESSIVE 3	MYO15A, GLU1105TER	121908971
602666	51168	MYO15A	0009	DEAFNESS, AUTOSOMAL RECESSIVE 3	MYO15A, 1-BP DEL, 3334G	
602666	51168	MYO15A	0010	DEAFNESS, AUTOSOMAL RECESSIVE 3	MYO15A, GLY1831VAL	121908972
602666	51168	MYO15A	0011	DEAFNESS, AUTOSOMAL RECESSIVE 3	MYO15A, IVS50AS, G-C, -1	
602666	51168	MYO15A	0012	DEAFNESS, AUTOSOMAL RECESSIVE 3	MYO15A, 1-BP DEL, 10573A	
602666	51168	MYO15A	0013	DEAFNESS, AUTOSOMAL RECESSIVE 3	MYO15A, 4-BP DEL, 9957TGAC	
602667	4683	NBN	0001	NIJMEGEN BREAKAGE SYNDROME OVARIAN CANCER, SUSCEPTIBILITY TO, INCLUDED	NBN, 5-BP DEL, NT657	
602667	4683	NBN	0002	NIJMEGEN BREAKAGE SYNDROME	NBN, 4-BP DEL, NT698	
602667	4683	NBN	0003	NIJMEGEN BREAKAGE SYNDROME	NBN, 4-BP DEL, NT835	
602667	4683	NBN	0004	NIJMEGEN BREAKAGE SYNDROME	NBN, 1-BP INS	
602667	4683	NBN	0005	NIJMEGEN BREAKAGE SYNDROME	NBN, 1-BP DEL, 1142C	
602667	4683	NBN	0006	NIJMEGEN BREAKAGE SYNDROME	NBN, GLN326TER	121908973
602667	4683	NBN	0007	APLASTIC ANEMIA LYMPHOBLASTIC LEUKEMIA, ACUTE, SUSCEPTIBILITY TO, INCLUDED	NBN, ILE171VAL	61754966
602667	4683	NBN	0008	NIJMEGEN BREAKAGE SYNDROME	NBN, TYR363TER	121908974
602667	4683	NBN	0009	NIJMEGEN BREAKAGE SYNDROME	NBN, ARG215TRP	34767364
602667	4683	NBN	0010	NIJMEGEN BREAKAGE SYNDROME	NBN, 2-BP INS, 742GG	
602669	5309	PITX3	0001	ANTERIOR SEGMENT MESENCHYMAL DYSGENESIS CATARACT 11, POSTERIOR POLAR, INCLUDED	PITX3, 17-BP DUP, NT657	
602669	5309	PITX3	0002	CATARACT 11, TOTAL	PITX3, SER13ASN	104894175
602669	5309	PITX3	0003	CATARACT 11, POSTERIOR POLAR CATARACT 11, POSTERIOR POLAR, WITH MICROPHTHALMIA AND NEURODEVELOPMENTAL ABNORMALITIES, INCLUDED	PITX3, 1-BP DEL, 650G	
602671	2542	SLC37A4	0001	GLYCOGEN STORAGE DISEASE Ib	SLC37A4, GLY339CYS	80356490
602671	2542	SLC37A4	0002	GLYCOGEN STORAGE DISEASE Ib	SLC37A4, GLU355TER	121908975
602671	2542	SLC37A4	0003	GLYCOGEN STORAGE DISEASE Ib	SLC37A4, TRP118ARG	80356489
602671	2542	SLC37A4	0004	GLYCOGEN STORAGE DISEASE Ib	SLC37A4, 4-BP DEL, 2-BP INS, NT1094	
602671	2542	SLC37A4	0005	GLYCOGEN STORAGE DISEASE Ib GLYCOGEN STORAGE DISEASE Ic, INCLUDED	SLC37A4, 170-BP DEL, NT148	
602671	2542	SLC37A4	0006	GLYCOGEN STORAGE DISEASE Ib GLYCOGEN STORAGE DISEASE Ic, INCLUDED	SLC37A4, 2-BP DEL, 1211CT	80356491
602671	2542	SLC37A4	0007	GLYCOGEN STORAGE DISEASE Ic	SLC37A4, IVS8, 4-BP DEL	
602671	2542	SLC37A4	0008	GLYCOGEN STORAGE DISEASE Ic	SLC37A4, TRP96TER	121908976
602671	2542	SLC37A4	0009	GLYCOGEN STORAGE DISEASE Ib GLYCOGEN STORAGE DISEASE Ic, INCLUDED	SLC37A4, 12-BP INS, NT1103	
602671	2542	SLC37A4	0010	GLYCOGEN STORAGE DISEASE Ib	SLC37A4, VAL235DEL	121908977
602671	2542	SLC37A4	0011	GLYCOGEN STORAGE DISEASE Ib	SLC37A4, IVS7, G-T, +1	
602671	2542	SLC37A4	0012	GLYCOGEN STORAGE DISEASE Ib	SLC37A4, IVS1, G-A, +1	
602671	2542	SLC37A4	0013	GLYCOGEN STORAGE DISEASE Ib	SLC37A4, ARG28HIS	121908978
602671	2542	SLC37A4	0014	GLYCOGEN STORAGE DISEASE Ib	SLC37A4, ARG415TER	121908979
602671	2542	SLC37A4	0015	GLYCOGEN STORAGE DISEASE Ib	SLC37A4, GLY339ASP	121908980
602671	2542	SLC37A4	0016	GLYCOGEN STORAGE DISEASE Ib	SLC37A4, 794G-A	
602686	8379	MAD1L1	0001	LYMPHOMA, SOMATIC	MAD1L1, TYR649TER	121908981
602686	8379	MAD1L1	0002	PROSTATE CANCER, SOMATIC	MAD1L1, ARG59CYS	121908982
602690	6392	SDHD	0001	PARAGANGLIOMAS 1	SDHD, GLN36TER	104894303
602690	6392	SDHD	0002	PARAGANGLIOMAS 1 PHEOCHROMOCYTOMA, INCLUDED	SDHD, ARG38TER	80338843
602690	6392	SDHD	0003	PARAGANGLIOMAS 1 PHEOCHROMOCYTOMA, SOMATIC, INCLUDED;; PARAGANGLIOMAS 1 WITH SENSORINEURAL HEARING LOSS, INCLUDED	SDHD, PRO81LEU	80338844
602690	6392	SDHD	0004	PARAGANGLIOMAS 1 PHEOCHROMOCYTOMA, INCLUDED	SDHD, ASP92TYR	80338845
602690	6392	SDHD	0005	PARAGANGLIOMAS 1	SDHD, HIS102LEU	104894302
602690	6392	SDHD	0006	PARAGANGLIOMAS 1	SDHD, 1-BP INS, 13732T	
602690	6392	SDHD	0007	PARAGANGLIOMAS 1	SDHD, TYR114CYS	104894304
602690	6392	SDHD	0008	PARAGANGLIOMAS 1	SDHD, SER32TER	104894305
602690	6392	SDHD	0009	PARAGANGLIOMAS 1	SDHD, 1-BP DEL, 13838G	
602690	6392	SDHD	0010	PARAGANGLIOMAS 1	SDHD, IVS1DS, T-G, +2	
602690	6392	SDHD	0011	COWDEN DISEASE 3 PARAGANGLIOMAS 1, INCLUDED;; CARCINOID TUMORS, INTESTINAL, INCLUDED;; PHEOCHROMOCYTOMA, INCLUDED	SDHD, GLY12SER	34677591
602690	6392	SDHD	0012	PARAGANGLIOMAS 1	SDHD, ARG22TER	104894306
602690	6392	SDHD	0013	PARAGANGLIOMAS 1 WITH SENSORINEURAL HEARING LOSS	SDHD, 2-BP DEL	
602690	6392	SDHD	0014	PARAGANGLIOMAS 1	SDHD, TYR93DEL	121908983
602690	6392	SDHD	0015	PARAGANGLIOMAS 1	SDHD, MET1ILE	80338842
602690	6392	SDHD	0016	PARAGANGLIOMAS 1	SDHD, LEU139PRO	80338847
602690	6392	SDHD	0017	PARAGANGLIOMAS 1	SDHD, 2-BP DEL	
602690	6392	SDHD	0019	CARCINOID TUMORS, INTESTINAL PHEOCHROMOCYTOMA, INCLUDED;; MERKEL CELL CARCINOMA, SOMATIC, INCLUDED;; COWDEN DISEASE 3, INCLUDED	SDHD, HIS50ARG	11214077
602690	6392	SDHD	0020	PARAGANGLIOMAS 1	SDHD, 1-BP DEL, 463A	
602690	6392	SDHD	0021	PARAGANGLIOMA, CAROTID BODY, SOMATIC	SDHD, MET1VAL	104894307
602690	6392	SDHD	0022	PARAGANGLIOMAS 1	SDHD, 4-BP DEL	
602690	6392	SDHD	0023	PARAGANGLIOMAS 1	SDHD, TRP43TER	104894308
602690	6392	SDHD	0024	PARAGANGLIOMAS 1	SDHD, 96-KB DEL	
602690	6392	SDHD	0025	PHEOCHROMOCYTOMA	SDHD, CYS11TER	104894309
602690	6392	SDHD	0026	PHEOCHROMOCYTOMA	SDHD, TRP5TER	104894310
602690	6392	SDHD	0027	PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA	SDHD, 1-BP DEL, 57G	
602690	6392	SDHD	0028	COWDEN DISEASE 3	SDHD, HIS145ASN	121908984
602694	4724	NDUFS4	0001	MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFS4, 5-BP DUP	
602694	4724	NDUFS4	0002	MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFS4, TRP96TER	121908985
602694	4724	NDUFS4	0003	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFS4, ARG106TER	104893898
602694	4724	NDUFS4	0004	MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFS4, TRP15TER	104893899
602694	4724	NDUFS4	0005	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFS4, IVS1AS, G-A, -1	
602694	4724	NDUFS4	0006	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFS4, 1-BP DEL, 462A	
602700	2033	EP300	0001	COLORECTAL CANCER, SOMATIC	EP300, ARG580TER	137853038
602700	2033	EP300	0002	COLORECTAL CANCER, SOMATIC	EP300, PRO2221GLN	28937578
602700	2033	EP300	0003	RUBINSTEIN-TAYBI SYNDROME 2	EP300, ARG648TER	137853039
602700	2033	EP300	0004	RUBINSTEIN-TAYBI SYNDROME 2	EP300, 8-BP DEL, NT2877	
602700	2033	EP300	0005	RUBINSTEIN-TAYBI SYNDROME 2	EP300, EX1 DEL	
602700	2033	EP300	0006	RUBINSTEIN-TAYBI SYNDROME 2	EP300, 1-BP DEL, 7100C	
602700	2033	EP300	0007	RUBINSTEIN-TAYBI SYNDROME 2	EP300, EX3-8DEL	
602700	2033	EP300	0008	RUBINSTEIN-TAYBI SYNDROME 2	EP300, 1-BP DEL, 638G	
602713	8754	ADAM9	0001	CONE-ROD DYSTROPHY 9	ADAM9, IVS11, G-A, +1	
602713	8754	ADAM9	0002	CONE-ROD DYSTROPHY 9	ADAM9, ARG256TER	137853040
602713	8754	ADAM9	0003	CONE-ROD DYSTROPHY 9	ADAM9, ARG490TER	137853041
602713	8754	ADAM9	0004	CONE-ROD DYSTROPHY 9	ADAM9, IVS5, A-G, -8	
602716	4868	NPHS1	0001	NEPHROTIC SYNDROME, TYPE 1	NPHS1, 2-BP DEL, 121CT	
602716	4868	NPHS1	0002	NEPHROTIC SYNDROME, TYPE 1	NPHS1, ARG1109TER	137853042
602716	4868	NPHS1	0003	NEPHROTIC SYNDROME, TYPE 1	NPHS1, 2-BP INS, 1306AC	
602716	4868	NPHS1	0004	NEPHROTIC SYNDROME, TYPE 1	NPHS1, 1-BP INS, 3250G	
602716	4868	NPHS1	0005	NEPHROTIC SYNDROME, TYPE 1	NPHS1, 1-BP DEL, 1481C	
602716	4868	NPHS1	0006	NEPHROTIC SYNDROME, TYPE 1	NPHS1, 1-BP DEL, 3250G	
602716	4868	NPHS1	0007	NEPHROTIC SYNDROME, TYPE 1	NPHS1, GLU447LYS AND ASP819VAL	28939695
602716	4868	NPHS1	0008	NEPHROTIC SYNDROME, TYPE 1	NPHS1, CYS265ARG	
602716	4868	NPHS1	0009	NEPHROTIC SYNDROME, TYPE 1	NPHS1, VAL822MET	
602716	4868	NPHS1	0010	NEPHROTIC SYNDROME, TYPE 1	NPHS1, ARG1160TER	
602727	1186	CLCN7	0001	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 4	CLCN7, GLN555TER	121434432
602727	1186	CLCN7	0002	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 4	CLCN7, ARG762GLN	121434433
602727	1186	CLCN7	0003	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 4	CLCN7, LEU766PRO	121434434
602727	1186	CLCN7	0004	OSTEOPETROSIS, AUTOSOMAL DOMINANT 2	CLCN7, ARG767TRP	121434435
602727	1186	CLCN7	0005	OSTEOPETROSIS, AUTOSOMAL DOMINANT 2	CLCN7, 2-BP DEL, 1423AG	
602727	1186	CLCN7	0006	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 4	CLCN7, ILE261PHE	121434436
602730	93	ACVR2B	0001	HETEROTAXY, VISCERAL, 4, AUTOSOMAL	ACVR2B, ARG40HIS	121434437
602730	93	ACVR2B	0002	HETEROTAXY, VISCERAL, 4, AUTOSOMAL	ACVR2B, VAL494ILE	121434438
602733	223	ALDH9A1	0001	ALDH9A1*2 POLYMORPHISM	ALDH9A1, CYS115SER	121908986
602743	51422	PRKAG2	0001	WOLFF-PARKINSON-WHITE SYNDROME CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 6, INCLUDED	PRKAG2, ARG302GLN	121908987
602743	51422	PRKAG2	0002	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 6	PRKAG2, HIS142ARG	121908988
602743	51422	PRKAG2	0003	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 6	PRKAG2, 3-BP INS, 327TTA	
602743	51422	PRKAG2	0004	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 6	PRKAG2, THR400ASN	28938173
602743	51422	PRKAG2	0005	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 6	PRKAG2, ASN488ILE	121908989
602743	51422	PRKAG2	0006	WOLFF-PARKINSON-WHITE SYNDROME, CHILDHOOD-ONSET	PRKAG2, ARG531GLY	121908990
602743	51422	PRKAG2	0007	GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	PRKAG2, ARG531GLN	121908991
602743	51422	PRKAG2	0008	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 6	PRKAG2, TYR487HIS	
602743	51422	PRKAG2	0009	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 6	PRKAG2, HIS530ARG	
602743	51422	PRKAG2	0010	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 6	PRKAG2, GLU506GLN	
602743	51422	PRKAG2	0011	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 6	PRKAG2, SER548PRO	
602744	8443	GNPAT	0001	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	GNPAT, ARG211HIS	121434439
602744	8443	GNPAT	0002	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	GNPAT, ARG211CYS	121434440
602744	8443	GNPAT	0003	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	GNPAT, 2-BP INS, 848TT	
602744	8443	GNPAT	0004	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	GNPAT, 1-BP DEL, NT780	
602744	8443	GNPAT	0005	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	GNPAT, 1-BP DEL, NT1575	
602744	8443	GNPAT	0006	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	GNPAT, ASP519GLY	
602744	8443	GNPAT	0007	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	GNPAT, IVS9, T-G, -3	
602744	8443	GNPAT	0008	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	GNPAT, 2-BP DEL, 1429AT	
602744	8443	GNPAT	0009	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	GNPAT, IVS14, G-A, +5	
602748	1848	DUSP6	0001	HYPOGONADOTROPIC HYPOGONADISM 19 WITH ANOSMIA	DUSP6, ASN189SER	
602748	1848	DUSP6	0002	HYPOGONADOTROPIC HYPOGONADISM 19 WITH ANOSMIA, SUSCEPTIBILITY TO	DUSP6, SER182PHE	
602748	1848	DUSP6	0003	HYPOGONADOTROPIC HYPOGONADISM 19 WITH ANOSMIA, SUSCEPTIBILITY TO	DUSP6, THR346MET	
602748	1848	DUSP6	0004	HYPOGONADOTROPIC HYPOGONADISM 19 WITHOUT ANOSMIA	DUSP6, PHE77ILE	
602753	401	PHOX2A	0001	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2	ARIX, IVS1, G-A, +1	
602753	401	PHOX2A	0002	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2	ARIX, IVS2, G-A, -1	
602753	401	PHOX2A	0003	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2	ARIX, ALA72VAL	104894269
602765	3889	KRT83	0001	MONILETHRIX	KRT82, GLU407LYS	57802288
602767	3891	KRT85	0001	ECTODERMAL DYSPLASIA 4, HAIR/NAIL TYPE	KRT85, ARG78HIS	61630004
602768	10683	DLL3	0001	SPONDYLOCOSTAL DYSOSTOSIS 1, AUTOSOMAL RECESSIVE	DLL3, 5-BP INS, NT593	
602768	10683	DLL3	0002	SPONDYLOCOSTAL DYSOSTOSIS 1, AUTOSOMAL RECESSIVE	DLL3, 2-BP DEL, 945AT	
602768	10683	DLL3	0003	SPONDYLOCOSTAL DYSOSTOSIS 1, AUTOSOMAL RECESSIVE	DLL3, GLY385ASP	104894674
602768	10683	DLL3	0004	SPONDYLOCOSTAL DYSOSTOSIS 1, AUTOSOMAL RECESSIVE	DLL3, 17-BP DEL, NT1285	
602768	10683	DLL3	0005	SPONDYLOCOSTAL DYSOSTOSIS 1, AUTOSOMAL RECESSIVE	DLL3, 1-BP DEL, 615C	
602768	10683	DLL3	0006	SPONDYLOCOSTAL DYSOSTOSIS 1, AUTOSOMAL RECESSIVE	DLL3, ARG238TER	104894675
602768	10683	DLL3	0007	SPONDYLOCOSTAL DYSOSTOSIS 1, AUTOSOMAL RECESSIVE	DLL3, 1-BP DEL, 1440G	
602768	10683	DLL3	0008	SPONDYLOCOSTAL DYSOSTOSIS 1, AUTOSOMAL RECESSIVE	DLL3, GLY504ASP	104894676
602770	84733	CBX2	0001	46,XY SEX REVERSAL 5	CBX2, PRO98LEU	121908255
602770	84733	CBX2	0002	46,XY SEX REVERSAL 5	CBX2, ARG443PRO	121908256
602774	5889	RAD51C	0001	FANCONI ANEMIA, COMPLEMENTATION GROUP O	RAD51C, ARG258HIS	
602774	5889	RAD51C	0002	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 3	RAD51C, IVS5DS, G-T, +5	
602774	5889	RAD51C	0003	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 3	RAD51C, GLY125VAL	
602774	5889	RAD51C	0004	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 3	RAD51C, LEU138PHE	
602774	5889	RAD51C	0005	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 3	RAD51C, GLN133TER	
602774	5889	RAD51C	0006	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 3	RAD51C, 1-BP DEL, 230G	
602774	5889	RAD51C	0007	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 3	RAD51C, 1-BP DEL, 93G	
602774	5889	RAD51C	0008	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 3	RAD51C, IVS5DS, G-A, +1	
602775	8036	SHOC2	0001	NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	SHOC2, SER2GLY	
602783	6687	SPG7	0001	SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE	SPG7, 2-BP DEL, NT784	
602783	6687	SPG7	0002	SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE	SPG7, 1-BP INS, 2228A	
602783	6687	SPG7	0003	SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE	SPG7, 9.5-KB DEL	
602783	6687	SPG7	0004	SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE	SPG7, 2-BP DEL, 1-BP INS, 850	
602783	6687	SPG7	0005	SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE	SPG7, 3-BP DEL, 1742TGG	
602783	6687	SPG7	0006	SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE	SPG7, SER692THR	121918357
602783	6687	SPG7	0007	SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE	SPG7, LEU78TER	121918358
602783	6687	SPG7	0008	SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE	SPG7, 1-BP DEL, 1616C	
602783	6687	SPG7	0009	SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE	SPG7, 5.1-KB DEL	
602783	6687	SPG7	0010	SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE	SPG7, GLY349SER	
602783	6687	SPG7	0011	SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE	SPG7, TRP583CYS	
602783	6687	SPG7	0012	SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE	SPG7, ALA510VAL	
602821	3798	KIF5A	0001	SPASTIC PARAPLEGIA 10	KIF5A, ASN256SER	121434441
602821	3798	KIF5A	0002	SPASTIC PARAPLEGIA 10 WITH OR WITHOUT PERIPHERAL NEUROPATHY	KIF5A, ARG280CYS	121434442
602821	3798	KIF5A	0003	SPASTIC PARAPLEGIA 10	KIF5A, TYR276CYS	121434443
602821	3798	KIF5A	0004	SPASTIC PARAPLEGIA 10	KIF5A, ALA361VAL	121434444
602821	3798	KIF5A	0005	SPASTIC PARAPLEGIA 10 WITH OR WITHOUT PERIPHERAL NEUROPATHY	KIF5A, GLU251LYS	
602821	3798	KIF5A	0006	SPASTIC PARAPLEGIA 10 WITH PERIPHERAL NEUROPATHY	KIF5A, ARG204GLN	
602821	3798	KIF5A	0007	SPASTIC PARAPLEGIA 10	KIF5A, ARG280HIS	
602821	3798	KIF5A	0008	SPASTIC PARAPLEGIA 10	KIF5A, GLU755LYS	
602821	3798	KIF5A	0009	SPASTIC PARAPLEGIA 10 WITH PERIPHERAL NEUROPATHY	KIF5A, GLY235GLU	
602851	84059	GPR98	0001	FEBRILE SEIZURES, FAMILIAL, 4	GPR98, SER2652TER	121909761
602851	84059	GPR98	0002	USHER SYNDROME, TYPE IIC	GPR98, GLN2301TER	121909762
602851	84059	GPR98	0003	USHER SYNDROME, TYPE IIC	GPR98, 4-BP INS	
602851	84059	GPR98	0004	USHER SYNDROME, TYPE IIC	GPR98, 1-BP DEL, 8790C	
602851	84059	GPR98	0005	USHER SYNDROME, TYPE IIC	GPR98, 19-BP DEL	
602851	84059	GPR98	0006	USHER SYNDROME, TYPE IIC	GPR98, TYR6044CYS	121909763
602851	84059	GPR98	0007	USHER SYNDROME, TYPE IIC	GPR98, 136-KB DEL, EX84-85	
602851	84059	GPR98	0008	USHER SYNDROME, TYPE IIC	GPR98, 13-BP DEL, NT2258	
602851	84059	GPR98	0009	USHER SYNDROME, TYPE IIC	GPR98, 2-BP DEL, 5356AA	
602851	84059	GPR98	0010	USHER SYNDROME, TYPE IIC, GPR98/PDZD7 DIGENIC	GPR98, 1-BP DEL, 17137G	
602855	5687	PSMA6	0001	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO	PSMA6, -8C-G, 5-PRIME UTR	1048990
602858	1717	DHCR7	0001	SMITH-LEMLI-OPITZ SYNDROME	DHCR7, IVS8AS, G-C, -1	80338863
602858	1717	DHCR7	0002	SMITH-LEMLI-OPITZ SYNDROME	DHCR7, 96-BP DEL	
602858	1717	DHCR7	0003	SMITH-LEMLI-OPITZ SYNDROME	DHCR7, 1-BP INS, 505C	
602858	1717	DHCR7	0004	SMITH-LEMLI-OPITZ SYNDROME	DHCR7, 1-BP INS, 586T	
602858	1717	DHCR7	0005	SMITH-LEMLI-OPITZ SYNDROME	DHCR7, HIS119LEU	28938174
602858	1717	DHCR7	0006	SMITH-LEMLI-OPITZ SYNDROME	DHCR7, GLY244ARG	121909764
602858	1717	DHCR7	0008	SMITH-LEMLI-OPITZ SYNDROME	DHCR7, TRP248CYS	104894212
602858	1717	DHCR7	0009	SMITH-LEMLI-OPITZ SYNDROME	DHCR7, THR93MET	80338853
602858	1717	DHCR7	0010	SMITH-LEMLI-OPITZ SYNDROME	DHCR7, TRP151TER	11555217
602858	1717	DHCR7	0011	SMITH-LEMLI-OPITZ SYNDROME	DHCR7, VAL326LEU	80338859
602858	1717	DHCR7	0012	SMITH-LEMLI-OPITZ SYNDROME	DHCR7, TRP37TER	
602858	1717	DHCR7	0013	SMITH-LEMLI-OPITZ SYNDROME	DHCR7, ARG352TRP	80338860
602858	1717	DHCR7	0014	SMITH-LEMLI-OPITZ SYNDROME	DHCR7, ARG404CYS	61757582
602858	1717	DHCR7	0015	SMITH-LEMLI-OPITZ SYNDROME	DHCR7, THR289ILE	121909765
602858	1717	DHCR7	0016	SMITH-LEMLI-OPITZ SYNDROME	DHCR7, TYR280CYS	121909766
602858	1717	DHCR7	0017	SMITH-LEMLI-OPITZ SYNDROME, MILD	DHCR7, MET1LEU	121909767
602858	1717	DHCR7	0018	SMITH-LEMLI-OPITZ SYNDROME, MILD	DHCR7, GLU448LYS	80338864
602858	1717	DHCR7	0019	SMITH-LEMLI-OPITZ SYNDROME, MILD	DHCR7, PHE284LEU	
602858	1717	DHCR7	0020	SMITH-LEMLI-OPITZ SYNDROME, MILD	DHCR7, MET1VAL	104886033
602858	1717	DHCR7	0021	SMITH-LEMLI-OPITZ SYNDROME	DHCR7, ARG352GLN	121909768
602858	1717	DHCR7	0022	SMITH-LEMLI-OPITZ SYNDROME	DHCR7, IVS5DS, A-T, +3	
602859	5192	PEX10	0001	PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER)	PEX10, IVS, G-A, +1	
602859	5192	PEX10	0002	PEROXISOME BIOGENESIS DISORDER 6B	PEX10, HIS290GLN	61752095
602859	5192	PEX10	0003	PEROXISOME BIOGENESIS DISORDER 6B	PEX10, ARG125TER	61750434
602859	5192	PEX10	0004	PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER)	PEX10, 2-BP DEL, 814CT	
602859	5192	PEX10	0005	PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER)	PEX10, 1 BP-INS, 704A	
602859	5192	PEX10	0006	PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER)	PEX10, DEL/INS/FS, NT13	
602860	701	BUB1B	0001	COLORECTAL CANCER, SOMATIC	BUB1B, THR40MET	56079734
602860	701	BUB1B	0002	COLORECTAL CANCER, SOMATIC	BUB1B, 1-BP DEL, CODON 1023	
602860	701	BUB1B	0003	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1 PREMATURE CHROMATID SEPARATION TRAIT, INCLUDED	BUB1B, ARG194TER	28989186
602860	701	BUB1B	0004	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1 PREMATURE CHROMATID SEPARATION TRAIT, INCLUDED	BUB1B, LEU844PHE	28989181
602860	701	BUB1B	0005	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1 PREMATURE CHROMATID SEPARATION TRAIT, INCLUDED	BUB1B, GLN921HIS	28989183
602860	701	BUB1B	0006	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1 PREMATURE CHROMATID SEPARATION TRAIT, INCLUDED	BUB1B, 4-BP INS, 2211GTTA	
602860	701	BUB1B	0007	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1 PREMATURE CHROMATID SEPARATION TRAIT, INCLUDED	BUB1B, ARG814HIS	28989182
602860	701	BUB1B	0008	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1 PREMATURE CHROMATID SEPARATION TRAIT, INCLUDED	BUB1B, LEU1012PRO	28989185
602860	701	BUB1B	0009	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1 PREMATURE CHROMATID SEPARATION TRAIT, INCLUDED	BUB1B, ARG550GLN	28989187
602860	701	BUB1B	0010	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1 PREMATURE CHROMATID SEPARATION TRAIT, INCLUDED	BUB1B, IVS10, G-T, -1	
602860	701	BUB1B	0011	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1 PREMATURE CHROMATID SEPARATION TRAIT, INCLUDED	BUB1B, 1-BP DEL, 1833T	
602860	701	BUB1B	0012	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1 PREMATURE CHROMATID SEPARATION TRAIT, INCLUDED	BUB1B, IVS10AS, A-G, -5	
602860	701	BUB1B	0013	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1 PREMATURE CHROMATID SEPARATION TRAIT, INCLUDED	BUB1B, IVS18AS, A-G, -11	
602861	5318	PKP2	0001	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 9	PKP2, ARG79TER	121434420
602861	5318	PKP2	0002	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 9	PKP2, ARG735TER	121434421
602861	5318	PKP2	0003	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 9	PKP2, IVS10, G-C, -1	
602861	5318	PKP2	0004	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 9	PKP2, IVS12, G-A, +1	
602867	3490	IGFBP7	0001	RETINAL ARTERIAL MACROANEURYSM WITH SUPRAVASCULAR PULMONIC STENOSIS	IGFBP7, IVS4, G-A, -1	
602876	100506658	OCLN	0001	BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA	OCLN, 22-BP DEL, NT171	
602876	100506658	OCLN	0002	BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA	OCLN, 1-BP DUP, 512A	
602876	100506658	OCLN	0003	BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA	OCLN, PHE219SER	
602876	100506658	OCLN	0004	BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA	OCLN, IVS5DS, G-A, +5	
602879	2036	EPB41L1	0001	MENTAL RETARDATION, AUTOSOMAL DOMINANT 11	EPB41L1, PRO854SER	
602880	2657	GDF1	0001	TRANSPOSITION OF GREAT ARTERIES, DEXTRO-LOOPED 3	GDF1, CYS227TER	121434422
602880	2657	GDF1	0002	DOUBLE-OUTLET RIGHT VENTRICLE	GDF1, CYS267TYR	121434423
602880	2657	GDF1	0003	TETRALOGY OF FALLOT	GDF1, GLY162ASP	121434424
602897	5602	MAPK10	0001	EPILEPTIC ENCEPHALOPATHY, LENNOX-GASTAUT TYPE	MAPK10, EX10-14 DEL	
602900	1789	DNMT3B	0001	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 1	DNMT3B, ASP809GLY	121908939
602900	1789	DNMT3B	0002	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 1	DNMT3B, VAL810MET	121908940
602900	1789	DNMT3B	0003	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 1	DNMT3B, VAL718GLY	121908941
602900	1789	DNMT3B	0004	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 1	DNMT3B, GLY655SER	121908942
602900	1789	DNMT3B	0005	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 1	DNMT3B, LEU656THR	
602900	1789	DNMT3B	0006	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 1	DNMT3B, EX21-22DEL	
602900	1789	DNMT3B	0007	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 1	DNMT3B, 1-BP INS, CODON 53	
602900	1789	DNMT3B	0008	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 1	DNMT3B, ALA603THR	121908943
602900	1789	DNMT3B	0009	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 1	DNMT3B, IVS22AS, G-A, -11	
602900	1789	DNMT3B	0010	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 1	DNMT3B, VAL726GLY	121908944
602900	1789	DNMT3B	0011	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 1	DNMT3B, GLN42TER	121908945
602900	1789	DNMT3B	0012	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 1	DNMT3B, ARG832GLN	121908946
602900	1789	DNMT3B	0013	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 1	DNMT3B, SER282PRO	121908947
602911	10369	CACNG2	0001	MENTAL RETARDATION, AUTOSOMAL DOMINANT 10	CACNG2, VAL143LEU	
602926	6812	STXBP1	0001	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	STXBP1, GLY544ASP	121918317
602926	6812	STXBP1	0002	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	STXBP1, CYS180TYR	121918318
602926	6812	STXBP1	0003	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	STXBP1, MET443ARG	121918319
602926	6812	STXBP1	0004	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	STXBP1, VAL84ASP	121918320
602926	6812	STXBP1	0005	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	STXBP1, ARG388TER	121918321
602926	6812	STXBP1	0006	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	STXBP1, IVS3DS, G-A, +1	
602926	6812	STXBP1	0007	VARIANT OF UNKNOWN SIGNIFICANCE	STXBP1, 1-BP DEL, 1206T	
602931	4091	SMAD6	0001	AORTIC VALVE DISEASE 2	SMAD6, CYS484PHE	
602931	4091	SMAD6	0002	AORTIC VALVE DISEASE 2	SMAD6, PRO415LEU	
602932	4092	SMAD7	0001	COLORECTAL CANCER, SUSCEPTIBILITY TO, 3	SMAD7, IVS3, T/C	4939827
602935	2166	FAAH	0001	DRUG ADDICTION, SUSCEPTIBILITY TO	FAAH, PRO129THR	324420
602937	10370	CITED2	0001	VENTRICULAR SEPTAL DEFECT 2	CITED2, 27-BP DEL, NT508	
602937	10370	CITED2	0002	ATRIAL SEPTAL DEFECT 8	CITED2, 27-BP INS, NT534	
602937	10370	CITED2	0003	ATRIAL SEPTAL DEFECT 8	CITED2, 6-BP DEL, NT592	
602938	570	BAAT	0001	HYPERCHOLANEMIA, FAMILIAL	BAAT, MET76VAL	28937579
602954	5892	RAD51D	0001	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	RAD51D, 1-BP DEL, 363A	
602954	5892	RAD51D	0002	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	RAD51D, TRP268TER	
602954	5892	RAD51D	0003	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	RAD51D, ARG186TER	
602954	5892	RAD51D	0004	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	RAD51D, NT480, G-A, +1	
602954	5892	RAD51D	0005	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	RAD51D, GLN115HIS	
602954	5892	RAD51D	0006	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	RAD51D, ARG253TER	
602956	2189	FANCG	0001	FANCONI ANEMIA, COMPLEMENTATION GROUP G	FANCG, GLU105TER	121434425
602956	2189	FANCG	0002	FANCONI ANEMIA, COMPLEMENTATION GROUP G	FANCG, IVS13, G-C, -1	
602956	2189	FANCG	0003	FANCONI ANEMIA, COMPLEMENTATION GROUP G	FANCG, IVS3, G-C, +1	
602956	2189	FANCG	0004	FANCONI ANEMIA, COMPLEMENTATION GROUP G	FANCG, GLN356TER	121434426
602956	2189	FANCG	0005	FANCONI ANEMIA, COMPLEMENTATION GROUP G	FANCG, IVS8AS, A-G, -2	
602956	2189	FANCG	0006	FANCONI ANEMIA, COMPLEMENTATION GROUP G	FANCG, IVS11DS, G-C, +1	
602956	2189	FANCG	0007	FANCONI ANEMIA, COMPLEMENTATION GROUP G	FANCG, 10-BP DEL, NT1794	
602956	2189	FANCG	0008	FANCONI ANEMIA, COMPLEMENTATION GROUP G	FANCG, 7-BP DEL	
602974	364	AQP7	0001	GLYCEROL QUANTITATIVE TRAIT LOCUS	AQP7, GLY264VAL	
602974	364	AQP7	0002	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 17	AQP7, -953, A-G	
602985	4720	NDUFS2	0001	MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFS2, ARG228GLN	121434427
602985	4720	NDUFS2	0002	MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFS2, PRO229GLN	121434428
602985	4720	NDUFS2	0003	MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFS2, SER413PRO	121434429
602991	9241	NOG	0001	SYMPHALANGISM, PROXIMAL, 1A	NOG, TYR222CYS	104894602
602991	9241	NOG	0002	SYMPHALANGISM, PROXIMAL, 1A	NOG, TYR222ASP	121908948
602991	9241	NOG	0003	MULTIPLE SYNOSTOSES SYNDROME 1	NOG, TRP217GLY	104894603
602991	9241	NOG	0004	SYMPHALANGISM, PROXIMAL, 1A	NOG, PRO223LEU	104894608
602991	9241	NOG	0005	SYMPHALANGISM, PROXIMAL, 1A	NOG, GLY189CYS	104894609
602991	9241	NOG	0006	TARSAL-CARPAL COALITION SYNDROME	NOG, ARG204LEU	104894610
602991	9241	NOG	0007	TARSAL-CARPAL COALITION SYNDROME SYMPHALANGISM, PROXIMAL, 1A, INCLUDED	NOG, PRO35ARG	104894611
602991	9241	NOG	0008	TARSAL-CARPAL COALITION SYNDROME SYMPHALANGISM, PROXIMAL, 1A, INCLUDED	NOG, TYR222CYS	104894602
602991	9241	NOG	0009	SYMPHALANGISM, PROXIMAL, 1A	NOG, CYS184TYR	104894612
602991	9241	NOG	0010	SYMPHALANGISM, PROXIMAL, 1A	NOG, LEU129TER	104894613
602991	9241	NOG	0011	MULTIPLE SYNOSTOSES SYNDROME 1	NOG, 1-BP DEL	
602991	9241	NOG	0012	SYMPHALANGISM, PROXIMAL, 1A BRACHYDACTYLY, TYPE B2, INCLUDED;; STAPES ANKYLOSIS WITH BROAD THUMB AND TOES, INCLUDED	NOG, PRO35SER	28937580
602991	9241	NOG	0013	STAPES ANKYLOSIS SYNDROME WITHOUT SYMPHALANGISM	NOG, GLN110TER	104894614
602991	9241	NOG	0014	STAPES ANKYLOSIS SYNDROME WITHOUT SYMPHALANGISM	NOG, 1-BP INS, 252C	
602991	9241	NOG	0015	MULTIPLE SYNOSTOSES SYNDROME 1	NOG, TRP205TER	
602991	9241	NOG	0016	MULTIPLE SYNOSTOSES SYNDROME 1	NOG, TRP205CYS	104894615
602991	9241	NOG	0017	BRACHYDACTYLY, TYPE B2	NOG, PRO35ALA	28937580
602991	9241	NOG	0018	BRACHYDACTYLY, TYPE B2	NOG, ARG167GLY	121908949
602991	9241	NOG	0019	MULTIPLE SYNOSTOSES SYNDROME 1	NOG, CYS232TRP	
602997	8029	CUBN	0001	MEGALOBLASTIC ANEMIA 1, FINNISH TYPE	CUBN, PRO1297LEU	121434430
602997	8029	CUBN	0002	MEGALOBLASTIC ANEMIA 1, FINNISH TYPE	CUBN, IVS6, C-G	
602997	8029	CUBN	0003	MEGALOBLASTIC ANEMIA 1, FINNISH TYPE	CUBN, IVS23, G-T, +1	
603005	9060	PAPSS2	0001	BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES	PAPSS2, SER438TER	121908950
603005	9060	PAPSS2	0002	BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES	PAPSS2, THR48ARG	121908951
603005	9060	PAPSS2	0003	BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES	PAPSS2, ARG329TER	121908952
603005	9060	PAPSS2	0004	BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES	PAPSS2, 1-BP INS, 337G	
603005	9060	PAPSS2	0005	BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES	PAPSS2, 19-BP DEL, NT616	
603005	9060	PAPSS2	0006	BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES	PAPSS2, 2-BP DEL, 1309AG	
603005	9060	PAPSS2	0007	BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES	PAPSS2, 4-BP INS, 480CGTA	
603005	9060	PAPSS2	0008	BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES	PAPSS2, 1-BP DEL, 661A	
603009	8291	DYSF	0001	MIYOSHI MYOPATHY	DYSF, GLN605TER	121908953
603009	8291	DYSF	0002	MYOPATHY, DISTAL, WITH ANTERIOR TIBIAL ONSET	DYSF, 1-BP DEL, 5966G	
603009	8291	DYSF	0003	MIYOSHI MYOPATHY MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B, INCLUDED	DYSF, ILE1298VAL	121908954
603009	8291	DYSF	0004	MIYOSHI MYOPATHY MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B, INCLUDED	DYSF, ARG2042CYS	121908955
603009	8291	DYSF	0005	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B	DYSF, 5-BP DELETION AND 4-BP INSERTION, NT4872	
603009	8291	DYSF	0006	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B	DYSF, 23-BP INS	
603009	8291	DYSF	0007	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B MIYOSHI MYOPATHY, INCLUDED	DYSF, PRO791ARG	121908956
603009	8291	DYSF	0008	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B	DYSF, NT5711, G-A, +5	
603009	8291	DYSF	0009	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B	DYSF, VAL67ASP	121908957
603009	8291	DYSF	0010	MIYOSHI MYOPATHY	DYSF, TRP999CYS	28937581
603009	8291	DYSF	0011	MIYOSHI MYOPATHY	DYSF, ARG1046HIS	121908958
603009	8291	DYSF	0012	MIYOSHI MYOPATHY MYOPATHY, DISTAL, WITH ANTERIOR TIBIAL ONSET, INCLUDED;; MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B, INCLUDED	DYSF, ARG1905TER	121908959
603009	8291	DYSF	0013	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B	DYSF, ASP625TYR	121908960
603009	8291	DYSF	0014	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B	DYSF, GLU1734GLY	121908961
603009	8291	DYSF	0015	MIYOSHI MYOPATHY	DYSF, GLY519ARG	121908962
603009	8291	DYSF	0016	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B	DYSF, IVS31DS, A-G, -33	
603009	8291	DYSF	0017	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B	DYSF, GLY299ARG	121908963
603009	8291	DYSF	0018	MIYOSHI MYOPATHY	DYSF, GLY299TRP	
603009	8291	DYSF	0019	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B	DYSF, IVS14AS, A-G, -2	
603009	8291	DYSF	0020	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B	DYSF, 1-BP DEL, 855+1G	
603009	8291	DYSF	0021	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B	DYSF, 1-BP DEL, 2776G	
603009	8291	DYSF	0022	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B	DYSF, 5492G-A	
603024	8289	ARID1A	0001	MENTAL RETARDATION, AUTOSOMAL DOMINANT 14	ARID1A, 31_56DEL	
603024	8289	ARID1A	0002	MENTAL RETARDATION, AUTOSOMAL DOMINANT 14	ARID1A, GLN920TER	
603024	8289	ARID1A	0003	MENTAL RETARDATION, AUTOSOMAL DOMINANT 14	ARID1A, ARG1335TER	
603028	7097	TLR2	0001	LEPROSY, SUSCEPTIBILITY TO, 3	TLR2, ARG677TRP	
603028	7097	TLR2	0002	COLORECTAL CANCER, SUSCEPTIBILITY TO	TLR2, IVS2, GT(n) REPEAT POLYMORPHISM	
603028	7097	TLR2	0003	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO	TLR2, ARG753GLN	
603029	7098	TLR3	0001	HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 2	TLR3, PRO554SER	121434431
603029	7098	TLR3	0002	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO	TLR3, LEU412PHE	
603030	7099	TLR4	0001	ENDOTOXIN HYPORESPONSIVENESS MACULAR DEGENERATION, AGE-RELATED, 10, SUSCEPTIBILITY TO, INCLUDED;; COLORECTAL CANCER, SUSCEPTIBILITY TO, INCLUDED	TLR4, ASP299GLY	4986790
603030	7099	TLR4	0002	ENDOTOXIN HYPORESPONSIVENESS	TLR4, THR399ILE	4986791
603031	7100	TLR5	0001	LEGIONNAIRE DISEASE, SUSCEPTIBILITY TO SYSTEMIC LUPUS ERYTHEMATOSUS, RESISTANCE TO, 1, INCLUDED	TLR5, ARG392TER	5744168
603031	7100	TLR5	0002	LEGIONNAIRE DISEASE, SUSCEPTIBILITY TO	TLR5, ASN592SER	2072493
603033	8292	COLQ	0001	ENDPLATE ACETYLCHOLINESTERASE DEFICIENCY	COLQ, 215-BP DEL, NT107	
603033	8292	COLQ	0002	ENDPLATE ACETYLCHOLINESTERASE DEFICIENCY	COLQ, GLU214TER	104893733
603033	8292	COLQ	0003	ENDPLATE ACETYLCHOLINESTERASE DEFICIENCY	COLQ, SER169TER	104893734
603033	8292	COLQ	0004	ENDPLATE ACETYLCHOLINESTERASE DEFICIENCY	COLQ, ARG282TER	121908922
603033	8292	COLQ	0005	ENDPLATE ACETYLCHOLINESTERASE DEFICIENCY	COLQ, 1-BP DEL, 1082C	
603033	8292	COLQ	0006	ENDPLATE ACETYLCHOLINESTERASE DEFICIENCY	COLQ, 1-BP INS, 788C	
603033	8292	COLQ	0007	ENDPLATE ACETYLCHOLINESTERASE DEFICIENCY	COLQ, TYR431SER	121908923
603033	8292	COLQ	0008	ENDPLATE ACETYLCHOLINESTERASE DEFICIENCY	COLQ, ARG315TER	121908924
603033	8292	COLQ	0009	ENDPLATE ACETYLCHOLINESTERASE DEFICIENCY	COLQ, IVS16DS, A-G, +3	
603033	8292	COLQ	0010	ENDPLATE ACETYLCHOLINESTERASE DEFICIENCY	COLQ, GLY240TER	104893735
603051	8540	AGPS	0001	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 3	AGPS, ARG419HIS	121434411
603051	8540	AGPS	0002	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 3	AGPS, THR309ILE	121434412
603051	8540	AGPS	0003	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 3	AGPS, LEU469PRO	121434413
603051	8540	AGPS	0004	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 3	AGPS, THR568MET	
603056	5000	ORC4	0001	MEIER-GORLIN SYNDROME 2	ORC4, TYR174CYS	
603056	5000	ORC4	0002	MEIER-GORLIN SYNDROME 2	ORC4, 4-BP INS, 874AACA	
603056	5000	ORC4	0003	MEIER-GORLIN SYNDROME 2	ORC4, 38-KB DEL	
603066	8985	PLOD3	0001	LYSYL HYDROXYLASE 3 DEFICIENCY	PLOD3, ASN223SER	121434414
603066	8985	PLOD3	0002	LYSYL HYDROXYLASE 3 DEFICIENCY	PLOD3, 1-BP DEL, 2071T	
603072	6790	AURKA	0001	COLON CANCER, SUSCEPTIBILITY TO	AURKA, PHE31ILE	2273535
603073	7546	ZIC2	0001	HOLOPROSENCEPHALY 5	ZIC2, 56-BP INS	
603073	7546	ZIC2	0002	HOLOPROSENCEPHALY 5	ZIC2, 1-BP INS	
603073	7546	ZIC2	0003	HOLOPROSENCEPHALY 5	ZIC2, 30-BP INS	193922899
603073	7546	ZIC2	0004	HOLOPROSENCEPHALY 5	ZIC2, 7-BP DEL	
603073	7546	ZIC2	0005	HOLOPROSENCEPHALY 5	ZIC2, 2-BP DEL, 180AC	
603073	7546	ZIC2	0006	HOLOPROSENCEPHALY 5	ZIC2, 7-BP DEL, NT392	
603084	1615	DARS	0001	HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEG SPASTICITY	DARS, ASP367TYR	
603084	1615	DARS	0002	HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEG SPASTICITY	DARS, ALA274VAL	
603084	1615	DARS	0003	HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEG SPASTICITY	DARS, MET256LEU	
603084	1615	DARS	0004	HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEG SPASTICITY	DARS, ARG487CYS	
603084	1615	DARS	0005	HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEG SPASTICITY	DARS, ARG460HIS	
603084	1615	DARS	0006	HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEG SPASTICITY	DARS, ARG494GLY	
603089	8314	BAP1	0001	TUMOR PREDISPOSITION SYNDROME	BAP1, 1-BP DEL, 1305G	
603089	8314	BAP1	0002	TUMOR PREDISPOSITION SYNDROME	BAP1, IVS16AS, -2, A-G	
603089	8314	BAP1	0003	TUMOR PREDISPOSITION SYNDROME	BAP1, IVS6AS, A-G, -2	
603089	8314	BAP1	0004	TUMOR PREDISPOSITION SYNDROME	BAP1, GLN684TER	
603089	8314	BAP1	0005	TUMOR PREDISPOSITION SYNDROME	BAP1, 1-BP DEL, 1832C	
603089	8314	BAP1	0006	TUMOR PREDISPOSITION SYNDROME	BAP1, 4-BP DEL, 2008TCAC	
603089	8314	BAP1	0007	TUMOR PREDISPOSITION SYNDROME	BAP1, GLN267TER	
603094	8706	B3GALNT1	0001	P1PK BLOOD GROUP SYSTEM, P(k) PHENOTYPE	B3GALT3, 202C-T	
603094	8706	B3GALNT1	0002	P1PK BLOOD GROUP SYSTEM, P(k) PHENOTYPE	B3GALT3, 1-BP INS, 537A	
603094	8706	B3GALNT1	0003	P1PK BLOOD GROUP SYSTEM, P(k) PHENOTYPE	B3GALT3, ARG271GLY	104893683
603094	8706	B3GALNT1	0004	P1PK BLOOD GROUP SYSTEM, P(k) PHENOTYPE	B3GALT3, GLU266ALA	28937582
603100	10555	AGPAT2	0001	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	AGPAT2, ARG68TER	104894093
603100	10555	AGPAT2	0002	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	AGPAT2, IVS4AS, A-G, -2	
603100	10555	AGPAT2	0003	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	AGPAT2, 1-BP INS, 377T	
603100	10555	AGPAT2	0004	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	AGPAT2, LEU228PRO	104894100
603100	10555	AGPAT2	0005	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	AGPAT2, 3-BP DEL, 418TTC	
603100	10555	AGPAT2	0006	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	AGPAT2, LYS215TER	121908925
603100	10555	AGPAT2	0007	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	AGPAT2, IVS3, A-G, -1	
603100	10555	AGPAT2	0008	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	AGPAT2, PHE189TER	121908926
603100	10555	AGPAT2	0009	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	AGPAT2, 1,036-BP DEL	
603103	1369	CPN1	0001	CARBOXYPEPTIDASE N DEFICIENCY	CPN1, 1-BP INS, 385G	
603103	1369	CPN1	0002	CARBOXYPEPTIDASE N DEFICIENCY	CPN1, GLY178ASP	61751507
603109	4088	SMAD3	0001	LOEYS-DIETZ SYNDROME, TYPE 3	SMAD3, ARG287TRP	
603109	4088	SMAD3	0002	LOEYS-DIETZ SYNDROME, TYPE 3	SMAD3, 2-BP DEL, 741AT	
603109	4088	SMAD3	0003	LOEYS-DIETZ SYNDROME, TYPE 3	SMAD3, THR261ILE	
603109	4088	SMAD3	0004	LOEYS-DIETZ SYNDROME, TYPE 3	SMAD3, 1-BP DEL, 652A	
603109	4088	SMAD3	0005	LOEYS-DIETZ SYNDROME, TYPE 3	SMAD3, ARG279LYS	
603109	4088	SMAD3	0006	LOEYS-DIETZ SYNDROME, TYPE 3	SMAD3, GLU239LYS	
603109	4088	SMAD3	0007	LOEYS-DIETZ SYNDROME, TYPE 3	SMAD3, ALA112VAL	
603109	4088	SMAD3	0008	LOEYS-DIETZ SYNDROME, TYPE 3	SMAD3, 1-BP DEL, 313G	
603109	4088	SMAD3	0009	LOEYS-DIETZ SYNDROME, TYPE 3	SMAD3, PRO263LEU	
603109	4088	SMAD3	0010	LOEYS-DIETZ SYNDROME, TYPE 3	SMAD3, GLU361TER	
603111	6605	SMARCE1	0001	VARIANT OF UNKNOWN SIGNIFICANCE	SMARCE1, TYR73CYS	
603111	6605	SMARCE1	0002	MENINGIOMA, FAMILIAL, SUSCEPTIBILITY TO	SMARCE1, ARG239TER	
603111	6605	SMARCE1	0003	MENINGIOMA, FAMILIAL, SUSCEPTIBILITY TO	SMARCE1, IVS5DS, T-C, +2	
603111	6605	SMARCE1	0004	MENINGIOMA, FAMILIAL, SUSCEPTIBILITY TO	SMARCE1, TRP104TER	
603111	6605	SMARCE1	0005	MENINGIOMA, FAMILIAL, SUSCEPTIBILITY TO	SMARCE1, 1-BP INS, 572C	
603113	5519	PPP2R1B	0001	LUNG CANCER	PPP2R1B, GLY90ASP	1805076
603136	8452	CUL3	0001	PSEUDOHYPOALDOSTERONISM, TYPE IIE	CUL3, IVS8, A-G, -26	
603136	8452	CUL3	0002	PSEUDOHYPOALDOSTERONISM, TYPE IIE	CUL3, IVS8, T-G, -28	
603136	8452	CUL3	0003	PSEUDOHYPOALDOSTERONISM, TYPE IIE	CUL3, IVS8, T-G, -12	
603136	8452	CUL3	0004	PSEUDOHYPOALDOSTERONISM, TYPE IIE	CUL3, IVS8, T-A, -5	
603136	8452	CUL3	0005	PSEUDOHYPOALDOSTERONISM, TYPE IIE	CUL3, IVS8, C-T, -3	
603136	8452	CUL3	0006	PSEUDOHYPOALDOSTERONISM, TYPE IIE	CUL3, IVS8, G-A, -1	
603136	8452	CUL3	0007	PSEUDOHYPOALDOSTERONISM, TYPE IIE	CUL3, ASP413GLY	
603155	5784	PTPN14	0001	CHOANAL ATRESIA AND LYMPHEDEMA	PTPN14, 2,016-BP DEL	
603157	5296	PIK3R2	0001	MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME	PIK3R2, GLY373ARG	
603164	8504	PEX3	0001	PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER)	PEX3, 1-BP INS, 543T	
603164	8504	PEX3	0002	PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER)	PEX3, IVS10AS, T-G, -8	
603178	4329	ALDH6A1	0001	METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	ALDH6A1, GLY446ARG	72552258
603183	6253	RTN2	0001	SPASTIC PARAPLEGIA 12, AUTOSOMAL DOMINANT	RTN2, 1-BP INS, 178C	
603183	6253	RTN2	0002	SPASTIC PARAPLEGIA 12, AUTOSOMAL DOMINANT	RTN2, DEL	
603183	6253	RTN2	0003	SPASTIC PARAPLEGIA 12, AUTOSOMAL DOMINANT	RTN2, SER367PHE	
603196	1690	COCH	0001	DEAFNESS, AUTOSOMAL DOMINANT 9	COCH, VAL66GLY	121908927
603196	1690	COCH	0002	DEAFNESS, AUTOSOMAL DOMINANT 9	COCH, GLY88GLU	121908928
603196	1690	COCH	0003	DEAFNESS, AUTOSOMAL DOMINANT 9	COCH, TRP117ARG	121908929
603196	1690	COCH	0004	DEAFNESS, AUTOSOMAL DOMINANT 9	COCH, PRO51SER	28938175
603196	1690	COCH	0005	DEAFNESS, AUTOSOMAL DOMINANT 9	COCH, ILE109ASN	121908930
603196	1690	COCH	0006	DEAFNESS, AUTOSOMAL DOMINANT 9	COCH, ALA119THR	121908931
603196	1690	COCH	0007	DEAFNESS, AUTOSOMAL DOMINANT 9	COCH, CYS542PHE	121908932
603196	1690	COCH	0008	DEAFNESS, AUTOSOMAL DOMINANT 9	COCH, CYS542TYR	
603196	1690	COCH	0009	DEAFNESS, AUTOSOMAL DOMINANT 9	COCH, MET512THR	121908934
603197	10908	PNPLA6	0001	SPASTIC PARAPLEGIA 39, AUTOSOMAL RECESSIVE	PNPLA6, MET1012VAL	121434415
603197	10908	PNPLA6	0002	SPASTIC PARAPLEGIA 39, AUTOSOMAL RECESSIVE	NTE, ARG890HIS	121434416
603197	10908	PNPLA6	0003	SPASTIC PARAPLEGIA 39, AUTOSOMAL RECESSIVE	NTE, 4-BP INS, 2946CAGC	
603198	284119	PTRF	0001	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4	PTRF, 1-BP INS, 696C	
603198	284119	PTRF	0002	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4	PTRF, 1-BP DEL, 525G	
603198	284119	PTRF	0003	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4	PTRF, 1-BP DEL, 160G	
603198	284119	PTRF	0004	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4	PTRF, 1-BP DUP, 362T	
603198	284119	PTRF	0005	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4	PTRF, 1-BP DEL, 135G	
603198	284119	PTRF	0006	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4	PTRF, 4-BP INS, 481GTGA	
603198	284119	PTRF	0007	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4	PTRF, 4-BP DEL, 518AAGA	
603198	284119	PTRF	0008	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4	PTRF, IVS1DS, G-T, +1	
603200	8625	RFXANK	0001	BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP B	RFXANK, 26-BP DEL, NT752	
603200	8625	RFXANK	0002	BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP B	RFXANK, 58-BP DEL	
603200	8625	RFXANK	0003	BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP B	RFXANK, IVS4DS, G-C, +1	
603200	8625	RFXANK	0004	BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP B	RFXANK, ASP121VAL	104894709
603201	8647	ABCB11	0001	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2	ABCB11, ARG575TER	72549401
603201	8647	ABCB11	0002	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2 CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC 2, INCLUDED	ABCB11, GLU297GLY	11568372
603201	8647	ABCB11	0003	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2	ABCB11, 1-BP DEL, 908G	
603201	8647	ABCB11	0004	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2	ABCB11, 1-BP INS, 3767C	
603201	8647	ABCB11	0005	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2	ABCB11, IVS4DS, A-C, +3	
603201	8647	ABCB11	0006	CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC 2	ABCB11, ARG432THR	121908935
603201	8647	ABCB11	0007	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2	ABCB11, ARG1057TER	72549397
603201	8647	ABCB11	0008	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2	ABCB11, 5-BP INS, GAGAT	
603202	3938	LCT	0001	LACTASE DEFICIENCY, CONGENITAL	LCT, TYR1390TER	121908936
603202	3938	LCT	0002	LACTASE DEFICIENCY, CONGENITAL	LCT, 4-BP DEL, NT4998	
603202	3938	LCT	0003	LACTASE DEFICIENCY, CONGENITAL	LCT, GLN268HIS	121908937
603208	3769	KCNJ13	0001	SNOWFLAKE VITREORETINAL DEGENERATION	KCNJ13, ARG162TRP	121918542
603208	3769	KCNJ13	0002	LEBER CONGENITAL AMAUROSIS 16	KCNJ13, ARG166TER	
603208	3769	KCNJ13	0003	LEBER CONGENITAL AMAUROSIS 16	KCNJ13, LEU241PRO	
603212	8419	BFSP2	0001	CATARACT 12, MULTIPLE TYPES	BFSP2, ARG287TRP	104893685
603212	8419	BFSP2	0002	CATARACT 12, MULTIPLE TYPES	BFSP2, 3-BP DEL, 696GAA	121908938
603213	3835	KIF22	0001	SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	KIF22, PRO148SER	
603213	3835	KIF22	0002	SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	KIF22, PRO148LEU	
603213	3835	KIF22	0003	SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	KIF22, ARG149GLN	
603213	3835	KIF22	0004	SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	KIF22, ARG149LEU	
603214	5826	ABCD4	0001	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblJ TYPE	ABCD4, TYR319CYS	
603214	5826	ABCD4	0002	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblJ TYPE	ABCD4, 2-BP INS, 1746CT	
603214	5826	ABCD4	0003	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblJ TYPE	ABCD4, IVS5DS, G-T, +1	
603214	5826	ABCD4	0004	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblJ TYPE	ABCD4, 1456G-T	
603234	368	ABCC6	0001	PSEUDOXANTHOMA ELASTICUM ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2, INCLUDED	ABCC6, ARG1141TER	72653706
603234	368	ABCC6	0002	PSEUDOXANTHOMA ELASTICUM	ABCC6, IVS21, G-T, +1	
603234	368	ABCC6	0003	PSEUDOXANTHOMA ELASTICUM	ABCC6, ARG1138GLN	60791294
603234	368	ABCC6	0004	PSEUDOXANTHOMA ELASTICUM	ABCC6, ARG1114PRO	63750427
603234	368	ABCC6	0005	PSEUDOXANTHOMA ELASTICUM	ABCC6, 1-BP DEL, 3775T	
603234	368	ABCC6	0006	PSEUDOXANTHOMA ELASTICUM ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2, INCLUDED	ABCC6, ARG1314TRP	63750759
603234	368	ABCC6	0007	PSEUDOXANTHOMA ELASTICUM	ABCC6, 1-BP DEL, 3798T	
603234	368	ABCC6	0008	PSEUDOXANTHOMA ELASTICUM	ABCC6, 4-BP INS, 4243AGAA	
603234	368	ABCC6	0009	PSEUDOXANTHOMA ELASTICUM	ABCC6, 22-BP DEL	
603234	368	ABCC6	0010	PSEUDOXANTHOMA ELASTICUM	ABCC6, DEL	
603234	368	ABCC6	0011	PSEUDOXANTHOMA ELASTICUM	ABCC6, ARG1268GLN	2238472
603234	368	ABCC6	0012	PSEUDOXANTHOMA ELASTICUM	ABCC6, ARG1138TRP	28939701
603234	368	ABCC6	0013	PSEUDOXANTHOMA ELASTICUM	ABCC6, ARG1164TER	72653744
603234	368	ABCC6	0014	PSEUDOXANTHOMA ELASTICUM	ABCC6, 1,213-NT DEL	
603234	368	ABCC6	0015	PSEUDOXANTHOMA ELASTICUM ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2, INCLUDED	ABCC6, IVS26, G-A, -1	
603234	368	ABCC6	0016	PSEUDOXANTHOMA ELASTICUM	ABCC6, EX23-29DEL	
603234	368	ABCC6	0017	PSEUDOXANTHOMA ELASTICUM	ABCC6, ARG1339CYS	28939702
603234	368	ABCC6	0018	PSEUDOXANTHOMA ELASTICUM	ABCC6, ARG1459CYS	72547524
603234	368	ABCC6	0019	PSEUDOXANTHOMA ELASTICUM	ABCC6, VAL1298PHE	63751325
603234	368	ABCC6	0020	PSEUDOXANTHOMA ELASTICUM	ABCC6, GLY1302ARG	63749856
603234	368	ABCC6	0021	PSEUDOXANTHOMA ELASTICUM	ABCC6, GLY1321SER	63749823
603234	368	ABCC6	0022	PSEUDOXANTHOMA ELASTICUM	ABCC6, ASP1238HIS	63749796
603234	368	ABCC6	0023	PSEUDOXANTHOMA ELASTICUM	ABCC6, 33-BP DEL	
603234	368	ABCC6	0024	PSEUDOXANTHOMA ELASTICUM	ABCC6, THR1130MET	63750459
603234	368	ABCC6	0025	PSEUDOXANTHOMA ELASTICUM ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2, INCLUDED	ABCC6, ARG765GLN	
603234	368	ABCC6	0026	PSEUDOXANTHOMA ELASTICUM ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2, INCLUDED	ABCC6, GLN1406LYS	
603234	368	ABCC6	0027	ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2 PSEUDOXANTHOMA ELASTICUM, INCLUDED	ABCC6, ARG518TER	
603234	368	ABCC6	0028	ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2	ABCC6, 1-BP INS, 450C	
603234	368	ABCC6	0029	ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2 PSEUDOXANTHOMA ELASTICUM, INCLUDED	ABCC6, IVS21, G-T, +1	
603248	658	BMPR1B	0001	BRACHYDACTYLY, TYPE A2	BMPR1B, ILE200LYS	121434417
603248	658	BMPR1B	0002	BRACHYDACTYLY, TYPE A2	BMPR1B, ARG486TRP	121434418
603248	658	BMPR1B	0003	CHONDRODYSPLASIA, ACROMESOMELIC, WITH GENITAL ANOMALIES	BMPR1B, 8-BP DEL, NT359	
603248	658	BMPR1B	0004	BRACHYDACTYLY, TYPE A2	BMPR1B, ARG486GLN	121434419
603254	6597	SMARCA4	0001	RHABDOID TUMOR PREDISPOSITION SYNDROME 2	SMARCA4, ARG1189TER	
603254	6597	SMARCA4	0002	MENTAL RETARDATION, AUTOSOMAL DOMINANT 16	SMARCA4, LYS546DEL	
603254	6597	SMARCA4	0003	MENTAL RETARDATION, AUTOSOMAL DOMINANT 16	SMARCA4, THR859MET	
603254	6597	SMARCA4	0004	MENTAL RETARDATION, AUTOSOMAL DOMINANT 16	SMARCA4, ARG885CYS	
603254	6597	SMARCA4	0005	MENTAL RETARDATION, AUTOSOMAL DOMINANT 16	SMARCA4, LEU921PHE	
603254	6597	SMARCA4	0006	MENTAL RETARDATION, AUTOSOMAL DOMINANT 16	SMARCA4, MET1011THR	
603254	6597	SMARCA4	0007	MENTAL RETARDATION, AUTOSOMAL DOMINANT 16	SMARCA4, ARG1157GLY	
603263	771	CA12	0001	HYPERCHLORHIDROSIS, ISOLATED	CA12, GLU143LYS	
603273	8626	TP63	0001	ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3	TP63, ARG204TRP	121908835
603273	8626	TP63	0002	ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3	TP63, ARG204GLN	121908836
603273	8626	TP63	0003	ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3	TP63, CYS306ARG	121908837
603273	8626	TP63	0004	ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3	TP63, 1-BP INS, 1572A	
603273	8626	TP63	0005	SPLIT-HAND/FOOT MALFORMATION 4	TP63, LYS194GLU	121908838
603273	8626	TP63	0006	SPLIT-HAND/FOOT MALFORMATION 4	TP63, ARG280CYS	121908839
603273	8626	TP63	0007	ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3 RAPP-HODGKIN SYNDROME, INCLUDED	TP63, ARG279HIS	121908840
603273	8626	TP63	0008	ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3	TP63, ARG304GLN	121908841
603273	8626	TP63	0009	ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	TP63, LEU514PHE	121908842
603273	8626	TP63	0010	ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	TP63, CYS522GLY	121908843
603273	8626	TP63	0011	ADULT SYNDROME	TP63, ASN6HIS	113993963
603273	8626	TP63	0012	LIMB-MAMMARY SYNDROME	TP63, 2-BP DEL, 1576TT	
603273	8626	TP63	0013	LIMB-MAMMARY SYNDROME	TP63, 2-BP DEL, 1743AA	
603273	8626	TP63	0014	ADULT SYNDROME	TP63, ARG298GLN	113993967
603273	8626	TP63	0015	ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3	TP63, ASP312GLY	121908844
603273	8626	TP63	0016	RAPP-HODGKIN SYNDROME	TP63, 1-BP DEL, 1709A	
603273	8626	TP63	0017	RAPP-HODGKIN SYNDROME	TP63, 1-BP DEL, 1859A	
603273	8626	TP63	0018	ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE RAPP-HODGKIN SYNDROME, INCLUDED	TP63, ILE510THR	121908845
603273	8626	TP63	0019	RAPP-HODGKIN SYNDROME	TP63, ARG545PRO	121908846
603273	8626	TP63	0020	ADULT SYNDROME	TP63, VAL114MET	
603273	8626	TP63	0021	OROFACIAL CLEFT 8	TP63, ARG313GLY	121908847
603273	8626	TP63	0022	ADULT SYNDROME	TP63, ARG298GLY	113993966
603273	8626	TP63	0023	SPLIT-HAND/FOOT MALFORMATION 4	TP63, ARG97CYS	121908848
603273	8626	TP63	0024	ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3 ADULT SYNDROME, INCLUDED	TP63, ARG227GLN	121908849
603273	8626	TP63	0025	RAPP-HODGKIN SYNDROME	TP63, 1-BP DEL, 1783C	
603273	8626	TP63	0026	ADULT SYNDROME	TP63, PRO127LEU	
603273	8626	TP63	0027	RAPP-HODGKIN SYNDROME ANKYLOBLEPHARON-ECTODERMAL DEFECTS, CLEFT LIP/PALATE, INCLUDED	TP63, 11-BP DUP, NT1716	
603273	8626	TP63	0028	ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3	TP63, ARG227PRO	
603286	3814	KISS1	0001	HYPOGONADOTROPIC HYPOGONADISM 13 WITHOUT ANOSMIA	KISS1, ASN115LYS	
603287	55163	PNPO	0001	PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	PNPO, ARG229TRP	104894629
603287	55163	PNPO	0002	PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	PNPO, IVS3, G-A, -1	
603287	55163	PNPO	0003	PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	PNPO, TER262GLN	104894631
603287	55163	PNPO	0004	PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	PNPO, ALA174TER	
603288	11081	KERA	0001	CORNEA PLANA 2	KERA, ASN247SER	
603288	11081	KERA	0002	CORNEA PLANA 2	KERA, GLN174TER	
603288	11081	KERA	0003	CORNEA PLANA 2	KERA, THR215LYS	
603288	11081	KERA	0004	CORNEA PLANA 2	KERA, ARG313TER	
603290	22941	SHANK2	0001	AUTISM, SUSCEPTIBILITY TO, 17	SHANK2, 120-KB DEL	
603290	22941	SHANK2	0002	AUTISM, SUSCEPTIBILITY TO, 17	SHANK2, 69-KB DEL	
603290	22941	SHANK2	0003	AUTISM, SUSCEPTIBILITY TO, 17	SHANK2, ARG462TER	
603295	4093	SMAD9	0001	PULMONARY HYPERTENSION, PRIMARY	SMAD9, CYS202TER	121918359
603297	79659	DYNC2H1	0001	ASPHYXIATING THORACIC DYSTROPHY 3	DYNC2H1, MET1991LEU	137853025
603297	79659	DYNC2H1	0002	ASPHYXIATING THORACIC DYSTROPHY 3	DYNC2H1, MET3762VAL	137853026
603297	79659	DYNC2H1	0003	ASPHYXIATING THORACIC DYSTROPHY 3	DYNC2H1, 29-BP INS, NT654	
603297	79659	DYNC2H1	0004	ASPHYXIATING THORACIC DYSTROPHY 3	DYNC2H1, ASP3015GLY	137853027
603297	79659	DYNC2H1	0005	ASPHYXIATING THORACIC DYSTROPHY 3	DYNC2H1, ILE1240THR	137853028
603297	79659	DYNC2H1	0006	ASPHYXIATING THORACIC DYSTROPHY 3	DYNC2H1, GLY3355TER	137853029
603297	79659	DYNC2H1	0007	SHORT RIB-POLYDACTYLY SYNDROME, TYPE III	DYNC2H1, ARG587CYS	137853030
603297	79659	DYNC2H1	0008	SHORT RIB-POLYDACTYLY SYNDROME, TYPE III	DYNC2H1, ARG2205HIS	137853031
603297	79659	DYNC2H1	0009	SHORT RIB-POLYDACTYLY SYNDROME, TYPE III	DYNC2H1, ARG2838TER	137853032
603297	79659	DYNC2H1	0010	SHORT RIB-POLYDACTYLY SYNDROME, TYPE III	DYNC2H1, 2-BP DEL/INS	
603297	79659	DYNC2H1	0011	SHORT RIB-POLYDACTYLY SYNDROME, TYPE III	DYNC2H1, IVS33, G-T, +1	
603297	79659	DYNC2H1	0012	SHORT RIB-POLYDACTYLY SYNDROME, TYPE III	DYNC2H1, GLN1537ARG	137853033
603297	79659	DYNC2H1	0013	SHORT RIB-POLYDACTYLY SYNDROME, TYPE III	DYNC2H1, GLY2461VAL	137853034
603297	79659	DYNC2H1	0014	SHORT RIB-POLYDACTYLY SYNDROME, TYPE III	DYNC2H1, THR1987ALA	137853035
603297	79659	DYNC2H1	0015	SHORT RIB-POLYDACTYLY SYNDROME, TYPE III	DYNC2H1, 1-BP DEL, 10130T	
603297	79659	DYNC2H1	0016	SHORT RIB-POLYDACTYLY SYNDROME, TYPE IIA/B, DIGENIC	DYNC2H1, GLY3916ASP	
603297	79659	DYNC2H1	0017	SHORT RIB-POLYDACTYLY SYNDROME, TYPE IIB	DYNC2H1, ARG2662GLN	
603297	79659	DYNC2H1	0018	SHORT RIB-POLYDACTYLY SYNDROME, TYPE IIB	DYNC2H1, PRO2496SER	
603297	79659	DYNC2H1	0019	SHORT RIB-POLYDACTYLY SYNDROME, TYPE IIB	DYNC2H1, ARG330CYS	
603297	79659	DYNC2H1	0020	SHORT RIB-POLYDACTYLY SYNDROME, TYPE IIB	DYNC2H1, 1-BP DEL, 8534A	
603301	8462	KLF11	0001	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 7	KLF11, ALA349SER	121912645
603301	8462	KLF11	0002	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 7	KLF11, THR220MET	34336420
603307	631	BFSP1	0001	CATARACT, CORTICAL, JUVENILE-ONSET	BFSP1, 3.3-KB DEL, NT736	
603313	84920	ALG10	0001	LONG QT SYNDROME 2, ACQUIRED, REDUCED SUSCEPTIBILITY TO	ALG10, ILE447VAL	121908850
603317	374462	PTPRQ	0001	DEAFNESS, AUTOSOMAL RECESSIVE 84A	PTPRQ, TYR497TER	
603317	374462	PTPRQ	0002	DEAFNESS, AUTOSOMAL RECESSIVE 84A	PTPRQ, ARG457GLY	
603324	2707	GJB3	0001	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA	GJB3, GLY12ARG	74315315
603324	2707	GJB3	0002	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA	GJB3, GLY12ASP	74315316
603324	2707	GJB3	0003	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA	GJB3, CYS86SER	74315317
603324	2707	GJB3	0004	DEAFNESS, AUTOSOMAL DOMINANT 2B	GJB3, GLU183LYS	74315318
603324	2707	GJB3	0005	DEAFNESS, AUTOSOMAL DOMINANT 2B	GJB3, ARG180TER	74315319
603324	2707	GJB3	0006	DEAFNESS, AUTOSOMAL RECESSIVE	GJB3, 3-BP DEL, 423ATT	
603324	2707	GJB3	0007	DEAFNESS, AUTOSOMAL RECESSIVE	GJB3, ILE141VAL	74315320
603324	2707	GJB3	0008	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA	GJB3, ARG42PRO	74315321
603324	2707	GJB3	0009	DEAFNESS, AUTOSOMAL DOMINANT, WITH PERIPHERAL NEUROPATHY	GJB3, 3-BP DEL, ASP66	
603324	2707	GJB3	0010	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA	GJB3, LEU34PRO	28937583
603324	2707	GJB3	0011	DEAFNESS, DIGENIC, GJB2/GJB3	GJB3, ASN166SER	121908851
603324	2707	GJB3	0012	DEAFNESS, DIGENIC, GJB2/GJB3	GJB3, ALA194THR	117385606
603335	1767	DNAH5	0001	CILIARY DYSKINESIA, PRIMARY, 3	DNAH5, 1-BP INS, 5563A	
603335	1767	DNAH5	0002	CILIARY DYSKINESIA, PRIMARY, 3	DNAH5, GLY3519ARG	79967166
603335	1767	DNAH5	0003	CILIARY DYSKINESIA, PRIMARY, 3	DNAH5, IVS74AS, G-C, -1	
603335	1767	DNAH5	0004	CILIARY DYSKINESIA, PRIMARY, 3	DNAH5, GLN610TER	121908853
603335	1767	DNAH5	0005	CILIARY DYSKINESIA, PRIMARY, 3	DNAH5, 1-BP INS, 5130A	
603335	1767	DNAH5	0006	CILIARY DYSKINESIA, PRIMARY, 3	DNAH5, 1-BP INS, 2261T	
603335	1767	DNAH5	0007	CILIARY DYSKINESIA, PRIMARY, 3	DNAH5, 6249G-A	
603335	1767	DNAH5	0008	CILIARY DYSKINESIA, PRIMARY, 3	DNAH5, ILE374THR	
603335	1767	DNAH5	0009	CILIARY DYSKINESIA, PRIMARY, 3	DNAH5, GLY1047ARG	
603339	8701	DNAH11	0001	CILIARY DYSKINESIA, PRIMARY, 7	DNAH11, ARG2852TER	121908854
603339	8701	DNAH11	0002	CILIARY DYSKINESIA, PRIMARY, 7	DNAH11, TYR4128TER	121908855
603339	8701	DNAH11	0003	CILIARY DYSKINESIA, PRIMARY, 7	DNAH11, 57-BP DEL, NT13552	
603339	8701	DNAH11	0004	CILIARY DYSKINESIA, PRIMARY, 7	DNAH11, ARG2907TER	
603339	8701	DNAH11	0005	CILIARY DYSKINESIA, PRIMARY, 7	DNAH11, PRO2598LEU	
603339	8701	DNAH11	0006	CILIARY DYSKINESIA, PRIMARY, 7	DNAH11, SER2176TER	
603345	8671	SLC4A4	0001	RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTAL RETARDATION	SLC4A4, ARG298SER	121908856
603345	8671	SLC4A4	0002	RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTAL RETARDATION	SLC4A4, ARG510HIS	121908857
603345	8671	SLC4A4	0003	RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTAL RETARDATION	SLC4A4, GLN29TER	121908858
603349	2034	EPAS1	0001	ERYTHROCYTOSIS, FAMILIAL, 4	EPAS1, GLY537TRP	137853036
603349	2034	EPAS1	0002	ERYTHROCYTOSIS, FAMILIAL, 4	EPAS1, GLY537ARG	137853036
603349	2034	EPAS1	0003	ERYTHROCYTOSIS, FAMILIAL, 4	EPAS1, MET535VAL	137853037
603360	9409	PEX16	0001	PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER)	PEX16, ARG176TER	61752117
603360	9409	PEX16	0002	PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER)	PEX16, IVSDS10, T-C, +2	
603360	9409	PEX16	0003	PEROXISOME BIOGENESIS DISORDER 8B	PEX16, 1-BP DEL, 984G	
603360	9409	PEX16	0004	PEROXISOME BIOGENESIS DISORDER 8B	PEX16, TYR331CYS	
603360	9409	PEX16	0005	PEROXISOME BIOGENESIS DISORDER 8B	PEX16, DEL, EX11	
603371	2733	GLE1	0001	LETHAL CONGENITAL CONTRACTURE SYNDROME 1	GLE1, IVS3, A-G, -10	
603371	2733	GLE1	0002	LETHAL CONGENITAL CONTRACTURE SYNDROME 1	GLE1, ARG569HIS	121434407
603371	2733	GLE1	0003	LETHAL ARTHROGRYOPOSIS WITH ANTERIOR HORN CELL DISEASE	GLE1, VAL617MET	121434408
603371	2733	GLE1	0004	LETHAL ARTHROGRYOPOSIS WITH ANTERIOR HORN CELL DISEASE	GLE1, ILE684THR	121434409
603372	7253	TSHR	0001	THYROTROPIN RECEPTOR POLYMORPHISM	TSHR, ASP36HIS	61747482
603372	7253	TSHR	0002	THYROID ADENOMA, HYPERFUNCTIONING, SOMATIC	TSHR, ASP619GLY	121908859
603372	7253	TSHR	0003	THYROID ADENOMA, HYPERFUNCTIONING, SOMATIC	TSHR, ALA623ILE	121908860
603372	7253	TSHR	0004	HYPERTHYROIDISM, NONAUTOIMMUNE THYROID ADENOMA, HYPERFUNCTIONING, SOMATIC, INCLUDED	TSHR, PHE631LEU	121908861
603372	7253	TSHR	0005	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 1	TSHR, ILE167ASN	121908862
603372	7253	TSHR	0006	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 1	TSHR, PRO162ALA	121908863
603372	7253	TSHR	0007	HYPERTHYROIDISM, NONAUTOIMMUNE	TSHR, MET453THR	121908864
603372	7253	TSHR	0008	THYROID CARCINOMA WITH THYROTOXICOSIS	TSHR, ASP633HIS	28937584
603372	7253	TSHR	0009	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 1	TSHR, ARG109GLN	121908865
603372	7253	TSHR	0010	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 1	TSHR, TRP546TER	121908866
603372	7253	TSHR	0011	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 1	TSHR, GLN324TER	121908867
603372	7253	TSHR	0012	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 1	TSHR, ASP410ASN	121908868
603372	7253	TSHR	0013	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 1	TSHR, CYS41SER	121908869
603372	7253	TSHR	0014	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 1	TSHR, PHE525LEU	121908870
603372	7253	TSHR	0015	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 1	TSHR, CYS390TRP	121908871
603372	7253	TSHR	0016	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 1	TSHR, ALA553THR	121908872
603372	7253	TSHR	0017	THYROID ADENOMA, HYPERFUNCTIONING, SOMATIC	TSHR, SER281ILE	121908873
603372	7253	TSHR	0018	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 1	TSHR, 18-BP DEL, 4-BP INS	
603372	7253	TSHR	0019	HYPERTHYROIDISM, NONAUTOIMMUNE	TSHR, VAL509ALA	121908874
603372	7253	TSHR	0020	HYPERTHYROIDISM, NONAUTOIMMUNE	TSHR, CYS672TYR	121908875
603372	7253	TSHR	0021	HYPERTHYROIDISM, NONAUTOIMMUNE	TSHR, SER505ASN	121908876
603372	7253	TSHR	0022	HYPERTHYROIDISM, NONAUTOIMMUNE THYROID ADENOMA, HYPERFUNCTIONING, SOMATIC, INCLUDED	TSHR, LEU629PHE	121908877
603372	7253	TSHR	0023	HYPERTHYROIDISM, NONAUTOIMMUNE	TSHR, SER281ASN	
603372	7253	TSHR	0024	HYPERTHYROIDISM, FAMILIAL GESTATIONAL	TSHR, LYS183ARG	121908879
603372	7253	TSHR	0025	HYPERTHYROIDISM, NONAUTOIMMUNE	TSHR, PRO639SER	121908880
603372	7253	TSHR	0026	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 1	TSHR, THR477ILE	121908881
603372	7253	TSHR	0027	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 1	TSHR, ARG310CYS	121908882
603372	7253	TSHR	0028	HYPERTHYROIDISM, NONAUTOIMMUNE	TSHR, GLY431SER	121908883
603372	7253	TSHR	0029	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 1	TSHR, CYS600ARG	121908884
603372	7253	TSHR	0030	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 1	TSHR, LEU467PRO	121908885
603372	7253	TSHR	0031	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 1	TSHR, 2-BP DEL, 654AC	
603372	7253	TSHR	0032	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 1	TSHR, IVS6, G-C, +3	
603377	6584	SLC22A5	0001	CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	SLC22A5, 113-BP DEL	
603377	6584	SLC22A5	0002	CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	SLC22A5, 1-BP INS, 226C	
603377	6584	SLC22A5	0003	CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	SLC22A5, TRP132TER	72552727
603377	6584	SLC22A5	0004	CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	SLC22A5, IVS8AS, G-A, -1	
603377	6584	SLC22A5	0005	CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	SLC22A5, 1394-BP DEL	
603377	6584	SLC22A5	0006	CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	SLC22A5, 19-BP INS, NT874	
603377	6584	SLC22A5	0007	CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	SLC22A5, 171-BP DEL, NT875	
603377	6584	SLC22A5	0008	CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	SLC22A5, ARG282TER	121908886
603377	6584	SLC22A5	0009	CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	SLC22A5, TYR401TER	121908887
603377	6584	SLC22A5	0010	CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	SLC22A5, 1-BP DEL, 1345G	
603377	6584	SLC22A5	0011	CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	SLC22A5, PRO478LEU	72552735
603377	6584	SLC22A5	0012	CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	SLC22A5, TYR211CYS	121908888
603377	6584	SLC22A5	0013	CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	SLC22A5, ARG169GLN	121908889
603377	6584	SLC22A5	0014	CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	SLC22A5, ARG169TRP	121908890
603377	6584	SLC22A5	0015	CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	SLC22A5, TRP351ARG	68018207
603377	6584	SLC22A5	0016	CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	SLC22A5, ARG399GLN	121908891
603377	6584	SLC22A5	0017	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	SLC22A5, -207G-C	
603377	6584	SLC22A5	0018	CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	SLC22A5, MET1ILE	121908892
603377	6584	SLC22A5	0019	CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	SLC22A5, ARG254TER	121908893
603377	6584	SLC22A5	0020	CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	SLC22A5, ARG399TRP	
603377	6584	SLC22A5	0021	CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	SLC22A5, ALA442ILE	
603377	6584	SLC22A5	0022	CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	SLC22A5, GLY15TRP	
603381	2317	FLNB	0001	SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME	FLNB, SER2137TER	80356521
603381	2317	FLNB	0002	SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME	FLNB, ARG818TER	80356519
603381	2317	FLNB	0003	SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME	FLNB, ARG1607TER	80356520
603381	2317	FLNB	0004	LARSEN SYNDROME	FLNB, PHE161CYS	80356506
603381	2317	FLNB	0005	LARSEN SYNDROME	FLNB, GLY1586ARG	80356513
603381	2317	FLNB	0006	ATELOSTEOGENESIS, TYPE I	FLNB, ALA173VAL	121908894
603381	2317	FLNB	0007	ATELOSTEOGENESIS, TYPE I ATELOSTEOGENESIS, TYPE III, INCLUDED	FLNB, MET202VAL	121908895
603381	2317	FLNB	0008	ATELOSTEOGENESIS, TYPE III	FLNB, GLY751ARG	28937587
603381	2317	FLNB	0009	BOOMERANG DYSPLASIA	FLNBA, LEU171ARG	80356494
603381	2317	FLNB	0010	BOOMERANG DYSPLASIA	FLNB, SER235PRO	121908896
603381	2317	FLNB	0011	LARSEN SYNDROME	FLNB, GLU227LYS	80356508
603381	2317	FLNB	0012	LARSEN SYNDROME	FLNB, GLY1691SER	80356503
603381	2317	FLNB	0013	SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME	FLNB, ARG2004TER	121908897
603381	2317	FLNB	0014	SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME	FLNB, GLY1850TER	121908898
603384	8831	SYNGAP1	0001	MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	SYNGAP1, LYS138TER	121918315
603384	8831	SYNGAP1	0002	MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	SYNGAP1, ARG579TER	121918316
603384	8831	SYNGAP1	0003	MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	SYNGAP1, 1-BP DEL, 2438T	
603384	8831	SYNGAP1	0004	MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	SYNGAP1, 501, G-A, -1	
603384	8831	SYNGAP1	0005	MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	SYNGAP1, 1-BP DEL, 2677C	
603384	8831	SYNGAP1	0006	MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	SYNGAP1, IVS13DS, G-A, +1	
603384	8831	SYNGAP1	0007	MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	SYNGAP1, TRP362ARG	
603384	8831	SYNGAP1	0008	MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	SYNGAP1, PRO562LEU	
603390	8622	PDE8B	0001	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 3	PDE8B, HIS305PRO	121918360
603390	8622	PDE8B	0002	STRIATAL DEGENERATION, AUTOSOMAL DOMINANT	PDE8B, 94G-C AND 1-BP DEL, 95T	
603400	8838	WISP3	0001	ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	WISP3, CYS145TYR	121908899
603400	8838	WISP3	0002	ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	WISP3, TRP331TER	121908900
603400	8838	WISP3	0003	ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	WISP3, CYS52TER	121908901
603400	8838	WISP3	0004	ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	WISP3, CYS78ARG	17073260
603400	8838	WISP3	0005	ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	WISP3, 1-BP DEL, 246A	
603400	8838	WISP3	0006	ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	WISP3, IVS1DS, 1-BP INS, +2T	
603400	8838	WISP3	0007	ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	WISP3, 2-BP INS, 863AC	
603400	8838	WISP3	0008	ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	WISP3, 2-BP DEL, 43GC	
603400	8838	WISP3	0009	ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	WISP3, 2-BP DEL, 866AG	
603400	8838	WISP3	0010	SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH PROGRESSIVE ARTHROPATHY	WISP3, SER334PRO	121908903
603400	8838	WISP3	0011	SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH PROGRESSIVE ARTHROPATHY	WISP3, 1-BP DEL, 855T	
603401	8546	AP3B1	0001	HERMANSKY-PUDLAK SYNDROME 2	AP3B1, 63-BP DEL	
603401	8546	AP3B1	0002	HERMANSKY-PUDLAK SYNDROME 2	AP3B1, LEU540ARG	121908904
603401	8546	AP3B1	0003	HERMANSKY-PUDLAK SYNDROME 2	AP3B1, 1-BP INS, 1618G	
603401	8546	AP3B1	0004	HERMANSKY-PUDLAK SYNDROME 2	AP3B1, IVS14DS, T-C, +6	
603401	8546	AP3B1	0005	HERMANSKY-PUDLAK SYNDROME 2	AP3B1, EX15DEL	
603401	8546	AP3B1	0006	HERMANSKY-PUDLAK SYNDROME 2	AP3B1, ARG302TER	121908905
603401	8546	AP3B1	0007	HERMANSKY-PUDLAK SYNDROME 2	AP3B1, ARG509TER	121908906
603401	8546	AP3B1	0008	HERMANSKY-PUDLAK SYNDROME 2	AP3B1, GLU659TER	121908907
603409	8323	FZD6	0001	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 10	FZD6, GLU584TER	
603409	8323	FZD6	0002	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 10	FZD6, ARG511CYS	
603415	6335	SCN9A	0001	ERYTHERMALGIA, PRIMARY	SCN9A, LEU858HIS	80356475
603415	6335	SCN9A	0002	ERYTHERMALGIA, PRIMARY	SCN9A, ILE848THR	80356474
603415	6335	SCN9A	0003	ERYTHERMALGIA, PRIMARY	SCN9A, SER241THR	80356470
603415	6335	SCN9A	0004	ERYTHERMALGIA, PRIMARY	SCN9A, PHE1449VAL	80356478
603415	6335	SCN9A	0005	INSENSITIVITY TO PAIN, CHANNELOPATHY-ASSOCIATED	SCN9A, SER459TER	121908908
603415	6335	SCN9A	0006	INSENSITIVITY TO PAIN, CHANNELOPATHY-ASSOCIATED	SCN9A, 1-BP DEL, 2298T	
603415	6335	SCN9A	0007	INSENSITIVITY TO PAIN, CHANNELOPATHY-ASSOCIATED	SCN9A, TRP897TER	121908909
603415	6335	SCN9A	0008	PAROXYSMAL EXTREME PAIN DISORDER	SCN9A, ARG996CYS	121908910
603415	6335	SCN9A	0009	PAROXYSMAL EXTREME PAIN DISORDER	SCN9A, VAL1298ASP	121908911
603415	6335	SCN9A	0010	PAROXYSMAL EXTREME PAIN DISORDER	SCN9A, VAL1298PHE	121908912
603415	6335	SCN9A	0011	PAROXYSMAL EXTREME PAIN DISORDER	SCN9A, VAL1299PHE	121908913
603415	6335	SCN9A	0012	PAROXYSMAL EXTREME PAIN DISORDER	SCN9A, ILE1461THR	121908914
603415	6335	SCN9A	0013	PAROXYSMAL EXTREME PAIN DISORDER	SCN9A, THR1464ILE	121908915
603415	6335	SCN9A	0014	INSENSITIVITY TO PAIN, CHANNELOPATHY-ASSOCIATED	SCN9A, ARG277TER	121908916
603415	6335	SCN9A	0015	INSENSITIVITY TO PAIN, CHANNELOPATHY-ASSOCIATED	SCN9A, TYR328TER	121908917
603415	6335	SCN9A	0016	ERYTHERMALGIA, PRIMARY	SCN9A, LEU858PHE	80356476
603415	6335	SCN9A	0017	ERYTHERMALGIA, PRIMARY	SCN9A, PHE216SER	80356469
603415	6335	SCN9A	0018	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 7	SCN9A, ASN641TYR	121908918
603415	6335	SCN9A	0019	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 7	SCN9A, LYS655ARG	121908919
603415	6335	SCN9A	0020	FEBRILE SEIZURES, FAMILIAL, 3B	SCN9A, ILE62VAL	121908920
603415	6335	SCN9A	0021	FEBRILE SEIZURES, FAMILIAL, 3B	SCN9A, PRO149GLN	121908921
603415	6335	SCN9A	0022	ERYTHERMALGIA, PRIMARY	SCN9A, GLN10ARG	
603415	6335	SCN9A	0023	NEUROPATHY, SMALL FIBER	SCN9A, ILE720LYS	
603415	6335	SCN9A	0024	NEUROPATHY, SMALL FIBER	SCN9A, ASP623ASN	
603415	6335	SCN9A	0025	NEUROPATHY, SMALL FIBER	SCN9A, MET932LEU AND VAL991LEU	
603422	8572	PDLIM4	0001	OSTEOPOROSIS, SUSCEPTIBILITY TO	RIL, -3333T-C	
603424	8575	PRKRA	0001	DYSTONIA 16	PRKRA, PRO222LEU	121434410
603424	8575	PRKRA	0002	DYSTONIA 16	PRKRA, 2-BP DEL, 266AT	
603426	8864	PER2	0001	ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 1	PER2, SER662GLY	121908635
603454	8738	CRADD	0001	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34	CRADD, GLY128ARG	
603470	445	ASS1	0001	CITRULLINEMIA, CLASSIC	ASS1, EX5DEL	
603470	445	ASS1	0002	CITRULLINEMIA, CLASSIC	ASS1, EX6DEL	
603470	445	ASS1	0003	CITRULLINEMIA, CLASSIC	ASS1, IVS6AS, A-G, -2	
603470	445	ASS1	0004	CITRULLINEMIA, CLASSIC	ASS1, GLY14SER	121908636
603470	445	ASS1	0005	CITRULLINEMIA, CLASSIC	ASS1, ARG157HIS	121908637
603470	445	ASS1	0006	CITRULLINEMIA, CLASSIC	ASS1, SER180ASN	121908638
603470	445	ASS1	0007	CITRULLINEMIA, CLASSIC	ASS1, GLY324SER	121908639
603470	445	ASS1	0008	CITRULLINEMIA, CLASSIC	ASS1, ARG363TRP	121908640
603470	445	ASS1	0009	CITRULLINEMIA, CLASSIC	ASS1, GLY390ARG	121908641
603470	445	ASS1	0010	CITRULLINEMIA, CLASSIC	ASS1, ARG304TRP	121908642
603470	445	ASS1	0011	CITRULLINEMIA, CLASSIC	ASS1, SER18LEU	121908643
603470	445	ASS1	0012	CITRULLINEMIA, CLASSIC	ASS1, ARG86CYS	121908644
603470	445	ASS1	0013	CITRULLINEMIA, CLASSIC	ASS1, ARG279TER	121908645
603470	445	ASS1	0014	CITRULLINEMIA, CLASSIC	ASS1, ARG108LEU	35269064
603470	445	ASS1	0015	CITRULLINEMIA, MILD	ASS1, TRP179ARG	121908646
603470	445	ASS1	0016	CITRULLINEMIA, MILD	ASS1, GLY362VAL	121908647
603470	445	ASS1	0017	CITRULLINEMIA, CLASSIC	ASS1, IVS6, G-A, +5	
603470	445	ASS1	0018	CITRULLINEMIA, CLASSIC	ASS1, IVS15, G-C, -1	
603470	445	ASS1	0019	CITRULLINEMIA, CLASSIC	ASS1, LYS310GLN	121908648
603474	6223	RPS19	0001	DIAMOND-BLACKFAN ANEMIA	RPS19, ARG94TER	61762293
603474	6223	RPS19	0002	DIAMOND-BLACKFAN ANEMIA	RPS19, ARG62TRP	104894711
603474	6223	RPS19	0003	DIAMOND-BLACKFAN ANEMIA	RPS19, TRP33TER	104894716
603474	6223	RPS19	0004	DIAMOND-BLACKFAN ANEMIA	RPS19, ARG84TER	121908649
603474	6223	RPS19	0005	DIAMOND-BLACKFAN ANEMIA	RPS19, 1-BP DEL, 329G	
603474	6223	RPS19	0006	DIAMOND-BLACKFAN ANEMIA	RPS19, LEU45GLN AND 2-BP INS, 160CT	
603474	6223	RPS19	0007	DIAMOND-BLACKFAN ANEMIA	RPS19, VAL15PHE, THR55MET	104894717
603474	6223	RPS19	0008	DIAMOND-BLACKFAN ANEMIA	RPS19, GLY127GLN	
603489	8483	CILP	0001	LUMBAR DISC DISEASE, SUSCEPTIBILITY TO	CILP, ILE395THR	2073711
603490	54361	WNT4	0001	MULLERIAN APLASIA AND HYPERANDROGENISM	WNT4, GLU226GLY	121908650
603490	54361	WNT4	0002	SERKAL SYNDROME	WNT4, ALA114VAL	121908651
603490	54361	WNT4	0003	MULLERIAN APLASIA AND HYPERANDROGENISM	WNT4, ARG83CYS	121908652
603490	54361	WNT4	0004	MULLERIAN APLASIA AND HYPERANDROGENISM	WNT4, LEU12PRO	121908653
603495	6795	AURKC	0001	SPERMATOGENIC FAILURE 5	AURKC, 1-BP DEL, 144C	
603495	6795	AURKC	0002	SPERMATOGENIC FAILURE 5	AURKC, CYS229TYR	121908654
603499	8792	TNFRSF11A	0001	EXPANSILE OSTEOLYSIS, FAMILIAL	TNFRSF11A, 18-BP DUP, NT84	
603499	8792	TNFRSF11A	0002	PAGET DISEASE OF BONE 2	TNFRSF11A, 27-BP DUP, NT75	
603499	8792	TNFRSF11A	0003	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7	TNFRSF11A, ARG170GLY	121908655
603499	8792	TNFRSF11A	0004	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7	TNFRSF11A, CYS175ARG	121908656
603499	8792	TNFRSF11A	0005	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7	TNFRSF11A, ARG129CYS	121908657
603499	8792	TNFRSF11A	0006	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7	TNFRSF11A, ALA244SER	121908658
603499	8792	TNFRSF11A	0007	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7	TNFRSF11A, GLY53ARG	121908659
603503	8813	DPM1	0001	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie	DPM1, ARG92GLY	121908583
603503	8813	DPM1	0002	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie	DPM1, 13-BP DEL	
603503	8813	DPM1	0003	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie	DPM1, 1-BP DEL, 628C	
603506	4041	LRP5	0001	OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	LRP5, TRP10TER	121908660
603506	4041	LRP5	0002	OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	LRP5, ARG428TER	121908661
603506	4041	LRP5	0003	OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	LRP5, 1-BP DEL, 1467G	
603506	4041	LRP5	0004	OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	LRP5, ASP718TER	121908662
603506	4041	LRP5	0005	OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	LRP5, GLN853TER	121908663
603506	4041	LRP5	0006	OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	LRP5, 1-BP DEL, 3804A	
603506	4041	LRP5	0007	OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	LRP5, ARG494GLN	121908664
603506	4041	LRP5	0008	OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	LRP5, ARG570TRP	121908665
603506	4041	LRP5	0009	OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	LRP5, VAL667MET	4988321
603506	4041	LRP5	0010	OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	LRP5, GLU485TER	121908666
603506	4041	LRP5	0011	OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	LRP5, TRP734TER	121908667
603506	4041	LRP5	0012	OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	LRP5, 1-BP DEL, 2305G	
603506	4041	LRP5	0013	HIGH BONE MASS	LRP5, GLY171VAL	121908668
603506	4041	LRP5	0014	OSTEOPETROSIS, AUTOSOMAL DOMINANT 1	LRP5, GLY171ARG	121908669
603506	4041	LRP5	0015	ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT OSTEOPETROSIS, AUTOSOMAL DOMINANT 1, INCLUDED;; VAN BUCHEM DISEASE, TYPE 2, INCLUDED	LRP5, ALA242THR	121908670
603506	4041	LRP5	0016	ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT	LRP5, ALA214THR	121908671
603506	4041	LRP5	0017	OSTEOSCLEROSIS, AUTOSOMAL DOMINANT	LRP5, ALA214VAL	121908672
603506	4041	LRP5	0018	OSTEOPETROSIS, AUTOSOMAL DOMINANT 1	LRP5, THR253ILE	121908673
603506	4041	LRP5	0019	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 1	LRP5, 2220C-T	
603506	4041	LRP5	0020	EXUDATIVE VITREORETINOPATHY 4, AUTOSOMAL DOMINANT	LRP5, IVS21DS, T-G, +2	80358322
603506	4041	LRP5	0021	EXUDATIVE VITREORETINOPATHY 4, AUTOSOMAL DOMINANT	LRP5, 1-BP INS, 4119C	80358321
603506	4041	LRP5	0022	EXUDATIVE VITREORETINOPATHY 4, AUTOSOMAL RECESSIVE	LRP5, ARG570GLN	80358312
603506	4041	LRP5	0023	EXUDATIVE VITREORETINOPATHY 4, AUTOSOMAL RECESSIVE	LRP5, ARG752GLY	121908674
603506	4041	LRP5	0024	EXUDATIVE VITREORETINOPATHY 4, AUTOSOMAL RECESSIVE	LRP5, GLU1367LYS	28939709
603506	4041	LRP5	0025	EXUDATIVE VITREORETINOPATHY 4, AUTOSOMAL DOMINANT OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME, INCLUDED	LRP5, LEU145PHE	80358305
603506	4041	LRP5	0026	EXUDATIVE VITREORETINOPATHY 4, DIGENIC	LRP5, ARG444CYS	80358308
603506	4041	LRP5	0027	EXUDATIVE VITREORETINOPATHY 4, AUTOSOMAL RECESSIVE	LRP5, GLY610ARG	80358313
603506	4041	LRP5	0028	EXUDATIVE VITREORETINOPATHY 4, AUTOSOMAL RECESSIVE	LRP5, 10-BP DEL, NT803	80358307
603506	4041	LRP5	0029	OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	LRP5, THR552MET	
603506	4041	LRP5	0030	OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	LRP5, PRO382LEU	
603506	4041	LRP5	0031	OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	LRP5, THR244MET	
603506	4041	LRP5	0032	OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	LRP5, ARG1534TER	
603506	4041	LRP5	0033	OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	LRP5, IVS7, G-A, +1	
603506	4041	LRP5	0034	OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	LRP5, 7.2-KB DEL, EXONS 22-23	
603507	4040	LRP6	0001	CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2	LRP6, ARG611CYS	121918313
603517	8915	BCL10	0001	MALT LYMPHOMA, SOMATIC MESOTHELIOMA, SOMATIC, INCLUDED;; MALE GERM CELL TUMOR, SOMATIC, INCLUDED	BCL10, 1-BP INS, 499T	
603517	8915	BCL10	0002	MALT LYMPHOMA, SOMATIC	BCL10, 1-BP INS, 163A	
603517	8915	BCL10	0003	MALT LYMPHOMA, SOMATIC	BCL10, 1-BP DEL, 345A	
603517	8915	BCL10	0004	FOLLICULAR LYMPHOMA, SOMATIC	BCL10, 2-BP INS, 428TT	
603517	8915	BCL10	0005	FOLLICULAR LYMPHOMA, SOMATIC	BCL10, 1-BP INS, 231A	
603517	8915	BCL10	0006	FOLLICULAR LYMPHOMA, SOMATIC	BCL10, 17-BP DEL, NT525	
603517	8915	BCL10	0007	FOLLICULAR LYMPHOMA, SOMATIC	BCL10, 1-BP DEL, 410A	
603517	8915	BCL10	0008	FOLLICULAR LYMPHOMA, SOMATIC	BCL10, 1-BP INS, 398T	
603517	8915	BCL10	0009	FOLLICULAR LYMPHOMA, SOMATIC	BCL10, 3-BP DEL, GLU210DEL	
603517	8915	BCL10	0010	T-CELL ACUTE LYMPHOCYTIC LEUKEMIA, SOMATIC COLON CANCER, SOMATIC, INCLUDED	BCL10, 1-BP INS, 136A	
603517	8915	BCL10	0011	SEZARY SYNDROME, SOMATIC	BCL10, 1-BP DEL, 428T	
603517	8915	BCL10	0013	MOVED TO 603517.0001 .0014 MESOTHELIOMA, SOMATIC	BCL10, 1-BP DEL, 136A	
603517	8915	BCL10	0016	MALE GERM CELL TUMOR, SOMATIC	BCL10, ARG58GLY	121918314
603517	8915	BCL10	0017	MALE GERM CELL TUMOR, SOMATIC	BCL10, ARG58TER	121918314
603517	8915	BCL10	0018	TESTICULAR TERATOMA, SOMATIC	BCL10, THR161MET	
603518	7072	TIA1	0001	WELANDER DISTAL MYOPATHY	TIA1, GLU384LYS	
603531	1174	AP1S1	0001	MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	AP1S1, IVS2AS, A-G, -2	
603537	9132	KCNQ4	0001	DEAFNESS, AUTOSOMAL DOMINANT 2A	KCNQ4, GLY285SER	28937588
603537	9132	KCNQ4	0002	DEAFNESS, AUTOSOMAL DOMINANT 2A	KCNQ4, TRP276SER	80358277
603537	9132	KCNQ4	0003	DEAFNESS, AUTOSOMAL DOMINANT 2A	KCNQ4, GLY321SER	28939710
603537	9132	KCNQ4	0004	DEAFNESS, AUTOSOMAL DOMINANT 2A	KCNQ4, GLY285CYS	28937588
603537	9132	KCNQ4	0005	DEAFNESS, AUTOSOMAL DOMINANT 2A	KCNQ4, 13-BP DEL, NT211	80358271
603537	9132	KCNQ4	0006	DEAFNESS, AUTOSOMAL DOMINANT 2A	KCNQ4, LEU281SER	80358278
603537	9132	KCNQ4	0007	DEAFNESS, AUTOSOMAL DOMINANT 2A	KCNQ4, LEU274HIS	80358276
603537	9132	KCNQ4	0008	DEAFNESS, AUTOSOMAL DOMINANT 2A	KCNQ4, 1-BP DEL, 211C	80358272
603537	9132	KCNQ4	0009	DEAFNESS, AUTOSOMAL DOMINANT 2A	KCNQ4, GLY296SER	80358279
603550	2070	EYA4	0001	DEAFNESS, AUTOSOMAL DOMINANT 10	EYA4, 2-BP INS, 1468AA	
603550	2070	EYA4	0002	DEAFNESS, AUTOSOMAL DOMINANT 10	EYA4, 2200C-T	
603550	2070	EYA4	0003	CARDIOMYOPATHY, DILATED, 1J	EYA4, 4,846-BP DEL	
603550	2070	EYA4	0004	DEAFNESS, AUTOSOMAL DOMINANT 10	EYA4, 2-BP INS, 1490AA	
603550	2070	EYA4	0005	DEAFNESS, AUTOSOMAL DOMINANT 10	EYA4, IVS14, 1282-12T-A	
603557	8898	MTMR2	0001	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1	MTMR2, GLN426TER	121434402
603557	8898	MTMR2	0002	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1	MTMR2, IVS13, G-A, +1	
603557	8898	MTMR2	0003	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1	MTMR2, GLU276TER	121434403
603557	8898	MTMR2	0004	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1	MTMR2, GLN482TER	121434404
603557	8898	MTMR2	0005	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1	MTMR2, 10-BP DEL/2-BP INS	
603560	6305	SBF1	0001	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3 (1 family)	SBF1, MET417VAL	
603560	6305	SBF1	0002	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3 (1 family)	SBF1, THR1590ALA	
603564	8818	DPM2	0001	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu	DPM2, TYR23CYS	
603564	8818	DPM2	0002	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu	DPM2, IVS1AS, G-C, -1	
603570	8876	VNN1	0001	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 8	VNN1, G-137T	
603576	4308	TRPM1	0001	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C	TRPM1, IVS16DS, T-C, +2	
603576	4308	TRPM1	0002	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C	TRPM1, 1-BP DEL, 412G	
603576	4308	TRPM1	0003	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C	TRPM1, TYR1035TER	
603576	4308	TRPM1	0004	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C	TRPM1, GLN11TER	
603576	4308	TRPM1	0005	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C	TRPM1, LEU99PRO	
603576	4308	TRPM1	0006	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C	TRPM1, PRO611HIS	
603576	4308	TRPM1	0007	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C	TRPM1, 36.4-KB DEL, EX2-7	
603576	4308	TRPM1	0008	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C	TRPM1, ARG624CYS	
603576	4308	TRPM1	0009	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C	TRPM1, SER882TER	
603576	4308	TRPM1	0010	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C	TRPM1, IVS8, 4-BP DEL, +3	
603590	9215	LARGE	0001	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	LARGE, GLU509LYS	121908675
603590	9215	LARGE	0002	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	LARGE, 1-BP INS, 1999T	
603590	9215	LARGE	0003	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 6	LARGE, 63-KB DEL	
603590	9215	LARGE	0004	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 6	LARGE, TRP495ARG	
603590	9215	LARGE	0005	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 6	LARGE, GLN87FS	
603590	9215	LARGE	0006	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 6	LARGE, SER331PHE	
603590	9215	LARGE	0007	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	LARGE, 667FS	
603590	9215	LARGE	0008	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	LARGE, 42.9-KB INS/4.1-KB DEL	
603593	9056	SLC7A7	0001	LYSINURIC PROTEIN INTOLERANCE	SLC7A7, IVS6AS, A-T, -2	
603593	9056	SLC7A7	0002	LYSINURIC PROTEIN INTOLERANCE	SLC7A7, 455-BP DEL, NT197	
603593	9056	SLC7A7	0003	LYSINURIC PROTEIN INTOLERANCE	SLC7A7, 4-BP INS, 1384ATCA	
603593	9056	SLC7A7	0004	LYSINURIC PROTEIN INTOLERANCE	SLC7A7, MET1LEU	121908676
603593	9056	SLC7A7	0005	LYSINURIC PROTEIN INTOLERANCE	SLC7A7, LEU334ARG	72552272
603593	9056	SLC7A7	0006	LYSINURIC PROTEIN INTOLERANCE	SLC7A7, 4-BP DEL, 1005CTTT	
603593	9056	SLC7A7	0007	LYSINURIC PROTEIN INTOLERANCE	SLC7A7, GLY54VAL	121908677
603593	9056	SLC7A7	0008	LYSINURIC PROTEIN INTOLERANCE	SLC7A7, ARG410TER	121908678
603593	9056	SLC7A7	0009	LYSINURIC PROTEIN INTOLERANCE	SLC7A7, IVS4DS, G-A, +1	
603593	9056	SLC7A7	0010	LYSINURIC PROTEIN INTOLERANCE	SLC7A7, TRP242TER	121908679
603593	9056	SLC7A7	0011	LYSINURIC PROTEIN INTOLERANCE	SLC7A7, EX6-11, DEL	
603604	8398	PLA2G6	0001	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	PLA2G6, TYR790TER	121908680
603604	8398	PLA2G6	0002	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B	PLA2G6, LYS545THR	121908681
603604	8398	PLA2G6	0003	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	PLA2G6, VAL310GLU	121908682
603604	8398	PLA2G6	0004	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	PLA2G6, 2-BP DEL, 2070TGT	
603604	8398	PLA2G6	0005	KARAK SYNDROME	PLA2G6, ARG632TRP	121908683
603604	8398	PLA2G6	0006	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	PLA2G6, TYR790TER	121908680
603604	8398	PLA2G6	0007	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B, INCLUDED	PLA2G6, 2-BP DEL, 2370TG	
603604	8398	PLA2G6	0008	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B	PLA2G6, ALA80THR	121908685
603604	8398	PLA2G6	0009	PARKINSON DISEASE 14	PLA2G6, ARG741GLN	121908686
603604	8398	PLA2G6	0010	PARKINSON DISEASE 14	PLA2G6, ARG747TRP	121908687
603604	8398	PLA2G6	0011	PARKINSON DISEASE 14	PLA2G6, ARG635GLN	
603604	8398	PLA2G6	0012	PARKINSON DISEASE 14	PLA2G6, GLN452TER	
603604	8398	PLA2G6	0013	PARKINSON DISEASE 14	PLA2G6, PHE72LEU	
603604	8398	PLA2G6	0014	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	PLA2G6, 6.6-KB DEL	
603604	8398	PLA2G6	0015	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	PLA2G6, ARG37TER	
603604	8398	PLA2G6	0016	PARKINSON DISEASE 14	PLA2G6, ASP331TYR	
603605	9255	AIMP1	0001	LEUKODYSTROPHY, HYPOMYELINATING, 3	AIMP1, 2-BP DEL, 292CA	
603612	8795	TNFRSF10B	0001	SQUAMOUS CELL CARCINOMA, HEAD AND NECK	TNFRSF10B, 2-BP INS	
603615	8438	RAD54L	0001	ADENOCARCINOMA, COLONIC, SOMATIC	RAD54L, PRO63HIS	121908688
603615	8438	RAD54L	0002	LYMPHOMA, NON-HODGKIN, SOMATIC	RAD54L, VAL444GLU	121908689
603615	8438	RAD54L	0003	BREAST CANCER, INVASIVE DUCTAL	RAD54L, GLY325ARG	121908690
603617	9187	SLC24A1	0001	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1D	SLC24A1, 2-BP DEL, EXON 2	
603623	8565	YARS	0001	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE C	YARS, GLY41ARG	121908833
603623	8565	YARS	0002	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE C	YARS, GLU196LYS	121908834
603623	8565	YARS	0003	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE C	YARS, 12-BP DEL	
603632	6204	RPS10	0001	DIAMOND-BLACKFAN ANEMIA 9	RPS10, MET1ILE	
603632	6204	RPS10	0002	DIAMOND-BLACKFAN ANEMIA 9	RPS10, 1-BP INS, 260C	
603632	6204	RPS10	0003	DIAMOND-BLACKFAN ANEMIA 9	RPS10, ARG113TER	
603634	6125	RPL5	0001	DIAMOND-BLACKFAN ANEMIA 6	RPL5, ARG23TER	121434405
603634	6125	RPL5	0002	DIAMOND-BLACKFAN ANEMIA 6	RPL5, GLY140SER	121434406
603634	6125	RPL5	0003	DIAMOND-BLACKFAN ANEMIA 6	RPL5, 2-BP DEL, 173GA	
603634	6125	RPL5	0004	DIAMOND-BLACKFAN ANEMIA 6	RPL5, 1-BP INS, 235T	
603634	6125	RPL5	0005	DIAMOND-BLACKFAN ANEMIA 6	RPL5, 5-BP DEL/39-BP INS, NT498	
603634	6125	RPL5	0006	DIAMOND-BLACKFAN ANEMIA 6	RPL5, IVS2DS, T-G, +2	
603639	6868	ADAM17	0001	INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL	ADAM17, 4-BP DEL, 603CAGA	
603644	6341	SCO1	0001	HEPATIC FAILURE, EARLY-ONSET, AND NEUROLOGIC DISORDER DUE TO CYTOCHROME c OXIDASE DEFICIENCY	SCO1, 2-BP DEL, 363GA	
603644	6341	SCO1	0002	HEPATIC FAILURE, EARLY-ONSET, AND NEUROLOGIC DISORDER DUE TO CYTOCHROME c OXIDASE DEFICIENCY	SCO1, PRO174LEU	104894630
603646	1355	COX15	0001	CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 2 LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX IV DEFICIENCY, INCLUDED	COX15, ARG217TRP	28939711
603646	1355	COX15	0002	CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 2	COX15, IVS3, C-G, -3	
603646	1355	COX15	0003	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX IV DEFICIENCY	COX15, SER151TER	
603646	1355	COX15	0004	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX IV DEFICIENCY	COX15, SER344PRO	
603647	617	BCS1L	0001	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	BCS1L, SER277ASN	121908571
603647	617	BCS1L	0002	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX III DEFICIENCY	BCS1L, PRO99LEU	121908572
603647	617	BCS1L	0003	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	BCS1L, ARG155PRO	121908573
603647	617	BCS1L	0004	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	BCS1L, VAL353MET	121908574
603647	617	BCS1L	0005	GRACILE SYNDROME	BCS1L, SER78GLY	28937590
603647	617	BCS1L	0006	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	BCS1L, ARG45CYS	121908575
603647	617	BCS1L	0007	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	BCS1L, ARG56TER	121908576
603647	617	BCS1L	0008	BJORNSTAD SYNDROME	BCS1L, ARG183HIS	121908577
603647	617	BCS1L	0009	BJORNSTAD SYNDROME WITH MILD MITOCHONDRIAL COMPLEX III DEFICIENCY MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1, INCLUDED	BCS1L, ARG184CYS	121908578
603647	617	BCS1L	0010	BJORNSTAD SYNDROME WITH MILD MITOCHONDRIAL COMPLEX III DEFICIENCY	BCS1L, GLY35ARG	121908579
603647	617	BCS1L	0011	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	BCS1L, THR50ALA	121908580
603647	617	BCS1L	0012	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	BCS1L, ARG183CYS	
603650	129880	BBS5	0001	BARDET-BIEDL SYNDROME 5	BBS5, IVS6DS, A-G, +3	
603650	129880	BBS5	0002	BARDET-BIEDL SYNDROME 5	BBS5, LEU142TER	
603650	129880	BBS5	0003	BARDET-BIEDL SYNDROME 5	BBS5, 8-BP DEL/7-BP INS, NT263	
603650	129880	BBS5	0004	BARDET-BIEDL SYNDROME 5	BBS5, TRP59TER	
603650	129880	BBS5	0005	BARDET-BIEDL SYNDROME 5	BBS5, GLY72SER	121908581
603650	129880	BBS5	0006	BARDET-BIEDL SYNDROME 5	BBS5, THR183ALA	121908582
603652	7225	TRPC6	0001	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2	TRPC6, PRO112GLN	121434390
603652	7225	TRPC6	0002	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2	TRPC6, ASN143SER	121434391
603652	7225	TRPC6	0003	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2	TRPC6, SER270THR	121434392
603652	7225	TRPC6	0004	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2	TRPC6, LYS874TER	121434393
603652	7225	TRPC6	0005	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2	TRPC6, ARG895CYS	121434394
603652	7225	TRPC6	0006	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2	TRPC6, GLU897LYS	121434395
603658	6201	RPS7	0001	DIAMOND-BLACKFAN ANEMIA 8	RPS7, IVS3DS, G-A, +1	116840810
603666	8675	STX16	0001	PSEUDOHYPOPARATHYROIDISM, TYPE IB	STX16, 3-KB TO 4.4-KB MICRODELETION	
603667	8604	SLC25A12	0001	HYPOMYELINATION, GLOBAL CEREBRAL	SLC25A12, GLN590ARG	121434396
603673	8643	PTCH2	0001	MEDULLOBLASTOMA, SOMATIC	PTCH2, 2-BP DEL, NT1170	
603673	8643	PTCH2	0002	BASAL CELL CARCINOMA, SOMATIC	PTCH2, IVS20DS, T, +5	
603673	8643	PTCH2	0003	BASAL CELL NEVUS SYNDROME	PTCH2, ARG719GLN	121434397
603680	6315	ATXN8OS	0001	SPINOCEREBELLAR ATAXIA 8 PARKINSON DISEASE, LATE-ONSET, SUSCEPTIBILITY TO, INCLUDED	ATXN8OS, (CTG)n EXPANSION	193922930
603681	9381	OTOF	0001	DEAFNESS, AUTOSOMAL RECESSIVE 9	OTOF, TYR730TER	80356600
603681	9381	OTOF	0002	DEAFNESS, AUTOSOMAL RECESSIVE 9	OTOF, IVS8AS, A-G, -2	80356584
603681	9381	OTOF	0003	DEAFNESS, AUTOSOMAL RECESSIVE 9	OTOF, IVS5, G-A, +1	
603681	9381	OTOF	0004	DEAFNESS, AUTOSOMAL RECESSIVE 9	OTOF, GLN829TER	80356593
603681	9381	OTOF	0005	DEAFNESS, AUTOSOMAL RECESSIVE 9	OTOF, PRO1825ALA	28937591
603681	9381	OTOF	0006	AUDITORY NEUROPATHY, AUTOSOMAL RECESSIVE, 1	OTOF, 1-BP DEL, 1778G	
603681	9381	OTOF	0007	AUDITORY NEUROPATHY, AUTOSOMAL RECESSIVE, 1	OTOF, 6141G-A	
603681	9381	OTOF	0008	AUDITORY NEUROPATHY, AUTOSOMAL RECESSIVE, 1	OTOF, IVS39, +1, G-C	80356602
603681	9381	OTOF	0009	AUDITORY NEUROPATHY, AUTOSOMAL RECESSIVE, 1	OTOF, PRO50ARG	121908598
603681	9381	OTOF	0010	AUDITORY NEUROPATHY, AUTOSOMAL RECESSIVE, 1	OTOF, LEU1011PRO	80356596
603681	9381	OTOF	0011	AUDITORY NEUROPATHY, AUTOSOMAL RECESSIVE, 1	OTOF, ILE515THR	80356586
603681	9381	OTOF	0012	AUDITORY NEUROPATHY, AUTOSOMAL RECESSIVE, 1	OTOF, ARG1939GLN	
603681	9381	OTOF	0013	AUDITORY NEUROPATHY, AUTOSOMAL RECESSIVE, 1, TEMPERATURE-SENSITIVE	OTOF, GLY541SER	
603690	9197	SLC33A1	0001	SPASTIC PARAPLEGIA 42, AUTOSOMAL DOMINANT	SLC33A1, SER113ARG	121909484
603690	9197	SLC33A1	0002	CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION	SLC33A1, ALA110PRO	
603690	9197	SLC33A1	0003	CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION	SLC33A1, IVS5AS, G-A, -1	
603690	9197	SLC33A1	0004	CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION	SLC33A1, TYR366TER	
603690	9197	SLC33A1	0005	CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION	SLC33A1, 1-BP INS, 614T	
603690	9197	SLC33A1	0006	CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION	SLC33A1, 18-BP DEL, NT1474	
603693	23414	ZFPM2	0001	TETRALOGY OF FALLOT	ZFPM2, SER657GLY	28374544
603693	23414	ZFPM2	0002	TETRALOGY OF FALLOT DOUBLE-OUTLET RIGHT VENTRICLE, INCLUDED	ZFPM2, GLU30GLY	121908601
603693	23414	ZFPM2	0003	DIAPHRAGMATIC HERNIA 3	ZFPM2, ARG112TER	121908602
603693	23414	ZFPM2	0004	DIAPHRAGMATIC HERNIA 3 DOUBLE-OUTLET RIGHT VENTRICLE, INCLUDED	ZFPM2, MET703LEU	121908603
603693	23414	ZFPM2	0005	DIAPHRAGMATIC HERNIA 3	ZFPM2, THR843ALA	121908604
603693	23414	ZFPM2	0006	DOUBLE-OUTLET RIGHT VENTRICLE	ZFPM2, ILE227MET	
603693	23414	ZFPM2	0007	TETRALOGY OF FALLOT	ZFPM2, MET544ILE	
603693	23414	ZFPM2	0008	DOUBLE-OUTLET RIGHT VENTRICLE	ZFPM2, LYS737GLU	
603701	6231	RPS26	0001	DIAMOND-BLACKFAN ANEMIA 10	RPS26, MET1VAL	
603701	6231	RPS26	0002	DIAMOND-BLACKFAN ANEMIA 10	RPS26, MET1LEU	
603701	6231	RPS26	0003	DIAMOND-BLACKFAN ANEMIA 10	RPS26, ASP33ASN	
603701	6231	RPS26	0004	DIAMOND-BLACKFAN ANEMIA 10	RPS26, 1-BP INS, 31G	
603701	6231	RPS26	0005	DIAMOND-BLACKFAN ANEMIA 10	RPS26, IVS1, G-A, +1	
603704	6154	RPL26	0001	DIAMOND-BLACKFAN ANEMIA 11	RPL26, 2-BP DEL, 120GA	
603707	4337	MOCS1	0001	MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A	MOCS1, 1-BP DEL, 722T	
603707	4337	MOCS1	0002	MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A	MOCS1, 2-BP DEL, 1523AG	
603707	4337	MOCS1	0003	MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A	MOCS1, ARG319GLN	104893969
603707	4337	MOCS1	0004	MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A	MOCS1, IVS2, 418, G-A, +1	
603707	4337	MOCS1	0005	MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A	MOCS1, ARG73TRP	104893970
603708	4338	MOCS2	0001	MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B	MOCS2, 2-BP DEL, NT726	
603708	4338	MOCS2	0002	MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B	MOCS2, GLU168LYS	121908605
603708	4338	MOCS2	0003	MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B	MOCS2, 4-BP DEL, NT533	
603708	4338	MOCS2	0004	MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B	MOCS2, 1-BP INS, 252C	
603708	4338	MOCS2	0005	MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B	MOCS2, MET1ILE	121908606
603708	4338	MOCS2	0006	MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B	MOCS2, GLN6TER	121908607
603708	4338	MOCS2	0007	MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B	MCOS2, VAL7PHE	121908608
603708	4338	MOCS2	0008	MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B	MCOS2, TER189TYR	121908609
603708	4338	MOCS2	0009	MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B	MCOS2, 23-BP DEL, NT148	
603711	9420	CYP7B1	0001	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 3 SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE, INCLUDED	CYP7B1, ARG388TER	72554620
603711	9420	CYP7B1	0002	SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE	CYP7B1, SER363PHE	121908610
603711	9420	CYP7B1	0003	SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE	CYP7B1, GLY57ARG	121908614
603711	9420	CYP7B1	0004	SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE	CYP7B1, ARG417HIS	121908611
603711	9420	CYP7B1	0005	SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE	CYP7B1, PHE216SER	121908612
603711	9420	CYP7B1	0006	SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE	CYP7B1, TYR275TER	121908613
603711	9420	CYP7B1	0007	SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE	CYP7B1, PHE470ILE	
603711	9420	CYP7B1	0008	SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE	CYP7B1, ARG486CYS	
603714	6496	SIX3	0001	HOLOPROSENCEPHALY 2	SIX3, LEU226VAL	
603714	6496	SIX3	0002	HOLOPROSENCEPHALY 2	SIX3, ARG257PRO	
603714	6496	SIX3	0003	HOLOPROSENCEPHALY 2	SIX3, VAL250ALA	
603714	6496	SIX3	0004	HOLOPROSENCEPHALY 2	SIX3, 2-BP INS, 557GG	
603714	6496	SIX3	0005	HOLOPROSENCEPHALY 2	SIX3, 2-BP INS, 406GC	
603714	6496	SIX3	0006	HOLOPROSENCEPHALY 2	SIX3, GLY69ASP	
603714	6496	SIX3	0007	HOLOPROSENCEPHALY 2	SIX3, TRP113CYS	137853021
603714	6496	SIX3	0008	HOLOPROSENCEPHALY 2 SCHIZENCEPHALY, INCLUDED	SIX3, GLU129TER	
603714	6496	SIX3	0009	HOLOPROSENCEPHALY 2 SCHIZENCEPHALY, INCLUDED	SIX3, GLY37CYS	
603714	6496	SIX3	0010	SCHIZENCEPHALY	SIX3, ALA167SER	
603716	9247	GCM2	0001	HYPOPARATHYROIDISM, FAMILIAL ISOLATED	GCM2, EX1-4DEL	
603716	9247	GCM2	0002	HYPOPARATHYROIDISM, FAMILIAL ISOLATED	GCM2, ARG47LEU	104893959
603716	9247	GCM2	0003	HYPOPARATHYROIDISM, FAMILIAL ISOLATED	GCM2, GLY63SER	104893960
603718	9076	CLDN1	0001	NEONATAL ICHTHYOSIS-SCLEROSING CHOLANGITIS SYNDROME	CLDN1, 2-BP DEL, 200TT	
603718	9076	CLDN1	0002	NEONATAL ICHTHYOSIS-SCLEROSING CHOLANGITIS SYNDROME	CLDN1, 1-BP DEL, 358G	
603722	8518	IKBKAP	0001	DYSAUTONOMIA, FAMILIAL	IKBKAP, IVS20DS, T-C, +6	111033171
603722	8518	IKBKAP	0002	DYSAUTONOMIA, FAMILIAL	IKBKAP, ARG696PRO	137853022
603722	8518	IKBKAP	0003	DYSAUTONOMIA, FAMILIAL	IKBKAP, PRO914LEU	28939712
603725	8822	FGF17	0001	HYPOGONADOTROPIC HYPOGONADISM 20 WITH ANOSMIA, SUSCEPTIBILITY TO	FGF17, ILE108THR	
603725	8822	FGF17	0002	HYPOGONADOTROPIC HYPOGONADISM 20 WITHOUT ANOSMIA	FGF17, ARG177HIS	
603725	8822	FGF17	0003	HYPOGONADOTROPIC HYPOGONADISM 20 WITH ANOSMIA	FGF17, ASN187SER	
603741	242	ALOX12B	0001	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	ALOX12B, 1-BP DEL, 1387T	
603741	242	ALOX12B	0002	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	ALOX12B, LEU426PRO	137853023
603741	242	ALOX12B	0003	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	ALOX12B, HIS578GLN	137853024
603741	242	ALOX12B	0004	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	ALOX12B, ARG114TRP	
603741	242	ALOX12B	0005	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	ALOX12B, ARG432TER	
603741	242	ALOX12B	0006	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	ALOX12B, ARG679LEU	
603741	242	ALOX12B	0007	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	ALOX12B, GLU394LYS	
603741	242	ALOX12B	0008	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	ALOX12B, ILE137ASN	
603741	242	ALOX12B	0009	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	ALOX12B, HIS403TYR	
603741	242	ALOX12B	0010	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	ALOX12B, IVS2, G-A, -1	
603741	242	ALOX12B	0011	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	ALOX12B, ARG548TRP	
603741	242	ALOX12B	0012	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	ALOX12B, TYR521CYS	
603741	242	ALOX12B	0013	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	ALOX12B, ILE67PHE	
603743	8542	APOL1	0001	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 4, SUSCEPTIBILITY TO	APOL1, SER342GLY, ILE384MET	73885319
603743	8542	APOL1	0002	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 4, SUSCEPTIBILITY TO	APOL1, 6-BP DEL, N388/Y389	71785313
603756	9429	ABCG2	0001	JUNIOR BLOOD GROUP SYSTEM, JR(a-) PHENOTYPE	ABCG2, ARG246TER	
603756	9429	ABCG2	0002	URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1 JUNIOR BLOOD GROUP SYSTEM, JR(a-) PHENOTYPE, INCLUDED	ABCG2, GLN126TER	
603756	9429	ABCG2	0003	URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1 JUNIOR BLOOD GROUP SYSTEM, JR(a-) PHENOTYPE, INCLUDED	ABCG2, VAL12MET	
603756	9429	ABCG2	0004	JUNIOR BLOOD GROUP SYSTEM, JR(a-) PHENOTYPE	ABCG2, ARG236TER	
603756	9429	ABCG2	0005	JUNIOR BLOOD GROUP SYSTEM, JR(a-) PHENOTYPE	ABCG2, 2-BP DEL, 791TT	
603756	9429	ABCG2	0006	JUNIOR BLOOD GROUP SYSTEM, JR(a-) PHENOTYPE	ABCG2, 2-BP DEL, 1111AC	
603756	9429	ABCG2	0007	URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1 JUNIOR BLOOD GROUP SYSTEM, JR(a-) PHENOTYPE, INCLUDED	ABCG2, GLN141LYS	
603767	9622	KLK4	0001	AMELOGENESIS IMPERFECTA, PIGMENTED HYPOMATURATION TYPE	KLK4, TRP153TER	104894704
603779	9627	SNCAIP	0001	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	SNCAIP, ARG621CYS	28937592
603780	9401	RECQL4	0001	ROTHMUND-THOMSON SYNDROME	RECQL4, 7-BP DEL, NT1650	
603780	9401	RECQL4	0002	ROTHMUND-THOMSON SYNDROME	RECQL4, GLN757TER	137853229
603780	9401	RECQL4	0003	ROTHMUND-THOMSON SYNDROME	RECQL4, 2-BP DEL, NT2492	
603780	9401	RECQL4	0004	ROTHMUND-THOMSON SYNDROME	RECQL4, IVS12AS, G-T, -1	
603780	9401	RECQL4	0005	ROTHMUND-THOMSON SYNDROME	RECQL4, 1-BP DEL, 1573T	
603780	9401	RECQL4	0006	ROTHMUND-THOMSON SYNDROME	RECQL4, IVS7AS, G-A	
603780	9401	RECQL4	0007	ROTHMUND-THOMSON SYNDROME	RECQL4, 1-BP DEL, 1473T	
603780	9401	RECQL4	0008	ROTHMUND-THOMSON SYNDROME	RECQL4, IVS12AS, G-C, -1	
603780	9401	RECQL4	0009	RAPADILINO SYNDROME	RECQL4, IVS7, 1-BP DEL, +2	
603780	9401	RECQL4	0010	RAPADILINO SYNDROME	RECQL4, GLU1091TER	137853230
603780	9401	RECQL4	0011	RAPADILINO SYNDROME	RECQL4, TRP269TER	137853231
603780	9401	RECQL4	0012	BALLER-GEROLD SYNDROME	RECQL4, ARG1021TRP	137853232
603780	9401	RECQL4	0013	BALLER-GEROLD SYNDROME ROTHMUND-THOMSON SYNDROME, INCLUDED	RECQL4, 1-BP DEL, 2886T	
603780	9401	RECQL4	0014	BALLER-GEROLD SYNDROME	RECQL4, IVS17AS, A-C, -2	
603780	9401	RECQL4	0015	ROTHMUND-THOMSON SYNDROME	RECQL4, 6-BP DEL, NT1919	
603780	9401	RECQL4	0016	ROTHMUND-THOMSON SYNDROME	RECQL4, IVS10DS, G-A, +1	
603785	8777	MPDZ	0001	HYDROCEPHALUS, NONSYNDROMIC, AUTOSOMAL RECESSIVE 2	MPDZ, GLN210TER	
603795	9516	LITAF	0001	CHARCOT-MARIE-TOOTH DISEASE, TYPE 1C	LITAF, GLY112SER	104894519
603795	9516	LITAF	0002	CHARCOT-MARIE-TOOTH DISEASE, TYPE 1C	LITAF, THR115ASN	104894520
603795	9516	LITAF	0003	CHARCOT-MARIE-TOOTH DISEASE, TYPE 1C	LITAF, TRP116GLY	104894521
603795	9516	LITAF	0004	CHARCOT-MARIE-TOOTH DISEASE, TYPE 1C	LITAF, LEU122VAL	104894522
603795	9516	LITAF	0005	CHARCOT-MARIE-TOOTH DISEASE, TYPE 1C	LITAF, VAL144MET	121908615
603796	9992	KCNE2	0001	LONG QT SYNDROME 6, ACQUIRED, SUSCEPTIBILITY TO	KCNE2, GLN9GLU	16991652
603796	9992	KCNE2	0002	LONG QT SYNDROME 6	KCNE2, MET54THR	74315447
603796	9992	KCNE2	0003	LONG QT SYNDROME 6	KCNE2, ILE57THR	74315448
603796	9992	KCNE2	0004	ATRIAL FIBRILLATION, FAMILIAL, 4	KCNE2, ARG27CYS	74315449
603796	9992	KCNE2	0005	LONG QT SYNDROME 3/6, DIGENIC	KCNE2, PHE60LEU	16991654
603799	9469	CHST3	0001	SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	CHST3, ARG304GLN	28937593
603799	9469	CHST3	0002	SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	CHST3, LEU259PRO	121908616
603799	9469	CHST3	0003	SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	CHST3, ARG222TRP	121908617
603799	9469	CHST3	0004	SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	CHST3, LEU307PRO	121908618
603799	9469	CHST3	0005	SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	CHST3, 1-BP DEL, 1086G	
603799	9469	CHST3	0006	SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	CHST3, TYR201TER	121908619
603799	9469	CHST3	0007	SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	CHST3, LEU286PRO	121908620
603799	9469	CHST3	0008	SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	CHST3, GLU372LYS	
603799	9469	CHST3	0009	SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	CHST3, THR141MET	
603799	9469	CHST3	0010	SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	CHST3, PHE159ILE	
603799	9469	CHST3	0011	SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	CHST3, LEU161PHE	
603799	9469	CHST3	0012	SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	CHST3, GLN330TER	
603805	9333	TGM5	0001	PEELING SKIN SYNDROME, ACRAL TYPE	TGM5, GLY113CYS	112292549
603810	9440	MED17	0001	MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY	MED17, LEU371PRO	
603811	8815	BANF1	0001	NESTOR-GUILLERMO PROGERIA SYNDROME	BANF1, ALA12THR	
603816	8312	AXIN1	0001	HEPATOCELLULAR CARCINOMA, SOMATIC	AXIN1, 33-BP DEL	
603816	8312	AXIN1	0002	CAUDAL DUPLICATION ANOMALY	AXIN1, PROMOTER HYPERMETHYLATION	
603824	10020	GNE	0001	SIALURIA	GNE, ARG266TRP	121908621
603824	10020	GNE	0002	SIALURIA	GNE, ARG266GLN	121908622
603824	10020	GNE	0003	SIALURIA	GNE, ARG263LEU	121908623
603824	10020	GNE	0004	SIALURIA	GNE, ARG266GLN	121908622
603824	10020	GNE	0005	INCLUSION BODY MYOPATHY 2, AUTOSOMAL RECESSIVE NONAKA MYOPATHY, INCLUDED	GNE, MET712THR	28937594
603824	10020	GNE	0006	INCLUSION BODY MYOPATHY 2, AUTOSOMAL RECESSIVE	GNE, GLY576GLU	121908625
603824	10020	GNE	0007	INCLUSION BODY MYOPATHY 2, AUTOSOMAL RECESSIVE	GNE, ALA631THR	121908626
603824	10020	GNE	0008	INCLUSION BODY MYOPATHY 2, AUTOSOMAL RECESSIVE	GNE, VAL696MET	121908627
603824	10020	GNE	0009	INCLUSION BODY MYOPATHY 2, AUTOSOMAL RECESSIVE	GNE, CYS303TER	121908628
603824	10020	GNE	0010	INCLUSION BODY MYOPATHY 2, AUTOSOMAL RECESSIVE	GNE, ARG246GLN	121908629
603824	10020	GNE	0011	INCLUSION BODY MYOPATHY 2, AUTOSOMAL RECESSIVE	GNE, ASP225ASN	121908630
603824	10020	GNE	0012	NONAKA MYOPATHY	GNE, ALA460VAL	121908631
603824	10020	GNE	0013	NONAKA MYOPATHY	GNE, VAL572LEU	121908632
603824	10020	GNE	0014	NONAKA MYOPATHY	GNE, CYS303VAL	121908633
603824	10020	GNE	0015	NONAKA MYOPATHY	GNE, ALA631VAL	62541771
603824	10020	GNE	0016	INCLUSION BODY MYOPATHY 2, AUTOSOMAL RECESSIVE	GNE, MET171VAL	121908634
603834	4704	NDUFA9	0001	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFA9, ARG321PRO	
603835	4705	NDUFA10	0001	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFA10, MET1VAL	
603835	4705	NDUFA10	0002	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFA10, GLN142ARG	
603839	4709	NDUFB3	0001	MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFB3, TRP22ARG	
603839	4709	NDUFB3	0002	MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFB3, GLY70TER	
603846	4722	NDUFS3	0001	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFS3, THR145ILE	28939714
603846	4722	NDUFS3	0002	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY MITOCHONDRIAL COMPLEX I DEFICIENCY, INCLUDED	NDUFS3, ARG199TRP	104894270
603848	4726	NDUFS6	0001	MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFS6, IVS2DS, T-A, +2	
603848	4726	NDUFS6	0002	MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFS6, EX3-4DEL	
603848	4726	NDUFS6	0003	MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFS6, CYS115TYR	
603850	10059	DNM1L	0001	ENCEPHALOPATHY, LETHAL, DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION	DNM1L, ALA395ASP	121908531
603851	8929	PHOX2B	0001	CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL CCHS WITH HIRSCHSPRUNG DISEASE, INCLUDED;; CENTRAL HYPOVENTILATION SYNDROME, LATE-ONSET, INCLUDED	PHOX2B, ALA TRACT EXP	193922943
603851	8929	PHOX2B	0002	CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL	PHOX2B, 1-BP INS, 618C	
603851	8929	PHOX2B	0003	CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL	PHOX2B, 37-BP DEL, NT722	
603851	8929	PHOX2B	0005	NEUROBLASTOMA, SUSCEPTIBILITY TO, 2	PHOX2B, ARG100LEU	104893855
603851	8929	PHOX2B	0006	NEUROBLASTOMA WITH HIRSCHSPRUNG DISEASE	PHOX2B, ARG141GLY	28939716
603851	8929	PHOX2B	0007	NEUROBLASTOMA WITH HIRSCHSPRUNG DISEASE	PHOX2B, 1-BP DEL, 676G	
603851	8929	PHOX2B	0008	NEUROBLASTOMA, SUSCEPTIBILITY TO, 2	PHOX2B, GLY197ASP	104893856
603859	10165	SLC25A13	0001	CITRULLINEMIA, TYPE II, ADULT-ONSET CITRULLINEMIA, TYPE II, NEONATAL-ONSET, INCLUDED	SLC25A13, 4-BP DEL, 851GTAT	80338720
603859	10165	SLC25A13	0002	CITRULLINEMIA, TYPE II, ADULT-ONSET CITRULLINEMIA, TYPE II, NEONATAL-ONSET, INCLUDED	SLC25A13, IVS11DS, G-A, +1	80338722
603859	10165	SLC25A13	0003	CITRULLINEMIA, TYPE II, ADULT-ONSET	SLC25A13, 23-BP INS, NT1638	80338725
603859	10165	SLC25A13	0004	CITRULLINEMIA, TYPE II, ADULT-ONSET	SLC25A13, SER225TER	80338719
603859	10165	SLC25A13	0005	CITRULLINEMIA, TYPE II, ADULT-ONSET	SLC25A13, IVS13DS, G-A, +1	80338723
603859	10165	SLC25A13	0006	CITRULLINEMIA, TYPE II, ADULT-ONSET CITRULLINEMIA, TYPE II, NEONATAL-ONSET, INCLUDED	SLC25A13, 1-BP INS, NT1800	
603859	10165	SLC25A13	0007	CITRULLINEMIA, TYPE II, ADULT-ONSET	SLC25A13, ARG588GLN	121908532
603861	10166	SLC25A15	0001	HHH SYNDROME	SLC25A15, 3-BP DEL, PHE188	
603861	10166	SLC25A15	0002	HHH SYNDROME	SLC25A15, GLU180LYS	104894424
603861	10166	SLC25A15	0003	HHH SYNDROME	SLC25A15, ARG179TER	104894429
603861	10166	SLC25A15	0004	HHH SYNDROME	SLC25A15, GLY27ARG	104894430
603861	10166	SLC25A15	0005	HHH SYNDROME	SLC25A15, ARG275GLN	104894431
603861	10166	SLC25A15	0006	HHH SYNDROME	SLC25A15, MET37ARG	121908533
603861	10166	SLC25A15	0007	HHH SYNDROME	SLC25A15, LEU71GLN	121908534
603861	10166	SLC25A15	0008	HHH SYNDROME	SLC25A15, THR272ILE	121908535
603861	10166	SLC25A15	0009	HHH SYNDROME	SLC25A15, THR32ARG	121908536
603864	9973	CCS	0001	VARIANT OF UNKNOWN SIGNIFICANCE	CCS, ARG163TRP	
603867	8799	PEX11B	0001	PEROXISOME BIOGENESIS DISORDER 14B	PEX11B, GLN22TER	
603868	5873	RAB27A	0001	GRISCELLI SYNDROME, TYPE 2	RAB27A, TRP73GLY	28938176
603868	5873	RAB27A	0002	GRISCELLI SYNDROME, TYPE 2	RAB27A, INV3DS, A-G, +3	
603868	5873	RAB27A	0003	GRISCELLI SYNDROME, TYPE 2	RAB27A, 550C-T	
603868	5873	RAB27A	0004	GRISCELLI SYNDROME, TYPE 2	RAB27A, 67.5-KB DEL	
603868	5873	RAB27A	0005	GRISCELLI SYNDROME, TYPE 2	RAB27A, LEU130PRO	104894498
603868	5873	RAB27A	0006	GRISCELLI SYNDROME, TYPE 2	RAB27A, ALA152PRO	104894499
603868	5873	RAB27A	0007	GRISCELLI SYNDROME, TYPE 2	RAB27A, 2-BP DEL, 51CT	
603868	5873	RAB27A	0008	GRISCELLI SYNDROME, TYPE 2	RAB27A, IVS5, G-C, +1	
603868	5873	RAB27A	0009	GRISCELLI SYNDROME, TYPE 2	RAB27A, GLN118TER	104894500
603868	5873	RAB27A	0010	GRISCELLI SYNDROME, TYPE 2	RAB27A, ALA87PRO	104894497
603883	9531	BAG3	0001	MYOPATHY, MYOFIBRILLAR, BAG3-RELATED	BAG3, PRO209LEU	121918312
603883	9531	BAG3	0002	CARDIOMYOPATHY, DILATED, 1HH	BAG3, EX4DEL	
603883	9531	BAG3	0003	CARDIOMYOPATHY, DILATED, 1HH	BAG3, ARG71TRP	
603883	9531	BAG3	0004	CARDIOMYOPATHY, DILATED, 1HH	BAG3, ARG123TER	
603883	9531	BAG3	0005	CARDIOMYOPATHY, DILATED, 1HH	BAG3, 1-BP DEL, 652C	
603883	9531	BAG3	0006	CARDIOMYOPATHY, DILATED, 1HH	BAG3, ARG477HIS	
603883	9531	BAG3	0007	CARDIOMYOPATHY, DILATED, 1HH	BAG3, ARG218TRP	
603883	9531	BAG3	0008	CARDIOMYOPATHY, DILATED, 1HH	BAG3, LEU462PRO	
603883	9531	BAG3	0009	VARIANT OF UNKNOWN SIGNIFICANCE	BAG3, ARG258TRP	
603892	9343	EFTUD2	0001	MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE	EFTUD2, ARG262TRP	
603892	9343	EFTUD2	0002	MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE	EFTUD2, GLN924TER	
603892	9343	EFTUD2	0003	MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE	EFTUD2, 1-BP DEL, NT1758	
603892	9343	EFTUD2	0004	MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE	EFTUD2, TYR831TER	
603892	9343	EFTUD2	0005	MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE	EFTUD2, LEU637ARG	
603892	9343	EFTUD2	0006	MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE	EFTUD2, TYR832TER	
603892	9343	EFTUD2	0007	MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE	EFTUD2, HIS208ARG	
603892	9343	EFTUD2	0008	MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE	EFTUD2, IVS27, 1-BP DEL, +1	
603904	9445	ITM2B	0001	DEMENTIA, FAMILIAL BRITISH	ITM2B, TER267ARG	104894417
603904	9445	ITM2B	0002	DEMENTIA, FAMILIAL DANISH	ITM2B, 10-BP DUP, NT795	
603921	8803	SUCLA2	0001	MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC TYPE WITH METHYLMALONIC ACIDURIA)	SUCLA2, 43-BP DEL AND 5-BP INS	
603921	8803	SUCLA2	0002	MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC TYPE WITH METHYLMALONIC ACIDURIA)	SUCLA2, IVS4DS, G-A, +1	113994161
603921	8803	SUCLA2	0003	MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC TYPE WITH METHYLMALONIC ACIDURIA)	SUCLA2, GLY118ARG	121908537
603921	8803	SUCLA2	0004	MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC TYPE WITH METHYLMALONIC ACIDURIA)	SUCLA2, ARG284CYS	121908538
603924	3026	HABP2	0001	FACTOR VII-ACTIVATING PROTEASE MARBURG I CAROTID STENOSIS, SUSCEPTIBILITY TO, INCLUDED;; VENOUS THROMBOEMBOLISM, SUSCEPTIBILITY TO, INCLUDED	HABP2, GLY534GLU	7080536
603930	10243	GPHN	0001	MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C	GPHN, EX2-3DEL	
603930	10243	GPHN	0002	VARIANT OF UNKNOWN SIGNIFICANCE	GPHN, ASN10TYR	121908539
603937	6101	RP1	0001	RETINITIS PIGMENTOSA 1	RP1, ARG677TER	104894082
603937	6101	RP1	0002	RETINITIS PIGMENTOSA 1	RP1, 5-BP DEL	
603937	6101	RP1	0003	RETINITIS PIGMENTOSA 1	RP1, 4-BP DEL	
603937	6101	RP1	0004	RETINITIS PIGMENTOSA 1	RP1, GLN679TER	104894083
603937	6101	RP1	0005	HYPERTRIGLYCERIDEMIA, SUSCEPTIBILITY TO	RP1, ASN985TYR	2293869
603937	6101	RP1	0006	RETINITIS PIGMENTOSA 1	RP1, THR373ILE	77775126
603937	6101	RP1	0007	RETINITIS PIGMENTOSA 1	RP1, 4-BP INS, 1461TGAA	
603941	10560	SLC19A2	0001	THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	SLC19A2, ARG162TER	74315373
603941	10560	SLC19A2	0002	THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	SLC19A2, 1-BP DEL, 724C	
603941	10560	SLC19A2	0003	THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	SLC19A2, GLY172ASP	28937595
603941	10560	SLC19A2	0004	THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	SLC19A2, TRP250TER	74315374
603941	10560	SLC19A2	0005	THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	SLC19A2, 1-BP DEL, 885T	
603941	10560	SLC19A2	0006	THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	SLC19A2, 2-BP DEL, 1147GT	
603941	10560	SLC19A2	0007	THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	SLC19A2, 1-BP INS, 242A	
603941	10560	SLC19A2	0008	THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	SLC19A2, 2-BP DEL, 429TT	
603941	10560	SLC19A2	0009	THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	SLC19A2, TRP358TER	74315375
603941	10560	SLC19A2	0010	THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	SLC19A2, CYS152THR	121908540
603942	2992	GYG1	0001	GLYCOGEN STORAGE DISEASE XV	GYG1, 1-BP DEL, 487G	
603942	2992	GYG1	0002	GLYCOGEN STORAGE DISEASE XV	GYG1, THR83MET	
603945	8893	EIF2B5	0001	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER	EIF2B5, THR91ALA	28939717
603945	8893	EIF2B5	0002	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER	EIF2B5, TRP628ARG	28937596
603945	8893	EIF2B5	0003	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER	EIF2B5, GLY386VAL	113994074
603945	8893	EIF2B5	0004	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER, ADULT-ONSET OVARIOLEUKODYSTROPHY, INCLUDED	EIF2B5, ARG113HIS	113994049
603945	8893	EIF2B5	0005	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER	EIF2B5, ARG195HIS	113994054
603945	8893	EIF2B5	0006	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER	EIF2B5, LEU309VAL	113994061
603945	8893	EIF2B5	0007	OVARIOLEUKODYSTROPHY	EIF2B5, ARG195CYS	113994055
603945	8893	EIF2B5	0008	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER, ADULT-ONSET	EIF2B5, THR182MET	113994053
603945	8893	EIF2B5	0009	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER	EIF2B5, ARG315HIS	113994064
603945	8893	EIF2B5	0010	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER	EIF2B5, PHE56VAL	113994043
603945	8893	EIF2B5	0011	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER	EIF2B5, PHE56CYS	121908541
603945	8893	EIF2B5	0012	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER, ADULT-ONSET	EIF2B5, ASP270HIS	
603951	3779	KCNMB1	0001	HYPERTENSION, DIASTOLIC, RESISTANCE TO	KCNMB1, GLU65LYS	11739136
603959	10686	CLDN16	0001	HYPOMAGNESEMIA 3, RENAL	CLDN16, ARG149TER	104893720
603959	10686	CLDN16	0002	HYPOMAGNESEMIA 3, RENAL	CLDN16, GLY239ARG	104893721
603959	10686	CLDN16	0003	HYPOMAGNESEMIA 3, RENAL	CLDN16, GLY191ARG	104893722
603959	10686	CLDN16	0004	HYPOMAGNESEMIA 3, RENAL	CLDN16, GLY198ASP	104893723
603959	10686	CLDN16	0005	HYPOMAGNESEMIA 3, RENAL	CLDN16, MET71ARG	104893724
603959	10686	CLDN16	0006	HYPOMAGNESEMIA 3, RENAL	CLDN16, LEU167PRO	104893725
603959	10686	CLDN16	0007	HYPOMAGNESEMIA 3, RENAL	CLDN16, PHE232CYS	104893726
603959	10686	CLDN16	0008	HYPOMAGNESEMIA 3, RENAL	CLDN16, GLY233ASP	104893727
603959	10686	CLDN16	0009	HYPOMAGNESEMIA 3, RENAL	CLDN16, SER235PHE	104893728
603959	10686	CLDN16	0010	HYPOMAGNESEMIA 3, RENAL	CLDN16, LEU151PHE	104893729
603959	10686	CLDN16	0011	HYPOMAGNESEMIA 3, RENAL	CLDN16, LEU151TRP	104893730
603959	10686	CLDN16	0012	HYPOMAGNESEMIA 3, RENAL	CLDN16, LEU145PRO	104893731
603959	10686	CLDN16	0013	HYPOMAGNESEMIA 3, RENAL	CLDN16, TRP117TER	104893732
603959	10686	CLDN16	0014	HYPOMAGNESEMIA 3, RENAL	CLDN16, LEU151PRO	
603959	10686	CLDN16	0015	HYPERCALCIURIA, CHILDHOOD, SELF-LIMITING	CLDN16, THR303ARG	121908542
603959	10686	CLDN16	0016	HYPOMAGNESEMIA 3, RENAL	CLDN16, TYR277TER	121908543
603959	10686	CLDN16	0017	HYPOMAGNESEMIA, 3, RENAL	CLDN16, LYS275TER	
603961	10371	SEMA3A	0001	HYPOGONADOTROPIC HYPOGONADISM 16 WITH ANOSMIA, SUSCEPTIBILITY TO	SEMA3A, 213-KB DEL	
603961	10371	SEMA3A	0002	HYPOGONADOTROPIC HYPOGONADISM 16 WITH ANOSMIA, SUSCEPTIBILITY TO	SEMA3A, VAL435ILE	
603961	10371	SEMA3A	0003	HYPOGONADOTROPIC HYPOGONADISM 16 WITH ANOSMIA, SUSCEPTIBILITY TO	SEMA3A, 13-BP DEL, NT1613	
603967	6329	SCN4A	0001	HYPERKALEMIC PERIODIC PARALYSIS PARAMYOTONIA CONGENITA/HYPERKALEMIC PERIODIC PARALYSIS, INCLUDED	SCN4A, THR704MET	80338957
603967	6329	SCN4A	0002	HYPERKALEMIC PERIODIC PARALYSIS PARAMYOTONIA CONGENITA/HYPERKALEMIC PERIODIC PARALYSIS, INCLUDED	SCN4A, MET1592VAL	80338962
603967	6329	SCN4A	0003	PARAMYOTONIA CONGENITA	SCN4A, ARG1448CYS	121908544
603967	6329	SCN4A	0004	PARAMYOTONIA CONGENITA	SCN4A, ARG1448HIS	121908545
603967	6329	SCN4A	0005	PARAMYOTONIA CONGENITA/HYPERKALEMIC PERIODIC PARALYSIS	SCN4A, ALA1156THR	80338958
603967	6329	SCN4A	0006	PARAMYOTONIA CONGENITA/MYOTONIA CONGENITA MYOTONIA FLUCTUANS, INCLUDED	SCN4A, SER804PHE	121908546
603967	6329	SCN4A	0007	PARAMYOTONIA CONGENITA MYOTONIA, POTASSIUM-AGGRAVATED, INCLUDED	SCN4A, GLY1306VAL	80338792
603967	6329	SCN4A	0008	PARAMYOTONIA CONGENITA	SCN4A, THR1313MET	121908547
603967	6329	SCN4A	0009	MYOTONIA, POTASSIUM-AGGRAVATED PARAMYOTONIA CONGENITA, INCLUDED	SCN4A, VAL1589MET	121908548
603967	6329	SCN4A	0010	MYOTONIA CONGENITA, ATYPICAL, ACETAZOLAMIDE-RESPONSIVE	SCN4A, ILE1160VAL	121908549
603967	6329	SCN4A	0011	PARAMYOTONIA CONGENITA	SCN4A, LEU1433ARG	121908550
603967	6329	SCN4A	0012	MYOTONIA FLUCTUANS	SCN4A, GLY1306ALA	80338792
603967	6329	SCN4A	0013	PARAMYOTONIA CONGENITA	SCN4A, VAL1293ILE	121908551
603967	6329	SCN4A	0014	MYOTONIA CONGENITA, ATYPICAL	SCN4A, VAL445MET	121908552
603967	6329	SCN4A	0015	HYPOKALEMIC PERIODIC PARALYSIS, TYPE 2	SCN4A, ARG669HIS	80338784
603967	6329	SCN4A	0016	HYPOKALEMIC PERIODIC PARALYSIS, TYPE 2	SCN4A, ARG672HIS	80338788
603967	6329	SCN4A	0017	HYPOKALEMIC PERIODIC PARALYSIS, TYPE 2	SCN4A, ARG672GLY	80338785
603967	6329	SCN4A	0018	MYASTHENIC SYNDROME, CONGENITAL, ACETAZOLAMIDE-RESPONSIVE	SCN4A, VAL1442GLU	121908553
603967	6329	SCN4A	0019	PARAMYOTONIA CONGENITA	SCN4A, GLY1456GLU	121908554
603967	6329	SCN4A	0020	HYPOKALEMIC PERIODIC PARALYSIS, TYPE 2	SCN4A, ARG672SER	80338785
603967	6329	SCN4A	0021	HYPOKALEMIC PERIODIC PARALYSIS, TYPE 2	SCN4A, PRO1158SER	121908555
603967	6329	SCN4A	0022	NORMOKALEMIC PERIODIC PARALYSIS, POTASSIUM-SENSITIVE	SCN4A, ARG675GLY	121908556
603967	6329	SCN4A	0023	NORMOKALEMIC PERIODIC PARALYSIS, POTASSIUM-SENSITIVE	SCN4A, ARG675GLN	121908557
603967	6329	SCN4A	0024	NORMOKALEMIC PERIODIC PARALYSIS, POTASSIUM-SENSITIVE	SCN4A, ARG675TRP	121908556
603967	6329	SCN4A	0025	MYOTONIA PERMANENS	SCN4A, GLY1306GLU	80338792
603967	6329	SCN4A	0026	PARAMYOTONIA CONGENITA	SCN4A, MET1476ILE	121908559
603967	6329	SCN4A	0027	PARAMYOTONIA CONGENITA/HYPERKALEMIC PERIODIC PARALYSIS	SCN4A, ASN1297LYS	121908560
603967	6329	SCN4A	0028	PARAMYOTONIA CONGENITA	SCN4A, ILE693THR	80338956
603967	6329	SCN4A	0029	PARAMYOTONIA CONGENITA	SCN4A, ILE141VAL	121908561
603967	6329	SCN4A	0030	HYPOKALEMIC PERIODIC PARALYSIS, TYPE 2	SCN4A, ARG1132GLN	
603968	5429	POLH	0001	XERODERMA PIGMENTOSUM, VARIANT TYPE	POLH, 13-BP DEL, NT343	
603968	5429	POLH	0002	XERODERMA PIGMENTOSUM, VARIANT TYPE	POLH, 4-BP DEL, NT289	
603968	5429	POLH	0003	XERODERMA PIGMENTOSUM, VARIANT TYPE	POLH, 2-BP DEL, NT770	
603968	5429	POLH	0004	XERODERMA PIGMENTOSUM, VARIANT TYPE	POLH, GLU306TER	121908562
603968	5429	POLH	0005	XERODERMA PIGMENTOSUM, VARIANT TYPE	POLH, DEL AND TRP297TER	
603968	5429	POLH	0006	XERODERMA PIGMENTOSUM, VARIANT TYPE	POLH, VAL125TER	121908563
603968	5429	POLH	0007	XERODERMA PIGMENTOSUM, VARIANT TYPE	POLH, VAL372TER	121908564
603968	5429	POLH	0009	XERODERMA PIGMENTOSUM, VARIANT TYPE	POLH, 104-BP DEL, NT661	
603968	5429	POLH	0010	XERODERMA PIGMENTOSUM, VARIANT TYPE	POLH, 1-BP DEL, 207G	
603968	5429	POLH	0011	XERODERMA PIGMENTOSUM, VARIANT TYPE	POLH, 3-BP DEL, NT222	
603968	5429	POLH	0012	XERODERMA PIGMENTOSUM, VARIANT TYPE	POLH, LYS535GLU	56307355
603968	5429	POLH	0013	XERODERMA PIGMENTOSUM, VARIANT TYPE	POLH, LYS589THR	121908565
604001	10142	AKAP9	0001	LONG QT SYNDROME 11	KCNQ1, SER1570LEU	121908566
604011	9094	UNC119	0001	CONE-ROD DYSTROPHY	UNC119, LYS57TER	
604025	8313	AXIN2	0001	COLORECTAL CANCER, SOMATIC	AXIN2, GLU706TER	121908567
604025	8313	AXIN2	0002	COLORECTAL CANCER, SOMATIC	AXIN2, LEU688TER	
604025	8313	AXIN2	0003	OLIGODONTIA-COLORECTAL CANCER SYNDROME	AXIN2, ARG656TER	121908568
604025	8313	AXIN2	0004	OLIGODONTIA-COLORECTAL CANCER SYNDROME	AXIN2, TRP663TER	
604027	9570	GOSR2	0001	EPILEPSY, PROGRESSIVE MYOCLONIC 6	GOSR2, GLY144TRP	
604032	9451	EIF2AK3	0001	WOLCOTT-RALLISON SYNDROME	EIF2AK3, 1-BP INS, 1103T	
604032	9451	EIF2AK3	0002	WOLCOTT-RALLISON SYNDROME	EIF2AK3, ARG587GLN	121908569
604032	9451	EIF2AK3	0003	WOLCOTT-RALLISON SYNDROME	EIF2AK3, IVS14DS, G-A, +1	
604032	9451	EIF2AK3	0004	WOLCOTT-RALLISON SYNDROME	EIF2AK3, 4-BP DEL, 1563GAAA	
604032	9451	EIF2AK3	0005	WOLCOTT-RALLISON SYNDROME	EIF2AK3, GLU331TER	121908570
604040	10111	RAD50	0001	NIJMEGEN BREAKAGE SYNDROME-LIKE DISORDER	RAD50, ARG1093TER	121912628
604040	10111	RAD50	0002	NIJMEGEN BREAKAGE SYNDROME-LIKE DISORDER	RAD50, TER1313TYR	
604041	9526	MPDU1	0001	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE If	MPDU1, GLY73GLU	104894586
604041	9526	MPDU1	0002	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE If	MPDU1, LEU119PRO	104894587
604041	9526	MPDU1	0003	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE If	MPDU1, MET1THR	104894588
604041	9526	MPDU1	0004	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE If	MPDU1, 1-BP DEL, 511C	
604041	9526	MPDU1	0005	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE If	MPDU1, LEU74SER	104894589
604061	10801	SEPT9	0001	AMYOTROPHY, HEREDITARY NEURALGIC	SEPT9, ARG88TRP	80338761
604061	10801	SEPT9	0002	AMYOTROPHY, HEREDITARY NEURALGIC	SEPT9, SER93PHE	80338762
604061	10801	SEPT9	0003	AMYOTROPHY, HEREDITARY NEURALGIC	SEPT9, -131G-C, 5-PRIME UTR	80338760
604061	10801	SEPT9	0004	AMYOTROPHY, HEREDITARY NEURALGIC	SEPT9, 38-KB DUP	
604067	8787	RGS9	0001	BRADYOPSIA	RGS9, TRP299ARG	121908449
604088	10842	PPP1R17	0001	HYPERCHOLESTEROLEMIA, SUSCEPTIBILITY TO	GSBS, -1323T-C	
604095	10913	EDAR	0001	ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE	EDAR, 18-BP DEL, IVS2	
604095	10913	EDAR	0002	ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE ECTODERMAL DYSPLASIA 10A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT, INCLUDED	EDAR, ARG89HIS	121908450
604095	10913	EDAR	0003	ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE	EDAR, DEL	
604095	10913	EDAR	0004	ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE	EDAR, CYS87ARG	121908451
604095	10913	EDAR	0005	ECTODERMAL DYSPLASIA 10A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT	EDAR, ARG358TER	121908452
604095	10913	EDAR	0006	ECTODERMAL DYSPLASIA 10A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT	EDAR, ARG420GLN	121908453
604095	10913	EDAR	0007	ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE	EDAR, IVS2DS, G-A, +1	
604095	10913	EDAR	0008	ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE	EDAR, ARG375HIS	121908454
604095	10913	EDAR	0009	ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE	EDAR, ASP110ALA	121908455
604095	10913	EDAR	0010	ECTODERMAL DYSPLASIA 10A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT	EDAR, GLU354TER	121908456
604095	10913	EDAR	0011	HAIR MORPHOLOGY 1, HAIR THICKNESS	EDAR, VAL370ALA	3827760
604095	10913	EDAR	0012	ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE	EDAR, 4-BP DEL, 718AAAG	
604095	10913	EDAR	0013	ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE	EDAR, IVS9, G-A, +1	
604096	2916	GRM6	0001	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B	GRM6, ARG621TER	62638214
604096	2916	GRM6	0002	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B	GRM6, GLU781LYS	62638625
604096	2916	GRM6	0003	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B	GRM6, GLN708TER	62638624
604096	2916	GRM6	0004	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B	GRM6, GLY150SER	62638202
604096	2916	GRM6	0005	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B	GRM6, PRO46LEU	62638197
604096	2916	GRM6	0006	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B	GRM6, 1-BP INS, 720G	
604096	2916	GRM6	0007	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B	GRM6, CYS522TYR	62638208
604096	2916	GRM6	0008	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B	GRM6, ILE405THR	121434304
604103	9499	MYOT	0001	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1A	MYOT, THR57ILE	28937597
604103	9499	MYOT	0002	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1A MYOTILINOPATHY, INCLUDED	MYOT, SER55PHE	121908457
604103	9499	MYOT	0003	MYOTILINOPATHY	MYOT, SER60CYS	121908458
604103	9499	MYOT	0004	MYOTILINOPATHY	MYOT, SER60PHE	121908458
604103	9499	MYOT	0005	MYOTILINOPATHY	MYOT, SER95ILE	121908460
604103	9499	MYOT	0006	MYOPATHY, SPHEROID BODY	MYOT, SER39PHE	121908461
604103	9499	MYOT	0007	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1A	MYOT, ARG6HIS	
604110	9289	GPR56	0001	POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	GPR56, IVS9, G-C, +3	
604110	9289	GPR56	0002	POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	GPR56, EX5, G-C, -1	
604110	9289	GPR56	0003	POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	GPR56, 7-BP DEL, NT739	
604110	9289	GPR56	0004	POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	GPR56, ARG38TRP	121908462
604110	9289	GPR56	0005	POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	GPR56, CYS346SER	121908463
604110	9289	GPR56	0006	POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	GPR56, ARG565TRP	121908464
604110	9289	GPR56	0007	POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	GPR56, CYS91SER	121908465
604110	9289	GPR56	0008	POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	GPR56, TYR88CYS	121908466
604115	10984	KCNQ1OT1	0001	BECKWITH-WIEDEMANN SYNDROME	KCNQ1OT1, DEL	
604124	5932	RBBP8	0001	PANCREATIC CARCINOMA, SOMATIC	RBBP8, LYS337GLU	121434388
604124	5932	RBBP8	0002	SECKEL SYNDROME 2	RBBP8, IVS15, T-G, +53	
604124	5932	RBBP8	0003	JAWAD SYNDROME	RBBP8, 2-BP DEL, 1868TA	
604127	6913	TBX15	0001	COUSIN SYNDROME	TBX15, 1-BP DEL, 1042A	
604127	6913	TBX15	0002	COUSIN SYNDROME	TBX15, 1-BP DEL, 1044A	
604134	11093	ADAMTS13	0001	THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL	ADAMTS13, HIS96ASP	121908467
604134	11093	ADAMTS13	0002	THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL	ADAMTS13, CYS951GLY	121908468
604134	11093	ADAMTS13	0003	THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL	ADAMTS13, ARG102CYS	121908469
604134	11093	ADAMTS13	0004	THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL	ADAMTS13, THR196ILE	121908470
604134	11093	ADAMTS13	0005	THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL	ADAMTS13, ARG398HIS	121908471
604134	11093	ADAMTS13	0006	THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL	ADAMTS13, CYS1024GLY	121908472
604134	11093	ADAMTS13	0007	THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL	ADAMTS13, ARG528GLY	121908473
604134	11093	ADAMTS13	0008	THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL	ADAMTS13, 1-BP INS, 3769T	
604134	11093	ADAMTS13	0009	THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL	ADAMTS13, 25-BP DEL, NT2376	
604134	11093	ADAMTS13	0010	THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL	ADAMTS13, CYS1213TYR	121908474
604134	11093	ADAMTS13	0011	THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL	ADAMTS13, ARG692CYS	121908475
604134	11093	ADAMTS13	0012	THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL	ADAMTS13, IVS13DS, G-A, +5	
604134	11093	ADAMTS13	0013	THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL	ADAMTS13, GLN449TER	121908476
604134	11093	ADAMTS13	0014	THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL	ADAMTS13, ARG268PRO	121908477
604134	11093	ADAMTS13	0015	THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL	ADAMTS13, GLN448GLU AND CYS508TYR	2301612
604134	11093	ADAMTS13	0016	THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL	ADAMTS13, PRO475SER	11575933
604134	11093	ADAMTS13	0017	THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL	ADAMTS13, 2-BP DEL, 1783TT	
604134	11093	ADAMTS13	0018	THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL	ADAMTS13, 1-BP INS, 4143A	
604134	11093	ADAMTS13	0019	THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL	ADAMTS13, IVS4DS, G-A, +1	
604134	11093	ADAMTS13	0020	THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL	ADAMTS13, ALA250VAL	121908478
604134	11093	ADAMTS13	0021	THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL	ADAMTS13, IVS3DS, G-A	
604134	11093	ADAMTS13	0022	THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL	ADAMTS13, 29-BP DEL, NT291	
604134	11093	ADAMTS13	0023	THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL	ADAMTS13, 1-BP INS, 4143A	
604134	11093	ADAMTS13	0024	THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL	ADAMTS13, 6-BP DEL, NT2930	
604139	3300	DNAJB2	0001	SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5	DNAJB2, IVS5DS, G-A, +1	
604142	7305	TYROBP	0001	POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY	TYROBP, EX1-4DEL	
604142	7305	TYROBP	0002	POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY	TYROBP, 1-BP DEL, 141G	
604142	7305	TYROBP	0003	POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY	TYROBP, MET1THR	104894732
604144	11136	SLC7A9	0001	CYSTINURIA	SLC7A9, VAL170MET	121908479
604144	11136	SLC7A9	0002	CYSTINURIA	SLC7A9, GLY105ARG	121908480
604144	11136	SLC7A9	0003	CYSTINURIA	SLC7A9, ALA182THR	79389353
604144	11136	SLC7A9	0004	CYSTINURIA	SLC7A9, GLY195ARG	121908482
604144	11136	SLC7A9	0005	CYSTINURIA	SLC7A9, GLY259ARG	121908483
604144	11136	SLC7A9	0006	CYSTINURIA	SLC7A9, 2-BP DEL, 596TG	
604144	11136	SLC7A9	0007	CYSTINURIA	SLC7A9, 1-BP INS, 520T	
604144	11136	SLC7A9	0008	CYSTINURIA	SLC7A9, ARG333TRP	121908484
604144	11136	SLC7A9	0009	CYSTINURIA	SLC7A9, ILE44THR	121908485
604144	11136	SLC7A9	0010	CYSTINURIA	SLC7A9, PRO261LEU	121908486
604144	11136	SLC7A9	0011	CYSTINURIA	SLC7A9, 1-BP INS, 799A	
604144	11136	SLC7A9	0012	CYSTINURIA	SLC7A9, TYR232CYS	121908487
604144	11136	SLC7A9	0013	CYSTINURIA	SLC7A9, 789+2T-C	
604144	11136	SLC7A9	0014	CYSTINURIA	SLC7A9, THR123MET	79987078
604144	11136	SLC7A9	0015	CYSTINURIA	SLC7A9, IVS5AS, C-A, -3	
604149	8910	SGCE	0001	MYOCLONUS-DYSTONIA SYNDROME	SGCE, ARG97TER	121908489
604149	8910	SGCE	0002	MYOCLONUS-DYSTONIA SYNDROME	SGCE, ARG102TER	121908490
604149	8910	SGCE	0003	MYOCLONUS-DYSTONIA SYNDROME	SGCE, 1-BP DEL, 565A	
604149	8910	SGCE	0004	MYOCLONUS-DYSTONIA SYNDROME	SGCE, 97-BP DEL	
604149	8910	SGCE	0005	MYOCLONUS-DYSTONIA SYNDROME	SGCE, 5-BP DEL, NT835	
604149	8910	SGCE	0006	MYOCLONUS-DYSTONIA SYNDROME	SGCE, LEU196ARG	121908491
604149	8910	SGCE	0007	MYOCLONUS-DYSTONIA SYNDROME	SGCE, 1-BP INS, 885T	
604149	8910	SGCE	0008	MYOCLONUS-DYSTONIA SYNDROME	SGCE, 1-BP DEL, 974C	
604149	8910	SGCE	0009	MYOCLONUS-DYSTONIA SYNDROME	SGCE, ARG372TER	121908492
604149	8910	SGCE	0010	MYOCLONUS-DYSTONIA SYNDROME	SGCE, EX5 DEL	
604149	8910	SGCE	0011	MYOCLONUS-DYSTONIA SYNDROME	SGCE, EX6 DEL	
604149	8910	SGCE	0012	MYOCLONUS-DYSTONIA SYNDROME	SGCE, 2-BP DEL, 619AG	
604159	9152	SLC6A5	0001	HYPEREKPLEXIA 3, AUTOSOMAL RECESSIVE	SLC6A5, TYR377TER	121908493
604159	9152	SLC6A5	0002	HYPEREKPLEXIA 3, AUTOSOMAL RECESSIVE	SLC6A5, VAL432PHE	
604159	9152	SLC6A5	0003	HYPEREKPLEXIA 3, AUTOSOMAL RECESSIVE	SLC6A5, TYR491CYS	121908494
604159	9152	SLC6A5	0004	HYPEREKPLEXIA 3, AUTOSOMAL RECESSIVE	SLC6A5, GLN630TER	121908495
604159	9152	SLC6A5	0005	HYPEREKPLEXIA 3, AUTOSOMAL RECESSIVE	SLC6A5, LEU306VAL	121908496
604159	9152	SLC6A5	0006	HYPEREKPLEXIA 3, AUTOSOMAL RECESSIVE	SLC6A5, ASN509SER	121908497
604159	9152	SLC6A5	0007	HYPEREKPLEXIA 3, AUTOSOMAL RECESSIVE	SLC6A5, THR425MET	121908498
604159	9152	SLC6A5	0008	HYPEREKPLEXIA 3, AUTOSOMAL DOMINANT	SLC6A5, SER510ARG	
604161	84634	KISS1R	0001	HYPOGONADOTROPIC HYPOGONADISM 8 WITHOUT ANOSMIA	KISS1R, LEU148SER	28939719
604161	84634	KISS1R	0002	HYPOGONADOTROPIC HYPOGONADISM 8 WITHOUT ANOSMIA	KISS1R, ARG331TER	104894701
604161	84634	KISS1R	0003	HYPOGONADOTROPIC HYPOGONADISM 8 WITHOUT ANOSMIA	KISS1R, TER399ARG	104894702
604161	84634	KISS1R	0004	HYPOGONADOTROPIC HYPOGONADISM 8 WITHOUT ANOSMIA	KISS1R, 155-BP DEL	
604161	84634	KISS1R	0005	HYPOGONADOTROPIC HYPOGONADISM 8 WITHOUT ANOSMIA	KISS1R, LEU102PRO	104894703
604161	84634	KISS1R	0006	PRECOCIOUS PUBERTY, CENTRAL	KISS1R, ARG386PRO	121908499
604161	84634	KISS1R	0007	HYPOGONADOTROPIC HYPOGONADISM 8 WITH ANOSMIA, SUSCEPTIBILITY TO	KISS1R, ALA194ASP	
604175	6135	RPL11	0001	DIAMOND-BLACKFAN ANEMIA 7	RPL11, ARG75TER	121434389
604175	6135	RPL11	0002	DIAMOND-BLACKFAN ANEMIA 7	RPL11, 2-BP DEL, 60CT	
604175	6135	RPL11	0003	DIAMOND-BLACKFAN ANEMIA 7	RPL11, 3-BP DEL, 482AGG	
604175	6135	RPL11	0004	DIAMOND-BLACKFAN ANEMIA 7	RPL11, IVS2AS, G-A, -1	
604190	6583	SLC22A4	0001	RHEUMATOID ARTHRITIS, SUSCEPTIBILITY TO	SLC22A4, IVS1, T-C	
604190	6583	SLC22A4	0002	SLC22A4 POLYMORPHISM	SLC22A4, LEU503PHE	1050152
604194	10999	SLC27A4	0001	ICHTHYOSIS PREMATURITY SYNDROME	SLC27A4, CYS168TER	137853131
604194	10999	SLC27A4	0002	ICHTHYOSIS PREMATURITY SYNDROME	SLC27A4, IVS4AS, G-A, -1	
604194	10999	SLC27A4	0003	ICHTHYOSIS PREMATURITY SYNDROME	SLC27A4, ALA92THR	137853132
604194	10999	SLC27A4	0004	ICHTHYOSIS PREMATURITY SYNDROME	SLC27A4, SER247PRO	137853133
604194	10999	SLC27A4	0005	ICHTHYOSIS PREMATURITY SYNDROME	SLC27A4, GLN300ARG	137853134
604194	10999	SLC27A4	0006	ICHTHYOSIS PREMATURITY SYNDROME	SLC27A4, IVS7AS, A-G, -2	
604194	10999	SLC27A4	0007	ICHTHYOSIS PREMATURITY SYNDROME	SLC27A4, ARG583HIS	137853135
604202	9342	SNAP29	0001	CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMA SYNDROME	SNAP29, 1-BP DEL, 220G	
604202	9342	SNAP29	0002	CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMA SYNDROME	SNAP29, 1-BP INS, 486A	
604210	23418	CRB1	0001	RETINITIS PIGMENTOSA 12	CRB1, ALU INS, NT2320	
604210	23418	CRB1	0002	RETINITIS PIGMENTOSA 12	CRB1, MET1041THR	62635656
604210	23418	CRB1	0003	RETINITIS PIGMENTOSA 12	CRB1, GLU995TER	62635655
604210	23418	CRB1	0004	RETINITIS PIGMENTOSA 12	CRB1, ARG764CYS	62635654
604210	23418	CRB1	0005	RETINITIS PIGMENTOSA 12	CRB1, THR745MET	28939720
604210	23418	CRB1	0006	LEBER CONGENITAL AMAUROSIS 8	CRB1, ILE1100ARG	62635659
604210	23418	CRB1	0007	LEBER CONGENITAL AMAUROSIS 8	CRB1, GLU1333TER	137853136
604210	23418	CRB1	0008	RETINITIS PIGMENTOSA 12	CRB1, LYS801TER	137853137
604210	23418	CRB1	0009	RETINITIS PIGMENTOSA 12	CRB1, CYS1181ARG	62636291
604210	23418	CRB1	0010	PIGMENTED PARAVENOUS CHORIORETINAL ATROPHY	CRB1, VAL162MET	137853138
604210	23418	CRB1	0011	LEBER CONGENITAL AMAUROSIS 8 RETINITIS PIGMENTOSA 12, INCLUDED	CRB1, GLY1103ARG	62636275
604210	23418	CRB1	0012	RETINITIS PIGMENTOSA 12 LEBER CONGENITAL AMAUROSIS 8, INCLUDED	CRB1, 10-BP DEL, NT4121	
604210	23418	CRB1	0013	LEBER CONGENITAL AMAUROSIS 8 RETINITIS PIGMENTOSA 12, INCLUDED	CRB1, CYS948TYR	
604214	889	KRIT1	0001	CEREBRAL CAVERNOUS MALFORMATIONS 1	KRIT1, 1283C-T	
604214	889	KRIT1	0002	CEREBRAL CAVERNOUS MALFORMATIONS 1	KRIT1, 1-BP DEL, 1342A	
604214	889	KRIT1	0003	CEREBRAL CAVERNOUS MALFORMATIONS 1	KRIT1, 1-BP INS, 1271C	
604214	889	KRIT1	0004	CEREBRAL CAVERNOUS MALFORMATIONS 1	KRIT1, 742C-T, GLN248TER	
604214	889	KRIT1	0005	HYPERKERATOTIC CUTANEOUS CAPILLARY-VENOUS MALFORMATIONS ASSOCIATED WITH CEREBRAL CAPILLARY MALFORMATIONS	KRIT1, 1-BP DEL, 103G	
604214	889	KRIT1	0006	CEREBRAL CAVERNOUS MALFORMATIONS 1	KRIT1, IVS2, T-C, +2	
604214	889	KRIT1	0007	CEREBRAL CAVERNOUS MALFORMATIONS 1	KRIT1, 2-BP DEL, 741TC	
604214	889	KRIT1	0008	CEREBRAL CAVERNOUS MALFORMATIONS 1	KRIT1, ASP137GLY	137853139
604214	889	KRIT1	0009	CEREBRAL CAVERNOUS MALFORMATIONS 1	KRIT1, GLN201GLU	137853140
604214	889	KRIT1	0010	CAVERNOUS MALFORMATIONS OF CNS AND RETINA	KRIT1, 1-BP INS, 1374C	
604214	889	KRIT1	0011	CEREBRAL CAVERNOUS MALFORMATIONS 1	KRIT1, CYS329TER	
604217	10568	SLC34A2	0001	PULMONARY ALVEOLAR MICROLITHIASIS	SLC34A2, 186-BP DEL	
604217	10568	SLC34A2	0002	PULMONARY ALVEOLAR MICROLITHIASIS	SLC34A2, 1-BP DEL, 114A	
604217	10568	SLC34A2	0003	PULMONARY ALVEOLAR MICROLITHIASIS	SLC34A2, GLN76TER	137853141
604217	10568	SLC34A2	0004	PULMONARY ALVEOLAR MICROLITHIASIS	SLC34A2, GLY106ARG	137853142
604237	9244	CRLF1	0001	COLD-INDUCED SWEATING SYNDROME 1	CRLF1, 2-BP DEL, 844GT	137853928
604237	9244	CRLF1	0002	COLD-INDUCED SWEATING SYNDROME 1	CRLF1, ARG81HIS AND LEU374ARG	104894668
604237	9244	CRLF1	0003	COLD-INDUCED SWEATING SYNDROME 1	CRLF1, 1-BP INS, 676A	
604237	9244	CRLF1	0004	COLD-INDUCED SWEATING SYNDROME 1	CRLF1, TRP76GLY	137853143
604237	9244	CRLF1	0005	COLD-INDUCED SWEATING SYNDROME 1	CRLF1, 527+5G-A	
604237	9244	CRLF1	0006	COLD-INDUCED SWEATING SYNDROME 1	CRLF1, 1-BP DUP, 713C	
604237	9244	CRLF1	0007	COLD-INDUCED SWEATING SYNDROME 1	CRLF1, LYS368TER	137853144
604237	9244	CRLF1	0008	COLD-INDUCED SWEATING SYNDROME 1	CRLF1, 2-BP DEL/1-BP INS, NT708	
604237	9244	CRLF1	0009	COLD-INDUCED SWEATING SYNDROME 1	CRLF1, ARG277TER	137853145
604241	23607	CD2AP	0001	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 3	CD2AP, IVS6, GC-CT, -1	
604241	23607	CD2AP	0002	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 3	CD2AP, ARG612TER	
604242	6049	RNF6	0001	ESOPHAGEAL SQUAMOUS CELL CARCINOMA, SOMATIC	RNF6, ARG102LYS	121434522
604242	6049	RNF6	0002	ESOPHAGEAL SQUAMOUS CELL CARCINOMA, SOMATIC	RNF6, ALA242THR	121434523
604242	6049	RNF6	0003	ESOPHAGEAL SQUAMOUS CELL CARCINOMA, SOMATIC	RNF6, GLY244ASP	121434524
604258	10395	DLC1	0001	COLORECTAL CANCER, SOMATIC	DLC1, THR522ALA	121908500
604260	6777	STAT5B	0001	GROWTH HORMONE INSENSITIVITY WITH IMMUNODEFICIENCY	STAT5B, ALA630PRO	121908501
604260	6777	STAT5B	0002	GROWTH HORMONE INSENSITIVITY WITH IMMUNODEFICIENCY	STAT5B, 1-BP INS, 1191G	
604260	6777	STAT5B	0003	GROWTH HORMONE INSENSITIVITY WITH IMMUNODEFICIENCY	STAT5B, 1-BP INS, 1102C	
604260	6777	STAT5B	0004	GROWTH HORMONE INSENSITIVITY WITH IMMUNODEFICIENCY	STAT5B, ARG152TER	121908502
604260	6777	STAT5B	0005	GROWTH HORMONE INSENSITIVITY WITH IMMUNODEFICIENCY	STAT5B, 1-BP DEL, EXON 13/INTRON 13 JUNCTION	
604264	1951	CELSR3	0001	VARIANT OF UNKNOWN SIGNIFICANCE	CELSR3, MET2630ILE	
604267	1954	MEGF8	0001	CARPENTER SYNDROME 2	MEGF8, ARG1499HIS	
604267	1954	MEGF8	0002	CARPENTER SYNDROME 2	MEGF8, SER2367GLY	
604267	1954	MEGF8	0003	CARPENTER SYNDROME 2	MEGF8, ARG448TER	
604267	1954	MEGF8	0004	CARPENTER SYNDROME 2	MEGF8, GLY199ARG	
604270	4038	LRP4	0001	CENANI-LENZ SYNDACTYLY SYNDROME	LRP4, ASP529ASN	
604270	4038	LRP4	0002	CENANI-LENZ SYNDACTYLY SYNDROME	LRP4, ASP137ASN	
604270	4038	LRP4	0003	CENANI-LENZ SYNDACTYLY SYNDROME	LRP4, IVS6DS, G-A, +1	
604270	4038	LRP4	0004	CENANI-LENZ SYNDACTYLY SYNDROME	LRP4, CYS160TYR	
604270	4038	LRP4	0005	CENANI-LENZ SYNDACTYLY SYNDROME	LRP4, ASP449ASN	
604270	4038	LRP4	0006	CENANI-LENZ SYNDACTYLY SYNDROME	LRP4, THR461PRO	
604270	4038	LRP4	0007	CENANI-LENZ SYNDACTYLY SYNDROME	LRP4, IVS2AS, G-A, -9	
604270	4038	LRP4	0008	CENANI-LENZ SYNDACTYLY SYNDROME	LRP4, 4959G-C	
604270	4038	LRP4	0009	SCLEROSTEOSIS 2	LRP4, TRP1186SER	
604270	4038	LRP4	0010	SCLEROSTEOSIS 2	LRP4, ARG1170TRP	
604272	9997	SCO2	0001	CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 1 MYOPIA 6, INCLUDED	SCO2, GLN53TER	74315510
604272	9997	SCO2	0002	CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 1 MYOPIA 6, INCLUDED	SCO2, GLU140LYS	74315511
604272	9997	SCO2	0003	CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 1	SCO2, SER225PHE	80358232
604272	9997	SCO2	0004	CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 1	SCO2, ARG171TRP	28937598
604272	9997	SCO2	0005	CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 1	SCO2, ARG90TER	74315512
604272	9997	SCO2	0006	CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 1	SCO2, 10-BP DUP, NT1302	
604272	9997	SCO2	0007	CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 1	SCO2, CYS133TYR	28937868
604272	9997	SCO2	0008	CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 1	SCO2, TRP36TER	121908508
604272	9997	SCO2	0009	MYOPIA 6	SCO2, ARG114HIS	
604277	6683	SPAST	0001	SPASTIC PARAPLEGIA 4	SPAST, SER362CYS	121908509
604277	6683	SPAST	0002	SPASTIC PARAPLEGIA 4	SPAST, CYS448TYR	121908510
604277	6683	SPAST	0003	SPASTIC PARAPLEGIA 4	SPAST, 1-BP DEL, 1520T	
604277	6683	SPAST	0004	SPASTIC PARAPLEGIA 4	SPAST, ARG499CYS	121908511
604277	6683	SPAST	0005	SPASTIC PARAPLEGIA 4	SPAST, 1813, A-G, -2	
604277	6683	SPAST	0007	SPASTIC PARAPLEGIA 4	SPAST, LYS229TER	
604277	6683	SPAST	0008	SPASTIC PARAPLEGIA 4	SPAST, 1-BP INS, 578A	
604277	6683	SPAST	0009	SPASTIC PARAPLEGIA 4	SPAST, ASP441GLY	121908512
604277	6683	SPAST	0010	SPASTIC PARAPLEGIA 4	SPAST, IVS16DS, G-C, +1	
604277	6683	SPAST	0011	SPASTIC PARAPLEGIA 4	SPAST, IVS9, A-G, +4	
604277	6683	SPAST	0012	SPASTIC PARAPLEGIA 4	SPAST, 1-BP INS, T, IVS11, +2	
604277	6683	SPAST	0013	SPASTIC PARAPLEGIA 4	SPAST, ILE344LYS	121908513
604277	6683	SPAST	0014	SPASTIC PARAPLEGIA 4	SPAST, ASN386SER	121908514
604277	6683	SPAST	0015	SPASTIC PARAPLEGIA 4, MODIFIER OF	SPAST, SER44LEU	121908515
604277	6683	SPAST	0016	SPASTIC PARAPLEGIA 4	SPAST, ASP470VAL	121908516
604277	6683	SPAST	0017	SPASTIC PARAPLEGIA 4, MODIFIER OF	SPAST, PRO45GLN	121908517
604277	6683	SPAST	0018	SPASTIC PARAPLEGIA 4	SPAST, ARG562GLY	121908518
604277	6683	SPAST	0019	SPASTIC PARAPLEGIA 4	SPAST, 2.3-KB DEL	
604277	6683	SPAST	0020	SPASTIC PARAPLEGIA 4	SPAST, 30-BP DEL, NT1216	
604277	6683	SPAST	0021	SPASTIC PARAPLEGIA 4	SPAST, SER445ARG	121908519
604277	6683	SPAST	0022	SPASTIC PARAPLEGIA 4	SPAST, EX10-EX12, DUP	
604283	10216	PRG4	0001	CAMPTODACTYLY-ARTHROPATHY-COXA VARA-PERICARDITIS SYNDROME	PRG4, 5-BP DEL, NT2805	
604283	10216	PRG4	0002	CAMPTODACTYLY-ARTHROPATHY-COXA VARA-PERICARDITIS SYNDROME	PRG4, 7-BP DEL, NT3240	
604283	10216	PRG4	0003	CAMPTODACTYLY-ARTHROPATHY-COXA VARA-PERICARDITIS SYNDROME	PRG4, 2-BP DEL, NT3023	
604283	10216	PRG4	0004	CAMPTODACTYLY-ARTHROPATHY-COXA VARA-PERICARDITIS SYNDROME	PRG4, 5-BP DEL, NT3690	
604283	10216	PRG4	0005	CAMPTODACTYLY-ARTHROPATHY-COXA VARA-PERICARDITIS SYNDROME	PRG4, 4190CC-AG	
604283	10216	PRG4	0006	CAMPTODACTYLY-ARTHROPATHY-COXA VARA-PERICARDITIS SYNDROME	PRG4, IVS6, 41-BP INS	
604285	189	AGXT	0001	HYPEROXALURIA, PRIMARY, TYPE I	AGXT, SER205PRO	121908520
604285	189	AGXT	0002	HYPEROXALURIA, PRIMARY, TYPE I	AGXT, PRO11LEU	34116584
604285	189	AGXT	0003	HYPEROXALURIA, PRIMARY, TYPE I	AGXT, TYR66TER	121908521
604285	189	AGXT	0004	HYPEROXALURIA, PRIMARY, TYPE I	AGXT, GLY82GLN	121908522
604285	189	AGXT	0005	HYPEROXALURIA, PRIMARY, TYPE I	AGXT, GLY41ARG	121908523
604285	189	AGXT	0006	HYPEROXALURIA, PRIMARY, TYPE I	AGXT, PHE152ILE	121908524
604285	189	AGXT	0007	HYPEROXALURIA, PRIMARY, TYPE I	AGXT, ILE244THR	121908525
604285	189	AGXT	0008	HYPEROXALURIA, PRIMARY, TYPE I	AGXT, ARG233CYS	121908526
604285	189	AGXT	0009	HYPEROXALURIA, PRIMARY, TYPE I	AGXT, ARG233HIS	121908527
604285	189	AGXT	0010	HYPEROXALURIA, PRIMARY, TYPE I	AGXT, TRP246TER	121908528
604285	189	AGXT	0012	HYPEROXALURIA, PRIMARY, TYPE I	AGXT, GLY158ARG	121908530
604285	189	AGXT	0013	HYPEROXALURIA, PRIMARY, TYPE I	AGXT, GLY170ARG	
604285	189	AGXT	0014	HYPEROXALURIA, PRIMARY, TYPE I	AGXT, ILE340MET	
604285	189	AGXT	0015	HYPEROXALURIA, PRIMARY, TYPE I	AGXT, 1-BP INS, 33C	
604289	25788	RAD54B	0001	LYMPHOMA, NON-HODGKIN	RAD54B, ASN593SER	114216685
604289	25788	RAD54B	0002	COLON CANCER	RAD54B, ASP418TYR	119490107
604294	11023	VAX1	0001	MICROPHTHALMIA, SYNDROMIC 11	VAX1, ARG152SER	
604296	9380	GRHPR	0001	HYPEROXALURIA, PRIMARY, TYPE II	GRHPR, 1-BP DEL, 103G	80356708
604296	9380	GRHPR	0002	HYPEROXALURIA, PRIMARY, TYPE II	GRHPR, ARG99TER	119490108
604310	26258	BLOC1S6	0001	HERMANSKY-PUDLAK SYNDROME 9	BLOC1S6, GLN78TER	
604312	1471	CST3	0001	AMYLOIDOSIS, CEREBROARTERIAL, ICELANDIC TYPE	CST3, LEU68GLN	28939068
604312	1471	CST3	0002	MACULAR DEGENERATION, AGE-RELATED, 11	CST3, ALA25THR	1064039
604313	2584	GALK1	0001	GALACTOKINASE DEFICIENCY	GALK1, VAL32MET	104894576
604313	2584	GALK1	0002	GALACTOKINASE DEFICIENCY	GALK1, GLU80TER	104894577
604313	2584	GALK1	0003	GALACTOKINASE DEFICIENCY	GALK1, PRO28THR	104894572
604313	2584	GALK1	0004	GALACTOKINASE DEFICIENCY	GALK1, GLN382TER	111033608
604313	2584	GALK1	0005	GALACTOKINASE DEFICIENCY	GALK1, 1-BP DEL, 761G	
604313	2584	GALK1	0006	GALACTOKINASE DEFICIENCY	GALK1, ALA198VAL	80084721
604319	26277	TINF2	0001	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 3	TINF2, LYS280GLU	121918543
604319	26277	TINF2	0002	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 3 REVESZ SYNDROME, INCLUDED	TINF2, ARG282HIS	121918544
604319	26277	TINF2	0003	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 3	TINF2, ARG282SER	121918545
604319	26277	TINF2	0004	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 3	TINF2, ARG282CYS	
604319	26277	TINF2	0005	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 3	TINF2, GLN269TER	
604319	26277	TINF2	0006	REVESZ SYNDROME	TINF2, 1-BP DEL, 839A	
604319	26277	TINF2	0007	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 3	TINF2, GLN271TER	
604319	26277	TINF2	0008	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 3	TINF2, 1-BP DEL, 826A	
604322	26503	SLC17A5	0001	SALLA DISEASE	SLC17A5, ARG39CYS	80338794
604322	26503	SLC17A5	0002	INFANTILE SIALIC ACID STORAGE DISORDER	SLC17A5, 1-BP DEL, 533C	
604322	26503	SLC17A5	0003	INFANTILE SIALIC ACID STORAGE DISORDER	SLC17A5, 148-BP DEL, NT1112	
604322	26503	SLC17A5	0004	INFANTILE SIALIC ACID STORAGE DISORDER	SLC17A5, HIS183ARG	119491109
604322	26503	SLC17A5	0005	INFANTILE SIALIC ACID STORAGE DISORDER	SLC17A5, PRO334ARG	119491110
604322	26503	SLC17A5	0006	INFANTILE SIALIC ACID STORAGE DISORDER	SLC17A5, 500-BP INS, NT978	
604322	26503	SLC17A5	0007	INFANTILE SIALIC ACID STORAGE DISORDER	SLC17A5, 15-BP DEL, NT802	
604322	26503	SLC17A5	0008	INFANTILE SIALIC ACID STORAGE DISORDER SALLA DISEASE, INCLUDED	SLC17A5, 15-BP DEL	
604322	26503	SLC17A5	0009	SALLA DISEASE	SLC17A5, LYS136GLU	80338795
604325	5521	PPP2R2B	0001	SPINOCEREBELLAR ATAXIA 12	PPP2R2B, (CAG)n EXPANSION	193922942
604327	11285	B4GALT7	0001	EHLERS-DANLOS SYNDROME, PROGEROID FORM	B4GALT7, ALA186ASP	
604327	11285	B4GALT7	0002	EHLERS-DANLOS SYNDROME, PROGEROID FORM	B4GALT7, LEU206PRO	
604327	11285	B4GALT7	0003	EHLERS-DANLOS SYNDROME, PROGEROID FORM	B4GALT7, ARG270CYS	28937869
604346	11253	MAN1B1	0001	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15	MAN1B1, GLU397LYS	
604346	11253	MAN1B1	0002	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15	MAN1B1, TRP473TER	
604346	11253	MAN1B1	0003	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15	MAN1B1, ARG334CYS	
604349	10319	LAMC3	0001	CORTICAL MALFORMATIONS, OCCIPITAL	LAMC3, 2-BP DEL, TG	
604349	10319	LAMC3	0002	CORTICAL MALFORMATIONS, OCCIPITAL	LAMC3, TRP157TER	
604349	10319	LAMC3	0003	CORTICAL MALFORMATIONS, OCCIPITAL	LAMC3, GLN386TER	
604349	10319	LAMC3	0004	CORTICAL MALFORMATIONS, OCCIPITAL	LAMC3, GLY350ARG	
604365	8842	PROM1	0001	RETINITIS PIGMENTOSA 41	PROM1, 1-BP DEL, 1878G	
604365	8842	PROM1	0002	RETINITIS PIGMENTOSA 41	PROM1, GLN576TER	137853005
604365	8842	PROM1	0003	STARGARDT DISEASE 4 MACULAR DYSTROPHY, RETINAL, 2, INCLUDED;; CONE-ROD DYSTROPHY 12, INCLUDED	PROM1, ARG373CYS	137853006
604366	27019	DNAI1	0001	CILIARY DYSKINESIA, PRIMARY, 1	DNAI1, IVS1DS, 1-BP INS, +3T	
604366	27019	DNAI1	0002	CILIARY DYSKINESIA, PRIMARY, 1	DNAI1, 4-BP INS, CODON 95	
604366	27019	DNAI1	0003	CILIARY DYSKINESIA, PRIMARY, 1	DNAI1, GLY515SER	
604366	27019	DNAI1	0004	CILIARY DYSKINESIA, PRIMARY, 1	DNAI1, 12-BP DEL	
604373	11200	CHEK2	0001	LI-FRAUMENI SYNDROME 2 BREAST CANCER, SUSCEPTIBILITY TO, INCLUDED;; PROSTATE CANCER, SUSCEPTIBILITY TO, INCLUDED;; BREAST AND COLORECTAL CANCER, SUSCEPTIBILITY TO, INCLUDED	CHEK2, 1-BP DEL, 1100C	
604373	11200	CHEK2	0002	LI-FRAUMENI SYNDROME 2 COLORECTAL CANCER, SUSCEPTIBILITY TO, INCLUDED;; CANCER OF MULTIPLE TYPES, SUSCEPTIBILITY TO, INCLUDED;; PROSTATE CANCER, SUSCEPTIBILITY TO, INCLUDED	CHEK2, ILE157THR	17879961
604373	11200	CHEK2	0003	LI-FRAUMENI SYNDROME 2	CHEK2, ARG145TRP	137853007
604373	11200	CHEK2	0004	LI-FRAUMENI SYNDROME 2	CHEK2, 1-BP DEL, 1422T	
604373	11200	CHEK2	0005	OSTEOSARCOMA, SOMATIC	CHEK2, PRO85LEU	17883862
604373	11200	CHEK2	0006	OSTEOSARCOMA, SOMATIC	CHEK2, ALA17SER	137853008
604373	11200	CHEK2	0007	PROSTATE CANCER, SOMATIC	CHEK2, ARG180HIS	137853009
604373	11200	CHEK2	0008	PROSTATE CANCER, SOMATIC	CHEK2, ARG181CYS	137853010
604373	11200	CHEK2	0009	PROSTATE CANCER, SOMATIC	CHEK2, ARG181HIS	121908701
604373	11200	CHEK2	0010	PROSTATE CANCER, SOMATIC	CHEK2, GLU239TER	121908702
604373	11200	CHEK2	0011	PROSTATE CANCER, SOMATIC	CHEK2, GLU239LYS	121908702
604373	11200	CHEK2	0012	BREAST CANCER, SUSCEPTIBILITY TO PROSTATE CANCER, SUSCEPTIBILITY TO, INCLUDED	CHEK2, 5.4-KB DEL	
604373	11200	CHEK2	0013	PROSTATE CANCER, SUSCEPTIBILITY TO CANCER OF MULTIPLE TYPES, SUSCEPTIBILITY TO, INCLUDED	CHEK2, IVS2DS, G-A, +1	
604373	11200	CHEK2	0014	BREAST CANCER, SUSCEPTIBILITY TO	CHEK2, SER428PHE	137853011
604384	27032	ATP2C1	0001	HAILEY-HAILEY DISEASE	ATP2C1, 4-BP INS, 767CCCT	
604384	27032	ATP2C1	0002	HAILEY-HAILEY DISEASE	ATP2C1, ALA304THR	137853012
604384	27032	ATP2C1	0003	HAILEY-HAILEY DISEASE	ATP2C1, ARG468TER	137853013
604384	27032	ATP2C1	0004	HAILEY-HAILEY DISEASE	ATP2C1, 4-BP DEL, 2374TTTG	
604384	27032	ATP2C1	0005	HAILEY-HAILEY DISEASE	ATP2C1, IVS11, G-A, -1	
604384	27032	ATP2C1	0006	HAILEY-HAILEY DISEASE	ATP2C1, CYS490PHE	137853014
604384	27032	ATP2C1	0007	HAILEY-HAILEY DISEASE	ATP2C1, 1-BP DEL, 2460G	
604384	27032	ATP2C1	0008	HAILEY-HAILEY DISEASE	ATP2C1, LEU584PRO	137853015
604384	27032	ATP2C1	0009	HAILEY-HAILEY DISEASE	ATP2C1, IVS22, G-A, +1	
604386	7227	TRPS1	0001	TRICHORHINOPHALANGEAL SYNDROME, TYPE I	TRPS1, CYS351TER	121908430
604386	7227	TRPS1	0002	TRICHORHINOPHALANGEAL SYNDROME, TYPE I	TRPS1, ARG624TER	121908431
604386	7227	TRPS1	0003	TRICHORHINOPHALANGEAL SYNDROME, TYPE I	TRPS1, 1-BP INS, 2406G	
604386	7227	TRPS1	0004	TRICHORHINOPHALANGEAL SYNDROME, TYPE I	TRPS1, 1-BP INS, 2441T	
604386	7227	TRPS1	0005	TRICHORHINOPHALANGEAL SYNDROME, TYPE I	TRPS1, ARG853TER	121908432
604386	7227	TRPS1	0006	TRICHORHINOPHALANGEAL SYNDROME, TYPE I	TRPS1, 4-BP INS, 3360GGAG	
604386	7227	TRPS1	0007	TRICHORHINOPHALANGEAL SYNDROME, TYPE III	TRPS1, THR914PRO	121908433
604386	7227	TRPS1	0008	TRICHORHINOPHALANGEAL SYNDROME, TYPE I	TRPS1, TYR1105TER	121908434
604386	7227	TRPS1	0009	TRICHORHINOPHALANGEAL SYNDROME, TYPE III	TRPS1, ARG921GLN	121908435
604386	7227	TRPS1	0010	TRICHORHINOPHALANGEAL SYNDROME, TYPE III	TRPS1, ALA932VAL	121908436
604386	7227	TRPS1	0011	TRICHORHINOPHALANGEAL SYNDROME, TYPE I	TRPS1, ARG965CYS	28939069
604386	7227	TRPS1	0012	TRICHORHINOPHALANGEAL SYNDROME, TYPE I	TRPS1, ARG952HIS	28939070
604392	23746	AIPL1	0001	LEBER CONGENITAL AMAUROSIS 4	AIPL1, TRP278TER	62637014
604392	23746	AIPL1	0002	LEBER CONGENITAL AMAUROSIS 4	AIPL1, 2-BP DEL	
604392	23746	AIPL1	0003	LEBER CONGENITAL AMAUROSIS 4	AIPL1, CYS239ARG	62637012
604392	23746	AIPL1	0004	RETINITIS PIGMENTOSA, JUVENILE, AIPL1-RELATED CONE-ROD DYSTROPHY, AIPL1-RELATED, INCLUDED	AIPL1, 12-BP DEL, NT1053	
604395	27030	MLH3	0001	COLORECTAL CANCER, SOMATIC	MLH3, 2483G-T	
604395	27030	MLH3	0002	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	MLH3, GLN24GLU	28937870
604395	27030	MLH3	0003	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	MLH3, ASN499SER	28937871
604395	27030	MLH3	0004	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	MLH3, GLU624GLN	28756986
604395	27030	MLH3	0005	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	MLH3, GLU1451LYS	28939071
604395	27030	MLH3	0006	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 7 ENDOMETRIAL CANCER, INCLUDED	MLH3, 1-BP DEL, 885G	
604395	27030	MLH3	0007	ENDOMETRIAL CANCER COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 7	MLH3, VAL741PHE	28756990
604395	27030	MLH3	0008	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 7	MLH3, TRP1276ARG	121908439
604402	8869	ST3GAL5	0001	AMISH INFANTILE EPILEPSY SYNDROME	ST3GAL5, ARG288TER	104893668
604404	10082	GPC6	0001	OMODYSPLASIA 1	GPC6, 1-BP DEL, 778C	
604404	10082	GPC6	0002	OMODYSPLASIA 1	GPC6, 66.4-KB DEL	
604404	10082	GPC6	0003	OMODYSPLASIA 1	GPC6, 99.3-KB DEL	
604404	10082	GPC6	0004	OMODYSPLASIA 1	GPC6, ARG234TER	121908440
604404	10082	GPC6	0005	OMODYSPLASIA 1	GPC6, EX4DUP	
604404	10082	GPC6	0006	OMODYSPLASIA 1	GPC6, 89.6-KB DEL	
604404	10082	GPC6	0007	OMODYSPLASIA 1	GPC6, 257-KB DEL	
604418	10804	GJB6	0001	DEAFNESS, AUTOSOMAL DOMINANT 3B	GJB6, THR5MET	104894414
604418	10804	GJB6	0002	ECTODERMAL DYSPLASIA, HIDROTIC	GJB6, GLY11ARG	104894415
604418	10804	GJB6	0003	ECTODERMAL DYSPLASIA, HIDROTIC	GJB6, ALA88VAL	28937872
604418	10804	GJB6	0004	DEAFNESS, AUTOSOMAL RECESSIVE 1B DEAFNESS, DIGENIC, GJB2/GJB6, INCLUDED	GJB6, 309-KB DEL	
604418	10804	GJB6	0005	ECTODERMAL DYSPLASIA, HIDROTIC	GJB6, VAL37GLU	104894416
604418	10804	GJB6	0006	DEAFNESS, DIGENIC, GJB2/GJB6	GJB6, 232-KB DEL	
604433	10008	KCNE3	0001	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	KCNE3, ARG83HIS	17215437
604433	10008	KCNE3	0002	BRUGADA SYNDROME 6	KCNE3, ARG99HIS	121908441
604455	1757	SARDH	0001	SARCOSINEMIA	SARDH, VAL71PHE	
604455	1757	SARDH	0002	SARCOSINEMIA	SARDH, PRO287LEU	
604455	1757	SARDH	0003	SARCOSINEMIA	SARDH, ARG723TER	
604455	1757	SARDH	0004	SARCOSINEMIA	SARDH, ARG514TER	
604457	3431	SP110	0001	HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	SP110, 1-BP DEL, 642C	
604457	3431	SP110	0002	HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	SP110, 1-BP DEL, 40C	
604457	3431	SP110	0003	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO	SP110, LEU425SER	3948464
604457	3431	SP110	0004	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO	SP110, C-T, INTRON 6	2114592
604459	11213	IRAK3	0001	ASTHMA SUSCEPTIBILITY 5	IRAK3, TRP76TER	121912630
604459	11213	IRAK3	0002	ASTHMA SUSCEPTIBILITY 5	IRAK3, IVS3, G-T, +1	
604473	2911	GRM1	0001	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	GRM1, 3-BP DEL, NT2652 AND IVS8DS, T-G, +2	
604479	23411	SIRT1	0001	VARIANT OF UNKNOWN SIGNIFICANCE	SIRT1, LEU107PRO	
604485	10002	NR2E3	0001	ENHANCED S-CONE SYNDROME RETINITIS PIGMENTOSA 37, INCLUDED	NR2E3, IVS1AS, A-C	
604485	10002	NR2E3	0002	ENHANCED S-CONE SYNDROME	NR2E3, ARG76TRP	104894492
604485	10002	NR2E3	0003	ENHANCED S-CONE SYNDROME	NR2E3, ARG76GLN	104894493
604485	10002	NR2E3	0004	ENHANCED S-CONE SYNDROME	NR2E3, 9-BP DEL	
604485	10002	NR2E3	0005	ENHANCED S-CONE SYNDROME GOLDMANN-FAVRE SYNDROME, INCLUDED	NR2E3, ARG311GLN	28937873
604485	10002	NR2E3	0006	RETINITIS PIGMENTOSA 37	NR2E3, GLY56ARG	121912631
604485	10002	NR2E3	0007	RETINITIS PIGMENTOSA 37	NR2E3, 5-BP DEL, NT1034	
604487	340990	OTOG	0001	DEAFNESS, AUTOSOMAL RECESSIVE 18B	OTOG, 1-BP DEL, 5508C	
604487	340990	OTOG	0002	DEAFNESS, AUTOSOMAL RECESSIVE 18B	OTOG, PRO2116LEU	
604487	340990	OTOG	0003	DEAFNESS, AUTOSOMAL RECESSIVE 18B	OTOG, ARG2187TER	
604488	8557	TCAP	0001	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2G	TCAP, GLN53TER	104894655
604488	8557	TCAP	0002	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2G	TCAP, 2-BP DEL, 637GG	
604488	8557	TCAP	0003	CARDIOMYOPATHY, DILATED, 1N	TCAP, ARG87GLN	121434298
604489	23600	AMACR	0001	ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4, INCLUDED	AMACR, SER52PRO	
604489	23600	AMACR	0002	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4	AMACR, LEU107PRO	
604490	26278	SACS	0001	SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	SACS, 1-BP DEL, 6594T	
604490	26278	SACS	0002	SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	SACS, 5254C-T	
604490	26278	SACS	0003	SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	SACS, ALA3324PRO	137853016
604490	26278	SACS	0004	SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	SACS, 1-BP DEL, 1411T	
604490	26278	SACS	0005	SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	SACS, 1-BP INS, 1155A	
604490	26278	SACS	0006	SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	SACS, TRP1196ARG	137853017
604490	26278	SACS	0007	SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	SACS, 1-BP INS, 1859C	
604490	26278	SACS	0008	SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	SACS, TRP2498ARG	137853018
604490	26278	SACS	0009	SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	SACS, PHE304SER	137853019
604490	26278	SACS	0010	SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	SACS, 10-BP DEL, NT32627	
604490	26278	SACS	0011	SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	SACS, 1-BP DEL, 31760T	
604505	9321	TRIP11	0001	ACHONDROGENESIS, TYPE IA	TRIP11, ARG264TER	
604505	9321	TRIP11	0002	ACHONDROGENESIS, TYPE IA	TRIP11, TRP1224TER	
604505	9321	TRIP11	0003	ACHONDROGENESIS, TYPE IA	TRIP11, IVS2AS, A-G, -2	
604505	9321	TRIP11	0004	ACHONDROGENESIS, TYPE IA	TRIP11, ASN701SER	
604515	29760	BLNK	0001	AGAMMAGLOBULINEMIA 4, AUTOSOMAL RECESSIVE (1 family)	BLNK, IVS1DS, A-T, +3	
604526	3420	IDH3B	0001	RETINITIS PIGMENTOSA 46	IDH3B, 1-BP DEL, 589A	
604526	3420	IDH3B	0002	RETINITIS PIGMENTOSA 46	IDH3B, LEU98PRO	137853020
604539	9509	ADAMTS2	0001	EHLERS-DANLOS SYNDROME, TYPE VIIC	ADAMTS2, GLN225TER	137853146
604539	9509	ADAMTS2	0002	EHLERS-DANLOS SYNDROME, TYPE VIIC	ADAMTS2, TRP795TER	137853147
604539	9509	ADAMTS2	0003	EHLERS-DANLOS SYNDROME, TYPE VIIC	ADAMTS2, EX3-5 DEL	
604557	23090	ZNF423	0001	NEPHRONOPHTHISIS 14	ZNF423, PRO913LEU	
604557	23090	ZNF423	0002	JOUBERT SYNDROME 19	ZNF423, 1-BP DEL, 1518C	
604557	23090	ZNF423	0003	JOUBERT SYNDROME 19	ZNF423, HIS1277TYR	
604558	29851	ICOS	0001	IMMUNODEFICIENCY, COMMON VARIABLE, 1	ICOS, EX2-3 DEL	
604566	29929	ALG6	0001	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic	ALG6, ALA333VAL	121908443
604566	29929	ALG6	0002	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic	ALG6, SER478PRO	121908444
604566	29929	ALG6	0003	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic	ALG6, IVS3DS, G-A, +5	
604566	29929	ALG6	0004	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic	ALG6, 3-BP DEL, 895ATA	
604566	29929	ALG6	0005	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic	ALG6, 3-BP DEL, 897AAT	
604566	29929	ALG6	0006	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic	ALG6, IVS7DS, T-G, +2	
604566	29929	ALG6	0007	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic	ALG6, TYR131HIS	
604569	26047	CNTNAP2	0001	CORTICAL DYSPLASIA-FOCAL EPILEPSY SYNDROME	CNTNAP2, 1-BP DEL, 3709G	
604569	26047	CNTNAP2	0002	AUTISM, SUSCEPTIBILITY TO, 15	CNTNAP2, IVS13, C-T	2710102
604569	26047	CNTNAP2	0003	AUTISM, SUSCEPTIBILITY TO, 15	CNTNAP2, IVS2, A-T	7794745
604569	26047	CNTNAP2	0004	AUTISM, SUSCEPTIBILITY TO, 15	CNTNAP2, ILE869THR	121908445
604569	26047	CNTNAP2	0005	PITT-HOPKINS-LIKE SYNDROME 1	CNTNAP2, 1.1-MB DEL, EX2-9	
604569	26047	CNTNAP2	0006	PITT-HOPKINS-LIKE SYNDROME 1	CNTNAP2, IVS10AS, G-T, -1	
604569	26047	CNTNAP2	0007	PITT-HOPKINS-LIKE SYNDROME 1	CNTNAP2, 180-KB DEL, EX5-8	
604579	8322	FZD4	0001	EXUDATIVE VITREORETINOPATHY 1	FZD4, 6-BP DEL, NT1479	80358301
604579	8322	FZD4	0002	EXUDATIVE VITREORETINOPATHY 1	FZD4, 2-BP DEL, 1501CT	80358303
604579	8322	FZD4	0003	EXUDATIVE VITREORETINOPATHY 1 EXUDATIVE VITREORETINOPATHY, DIGENIC, INCLUDED	FZD4, ARG417GLN	80358294
604579	8322	FZD4	0004	EXUDATIVE VITREORETINOPATHY 1	FZD4, MET342VAL	80358293
604579	8322	FZD4	0005	EXUDATIVE VITREORETINOPATHY 1	FZD4, TRP335CYS	80358292
604579	8322	FZD4	0006	RETINOPATHY OF PREMATURITY	FZD4, ILE256VAL	104894223
604580	10516	FBLN5	0001	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA	FBLN5, SER227PRO	28939370
604580	10516	FBLN5	0002	CUTIS LAXA, AUTOSOMAL DOMINANT 2	FBLN5, 483-BP DUP	
604580	10516	FBLN5	0003	MACULAR DEGENERATION, AGE-RELATED, 3	FBLN5, VAL60LEU	121434299
604580	10516	FBLN5	0004	MACULAR DEGENERATION, AGE-RELATED, 3	FBLN5, ARG71GLN	121434300
604580	10516	FBLN5	0005	MACULAR DEGENERATION, AGE-RELATED, 3	FBLN5, PRO87SER	121434301
604580	10516	FBLN5	0006	MACULAR DEGENERATION, AGE-RELATED, 3	FBLN5, ILE169THR	28939072
604580	10516	FBLN5	0007	MACULAR DEGENERATION, AGE-RELATED, 3	FBLN5, ARG351TRP	28939073
604580	10516	FBLN5	0008	MACULAR DEGENERATION, AGE-RELATED, 3	FBLN5, ALA363THR	121434302
604580	10516	FBLN5	0009	MACULAR DEGENERATION, AGE-RELATED, 3	FBLN5, GLY412GLU	121434303
604580	10516	FBLN5	0010	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA	FBLN5, CYS217ARG	
604580	10516	FBLN5	0011	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA	FBLN5, GLU391TER	
604581	10939	AFG3L2	0001	SPINOCEREBELLAR ATAXIA 28	AFG3L2, GLU691LYS	
604581	10939	AFG3L2	0002	SPINOCEREBELLAR ATAXIA 28	AFG3L2, 2-BP DEL/2-BP INS, NT2021	151344519
604581	10939	AFG3L2	0003	SPINOCEREBELLAR ATAXIA 28	AFG3L2, ALA694GLU	
604581	10939	AFG3L2	0004	SPINOCEREBELLAR ATAXIA 28	AFG3L2, ARG702GLN	
604581	10939	AFG3L2	0005	SPINOCEREBELLAR ATAXIA 28	AFG3L2, ASN432THR	
604581	10939	AFG3L2	0006	SPINOCEREBELLAR ATAXIA 28	AFG3L2, MET666VAL	
604581	10939	AFG3L2	0007	SPINOCEREBELLAR ATAXIA 28	AFG3L2, MET666ARG	
604581	10939	AFG3L2	0008	SPINOCEREBELLAR ATAXIA 28	AFG3L2, GLY671ARG	
604581	10939	AFG3L2	0009	SPINOCEREBELLAR ATAXIA 28	AFG3L2, THR654ILE	
604581	10939	AFG3L2	0010	SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	AFG3L2, TYR616CYS	
604584	5157	PDGFRL	0001	COLORECTAL CANCER, SOMATIC	PDGRL, HIS23TYR	137853148
604584	5157	PDGFRL	0002	HEPATOCELLULAR CARCINOMA, SOMATIC	PDGRL, 2-BP DEL	
604588	4750	NEK1	0001	SHORT RIB-POLYDACTYLY SYNDROME, TYPE IIA	NEK1, ARG127TER	
604588	4750	NEK1	0002	SHORT RIB-POLYDACTYLY SYNDROME, TYPE IIA	NEK1, IVS10, A-G, -2	
604588	4750	NEK1	0003	SHORT RIB-POLYDACTYLY SYNDROME, TYPE IIA/B, DIGENIC	NEK1, 1-BP INS, 1640A	
604588	4750	NEK1	0004	SHORT RIB-POLYDACTYLY SYNDROME, TYPE IIA	NEK1, GLY145ARG	
604590	2213	FCGR2B	0001	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO	FCGR2B, -343G-C	3219018
604590	2213	FCGR2B	0002	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO MALARIA, RESISTANCE TO, INCLUDED	FCGR2B, ILE232THR	1050501
604592	10312	TCIRG1	0001	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1	TCIRG1, 1-BP DEL, 5272C	
604592	10312	TCIRG1	0002	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1	TCIRG1, CYS464TER	137853149
604592	10312	TCIRG1	0003	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1	TCIRG1,IVS15AS, G-A, -1	
604592	10312	TCIRG1	0004	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1	TCIRG1, IVS2AS, A-T, +4	
604592	10312	TCIRG1	0005	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1	TCIRG1, GLY405ARG	137853150
604592	10312	TCIRG1	0006	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1	TCIRG1, ARG444LEU	137853151
604592	10312	TCIRG1	0007	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1	TCIRG1, 26-BP DEL, CODON 216	
604597	23426	GRIP1	0001	FRASER SYNDROME	GRIP1, IVS17, G-C, +1	
604597	23426	GRIP1	0002	FRASER SYNDROME	GRIP1, 4-BP DEL, 1181AAGA	
604605	8997	KALRN	0001	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 5	KALRN, G-T	9289231
604610	641	BLM	0001	BLOOM SYNDROME	RECQL3, 6-BP DEL/7-BP INS	113993962
604610	641	BLM	0002	BLOOM SYNDROME	RECQL3, 3-BP DEL, 631CAA	
604610	641	BLM	0003	BLOOM SYNDROME	RECQL3, EX11,12DEL	137853152
604610	641	BLM	0004	BLOOM SYNDROME	RECQL3, CYS1036PHE	137853153
604611	7486	WRN	0001	WERNER SYNDROME	RECQL2, ARG1305TER	121908446
604611	7486	WRN	0002	WERNER SYNDROME	RECQL2, GLN1165TER	121908447
604611	7486	WRN	0003	WERNER SYNDROME	RECQL2, 4-BP DEL, FS1393TER	
604611	7486	WRN	0004	WERNER SYNDROME	RECQL2, IVS25DS, G-C, -1, FS1061TER	113993961
604611	7486	WRN	0005	WERNER SYNDROME	RECQL2, 1-BP INS, 4146A	
604611	7486	WRN	0006	WERNER SYNDROME	RECQL2, ARG368TER	17847577
604611	7486	WRN	0007	WERNER SYNDROME	RECQL2, IVS31DS, A-T, +2, FS1158TER	
604611	7486	WRN	0008	WERNER SYNDROME	RECQL2, 1-BP DEL, NT1396	
604611	7486	WRN	0009	WERNER SYNDROME	RECQL2, LYS577MET	121908448
604611	7486	WRN	0010	WERNER SYNDROME	RECQL2, LYS125ASN, LYS135GLU	
604614	9095	TBX19	0001	ACTH DEFICIENCY, ISOLATED	TBX19, ARG286TER	74315376
604614	9095	TBX19	0002	ACTH DEFICIENCY, ISOLATED	TBX19, SER128PHE	74315377
604614	9095	TBX19	0003	ACTH DEFICIENCY, ISOLATED	TBX19, MET86ARG	74315378
604614	9095	TBX19	0004	ACTH DEFICIENCY, ISOLATED	TBX19, 1-BP DEL, 782A	
604619	9211	LGI1	0001	EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	LGI1, GLU383ALA	28937874
604619	9211	LGI1	0002	EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	LGI1, 1-BP DEL, 835C	
604619	9211	LGI1	0003	EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	LGI1, IVS3AS, C-A, -3	
604619	9211	LGI1	0004	EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	LGI1, CYS46ARG	104894166
604619	9211	LGI1	0005	EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	LGI1, 1320C-T	
604619	9211	LGI1	0007	EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	LGI1, PHE318CYS	28939075
604619	9211	LGI1	0008	EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	LGI1, IVS5DS, G-A, +1	
604619	9211	LGI1	0009	EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	LGI1, LEU232PRO	104894167
604619	9211	LGI1	0010	EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	LGI1, ARG136TRP	119488099
604619	9211	LGI1	0011	EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	LGI1, ILE122LYS	119488100
604619	9211	LGI1	0012	EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	LGI1, 81-KB DEL	
604624	8988	HSPB3	0001	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIC	HSPB3, ARG7SER	
604629	9313	MMP20	0001	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA2	MMP20, IVS6, A-T, -2	
604630	8431	NR0B2	0001	OBESITY, MILD, EARLY-ONSET	NR0B2, ARG34TER	74315349
604630	8431	NR0B2	0002	OBESITY, MILD, EARLY-ONSET	NR0B2, ALA195SER	74315350
604633	30008	EFEMP2	0001	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	EFEMP2, GLU57LYS	119489101
604633	30008	EFEMP2	0002	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	EFEMP2, ARG279CYS	119489102
604633	30008	EFEMP2	0003	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	EFEMP2, 4-BP DUP, 1070CCGC	193302865
604633	30008	EFEMP2	0004	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	EFEMP2, CYS267TYR	
604633	30008	EFEMP2	0005	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	EFEMP2, GLU126LYS	
604633	30008	EFEMP2	0006	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	EFEMP2, GLU126VAL	
604633	30008	EFEMP2	0007	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	EFEMP2, 1-BP DEL, 577C	
604633	30008	EFEMP2	0008	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	EFEMP2, ALA397THR	
604633	30008	EFEMP2	0009	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE 1B	EFEMP2, ASP203ALA	
604633	30008	EFEMP2	0010	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE 1B	EFEMP2, ARG227CYS	
604638	81	ACTN4	0001	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1	ACTN4, LYS228GLU	121908415
604638	81	ACTN4	0002	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1	ACTN4, THR232ILE	121908416
604638	81	ACTN4	0003	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1	ACTN4, SER235PRO	121908417
604641	9479	MAPK8IP1	0001	DIABETES MELLITUS, NONINSULIN-DEPENDENT	MAPK8IP1, SER59ASN	119489103
604653	30061	SLC40A1	0001	HEMOCHROMATOSIS, TYPE 4	SLC40A1, ASN144HIS	104893662
604653	30061	SLC40A1	0002	HEMOCHROMATOSIS, TYPE 4	SLC40A1, ALA77ASP	28939076
604653	30061	SLC40A1	0003	HEMOCHROMATOSIS, TYPE 4	SLC40A1, 3-BP DEL, VAL162DEL	
604653	30061	SLC40A1	0004	HEMOCHROMATOSIS, TYPE 4	SLC40A1, ASP157GLY	104893663
604653	30061	SLC40A1	0005	HEMOCHROMATOSIS, TYPE 4	SLC40A1, GLN182HIS	104893670
604653	30061	SLC40A1	0006	HEMOCHROMATOSIS, TYPE 4	SLC40A1, GLY323VAL	104893671
604653	30061	SLC40A1	0007	HEMOCHROMATOSIS, TYPE 4	SLC40A1, ASP181VAL	104893672
604653	30061	SLC40A1	0008	HEMOCHROMATOSIS, TYPE 4	SLC40A1, GLY80VAL	104893673
604653	30061	SLC40A1	0009	HEMOCHROMATOSIS, TYPE 4	SLC40A1, GLY267ASP	104893664
604672	30835	CD209	0001	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO DENGUE FEVER, PROTECTION AGAINST, INCLUDED;; MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO, INCLUDED	CD209, -336A-G	
604672	30835	CD209	0002	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO	CD209, -871G-A	
604685	3199	HOXA2	0001	MICROTIA, HEARING IMPAIRMENT, AND CLEFT PALATE	HOXA2, GLN186LYS	119489104
604687	5729	PTGDR	0001	ASTHMA SUSCEPTIBILITY 1	PTGDR, HAPLOTYPE TCT	
604687	5729	PTGDR	0002	ASTHMA SUSCEPTIBILITY 1	PTGDR, HAPLOTYPE CCC	
604694	11216	AKAP10	0001	CARDIAC CONDUCTION DEFECT, SUSCEPTIBILITY TO	AKAP10, ILE646VAL	203462
604705	10461	MERTK	0001	RETINITIS PIGMENTOSA 38	MERTK, 5-BP DEL, NT2070	
604705	10461	MERTK	0002	RETINITIS PIGMENTOSA 38	MERTK, IVS10AS, A-G, -2	
604705	10461	MERTK	0003	RETINITIS PIGMENTOSA 38	MERTK, ARG651TER	119489105
604705	10461	MERTK	0004	RETINITIS PIGMENTOSA 38	MERTK, IVS16DS, G-T, +1	
604705	10461	MERTK	0005	RETINITIS PIGMENTOSA 38	MERTK, 9-KB DEL	
604705	10461	MERTK	0006	RETINITIS PIGMENTOSA 38	MERTK, IVS1, G-A, +1	
604705	10461	MERTK	0007	RETINITIS PIGMENTOSA 38	MERTK, 91-KB DEL	
604705	10461	MERTK	0008	RETINITIS PIGMENTOSA 38	MERTK, ARG775TER	
604710	8425	LTBP4	0001	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC	LTBP4, 1-BP DEL, 355A	
604710	8425	LTBP4	0002	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC	LTBP4, 1-BP DEL, 791C	
604710	8425	LTBP4	0003	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC	LTBP4, CYS857TER	
604710	8425	LTBP4	0004	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC	LTBP4, CYS274GLY	
604710	8425	LTBP4	0005	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC	LTBP4, 1-BP INS, 4128C	
604710	8425	LTBP4	0006	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC	LTBP4, ARG448TER	
604710	8425	LTBP4	0007	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC	LTBP4, 1-BP DUP, 4115C	
604710	8425	LTBP4	0008	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC	LTBP4, ARG1337TER	
604712	50484	RRM2B	0001	MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	RRM2B, GLN284TER	121918307
604712	50484	RRM2B	0002	MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	RRM2B, IVS3AS, A-G, -2	
604712	50484	RRM2B	0003	MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	RRM2B, GLU194LYS	121918308
604712	50484	RRM2B	0004	MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	RRM2B, 3-BP DEL, 253GAG	
604712	50484	RRM2B	0005	MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	RRM2B, CYS236PHE	121918309
604712	50484	RRM2B	0006	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 5	RRM2B, ARG327TER	121918310
604712	50484	RRM2B	0007	MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	RRM2B, GLY229VAL	121918311
604712	50484	RRM2B	0008	MITOCHONDRIAL DNA DEPLETION SYNDROME 8B (MNGIE TYPE)	RRM2B, ARG110HIS	
604712	50484	RRM2B	0009	MITOCHONDRIAL DNA DEPLETION SYNDROME 8B (MNGIE TYPE)	RRM2B, ARG121HIS	
604712	50484	RRM2B	0010	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 5	RRM2B, 1-BP DEL, 950T	
604712	50484	RRM2B	0011	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 5	RRM2B, 1-BP DUP, 965A	
604712	50484	RRM2B	0012	VARIANT OF UNKNOWN SIGNIFICANCE	RRM2B, PHE202LEU	
604712	50484	RRM2B	0013	VARIANT OF UNKNOWN SIGNIFICANCE	RRM2B, GLY273SER	
604712	50484	RRM2B	0014	VARIANT OF UNKNOWN SIGNIFICANCE	RRM2B, PRO33SER	
604714	7259	TSPYL1	0001	SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	TSPYL1, 1-BP INS, 457G	
604720	7036	TFR2	0001	HEMOCHROMATOSIS, TYPE 3	TFR2, TYR250TER	80338880
604720	7036	TFR2	0002	HEMOCHROMATOSIS, TYPE 3	TFR2, 1-BP INS, 84C	80338877
604720	7036	TFR2	0003	HEMOCHROMATOSIS, TYPE 3	TFR2, MET172LYS	80338879
604720	7036	TFR2	0004	HEMOCHROMATOSIS, TYPE 1, MODIFIER OF	TFR2, ARG455GLN	41303501
604720	7036	TFR2	0005	HEMOCHROMATOSIS, TYPE 3	TFR2, GLN690PRO	80338889
604723	10102	TSFM	0001	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	TSFM, ARG333TRP	121909485
604741	6718	AKR1D1	0001	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2	AKR1D1, PRO198LEU	121918342
604741	6718	AKR1D1	0002	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2	AKR1D1, 1-BP DEL, 511T	
604741	6718	AKR1D1	0003	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2	AKR1D1, LEU106PHE	121918343
604741	6718	AKR1D1	0004	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2	AKR1D1, PRO133ARG	
604741	6718	AKR1D1	0005	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2	AKR1D1, ARG261CYS	
604759	50511	SYCP3	0001	SPERMATOGENIC FAILURE 4	SYCP3, 1-BP DEL, 643A	
604759	50511	SYCP3	0002	PREGNANCY LOSS, SUSCEPTIBILITY TO, 4	SYCP3, IVS7, 4-BP DEL, -16ACTT	
604759	50511	SYCP3	0003	PREGNANCY LOSS, SUSCEPTIBILITY TO, 4	SYCP3, 657T-C	
604766	7827	NPHS2	0001	NEPHROTIC SYNDROME, TYPE 2	NPHS2, ARG138GLN	74315342
604766	7827	NPHS2	0002	NEPHROTIC SYNDROME, TYPE 2	NPHS2, ARG138TER	74315343
604766	7827	NPHS2	0003	NEPHROTIC SYNDROME, TYPE 2	NPHS2, 1-BP INS, 104G	
604766	7827	NPHS2	0004	NEPHROTIC SYNDROME, TYPE 2	NPHS2, 1-BP DEL, 419G	
604766	7827	NPHS2	0005	NEPHROTIC SYNDROME, TYPE 2	NPHS2, 2-BP DEL, 855AA	
604766	7827	NPHS2	0006	NEPHROTIC SYNDROME, TYPE 2	NPHS2, PRO20LEU	74315344
604766	7827	NPHS2	0007	NEPHROTIC SYNDROME, TYPE 2	NPHS2, GLY92CYS	74315345
604766	7827	NPHS2	0008	NEPHROTIC SYNDROME, TYPE 2	NPHS2, ASP160GLY	74315346
604766	7827	NPHS2	0009	NEPHROTIC SYNDROME, TYPE 2	NPHS2, VAL180MET	74315347
604766	7827	NPHS2	0010	NEPHROTIC SYNDROME, TYPE 2	NPHS2, ARG291TRP	74315348
604766	7827	NPHS2	0011	NEPHROTIC SYNDROME, TYPE 2, SUSCEPTIBILITY TO	NPHS2, ARG229GLN	61747728
604773	27034	ACAD8	0001	ISOBUTYRYL-CoA DEHYDROGENASE DEFICIENCY	ACAD8, MET103THR	121908418
604773	27034	ACAD8	0002	ISOBUTYRYL-CoA DEHYDROGENASE DEFICIENCY	ACAD8, GLY355SER	121908419
604773	27034	ACAD8	0003	ISOBUTYRYL-CoA DEHYDROGENASE DEFICIENCY	ACAD8, ARG308TRP	121908420
604773	27034	ACAD8	0004	ISOBUTYRYL-CoA DEHYDROGENASE DEFICIENCY	ACAD8, HIS267GLN	121908421
604773	27034	ACAD8	0005	ISOBUTYRYL-CoA DEHYDROGENASE DEFICIENCY	ACAD8, ARG302GLN	121908422
604774	27329	ANGPTL3	0001	HYPOBETALIPOPROTEINEMIA, FAMILIAL, 2	ANGPTL3, SER17TER	
604774	27329	ANGPTL3	0002	HYPOBETALIPOPROTEINEMIA, FAMILIAL, 2	ANGPTL3, GLU129TER	
604775	8989	TRPA1	0001	EPISODIC PAIN SYNDROME, FAMILIAL	TRPA1, ASN855SER	
604780	51099	ABHD5	0001	CHANARIN-DORFMAN SYNDROME	ABHD5, IVS6, G-A, -1	
604780	51099	ABHD5	0002	CHANARIN-DORFMAN SYNDROME	ABHD5, SER33TER	104893675
604780	51099	ABHD5	0003	CHANARIN-DORFMAN SYNDROME	ABHD5, IVS3, A-G, -2	
604780	51099	ABHD5	0004	CHANARIN-DORFMAN SYNDROME	ABHD5, GLN130PRO	28939077
604780	51099	ABHD5	0005	CHANARIN-DORFMAN SYNDROME	ABHD5, GLU7LYS	104893676
604780	51099	ABHD5	0006	CHANARIN-DORFMAN SYNDROME	ABHD5, 1-BP INS, 594C	
604780	51099	ABHD5	0007	CHANARIN-DORFMAN SYNDROME	ABHD5, GLU260LYS	28939078
604780	51099	ABHD5	0008	CHANARIN-DORFMAN SYNDROME	ABHD5, 2-BP DEL, 46AG	
604808	23767	FLRT3	0001	HYPOGONADOTROPIC HYPOGONADISM 21 WITH ANOSMIA, SUSCEPTIBILITY TO	FLRT3, GLU97GLY	
604808	23767	FLRT3	0002	HYPOGONADOTROPIC HYPOGONADISM 21 WITH ANOSMIA, SUSCEPTIBILITY TO	FLRT3, SER144ILE	
604808	23767	FLRT3	0003	HYPOGONADOTROPIC HYPOGONADISM 21 WITH ANOSMIA, SUSCEPTIBILITY TO	FLRT3, GLN69LYS	
604808	23767	FLRT3	0004	HYPOGONADOTROPIC HYPOGONADISM 21 WITH ANOSMIA	FLRT3, LYS339ARG	
604824	9365	KL	0001	CORONARY ARTERY DISEASE, SUSCEPTIBILITY TO	KL, KL-VS HAPLOTYPE	
604824	9365	KL	0002	TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC	KL, HIS193ARG	121908423
604831	2121	EVC	0001	ELLIS-VAN CREVELD SYNDROME	EVC, IVS13DS, G-T, +5	
604831	2121	EVC	0002	ELLIS-VAN CREVELD SYNDROME	EVC, GLN879TER	121908424
604831	2121	EVC	0003	ELLIS-VAN CREVELD SYNDROME	EVC, ARG340TER	121908425
604831	2121	EVC	0004	ELLIS-VAN CREVELD SYNDROME	EVC, 734T DEL	
604831	2121	EVC	0005	ELLIS-VAN CREVELD SYNDROME	EVC, ARG443GLN	35953626
604831	2121	EVC	0006	WEYERS ACRODENTAL DYSOSTOSIS ELLIS-VAN CREVELD SYNDROME	EVC, SER307PRO	121908426
604831	2121	EVC	0007	ELLIS-VAN CREVELD SYNDROME	EVC, 1-BP DEL, 2456G	
604843	10599	SLCO1B1	0001	HYPERBILIRUBINEMIA, ROTOR TYPE, DIGENIC	SLCO1B1, ARG580TER	
604843	10599	SLCO1B1	0002	HYPERBILIRUBINEMIA, ROTOR TYPE, DIGENIC	SLCO1B1, IVS5DS, G-T, +1	
604843	10599	SLCO1B1	0003	HYPERBILIRUBINEMIA, ROTOR TYPE, DIGENIC	SLCO1B1, ARG253TER	
604846	9394	HS6ST1	0001	HYPOGONADOTROPIC HYPOGONADISM 15 WITH OR WITHOUT ANOSMIA, SUSCEPTIBILITY TO	HS6ST1, ARG372TRP	
604846	9394	HS6ST1	0002	HYPOGONADOTROPIC HYPOGONADISM 15 WITH ANOSMIA, SUSCEPTIBILITY TO	HS6ST1, ARG296TRP	
604846	9394	HS6ST1	0003	HYPOGONADOTROPIC HYPOGONADISM 15 WITH ANOSMIA, SUSCEPTIBILITY TO	HS6ST1, ARG296GLN	
604846	9394	HS6ST1	0004	HYPOGONADOTROPIC HYPOGONADISM 15 WITH ANOSMIA, SUSCEPTIBILITY TO	HS6ST1, ARG313GLN	
604846	9394	HS6ST1	0005	HYPOGONADOTROPIC HYPOGONADISM 15 WITH ANOSMIA, SUSCEPTIBILITY TO	HS6ST1, MET394VAL	
604862	50489	CD207	0001	BIRBECK GRANULE DEFICIENCY	CD207, TRP264ARG	
604863	9227	LRAT	0001	RETINAL DYSTROPHY, EARLY-ONSET SEVERE, LRAT-RELATED	LRAT, SER175ARG	104893848
604863	9227	LRAT	0002	RETINAL DYSTROPHY, EARLY-ONSET SEVERE, LRAT-RELATED	LRAT, 2-BP DEL, 396AA	
604863	9227	LRAT	0003	LEBER CONGENITAL AMAUROSIS 14 RETINITIS PIGMENTOSA, JUVENILE, LRAT-RELATED, INCLUDED	LRAT, 2-BP DEL, 217AT	
604867	50833	TAS2R16	0001	BETA-GLYCOPYRANOSIDE TASTING ALCOHOL DEPENDENCE, SUSCEPTIBILITY TO, INCLUDED	TAS2R16, LYS172ASN	846664
604878	9990	SLC12A6	0001	AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY	SLC12A6, 1-BP DEL, 2436G	
604878	9990	SLC12A6	0002	AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY	SLC12A6, 2-BP DEL, 1584CT AND 1-BP INS, 1584G	
604878	9990	SLC12A6	0003	AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY	SLC12A6, ARG1011TER	121908427
604878	9990	SLC12A6	0004	AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY	SLC12A6, ARG675TER	121908428
604878	9990	SLC12A6	0005	AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY	SLC12A6, 1-BP INS, 2031T	
604878	9990	SLC12A6	0006	AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY	SLC12A6, 8-BP DEL, NT1478	
604878	9990	SLC12A6	0007	AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY	SLC12A6, 1-BP DEL, 901A	
604878	9990	SLC12A6	0008	AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY	SLC12A6, ARG207CYS	121908429
604878	9990	SLC12A6	0009	AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY	SLC12A6, 10-BP DEL, NT2994	
604878	9990	SLC12A6	0010	AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY	SLC12A6, ARG1134TER	
604882	50674	NEUROG3	0001	DIARRHEA 4, MALABSORPTIVE, CONGENITAL	NEUROG3, ARG107SER	
604882	50674	NEUROG3	0002	DIARRHEA 4, MALABSORPTIVE, CONGENITAL	NEUROG3, ARG93LEU	
604895	30009	TBX21	0001	ASTHMA, ASPIRIN-INDUCED, SUSCEPTIBILITY TO ASTHMA AND NASAL POLYPS, INCLUDED	TBX21, -1993T-C	
604896	8195	MKKS	0001	MCKUSICK-KAUFMAN SYNDROME	MKKS, HIS84TYR AND ALA242SER	74315394
604896	8195	MKKS	0003	MCKUSICK-KAUFMAN SYNDROME BARDET-BIEDL SYNDROME 6, INCLUDED	MKKS, TYR37CYS	74315396
604896	8195	MKKS	0004	MCKUSICK-KAUFMAN SYNDROME	MKKS, 2-BP DEL, 2111GG	
604896	8195	MKKS	0005	BARDET-BIEDL SYNDROME 6	MKKS, GLY52ASP	28937875
604896	8195	MKKS	0006	BARDET-BIEDL SYNDROME 6	MKKS, TYR264TER	74315397
604896	8195	MKKS	0007	BARDET-BIEDL SYNDROME 6	MKKS, 1-BP DEL, 281T	
604896	8195	MKKS	0008	BARDET-BIEDL SYNDROME 6	MKKS, LEU277PRO	74315398
604896	8195	MKKS	0009	BARDET-BIEDL SYNDROME 6	MKKS, 2-BP DEL, 429CT AND 2-BP DEL, 433AG	
604896	8195	MKKS	0010	BARDET-BIEDL SYNDROME 6	MKKS, THR57ALA	74315399
604896	8195	MKKS	0012	BARDET-BIEDL SYNDROME 6	MKKS, GLN147TER	137853154
604896	8195	MKKS	0013	BARDET-BIEDL SYNDROME 6	MKKS, CYS499SER	137853155
604896	8195	MKKS	0014	BARDET-BIEDL SYNDROME 1, MODIFIER OF	MKKS, THR325PRO	137853156
604907	23495	TNFRSF13B	0001	IMMUNODEFICIENCY, COMMON VARIABLE, 2 IMMUNOGLOBULIN A DEFICIENCY 2, INCLUDED	TNFRSF13B, CYS104ARG	34557412
604907	23495	TNFRSF13B	0002	IMMUNODEFICIENCY, COMMON VARIABLE, 2 IMMUNOGLOBULIN A DEFICIENCY 2, INCLUDED	TNFRSF13B, ALA181GLU	72553883
604907	23495	TNFRSF13B	0003	IMMUNODEFICIENCY, COMMON VARIABLE, 2	TNFRSF13B, ARG202HIS	104894649
604907	23495	TNFRSF13B	0004	IMMUNODEFICIENCY, COMMON VARIABLE, 2 IMMUNOGLOBULIN A DEFICIENCY 2, INCLUDED	TNFRSF13B, 1-BP INS, 204A	
604907	23495	TNFRSF13B	0005	IMMUNODEFICIENCY, COMMON VARIABLE, 2	TNFRSF13B, SER194TER	121908379
604907	23495	TNFRSF13B	0006	IMMUNODEFICIENCY, COMMON VARIABLE, 2	TNFRSF13B, SER144TER	104894650
604927	9150	CTDP1	0001	CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY	CTDP1, IVS6, C-T, +389	113994102
604933	4595	MUTYH	0001	FAMILIAL ADENOMATOUS POLYPOSIS 2 ENDOMETRIAL CANCER, INCLUDED	MUTYH, TYR165CYS	34612342
604933	4595	MUTYH	0002	FAMILIAL ADENOMATOUS POLYPOSIS 2 ENDOMETRIAL CANCER, INCLUDED	MUTYH, GLY382ASP	36053993
604933	4595	MUTYH	0003	FAMILIAL ADENOMATOUS POLYPOSIS 2	MUTYH, 1-BP DEL, 1419C	
604933	4595	MUTYH	0004	FAMILIAL ADENOMATOUS POLYPOSIS 2	MUTYH, TYR90TER	121908380
604933	4595	MUTYH	0005	FAMILIAL ADENOMATOUS POLYPOSIS 2	MUTYH, GLU466TER	121908381
604933	4595	MUTYH	0006	GASTRIC CANCER, SOMATIC	MUTYH, PRO391SER	121908382
604933	4595	MUTYH	0007	GASTRIC CANCER, SOMATIC	MUTYH, GLN400ARG	121908383
604933	4595	MUTYH	0008	FAMILIAL ADENOMATOUS POLYPOSIS 2 WITH PILOMATRICOMAS	MUTYH, 2-BP INS, 1186GG	
604933	4595	MUTYH	0009	FAMILIAL ADENOMATOUS POLYPOSIS 2	MUTYH, EX3-6DEL	
604934	6905	TBCE	0001	HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME KENNY-CAFFEY SYNDROME, TYPE I, INCLUDED	TBCE, 12-BP DEL, NT155	
604934	6905	TBCE	0002	HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	TBCE, 2-BP DEL, 66AG	
604934	6905	TBCE	0003	HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	TBCE, CYS371TER	121908384
604943	375611	SLC26A5	0001	DEAFNESS, AUTOSOMAL RECESSIVE 61	PRES, IVS2, A-G, -2	
604946	3811	KIR3DL1	0001	AIDS, DELAYED/RAPID PROGRESSION TO	KIR3DS, KIR3DS +/- HLA-B Bw4-80ILE	
604961	50940	PDE11A	0001	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	PDE11A, ARG307TER	76308115
604961	50940	PDE11A	0002	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	PDE11A, 1-BP DEL, 171T	
604965	6789	STK4	0001	T-CELL IMMUNODEFICIENCY, RECURRENT INFECTIONS, AUTOIMMUNITY, AND CARDIAC MALFORMATIONS	STK4, ARG117TER	
604965	6789	STK4	0002	T-CELL IMMUNODEFICIENCY, RECURRENT INFECTIONS, AUTOIMMUNITY, AND CARDIAC MALFORMATIONS	STK4, 1-BP DEL, 1103T	
604965	6789	STK4	0003	T-CELL IMMUNODEFICIENCY, RECURRENT INFECTIONS, AUTOIMMUNITY, AND CARDIAC MALFORMATIONS	STK4, TRP250TER	
604973	8547	FCN3	0001	IMMUNODEFICIENCY DUE TO FICOLIN 3 DEFICIENCY	FCN3, 1-BP DEL, 1637C	28357092
604976	53632	PRKAG3	0001	GLYCOGEN CONTENT IN SKELETAL MUSCLE, INCREASED	PRKAG3, ARG225TRP	
604982	3257	HPS1	0001	HERMANSKY-PUDLAK SYNDROME 1	HPS1, 16-BP DUP	
604982	3257	HPS1	0002	HERMANSKY-PUDLAK SYNDROME 1	HPS1, 1-BP INS, 322C	
604982	3257	HPS1	0003	HERMANSKY-PUDLAK SYNDROME 1	HPS1, GLU666TER	121908385
604982	3257	HPS1	0004	HERMANSKY-PUDLAK SYNDROME 1	HPS1, 1-BP DEL, 322C	
604982	3257	HPS1	0005	HERMANSKY-PUDLAK SYNDROME 1	HPS1, GLU133TER	121908386
604982	3257	HPS1	0006	HERMANSKY-PUDLAK SYNDROME 1	HPS1, 1-BP INS, 962G	
604982	3257	HPS1	0007	HERMANSKY-PUDLAK SYNDROME 1	HPS1, IVS5, G-A, +5	
604983	11232	POLG2	0001	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 4	POLG2, GLY451GLU	104894632
604983	11232	POLG2	0002	VARIANT OF UNKNOWN SIGNIFICANCE	POLG2, 24-BP INS, NT1207	
604983	11232	POLG2	0003	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 4	POLG2, PRO205ARG	
604983	11232	POLG2	0004	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 4	POLG2, ARG369GLY	
604983	11232	POLG2	0005	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 4	POLG2, 2-BP DEL, 1423TT	
604985	6712	SPTBN2	0001	SPINOCEREBELLAR ATAXIA 5	SPTBN2, 39-BP DEL	
604985	6712	SPTBN2	0002	SPINOCEREBELLAR ATAXIA 5	SPTBN2, 15-BP DEL, NT1886	
604985	6712	SPTBN2	0003	SPINOCEREBELLAR ATAXIA 5	SPTBN2, LEU253PRO	121918306
604990	9368	SLC9A3R1	0001	NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 2	SLC9A3R1, LEU110VAL	35910969
604990	9368	SLC9A3R1	0002	NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 2	SLC9A3R1, ARG153GLN	41282065
604990	9368	SLC9A3R1	0003	NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 2	SLC9A3R1, GLU225LYS	119486097
605000	11151	CORO1A	0001	VARIANT OF UNKNOWN SIGNIFICANCE	CORO1A, 2-BP DEL, 248CT	
605010	11005	SPINK5	0001	NETHERTON SYNDROME	SPINK5, ARG790TER	121908387
605010	11005	SPINK5	0002	NETHERTON SYNDROME	SPINK5, IVS4AS, A-T, -2	
605010	11005	SPINK5	0003	NETHERTON SYNDROME	SPINK5, 1-BP INS, 2468A	
605010	11005	SPINK5	0004	ATOPY, SUSCEPTIBILITY TO DERMATITIS, ATOPIC, 6, SUSCEPTIBILITY TO, INCLUDED;; ASTHMA, SUSCEPTIBILITY TO, INCLUDED	SPINK5, GLU420LYS	2303067
605014	8676	STX11	0001	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	STX11, 5-BP DEL	
605014	8676	STX11	0002	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	STX11, 19.2-KB DEL	
605014	8676	STX11	0003	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	STX11, GLN268TER	104893996
605018	1540	CYLD	0001	CYLINDROMATOSIS, FAMILIAL	CYLD, NT2469, G-A, +1	
605018	1540	CYLD	0002	CYLINDROMATOSIS, FAMILIAL	CYLD, ARG758TER	121908388
605018	1540	CYLD	0003	CYLINDROMATOSIS, FAMILIAL BROOKE-SPIEGLER SYNDROME, INCLUDED	CYLD, 1-BP DEL, 2253G	
605018	1540	CYLD	0004	BROOKE-SPIEGLER SYNDROME	CYLD, 1-BP DEL, 2172A	
605018	1540	CYLD	0005	TRICHOEPITHELIOMA, MULTIPLE FAMILIAL, 1	CYLD, 2-BP DEL, 2241AG	
605018	1540	CYLD	0006	TRICHOEPITHELIOMA, MULTIPLE FAMILIAL, 1	CYLD, IVS12AS, T-G, +2	
605018	1540	CYLD	0007	TRICHOEPITHELIOMA, MULTIPLE FAMILIAL, 1 BROOKE-SPIEGLER SYNDROME, INCLUDED	CYLD, GLU747GLY	121908389
605018	1540	CYLD	0008	CYLINDROMATOSIS, FAMILIAL TRICHOEPITHELIOMA, MULTIPLE FAMILIAL, 1, INCLUDED;; BROOKE-SPIEGLER SYNDROME, INCLUDED	CYLD, ARG936TER	121908390
605018	1540	CYLD	0009	CYLINDROMATOSIS, FAMILIAL	CYLD, 1-BP DUP, 561T	
605018	1540	CYLD	0010	BROOKE-SPIEGLER SYNDROME	CYLD, 1-BP DUP, 1392T	
605018	1540	CYLD	0011	CYLINDROMATOSIS, FAMILIAL	CYLD, 4-BP DEL, 1950-1GATA	
605020	30813	VSX1	0001	KERATOCONUS 1	VSX1, ARG166TRP	74315432
605020	30813	VSX1	0002	CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 1 KERATOCONUS 1, INCLUDED	VSX1, GLY160ASP	74315433
605020	30813	VSX1	0003	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	VSX1, LEU159MET	74315434
605020	30813	VSX1	0004	CRANIOFACIAL ANOMALIES AND ANTERIOR SEGMENT DYSGENESIS SYNDROME	VSX1, ALA256SER	74315435
605020	30813	VSX1	0005	KERATOCONUS 1	VSX1, LEU17PRO	74315436
605025	3675	ITGA3	0001	INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL	ITGA3, 1-BP DEL, NT1173	
605025	3675	ITGA3	0002	INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL	ITGA3, IVS11AS, G-A, -1	
605025	3675	ITGA3	0003	INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL	ITGA3, ARG628PRO	
605042	9439	MED23	0001	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 18	MED23, ARG617GLN	
605073	4591	TRIM37	0001	MULIBREY NANISM	TRIM37, 5-BP DEL, NT493	
605073	4591	TRIM37	0002	MULIBREY NANISM	TRIM37, 1-BP DEL, 2212G	
605073	4591	TRIM37	0003	MULIBREY NANISM	TRIM37, 5-BP DEL, NT838	
605073	4591	TRIM37	0004	MULIBREY NANISM	TRIM37, 1-BP INS, 1346A	
605073	4591	TRIM37	0005	MULIBREY NANISM	TRIM37, 8-BP DEL, NT855	
605073	4591	TRIM37	0006	MULIBREY NANISM	TRIM37, CYS109SER	121908391
605073	4591	TRIM37	0007	MULIBREY NANISM	TRIM37, DEL EXON 10	
605078	23435	TARDBP	0001	AMYOTROPHIC LATERAL SCLEROSIS 10 WITHOUT FRONTOTEMPORAL DEMENTIA AND WITH TDP43 INCLUSIONS	TARDBP, MET337VAL	80356730
605078	23435	TARDBP	0002	AMYOTROPHIC LATERAL SCLEROSIS 10 WITHOUT FRONTOTEMPORAL DEMENTIA AND WITH TDP43 INCLUSIONS	TARDBP, GLN331LYS	80356727
605078	23435	TARDBP	0003	AMYOTROPHIC LATERAL SCLEROSIS 10 WITHOUT FRONTOTEMPORAL DEMENTIA AND WITH TDP43 INCLUSIONS	TARDBP, GLY294ALA	80356721
605078	23435	TARDBP	0004	AMYOTROPHIC LATERAL SCLEROSIS 10 WITHOUT FRONTOTEMPORAL DEMENTIA AND WITH TDP43 INCLUSIONS	TARDBP, GLY290ALA	121908395
605078	23435	TARDBP	0005	AMYOTROPHIC LATERAL SCLEROSIS 10 WITHOUT FRONTOTEMPORAL DEMENTIA AND WITH TDP43 INCLUSIONS	TARDBP, GLY298SER	4884357
605078	23435	TARDBP	0006	AMYOTROPHIC LATERAL SCLEROSIS 10 WITHOUT FRONTOTEMPORAL DEMENTIA AND WITH TDP43 INCLUSIONS	TARDBP, ASP169GLY	80356717
605078	23435	TARDBP	0007	AMYOTROPHIC LATERAL SCLEROSIS 10 WITHOUT FRONTOTEMPORAL DEMENTIA AND WITH TDP43 INCLUSIONS	TARDBP, GLY348CYS	80356733
605078	23435	TARDBP	0008	AMYOTROPHIC LATERAL SCLEROSIS 10 WITHOUT FRONTOTEMPORAL DEMENTIA AND WITH TDP43 INCLUSIONS	TARDBP, GLN343ARG	80356731
605078	23435	TARDBP	0009	AMYOTROPHIC LATERAL SCLEROSIS 10 WITHOUT FRONTOTEMPORAL DEMENTIA AND WITH TDP43 INCLUSIONS	TARDBP, ALA315THR	80356726
605078	23435	TARDBP	0010	AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA AND WITH TDP43 INCLUSIONS	TARDBP, GLY295SER	80356723
605078	23435	TARDBP	0011	FRONTOTEMPORAL DEMENTIA WITH TDP43 INCLUSIONS, TARDBP-RELATED	TARDBP, LYS263GLU	
605078	23435	TARDBP	0012	AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA AND WITH TDP43 INCLUSIONS FRONTOTEMPORAL DEMENTIA WITH TDP43 INCLUSIONS, TARDBP-RELATED, INCLUDED	TARDBP, 2076G-A, 3-PRIME UTR	
605078	23435	TARDBP	0013	AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA AND WITH TDP43 INCLUSIONS	TARDBP, ALA382THR	
605080	54714	CNGB3	0001	ACHROMATOPSIA 3	CNGB3, SER435PHE	121918344
605080	54714	CNGB3	0002	ACHROMATOPSIA 3 MACULAR DEGENERATION, JUVENILE, INCLUDED	CNGB3, 1-BP DEL, 1148C	
605080	54714	CNGB3	0003	ACHROMATOPSIA 3	CNGB3, 8-BP DEL, NT819	
605080	54714	CNGB3	0004	ACHROMATOPSIA 3	CNGB3, 607C-T, ARG203TER	
605080	54714	CNGB3	0005	ACHROMATOPSIA 3	CNGB3, 1-BP INS, 492T	
605080	54714	CNGB3	0006	MACULAR DEGENERATION, JUVENILE	CNGB3, TYR469ASP	35365413
605083	2487	FRZB	0001	OSTEOARTHRITIS SUSCEPTIBILITY 1	FRZB, ARG324GLY	7775
605083	2487	FRZB	0002	OSTEOARTHRITIS SUSCEPTIBILITY 1	FRZB, ARG200TRP	288326
605086	54209	TREM2	0001	POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY	TREM2, TRP78TER	104893998
605086	54209	TREM2	0002	POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY	TREM2, LYS186ASN	28937876
605086	54209	TREM2	0003	POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY	TREM2, ASP134GLY	28939079
605086	54209	TREM2	0004	POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY	TREM2, IVS3, T-C, +2	
605086	54209	TREM2	0005	POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY	TREM2, TRP44TER	104894001
605086	54209	TREM2	0006	POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY	TREM2, VAL126GLY	121908402
605086	54209	TREM2	0007	POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY	TREM2, GLN33TER	104894002
605093	10019	SH2B3	0001	MYELOFIBROSIS, SOMATIC	SH2B3, 5-BP DEL	
605093	10019	SH2B3	0002	THROMBOCYTHEMIA, SOMATIC	SH2B3, GLU208GLN	
605093	10019	SH2B3	0003	ERYTHROCYTOSIS, SOMATIC	SH2B3, GLU208TER	
605101	23118	TAB2	0001	CONGENITAL HEART DISEASE, MULTIPLE TYPES, 2	TAB2, PRO208SER	
605101	23118	TAB2	0002	CONGENITAL HEART DISEASE, MULTIPLE TYPES, 2	TAB2, GLN230LYS	
605102	10747	MASP2	0001	MASP2 DEFICIENCY	MASP2, ASP105GLY	72550870
605113	10157	AASS	0001	HYPERLYSINEMIA	AASS, 9-BP DEL	
605124	10653	SPINT2	0001	DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, SYNDROMIC	SPINT2, IVS6, G-A, -1	
605124	10653	SPINT2	0002	DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, SYNDROMIC	SPINT2, TYR163CYS	121908403
605124	10653	SPINT2	0003	DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, SYNDROMIC	SPINT2, IVS3, T-C, +2	
605124	10653	SPINT2	0004	DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, SYNDROMIC	SPINT2, IVS5, T-A, +2	
605124	10653	SPINT2	0005	DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, SYNDROMIC	SPINT2, MET1LEU	121908404
605131	51741	WWOX	0001	ESOPHAGEAL SQUAMOUS CELL CARCINOMA, SOMATIC	WWOX, LEU291PRO	119487098
605145	56172	ANKH	0001	CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	ANKH, PHE377DEL	121908405
605145	56172	ANKH	0002	CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT CHONDROCALCINOSIS 2, INCLUDED	ANKH, GLY389ARG	28939080
605145	56172	ANKH	0003	CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	ANKH, IVS9, A-G, -4	
605145	56172	ANKH	0005	CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	ANKH, SER375DEL	121908406
605145	56172	ANKH	0006	CHONDROCALCINOSIS 2	ANKH, MET48THR	121908407
605145	56172	ANKH	0007	CHONDROCALCINOSIS 2	ANKH, -11C-T	
605145	56172	ANKH	0008	CHONDROCALCINOSIS 2, SPORADIC	ANKH, GLU490DEL	121908408
605145	56172	ANKH	0009	CHONDROCALCINOSIS 2	ANKH, PRO5LEU	121908409
605145	56172	ANKH	0010	CHONDROCALCINOSIS 2	ANKH, PRO5THR	121908410
605145	56172	ANKH	0011	CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	ANKH, CYS339ARG	
605145	56172	ANKH	0012	CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	ANKH, LEU391PRO	
605145	56172	ANKH	0013	CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	ANKH, LEU334ARG	
605194	55997	CFC1	0001	HETEROTAXY, VISCERAL, 2, AUTOSOMAL	CFC1, ARG112CYS	104893611
605194	55997	CFC1	0002	HETEROTAXY, VISCERAL, 2, AUTOSOMAL	CFC1, 1-BP DEL, 522C	
605194	55997	CFC1	0003	DOUBLE-OUTLET RIGHT VENTRICLE HETEROTAXY, VISCERAL, 2, AUTOSOMAL, INCLUDED	CFC1, 1-BP DEL, 174G	
605194	55997	CFC1	0004	TRANSPOSITION OF THE GREAT ARTERIES, DEXTRO-LOOPED 2	CFC1, IVS4DS, 20-BP DUP	
605195	145873	MESP2	0001	SPONDYLOCOSTAL DYSOSTOSIS 2, AUTOSOMAL RECESSIVE	MESP2, 4-BP DUP, 500ACCG	113994158
605195	145873	MESP2	0002	SPONDYLOCOSTAL DYSOSTOSIS 2, AUTOSOMAL RECESSIVE	MESP2, GLU103TER	71647808
605195	145873	MESP2	0003	SPONDYLOCOSTAL DYSOSTOSIS 2, AUTOSOMAL RECESSIVE	MESP2, LEU125VAL	71647806
605195	145873	MESP2	0004	SPONDYLOCOSTAL DYSOSTOSIS 2, AUTOSOMAL RECESSIVE	MESP2, GLU230TER	118204035
605204	1861	TOR1A	0001	DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	TOR1A, 3-BP DEL, GLU DEL	80358233
605204	1861	TOR1A	0002	DYSTONIA, EARLY-ONSET ATYPICAL, WITH MYOCLONIC FEATURES	TOR1A, 18-BP DEL, NT966	80358235
605204	1861	TOR1A	0003	DYSTONIA 1, TORSION, MODIFIER OF	TOR1A, ASP216HIS	1801968
605204	1861	TOR1A	0004	DYSTONIA 1, TORSION, LATE-ONSET	TOR1A, PHE205ILE	
605205	55811	ADCY10	0001	HYPERCALCIURIA, ABSORPTIVE, SUSCEPTIBILITY TO	SAC, 923C-T	
605205	55811	ADCY10	0002	HYPERCALCIURIA, ABSORPTIVE, SUSCEPTIBILITY TO	SAC, 1438+30T-C	
605206	10021	HCN4	0001	SICK SINUS SYNDROME 2, AUTOSOMAL DOMINANT	HCN4, SER672ARG	104894488
605206	10021	HCN4	0002	SICK SINUS SYNDROME 2, AUTOSOMAL DOMINANT	HCN4, 1-BP DEL, 1631C	
605206	10021	HCN4	0003	SICK SINUS SYNDROME 2, AUTOSOMAL DOMINANT	HCN4, ASP553ASN	104894485
605206	10021	HCN4	0004	SICK SINUS SYNDROME 2, AUTOSOMAL DOMINANT	HCN4, GLY480ARG	121908411
605206	10021	HCN4	0005	BRUGADA SYNDROME 8	HCN4, 4-BP INS, GTGA	
605207	56603	CYP26B1	0001	RADIOHUMERAL FUSIONS WITH OTHER SKELETAL AND CRANIOFACIAL ANOMALIES	CYP26B1, ARG363LEU	
605207	56603	CYP26B1	0002	RADIOHUMERAL FUSIONS WITH OTHER SKELETAL AND CRANIOFACIAL ANOMALIES	CYP26B1, SER146PRO	
605210	27185	DISC1	0001	SCHIZOPHRENIA 9	DISC1, HAPLOTYPE, HEP3	751229
605219	56616	DIABLO	0001	DEAFNESS, AUTOSOMAL DOMINANT 64	DIABLO, SER126LEU	
605232	65125	WNK1	0001	PSEUDOHYPOALDOSTERONISM, TYPE IIC	WNK1, 41-KB DEL, IVS1	
605232	65125	WNK1	0002	PSEUDOHYPOALDOSTERONISM, TYPE IIC	WNK1, 22-KB DEL, IVS1	
605232	65125	WNK1	0003	NEUROPATHY, HEREDITARY SENSORY, TYPE II	WNK1, 1-BP DEL, 594A	111033590
605232	65125	WNK1	0004	NEUROPATHY, HEREDITARY SENSORY, TYPE II	WNK1, 1-BP INS, 918A	
605232	65125	WNK1	0005	NEUROPATHY, HEREDITARY SENSORY, TYPE II	WNK1, GLN315TER	111033590
605232	65125	WNK1	0006	NEUROPATHY, HEREDITARY SENSORY, TYPE II	WNK1, 1-BP DEL, 947C	
605232	65125	WNK1	0007	NEUROPATHY, HEREDITARY SENSORY, TYPE II	WNK1, ARG290TER	111033591
605232	65125	WNK1	0008	NEUROPATHY, HEREDITARY SENSORY, TYPE II	WNK1, 1-BP INS, 1134T	
605232	65125	WNK1	0009	NEUROPATHY, HEREDITARY SENSORY, TYPE II	WNK1, GLN73TER	111033592
605232	65125	WNK1	0010	NEUROPATHY, HEREDITARY SENSORY, TYPE II	WNK1, 1-BP DEL, 639A	
605232	65125	WNK1	0011	NEUROPATHY, HEREDITARY SENSORY, TYPE II	WNK1, 2-BP DEL, 1584AG	
605232	65125	WNK1	0012	VARIANT OF UNKNOWN SIGNIFICANCE	WNK1, ILE1172MET	
605232	65125	WNK1	0013	VARIANT OF UNKNOWN SIGNIFICANCE	WNK1, SER2047ASN	
605235	8996	NOL3	0001	MYOCLONUS, FAMILIAL CORTICAL	NOL3, GLU21GLN	
605236	10699	CORIN	0001	PREECLAMPSIA/ECLAMPSIA 5	CORIN, LYS317GLU	
605236	10699	CORIN	0002	PREECLAMPSIA/ECLAMPSIA 5	CORIN, SER472GLY	
605236	10699	CORIN	0003	VARIANT OF UNKNOWN SIGNIFICANCE	CORIN, ARG539CYS	
605238	3176	HNMT	0001	ASTHMA, SUSCEPTIBILITY TO	HNMT, THR105ILE	11558538
605239	50617	ATP6V0A4	0001	RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE	ATP6V0A4, GLU753TER	121908367
605239	50617	ATP6V0A4	0002	RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE	ATP6V0A4, GLY820ARG1	
605239	50617	ATP6V0A4	0003	RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE	ATP6V0A4, IVS17, G-A, +1	
605239	50617	ATP6V0A4	0004	RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE	ATP6V0A4, 1-BP DEL, VAL35	
605239	50617	ATP6V0A4	0005	RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE	ATP6V0A4, MET580THR	3807153
605239	50617	ATP6V0A4	0006	RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE	ATP6V0A4, IVS6, G-A, -1	
605239	50617	ATP6V0A4	0007	RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE	ATP6V0A4, 1-BP DEL, GLN276	
605239	50617	ATP6V0A4	0008	RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE	ATP6V0A4, PRO524LEU	121908368
605239	50617	ATP6V0A4	0009	RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE, WITH LATE-ONSET SENSORINEURAL HEARING LOSS	ATP6V0A4, TYR502TER	121908369
605239	50617	ATP6V0A4	0010	RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE, WITH LATE-ONSET SENSORINEURAL HEARING LOSS	ATP6V0A4, ARG807GLN	28939081
605242	10083	USH1C	0001	USHER SYNDROME, TYPE IC	USH1C, IVS5AS, A DEL, -2	
605242	10083	USH1C	0002	USHER SYNDROME, TYPE IC	USH1C, 1-BP INS, 238C	
605242	10083	USH1C	0003	USHER SYNDROME, TYPE IC	USH1C, VNTR EXP	
605242	10083	USH1C	0004	USHER SYNDROME, TYPE IC	USH1C, 216G-A	
605242	10083	USH1C	0005	USHER SYNDROME, TYPE IC	USH1C, IVS1DS, G-T, +1	
605242	10083	USH1C	0006	USHER SYNDROME, TYPE IC	USH1C, IVS5DS, G-A, +1	
605242	10083	USH1C	0007	USHER SYNDROME, TYPE IC	USH1C, ARG31TER	121908370
605242	10083	USH1C	0008	DEAFNESS, AUTOSOMAL RECESSIVE 18A	USH1C, IVS12DS, G-C, +5	
605242	10083	USH1C	0009	DEAFNESS, AUTOSOMAL RECESSIVE 18A	USH1C, ARG608PRO	41282932
605242	10083	USH1C	0010	USHER SYNDROME, TYPE IC	USH1C, VAL130ILE	55843567
605242	10083	USH1C	0011	USHER SYNDROME, TYPE IC	USH1C, ARG103HIS	
605242	10083	USH1C	0012	USHER SYNDROME, TYPE IC	USH1C, IVS16, G-T, -1	
605242	10083	USH1C	0013	USHER SYNDROME, TYPE IC	USH1C, 1-BP DEL, 1220G	
605248	57192	MCOLN1	0001	MUCOLIPIDOSIS IV	MCOLN1, IVS3AS, A-G, -2	104886461
605248	57192	MCOLN1	0002	MUCOLIPIDOSIS IV	MCOLN1, 6,450-BP DEL	
605248	57192	MCOLN1	0003	MUCOLIPIDOSIS IV	MCOLN1, ARG321TER	121908371
605248	57192	MCOLN1	0004	MUCOLIPIDOSIS IV	MCOLN1, 3-BP DEL, 1346CTT	
605248	57192	MCOLN1	0005	MUCOLIPIDOSIS IV	MCOLN1, ASP362TYR	121908372
605248	57192	MCOLN1	0006	MUCOLIPIDOSIS IV	MCOLN1, ARG102TER	121908373
605248	57192	MCOLN1	0007	MUCOLIPIDOSIS IV	MCOLN1, ARG403CYS	121908374
605248	57192	MCOLN1	0008	MUCOLIPIDOSIS IV	MCOLN1, 93-BP INS, NT236	
605248	57192	MCOLN1	0009	MUCOLIPIDOSIS IV	MCOLN1, 1704A-T	
605254	23385	NCSTN	0001	ACNE INVERSA, FAMILIAL, 1	NCSTN, 1-BP DEL, 1752G	
605254	23385	NCSTN	0002	ACNE INVERSA, FAMILIAL, 1	NCSTN, IVS13, G-A, +1	
605254	23385	NCSTN	0003	ACNE INVERSA, FAMILIAL, 1	NCSTN, ARG117TER	
605257	57379	AICDA	0001	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 2	AICDA, ARG24TRP	104894324
605257	57379	AICDA	0002	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 2	AICDA, TRP68TER	104894325
605257	57379	AICDA	0003	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 2	AICDA, TRP80ARG	104894320
605257	57379	AICDA	0004	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 2	AICDA, LEU106PRO	104894321
605257	57379	AICDA	0005	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 2	AICDA, MET139VAL	104894322
605257	57379	AICDA	0006	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 2	AICDA, CYS147TER	104894323
605257	57379	AICDA	0007	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 2	AICDA, PHE151SER	104894327
605257	57379	AICDA	0008	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 2	AICDA, 19-BP DEL, NT21	
605257	57379	AICDA	0009	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 2	AICDA, 9-BP DEL, NT175	
605262	10397	NDRG1	0001	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4D	NDRG1, ARG148TER	119483085
605262	10397	NDRG1	0002	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4D	NDRG1, IVS8AS-1G-A	
605267	57158	JPH2	0001	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC 17	JPH2, SER101ARG	
605267	57158	JPH2	0002	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC 17	JPH2, TYR141HIS	
605267	57158	JPH2	0003	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC 17	JPH2, SER165PHE	
605267	57158	JPH2	0004	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC 17	JPH2, GLY505SER	
605268	57338	JPH3	0001	HUNTINGTON DISEASE-LIKE 2	JPH3, CAG(n) EXPANSION	193922903
605270	6448	SGSH	0001	SANFILIPPO SYNDROME A	SGSH, ARG245HIS	104894635
605270	6448	SGSH	0002	SANFILIPPO SYNDROME A	SGSH, ARG74CYS	104894636
605270	6448	SGSH	0003	SANFILIPPO SYNDROME A	SGSH, SER66TRP	104894637
605270	6448	SGSH	0004	SANFILIPPO SYNDROME A	SGSH, 1-BP DEL, 1091C	
605270	6448	SGSH	0005	SANFILIPPO SYNDROME A	SGSH, ARG150GLN	104894638
605270	6448	SGSH	0006	SANFILIPPO SYNDROME A	SGSH, GLU447LYS	104894639
605270	6448	SGSH	0007	SANFILIPPO SYNDROME A	SGSH, 9-BP DEL, NT1307	
605270	6448	SGSH	0008	SANFILIPPO SYNDROME A	SGSH, 11-BP DEL, NT1284	
605270	6448	SGSH	0009	SANFILIPPO SYNDROME A, ATTENUATED	SGSH, GLU369LYS	104894640
605270	6448	SGSH	0010	SANFILIPPO SYNDROME A	SGSH, ARG433GLN	104894641
605270	6448	SGSH	0011	SANFILIPPO SYNDROME A	SGSH, PRO128LEU	104894642
605270	6448	SGSH	0012	SANFILIPPO SYNDROME A, ATTENUATED	SGSH, ARG206PRO	104894643
605270	6448	SGSH	0013	SANFILIPPO SYNDROME A, ATTENUATED	SGSH, SER298PRO	
605271	51156	SERPINA10	0001	VENOUS THROMBOSIS, SUSCEPTIBILITY TO	SERPINA10, TRP303TER	61754487
605284	7248	TSC1	0001	TUBEROUS SCLEROSIS 1	TSC1, 4-BP DEL, 2105AAAG	
605284	7248	TSC1	0002	TUBEROUS SCLEROSIS 1	TSC1, LEU250TER	118203447
605284	7248	TSC1	0003	TUBEROUS SCLEROSIS 1	TSC1, LYS585ARG	118203576
605284	7248	TSC1	0004	TUBEROUS SCLEROSIS 1	TSC1, 2-BP DEL, 2122AC	
605284	7248	TSC1	0005	TUBEROUS SCLEROSIS 1	TSC1, 23-BP DUP	
605284	7248	TSC1	0006	LYMPHANGIOLEIOMYOMATOSIS	TSC1, CYS165TER	118203388
605284	7248	TSC1	0007	FOCAL CORTICAL DYSPLASIA OF TAYLOR, TYPE IIB TUBEROUS SCLEROSIS 1, INCLUDED	TSC1, HIS732TYR	118203657
605284	7248	TSC1	0008	TUBEROUS SCLEROSIS 1	TSC1, MET224ARG	118203426
605284	7248	TSC1	0009	TUBEROUS SCLEROSIS 1	TSC1, LEU180PRO	118203396
605286	11132	CAPN10	0001	DIABETES MELLITUS, NONINSULIN-DEPENDENT, SUSCEPTIBILITY TO	CAPN10, IVS3, g.4852G-A	3792267
605286	11132	CAPN10	0002	DIABETES MELLITUS, NONINSULIN-DEPENDENT, SUSCEPTIBILITY TO	CAPN10, IVS6, INS/DEL, 39-BP	3842570
605286	11132	CAPN10	0003	DIABETES MELLITUS, NONINSULIN-DEPENDENT, SUSCEPTIBILITY TO	CAPN10, IVS13, g.16378G-T	5030952
605286	11132	CAPN10	0004	DIABETES MELLITUS, NONINSULIN-DEPENDENT, SUSCEPTIBILITY TO POLYCYSTIC OVARY SYNDROME, SUSCEPTIBILITY TO, INCLUDED	CAPN10, IVS3, g.4841T-C	
605290	4976	OPA1	0001	OPTIC ATROPHY 1	OPA1, GLY300GLU	28939082
605290	4976	OPA1	0002	OPTIC ATROPHY 1	OPA1, IVS9AS, G-A, -1	
605290	4976	OPA1	0003	OPTIC ATROPHY 1 OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY, INCLUDED	OPA1, 4-BP DEL, 2708TTAG	80356530
605290	4976	OPA1	0004	OPTIC ATROPHY 1	OPA1, 4-BP DEL, 2823AGTT	
605290	4976	OPA1	0005	OPTIC ATROPHY 1	OPA1, ARG290GLN	121908375
605290	4976	OPA1	0006	OPTIC ATROPHY 1	OPA1, ARG366TER	104893752
605290	4976	OPA1	0007	OPTIC ATROPHY 1	OPA1, 3-BP DEL, 1296CAT	
605290	4976	OPA1	0008	OPTIC ATROPHY 1	OPA1, 1-BP DEL, 1354G	
605290	4976	OPA1	0009	OPTIC ATROPHY 1	OPA1, 1-BP DEL, 2826T	80356531
605290	4976	OPA1	0010	GLAUCOMA, NORMAL TENSION, SUSCEPTIBILITY TO	OPA1, IVS8, C-T, +4 AND IVS8, T-C, +32	
605290	4976	OPA1	0011	OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	OPA1, ARG445HIS	80356529
605290	4976	OPA1	0012	OPTIC ATROPHY 1 OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY, INCLUDED	OPA1, 2-BP DEL, 2848GA	
605290	4976	OPA1	0013	OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	OPA1, TYR582CYS	121908376
605290	4976	OPA1	0014	OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	OPA1, ILE432VAL	
605290	4976	OPA1	0015	OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	OPA1, SER545ARG	
605290	4976	OPA1	0016	OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	OPA1, GLY439VAL	
605290	4976	OPA1	0017	OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	OPA1, VAL910ASP	
605290	4976	OPA1	0018	OPTIC ATROPHY 1 OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY, INCLUDED	OPA1, ILE382MET	
605294	4166	CHST6	0001	MACULAR CORNEAL DYSTROPHY, TYPE I	CHST6, LYS174ARG	28937877
605294	4166	CHST6	0002	MACULAR CORNEAL DYSTROPHY, TYPE I	CHST6, ASP203GLU	28937878
605294	4166	CHST6	0003	MACULAR CORNEAL DYSTROPHY, TYPE II	CHST6, REPLACEMENT OF 5-PRIME REGION	
605294	4166	CHST6	0004	MACULAR CORNEAL DYSTROPHY, TYPE II	CHST6, DELETION OF 5-PRIME REGION	
605294	4166	CHST6	0005	MACULAR CORNEAL DYSTROPHY, TYPE I MACULAR CORNEAL DYSTROPHY, TYPE II, INCLUDED	CHST6, LEU200ARG	28937879
605294	4166	CHST6	0006	MACULAR CORNEAL DYSTROPHY, TYPE I	CHST6, CYS102GLY	
605294	4166	CHST6	0007	MACULAR CORNEAL DYSTROPHY, TYPE I	CHST6, TYR110CYS	72547544
605294	4166	CHST6	0008	MACULAR CORNEAL DYSTROPHY, TYPE I	CHST6, LEU276PRO	
605294	4166	CHST6	0009	MACULAR CORNEAL DYSTROPHY, TYPE II	CHST6, ARG93SER	
605313	9939	RBM8A	0001	THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME	RBM8A, 5-PRIME UTR, G-A	
605313	9939	RBM8A	0002	THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME	RBM8A, IVS1, G-C	
605313	9939	RBM8A	0003	THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME	RBM8A, 4-BP INS, EX4	
605313	9939	RBM8A	0004	THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME	RBM8A, C-T, EX6	
605314	9759	HDAC4	0001	BRACHYDACTYLY-MENTAL RETARDATION SYNDROME	HDAC4, 1-BP INS, 2399C	
605314	9759	HDAC4	0002	BRACHYDACTYLY-MENTAL RETARDATION SYNDROME	HDAC4, 65-BP DEL, NT490+56	
605317	93986	FOXP2	0001	DEVELOPMENTAL VERBAL DYSPRAXIA	FOXP2, ARG553HIS	121908377
605317	93986	FOXP2	0002	DEVELOPMENTAL VERBAL DYSPRAXIA	FOXP2, ARG328TER	121908378
605325	1577	CYP3A5	0001	HYPERTENSION, SALT-SENSITIVE ESSENTIAL, SUSCEPTIBILITY TO	CYP3A5, 6986A-G	
605336	10878	CFHR3	0001	MACULAR DEGENERATION, AGE-RELATED, REDUCED RISK OF HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, INCLUDED	CFHR3, 84-KB DEL	
605353	51738	GHRL	0001	OBESITY, SUSCEPTIBILITY TO METABOLIC SYNDROME, SUSCEPTIBILITY TO, INCLUDED	GHRL, ARG51GLN	34911341
605353	51738	GHRL	0002	OBESITY, AGE AT ONSET OF METABOLIC SYNDROME, SUSCEPTIBILITY TO, INCLUDED	GHRL, LEU72MET	696217
605353	51738	GHRL	0003	OBESITY, SUSCEPTIBILITY TO	GHRL, GLN90LEU	4684677
605353	51738	GHRL	0004	GHRELIN POLYMORPHISM	GHRL, 2-BP DEL, CODON 34	
605363	2571	GAD1	0001	CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 1	GAD1, SER12CYS	121918345
605367	60528	ELAC2	0001	PROSTATE CANCER, HEREDITARY, 2	ELAC2, SER217LEU	4792311
605367	60528	ELAC2	0002	PROSTATE CANCER, HEREDITARY, 2	ELAC2, ALA541THR	5030739
605367	60528	ELAC2	0003	PROSTATE CANCER, HEREDITARY, 2	ELAC2, 1-BP, 1641G	
605367	60528	ELAC2	0004	PROSTATE CANCER, HEREDITARY, 2	ELAC2, ARG781HIS	119484086
605367	60528	ELAC2	0005	PROSTATE CANCER, HEREDITARY, 2	ELAC2, GLU622VAL	119484087
605370	23092	ARHGAP26	0001	LEUKEMIA, JUVENILE MYELOMONOCYTIC, SOMATIC	ARHGAP26, ASN417SER	121918546
605370	23092	ARHGAP26	0002	LEUKEMIA, JUVENILE MYELOMONOCYTIC, SOMATIC	ARHGAP26, 52-BP INS	
605370	23092	ARHGAP26	0003	LEUKEMIA, JUVENILE MYELOMONOCYTIC, SOMATIC	ARHGAP26, 74-BP INS	
605371	10564	ARFGEF2	0001	PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE	ARFGEF2, GLU209LYS	28937880
605371	10564	ARFGEF2	0002	PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE	ARFGEF2, 242C-A, 247G-T, 249A DEL	
605377	1760	DMPK	0001	MYOTONIC DYSTROPHY 1	DM, (CTG)n EXPANSION	193922940
605378	8086	AAAS	0001	ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME	AAAS, ARG312TER	121918547
605378	8086	AAAS	0002	ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME	AAAS, ARG478TER	121918548
605378	8086	AAAS	0003	ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME	AAAS, 1-BP INS, 1071T	
605378	8086	AAAS	0004	ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME	AAAS, IVS4AS, A-G, -2	
605378	8086	AAAS	0005	ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME	AAAS, IVS14DS, G-A, +1	
605378	8086	AAAS	0006	ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME	AAAS, GLN15LYS	121918549
605378	8086	AAAS	0007	ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME	AAAS, SER263PRO	121918550
605378	8086	AAAS	0008	ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME	AAAS, IVS11, G-A, +1	
605378	8086	AAAS	0009	ACHALASIA-ALACRIMA SYNDROME	AAAS, LEU430PHE	121918551
605378	8086	AAAS	0010	ACHALASIA-ALACRIMA SYNDROME	AAAS, 251G-A	
605379	8139	GAN	0001	GIANT AXONAL NEUROPATHY 1	GAN, GLU486LYS	119485088
605379	8139	GAN	0002	GIANT AXONAL NEUROPATHY 1	GAN, GLN483TER	119485089
605379	8139	GAN	0003	GIANT AXONAL NEUROPATHY 1	GAN, 1-BP INS, 18A	
605379	8139	GAN	0004	GIANT AXONAL NEUROPATHY 1	GAN, ARG201TER	119485090
605379	8139	GAN	0005	GIANT AXONAL NEUROPATHY 1	GAN, ILE423THR	119485091
605379	8139	GAN	0006	GIANT AXONAL NEUROPATHY 1	GAN, ARG138HIS	119485092
605379	8139	GAN	0007	GIANT AXONAL NEUROPATHY 1	GAN, ARG15SER	119485093
605379	8139	GAN	0008	GIANT AXONAL NEUROPATHY 1	GAN, ARG477TER	119485094
605379	8139	GAN	0009	GIANT AXONAL NEUROPATHY 1	GAN, GLU169LYS	119485095
605380	8074	FGF23	0001	HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	FGF23, ARG176GLN	104894347
605380	8074	FGF23	0002	HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	FGF23, ARG179TRP	28937882
605380	8074	FGF23	0003	TUMORAL CALCINOSIS, FAMILIAL, HYPERPHOSPHATEMIC	FGF23, SER71GLY	104894342
605380	8074	FGF23	0004	TUMORAL CALCINOSIS, FAMILIAL, HYPERPHOSPHATEMIC	FGF23, MET96THR	104894343
605380	8074	FGF23	0005	TUMORAL CALCINOSIS, FAMILIAL, HYPERPHOSPHATEMIC	FGF23, SER129PHE	104894344
605383	50615	IL21R	0001	IgE, ELEVATED LEVEL OF	IL21R, -83T-C	
605383	50615	IL21R	0002	IL21R IMMUNODEFICIENCY	IL21R, ARG201LEU	
605383	50615	IL21R	0003	IL21R IMMUNODEFICIENCY	IL21R, 6-BP DEL, 240CTGCCA	
605391	9562	MINPP1	0001	THYROID CARCINOMA, FOLLICULAR	MINPP1, SER41LEU	119486096
605391	9562	MINPP1	0002	THYROID CARCINOMA, FOLLICULAR	MINPP1, GLN270ARG	104894171
605391	9562	MINPP1	0003	THYROID ADENOMA, FOLLICULAR	MINPP1, IVS3, T-A, +34	
605420	60529	ALX4	0001	PARIETAL FORAMINA 2	ALX4, GLN140TER	104894191
605420	60529	ALX4	0002	PARIETAL FORAMINA 2	ALX4, GLN246TER	104894192
605420	60529	ALX4	0003	PARIETAL FORAMINA 2	ALX4, ARG218GLN	104894193
605420	60529	ALX4	0004	PARIETAL FORAMINA 2	ALX4, 1-BP DEL, 504T	
605420	60529	ALX4	0005	PARIETAL FORAMINA 2	ALX4, ARG272PRO	104894196
605420	60529	ALX4	0006	PARIETAL FORAMINA 2	ALX4, SER207TER	104894197
605420	60529	ALX4	0007	PARIETAL FORAMINA 2	ALX4, 10-BP DEL, NT385	
605420	60529	ALX4	0008	FRONTONASAL DYSPLASIA 2	ALX4, ARG265TER	
605423	50846	DHH	0001	46,XY GONADAL DYSGENESIS, PARTIAL, WITH MINIFASCICULAR NEUROPATHY	DHH, MET1THR	104894346
605423	50846	DHH	0002	46,XY GONADAL DYSGENESIS, COMPLETE, DHH-RELATED	DHH, LEU162PRO	111033589
605423	50846	DHH	0003	46,XY GONADAL DYSGENESIS, COMPLETE, DHH-RELATED	DHH, 1-BP DEL, 1086G	
605425	127534	GJB4	0001	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA	GJB4, PHE137LEU, 409T-C	80358206
605425	127534	GJB4	0002	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA	GJB4, PHE137LEU, 411C-A	80358206
605425	127534	GJB4	0003	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA	GJB4, THR85PRO	80358210
605425	127534	GJB4	0004	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA	GJB4, GLY12ASP	80358211
605425	127534	GJB4	0005	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA	GJB4, ARG22HIS	80358212
605425	127534	GJB4	0006	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA	GJB4, PHE189TYR	80358213
605427	59341	TRPV4	0001	BRACHYOLMIA TYPE 3	TRPV4, ARG616GLN	121912632
605427	59341	TRPV4	0002	BRACHYOLMIA TYPE 3	TRPV4, VAL620ILE	121912633
605427	59341	TRPV4	0003	SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE PARASTREMMATIC DWARFISM, INCLUDED	TRPV4, ARG594HIS	77975504
605427	59341	TRPV4	0004	SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	TRPV4, ASP333GLY	121912634
605427	59341	TRPV4	0005	SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	TRPV4, ALA716SER	121912635
605427	59341	TRPV4	0006	METATROPIC DYSPLASIA	TRPV4, ILE331PHE	121912636
605427	59341	TRPV4	0007	METATROPIC DYSPLASIA SPONDYLOEPIPHYSEAL DYSPLASIA, MAROTEAUX TYPE, INCLUDED	TRPV4, PRO799LEU	121912637
605427	59341	TRPV4	0008	SPINAL MUSCULAR ATROPHY, DISTAL, CONGENITAL NONPROGRESSIVE SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY, INCLUDED;; HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC, INCLUDED	TRPV4, ARG315TRP	
605427	59341	TRPV4	0009	SPINAL MUSCULAR ATROPHY, DISTAL, CONGENITAL NONPROGRESSIVE HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC, INCLUDED	TRPV4, ARG269HIS	
605427	59341	TRPV4	0010	HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY, INCLUDED	TRPV4, ARG316CYS	
605427	59341	TRPV4	0011	HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC SPINAL MUSCULAR ATROPHY, DISTAL, CONGENITAL NONPROGRESSIVE, INCLUDED;; SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY, INCLUDED	TRPV4, ARG269CYS	
605427	59341	TRPV4	0012	SODIUM SERUM LEVEL QUANTITATIVE TRAIT LOCUS 1	TRPV4, PRO19SER	3742030
605427	59341	TRPV4	0013	METATROPIC DYSPLASIA	TRPV4, PRO799ALA	
605427	59341	TRPV4	0014	METATROPIC DYSPLASIA	TRPV4, PRO799SER	
605427	59341	TRPV4	0015	METATROPIC DYSPLASIA	TRPV4, PRO799ARG	
605427	59341	TRPV4	0016	METATROPIC DYSPLASIA	TRPV4, 3-BP DEL, 1411TTC	
605427	59341	TRPV4	0017	SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	TRPV4, GLU278LYS	
605427	59341	TRPV4	0018	SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE SPONDYLOEPIPHYSEAL DYSPLASIA, MAROTEAUX TYPE, INCLUDED;; METATROPIC DYSPLASIA, INCLUDED	TRPV4, GLU797LYS	
605427	59341	TRPV4	0019	SPONDYLOEPIPHYSEAL DYSPLASIA, MAROTEAUX TYPE	TRPV4, 17-BP DEL, NT2396	
605427	59341	TRPV4	0020	SPONDYLOEPIPHYSEAL DYSPLASIA, MAROTEAUX TYPE	TRPV4, GLU183LYS	
605427	59341	TRPV4	0021	SPONDYLOEPIPHYSEAL DYSPLASIA, MAROTEAUX TYPE	TRPV4, TYR602CYS	
605427	59341	TRPV4	0022	HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC	TRPV4, SER542TYR	
605427	59341	TRPV4	0023	METATROPIC DYSPLASIA	TRPV4, THR89ILE	
605427	59341	TRPV4	0024	METATROPIC DYSPLASIA	TRPV4, LYS197ARG	
605427	59341	TRPV4	0025	HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC SPINAL MUSCULAR ATROPHY, DISTAL, CONGENITAL NONPROGRESSIVE, INCLUDED	TRPV4, ARG232CYS	
605427	59341	TRPV4	0026	HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC	TRPV4, ARG316HIS	
605427	59341	TRPV4	0027	METATROPIC DYSPLASIA	TRPV4, GLY78TRP	
605427	59341	TRPV4	0028	METATROPIC DYSPLASIA	TRPV4, THR740ILE	
605427	59341	TRPV4	0029	METATROPIC DYSPLASIA	TRPV4, LYS276GLU	
605427	59341	TRPV4	0030	DIGITAL ARTHROPATHY-BRACHYDACTYLY, FAMILIAL	TRPV4, PHE273LEU	
605427	59341	TRPV4	0031	DIGITAL ARTHROPATHY-BRACHYDACTYLY, FAMILIAL	TRPV4, ARG271PRO	
605427	59341	TRPV4	0032	DIGITAL ARTHROPATHY-BRACHYDACTYLY, FAMILIAL	TRPV4, GLY270VAL	
605427	59341	TRPV4	0033	HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC	TRPV4, ARG186GLN	
605437	5583	PRKCH	0001	CEREBRAL INFARCTION, SUSCEPTIBILITY TO	PRKCH, VAL374ILE	2230500
605441	9370	ADIPOQ	0001	ADIPONECTIN DEFICIENCY	ADIPOQ, ARG112CYS	
605446	57096	RPGRIP1	0001	LEBER CONGENITAL AMAUROSIS 6	RPGRIP1, 1-BP DEL, ASP1176	
605446	57096	RPGRIP1	0002	LEBER CONGENITAL AMAUROSIS 6	RPGRIP1, TRP65TER	137853124
605446	57096	RPGRIP1	0003	LEBER CONGENITAL AMAUROSIS 6	RPGRIP1, 1-BP INS, GLN893	
605446	57096	RPGRIP1	0004	LEBER CONGENITAL AMAUROSIS 6	RPGRIP1, 1-BP DEL, LYS342	
605446	57096	RPGRIP1	0005	CONE-ROD DYSTROPHY 13	RPGRIP1, ARG827LEU	28937883
605446	57096	RPGRIP1	0006	CONE-ROD DYSTROPHY 13	RPGRIP1, ALA547SER	10151259
605446	57096	RPGRIP1	0007	LEBER CONGENITAL AMAUROSIS 6	RPGRIP1, ASP1114GLY	17103671
605446	57096	RPGRIP1	0008	LEBER CONGENITAL AMAUROSIS 6	RPGRIP1, 3-BP DEL, 3835GAG	
605452	10058	ABCB6	0001	LANGEREIS BLOOD GROUP SYSTEM, LAN(-) PHENOTYPE	ABCB6, GLN239TER	
605452	10058	ABCB6	0002	LANGEREIS BLOOD GROUP SYSTEM, LAN(-) PHENOTYPE	ABCB6, 2-BP DEL, 1690AT	
605452	10058	ABCB6	0003	LANGEREIS BLOOD GROUP SYSTEM, LAN(-) PHENOTYPE	ABCB6, ARG648TER	
605452	10058	ABCB6	0004	LANGEREIS BLOOD GROUP SYSTEM, LAN(-) PHENOTYPE	ABCB6, 2-BP DEL, 1985TC	
605452	10058	ABCB6	0005	LANGEREIS BLOOD GROUP SYSTEM, LAN(-) PHENOTYPE	ABCB6, IVS16DS, T-G, +2	
605452	10058	ABCB6	0006	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 7	ABCB6, LEU811VAL	
605452	10058	ABCB6	0007	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 7	ABCB6, ALA57THR	
605459	64240	ABCG5	0001	SITOSTEROLEMIA	ABCG5, ARG408TER	119479065
605459	64240	ABCG5	0002	SITOSTEROLEMIA	ABCG5, ARG243TER	119479066
605459	64240	ABCG5	0003	SITOSTEROLEMIA	ABCG5, ARG419HIS	119479067
605459	64240	ABCG5	0004	SITOSTEROLEMIA	ABCG5, ARG419PRO	119479067
605459	64240	ABCG5	0005	SITOSTEROLEMIA	ABCG5, ARG389HIS	119480069
605459	64240	ABCG5	0006	SITOSTEROLEMIA	ABCG5, GLU77TER	119480070
605459	64240	ABCG5	0007	SITOSTEROLEMIA	ABCG5, GLN16TER	
605459	64240	ABCG5	0008	SITOSTEROLEMIA	ABCG5, ARG446TER	
605460	64241	ABCG8	0001	SITOSTEROLEMIA	ABCG8, TRP361TER	137852987
605460	64241	ABCG8	0002	SITOSTEROLEMIA	ABCG8, GLY574ARG	137852988
605460	64241	ABCG8	0003	SITOSTEROLEMIA	ABCG8, TYR658TER	137852989
605460	64241	ABCG8	0004	SITOSTEROLEMIA	ABCG8, ARG263GLN	137852990
605460	64241	ABCG8	0005	SITOSTEROLEMIA	ABCG8, 1-BP DEL, 547C	
605460	64241	ABCG8	0006	SITOSTEROLEMIA	ABCG8, ARG412TER	137852991
605460	64241	ABCG8	0007	SITOSTEROLEMIA	ABCG8, LEU596ARG	137852992
605460	64241	ABCG8	0008	SITOSTEROLEMIA	ABCG8, PRO231THR	137852993
605460	64241	ABCG8	0009	GALLBLADDER DISEASE 4	ABCG8, ASP19HIS	11887534
605460	64241	ABCG8	0010	SITOSTEROLEMIA	ABCG8, SER107TER	
605461	23765	IL17RA	0001	CANDIDIASIS, FAMILIAL, 5	IL17RA, GLN284TER	
605481	259266	ASPM	0001	MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	ASPM, 2-BP DEL, 719CT	199422135
605481	259266	ASPM	0002	MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	ASPM, 7-BP DEL, NT1258	199422139
605481	259266	ASPM	0003	MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	ASPM, 7761T-G	189678019
605481	259266	ASPM	0004	MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	ASPM, 1-BP DEL, 9159A	199422184
605481	259266	ASPM	0005	MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	ASPM, GLN3060TER	137852994
605481	259266	ASPM	0006	MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	ASPM, TRP1326TER	137852995
605481	259266	ASPM	0007	MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	ASPM, ARG117TER	137852996
605481	259266	ASPM	0008	MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	ASPM, TYR2063TER	137852997
605481	259266	ASPM	0009	MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	ASPM, 1-BP INS, 4195A	199422163
605481	259266	ASPM	0010	MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	ASPM, ARG797TER	
605481	259266	ASPM	0011	MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	ASPM, 2-BP DEL, 7781AG	
605483	64446	DNAI2	0001	CILIARY DYSKINESIA, PRIMARY, 9	DNAI2, IVS11DS, G-A, +1	
605483	64446	DNAI2	0002	CILIARY DYSKINESIA, PRIMARY, 9	DNAI2, IVS3AS, T-G, -3	
605483	64446	DNAI2	0003	CILIARY DYSKINESIA, PRIMARY, 9	DNAI2, ARG263TER	137852998
605483	64446	DNAI2	0004	CILIARY DYSKINESIA, PRIMARY, 9	DNAI2, TRP453TER	
605495	28234	SLCO1B3	0001	HYPERBILIRUBINEMIA, ROTOR TYPE, DIGENIC	SLCO1B3, 7.2-KB DEL	
605495	28234	SLCO1B3	0002	HYPERBILIRUBINEMIA, ROTOR TYPE, DIGENIC	SLCO1B3, ARG253TER	
605497	10491	CRTAP	0001	OSTEOGENESIS IMPERFECTA, TYPE VII	CRTAP, IVS1, -1021C-G	
605497	10491	CRTAP	0002	OSTEOGENESIS IMPERFECTA, TYPE VII	CRTAP, 1-BP DEL, 879T	
605497	10491	CRTAP	0003	OSTEOGENESIS IMPERFECTA, TYPE VII	CRTAP, IVS1, G-C, +1	
605497	10491	CRTAP	0004	OSTEOGENESIS IMPERFECTA, TYPE VII	CRTAP, GLN276TER	72659361
605497	10491	CRTAP	0005	OSTEOGENESIS IMPERFECTA, TYPE VII	CRTAP, MET1ILE	72659357
605497	10491	CRTAP	0006	OSTEOGENESIS IMPERFECTA, TYPE VII	CRTAP, 16-BP DUP	
605497	10491	CRTAP	0007	OSTEOGENESIS IMPERFECTA, TYPE VII	CRTAP, 16-BP DEL/5-BP INS, NT118	
605497	10491	CRTAP	0008	OSTEOGENESIS IMPERFECTA, TYPE VII	CRTAP, TYR187TER	
605507	26525	IL36RN	0001	PUSTULAR PSORIASIS, GENERALIZED	IL36RN, LEU27PRO	
605507	26525	IL36RN	0002	PUSTULAR PSORIASIS, GENERALIZED	IL36RN, SER113LEU	
605507	26525	IL36RN	0003	PUSTULAR PSORIASIS, GENERALIZED	IL36RN, ARG48TRP	
605507	26525	IL36RN	0004	PUSTULAR PSORIASIS, GENERALIZED	IL36RN, IVS3, T-C, +6	
605507	26525	IL36RN	0005	PUSTULAR PSORIASIS, GENERALIZED	IL36RN, THR123ARG	
605507	26525	IL36RN	0006	PUSTULAR PSORIASIS, GENERALIZED	IL36RN, ARG10TER	
605511	64699	TMPRSS3	0001	DEAFNESS, AUTOSOMAL RECESSIVE 8	TMPRSS3, 8-BP DEL, SATELLITE REPEAT INS	
605511	64699	TMPRSS3	0002	DEAFNESS, AUTOSOMAL RECESSIVE 8	TMPRSS3, IVS4AS, G-A, -6	
605511	64699	TMPRSS3	0003	DEAFNESS, AUTOSOMAL RECESSIVE 8	TMPRSS3, TRP251CYS	137852999
605511	64699	TMPRSS3	0004	DEAFNESS, AUTOSOMAL RECESSIVE 8	TMPRSS3, PRO404LEU	28939084
605511	64699	TMPRSS3	0005	DEAFNESS, AUTOSOMAL RECESSIVE 8	TMPRSS3, ARG216LEU	137853000
605511	64699	TMPRSS3	0006	DEAFNESS, AUTOSOMAL RECESSIVE 8	TMPRSS3, 1-BP DEL, 207C	
605511	64699	TMPRSS3	0007	DEAFNESS, AUTOSOMAL RECESSIVE 8	TMPRSS3, ASP103GLY	
605512	6785	ELOVL4	0001	STARGARDT DISEASE 3	ELOVL4, 5-BP DEL, NT797	
605512	6785	ELOVL4	0002	STARGARDT DISEASE 3	ELOVL4, 2-BP DEL, 790T AND 794T	
605512	6785	ELOVL4	0004	STARGARDT DISEASE 3	ELOVL4, TYR270TER	104893946
605512	6785	ELOVL4	0005	ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION	ELOVL4, ARG216TER	
605512	6785	ELOVL4	0006	ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION	ELOVL4, 1-BP DEL, 690T	
605514	65217	PCDH15	0001	USHER SYNDROME, TYPE IF	PCDH15, IVS27, A-G, -2	
605514	65217	PCDH15	0002	USHER SYNDROME, TYPE IF	PCDH15, ARG3TER	137853001
605514	65217	PCDH15	0003	USHER SYNDROME, TYPE IF	PCDH15, 1-BP DEL, 1471T	199469706
605514	65217	PCDH15	0004	USHER SYNDROME, TYPE IF	PCDH15, ARG245TER	111033260
605514	65217	PCDH15	0005	USHER SYNDROME, TYPE IF USHER SYNDROME, TYPE ID/F, DIGENIC, INCLUDED	PCDH15, 3-BP DEL, 5601AAC	
605514	65217	PCDH15	0006	DEAFNESS, AUTOSOMAL RECESSIVE 23	PCDH15, GLY262ASP	137853002
605514	65217	PCDH15	0007	DEAFNESS, AUTOSOMAL RECESSIVE 23	PCDH15, ARG134GLY	137853003
605514	65217	PCDH15	0008	USHER SYNDROME, TYPE ID/F, DIGENIC	PCDH15, 1-BP DEL, 16T	
605514	65217	PCDH15	0009	USHER SYNDROME, TYPE IF	PCDH15, SER647TER	137853004
605514	65217	PCDH15	0010	DEAFNESS, AUTOSOMAL RECESSIVE 23	PCDH15, VAL528ASP	
605515	27086	FOXP1	0001	MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND AUTISTIC FEATURES	FOXP1, 390-KB DEL	
605515	27086	FOXP1	0002	MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND AUTISTIC FEATURES	FOXP1, ARG525TER	
605516	64072	CDH23	0001	USHER SYNDROME, TYPE ID	CDH23, GLN1496HIS	121908347
605516	64072	CDH23	0002	USHER SYNDROME, TYPE ID	CDH23, ARG1746GLN	111033270
605516	64072	CDH23	0003	USHER SYNDROME, TYPE ID	CDH23, 3-BP DEL, 3841ATG	
605516	64072	CDH23	0004	USHER SYNDROME, TYPE ID	CDH23, IVS51, G-A, +5	
605516	64072	CDH23	0005	DEAFNESS, AUTOSOMAL RECESSIVE 12	CDH23, ASP1243ASN	121908348
605516	64072	CDH23	0006	DEAFNESS, AUTOSOMAL RECESSIVE 12	CDH23, ASP1400ASN	121908349
605516	64072	CDH23	0007	USHER SYNDROME, TYPE ID	CDH23, GLN492TER	121908350
605516	64072	CDH23	0008	DEAFNESS, AUTOSOMAL RECESSIVE 12	CDH23, ASP2148ASN	111033271
605516	64072	CDH23	0009	DEAFNESS, AUTOSOMAL RECESSIVE 12	CDH23, ASP1341ASN	121908351
605516	64072	CDH23	0010	DEAFNESS, AUTOSOMAL RECESSIVE 12	CDH23, PHE1888SER	121908352
605516	64072	CDH23	0011	USHER SYNDROME, TYPE ID USHER SYNDROME, TYPE ID/F, DIGENIC, INCLUDED	CDH23, 1-BP DEL, 193C	
605516	64072	CDH23	0012	USHER SYNDROME, TYPE ID/F, DIGENIC	CDH23, ARG3189TRP	121908353
605516	64072	CDH23	0013	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	CDH23, THR1209ALA	41281314
605516	64072	CDH23	0014	DEAFNESS, AUTOSOMAL RECESSIVE 12	CDH23, PRO240LEU	121908354
605516	64072	CDH23	0015	DEAFNESS, AUTOSOMAL RECESSIVE 12	CDH23, ARG301GLN	121908355
605517	11041	B3GNT1	0001	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13 (1 family)	B3GNT1, ASN390ASP AND ALA406VAL	
605518	23175	LPIN1	0001	MYOGLOBINURIA, RECURRENT, AUTOSOMAL RECESSIVE	LPIN1, GLU215TER	119480071
605518	23175	LPIN1	0002	MYOGLOBINURIA, RECURRENT, AUTOSOMAL RECESSIVE	LPIN1, ARG388TER	119480072
605518	23175	LPIN1	0003	MYOGLOBINURIA, RECURRENT, AUTOSOMAL RECESSIVE	LPIN1, ARG801TER	119480073
605518	23175	LPIN1	0004	MYOGLOBINURIA, RECURRENT, AUTOSOMAL RECESSIVE	LPIN1, 2-KB DEL, EX18-19	
605518	23175	LPIN1	0005	MYOGLOBINURIA, RECURRENT, AUTOSOMAL RECESSIVE	LPIN1, IVS8DS, T-C, +2	
605519	9663	LPIN2	0001	MAJEED SYNDROME	LPIN2, SER734LEU	80338807
605519	9663	LPIN2	0002	MAJEED SYNDROME	LPIN2, 2-BP DEL, 540AT	
605522	64327	LMBR1	0001	ACHEIROPODY	LMBR1, 4- TO 6-KB DEL	
605522	64327	LMBR1	0002	POLYDACTYLY, PREAXIAL II	LMBR1, 105C-G	
605522	64327	LMBR1	0003	POLYDACTYLY, PREAXIAL II	LMBR1, 404G-A	
605522	64327	LMBR1	0004	POLYDACTYLY, PREAXIAL II	LMBR1, 305A-T	
605522	64327	LMBR1	0005	POLYDACTYLY, PREAXIAL II TRIPHALANGEAL THUMB, INCLUDED	LMBR1, 323T-C	
605522	64327	LMBR1	0006	TRIPHALANGEAL THUMB-POLYSYNDACTYLY SYNDROME	LMBR1, 398-KB DUP, IVS5	
605522	64327	LMBR1	0007	POLYDACTYLY, PREAXIAL II TRIPHALANGEAL THUMB, INCLUDED	LMBR1, 739A-G	
605522	64327	LMBR1	0008	POLYDACTYLY, PREAXIAL II TRIPHALANGEAL THUMB, INCLUDED	LMBR1, 621C-G	
605522	64327	LMBR1	0009	TRIPHALANGEAL THUMB-POLYSYNDACTYLY SYNDROME	LMBR1, 589-KB DUP, IVS5	
605522	64327	LMBR1	0010	SYNDACTYLY, TYPE IV	LMBR1, 235-KB DUP, IVS5	
605522	64327	LMBR1	0011	TRIPHALANGEAL THUMB POLYDACTYLY, PREAXIAL II, INCLUDED	LMBR1, 295T-C	
605522	64327	LMBR1	0012	POLYDACTYLY, PREAXIAL II	LMRB1, 4909C-T	
605522	64327	LMBR1	0013	POLYDACTYLY, PREAXIAL II	LMRB1, 297G-A	
605522	64327	LMBR1	0014	POLYDACTYLY, PREAXIAL II	LMRB1, 334T-G	
605525	81620	CDT1	0001	MEIER-GORLIN SYNDROME 4	CDT1, ARG462GLN	
605525	81620	CDT1	0002	MEIER-GORLIN SYNDROME 4	CDT1, TYR520TER	
605525	81620	CDT1	0003	MEIER-GORLIN SYNDROME 4	CDT1, IVS2, G-C, +1	
605525	81620	CDT1	0004	MEIER-GORLIN SYNDROME 4	CDT1, ALA66THR	
605525	81620	CDT1	0005	MEIER-GORLIN SYNDROME 4	CDT1, GLU468LYS	
605546	51206	GP6	0001	BLEEDING DISORDER, PLATELET-TYPE, 11	GP6, ARG38CYS	
605546	51206	GP6	0002	BLEEDING DISORDER, PLATELET-TYPE, 11	GP6, 5-BP DUP, 356AGCCC	
605546	51206	GP6	0003	BLEEDING DISORDER, PLATELET-TYPE, 11	GP6, SER175ASN	
605546	51206	GP6	0004	BLEEDING DISORDER, PLATELET-TYPE, 11	GP6, 16-BP DEL	
605554	51744	CD244	0001	RHEUMATOID ARTHRITIS, SUSCEPTIBILITY TO	CD244, rs3766379	3766379
605555	9049	AIP	0001	PITUITARY ADENOMA, GROWTH HORMONE-SECRETING PITUITARY ADENOMA, PROLACTIN-SECRETING, INCLUDED	AIP, GLN14TER	104894194
605555	9049	AIP	0002	PITUITARY ADENOMA, GROWTH HORMONE-SECRETING	AIP, IVS3, G-A, -1	
605555	9049	AIP	0003	PITUITARY ADENOMA, GROWTH HORMONE-SECRETING	AIP, ARG304TER	104894195
605555	9049	AIP	0004	PITUITARY ADENOMA, GROWTH HORMONE-SECRETING	AIP, 6-BP DEL, NT66	
605555	9049	AIP	0005	PITUITARY ADENOMA, GROWTH HORMONE-SECRETING	AIP, 1-BP INS, 824A	
605555	9049	AIP	0006	PITUITARY ADENOMA, GROWTH HORMONE-SECRETING	AIP, 1-BP DEL, 542T	
605555	9049	AIP	0007	PITUITARY ADENOMA PREDISPOSITION	AIP, TYR268TER	121908356
605555	9049	AIP	0008	PITUITARY ADENOMA, ACTH-SECRETING	AIP, ARG304GLN	104894190
605555	9049	AIP	0009	PITUITARY ADENOMA, GROWTH HORMONE-SECRETING	AIP, ARG22TER	121908357
605558	26281	FGF20	0001	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	FGF20, 951C/T	
605564	10518	CIB2	0001	DEAFNESS, AUTOSOMAL RECESSIVE 48	CIB2, PHE91SER	
605564	10518	CIB2	0002	DEAFNESS, AUTOSOMAL RECESSIVE 48	CIB2, CYS99TRP	
605564	10518	CIB2	0003	DEAFNESS, AUTOSOMAL RECESSIVE 48	CIB2, ILE123THR	
605564	10518	CIB2	0004	USHER SYNDROME, TYPE IJ	CIB2, GLU64ASP	
605565	56729	RETN	0001	DIABETES MELLITUS, NONINSULIN-DEPENDENT, SUSCEPTIBILITY TO HYPERTENSION, INSULIN RESISTANCE-RELATED, SUSCEPTIBILITY TO, INCLUDED	RETN, +62G-A	
605566	65078	RTN4R	0001	SCHIZOPHRENIA, SUSCEPTIBILITY TO	RTN4R, ARG119TRP	74315508
605566	65078	RTN4R	0002	SCHIZOPHRENIA, SUSCEPTIBILITY TO	RTN4R, ARG196HIS	74315509
605573	3293	HSD17B3	0001	17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	HSD17B3, SER232LEU	28939085
605573	3293	HSD17B3	0002	17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	HSD17B3, MET235VAL	119481074
605573	3293	HSD17B3	0003	17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	HSD17B3, ARG80GLN	119481075
605573	3293	HSD17B3	0004	17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	HSD17B3, ALA203VAL	119481076
605573	3293	HSD17B3	0005	17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	HSD17B3, IVS3AS, G-C, -1	
605573	3293	HSD17B3	0006	17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	HSD17B3, IVS8AS, G-A, -1	
605573	3293	HSD17B3	0007	17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	HSD17B3, ARG80TRP	119481077
605573	3293	HSD17B3	0008	17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	HSD17B3, ALA56THR	119481078
605573	3293	HSD17B3	0009	17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	HSD17B3, ASN130SER	119481079
605573	3293	HSD17B3	0010	17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	HSD17B3, CYS268TYR	119481080
605579	10410	IFITM3	0001	INFLUENZA, SEVERE, SUSCEPTIBILITY TO	IFITM3, 42T-C	
605593	10262	SF3B4	0001	ACROFACIAL DYSOSTOSIS 1, NAGER TYPE	SF3B4, MET1VAL	
605593	10262	SF3B4	0002	ACROFACIAL DYSOSTOSIS 1, NAGER TYPE	SF3B4, 1-BP INS, 1147C	
605593	10262	SF3B4	0003	ACROFACIAL DYSOSTOSIS 1, NAGER TYPE	SF3B4, 1-BP INS, 1147C	
605593	10262	SF3B4	0004	ACROFACIAL DYSOSTOSIS 1, NAGER TYPE	SF3B4, IVS4, G-A, +1	
605597	668	FOXL2	0001	BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I	FOXL2, GLN219TER	104893741
605597	668	FOXL2	0002	BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE II BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE II WITH DUANE RETRACTION SYNDROME, INCLUDED	FOXL2, 30-BP DUP, NT909	193922948
605597	668	FOXL2	0003	BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I	FOXL2, 2-BP DEL, 290CA	
605597	668	FOXL2	0004	BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I	FOXL2, 8-BP DUP, NT1149	
605597	668	FOXL2	0005	BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE II	FOXL2, 15-BP DUP, NT415	
605597	668	FOXL2	0006	BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE II BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I, INCLUDED	FOXL2, 1-BP INS, 1041C	
605597	668	FOXL2	0007	BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE II	FOXL2, 17-BP DEL, NT1092	
605597	668	FOXL2	0008	BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I	FOXL2, GLN53TER	104893737
605597	668	FOXL2	0009	BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE II, INCLUDED	FOXL2, TYR274TER	104893738
605597	668	FOXL2	0010	BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE II	FOXL2, 15-BP TRIP, NT921	
605597	668	FOXL2	0011	BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I	FOXL2, ILE84SER	28937884
605597	668	FOXL2	0012	BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I	FOXL2, GLN99TER	121908358
605597	668	FOXL2	0013	BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	FOXL2, GLN196TER	104893739
605597	668	FOXL2	0014	BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I	FOXL2, 17-BP DUP, NT1092	
605597	668	FOXL2	0015	BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I	FOXL2, 1-BP INS, 959G	
605597	668	FOXL2	0016	PREMATURE OVARIAN FAILURE 3	FOXL2, 30-BP DEL, NT898	
605597	668	FOXL2	0017	PREMATURE OVARIAN FAILURE 3	FOXL2, TYR258ASN	28937885
605597	668	FOXL2	0018	BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I, AUTOSOMAL RECESSIVE	FOXL2, 15-BP DUP, NT684	
605597	668	FOXL2	0019	PREMATURE OVARIAN FAILURE 3	FOXL2, GLY187ASP	121908359
605597	668	FOXL2	0020	BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I	FOXL2, GLU69LYS	
605602	51778	MYOZ2	0001	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 16	MYOZ2, SER48PRO	
605602	51778	MYOZ2	0002	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 16	MYOZ2, ILE246MET	
605608	23562	CLDN14	0001	DEAFNESS, AUTOSOMAL RECESSIVE 29	CLDN14, 1-BP DEL, 398T	
605608	23562	CLDN14	0002	DEAFNESS, AUTOSOMAL RECESSIVE 29	CLDN14, VAL85ASP	74315437
605608	23562	CLDN14	0003	DEAFNESS, AUTOSOMAL RECESSIVE 29	CLDN14, GLY101ARG	74315438
605610	11284	PNKP	0001	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 10	PNKP, GLU326LYS	
605610	11284	PNKP	0002	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 10	PNKP, 17-BP DUP, NT1250	
605610	11284	PNKP	0003	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 10	PNKP, LEU176PHE	
605610	11284	PNKP	0004	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 10	PNKP, 17-BP DEL	
605616	54716	SLC6A20	0001	HYPERGLYCINURIA IMINOGLYCINURIA, DIGENIC, INCLUDED	SLC6A20, THR199MET	17279437
605634	10559	SLC35A1	0001	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf, MODIFIER OF	SLC35A1, 4-BP INS, CACT	
605634	10559	SLC35A1	0002	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf	SLC35A1, 2-BP DEL, 277G AND 281C, AND 147T-C	
605646	5172	SLC26A4	0001	PENDRED SYNDROME	SLC26A4, PHE667CYS	121908360
605646	5172	SLC26A4	0002	PENDRED SYNDROME	SLC26A4, 1-BP DEL, 1565G	
605646	5172	SLC26A4	0003	PENDRED SYNDROME	SLC26A4, 1-BP DEL, 1421T	
605646	5172	SLC26A4	0004	DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT	SLC26A4, GLY497SER/ILE490LEU	
605646	5172	SLC26A4	0005	PENDRED SYNDROME	SLC26A4, LEU236PRO	80338848
605646	5172	SLC26A4	0006	PENDRED SYNDROME	SLC26A4, THR416PRO	28939086
605646	5172	SLC26A4	0007	PENDRED SYNDROME	SLC26A4, IVS8, G-A, +1	80338849
605646	5172	SLC26A4	0008	PENDRED SYNDROME	SLC26A4, GLU384GLY	111033244
605646	5172	SLC26A4	0009	DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT	SLC26A4, GLY209VAL	111033303
605646	5172	SLC26A4	0010	DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT	SLC26A4, LYS369GLU	121908361
605646	5172	SLC26A4	0011	DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT PENDRED SYNDROME, INCLUDED	SLC26A4, HIS723ARG	121908362
605646	5172	SLC26A4	0012	DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT PENDRED SYNDROME, INCLUDED	SLC26A4, THR721MET	121908363
605646	5172	SLC26A4	0013	DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT	SLC26A4, 1-BP DEL, 917T	
605646	5172	SLC26A4	0014	DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT	SLC26A4, ALA372VAL	121908364
605646	5172	SLC26A4	0015	DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT	SLC26A4, 5-BP INS, NT2111	
605646	5172	SLC26A4	0016	PENDRED SYNDROME	SLC26A4, 1-BP DEL, 279T	
605646	5172	SLC26A4	0017	PENDRED SYNDROME	SLC26A4, IVS4DS, A-G, +7	
605646	5172	SLC26A4	0018	PENDRED SYNDROME	SLC26A4, LEU445TRP	111033307
605646	5172	SLC26A4	0019	PENDRED SYNDROME	SLC26A4, THR193ILE	111033348
605646	5172	SLC26A4	0020	PENDRED SYNDROME	SLC26A4, 1-BP DEL, 1197T	
605646	5172	SLC26A4	0021	PENDRED SYNDROME	SLC26A4, 1-BP INS, 2182G	
605646	5172	SLC26A4	0022	PENDRED SYNDROME	SLC26A4, IVS8, C-G, 1002-4	
605646	5172	SLC26A4	0023	PENDRED SYNDROME	SLC26A4, SER133THR	121908365
605646	5172	SLC26A4	0024	PENDRED SYNDROME	SLC26A4, VAL138PHE	111033199
605646	5172	SLC26A4	0025	PENDRED SYNDROME	SLC26A4, TYR530HIS	111033254
605646	5172	SLC26A4	0026	PENDRED SYNDROME	SLC26A4, GLU384GLY	111033244
605646	5172	SLC26A4	0027	PENDRED SYNDROME DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT, INCLUDED	SLC26A4, -103T-C, 5-PRIME UTR	60284988
605646	5172	SLC26A4	0028	DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT, DIGENIC	SLC26A4, GLU29GLN	111033205
605646	5172	SLC26A4	0029	DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT, DIGENIC, INCLUDED	SLC26A4, IVS7AS, A-G, -2	
605646	5172	SLC26A4	0030	DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT	SLC26A4, GLN514LYS	121908366
605646	5172	SLC26A4	0031	DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT, DIGENIC	SLC26A4, PHE335LEU	111033212
605648	25793	FBXO7	0001	PARKINSON DISEASE 15, AUTOSOMAL RECESSIVE	FBXO7, ARG378GLY	71799110
605648	25793	FBXO7	0002	PARKINSON DISEASE 15, AUTOSOMAL RECESSIVE	FBXO7, ARG498TER	121918304
605648	25793	FBXO7	0003	PARKINSON DISEASE 15, AUTOSOMAL RECESSIVE	FBXO7, IVS7DS, G-T, +1	
605648	25793	FBXO7	0004	PARKINSON DISEASE 15, AUTOSOMAL RECESSIVE	FBXO7, THR22MET	121918305
605692	54822	TRPM7	0001	AMYOTROPHIC LATERAL SCLEROSIS-PARKINSONISM/DEMENTIA COMPLEX 1, SUSCEPTIBILITY TO	TRPM7, THR1482ILE,	8042919
605704	9217	VAPB	0001	AMYOTROPHIC LATERAL SCLEROSIS 8 SPINAL MUSCULAR ATROPHY, LATE-ONSET, FINKEL TYPE, INCLUDED;; AMYOTROPHIC LATERAL SCLEROSIS, TYPICAL, INCLUDED	VAPB, PRO56SER	74315431
605704	9217	VAPB	0002	AMYOTROPHIC LATERAL SCLEROSIS 8	VAPB, THR46ILE	
605706	54101	RIPK4	0001	POPLITEAL PTERYGIUM SYNDROME, LETHAL TYPE	RIPK4, SER376TER	
605706	54101	RIPK4	0002	POPLITEAL PTERYGIUM SYNDROME, LETHAL TYPE	RIPK4, ILE81ASN	
605706	54101	RIPK4	0003	POPLITEAL PTERYGIUM SYNDROME, LETHAL TYPE	RIPK4, ILE121ASN	
605706	54101	RIPK4	0004	POPLITEAL PTERYGIUM SYNDROME, LETHAL TYPE	RIPK4, 1-BP INS, 777A	
605712	10558	SPTLC1	0001	NEUROPATHY, HEREDITARY SENSORY, TYPE I	SPTLC1, CYS133TYR	119482081
605712	10558	SPTLC1	0002	NEUROPATHY, HEREDITARY SENSORY, TYPE I	SPTLC1, CYS133TRP	119482082
605712	10558	SPTLC1	0003	NEUROPATHY, HEREDITARY SENSORY, TYPE I	SPTLC1, VAL144ASP	119482083
605712	10558	SPTLC1	0004	NEUROPATHY, HEREDITARY SENSORY, TYPE I	SPTLC1, GLY387ALA	119482084
605712	10558	SPTLC1	0005	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE I, SEVERE	SPTLC1, SER331PHE	
605712	10558	SPTLC1	0006	NEUROPATHY, HEREDITARY SENSORY, TYPE I	SPTLC1, ALA352VAL	
605713	9517	SPTLC2	0001	NEUROPATHY, HEREDITARY SENSORY, TYPE IC	SPTLC2, GLY382VAL	
605713	9517	SPTLC2	0002	NEUROPATHY, HEREDITARY SENSORY, TYPE IC	SPTLC2, VAL359MET	
605713	9517	SPTLC2	0003	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC, SEVERE	SPTLC2, ILE504PHE	
605725	57716	PRX	0001	DEJERINE-SOTTAS NEUROPATHY, AUTOSOMAL RECESSIVE	PRX, ARG953TER	104894714
605725	57716	PRX	0002	DEJERINE-SOTTAS NEUROPATHY, AUTOSOMAL RECESSIVE	PRX, 1-BP DEL, 2787C	
605725	57716	PRX	0003	DEJERINE-SOTTAS NEUROPATHY, AUTOSOMAL RECESSIVE	PRX, ARG368TER	104894715
605725	57716	PRX	0004	DEJERINE-SOTTAS NEUROPATHY, AUTOSOMAL RECESSIVE	PRX, 1-BP DEL, 2289T	
605725	57716	PRX	0005	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4F	PRX, ARG196TER	104894706
605725	57716	PRX	0006	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4F	PRX, CYS715TER	104894707
605725	57716	PRX	0007	DEJERINE-SOTTAS NEUROPATHY, AUTOSOMAL RECESSIVE	PRX, 1-BP DEL, 247C	
605725	57716	PRX	0008	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4F	PRX, ARG1070TER	104894708
605725	57716	PRX	0009	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4F	PRX, 10-BP INS, NT394	
605725	57716	PRX	0010	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4F	PRX, 4-BP DEL, 1194TTCC	
605725	57716	PRX	0011	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4F, LATE-ONSET	PRX, ASP651ASN	
605740	50964	SOST	0001	SCLEROSTEOSIS	SOST, GLN24TER	
605740	50964	SOST	0002	SCLEROSTEOSIS	SOST, IVS1DS, A-T, +3 AND/OR IVS1AS, A-C, -67	
605740	50964	SOST	0003	SCLEROSTEOSIS	SOST, TRP124TER	104894644
605740	50964	SOST	0004	SCLEROSTEOSIS	SOST, ARG126TER	104894645
605740	50964	SOST	0005	CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	SOST, VAL21MET	
605740	50964	SOST	0006	CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	SOST, VAL21LEU	
605742	51807	TUBA8	0001	POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	TUBA8, 14-BP DEL	
605747	26119	LDLRAP1	0001	HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE	LDLRAP1, TRP22TER	121908324
605747	26119	LDLRAP1	0002	HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE	LDLRAP1, 1-BP INS, 432A	
605747	26119	LDLRAP1	0003	HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE	LDLRAP1, GLN136TER	121908325
605747	26119	LDLRAP1	0004	HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE	LDLRAP1, PRO202HIS	121908326
605747	26119	LDLRAP1	0005	HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE	LDLRAP1, 1-BP INS, 72G	
605747	26119	LDLRAP1	0006	HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE	LDLRAP1, 1-BP DEL, 71G	
605747	26119	LDLRAP1	0007	HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE	LDLRAP1, IVS1AS, G-C, -1	
605747	26119	LDLRAP1	0008	HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE	LDLRAP1, IVS4DS, T-G, +2	
605747	26119	LDLRAP1	0009	HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE	LDLRAP1, 1-BP INS, 599C	
605748	53630	BCMO1	0001	HYPERCAROTENEMIA AND VITAMIN A DEFICIENCY, AUTOSOMAL DOMINANT	BCMO1, THR170MET	119478057
605775	26249	KLHL3	0001	PSEUDOHYPOALDOSTERONISM, TYPE IID, AUTOSOMAL RECESSIVE	KLHL3, TRP470TER	
605775	26249	KLHL3	0002	PSEUDOHYPOALDOSTERONISM, TYPE IID, AUTOSOMAL RECESSIVE	KLHL3, PHE322CYS	
605775	26249	KLHL3	0003	PSEUDOHYPOALDOSTERONISM, TYPE IID, AUTOSOMAL DOMINANT OR RECESSIVE	KLHL3, SER410LEU	
605775	26249	KLHL3	0004	PSEUDOHYPOALDOSTERONISM, TYPE IID, AUTOSOMAL DOMINANT	KLHL3, ARG528HIS	
605775	26249	KLHL3	0005	PSEUDOHYPOALDOSTERONISM, TYPE IID, AUTOSOMAL RECESSIVE	KLHL3, ARG240TER	
605775	26249	KLHL3	0006	PSEUDOHYPOALDOSTERONISM, TYPE IID, AUTOSOMAL RECESSIVE	KLHL3, ARG336ILE	
605775	26249	KLHL3	0007	PSEUDOHYPOALDOSTERONISM, TYPE IID, AUTOSOMAL RECESSIVE	KLHL3, TYR557CYS	
605775	26249	KLHL3	0008	PSEUDOHYPOALDOSTERONISM, TYPE IID, AUTOSOMAL DOMINANT	KLHL3, ARG528CYS	
605775	26249	KLHL3	0009	PSEUDOHYPOALDOSTERONISM, TYPE IID, AUTOSOMAL DOMINANT	KLHL3, SER433ASN	
605775	26249	KLHL3	0010	PSEUDOHYPOALDOSTERONISM, TYPE IID, AUTOSOMAL DOMINANT	KLHL3, ALA398VAL	
605775	26249	KLHL3	0011	PSEUDOHYPOALDOSTERONISM, TYPE IID, AUTOSOMAL DOMINANT	KLHL3, ASN529LYS	
605775	26249	KLHL3	0012	PSEUDOHYPOALDOSTERONISM, TYPE IID, AUTOSOMAL DOMINANT	KLHL3, PRO426LEU	
605799	81693	AMN	0001	MEGALOBLASTIC ANEMIA 1, NORWEGIAN TYPE	AMN, 1-BP DEL, 14G	
605799	81693	AMN	0002	MEGALOBLASTIC ANEMIA 1, NORWEGIAN TYPE	AMN, THR41ILE	119478058
605799	81693	AMN	0003	MEGALOBLASTIC ANEMIA 1	AMN, IVS3, A-G, -2	
605802	9839	ZEB2	0001	MOWAT-WILSON SYNDROME	ZEB2, ARG549TER	137852980
605802	9839	ZEB2	0002	MOWAT-WILSON SYNDROME	ZEB2, ARG695TER	137852981
605802	9839	ZEB2	0003	MOWAT-WILSON SYNDROME	ZEB2, 4-BP DEL, NT1173	
605802	9839	ZEB2	0004	MOWAT-WILSON SYNDROME	ZEB2, 1-BP INS, 1421A	
605802	9839	ZEB2	0005	MOWAT-WILSON SYNDROME	ZEB2, 2-BP INS, 760CA	
605802	9839	ZEB2	0006	MOWAT-WILSON SYNDROME	ZEB2, 1-BP INS, 2453T	
605802	9839	ZEB2	0007	MOWAT-WILSON SYNDROME	ZEB2, 1-BP DEL, 1892A	
605802	9839	ZEB2	0008	MOWAT-WILSON SYNDROME	ZEB2, 2-BP INS, 553TG	
605802	9839	ZEB2	0009	MOWAT-WILSON SYNDROME	ZEB2, SER852TER	137852982
605802	9839	ZEB2	0010	MOWAT-WILSON SYNDROME	ZEB2, 2-BP INS, 3567CC	
605802	9839	ZEB2	0011	HIRSCHSPRUNG DISEASE-MENTAL RETARDATION SYNDROME, LATE INFANTILE	ZEB2, 3-BP DEL, 295AAC	
605802	9839	ZEB2	0012	MOWAT-WILSON SYNDROME	ZEB2, 300-KB DEL	
605802	9839	ZEB2	0013	MOWAT-WILSON SYNDROME	ZEB2, 1-BP DEL, 1862T	
605802	9839	ZEB2	0014	MOWAT-WILSON SYNDROME	ZEB2, IVS1AS, G-A, -1	
605802	9839	ZEB2	0015	MOWAT-WILSON SYNDROME	ZEB2, GLN1119ARG	137852983
605810	56945	MRPS22	0001	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5	MRPS22, ARG170HIS	119478059
605810	56945	MRPS22	0002	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5	MRPS22, LEU215PRO	
605815	23636	NUP62	0001	STRIATONIGRAL DEGENERATION, INFANTILE	NUP62, GLN391PRO	
605828	11322	TMC6	0001	EPIDERMODYSPLASIA VERRUCIFORMIS	TMC6, ARG94TER	121908327
605828	11322	TMC6	0002	EPIDERMODYSPLASIA VERRUCIFORMIS	TMC6, GLU576TER	121908328
605828	11322	TMC6	0003	EPIDERMODYSPLASIA VERRUCIFORMIS	TMC6, TYR248TER	121908329
605828	11322	TMC6	0004	EPIDERMODYSPLASIA VERRUCIFORMIS	TMC6, IVS8AS, A-T, -2	
605829	147138	TMC8	0001	EPIDERMODYSPLASIA VERRUCIFORMIS	TMC8, 1-BP DEL, 754T	
605829	147138	TMC8	0002	EPIDERMODYSPLASIA VERRUCIFORMIS	TMC8, GLU362TER	121908330
605837	8924	HERC2	0001	SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES SKIN/HAIR/EYE PIGMENTATION 1, BLOND/BROWN HAIR, INCLUDED	HERC2, IVS4, A/G	1667394
605837	8924	HERC2	0002	SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES	HERC2, IVS12, C/T	916977
605837	8924	HERC2	0003	SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES	HERC2, IVS86, C/T	12913832
605849	29958	DMGDH	0001	DIMETHYLGLYCINE DEHYDROGENASE DEFICIENCY	DMGDH, HIS81ARG	121908331
605862	10329	TMEM5	0001	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 10	TMEM5, 1-BP DEL, 795G	
605862	10329	TMEM5	0002	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 10	TMEM5, TYR339CYS	
605862	10329	TMEM5	0003	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 10	TMEM5, ARG340LEU	
605862	10329	TMEM5	0004	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 10	TMEM5, 28-BP DEL, NT1064	
605862	10329	TMEM5	0005	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 10	TMEM5, 1-BP DEL, 279A	
605862	10329	TMEM5	0006	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 10	TMEM5, ARG340TER	
605862	10329	TMEM5	0007	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 10	TMEM5, 1-BP DEL, 139G	
605870	51761	ATP8A2	0001	CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 4 (1 family)	ATP8A2, ILE376MET	
605874	51305	KCNK9	0001	BIRK-BAREL SYNDROME	KCNK9, GLY236ARG	121908332
605880	23522	KAT6B	0001	SAY-BARBER-BIESECKER-YOUNG-SIMPSON SYNDROME	KAT6B, 1-BP INS, NT4405	
605880	23522	KAT6B	0002	SAY-BARBER-BIESECKER-YOUNG-SIMPSON SYNDROME	KAT6B, 2-BP DEL, NT5370	
605880	23522	KAT6B	0003	SAY-BARBER-BIESECKER-YOUNG-SIMPSON SYNDROME	KAT6B, 1-BP DEL, NT3018	
605880	23522	KAT6B	0004	SAY-BARBER-BIESECKER-YOUNG-SIMPSON SYNDROME	KAT6B, GLU1357TER	
605880	23522	KAT6B	0005	GENITOPATELLAR SYNDROME	KAT6B, DEL/INS, NT4360	
605880	23522	KAT6B	0006	GENITOPATELLAR SYNDROME	KAT6B, 4-BP DEL, 3769TCTA	
605880	23522	KAT6B	0007	GENITOPATELLAR SYNDROME	KAT6B, 2-BP DEL, 3788AA	
605880	23522	KAT6B	0008	GENITOPATELLAR SYNDROME	KAT6B, GLY1298TER	
605880	23522	KAT6B	0009	GENITOPATELLAR SYNDROME	KAT6B, GLY1268TER	
605880	23522	KAT6B	0010	GENITOPATELLAR SYNDROME	KAT6B, 4-BP DEL, NT1227	
605880	23522	KAT6B	0011	SAY-BARBER-BIESECKER-YOUNG-SIMPSON SYNDROME	KAT6B, 8-BP DEL/4-BP INS, NT5064	
605880	23522	KAT6B	0012	SAY-BARBER-BIESECKER-YOUNG-SIMPSON SYNDROME	KAT6B, ARG1797TER	
605881	55343	SLC35C1	0001	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc	SLC35C1, ARG147CYS	28939087
605881	55343	SLC35C1	0002	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc	SLC35C1, THR308ARG	28937886
605882	83990	BRIP1	0001	BREAST CANCER, EARLY-ONSET	BRIP1, PRO47ALA	28903098
605882	83990	BRIP1	0002	BREAST CANCER, EARLY-ONSET	BRIP1, MET299ILE	137852985
605882	83990	BRIP1	0003	FANCONI ANEMIA, COMPLEMENTATION GROUP J	BRIP1, ARG798TER	137852986
605882	83990	BRIP1	0004	FANCONI ANEMIA, COMPLEMENTATION GROUP J	BRIP1, ALA349PRO	
605896	9427	ECEL1	0001	ARTHROGRYPOSIS, DISTAL, TYPE 5D	ECEL1, TYR239TER	
605896	9427	ECEL1	0002	ARTHROGRYPOSIS, DISTAL, TYPE 5D	ECEL1, 11-BP DEL, NT344	
605896	9427	ECEL1	0003	ARTHROGRYPOSIS, DISTAL, TYPE 5D	ECEL1, ARG418SER	
605896	9427	ECEL1	0004	ARTHROGRYPOSIS, DISTAL, TYPE 5D	ECEL1, IVS6, A-T, +3	
605896	9427	ECEL1	0005	ARTHROGRYPOSIS, DISTAL, TYPE 5D	ECEL1, ARG418CYS	
605896	9427	ECEL1	0006	ARTHROGRYPOSIS, DISTAL, TYPE 5D	ECEL1, GLY197ASP	
605906	11155	LDB3	0001	MYOPATHY, MYOFIBRILLAR, ZASP-RELATED	LDB3, ALA147THR	121908333
605906	11155	LDB3	0002	MYOPATHY, MYOFIBRILLAR, ZASP-RELATED	LDB3, ALA165VAL	121908334
605906	11155	LDB3	0003	MYOPATHY, MYOFIBRILLAR, ZASP-RELATED	LDB3, ARG268CYS	121908335
605906	11155	LDB3	0004	CARDIOMYOPATHY, DILATED, 1C	LDB3, ILE352MET	121908336
605906	11155	LDB3	0005	CARDIOMYOPATHY, DILATED, WITH LEFT VENTRICULAR NONCOMPACTION	LDB3, SER196LEU	45487699
605906	11155	LDB3	0006	CARDIOMYOPATHY, DILATED, WITH LEFT VENTRICULAR NONCOMPACTION	LDB3, THR213ILE	121908337
605906	11155	LDB3	0007	CARDIOMYOPATHY, DILATED, WITH LEFT VENTRICULAR NONCOMPACTION	LDB3, ASP117ASN	121908338
605906	11155	LDB3	0008	CARDIOMYOPATHY, DILATED, 1C	LDB3, LYS136MET	121908339
605906	11155	LDB3	0009	CARDIOMYOPATHY, DILATED, 1C LEFT VENTRICULAR NONCOMPACTION 3, INCLUDED	LDB3, ASP626ASN	45514002
605907	56052	ALG1	0001	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik	ALG1, SER258LEU	28939378
605907	56052	ALG1	0002	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik	ALG1, GLU342PRO	
605907	56052	ALG1	0003	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik	ALG1, SER150ARG	121908340
605907	56052	ALG1	0004	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik	ALG1, MET377VAL	
605907	56052	ALG1	0005	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik	ALG1, GLY145ASP	
605907	56052	ALG1	0006	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik	ALG1, CYS396TER	
605907	56052	ALG1	0007	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik	ALG1, ARG276TRP	
605908	23209	MLC1	0001	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1	MLC1, SER280LEU	121908341
605908	23209	MLC1	0002	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1	MLC1, SER93LEU	80358245
605908	23209	MLC1	0003	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1	MLC1, 7-BP DEL, NT564	
605908	23209	MLC1	0004	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1	MLC1, IVS10AS, A-G, -2	
605908	23209	MLC1	0005	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1	MLC1, ASN141LYS	121908343
605908	23209	MLC1	0006	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1	MLC1, ASN141SER	121908344
605908	23209	MLC1	0007	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1	MLC1, PRO92SER	121908345
605908	23209	MLC1	0008	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1	MLC1, TYR198TER	
605908	23209	MLC1	0009	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1	MLC1, GLY59GLU	80358242
605908	23209	MLC1	0011	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1	MLC1, 1-BP INS, 135C	80358241
605908	23209	MLC1	0012	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1	MLC1, 17-BP DEL, G INS	
605908	23209	MLC1	0013	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1	MLC1, SER69LEU	
605910	51129	ANGPTL4	0001	REDUCED TRIGLYCERIDES, SUSCEPTIBILITY TO	ANGPTL4, GLU40LYS	116843064
605921	6786	STIM1	0001	IMMUNE DYSFUNCTION WITH T-CELL INACTIVATION DUE TO CALCIUM ENTRY DEFECT 2	STIM1, 1-BP INS, 380A	
605921	6786	STIM1	0002	IMMUNE DYSFUNCTION WITH T-CELL INACTIVATION DUE TO CALCIUM ENTRY DEFECT 2	STIM1, IVS7AS, G-A, -1	
605921	6786	STIM1	0003	IMMUNE DYSFUNCTION WITH T-CELL INACTIVATION DUE TO CALCIUM ENTRY DEFECT 2	STIM1, ARG429CYS	
605921	6786	STIM1	0004	MYOPATHY, TUBULAR AGGREGATE	STIM1, ASP84GLY	
605921	6786	STIM1	0005	MYOPATHY, TUBULAR AGGREGATE	STIM1, HIS109ASN	
605921	6786	STIM1	0006	MYOPATHY, TUBULAR AGGREGATE	STIM1, HIS109ARG	
605921	6786	STIM1	0007	MYOPATHY, TUBULAR AGGREGATE	STIM1, HIS72GLN	
605925	5116	PCNT	0001	MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II	PCNT, GLU220TER	119479061
605925	5116	PCNT	0002	MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II	PCNT, SER629FS	
605925	5116	PCNT	0003	MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II	PCNT, CYS1190FS	
605925	5116	PCNT	0004	MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II	PCNT, ARG1923TER	119479062
605925	5116	PCNT	0005	MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II	PCNT, 1-BP INS, 841G	
605925	5116	PCNT	0006	MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II	PCNT, GLU1037TER	119479063
605925	5116	PCNT	0007	MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II	PCNT, 486-BP DEL, NT84	
605925	5116	PCNT	0008	MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II	PCNT, ARG2918TER	119479064
605925	5116	PCNT	0009	MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II	PCNT, GLN1280HIS	
605925	5116	PCNT	0010	MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II	PCNT, 3-BP DEL, 9460AAG	
605925	5116	PCNT	0011	MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II	PCNT, GLU1154TER	
605925	5116	PCNT	0012	MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II	PCNT, 1-BP INS, 1527A	
605947	9487	PIGL	0001	COLOBOMA, CONGENITAL HEART DISEASE, ICHTHYOSIFORM DERMATOSIS, MENTAL RETARDATION, AND EAR ANOMALIES SYNDROME	PIGL, LEU167PRO	
605947	9487	PIGL	0002	COLOBOMA, CONGENITAL HEART DISEASE, ICHTHYOSIFORM DERMATOSIS, MENTAL RETARDATION, AND EAR ANOMALIES SYNDROME	PIGL, 1-BP DEL, 274C	
605947	9487	PIGL	0003	COLOBOMA, CONGENITAL HEART DISEASE, ICHTHYOSIFORM DERMATOSIS, MENTAL RETARDATION, AND EAR ANOMALIES SYNDROME	PIGL, GLN218TER	
605947	9487	PIGL	0004	COLOBOMA, CONGENITAL HEART DISEASE, ICHTHYOSIFORM DERMATOSIS, MENTAL RETARDATION, AND EAR ANOMALIES SYNDROME	PIGL, IVS3AS, G-A, -1	
605950	83452	RAB33B	0001	SMITH-MCCORT DYSPLASIA 2	RAB33B, LYS46GLN	
605950	83452	RAB33B	0002	SMITH-MCCORT DYSPLASIA 2	RAB33B, ASN148LYS	
605951	54344	DPM3	0001	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Io	DPM3, LEU85SER	121908155
605956	64127	NOD2	0001	INFLAMMATORY BOWEL DISEASE 1, SUSCEPTIBILITY TO	NOD2, 1-BP INS, 3020C	
605956	64127	NOD2	0002	INFLAMMATORY BOWEL DISEASE 1, SUSCEPTIBILITY TO	NOD2, GLY908ARG	2066845
605956	64127	NOD2	0003	INFLAMMATORY BOWEL DISEASE 1, SUSCEPTIBILITY TO	NOD2, ARG702TRP	2066844
605956	64127	NOD2	0004	BLAU SYNDROME	NOD2, ARG334GLN	104895461
605956	64127	NOD2	0005	BLAU SYNDROME	NOD2, LEU469PHE	104895460
605956	64127	NOD2	0006	BLAU SYNDROME SARCOIDOSIS, EARLY-ONSET, INCLUDED	NOD2, ARG334TRP	104895462
605956	64127	NOD2	0007	INFLAMMATORY BOWEL DISEASE 1, SUSCEPTIBILITY TO	NOD2, IVS8+158	
605956	64127	NOD2	0008	SARCOIDOSIS, EARLY-ONSET	NOD2, HIS496LEU	104895472
605956	64127	NOD2	0009	SARCOIDOSIS, EARLY-ONSET	NOD2, ASP382GLU	104895476
605956	64127	NOD2	0010	SARCOIDOSIS, EARLY-ONSET	CARD15, ALA612THR	104895438
605956	64127	NOD2	0011	BLAU SYNDROME	NOD2, GLU383LYS	104895477
605956	64127	NOD2	0012	INFLAMMATORY BOWEL DISEASE 1, SUSCEPTIBILITY TO	NOD2, 1-BP INS, 3016C	
605978	23230	VPS13A	0001	CHOREOACANTHOCYTOSIS	VPS13A, ILE90LYS	119477052
605978	23230	VPS13A	0002	CHOREOACANTHOCYTOSIS	VPS13A, 1-BP INS, 6404T	
605978	23230	VPS13A	0003	CHOREOACANTHOCYTOSIS	VPS13A, 260-BP DEL	
605978	23230	VPS13A	0004	CHOREOACANTHOCYTOSIS	VPS13A, ARG208TER	119477053
605978	23230	VPS13A	0005	CHOREOACANTHOCYTOSIS	VPS13A, 8035G-A	
605978	23230	VPS13A	0006	CHOREOACANTHOCYTOSIS	VPS13A, 1-BP DEL, 6059C	
605978	23230	VPS13A	0007	CHOREOACANTHOCYTOSIS	VPS13A, 7-KB DEL	
605978	23230	VPS13A	0008	CHOREOACANTHOCYTOSIS	VPS13A, 37-KB DEL	
605978	23230	VPS13A	0009	CHOREOACANTHOCYTOSIS	VPS13A, 2-BP DUP, 3556AC	
605978	23230	VPS13A	0010	CHOREOACANTHOCYTOSIS	VPS13A, TRP435TER	
605981	197131	UBR1	0001	JOHANSON-BLIZZARD SYNDROME	UBR1, HIS136ARG	119477054
605981	197131	UBR1	0002	JOHANSON-BLIZZARD SYNDROME	UBR1, IVS20DS, T-C, +2	
605981	197131	UBR1	0003	JOHANSON-BLIZZARD SYNDROME	UBR1, GLN513TER	119477055
605981	197131	UBR1	0004	JOHANSON-BLIZZARD SYNDROME	UBR1, IVS26DS, G-A, +5	
605981	197131	UBR1	0005	JOHANSON-BLIZZARD SYNDROME	UBR1, IVS12AS, G-A, -1	
605988	64421	DCLRE1C	0001	SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION	DCLRE1C, ARG74TER	121908156
605988	64421	DCLRE1C	0002	SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION	DCLRE1C, EX1-4DEL	
605988	64421	DCLRE1C	0003	SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION	DCLRE1C, EX5-6DEL	
605988	64421	DCLRE1C	0004	SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION	DCLRE1C, IVS11DS, G-C, +1	
605988	64421	DCLRE1C	0005	SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION	DCLRE1C, IVS10DS, G-A, +1	
605988	64421	DCLRE1C	0006	SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION	DCLRE1C, IVS5DS, G-T, +1	
605988	64421	DCLRE1C	0007	SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION	DCLRE1C, 1-BP DEL, 818G	
605988	64421	DCLRE1C	0008	SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION	DCLRE1C, EX5-8DEL	
605988	64421	DCLRE1C	0009	SEVERE COMBINED IMMUNODEFICIENCY, ATHABASCAN-TYPE	DCLRE1C, TYR192TER	121908157
605988	64421	DCLRE1C	0010	SEVERE COMBINED IMMUNODEFICIENCY, PARTIAL	DCLRE1C, 7-BP DEL	
605988	64421	DCLRE1C	0011	SEVERE COMBINED IMMUNODEFICIENCY, PARTIAL	DCLRE1C, 17-BP DEL	
605988	64421	DCLRE1C	0012	OMENN SYNDROME	DCLRE1C, MET1THR	121908158
605988	64421	DCLRE1C	0013	OMENN SYNDROME	DCLRE1C, HIS35ASP	121908159
605993	54704	PDP1	0001	PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	PDP1, 3-BP DEL, LEU213	
605993	54704	PDP1	0002	PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	PDP1, GLU93TER	
605995	23095	KIF1B	0001	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A1	KIF1B, GLN98LEU	121908160
605995	23095	KIF1B	0002	NEUROBLASTOMA, SUSCEPTIBILITY TO, 1	KIF1B, GLU656VAL	121908161
605995	23095	KIF1B	0003	NEUROBLASTOMA, SUSCEPTIBILITY TO, 1	KIF1B, THR827ILE	121908162
605995	23095	KIF1B	0004	NEUROBLASTOMA, SUSCEPTIBILITY TO, 1	KIF1B, PRO1217SER	121908163
605995	23095	KIF1B	0005	PHEOCHROMOCYTOMA NEUROBLASTOMA, SUSCEPTIBILITY TO, 1, INCLUDED	KIF1B, SER1481ASN	121908164
605998	10456	HAX1	0001	NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE	HAX1, GLN190TER	74315322
605998	10456	HAX1	0002	NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE	HAX1, 1-BP INS, 130A	
605998	10456	HAX1	0003	NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE	HAX1, 1-BP INS, 431G	
605998	10456	HAX1	0004	NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE	HAX1, 1-BP INS, 175C	
605998	10456	HAX1	0005	NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE	HAX1, ARG86TER	121908165
605998	10456	HAX1	0006	NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE	HAX1, 59-BP DEL, NT376	
605998	10456	HAX1	0007	NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE	HAX1, 1-BP INS, 121G	
605998	10456	HAX1	0008	NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE	HAX1, 1-BP DEL, 91G	
606000	56244	BTNL2	0001	SARCOIDOSIS, SUSCEPTIBILITY TO, 2	BTNL2, IVS5, G-A, -1	2076530
606014	257	ALX3	0001	FRONTONASAL DYSPLASIA 1	ALX3, IVS2, A-T, -2	
606014	257	ALX3	0002	FRONTONASAL DYSPLASIA 1	ALX3, ASN203SER	121908166
606014	257	ALX3	0003	FRONTONASAL DYSPLASIA 1	ALX3, LEU168VAL	121908167
606014	257	ALX3	0004	FRONTONASAL DYSPLASIA 1	ALX3, ARG183TRP	121908168
606014	257	ALX3	0005	FRONTONASAL DYSPLASIA 1	ALX3, TYR181TER	121908169
606014	257	ALX3	0006	FRONTONASAL DYSPLASIA 1	ALX3, 4-BP DEL, 578CTGA	
606014	257	ALX3	0007	FRONTONASAL DYSPLASIA 1	ALX3, ARG196TRP	121908170
606034	10535	RNASEH2A	0001	AICARDI-GOUTIERES SYNDROME 4	RNASEH2A, GLY37SER	76857106
606037	10225	CD96	0001	C SYNDROME	CD96, EXONIC BREAKPOINT	
606037	10225	CD96	0002	C SYNDROME	CD96, THR280MET	119477056
606045	55764	IFT122	0001	CRANIOECTODERMAL DYSPLASIA 1	IFT122, VAL553GLY	
606045	55764	IFT122	0002	CRANIOECTODERMAL DYSPLASIA 1	IFT122, SER373PHE	
606045	55764	IFT122	0003	CRANIOECTODERMAL DYSPLASIA 1	IFT122, IVS6, G-A, +5	
606045	55764	IFT122	0004	CRANIOECTODERMAL DYSPLASIA 1	IFT122, TRP7CYS	
606061	57057	TBX20	0001	ATRIAL SEPTAL DEFECT 4	TBX20, ILE152MET	137852954
606061	57057	TBX20	0002	ATRIAL SEPTAL DEFECT 4	TBX20, GLN195TER	137852955
606061	57057	TBX20	0003	ATRIAL SEPTAL DEFECT 4	TBX20, ILE121MET	
606062	9126	SMC3	0001	CORNELIA DE LANGE SYNDROME 3	SMC3, 3-BP DEL, 1464AGA	
606075	56652	C10orf2	0001	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 3	C10ORF2, 39-BP DUP	
606075	56652	C10orf2	0002	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 3	C10ORF2, ALA475PRO	111033572
606075	56652	C10orf2	0003	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 3	C10ORF2, ALA359THR	111033573
606075	56652	C10orf2	0004	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 3	C10ORF2, TRP474CYS	111033574
606075	56652	C10orf2	0005	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 3	C10ORF2, TRP315LEU	111033575
606075	56652	C10orf2	0006	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 3	C10ORF2, ARG354PRO	111033576
606075	56652	C10orf2	0007	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 3	C10ORF2, LEU381PRO	111033577
606075	56652	C10orf2	0008	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, DIGENIC	C10ORF2, ARG334GLN	28937887
606075	56652	C10orf2	0009	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 3	C10ORF2, SER369TYR	111033579
606075	56652	C10orf2	0010	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 3	C10ORF2, LYS319GLU	80356543
606075	56652	C10orf2	0011	MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	C10ORF2, THR457ILE	80356544
606075	56652	C10orf2	0012	MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	C10ORF2, Y508C	80356540
606075	56652	C10orf2	0013	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 3	C10ORF2, ARG303GLN	137852956
606075	56652	C10orf2	0014	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 3	C10ORF2, ARG374TRP	
606075	56652	C10orf2	0015	MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	C10ORF2, ALA318THR	
606097	23556	PIGN	0001	MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	PIGN, ARG709GLN	
606102	23396	PIP5K1C	0001	LETHAL CONGENITAL CONTRACTURE SYNDROME 3	PIP5K1C, ASP253ASN	121908315
606118	84343	HPS3	0001	HERMANSKY-PUDLAK SYNDROME 3	HPS3, 3904-BP DEL	
606118	84343	HPS3	0002	HERMANSKY-PUDLAK SYNDROME 3	HPS3, 1303, G-A, +1	
606118	84343	HPS3	0003	HERMANSKY-PUDLAK SYNDROME 3	HPS3, 1831+2T-G	
606118	84343	HPS3	0004	HERMANSKY-PUDLAK SYNDROME 3	HPS3, 2621-2A-G	
606118	84343	HPS3	0005	HERMANSKY-PUDLAK SYNDROME 3	HPS3, 2729+1G-C	
606118	84343	HPS3	0006	HERMANSKY-PUDLAK SYNDROME 3	HPS3, ARG396TRP	121908316
606118	84343	HPS3	0007	HERMANSKY-PUDLAK SYNDROME 3	HPS3, 89-BP INS	
606119	57152	SLURP1	0001	MAL DE MELEDA	SLURP1, 1-BP DEL, 82T	
606119	57152	SLURP1	0002	MAL DE MELEDA	SLURP1, IVS2, G-A, +1	
606119	57152	SLURP1	0003	MAL DE MELEDA	SLURP1, ARG96TER	121908317
606119	57152	SLURP1	0004	MAL DE MELEDA	SLURP1, 1764G-A, GLY86ARG	
606119	57152	SLURP1	0005	MAL DE MELEDA	SLURP1, 1764G-C, GLY86ARG	
606119	57152	SLURP1	0006	MAL DE MELEDA	SLURP1, MET1LEU	28937889
606119	57152	SLURP1	0007	MAL DE MELEDA	SLURP1, TRP15ARG	121908318
606119	57152	SLURP1	0008	MAL DE MELEDA	SLURP1, CYS77ALA	121908319
606119	57152	SLURP1	0009	MAL DE MELEDA	SLURP1, CYS99TYR	121908320
606142	56606	SLC2A9	0001	URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 2	SLC2A9, IVS6, A/G	7442295
606142	56606	SLC2A9	0002	URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 2	SLC2A9, IVS4, T/C	6449213
606142	56606	SLC2A9	0003	URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 2	SLC2A9, IVS7, G/T	737267
606142	56606	SLC2A9	0004	HYPOURICEMIA, RENAL, 2	SLC2A9, ARG380TRP	121908321
606142	56606	SLC2A9	0005	HYPOURICEMIA, RENAL, 2	SLC2A9, ARG198CYS	121908322
606142	56606	SLC2A9	0006	HYPOURICEMIA, RENAL, 2	SLC2A9, PRO412ARG	121908323
606144	51715	RAB23	0001	CARPENTER SYNDROME	RAB23, LEU145TER	121908171
606144	51715	RAB23	0002	CARPENTER SYNDROME	RAB23, 1-BP INS, 408T	
606144	51715	RAB23	0003	CARPENTER SYNDROME	RAB23, 1-BP DUP, 86A	
606145	81031	SLC2A10	0001	ARTERIAL TORTUOSITY SYNDROME	SLC2A10, TRP170TER	80358229
606145	81031	SLC2A10	0002	ARTERIAL TORTUOSITY SYNDROME	SLC2A10, 1-BP DEL, 961G	
606145	81031	SLC2A10	0003	ARTERIAL TORTUOSITY SYNDROME	SLC2A10, 1-BP DEL, 1334G	
606145	81031	SLC2A10	0004	ARTERIAL TORTUOSITY SYNDROME	SLC2A10, SER81ARG	80358230
606145	81031	SLC2A10	0005	ARTERIAL TORTUOSITY SYNDROME	SLC2A10, GLY426TRP	121908172
606145	81031	SLC2A10	0006	ARTERIAL TORTUOSITY SYNDROME	SLC2A10, ARG132TRP	121908173
606151	583	BBS2	0001	BARDET-BIEDL SYNDROME 2	BBS2, 1-BP DEL, 940A	
606151	583	BBS2	0002	BARDET-BIEDL SYNDROME 2	BBS2, VAL75GLY	121908174
606151	583	BBS2	0003	BARDET-BIEDL SYNDROME 2	BBS2, TYR24TER	121908175
606151	583	BBS2	0004	BARDET-BIEDL SYNDROME 2	BBS2, GLN59TER	121908176
606151	583	BBS2	0005	BARDET-BIEDL SYNDROME 2	BBS2, ARG275TER	121908177
606151	583	BBS2	0006	BARDET-BIEDL SYNDROME 2	BBS2, ARG315TRP	121908178
606151	583	BBS2	0007	BARDET-BIEDL SYNDROME 2	BBS2, ASP170FS, TER171	
606151	583	BBS2	0008	BARDET-BIEDL SYNDROME 2	BBS2, CYS210FS, TER246	
606151	583	BBS2	0009	BARDET-BIEDL SYNDROME 2	BBS2, ASP104ALA	121908179
606151	583	BBS2	0010	BARDET-BIEDL SYNDROME 2	BBS2, ARG634PRO	
606151	583	BBS2	0011	BARDET-BIEDL SYNDROME 2	BBS2, IVS1, G-C, -1	
606151	583	BBS2	0012	BARDET-BIEDL SYNDROME 2	BBS2, VAL158FS, TER200	
606151	583	BBS2	0013	BARDET-BIEDL SYNDROME 2	BBS2, ASN70SER	4784677
606151	583	BBS2	0014	BARDET-BIEDL SYNDROME 2	BBS2, LEU168FS, TER170	
606151	583	BBS2	0015	BARDET-BIEDL SYNDROME 2	BBS2, THR560ILE	
606151	583	BBS2	0016	BARDET-BIEDL SYNDROME 2	BBS2, ARG216TER	121908180
606151	583	BBS2	0017	BARDET-BIEDL SYNDROME 2	BBS2, GLY139VAL	121908181
606151	583	BBS2	0018	BARDET-BIEDL SYNDROME 2	BBS2, IVS3AS, G-A, -2	
606152	80704	SLC19A3	0001	THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE)	SLC19A3, GLY23VAL	
606152	80704	SLC19A3	0002	THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE)	SLC19A3, THR422ALA	
606152	80704	SLC19A3	0003	THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE)	SLC19A3, LYS44GLU	137852957
606152	80704	SLC19A3	0004	THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE)	SLC19A3, GLU320GLN	137852958
606152	80704	SLC19A3	0005	THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE)	SLC19A3, 1-BP DUP, 74T	
606152	80704	SLC19A3	0006	THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE)	SLC19A3, IVS3AS, A-G, -14	
606153	514	ATP5E	0001	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 3	ATP5E, TYR12CYS	
606157	80025	PANK2	0001	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1	PANK2, 7-BP DEL, NT627	
606157	80025	PANK2	0002	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1, ATYPICAL, INCLUDED	PANK2, GLY411ARG	137852959
606157	80025	PANK2	0003	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1	PANK2, TYR80TER	137852960
606157	80025	PANK2	0004	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1	PANK2, ARG154TRP	137852961
606157	80025	PANK2	0005	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1	PANK2, ARG176CYS	137852962
606157	80025	PANK2	0006	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1	PANK2, SER361ASN	137852963
606157	80025	PANK2	0007	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1, ATYPICAL	PANK2, SER240PRO	137852964
606157	80025	PANK2	0008	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1, ATYPICAL	PANK2, THR124ALA	137852965
606157	80025	PANK2	0009	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1, ATYPICAL	PANK2, ARG168CYS	137852966
606157	80025	PANK2	0010	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1, ATYPICAL, INCLUDED	PANK2, THR418MET	137852967
606157	80025	PANK2	0011	HARP SYNDROME	PANK2, ARG371TER	137852968
606157	80025	PANK2	0012	HARP SYNDROME	PANK2, MET327THR	28939088
606157	80025	PANK2	0013	HARP SYNDROME NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1, INCLUDED	PANK2, IVS4, G-T, -1	
606157	80025	PANK2	0014	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1	PANK2, 3-BP DEL, 1142GAG	
606157	80025	PANK2	0015	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1	PANK2, SER68TER	137852969
606158	26580	BSCL2	0001	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	BSCL2, 2-BP DEL/3-BP INS, NT536	
606158	26580	BSCL2	0002	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	BSCL2, 2-BP INS, 645AA	
606158	26580	BSCL2	0003	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	BSCL2, 2-BP DEL, 659GT	
606158	26580	BSCL2	0004	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	BSCL2, 258-BP DEL/12-BP INS	
606158	26580	BSCL2	0005	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	BSCL2, 5-BP DEL, NT659	
606158	26580	BSCL2	0006	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	BSCL2, 1-BP INS, 669A	
606158	26580	BSCL2	0007	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	BSCL2, ARG138TER	137852970
606158	26580	BSCL2	0008	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	BSCL2, IVS4, G-A, +1	
606158	26580	BSCL2	0009	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	BSCL2, ALA212PRO	137852971
606158	26580	BSCL2	0010	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	BSCL2, 1-BP DEL, 980C	
606158	26580	BSCL2	0011	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	BSCL2, IVS6, G-A, +5	
606158	26580	BSCL2	0012	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	BSCL2, IVS6, C-G, -3	
606158	26580	BSCL2	0013	SILVER SPASTIC PARAPLEGIA SYNDROME SPINAL MUSCULAR ATROPHY, DISTAL, TYPE VA, INCLUDED	BSCL2, ASN88SER	137852972
606158	26580	BSCL2	0014	SILVER SPASTIC PARAPLEGIA SYNDROME	BSCL2, SER90LEU	137852973
606158	26580	BSCL2	0015	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	BSCL2, ARG275TER	137852974
606158	26580	BSCL2	0016	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	BSCL2, GLU189TER	137852975
606195	10265	IRX5	0001	HAMAMY SYNDROME	IRX5, ASN166LYS	
606195	10265	IRX5	0002	HAMAMY SYNDROME	IRX5, ALA150PRO	
606200	79365	BHLHE41	0001	SHORT SLEEPER	BHLHE41, PRO385ARG	121912617
606201	7466	WFS1	0001	WOLFRAM SYNDROME 1	WFS1, 2-BP DEL, 2812TC	
606201	7466	WFS1	0002	WOLFRAM SYNDROME 1	WFS1, 15-BP DEL, NT1685	
606201	7466	WFS1	0003	WOLFRAM SYNDROME 1	WFS1, PRO724LEU	28937890
606201	7466	WFS1	0004	WOLFRAM SYNDROME 1	WFS1, GLY695VAL	28937891
606201	7466	WFS1	0005	WOLFRAM SYNDROME 1	WFS1, TRP648TER	104893879
606201	7466	WFS1	0006	WOLFRAM SYNDROME 1	WFS1, PRO504LEU	28937892
606201	7466	WFS1	0007	WOLFRAM SYNDROME 1	WFS1, 7-BP INS, NT1610	
606201	7466	WFS1	0008	WOLFRAM SYNDROME 1	WFS1, 9-BP DEL, NT1380	
606201	7466	WFS1	0009	WOLFRAM SYNDROME 1	WFS1, 460, G-A, +1	
606201	7466	WFS1	0010	WOLFRAM SYNDROME 1	WFS1, GLN226TER	104893880
606201	7466	WFS1	0011	WOLFRAM SYNDROME 1	WFS1, GLN819TER	104893881
606201	7466	WFS1	0012	WOLFRAM SYNDROME 1	WFS1, 4-BP DEL, NT2648	
606201	7466	WFS1	0013	WOLFRAM SYNDROME 1	WFS1, 16-BP DUP, NT409	
606201	7466	WFS1	0014	DEAFNESS, AUTOSOMAL DOMINANT 6	WFS1, ALA716THR	28937893
606201	7466	WFS1	0015	DEAFNESS, AUTOSOMAL DOMINANT 6	WFS1, LEU829PRO	104893883
606201	7466	WFS1	0016	DEAFNESS, AUTOSOMAL DOMINANT 6	WFS1, THR699MET	28937894
606201	7466	WFS1	0017	DEAFNESS, AUTOSOMAL DOMINANT 6	WFS1, GLY831ASP	28937895
606201	7466	WFS1	0018	DEAFNESS, AUTOSOMAL DOMINANT 6	WFS1, LYS634THR	104893882
606201	7466	WFS1	0019	WOLFRAM SYNDROME 1	WFS1, 16-BP DEL, NT1362	
606201	7466	WFS1	0020	WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT DEAFNESS, AUTOSOMAL DOMINANT 6, INCLUDED	WFS1, GLU864LYS	74315205
606201	7466	WFS1	0021	DIABETES MELLITUS, NONINSULIN-DEPENDENT, ASSOCIATION WITH	WFS1,	6446482
606201	7466	WFS1	0022	DIABETES MELLITUS, NONINSULIN-DEPENDENT, ASSOCIATION WITH	WFS1,	6446482
606201	7466	WFS1	0023	DEAFNESS, AUTOSOMAL DOMINANT 6	WFS1, ARG859GLN	121912618
606201	7466	WFS1	0024	WOLFRAM SYNDROME 1	WFS1, VAL707PHE AND 1-BP DEL, 2819C	
606201	7466	WFS1	0025	WOLFRAM SYNDROME 1	WFS1, 8-BP DEL, NT2106	
606201	7466	WFS1	0026	WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT	WFS1, ARG228GLN	
606201	7466	WFS1	0027	WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT	WFS1, LYS836ASN	
606201	7466	WFS1	0028	WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT WOLFRAM SYNDROME 1, INCLUDED	WSF1, ALA684VAL	
606201	7466	WFS1	0029	WOLFRAM SYNDROME 1	WFS1, 3-BP DEL, VAL415DEL	
606201	7466	WFS1	0030	WOLFRAM SYNDROME 1	WFS1, 4-BP DEL, 1387CTCT	
606201	7466	WFS1	0031	WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT	WFS1, GLY780SER	
606202	51151	SLC45A2	0001	OCULOCUTANEOUS ALBINISM, TYPE IV	SLC45A2, IVS2, G-A, -1	
606202	51151	SLC45A2	0002	OCULOCUTANEOUS ALBINISM, TYPE IV	SLC45A2, LEU361PRO	121912619
606202	51151	SLC45A2	0003	OCULOCUTANEOUS ALBINISM, TYPE IV	SLC45A2, 1-BP DEL, 986C	
606202	51151	SLC45A2	0004	OCULOCUTANEOUS ALBINISM, TYPE IV	SLC45A2, 3-BP DEL	
606202	51151	SLC45A2	0005	OCULOCUTANEOUS ALBINISM, TYPE IV	SLC45A2, ALA486VAL	121912620
606202	51151	SLC45A2	0006	OCULOCUTANEOUS ALBINISM, TYPE IV	SLC45A2, ASP157ASN	121912621
606202	51151	SLC45A2	0007	SKIN/HAIR/EYE PIGMENTATION 5, BLACK/NONBLACK HAIR SKIN/HAIR/EYE PIGMENTATION 5, DARK/FAIR SKIN, INCLUDED;; SKIN/HAIR/EYE PIGMENTATION 5, DARK/LIGHT EYES, INCLUDED	SLC45A2, GLU272LYS	26722
606202	51151	SLC45A2	0008	SKIN/HAIR/EYE PIGMENTATION 5, BLACK/NONBLACK HAIR SKIN/HAIR/EYE PIGMENTATION 5, DARK/FAIR SKIN, INCLUDED;; SKIN/HAIR/EYE PIGMENTATION 5, DARK/LIGHT EYES, INCLUDED	SLC45A2, PHE374LEU	16891982
606202	51151	SLC45A2	0009	OCULOCUTANEOUS ALBINISM, TYPE IV	SLC45A2, 1-BP DEL, 1121T	
606210	57190	SEPN1	0001	RIGID SPINE MUSCULAR DYSTROPHY 1	SEPN1, GLY273GLU	121908182
606210	57190	SEPN1	0002	RIGID SPINE MUSCULAR DYSTROPHY 1	SEPN1, SEC462TER	121908183
606210	57190	SEPN1	0003	RIGID SPINE MUSCULAR DYSTROPHY 1	SEPN1, MET1VAL	121908184
606210	57190	SEPN1	0004	RIGID SPINE MUSCULAR DYSTROPHY 1	SEPN1, ARG466GLN	121908185
606210	57190	SEPN1	0005	RIGID SPINE MUSCULAR DYSTROPHY 1	SEPN1, TRP453SER	121908186
606210	57190	SEPN1	0006	RIGID SPINE MUSCULAR DYSTROPHY 1	SEPN1, 1-BP INS, 713A	
606210	57190	SEPN1	0007	RIGID SPINE MUSCULAR DYSTROPHY 1	SEPN1, SEC462GLY	121908187
606210	57190	SEPN1	0008	RIGID SPINE MUSCULAR DYSTROPHY 1 MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, INCLUDED	SEPN1, GLY315SER	121908188
606210	57190	SEPN1	0009	RIGID SPINE MUSCULAR DYSTROPHY 1	SEPN1, 92-BP DEL	
606224	51251	NT5C3A	0001	HEMOLYTIC ANEMIA DUE TO UMPH1 DEFICIENCY	NT5C3, ASP98VAL	104894025
606224	51251	NT5C3A	0002	HEMOLYTIC ANEMIA DUE TO UMPH1 DEFICIENCY	NT5C3, GLN177TER	104894026
606224	51251	NT5C3A	0003	HEMOLYTIC ANEMIA DUE TO UMPH1 DEFICIENCY	NT5C3, IVS9AS, G-T, -1	
606224	51251	NT5C3A	0004	HEMOLYTIC ANEMIA DUE TO UMPH1 DEFICIENCY	NT5C3, 2-BP INS, 743GG	
606224	51251	NT5C3A	0005	HEMOLYTIC ANEMIA DUE TO UMPH1 DEFICIENCY	NT5C3, TYR181TER	104894027
606224	51251	NT5C3A	0006	HEMOLYTIC ANEMIA DUE TO UMPH1 DEFICIENCY	NT5C3, 1-BP INS, 384A	
606224	51251	NT5C3A	0007	HEMOLYTIC ANEMIA DUE TO UMPH1 DEFICIENCY	NT5C3, IVS9AS, G-C, -1	
606224	51251	NT5C3A	0008	HEMOLYTIC ANEMIA DUE TO UMPH1 DEFICIENCY	NT5C3, ASN190SER	104894028
606224	51251	NT5C3A	0009	HEMOLYTIC ANEMIA DUE TO UMPH1 DEFICIENCY	NT5C3, 1-BP DEL, 576G	
606224	51251	NT5C3A	0010	HEMOLYTIC ANEMIA DUE TO UMPH1 DEFICIENCY	NT5C3, GLY241ARG	104894029
606227	83552	MFRP	0001	NANOPHTHALMOS 2	MFRP, 1-BP INS, 1143C	
606227	83552	MFRP	0002	NANOPHTHALMOS 2	MFRP, GLN175TER	121908189
606227	83552	MFRP	0003	NANOPHTHALMOS 2	MFRP, 1-BP DEL, 492C	
606227	83552	MFRP	0004	NANOPHTHALMOS 2	MFRP, ILE182THR	121908190
606227	83552	MFRP	0005	MICROPHTHALMIA, ISOLATED 5	MFRP, 1-BP INS, 499C	
606230	85358	SHANK3	0001	PHELAN-MCDERMID SYNDROME	SHANK3, 1-BP INS, 3680G	
606230	85358	SHANK3	0002	SCHIZOPHRENIA 15	SHANK3, ARG1117TER	
606230	85358	SHANK3	0003	SCHIZOPHRENIA 15	SHANK3, ARG536TRP	
606230	85358	SHANK3	0004	PHELAN-MCDERMID SYNDROME	SHANK3, 1-BP DEL, 3931G	
606230	85358	SHANK3	0005	PHELAN-MCDERMID SYNDROME	SHANK3, 1-BP INS, 1339G	
606230	85358	SHANK3	0006	PHELAN-MCDERMID SYNDROME	SHANK3, PRO141ALA	
606241	23405	DICER1	0001	PLEUROPULMONARY BLASTOMA	DICER1, LEU1583ARG	137852976
606241	23405	DICER1	0002	PLEUROPULMONARY BLASTOMA	DICER1, GLU493TER	137852977
606241	23405	DICER1	0003	PLEUROPULMONARY BLASTOMA	DICER1, ARG934TER	137852978
606241	23405	DICER1	0004	PLEUROPULMONARY BLASTOMA	DICER1, 1-BP INS, 2574A	
606241	23405	DICER1	0005	PLEUROPULMONARY BLASTOMA	DICER1, ARG534TER	137852979
606241	23405	DICER1	0006	PLEUROPULMONARY BLASTOMA GOITER, MULTINODULAR 1, WITH OR WITHOUT SERTOLI-LEYDIG CELL TUMORS, INCLUDED	DICER1, SER1826TER	
606241	23405	DICER1	0007	GOITER, MULTINODULAR 1, WITH OR WITHOUT SERTOLI-LEYDIG CELL TUMORS	DICER1, 4-BP DEL, 871AAAG	
606241	23405	DICER1	0008	GOITER, MULTINODULAR 1, WITH OR WITHOUT SERTOLI-LEYDIG CELL TUMORS	DICER1, 2457C-G	
606241	23405	DICER1	0009	GOITER, MULTINODULAR 1, WITHOUT SERTOLI-LEYDIG CELL TUMORS	DICER, SER839PHE	
606241	23405	DICER1	0010	GOITER, MULTINODULAR 1, WITHOUT SERTOLI-LEYDIG CELL TUMORS	DICER1, IVS17AS, G-T, -1	
606247	10617	STAMBP	0001	MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	STAMBP, GLU42GLY	
606247	10617	STAMBP	0002	MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	STAMBP, ARG178TER	
606247	10617	STAMBP	0003	MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	STAMBP, ARG38CYS	
606247	10617	STAMBP	0004	MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	STAMBP, IVS4DS, G-T, +5	
606247	10617	STAMBP	0005	MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	STAMBP, ARG424TER	
606247	10617	STAMBP	0006	MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	STAMBP, PHE100TYR	
606247	10617	STAMBP	0007	MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	STAMBP, 1-BP DEL, 411C	
606252	114609	TIRAP	0001	INVASIVE PNEUMOCOCCAL DISEASE, PROTECTION AGAINST BACTEREMIA, RESISTANCE TO, INCLUDED;; MALARIA, RESISTANCE TO, INCLUDED;; MYCOBACTERIUM TUBERCULOSIS, PROTECTION AGAINST, INCLUDED	TIRAP, SER180LEU	8177374
606264	64581	CLEC7A	0001	CANDIDIASIS, FAMILIAL, 4 ASPERGILLOSIS, SUSCEPTIBILITY TO, INCLUDED	CLEC7A, TYR238TER	16910526
606268	80326	WNT10A	0001	ODONTOONYCHODERMAL DYSPLASIA	WNT10A, GLU233TER	121908118
606268	80326	WNT10A	0002	ODONTOONYCHODERMAL DYSPLASIA SCHOPF-SCHULZ-PASSARGE SYNDROME, INCLUDED;; TOOTH AGENESIS, SELECTIVE 4, INCLUDED	WNT10A, CYS107TER	121908119
606268	80326	WNT10A	0003	ODONTOONYCHODERMAL DYSPLASIA TOOTH AGENESIS, SELECTIVE, 4, INCLUDED	WNT10A, PHE228ILE	121908120
606268	80326	WNT10A	0004	ODONTOONYCHODERMAL DYSPLASIA TOOTH AGENESIS, SELECTIVE, 4, INCLUDED	WNT10A, ARG128GLN	121908121
606268	80326	WNT10A	0005	ODONTOONYCHODERMAL DYSPLASIA	WNT10A, CYS376TER	121908122
606268	80326	WNT10A	0006	ODONTOONYCHODERMAL DYSPLASIA	WNT10A, TRP9TER	121908123
606268	80326	WNT10A	0007	TOOTH AGENESIS, SELECTIVE, 4	WNT10A, ASP217ASN	
606268	80326	WNT10A	0008	TOOTH AGENESIS, SELECTIVE, 4	WNT10A, GLY95LYS	
606269	115650	TNFRSF13C	0001	IMMUNODEFICIENCY, COMMON VARIABLE, 4	TNFRSF13C, 24-BP DEL, NT89	
606272	1497	CTNS	0001	CYSTINOSIS, NEPHROPATHIC	CTNS, GLY95TER	121908124
606272	1497	CTNS	0002	CYSTINOSIS, NEPHROPATHIC	CTNS, 2-BP DEL, 397TG	
606272	1497	CTNS	0003	CYSTINOSIS, NEPHROPATHIC	CTNS, TRP138TER	113994205
606272	1497	CTNS	0004	CYSTINOSIS, NEPHROPATHIC CYSTINOSIS, LATE-ONSET JUVENILE OR ADOLESCENT NEPHROPATHIC TYPE, INCLUDED	CTNS, 4-BP DEL, 18GACT	
606272	1497	CTNS	0005	CYSTINOSIS, NEPHROPATHIC CYSTINOSIS, LATE-ONSET JUVENILE OR ADOLESCENT NEPHROPATHIC TYPE, INCLUDED;; CYSTINOSIS, OCULAR NONNEPHROPATHIC, INCLUDED	CTNS, 57-KB DEL	
606272	1497	CTNS	0006	CYSTINOSIS, NEPHROPATHIC	CTNS, GLY169ASP	121908126
606272	1497	CTNS	0007	CYSTINOSIS, ATYPICAL NEPHROPATHIC	CTNS, VAL42ILE	35086888
606272	1497	CTNS	0008	CYSTINOSIS, LATE-ONSET JUVENILE OR ADOLESCENT NEPHROPATHIC TYPE	CTNS, IVS7AS, C-G, -10	
606272	1497	CTNS	0009	CYSTINOSIS, OCULAR NONNEPHROPATHIC	CTNS, IVS10AS, C-G, -3	113994210
606272	1497	CTNS	0010	CYSTINOSIS, NEPHROPATHIC	CTNS, 5-BP DEL, NT545	
606272	1497	CTNS	0011	CYSTINOSIS, OCULAR NONNEPHROPATHIC	CTNS, GLY197ARG	113994207
606272	1497	CTNS	0012	CYSTINOSIS, NEPHROPATHIC	CTNS, -295G-C	
606272	1497	CTNS	0013	CYSTINOSIS, OCULAR NONNEPHROPATHIC	CTNS, -303G-T	
606272	1497	CTNS	0014	CYSTINOSIS, OCULAR NONNEPHROPATHIC	CTNS, 1-BP INS, -303T	
606272	1497	CTNS	0015	CYSTINOSIS, NEPHROPATHIC	CTNS, GLY339ARG	121908127
606272	1497	CTNS	0016	CYSTINOSIS, LATE-ONSET JUVENILE OR ADOLESCENT NEPHROPATHIC TYPE	CTNS, ASN323LYS	121908128
606272	1497	CTNS	0017	CYSTINOSIS, ATYPICAL NEPHROPATHIC	CTNS, GLY110VAL	121908129
606272	1497	CTNS	0018	CYSTINOSIS, LATE-ONSET JUVENILE OR ADOLESCENT NEPHROPATHIC TYPE CYSTINOSIS, ATYPICAL NEPHROPATHIC, INCLUDED	CTNS, SER139PHE	
606273	8891	EIF2B3	0001	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER	EIF2B3, ARG225GLN	113994024
606273	8891	EIF2B3	0002	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER	EIF2B3, 2-BP DEL, 1295TG	
606273	8891	EIF2B3	0003	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER	EIF2B3, ALA87VAL	113994022
606273	8891	EIF2B3	0004	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER	EIF2B3, ILE346THR	119474039
606273	8891	EIF2B3	0005	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER, ADULT-ONSET	EIF2B3, LEU27GLN	
606309	56145	PCDHA3	0001	VARIANT OF UNKNOWN SIGNIFICANCE	PCDHA3, SER584PRO	
606326	4990	SIX6	0001	MICROPHTHALMIA, ISOLATED, WITH CATARACT 2	SIX6, THR165ALA	104894480
606347	9051	PSTPIP1	0001	PYOGENIC STERILE ARTHRITIS, PYODERMA GANGRENOSUM, AND ACNE	PSTPIP1, GLU250GLN	28939089
606347	9051	PSTPIP1	0002	PYOGENIC STERILE ARTHRITIS, PYODERMA GANGRENOSUM, AND ACNE	PSTPIP1, ALA230THR	121908130
606350	54840	APTX	0001	ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA	APTX, 1-BP INS, 167T	
606350	54840	APTX	0002	ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA	APTX, PRO32LEU	121908131
606350	54840	APTX	0003	ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA	APTX, 1-BP DEL, 318T	
606350	54840	APTX	0004	ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA	APTX, VAL89GLY	121908132
606350	54840	APTX	0005	ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA	APTX, HIS27ARG	121908133
606350	54840	APTX	0006	ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA	APTX, TRP279TER	104894103
606350	54840	APTX	0007	ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA	APTX, DEL	
606350	54840	APTX	0008	ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA	APTX, IVS7AS, G-A, -1	
606350	54840	APTX	0009	ATAXIA, ADULT-ONSET, WITH OCULOMOTOR APRAXIA	APTX, LEU223PRO	
606351	83715	ESPN	0001	DEAFNESS, AUTOSOMAL RECESSIVE 36, WITH VESTIBULAR INVOLVEMENT	ESPN, 4-BP DEL, 2469GTCA	
606351	83715	ESPN	0002	DEAFNESS, AUTOSOMAL RECESSIVE 36, WITH VESTIBULAR INVOLVEMENT	ESPN, 4-BP DEL, 1988AGAG	
606351	83715	ESPN	0003	DEAFNESS, AUTOSOMAL DOMINANT, WITHOUT VESTIBULAR INVOLVEMENT	ESPN, SER719ARG	121908134
606351	83715	ESPN	0004	DEAFNESS, AUTOSOMAL DOMINANT, WITHOUT VESTIBULAR INVOLVEMENT	ESPN, ASP744ASN	121908135
606351	83715	ESPN	0005	DEAFNESS, AUTOSOMAL DOMINANT, WITHOUT VESTIBULAR INVOLVEMENT	ESPN, ARG774GLN	121908136
606351	83715	ESPN	0006	DEAFNESS, AUTOSOMAL DOMINANT, WITHOUT VESTIBULAR INVOLVEMENT	ESPN, 3-BP DEL, 2541AAG	
606351	83715	ESPN	0007	DEAFNESS, AUTOSOMAL RECESSIVE 36, WITHOUT VESTIBULAR INVOLVEMENT	ESPN, 1-BP INS, 1757G	
606352	57679	ALS2	0001	AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE	ALS2, 1-BP DEL, 138A	
606352	57679	ALS2	0002	PRIMARY LATERAL SCLEROSIS, JUVENILE	ALS2, 2-BP DEL, 1867CT	
606352	57679	ALS2	0004	PRIMARY LATERAL SCLEROSIS, JUVENILE	ALS2, 2-BP DEL, 1425AG	
606352	57679	ALS2	0005	SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING	ALS2, 1-BP DEL, 3742A	
606352	57679	ALS2	0006	SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING	ALS2, 10-BP DEL, NT1471	
606352	57679	ALS2	0007	SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING	ALS2, 2-BP DEL, 2660AT	
606352	57679	ALS2	0008	SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING	ALS2, 2-BP DEL, 1130AT	
606352	57679	ALS2	0009	SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING	ALS2, 1-BP DEL, 4844T	
606352	57679	ALS2	0010	SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING	ALS2, ARG998TER	121908137
606352	57679	ALS2	0011	AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE	ALS2, 1-BP DEL, 553A	
606352	57679	ALS2	0012	SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING	ALS2, CYS156TYR	121908138
606352	57679	ALS2	0013	PRIMARY LATERAL SCLEROSIS, JUVENILE	ALS2, IVS17AS, A-G, -2	
606352	57679	ALS2	0014	SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING	ALS2, GLN715TER	121908139
606368	116519	APOA5	0001	HYPERTRIGLYCERIDEMIA, SUSCEPTIBILITY TO	APOA5, GLY185CYS	2075291
606368	116519	APOA5	0002	HYPERTRIGLYCERIDEMIA, SUSCEPTIBILITY TO	APOA5, SER19TRP	3135506
606368	116519	APOA5	0003	HYPERLIPOPROTEINEMIA, TYPE V	APOA5, GLN139TER	
606370	27010	TPK1	0001	THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	TPK1, ASN50HIS	
606370	27010	TPK1	0002	THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	TPK1, IVS7DS, A-T, +4	
606370	27010	TPK1	0003	THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	TPK1, LEU40PRO	
606370	27010	TPK1	0004	THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	TPK1, 4-BP DEL, 179GAGA	
606370	27010	TPK1	0005	THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	TPK1, ASN219SER	
606374	26229	B3GAT3	0001	MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, CRANIOFACIAL DYSMORPHISM, AND CONGENITAL HEART DEFECTS	B3GAT3, ARG277GLN	
606389	117144	CATSPER1	0001	SPERMATOGENIC FAILURE 7	CATSPER1, 1-BP INS, 539T	193929390
606389	117144	CATSPER1	0002	SPERMATOGENIC FAILURE 7	CATSPER1, 5-BP INS, 948ATGGC	193929391
606397	7401	CLRN1	0001	USHER SYNDROME, TYPE IIIA	CLRN1, TYR176TER	121908140
606397	7401	CLRN1	0002	USHER SYNDROME, TYPE IIIA	CLRN1, MET120LYS	121908141
606397	7401	CLRN1	0003	USHER SYNDROME, TYPE IIIA	CLRN1, 3-BP DEL, 459ATT	
606397	7401	CLRN1	0004	USHER SYNDROME, TYPE IIIA	CLRN1, ASN48LYS	111033258
606397	7401	CLRN1	0005	USHER SYNDROME, TYPE IIIA	CLRN1, LEU150PRO	121908142
606397	7401	CLRN1	0006	USHER SYNDROME, TYPE IIIA	CLRN1, TYR63TER	111033267
606397	7401	CLRN1	0007	USHER SYNDROME, TYPE IIIA	CLRN1, 23-BP DEL, NT187	
606397	7401	CLRN1	0008	USHER SYNDROME, TYPE IIIA	CLRN1, CYS40GLY	121908143
606397	7401	CLRN1	0009	RETINITIS PIGMENTOSA 61	CLRN1, LEU154TRP	
606397	7401	CLRN1	0010	RETINITIS PIGMENTOSA 61	CLRN1, PRO31LEU	
606409	83737	ITCH	0001	AUTOIMMUNE DISEASE, SYNDROMIC MULTISYSTEM	ITCH, 1-BP INS, 394A	
606410	84168	ANTXR1	0001	HEMANGIOMA, CAPILLARY INFANTILE, SUSCEPTIBILITY TO	ANTXR1, ALA326THR	119475040
606410	84168	ANTXR1	0002	GAPO SYNDROME	ANTXR1, ARG169TER	
606410	84168	ANTXR1	0003	GAPO SYNDROME	NTXR1, ARG88TER	
606410	84168	ANTXR1	0004	GAPO SYNDROME	ANTXR1, IVS19, A-G, -12	
606412	7809	BSND	0001	BARTTER SYNDROME, TYPE 4A	BSND, MET1LEU	74315284
606412	7809	BSND	0002	BARTTER SYNDROME, TYPE 4A	BSND, ARG8TRP	74315285
606412	7809	BSND	0003	BARTTER SYNDROME, TYPE 4A	BSND, IVS1, 41-BP DEL	
606412	7809	BSND	0004	BARTTER SYNDROME, TYPE 4A	BSND, EX3-EX4 DEL	
606412	7809	BSND	0005	BARTTER SYNDROME, TYPE 4A	BSND, MET1ILE	74315286
606412	7809	BSND	0006	BARTTER SYNDROME, TYPE 4A	BSND, GLY10SER	74315287
606412	7809	BSND	0007	BARTTER SYNDROME, TYPE 4A	BSND, ARG8LEU	74315288
606412	7809	BSND	0008	BARTTER SYNDROME, TYPE 4A	BSND, GLY47ARG	74315289
606412	7809	BSND	0009	SENSORINEURAL DEAFNESS WITH MILD RENAL DYSFUNCTION	BSND, ILE12THR	121908144
606412	7809	BSND	0010	SENSORINEURAL DEAFNESS WITH MILD RENAL DYSFUNCTION	BSND, GLU4TER	121908145
606416	114548	NLRP3	0001	FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1	NLRP3, ALA439VAL	121908146
606416	114548	NLRP3	0002	FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1	NLRP3, VAL198MET	121908147
606416	114548	NLRP3	0003	FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1	NLRP3, GLU627GLY	121908148
606416	114548	NLRP3	0004	MUCKLE-WELLS SYNDROME	NLRP3, ALA352VAL	121908149
606416	114548	NLRP3	0005	MUCKLE-WELLS SYNDROME FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1, INCLUDED	NLRP3, ARG260TRP	121908150
606416	114548	NLRP3	0006	MUCKLE-WELLS SYNDROME	NLRP3, GLY569ARG	121908151
606416	114548	NLRP3	0007	CINCA SYNDROME	NLRP3, PHE573SER	121908152
606416	114548	NLRP3	0008	CINCA SYNDROME MUCKLE-WELLS SYNDROME, INCLUDED	NLRP3, ASP303ASN	121908153
606416	114548	NLRP3	0009	CINCA SYNDROME	NLRP3, PHE309SER	121908154
606416	114548	NLRP3	0010	FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1	NLRP3, LEU353PRO	28937896
606417	55717	WDR11	0001	HYPOGONADOTROPIC HYPOGONADISM 14 WITHOUT ANOSMIA	WDR11, PHE1150LEU	
606417	55717	WDR11	0002	HYPOGONADOTROPIC HYPOGONADISM 14 WITHOUT ANOSMIA	WDR11, ALA435THR	
606417	55717	WDR11	0003	HYPOGONADOTROPIC HYPOGONADISM 14 WITH ANOSMIA	WDR11, HIS690GLN	
606418	1718	DHCR24	0001	DESMOSTEROLOSIS	DHCR24, TYR471SER	28939092
606418	1718	DHCR24	0002	DESMOSTEROLOSIS	DHCR24, ASN294THR AND LYS306ASN	
606418	1718	DHCR24	0003	DESMOSTEROLOSIS	DHCR24, GLU191LYS	119475041
606418	1718	DHCR24	0004	DESMOSTEROLOSIS	DHCR24, ARG103CYS	
606418	1718	DHCR24	0005	DESMOSTEROLOSIS	DHCR24, ARG94HIS	
606418	1718	DHCR24	0006	DESMOSTEROLOSIS	DHCR24, GLU480LYS	
606419	26121	PRPF31	0001	RETINITIS PIGMENTOSA 11	PRPF31, 11-BP DEL, NT1115	
606419	26121	PRPF31	0002	RETINITIS PIGMENTOSA 11	PRPF31, ALA216PRO	119475042
606419	26121	PRPF31	0003	RETINITIS PIGMENTOSA 11	PRPF31, IVS6DS, A-G, +3	
606419	26121	PRPF31	0004	RETINITIS PIGMENTOSA 11	PRPF31, IVS6AS, 42-BP DEL, -3	
606419	26121	PRPF31	0005	RETINITIS PIGMENTOSA 11	PRPF31, ALA194GLU	119475043
606419	26121	PRPF31	0006	RETINITIS PIGMENTOSA 11	PRPF31, 33-BP INS, NT580	
606419	26121	PRPF31	0007	RETINITIS PIGMENTOSA 11	PRPF31, 1-BP INS, 769A	
606419	26121	PRPF31	0008	RETINITIS PIGMENTOSA 11	PRPF31, 12-BP DEL	
606419	26121	PRPF31	0009	RETINITIS PIGMENTOSA 11	PRPF31, IVS13, C-G, +654	
606425	54583	EGLN1	0001	ERYTHROCYTOSIS, FAMILIAL, 3	EGLN1, PRO317ARG	80358193
606425	54583	EGLN1	0002	ERYTHROCYTOSIS, FAMILIAL, 3	EGLN1, ARG371HIS	119476044
606425	54583	EGLN1	0003	ERYTHROCYTOSIS, FAMILIAL, 3	EGLN1, HIS374ARG	119476045
606439	51062	ATL1	0001	SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT	ATL1, ARG239CYS	119476046
606439	51062	ATL1	0002	SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT	ATL1, SER259TYR	119476047
606439	51062	ATL1	0003	SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT	ATL1, HIS258ARG	119476048
606439	51062	ATL1	0004	SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT	ATL1, ARG217GLN	119476049
606439	51062	ATL1	0005	SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT	ATL1, 1-BP INS, 1688A	
606439	51062	ATL1	0006	SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT	ATL1, MET408VAL	28939094
606439	51062	ATL1	0007	SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT	ATL1, ARG415TRP	119476050
606439	51062	ATL1	0008	SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT	ATL1, LEU157TRP	119476051
606439	51062	ATL1	0009	SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT	ATL1, 3-BP DEL	
606439	51062	ATL1	0010	NEUROPATHY, HEREDITARY SENSORY, TYPE ID	ATL1, ASN355LYS	
606439	51062	ATL1	0011	NEUROPATHY, HEREDITARY SENSORY, TYPE ID	ATL1, GLU66GLN	
606439	51062	ATL1	0012	NEUROPATHY, HEREDITARY SENSORY, TYPE ID	ATL1, 1-BP DEL, 976G	
606439	51062	ATL1	0013	SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT	ATL1, ARG416CYS	
606440	161497	STRC	0001	DEAFNESS, AUTOSOMAL RECESSIVE 16	STRC, 1-BP INS, 3157C	
606440	161497	STRC	0002	DEAFNESS, AUTOSOMAL RECESSIVE 16	STRC, 4-BP DEL, NT2171	
606440	161497	STRC	0003	DEAFNESS, AUTOSOMAL RECESSIVE 16	STRC, EXON 17-29 DEL	
606441	27429	HTRA2	0001	PARKINSON DISEASE 13, AUTOSOMAL DOMINANT	HTRA2, GLY399SER	72470545
606441	27429	HTRA2	0002	PARKINSON DISEASE 13, SUSCEPTIBILITY TO	HTRA2, ALA141SER	72470544
606441	27429	HTRA2	0003	PARKINSON DISEASE 13, SUSCEPTIBILITY TO	HTRA2, PRO143ALA	
606453	987	LRBA	0001	IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY	LRBA, ILE2657SER	
606453	987	LRBA	0002	IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY	LRBA, ARG1683TER	
606453	987	LRBA	0003	IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY	LRBA, GLU59TER	
606453	987	LRBA	0004	IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY	LRBA, 111.1-KB DEL	
606454	8892	EIF2B2	0001	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER OVARIOLEUKODYSTROPHY, INCLUDED	EIF2B2, GLU213GLY	104894425
606454	8892	EIF2B2	0002	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER	EIF2B2, VAL316ASP	104894426
606454	8892	EIF2B2	0003	OVARIOLEUKODYSTROPHY	EIF2B2, ARG183TER	104894427
606454	8892	EIF2B2	0004	OVARIOLEUKODYSTROPHY	EIF2B2, SER171PHE	104894428
606454	8892	EIF2B2	0005	OVARIOLEUKODYSTROPHY	EIF2B2, 6-BP DEL/2-BP INS, NT607	113994014
606454	8892	EIF2B2	0006	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER, ADULT-ONSET	EIF2B2, VAL85GLU	
606462	5885	RAD21	0001	CORNELIA DE LANGE SYNDROME 4	RAD21, PRO376ARG	
606462	5885	RAD21	0002	CORNELIA DE LANGE SYNDROME 4	RAD21, CYS585ARG	
606463	2629	GBA	0001	GAUCHER DISEASE, TYPE II GAUCHER DISEASE, TYPE III, INCLUDED;; GAUCHER DISEASE, TYPE I, INCLUDED;; PARKINSON DISEASE, LATE-ONSET SUSCEPTIBILITY TO, INCLUDED;; DEMENTIA, LEWY BODY, SUSCEPTIBILITY TO, INCLUDED	GBA, LEU444PRO	421016
606463	2629	GBA	0002	GAUCHER DISEASE, TYPE II	GBA, PRO415ARG	121908295
606463	2629	GBA	0003	GAUCHER DISEASE, TYPE I PARKINSON DISEASE, LATE-ONSET SUSCEPTIBILITY TO, INCLUDED;; DEMENTIA, LEWY BODY, SUSCEPTIBILITY TO, INCLUDED	GBA, ASN370SER	76763715
606463	2629	GBA	0004	GAUCHER DISEASE, TYPE I GAUCHER DISEASE, PERINATAL LETHAL, INCLUDED	GBA, ARG119GLN	79653797
606463	2629	GBA	0005	GAUCHER DISEASE, TYPE III GAUCHER DISEASE, TYPE I, INCLUDED	GBA, VAL394LEU	80356769
606463	2629	GBA	0006	GAUCHER DISEASE, TYPE IIIC GAUCHER DISEASE, TYPE I, INCLUDED;; GAUCHER DISEASE, TYPE II, INCLUDED;; GAUCHER DISEASE, TYPE III, INCLUDED;; GAUCHER DISEASE, PERINATAL LETHAL, INCLUDED	GBA, ASP409HIS	1064651
606463	2629	GBA	0007	GAUCHER DISEASE, TYPE III	GBA, ASP409VAL	77369218
606463	2629	GBA	0008	GAUCHER DISEASE, TYPE I GAUCHER DISEASE, TYPE II, INCLUDED;; GAUCHER DISEASE, TYPE III, INCLUDED;; PARKINSON DISEASE, LATE-ONSET, SUSCEPTIBILITY TO, INCLUDED	GBA, ARG463CYS	80356771
606463	2629	GBA	0009	GAUCHER DISEASE, TYPE I GAUCHER DISEASE, TYPE II, INCLUDED;; GAUCHER DISEASE, TYPE III, INCLUDED;; GAUCHER DISEASE, PERINATAL LETHAL, INCLUDED	GBA, LEU444PRO, ALA456PRO, AND VAL460VAL	421016
606463	2629	GBA	0010	GAUCHER DISEASE, TYPE I	GBA, PHE216TYR	74500255
606463	2629	GBA	0011	GAUCHER DISEASE, TYPE I	GBA, ASP140HIS AND GLU326LYS	2230288
606463	2629	GBA	0012	GAUCHER DISEASE, TYPE I	GBA, LYS157GLN	121908297
606463	2629	GBA	0013	GAUCHER DISEASE, TYPE III GAUCHER DISEASE, TYPE II, INCLUDED;; GAUCHER DISEASE, TYPE I, INCLUDED	GBA, PHE213ILE	381737
606463	2629	GBA	0014	GAUCHER DISEASE, TYPE I	GBA, 1-BP INS, 84G	
606463	2629	GBA	0015	GAUCHER DISEASE, TYPE I GAUCHER DISEASE, TYPE II, INCLUDED	GBA, IVS2DS, G-A, +1	104886460
606463	2629	GBA	0016	GAUCHER DISEASE, TYPE I	GBA, PRO289LEU	121908298
606463	2629	GBA	0017	GAUCHER DISEASE, TYPE I GAUCHER DISEASE, TYPE II, INCLUDED	GBA, THR323ILE	76539814
606463	2629	GBA	0018	GAUCHER DISEASE, TYPE I	GBA, 1-BP DEL, 72C	
606463	2629	GBA	0019	GAUCHER DISEASE, TYPE I	GBA, PRO122SER	121908299
606463	2629	GBA	0020	GAUCHER DISEASE, TYPE I	GBA, TYR212HIS	121908300
606463	2629	GBA	0021	GAUCHER DISEASE, TYPE I	GBA, GLY478SER	121908301
606463	2629	GBA	0022	GAUCHER DISEASE, TYPE I	GBA, ARG496HIS	80356773
606463	2629	GBA	0023	GAUCHER DISEASE, TYPE I GAUCHER DISEASE, PERINATAL LETHAL, INCLUDED	GBA, 55-BP DEL	80356768
606463	2629	GBA	0024	GAUCHER DISEASE, TYPE I	GBA, VAL15LEU	121908302
606463	2629	GBA	0025	GAUCHER DISEASE, TYPE I	GBA, GLY46GLU	77829017
606463	2629	GBA	0026	GAUCHER DISEASE, TYPE I GAUCHER DISEASE, TYPE III, INCLUDED	GBA, ASN188SER	364897
606463	2629	GBA	0027	GAUCHER DISEASE, TYPE I	GBA, PHE216VAL	121908303
606463	2629	GBA	0028	GAUCHER DISEASE, TYPE I	GBA, ALA309VAL	78396650
606463	2629	GBA	0029	GAUCHER DISEASE, TYPE I	GBA, TRP312CYS	121908304
606463	2629	GBA	0030	GAUCHER DISEASE, TYPE II	GBA, GLY325ARG	121908305
606463	2629	GBA	0031	GAUCHER DISEASE, TYPE II	GBA, CYS342GLY	121908306
606463	2629	GBA	0032	GAUCHER DISEASE, TYPE I	GBA, SER364THR	121908307
606463	2629	GBA	0033	GAUCHER DISEASE, TYPE I	GBA, 259C-T	
606463	2629	GBA	0034	GAUCHER DISEASE, PERINATAL LETHAL	GBA, 1-BP DEL, CODON 139C	
606463	2629	GBA	0035	GAUCHER DISEASE, TYPE III	GBA, ARG353GLY	121908308
606463	2629	GBA	0036	GAUCHER DISEASE, TYPE I	GBA, PRO401LEU	74598136
606463	2629	GBA	0037	GAUCHER DISEASE, PERINATAL LETHAL	GBA, HIS311ARG	78198234
606463	2629	GBA	0038	GAUCHER DISEASE, PERINATAL LETHAL	GBA, ARG359TER	121908309
606463	2629	GBA	0039	GAUCHER DISEASE, PERINATAL LETHAL	GBA, VAL398PHE	121908310
606463	2629	GBA	0040	GAUCHER DISEASE, TYPE I GAUCHER DISEASE, TYPE III, INCLUDED	GBA, GLY377SER	121908311
606463	2629	GBA	0041	GAUCHER DISEASE, PERINATAL LETHAL	GBA, ARG257GLU	
606463	2629	GBA	0042	GAUCHER DISEASE, PERINATAL LETHAL	GBA, ARG131LEU	80356763
606463	2629	GBA	0043	GAUCHER DISEASE, TYPE I GAUCHER DISEASE, TYPE III, INCLUDED	GBA, LYS79ASN	121908312
606463	2629	GBA	0044	GAUCHER DISEASE, PERINATAL LETHAL	GBA, PHE251LEU	121908313
606463	2629	GBA	0045	GAUCHER DISEASE, TYPE I	GBA, LEU371VAL	121908314
606463	2629	GBA	0046	GAUCHER DISEASE, PERINATAL LETHAL	GBA, IVS10DS, G-A, -1	
606463	2629	GBA	0047	GAUCHER DISEASE, TYPE II GAUCHER DISEASE, TYPE III, INCLUDED	GBA, HIS255GLN AND ASP409HIS	1064651
606463	2629	GBA	0048	PARKINSON DISEASE, LATE-ONSET, SUSCEPTIBILITY TO	GBA, ASP443ASN	
606464	57817	HAMP	0001	HEMOCHROMATOSIS, TYPE 2B	HAMP, 1-BP DEL, 93G	
606464	57817	HAMP	0002	HEMOCHROMATOSIS, TYPE 2B	HAMP, ARG56TER	104894695
606464	57817	HAMP	0003	HEMOCHROMATOSIS, JUVENILE, DIGENIC	HAMP, 4-BP DEL, ATGG	
606464	57817	HAMP	0004	HEMOCHROMATOSIS, TYPE 2A, MODIFIER OF	HAMP, GLY71ASP	104894696
606464	57817	HAMP	0005	HEMOCHROMATOSIS, TYPE 2B	HAMP, +14G-A, 5-PRIME UTR	
606470	55651	NHP2	0001	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 2	NOLA2, TYR139HIS	121908089
606470	55651	NHP2	0002	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 2	NOLA2, VAL126MET	121908090
606470	55651	NHP2	0003	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 2	NOLA2, TER154ARG	121908091
606471	55505	NOP10	0001	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 1	NOLA3, ARG34TRP	121908092
606475	51293	CD320	0001	METHYLMALONIC ACIDURIA DUE TO TRANSCOBALAMIN RECEPTOR DEFECT	CD320, 3-BP DEL, 262GAG	
606476	80271	ITPKC	0001	KAWASAKI DISEASE, SUSCEPTIBILITY TO	ITPKC, IVS1, G/C	28493229
606480	10269	ZMPSTE24	0001	MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY RESTRICTIVE DERMOPATHY, LETHAL, INCLUDED	ZMPSTE24, 1-BP DUP, 1085T	137854889
606480	10269	ZMPSTE24	0002	MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY	ZMPSTE24, TRP340ARG	121908093
606480	10269	ZMPSTE24	0004	MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY	ZMPSTE24, GLN41TER	121908094
606480	10269	ZMPSTE24	0005	MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY	ZMPSTE24, PRO248LEU	121908095
606480	10269	ZMPSTE24	0006	RESTRICTIVE DERMOPATHY, LETHAL	ZMPSTE24, GLU239TER	
606480	10269	ZMPSTE24	0007	RESTRICTIVE DERMOPATHY, LETHAL	ZMPSTE24, 1-BP DUP, 54T	
606480	10269	ZMPSTE24	0008	RESTRICTIVE DERMOPATHY, LETHAL	ZMPSTE24, 1-BP DUP, 591T	
606480	10269	ZMPSTE24	0009	MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY	ZMPSTE24, TRP450TER	
606480	10269	ZMPSTE24	0010	RESTRICTIVE DERMOPATHY, LETHAL	ZMPSTE24, 1-BP DEL, 50A	
606480	10269	ZMPSTE24	0011	RESTRICTIVE DERMOPATHY, LETHAL	ZMPSTE24, 2-BP DEL, 584AT	
606489	51010	EXOSC3	0001	PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	EXOSC3, ASP132ALA	
606489	51010	EXOSC3	0002	PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	EXOSC3, ALA139PRO	
606489	51010	EXOSC3	0003	PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	EXOSC3, 10-BP DEL, NT294	
606489	51010	EXOSC3	0004	PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	EXOSC3, GLY31ALA	
606489	51010	EXOSC3	0005	PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	EXOSC3, TRP238ARG	
606494	6487	ST3GAL3	0001	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 12	ST3GAL3, ALA13ASP	
606494	6487	ST3GAL3	0002	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 12	ST3GAL3, ASP370TYR	
606494	6487	ST3GAL3	0003	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15	ST3GAL3, ALA320PRO	
606496	112744	IL17F	0001	CANDIDIASIS, FAMILIAL, 6	IL17F, SER65LEU	
606518	26762	HAVCR1	0001	ATOPY, RESISTANCE TO	HAVCR1, 6-AA INS	
606521	60386	SLC25A19	0001	MICROCEPHALY, AMISH TYPE	SLC25A19, GLY177ALA	119473030
606521	60386	SLC25A19	0002	THIAMINE METABOLISM DYSFUNCTION SYNDROME 4 (BILATERAL STRIATAL DEGENERATION AND PROGRESSIVE POLYNEUROPATHY TYPE)	SLC25A19, GLY125SER	
606522	9573	GDF3	0001	KLIPPEL-FEIL SYNDROME 3, AUTOSOMAL DOMINANT MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6, INCLUDED	GDF3, ARG266CYS	
606522	9573	GDF3	0002	MICROPHTHALMIA, ISOLATED 7 COLOBOMA, OCULAR, INCLUDED	GDF3, LEU305PRO	
606522	9573	GDF3	0003	MICROPHTHALMIA, ISOLATED 7	GDF3, ARG195GLN	
606522	9573	GDF3	0004	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6	GDF3, ARG274TRP	
606526	79083	MLPH	0001	GRISCELLI SYNDROME, TYPE 3	MLPH, ARG35TRP	119473031
606530	1593	CYP27A1	0001	CEREBROTENDINOUS XANTHOMATOSIS	CYP27A1, ARG446CYS	72551322
606530	1593	CYP27A1	0002	CEREBROTENDINOUS XANTHOMATOSIS	CYP27A1, ARG362CYS	121908096
606530	1593	CYP27A1	0003	CEREBROTENDINOUS XANTHOMATOSIS	CYP27A1, 1-BP DEL	
606530	1593	CYP27A1	0004	CEREBROTENDINOUS XANTHOMATOSIS	CYP27A1, IVS4DS, G-A, +1	
606530	1593	CYP27A1	0005	CEREBROTENDINOUS XANTHOMATOSIS	CYP27A1, ARG441GLN	121908097
606530	1593	CYP27A1	0006	CEREBROTENDINOUS XANTHOMATOSIS	CYP27A1, ARG441TRP	121908098
606530	1593	CYP27A1	0007	CEREBROTENDINOUS XANTHOMATOSIS	CYP27A1, ARG372GLN	121908099
606530	1593	CYP27A1	0008	CEREBROTENDINOUS XANTHOMATOSIS	CYP27A1, ARG362SER	121908096
606530	1593	CYP27A1	0009	CEREBROTENDINOUS XANTHOMATOSIS	CYP27A1, IVS7, G-A, +1	
606530	1593	CYP27A1	0010	CEREBROTENDINOUS XANTHOMATOSIS	CYP27A1, ARG441TRP	121908098
606530	1593	CYP27A1	0011	CEREBROTENDINOUS XANTHOMATOSIS	CYP27A1, GLY112GLU	72551313
606530	1593	CYP27A1	0012	CEREBROTENDINOUS XANTHOMATOSIS	CYP27A1, 5-BP DEL, NT965	
606530	1593	CYP27A1	0013	CEREBROTENDINOUS XANTHOMATOSIS	CYP27A1, THR339MET	121908102
606530	1593	CYP27A1	0014	CEREBROTENDINOUS XANTHOMATOSIS	CYP27A1, ARG479GLY	72551322
606531	117156	SCGB3A2	0001	ASTHMA, SUSCEPTIBILITY TO	SCGB3A2, -112G/A	
606540	4645	MYO5B	0001	MICROVILLUS INCLUSION DISEASE	MYO5B, 9-BP INS, NT1362	
606540	4645	MYO5B	0002	MICROVILLUS INCLUSION DISEASE	MYO5B, IVS10AS, A-G, -2	
606540	4645	MYO5B	0003	MICROVILLUS INCLUSION DISEASE	MYO5B, VAL108GLY	121908103
606540	4645	MYO5B	0004	MICROVILLUS INCLUSION DISEASE	MYO5B, TRP375TER	121908104
606540	4645	MYO5B	0005	MICROVILLUS INCLUSION DISEASE	MYO5B, ARG656CYS	121908105
606540	4645	MYO5B	0006	MICROVILLUS INCLUSION DISEASE	MYO5B, PRO660LEU	121908106
606551	11178	LZTS1	0001	ESOPHAGEAL SQUAMOUS CELL CARCINOMA, SOMATIC	LZTS1, SER29PRO	28937897
606551	11178	LZTS1	0002	ESOPHAGEAL SQUAMOUS CELL CARCINOMA, SOMATIC	LZTS1, LYS119GLU	119473032
606566	85366	MYLK2	0001	CARDIOMYOPATHY, HYPERTROPHIC, MIDVENTRICULAR, DIGENIC	MYLK2, ALA87VAL	121908107
606566	85366	MYLK2	0002	CARDIOMYOPATHY, HYPERTROPHIC, MIDVENTRICULAR, DIGENIC	MYLK2, ALA95GLU	121908108
606568	54585	LZTFL1	0001	BARDET-BIEDL SYNDROME	LZTFL1, 5-BP DEL, NT402	
606580	80207	OPA3	0001	3-@METHYLGLUTACONIC ACIDURIA, TYPE III	OPA3, IVS1AS, G-C, -1	80356523
606580	80207	OPA3	0002	OPTIC ATROPHY AND CATARACT, AUTOSOMAL DOMINANT	OPA3, GLY93SER	80356524
606580	80207	OPA3	0003	OPTIC ATROPHY AND CATARACT, AUTOSOMAL DOMINANT	OPA3, GLN105GLU	80356525
606580	80207	OPA3	0004	3-@METHYLGLUTACONIC ACIDURIA, TYPE III	OPA3, 18-BP DEL, NT320	80356526
606585	10117	ENAM	0001	AMELOGENESIS IMPERFECTA, TYPE IB	ENAM, IVS7, G-A, +1	
606585	10117	ENAM	0002	AMELOGENESIS IMPERFECTA, TYPE IB	ENAM, LYS53TER	121908109
606585	10117	ENAM	0003	AMELOGENESIS IMPERFECTA, TYPE IC	ENAM, 2-BP INS, 13185AG	
606596	79147	FKRP	0001	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 5	FKRP, TYR309CYS	104894679
606596	79147	FKRP	0002	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 5	FKRP, SER385TER	104894680
606596	79147	FKRP	0003	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 5	FKRP, PRO448LEU	104894681
606596	79147	FKRP	0004	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5	FKRP, LEU276ILE	28937900
606596	79147	FKRP	0005	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5	FKRP, 4-BP INS, NT390	
606596	79147	FKRP	0006	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5	FKRP, TER496ARG	104894682
606596	79147	FKRP	0007	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 5	FKRP, PRO316THR	28937901
606596	79147	FKRP	0008	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 5	FKRP, SER221ARG	28937902
606596	79147	FKRP	0009	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 5	FKRP, ALA455ASP	28937903
606596	79147	FKRP	0010	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 5	FKRP, VAL405LEU	28937904
606596	79147	FKRP	0011	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5	FKRP, ARG54TRP	28937905
606596	79147	FKRP	0012	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5	FKRP, VAL79MET	104894683
606596	79147	FKRP	0013	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5	FKRP, TRP255TER	104894689
606596	79147	FKRP	0014	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5	FKRP, ARG134TRP	104894690
606596	79147	FKRP	0015	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5	FKRP, VAL300ALA	104894691
606596	79147	FKRP	0016	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5, INCLUDED	FKRP, TYR307ASN	104894692
606596	79147	FKRP	0017	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5	FKRP, CYS318TYR	104894684
606596	79147	FKRP	0018	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 5	FKRP, ASN463ASP	121908110
606597	5077	PAX3	0001	WAARDENBURG SYNDROME, TYPE 1	PAX3, 18-BP DEL, EX2	
606597	5077	PAX3	0002	WAARDENBURG SYNDROME, TYPE 1	PAX3, PRO50LEU	104893650
606597	5077	PAX3	0003	WAARDENBURG SYNDROME, TYPE 1	PAX3, 14-BP DEL, EX2	
606597	5077	PAX3	0004	WAARDENBURG SYNDROME, TYPE 1	PAX3, 1-BP DEL	
606597	5077	PAX3	0005	WAARDENBURG SYNDROME, TYPE 1	PAX3, 2-BP DEL, 556CA	
606597	5077	PAX3	0006	WAARDENBURG SYNDROME, TYPE 1	PAX3, GLY81ALA	121908111
606597	5077	PAX3	0008	WAARDENBURG SYNDROME TYPE 1	PAX3, 5-BP DEL, EX5	
606597	5077	PAX3	0009	WAARDENBURG SYNDROME, TYPE 3 WAARDENBURG SYNDROME, TYPE 1, INCLUDED	PAX3, SER84PHE	104893651
606597	5077	PAX3	0010	CRANIOFACIAL-DEAFNESS-HAND SYNDROME	PAX3, ASN47LYS	104893652
606597	5077	PAX3	0011	WAARDENBURG SYNDROME, TYPE 3	PAX3, ASN47HIS	104893653
606597	5077	PAX3	0012	WAARDENBURG SYNDROME, TYPE 3	PAX3, 13-BP DEL, NT384	
606597	5077	PAX3	0013	WAARDENBURG SYNDROME, TYPE 3	PAX3, TYR90HIS	104893654
606597	5077	PAX3	0014	WAARDENBURG SYNDROME, TYPE 1	PAX3, ARG56LEU	
606597	5077	PAX3	0015	WAARDENBURG SYNDROME, TYPE 1	PAX3, HIS80ASP	
606597	5077	PAX3	0016	WAARDENBURG SYNDROME, TYPE 1	PAX3, 1-BP DEL, 556C	
606598	54332	GDAP1	0001	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, AUTOSOMAL RECESSIVE, TYPE 4A	GDAP1, TRP31TER	121908112
606598	54332	GDAP1	0002	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, AUTOSOMAL RECESSIVE, TYPE 4A CHARCOT-MARIE-TOOTH DISEASE, AXONAL, WITH VOCAL CORD PARESIS, AUTOSOMAL RECESSIVE, INCLUDED;; CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2K, INCLUDED	GDAP1, SER194TER	104894075
606598	54332	GDAP1	0003	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, AUTOSOMAL RECESSIVE, TYPE 4A	GDAP1, ARG161HIS	104894076
606598	54332	GDAP1	0004	NEUROPATHY, AXONAL, WITH VOCAL CORD PARESIS, AUTOSOMAL RECESSIVE	GDAP1, GLN163TER	104894077
606598	54332	GDAP1	0005	NEUROPATHY, AXONAL, WITH VOCAL CORD PARESIS, AUTOSOMAL RECESSIVE	GDAP1, 1-BP INS, 863A	
606598	54332	GDAP1	0006	CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE A	GDAP1, ARG282CYS	28937906
606598	54332	GDAP1	0007	CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE A	GDAP1, 1-BP INS, 349T	
606598	54332	GDAP1	0008	CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE A	GDAP1, IVS4DS, G-A, +1	
606598	54332	GDAP1	0009	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2K	GDAP1, ARG120TRP	104894078
606598	54332	GDAP1	0010	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2K	GDAP1, THR157PRO	104894079
606598	54332	GDAP1	0011	CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE A CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2K, INCLUDED	GDAP1, LEU239PHE	104894080
606598	54332	GDAP1	0012	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2K	GDAP1, GLN218GLU	121908113
606598	54332	GDAP1	0013	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2K	GDAP1, PRO231LEU	121908114
606598	54332	GDAP1	0014	CHARCOT-MARIE-TOOTH DISEASE, AUTOSOMAL DOMINANT, TYPE 2K	GDAP1, CYS240TYR	121908115
606598	54332	GDAP1	0015	CHARCOT-MARIE-TOOTH DISEASE, AUTOSOMAL DOMINANT, TYPE 2K	GDAP1, ARG226SER	
606598	54332	GDAP1	0016	CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE A	GDAP1, GLY327ASP	
606598	54332	GDAP1	0017	CHARCOT-MARIE-TOOTH DISEASE, AUTOSOMAL DOMINANT, TYPE 2K	GDAP1, ALA156GLY	
606598	54332	GDAP1	0018	CHARCOT-MARIE-TOOTH DISEASE, AUTOSOMAL DOMINANT, TYPE 2K	GDAP1, HIS123ARG	
606598	54332	GDAP1	0019	CHARCOT-MARIE-TOOTH DISEASE, AUTOSOMAL DOMINANT, TYPE 2K	GDAP1, PRO274LEU	
606603	128178	EDARADD	0001	ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE	EDARADD, GLU142LYS	74315309
606603	128178	EDARADD	0002	ECTODERMAL DYSPLASIA 11A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT	EDARADD, LEU112ARG	121908116
606607	5688	PSMA7	0001	VARIANT OF UNKNOWN SIGNIFICANCE	PSMA7, ALA112PHE	
606609	11277	TREX1	0001	AICARDI-GOUTIERES SYNDROME 1 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, INCLUDED	TREX1, ARG114HIS	72556554
606609	11277	TREX1	0002	AICARDI-GOUTIERES SYNDROME 1	TREX1, ARG164TER	78218009
606609	11277	TREX1	0003	AICARDI-GOUTIERES SYNDROME 1	TREX1, 3-BP INS, 600GAT	74556809
606609	11277	TREX1	0004	AICARDI-GOUTIERES SYNDROME 1	TREX1, VAL201ASP	78408272
606609	11277	TREX1	0005	CHILBLAIN LUPUS	TREX1, 1-BP DUP, 375T	
606609	11277	TREX1	0006	AICARDI-GOUTIERES SYNDROME 1, AUTOSOMAL DOMINANT	TREX1, ASP200ASN	78846775
606609	11277	TREX1	0007	CHILBLAIN LUPUS AICARDI-GOUTIERES SYNDROME 1, AUTOSOMAL DOMINANT, INCLUDED	TREX1, ASP18ASN	121908117
606609	11277	TREX1	0008	VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY	TREX1, 1-BP INS, 3688G	
606609	11277	TREX1	0009	VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY	TREX1, 4-BP DUP, 3727GTCA	
606622	50485	SMARCAL1	0001	SCHIMKE IMMUNOOSSEOUS DYSPLASIA	SMARCAL1, GLU848TER	119473033
606622	50485	SMARCAL1	0002	SCHIMKE IMMUNOOSSEOUS DYSPLASIA	SMARCAL1, ARG17TER	119473034
606622	50485	SMARCAL1	0003	SCHIMKE IMMUNOOSSEOUS DYSPLASIA	SMARCAL1, GLN34TER	119473035
606622	50485	SMARCAL1	0004	SCHIMKE IMMUNOOSSEOUS DYSPLASIA	SMARCAL1, ILE548ASN	119473036
606622	50485	SMARCAL1	0005	SCHIMKE IMMUNOOSSEOUS DYSPLASIA	SMARCAL1, ARG645CYS	119473037
606622	50485	SMARCAL1	0006	SCHIMKE IMMUNOOSSEOUS DYSPLASIA	SMARCAL1, ARG586TRP	119473038
606622	50485	SMARCAL1	0007	SCHIMKE IMMUNOOSSEOUS DYSPLASIA	SMARCAL1, 4-BP DEL, 1146AAGT	
606622	50485	SMARCAL1	0008	SCHIMKE IMMUNOOSSEOUS DYSPLASIA	SMARCAL1, ARG764GLN	
606628	27232	GNMT	0001	GLYCINE N-METHYLTRANSFERASE DEFICIENCY	GNMT, LEU49PRO	121907888
606628	27232	GNMT	0002	GLYCINE N-METHYLTRANSFERASE DEFICIENCY	GNMT, HIS176ASN	121907889
606629	22999	RIMS1	0001	CONE-ROD DYSTROPHY 7	RIMS1, ARG820HIS	121918302
606633	121340	SP7	0001	OSTEOGENESIS IMPERFECTA, TYPE XII	SP7, 1-BP DEL, 1052A	
606635	5651	TMPRSS15	0001	ENTEROKINASE DEFICIENCY	PRSS7, SER712TER	77200626
606635	5651	TMPRSS15	0002	ENTEROKINASE DEFICIENCY	PRSS7, ARG857TER	121908059
606635	5651	TMPRSS15	0003	ENTEROKINASE DEFICIENCY	PRSS7, GLN261TER	121908060
606635	5651	TMPRSS15	0004	ENTEROKINASE DEFICIENCY	PRSS7, 2-BP DEL, 2707GT	
606636	22861	NLRP1	0001	VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1	NLRP1, LEU155HIS	12150220
606636	22861	NLRP1	0002	CORNEAL INTRAEPITHELIAL DYSKERATOSIS AND ECTODERMAL DYSPLASIA (1 family)	NLRP1, MET77THR	
606639	85476	GFM1	0001	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1	GFM1, ASN174SER	119470018
606639	85476	GFM1	0002	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1	GFM1, ARG47TER	119470019
606639	85476	GFM1	0003	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1	GFM1, MET496ARG	119470020
606639	85476	GFM1	0004	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1	GFM1, ARG250TRP	
606655	122042	RXFP2	0001	CRYPTORCHIDISM	LGR8, THR222PRO	121918303
606672	2811	GP1BA	0001	BERNARD-SOULIER SYNDROME, TYPE A1	GP1BA, TRP343TER	121908061
606672	2811	GP1BA	0002	PLATELET GLYCOPROTEIN Ib POLYMORPHISM NONARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY, SUSCEPTIBILITY TO, INCLUDED	GP1BA, 92-BP DUP, SER399-THR411 DUP, VARIABLE REPEATS	
606672	2811	GP1BA	0003	VON WILLEBRAND DISEASE, PLATELET-TYPE	GP1BA, GLY233VAL	121908062
606672	2811	GP1BA	0004	BERNARD-SOULIER SYNDROME, TYPE A2, AUTOSOMAL DOMINANT	GP1BA, LEU57PHE	121908063
606672	2811	GP1BA	0005	VON WILLEBRAND DISEASE, PLATELET-TYPE	GP1BA, MET239VAL	121908064
606672	2811	GP1BA	0006	BERNARD-SOULIER SYNDROME, TYPE A1 BERNARD-SOULIER SYNDROME, TYPE A2, AUTOSOMAL DOMINANT, INCLUDED	GP1BA, ALA156VAL	121908065
606672	2811	GP1BA	0007	BERNARD-SOULIER SYNDROME, TYPE A1	GP1BA, TRP498TER	
606672	2811	GP1BA	0008	BERNARD-SOULIER SYNDROME, TYPE A1	GP1BA, TRP126TER	
606673	51733	UPB1	0001	BETA-UREIDOPROPIONASE DEFICIENCY	UPB1, IVS1, A-G, -2	
606673	51733	UPB1	0002	BETA-UREIDOPROPIONASE DEFICIENCY	UPB1, IVS8, G-A, -1	
606673	51733	UPB1	0003	BETA-UREIDOPROPIONASE DEFICIENCY	UPB1, ALA85GLU	34035085
606673	51733	UPB1	0004	BETA-UREIDOPROPIONASE DEFICIENCY	UPB1, ARG70PRO	121908066
606681	64324	NSD1	0001	SOTOS SYNDROME 1	NSD1, 1.9-MB DEL	
606681	64324	NSD1	0002	SOTOS SYNDROME 1	NSD1, SER437TER	121908067
606681	64324	NSD1	0003	SOTOS SYNDROME 1	NSD1, 1-BP DEL, 3536A	
606681	64324	NSD1	0004	SOTOS SYNDROME 1	NSD1, 1-BP INS, 5998T	
606681	64324	NSD1	0005	SOTOS SYNDROME 1	NSD1, IVS20DS, G-A, +1	
606681	64324	NSD1	0006	SOTOS SYNDROME 1	NSD1, HIS2143GLU	121908068
606681	64324	NSD1	0007	SOTOS SYNDROME 1	NSD1, CYS2183SER	121908069
606681	64324	NSD1	0008	SOTOS SYNDROME 1	NSD1, 1-BP INS, 6450C	
606681	64324	NSD1	0009	SOTOS SYNDROME 1	NSD1, 1-BP DEL, 896C	
606681	64324	NSD1	0010	SOTOS SYNDROME 1	NSD1, ARG1320TER	121908070
606681	64324	NSD1	0011	BECKWITH-WIEDEMANN SYNDROME	NSD1, 1-BP INS, 4976G	
606681	64324	NSD1	0012	BECKWITH-WIEDEMANN SYNDROME	NSD1, 4-BP DEL, 7968GACA	
606681	64324	NSD1	0013	SOTOS SYNDROME 1	NSD1, CYS2202TYR	121908071
606682	89781	HPS4	0001	HERMANSKY-PUDLAK SYNDROME 4	HPS4, GLN631TER	119471021
606682	89781	HPS4	0002	HERMANSKY-PUDLAK SYNDROME 4	HPS4, 5-BP INS, GLN698	
606682	89781	HPS4	0003	HERMANSKY-PUDLAK SYNDROME 4	HPS4, 1-BP DEL, PHE19	
606682	89781	HPS4	0004	HERMANSKY-PUDLAK SYNDROME 4	HPS4, GLN181TER	119471022
606682	89781	HPS4	0005	HERMANSKY-PUDLAK SYNDROME 4	HPS4, 24-BP DUP	
606682	89781	HPS4	0006	HERMANSKY-PUDLAK SYNDROME 4	HPS4, ARG217TER	119471023
606682	89781	HPS4	0007	HERMANSKY-PUDLAK SYNDROME 4	HPS4, GLU138TER	119471024
606682	89781	HPS4	0008	HERMANSKY-PUDLAK SYNDROME 4	HPS4, GLU222TER	119471025
606682	89781	HPS4	0009	HERMANSKY-PUDLAK SYNDROME 4	HPS4, 1-BP DEL, C, CODON 685	
606686	1967	EIF2B1	0001	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER	EIF2B1, IVS2, G-A, +1	113994006
606686	1967	EIF2B1	0002	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER	EIF2B1, ASN208TYR	113994007
606687	8890	EIF2B4	0001	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER	EIF2B4, ARG357GLN	113994033
606687	8890	EIF2B4	0002	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER	EIF2B4, ARG374CYS	113994035
606687	8890	EIF2B4	0003	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER	EIF2B4, IVS11, G-A, +1	113994037
606687	8890	EIF2B4	0004	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER	EIF2B4, ALA228VAL	113994027
606687	8890	EIF2B4	0005	OVARIOLEUKODYSTROPHY	EIF2B4, CYS465ARG	113994038
606687	8890	EIF2B4	0006	OVARIOLEUKODYSTROPHY	EIF2B4, TYR489HIS	113994040
606702	5314	PKHD1	0001	POLYCYSTIC KIDNEY DISEASE, AUTOSOMAL RECESSIVE COLORECTAL CANCER, PROTECTION AGAINST, INCLUDED	PKHD1, THR36MET	137852944
606702	5314	PKHD1	0002	POLYCYSTIC KIDNEY DISEASE, AUTOSOMAL RECESSIVE	PKHD1, SER1664PHE	28937907
606702	5314	PKHD1	0003	POLYCYSTIC KIDNEY DISEASE, AUTOSOMAL RECESSIVE	PKHD1, SER3018PHE	137852945
606702	5314	PKHD1	0004	POLYCYSTIC KIDNEY DISEASE, AUTOSOMAL RECESSIVE	PKHD1, VAL1741MET	137852946
606702	5314	PKHD1	0005	POLYCYSTIC KIDNEY DISEASE, AUTOSOMAL RECESSIVE	PKHD1, ARG2671TER	137852947
606702	5314	PKHD1	0006	POLYCYSTIC KIDNEY DISEASE, AUTOSOMAL RECESSIVE	PKHD1, ILE3553THR	137852948
606702	5314	PKHD1	0007	POLYCYSTIC KIDNEY DISEASE, AUTOSOMAL RECESSIVE	PKHD1, ARG496TER	137852949
606702	5314	PKHD1	0008	POLYCYSTIC KIDNEY DISEASE, AUTOSOMAL RECESSIVE	PKHD1, VAL3471GLY	137852950
606702	5314	PKHD1	0009	POLYCYSTIC KIDNEY DISEASE, AUTOSOMAL RECESSIVE	PKHD1, IVS46DS, A-G, +653	
606706	117531	TMC1	0001	DEAFNESS, AUTOSOMAL DOMINANT 36	TMC1, ASP572ASN	121908072
606706	117531	TMC1	0002	DEAFNESS, AUTOSOMAL RECESSIVE 7	TMC1, ARG34TER	121908073
606706	117531	TMC1	0003	DEAFNESS, AUTOSOMAL RECESSIVE 7	TMC1, MET654VAL	121908074
606706	117531	TMC1	0004	DEAFNESS, AUTOSOMAL DOMINANT 36	TMC1, ASP572HIS	121908072
606706	117531	TMC1	0005	DEAFNESS, AUTOSOMAL RECESSIVE 7	TMC1, IVS5DS, G-T, +1	
606706	117531	TMC1	0006	DEAFNESS, AUTOSOMAL RECESSIVE 7	TMC1, CYS515ARG	121908076
606709	8492	PRSS12	0001	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1	PRSS12, 4-BP DEL, 1350ACGT	
606718	1836	SLC26A2	0001	DIASTROPHIC DYSPLASIA ACHONDROGENESIS, TYPE IB, INCLUDED;; ATELOSTEOGENESIS, TYPE II, INCLUDED	SLC26A2, 1-BP DEL, 1751A	
606718	1836	SLC26A2	0002	ATELOSTEOGENESIS, TYPE II DIASTROPHIC DYSPLASIA, INCLUDED;; EPIPHYSEAL DYSPLASIA, MULTIPLE, 4, INCLUDED	SLC26A2, ARG279TRP	104893915
606718	1836	SLC26A2	0003	ATELOSTEOGENESIS, TYPE II	SLC26A2, GLY255GLU	104893917
606718	1836	SLC26A2	0004	ATELOSTEOGENESIS, TYPE II	SLC26A2, ALA715VAL	104893918
606718	1836	SLC26A2	0005	ACHONDROGENESIS, TYPE IB DIASTROPHIC DYSPLASIA, INCLUDED	SLC26A2, ARG178TER	104893919
606718	1836	SLC26A2	0006	ACHONDROGENESIS, TYPE IB	SLC26A2, ASN425ASP	104893920
606718	1836	SLC26A2	0007	ACHONDROGENESIS, TYPE IB	SLC26A2, GLY678VAL	104893916
606718	1836	SLC26A2	0008	ACHONDROGENESIS, TYPE IB	SLC26A2, VAL340DEL	121908077
606718	1836	SLC26A2	0009	DIASTROPHIC DYSPLASIA, BROAD BONE-PLATYSPONDYLIC VARIANT	SLC26A2, GLN454PRO	104893921
606718	1836	SLC26A2	0010	DIASTROPHIC DYSPLASIA	SLC26A2, IVS1DS, T-C, +2	
606718	1836	SLC26A2	0011	EPIPHYSEAL DYSPLASIA, MULTIPLE, 4	SLC26A2, CYS653SER	104893924
606718	1836	SLC26A2	0012	ATELOSTEOGENESIS, TYPE II	SLC26A2, 1-BP DEL, 418C	
606718	1836	SLC26A2	0013	DE LA CHAPELLE DYSPLASIA DIASTROPHIC DYSPLASIA, INCLUDED	SLC26A2, THR512LYS	121908078
606718	1836	SLC26A2	0014	DIASTROPHIC DYSPLASIA	SLC26A2, ALA133VAL	
606725	54982	CLN6	0001	CEROID LIPOFUSCINOSIS, NEURONAL, 6	CLN6, GLU72TER	104894483
606725	54982	CLN6	0002	CEROID LIPOFUSCINOSIS, NEURONAL, 6	CLN6, TYR171DEL	121908079
606725	54982	CLN6	0003	CEROID LIPOFUSCINOSIS, NEURONAL, 6	CLN6, GLY123ASP	104894484
606725	54982	CLN6	0004	CEROID LIPOFUSCINOSIS, NEURONAL, 6	CLN6, 1-BP DEL, 6G	
606725	54982	CLN6	0005	CEROID LIPOFUSCINOSIS, NEURONAL, 6	CLN6, 1-BP INS, 316C	
606725	54982	CLN6	0006	CEROID LIPOFUSCINOSIS, NEURONAL, 6	CLN6, 2-BP DEL, 395CT	
606725	54982	CLN6	0007	CEROID LIPOFUSCINOSIS, NEURONAL, 6	CLN6, ILE154DEL	121908080
606725	54982	CLN6	0008	CEROID LIPOFUSCINOSIS, NEURONAL, 6	CLN6, TYR221TER	104894486
606725	54982	CLN6	0009	CEROID LIPOFUSCINOSIS, NEURONAL, 6	CLN6, IVS5DS, G-T, +5	
606725	54982	CLN6	0010	CEROID LIPOFUSCINOSIS, NEURONAL, 6	CLN6, 4-BP DUP, 267AACG	
606725	54982	CLN6	0011	CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	CLN6, LEU67PRO	
606725	54982	CLN6	0012	CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	CLN6, ARG103GLN	
606725	54982	CLN6	0013	CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	CLN6, LEU47PHE	
606725	54982	CLN6	0014	CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	CLN6, ARG6THR	
606742	7092	TLL1	0001	ATRIAL SEPTAL DEFECT 6	TLL1, MET182LEU	137852951
606742	7092	TLL1	0002	ATRIAL SEPTAL DEFECT 6	TLL1, VAL238ALA	137852952
606742	7092	TLL1	0003	ATRIAL SEPTAL DEFECT 6	TLL1, ILE629VAL	137852953
606754	25939	SAMHD1	0001	AICARDI-GOUTIERES SYNDROME 5	SAMHD1, GLY209SER	121434516
606754	25939	SAMHD1	0002	AICARDI-GOUTIERES SYNDROME 5	SAMHD1, ARG145TER	121434517
606754	25939	SAMHD1	0003	AICARDI-GOUTIERES SYNDROME 5	SAMHD1, IVS14AS, G-C, -1	
606754	25939	SAMHD1	0004	AICARDI-GOUTIERES SYNDROME 5	SAMHD1, GLN149TER	121434518
606754	25939	SAMHD1	0005	AICARDI-GOUTIERES SYNDROME 5	SAMHD1, GLN548TER	121434519
606754	25939	SAMHD1	0006	AICARDI-GOUTIERES SYNDROME 5	SAMHD1, HIS123PRO	121434520
606754	25939	SAMHD1	0007	AICARDI-GOUTIERES SYNDROME 5	SAMHD1, MET254VAL	121434521
606754	25939	SAMHD1	0008	AICARDI-GOUTIERES SYNDROME 5	SAMHD1, ARG164TER	
606754	25939	SAMHD1	0009	AICARDI-GOUTIERES SYNDROME 5	SAMHD1, 9.1-KB DEL	
606754	25939	SAMHD1	0010	AICARDI-GOUTIERES SYNDROME 5	SAMHD1, ARG143CYS	
606754	25939	SAMHD1	0011	AICARDI-GOUTIERES SYNDROME 5 CHILBLAIN LUPUS 2, INCLUDED	SAMHD1, ILE201ASN	
606759	50506	DUOX2	0001	THYROID DYSHORMONOGENESIS 6	DUOX2, ARG434TER	119472026
606759	50506	DUOX2	0002	THYROID DYSHORMONOGENESIS 6	DUOX2, GLN686TER	119472027
606759	50506	DUOX2	0003	THYROID DYSHORMONOGENESIS 6	DUOX2, ARG842TER	119472028
606759	50506	DUOX2	0004	THYROID DYSHORMONOGENESIS 6	DUOX2, ARG376TRP	119472029
606761	23417	MLYCD	0001	MALONYL-CoA DECARBOXYLASE DEFICIENCY	MLYCD, SER148TER	104894528
606761	23417	MLYCD	0002	MALONYL-CoA DECARBOXYLASE DEFICIENCY	MLYCD, IVS4AS, A-G, -14	
606761	23417	MLYCD	0003	MALONYL-CoA DECARBOXYLASE DEFICIENCY	MLYCD, 4-BP DEL, 638GTGA	
606761	23417	MLYCD	0004	MALONYL-CoA DECARBOXYLASE DEFICIENCY	MLYCD, 2-BP DEL, 947TT	
606761	23417	MLYCD	0005	MALONYL-CoA DECARBOXYLASE DEFICIENCY	MLYCD, GLY3ASP	121908081
606761	23417	MLYCD	0006	MALONYL-CoA DECARBOXYLASE DEFICIENCY	MLYCD, MET40THR	28937908
606761	23417	MLYCD	0007	MALONYL-CoA DECARBOXYLASE DEFICIENCY	MLYCD, 25-BP DEL, NT84	
606765	7173	TPO	0001	THYROID DYSHORMONOGENESIS 2A	TPO, 4-BP INS, NT1227	
606765	7173	TPO	0002	THYROID DYSHORMONOGENESIS 2A	TPO, 20-BP DUP	
606765	7173	TPO	0003	THYROID DYSHORMONOGENESIS 2A	TPO, ARG540TER	121908082
606765	7173	TPO	0004	THYROID DYSHORMONOGENESIS 2A	TPO, ILE447PHE	104893669
606765	7173	TPO	0005	THYROID DYSHORMONOGENESIS 2A	TPO, TYR453ASP	121908083
606765	7173	TPO	0006	THYROID DYSHORMONOGENESIS 2A	TPO, GLY590SER	121908084
606765	7173	TPO	0007	THYROID DYSHORMONOGENESIS 2A	TPO, GLU799LYS	121908085
606765	7173	TPO	0008	THYROID DYSHORMONOGENESIS 2A	TPO, 1-BP INS, 2505C	
606765	7173	TPO	0009	THYROID DYSHORMONOGENESIS 2A	TPO, ARG648GLN	121908086
606765	7173	TPO	0010	THYROID DYSHORMONOGENESIS 2A	TPO, 1-BP DEL, 2512T	
606765	7173	TPO	0011	THYROID DYSHORMONOGENESIS 2A	TPO, 1-BP INS, 2268T	
606765	7173	TPO	0012	THYROID DYSHORMONOGENESIS 2A	TPO, ARG693TRP	121908087
606765	7173	TPO	0013	THYROID DYSHORMONOGENESIS 2A	TPO, 1-BP DEL, 1496C	
606765	7173	TPO	0014	THYROID DYSHORMONOGENESIS 2A	TPO, GLN660GLU	121908088
606765	7173	TPO	0015	THYROID DYSHORMONOGENESIS 2A	TPO, 1-BP INS, 1955T	
606797	6768	ST14	0001	ICHTHYOSIS WITH HYPOTRICHOSIS, AUTOSOMAL RECESSIVE	ST14, GLY827ARG	137852931
606797	6768	ST14	0002	ICHTHYOSIS WITH HYPOTRICHOSIS, AUTOSOMAL RECESSIVE	ST14, MET1ILE	137852932
606800	2548	GAA	0001	ACID ALPHA-GLUCOSIDASE, ALLELE 2	GAA, ASP91ASN	1800299
606800	2548	GAA	0002	GLYCOGEN STORAGE DISEASE II, INFANTILE FORM	GAA, MET318THR	121907936
606800	2548	GAA	0003	GLYCOGEN STORAGE DISEASE II, INFANTILE FORM	GAA, GLU521LYS	121907937
606800	2548	GAA	0004	GLYCOGEN STORAGE DISEASE II, ADULT FORM	GAA, GLY643ARG	28937909
606800	2548	GAA	0005	GLYCOGEN STORAGE DISEASE II, ADULT FORM	GAA, ARG725TRP	121907938
606800	2548	GAA	0006	GLYCOGEN STORAGE DISEASE II, ADULT FORM	GAA, IVS1AS, T-G, -13	
606800	2548	GAA	0007	GLYCOGEN STORAGE DISEASE II, INFANTILE FORM	GAA, LYS903DEL	121907939
606800	2548	GAA	0008	GLYCOGEN STORAGE DISEASE II, INFANTILE FORM	GAA, LEU299ARG	121907940
606800	2548	GAA	0009	GLYCOGEN STORAGE DISEASE II, ADULT FORM	GAA, SER529VAL	121907941
606800	2548	GAA	0010	GLYCOGEN STORAGE DISEASE II, INFANTILE FORM	GAA, ASP645GLU	28940868
606800	2548	GAA	0011	ACID ALPHA-GLUCOSIDASE, ALLELE 4	GAA, GLU689LYS	1800309
606800	2548	GAA	0012	GLYCOGEN STORAGE DISEASE II	GAA, EX18DEL	
606800	2548	GAA	0013	GLYCOGEN STORAGE DISEASE II, ADULT FORM	GAA, PRO545LEU	121907942
606800	2548	GAA	0014	GLYCOGEN STORAGE DISEASE II	GAA, 1-BP DEL, 525T	
606800	2548	GAA	0015	GLYCOGEN STORAGE DISEASE II	GAA, ARG854TER	121907943
606800	2548	GAA	0016	GLYCOGEN STORAGE DISEASE II, ADULT FORM	GAA, ALA237VAL	121907944
606800	2548	GAA	0017	GLYCOGEN STORAGE DISEASE II, ADULT FORM	GAA, GLY293ARG	121907945
606800	2548	GAA	0018	GLYCOGEN STORAGE DISEASE II	GAA, IVS1AS, G-C, -1	
606806	10841	FTCD	0001	GLUTAMATE FORMIMINOTRANSFERASE DEFICIENCY	FTCD, ARG135CYS	28941768
606806	10841	FTCD	0002	GLUTAMATE FORMIMINOTRANSFERASE DEFICIENCY	FTCD, ARG299PRO	119469015
606806	10841	FTCD	0003	GLUTAMATE FORMIMINOTRANSFERASE DEFICIENCY	FTCD, 1033G INS	
606807	54756	IL17RD	0001	HYPOGONADOTROPIC HYPOGONADISM 18 WITH ANOSMIA	IL17RD, LYS131THR	
606807	54756	IL17RD	0002	HYPOGONADOTROPIC HYPOGONADISM 18 WITH ANOSMIA, SUSCEPTIBILITY TO	IL17RD, TYR379CYS	
606807	54756	IL17RD	0003	HYPOGONADOTROPIC HYPOGONADISM 18 WITH ANOSMIA, SUSCEPTIBILITY TO	IL17RD, ALA735VAL	
606807	54756	IL17RD	0004	HYPOGONADOTROPIC HYPOGONADISM 18 WITH ANOSMIA	IL17RD, SER468LEU	
606807	54756	IL17RD	0005	HYPOGONADOTROPIC HYPOGONADISM 18 WITH ANOSMIA	IL17RD, PRO577GLN	
606808	53904	MYO3A	0001	DEAFNESS, AUTOSOMAL RECESSIVE 30	MYO3A, TYR1043TER	193919333
606808	53904	MYO3A	0002	DEAFNESS, AUTOSOMAL RECESSIVE 30	MYO3A, IVS17, G-A, -12	
606808	53904	MYO3A	0003	DEAFNESS, AUTOSOMAL RECESSIVE 30	MYO3A, IVS7, A-G, -2	
606810	5625	PRODH	0001	HYPERPROLINEMIA, TYPE I SCHIZOPHRENIA, SUSCEPTIBILITY TO, 4, INCLUDED	PRODH, 350-KB DEL	
606810	5625	PRODH	0002	HYPERPROLINEMIA, TYPE I SCHIZOPHRENIA, SUSCEPTIBILITY TO, 4, INCLUDED	PRODH, ARG453CYS	3970559
606810	5625	PRODH	0003	HYPERPROLINEMIA, TYPE I SCHIZOPHRENIA, SUSCEPTIBILITY TO, 4, INCLUDED	PRODH, LEU289MET	137852934
606810	5625	PRODH	0004	HYPERPROLINEMIA, TYPE I SCHIZOPHRENIA, SUSCEPTIBILITY TO, 4, INCLUDED	PRODH, LEU441PRO	2904551
606810	5625	PRODH	0005	HYPERPROLINEMIA, TYPE I SCHIZOPHRENIA, SUSCEPTIBILITY TO, 4, INCLUDED	PRODH, ALA455SER	1807467
606810	5625	PRODH	0006	HYPERPROLINEMIA, TYPE I SCHIZOPHRENIA, SUSCEPTIBILITY TO, 4, INCLUDED	PRODH, GLN521ARG	450046
606810	5625	PRODH	0007	HYPERPROLINEMIA, TYPE I SCHIZOPHRENIA, SUSCEPTIBILITY TO, 4, INCLUDED	PRODH, ARG431HIS	2904552
606810	5625	PRODH	0008	HYPERPROLINEMIA, TYPE I	PRODH, GLN521GLU	193919334
606810	5625	PRODH	0009	HYPERPROLINEMIA, TYPE I SCHIZOPHRENIA, SUSCEPTIBILITY TO, 4, INCLUDED	PRODH, THR466MET	2870984
606811	8659	ALDH4A1	0001	HYPERPROLINEMIA, TYPE II	ALDH4A1, 1-BP INS, 1563T	
606811	8659	ALDH4A1	0002	HYPERPROLINEMIA, TYPE II	ALDH4A1, SER352LEU	137852937
606811	8659	ALDH4A1	0003	HYPERPROLINEMIA, TYPE II	ALDH4A1, 1-BP DEL, 21G	
606821	10466	COG5	0001	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIi	COG5, IVS14AS, T-C, -15	
606822	55624	POMGNT1	0001	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3	POMGNT1, IVS17DS, G-T, +1	
606822	55624	POMGNT1	0002	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3	POMGNT1, IVS17DS, G-A, +1	
606822	55624	POMGNT1	0003	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3	POMGNT1, SER550ASN	193919335
606822	55624	POMGNT1	0004	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3	POMGNT1, 1-BP DEL, 1813C	
606822	55624	POMGNT1	0005	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3	POMGNT1, PRO493ARG	28942068
606822	55624	POMGNT1	0006	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3	POMGNT1, 1-BP DEL, 1970G	
606822	55624	POMGNT1	0007	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3	POMGNT1, ARG442CYS	28940869
606822	55624	POMGNT1	0008	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3	POMGNT1, ARG311GLN	193919336
606822	55624	POMGNT1	0009	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3	POMGNT1, ARG63TER	193919337
606822	55624	POMGNT1	0011	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3	POMGNT1, 1-BP DEL, 1926T	
606822	55624	POMGNT1	0012	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3	POMGNT1, TRP475TER	
606822	55624	POMGNT1	0013	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 3	POMGNT1, ASP556ASN	74374973
606822	55624	POMGNT1	0014	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 3	POMGNT1, ARG605PRO	
606822	55624	POMGNT1	0015	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 3	POMGNT1, 652+1G-A	
606822	55624	POMGNT1	0016	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 3	POMGNT1, CYS490TYR	
606822	55624	POMGNT1	0017	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 3	POMGNT1, 9-BP DUP, -83	
606829	2395	FXN	0001	FRIEDREICH ATAXIA FRIEDREICH ATAXIA WITH RETAINED REFLEXES, INCLUDED	FXN, (GAA)n EXPANSION	193922938
606829	2395	FXN	0002	FRIEDREICH ATAXIA	FXN, LEU106TER	104894105
606829	2395	FXN	0003	FRIEDREICH ATAXIA	FXN, IVS3, A-G, -2	140987490
606829	2395	FXN	0004	FRIEDREICH ATAXIA	FXN, ILE154PHE	104894106
606829	2395	FXN	0005	FRIEDREICH ATAXIA	FXN, GLY130VAL	104894107
606829	2395	FXN	0006	FRIEDREICH ATAXIA	FXN, MET1ILE	104894108
606829	2395	FXN	0007	FRIEDREICH ATAXIA	FXN, TRP173GLY	56214919
606829	2395	FXN	0008	FRIEDREICH ATAXIA	FXN, 1-BP DEL, 157C	
606829	2395	FXN	0009	FRIEDREICH ATAXIA	FXN, 6-BP DEL/15-BP INS, NT371	
606837	9821	RB1CC1	0001	BREAST CANCER, SOMATIC	RB1CC1, EX3-24 DEL	
606837	9821	RB1CC1	0002	BREAST CANCER, SOMATIC	RB1CC1, EX9-23 DEL	
606844	7840	ALMS1	0001	ALSTROM SYNDROME	ALMS1, 19-BP INS	
606844	7840	ALMS1	0002	ALSTROM SYNDROME	ALMS1, GLU2795TER	193919338
606844	7840	ALMS1	0003	ALSTROM SYNDROME	ALMS1, 1-BP DEL, 10775C	
606844	7840	ALMS1	0004	ALSTROM SYNDROME	ALMS1, 2-BP DEL, 2141CT	
606844	7840	ALMS1	0005	ALSTROM SYNDROME	ALMS1, 1-BP DEL, 10775C	
606844	7840	ALMS1	0006	ALSTROM SYNDROME	ALMS1, TRP3664TER	193919339
606844	7840	ALMS1	0007	ALSTROM SYNDROME	ALMS1, ARG2722TER	193919340
606844	7840	ALMS1	0008	ALSTROM SYNDROME	ALMS1, 333-BP ALU INS, EX16	
606844	7840	ALMS1	0009	ALSTROM SYNDROME	ALMS1, GLU3649TER	
606847	6949	TCOF1	0001	TREACHER COLLINS SYNDROME	TCOF1, GLN252TER	119470016
606847	6949	TCOF1	0002	TREACHER COLLINS SYNDROME	TCOF1, 1-BP INS, 422A	
606847	6949	TCOF1	0003	TREACHER COLLINS SYNDROME	TCOF1, 4-BP DEL, NT497	
606847	6949	TCOF1	0004	TREACHER COLLINS SYNDROME	TCOF1, 5-BP DEL, NT4135	
606847	6949	TCOF1	0005	TREACHER COLLINS SYNDROME	TCOF1, TYR50CYS	28941769
606847	6949	TCOF1	0006	TREACHER COLLINS SYNDROME	TCOF1, 2-BP DEL, 1408AG	
606847	6949	TCOF1	0007	TREACHER COLLINS SYNDROME	TCOF1, ARG911TER	119470017
606847	6949	TCOF1	0008	TREACHER COLLINS SYNDROME	TCOF1, 18-BP DEL, NT376	
606847	6949	TCOF1	0009	TREACHER COLLINS SYNDROME	TCOF1, 1-BP DEL, 4134A	
606857	2729	GCLC	0001	GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO	GCLC, HIS370LEU	121907946
606857	2729	GCLC	0002	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO	GCLC, -129C-T	
606860	710	SERPING1	0001	ANGIOEDEMA, HEREDITARY, TYPE I	SERPING1, EX7DEL	
606860	710	SERPING1	0002	ANGIOEDEMA, HEREDITARY, TYPE II	SERPING1, ALA436THR	121907947
606860	710	SERPING1	0003	ANGIOEDEMA, HEREDITARY, TYPE II	SERPING1, ARG444HIS	121907948
606860	710	SERPING1	0004	ANGIOEDEMA, HEREDITARY, TYPE II	SERPING1, ARG444CYS	28940870
606860	710	SERPING1	0005	ANGIOEDEMA, HEREDITARY, TYPE II	SERPING1, ARG444SER	28940870
606860	710	SERPING1	0006	ANGIOEDEMA, HEREDITARY, TYPE I	SERPING1, 1-BP INS, 1304A	
606860	710	SERPING1	0007	ANGIOEDEMA, HEREDITARY, TYPE I	SERPING1, 1-BP DEL, 1298T	
606860	710	SERPING1	0008	ANGIOEDEMA, HEREDITARY, TYPE I	SERPING1, IVS6, G-T, +1	
606860	710	SERPING1	0009	ANGIOEDEMA, HEREDITARY, TYPE I	SERPING1, 1-BP DEL, 11698C	
606860	710	SERPING1	0010	ANGIOEDEMA, HEREDITARY, TYPE II	SERPING1, VAL432GLU	121907949
606860	710	SERPING1	0011	ANGIOEDEMA, HEREDITARY, TYPE II	SERPING1, 3-BP INS, 16749TGT	
606860	710	SERPING1	0012	COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF, DUE TO DYSFUNCTIONAL C1 INHIBITOR	SERPING1, ALA443VAL	121907950
606860	710	SERPING1	0013	ANGIOEDEMA, HEREDITARY, AUTOSOMAL RECESSIVE	SERPING1, C-T, -103	
606860	710	SERPING1	0014	ANGIOEDEMA, HEREDITARY, TYPE I	SERPING1, TYR199TER	121907951
606869	3073	HEXA	0001	TAY-SACHS DISEASE	HEXA, 4-BP INS, EX11	
606869	3073	HEXA	0002	TAY-SACHS DISEASE	HEXA, IVS12, G-C, +1	
606869	3073	HEXA	0003	TAY-SACHS DISEASE	HEXA, 7.6-KB DEL, EX1	
606869	3073	HEXA	0004	TAY-SACHS DISEASE	HEXA, GLU482LYS	121907952
606869	3073	HEXA	0005	TAY-SACHS DISEASE	HEXA, 1-BP DEL, 1510C	
606869	3073	HEXA	0006	TAY-SACHS DISEASE, B1 VARIANT HEXA, DN ALLELE	HEXA, ARG178HIS	28941770
606869	3073	HEXA	0007	TAY-SACHS DISEASE, B1 VARIANT HEXA, CZECHOSLOVAKIAN ALLELE	HEXA, ARG178CYS	121907953
606869	3073	HEXA	0008	GM2-GANGLIOSIDOSIS, ADULT	HEXA, GLY269SER	121907954
606869	3073	HEXA	0009	GM2-GANGLIOSIDOSIS, JUVENILE	HEXA, ARG504HIS	121907955
606869	3073	HEXA	0010	GM2-GANGLIOSIDOSIS, JUVENILE	HEXA, ARG499HIS	121907956
606869	3073	HEXA	0011	TAY-SACHS DISEASE	HEXA, ARG170GLN	121907957
606869	3073	HEXA	0012	TAY-SACHS DISEASE	HEXA, TRP420CYS	121907958
606869	3073	HEXA	0013	TAY-SACHS DISEASE, JUVENILE	HEXA, GLY250ASP	121907959
606869	3073	HEXA	0014	TAY-SACHS DISEASE	HEXA, PHE304DEL	121907960
606869	3073	HEXA	0015	GM2-GANGLIOSIDOSIS, CHRONIC	HEXA, ARG504CYS	28942071
606869	3073	HEXA	0016	TAY-SACHS DISEASE	HEXA, IVS4, G-T, -1	
606869	3073	HEXA	0017	TAY-SACHS DISEASE	HEXA, SER210PHE	121907961
606869	3073	HEXA	0019	TAY-SACHS DISEASE	HEXA, ARG137TER	121907962
606869	3073	HEXA	0020	TAY-SACHS DISEASE	HEXA, ARG393TER	121907963
606869	3073	HEXA	0021	TAY-SACHS DISEASE	HEXA, 5-BP DEL, TCTCC, IVS9	
606869	3073	HEXA	0022	TAY-SACHS DISEASE	HEXA, 2-BP DEL, TG, EX5	
606869	3073	HEXA	0023	TAY-SACHS DISEASE	HEXA, TRP26TER	121907964
606869	3073	HEXA	0024	TAY-SACHS DISEASE	HEXA, ARG178LEU	28941770
606869	3073	HEXA	0025	TAY-SACHS DISEASE	HEXA, IVS2, G-C, +1	
606869	3073	HEXA	0026	TAY-SACHS DISEASE	HEXA, IVS2, G-A, +1	
606869	3073	HEXA	0027	TAY-SACHS DISEASE	HEXA, MET1VAL	121907965
606869	3073	HEXA	0028	GM2-GANGLIOSIDOSIS, ADULT-ONSET	HEXA, ARG499CYS	121907966
606869	3073	HEXA	0029	GM2-GANGLIOSIDOSIS, B1 VARIANT	HEXA, TRP329TER	121907967
606869	3073	HEXA	0030	TAY-SACHS DISEASE	HEXA, TRP485ARG	121907968
606869	3073	HEXA	0031	TAY-SACHS DISEASE	HEXA, 1-BP INS	
606869	3073	HEXA	0032	TAY-SACHS DISEASE	HEXA, TYR180TER	121907969
606869	3073	HEXA	0033	TAY-SACHS DISEASE	HEXA, IVS9, G-A, +1	
606869	3073	HEXA	0034	TAY-SACHS DISEASE, B1 VARIANT	HEXA, GGA DEL, CODON 320 OR CODON 321	
606869	3073	HEXA	0035	BETA-HEXOSAMINIDASE A, PSEUDODEFICIENCY OF	HEXA, ARG247TRP	121907970
606869	3073	HEXA	0036	TAY-SACHS DISEASE, B1 VARIANT	HEXA, VAL192LEU AND VAL200MET	1800429
606869	3073	HEXA	0038	TAY-SACHS DISEASE, B1 VARIANT	HEXA, ASP258HIS	121907971
606869	3073	HEXA	0039	TAY-SACHS DISEASE	HEXA, ARG170TRP	121907972
606869	3073	HEXA	0040	TAY-SACHS DISEASE	HEXA, 2-BP DEL, CODON 310	
606869	3073	HEXA	0041	GM2-GANGLIOSIDOSIS, LATE ONSET	HEXA, LYS197THR	121907973
606869	3073	HEXA	0042	TAY-SACHS DISEASE, JUVENILE/ADULT	HEXA, IVS6, +1	
606869	3073	HEXA	0043	TAY-SACHS DISEASE	HEXA, PHE211SER	121907974
606869	3073	HEXA	0044	TAY-SACHS DISEASE	HEXA, LEU127ARG	121907975
606869	3073	HEXA	0045	TAY-SACHS DISEASE	HEXA, HIS204ARG	121907976
606869	3073	HEXA	0046	TAY-SACHS DISEASE	HEXA, 2-BP DEL, TT, CODON 142	
606869	3073	HEXA	0047	TAY-SACHS DISEASE	HEXA, MET301ARG	121907977
606869	3073	HEXA	0048	TAY-SACHS DISEASE	HEXA, GLY454SER	121907978
606869	3073	HEXA	0049	TAY-SACHS DISEASE	HEXA, LEU39ARG	121907979
606869	3073	HEXA	0050	TAY-SACHS DISEASE	HEXA, TRP392TER	
606869	3073	HEXA	0051	TAY-SACHS DISEASE	HEXA, IVS7, G-A, +1	
606869	3073	HEXA	0052	GM2-GANGLIOSIDOSIS, LATE ONSET	HEXA, GLY805ALA	121907980
606869	3073	HEXA	0053	GM2-GANGLIOSIDOSIS, LATE ONSET	HEXA, TYR180HIS	28941771
606869	3073	HEXA	0054	GM2-GANGLIOSIDOSIS, CHRONIC	HEXA, IVS7, G-A, -7	
606869	3073	HEXA	0055	GM2-GANGLIOSIDOSIS, SUBACUTE	HEXA, TRP474CYS	121907981
606869	3073	HEXA	0056	TAY-SACHS DISEASE	HEXA, LEU451VAL	28940871
606869	3073	HEXA	0057	GM2-GANGLIOSIDOSIS, SUBACUTE	HEXA, VAL324VAL	28942072
606869	3073	HEXA	0058	TAY SACHS DISEASE, MILD	HEXA, CYS58TYR	
606871	83700	JAM3	0001	HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION, AND CATARACTS	JAM3, IVS5DS, G-T, +1	
606871	83700	JAM3	0002	HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION, AND CATARACTS	JAM3, CYS219TYR	
606871	83700	JAM3	0003	HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION, AND CATARACTS	JAM3, GLU116LYS	
606871	83700	JAM3	0004	HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION, AND CATARACTS	JAM3, MET1ARG	
606873	3074	HEXB	0001	SANDHOFF DISEASE	HEXB, 16-KB DEL	
606873	3074	HEXB	0002	SANDHOFF DISEASE, JUVENILE TYPE	HEXB, 24-BP INS	
606873	3074	HEXB	0003	HEXOSAMINIDASE B (PARIS)	HEXB, 18-BP INS	
606873	3074	HEXB	0006	SANDHOFF DISEASE, JUVENILE TYPE	HEXB, TYR456SER	121907982
606873	3074	HEXB	0007	SANDHOFF DISEASE, JUVENILE TYPE	HEXB, PRO417LEU	28942073
606873	3074	HEXB	0008	HEXB POLYMORPHISM	HEXB, LYS121ARG	11556045
606873	3074	HEXB	0009	SANDHOFF DISEASE, ADULT TYPE	HEXB, ARG505GLN	121907983
606873	3074	HEXB	0010	SANDHOFF DISEASE, ADULT TYPE	HEXB, PRO405LEU	28942073
606873	3074	HEXB	0011	HEXOSAMINIDASE B, HEAT-LABILE POLYMORPHISM	HEXB, ALA543THR	121907984
606873	3074	HEXB	0012	SANDHOFF DISEASE, INFANTILE TYPE	HEXB, SER62LEU	820878
606873	3074	HEXB	0013	SANDHOFF DISEASE, INFANTILE TYPE	HEXB, PARTIAL DEL	
606873	3074	HEXB	0014	SANDHOFF DISEASE, CHRONIC	HEXB, PRO504SER	121907985
606873	3074	HEXB	0015	SANDHOFF DISEASE, INFANTILE	HEXB, IVS8, G-C, +5	
606873	3074	HEXB	0016	SANDHOFF DISEASE, INFANTILE	HEXB, 1-BP DEL, 76A	
606873	3074	HEXB	0017	SANDHOFF DISEASE, INFANTILE	HEXB, ARG284TER	121907986
606873	3074	HEXB	0018	SANDHOFF DISEASE, INFANTILE	HEXB, 1-BP DEL, 965T	
606879	26227	PHGDH	0001	PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	PHGDH, VAL490MET	121907987
606879	26227	PHGDH	0002	PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	PHGDH, VAL425MET	121907988
606879	26227	PHGDH	0003	PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	PHGDH, 1-BP DEL, 712G	
606879	26227	PHGDH	0004	PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	PHGDH, ARG135TRP	
606879	26227	PHGDH	0005	PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	PHGDH, GLY377SER	
606879	26227	PHGDH	0006	PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	PHGDH, VAL261MET	
606882	540	ATP7B	0001	WILSON DISEASE	ATP7B, 7-BP DEL, NT2010	
606882	540	ATP7B	0002	WILSON DISEASE	ATP7B, HIS714GLN	76151636
606882	540	ATP7B	0003	WILSON DISEASE	ATP7B, ASN915SER	121907990
606882	540	ATP7B	0004	WILSON DISEASE	ATP7B, 1-BP DEL, 2337C	
606882	540	ATP7B	0005	WILSON DISEASE	ATP7B, 1-BP INS, NT2487	
606882	540	ATP7B	0006	WILSON DISEASE	ATP7B, HIS1069GLN	76151636
606882	540	ATP7B	0007	WILSON DISEASE	ATP7B, GLY1267ARG	121907992
606882	540	ATP7B	0008	WILSON DISEASE	ATP7B, IVS4, G-C, -1	137853280
606882	540	ATP7B	0009	WILSON DISEASE	ATP7B, ARG778LEU	28942074
606882	540	ATP7B	0010	WILSON DISEASE	ATP7B, 15-BP DEL, NT-441	
606882	540	ATP7B	0011	WILSON DISEASE	ATP7B, 3-BP DEL, 3892GTC	
606882	540	ATP7B	0012	WILSON DISEASE	ATP7B, ASP765ASN	28942075
606882	540	ATP7B	0013	WILSON DISEASE	ATP7B, GLY943SER	28942076
606882	540	ATP7B	0014	WILSON DISEASE	ATP7B, ARG919GLY	121907993
606882	540	ATP7B	0015	WILSON DISEASE	ATP7B, 1-BP DEL, 2511A	
606882	540	ATP7B	0016	WILSON DISEASE	ATP7B, ALA874VAL	121907994
606882	540	ATP7B	0017	WILSON DISEASE	ATP7B, ASN1270SER	121907990
606882	540	ATP7B	0018	WILSON DISEASE	ATP7B, ARG969GLN	121907996
606882	540	ATP7B	0019	WILSON DISEASE	ATP7B, THR766ARG	121907997
606882	540	ATP7B	0020	WILSON DISEASE	ATP7B, MET645ARG	121907998
606882	540	ATP7B	0021	WILSON DISEASE	ATP7B, ILE1148THR AND GLY1176ARG	137853279
606882	540	ATP7B	0022	WILSON DISEASE	ATP7B, GLN289TER	121907999
606882	540	ATP7B	0023	WILSON DISEASE	ATP7B, LEU708PRO	121908000
606882	540	ATP7B	0024	WILSON DISEASE	ATP7B, GLY691ARG	121908001
606882	540	ATP7B	0025	WILSON DISEASE	ATP7B, ILE1148THR	
606883	51135	IRAK4	0001	IRAK4 DEFICIENCY	IRAK4, 1-BP DEL, 821T	
606883	51135	IRAK4	0002	IRAK4 DEFICIENCY	IRAK4, GLN293TER	121908002
606883	51135	IRAK4	0003	IRAK4 DEFICIENCY	IRAK4, 2-BP DEL, 620AC	
606883	51135	IRAK4	0004	INVASIVE PNEUMOCOCCAL DISEASE, RECURRENT ISOLATED, 1	IRAK4, IVS10, G-T, -1	
606883	51135	IRAK4	0005	INVASIVE PNEUMOCOCCAL DISEASE, RECURRENT ISOLATED, 1	IRAK4, IVS10 +520A-G	
606883	51135	IRAK4	0006	IRAK4 DEFICIENCY	IRAK4, ARG12CYS	
606883	51135	IRAK4	0007	IRAK4 DEFICIENCY	IRAK4, IVS7DS, G-T, +5	
606885	35	ACADS	0001	SCAD DEFICIENCY	ACADS, ARG46TRP	121908003
606885	35	ACADS	0002	SCAD DEFICIENCY	ACADS, ARG107CYS	61732144
606885	35	ACADS	0003	SCAD DEFICIENCY	ACADS, GLY68CYS	121908004
606885	35	ACADS	0004	SCAD DEFICIENCY	ACADS, TRP153ARG	57443665
606885	35	ACADS	0005	SCAD DEFICIENCY	ACADS, ARG359CYS	28940872
606885	35	ACADS	0006	SCAD DEFICIENCY	ACADS, ARG147TRP	1800556
606885	35	ACADS	0007	SCAD DEFICIENCY	ACADS, GLY185SER	1799958
606885	35	ACADS	0008	SCAD DEFICIENCY	ACADS, GLY66SER	121908005
606885	35	ACADS	0009	SCAD DEFICIENCY	ACADS, 3-BP DEL, 310GAG	
606885	35	ACADS	0010	SCAD DEFICIENCY	ACADS, ALA168VAL	28940874
606885	35	ACADS	0011	SCAD DEFICIENCY	ACADS, ARG301TRP	121908006
606885	35	ACADS	0012	SCAD DEFICIENCY	ACADS, SER329LEU	28941773
606885	35	ACADS	0013	SCAD DEFICIENCY	ACADS, ARG356TRP	28940875
606885	35	ACADS	0014	SCAD DEFICIENCY, MILD	ACADS, PRO55LEU	
606885	35	ACADS	0015	SCAD DEFICIENCY, MILD	ACADS, GLU344GLY	
606885	35	ACADS	0016	SCAD DEFICIENCY, MILD	ACADS, GLY108ASP	
606887	6821	SUOX	0001	SULFITE OXIDASE DEFICIENCY, ISOLATED	SUOX, ARG160GLN	121908007
606887	6821	SUOX	0002	SULFITE OXIDASE DEFICIENCY, ISOLATED	SUOX, ALA208ASP	121908008
606887	6821	SUOX	0003	SULFITE OXIDASE DEFICIENCY, ISOLATED	SUOX, SER370TYR	
606887	6821	SUOX	0004	SULFITE OXIDASE DEFICIENCY, ISOLATED	SUOX, GLY473ASP	121908009
606887	6821	SUOX	0005	SULFITE OXIDASE DEFICIENCY, ISOLATED	SUOX, 1-BP DEL, 1244G	
606890	2581	GALC	0001	KRABBE DISEASE	GALC, GLU385TER	121908010
606890	2581	GALC	0002	KRABBE DISEASE	GALC, 30-KB DEL, IVS10	
606890	2581	GALC	0003	KRABBE DISEASE	GALC, ASP544ASN	
606890	2581	GALC	0004	KRABBE DISEASE	GALC, ILE599SER	
606890	2581	GALC	0005	KRABBE DISEASE	GALC, GLY553ARG	
606890	2581	GALC	0006	KRABBE DISEASE	GALC, IVS13DS, G-A, +1	
606890	2581	GALC	0007	KRABBE DISEASE	GALC, 1-BP DEL, 1901T	
606890	2581	GALC	0008	KRABBE DISEASE	GALC, GLY286ASP	
606890	2581	GALC	0009	KRABBE DISEASE	GALC, PRO318ARG	
606890	2581	GALC	0010	KRABBE DISEASE	GALC, GLY41SER	
606897	1130	LYST	0001	CHEDIAK-HIGASHI SYNDROME, CHILDHOOD TYPE	LYST, 1-BP DEL	
606897	1130	LYST	0002	CHEDIAK-HIGASHI SYNDROME, ADULT TYPE	LYST, ARG1103TER	80338652
606897	1130	LYST	0003	CHEDIAK-HIGASHI SYNDROME, CHILDHOOD TYPE	LYST, 1-BP INS	
606897	1130	LYST	0004	CHEDIAK-HIGASHI SYNDROME, CHILDHOOD TYPE	LYST, 1-BP INS, FS638TER	
606897	1130	LYST	0005	CHEDIAK-HIGASHI SYNDROME, CHILDHOOD TYPE	LYST, 1-BP DEL, FS3258TER	
606897	1130	LYST	0006	CHEDIAK-HIGASHI SYNDROME, CHILDHOOD TYPE	LYST, ARG50TER	80338643
606897	1130	LYST	0007	CHEDIAK-HIGASHI SYNDROME, CHILDHOOD TYPE	LYST, GLN1029TER	80338651
606897	1130	LYST	0008	CHEDIAK-HIGASHI SYNDROME, CHILDHOOD TYPE	LYST, 1-BP DEL, 2620T	
606897	1130	LYST	0009	CHEDIAK-HIGASHI SYNDROME, ADULT TYPE	LYST, ARG1563HIS	80338657
606897	1130	LYST	0010	CHEDIAK-HIGASHI SYNDROME, ADULT TYPE	LYST, VAL1999ASP	28942077
606933	7299	TYR	0001	ALBINISM, OCULOCUTANEOUS, TYPE IA	TYR, 1-BP INS, 1012C	
606933	7299	TYR	0002	ALBINISM, OCULOCUTANEOUS, TYPE IB ALBINISM, OCULOCUTANEOUS, TYPE IA, INCLUDED	TYR, PRO81LEU	28940876
606933	7299	TYR	0003	ALBINISM, OCULOCUTANEOUS, TYPE IA	TYR, THR355LYS	61754388
606933	7299	TYR	0004	ALBINISM, OCULOCUTANEOUS, TYPE IA	TYR, ASP365ASN	121908011
606933	7299	TYR	0005	ALBINISM, OCULOCUTANEOUS, TYPE IA	TYR, ARG77GLN	61753185
606933	7299	TYR	0006	ALBINISM, OCULOCUTANEOUS, TYPE IB	TYR, PRO406LEU	104894313
606933	7299	TYR	0007	ALBINISM, OCULOCUTANEOUS, TYPE IB	TYR, VAL275PHE	104894314
606933	7299	TYR	0008	SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN SKIN/HAIR/EYE PIGMENTATION 3, FRECKLING, INCLUDED	TYR, SER192TYR	1042602
606933	7299	TYR	0009	ALBINISM, OCULOCUTANEOUS, TYPE IB WAARDENBURG SYNDROME 2 AND OCULAR ALBINISM, DIGENIC, INCLUDED;; ALBINISM, OCULOCUTANEOUS TYPE I, TEMPERATURE-SENSITIVE, INCLUDED;; MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 8, INCLUDED;; SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN, INCLUDED;; SKIN/HAIR/EYE PIGMENTATION 3, BLUE/GREEN EYES, INCLUDED	TYR, ARG402GLN	1126809
606933	7299	TYR	0010	ALBINISM, OCULOCUTANEOUS, TYPE IA	TYR, ARG59GLN	61753185
606933	7299	TYR	0011	ALBINISM, OCULOCUTANEOUS, TYPE IA	TYR, CYS89ARG	28940877
606933	7299	TYR	0012	ALBINISM, OCULOCUTANEOUS TYPE I, TEMPERATURE-SENSITIVE	TYR, ARG422GLN	61754393
606933	7299	TYR	0013	ALBINISM, OCULOCUTANEOUS, TYPE IA	TYR, -199C-A	
606933	7299	TYR	0014	ALBINISM, OCULOCUTANEOUS, TYPE IA	TYR, TRP178TER	61754360
606933	7299	TYR	0015	ALBINISM, OCULOCUTANEOUS, TYPE IA	TYR, GLY191ASP	61754361
606933	7299	TYR	0016	ALBINISM, OCULOCUTANEOUS, TYPE IA	TYR, ASN382LYS	104894315
606933	7299	TYR	0017	ALBINISM, OCULOCUTANEOUS, TYPE IA	TYR, 2-BP DEL, TG, CODONS 244,245	
606933	7299	TYR	0018	ALBINISM, OCULOCUTANEOUS, TYPE IA	TYR, MET96ASN	61753190
606933	7299	TYR	0019	ALBINISM, OCULOCUTANEOUS, TYPE IA	TYR, ASP42GLY	28940878
606933	7299	TYR	0020	ALBINISM, OCULOCUTANEOUS, TYPE IA	TYR, CYS55TYR	28940879
606933	7299	TYR	0021	ALBINISM, OCULOCUTANEOUS, TYPE IA	TYR, ALA206THR	28940880
606933	7299	TYR	0022	ALBINISM, OCULOCUTANEOUS, TYPE IA	TYR, GLY419ARG	61754392
606933	7299	TYR	0023	ALBINISM, OCULOCUTANEOUS, TYPE IA	TYR, PRO21SER	61753178
606933	7299	TYR	0024	ALBINISM, OCULOCUTANEOUS, TYPE IA ALBINISM, OCULOCUTANEOUS, TYPE IB, INCLUDED	TYR, GLY47ASP	61753180
606933	7299	TYR	0025	ALBINISM, OCULOCUTANEOUS, TYPE IA	TYR, ARG217TRP	63159160
606933	7299	TYR	0026	ALBINISM, OCULOCUTANEOUS, TYPE IA	TYR, ARG299HIS	61754375
606933	7299	TYR	0027	ALBINISM, OCULOCUTANEOUS, TYPE IA	TYR, 1-BP INS, C, CODON 310	
606933	7299	TYR	0028	ALBINISM, OCULOCUTANEOUS, TYPE IA	TYR, ASN371THR	61754387
606933	7299	TYR	0029	ALBINISM, OCULOCUTANEOUS, TYPE IA	TYR, 1-BP DEL, T, CODON 388	
606933	7299	TYR	0030	ALBINISM, OCULOCUTANEOUS, TYPE IA	TYR, ARG403SER	104894316
606933	7299	TYR	0031	ALBINISM, OCULOCUTANEOUS, TYPE IA	TYR, GLY446SER	104894317
606933	7299	TYR	0032	ALBINISM, OCULOCUTANEOUS, TYPE IA	TYR, ASP448ASN	104894318
606933	7299	TYR	0033	ALBINISM, OCULOCUTANEOUS, TYPE IA	TYR, THR489FS, 1-BP INS	
606933	7299	TYR	0034	ALBINISM, OCULOCUTANEOUS, TYPE IA	TYR, 1-BP INS, C, CODON 501	
606933	7299	TYR	0035	ALBINISM, OCULOCUTANEOUS, TYPE IA	TYR, TRP236TER	61754367
606933	7299	TYR	0036	ALBINISM, OCULOCUTANEOUS, TYPE IA	TYR, LEU216MET	61754363
606933	7299	TYR	0037	ALBINISM, OCULOCUTANEOUS, TYPE IB	TYR, MET1VAL	28940881
606933	7299	TYR	0038	ALBINISM, OCULOCUTANEOUS, TYPE IA	TYR, CYS91TYR	
606934	51103	NDUFAF1	0001	MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFAF1, THR207PRO	
606934	51103	NDUFAF1	0002	MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFAF1, LYS253ARG	
606934	51103	NDUFAF1	0003	MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFAF1, ARG211CYS	
606934	51103	NDUFAF1	0004	MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFAF1, GLY245ARG	
606936	54795	TRPM4	0001	PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IB	TRPM4, GLU7LYS	
606936	54795	TRPM4	0002	PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IB	TRPM4, ALA432THR	
606936	54795	TRPM4	0003	PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IB	TRPM4, ARG164TRP	
606936	54795	TRPM4	0004	PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IB	TRPM4, GLY844ASP	
606936	54795	TRPM4	0005	PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IB	TRPM4, GLY582SER	
606936	54795	TRPM4	0006	PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IB	TRPM4, LYS914ARG	
606938	7390	UROS	0001	PORPHYRIA, CONGENITAL ERYTHROPOIETIC	UROS, CYS73ARG	121908012
606938	7390	UROS	0002	PORPHYRIA, CONGENITAL ERYTHROPOIETIC	UROS, PRO53LEU	121908013
606938	7390	UROS	0003	PORPHYRIA, CONGENITAL ERYTHROPOIETIC	UROS, ALA66VAL	28941774
606938	7390	UROS	0004	PORPHYRIA, CONGENITAL ERYTHROPOIETIC	UROS, THR62ALA	28941775
606938	7390	UROS	0005	PORPHYRIA, CONGENITAL ERYTHROPOIETIC	UROS, THR228MET	121908014
606938	7390	UROS	0006	PORPHYRIA, CONGENITAL ERYTHROPOIETIC	UROS, LEU4PHE	121908015
606938	7390	UROS	0007	PORPHYRIA, CONGENITAL ERYTHROPOIETIC	UROS, 98-BP DEL, NT148	
606938	7390	UROS	0008	PORPHYRIA, CONGENITAL ERYTHROPOIETIC	UROS, 80-BP INS	
606938	7390	UROS	0009	PORPHYRIA, CONGENITAL ERYTHROPOIETIC	UROS, VAL82PHE	121908016
606938	7390	UROS	0010	PORPHYRIA, CONGENITAL ERYTHROPOIETIC	UROS, GLY188ARG	121908017
606938	7390	UROS	0011	PORPHYRIA, CONGENITAL ERYTHROPOIETIC	UROS, GLU81ASP	121908018
606938	7390	UROS	0012	PORPHYRIA, CONGENITAL ERYTHROPOIETIC	UROS, GLY188TRP	121908017
606938	7390	UROS	0013	PORPHYRIA, CONGENITAL ERYTHROPOIETIC	UROS, -70T-C	
606938	7390	UROS	0014	PORPHYRIA, CONGENITAL ERYTHROPOIETIC	UROS, -76G-A	
606938	7390	UROS	0015	PORPHYRIA, CONGENITAL ERYTHROPOIETIC	UROS, -86C-A	
606938	7390	UROS	0016	PORPHYRIA, CONGENITAL ERYTHROPOIETIC	UROS, -90C-A	
606938	7390	UROS	0017	PORPHYRIA, CONGENITAL ERYTHROPOIETIC	UROS, GLY225SER	121908020
606938	7390	UROS	0018	PORPHYRIA, CONGENITAL ERYTHROPOIETIC	UROS, IVS2DS, G-A, +1	
606938	7390	UROS	0019	PORPHYRIA, CONGENITAL ERYTHROPOIETIC	UROS, 1-BP INS, 398G	
606938	7390	UROS	0020	PORPHYRIA, CONGENITAL ERYTHROPOIETIC	UROS, PRO248GLN	121908021
606938	7390	UROS	0021	PORPHYRIA, CONGENITAL ERYTHROPOIETIC	UROS, IVS9, T-G, -31	
606941	79796	ALG9	0001	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il	ALG9, GLU523LYS	121908022
606941	79796	ALG9	0002	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il	ALG9, TYR286CYS	121908023
606945	3949	LDLR	0001	FH TURKEY	LDLR, GLN12TER	121908024
606945	3949	LDLR	0002	FH CAPE TOWN 1	LDLR, ASP26/GLY27DEL	
606945	3949	LDLR	0003	FH FRENCH CANADIAN 4	LDLR, TRP66GLY	121908025
606945	3949	LDLR	0004	FH PUERTO RICO	LDLR, SER156LEU	121908026
606945	3949	LDLR	0005	FH PISCATAWAY FH LITHUANIA	LDLR, GLY197DEL	121908027
606945	3949	LDLR	0006	FH AFRIKANER 1 FH MAINE	LDLR, ASP206GLU	121908028
606945	3949	LDLR	0007	FH MEXICO FH FRENCH CANADIAN 3	LDLR, GLU207LYS	121908029
606945	3949	LDLR	0008	FH DENVER 2	LDLR, ASP283ASN	121908030
606945	3949	LDLR	0009	FH AFRIKANER 2	LDLR, VAL408MET	28942078
606945	3949	LDLR	0010	FH ALGERIA	LDLR, ALA410THR	28942079
606945	3949	LDLR	0011	FH KUWAIT	LDLR, VAL502MET	28942080
606945	3949	LDLR	0012	FH SAINT OMER	LDLR, GLY525ASP	28942081
606945	3949	LDLR	0013	FH GENOA	LDLR, GLY528ASP	28941776
606945	3949	LDLR	0014	FH NAPLES	LDLR, GLY544VAL	28942082
606945	3949	LDLR	0015	FH FRENCH CANADIAN 2	LDLR, CYS646TYR	28942083
606945	3949	LDLR	0016	FH LEBANESE	LDLR, CYS660TER	121908031
606945	3949	LDLR	0017	FH ZAMBIA	LDLR, PRO664LEU	28942084
606945	3949	LDLR	0018	FH BAHRAIN	LDLR, TRP792TER	121908032
606945	3949	LDLR	0019	FH BARI FH SYRIA	LDLR, TYR807CYS	28942085
606945	3949	LDLR	0020	FH NASHVILLE	LDLR, 4-BP INS, EX8	
606945	3949	LDLR	0021	FH PARIS 3	LDLR, 4-BP INS, EX17	
606945	3949	LDLR	0022	FH PORTUGAL	LDLR, ASP203ASN	
606945	3949	LDLR	0023	FH ST. LOUIS	LDLR, EX2-8DUP	
606945	3949	LDLR	0024	FH PARIS 2	LDLR, EX2-5DUP	
606945	3949	LDLR	0025	FH FRENCH CANADIAN 1 FH DENVER	LDLR, PROMOTER/EX1 DEL	
606945	3949	LDLR	0026	FH FRENCH CANADIAN 5 FH TONAMI 2;; FH TSUKUBA 1	LDLR, EX2-3DEL	
606945	3949	LDLR	0027	FH PARIS 1	LDLR, EX5DEL	
606945	3949	LDLR	0028	FH CAPE TOWN 2 FH LEUVEN	LDLR, EX7-8DEL	
606945	3949	LDLR	0029	FH ROCHESTER FH OSAKA 1;; FH HELSINKI	LDLR, EX16-18DEL	
606945	3949	LDLR	0030	FH VANCOUVER 4 FH VANCOUVER 5	LDLR, EX2-6DEL	
606945	3949	LDLR	0031	FH VANCOUVER 3	LDLR, EX3-8DEL	
606945	3949	LDLR	0032	FH LONDON 1 FH ITALY 1;; FH VANCOUVER 1	LDLR, EX13-14DEL	
606945	3949	LDLR	0033	FH LONDON 2	LDLR, EX7DEL	
606945	3949	LDLR	0034	FH OSAKA 2	LDLR, EX7-14DEL	
606945	3949	LDLR	0035	FH VANCOUVER 2	LDLR, EX17DEL	
606945	3949	LDLR	0036	FH VANCOUVER 6	LDLR, EX4-6DEL	
606945	3949	LDLR	0037	FH REYKJAVIK	LDLR, EX9-10DEL	
606945	3949	LDLR	0038	FH TONAMI 1	LDLR, EX15DEL	
606945	3949	LDLR	0039	FH TSUKUBA 2	LDLR, EX16-17DEL	
606945	3949	LDLR	0040	FH BALTIMORE-1	LDLR, EX17-18DEL	
606945	3949	LDLR	0041	FH LEIDEN 3	LDLR, EX16DEL	
606945	3949	LDLR	0042	FH POTENZA	LDLR, EX13-15DEL	
606945	3949	LDLR	0043	FH BOLOGNA 2	LDLR, EX13-15DUP	
606945	3949	LDLR	0044	FH AFRIKANER 3	LDLR, ASP154ASN	121908033
606945	3949	LDLR	0045	FH DRUZE	LDLR, TYR167TER	121908034
606945	3949	LDLR	0046	FH PAVIA	LDLR, EX2-12DEL	
606945	3949	LDLR	0047	FH NORTH KARELIA	LDLR, 7-BP DEL, EX6	
606945	3949	LDLR	0048	FH LONDON 3	LDLR, CYS210TER	121908035
606945	3949	LDLR	0049	FH LONDON 4	LDLR, 2-BP DEL, 694AC	
606945	3949	LDLR	0050	FH OSAKA 3	LDLR, ASP412HIS	121908036
606945	3949	LDLR	0051	FH AFRIKANER 4	LDLR, 18-BP DUP	
606945	3949	LDLR	0052	FH TURKU	LDLR, GLY823ASP	121908037
606945	3949	LDLR	0053	FH PORI	LDLR, LEU380HIS	121908038
606945	3949	LDLR	0054	FH ELVERUM	LDLR, IVS3, G-A, +1	
606945	3949	LDLR	0055	FH AARHUS	LDLR, ASN543HIS AND 9-BP DEL	
606945	3949	LDLR	0056	FH ICELAND	LDLR, IVS4, T-C, +2	
606945	3949	LDLR	0058	FH GLASCO	LDLR, CYS163TYR	121908039
606945	3949	LDLR	0059	HYPERCHOLESTEROLEMIA, FAMILIAL	LDLR, CYS240PHE	121908040
606945	3949	LDLR	0060	HYPERCHOLESTEROLEMIA, FAMILIAL	LDLR, TRP23TER	
606945	3949	LDLR	0061	HYPERCHOLESTEROLEMIA, FAMILIAL	LDLR, CYS25SER	121908041
606945	3949	LDLR	0062	HYPERCHOLESTEROLEMIA, FAMILIAL	LDLR, CYS88SER	121908042
606945	3949	LDLR	0063	HYPERCHOLESTEROLEMIA, FAMILIAL	LDLR, IVS14, G-A, +1	
606945	3949	LDLR	0064	FH PYRGOS	LDLR, -45T DEL	
606945	3949	LDLR	0065	HYPERCHOLESTEROLEMIA, FAMILIAL	LDLR, ARG385ARG	121908043
606945	3949	LDLR	0066	HYPERCHOLESTEROLEMIA, FAMILIAL	LDLR, GLY186GLY	121908044
606945	3949	LDLR	0067	HYPERCHOLESTEROLEMIA, FAMILIAL	LDLR, IVS14, C-G, +86	
606953	2582	GALE	0001	GALACTOSE EPIMERASE DEFICIENCY	GALE, LEU183PRO	121908045
606953	2582	GALE	0002	GALACTOSE EPIMERASE DEFICIENCY	GALE, ASN34SER	121908046
606953	2582	GALE	0003	GALACTOSE EPIMERASE DEFICIENCY	GALE, GLY90GLU	28940882
606953	2582	GALE	0004	GALACTOSE EPIMERASE DEFICIENCY	GALE, ASP103GLY	28940883
606953	2582	GALE	0005	GALACTOSE EPIMERASE DEFICIENCY	GALE, LYS257ARG	28940884
606953	2582	GALE	0006	GALACTOSE EPIMERASE DEFICIENCY	GALE, LEU313MET	3180383
606953	2582	GALE	0007	GALACTOSE EPIMERASE DEFICIENCY	GALE, GLY319GLU	28940885
606953	2582	GALE	0008	GALACTOSE EPIMERASE DEFICIENCY, SEVERE	GALE, VAL94MET	121908047
606967	3931	LCAT	0001	LCAT DEFICIENCY	LCAT, TRP147ARG	
606967	3931	LCAT	0002	LCAT DEFICIENCY	LCAT, MET293ILE	121908048
606967	3931	LCAT	0003	LCAT DEFICIENCY	LCAT, 3-BP INS	
606967	3931	LCAT	0004	LCAT DEFICIENCY	LCAT, ASN228LYS	121908049
606967	3931	LCAT	0005	FISH-EYE DISEASE	LCAT, ILE123THR	121908050
606967	3931	LCAT	0006	LCAT DEFICIENCY	LCAT, 1-BP INS, EX1	
606967	3931	LCAT	0007	FISH-EYE DISEASE	LCAT, PRO10LEU	121908051
606967	3931	LCAT	0008	FISH-EYE DISEASE	LCAT, THR123ILE	121908050
606967	3931	LCAT	0009	FISH-EYE DISEASE	LCAT, THR347MET	121908053
606967	3931	LCAT	0010	LCAT DEFICIENCY	LCAT, MET252LYS	121908054
606967	3931	LCAT	0011	LCAT DEFICIENCY	LCAT, LEU209PRO	28942087
606967	3931	LCAT	0012	LCAT DEFICIENCY	LCAT, ALA93THR AND ARG158CYS	
606967	3931	LCAT	0013	LCAT DEFICIENCY	LCAT, ARG135TRP	28940887
606967	3931	LCAT	0014	LCAT DEFICIENCY	LCAT, 1-BP INS, GLN376THR, FS	
606967	3931	LCAT	0015	LCAT DEFICIENCY	LCAT, THR321MET	28940888
606967	3931	LCAT	0016	LCAT DEFICIENCY	LCAT, TYR83TER	121908055
606967	3931	LCAT	0017	FISH-EYE DISEASE	LCAT, LEU300DEL	121908056
606967	3931	LCAT	0018	FISH-EYE DISEASE	LCAT, ASN131ASP	121908057
606967	3931	LCAT	0019	FISH-EYE DISEASE	LCAT, IVS4AS, T-C, -22	
606973	9382	COG1	0001	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg	COG1, 1-BP INS, 2659C	
606973	9382	COG1	0002	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg	COG1, IVS6DS, G-A, +5	
606976	25839	COG4	0001	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj	COG4, ARG729TRP	
606976	25839	COG4	0002	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj	COG4, EX2-19, DEL	
606976	25839	COG4	0003	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj	COG4, GLU233TER	
606976	25839	COG4	0004	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj	COG4, LEU773ARG	
606977	57511	COG6	0001	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl	COG6, GLY549VAL	
606978	91949	COG7	0001	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe	COG7, IVS1DS, A-C, +4	
606978	91949	COG7	0002	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe	COG7, IVS1AS, A-G, -7	
606979	84342	COG8	0001	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIh	COG8, TYR537TER	121434387
606979	84342	COG8	0002	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIh	COG8, IVS3, G-A, +3	
606979	84342	COG8	0003	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIh	COG8, 2-BP DEL, 1687TT	
606980	56997	ADCK3	0001	COENZYME Q10 DEFICIENCY, PRIMARY, 4	ADCK3, GLU551LYS	119468004
606980	56997	ADCK3	0002	COENZYME Q10 DEFICIENCY, PRIMARY, 4	ADCK3, ARG213TRP	119468005
606980	56997	ADCK3	0003	COENZYME Q10 DEFICIENCY, PRIMARY, 4	ADCK3, GLY272VAL	119468006
606980	56997	ADCK3	0004	COENZYME Q10 DEFICIENCY, PRIMARY, 4	ADCK3, GLY272ASP	119468006
606980	56997	ADCK3	0005	COENZYME Q10 DEFICIENCY, PRIMARY, 4	ADCK3, 1-BP INS, 1812G	
606980	56997	ADCK3	0006	COENZYME Q10 DEFICIENCY, PRIMARY, 4	ADCK3, IVS11, T-C, +2	
606980	56997	ADCK3	0007	COENZYME Q10 DEFICIENCY, PRIMARY, 4	ADCK3, 22-BP DEL/3-BP INS	
606980	56997	ADCK3	0008	COENZYME Q10 DEFICIENCY, PRIMARY, 4	ADCK3, TYR514CYS	119468008
606980	56997	ADCK3	0009	COENZYME Q10 DEFICIENCY, PRIMARY, 4	ADCK3, 3-BP DEL, 1750ACC	
606980	56997	ADCK3	0010	COENZYME Q10 DEFICIENCY, PRIMARY, 4	ADCK3, 993C-T, EX8	
606980	56997	ADCK3	0011	COENZYME Q10 DEFICIENCY, PRIMARY, 4	ADCK3, GLY549SER	119468009
606989	4353	MPO	0001	MYELOPEROXIDASE DEFICIENCY	MPO, ARG569TRP	119468010
606989	4353	MPO	0002	MYELOPEROXIDASE DEFICIENCY	MPO, TYR173CYS	78950939
606989	4353	MPO	0003	MYELOPEROXIDASE DEFICIENCY	MPO, MET251THR	56378716
606989	4353	MPO	0004	MYELOPEROXIDASE DEFICIENCY	MPO, 14-BP DEL	
606989	4353	MPO	0005	MYELOPEROXIDASE DEFICIENCY	MPO, ALA332VAL	28730837
606989	4353	MPO	0006	MYELOPEROXIDASE DEFICIENCY	MPO, LEU572TRP	119469012
606989	4353	MPO	0007	MYELOPEROXIDASE DEFICIENCY	MPO, IVS11AS, A-C, -2, 109-BP DEL	
606989	4353	MPO	0008	ALZHEIMER DISEASE, SUSCEPTIBILITY TO LUNG CANCER, PROTECTION AGAINST, IN SMOKERS, INCLUDED	MPO, -463G-A	
606989	4353	MPO	0009	MYELOPEROXIDASE DEFICIENCY	MPO, GLY501SER	119469013
606989	4353	MPO	0010	MYELOPEROXIDASE DEFICIENCY	MPO, ARG499CYS	119469014
606999	2592	GALT	0001	GALACTOSEMIA	GALT, MET142LYS	111033695
606999	2592	GALT	0002	GALACTOSEMIA	GALT, ARG333TRP	111033800
606999	2592	GALT	0003	GALACTOSEMIA	GALT, VAL44MET	111033647
606999	2592	GALT	0004	GALT POLYMORPHISM	GALT, LEU62MET	1800461
606999	2592	GALT	0005	GALT POLYMORPHISM (DUARTE, D2)	GALT, ASN314ASP	2070074
606999	2592	GALT	0006	GALACTOSEMIA	GALT, GLN188ARG	75391579
606999	2592	GALT	0007	GALACTOSEMIA	GALT, LEU74PRO	111033663
606999	2592	GALT	0008	GALACTOSEMIA	GALT, PHE171SER	111033715
606999	2592	GALT	0009	GALACTOSEMIA	GALT, HIS319GLN	111033792
606999	2592	GALT	0010	GALACTOSEMIA	GALT, SER135LEU	111033690
606999	2592	GALT	0011	GALACTOSEMIA	GALT, PRO183THR	111033721
606999	2592	GALT	0012	GALT POLYMORPHISM (LOS ANGELES, D1)	GALT, LEU218LEU AND ASN314ASP	2070075
606999	2592	GALT	0013	GALACTOSEMIA	GALT, LYS285ASN	111033773
606999	2592	GALT	0014	GALACTOSEMIA	GALT, GLU203LYS	111033736
606999	2592	GALT	0015	GALACTOSEMIA	GALT, ARG333GLY	111033800
606999	2592	GALT	0016	GALACTOSEMIA	GALT, PHE194LEU	
606999	2592	GALT	0017	GALACTOSEMIA, DUARTE VARIANT	GALT, 4-BP DEL, -119GTCA	
607001	79813	EHMT1	0001	KLEEFSTRA SYNDROME	EHMT1, ARG1137TER	121918301
607001	79813	EHMT1	0002	KLEEFSTRA SYNDROME	EHMT1, 13-BP DEL	137852715
607001	79813	EHMT1	0003	KLEEFSTRA SYNDROME	EHMT1, CYS1042TYR	137852726
607001	79813	EHMT1	0004	KLEEFSTRA SYNDROME	EHMT1, ARG260TER	137852714
607002	60675	PROK2	0001	HYPOGONADOTROPIC HYPOGONADISM-4 WITH ANOSMIA	PROK2, GLY32ARG	104893767
607002	60675	PROK2	0002	HYPOGONADOTROPIC HYPOGONADISM-4 WITH ANOSMIA	PROK2, 1-BP INS, 234T	
607002	60675	PROK2	0003	HYPOGONADOTROPIC HYPOGONADISM-4 WITH OR WITHOUT ANOSMIA	PROK2, 1-BP DEL, 163A	
607002	60675	PROK2	0004	HYPOGONADOTROPIC HYPOGONADISM-4 WITH ANOSMIA	PROK2, ARG73CYS	121434272
607008	34	ACADM	0001	MCAD DEFICIENCY	ACADM, LYS304GLU	77931234
607008	34	ACADM	0002	MCAD DEFICIENCY	ACADM, 13-BP DUP	
607008	34	ACADM	0003	MCAD DEFICIENCY	ACADM, GLY267ARG	121434274
607008	34	ACADM	0004	MCAD DEFICIENCY	ACADM, ILE375THR	121434275
607008	34	ACADM	0005	MCAD DEFICIENCY	ACADM, CYS244ARG	121434276
607008	34	ACADM	0006	MCAD DEFICIENCY	ACADM, MET149ILE	121434277
607008	34	ACADM	0007	MCAD DEFICIENCY	ACADM, 4-BP DEL	
607008	34	ACADM	0008	MCAD DEFICIENCY	ACADM, 6-BP DEL, GLY90 AND CYS91	
607008	34	ACADM	0009	MCAD DEFICIENCY	ACADM, GLY170ARG	121434278
607008	34	ACADM	0010	MCAD DEFICIENCY	ACADM, THR168ALA	121434279
607008	34	ACADM	0011	MCAD DEFICIENCY	ACADM, TYR42HIS	121434280
607008	34	ACADM	0012	MCAD DEFICIENCY	ACADM, SER220LEU	121434281
607008	34	ACADM	0013	MCAD DEFICIENCY	ACADM, ARG256THR	121434282
607008	34	ACADM	0014	MCAD DEFICIENCY	ACADM, THR96ILE	121434283
607008	34	ACADM	0015	MCAD DEFICIENCY, MODIFIER OF	ACADM, 351A-C	
607009	140803	TRPM6	0001	HYPOMAGNESEMIA WITH SECONDARY HYPOCALCEMIA	TRPM6, SER590TER	121912622
607009	140803	TRPM6	0002	HYPOMAGNESEMIA WITH SECONDARY HYPOCALCEMIA	TRPM6, IVS18DS, G-A, +1	
607009	140803	TRPM6	0003	HYPOMAGNESEMIA WITH SECONDARY HYPOCALCEMIA	TRPM6, 1-BP DEL, 1280A	
607009	140803	TRPM6	0004	HYPOMAGNESEMIA WITH SECONDARY HYPOCALCEMIA	TRPM6, 13-BP DEL, NT3779	
607009	140803	TRPM6	0005	HYPOMAGNESEMIA WITH SECONDARY HYPOCALCEMIA	TRPM6, 1-BP DEL, 2207G	
607009	140803	TRPM6	0006	HYPOMAGNESEMIA WITH SECONDARY HYPOCALCEMIA	TRPM6, IVS16DS, G-A, +1	
607009	140803	TRPM6	0007	HYPOMAGNESEMIA WITH SECONDARY HYPOCALCEMIA	TRPM6, ARG484TER	121912623
607009	140803	TRPM6	0008	HYPOMAGNESEMIA WITH SECONDARY HYPOCALCEMIA	TRPM6, ARG56TER	121912624
607009	140803	TRPM6	0009	HYPOMAGNESEMIA WITH SECONDARY HYPOCALCEMIA	TRPM6, IVS8DS, G-C, +5	
607009	140803	TRPM6	0010	HYPOMAGNESEMIA WITH SECONDARY HYPOCALCEMIA	TRPM6, 3209A-G	
607009	140803	TRPM6	0011	HYPOMAGNESEMIA WITH SECONDARY HYPOCALCEMIA	TRPM6, SER141LEU	121912625
607031	11019	LIAS	0001	PYRUVATE DEHYDROGENASE LIPOIC ACID SYNTHETASE DEFICIENCY	LIAS, ARG249HIS	
607035	51684	SUFU	0001	MEDULLOBLASTOMA, SOMATIC	SUFU, PRO15LEU	28942088
607035	51684	SUFU	0002	MEDULLOBLASTOMA, DESMOPLASTIC	SUFU, 1-BP INS, 143A	
607035	51684	SUFU	0003	MEDULLOBLASTOMA, DESMOPLASTIC, SOMATIC BASAL CELL NEVUS SYNDROME, INCLUDED	SUFU, IVS8, G-A, +1	
607035	51684	SUFU	0004	MEDULLOBLASTOMA, DESMOPLASTIC	SUFU, 2.5-Mb DEL	
607035	51684	SUFU	0005	MEDULLOBLASTOMA, WITH EXTENSIVE NODULARITY	SUFU, 1-BP DEL, 71C	
607035	51684	SUFU	0006	MEDULLOBLASTOMA, DESMOPLASTIC MEDULLOBLASTOMA WITH EXTENSIVE NODULARITY, INCLUDED	SUFU, 1-BP INS, 71C	
607035	51684	SUFU	0007	MENINGIOMA, FAMILIAL, SUSCEPTIBILITY TO	SUFU, ARG123CYS	
607036	3712	IVD	0001	ISOVALERIC ACIDEMIA, TYPE I	IVD, LEU13PRO	121434284
607036	3712	IVD	0002	ISOVALERIC ACIDEMIA, TYPE I	IVD, GLY170VAL	121434285
607036	3712	IVD	0003	ISOVALERIC ACIDEMIA, TYPE III	IVD, 1-BP DEL, 1177T	
607036	3712	IVD	0004	ISOVALERIC ACIDEMIA, TYPE II	IVD, 90-BP DEL, NT145	
607036	3712	IVD	0005	ISOVALERIC ACIDEMIA	IVD, IVS7AS, G-A, -1	
607036	3712	IVD	0006	ISOVALERIC ACIDEMIA	IVD, ARG21CYS	34695403
607036	3712	IVD	0007	ISOVALERIC ACIDEMIA	IVD, ALA282VAL	28940889
607038	146183	OTOA	0001	DEAFNESS, AUTOSOMAL RECESSIVE 22	OTOA, IVS12DS, T-C, +2	
607038	146183	OTOA	0002	DEAFNESS, AUTOSOMAL RECESSIVE 22	OTOA, 500-KB DEL	
607040	85320	ABCC11	0001	APOCRINE GLAND SECRETION, VARIATION IN EAR WAX, WET/DRY, INCLUDED;; AXILLARY ODOR, INCLUDED;; COLOSTRUM SECRETION, INCLUDED	ABCC11, GLY180ARG	17822931
607040	85320	ABCC11	0002	APOCRINE GLAND SECRETION, VARIATION IN EAR WAX, WET/DRY, INCLUDED	ABCC11, 27-BP DEL	
607042	1201	CLN3	0001	CEROID LIPOFUSCINOSIS, NEURONAL, 3	CLN3, 1.02-KB DEL	
607042	1201	CLN3	0002	CEROID LIPOFUSCINOSIS, NEURONAL, 3	CLN3, 3-KB DEL, NT928	
607042	1201	CLN3	0003	CEROID LIPOFUSCINOSIS, NEURONAL, 3	CLN3, 6-KB DEL	
607042	1201	CLN3	0004	CEROID LIPOFUSCINOSIS, NEURONAL, 3	CLN3, IVSDS, G-C, +1/76-BP DEL	
607042	1201	CLN3	0005	CEROID LIPOFUSCINOSIS, NEURONAL, 3, PROTRACTED	CLN3, GLU295LYS	121434286
607042	1201	CLN3	0006	CEROID LIPOFUSCINOSIS, NEURONAL, 3, PROTRACTED	CLN3, TYR199TER	
607043	10758	TRAF3IP2	0001	PSORIASIS SUSCEPTIBILITY 13	TRAF3IP2, ASP19ASN	
607047	4287	ATXN3	0001	MACHADO-JOSEPH DISEASE PARKINSON DISEASE, LATE-ONSET, SUSCEPTIBILITY TO, INCLUDED	ATXN3, (CAG)n EXPANSION	193922928
607056	50939	IMPG2	0001	RETINITIS PIGMENTOSA 56	IMPG2, SER212TER	
607056	50939	IMPG2	0002	RETINITIS PIGMENTOSA 56	IMPG2, 1,850-BP DEL	
607056	50939	IMPG2	0003	RETINITIS PIGMENTOSA 56	IMPG2, ARG906TER	
607056	50939	IMPG2	0004	RETINITIS PIGMENTOSA 56	IMPG2, ARG964TER	
607056	50939	IMPG2	0005	MACULOPATHY, IMPG2-RELATED	IMPG2, PHE124LEU	
607059	55630	SLC39A4	0001	ACRODERMATITIS ENTEROPATHICA	SLC39A4, 5-BP DEL	
607059	55630	SLC39A4	0002	ACRODERMATITIS ENTEROPATHICA	SLC39A4, 4-BP DEL	
607059	55630	SLC39A4	0003	ACRODERMATITIS ENTEROPATHICA	SLC39A4, IVS1AS, G-A, -19	
607059	55630	SLC39A4	0004	ACRODERMATITIS ENTEROPATHICA	SLC39A4, PRO200LEU	121434287
607059	55630	SLC39A4	0005	ACRODERMATITIS ENTEROPATHICA	SLC39A4, GLY526ARG	121434288
607059	55630	SLC39A4	0006	ACRODERMATITIS ENTEROPATHICA	SLC39A4, GLY374ARG	121434289
607059	55630	SLC39A4	0007	ACRODERMATITIS ENTEROPATHICA	SLC39A4, ASN106LYS	121434290
607059	55630	SLC39A4	0008	ACRODERMATITIS ENTEROPATHICA	SLC39A4, 2-KB DEL	
607059	55630	SLC39A4	0009	ACRODERMATITIS ENTEROPATHICA	SLC39A4, GLY330ASP	121434291
607059	55630	SLC39A4	0010	ACRODERMATITIS ENTEROPATHICA	SLC39A4, 53-BP INS, NT1017	
607059	55630	SLC39A4	0011	ACRODERMATITIS ENTEROPATHICA	SLC39A4, ARG95CYS	121434292
607059	55630	SLC39A4	0012	ACRODERMATITIS ENTEROPATHICA	SLC39A4, GLN303HIS	121434293
607063	60681	FKBP10	0001	OSTEOGENESIS IMPERFECTA, TYPE XI	FKBP10, 33-BP DEL, NT321	
607063	60681	FKBP10	0002	OSTEOGENESIS IMPERFECTA, TYPE XI BRUCK SYNDROME 1, INCLUDED	FKBP10, 1-BP DUP, 831C	
607063	60681	FKBP10	0003	BRUCK SYNDROME 1	FKBP10, 8-BP DUP, NT1016	
607063	60681	FKBP10	0004	OSTEOGENESIS IMPERFECTA, TYPE XI	FKBP10, 35-BP DEL, NT122	
607063	60681	FKBP10	0005	BRUCK SYNDROME 1	FKBP10, 1-BP DUP, 1276G	
607063	60681	FKBP10	0006	BRUCK SYNDROME 1	FKBP10, ARG115GLN	
607063	60681	FKBP10	0007	BRUCK SYNDROME 1	FKBP10, 1-BP DUP, 743C	
607063	60681	FKBP10	0008	OSTEOGENESIS IMPERFECTA, TYPE XI	FKBP10, ARG403TER	
607063	60681	FKBP10	0009	BRUCK SYNDROME 1 OSTEOGENESIS IMPERFECTA, TYPE XI, INCLUDED	FKBP10, 2-BP DEL/1-BP INS, NT1271	
607063	60681	FKBP10	0010	BRUCK SYNDROME 1	FKBP10, GLU113LYS	
607063	60681	FKBP10	0011	OSTEOGENESIS IMPERFECTA, TYPE XI	FKBP10, 1-BP DUP, 948T	
607066	162514	TRPV3	0001	PALMOPLANTAR KERATODERMA, MUTILATING, WITH PERIORIFICIAL KERATOTIC PLAQUES	TRPV3, GLY573SER	
607066	162514	TRPV3	0002	PALMOPLANTAR KERATODERMA, MUTILATING, WITH PERIORIFICIAL KERATOTIC PLAQUES	TRPV3, GLY573CYS	
607066	162514	TRPV3	0003	PALMOPLANTAR KERATODERMA, MUTILATING, WITH PERIORIFICIAL KERATOTIC PLAQUES	TRPV3, TRP692GLY	
607071	3373	HYAL1	0001	MUCOPOLYSACCHARIDOSIS TYPE IX	HYAL1, GLU268LYS	104893743
607071	3373	HYAL1	0002	MUCOPOLYSACCHARIDOSIS TYPE IX	HYAL1, 37-BP INS/14-BP DEL, NT1361	
607082	9254	CACNA2D2	0001	VARIANT OF UNKNOWN SIGNIFICANCE	CACNA2D2, LEU1040PRO	
607093	4524	MTHFR	0001	HOMOCYSTINURIA DUE TO MTHFR DEFICIENCY	MTHFR, ARG184TER	121434294
607093	4524	MTHFR	0002	HOMOCYSTINURIA DUE TO MTHFR DEFICIENCY	MTHFR, ARG158GLN	121434295
607093	4524	MTHFR	0003	MTHFR THERMOLABILE POLYMORPHISM	MTHFR, 677C-T, ALA222VAL	1801133
607093	4524	MTHFR	0004	MTHFR THERMOLABILE POLYMORPHISM SCHIZOPHRENIA, SUSCEPTIBILITY TO, INCLUDED	MTHFR, 1298A-C, GLU429ALA	1801131
607093	4524	MTHFR	0005	HOMOCYSTINURIA DUE TO MTHFR DEFICIENCY	MTHFR, 983A-G, ASN324SER	
607093	4524	MTHFR	0006	HOMOCYSTINURIA DUE TO MTHFR DEFICIENCY	MTHFR, 1027T-G, TRP339GLY	
607093	4524	MTHFR	0007	HOMOCYSTINURIA DUE TO MTHFR DEFICIENCY	MTHFR, 1084C-T	
607093	4524	MTHFR	0008	HOMOCYSTINURIA DUE TO MTHFR DEFICIENCY	MTHFR, 1711C-T	
607093	4524	MTHFR	0009	HOMOCYSTINURIA DUE TO MTHFR DEFICIENCY	MTHFR, 1081C-T	
607093	4524	MTHFR	0010	HOMOCYSTEINURIA DUE TO MTHFR DEFICIENCY	MTHFR, MET581ILE	45590836
607093	4524	MTHFR	0011	HOMOCYSTINURIA DUE TO MTHFR DEFICIENCY	MTHFR, ARG377CYS	121434296
607093	4524	MTHFR	0012	HOMOCYSTINURIA DUE TO MTHFR DEFICIENCY	MTHFR, LEU323PRO	121434297
607096	116085	SLC22A12	0001	HYPOURICEMIA, RENAL, 1	SLC22A12, TRP258TER	121907892
607096	116085	SLC22A12	0002	HYPOURICEMIA, RENAL, 1	SLC22A12, THR217MET	121907893
607096	116085	SLC22A12	0003	HYPOURICEMIA, RENAL, 1	SLC22A12, GLU298ASP	121907894
607096	116085	SLC22A12	0004	HYPOURICEMIA, RENAL, 1	SLC22A12, LEU418ARG	121907895
607096	116085	SLC22A12	0005	HYPOURICEMIA, RENAL, 1	SLC22A12, ARG90HIS	121907896
607096	116085	SLC22A12	0006	HYPOURICEMIA, RENAL, 1	SLC22A12, GLY361VAL	121907897
607100	4867	NPHP1	0001	NEPHRONOPHTHISIS 1	NPHP1, IVS18, G-T, +1	
607100	4867	NPHP1	0002	NEPHRONOPHTHISIS 1	NPHP1, IVS14, 1-BP DEL, G, +1	
607100	4867	NPHP1	0003	NEPHRONOPHTHISIS 1	NPHP1, LEU27TER	121907898
607100	4867	NPHP1	0004	NEPHRONOPHTHISIS 1	NPHP1, GLY343ARG	121907899
607100	4867	NPHP1	0005	NEPHRONOPHTHISIS 1 SENIOR-LOKEN SYNDROME 1, INCLUDED;; JOUBERT SYNDROME 4, INCLUDED	NPHP1, DEL	
607102	7490	WT1	0001	WILMS TUMOR 1	WT1, 17-BP DEL, EX4	
607102	7490	WT1	0002	WILMS TUMOR 1	WT1, 1-BP DEL, G, EX6	
607102	7490	WT1	0003	DENYS-DRASH SYNDROME MEACHAM SYNDROME, INCLUDED;; NEPHROTIC SYNDROME TYPE 4, INCLUDED	WT1, ARG394TRP	121907900
607102	7490	WT1	0004	DENYS-DRASH SYNDROME	WT1, ARG366HIS	121907901
607102	7490	WT1	0005	DENYS-DRASH SYNDROME	WT1, ASP396GLY	121907902
607102	7490	WT1	0006	DENYS-DRASH SYNDROME NEPHROTIC SYNDROME, TYPE 4, INCLUDED	WT1, ASP396ASN	28941778
607102	7490	WT1	0007	DENYS-DRASH SYNDROME	WT1, ARG394PRO	121907903
607102	7490	WT1	0008	DENYS-DRASH SYNDROME	WT1, CYS330TYR	121907904
607102	7490	WT1	0009	DENYS-DRASH SYNDROME	WT1, IVS9DS, G-A, +5	
607102	7490	WT1	0010	WILMS TUMOR 1	WT1, ARG390TER	
607102	7490	WT1	0012	DENYS-DRASH SYNDROME NEPHROTIC SYNDROME, TYPE 4, INCLUDED	WT1, HIS377TYR	28942089
607102	7490	WT1	0013	DENYS-DRASH SYNDROME	WT1, CYS360GLY	121907905
607102	7490	WT1	0014	DENYS-DRASH SYNDROME WILMS TUMOR 1, INCLUDED	WT1, ARG362TER	121907906
607102	7490	WT1	0015	DENYS-DRASH SYNDROME	WT1, HIS373GLN	121907907
607102	7490	WT1	0016	MESOTHELIOMA, SOMATIC	WT1, SER273GLY	121907908
607102	7490	WT1	0018	FRASIER SYNDROME NEPHROTIC SYNDROME, TYPE 4, INCLUDED	WT1, IVS9DS, C-T, +4	
607102	7490	WT1	0019	FRASIER SYNDROME	WT1, IVS9DS, A-T, +6	
607102	7490	WT1	0020	FRASIER SYNDROME	WT1, IVS9DS, G-A, +5	
607102	7490	WT1	0022	NEPHROTIC SYNDROME, TYPE 4	WT1, PHE383LEU	28941777
607102	7490	WT1	0024	FRASIER SYNDROME	WT1, ARG390TER	121907909
607102	7490	WT1	0025	FRASIER SYNDROME	WT1, PHE392LEU	28941779
607102	7490	WT1	0026	MEACHAM SYNDROME	WT1, ARG366CYS	121907910
607102	7490	WT1	0027	WILMS TUMOR 1	WT1, TYR109TER	121907911
607108	5080	PAX6	0001	ANIRIDIA	PAX6, 2-BP INS	
607108	5080	PAX6	0002	ANIRIDIA	PAX6, EXON G DEL	
607108	5080	PAX6	0003	ANIRIDIA	PAX6, GLN116TER	121907912
607108	5080	PAX6	0004	PETERS ANOMALY ANIRIDIA, INCLUDED	PAX6, ARG26GLY	121907913
607108	5080	PAX6	0005	ANIRIDIA	PAX6, ARG103TER	121907914
607108	5080	PAX6	0006	CATARACTS, CONGENITAL, WITH LATE-ONSET CORNEAL DYSTROPHY	PAX6, SER353TER	121907915
607108	5080	PAX6	0007	ANIRIDIA	PAX6, IVS12DS, G-C, -1	
607108	5080	PAX6	0008	ANIRIDIA	PAX6, ARG203TER	121907916
607108	5080	PAX6	0009	ANIRIDIA	PAX6, ARG240TER	121907917
607108	5080	PAX6	0010	ANIRIDIA	PAX6, IVS11AS, A-G, -2	
607108	5080	PAX6	0011	KERATITIS, AUTOSOMAL DOMINANT	PAX6, IVS10AS, A-T, -2	
607108	5080	PAX6	0012	FOVEAL HYPOPLASIA, ISOLATED	PAX6, ARG125CYS	121907918
607108	5080	PAX6	0013	ANIRIDIA, ATYPICAL	PAX6, VAL126ASP	121907919
607108	5080	PAX6	0014	FOVEAL HYPOPLASIA AND PRESENILE CATARACT SYNDROME	PAX6, GLY64VAL	121907920
607108	5080	PAX6	0015	PETERS ANOMALY FOVEAL HYPOPLASIA, INCLUDED;; FOVEAL HYPOPLASIA WITH ANTERIOR SEGMENT ANOMALIES, INCLUDED	PAX6, VAL54ASP	121907921
607108	5080	PAX6	0016	ANIRIDIA	PAX6, TER423LEU	121907922
607108	5080	PAX6	0017	MORNING GLORY DISC ANOMALY	PAX6, PRO68SER	121907923
607108	5080	PAX6	0018	OPTIC NERVE HYPOPLASIA, BILATERAL	PAX6, GLN205TER	121907924
607108	5080	PAX6	0019	COLOBOMA OF OPTIC NERVE COLOBOMA, OCULAR, INCLUDED	PAX6, PHE258SER	121907925
607108	5080	PAX6	0020	OPTIC NERVE APLASIA, BILATERAL	PAX6, THR391ALA	121907926
607108	5080	PAX6	0021	FOVEAL HYPOPLASIA WITH ANTERIOR SEGMENT ANOMALIES	PAX6, IVS4DS, G-C, +5	
607108	5080	PAX6	0022	ANIRIDIA	PAX6, ARG24THR	121907927
607108	5080	PAX6	0023	ANIRIDIA	PAX6, SER119ARG	121907928
607108	5080	PAX6	0024	ANIRIDIA, CEREBELLAR ATAXIA, AND MENTAL RETARDATION	PAX6, IVS2, T-A, +2	
607108	5080	PAX6	0025	ANIRIDIA, CEREBELLAR ATAXIA, AND MENTAL RETARDATION	PAX6, TRP257TER	121907929
607108	5080	PAX6	0026	ANIRIDIA	PAX6, ARG38TRP	
607111	23111	SPG20	0001	SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE	SPG20, 1-BP DEL, 1110A	
607111	23111	SPG20	0002	SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE	SPG20, 2-BP DEL, 364AT	
607117	79648	MCPH1	0001	MICROCEPHALY 1, PRIMARY, AUTOSOMAL RECESSIVE	MCPH1, SER25TER	121434305
607117	79648	MCPH1	0002	MICROCEPHALY 1, PRIMARY, AUTOSOMAL RECESSIVE	MCPH1, 1-BP INS, 427A	199422125
607117	79648	MCPH1	0003	MICROCEPHALY 1, PRIMARY, AUTOSOMAL RECESSIVE	MCPH1, 150-KB DEL	
607117	79648	MCPH1	0004	MICROCEPHALY 1, PRIMARY, AUTOSOMAL RECESSIVE	MCPH1, 1-BP INS, 566A	
607117	79648	MCPH1	0005	MICROCEPHALY 1, PRIMARY, AUTOSOMAL RECESSIVE	MCPH1, HIS49GLN	
607117	79648	MCPH1	0006	MICROCEPHALY 1, PRIMARY, AUTOSOMAL RECESSIVE	MCPH1, SER72LEU	
607117	79648	MCPH1	0007	MICROCEPHALY 1, PRIMARY, AUTOSOMAL RECESSIVE	MCPH1, SER101TER	
607118	11222	MRPL3	0001	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9	MRPL3, PRO317ARG	
607120	23236	PLCB1	0001	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 12	PLCB1, 0.5-MB DEL	
607123	128674	PROKR2	0001	HYPOGONADOTROPIC HYPOGONADISM 3 WITH ANOSMIA	PROKR2, LEU173ARG	74315416
607123	128674	PROKR2	0002	HYPOGONADOTROPIC HYPOGONADISM 3 WITH ANOSMIA	PROKR2, GLN210ARG	74315417
607123	128674	PROKR2	0003	HYPOGONADOTROPIC HYPOGONADISM 3 WITH ANOSMIA	PROKR2, ARG85HIS	74315418
607123	128674	PROKR2	0004	HYPOGONADOTROPIC HYPOGONADISM 3 WITH ANOSMIA	PROKR2, 1-BP DEL, 58C	
607123	128674	PROKR2	0005	HYPOGONADOTROPIC HYPOGONADISM 3 WITH ANOSMIA	PROKR2, MET323ILE	74315419
607139	2175	FANCA	0001	FANCONI ANEMIA, COMPLEMENTATION GROUP A	FANCA, 274-BP DEL	
607139	2175	FANCA	0002	FANCONI ANEMIA, COMPLEMENTATION GROUP A	FANCA, 4-BP DEL, NT1155	
607139	2175	FANCA	0003	FANCONI ANEMIA, COMPLEMENTATION GROUP A	FANCA, 156-BP DEL, NT1515	
607139	2175	FANCA	0004	FANCONI ANEMIA, COMPLEMENTATION GROUP A	FANCA, 113-BP DEL, NT938	
607139	2175	FANCA	0005	FANCONI ANEMIA, COMPLEMENTATION GROUP A	FANCA, 1-NT DEL, 1615G	
607139	2175	FANCA	0006	FANCONI ANEMIA, COMPLEMENTATION GROUP A	FANCA, 1-NT DEL, 3559G	
607139	2175	FANCA	0007	FANCONI ANEMIA, COMPLEMENTATION GROUP A	FANCA, EX12-31DEL	
607139	2175	FANCA	0008	FANCONI ANEMIA, COMPLEMENTATION GROUP A	FANCA, 1-BP DEL, 1609T	
607139	2175	FANCA	0009	FANCONI ANEMIA, COMPLEMENTATION GROUP A	FANCA, TRP171TER	121907930
607139	2175	FANCA	0010	FANCONI ANEMIA, COMPLEMENTATION GROUP A	FANCA, 5-BP DEL, NT3720	
607144	79087	ALG12	0001	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig	ALG12, PHE142VAL	28942090
607144	79087	ALG12	0002	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig	ALG12, THR61MET	121907931
607144	79087	ALG12	0003	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig	ALG12, ARG146GLN	121907932
607144	79087	ALG12	0004	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig	ALG12, GLY101ARG	121907933
607144	79087	ALG12	0005	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig	ALG12, LEU158PRO	121907934
607144	79087	ALG12	0006	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig	ALG12, TYR414TER	121907935
607145	84062	DTNBP1	0001	HERMANSKY-PUDLAK SYNDROME 7	DTNBP1, GLN103TER	104893945
607170	78987	CRELD1	0001	ATRIOVENTRICULAR SEPTAL DEFECT, SUSCEPTIBILITY TO, 2	CRELD1, ARG329CYS	28942091
607170	78987	CRELD1	0002	ATRIOVENTRICULAR SEPTAL DEFECT, SUSCEPTIBILITY TO, 2	CRELD1, THR311ILE	28942092
607170	78987	CRELD1	0003	ATRIOVENTRICULAR SEPTAL DEFECT, PARTIAL, WITH HETEROTAXY SYNDROME	CRELD1, ARG107HIS	28941780
607170	78987	CRELD1	0004	ATRIOVENTRICULAR SEPTAL DEFECT, SUSCEPTIBILITY TO, 2	CRELD1, PRO162ALA	121912626
607170	78987	CRELD1	0005	ATRIOVENTRICULAR SEPTAL DEFECT, SUSCEPTIBILITY TO, 2	CRELD1, GLU414LYS	121912627
607182	79443	FYCO1	0001	CATARACT 18, AUTOSOMAL RECESSIVE	FYCO1, GLN349TER	
607182	79443	FYCO1	0002	CATARACT 18, AUTOSOMAL RECESSIVE	FYCO1, GLN736TER	
607182	79443	FYCO1	0003	CATARACT 18, AUTOSOMAL RECESSIVE	FYCO1, IVS9DS, G-T, +1	
607182	79443	FYCO1	0004	CATARACT 18, AUTOSOMAL RECESSIVE	FYCO1, 5-BP DUP, 3858GGAAT	
607182	79443	FYCO1	0005	CATARACT 18, AUTOSOMAL RECESSIVE	FYCO1, LEU1376PRO	
607182	79443	FYCO1	0006	CATARACT 18, AUTOSOMAL RECESSIVE	FYCO1, GLN516TER	
607194	256297	PTF1A	0001	PANCREATIC AND CEREBELLAR AGENESIS	PTF1A, ARG296TER	104894186
607194	256297	PTF1A	0002	PANCREATIC AND CEREBELLAR AGENESIS	PTF1A, 1-BP INS, 705G	
607194	256297	PTF1A	0003	PANCREATIC AND CEREBELLAR AGENESIS	PTF1A, 24-BP DEL, NT437	
607198	55775	TDP1	0001	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY	TDP1, HIS493ARG	119467003
607199	3664	IRF6	0001	VAN DER WOUDE SYNDROME 1	IRF6, GLU92TER	121434224
607199	3664	IRF6	0002	VAN DER WOUDE SYNDROME 1	IRF6, 18-BP DEL/1-BP INS	
607199	3664	IRF6	0003	POPLITEAL PTERYGIUM SYNDROME	IRF6, GLN393TER	121434225
607199	3664	IRF6	0004	POPLITEAL PTERYGIUM SYNDROME	IRF6, ARG84CYS	121434226
607199	3664	IRF6	0005	POPLITEAL PTERYGIUM SYNDROME	IRF6, ARG84HIS	121434227
607199	3664	IRF6	0006	VAN DER WOUDE SYNDROME 1	IRF6, ALA2VAL	28942093
607199	3664	IRF6	0007	VAN DER WOUDE SYNDROME 1	IRF6, ARG6CYS	28942094
607199	3664	IRF6	0008	VAN DER WOUDE SYNDROME 1	IRF6, TRP397TER	121434228
607199	3664	IRF6	0009	VAN DER WOUDE SYNDROME 1	IRF6, ARG400TRP	28942095
607199	3664	IRF6	0010	VAN DER WOUDE SYNDROME 1	IRF6, 17-BP DEL	
607199	3664	IRF6	0011	VAN DER WOUDE SYNDROME 1	IRF6, ARG45GLN	121434229
607199	3664	IRF6	0012	VAN DER WOUDE SYNDROME 1	IRF6, PRO396SER	121434230
607199	3664	IRF6	0013	VAN DER WOUDE SYNDROME 1 POPLITEAL PTERYGIUM SYNDROME, INCLUDED	IRF6, ARG339ILE	2235371
607199	3664	IRF6	0014	VAN DER WOUDE SYNDROME 1 POPLITEAL PTERYGIUM SYNDROME, INCLUDED	IRF6, LEU22PRO	
607199	3664	IRF6	0015	POPLITEAL PTERYGIUM SYNDROME	IRF6, ARG84LEU	
607199	3664	IRF6	0016	POPLITEAL PTERYGIUM SYNDROME	IRF6, SER424LEU	
607199	3664	IRF6	0017	VAN DER WOUDE SYNDROME 1	IRF6, GLN49TER	
607206	59344	ALOXE3	0001	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 3	ALOXE3, VAL500PHE	121434232
607206	59344	ALOXE3	0002	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 3	ALOXE3, ARG234TER	121434233
607206	59344	ALOXE3	0003	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 3	ALOXE3, ARG396SER	121434234
607206	59344	ALOXE3	0004	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	ALOXE3, LEU237MET	121434235
607206	59344	ALOXE3	0005	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 3	ALOXE3, GLY281VAL	
607206	59344	ALOXE3	0006	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 3	ALOXE3, PRO630LEU	
607206	59344	ALOXE3	0007	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 3	ALOXE3, ARG145HIS	
607206	59344	ALOXE3	0008	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 3	ALOXE3, LEU427PRO	
607210	84433	CARD11	0001	PERSISTENT POLYCLONAL B-CELL LYMPHOCYTOSIS	CARD11, GLU127GLY	
607210	84433	CARD11	0002	PERSISTENT POLYCLONAL B-CELL LYMPHOCYTOSIS	CARD11, GLY116SER	
607210	84433	CARD11	0003	CARD11 IMMUNODEFICIENCY	CARD11, GLN945TER	
607210	84433	CARD11	0004	CARD11 IMMUNODEFICIENCY	CARD11, 1,377-BP DEL	
607211	79092	CARD14	0001	PSORIASIS SUSCEPTIBILITY 2	CARD14, GLY117SER	
607211	79092	CARD14	0002	PSORIASIS SUSCEPTIBILITY 2	CARD14, IVS3, G-A, +5	
607211	79092	CARD14	0003	PSORIASIS SUSCEPTIBILITY 2	CARD14, GLU138ALA	
607211	79092	CARD14	0004	PSORIASIS SUSCEPTIBILITY 2	CARD14, GLU142LYS	
607211	79092	CARD14	0005	PSORIASIS SUSCEPTIBILITY 2	CARD14, GLU142GLY	
607211	79092	CARD14	0006	PITYRIASIS RUBRA PILARIS	CARD14, LEU156PRO	
607211	79092	CARD14	0007	PITYRIASIS RUBRA PILARIS	CARD14, 3-BP DEL, 412GAG	
607211	79092	CARD14	0008	PITYRIASIS RUBRA PILARIS	CARD14, IVS3, G-A, +1	
607212	64170	CARD9	0001	CANDIDIASIS, FAMILIAL, 2	CARD9, GLN295TER	121918338
607213	23594	ORC6	0001	MEIER-GORLIN SYNDROME 3	ORC6, 2-BP DEL, 257TT	
607213	23594	ORC6	0002	MEIER-GORLIN SYNDROME 3	ORC6, TYR232SER	
607215	261734	NPHP4	0001	NEPHRONOPHTHISIS 4	NPHP4, GLU790TER	137852918
607215	261734	NPHP4	0002	NEPHRONOPHTHISIS 4	NPHP4, GLN793TER	137852919
607215	261734	NPHP4	0003	NEPHRONOPHTHISIS 4	NPHP4, ARG682TER	137852920
607215	261734	NPHP4	0004	NEPHRONOPHTHISIS 4	NPHP4, PHE991SER	28940891
607215	261734	NPHP4	0005	NEPHRONOPHTHISIS 4	NPHP4, 1-BP DEL, 3272T	
607215	261734	NPHP4	0006	SENIOR-LOKEN SYNDROME 4	NPHP4, GLN779TER	137852922
607215	261734	NPHP4	0007	SENIOR-LOKEN SYNDROME 4	NPHP4, ARG658TER	137852923
607218	3663	IRF5	0001	INFLAMMATORY BOWEL DISEASE 14, SUSCEPTIBILITY TO SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 10, INCLUDED	IRF5, 5-BP INS, PROMOTER REGION	
607218	3663	IRF5	0002	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 10 RHEUMATOID ARTHRITIS, INCLUDED	IRF5, G/T	2004640
607218	3663	IRF5	0003	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 10	IRF5, A/G	10954213
607218	3663	IRF5	0004	SYSTEMIC LUPUS ERYTHEMATOSUS, ASSOCIATION WITH SUSCEPTIBILITY TO, 10	IRF5, C/T	2070197
607223	64094	SMOC2	0001	DENTIN DYSPLASIA, TYPE I, WITH EXTREME MICRODONTIA AND MISSHAPEN TEETH	SMOC2, IVS1DS, G-T, 84+1	
607237	259236	TMIE	0001	DEAFNESS, AUTOSOMAL RECESSIVE 6	TMIE, 4-BP INS, 125CGCC	
607237	259236	TMIE	0002	DEAFNESS, AUTOSOMAL RECESSIVE 6	TMIE, ARG81CYS	28942096
607237	259236	TMIE	0003	DEAFNESS, AUTOSOMAL RECESSIVE 6	TMIE, ARG84TRP	28942097
607237	259236	TMIE	0004	DEAFNESS, AUTOSOMAL RECESSIVE 6	TMIE, ARG92TRP	28941781
607237	259236	TMIE	0005	DEAFNESS, AUTOSOMAL RECESSIVE 6	TMIE, 6-BP DEL/1-BP INS	
607237	259236	TMIE	0006	DEAFNESS, AUTOSOMAL RECESSIVE 6	TMIE, TRP57TER	
607243	11154	AP4S1	0001	SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	AP4S1, ARG42TER	
607244	23431	AP4E1	0001	SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE	AP4E1, 192-KB DEL	
607244	23431	AP4E1	0002	SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE	AP4E1, 4-BP DEL, IVS5DS, 542+1GTAA	
607244	23431	AP4E1	0003	SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE	AP4E1, VAL454FS	
607245	10717	AP4B1	0001	SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE	AP4B1, 3-BP INS, 487TAT	
607245	10717	AP4B1	0002	SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE	AP4B1, 1-BP DEL, 664C	
607261	132884	EVC2	0001	ELLIS-VAN CREVELD SYNDROME	EVC2, 1-BP DEL, 3660C	
607261	132884	EVC2	0002	ELLIS-VAN CREVELD SYNDROME	EVC2, 5-BP INS, NT198	
607261	132884	EVC2	0003	ELLIS-VAN CREVELD SYNDROME	EVC2, 1-BP INS, 2056C	
607261	132884	EVC2	0004	ELLIS-VAN CREVELD SYNDROME	EVC2, ARG399TER	137852924
607261	132884	EVC2	0005	ELLIS-VAN CREVELD SYNDROME	EVC2, GLN619TER	137852925
607261	132884	EVC2	0006	ELLIS-VAN CREVELD SYNDROME	EVC2, ILE283ARG	137852926
607261	132884	EVC2	0007	ELLIS-VAN CREVELD SYNDROME	EVC2, GLN1009TER	137852927
607261	132884	EVC2	0008	ELLIS-VAN CREVELD SYNDROME	EVC2, ARG870TRP	137852928
607261	132884	EVC2	0009	WEYERS ACROFACIAL DYSOSTOSIS	EVC2, 1-BP DEL, 3793C	
607261	132884	EVC2	0010	ELLIS-VAN CREVELD SYNDROME	EVC2, IVS5, A-G, -2	
607261	132884	EVC2	0011	ELLIS-VAN CREVELD SYNDROME	EVC2, ARG884TER	
607273	201163	FLCN	0001	BIRT-HOGG-DUBE SYNDROME PNEUMOTHORAX, PRIMARY SPONTANEOUS, INCLUDED	FLCN, 1-BP DUP, 1285C	80338682
607273	201163	FLCN	0002	BIRT-HOGG-DUBE SYNDROME	FLCN, 1-BP DEL, 1285C	80338683
607273	201163	FLCN	0003	BIRT-HOGG-DUBE SYNDROME	FLCN, 2-BP DEL, 632AG AND 1-BP INS, 632C	
607273	201163	FLCN	0004	BIRT-HOGG-DUBE SYNDROME	FLCN, 28-BP DUP, NT923	
607273	201163	FLCN	0005	BIRT-HOGG-DUBE SYNDROME	FLCN, TYR463TER	137852929
607273	201163	FLCN	0006	RENAL CARCINOMA, CHROMOPHOBE, SOMATIC	FLCN, 2-BP DEL, 1284TC AND 2-BP INS, 1284AC	
607273	201163	FLCN	0007	COLORECTAL CANCER, SOMATIC	FLCN, SER79TRP	137852930
607273	201163	FLCN	0008	COLORECTAL CANCER, SOMATIC	FLCN, ALA445THR	41419545
607273	201163	FLCN	0009	PNEUMOTHORAX, PRIMARY SPONTANEOUS	FLCN, 4-BP DEL, 235TCGG	
607273	201163	FLCN	0010	PNEUMOTHORAX, PRIMARY SPONTANEOUS	FLCN, 4-BP DEL, 1533GATG	
607273	201163	FLCN	0011	PNEUMOTHORAX, PRIMARY SPONTANEOUS	FLCN, 1-BP DEL, 404C	
607273	201163	FLCN	0012	PNEUMOTHORAX, PRIMARY SPONTANEOUS	FLCN, 3-BP DEL, 469TTC	
607273	201163	FLCN	0013	PNEUMOTHORAX, PRIMARY SPONTANEOUS	FLCN, 20-BP DEL, NT1156	
607273	201163	FLCN	0014	BIRT-HOGG-DUBE SYNDROME	FLCN, IVS4AS, A-G, -2	
607273	201163	FLCN	0015	BIRT-HOGG-DUBE SYNDROME	FLCN, 11-BP DEL, NT1301-2 AND 1-BP DEL/2-BP INS, NT1323	
607273	201163	FLCN	0016	BIRT-HOGG-DUBE SYNDROME	FLCN, 2-BP DEL/2-BP INS, NT610	
607273	201163	FLCN	0017	PNEUMOTHORAX, PRIMARY SPONTANEOUS	FLCN, EX9-14 DEL	
607292	64218	SEMA4A	0001	RETINITIS PIGMENTOSA 35 CONE-ROD DYSTROPHY 10, INCLUDED	SEMA4A, ASP345HIS	
607292	64218	SEMA4A	0002	RETINITIS PIGMENTOSA 35 CONE-ROD DYSTROPHY 10, INCLUDED	SEMA4A, PHE350CYS	
607292	64218	SEMA4A	0003	RETINITIS PIGMENTOSA 35	SEMA4A, ARG713GLN	41265017
607300	10594	PRPF8	0001	RETINITIS PIGMENTOSA 13	PRPF8, HIS2309ARG	121434236
607300	10594	PRPF8	0002	RETINITIS PIGMENTOSA 13	PRPF8, HIS2309PRO	121434236
607300	10594	PRPF8	0003	RETINITIS PIGMENTOSA 13	PRPF8, ARG2310LYS	121434238
607300	10594	PRPF8	0004	RETINITIS PIGMENTOSA 13	PRPF8, PRO2301THR	121434239
607300	10594	PRPF8	0005	RETINITIS PIGMENTOSA 13	PRPF8, PHE2304LEU	121434240
607300	10594	PRPF8	0006	RETINITIS PIGMENTOSA 13	PRPF8, SER2118PHE	
607300	10594	PRPF8	0007	RETINITIS PIGMENTOSA 13	PRPF8, ARG2310SER	
607301	9129	PRPF3	0001	RETINITIS PIGMENTOSA 18	PRPF3, THR494MET	121434241
607301	9129	PRPF3	0002	RETINITIS PIGMENTOSA 18	PRPF3, PRO493SER	121434242
607301	9129	PRPF3	0003	RETINITIS PIGMENTOSA 18	PRPF3, ALA489ASP	121434243
607306	6716	SRD5A2	0001	PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS	SRD5A2, DEL	
607306	6716	SRD5A2	0002	PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS	SRD5A2, ARG246TRP	121434244
607306	6716	SRD5A2	0003	PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS	SRD5A2, 3-BP DEL, MET157DEL	
607306	6716	SRD5A2	0004	PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS	SRD5A2, LEU55GLN	121434245
607306	6716	SRD5A2	0005	PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS	SRD5A2, GLY115ASP	121434246
607306	6716	SRD5A2	0006	PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS	SRD5A2, GLY183SER	121434247
607306	6716	SRD5A2	0007	PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS	SRD5A2, ARG227TER	121434248
607306	6716	SRD5A2	0008	PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS	SRD5A2, 1-BP DEL, PRO251DEL	
607306	6716	SRD5A2	0009	PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS	SRD5A2, ALA228THR	121434249
607306	6716	SRD5A2	0010	PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS	SRD5A2, GLY196SER	121434250
607306	6716	SRD5A2	0011	PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS	SRD5A2, HIS231ARG	121434251
607306	6716	SRD5A2	0012	STEROID 5-ALPHA-REDUCTASE POLYMORPHISM	SRD5A2, ALA49THR	9282858
607306	6716	SRD5A2	0013	PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS	SRD5A2, PRO212ARG	121434252
607306	6716	SRD5A2	0014	PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS	SRD5A2, GLU197ASP	121434253
607306	6716	SRD5A2	0015	MICROPENIS	SRD5A2, TYR26TER	104893667
607306	6716	SRD5A2	0016	MICROPENIS	SRD5A2, ARG227GLN	9332964
607314	51475	CABP2	0001	DEAFNESS, AUTOSOMAL RECESSIVE 93	CABP2, IVS6DS, G-T, +1	
607331	6100	RP9	0001	RETINITIS PIGMENTOSA 9	RP9, HIS137LEU	104894037
607331	6100	RP9	0002	RETINITIS PIGMENTOSA 9	RP9, ASP170GLY	104894039
607340	9568	GABBR2	0001	NICOTINE DEPENDENCE, SUSCEPTIBILITY TO GABABR2, HAPLOTYPE, CCG (dbSNP rs2491397, dbSNP rs2184026, dbSNP	rs3750344)	2491397
607340	9568	GABBR2	0002	NICOTINE DEPENDENCE, SUSCEPTIBILITY TO GABABR2, HAPLOTYPE, TATA (dbSNP rs1435252, dbSNP rs3780422, dbSNP	rs2779562, dbSNP rs3750344)	2779562
607340	9568	GABBR2	0003	NICOTINE DEPENDENCE, PROTECTION AGAINST GABABR2, HAPLOTYPE, CACA (dbSNP rs1435252, dbSNP rs3780422, dbSNP	rs2779562, dbSNP rs3750344)	2779562
607343	57167	SALL4	0001	DUANE-RADIAL RAY SYNDROME	SALL4, GLN652TER	74315424
607343	57167	SALL4	0002	DUANE-RADIAL RAY SYNDROME	SALL4, 1-BP DEL, 1053G	
607343	57167	SALL4	0003	DUANE-RADIAL RAY SYNDROME	SALL4, 1-BP INS, 940C	
607343	57167	SALL4	0004	DUANE-RADIAL RAY SYNDROME	SALL4, 1-BP DEL, 1904T	
607343	57167	SALL4	0005	DUANE-RADIAL RAY SYNDROME	SALL4, ARG865TER	74315425
607343	57167	SALL4	0006	DUANE-RADIAL RAY SYNDROME	SALL4, 1-BP DEL, 2425G	
607343	57167	SALL4	0007	DUANE-RADIAL RAY SYNDROME	SALL4, 1-BP DEL, 326C	
607343	57167	SALL4	0008	DUANE-RADIAL RAY SYNDROME	SALL4, LYS175TER	74315426
607343	57167	SALL4	0009	DUANE-RADIAL RAY SYNDROME	SALL4, ARG617TER	74315427
607343	57167	SALL4	0010	DUANE-RADIAL RAY SYNDROME	SALL4, DEL	
607343	57167	SALL4	0011	DUANE-RADIAL RAY SYNDROME	SALL4, ARG905TER	74315428
607343	57167	SALL4	0012	DUANE-RADIAL RAY SYNDROME	SALL4, HIS888ARG	74315429
607343	57167	SALL4	0013	IVIC SYNDROME	SALL4, 1-BP DEL, 2607A	
607358	326	AIRE	0001	AUTOIMMUNE POLYENDOCRINOPATHY SYNDROME, TYPE I	AIRE, ARG257TER	121434254
607358	326	AIRE	0002	AUTOIMMUNE POLYENDOCRINOPATHY SYNDROME, TYPE I	AIRE, LYS83GLU	121434255
607358	326	AIRE	0003	AUTOIMMUNE POLYENDOCRINOPATHY SYNDROME, TYPE I AUTOIMMUNE POLYENDOCRINOPATHY SYNDROME, TYPE I, WITH REVERSIBLE METAPHYSEAL DYSPLASIA, INCLUDED	AIRE, 13-BP DEL, NT1094	
607358	326	AIRE	0004	AUTOIMMUNE POLYENDOCRINOPATHY SYNDROME, TYPE I	AIRE, ARG139TER	121434256
607358	326	AIRE	0005	AUTOIMMUNE POLYENDOCRINOPATHY SYNDROME, TYPE I	AIRE, 1-BP INS, 29635C	
607358	326	AIRE	0006	AUTOIMMUNE POLYENDOCRINOPATHY SYNDROME, TYPE I	AIRE, 1-BP DEL, 33031G	
607358	326	AIRE	0007	AUTOIMMUNE POLYENDOCRINOPATHY SYNDROME, TYPE I, AUTOSOMAL DOMINANT	AIRE, GLY228TRP	121434257
607358	326	AIRE	0008	AUTOIMMUNE POLYENDOCRINOPATHY SYNDROME, TYPE I	AIRE, MET1LEU	121434258
607358	326	AIRE	0009	AUTOIMMUNE POLYENDOCRINOPATHY SYNDROME, TYPE I, WITH REVERSIBLE METAPHYSEAL DYSPLASIA	AIRE, 1-BP DEL, 909C	
607358	326	AIRE	0010	AUTOIMMUNE POLYENDOCRINOPATHY SYNDROME, TYPE I	AIRE, 4-BP DUP, 205CAGG	
607358	326	AIRE	0011	AUTOIMMUNE POLYENDOCRINOPATHY SYNDROME, TYPE I	AIRE, VAL80GLY	
607365	200879	LIPH	0001	HYPOTRICHOSIS 7	LIPH, EX4 DEL	
607365	200879	LIPH	0002	HYPOTRICHOSIS 7	LIPH, 5-BP DEL, NT346	
607365	200879	LIPH	0003	HYPOTRICHOSIS 7 WOOLLY HAIR, AUTOSOMAL RECESSIVE 2, WITH OR WITHOUT HYPOTRICHOSIS, INCLUDED	LIPH, 2-BP DEL, 659TA	
607365	200879	LIPH	0004	WOOLLY HAIR, AUTOSOMAL RECESSIVE 2, WITH OR WITHOUT HYPOTRICHOSIS HYPOTRICHOSIS 7, INCLUDED	LIPH, EXONS 7-8 DEL	
607365	200879	LIPH	0005	WOOLLY HAIR, AUTOSOMAL RECESSIVE 2, WITH OR WITHOUT HYPOTRICHOSIS	LIPH, TRP108ARG	
607365	200879	LIPH	0006	WOOLLY HAIR, AUTOSOMAL RECESSIVE 2, WITH OR WITHOUT HYPOTRICHOSIS	LIPH, 90-BP DUP, NT280	
607365	200879	LIPH	0007	WOOLLY HAIR, AUTOSOMAL RECESSIVE 2, WITH OR WITHOUT HYPOTRICHOSIS	LIPH, CYS246SER	
607365	200879	LIPH	0008	WOOLLY HAIR, AUTOSOMAL RECESSIVE 2, WITH OR WITHOUT HYPOTRICHOSIS	LIPH, HIS248ASN	
607379	4771	NF2	0001	NEUROFIBROMATOSIS, TYPE II	NF2, LEU360PRO	74315492
607379	4771	NF2	0002	NEUROFIBROMATOSIS, TYPE II	NF2, IVS2, G-T, +1	
607379	4771	NF2	0003	MENINGIOMA, SOMATIC	NF2, 1-BP DEL, 993A	
607379	4771	NF2	0004	MENINGIOMA, SOMATIC	NF2, ARG57TER	121434259
607379	4771	NF2	0005	NEUROFIBROMATOSIS, TYPE II	NF2, LEU535PRO	74315493
607379	4771	NF2	0006	NEUROFIBROMATOSIS, TYPE II	NF2, GLN538PRO	74315494
607379	4771	NF2	0007	NEUROFIBROMATOSIS, TYPE II	NF2, PHE96DEL	121434260
607379	4771	NF2	0008	NEUROFIBROMATOSIS, TYPE II	NF2, GLU182TER	74315495
607379	4771	NF2	0009	NEUROFIBROMATOSIS, TYPE II	NF2, ARG262TER	74315496
607379	4771	NF2	0010	NEUROFIBROMATOSIS, TYPE II	NF2, GLN320TER	74315497
607379	4771	NF2	0011	NEUROFIBROMATOSIS, TYPE II	NF2, ARG341TER	74315499
607379	4771	NF2	0012	NEUROFIBROMATOSIS, TYPE II	NF2, GLN407TER	74315500
607379	4771	NF2	0013	NEUROFIBROMATOSIS, TYPE II	NF2, GLU463TER	74315503
607379	4771	NF2	0014	NEUROFIBROMATOSIS, TYPE II	NF2, ARG466TER	74315504
607379	4771	NF2	0015	NEUROFIBROMATOSIS, TYPE II	NF2, GLU527TER	74315505
607379	4771	NF2	0016	NEUROFIBROMATOSIS, TYPE II	NF2, PHE62SER	121434261
607379	4771	NF2	0017	SCHWANNOMATOSIS, SOMATIC	NF2, 245-BP DEL	
607379	4771	NF2	0018	SCHWANNOMATOSIS, SOMATIC	NF2, 1-BP INS	
607379	4771	NF2	0019	SCHWANNOMATOSIS, SOMATIC	NF2, 7-BP DEL, NT105	
607393	79577	CDC73	0001	HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	CDC73, MET1ILE	28942098
607393	79577	CDC73	0002	HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	CDC73, ARG9TER	121434262
607393	79577	CDC73	0003	HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	CDC73, 41-BP DUP/INS	
607393	79577	CDC73	0004	HYPERPARATHYROIDISM-JAW TUMOR SYNDROME PARATHYROID CARCINOMA, INCLUDED;; HYPERPARATHYROIDISM, FAMILIAL ISOLATED PRIMARY, INCLUDED	CDC73, 2-BP INS, 679AG	
607393	79577	CDC73	0005	PARATHYROID CARCINOMA, SOMATIC	CDC73, TRP43TER	121434263
607393	79577	CDC73	0006	HYPERPARATHYROIDISM, FAMILIAL ISOLATED PRIMARY	CDC73, LEU64PRO	121434264
607393	79577	CDC73	0007	CYSTIC PARATHYROID ADENOMA, SOMATIC	CDC73, 1-BP DEL, 53T	
607393	79577	CDC73	0008	PARATHYROID CARCINOMA, SOMATIC	CDC73, TYR54TER	121434265
607393	79577	CDC73	0009	PARATHYROID CARCINOMA	CDC73, 1-BP INS, 373A	
607393	79577	CDC73	0010	HYPERPARATHYROIDISM, FAMILIAL ISOLATED PRIMARY PARATHYROID ADENOMA, SOMATIC, INCLUDED	CDC73, IVS1DS, G-A, +1	
607393	79577	CDC73	0011	HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	CDC73, 2-BP DEL	
607393	79577	CDC73	0012	PARATHYROID ADENOMA PARATHYROID CARCINOMA, INCLUDED	CDC73, 4-BP DEL, 685AGAG	
607393	79577	CDC73	0013	HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	HRPT2, IVS2, G-A, -1	
607393	79577	CDC73	0014	PARATHYROID CARCINOMA, SOMATIC	HRPT2, 1-BP DEL, 85G	
607393	79577	CDC73	0015	PARATHYROID CARCINOMA, SOMATIC	HRPT2, 18-BP DEL, NT13	
607397	4158	MC2R	0001	GLUCOCORTICOID DEFICIENCY 1	MC2R, SER74ILE	104894658
607397	4158	MC2R	0002	GLUCOCORTICOID DEFICIENCY 1	MC2R, ARG201TER	104894659
607397	4158	MC2R	0003	GLUCOCORTICOID DEFICIENCY 1	MC2R, SER120ARG	104894656
607397	4158	MC2R	0004	GLUCOCORTICOID DEFICIENCY 1	MC2R, ARG128CYS	104894657
607397	4158	MC2R	0005	GLUCOCORTICOID DEFICIENCY 1	MC2R, ASP107ASN	104894661
607397	4158	MC2R	0006	GLUCOCORTICOID DEFICIENCY 1	MC2R, 1-BP INS, 1347A	
607397	4158	MC2R	0007	GLUCOCORTICOID DEFICIENCY 1	MC2R, CYS251PHE	104894662
607397	4158	MC2R	0008	GLUCOCORTICOID DEFICIENCY 1	MC2R, ARG137TRP	104894660
607397	4158	MC2R	0009	GLUCOCORTICOID DEFICIENCY 1	MC2R, TYR254CYS	28940892
607397	4158	MC2R	0010	GLUCOCORTICOID DEFICIENCY 1	MC2R, ALA126SER	
607421	51314	NME8	0001	CILIARY DYSKINESIA, PRIMARY, 6	TXNDC3, LEU426TER	121918300
607421	51314	NME8	0002	CILIARY DYSKINESIA, PRIMARY, 6	TXNDC3, IVS6AS, C-T, -27	
607423	10585	POMT1	0001	MUSCULAR DYSTROPHY-DYSTROGLYCANOPTHY (CONGENITAL WITH EYE AND BRAIN ANOMALIES), TYPE A, 1	POMT1, GLY76ARG	28941782
607423	10585	POMT1	0002	MUSCULAR DYSTROPHY-DYSTROGLYCANOPTHY (CONGENITAL WITH EYE AND BRAIN ANOMALIES), TYPE A, 1	POMT1, GLN303TER	119462981
607423	10585	POMT1	0003	MUSCULAR DYSTROPHY-DYSTROGLYCANOPTHY (CONGENITAL WITH EYE AND BRAIN ANOMALIES), TYPE A, 1	POMT1, 1-BP INS, 2110G	
607423	10585	POMT1	0004	MUSCULAR DYSTROPHY-DYSTROGLYCANOPTHY (CONGENITAL WITH EYE AND BRAIN ANOMALIES), TYPE A, 1	POMT1, 3-BP DEL, 1260CCT	
607423	10585	POMT1	0005	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1	POMT1, ALA200PRO	119462982
607423	10585	POMT1	0006	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1	POMT1, GLY65ARG	119462983
607423	10585	POMT1	0007	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1	POMT1, TRP582CYS	119462984
607423	10585	POMT1	0008	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1	POMT1, ARG514TER	119462985
607423	10585	POMT1	0009	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1	POMT1, GLN590HIS	119462986
607423	10585	POMT1	0010	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1	POMT1, GLY65ARG	
607423	10585	POMT1	0011	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1	POMT1, ARG541TER	
607423	10585	POMT1	0012	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1	POMT1, GLN590HIS	
607423	10585	POMT1	0013	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1	POMT1, ALA669THR	119462987
607423	10585	POMT1	0014	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1	POMT1, IVS12DS, G-A, +1	
607423	10585	POMT1	0015	MUSCULAR DYSTROPHY-DYSTROGLYCANOPTHY (CONGENITAL WITH EYE AND BRAIN ANOMALIES), TYPE A, 1	POMT1, 2-BP DEL, 2179TC	
607423	10585	POMT1	0016	MUSCULAR DYSTROPHY-DYSTROGLYCANOPTHY (CONGENITAL WITH EYE AND BRAIN ANOMALIES), TYPE A, 1	POMT1, 1-BP INS, 2111G	
607423	10585	POMT1	0017	MUSCULAR DYSTROPHY-DYSTROGLYCANOPTHY (CONGENITAL WITH EYE AND BRAIN ANOMALIES), TYPE A, 1	POMT1, 3-BP DEL, 418ATG	
607423	10585	POMT1	0018	MUSCULAR DYSTROPHY-DYSTROGLYCANOPTHY (CONGENITAL WITH EYE AND BRAIN ANOMALIES), TYPE A, 1	POMT1, 1-BP DUP, 2167G	
607423	10585	POMT1	0019	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1	POMT1, ASN144ASP	
607423	10585	POMT1	0020	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1	POMT1, THR414MET	
607429	23590	PDSS1	0001	COENZYME Q10 DEFICIENCY, PRIMARY, 2	PDSS1, ASP308GLU	119463988
607439	29954	POMT2	0001	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 2	POMT2, ARG638TER	119463989
607439	29954	POMT2	0002	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 2	POMT2, IVS8DS, G-A, +1	
607439	29954	POMT2	0003	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 2	POMT2, 1-BP DEL, 1261C	
607439	29954	POMT2	0004	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 2, INCLUDED	POMT2, TYR666CYS	
607439	29954	POMT2	0005	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	POMT2, TRP647TER	
607439	29954	POMT2	0006	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	POMT2, TRP748ARG	
607439	29954	POMT2	0007	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 2	POMT2, ARG413PRO	
607439	29954	POMT2	0008	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 2	POMT2, VAL373PHE	
607439	29954	POMT2	0009	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 2	POMT2, ILE198ASN	
607439	29954	POMT2	0010	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 2	POMT2, THR184MET	
607439	29954	POMT2	0011	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 2	POMT2, TRP748SER	
607439	29954	POMT2	0012	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 2	POMT2, GLY353SER	
607439	29954	POMT2	0013	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 2	POMT2, GLY726GLU	
607439	29954	POMT2	0014	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	POMT2, GLY353SER	
607439	29954	POMT2	0015	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	POMT2, GLY726GLU	
607439	29954	POMT2	0016	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	POMT2, GLY246ASP	
607439	29954	POMT2	0017	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	POMT2, IVS1DS, G-C, +5	
607439	29954	POMT2	0018	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 2	POMT2, IVS12AS, G-A, -14	
607439	29954	POMT2	0019	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 2	POMT2, GLY482VAL	
607440	2218	FKTN	0001	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4 CARDIOMYOPATHY, DILATED, 1X, INCLUDED	FKTN, 3-KB INS, SVA RETROTRANSPOSON INS	
607440	2218	FKTN	0002	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4	FKTN, ARG47TER	119463990
607440	2218	FKTN	0003	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4	FKTN, 2-BP DEL, NT298	
607440	2218	FKTN	0004	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4	FKTN, L1 INS	
607440	2218	FKTN	0005	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4, INCLUDED	FKTN, 1-BP INS, 1279A	
607440	2218	FKTN	0006	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4	FKTN, 1-BP INS, 504T	
607440	2218	FKTN	0007	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4	FKTN, GLN116TER	119463991
607440	2218	FKTN	0008	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4	FKTN, 1-BP DEL, 1363G	
607440	2218	FKTN	0009	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4, INCLUDED	FKTN, ARG307GLN	119463992
607440	2218	FKTN	0010	CARDIOMYOPATHY, DILATED, 1X	FKTN, GLN358PRO	119463993
607440	2218	FKTN	0011	CARDIOMYOPATHY, DILATED, 1X	FKTN, ARG179THR	119463994
607440	2218	FKTN	0012	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	FKTN, GLY125SER	34006675
607440	2218	FKTN	0013	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4	FKTN, 473-BP DEL, NT5370	
607440	2218	FKTN	0014	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4	FKTN, ALA114THR	119463995
607440	2218	FKTN	0015	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4	FKTN, PHE176SER	119463996
607440	2218	FKTN	0016	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4	FKTN, ALA170GLU	119464997
607440	2218	FKTN	0017	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4	FKTN, TYR371CYS	119464998
607440	2218	FKTN	0018	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4	FKTN, ARG307TER	
607440	2218	FKTN	0019	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4	FKTN, 1-BP DEL, 42G	
607444	51119	SBDS	0001	SHWACHMAN-DIAMOND SYNDROME	SBDS, LYS62TER	120074160
607444	51119	SBDS	0002	SHWACHMAN-DIAMOND SYNDROME APLASTIC ANEMIA, SUSCEPTIBILITY TO, INCLUDED	SBDS, IVS2DS, T-C, +2	113993993
607444	51119	SBDS	0003	SHWACHMAN-DIAMOND SYNDROME	SBDS, ASN8LYS	28942099
607444	51119	SBDS	0004	SHWACHMAN-DIAMOND SYNDROME	SBDS, 1-BP INS, 96A	
607456	84916	CIRH1A	0001	NORTH AMERICAN INDIAN CHILDHOOD CIRRHOSIS	CIRH1A, ARG565TRP	119465999
607461	54808	DYM	0001	DYGGVE-MELCHIOR-CLAUSEN DISEASE	DYM, TYR16TER	120074161
607461	54808	DYM	0002	DYGGVE-MELCHIOR-CLAUSEN DISEASE	DYM, 1-BP DEL	
607461	54808	DYM	0003	DYGGVE-MELCHIOR-CLAUSEN DISEASE	DYM, TYR132TER	120074162
607461	54808	DYM	0004	DYGGVE-MELCHIOR-CLAUSEN DISEASE	DYM, ASN469TYR	120074163
607461	54808	DYM	0005	SMITH-MCCORT DYSPLASIA 1 DYGGVE-MELCHIOR-CLAUSEN DISEASE, INCLUDED	DYM, IVS7AS, A-G, -2	
607461	54808	DYM	0006	SMITH-MCCORT DYSPLASIA 1	DYM, GLU87LYS	120074164
607461	54808	DYM	0007	DYGGVE-MELCHIOR-CLAUSEN DISEASE	DYM, IVS11, G-A, -1	
607461	54808	DYM	0008	DYGGVE-MELCHIOR-CLAUSEN DISEASE	DYM, 1-BP DEL, 1877A	
607461	54808	DYM	0009	DYGGVE-MELCHIOR-CLAUSEN DISEASE	DYM, IVS5AS, A-G, -2	
607461	54808	DYM	0010	SMITH-McCORT DYSPLASIA 1	DYM, CYS542ARG	120074165
607462	1822	ATN1	0001	DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY	ATN1, (CAG)n EXPANSION	193922934
607465	146059	CDAN1	0001	ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE I	CDAN1, ARG1040TRP	80338697
607465	146059	CDAN1	0002	ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE I	CDAN1, PRO1129LEU	80338699
607465	146059	CDAN1	0003	ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE I	CDAN1, ASN598SER	120074166
607465	146059	CDAN1	0004	ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE I	CDAN1, PRO671LEU	80338695
607465	146059	CDAN1	0005	ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE I	CDAN1, PHE866ILE	120074168
607465	146059	CDAN1	0006	ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE I	CDAN1, IVS12, G-A, +5	
607465	146059	CDAN1	0007	ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE I	CDAN1, VAL372DEL	120074169
607474	3081	HGD	0001	ALKAPTONURIA	HGD, PRO230SER	28942100
607474	3081	HGD	0002	ALKAPTONURIA	HGD, VAL300GLY	120074170
607474	3081	HGD	0003	ALKAPTONURIA	HGD, GLY161ARG	28941783
607474	3081	HGD	0004	ALKAPTONURIA	HGD, 1-BP INS, 454G	
607474	3081	HGD	0005	ALKAPTONURIA	HGD, IVS1AS, G-A, -1	
607474	3081	HGD	0006	ALKAPTONURIA	HGD, 1-BP DEL, 342A	
607474	3081	HGD	0007	ALKAPTONURIA	HGD, ARG330SER	120074171
607474	3081	HGD	0008	ALKAPTONURIA	HGD, HIS371ARG	120074172
607474	3081	HGD	0009	ALKAPTONURIA	HGD, MET368VAL	120074173
607474	3081	HGD	0010	ALKAPTONURIA	HGD, 1-BP INS, 621G	
607474	3081	HGD	0011	ALKAPTONURIA	HGD, GLY270ARG	120074174
607478	121278	TPH2	0001	UNIPOLAR DEPRESSION, SUSCEPTIBILITY TO	TPH2, ARG441HIS	120074175
607478	121278	TPH2	0002	ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 7	TPH2, ARG303TRP	120074176
607478	121278	TPH2	0003	BIPOLAR AFFECTIVE DISORDER, SUSCEPTIBILITY TO	TPH2, PRO206SER	17110563
607479	147495	APCDD1	0001	HYPOTRICHOSIS 1	APCDD1, LEU9ARG	
607481	166785	MMAA	0001	METHYLMALONIC ACIDURIA, cblA TYPE	MMAA, 4-BP DEL, 592ACTG	
607481	166785	MMAA	0002	METHYLMALONIC ACIDURIA, cblA TYPE	MMAA, 8-BP INS, NT260	
607481	166785	MMAA	0003	METHYLMALONIC ACIDURIA, cblA TYPE	MMAA, GLN95TER	104893846
607481	166785	MMAA	0004	METHYLMALONIC ACIDURIA, cblA TYPE	MMAA, TYR207CYS	104893849
607481	166785	MMAA	0005	METHYLMALONIC ACIDURIA, cblA TYPE	MMAA, ARG145TER	104893851
607492	55690	PACS1	0001	MENTAL RETARDATION, AUTOSOMAL DOMINANT 17	PACS1, ARG203TRP	
607511	170691	ADAMTS17	0001	WEILL-MARCHESANI-LIKE SYNDROME	ADAMTS17, 1-BP INS, 2458G	
607511	170691	ADAMTS17	0002	WEILL-MARCHESANI-LIKE SYNDROME	ADAMTS17, GLN254TER	
607511	170691	ADAMTS17	0003	WEILL-MARCHESANI-LIKE SYNDROME	ADAMTS17, IVS12, G-A, +1	
607512	170692	ADAMTS18	0001	KNOBLOCH SYNDROME 2	ADAMTS18, SER179LEU	
607521	11234	HPS5	0001	HERMANSKY-PUDLAK SYNDROME 5	HPS5, 4-BP DEL, CODON 675, AGTT	
607522	79803	HPS6	0001	HERMANSKY-PUDLAK SYNDROME 6	HPS6, 4-BP DEL, CODON 571, TCTG	
607522	79803	HPS6	0002	HERMANSKY-PUDLAK SYNDROME 6	HPS6, 1-BP INS, 1066G	
607522	79803	HPS6	0003	HERMANSKY-PUDLAK SYNDROME 6	HPS6, 2-BP DEL, 1865TG	
607522	79803	HPS6	0004	HERMANSKY-PUDLAK SYNDROME 6	HPS6, GLN305TER	
607522	79803	HPS6	0005	HERMANSKY-PUDLAK SYNDROME 6	HPS6, 1-BP DUP, 238G	
607522	79803	HPS6	0006	HERMANSKY-PUDLAK SYNDROME 6	HPS6, THR272ILE	
607522	79803	HPS6	0007	HERMANSKY-PUDLAK SYNDROME 6	HPS6, GLN75TER	
607522	79803	HPS6	0008	HERMANSKY-PUDLAK SYNDROME 6	HPS6, GLN412TER	
607542	3784	KCNQ1	0001	LONG QT SYNDROME 1	KCNQ1, 3-BP DEL	
607542	3784	KCNQ1	0002	LONG QT SYNDROME 1	KCNQ1, ALA178PRO	120074177
607542	3784	KCNQ1	0003	LONG QT SYNDROME 1	KCNQ1, GLY189ARG	104894252
607542	3784	KCNQ1	0004	LONG QT SYNDROME 1	KCNQ1, ARG190GLN	120074178
607542	3784	KCNQ1	0005	LONG QT SYNDROME 1	KCNQ1, VAL254MET	120074179
607542	3784	KCNQ1	0006	LONG QT SYNDROME 1	KCNQ1, LEU273PHE	120074180
607542	3784	KCNQ1	0007	LONG QT SYNDROME 1	KCNQ1, GLY306ARG	120074181
607542	3784	KCNQ1	0008	LONG QT SYNDROME 1	KCNQ1, THR312ILE	120074182
607542	3784	KCNQ1	0009	LONG QT SYNDROME 1 LONG QT SYNDROME 1/2, DIGENIC, INCLUDED	KCNQ1, ALA341GLU	12720459
607542	3784	KCNQ1	0010	LONG QT SYNDROME 1	KCNQ1, ALA341VAL	12720459
607542	3784	KCNQ1	0011	LONG QT SYNDROME 1	KCNQ1, GLY345GLU	120074183
607542	3784	KCNQ1	0012	LONG QT SYNDROME 1	KCNQ1, GLY314SER	120074184
607542	3784	KCNQ1	0013	JERVELL AND LANGE-NIELSEN SYNDROME 1	KCNQ1, 7-BP DEL/8-BP INS, NT1244	
607542	3784	KCNQ1	0014	JERVELL AND LANGE-NIELSEN SYNDROME 1	KCNQ1, 1-BP INS, 282G	
607542	3784	KCNQ1	0015	LONG QT SYNDROME 1	KCNQ1, ARG555CYS	120074185
607542	3784	KCNQ1	0016	JERVELL AND LANGE-NIELSEN SYNDROME 1	KCNQ1, TRP305SER	120074186
607542	3784	KCNQ1	0017	LONG QT SYNDROME 1	KCNQ1, ALA300THR	120074187
607542	3784	KCNQ1	0018	LONG QT SYNDROME 1	KCNQ1, 3-BP DEL, PHE339DEL	
607542	3784	KCNQ1	0019	LONG QT SYNDROME 1	KCNQ1, 9-BP DEL, NT373	
607542	3784	KCNQ1	0020	LONG QT SYNDROME 1, RECESSIVE	KCNQ1, ARG518TER	17215500
607542	3784	KCNQ1	0021	LONG QT SYNDROME 1, RECESSIVE	KCNQ1, ALA525THR	120074188
607542	3784	KCNQ1	0022	JERVELL AND LANGE-NIELSEN SYNDROME 1	KCNQ1, 2-BP DEL	
607542	3784	KCNQ1	0023	LONG QT SYNDROME 1	KCNQ1, IVS5, -1	
607542	3784	KCNQ1	0024	LONG QT SYNDROME 1	KCNQ1, CODON 344 SPLICE MUTATION	
607542	3784	KCNQ1	0025	LONG QT SYNDROME 1	KNCQ1, 1-BP INS	
607542	3784	KCNQ1	0026	JERVELL AND LANGE-NIELSEN SYNDROME 1	KCNQ1, 20-BP DEL, NT1892	
607542	3784	KCNQ1	0027	JERVELL AND LANGE-NIELSEN SYNDROME 1	KCNQ1, THR587MET	120074189
607542	3784	KCNQ1	0028	JERVELL AND LANGE-NIELSEN SYNDROME 1	KCNQ1, IVS1	
607542	3784	KCNQ1	0029	LONG QT SYNDROME 1 JERVELL AND LANGE-NIELSEN SYNDROME 1, INCLUDED	KCNQ1, GLY589ASP	120074190
607542	3784	KCNQ1	0030	LONG QT SYNDROME 1	KCNQ1, PRO117LEU	120074191
607542	3784	KCNQ1	0031	LONG QT SYNDROME 1 LONG QT SYNDROME 1, ACQUIRED, SUSCEPTIBILITY TO, INCLUDED	KCNQ1, ARG583CYS	17221854
607542	3784	KCNQ1	0032	ATRIAL FIBRILLATION, FAMILIAL, 3	KCNQ1, SER140GLY	120074192
607542	3784	KCNQ1	0033	LONG QT SYNDROME 1	KCNQ1, GLY269SER	120074193
607542	3784	KCNQ1	0034	LONG QT SYNDROME 1	KCNQ1, GLY269ASP	120074194
607542	3784	KCNQ1	0035	LONG QT SYNDROME 1	KCNQ1, VAL254MET AND VAL417MET	
607542	3784	KCNQ1	0036	LONG QT SYNDROME 1	KCNQ1, 1-BP DEL/2-BP INS, NT533	
607542	3784	KCNQ1	0037	SHORT QT SYNDROME 2	KCNQ1, VAL307LEU	120074195
607542	3784	KCNQ1	0038	LONG QT SYNDROME 1/2, DIGENIC	KCNQ1, 1-BP DEL, 562T	
607542	3784	KCNQ1	0039	LONG QT SYNDROME 1/2, DIGENIC	KCNQ1, ARG243PRO	120074196
607542	3784	KCNQ1	0040	LONG QT SYNDROME 1	KCNQ1, VAL205MET	
607544	10128	LRPPRC	0001	LEIGH SYNDROME, FRENCH-CANADIAN TYPE	LRPPRC, ALA354VAL	119466000
607544	10128	LRPPRC	0002	LEIGH SYNDROME, FRENCH-CANADIAN TYPE	LRPPRC, 8-BP DEL, EXON 35	
607556	117581	TWIST2	0001	FOCAL FACIAL DERMAL DYSPLASIA 3, SETLEIS TYPE	TWIST2, GLN119TER	
607556	117581	TWIST2	0002	FOCAL FACIAL DERMAL DYSPLASIA 3, SETLEIS TYPE	TWIST2, GLN65TER	
607556	117581	TWIST2	0003	FOCAL FACIAL DERMAL DYSPLASIA 3, SETLEIS TYPE	TWIST2, 1-BP DEL, 168C	
607557	246213	SLC17A8	0001	DEAFNESS, AUTOSOMAL DOMINANT 25	SLC17A8, ALA211VAL	121918339
607562	149233	IL23R	0001	INFLAMMATORY BOWEL DISEASE 17, PROTECTION AGAINST PSORIASIS, PROTECTION AGAINST, INCLUDED	IL23R, ARG381GLN	11209026
607566	7957	EPM2A	0001	EPILEPSY, PROGRESSIVE MYOCLONIC 2A	EPM2A, ARG168TER	
607566	7957	EPM2A	0002	EPILEPSY, PROGRESSIVE MYOCLONIC 2A	EPM2A, GLY216SER	
607566	7957	EPM2A	0003	EPILEPSY, PROGRESSIVE MYOCLONIC 2A	EPM2A, ARG45CYS	137852915
607566	7957	EPM2A	0004	EPILEPSY, PROGRESSIVE MYOCLONIC 2A	EPM2A, 1-BP INS, 94A	
607566	7957	EPM2A	0005	EPILEPSY, PROGRESSIVE MYOCLONIC 2A	EPM2A, ARG90HIS	137852916
607566	7957	EPM2A	0006	EPILEPSY, PROGRESSIVE MYOCLONIC 2A	EPM2A, ARG160TER	
607566	7957	EPM2A	0007	EPILEPSY, PROGRESSIVE MYOCLONIC 2A	EPM2A, GLY198SER	137852917
607566	7957	EPM2A	0008	EPILEPSY, PROGRESSIVE MYOCLONIC 2A	EPM2A, ARG241TER	104893950
607566	7957	EPM2A	0009	EPILEPSY, PROGRESSIVE MYOCLONIC 2A	EPM2A, 1-BP INS, 950T	
607566	7957	EPM2A	0010	EPILEPSY, PROGRESSIVE MYOCLONIC 2A	EPM2A, TRP32GLY	104893955
607568	326625	MMAB	0001	METHYLMALONIC ACIDURIA, cblB TYPE	MMAB, ARG186TRP	28941784
607568	326625	MMAB	0002	METHYLMALONIC ACIDURIA, cblB TYPE	MMAB, IVS3, G-A, -1	
607568	326625	MMAB	0003	METHYLMALONIC ACIDURIA, cblB TYPE	MMAB, 5-BP DEL, NT572	
607574	410	ARSA	0001	ARYLSULFATASE A PSEUDODEFICIENCY	ARSA, MUTATION IN POLYADENYLATION SIGNAL	
607574	410	ARSA	0002	ARYLSULFATASE A POLYMORPHISM	ARSA, ASN350SER	2071421
607574	410	ARSA	0003	METACHROMATIC LEUKODYSTROPHY, JUVENILE ARYLSULFATASE A, ALLELE I, INCLUDED;; METACHROMATIC LEUKODYSTROPHY, ADULT, INCLUDED	ARSA, IVS2DS, G-A, +1	80338815
607574	410	ARSA	0004	METACHROMATIC LEUKODYSTROPHY, JUVENILE ARYLSULFATASE A, ALLELE A, INCLUDED;; METACHROMATIC LEUKODYSTROPHY, ADULT, INCLUDED	ARSA, PRO426LEU	28940893
607574	410	ARSA	0005	METACHROMATIC LEUKODYSTROPHY, ADULT	ARSA, GLY99ASP	74315455
607574	410	ARSA	0006	METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE	ARSA, SER96PHE	74315456
607574	410	ARSA	0007	METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE	ARSA, 11-BP DEL, EX8	
607574	410	ARSA	0008	METACHROMATIC LEUKODYSTROPHY, JUVENILE METACHROMATIC LEUKODYSTROPHY, ADULT, INCLUDED	ARSA, ILE179SER	74315457
607574	410	ARSA	0009	METACHROMATIC LEUKODYSTROPHY, JUVENILE	ARSA, IVS7DS, G-A, +1	80338820
607574	410	ARSA	0010	METACHROMATIC LEUKODYSTROPHY, LATE-ONSET	ARSA, ARG84GLN	74315458
607574	410	ARSA	0011	METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE	ARSA, GLY309SER	74315459
607574	410	ARSA	0012	METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE	ARSA, 1-BP DEL, 447C	
607574	410	ARSA	0013	METACHROMATIC LEUKODYSTROPHY, SEVERE	ARSA, GLY86ASP	74315460
607574	410	ARSA	0014	METACHROMATIC LEUKODYSTROPHY, SEVERE	ARSA, SER96LEU	
607574	410	ARSA	0015	METACHROMATIC LEUKODYSTROPHY	ARSA, GLY122SER	74315461
607574	410	ARSA	0016	METACHROMATIC LEUKODYSTROPHY, SEVERE	ARSA, PRO136LEU	74315462
607574	410	ARSA	0017	METACHROMATIC LEUKODYSTROPHY	ARSA, 1-BP DEL, 297C	
607574	410	ARSA	0018	METACHROMATIC LEUKODYSTROPHY	ARSA, GLY154ASP	74315463
607574	410	ARSA	0019	ARYLSULFATASE A PSEUDODEFICIENCY	ARSA, PRO155ARG	74315464
607574	410	ARSA	0020	METACHROMATIC LEUKODYSTROPHY	ARSA, PRO167ARG	74315465
607574	410	ARSA	0021	ARYLSULFATASE A PSEUDODEFICIENCY	ARSA, ASP169ASN	74315466
607574	410	ARSA	0022	METACHROMATIC LEUKODYSTROPHY	ARSA, ALA212VAL	74315467
607574	410	ARSA	0023	METACHROMATIC LEUKODYSTROPHY	ARSA, ALA224VAL	74315468
607574	410	ARSA	0024	METACHROMATIC LEUKODYSTROPHY	ARSA, PRO231THR	74315469
607574	410	ARSA	0025	METACHROMATIC LEUKODYSTROPHY	ARSA, ARG244CYS	74315470
607574	410	ARSA	0026	METACHROMATIC LEUKODYSTROPHY, SEVERE	ARSA, GLY245ARG	74315471
607574	410	ARSA	0027	METACHROMATIC LEUKODYSTROPHY, SEVERE	ARSA, THR274MET	74315472
607574	410	ARSA	0028	METACHROMATIC LEUKODYSTROPHY, SEVERE	ARSA, IVS4DS, G-A, +1	
607574	410	ARSA	0029	METACHROMATIC LEUKODYSTROPHY	ARSA, ARG288CYS	74315473
607574	410	ARSA	0030	METACHROMATIC LEUKODYSTROPHY, SEVERE	ARSA, SER295TYR	74315474
607574	410	ARSA	0031	ARYLSULFATASE A PSEUDODEFICIENCY	ARSA, IVS5DS, G-T, -1, GLY325CYS	
607574	410	ARSA	0032	METACHROMATIC LEUKODYSTROPHY, SEVERE	ARSA, ASP335VAL	74315475
607574	410	ARSA	0033	METACHROMATIC LEUKODYSTROPHY, SEVERE	ARSA, ARG370TRP	74315476
607574	410	ARSA	0034	METACHROMATIC LEUKODYSTROPHY, MILD	ARSA, ARG370GLN	74315477
607574	410	ARSA	0035	ARYLSULFATASE A PSEUDODEFICIENCY, SEVERE	ARSA, PRO377LEU	74315478
607574	410	ARSA	0036	ARYLSULFATASE A PSEUDODEFICIENCY, INTERMEDIATE	ARSA, GLU382LYS	74315479
607574	410	ARSA	0037	METACHROMATIC LEUKODYSTROPHY	ARSA, ARG390TRP	74315480
607574	410	ARSA	0038	METACHROMATIC LEUKODYSTROPHY	ARSA, 3-BP DEL, PHE398DEL	
607574	410	ARSA	0039	METACHROMATIC LEUKODYSTROPHY, MILD	ARSA, THR409ILE	74315481
607574	410	ARSA	0040	ARYLSULFATASE A PSEUDODEFICIENCY	ARSA, GLN486TER	74315482
607574	410	ARSA	0042	METACHROMATIC LEUKODYSTROPHY, ADULT	ARSA, PRO135LEU	121434215
607574	410	ARSA	0043	METACHROMATIC LEUKODYSTROPHY, ADULT	ARSA, THR286PRO	28940894
607574	410	ARSA	0044	METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE	ARSA, GLU253LYS	74315483
607574	410	ARSA	0045	METACHROMATIC LEUKODYSTROPHY, ADULT	ARSA, THR408ILE	28940895
607574	410	ARSA	0046	METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE	ARSA, CYS300PHE	74315484
607574	410	ARSA	0047	METACHROMATIC LEUKODYSTROPHY, JUVENILE	ARSA, PRO425THR	74315485
607585	472	ATM	0001	ATAXIA-TELANGIECTASIA, COMPLEMENTATION GROUP A	ATM, 3-BP DEL, SER1512DEL	
607585	472	ATM	0002	ATAXIA-TELANGIECTASIA, COMPLEMENTATION GROUP E	ATM, 9-BP DEL, CODONS 1198-1200	
607585	472	ATM	0003	ATAXIA-TELANGIECTASIA, COMPLEMENTATION GROUP D	ATM, 6-BP DEL, CODONS 1079-1080	
607585	472	ATM	0004	ATAXIA-TELANGIECTASIA VARIANT	ATM, 137-BP INS, NT5762	
607585	472	ATM	0005	ATAXIA-TELANGIECTASIA VARIANT T-CELL PROLYMPHOCYTIC LEUKEMIA, SOMATIC, INCLUDED;; BREAST CANCER, SUSCEPTIBILITY TO, INCLUDED	ATM, VAL2424GLY	28904921
607585	472	ATM	0006	ATAXIA-TELANGIECTASIA VARIANT	ATM, PHE2827CYS	121434216
607585	472	ATM	0007	ATAXIA-TELANGIECTASIA T-CELL PROLYMPHOCYTIC LEUKEMIA, SOMATIC, INCLUDED	ATM, 9-BP DEL, CODONS 2546-2548	
607585	472	ATM	0008	ATAXIA-TELANGIECTASIA	ATM, ARG35TER	55861249
607585	472	ATM	0009	T-CELL PROLYMPHOCYTIC LEUKEMIA, SOMATIC	ATM, ASP1682HIS	121434217
607585	472	ATM	0010	B-CELL NON-HODGKIN LYMPHOMA, SOMATIC	ATM, MET1040VAL	3092857
607585	472	ATM	0011	ATAXIA-TELANGIECTASIA WITHOUT IMMUNODEFICIENCY	ATM, LEU2656PRO	121434218
607585	472	ATM	0012	ATAXIA-TELANGIECTASIA WITHOUT IMMUNODEFICIENCY	ATM, ARG3047TER	121434219
607585	472	ATM	0013	ATAXIA-TELANGIECTASIA	ATM, ASP2625GLU, ALA2626PRO	
607585	472	ATM	0014	ATAXIA-TELANGIECTASIA, FRESNO VARIANT	ATM, IVS33, T-C, +2	
607585	472	ATM	0015	ATAXIA-TELANGIECTASIA	ATM, 5-BP DEL, NT7884	
607585	472	ATM	0016	ATAXIA-TELANGIECTASIA	ATM, 3-BP DEL/4-BP, NT3245	
607585	472	ATM	0017	ATAXIA-TELANGIECTASIA	ATM, 3-BP DEL, VAL2662DEL	
607585	472	ATM	0018	ATAXIA-TELANGIECTASIA	ATM, 3576G-A	
607585	472	ATM	0019	ATAXIA-TELANGIECTASIA	ATM, ARG2443TER	121434220
607585	472	ATM	0020	BREAST CANCER, FAMILIAL KIDNEY CANCER, INCLUDED	ATM, IVS61DS, 2-BP INS, +2TA	
607585	472	ATM	0021	ATAXIA TELANGIECTASIA BREAST CANCER, SUSCEPTIBILITY TO, INCLUDED	ATM, IVS10AS, T-G, -6	
607585	472	ATM	0022	MANTLE CELL LYMPHOMA	ATM, GLU2423GLY	121434221
607585	472	ATM	0023	MANTLE CELL LYMPHOMA	ATM, 3-BP INS, 7253GAA	
607585	472	ATM	0024	MANTLE CELL LYMPHOMA, SOMATIC	ATM, GLN1361TER	121434222
607585	472	ATM	0025	T-CELL PROLYMPHOCYTIC LEUKEMIA, SOMATIC	ATM, SER1770TER	121434223
607585	472	ATM	0026	ATAXIA-TELANGIECTASIA	ATM, 4-BP DEL, IVS20	
607585	472	ATM	0027	ATAXIA-TELANGIECTASIA	ATM, 2250G-A	
607585	472	ATM	0028	ATAXIA-TELANGIECTASIA VARIANT	ATM, TYR2677CYS	28942103
607585	472	ATM	0029	ATAXIA-TELANGIECTASIA VARIANT	ATM, TYR2677CYS	28942103
607585	472	ATM	0031	ATAXIA-TELANGIECTASIA VARIANT	ATM, IVS7, G-A, +5	
607585	472	ATM	0032	BREAST CANCER, SUSCEPTIBILITY TO	ATM, SER49CYS	1800054
607585	472	ATM	0033	ATAXIA-TELANGIECTASIA VARIANT	ATM, ALA2067ASP	
607590	55212	BBS7	0001	BARDET-BIEDL SYNDROME 7	BBS7, HIS323ARG	119466001
607590	55212	BBS7	0002	BARDET-BIEDL SYNDROME 7	BBS7, THR211ILE	119466002
607590	55212	BBS7	0003	BARDET-BIEDL SYNDROME 7	BBS7, 4-BP DEL	
607590	55212	BBS7	0004	BARDET-BIEDL SYNDROME 7	BBS7, 6-BP DEL, NT533	
607601	148022	TICAM1	0001	HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 4	TICAM1, ARG141TER	
607601	148022	TICAM1	0002	HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 4	TICAM1, SER186LEU	
607604	169522	KCNV2	0001	RETINAL CONE DYSTROPHY 3B	KCNV2, GLU143TER	104894113
607604	169522	KCNV2	0002	RETINAL CONE DYSTROPHY 3B	KCNV2, GLU306TER	104894114
607604	169522	KCNV2	0003	RETINAL CONE DYSTROPHY 3B	KCNV2, GLY459ASP	104894115
607604	169522	KCNV2	0004	RETINAL CONE DYSTROPHY 3B	KCNV2, 9-BP DEL, NT1015	
607604	169522	KCNV2	0005	RETINAL CONE DYSTROPHY 3B	KCNV2, SER256TRP	104894116
607604	169522	KCNV2	0006	RETINAL CONE DYSTROPHY 3B	KCNV2, GLY461ARG	
607604	169522	KCNV2	0007	RETINAL CONE DYSTROPHY 3B	KCNV2, 1-BP INS, 357C	
607604	169522	KCNV2	0008	RETINAL CONE DYSTROPHY 3B	KCNV2, GLN76TER	
607604	169522	KCNV2	0009	RETINAL CONE DYSTROPHY 3B	KCNV2, GLU148TER	
607604	169522	KCNV2	0010	RETINAL CONE DYSTROPHY 3B	KCNV2, PHE164SER	
607604	169522	KCNV2	0011	RETINAL CONE DYSTROPHY 3B	KCNV2, 4-BP DEL, NT8	
607604	169522	KCNV2	0012	RETINAL CONE DYSTROPHY 3B	KCNV2, EX1 DEL	
607606	3857	KRT9	0001	PALMOPLANTAR KERATODERMA, EPIDERMOLYTIC PALMOPLANTAR KERATODERMA, EPIDERMOLYTIC, WITH KNUCKLE PADS, INCLUDED	KRT9, ARG163TRP	59616921
607606	3857	KRT9	0002	PALMOPLANTAR KERATODERMA, EPIDERMOLYTIC	KRT9, GLN172PRO	59878153
607606	3857	KRT9	0003	PALMOPLANTAR KERATODERMA, EPIDERMOLYTIC	KRT9, ASN161TYR	59296273
607606	3857	KRT9	0004	PALMOPLANTAR KERATODERMA, EPIDERMOLYTIC	KRT9, ASN161LYS	57536312
607606	3857	KRT9	0005	PALMOPLANTAR KERATODERMA, EPIDERMOLYTIC	KRT9, ARG163GLN	57758262
607606	3857	KRT9	0006	PALMOPLANTAR KERATODERMA, EPIDERMOLYTIC	KRT9, MET157VAL	58597584
607606	3857	KRT9	0007	PALMOPLANTAR KERATODERMA, EPIDERMOLYTIC	KRT9, ASN161SER	56707768
607606	3857	KRT9	0008	PALMOPLANTAR KERATODERMA, EPIDERMOLYTIC	KRT9, LEU168SER	61157095
607606	3857	KRT9	0009	PALMOPLANTAR KERATODERMA, EPIDERMOLYTIC	KRT9, LEU160VAL	28940896
607606	3857	KRT9	0010	PALMOPLANTAR KERATODERMA, EPIDERMOLYTIC	KRT9, MET157THR	59510579
607606	3857	KRT9	0011	PALMOPLANTAR KERATODERMA, EPIDERMOLYTIC	KRT9, VAL171MET	57019720
607606	3857	KRT9	0012	PALMOPLANTAR KERATODERMA, EPIDERMOLYTIC, WITH KNUCKLE PADS	KRT9, LEU160PHE	28940896
607606	3857	KRT9	0013	PALMOPLANTAR KERATODERMA, EPIDERMOLYTIC, WITH KNUCKLE PADS	KRT9, ASN161ILE	56707768
607608	6609	SMPD1	0001	NIEMANN-PICK DISEASE, TYPE A	SMPD1, ARG496LEU	120074117
607608	6609	SMPD1	0002	NIEMANN-PICK DISEASE, TYPE B	SMPD1, ARG608DEL	120074118
607608	6609	SMPD1	0003	NIEMANN-PICK DISEASE, TYPE A	SMPD1, GLY577SER	120074119
607608	6609	SMPD1	0004	NIEMANN-PICK DISEASE, TYPE B	SMPD1, SER436ARG	
607608	6609	SMPD1	0005	NIEMANN-PICK DISEASE, TYPE A	SMPD1, LEU261TER	120074120
607608	6609	SMPD1	0006	NIEMANN-PICK DISEASE, TYPE A	SMPD1, 2-BP DEL, LEU178FS	
607608	6609	SMPD1	0007	NIEMANN-PICK DISEASE, TYPE A	SMPD1, MET382ILE	120074121
607608	6609	SMPD1	0008	NIEMANN-PICK DISEASE, TYPE B	SMPD1, GLY242ARG	120074122
607608	6609	SMPD1	0009	NIEMANN-PICK DISEASE, TYPE B	SMPD1, ASN383SER	120074123
607608	6609	SMPD1	0010	NIEMANN-PICK DISEASE, TYPE A	SMPD1, LEU302PRO	120074124
607608	6609	SMPD1	0011	NIEMANN-PICK DISEASE, TYPE A	SMPD1, 1-BP DEL, PRO330FS	
607608	6609	SMPD1	0012	NIEMANN-PICK DISEASE, INTERMEDIATE, PROTRACTED NEUROVISCERAL	SMPD1, TRP391GLY	120074125
607608	6609	SMPD1	0013	NIEMANN-PICK DISEASE, TYPE B	SMPD1, HIS421TYR	120074126
607608	6609	SMPD1	0014	NIEMANN-PICK DISEASE, TYPE B	SMPD1, ARG441TER	120074127
607608	6609	SMPD1	0015	NIEMANN-PICK DISEASE, TYPE B NIEMANN-PICK DISEASE, INTERMEDIATE, PROTRACTED NEUROVISCERAL, INCLUDED	SMPD1, GLN292LYS	120074128
607608	6609	SMPD1	0016	NIEMANN-PICK DISEASE, TYPE A	SMPD1, ALA482GLU	
607608	6609	SMPD1	0017	NIEMANN-PICK DISEASE, TYPE A	SMPD1, TYR467SER	
607623	4864	NPC1	0001	NIEMANN-PICK DISEASE, TYPE C1	NPC1, GLN928PRO	28940897
607623	4864	NPC1	0002	NIEMANN-PICK DISEASE, TYPE C1	NPC1, THR1036MET	28942104
607623	4864	NPC1	0003	NIEMANN-PICK DISEASE, TYPE C1	NPC1, ASN1156SER	28942105
607623	4864	NPC1	0004	NIEMANN-PICK DISEASE, TYPE D	NPC1, GLY992TRP	80358254
607623	4864	NPC1	0005	NIEMANN-PICK DISEASE, TYPE C1	NPC1, 1553G-A	
607623	4864	NPC1	0006	NIEMANN-PICK DISEASE, TYPE C1, ADULT FORM	NPC1, VAL889MET	120074130
607623	4864	NPC1	0007	NIEMANN-PICK DISEASE, TYPE C1, ADULT FORM	NPC1, IVS, 1-BP DEL, A, 3043-2	
607623	4864	NPC1	0008	NIEMANN-PICK DISEASE, TYPE C1, JUVENILE FORM	NPC1, TYR1088CYS	28942106
607623	4864	NPC1	0009	NIEMANN-PICK DISEASE, TYPE C1, JUVENILE FORM	NPC1, LEU1213PHE	120074131
607623	4864	NPC1	0010	NIEMANN-PICK DISEASE, TYPE C1	NPC1, ILE1061THR	80358259
607623	4864	NPC1	0011	NIEMANN-PICK DISEASE, VARIANT TYPE C1	NPC1, ARG958GLN	120074132
607623	4864	NPC1	0012	NIEMANN-PICK DISEASE, VARIANT TYPE C1	NPC1, PRO1007ALA	80358257
607623	4864	NPC1	0013	NIEMANN-PICK DISEASE, TYPE C1	NPC1, GLY992ARG	80358254
607623	4864	NPC1	0014	NIEMANN-PICK DISEASE, TYPE C1	NPC1, VAL378ALA	120074134
607623	4864	NPC1	0015	NIEMANN-PICK DISEASE, TYPE C1	NPC1, VAL950MET	120074135
607623	4864	NPC1	0016	NIEMANN-PICK DISEASE, TYPE C1	NPC1, ALA1035VAL	28942107
607623	4864	NPC1	0017	NIEMANN-PICK DISEASE, TYPE C1	NPC1, IVS23, G-A, +1	
607623	4864	NPC1	0018	NIEMANN-PICK DISEASE, TYPE C1	NPC1, CYS177TYR	80358252
607623	4864	NPC1	0019	NIEMANN-PICK DISEASE, TYPE C1	NPC1, IVS16, G-A, -82	
607623	4864	NPC1	0020	NIEMANN-PICK DISEASE, TYPE C1	NPC1, ARG978CYS	28942108
607623	4864	NPC1	0021	NIEMANN-PICK DISEASE, TYPE C1	NPC1, 1-BP DEL, 3662T	
607623	4864	NPC1	0022	NIEMANN-PICK DISEASE, TYPE C1	NPC1, CYS113ARG	120074136
607623	4864	NPC1	0023	NIEMANN-PICK DISEASE, TYPE C1	NPC1, 4-BP DEL, 3611-3614	
607632	55851	PSENEN	0001	ACNE INVERSA, FAMILIAL, 2	PSENEN, 1-BP DEL, 66G	
607632	55851	PSENEN	0002	ACNE INVERSA, FAMILIAL, 2	PSENEN, 1-BP DEL, 279C	
607633	7498	XDH	0001	XANTHINURIA, TYPE I	XDH, ARG228TER	119460972
607633	7498	XDH	0002	XANTHINURIA, TYPE I	XDH, 1-BP DEL, 2567C	
607633	7498	XDH	0003	XANTHINURIA, TYPE I	XDH, ARG149CYS	72549369
607640	6314	ATXN7	0001	SPINOCEREBELLAR ATAXIA 7	ATXN7, (CAG)n EXPANSION	193922929
607642	10743	RAI1	0001	SMITH-MAGENIS SYNDROME	RAI1, 1-BP DEL, 4929C	
607642	10743	RAI1	0002	SMITH-MAGENIS SYNDROME	RAI1, 1-BP DEL, 1308C	
607642	10743	RAI1	0003	SMITH-MAGENIS SYNDROME	RAI1, 29-BP DEL	
607642	10743	RAI1	0004	SMITH-MAGENIS SYNDROME	RAI1, SER1808ASN	104894633
607642	10743	RAI1	0005	SMITH-MAGENIS SYNDROME	RAI1, GLN1562ARG	104894634
607642	10743	RAI1	0006	SMITH-MAGENIS SYNDROME	RAI1, 1-BP DEL, 3801C	
607642	10743	RAI1	0007	SMITH-MAGENIS SYNDROME	RAI1, 19-BP DEL	
607643	25794	FSCN2	0001	RETINITIS PIGMENTOSA 30	FSCN2, 1-BP DEL, 208G	
607649	28962	OSTM1	0001	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5	OSTM1, IVS5, G-A, +5	
607649	28962	OSTM1	0002	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5	OSTM1, 2-BP DEL, 415AG	
607649	28962	OSTM1	0003	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5	OSTM1, CYS12TER	119460973
607657	1491	CTH	0001	CYSTATHIONINURIA	CTH, 2-BP DEL, 940CT	
607657	1491	CTH	0002	CYSTATHIONINURIA	CTH, 1-BP DEL, 1220C	
607657	1491	CTH	0003	CYSTATHIONINURIA	CTH, THR67ILE	28941785
607657	1491	CTH	0004	CYSTATHIONINURIA	CTH, GLN240GLU	28941786
607657	1491	CTH	0005	HOMOCYSTEINE, TOTAL PLASMA, ELEVATED	CTH, 1364G-T, SER403ILE	1021737
607664	2799	GNS	0001	MUCOPOLYSACCHARIDOSIS TYPE IIID	GNS, ARG355TER	119461974
607664	2799	GNS	0002	MUCOPOLYSACCHARIDOSIS TYPE IIID	GNS, 1-BP DEL, 1169A	
607664	2799	GNS	0003	MUCOPOLYSACCHARIDOSIS TYPE IIID	GNS, GLN390TER	119461975
607664	2799	GNS	0004	MUCOPOLYSACCHARIDOSIS TYPE IIID	GNS, 5-BP INS, 1138GTCCT	
607664	2799	GNS	0005	MUCOPOLYSACCHARIDOSIS TYPE IIID	GNS, 1-BP INS, 1226G	
607672	23529	CLCF1	0001	COLD-INDUCED SWEATING SYNDROME 2	CLCF1, TYR107TER	104894198
607672	23529	CLCF1	0002	COLD-INDUCED SWEATING SYNDROME 2	CLCF1, ARG197LEU	104894203
607672	23529	CLCF1	0003	COLD-INDUCED SWEATING SYNDROME 2	CLCF1, CYS16ARG	
607672	23529	CLCF1	0004	COLD-INDUCED SWEATING SYNDROME 2	CLCF1, 676T-C	
607690	51128	SAR1B	0001	CHYLOMICRON RETENTION DISEASE	SAR1B, GLY37ARG	
607690	51128	SAR1B	0002	CHYLOMICRON RETENTION DISEASE	SAR1B, ASP137ASN	28942109
607690	51128	SAR1B	0003	CHYLOMICRON RETENTION DISEASE	SAR1B, 2-BP DEL, 75TG	
607690	51128	SAR1B	0004	CHYLOMICRON RETENTION DISEASE	SAR1B, SER179ARG	28942110
607690	51128	SAR1B	0005	CHYLOMICRON RETENTION DISEASE	SAR1B, 4-BP DUP, 555TTAC	
607690	51128	SAR1B	0006	CHYLOMICRON RETENTION DISEASE	SAR1B, 349, G-C, -1	
607690	51128	SAR1B	0007	CHYLOMICRON RETENTION DISEASE	SAR1B, GLU122TER	137853125
607690	51128	SAR1B	0008	CHYLOMICRON RETENTION DISEASE	SAR1B, GLY185VAL	137853126
607693	79048	SECISBP2	0001	THYROID HORMONE METABOLISM, ABNORMAL	SECISBP2, ARG540GLN	119461976
607693	79048	SECISBP2	0002	THYROID HORMONE METABOLISM, ABNORMAL	SECISBP2, LYS438TER	119461977
607693	79048	SECISBP2	0003	THYROID HORMONE METABOLISM, ABNORMAL	SECISBP2, IVS8DS, G-A, +29	
607696	124590	USH1G	0001	USHER SYNDROME, TYPE IG	USH1G, LEU48PRO	104894651
607696	124590	USH1G	0002	USHER SYNDROME, TYPE IG	USH1G, 2-BP DEL, 186CA	
607696	124590	USH1G	0003	USHER SYNDROME, TYPE IG	USH1G, 20-BP DEL, NT829	
607696	124590	USH1G	0004	USHER SYNDROME, TYPE IG	USH1G, 1-BP INS, 393G	
607696	124590	USH1G	0005	USHER SYNDROME, TYPE IG	USH1G, TRP38TER	104894652
607696	124590	USH1G	0006	USHER SYNDROME, TYPE IG, MILD	USH1G, 15-BP DEL, NT163	
607697	81846	SBF2	0001	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2	SBF2, EX11-12DEL	
607697	81846	SBF2	0002	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2, WITH EARLY-ONSET GLAUCOMA	SBF2, GLN956TER	120074137
607697	81846	SBF2	0003	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2, WITH EARLY-ONSET GLAUCOMA	SBF2, ARG1196TER	120074138
607697	81846	SBF2	0004	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2, WITH EARLY-ONSET GLAUCOMA	SBF2, ARG487TER	120074139
607697	81846	SBF2	0005	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2	SBF2, IVS32DS, G-C, +1	
607704	23189	KANK1	0001	CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 2	KANK1, DEL, PATERNAL ALLELE	
607709	9414	TJP2	0001	HYPERCHOLANEMIA, FAMILIAL	TJP2, VAL48ALA	121918299
607751	5726	TAS2R38	0001	PHENYLTHIOCARBAMIDE TASTING	TAS2R38, ALA49PRO	713598
607751	5726	TAS2R38	0002	PHENYLTHIOCARBAMIDE TASTING	TAS2R38, VAL262ALA	1726866
607751	5726	TAS2R38	0003	PHENYLTHIOCARBAMIDE TASTING	TAS2R38, ILE296VAL	10246939
607759	3674	ITGA2B	0002	GLANZMANN THROMBASTHENIA	ITGA2B, 13-BP DEL	
607759	3674	ITGA2B	0003	GLANZMANN THROMBASTHENIA	ITGA2B, 4.5-KB DEL, EX2-9	
607759	3674	ITGA2B	0004	BAK PLATELET-SPECIFIC ANTIGEN	ITGA2B, ILE843SER	5911
607759	3674	ITGA2B	0005	GLANZMANN THROMBASTHENIA	ITGA2B, ARG584TER	137852906
607759	3674	ITGA2B	0006	GLANZMANN THROMBASTHENIA	ITGA2B, IVS25AS, C-G, -3	
607759	3674	ITGA2B	0007	GLANZMANN THROMBASTHENIA	ITGA2B, GLY273ASP	137852907
607759	3674	ITGA2B	0008	GLANZMANN THROMBASTHENIA	ITGA2B, IVS15DS, G-A, +1	
607759	3674	ITGA2B	0009	GLANZMANN THROMBASTHENIA	ITGA2B, ARG327HIS	137852908
607759	3674	ITGA2B	0010	GLANZMANN THROMBASTHENIA	ITGA2B, GLY418ASP	137852909
607759	3674	ITGA2B	0011	GLANZMANN THROMBASTHENIA	ITGA2B, VAL425DEL AND ASP426DEL	
607759	3674	ITGA2B	0012	GLANZMANN THROMBASTHENIA	ITGA2B, GLU324LYS	137852910
607759	3674	ITGA2B	0013	GLANZMANN THROMBASTHENIA	ITGA2B, ILE565THR	76811038
607759	3674	ITGA2B	0014	GLANZMANN THROMBASTHENIA	ITGA2B, LEU214PRO	137852911
607759	3674	ITGA2B	0015	GLANZMANN THROMBASTHENIA	ITGA2B, SER926LEU	
607759	3674	ITGA2B	0016	GLANZMANN THROMBASTHENIA	ITGA2B, GLN595HIS	
607759	3674	ITGA2B	0017	BLEEDING DISORDER, PLATELET-TYPE, 16	ITGA2B, ARG995GLN	
607759	3674	ITGA2B	0018	BLEEDING DISORDER, PLATELET-TYPE, 16	ITGA2B, ARG995TRP	
607761	84623	KIRREL3	0001	MENTAL RETARDATION, AUTOSOMAL DOMINANT 4	KIRREL3, ARG40TRP	119462978
607761	84623	KIRREL3	0002	MENTAL RETARDATION, AUTOSOMAL DOMINANT 4	KIRREL3, ARG336GLN	114378922
607761	84623	KIRREL3	0003	MENTAL RETARDATION, AUTOSOMAL DOMINANT 4	KIRREL3, VAL731PHE	119462980
607764	80270	HSD3B7	0001	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1	HSD3B7, 2-BP DEL, NT1057	
607764	80270	HSD3B7	0002	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1	HSD3B7, 1-BP INS, 310C	
607764	80270	HSD3B7	0003	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1	HSD3B7, IVS2, 340G-T, +1	
607764	80270	HSD3B7	0004	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1	HSD3B7, GLU147LYS	104894518
607764	80270	HSD3B7	0005	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1	HSD3B7, 2-BP DEL, 63AG	
607786	255738	PCSK9	0001	HYPERCHOLESTEROLEMIA, FAMILIAL, 3	PCSK9, SER127ARG	28942111
607786	255738	PCSK9	0002	HYPERCHOLESTEROLEMIA, FAMILIAL, 3	PCSK9, PHE216LEU	28942112
607786	255738	PCSK9	0003	HYPERCHOLESTEROLEMIA, FAMILIAL, 3	PCSK9, ASP374TYR	137852912
607786	255738	PCSK9	0004	LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 1	PCSK9, TYR142TER	67608943
607786	255738	PCSK9	0005	LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 1	PCSK9, CYS679TER	28362286
607786	255738	PCSK9	0006	LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 1	PCSK9, ARG46LEU	11591147
607786	255738	PCSK9	0007	LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 1	PCSK9, TYR142TER	67608943
607786	255738	PCSK9	0008	LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 1	PCSK9, 3-BP DEL, 290GCC	
607788	90411	MCFD2	0001	FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 2	MCFD2, 149G-A, +5	
607788	90411	MCFD2	0002	FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 2	MCFD2, 309G-A, +1	
607788	90411	MCFD2	0003	FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 2	MCFD2, 1-BP DEL, 103C	
607788	90411	MCFD2	0004	FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 2	MCFD2, 1-BP DEL, 249T	
607788	90411	MCFD2	0005	FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 2	MCFD2, 8-BP DEL, NT263	
607788	90411	MCFD2	0006	FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 2	MCFD2, ASP129GLU	137852913
607788	90411	MCFD2	0007	FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 2	MCFD2, ILE136THR	137852914
607788	90411	MCFD2	0008	FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 2	MCFD2, ASP81TYR	78289603
607800	26154	ABCA12	0001	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A	ABCA12, GLY1381GLU	28940268
607800	26154	ABCA12	0002	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A	ABCA12, ASN1380SER	28940269
607800	26154	ABCA12	0003	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A	ABCA12, GLY1651SER	28940568
607800	26154	ABCA12	0004	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A	ABCA12, ARG1514HIS	28940270
607800	26154	ABCA12	0005	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A	ABCA12, GLU1539LYS	28940271
607800	26154	ABCA12	0006	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B	ABCA12, 1-BP DEL, 7541C	
607800	26154	ABCA12	0007	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B	ABCA12, 1-BP DEL, 5229A	
607800	26154	ABCA12	0008	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B	ABCA12, ASP2363ASN	726070
607800	26154	ABCA12	0009	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B	ABCA12, ARG2203TER	137853289
607800	26154	ABCA12	0010	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B	ABCA12, GLY1179ARG	
607800	26154	ABCA12	0011	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B	ABCA12, EX8DEL	
607803	54805	CNNM2	0001	HYPOMAGNESEMIA 6, RENAL	CNNM2, 1-BP DEL, 117G	
607803	54805	CNNM2	0002	HYPOMAGNESEMIA 6, RENAL	CNNM2, THR568ILE	
607805	26504	CNNM4	0001	JALILI SYNDROME	CNNM4, 1-BP DUP, 1312C	
607805	26504	CNNM4	0002	JALILI SYNDROME	CNNM4, ARG236GLN	75267011
607805	26504	CNNM4	0003	JALILI SYNDROME	CNNM4, LEU324PRO	74552543
607805	26504	CNNM4	0004	JALILI SYNDROME	CNNM4, GLN564TER	80100937
607805	26504	CNNM4	0005	JALILI SYNDROME	CNNM4, SER200TYR	79424354
607805	26504	CNNM4	0006	JALILI SYNDROME	CNNM4, GLN717TER	75559353
607805	26504	CNNM4	0007	JALILI SYNDROME	CNNM4, 83-BP DEL, NT62	
607809	38	ACAT1	0001	3-@KETOTHIOLASE DEFICIENCY	ACAT1, ALA347THR	120074140
607809	38	ACAT1	0002	3-@KETOTHIOLASE DEFICIENCY	ACAT1, GLY150ARG	120074141
607809	38	ACAT1	0003	3-@KETOTHIOLASE DEFICIENCY	ACAT1, IVS8, G-T, +1	
607809	38	ACAT1	0004	3-@KETOTHIOLASE DEFICIENCY	ACAT1, IVS10, A-C, -2	
607809	38	ACAT1	0005	3-@KETOTHIOLASE DEFICIENCY	ACAT1, IVS10, G-C, -1	
607809	38	ACAT1	0006	3-@KETOTHIOLASE DEFICIENCY	ACAT1, IVS11, T-C, +2	
607809	38	ACAT1	0007	3-@KETOTHIOLASE DEFICIENCY	ACAT1, MET1LYS	120074142
607809	38	ACAT1	0008	3-@KETOTHIOLASE DEFICIENCY	ACAT1, GLY379VAL	120074143
607809	38	ACAT1	0009	3-@KETOTHIOLASE DEFICIENCY	ACAT1, GLN272TER	120074144
607809	38	ACAT1	0010	3-@KETOTHIOLASE DEFICIENCY	ACAT1, 3-BP DEL, 1033GAA	
607809	38	ACAT1	0011	3-@KETOTHIOLASE DEFICIENCY	ACAT1, 1-BP INS, 1083A	
607809	38	ACAT1	0012	3-@KETOTHIOLASE DEFICIENCY	ACAT1, ASN93SER	120074145
607809	38	ACAT1	0013	3-@KETOTHIOLASE DEFICIENCY	ACAT1, ILE312THR	120074146
607809	38	ACAT1	0014	3-@KETOTHIOLASE DEFICIENCY	ACAT1, ALA333PRO	120074147
607809	38	ACAT1	0015	3-@KETOTHIOLASE DEFICIENCY	ACAT1, GLN145GLU	120074148
607814	388531	RGS9BP	0001	BRADYOPSIA	R9AP, 1-BP INS, 194C	
607817	157680	VPS13B	0001	COHEN SYNDROME	VPS13B, 2-BP DEL	180177327
607817	157680	VPS13B	0002	COHEN SYNDROME	VPS13B, LEU2193ARG	120074149
607817	157680	VPS13B	0003	COHEN SYNDROME	VPS13B, ARG2351TER	120074150
607817	157680	VPS13B	0004	COHEN SYNDROME	VPS13B, ASN2993SER	28940272
607817	157680	VPS13B	0005	COHEN SYNDROME	VPS13B, GLU1491TER	120074151
607817	157680	VPS13B	0006	COHEN SYNDROME	VPS13B, ARG971TER	120074152
607817	157680	VPS13B	0007	COHEN SYNDROME	VPS13B, GLY2645ASP	120074153
607817	157680	VPS13B	0008	COHEN SYNDROME	VPS13B, GLN3630TER	120074154
607817	157680	VPS13B	0009	COHEN SYNDROME	VPS13B, 1-BP INS, 9258T	180177329
607817	157680	VPS13B	0010	COHEN SYNDROME	VPS13B, ILE2820THR	120074155
607817	157680	VPS13B	0011	COHEN SYNDROME	VPS13B, EX6-16DEL	
607817	157680	VPS13B	0012	COHEN SYNDROME	VPS13B, 1-BP DEL, 11564A	
607817	157680	VPS13B	0013	COHEN SYNDROME	VPS13B, EX46-50DEL	
607818	22891	ZNF365	0001	URIC ACID NEPHROLITHIASIS, SUSCEPTIBILITY TO	ZNF365, ALA62THR	7076156
607830	80144	FRAS1	0001	FRASER SYNDROME	FRAS1, GLN2863TER	120074156
607830	80144	FRAS1	0002	FRASER SYNDROME	FRAS1, GLN3000TER	120074157
607830	80144	FRAS1	0003	FRASER SYNDROME	FRAS1, 1-BP INS, 5605T	
607830	80144	FRAS1	0004	FRASER SYNDROME	FRAS1, GLN1266TER	120074158
607830	80144	FRAS1	0005	FRASER SYNDROME	FRAS1, SER1423TER	120074159
607830	80144	FRAS1	0006	FRASER SYNDROME	FRAS1, 6-BP DEL, NT5446	
607830	80144	FRAS1	0007	FRASER SYNDROME	FRAS1, 2-BP INS, 6992GG	
607830	80144	FRAS1	0008	FRASER SYNDROME	FRAS1, IVS53, G-T, +1	
607837	2055	CLN8	0001	CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	CLN8, ARG24GLY	104894064
607837	2055	CLN8	0002	CEROID LIPOFUSCINOSIS, NEURONAL, 8	CLN8, TRP263CYS	28940569
607837	2055	CLN8	0003	CEROID LIPOFUSCINOSIS, NEURONAL, 8	CLN8, ARG204CYS	104894060
607837	2055	CLN8	0004	CEROID LIPOFUSCINOSIS, NEURONAL, 8	CLN8, 1-BP DEL, 88G	
607837	2055	CLN8	0005	CEROID LIPOFUSCINOSIS, NEURONAL, 8	CLN8, ALA30PRO	137852883
607837	2055	CLN8	0006	CEROID LIPOFUSCINOSIS, NEURONAL, 8	CLN8, 1-BP DEL, 66G	
607837	2055	CLN8	0007	CEROID LIPOFUSCINOSIS, NEURONAL, 8	CLN8, 3-BP DEL, 180GAA	
607838	84572	GNPTG	0001	MUCOLIPIDOSIS III GAMMA	GNPTG, 1-BP INS	
607838	84572	GNPTG	0002	MUCOLIPIDOSIS III GAMMA	GNPTG, 1-BP DEL, 611G	193302856
607838	84572	GNPTG	0003	MUCOLIPIDOSIS III GAMMA	GNPTG, 28-BP DEL, NT640	193302859
607838	84572	GNPTG	0004	MUCOLIPIDOSIS III GAMMA	GNPTG, TRP111TER	
607838	84572	GNPTG	0005	MUCOLIPIDOSIS III GAMMA	GNPTG, IVS8AS, A-G, -2	
607838	84572	GNPTG	0006	MUCOLIPIDOSIS III GAMMA	GNPTG, GLY106SER	
607838	84572	GNPTG	0007	MUCOLIPIDOSIS III GAMMA	GNPTG, 1-BP DEL, 639T	
607838	84572	GNPTG	0008	MUCOLIPIDOSIS III GAMMA	GNPTG, IVS8AS, G-T, -1	
607838	84572	GNPTG	0009	MUCOLIPIDOSIS III GAMMA	GNPTG, IVS7AS, G-A, -10	
607839	2632	GBE1	0001	GLYCOGEN STORAGE DISEASE IV, CONGENITAL NEUROMUSCULAR	GBE1, IVSAS, G-A, -1	
607839	2632	GBE1	0002	GLYCOGEN STORAGE DISEASE IV, NONPROGRESSIVE HEPATIC ADULT POLYGLUCOSAN BODY DISEASE, INCLUDED	GBE1, TYR329SER	80338671
607839	2632	GBE1	0003	GLYCOGEN STORAGE DISEASE IV, NONPROGRESSIVE HEPATIC	GBE1, LEU224PRO	137852886
607839	2632	GBE1	0004	GLYCOGEN STORAGE DISEASE IV, CLASSIC HEPATIC ADULT POLYGLUCOSAN BODY DISEASE, INCLUDED	GBE1, ARG515CYS	80338672
607839	2632	GBE1	0005	GLYCOGEN STORAGE DISEASE IV, CLASSIC HEPATIC	GBE1, PHE257LEU	137852887
607839	2632	GBE1	0006	GLYCOGEN STORAGE DISEASE IV, CLASSIC HEPATIC GLYCOGEN STORAGE DISEASE IV, CHILDHOOD NEUROMUSCULAR, INCLUDED	GBE1, ARG524TER	137852888
607839	2632	GBE1	0007	GLYCOGEN STORAGE DISEASE IV, COMBINED HEPATIC AND MYOPATHIC ADULT POLYGLUCOSAN BODY DISEASE, INCLUDED	GBE1, ARG524GLN	80338673
607839	2632	GBE1	0008	GLYCOGEN STORAGE DISEASE IV, CONGENITAL NEUROMUSCULAR	GBE1, 627-BP DEL , EX8-12DEL	
607839	2632	GBE1	0009	GLYCOGEN STORAGE DISEASE IV, FATAL PERINATAL NEUROMUSCULAR	GBE1, IVS1DS, G-A, +1	
607839	2632	GBE1	0010	GLYCOGEN STORAGE DISEASE IV, FATAL PERINATAL NEUROMUSCULAR	GBE1, HIS545ARG	137852889
607839	2632	GBE1	0011	GLYCOGEN STORAGE DISEASE IV, CONGENITAL NEUROMUSCULAR	GBE1, GLU592TER	137852890
607839	2632	GBE1	0012	GLYCOGEN STORAGE DISEASE IV, CONGENITAL NEUROMUSCULAR	GBE1, 253-BP DEL	
607839	2632	GBE1	0013	GLYCOGEN STORAGE DISEASE IV, CHILDHOOD NEUROMUSCULAR	GBE1, HIS628ARG	137852891
607839	2632	GBE1	0014	GLYCOGEN STORAGE DISEASE IV, COMBINED HEPATIC AND MYOPATHIC	GBE1, 1-BP INS, 38A	
607839	2632	GBE1	0015	GLYCOGEN STORAGE DISEASE IV, CONGENITAL NEUROMUSCULAR	GBE1, GLN236HIS	137852892
607839	2632	GBE1	0016	GLYCOGEN STORAGE DISEASE IV, CONGENITAL NEUROMUSCULAR	GBE1, ARG262CYS	137852893
607839	2632	GBE1	0017	GLYCOGEN STORAGE DISEASE IV, CONGENITAL NEUROMUSCULAR	GBE1, IVS5DS, G-C, +5	
607839	2632	GBE1	0018	GLYCOGEN STORAGE DISEASE IV, CONGENITAL NEUROMUSCULAR	GBE1, TRP548TER	137852894
607840	79158	GNPTAB	0001	MUCOLIPIDOSIS III ALPHA/BETA, ATYPICAL	GNPTAB, G-A, EX7	
607840	79158	GNPTAB	0002	MUCOLIPIDOSIS III ALPHA/BETA	GNPTAB, ASP407GLY	137852895
607840	79158	GNPTAB	0003	MUCOLIPIDOSIS II ALPHA/BETA	GNPTAB, GLN104TER	137852896
607840	79158	GNPTAB	0004	MUCOLIPIDOSIS II ALPHA/BETA MUCOLIPIDOSIS III ALPHA/BETA, INCLUDED	GNPTAB, ARG1189TER	137852897
607840	79158	GNPTAB	0005	MUCOLIPIDOSIS II ALPHA/BETA	GNPTAB, SER1058TER	137852898
607840	79158	GNPTAB	0006	MUCOLIPIDOSIS II ALPHA/BETA	GNPTAB, 2-BP DEL, 3474TA	
607840	79158	GNPTAB	0007	MUCOLIPIDOSIS II ALPHA/BETA	GNPTAB, TRP894TER	137852899
607840	79158	GNPTAB	0008	MUCOLIPIDOSIS II ALPHA/BETA	GNPTAB, IVS13, G-A, +1	
607840	79158	GNPTAB	0009	MUCOLIPIDOSIS II ALPHA/BETA	GNPTAB, 2-BP DEL, 2574GA	
607840	79158	GNPTAB	0010	MUCOLIPIDOSIS II ALPHA/BETA	GNPTAB, 1-BP INS, 1625C	
607840	79158	GNPTAB	0011	MUCOLIPIDOSIS II ALPHA/BETA MUCOLIPIDOSIS III ALPHA/BETA, INCLUDED	GNPTAB, 2-BP DEL, 3665TC	
607840	79158	GNPTAB	0012	MUCOLIPIDOSIS II ALPHA/BETA	GNPTAB, IVS17DS, G-A, +1	
607840	79158	GNPTAB	0013	MUCOLIPIDOSIS III ALPHA/BETA	GNPTAB, IVS17DS, T-G, +6	
607840	79158	GNPTAB	0014	MUCOLIPIDOSIS III ALPHA/BETA	GNPTAB, LYS4GLN	34159654
607840	79158	GNPTAB	0015	MUCOLIPIDOSIS III ALPHA/BETA MUCOLIPIDOSIS II ALPHA/BETA, INCLUDED	GNPTAB, PHE374LEU	137852900
607844	23592	LEMD3	0001	OSTEOPOIKILOSIS	LEMD3, 457C-T	
607844	23592	LEMD3	0002	BUSCHKE-OLLENDORFF SYNDROME	LEMD3, 3-BP DEL/1-BP INS	
607844	23592	LEMD3	0003	BUSCHKE-OLLENDORFF SYNDROME	LEMD3, 1-BP DUP, 1185T	
607844	23592	LEMD3	0004	OSTEOPOIKILOSIS WITH MELORHEOSTOSIS	LEMD3, 1609C-T	
607844	23592	LEMD3	0005	OSTEOPOIKILOSIS	LEMD3, 1941+5delG	
607844	23592	LEMD3	0006	BUSCHKE-OLLENDORFF SYNDROME OSTEOPOIKILOSIS, INCLUDED	LEMD3, 1-BP DUP, 2154A	
607844	23592	LEMD3	0007	BUSCHKE-OLLENDORFF SYNDROME	LEMD3, TRP855TER	
607844	23592	LEMD3	0008	OSTEOPOIKILOSIS WITH MELORHEOSTOSIS DERMATOFIBROSIS LENTICULARIS DISSEMINATA, ISOLATED, INCLUDED	LEMD3, ARG655TER	
607844	23592	LEMD3	0009	DERMATOFIBROSIS LENTICULARIS DISSEMINATA, ISOLATED	LEMD3, IVS1DS, G-A, +1	
607854	7439	BEST1	0001	BEST MACULAR DYSTROPHY	BEST1, TRP93CYS	28940273
607854	7439	BEST1	0002	BEST MACULAR DYSTROPHY	BEST1, TYR85HIS	28940274
607854	7439	BEST1	0003	BEST MACULAR DYSTROPHY	BEST1, GLY299GLU	28941468
607854	7439	BEST1	0004	BEST MACULAR DYSTROPHY	BEST1, TYR227ASN	28941469
607854	7439	BEST1	0005	BEST MACULAR DYSTROPHY VITELLIFORM MACULAR DYSTROPHY, ADULT-ONSET, INCLUDED;; BEST VITELLIFORM MACULAR DYSTROPHY, MULTIFOCAL, INCLUDED	BEST1, THR6PRO	28940275
607854	7439	BEST1	0006	BEST MACULAR DYSTROPHY	BEST1, ILE295DEL	121918283
607854	7439	BEST1	0007	BEST MACULAR DYSTROPHY	BEST1, VAL9MET	28940276
607854	7439	BEST1	0008	MACULOPATHY, BULL'S-EYE	BEST1, GLU119GLN	1805142
607854	7439	BEST1	0009	VITELLIFORM MACULAR DYSTROPHY, ADULT-ONSET	BEST1, ALA146LYS	1800995
607854	7439	BEST1	0010	BEST MACULAR DYSTROPHY VITELLIFORM MACULAR DYSTROPHY, ADULT-ONSET, INCLUDED	BEST1, ALA243VAL	28940570
607854	7439	BEST1	0011	VITELLIFORM MACULAR DYSTROPHY, ADULT-ONSET	BEST1, ARG47HIS	28940278
607854	7439	BEST1	0012	BEST MACULAR DYSTROPHY	BEST1, 2-BP DEL, 1574CA	
607854	7439	BEST1	0013	BEST MACULAR DYSTROPHY BESTROPHINOPATHY, AUTOSOMAL RECESSIVE, INCLUDED;; BEST VITELLIFORM MACULAR DYSTROPHY, MULTIFOCAL, INCLUDED	BEST1, ARG141HIS	121918284
607854	7439	BEST1	0014	BEST MACULAR DYSTROPHY	BEST1, TYR29TER	121918285
607854	7439	BEST1	0015	BESTROPHINOPATHY, AUTOSOMAL RECESSIVE	BEST1, ARG200TER	121918286
607854	7439	BEST1	0017	BESTROPHINOPATHY, AUTOSOMAL RECESSIVE	BEST1, VAL317MET	121918287
607854	7439	BEST1	0018	BESTROPHINOPATHY, AUTOSOMAL RECESSIVE	BEST1, LEU41PRO	121918288
607854	7439	BEST1	0019	VITREORETINOCHOROIDOPATHY	BEST1, VAL86MET	121918289
607854	7439	BEST1	0020	MICROCORNEA, ROD-CONE DYSTROPHY, CATARACT, AND POSTERIOR STAPHYLOMA	BEST1, VAL239MET	121918290
607854	7439	BEST1	0021	VITREORETINOCHOROIDOPATHY	BEST1, TYR236CYS	121918291
607854	7439	BEST1	0022	RETINITIS PIGMENTOSA 50	BEST1, ILE205THR	
607854	7439	BEST1	0023	RETINITIS PIGMENTOSA 50 RETINITIS PIGMENTOSA, CONCENTRIC, INCLUDED	BEST1, ASP228ASN	
607854	7439	BEST1	0024	BEST MACULAR DYSTROPHY RETINITIS PIGMENTOSA, CONCENTRIC, INCLUDED	BEST1, TYR227CYS	
607854	7439	BEST1	0025	RETINITIS PIGMENTOSA 50	BEST1, LEU140VAL	
607854	7439	BEST1	0026	VITREORETINOCHOROIDOPATHY	BEST1, VAL235ALA	
607878	23530	NNT	0001	GLUCOCORTICOID DEFICIENCY 4	NNT, ALA533VAL	
607878	23530	NNT	0002	GLUCOCORTICOID DEFICIENCY 4	NNT, 1-BP DEL, 600G	
607878	23530	NNT	0003	GLUCOCORTICOID DEFICIENCY 4	NNT, LEU977PRO	
607878	23530	NNT	0004	GLUCOCORTICOID DEFICIENCY 4	NNT, 4-BP DEL, 1107TCAC	
607878	23530	NNT	0005	GLUCOCORTICOID DEFICIENCY 4	NNT, ASN1009LYS	
607878	23530	NNT	0006	GLUCOCORTICOID DEFICIENCY 4	NNT, ALA1008PRO	
607882	79581	SLC52A2	0001	BROWN-VIALETTO-VAN LAERE SYNDROME 2	SLC52A2, GLY306ARG	
607882	79581	SLC52A2	0002	BROWN-VIALETTO-VAN LAERE SYNDROME 2	SLC52A2, LEU123PRO	
607882	79581	SLC52A2	0003	BROWN-VIALETTO-VAN LAERE SYNDROME 2	SLC52A2, LEU339PRO	
607882	79581	SLC52A2	0004	BROWN-VIALETTO-VAN LAERE SYNDROME 2	SLC52A2, SER52PHE	
607882	79581	SLC52A2	0005	BROWN-VIALETTO-VAN LAERE SYNDROME 2	SLC52A2, GLY419SER	
607883	55065	SLC52A1	0001	RIBOFLAVIN DEFICIENCY	SLC52A1, 1.9-KB DEL	
607892	147409	DSG4	0001	HYPOTRICHOSIS 6	DSG4, EX5-8DEL	
607892	147409	DSG4	0002	HYPOTRICHOSIS 6	DSG4, 1-BP DEL, 87G	
607892	147409	DSG4	0003	HYPOTRICHOSIS 6	DSG4, SER192PRO	
607892	147409	DSG4	0004	HYPOTRICHOSIS 6	DSG4, 1-BP INS, 2039T	
607892	147409	DSG4	0005	HYPOTRICHOSIS 6	DSG4, IVS3, G-T, +1	
607892	147409	DSG4	0006	HYPOTRICHOSIS 6	DSG4, PRO267ARG	
607892	147409	DSG4	0007	HYPOTRICHOSIS 6	DSG4, 1-BP DEL, 763T	
607892	147409	DSG4	0008	HYPOTRICHOSIS 6	DSG4, ARG289TER	
607900	55612	FERMT1	0001	KINDLER SYNDROME	FERMT1, IVS3, T-C, +2	
607900	55612	FERMT1	0002	KINDLER SYNDROME	FERMT1, GLN263TER	121918292
607900	55612	FERMT1	0003	KINDLER SYNDROME	FERMT1, 1-BP INS, 1714A	
607900	55612	FERMT1	0004	KINDLER SYNDROME	FERMT1, 1-BP DEL, 464A	
607900	55612	FERMT1	0005	KINDLER SYNDROME	FERMT1, ARG271TER	121918293
607900	55612	FERMT1	0006	KINDLER SYNDROME	FERMT1, ARG288TER	121918294
607901	83706	FERMT3	0001	LEUKOCYTE ADHESION DEFICIENCY, TYPE III	FERMT3, ARG509TER	121918295
607901	83706	FERMT3	0002	LEUKOCYTE ADHESION DEFICIENCY, TYPE III	FERMT3, IVS13AS, A-G, -2	
607901	83706	FERMT3	0003	LEUKOCYTE ADHESION DEFICIENCY, TYPE III	FERMT3, TRP16TER	121918296
607901	83706	FERMT3	0004	LEUKOCYTE ADHESION DEFICIENCY, TYPE III	FERMT3, ARG573TER	121918297
607901	83706	FERMT3	0005	LEUKOCYTE ADHESION DEFICIENCY, TYPE III	FERMT3, TRP229TER	121918298
607901	83706	FERMT3	0006	LEUKOCYTE ADHESION DEFICIENCY, TYPE III	FERMT3, ARG513TER	121918295
607901	83706	FERMT3	0007	LEUKOCYTE ADHESION DEFICIENCY, TYPE III	FERMT3, GLY308ARG	
607901	83706	FERMT3	0008	LEUKOCYTE ADHESION DEFICIENCY, TYPE III	FERMT3, 1-BP DEL, 1275T	
607901	83706	FERMT3	0009	LEUKOCYTE ADHESION DEFICIENCY, TYPE III	FERMT3, IVS2AS, A-C, -2	
607904	8912	CACNA1H	0001	EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 6	CACNA1H, PHE161LEU	119454947
607904	8912	CACNA1H	0002	EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 6	CACNA1H, GLU282LYS	119454948
607904	8912	CACNA1H	0003	EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 6	CACNA1H, VAL831MET	119454949
607904	8912	CACNA1H	0004	EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 6	CACNA1H, GLY773ASP AND ARG788CYS	3751664
607904	8912	CACNA1H	0005	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 6	CACNA1H, PRO618LEU	60734921
607904	8912	CACNA1H	0006	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 6	CACNA1H, ALA876THR	58173258
607905	85365	ALG2	0001	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii	ALG2, 1-BP DEL, 1040G	
607905	85365	ALG2	0002	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii	ALG2, 393G-T	
607922	53947	A4GALT	0001	P1PK BLOOD GROUP SYSTEM, p PHENOTYPE	A4GALT, MET183LYS	74315453
607922	53947	A4GALT	0002	P1PK BLOOD GROUP SYSTEM, p PHENOTYPE	A4GALT, PRO251LEU	28940571
607922	53947	A4GALT	0003	P1PK BLOOD GROUP SYSTEM, p PHENOTYPE	A4GALT, TRP261TER	74315454
607922	53947	A4GALT	0004	P1PK BLOOD GROUP SYSTEM, p PHENOTYPE	A4GALT, GLY187ASP	28940572
607922	53947	A4GALT	0005	P1PK BLOOD GROUP SYSTEM, p PHENOTYPE	A4GALT, 3-BP DEL, 237CTT	
607922	53947	A4GALT	0006	P1PK BLOOD GROUP SYSTEM, p PHENOTYPE	A4GALT, 1-BP INS, 1029C	
607922	53947	A4GALT	0007	P1PK BLOOD GROUP SYSTEM, P(2) PHENOTYPE	A4GALT, 42C-T	
607922	53947	A4GALT	0008	NOR POLYAGGLUTINATION SYNDROME	A4GALT, GLN211GLU	
607928	25861	DFNB31	0001	DEAFNESS, AUTOSOMAL RECESSIVE 31	WHRN, ARG778TER	137852839
607928	25861	DFNB31	0002	USHER SYNDROME, TYPE IID	WHRN, GLN103TER	137852840
607928	25861	DFNB31	0003	USHER SYNDROME, TYPE IID	WHRN, IVS2DS, G-A, +1	
607928	25861	DFNB31	0004	USHER SYNDROME, TYPE IID	WHRN, 1-BP DEL, 737C	
607928	25861	DFNB31	0005	USHER SYNDROME, TYPE IID	WHRN, 1-BP INS, 680G	
607929	83605	CCM2	0001	CEREBRAL CAVERNOUS MALFORMATIONS 2	CCM2, 1-BP DEL, 23G	
607929	83605	CCM2	0002	CEREBRAL CAVERNOUS MALFORMATIONS 2	CCM2, GLN107TER	137852841
607929	83605	CCM2	0003	CEREBRAL CAVERNOUS MALFORMATIONS 2	CCM2, IVS5, G-A, -1	
607929	83605	CCM2	0004	CEREBRAL CAVERNOUS MALFORMATIONS 2	CCM2, 4-BP DEL, NT169	
607929	83605	CCM2	0005	CEREBRAL CAVERNOUS MALFORMATIONS 2	CCM2, MET1VAL	137852842
607929	83605	CCM2	0006	CEREBRAL CAVERNOUS MALFORMATIONS 2	CCM2, IVS3, G-A, +1	
607929	83605	CCM2	0007	CEREBRAL CAVERNOUS MALFORMATIONS 2	CCM2, LEU198ARG	137852843
607929	83605	CCM2	0008	CEREBRAL CAVERNOUS MALFORMATIONS 2	CCM2, 2-BP DEL, 1248AG	
607929	83605	CCM2	0009	CEREBRAL CAVERNOUS MALFORMATIONS 2	CCM2, 77.6-KB DEL	
607929	83605	CCM2	0010	CEREBRAL CAVERNOUS MALFORMATIONS 2	CCM2, IVS1, GC-TT, +5	
607939	285362	SUMF1	0001	MULTIPLE SULFATASE DEFICIENCY	SUMF1, IVS3DS, 4-BP DEL, +5	
607939	285362	SUMF1	0002	MULTIPLE SULFATASE DEFICIENCY	SUMF1, SER359TER	137852844
607939	285362	SUMF1	0003	MULTIPLE SULFATASE DEFICIENCY	SUMF1, ARG327TER	137852845
607939	285362	SUMF1	0004	MULTIPLE SULFATASE DEFICIENCY	SUMF1, ARG349TRP	137852846
607939	285362	SUMF1	0005	MULTIPLE SULFATASE DEFICIENCY	SUMF1, ARG349GLN	137852847
607939	285362	SUMF1	0006	MULTIPLE SULFATASE DEFICIENCY	SUMF1, CYS336ARG	137852848
607939	285362	SUMF1	0007	MULTIPLE SULFATASE DEFICIENCY	SUMF1, ALA279VAL	137852849
607939	285362	SUMF1	0008	MULTIPLE SULFATASE DEFICIENCY	SUMF1, 1-BP DEL, 243C	
607939	285362	SUMF1	0009	MULTIPLE SULFATASE DEFICIENCY	SUMF1, 1-BP DEL, 661G	
607939	285362	SUMF1	0010	MULTIPLE SULFATASE DEFICIENCY	SUMF1, SER155PRO	137852850
607939	285362	SUMF1	0011	MULTIPLE SULFATASE DEFICIENCY	SUMF1, MET1ARG	137852851
607939	285362	SUMF1	0012	MULTIPLE SULFATASE DEFICIENCY	SUMF1, 1-BP DEL, 276C	
607939	285362	SUMF1	0013	MULTIPLE SULFATASE DEFICIENCY	SUMF1, ARG345CYS	137852852
607939	285362	SUMF1	0014	MULTIPLE SULFATASE DEFICIENCY	SUMF1, ALA348PRO	137852853
607939	285362	SUMF1	0015	MULTIPLE SULFATASE DEFICIENCY	SUMF1, CYS218TYR	137852854
607939	285362	SUMF1	0016	MULTIPLE SULFATASE DEFICIENCY	SUMF1, IVS5AS, 1-BP DEL, -2A	
607939	285362	SUMF1	0017	MULTIPLE SULFATASE DEFICIENCY	SUMF1, MET1VAL	137852855
607939	285362	SUMF1	0018	MULTIPLE SULFATASE DEFICIENCY	SUMF1, GLY263VAL	
607951	9702	CEP57	0001	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2	CEP57, 2-BP DEL, 520GA	
607951	9702	CEP57	0002	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2	CEP57, 11-BP DUP, NT915	
607951	9702	CEP57	0003	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2	CEP57, ARG81TER	
607961	8482	SEMA7A	0001	JOHN MILTON HAGEN BLOOD GROUP SYSTEM, JMH-VARIANT PHENOTYPE	SEMA7A, ARG207GLN	
607961	8482	SEMA7A	0002	JOHN MILTON HAGEN BLOOD GROUP SYSTEM, JMH-VARIANT PHENOTYPE	SEMA7A, ARG207TRP	
607961	8482	SEMA7A	0003	JOHN MILTON HAGEN BLOOD GROUP SYSTEM, JMH-VARIANT PHENOTYPE	SEMA7A, ARG460HIS	
607961	8482	SEMA7A	0004	JOHN MILTON HAGEN BLOOD GROUP SYSTEM, JMH-VARIANT PHENOTYPE	SEMA7A, ARG461CYS	
607961	8482	SEMA7A	0005	JOHN MILTON HAGEN BLOOD GROUP SYSTEM, JMH-VARIANT PHENOTYPE	SEMA7A, ARG347LEU	
607968	27241	BBS9	0001	BARDET-BIEDL SYNDROME 9	PTHB1, IVS17DS, G-A, +1	
607968	27241	BBS9	0002	BARDET-BIEDL SYNDROME 9	PTHB1, ARG598TER	137852856
607968	27241	BBS9	0003	BARDET-BIEDL SYNDROME 9	PTHB1, 1-BP INS, 2046C	
607968	27241	BBS9	0004	BARDET-BIEDL SYNDROME 9	PTHB1, GLY141ARG	137852857
607968	27241	BBS9	0005	BARDET-BIEDL SYNDROME 9	PTHB1, GLN355TER	137852858
607968	27241	BBS9	0006	BARDET-BIEDL SYNDROME 9	PTHB1, IVS5DS, G-C, +1	
607968	27241	BBS9	0007	BARDET-BIEDL SYNDROME 9	PTHB1, 4-BP DEL, 1887AACA	
607968	27241	BBS9	0008	BARDET-BIEDL SYNDROME 9	PTHB1, EX6DEL	
607976	84701	COX4I2	0001	EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIAL HYPEROSTOSIS	COX4I2, GLU138LYS	119455950
607983	92344	GORAB	0001	GERODERMA OSTEODYSPLASTICUM	GORAB, GLU123TER	119455951
607983	92344	GORAB	0002	GERODERMA OSTEODYSPLASTICUM	GORAB, 2-BP DEL/2-BP INS, NT-1	
607983	92344	GORAB	0003	GERODERMA OSTEODYSPLASTICUM	GORAB, ARG262TER	119455952
607983	92344	GORAB	0004	GERODERMA OSTEODYSPLASTICUM	GORAB, IVS4, G-C, +5	
607983	92344	GORAB	0005	GERODERMA OSTEODYSPLASTICUM	GORAB, 1-BP DEL, 257C	
607984	81848	SPRY4	0001	HYPOGONADOTROPIC HYPOGONADISM 17 WITH ANOSMIA	SPRY4, LYS177ARG	
607984	81848	SPRY4	0002	HYPOGONADOTROPIC HYPOGONADISM 17 WITH OR WITHOUT ANOSMIA, SUSCEPTIBILITY TO	SPRY4, SER241TYR	
607984	81848	SPRY4	0003	HYPOGONADOTROPIC HYPOGONADISM 17 WITHOUT ANOSMIA	SPRY4, VAL16ILE	
607984	81848	SPRY4	0004	HYPOGONADOTROPIC HYPOGONADISM 17 WITHOUT ANOSMIA	SPRY4, VAL304ILE	
607985	51172	NAGPA	0001	VARIANT OF UNKNOWN SIGNIFICANCE	NAGPA, HIS84GLN	
607985	51172	NAGPA	0002	VARIANT OF UNKNOWN SIGNIFICANCE	NAGPA, ARG328CYS	
607985	51172	NAGPA	0003	VARIANT OF UNKNOWN SIGNIFICANCE	NAGPA, 16-BP DEL	
607998	1200	TPP1	0001	CEROID LIPOFUSCINOSIS, NEURONAL, 2	TPP1, CYS365ARG	119455953
607998	1200	TPP1	0002	CEROID LIPOFUSCINOSIS, NEURONAL, 2	TPP1, CYS365TYR	119455954
607998	1200	TPP1	0003	CEROID LIPOFUSCINOSIS, NEURONAL, 2	TPP1, ARG208TER	119455955
607998	1200	TPP1	0004	CEROID LIPOFUSCINOSIS, NEURONAL, 2	TPP1, IVS5AS, G-C, -1	
607998	1200	TPP1	0005	CEROID LIPOFUSCINOSIS, NEURONAL, 2	TPP1, ARG447HIS	119455956
607998	1200	TPP1	0006	CEROID LIPOFUSCINOSIS, NEURONAL, 2	TPP1, ARG206CYS	28940573
607998	1200	TPP1	0007	CEROID LIPOFUSCINOSIS, NEURONAL, 2	TPP1, GLY284VAL	119455957
607998	1200	TPP1	0008	CEROID LIPOFUSCINOSIS, NEURONAL, 2	TPP1, ASN286SER	119455958
607998	1200	TPP1	0009	CEROID LIPOFUSCINOSIS, NEURONAL, 2	TPP1, IVS7AS, A-G, -10	
608002	27031	NPHP3	0001	NEPHRONOPHTHISIS 3	NPHP3, GLY1275DEL	119456959
608002	27031	NPHP3	0002	NEPHRONOPHTHISIS 3	NPHP3, SER360THR	119456960
608002	27031	NPHP3	0003	NEPHRONOPHTHISIS 3	NPHP3, GLU461TER	119456961
608002	27031	NPHP3	0004	MECKEL SYNDROME, TYPE 7 RENAL-HEPATIC-PANCREATIC DYSPLASIA, INCLUDED	NPHP3, IVS19AS, 2-BP DEL	
608002	27031	NPHP3	0005	MECKEL SYNDROME, TYPE 7	NPHP3, ARG577TER	119456962
608002	27031	NPHP3	0006	RENAL-HEPATIC-PANCREATIC DYSPLASIA	NPHP3, ARG973GLN	119456963
608002	27031	NPHP3	0007	RENAL-HEPATIC-PANCREATIC DYSPLASIA	NPHP3, GLN1114TER	119456964
608002	27031	NPHP3	0008	RENAL-HEPATIC-PANCREATIC DYSPLASIA	NPHP3, IVS13AS, G-A, +5	
608002	27031	NPHP3	0009	NEPHRONOPHTHISIS 3	NPHP3, ARG702TER	
608005	64374	SIL1	0001	MARINESCO-SJOGREN SYNDROME	SIL1, 4-BP DUP, 506AAGA	
608005	64374	SIL1	0002	MARINESCO-SJOGREN SYNDROME	SIL1, IVS6, G-A, +1	
608005	64374	SIL1	0003	MARINESCO-SJOGREN SYNDROME	SIL1, IVS6, T-C, +2	
608005	64374	SIL1	0004	MARINESCO-SJOGREN SYNDROME	SIL1, ARG111TER	119456965
608005	64374	SIL1	0005	MARINESCO-SJOGREN SYNDROME	SIL1, IVS9, G-A, +1	
608005	64374	SIL1	0006	MARINESCO-SJOGREN SYNDROME	SIL1, GLN438TER	119456966
608005	64374	SIL1	0007	MARINESCO-SJOGREN SYNDROME	SIL1, LEU457PRO	119456967
608005	64374	SIL1	0008	MARINESCO-SJOGREN SYNDROME	SIL1, 1-BP DUP, 936G	
608005	64374	SIL1	0009	MARINESCO-SJOGREN SYNDROME	SIL1, 5-BP DEL, 598GAAGA	
608005	64374	SIL1	0010	MARINESCO-SJOGREN SYNDROME	SIL1, 58-KB DEL	
608010	29881	NPC1L1	0001	EZETIMIBE, NONRESPONSE TO	NPC1L1, VAL55LEU	119457968
608010	29881	NPC1L1	0002	EZETIMIBE, NONRESPONSE TO	NPC1L1, ILE1233ASN	52815063
608014	26353	HSPB8	0001	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIA	HSPB8, 423G-C, LYS141ASN	104894345
608014	26353	HSPB8	0002	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIA	HSPB8, LYS141GLU	104894351
608014	26353	HSPB8	0003	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2L	HSPB8, 423G-T, LYS141ASN	
608025	51594	NBAS	0001	SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY	NBAS, ARG1914HIS	
608034	443	ASPA	0001	CANAVAN DISEASE	ASPA, GLU285ALA	28940279
608034	443	ASPA	0002	CANAVAN DISEASE	ASPA, CYS152ARG	104894548
608034	443	ASPA	0003	CANAVAN DISEASE	ASPA, ALA305GLU	28940574
608034	443	ASPA	0004	CANAVAN DISEASE	ASPA, CYS218TER	104894549
608034	443	ASPA	0005	CANAVAN DISEASE	ASPA, TYR231TER	12948217
608034	443	ASPA	0006	CANAVAN DISEASE	ASPA, 4-BP DEL, 876AGAA	
608034	443	ASPA	0007	CANAVAN DISEASE	ASPA, 1-BP DEL, 32T	
608034	443	ASPA	0008	CANAVAN DISEASE	ASPA, TYR231CYS	104894550
608034	443	ASPA	0009	CANAVAN DISEASE	ASPA, EX4DEL	
608034	443	ASPA	0010	CANAVAN DISEASE	ASPA, GLU24GLY	104894551
608034	443	ASPA	0011	CANAVAN DISEASE	ASPA, ASP249VAL	104894552
608034	443	ASPA	0012	CANAVAN DISEASE, MILD	ASPA, ARG71HIS	104894553
608041	118429	ANTXR2	0001	HYALINE FIBROMATOSIS SYNDROME	ANTXR2, EX14DEL	
608041	118429	ANTXR2	0002	HYALINE FIBROMATOSIS SYNDROME	ANTXR2, TYR381CYS	137852901
608041	118429	ANTXR2	0003	HYALINE FIBROMATOSIS SYNDROME	ANTXR2, GLY105ASP	137852902
608041	118429	ANTXR2	0004	HYALINE FIBROMATOSIS SYNDROME	ANTXR2, LEU329ARG	137852903
608041	118429	ANTXR2	0005	HYALINE FIBROMATOSIS SYNDROME	ANTXR2, GLU220TER	137852904
608041	118429	ANTXR2	0006	HYALINE FIBROMATOSIS SYNDROME	ANTXR2, ILE189THR	137852905
608041	118429	ANTXR2	0007	HYALINE FIBROMATOSIS SYNDROME	ANTXR2, 1-BP INS, 1073C	
608041	118429	ANTXR2	0008	HYALINE FIBROMATOSIS SYNDROME	ANTXR2, 1-BP DEL, 1074T	
608047	89910	UBE3B	0001	BLEPHAROPHIMOSIS-PTOSIS-INTELLECTUAL DISABILITY SYNDROME	UBE3B, IVS15DS, T-C, +2	
608047	89910	UBE3B	0002	BLEPHAROPHIMOSIS-PTOSIS-INTELLECTUAL DISABILITY SYNDROME	UBE3B, 2-BP DEL, 2223AG	
608047	89910	UBE3B	0003	BLEPHAROPHIMOSIS-PTOSIS-INTELLECTUAL DISABILITY SYNDROME	UBE3B, IVS7AS, A-G, -2	
608047	89910	UBE3B	0004	BLEPHAROPHIMOSIS-PTOSIS-INTELLECTUAL DISABILITY SYNDROME	UBE3B, GLN727PRO	
608053	2108	ETFA	0001	GLUTARIC ACIDEMIA IIA	ETFA, VAL157GLY	119458969
608053	2108	ETFA	0002	GLUTARIC ACIDEMIA IIA	ETFA, THR266MET	119458970
608053	2108	ETFA	0003	GLUTARIC ACIDEMIA IIA	ETFA, GLY116ARG	119458971
608053	2108	ETFA	0004	GLUTARIC ACIDEMIA IIA	ETFA, 3-BP DEL, NT808	
608053	2108	ETFA	0005	GLUTARIC ACIDEMIA IIA	ETFA, IVS11DS, 1-BP DEL, +1G	
608059	84667	HES7	0001	SPONDYLOCOSTAL DYSOSTOSIS 4	HES7, ARG25TRP	
608059	84667	HES7	0002	SPONDYLOCOSTAL DYSOSTOSIS 4	HES7, ASP186TYR	
608059	84667	HES7	0003	SPONDYLOCOSTAL DYSOSTOSIS 4	HES7, ILE58VAL	
608072	378884	NHLRC1	0001	EPILEPSY, PROGRESSIVE MYOCLONIC 2B	NHLRC1, CYS26SER	28940575
608072	378884	NHLRC1	0002	EPILEPSY, PROGRESSIVE MYOCLONIC 2B	NHLRC1, PRO69ALA	28940576
608072	378884	NHLRC1	0003	EPILEPSY, PROGRESSIVE MYOCLONIC 2B	NHLRC1, 2-BP DEL, 468AG	
608072	378884	NHLRC1	0004	EPILEPSY, PROGRESSIVE MYOCLONIC 2B	NHLRC1, 1-BP DEL, 990G	
608072	378884	NHLRC1	0005	EPILEPSY, PROGRESSIVE MYOCLONIC 2B	NHLRC1, ARG265TER	
608072	378884	NHLRC1	0006	EPILEPSY, PROGRESSIVE MYOCLONIC 2B	NHLRC1, ILE198ASN	
608072	378884	NHLRC1	0007	EPILEPSY, PROGRESSIVE MYOCLONIC 2B	NHLRC1, ASP308ALA	137852859
608083	344	APOC2	0001	APOLIPOPROTEIN C-II (AFRICAN)	APOC2, LYS55GLN	5126
608083	344	APOC2	0002	APOLIPOPROTEIN C-II (PADOVA) HYPERLIPOPROTEINEMIA, TYPE IB, INCLUDED	APOC2, TYR37TER	120074111
608083	344	APOC2	0003	APOLIPOPROTEIN C-II (ST. MICHAEL) HYPERLIPOPROTEINEMIA, TYPE IB, INCLUDED	APOC2, 1-BP INS	
608083	344	APOC2	0004	APOLIPOPROTEIN C-II (TORONTO) HYPERLIPOPROTEINEMIA, TYPE IB, INCLUDED	APOC2, 1-BP DEL	
608083	344	APOC2	0005	APOLIPOPROTEIN C-II (HAMBURG) HYPERLIPOPROTEINEMIA, TYPE IB, INCLUDED	APOC2, IVS2, G-C, +1	
608083	344	APOC2	0006	APOLIPOPROTEIN C-II (NIJMEGEN) HYPERLIPOPROTEINEMIA, TYPE IB, INCLUDED	APOC2, 1-BP DEL, 2943G	
608083	344	APOC2	0007	APOLIPOPROTEIN C-II (PARIS) HYPERLIPOPROTEINEMIA, TYPE IB, INCLUDED	APOC2, MET1VAL	120074112
608083	344	APOC2	0008	APOLIPOPROTEIN C-II (BARI) HYPERLIPOPROTEINEMIA, TYPE IB, INCLUDED	APOC2, TYR37TER	120074111
608083	344	APOC2	0009	APOLIPOPROTEIN C-II VARIANT	APOC2, LYS19THR	120074114
608083	344	APOC2	0010	APOLIPOPROTEIN C-II (SAN FRANCISCO)	APOC2, GLU38LYS	5122
608083	344	APOC2	0011	APOLIPOPROTEIN C-II (WAKAYAMA) HYPERLIPOPROTEINEMIA, TYPE IB, INCLUDED	APOC2, TRP26ARG	120074115
608083	344	APOC2	0012	APOLIPOPROTEIN C-II (AUCKLAND) HYPERLIPOPROTEINEMIA, TYPE IB, INCLUDED	APOC2, TYR63TER	120074116
608092	23022	PALLD	0001	PANCREATIC CANCER, SUSCEPTIBILITY TO, 1	PALLD, PRO239SER	121908291
608100	27247	NFU1	0001	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1	NFU1, 545G-A	
608100	27247	NFU1	0002	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1	NFU1, GLY208CYS	
608102	1203	CLN5	0001	CEROID LIPOFUSCINOSIS, NEURONAL, 5	CLN5, 2-BP DEL, 2467AT	
608102	1203	CLN5	0002	CEROID LIPOFUSCINOSIS, NEURONAL, 5	CLN5, TRP75TER	104894385
608102	1203	CLN5	0003	CEROID LIPOFUSCINOSIS, NEURONAL, 5	CLN5, ASP279ASN	28940280
608102	1203	CLN5	0004	CEROID LIPOFUSCINOSIS, NEURONAL, 5	CLN5, ARG112HIS	104894386
608102	1203	CLN5	0005	CEROID LIPOFUSCINOSIS, NEURONAL, 5	CLN5, GLU352TER	121908292
608102	1203	CLN5	0006	CEROID LIPOFUSCINOSIS, NEURONAL, 5	CLN5, CYS126TYR	
608102	1203	CLN5	0007	CEROID LIPOFUSCINOSIS, NEURONAL, 5	CLN5, TYR374CYS	
608102	1203	CLN5	0008	CEROID LIPOFUSCINOSIS, NEURONAL, 5	CLN5, EX4 DEL	
608103	79053	ALG8	0001	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih	ALG8, 1-BP DEL, 413C	
608103	79053	ALG8	0002	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih	ALG8, 1-BP INS, 396A	
608103	79053	ALG8	0003	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih	ALG8, IVS1AS, A-G, -2	
608103	79053	ALG8	0004	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih	ALG8, THR47PRO	121908293
608103	79053	ALG8	0005	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih	ALG8, IVS6DS, A-G, +4	
608103	79053	ALG8	0006	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih	ALG8, GLY275ASP	121908294
608107	4210	MEFV	0001	FAMILIAL MEDITERRANEAN FEVER	MEFV, MET694VAL	61752717
608107	4210	MEFV	0002	FAMILIAL MEDITERRANEAN FEVER	MEFV, MET694ILE	28940578
608107	4210	MEFV	0003	FAMILIAL MEDITERRANEAN FEVER	MEFV, VAL726ALA	28940579
608107	4210	MEFV	0004	FAMILIAL MEDITERRANEAN FEVER	MEFV, MET680ILE, 2040G-C	
608107	4210	MEFV	0005	FAMILIAL MEDITERRANEAN FEVER	MEFV, GLU148GLN	3743930
608107	4210	MEFV	0006	FAMILIAL MEDITERRANEAN FEVER	MEFV, GLU167ASP	104895079
608107	4210	MEFV	0007	FAMILIAL MEDITERRANEAN FEVER	MEFV, THR267ILE	104895081
608107	4210	MEFV	0008	FAMILIAL MEDITERRANEAN FEVER	MEFV, PHE479LEU	104895083
608107	4210	MEFV	0009	FAMILIAL MEDITERRANEAN FEVER	MEFV, ILE692DEL	121907890
608107	4210	MEFV	0010	FAMILIAL MEDITERRANEAN FEVER	MEFV, LYS695ARG	104895094
608107	4210	MEFV	0011	FAMILIAL MEDITERRANEAN FEVER	MEFV, ALA744SER	61732874
608107	4210	MEFV	0012	FAMILIAL MEDITERRANEAN FEVER	MEFV, ARG761HIS	104895097
608107	4210	MEFV	0013	FAMILIAL MEDITERRANEAN FEVER	MEFV, MET680ILE, 2040G-A	
608107	4210	MEFV	0014	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	MEFV, PRO369SER	11466023
608107	4210	MEFV	0015	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	MEFV, ARG408GLN	11466024
608107	4210	MEFV	0016	FAMILIAL MEDITERRANEAN FEVER	MEFV, ARG653HIS	104895085
608107	4210	MEFV	0017	FAMILIAL MEDITERRANEAN FEVER	MEFV, GLU148VAL	104895076
608107	4210	MEFV	0018	FAMILIAL MEDITERRANEAN FEVER, AUTOSOMAL DOMINANT	MEFV, GLU148GLN AND MET694ILE	
608107	4210	MEFV	0019	FAMILIAL MEDITERRANEAN FEVER, AUTOSOMAL DOMINANT	MEFV, 3-BP DEL, 2080ATG	
608107	4210	MEFV	0020	FAMILIAL MEDITERRANEAN FEVER, AUTOSOMAL DOMINANT	MEFV, HIS478TYR	104895105
608109	80324	PUS1	0001	MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1	PUS1, ARG116TRP	104894371
608109	80324	PUS1	0002	MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1	PUS1, GLU220TER	104894372
608111	55120	FANCL	0001	FANCONI ANEMIA, COMPLEMENTATION GROUP L	FANCL, 177-BP INS, EX11DEL	
608111	55120	FANCL	0002	FANCONI ANEMIA, COMPLEMENTATION GROUP L	FANCL, 3-BP DEL, 1007TAT	
608111	55120	FANCL	0003	FANCONI ANEMIA, COMPLEMENTATION GROUP L	FANCL, 4-BP DUP, 1095AAAT	
608124	64131	XYLT1	0001	PSEUDOXANTHOMA ELASTICUM, MODIFIER OF SEVERITY OF	XYLT1, ALA115SER	61758388
608125	64132	XYLT2	0001	PSEUDOXANTHOMA ELASTICUM, MODIFIER OF SEVERITY OF	XYLT2, THR801ARG	6504649
608132	123016	TTC8	0001	BARDET-BIEDL SYNDROME 8	TTC8, 6-BP DEL	
608132	123016	TTC8	0002	BARDET-BIEDL SYNDROME 8	TTC8, 3-BP DEL	
608132	123016	TTC8	0003	BARDET-BIEDL SYNDROME 8	TTC8, THR153THR	119103286
608132	123016	TTC8	0004	BARDET-BIEDL SYNDROME 8	TTC8, IVS6DS, G-A, +1	
608132	123016	TTC8	0005	RETINITIS PIGMENTOSA 51	TTC8, IVS1AS, A-G, -2	
608135	54829	ASPN	0001	OSTEOARTHRITIS SUSCEPTIBILITY 3 LUMBAR DISC DEGENERATION, SUSCEPTIBILITY TO, INCLUDED	ASPN, 14 ASP REPEAT	
608136	9639	ARHGEF10	0001	SLOWED NERVE CONDUCTION VELOCITY, AUTOSOMAL DOMINANT	ARHGEF10, THR332ILE, dbSNP rs28940281	28940281
608137	26012	NSMF	0001	HYPOGONADOTROPIC HYPOGONADISM 9 WITHOUT ANOSMIA, SUSCEPTIBILITY TO	NELF, THR480ALA	121918340
608137	26012	NSMF	0002	HYPOGONADOTROPIC HYPOGONADISM 9 WITH ANOSMIA, SUSCEPTIBILITY TO	NELF, 8-BP DEL, IVS9, -14	
608145	123606	NIPA1	0001	SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	NIPA1, THR45ARG	104894496
608145	123606	NIPA1	0002	SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	NIPA1, 316G-C, GLY106ARG	104894490
608145	123606	NIPA1	0003	SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	NIPA1, 316G-A, GLY106ARG	
608145	123606	NIPA1	0004	SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	NIPA1, GLY106ARG	104894490
608148	23314	SATB2	0001	CLEFT PALATE, ISOLATED, AND MENTAL RETARDATION	SATB2, ARG239TER	137853127
608151	57728	WDR19	0001	CRANIOECTODERMAL DYSPLASIA 4	WDR19, LEU710SER	
608151	57728	WDR19	0002	CRANIOECTODERMAL DYSPLASIA 4	WDR19, ARG1103TER	
608151	57728	WDR19	0003	ASPHYXIATING THORACIC DYSTROPHY 5	WDR19, LEU7PRO	
608151	57728	WDR19	0004	NEPHRONOPHTHISIS 13	WDR19, VAL345GLY	
608151	57728	WDR19	0005	NEPHRONOPHTHISIS 13	WDR19, 1-BP DUP, 3068A	
608160	6662	SOX9	0001	CAMPOMELIC DYSPLASIA	SOX9, 583C-T	
608160	6662	SOX9	0002	CAMPOMELIC DYSPLASIA WITH AUTOSOMAL SEX REVERSAL	SOX9, 1-BP INS, 783G	
608160	6662	SOX9	0003	CAMPOMELIC DYSPLASIA WITH AUTOSOMAL SEX REVERSAL	SOX9, 4-BP INS	
608160	6662	SOX9	0004	CAMPOMELIC DYSPLASIA CAMPOMELIC DYSPLASIA WITH AUTOSOMAL SEX REVERSAL, INCLUDED	SOX9, 1-BP INS, 1096C	
608160	6662	SOX9	0005	CAMPOMELIC DYSPLASIA WITH AUTOSOMAL SEX REVERSAL	SOX9, TYR440TER	80338688
608160	6662	SOX9	0006	ACAMPOMELIC CAMPOMELIC DYSPLASIA	SOX9, LYS173GLU	104894647
608160	6662	SOX9	0007	CAMPOMELIC DYSPLASIA WITH AUTOSOMAL SEX REVERSAL	SOX9, 1-BP DEL, 296G	
608160	6662	SOX9	0008	ACAMPOMELIC CAMPOMELIC DYSPLASIA	SOX9, HIS165TYR	28940282
608160	6662	SOX9	0009	ACAMPOMELIC CAMPOMELIC DYSPLASIA	SOX9, ALA76GLU	137853128
608160	6662	SOX9	0010	CAMPOMELIC DYSPLASIA	SOX9, 30-BP DEL	
608160	6662	SOX9	0011	CAMPOMELIC DYSPLASIA	SOX9, PHE154LEU	137853129
608160	6662	SOX9	0012	CAMPOMELIC DYSPLASIA WITH AUTOSOMAL SEX REVERSAL	SOX9, ALA158THR	137853130
608160	6662	SOX9	0013	CAMPOMELIC DYSPLASIA CAMPOMELIC DYSPLASIA WITH AUTOSOMAL SEX REVERSAL, INCLUDED	SOX9, 1-BP INS, 1103A	
608160	6662	SOX9	0014	46,XX SEX REVERSAL 2	SOX9, 178-KB DUP, UPSTREAM REGULATORY REGION	
608160	6662	SOX9	0015	ACAMPOMELIC CAMPOMELIC DYSPLASIA WITH AUTOSOMAL SEX REVERSAL	SOX9, 960-KB DEL, UPSTREAM REGULATORY REGION	
608166	9723	SEMA3E	0001	CHARGE SYNDROME	SEMA3E, SER703LEU	121918341
608167	57582	KCNT1	0001	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14	KCNT1, ARG428GLN	
608167	57582	KCNT1	0002	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14	KCNT1, ALA934THR	
608167	57582	KCNT1	0003	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14	KCNT1, ARG474HIS	
608167	57582	KCNT1	0004	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14	KCNT1, ILE760MET	
608167	57582	KCNT1	0005	EPILEPSY, NOCTURNAL FRONTAL LOBE, 5	KCNT1, ARG928CYS	
608167	57582	KCNT1	0006	EPILEPSY, NOCTURNAL FRONTAL LOBE, 5	KCNT1, TYR796HIS	
608167	57582	KCNT1	0007	EPILEPSY, NOCTURNAL FRONTAL LOBE, 5	KCNT1, ARG398GLN	
608167	57582	KCNT1	0008	EPILEPSY, NOCTURNAL FRONTAL LOBE, 5	KCNT1, MET896ILE	
608171	93589	CACNA2D4	0001	RETINAL CONE DYSTROPHY 4	CACNA2D4, TYR802TER	71454844
608172	79947	DHDDS	0001	RETINITIS PIGMENTOSA 59	DHDDS, LYS42GLU	
608177	2131	EXT1	0001	EXOSTOSES, MULTIPLE, TYPE I	EXT1, 1-BP DEL, 2120T	
608177	2131	EXT1	0002	EXOSTOSES, MULTIPLE, TYPE I	EXT1, 1-BP DEL, 1364C	
608177	2131	EXT1	0003	EXOSTOSES, MULTIPLE, TYPE I	EXT1, 4-BP INS, NT1035	
608177	2131	EXT1	0004	EXOSTOSES, MULTIPLE, TYPE I	EXT1, ARG340LEU	119103287
608177	2131	EXT1	0005	CHONDROSARCOMA, SPORADIC	EXT1, 1-BP INS, 2077C	
608177	2131	EXT1	0006	CHONDROSARCOMA, SOMATIC	EXT1, 8-BP DEL, NT1178	
608177	2131	EXT1	0007	EXOSTOSES, MULTIPLE, TYPE I	EXT1, GLY339ASP	119103288
608177	2131	EXT1	0008	EXOSTOSES, MULTIPLE, TYPE I	EXT1, TYR119TER	119103289
608177	2131	EXT1	0009	EXOSTOSES, MULTIPLE, TYPE I	EXT1, ARG340CYS	119103290
608177	2131	EXT1	0010	EXOSTOSES, MULTIPLE, TYPE I	EXT1, IVS1DS, G-C	
608177	2131	EXT1	0011	EXOSTOSES, MULTIPLE, TYPE I	EXT1, 1-BP INS, 1664A	
608177	2131	EXT1	0012	EXOSTOSES, MULTIPLE, TYPE I	EXT1, IVS1DS, 4-BP DEL	
608179	85300	ATCAY	0001	CAYMAN ATAXIA	ATCAY, IVS9, G-T, +3, SER301ARG	
608181	51324	SPG21	0001	MAST SYNDROME	ACP33, 1-BP INS, 601A	
608183	22856	CHSY1	0001	TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	CHSY1, 30-BP DEL, NT55	
608183	22856	CHSY1	0002	TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	CHSY1, 1-BP DEL, 14G	
608183	22856	CHSY1	0003	TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	CHSY1, GLN69TER	
608183	22856	CHSY1	0004	TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	CHSY1, IVS1AS, C-G, -3	
608183	22856	CHSY1	0005	TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	CHSY1, PRO539ARG	
608183	22856	CHSY1	0006	TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	CHSY1, 1-BP DEL, 96C	
608201	55755	CDK5RAP2	0001	MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE	CDK5RAP2, SER81TER	
608201	55755	CDK5RAP2	0002	MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE	CDK5RAP2, IVS26AS, A-G, -15	199422127
608204	81622	UNC93B1	0001	HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 1	UNC93B1, 4-BP DEL, 1034CTTT	
608204	81622	UNC93B1	0002	HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 1	UNC93B1, 781G-A	
608206	79628	SH3TC2	0001	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C	SH3TC2, ARG529GLN	80338923
608206	79628	SH3TC2	0002	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C	SH3TC2, 2-BP DEL, 1747AG	80338924
608206	79628	SH3TC2	0003	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C	SH3TC2, IVS5AS, A-G, -2	80338920
608206	79628	SH3TC2	0004	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C	SH3TC2, TYR943TER	80338932
608206	79628	SH3TC2	0005	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C MONONEUROPATHY OF THE MEDIAN NERVE, MILD, INCLUDED	SH3TC2, ARG954TER	80338933
608206	79628	SH3TC2	0006	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C	SH3TC2, ARG1109TER	80338934
608206	79628	SH3TC2	0007	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C	SH3TC2, GLU657LYS	80338925
608206	79628	SH3TC2	0008	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C MONONEUROPATHY OF THE MEDIAN NERVE, MILD, INCLUDED	SH3TC2, TYR169HIS	
608210	2132	EXT2	0001	EXOSTOSES, MULTIPLE, TYPE II	EXT2, 4-BP DEL	
608210	2132	EXT2	0002	EXOSTOSES, MULTIPLE, TYPE II	EXT2, GLN172TER	121918279
608210	2132	EXT2	0003	EXOSTOSES, MULTIPLE, TYPE II	EXT2, IVSDS, G-A, +1	
608210	2132	EXT2	0004	EXOSTOSES, MULTIPLE, TYPE II	EXT2, ASP227ASN	121918280
608210	2132	EXT2	0005	EXOSTOSES, MULTIPLE, TYPE II	EXT2, TYR222TER	121918281
608210	2132	EXT2	0006	EXOSTOSES, MULTIPLE, TYPE II	EXT2, GLN258TER	
608210	2132	EXT2	0007	EXOSTOSES, MULTIPLE, TYPE II	EXT2, IVS4AS, A-C, -2	
608212	345611	IRGM	0001	INFLAMMATORY BOWEL DISEASE 19	IRGM, 313C-T, LEU105LEU	
608214	55800	SCN3B	0001	BRUGADA SYNDROME 7	SCN3B, LEU10PRO	121918282
608221	84930	MASTL	0001	THROMBOCYTOPENIA 2	MASTL, GLU167ASP	28941470
608222	158	ADSL	0001	ADENYLOSUCCINASE DEFICIENCY	ADSL, SER413PRO	119450940
608222	158	ADSL	0002	ADENYLOSUCCINASE DEFICIENCY	ADSL, ARG426HIS	119450941
608222	158	ADSL	0003	ADENYLOSUCCINASE DEFICIENCY	ADSL, PRO75ALA	119450942
608222	158	ADSL	0004	ADENYLOSUCCINASE DEFICIENCY	ADSL, ASP397TYR	119450943
608222	158	ADSL	0005	ADENYLOSUCCINASE DEFICIENCY	ADSL, ARG190GLN	28941471
608222	158	ADSL	0006	ADENYLOSUCCINASE DEFICIENCY	ADSL, LYS246GLU	119450944
608222	158	ADSL	0007	ADENYLOSUCCINASE DEFICIENCY	ADSL, -49T-C	
608222	158	ADSL	0008	ADENYLOSUCCINASE DEFICIENCY	ADSL, MET225THR	119450945
608241	79753	SNIP1	0001	PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	SNIP1, GLU366GLY	
608248	121391	KRT74	0001	WOOLLY HAIR, AUTOSOMAL DOMINANT	KRT74, ASN148LYS	
608248	121391	KRT74	0002	WOOLLY HAIR, AUTOSOMAL DOMINANT	KRT74, IVS8AS, G-A, -1	
608248	121391	KRT74	0003	HYPOTRICHOSIS 3	KRT74, ASP482ASN	
608256	6330	SCN4B	0001	LONG QT SYNDROME 10	SCN4B, LEU179PHE	121434386
608272	4758	NEU1	0001	SIALIDOSIS, TYPE I	NEU1, GLU377TER	104893971
608272	4758	NEU1	0002	SIALIDOSIS, TYPE II	NEU1, LEU91ARG	104893972
608272	4758	NEU1	0003	SIALIDOSIS, TYPE II	NEU1, 1-BP DEL, 1337C	
608272	4758	NEU1	0004	SIALIDOSIS, TYPE II	NEU1, PHE260TYR	104893977
608272	4758	NEU1	0005	SIALIDOSIS, TYPE II	NEU1, LEU303PRO	193922915
608272	4758	NEU1	0006	SIALIDOSIS, TYPE II	NEU1, 1-BP DEL, 623G	
608272	4758	NEU1	0007	SIALIDOSIS, TYPE I	NEU1, VAL217MET	28940583
608272	4758	NEU1	0008	SIALIDOSIS, TYPE I	NEU1, GLY243ARG	104893983
608272	4758	NEU1	0009	SIALIDOSIS, TYPE II	NEU1, TRP29TER	104893984
608272	4758	NEU1	0010	SIALIDOSIS, TYPE II	NEU1, PRO80LEU	104893985
608272	4758	NEU1	0011	SIALIDOSIS, TYPE II	NEU1, TRP240ARG	104893978
608272	4758	NEU1	0012	SIALIDOSIS, TYPE I	NEU1, PRO316SER	104893979
608272	4758	NEU1	0013	SIALIDOSIS, TYPE II	NEU1, IVSEDS, G-C, +1	
608272	4758	NEU1	0014	SIALIDOSIS, TYPE II	NEU1, ARG225PRO	104893980
608272	4758	NEU1	0015	SIALIDOSIS, TYPE II	NEU1, ALA298VAL	104893981
608272	4758	NEU1	0016	SIALIDOSIS, TYPE II	NEU1, TRP23TER	104893986
608283	55605	KIF21A	0001	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 1 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3B, INCLUDED	KIF21A, ARG954TRP	121912585
608283	55605	KIF21A	0002	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 1 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3B, INCLUDED	KIF21A, ARG954GLN	121912586
608283	55605	KIF21A	0003	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 1	KIF21A, ILE1010THR	121912587
608283	55605	KIF21A	0004	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 1	KIF21A, MET356THR	121912588
608283	55605	KIF21A	0005	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 1	KIF21A, MET947VAL	121912589
608283	55605	KIF21A	0006	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 1	KIF21A, MET947ARG	121912590
608283	55605	KIF21A	0007	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3B	KIF21A, MET947ILE	
608289	10644	IGF2BP2	0001	DIABETES MELLITUS, NONINSULIN-DEPENDENT, SUSCEPTIBILITY TO	IGF2BP2, rs4402960	4402960
608300	162417	NAGS	0001	N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	NAGS, 1-BP DEL, 1025G	
608300	162417	NAGS	0002	N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	NAGS, TRP324TER	104894604
608300	162417	NAGS	0003	N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	NAGS, IVS3AS, A-T, -2	
608300	162417	NAGS	0004	N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	NAGS, 1-BP INS, 1306T	
608300	162417	NAGS	0005	N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	NAGS, ALA279THR	121912591
608300	162417	NAGS	0006	N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	NAGS, LEU430PRO	104894605
608300	162417	NAGS	0007	N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	NAGS, TRP484ARG	104894606
608300	162417	NAGS	0008	N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	NAGS, GLU433ASP	104894607
608307	1373	CPS1	0001	CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY	CPS1, 9-BP DEL	
608307	1373	CPS1	0002	CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY	CPS1, THR544MET	121912592
608307	1373	CPS1	0003	CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY	CPS1, GLN44TER	121912593
608307	1373	CPS1	0004	CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY	CPS1, HIS337ARG	28940283
608307	1373	CPS1	0005	CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY	CPS1, 375-BP DEL	
608307	1373	CPS1	0006	PULMONARY HYPERTENSION, FAMILIAL PERSISTENT, OF THE NEWBORN, SUSCEPTIBILITY TO VENOOCCLUSIVE DISEASE AFTER BONE MARROW TRANSPLANTATION, SUSCEPTIBILITY TO, INCLUDED	CPS1, THR1405ASN	121912594
608307	1373	CPS1	0007	CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY	CPS1, GLY982ASP	121912595
608307	1373	CPS1	0008	CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY	CPS1, 1-BP DEL, 1528G	
608307	1373	CPS1	0009	CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY	CPS1, ARG787TER	121912596
608307	1373	CPS1	0010	CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY	CPS1, IVS29DS, G-C, +1	
608307	1373	CPS1	0011	CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY	CPS1, IVS34DS, T-C, +2	
608309	65018	PINK1	0001	PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET	PINK1, GLY309ASP	74315355
608309	65018	PINK1	0002	PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET	PINK1, TRP437TER	74315356
608309	65018	PINK1	0003	PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET	PINK1, ARG246TER	74315357
608309	65018	PINK1	0004	PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET	PINK1, HIS271GLN	28940284
608309	65018	PINK1	0005	PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET	PINK1, LEU347PRO	28940285
608309	65018	PINK1	0006	PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET	PINK1, 4-BP INS, 1573TTAG	
608309	65018	PINK1	0007	PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET	PINK1, 3-BP INS, 1602CAA	
608309	65018	PINK1	0008	PARKINSON DISEASE 6, EARLY-ONSET	PINK1, ARG279HIS	74315358
608309	65018	PINK1	0009	PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET	PINK1, EX6-8DEL	
608309	65018	PINK1	0010	PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET	PINK1, THR313MET	74315359
608309	65018	PINK1	0011	PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET	PINK1, ALA217ASP	74315360
608309	65018	PINK1	0012	PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET	PINK1, GLN456TER	45539432
608309	65018	PINK1	0013	PARKINSON DISEASE 6, LATE-ONSET, SUSCEPTIBILITY TO	PINK1, TYR431HIS	74315361
608309	65018	PINK1	0014	PARKINSON DISEASE, AUTOSOMAL RECESSIVE EARLY-ONSET, DIGENIC, PINK1/DJ1	PINK1, PRO399LEU	119451946
608310	435	ASL	0001	ARGININOSUCCINIC ACIDURIA	ASL, ARG95CYS	28940585
608310	435	ASL	0002	ARGININOSUCCINIC ACIDURIA	ASL, GLN286ARG	28941472
608310	435	ASL	0003	ARGININOSUCCINIC ACIDURIA	ASL, IVS5, G-A, +1	
608310	435	ASL	0004	ARGININOSUCCINIC ACIDURIA	ASL, ARG385CYS	28940286
608310	435	ASL	0005	ARGININOSUCCINIC ACIDURIA	ASL, VAL178MET	28941473
608310	435	ASL	0006	ARGININOSUCCINIC ACIDURIA	ASL, ARG379CYS	28940287
608313	383	ARG1	0001	ARGININEMIA	ARG1, 4-BP DEL	
608313	383	ARG1	0002	ARGININEMIA	ARG1, 1-BP DEL	
608313	383	ARG1	0003	ARGININEMIA	ARG1, ARG291TER	104893940
608313	383	ARG1	0004	ARGININEMIA	ARG1, THR290SER	104893942
608313	383	ARG1	0005	ARGININEMIA	ARG1, TRP122TER	104893947
608313	383	ARG1	0006	ARGININEMIA	ARG1, GLY235ARG	104893948
608313	383	ARG1	0007	ARGININEMIA	ARG1, 1-BP DEL, 842C	
608313	383	ARG1	0008	ARGININEMIA	ARG1, ILE11THR	28941474
608313	383	ARG1	0009	ARGININEMIA	ARG1, GLY138VAL	104893943
608313	383	ARG1	0010	ARGININEMIA	ARG1, IVS1, G-A, +1	
608313	383	ARG1	0011	ARGININEMIA	ARG1, IVS4, A-G, -2	
608313	383	ARG1	0012	ARGININEMIA	ARG1, ARG21TER	104893944
608331	153201	SLC36A2	0001	IMINOGLYCINURIA, DIGENIC HYPERGLYCINURIA, INCLUDED	SLC36A2, GLY87VAL	
608331	153201	SLC36A2	0002	HYPERGLYCINURIA IMINOGLYCINURIA, INCLUDED	SLC36A2, IVS1, G-A, +1	
608348	593	BCKDHA	0001	MAPLE SYRUP URINE DISEASE, CLASSIC, TYPE IA	BCKDHA, TYR393ASN	137852870
608348	593	BCKDHA	0002	MAPLE SYRUP URINE DISEASE, CLASSIC, TYPE IA	BCKDHA, 8-BP DEL, 887-894	
608348	593	BCKDHA	0003	MAPLE SYRUP URINE DISEASE, INTERMEDIATE, TYPE IA	BCKDHA, GLY245ARG	137852871
608348	593	BCKDHA	0004	MAPLE SYRUP URINE DISEASE, INTERMEDIATE, TYPE IA MAPLE SYRUP URINE DISEASE, CLASSIC, TYPE IA, INCLUDED	BCKDHA, PHE364CYS	137852872
608348	593	BCKDHA	0005	MAPLE SYRUP URINE DISEASE, CLASSIC, TYPE IA	BCKDHA, ARG220TRP	137852873
608348	593	BCKDHA	0006	MAPLE SYRUP URINE DISEASE, CLASSIC, TYPE IA	BCKDHA, GLY204SER	137852874
608348	593	BCKDHA	0007	MAPLE SYRUP URINE DISEASE, CLASSIC, TYPE IA	BCKDHA, THR265ARG	137852875
608348	593	BCKDHA	0008	MAPLE SYRUP URINE DISEASE, CLASSIC, TYPE IA	BCKDHA, CYS219TRP	137852876
608348	593	BCKDHA	0009	MAPLE SYRUP URINE DISEASE, CLASSIC, TYPE IA	BCKDHA, 1-BP DEL, 117C	
608360	56262	LRRC8A	0001	AGAMMAGLOBULINEMIA 5 (1 family)	LRRC8A, 1-BP INS, 2681T, TRANSLOCATION 20	
608374	148738	HFE2	0001	HEMOCHROMATOSIS, TYPE 2A HEMOCHROMATOSIS, HEREDITARY, INCLUDED	HJV, GLY320VAL	74315323
608374	148738	HFE2	0002	HEMOCHROMATOSIS, TYPE 2A	HJV, ARG326TER	74315324
608374	148738	HFE2	0003	HEMOCHROMATOSIS, TYPE 2A	HJV, ILE222ASN	74315325
608374	148738	HFE2	0004	HEMOCHROMATOSIS, TYPE 2A	HJV, ILE281THR	74315326
608374	148738	HFE2	0005	HEMOCHROMATOSIS, TYPE 2A	HJV, CYS80ARG	28940586
608374	148738	HFE2	0006	HEMOCHROMATOSIS, TYPE 2A	HJV, LEU101PRO	74315327
608374	148738	HFE2	0007	HEMOCHROMATOSIS, TYPE 2A HEMOCHROMATOSIS, HEREDITARY, INCLUDED	HJV, CYS321TER	121434374
608374	148738	HFE2	0008	HEMOCHROMATOSIS, TYPE 2A	HJV, 4-BP DEL, NT980	
608374	148738	HFE2	0009	HEMOCHROMATOSIS, TYPE 2A	HJV, ARG54TER	121434375
608381	375298	CERKL	0001	RETINITIS PIGMENTOSA 26	CERKL, ARG257TER	121909398
608396	285195	SLC9A9	0001	AUTISM, SUSCEPTIBILITY TO, 16	SLC9A9, ARG423TER	121912597
608400	7399	USH2A	0001	USHER SYNDROME, TYPE IIA	USH2A, 1-BP DEL, 2299G	
608400	7399	USH2A	0002	USHER SYNDROME, TYPE IIA	USH2A, 1-BP DEL, 2898G	
608400	7399	USH2A	0003	USHER SYNDROME, TYPE IIA	USH2A, 2-BP DEL, 4338CT	
608400	7399	USH2A	0004	USHER SYNDROME, TYPE IIA	USH2A, LEU260TER	121912598
608400	7399	USH2A	0005	USHER SYNDROME, TYPE IIA	USH2A, CYS319TYR	121912599
608400	7399	USH2A	0006	RETINITIS PIGMENTOSA 39	USH2A, CYS759PHE	80338902
608400	7399	USH2A	0007	USHER SYNDROME, TYPE IIA	USH2A, TRP3955TER	111033364
608400	7399	USH2A	0008	USHER SYNDROME, TYPE IIA	USH2A, 949C-A, ARG317ARG	
608400	7399	USH2A	0009	USHER SYNDROME, TYPE IIA	USH2A, CYS419PHE	121912600
608400	7399	USH2A	0010	USHER SYNDROME, TYPE IIA RETINITIS PIGMENTOSA 39, INCLUDED	USH2A, 4-BP INS, NT239	
608400	7399	USH2A	0011	USHER SYNDROME, TYPE IIA RETINITIS PIGMENTOSA 39, INCLUDED	USH2A, ARG737TER	111033334
608400	7399	USH2A	0012	RETINITIS PIGMENTOSA 39	USH2A, ARG4674GLY	80338904
608400	7399	USH2A	0013	USHER SYNDROME, TYPE IIA	USH2A, IVS40AS, A-G, -2144	
608400	7399	USH2A	0014	USHER SYNDROME, TYPE IIA	USH2A, 1-BP DUP, 3129T	
608400	7399	USH2A	0015	USHER SYNDROME, TYPE IIA	USH2A, 1-BP DUP, 8890T	
608414	51196	PLCE1	0001	NEPHROTIC SYNDROME, TYPE 3	PLCE1, 1-BP DEL, 1146G	
608414	51196	PLCE1	0002	NEPHROTIC SYNDROME, TYPE 3	PLCE1, ARG493TER	121912601
608414	51196	PLCE1	0003	NEPHROTIC SYNDROME, TYPE 3	PLCE1, ARG1116TER	121912602
608414	51196	PLCE1	0004	NEPHROTIC SYNDROME, TYPE 3	PLCE1, 1-BP DEL, 3843G	
608414	51196	PLCE1	0005	NEPHROTIC SYNDROME, TYPE 3	PLCE1, GLN1616TER	121912603
608414	51196	PLCE1	0006	NEPHROTIC SYNDROME, TYPE 3	PLCE1, GLN1854TER	121912604
608414	51196	PLCE1	0007	NEPHROTIC SYNDROME, TYPE 3	PLCE1, SER1484LEU	121912605
608414	51196	PLCE1	0008	NEPHROTIC SYNDROME, TYPE 3	PLCE1, ARG2150TER	
608414	51196	PLCE1	0009	NEPHROTIC SYNDROME, TYPE 3	PLCE1, ARG321TER	
608414	51196	PLCE1	0010	NEPHROTIC SYNDROME, TYPE 3	PLCE1, ARG1246TER	
608419	84693	MCEE	0001	METHYLMALONYL-CoA EPIMERASE DEFICIENCY	MCEE, ARG47TER	111033538
608428	340665	CYP26C1	0001	FOCAL FACIAL DERMAL DYSPLASIA 4	CYP26C1, 7-BP DUP, NT844	
608429	113189	CHST14	0001	EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE	CHST14, 1-BP DEL, 145G	
608429	113189	CHST14	0002	EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE	CHST14, ARG213PRO	121908257
608429	113189	CHST14	0003	EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE	CHST14, ARG135GLY AND LEU137GLN	
608429	113189	CHST14	0004	EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE	CHST14, TYR293CYS	121908258
608429	113189	CHST14	0005	EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE	CHST14, PRO281LEU	
608429	113189	CHST14	0006	EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE	CHST14, LYS69TER	
608429	113189	CHST14	0007	EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE	CHST14, CYS289SER	
608429	113189	CHST14	0008	EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE	CHST14, 20-BP DUP, NT981	
608429	113189	CHST14	0009	EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE	CHST14, ARG274PRO	
608441	23345	SYNE1	0001	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8	SYNE1, IVS84AS, A-G, -2	
608441	23345	SYNE1	0002	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8	SYNE1, IVS81AS, A-G, -2	
608441	23345	SYNE1	0003	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8	SYNE1, ARG2906TER	119103243
608441	23345	SYNE1	0004	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8	SYNE1, 5-BP DEL, NT334338	
608441	23345	SYNE1	0005	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8	SYNE1, GLN7640TER	119103244
608441	23345	SYNE1	0006	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8	SYNE1, GLN7386TER	119103245
608441	23345	SYNE1	0007	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8	SYNE1, 2-BP DEL, 281100TG	
608441	23345	SYNE1	0008	EMERY-DREIFUSS MUSCULAR DYSTROPHY 4 WITH VARIABLE FEATURES	SYNE1, ARG257HIS	119103246
608441	23345	SYNE1	0009	EMERY-DREIFUSS MUSCULAR DYSTROPHY 4	SYNE1, VAL572LEU	119103247
608441	23345	SYNE1	0010	EMERY-DREIFUSS MUSCULAR DYSTROPHY 4 WITH VARIABLE FEATURES	SYNE1, GLU646LYS	119103248
608441	23345	SYNE1	0011	EMERY-DREIFUSS MUSCULAR DYSTROPHY 4 WITH VARIABLE FEATURES	SYNE1, IVS136AS, A-G, -2	
608442	23224	SYNE2	0001	EMERY-DREIFUSS MUSCULAR DYSTROPHY 5	SYNE2, THR89MET	36215895
608451	23474	ETHE1	0001	ENCEPHALOPATHY, ETHYLMALONIC	ETHE1, ARG163TRP	28940289
608451	23474	ETHE1	0002	ENCEPHALOPATHY, ETHYLMALONIC	ETHE1, MET1ILE	119103249
608451	23474	ETHE1	0003	ENCEPHALOPATHY, ETHYLMALONIC	ETHE1, 1-BP INS, 604G	
608451	23474	ETHE1	0004	ENCEPHALOPATHY, ETHYLMALONIC	ETHE1, 1-BP INS, 221A	
608451	23474	ETHE1	0005	ENCEPHALOPATHY, ETHYLMALONIC	ETHE1, 11-BP DEL, NT440	
608451	23474	ETHE1	0006	ENCEPHALOPATHY, ETHYLMALONIC	ETHE1, IVS4DS, G-T, +1	
608451	23474	ETHE1	0007	ENCEPHALOPATHY, ETHYLMALONIC	ETHE1, EX4DEL	
608451	23474	ETHE1	0008	ENCEPHALOPATHY, ETHYLMALONIC	ETHE1, LEU185ARG	
608455	5837	PYGM	0001	MCARDLE DISEASE	PYGM, ARG50TER	116987552
608455	5837	PYGM	0002	MCARDLE DISEASE	PYGM, GLY205SER	119103251
608455	5837	PYGM	0003	MCARDLE DISEASE	PYGM, LYS543THR	119103252
608455	5837	PYGM	0004	MCARDLE DISEASE	PYGM, MET1GLY	
608455	5837	PYGM	0005	MCARDLE DISEASE	PYGM, GLU654LYS	119103253
608455	5837	PYGM	0006	MCARDLE DISEASE	PYGM, LEU396PRO	119103254
608455	5837	PYGM	0007	MCARDLE DISEASE	PYGM, IVS14, G-A, +1	
608455	5837	PYGM	0008	MCARDLE DISEASE	PYGM, GLY685ARG	
608455	5837	PYGM	0009	MCARDLE DISEASE	PYGM, ARG575TER	119103255
608455	5837	PYGM	0010	MCARDLE DISEASE	PYGM, GLN665GLU	119103256
608455	5837	PYGM	0011	MCARDLE DISEASE	PYGM, 1-BP DEL, A, CODON 753	
608455	5837	PYGM	0012	MCARDLE DISEASE	PYGM, MET1VAL	
608455	5837	PYGM	0013	MCARDLE DISEASE	PYGM, GLU540TER	119103257
608455	5837	PYGM	0014	MCARDLE DISEASE	PYGM, 1-BP INS, A/8-BP DEL, CODON 387	
608455	5837	PYGM	0015	MCARDLE DISEASE	PYGM, TRP797ARG	119103258
608455	5837	PYGM	0016	MCARDLE DISEASE	PYGM, LYS608LYS	119103259
608455	5837	PYGM	0017	MCARDLE DISEASE	PYGM, TYR573TER	119103260
608455	5837	PYGM	0018	MCARDLE DISEASE, MILD	PYGM, IVS5AS, G-A, -601	
608455	5837	PYGM	0019	MCARDLE DISEASE, MILD	PYGM, IVS3AS, A-G, -26	
608455	5837	PYGM	0020	MCARDLE DISEASE	PYGM, ASP51GLY	
608455	5837	PYGM	0021	MCARDLE DISEASE	PYGM, 3-BP DEL, 158ACT	
608465	23064	SETX	0001	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1	SETX, ARG1363TER	121434376
608465	23064	SETX	0002	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1	SETX, GLN868TER	121434377
608465	23064	SETX	0003	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1	SETX, PRO2213LEU	28940290
608465	23064	SETX	0004	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1	SETX, 5-BP DEL, NT2966	
608465	23064	SETX	0005	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1	SETX, ARG332TRP	29001665
608465	23064	SETX	0006	AMYOTROPHIC LATERAL SCLEROSIS 4, JUVENILE	SETX, LEU389SER	29001584
608465	23064	SETX	0007	AMYOTROPHIC LATERAL SCLEROSIS 4, JUVENILE	SETX, THR3ILE	28941475
608465	23064	SETX	0008	AMYOTROPHIC LATERAL SCLEROSIS 4, JUVENILE	SETX, ARG2136HIS	121434378
608465	23064	SETX	0009	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1	SETX, LEU1976ARG	121434379
608465	23064	SETX	0010	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1	SETX, ASN603ASP AND GLN653LYS	
608465	23064	SETX	0011	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1	SETX, MET274ILE AND ARG1294CYS	
608465	23064	SETX	0012	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1	SETX, LEU1977PHE	121434380
608465	23064	SETX	0013	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1	SETX, GLU343TER	121434381
608465	23064	SETX	0014	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1	SETX, 3-BP DEL, 340CTT	
608480	116369	SLC26A8	0001	SPERMATOGENIC FAILURE 3	SLC26A8, ARG87GLN	
608480	116369	SLC26A8	0002	SPERMATOGENIC FAILURE 3	SLC26A8, GLU812LYS	
608480	116369	SLC26A8	0003	SPERMATOGENIC FAILURE 3	SLC26A8, ARG954CYS	
608488	64093	SMOC1	0001	MICROPHTHALMIA AND LIMB ANOMALIES	SMOC1, GLN240TER	
608488	64093	SMOC1	0002	MICROPHTHALMIA AND LIMB ANOMALIES	SMOC1, IVS7, G-A., +1	
608488	64093	SMOC1	0003	MICROPHTHALMIA AND LIMB ANOMALIES	SMOC1, IVS3, G-A, +1	
608500	144165	PRICKLE1	0001	EPILEPSY, PROGRESSIVE MYOCLONIC 1B	PRICKLE1, ARG104GLN	113994140
608500	144165	PRICKLE1	0002	EPILEPSY, PROGRESSIVE MYOCLONIC 1B	PRICKLE1, ARG144HIS	
608500	144165	PRICKLE1	0003	EPILEPSY, PROGRESSIVE MYOCLONIC 1B	PRICKLE1, TYR472HIS	
608501	166336	PRICKLE2	0001	EPILEPSY, PROGRESSIVE MYOCLONIC 5	PRICKLE2, ARG148HIS AND VAL153ILE	
608501	166336	PRICKLE2	0002	EPILEPSY, PROGRESSIVE MYOCLONIC 5	PRICKLE2, VAL605PHE	
608507	9927	MFN2	0001	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2	MFN2, ARG94GLN	28940291
608507	9927	MFN2	0002	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2	MFN2, TRP740SER	28940292
608507	9927	MFN2	0003	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2	MFN2, LEU76PRO	28940293
608507	9927	MFN2	0004	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2	MFN2, ARG280HIS	28940294
608507	9927	MFN2	0005	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2	MFN2, PRO251ALA	28940295
608507	9927	MFN2	0006	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2	MFN2, VAL69PHE	28940296
608507	9927	MFN2	0007	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2	MFN2, LYS357ASN	119103261
608507	9927	MFN2	0008	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2	MFN2, HIS165ASP	119103262
608507	9927	MFN2	0009	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2 HEREDITARY MOTOR AND SENSORY NEUROPATHY VI, INCLUDED	MFN2, ARG94TRP	119103263
608507	9927	MFN2	0010	HEREDITARY MOTOR AND SENSORY NEUROPATHY VI	MFN2, GLN276ARG	119103264
608507	9927	MFN2	0011	HEREDITARY MOTOR AND SENSORY NEUROPATHY VI CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2, INCLUDED	MFN2, ARG364TRP	119103265
608507	9927	MFN2	0012	HEREDITARY MOTOR AND SENSORY NEUROPATHY VI	MFN2, THR206ILE	119103266
608507	9927	MFN2	0013	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2	MFN2, ARG707TRP	119103267
608507	9927	MFN2	0014	HEREDITARY MOTOR AND SENSORY NEUROPATHY VI CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2, INCLUDED	MFN2, ARG104TRP	119103268
608507	9927	MFN2	0015	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2	MFN2, ARG468HIS	
608507	9927	MFN2	0016	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2	MFN2, IVS13DS, T-C, +2	
608507	9927	MFN2	0017	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2, AUTOSOMAL RECESSIVE	MFN2, PHE216SER	
608507	9927	MFN2	0018	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2, AUTOSOMAL RECESSIVE	MFN2, EX7-8DEL	
608507	9927	MFN2	0019	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2, AUTOSOMAL RECESSIVE, INCLUDED	MFN2, THR362MET	
608507	9927	MFN2	0020	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2, AUTOSOMAL RECESSIVE	MFN2, 3-BP DEL, 113AGA	
608508	1535	CYBA	0001	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-NEGATIVE	CYBA, 10-KB DEL	
608508	1535	CYBA	0002	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-NEGATIVE	CYBA, 1-BP DEL, 272C	
608508	1535	CYBA	0003	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-NEGATIVE	CYBA, ARG90GLN	104894513
608508	1535	CYBA	0004	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-NEGATIVE	CYBA, SER118ARG	104894514
608508	1535	CYBA	0005	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-NEGATIVE	CYBA, PRO156GLN	104894515
608508	1535	CYBA	0006	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-NEGATIVE	CYBA, HIS94ARG	104894510
608508	1535	CYBA	0007	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-NEGATIVE	CYBA, IVS4DS, G-A, +1	
608508	1535	CYBA	0008	CYBA POLYMORPHISM	CYBA, HIS72TYR, 242C-T	4673
608508	1535	CYBA	0009	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-NEGATIVE	CYBA, GLN3TER	104894511
608508	1535	CYBA	0010	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-NEGATIVE	CYBA, GLY24ARG	28941476
608508	1535	CYBA	0011	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-NEGATIVE	CYBA, 36-BP DEL	
608508	1535	CYBA	0012	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-NEGATIVE	CYBA, ALA125THR	119103269
608512	653361	NCF1	0001	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE I	NCF1, 2-BP DEL, 75GT	
608512	653361	NCF1	0002	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE I	NCF1, 1-BP DEL, 502G	
608512	653361	NCF1	0003	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE I	NCF1, ARG42GLN	119103270
608512	653361	NCF1	0004	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE I	NCF1, 1-BP DEL, NT811	
608512	653361	NCF1	0005	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE I	NCF1, GLN91TER	119103271
608512	653361	NCF1	0006	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE I	NCF1, CYS111TER	119103272
608512	653361	NCF1	0007	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE I	NCF1, GLY192SER	119103273
608515	4688	NCF2	0001	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE II	NCF2, 2-BP INS, 399AG	
608515	4688	NCF2	0002	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE II	NCF2, LYS160GLU AND ASP161VAL	
608515	4688	NCF2	0003	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE II	NCF2, 304C-T	
608515	4688	NCF2	0004	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE II	NCF2, 5-BP DEL, NT1169	
608515	4688	NCF2	0005	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE II	NCF2, IVS4DS, G-A, +1	
608515	4688	NCF2	0006	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE II	NCF2, 9-BP DEL, NT55	
608515	4688	NCF2	0007	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE II	NCF2, ALA128VAL	119103274
608515	4688	NCF2	0008	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE II	NCF2, ARG77GLN	119103275
608515	4688	NCF2	0009	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE II	NCF2, GLN100TER	119103276
608515	4688	NCF2	0010	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE II	NCF2, ARG395TRP	13306575
608517	84665	MYPN	0001	CARDIOMYOPATHY, DILATED, 1KK	MYPN, ARG1088HIS	
608517	84665	MYPN	0002	CARDIOMYOPATHY, DILATED, 1KK CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 22, INCLUDED	MYPN, PRO1112LEU	
608517	84665	MYPN	0003	CARDIOMYOPATHY, DILATED, 1KK	MYPN, VAL1195MET	
608517	84665	MYPN	0004	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 22 CARDIOMYOPATHY, DILATED, 1KK, INCLUDED	MYPN, TYR20CYS	
608517	84665	MYPN	0005	CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 4	MYPN, GLN529TER	
608517	84665	MYPN	0006	CARDIOMYOPATHY, DILATED, 1KK	MYPN, PRO961LEU	
608537	7428	VHL	0001	VON HIPPEL-LINDAU SYNDROME	VHL, 3-BP DEL, ILE75DEL	
608537	7428	VHL	0002	RENAL CELL CARCINOMA, SOMATIC	VHL, SER183TER	5030823
608537	7428	VHL	0003	VON HIPPEL-LINDAU SYNDROME PHEOCHROMOCYTOMA, INCLUDED	VHL, ARG167TRP	5030820
608537	7428	VHL	0004	VON HIPPEL-LINDAU SYNDROME	VHL, ARG167GLY	5030820
608537	7428	VHL	0005	VON HIPPEL-LINDAU SYNDROME	VHL, ARG167GLN	5030821
608537	7428	VHL	0006	VON HIPPEL-LINDAU SYNDROME	VHL, ARG161TER	5030818
608537	7428	VHL	0007	HEMANGIOBLASTOMA, SPORADIC CEREBELLAR VON HIPPEL-LINDAU SYNDROME, INCLUDED	VHL, TRP88SER	119103277
608537	7428	VHL	0008	HEMANGIOBLASTOMA, SPORADIC CEREBELLAR	VHL, LEU135PHE	119103278
608537	7428	VHL	0009	VON HIPPEL-LINDAU SYNDROME	VHL, TYR98HIS	5030809
608537	7428	VHL	0011	MOVED TO 608537.0003 .0012 VON HIPPEL-LINDAU SYNDROME	VHL, TYR112HIS	
608537	7428	VHL	0013	VON HIPPEL-LINDAU SYNDROME	VHL, VAL166PHE	104893825
608537	7428	VHL	0014	VON HIPPEL-LINDAU SYNDROME ERYTHROCYTOSIS, FAMILIAL, 2, INCLUDED;; PHEOCHROMOCYTOMA, INCLUDED	VHL, LEU188VAL	5030824
608537	7428	VHL	0015	PHEOCHROMOCYTOMA	VHL, ARG64PRO	104893826
608537	7428	VHL	0016	PHEOCHROMOCYTOMA	VHL, LEU63PRO	104893827
608537	7428	VHL	0017	VON HIPPEL-LINDAU SYNDROME	VHL, TYR112ASN	104893824
608537	7428	VHL	0018	RENAL CELL CARCINOMA WITH PARANEOPLASTIC ERYTHROCYTOSIS	VHL, LEU163PRO	28940297
608537	7428	VHL	0019	POLYCYTHEMIA, CHUVASH TYPE	VHL, ARG200TRP	28940298
608537	7428	VHL	0020	VON HIPPEL-LINDAU SYNDROME	VHL, PRO81SER	104893829
608537	7428	VHL	0021	ERYTHROCYTOSIS, FAMILIAL, 2	VHL, VAL130LEU	104893830
608537	7428	VHL	0022	ERYTHROCYTOSIS, FAMILIAL, 2	VHL, ASP126TYR	104893831
608537	7428	VHL	0023	ERYTHROCYTOSIS, FAMILIAL, 2	VHL, PRO192SER	28940300
608537	7428	VHL	0024	ERYTHROCYTOSIS, FAMILIAL, 2	VHL, HIS191ASP	28940301
608537	7428	VHL	0025	VON HIPPEL-LINDAU SYNDROME	VHL, VAL84LEU	5030827
608537	7428	VHL	0026	PHEOCHROMOCYTOMA	VHL, GLY93SER	5030808
608537	7428	VHL	0027	VON HIPPEL-LINDAU SYNDROME	VHL, GLN164ARG	
608539	84662	GLIS2	0001	NEPHRONOPHTHISIS 7	GLIS2, IVS5DS, G-T, +1	
608547	79001	VKORC1	0001	VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 2	VKORC1, ARG98TRP	72547528
608547	79001	VKORC1	0002	WARFARIN RESISTANCE	VKORC1, VAL29LEU	104894539
608547	79001	VKORC1	0003	WARFARIN RESISTANCE	VKORC1, VAL45ALA	104894540
608547	79001	VKORC1	0004	WARFARIN RESISTANCE	VKORC1, ARG58GLY	104894541
608547	79001	VKORC1	0005	WARFARIN RESISTANCE	VKORC1, LEU128ARG	104894542
608547	79001	VKORC1	0006	WARFARIN SENSITIVITY	VKORC1, -1639G-A	9923231
608547	79001	VKORC1	0007	WARFARIN RESISTANCE	VKORC1, ASP36TYR	61742245
608548	83872	HMCN1	0001	MACULAR DEGENERATION, AGE-RELATED, 1, SUSCEPTIBILITY TO	HMCN1, GLN5345ARG	121434382
608552	26276	VPS33B	0001	ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	VPS33B, ARG532TER	121434383
608552	26276	VPS33B	0002	ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	VPS33B, ARG438TER	121434384
608552	26276	VPS33B	0003	ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	VPS33B, LEU30PRO	121434385
608552	26276	VPS33B	0004	ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	VPS33B, IVS9, G-A, +1	
608568	79784	MYH14	0001	DEAFNESS, AUTOSOMAL DOMINANT 4	MYH14, SER7TER	119103279
608568	79784	MYH14	0002	DEAFNESS, AUTOSOMAL DOMINANT 4	MYH14, LEU976PHE	28940306
608568	79784	MYH14	0003	DEAFNESS, AUTOSOMAL DOMINANT 4	MYH14, ARG726SER	28940307
608568	79784	MYH14	0004	DEAFNESS, AUTOSOMAL DOMINANT 4	MYH14, GLY376CYS	119103280
608568	79784	MYH14	0005	DEAFNESS, AUTOSOMAL DOMINANT 4	MYH14, SER120LEU	119103281
608568	79784	MYH14	0006	PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS	MYH14, ARG941LEU	
608576	79977	GRHL2	0001	DEAFNESS, AUTOSOMAL DOMINANT 28	GRHL2, 1-BP INS, 1609C	
608581	94137	RP1L1	0001	OCCULT MACULAR DYSTROPHY, SUSCEPTIBILITY TO	RP1L1, ARG45TRP	
608581	94137	RP1L1	0002	OCCULT MACULAR DYSTROPHY	RP1L1, TRP960ARG	
608581	94137	RP1L1	0003	VARIANT OF UNKNOWN SIGNIFICANCE	RP1L1, 1-BP DEL, 601G	
608593	81494	CFHR5	0001	CFHR5 DEFICIENCY	CFHR5, EX2-3, DUP	
608593	81494	CFHR5	0002	CFHR5 DEFICIENCY	CFHR5, 1-BP INS, 485A	
608593	81494	CFHR5	0003	VARIANT OF UNKNOWN SIGNIFICANCE	CFHR5, TRP436CYS	
608593	81494	CFHR5	0004	VARIANT OF UNKNOWN SIGNIFICANCE	CFHR5, LEU105ARG	
608593	81494	CFHR5	0005	VARIANT OF UNKNOWN SIGNIFICANCE	CFHR5, SER195THR	
608595	387129	NPSR1	0001	ASTHMA SUSCEPTIBILITY 2	NPSR1, ASN107ILE	324981
608614	285440	CYP4V2	0001	BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY	CYP4V2, TRP44ARG	119103282
608614	285440	CYP4V2	0002	BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY	CYP4V2, ILE111THR	119103283
608614	285440	CYP4V2	0003	BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY	CYP4V2, ARG508HIS	119103284
608614	285440	CYP4V2	0004	BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY	CYP4V2, GLY61SER	119103285
608614	285440	CYP4V2	0005	BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY	CYP4V2, IVS8AS, A-G, -2	
608626	92335	STRADA	0001	POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY	LYK5, 7-KB DEL	
608630	64221	ROBO3	0001	GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS	ROBO3, GLY361GLU	121918270
608630	64221	ROBO3	0002	GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS	ROBO3, 1-BP INS, 3325G	
608630	64221	ROBO3	0003	GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS	ROBO3, ARG703PRO	121918271
608630	64221	ROBO3	0004	GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS	ROBO3, SER705PRO	121918272
608630	64221	ROBO3	0005	GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS	ROBO3, GLY456TER	121918273
608630	64221	ROBO3	0006	GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS	ROBO3, GLU319LYS	121918274
608630	64221	ROBO3	0007	GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS	ROBO3, 1-BP INS, 2310C	
608630	64221	ROBO3	0008	GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS	ROBO3, LEU5PRO	121918275
608630	64221	ROBO3	0009	GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS	ROBO3, ILE66LEU	121918276
608630	64221	ROBO3	0010	GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS	ROBO3, IVS13, G-A, +1	
608630	64221	ROBO3	0011	GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS	ROBO3, 2-BP DEL, 1844CA	
608630	64221	ROBO3	0012	GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS	ROBO3, 2-BP DEL, 1886TT	
608630	64221	ROBO3	0013	GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS	ROBO3, ARG245TRP	121918277
608630	64221	ROBO3	0014	GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS	ROBO3, GLN773TER	121918278
608633	100506742	CASP12	0001	SEPSIS, SUSCEPTIBILITY TO	CASP12, TER125ARG	
608648	11231	SEC63	0001	POLYCYSTIC LIVER DISEASE	SEC63, TRP58TER	119103233
608648	11231	SEC63	0002	POLYCYSTIC LIVER DISEASE	SEC63, 1-BP INS, 442A	
608648	11231	SEC63	0003	POLYCYSTIC LIVER DISEASE	SEC63, IVS8DS, G-A, +1	
608648	11231	SEC63	0004	POLYCYSTIC LIVER DISEASE	SEC63, GLU568 DEL	
608662	203859	ANO5	0001	GNATHODIAPHYSEAL DYSPLASIA	ANO5, CYS356ARG	119103234
608662	203859	ANO5	0002	GNATHODIAPHYSEAL DYSPLASIA	ANO5, CYS356GLY	119103234
608662	203859	ANO5	0003	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2L	ANO5, 1295C-G	137854524
608662	203859	ANO5	0004	MIYOSHI MUSCULAR DYSTROPHY 3 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2L, INCLUDED	ANO5, 1-BP DUP, 191A	137854521
608662	203859	ANO5	0005	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2L	ANO5, GLY231VAL	137854523
608662	203859	ANO5	0006	MIYOSHI MUSCULAR DYSTROPHY 3 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2L, INCLUDED	ANO5, ARG758CYS	137854529
608662	203859	ANO5	0007	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2L MIYOSHI MUSCULAR DYSTROPHY 3, INCLUDED	ANO5, IVS14DS, G-A, +5	
608662	203859	ANO5	0008	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2L	ANO5, 2-BP DEL, 2311CA	
608663	196527	ANO6	0001	SCOTT SYNDROME	ANO6, IVS12AS, G-T, -1	
608665	29893	PSMC3IP	0001	OVARIAN DYSGENESIS 3	PSMC3IP, 3-BP DEL, 600GAG	
608666	55670	PEX26	0001	PEROXISOME BIOGENESIS DISORDER 7B	PEX26, ARG98TRP	62641228
608666	55670	PEX26	0002	PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER)	PEX26, GLY89ARG	28940308
608666	55670	PEX26	0003	PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER)	PEX26, 1-BP INS, 35C	
608666	55670	PEX26	0004	PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER)	PEX26, 147-BP DEL, NT668	
608666	55670	PEX26	0005	PEROXISOME BIOGENESIS DISORDER 7B	PEX26, MET1THR	74315506
608666	55670	PEX26	0006	PEROXISOME BIOGENESIS DISORDER 7B	PEX26, LEU45PRO	61752132
608666	55670	PEX26	0007	PEROXISOME BIOGENESIS DISORDER 7B	PEX26, 1-BP INS, 255T	
608666	55670	PEX26	0008	PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER)	PEX26, IVS2DS, G-T, +1	
608666	55670	PEX26	0009	PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER)	PEX26, 1-BP INS, 254T	
608667	25836	NIPBL	0001	CORNELIA DE LANGE SYNDROME 1	NIPBL, MET1LYS	121918264
608667	25836	NIPBL	0002	CORNELIA DE LANGE SYNDROME 1	NIPBL, TYR2430CYS	121918265
608667	25836	NIPBL	0003	CORNELIA DE LANGE SYNDROME 1	NIPBL, 1-BP DEL, 150G	
608667	25836	NIPBL	0004	CORNELIA DE LANGE SYNDROME 1	NIPBL, 1-BP INS, 7306G	
608667	25836	NIPBL	0005	CORNELIA DE LANGE SYNDROME 1	NIPBL, 1-BP INS, 1546G	
608667	25836	NIPBL	0006	CORNELIA DE LANGE SYNDROME 1	NIPBL, ILE1206DEL	121918266
608667	25836	NIPBL	0007	CORNELIA DE LANGE SYNDROME 1	NIPBL, 2-BP DEL, 2479AG	
608667	25836	NIPBL	0008	CORNELIA DE LANGE SYNDROME 1	NIPBL, ARG1723TER	121918267
608667	25836	NIPBL	0009	CORNELIA DE LANGE SYNDROME 1	NIPBL, ALA1246GLY	121918268
608667	25836	NIPBL	0010	CORNELIA DE LANGE SYNDROME 1	NIPBL, IVS45AS, G-C, -1	
608667	25836	NIPBL	0011	CORNELIA DE LANGE SYNDROME 1	NIPBL, IVS44DS, A-G, +4	
608667	25836	NIPBL	0012	CORNELIA DE LANGE SYNDROME 1	NIPBL, ARG1536TER	121918269
608667	25836	NIPBL	0013	CORNELIA DE LANGE SYNDROME 1	NIPBL, 2-BP DEL/1-BP INS	
608677	57534	MIB1	0001	LEFT VENTRICULAR NONCOMPACTION 7	MIB1, VAL943PHE	
608677	57534	MIB1	0002	LEFT VENTRICULAR NONCOMPACTION 7	MIB1, ARG530TER	
608684	51199	NIN	0001	SECKEL SYNDROME 7	NIN, GLN1222ARG	
608684	51199	NIN	0002	SECKEL SYNDROME 7	NIN, ASN1709SER	
608697	344018	FIGLA	0001	PREMATURE OVARIAN FAILURE 6	FIGLA, 22-BP DEL, NT15	
608697	344018	FIGLA	0002	PREMATURE OVARIAN FAILURE 6	FIGLA, 3-BP DEL, 419ACA	
608699	168667	BMPER	0001	DIAPHANOSPONDYLODYSOSTOSIS	BMPER, GLN309TER	
608699	168667	BMPER	0002	DIAPHANOSPONDYLODYSOSTOSIS	BMPER, 10-BP DEL/14-BP INS, NT26	
608699	168667	BMPER	0003	DIAPHANOSPONDYLODYSOSTOSIS	BMPER, IVS11DS, G-A, +5	
608699	168667	BMPER	0004	DIAPHANOSPONDYLODYSOSTOSIS	BMPER, PRO370LEU	
608699	168667	BMPER	0005	DIAPHANOSPONDYLODYSOSTOSIS	BMPER, CYS546TER	
608700	64802	NMNAT1	0001	LEBER CONGENITAL AMAUROSIS 9	NMNAT1, TER280GLN	
608700	64802	NMNAT1	0002	LEBER CONGENITAL AMAUROSIS 9	NMNAT1, GLU257LYS	
608700	64802	NMNAT1	0003	LEBER CONGENITAL AMAUROSIS 9	NMNAT1, ASN273ASP	
608700	64802	NMNAT1	0004	LEBER CONGENITAL AMAUROSIS 9	NMNAT1, VAL151PHE	
608700	64802	NMNAT1	0005	LEBER CONGENITAL AMAUROSIS 9	NMNAT1, ARG207TRP	
608700	64802	NMNAT1	0006	LEBER CONGENITAL AMAUROSIS 9	NMNAT1, TRP169TER	
608700	64802	NMNAT1	0007	LEBER CONGENITAL AMAUROSIS 9	NMNAT1, ARG237LEU	
608700	64802	NMNAT1	0008	LEBER CONGENITAL AMAUROSIS 9	NMNAT1, LEU153VAL	
608700	64802	NMNAT1	0009	LEBER CONGENITAL AMAUROSIS 9	NMNAT1, VAL9MET	
608706	161582	DYX1C1	0001	DYSLEXIA, SUSCEPTIBILITY TO, 1	DYX1C1, G-3A	
608706	161582	DYX1C1	0002	DYSLEXIA, SUSCEPTIBILITY TO, 1	DYX1C1, GLU417TER	57809907
608707	50937	CDON	0001	HOLOPROSENCEPHALY 11	CDON, PRO689ALA	
608707	50937	CDON	0002	HOLOPROSENCEPHALY 11	CDON, VAL780GLU	
608707	50937	CDON	0003	HOLOPROSENCEPHALY 11	CDON, THR790ALA	
608707	50937	CDON	0004	HOLOPROSENCEPHALY 11	CDON, SER940ARG	
608713	120227	CYP2R1	0001	VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	CYP2R1, LEU99PRO	61495246
608735	91252	SLC39A13	0001	SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	SLC39A13, 9-BP DEL, NT483	
608735	91252	SLC39A13	0002	SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	SLC39A13, GLY74ASP	121434363
608750	10195	ALG3	0001	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id	ALG3, GLY118ASP	28940588
608750	10195	ALG3	0002	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id	ALG3, 37-BP DEL, NT160	
608750	10195	ALG3	0003	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id	ALG3, ARG171GLN	119103236
608750	10195	ALG3	0004	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id	ALG3, TRP71ARG	119103237
608750	10195	ALG3	0005	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id	ALG3, MET157LYS	119103238
608752	114902	C1QTNF5	0001	RETINAL DEGENERATION, LATE-ONSET, AUTOSOMAL DOMINANT	C1QTNF5, SER163ARG	111033578
608753	80746	TSEN2	0001	PONTOCEREBELLAR HYPOPLASIA, TYPE 2B	TSEN2, TYR309CYS	113994149
608754	79042	TSEN34	0001	PONTOCEREBELLAR HYPOPLASIA, TYPE 2C	TSEN34, ARG58TRP	113994150
608755	283989	TSEN54	0001	PONTOCEREBELLAR HYPOPLASIA, TYPE 2A PONTOCEREBELLAR HYPOPLASIA TYPE 4, INCLUDED	TSEN54, ALA307SER	113994152
608755	283989	TSEN54	0002	PONTOCEREBELLAR HYPOPLASIA, TYPE 4	TSEN54, ALA307SER/SER93PRO	113994151
608755	283989	TSEN54	0003	PONTOCEREBELLAR HYPOPLASIA, TYPE 4	TSEN54, GLN246TER	113994153
608755	283989	TSEN54	0004	PONTOCEREBELLAR HYPOPLASIA, TYPE 4	TSEN54, GLN343TER	113994154
608755	283989	TSEN54	0005	PONTOCEREBELLAR HYPOPLASIA, TYPE 4	TSEN54, 14-BP DEL, NT1170	
608761	60482	SLC5A7	0001	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIA	SLC5A7, 1-BP DEL, 1497G	
608769	8050	PDHX	0001	PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	PDHX, 85-BP DEL	
608769	8050	PDHX	0002	PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	PDHX, 69-BP DEL	
608769	8050	PDHX	0003	PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	PDHX, 4-BP DEL, 125GAAG	
608769	8050	PDHX	0004	PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	PDHX, IVS5DS, G-A	
608769	8050	PDHX	0005	PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	PDHX, IVS8AS, G-A, -1	
608769	8050	PDHX	0006	PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	PDHX, 1-BP DEL, 620C	
608769	8050	PDHX	0007	PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	PDHX, 46-KB DEL	
608769	8050	PDHX	0008	PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	PDHX, GLN248TER	113309941
608769	8050	PDHX	0009	PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	PDHX, 3,913-BP DEL	
608769	8050	PDHX	0010	PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	PDHX, ARG15HIS	
608770	1737	DLAT	0001	PYRUVATE DEHYDROGENASE E2 DEFICIENCY	DLAT, 3-BP DEL, 361GAA	
608770	1737	DLAT	0002	PYRUVATE DEHYDROGENASE E2 DEFICIENCY	DLAT, PHE576LEU	119103240
608771	23389	MED13L	0001	TRANSPOSITION OF THE GREAT ARTERIES, DEXTRO-LOOPED 1	MED13L, GLU251GLY	28940309
608771	23389	MED13L	0002	TRANSPOSITION OF THE GREAT ARTERIES, DEXTRO-LOOPED 1	MED13L, ARG1872HIS	28940310
608771	23389	MED13L	0003	TRANSPOSITION OF THE GREAT ARTERIES, DEXTRO-LOOPED 1	MED13L, ASP2023GLY	121918333
608774	255239	ANKK1	0001	DOPAMINE RECEPTOR D2, REDUCED BRAIN DENSITY OF	ANKK1, GLU713LYS	1800497
608778	317719	KLHL10	0001	SPERMATOGENIC FAILURE 11	KLHL10, GLN216PRO	
608778	317719	KLHL10	0002	SPERMATOGENIC FAILURE 11	KLHL10, ALA313THR	
608778	317719	KLHL10	0003	SPERMATOGENIC FAILURE 11	KLHL10, IVS3, 4-BP DEL, +121	
608780	404672	GTF2H5	0001	TRICHOTHIODYSTROPHY, COMPLEMENTATION GROUP A	GTF2H5, ARG56TER	121434364
608780	404672	GTF2H5	0002	TRICHOTHIODYSTROPHY, COMPLEMENTATION GROUP A	GTF2H5, LEU21PRO	121434365
608786	5091	PC	0001	PYRUVATE CARBOXYLASE DEFICIENCY	PC, ALA610THR	28940589
608786	5091	PC	0002	PYRUVATE CARBOXYLASE DEFICIENCY	PC, MET743ILE	28940590
608786	5091	PC	0003	PYRUVATE CARBOXYLASE DEFICIENCY	PC, VAL145ALA	28940591
608786	5091	PC	0004	PYRUVATE CARBOXYLASE DEFICIENCY	PC, ARG451CYS	113994143
608786	5091	PC	0005	PYRUVATE CARBOXYLASE DEFICIENCY	PC, IVS15, 4-BP DEL, TAGG, +2-5	
608786	5091	PC	0006	PYRUVATE CARBOXYLASE DEFICIENCY	PC, 2-BP DEL, 2491GT	
608786	5091	PC	0007	PYRUVATE CARBOXYLASE DEFICIENCY	PC, ARG156GLN	119103241
608786	5091	PC	0008	PYRUVATE CARBOXYLASE DEFICIENCY	PC, ARG583LEU	119103242
608786	5091	PC	0009	PYRUVATE CARBOXYLASE DEFICIENCY	PC, 1-BP DUP, 2876T	
608792	126326	GIPC3	0001	DEAFNESS, AUTOSOMAL RECESSIVE 15	GIPC3, LEU262ARG	
608792	126326	GIPC3	0002	DEAFNESS, AUTOSOMAL RECESSIVE 15	GIPC3, TRP301TER	
608792	126326	GIPC3	0003	DEAFNESS, AUTOSOMAL RECESSIVE 15	GIPC3, 1-BP DUP, 685G	
608792	126326	GIPC3	0004	DEAFNESS, AUTOSOMAL RECESSIVE 15	GIPC3, GLY256ASP	
608792	126326	GIPC3	0005	DEAFNESS, AUTOSOMAL RECESSIVE 15	GIPC3, GLY46ARG	
608792	126326	GIPC3	0006	DEAFNESS, AUTOSOMAL RECESSIVE 15	GIPC3, ARG189CYS	
608798	1687	DFNA5	0001	DEAFNESS, AUTOSOMAL DOMINANT 5	DFNA5, INV/DEL, EX8DEL	
608798	1687	DFNA5	0002	DEAFNESS, AUTOSOMAL DOMINANT 5	DFNA5, 3-BP DEL, IVS7, -17CTT	
608798	1687	DFNA5	0003	DEAFNESS, AUTOSOMAL DOMINANT 5	DFNA5, IVS7, C-G, -6	
608798	1687	DFNA5	0004	DEAFNESS, AUTOSOMAL DOMINANT 5	DFNA5, IVS8DS, A-G, +4	
608801	2639	GCDH	0001	GLUTARIC ACIDEMIA I	GCDH, TYR295HIS	121434366
608801	2639	GCDH	0002	GLUTARIC ACIDEMIA I	GCDH, ALA421VAL	121434367
608801	2639	GCDH	0003	GLUTARIC ACIDEMIA I	GCDH, THR416ILE	121434368
608801	2639	GCDH	0004	GLUTARIC ACIDEMIA I	GCDH, ARG402TRP	121434369
608801	2639	GCDH	0005	GLUTARIC ACIDEMIA I	GCDH, GLU365LYS	121434370
608801	2639	GCDH	0006	GLUTARIC ACIDEMIA I	GCDH, IVS1, G-T, +5	
608801	2639	GCDH	0007	GLUTARIC ACIDEMIA I	GCDH, ALA293THR	121434371
608801	2639	GCDH	0008	GLUTARIC ACIDEMIA I	GCDH, VAL400MET	121434372
608801	2639	GCDH	0009	GLUTARIC ACIDEMIA I	GCDH, ARG227PRO	121434373
608803	57165	GJC2	0001	LEUKODYSTROPHY, HYPOMYELINATING, 2	GJC2, MET286THR	74315311
608803	57165	GJC2	0002	LEUKODYSTROPHY, HYPOMYELINATING, 2	GJC2, PRO90SER	74315312
608803	57165	GJC2	0003	LEUKODYSTROPHY, HYPOMYELINATING, 2	GJC2, 1-BP DEL, 989C	
608803	57165	GJC2	0004	LEUKODYSTROPHY, HYPOMYELINATING, 2	GJC2, ARG240TER	74315313
608803	57165	GJC2	0005	LEUKODYSTROPHY, HYPOMYELINATING, 2	GJC2, TYR272ASP	74315314
608803	57165	GJC2	0006	LEUKODYSTROPHY, HYPOMYELINATING, 2	GJC2, 34-BP DEL, NT914	
608803	57165	GJC2	0007	LEUKODYSTROPHY, HYPOMYELINATING, 2	GJC2, 1-BP INS, 695G	
608803	57165	GJC2	0008	SPASTIC PARAPLEGIA 44	GJC2, ILE33MET	
608803	57165	GJC2	0009	LYMPHEDEMA, HEREDITARY, IC	GJC2, SER48LEU	
608803	57165	GJC2	0010	LYMPHEDEMA, HEREDITARY, IC	GJC2, ARG260CYS	
608803	57165	GJC2	0011	LEUKODYSTROPHY, HYPOMYELINATING, 2	GJC2, -167A-G	
608815	114327	EFHC1	0001	MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 1	EFHC1, ARG182HIS	3804505
608815	114327	EFHC1	0002	MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 1	EFHC1, PHE229LEU	137852776
608815	114327	EFHC1	0003	MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 1	EFHC1, ASP210ASN	137852777
608815	114327	EFHC1	0004	MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 1	EFHC1, ASP253TYR	137852778
608815	114327	EFHC1	0005	MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 1	EFHC1, PRO77THR AND ARG221HIS	79761183
608815	114327	EFHC1	0006	EPILEPSY, JUVENILE ABSENCE, SUSCEPTIBILITY TO, 1	EFHC1, ILE174VAL	137852779
608815	114327	EFHC1	0007	EPILEPSY, JUVENILE ABSENCE, SUSCEPTIBILITY TO, 1	EFHC1, CYS259TYR	137852780
608815	114327	EFHC1	0008	MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 1	EFHC1, GLN277TER	137852781
608829	387082	SUMO4	0001	DIABETES MELLITUS, INSULIN-DEPENDENT, 5	SUMO4, MET55VAL	237025
608830	145226	RDH12	0001	LEBER CONGENITAL AMAUROSIS 13	RDH12, TYR226CYS	28940313
608830	145226	RDH12	0002	LEBER CONGENITAL AMAUROSIS 13	RDH12, 5-BP DEL, NT806	
608830	145226	RDH12	0003	LEBER CONGENITAL AMAUROSIS 13	RDH12, GLN189TER	104894470
608830	145226	RDH12	0004	LEBER CONGENITAL AMAUROSIS 13	RDH12, THR49MET	28940314
608830	145226	RDH12	0005	LEBER CONGENITAL AMAUROSIS 13	RDH12, ARG62TER	104894471
608830	145226	RDH12	0006	LEBER CONGENITAL AMAUROSIS 13	RDH12, GLY127TER	104894474
608830	145226	RDH12	0007	LEBER CONGENITAL AMAUROSIS 13	RDH12, HIS151ASN	104894475
608830	145226	RDH12	0008	LEBER CONGENITAL AMAUROSIS 13	RDH12, PRO230ALA	104894476
608830	145226	RDH12	0009	LEBER CONGENITAL AMAUROSIS 13	RDH12, HIS151ASP	104894475
608830	145226	RDH12	0010	LEBER CONGENITAL AMAUROSIS 13	RDH12, LEU99ILE	28940315
608830	145226	RDH12	0011	LEBER CONGENITAL AMAUROSIS 13	RDH12, SER175PRO	104894472
608830	145226	RDH12	0012	LEBER CONGENITAL AMAUROSIS 13	RDH12, ILE51ASN	104894473
608830	145226	RDH12	0013	LEBER CONGENITAL AMAUROSIS 13	RDH12, 658G-A, +1	
608830	145226	RDH12	0014	LEBER CONGENITAL AMAUROSIS 13	RDH12, THR155ILE	121434337
608830	145226	RDH12	0015	RETINITIS PIGMENTOSA 53	RDH12, 1-BP DEL, 776G	
608830	145226	RDH12	0016	RETINITIS PIGMENTOSA 53	RDH12, ALA126VAL	
608833	51750	RTEL1	0001	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 5	RTEL1, GLY763VAL	
608833	51750	RTEL1	0002	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 5	RTEL1, ARG1264HIS	
608833	51750	RTEL1	0003	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 5	RTEL1, MET516ILE	
608833	51750	RTEL1	0004	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 5	RTEL1, ARG998TER	
608833	51750	RTEL1	0005	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 5	RTEL1, ARG981TRP	
608833	51750	RTEL1	0006	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 5	RTEL1, GLU275LYS	
608845	84100	ARL6	0001	BARDET-BIEDL SYNDROME 3	ARL6, ARG122TER	104893678
608845	84100	ARL6	0002	BARDET-BIEDL SYNDROME 3 BARDET-BIEDL SYNDROME 1, MODIFIER OF, INCLUDED	ARL6, 859G-C, GLY169ALA	104893679
608845	84100	ARL6	0003	BARDET-BIEDL SYNDROME 3	ARL6, THR31MET	104893680
608845	84100	ARL6	0004	BARDET-BIEDL SYNDROME 3	ARL6, LEU170TRP	104893681
608845	84100	ARL6	0005	BARDET-BIEDL SYNDROME 3	ARL6, THR31ARG	104893680
608845	84100	ARL6	0006	RETINITIS PIGMENTOSA 55	ARL6, ARG89VAL	
608869	9860	LRIG2	0001	UROFACIAL SYNDROME 2	LRIG2, 1-BP DEL, 1230A	
608869	9860	LRIG2	0002	UROFACIAL SYNDROME 2	LRIG2, ARG709TER	
608869	9860	LRIG2	0003	UROFACIAL SYNDROME 2	LRIG2, 1-BP DEL, 2088C	
608869	9860	LRIG2	0004	UROFACIAL SYNDROME 2	LRIG2, 371-BP INS, NT1980	
608886	133522	PPARGC1B	0001	OBESITY, VARIATION IN	PPARBC1B, ALA203PRO	7732671
608892	55636	CHD7	0001	CHARGE SYNDROME	CHD7, ILE1028VAL	121434338
608892	55636	CHD7	0002	CHARGE SYNDROME	CHD7, LEU1257ARG	121434339
608892	55636	CHD7	0003	CHARGE SYNDROME	CHD7, TYR1806TER	121434340
608892	55636	CHD7	0004	CHARGE SYNDROME	CHD7, IVS26AS, G-A, -7	
608892	55636	CHD7	0005	CHARGE SYNDROME	CHD7, TRP2332TER	
608892	55636	CHD7	0006	CHARGE SYNDROME	CHD7, ARG2319SER	121434341
608892	55636	CHD7	0007	CHARGE SYNDROME	CHD7, GLU1271TER	121434342
608892	55636	CHD7	0008	CHARGE SYNDROME	CHD7, 1-BP INS, 5752A	
608892	55636	CHD7	0009	SCOLIOSIS, IDIOPATHIC, SUSCEPTIBILITY TO, 3	CHD7, A-G	4738824
608892	55636	CHD7	0010	CHARGE SYNDROME	CHD7, DEL EXONS 8-12	
608892	55636	CHD7	0011	CHARGE SYNDROME	CHD7, GLY2108ARG	121434343
608892	55636	CHD7	0012	CHARGE SYNDROME HYPOGONADOTROPIC HYPOGONADISM 5 WITHOUT ANOSMIA, INCLUDED	CHD7, SER834PHE	121434344
608892	55636	CHD7	0013	CHARGE SYNDROME HYPOGONADOTROPIC HYPOGONADISM 5 WITH ANOSMIA, INCLUDED	CHD7, IVS6, G-C, +5	
608892	55636	CHD7	0014	HYPOGONADOTROPHIC HYPOGONADISM 5 WITHOUT ANOSMIA	CHD7, IVS8, G-A, +5	
608892	55636	CHD7	0015	HYPOGONADOTROPIC HYPOGONADISM 5 WITH ANOSMIA	CHD7, HIS55ARG	121434345
608892	55636	CHD7	0016	CHARGE SYNDROME	CHD7, 1-BP INS, 8682T	
608892	55636	CHD7	0017	CHARGE SYNDROME	CHD7, GLN1599TER	
608893	340024	SLC6A19	0001	HARTNUP DISORDER	SLC6A19, IVS8, T-G, +2	
608893	340024	SLC6A19	0002	HARTNUP DISORDER	SLC6A19, 2-BP DEL, 884-885TG	
608893	340024	SLC6A19	0003	HARTNUP DISORDER	SLC6A19, ASP173ASN	121434346
608893	340024	SLC6A19	0004	HARTNUP DISORDER	SLC6A16, ARG240TER	121434347
608893	340024	SLC6A19	0005	IMINOGLYCINURIA, DIGENIC HYPERGLYCINURIA, INCLUDED	SLC6A19, IVS7, G-A, -4	
608894	54806	AHI1	0001	JOUBERT SYNDROME 3	AHI1, ARG351TER	121434348
608894	54806	AHI1	0002	JOUBERT SYNDROME 3	AHI1, ARG435TER	121434349
608894	54806	AHI1	0003	JOUBERT SYNDROME 3	AHI1, VAL443ASP	121434350
608894	54806	AHI1	0004	JOUBERT SYNDROME 3	AHI1, 2-BP DEL, 3263GG	
608894	54806	AHI1	0005	JOUBERT SYNDROME 3	AHI1, ARG589TER,	
608894	54806	AHI1	0006	JOUBERT SYNDROME 3	AHI1, ARG723GLN	121434351
608894	54806	AHI1	0007	JOUBERT SYNDROME 3	AHI1, 1-BP INS, 2369T	
608894	54806	AHI1	0008	JOUBERT SYNDROME 3	AHI1, ARG329TER	
608894	54806	AHI1	0009	JOUBERT SYNDROME 3	AHI1, ARG495HIS	
608896	6445	SGCG	0001	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2C	SGCG, 1-BP DEL, 525T	
608896	6445	SGCG	0002	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2C	SGCG, CYS283TYR	104894422
608896	6445	SGCG	0003	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2C	SGCG, 2-BP DEL, 793TG	
608896	6445	SGCG	0004	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2C	SGCG, 2-BP DEL, 801TC	
608896	6445	SGCG	0006	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2C	SGCG, 1-BP INS, 87T	
608896	6445	SGCG	0008	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2C	SGCG, GLU263LYS	104894423
608897	201294	UNC13D	0001	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 3	UNC13D, 12-BP DEL, NT1822	
608897	201294	UNC13D	0002	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 3	UNC13D, 1-BP DEL, 214C	
608897	201294	UNC13D	0003	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 3	UNC13D, 1-BP INS, 1755T	
608897	201294	UNC13D	0004	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 3	UNC13D, IVS15DS, G-A, +1	
608897	201294	UNC13D	0005	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 3	UNC13D, ARG256TER	121434352
608897	201294	UNC13D	0006	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 3	UNC13D, IVS9DS, G-T, +1	
608897	201294	UNC13D	0007	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 3	UNC13D, LEU403PRO	121434353
608897	201294	UNC13D	0009	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 3	UNC13D, PHE857CYS	121434354
608918	91647	ATPAF2	0001	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1	ATPAF2, TRP94ARG	104894554
608921	83394	PITPNM3	0001	CONE-ROD DYSTROPHY 5	PITPNM3, GLN626HIS	76024428
608922	200894	ARL13B	0001	JOUBERT SYNDROME 8	ARL13B, ARG79GLN	121912606
608922	200894	ARL13B	0002	JOUBERT SYNDROME 8	ARL13B, TRP82TER	121912607
608922	200894	ARL13B	0003	JOUBERT SYNDROME 8	ARL13B, ARG200CYS	121912608
608944	158326	FREM1	0001	BIFID NOSE WITH OR WITHOUT ANORECTAL AND RENAL ANOMALIES	FREM1, 1-BP DEL, 2721G	
608944	158326	FREM1	0002	BIFID NOSE WITH OR WITHOUT ANORECTAL AND RENAL ANOMALIES	FREM1, ARG649TRP	121912609
608944	158326	FREM1	0003	BIFID NOSE WITH OR WITHOUT ANORECTAL AND RENAL ANOMALIES	FREM1, GLY1440SER	121912610
608944	158326	FREM1	0004	MANITOBA OCULOTRICHOANAL SYNDROME	FREM1, 60.1-KB DEL	
608944	158326	FREM1	0005	MANITOBA OCULOTRICHOANAL SYNDROME	FREM1, 4-BP DEL, 2097ATTA	
608944	158326	FREM1	0006	MANITOBA OCULOTRICHOANAL SYNDROME	FREM1, LEU1324ARG	
608944	158326	FREM1	0007	MANITOBA OCULOTRICHOANAL SYNDROME	FREM1, VAL209ILE	
608944	158326	FREM1	0008	TRIGONOCEPHALY 2	FREM1, GLU1500VAL	
608944	158326	FREM1	0009	TRIGONOCEPHALY 2	FREM1, ARG498GLN	
608945	341640	FREM2	0001	FRASER SYNDROME	FREM2, GLU1974LYS	121434355
608945	341640	FREM2	0002	FRASER SYNDROME	FREM2, IVS14, G-A, +1	
608945	341640	FREM2	0003	FRASER SYNDROME	FREM2, GLU1972LYS	121434356
608958	100	ADA	0001	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	ADA, LYS80ARG	11555566
608958	100	ADA	0002	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	ADA, ARG101TRP	121908717
608958	100	ADA	0003	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	ADA, ARG101GLN	121908714
608958	100	ADA	0004	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	ADA, ARG211HIS	121908716
608958	100	ADA	0005	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	ADA, LEU304ARG	199422327
608958	100	ADA	0006	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	ADA, ALA329VAL	121908715
608958	100	ADA	0008	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	ADA, 3.25-KB DEL, ALU-RELATED	
608958	100	ADA	0009	ADENOSINE DEAMINASE DEFICIENCY, PARTIAL	ADA, PRO297GLN	121908718
608958	100	ADA	0010	ADENOSINE DEAMINASE DEFICIENCY, PARTIAL	ADA, ARG76TRP	121908736
608958	100	ADA	0011	ADENOSINE DEAMINASE DEFICIENCY, PARTIAL	ADA, ARG149GLN	121908737
608958	100	ADA	0012	ADENOSINE DEAMINASE DEFICIENCY, PARTIAL	ADA, PRO274LEU	121908738
608958	100	ADA	0013	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	ADA, LEU107PRO	121908739
608958	100	ADA	0014	ADENOSINE DEAMINASE DEFICIENCY, PARTIAL	ADA, ARG211CYS	121908740
608958	100	ADA	0015	ADENOSINE DEAMINASE DEFICIENCY, PARTIAL	ADA, ALA215THR	114025668
608958	100	ADA	0016	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	ADA, GLY216ARG	121908723
608958	100	ADA	0017	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	ADA, IVS3AS, A-G, -2, EX4DEL	
608958	100	ADA	0018	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	ADA, ARG156CYS	121908735
608958	100	ADA	0019	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	ADA, SER291LEU	121908721
608958	100	ADA	0020	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY, LATE-ONSET	ADA, IVS10AS, G-A, -34	
608958	100	ADA	0021	ADENOSINE DEAMINASE 2 ALLOZYME	ADA, ASP8ASN	73598374
608958	100	ADA	0022	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	ADA, IVS2DS, G-A, +1	
608958	100	ADA	0023	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	ADA, 7-BP INS, IVS8AS	
608958	100	ADA	0024	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	ADA, IVS1DS, G-C, +1	
608958	100	ADA	0025	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	ADA, GLY74VAL	199422328
608958	100	ADA	0026	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	ADA, IVS5DS, G-A, +1	
608958	100	ADA	0027	ADENOSINE DEAMINASE DEFICIENCY, PARTIAL	ADA, LEU152MET	121908728
608958	100	ADA	0028	ADENOSINE DEAMINASE DEFICIENCY, PARTIAL	ADA, THR233ILE	121908729
608958	100	ADA	0029	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADA DEFICIENCY	ADA, TYR97CYS AND LEU106VAL	
608958	100	ADA	0030	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY, DELAYED ONSET	ADA, IVS11AS, 31701T-A	
608958	100	ADA	0031	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY, LATE-ONSET	ADA, IVS11AS, 31701T-A, AND 11-BP DEL, NT31702	
608958	100	ADA	0032	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY, LATE ONSET	ADA, ARG156HIS	121908722
608965	57010	CABP4	0001	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B	CABP4, 2-BP DEL, 800AG	
608965	57010	CABP4	0002	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B	CABP4, ARG124CYS	
608968	9935	MAFB	0001	MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME	MAFB, THR62PRO	
608968	9935	MAFB	0002	MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME	MAFB, SER70ALA	
608968	9935	MAFB	0003	MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME	MAFB, SER70LEU	
608968	9935	MAFB	0004	MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME	MAFB, PRO71SER	
608968	9935	MAFB	0005	MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME	MAFB, PRO71LEU	
608968	9935	MAFB	0006	MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME	MAFB, PRO54LEU	
608977	131118	DNAJC19	0001	3-@METHYLGLUTACONIC ACIDURIA, TYPE V	DNAJC19, IVS3, G-C, -1	137854888
608990	81794	ADAMTS10	0001	WEILL-MARCHESANI SYNDROME 1	ADAMTS10, ARG237TER	121434357
608990	81794	ADAMTS10	0002	WEILL-MARCHESANI SYNDROME 1	ADAMTS10, 1190IVS10, G-A, +1	
608990	81794	ADAMTS10	0003	WEILL-MARCHESANI SYNDROME 1	ADAMTS10, 810G-A, +1	
608990	81794	ADAMTS10	0004	WEILL-MARCHESANI SYNDROME 1	ADAMTS10, ALA25THR	121434358
608990	81794	ADAMTS10	0005	WEILL-MARCHESANI SYNDROME 1	ADAMTS10, GLN318TER	121434359
608990	81794	ADAMTS10	0006	WEILL-MARCHESANI SYNDROME 1	ADAMTS10, GLY518ASP	
608990	81794	ADAMTS10	0007	WEILL-MARCHESANI SYNDROME 1	ADAMTS10, GLY700CYS	
609007	120892	LRRK2	0001	PARKINSON DISEASE 8, AUTOSOMAL DOMINANT	LRRK2, ARG1441GLY	33939927
609007	120892	LRRK2	0002	PARKINSON DISEASE 8, AUTOSOMAL DOMINANT	LRRK2, TYR1699CYS	35801418
609007	120892	LRRK2	0003	PARKINSON DISEASE 8, AUTOSOMAL DOMINANT	LRRK2, ARG1441CYS	33939927
609007	120892	LRRK2	0005	PARKINSON DISEASE 8, AUTOSOMAL DOMINANT	LRRK2, ILE1122VAL	34805604
609007	120892	LRRK2	0006	PARKINSON DISEASE 8, AUTOSOMAL DOMINANT	LRRK2, GLY2019SER	34637584
609007	120892	LRRK2	0007	PARKINSON DISEASE 8, AUTOSOMAL DOMINANT	LRRK2, ILE2020THR	35870237
609007	120892	LRRK2	0008	PARKINSON DISEASE 8, AUTOSOMAL DOMINANT	LRRK2, ARG1441HIS	34995376
609007	120892	LRRK2	0009	PARKINSON DISEASE 8, SUSCEPTIBILITY TO	LRRK2, GLY2385ARG,	34778348
609010	56922	MCCC1	0001	3-@METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY	MCCC1, MET325ARG	119103212
609010	56922	MCCC1	0002	3-@METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY	MCCC1, ARG385SER	119103213
609010	56922	MCCC1	0003	3-@METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY	MCCC1, ASP532HIS	119103214
609010	56922	MCCC1	0004	3-@METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY	MCCC1, LEU437PRO	119103215
609010	56922	MCCC1	0005	3-@METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY	MCCC1, SER535PHE	119103216
609010	56922	MCCC1	0006	3-@METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY	MCCC1, VAL694TER	119103217
609010	56922	MCCC1	0007	3-@METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY	MCCC1, ILE460MET	119103218
609014	64087	MCCC2	0001	3-@METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY	MCCC2, 1-BP INS, 517T	
609014	64087	MCCC2	0002	3-@METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY	MCCC2, GLU99GLN	119103219
609014	64087	MCCC2	0003	3-@METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY	MCCC2, ARG155GLN	119103220
609014	64087	MCCC2	0004	3-@METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY	MCCC2, PRO310ARG	119103221
609014	64087	MCCC2	0005	3-@METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY	MCCC2, CYS167ARG	119103222
609014	64087	MCCC2	0006	3-@METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY	MCCC2, ARG268THR	119103223
609014	64087	MCCC2	0007	3-@METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY	MCCC2, ILE437VAL	119103224
609014	64087	MCCC2	0008	3-@METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY	MCCC2, HIS190ARG	119103225
609014	64087	MCCC2	0009	3-@METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY	MCCC2, ASP280TYR	119103226
609014	64087	MCCC2	0010	3-@METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY	MCCC2, IVS16DS, G-A, +1	
609017	114625	ERMAP	0001	SCIANNA BLOOD GROUP SYSTEM, SC:-1,-2	ERMAP, 2-BP DEL	
609017	114625	ERMAP	0002	SCIANNA BLOOD GROUP SYSTEM, SC:-1,2	ERMAP, GLY57ARG	56025238
609017	114625	ERMAP	0003	RADIN BLOOD GROUP ANTIGEN	ERMAP, PRO60ALA	56136737
609017	114625	ERMAP	0004	SCIANNA BLOOD GROUP SYSTEM, STAR ANTIGEN	ERMAP, GLU47LYS	56047316
609018	3141	HLCS	0001	HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	HLCS, 1-BP DEL, 780G	
609018	3141	HLCS	0002	HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	HLCS, LEU237PRO	119103227
609018	3141	HLCS	0003	HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	HLCS, ASP571ASN	119103228
609018	3141	HLCS	0004	HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	HLCS, ARG508TRP	119103229
609018	3141	HLCS	0005	HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	HLCS, GLY581SER	119103230
609018	3141	HLCS	0006	HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	HLCS, VAL550MET	119103231
609018	3141	HLCS	0007	HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	HLCS, IVS10, G-A, +5	
609018	3141	HLCS	0008	HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	HLCS, 1-BP INS, 655A	
609018	3141	HLCS	0009	HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	HLCS, LEU216ARG	28934602
609019	686	BTD	0001	BIOTINIDASE DEFICIENCY	BTD, 7-BP DEL/3-BP INS	80338684
609019	686	BTD	0002	BIOTINIDASE DEFICIENCY	BTD, 15-BP DEL/11-BP INS	
609019	686	BTD	0003	BIOTINIDASE DEFICIENCY	BTD, ARG538CYS	80338686
609019	686	BTD	0004	BIOTINIDASE DEFICIENCY	BTD, GLY34SER	119103232
609019	686	BTD	0005	BIOTINIDASE DEFICIENCY	BTD, ALA171THR AND ASP444HIS	13073139
609019	686	BTD	0006	BIOTINIDASE DEFICIENCY	BTD, ASP252GLY	28934601
609019	686	BTD	0007	BIOTINIDASE DEFICIENCY	BTD, GLN456HIS	80338685
609019	686	BTD	0008	BIOTINIDASE DEFICIENCY	BTD, ASN489THR	104893692
609019	686	BTD	0009	BIOTINIDASE DEFICIENCY	BTD, PHE403VAL AND ASP444HIS	104893686
609019	686	BTD	0010	BIOTINIDASE DEFICIENCY	BTD, ARG79CYS	104893687
609019	686	BTD	0011	BIOTINIDASE DEFICIENCY	BTD, THR532MET	104893688
609023	25953	PNKD	0001	PAROXYSMAL NONKINESIGENIC DYSKINESIA 1	PNKD, ALA9VAL	121434511
609023	25953	PNKD	0002	PAROXYSMAL NONKINESIGENIC DYSKINESIA 1	PNKD, ALA7VAL	121434512
609023	25953	PNKD	0003	PAROXYSMAL NONKINESIGENIC DYSKINESIA 1	PNKD, ALA33PRO	121434513
609025	9119	KRT75	0001	PSEUDOFOLLICULITIS BARBAE, SUSCEPTIBILITY TO	KRT75, ALA12THR	2232387
609044	338557	FFAR4	0001	OBESITY, SUSCEPTIBILITY TO	GPR120, ARG270HIS	
609058	4594	MUT	0001	METHYLMALONIC ACIDURIA, mut(0) TYPE	MUT, GLN17TER	121918248
609058	4594	MUT	0002	METHYLMALONIC ACIDURIA, mut(0) TYPE	MUT, TRP105ARG	121918249
609058	4594	MUT	0003	METHYLMALONIC ACIDURIA, mut(0) TYPE	MUT, ALA378GLU	121918250
609058	4594	MUT	0004	METHYLMALONIC ACIDURIA, mut(0) TYPE	MUT, ARG93HIS	121918251
609058	4594	MUT	0005	METHYLMALONIC ACIDURIA, mut(-) TYPE	MUT, GLY717VAL	121918252
609058	4594	MUT	0006	METHYLMALONIC ACIDURIA, mut(-) TYPE	MUT, GLU117TER	121918253
609058	4594	MUT	0007	METHYLMALONIC ACIDURIA, mut(-) TYPE	MUT, 2-BP DEL, 769CA	
609058	4594	MUT	0008	METHYLMALONIC ACIDURIA, mut(0) TYPE	MUT, GLY623ARG	121918254
609058	4594	MUT	0009	METHYLMALONIC ACIDURIA, mut(0) TYPE	MUT, GLY703ARG	121918255
609058	4594	MUT	0010	METHYLMALONIC ACIDURIA, mut(0) TYPE	MUT, ASN219TYR	121918256
609058	4594	MUT	0011	METHYLMALONIC ACIDURIA, mut(0) TYPE	MUT, ARG108CYS	121918257
609058	4594	MUT	0012	METHYLMALONIC ACIDURIA, mut(0) TYPE	MUT, GLY215SER	121918258
609058	4594	MUT	0013	METHYLMALONIC ACIDURIA, mut(0) TYPE	MUT, IVS11, C-A, -891	
609058	4594	MUT	0014	METHYLMALONIC ACIDURIA, mut(0) TYPE	MUT, 1808G-A	
609059	57104	PNPLA2	0001	NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY	PNPLA2, 1-BP DEL, 808C	
609059	57104	PNPLA2	0002	NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY	PNPLA2, PRO195LEU	121918259
609059	57104	PNPLA2	0003	NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY	PNPLA2, 1-BP DEL, 847C	
609059	57104	PNPLA2	0004	NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY	PNPLA2, GLN289TER	121918260
609059	57104	PNPLA2	0005	NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY	PNPLA2, IVS6DS, T-C, +2	
609059	57104	PNPLA2	0006	NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY	PNPLA2, GLN250PRO	
609059	57104	PNPLA2	0007	NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY	PNPLA2, IVS6DS, G-T, +1	
609059	57104	PNPLA2	0008	NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY	PNPLA2, 1-BP DEL, 467C	
609062	11281	POU6F2	0001	WILMS TUMOR, SUSCEPTIBILITY TO	POU6F2, GLN184HIS	121918261
609062	11281	POU6F2	0002	WILMS TUMOR 5	POU6F2, C-G, EXON 1C, 5-PRIME UTR	
609118	11235	PDCD10	0001	CEREBRAL CAVERNOUS MALFORMATIONS 3	PDCD10, 586C-T	
609118	11235	PDCD10	0002	CEREBRAL CAVERNOUS MALFORMATIONS 3	PDCD10, 385C-T	
609118	11235	PDCD10	0003	CEREBRAL CAVERNOUS MALFORMATIONS 3	PDCD10, 103C-T	
609118	11235	PDCD10	0004	CEREBRAL CAVERNOUS MALFORMATIONS 3	PDCD10, 54-BP DEL	
609118	11235	PDCD10	0005	CEREBRAL CAVERNOUS MALFORMATIONS 3	PDCD10, 4-BP DEL	
609118	11235	PDCD10	0006	CEREBRAL CAVERNOUS MALFORMATIONS 3	PDCD10, IVS8AS, G-A, -1	
609118	11235	PDCD10	0007	CEREBRAL CAVERNOUS MALFORMATIONS 3	PDCD10, DEL	
609139	65055	REEP1	0001	SPASTIC PARAPLEGIA 31, AUTOSOMAL DOMINANT	REEP1, 1-BP DEL, 507C	
609139	65055	REEP1	0002	SPASTIC PARAPLEGIA 31, AUTOSOMAL DOMINANT	REEP1, IVS3AS, A-G, -2	
609139	65055	REEP1	0003	SPASTIC PARAPLEGIA 31, AUTOSOMAL DOMINANT	REEP1, 606+43G-T, 3-PRIME UTR	
609139	65055	REEP1	0004	SPASTIC PARAPLEGIA 31, AUTOSOMAL DOMINANT	REEP1, ALA20GLU	121918262
609139	65055	REEP1	0005	SPASTIC PARAPLEGIA 31, AUTOSOMAL DOMINANT	REEP1, ARG113TER	121918263
609139	65055	REEP1	0006	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VB	REEP1, IVS4AS, A-G, -2	
609144	28982	FLVCR1	0001	POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA	FLVCR1, ASN121ASP	
609144	28982	FLVCR1	0002	POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA	FLVCR1, ALA241THR	
609144	28982	FLVCR1	0003	POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA	FLVCR1, CYS192ARG	
609144	28982	FLVCR1	0004	POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA	FLVCR1, GLY493ARG	
609173	57082	CASC5	0001	MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE	CASC5, MET2041ILE	
609186	728294	D2HGDH	0001	D-2-@HYDROXYGLUTARIC ACIDURIA 1	D2HGDH, VAL444ALA	121434360
609186	728294	D2HGDH	0002	D-2-@HYDROXYGLUTARIC ACIDURIA 1	D2HGDH, ILE147SER	121434361
609186	728294	D2HGDH	0003	D-2-@HYDROXYGLUTARIC ACIDURIA 1	D2HGDH, IVS1, A-G, -23	
609186	728294	D2HGDH	0004	D-2-@HYDROXYGLUTARIC ACIDURIA 1	D2HGDH, IVS4, A-G, -2	
609186	728294	D2HGDH	0005	D-2-@HYDROXYGLUTARIC ACIDURIA 1	D2HGDH, ASN439ASP	121434362
609186	728294	D2HGDH	0006	D-2-@HYDROXYGLUTARIC ACIDURIA 1	D2HGDH, 2-BP DUP, 326TC	
609186	728294	D2HGDH	0007	D-2-@HYDROXYGLUTARIC ACIDURIA 1	D2HGDH, ASP375TYR	
609187	79783	C7orf10	0001	GLUTARIC ACIDURIA III	C7ORF10, ARG299TRP	137852860
609187	79783	C7orf10	0002	GLUTARIC ACIDURIA III	C7ORF10, ARG142TER	137852861
609187	79783	C7orf10	0003	GLUTARIC ACIDURIA III	C7ORF10, ARG108TER	137852862
609188	136647	MPLKIP	0001	TRICHOTHIODYSTROPHY, NONPHOTOSENSITIVE 1	C7ORF11, MET144VAL	137853117
609188	136647	MPLKIP	0002	TRICHOTHIODYSTROPHY, NONPHOTOSENSITIVE 1	C7ORF11, 2-BP DEL, 187GG	
609188	136647	MPLKIP	0003	TRICHOTHIODYSTROPHY, NONPHOTOSENSITIVE 1	C7ORF11, EX1-2DEL	
609188	136647	MPLKIP	0004	TRICHOTHIODYSTROPHY, NONPHOTOSENSITIVE 1	C7ORF11, 1-BP DEL, 277T	
609188	136647	MPLKIP	0005	TRICHOTHIODYSTROPHY, NONPHOTOSENSITIVE 1	C7ORF11, 5-BP DEL, 148CACAC	
609196	56246	MRAP	0001	GLUCOCORTICOID DEFICIENCY 2	MRAP, IVS3, G-T, +1	
609196	56246	MRAP	0002	GLUCOCORTICOID DEFICIENCY 2	MRAP, IVS3, G-C, +1	
609196	56246	MRAP	0003	GLUCOCORTICOID DEFICIENCY 2	MRAP, IVS3, G-A, +1	
609196	56246	MRAP	0004	GLUCOCORTICOID DEFICIENCY 2	MRAP, IVS3, G DEL, +1	
609196	56246	MRAP	0005	GLUCOCORTICOID DEFICIENCY 2	MRAP, IVS3, T INS, +3	
609196	56246	MRAP	0006	GLUCOCORTICOID DEFICIENCY 2	MRAP, MET1ILE	80358231
609196	56246	MRAP	0007	GLUCOCORTICOID DEFICIENCY 2	MRAP, 1-BP DEL, 128G	
609196	56246	MRAP	0008	GLUCOCORTICOID DEFICIENCY 2	MRAP, 7-BP DEL, NT17	
609204	51021	MRPS16	0001	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2	MRPS16, ARG111TER	104894168
609237	9657	IQCB1	0001	SENIOR-LOKEN SYNDROME 5	IQCB1, ARG461TER	121918244
609237	9657	IQCB1	0002	SENIOR-LOKEN SYNDROME 5	IQCB1, 2-BP DEL, 424TT	
609237	9657	IQCB1	0003	SENIOR-LOKEN SYNDROME 5	IQCB1, 4-BP DEL, 445CTCT	
609237	9657	IQCB1	0004	SENIOR-LOKEN SYNDROME 5	IQCB1, 4-BP DEL, 825ACAG	
609237	9657	IQCB1	0005	SENIOR-LOKEN SYNDROME 5	IQCB1, GLN357TER	121918245
609237	9657	IQCB1	0006	SENIOR-LOKEN SYNDROME 5	IQCB1, 1-BP DEL, 333T	
609237	9657	IQCB1	0007	SENIOR-LOKEN SYNDROME 5	IQCB1, 2-BP DEL, 1516CA	
609237	9657	IQCB1	0008	SENIOR-LOKEN SYNDROME 5	IQCB1, ARG489TER	
609237	9657	IQCB1	0009	SENIOR-LOKEN SYNDROME 5	IQCB1, GLU346TER	
609239	10161	LPAR6	0001	HYPOTRICHOSIS 8	LPAR6, GLN155TER	121434306
609239	10161	LPAR6	0002	HYPOTRICHOSIS 8	LPAR6, 2-BP DEL, 373AA	
609239	10161	LPAR6	0003	WOOLLY HAIR, AUTOSOMAL RECESSIVE 1, WITH OR WITHOUT HYPOTRICHOSIS HYPOTRICHOSIS 8, INCLUDED	LPAR6, 4-BP INS, 69CATG	
609239	10161	LPAR6	0004	WOOLLY HAIR, AUTOSOMAL RECESSIVE 1, WITH OR WITHOUT HYPOTRICHOSIS	LPAR6, ILE188PHE	121434307
609239	10161	LPAR6	0005	HYPOTRICHOSIS 8	LPAR6, GLY146ARG	121434308
609239	10161	LPAR6	0006	WOOLLY HAIR, AUTOSOMAL RECESSIVE 1 HYPOTRICHOSIS 8, INCLUDED	LPAR6, GLU189LYS	121434309
609239	10161	LPAR6	0007	HYPOTRICHOSIS 8	LPAR6, PRO196LEU	
609245	29899	GPSM2	0001	CHUDLEY-MCCULLOUGH SYNDROME	GPSM2, ARG127TER	
609245	29899	GPSM2	0002	CHUDLEY-MCCULLOUGH SYNDROME	GPSM2, GLN562TER	
609245	29899	GPSM2	0003	CHUDLEY-MCCULLOUGH SYNDROME	GPSM2, 1-BP DEL, 1473G	
609245	29899	GPSM2	0004	CHUDLEY-MCCULLOUGH SYNDROME	GPSM2, 1-BP DEL, 741C	
609245	29899	GPSM2	0005	CHUDLEY-MCCULLOUGH SYNDROME	GPSM2, SER554TER	
609245	29899	GPSM2	0006	CHUDLEY-MCCULLOUGH SYNDROME	GPSM2, IVS9DS, G-T, +1	
609252	149998	LIPI	0001	HYPERTRIGLYCERIDEMIA, SUSCEPTIBILITY TO	LIPI, CYS55TYR	
609262	51185	CRBN	0001	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2	CRBN, ARG419TER	121918368
609275	25782	RAB3GAP2	0001	MARTSOLF SYNDROME	RAB3GAP2, GLY1051CYS	121434310
609275	25782	RAB3GAP2	0002	WARBURG MICRO SYNDROME 2	RAB3GAP2, 9-BP DEL, NT499	
609279	55835	CENPJ	0001	MICROCEPHALY 6, PRIMARY, AUTOSOMAL RECESSIVE	CENPJ, 1-BP DEL, 17C	199422202
609279	55835	CENPJ	0002	MICROCEPHALY 6, PRIMARY, AUTOSOMAL RECESSIVE	CENPJ, GLU1235VAL	121434311
609279	55835	CENPJ	0003	MICROCEPHALY 6, PRIMARY, AUTOSOMAL RECESSIVE	CENPJ, 4-BP DEL, 3243TCAG	199422203
609279	55835	CENPJ	0004	SECKEL SYNDROME 4	CENPJ, IVS11, G-C, -1	
609279	55835	CENPJ	0005	MICROCEPHALY 6, PRIMARY, AUTOSOMAL RECESSIVE	CENPJ, THR821MET	
609291	161742	SPRED1	0001	LEGIUS SYNDROME	SPRED1, ARG117TER	121434312
609291	161742	SPRED1	0002	LEGIUS SYNDROME	SPRED1, ARG24TER	121434313
609291	161742	SPRED1	0003	LEGIUS SYNDROME	SPRED1, IVS5DS, G-A, +1	
609291	161742	SPRED1	0004	LEGIUS SYNDROME	SPRED1, GLN215TER	121434314
609291	161742	SPRED1	0005	LEGIUS SYNDROME	SPRED1, ARG64TER	121434315
609291	161742	SPRED1	0006	LEGIUS SYNDROME	SPRED1, GLN213TER	121434316
609291	161742	SPRED1	0007	LEGIUS SYNDROME	SPRED1, ARG262TER	121434317
609291	161742	SPRED1	0008	LEGIUS SYNDROME	SPRED1, VAL44ASP	121434318
609291	161742	SPRED1	0009	LEGIUS SYNDROME	SPRED1, 2-BP DEL, 1045AG	
609300	1586	CYP17A1	0001	17-@ALPHA-HYDROXYLASE/17,20-LYASE DEFICIENCY, COMBINED COMPLETE	CYP17A1, 4-BP DUP, EX8	
609300	1586	CYP17A1	0002	17-@ALPHA-HYDROXYLASE/17,20-LYASE DEFICIENCY, COMBINED PARTIAL	CYP17A1, PHE53DEL	121434319
609300	1586	CYP17A1	0003	17-@ALPHA-HYDROXYLASE/17,20-LYASE DEFICIENCY, COMBINED COMPLETE	CYP17A1, 7-BP DUP, EX2	
609300	1586	CYP17A1	0004	17-@ALPHA-HYDROXYLASE/17,20-LYASE DEFICIENCY, COMBINED COMPLETE	CYP17A1, SER106PRO	104894135
609300	1586	CYP17A1	0005	17-@ALPHA-HYDROXYLASE/17,20-LYASE DEFICIENCY, COMBINED COMPLETE	CYP17A1, 469-BP INS, 518-BP DEL	
609300	1586	CYP17A1	0006	17-@ALPHA-HYDROXYLASE/17,20-LYASE DEFICIENCY, COMBINED PARTIAL BREAST CANCER, SUSCEPTIBILITY TO, INCLUDED	CYP17A1, ARG239TER	104894136
609300	1586	CYP17A1	0007	17-@ALPHA-HYDROXYLASE/17,20-LYASE DEFICIENCY, COMBINED PARTIAL	CYP17A1, PRO342THR	104894137
609300	1586	CYP17A1	0008	17-@ALPHA-HYDROXYLASE/17,20-LYASE DEFICIENCY, COMBINED PARTIAL	CYP17A1, 1-BP DEL	
609300	1586	CYP17A1	0009	17-@ALPHA-HYDROXYLASE/17,20-LYASE DEFICIENCY, COMBINED COMPLETE	CYP17A1, ARG96TRP	104894138
609300	1586	CYP17A1	0011	17-@ALPHA-HYDROXYLASE/17,20-LYASE DEFICIENCY, COMBINED COMPLETE	CYP17A1, IVS7+5G-A	
609300	1586	CYP17A1	0012	17,20-@LYASE DEFICIENCY, ISOLATED	CYP17A1, ARG347HIS	61754278
609300	1586	CYP17A1	0013	17,20-@LYASE DEFICIENCY, ISOLATED	CYP17A1, ARG358GLN	104894139
609300	1586	CYP17A1	0015	REMOVED FROM DATABASE .0016 17-@ALPHA-HYDROXYLASE/17,20-LYASE DEFICIENCY, COMBINED COMPLETE	CYP17A1, TRP17TER	
609300	1586	CYP17A1	0017	17-@ALPHA-HYDROXYLASE/17,20-LYASE DEFICIENCY, COMBINED COMPLETE	CYP17A1, IVS2, G-T, +5	
609300	1586	CYP17A1	0018	17-@ALPHA-HYDROXYLASE/17,20-LYASE DEFICIENCY, COMBINED COMPLETE	CYP17A1, PHE93CYS	104894146
609300	1586	CYP17A1	0019	17-@ALPHA-HYDROXYLASE/17,20-LYASE DEFICIENCY, COMBINED COMPLETE	CYP17A1, PHE114VAL	104894147
609300	1586	CYP17A1	0020	17-@ALPHA-HYDROXYLASE/17,20-LYASE DEFICIENCY, COMBINED PARTIAL	CYP17A1, ASP116VAL	104894148
609300	1586	CYP17A1	0021	17-@ALPHA-HYDROXYLASE/17,20-LYASE DEFICIENCY, COMBINED PARTIAL	CYP17A1, ARG347CYS	104894149
609300	1586	CYP17A1	0022	17-@ALPHA-HYDROXYLASE/17,20-LYASE DEFICIENCY, COMBINED PARTIAL	CYP17A1, 25-BP DEL, NT204	
609300	1586	CYP17A1	0023	17-@ALPHA-HYDROXYLASE/17,20-LYASE DEFICIENCY, COMBINED COMPLETE	CYP17A1, ARG362CYS	104894142
609300	1586	CYP17A1	0024	17-@ALPHA-HYDROXYLASE/17,20-LYASE DEFICIENCY, COMBINED COMPLETE	CYP17A1, TRP406ARG	104894143
609300	1586	CYP17A1	0025	17-@ALPHA-HYDROXYLASE/17,20-LYASE DEFICIENCY, COMBINED COMPLETE	CYP17A1, TYR329ASP	104894144
609300	1586	CYP17A1	0026	17-@ALPHA-HYDROXYLASE/17,20-LYASE DEFICIENCY, COMBINED COMPLETE	CYP17A1, PRO428LEU	104894145
609300	1586	CYP17A1	0027	17-@ALPHA-HYDROXYLASE/17,20-LYASE DEFICIENCY, COMBINED PARTIAL	CYP17A1, TYR201ASN	104894150
609300	1586	CYP17A1	0028	17-@ALPHA-HYDROXYLASE/17,20-LYASE DEFICIENCY, COMBINED COMPLETE	CYP17A1, TYR27TER	104894152
609300	1586	CYP17A1	0029	17-@ALPHA-HYDROXYLASE/17,20-LYASE DEFICIENCY, COMBINED COMPLETE	CYP17A1, ARG96GLN	104894153
609300	1586	CYP17A1	0030	17-@ALPHA-HYDROXYLASE/17,20-LYASE DEFICIENCY, COMBINED COMPLETE	CYP17A1, ARG125GLN	104894154
609300	1586	CYP17A1	0031	17-@ALPHA-HYDROXYLASE/17,20-LYASE DEFICIENCY, COMBINED COMPLETE	CYP17A1, ARG416HIS	104894155
609300	1586	CYP17A1	0032	17-@ALPHA-HYDROXYLASE/17,20-LYASE DEFICIENCY, COMBINED COMPLETE	CYP17A1, 9-BP DEL	
609300	1586	CYP17A1	0033	17-@ALPHA-HYDROXYLASE/17,20-LYASE DEFICIENCY, COMBINED PARTIAL	CYP17A1, PHE453SER	104894151
609300	1586	CYP17A1	0034	17-@ALPHA-HYDROXYLASE/17,20-LYASE DEFICIENCY, COMBINED PARTIAL	CYP17A1, IVS2AS, A-C, -2	
609300	1586	CYP17A1	0035	17-@ALPHA-HYDROXYLASE/17,20-LYASE DEFICIENCY, COMBINED COMPLETE	CYP17A1, IVS3AS, 4-BP DEL	
609302	79751	SLC25A22	0001	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 3	SLC25A22, PRO206LEU	121918334
609302	79751	SLC25A22	0002	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 3	SLC25A22, GLY236TRP	121918335
609309	4436	MSH2	0001	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 1	MSH2, PRO622LEU	28929483
609309	4436	MSH2	0002	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 1	MSH2, DEL 50 CODONS	
609309	4436	MSH2	0003	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 1	MSH2, ARG406TER	63751108
609309	4436	MSH2	0004	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 1	MSH2, HIS639TYR	
609309	4436	MSH2	0005	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 1	MSH2, 3-BP DEL, ASN596DEL	
609309	4436	MSH2	0006	MUIR-TORRE SYNDROME	MSH2, GLN601TER	63750047
609309	4436	MSH2	0007	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 1	MSH2, ARG524PRO	63751207
609309	4436	MSH2	0008	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 1	MSH2, 1-BP DEL	
609309	4436	MSH2	0009	MUIR-TORRE SYNDROME	MSH2, 22-BP INS	
609309	4436	MSH2	0010	MSH2 POLYMORPHISM	MSH2, GLY322ASP	4987188
609309	4436	MSH2	0011	COLORECTAL CANCER, HEREDITARY, NONPOLYPOSIS, TYPE 1	MSH2, DEL EXON 5	
609309	4436	MSH2	0012	COLORECTAL CANCER, HEREDITARY, NONPOLYPOSIS, TYPE 1	MSH2, ALA636PRO	63750875
609309	4436	MSH2	0013	COLORECTAL CANCER, HEREDITARY, NONPOLYPOSIS, TYPE 1	MSH2, 24-BP INS	
609309	4436	MSH2	0014	MISMATCH REPAIR CANCER SYNDROME	MSH2, IVS10, G-A, -1	
609309	4436	MSH2	0015	MISMATCH REPAIR CANCER SYNDROME COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 1, INCLUDED	MSH2, EX1-6 DEL	
609309	4436	MSH2	0016	MISMATCH REPAIR CANCER SYNDROME	MSH2, 1-BP DEL	
609309	4436	MSH2	0017	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 1	MSH2, 11.4-KB DEL	
609309	4436	MSH2	0018	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 1	MSH2, 16-KB DEL, EX1-6	
609309	4436	MSH2	0019	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 1	MSH2, 4-BP DEL, 1452AATG	
609309	4436	MSH2	0020	MISMATCH REPAIR CANCER SYNDROME	MSH2, IVS12AS, T-A, -5	
609309	4436	MSH2	0021	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 1	MSH2, IVS5DS, A-T, +3	
609309	4436	MSH2	0023	MUIR-TORRE SYNDROME COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 1, INCLUDED	MSH2, 32-KB DEL, EX1-6	
609309	4436	MSH2	0024	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 1	MSH2, 3.5-KB DEL AND 15-BP INS	
609309	4436	MSH2	0025	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 1	MSH2, 19.28-KB DEL	
609312	1621	DBH	0001	DOPAMINE BETA-HYDROXYLASE ACTIVITY, PLASMA	DBH, -970C-T	
609312	1621	DBH	0002	DOPAMINE BETA-HYDROXYLASE DEFICIENCY	DBH, IVS1DS, T-C, +2	
609312	1621	DBH	0003	DOPAMINE BETA-HYDROXYLASE DEFICIENCY	DBH, ASP100GLU	77576840
609312	1621	DBH	0004	DOPAMINE BETA-HYDROXYLASE DEFICIENCY	DBH, VAL87MET AND ASP331ASN	
609332	57217	TTC7A	0001	INTESTINAL ATRESIA, MULTIPLE	TTC7A, 4-BP DEL, 53344AAGT	
609332	57217	TTC7A	0002	INTESTINAL ATRESIA, MULTIPLE	TTC7A, LEU823PRO	
609342	2694	GIF	0001	INTRINSIC FACTOR DEFICIENCY, CONGENITAL, SUSCEPTIBILITY TO	GIF, GLN5ARG	35211634
609342	2694	GIF	0002	INTRINSIC FACTOR DEFICIENCY	GIF, 4-BP DEL, 183GAAT	
609342	2694	GIF	0003	INTRINSIC FACTOR DEFICIENCY	GIF, IVS1DS, G-A, +1	
609342	2694	GIF	0004	INTRINSIC FACTOR DEFICIENCY	GIF, IVS1AS, G-A, -1	
609342	2694	GIF	0005	INTRINSIC FACTOR DEFICIENCY	GIF, SER46LEU	121434322
609342	2694	GIF	0006	INTRINSIC FACTOR DEFICIENCY	GIF, 1-BP DEL 161A	
609342	2694	GIF	0007	INTRINSIC FACTOR DEFICIENCY	GIF, 1-BP INS, 1175T	
609353	157570	ESCO2	0001	ROBERTS SYNDROME	ESCO2, TRP539GLY	80359868
609353	157570	ESCO2	0002	ROBERTS SYNDROME	ESCO2, ARG169TER	80359849
609353	157570	ESCO2	0003	ROBERTS SYNDROME	ESCO2, 1-BP INS, 750G	80359852
609353	157570	ESCO2	0004	SC PHOCOMELIA SYNDROME	ESCO2, 1-BP INS, 750A	80359853
609353	157570	ESCO2	0005	SC PHOCOMELIA SYNDROME	ESCO2, TRP423TER	80359864
609353	157570	ESCO2	0006	SC PHOCOMELIA SYNDROME	ESCO2, GLN202TER	80359850
609353	157570	ESCO2	0007	SC PHOCOMELIA SYNDROME	ESCO2, 1-BP DEL, 752A	80359854
609367	26128	KIAA1279	0001	GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	KIAA1279, ARG90TER	121434514
609367	26128	KIAA1279	0002	GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	KIAA1279, GLU84TER	121434515
609382	51124	IER3IP1	0001	MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	IER3IP1, VAL21GLY	
609382	51124	IER3IP1	0002	MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	IER3IP1, LEU78PRO	
609383	348938	NIPAL4	0001	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 6	NIPAL4, ARG83TER	199422216
609383	348938	NIPAL4	0002	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 6	NIPAL4, ALA114ASN	
609383	348938	NIPAL4	0003	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 6	NIPAL4, ALA176ASP	199422217
609383	348938	NIPAL4	0004	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 6	NIPAL4, IVS5, G-A, +1	
609390	9896	FIG4	0001	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J	FIG4, ILE41THR	121908287
609390	9896	FIG4	0002	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J	FIG4, 1-BP DEL, 294T	
609390	9896	FIG4	0003	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J	FIG4, ARG183TER	121908288
609390	9896	FIG4	0004	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J	FIG4, 8-BP DEL, NT1043	
609390	9896	FIG4	0005	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J	FIG4, 1-BP DEL, 759G	
609390	9896	FIG4	0006	AMYOTROPHIC LATERAL SCLEROSIS 11	FIG4, ARG183TER	121908288
609390	9896	FIG4	0007	AMYOTROPHIC LATERAL SCLEROSIS 11	FIG4, IVS11DS, G-T, +5	
609390	9896	FIG4	0008	AMYOTROPHIC LATERAL SCLEROSIS 11	FIG4, ASP53TYR	121908290
609390	9896	FIG4	0009	YUNIS-VARON SYNDROME	FIG4, 2-BP DEL, 1260GT	
609390	9896	FIG4	0010	YUNIS-VARON SYNDROME	FIG4, GLY104ASP	
609390	9896	FIG4	0011	YUNIS-VARON SYNDROME	FIG4, 8-BP DEL, NT831	
609390	9896	FIG4	0012	YUNIS-VARON SYNDROME	FIG4, LEU175PRO	
609397	219736	STOX1	0001	PREECLAMPSIA/ECLAMPSIA 4	STOX1, TYR153HIS	1341667
609397	219736	STOX1	0002	PREECLAMPSIA/ECLAMPSIA 4	STOX1, GLU608ASP	10509305
609412	1161	ERCC8	0001	COCKAYNE SYNDROME A	ERCC8, 279-BP DEL, 81-BP DEL	
609412	1161	ERCC8	0002	COCKAYNE SYNDROME A	ERCC8, TYR322TER	121434323
609412	1161	ERCC8	0003	COCKAYNE SYNDROME A	ERCC8, GLU13TER	121434324
609412	1161	ERCC8	0004	COCKAYNE SYNDROME A	ERCC8, ALA160VAL	121434325
609412	1161	ERCC8	0005	COCKAYNE SYNDROME A	ERCC8, ALA205PRO	121434326
609412	1161	ERCC8	0006	UV-SENSITIVE SYNDROME 2	ERCC8, TRP361CYS	
609413	2074	ERCC6	0001	COCKAYNE SYNDROME B	ERCC6, TRP517TER	121917900
609413	2074	ERCC6	0002	COCKAYNE SYNDROME B DE SANCTIS-CACCHIONE SYNDROME, INCLUDED	ERCC6, ARG735TER	121917901
609413	2074	ERCC6	0003	COCKAYNE SYNDROME B	ERCC6, 1-BP DEL, 1597G	
609413	2074	ERCC6	0004	COCKAYNE SYNDROME B	ERCC6, ARG453TER	121917902
609413	2074	ERCC6	0005	COCKAYNE SYNDROME B	ERCC6, 1-BP INS, 1051A	
609413	2074	ERCC6	0006	COCKAYNE SYNDROME B	ERCC6, 4-BP INS, 1053TGTC	
609413	2074	ERCC6	0007	CEREBROOCULOFACIOSKELETAL SYNDROME 1	ERCC6, 2-BP DEL, 3794AA	
609413	2074	ERCC6	0008	COCKAYNE SYNDROME B	ERCC6, PRO1095ARG	4253208
609413	2074	ERCC6	0009	UV-SENSITIVE SYNDROME 1	ERCC6, ARG77TER	121917903
609413	2074	ERCC6	0010	MACULAR DEGENERATION, AGE-RELATED, 5, SUSCEPTIBILITY TO LUNG CANCER, SUSCEPTIBILITY TO, INCLUDED	ERCC6, -6530C-G	380390
609413	2074	ERCC6	0011	COCKAYNE SYNDROME B	ERCC6, 1-BP INS, 1034T	
609413	2074	ERCC6	0012	CEREBROOCULOFACIOSKELETAL SYNDROME 1	ERCC6, ARG683TER	121917904
609413	2074	ERCC6	0013	CEREBROOCULOFACIOSKELETAL SYNDROME 1	ERCC6, LEU987PRO	121917905
609413	2074	ERCC6	0014	CEREBROOCULOFACIOSKELETAL SYNDROME 1	ERCC6, 2254A-G	
609413	2074	ERCC6	0015	CEREBROOCULOFACIOSKELETAL SYNDROME 1	ERCC6, ARG1288TER	
609414	200576	PIKFYVE	0001	FLECK CORNEAL DYSTROPHY	PIKFYVE, LYS1103ARG	121918336
609414	200576	PIKFYVE	0002	FLECK CORNEAL DYSTROPHY	PIKFYVE, GLN988TER	121918337
609414	200576	PIKFYVE	0003	FLECK CORNEAL DYSTROPHY	PIKFYVE, 4-BP DEL, 4166AAGT	
609427	222662	LHFPL5	0001	DEAFNESS, AUTOSOMAL RECESSIVE 67	LHFPL5, 1-BP DEL, 246C	
609427	222662	LHFPL5	0002	DEAFNESS, AUTOSOMAL RECESSIVE 67	LHFPL5, TYR127CYS	104893975
609427	222662	LHFPL5	0003	DEAFNESS, AUTOSOMAL RECESSIVE 67	LHFPL5, 1-BP DEL, 649G	
609427	222662	LHFPL5	0004	DEAFNESS, AUTOSOMAL RECESSIVE 67	LHFPL5, THR165MET	104893976
609435	51079	NDUFA13	0001	THYROID CARCINOMA, HURTHLE CELL	NDUFA13, LYS88ASN	137852869
609449	54820	NDE1	0001	LISSENCEPHALY 4	NDE1, 2-BP DEL, 684AC	
609449	54820	NDE1	0002	LISSENCEPHALY 4	NDE1, IVS2DS, G-T, +1	
609449	54820	NDE1	0003	LISSENCEPHALY 4	NDE1, 1-BP DUP, 733C	
609457	3034	HAL	0001	HISTIDINEMIA	HAL, ARG206THR	121434327
609457	3034	HAL	0002	HISTIDINEMIA	HAL, ARG208LEU	121434328
609457	3034	HAL	0003	HISTIDINEMIA	HAL, PRO259LEU	121434329
609457	3034	HAL	0004	HISTIDINEMIA	HAL, ARG322PRO	121434330
609458	4125	MAN2B1	0001	ALPHA-MANNOSIDOSIS	MAN2B1, HIS71LEU	28934600
609458	4125	MAN2B1	0002	ALPHA-MANNOSIDOSIS	MAN2B1, ARG760TER	121434331
609458	4125	MAN2B1	0003	ALPHA-MANNOSIDOSIS	MAN2B1, GLN639TER	121434332
609458	4125	MAN2B1	0004	ALPHA-MANNOSIDOSIS	MAN2B1, ARG750TRP	80338680
609458	4125	MAN2B1	0005	ALPHA-MANNOSIDOSIS	MAN2B1, PRO356ARG	121434333
609458	4125	MAN2B1	0006	ALPHA-MANNOSIDOSIS	MAN2B1, IVS14DS, G-C, +1	
609458	4125	MAN2B1	0007	ALPHA-MANNOSIDOSIS	MAN2B1, LEU809PRO	
609471	57704	GBA2	0001	SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE	GBA2, ARG630TRP	
609471	57704	GBA2	0002	SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE	GBA2, ARG234TER	
609471	57704	GBA2	0003	SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE	GBA2, TRP173TER	
609471	57704	GBA2	0004	SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE	GBA2, 4-BP DUP, 1471GGCA	
609471	57704	GBA2	0005	SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE	GBA2, ARG340TER	
609471	57704	GBA2	0006	SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE	GBA2, ARG873HIS	
609471	57704	GBA2	0007	SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE	GBA2, TYR121TER	
609489	4126	MANBA	0001	BETA-MANNOSIDOSIS	MANBA, IVS-AS, A-G, -2	
609489	4126	MANBA	0002	BETA-MANNOSIDOSIS	MANBA, IVS7, A-G, +1	
609489	4126	MANBA	0003	BETA-MANNOSIDOSIS	MANBA, 10-BP INS, NT562	
609489	4126	MANBA	0004	BETA-MANNOSIDOSIS	MANBA, IVS13AS, G-A, -1	
609489	4126	MANBA	0005	BETA-MANNOSIDOSIS	MANBA, SER505PRO	121434334
609489	4126	MANBA	0006	BETA-MANNOSIDOSIS	MANBA, 375A-G	
609489	4126	MANBA	0007	BETA-MANNOSIDOSIS	MANBA, GLU83TER	121434335
609489	4126	MANBA	0008	BETA-MANNOSIDOSIS	MANBA, GLN426TER	121434336
609489	4126	MANBA	0009	BETA-MANNOSIDOSIS	MANBA, 2-BP DEL, 1541AT	
609502	92211	CDHR1	0001	CONE-ROD DYSTROPHY 15	CDHR1, 1-BP INS, 524A	
609502	92211	CDHR1	0002	RETINITIS PIGMENTOSA 65	CDHR1, 1-BP DEL, 338G	
609502	92211	CDHR1	0003	RETINITIS PIGMENTOSA 65	CDHR1,  1-BP DEL, 1459G	
609506	1594	CYP27B1	0001	VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	CYP27B1, ARG107HIS	28934604
609506	1594	CYP27B1	0002	VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	CYP27B1, GLY125GLU	28934605
609506	1594	CYP27B1	0003	VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	CYP27B1, ARG335PRO	28934606
609506	1594	CYP27B1	0004	VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	CYP27B1, PRO382SER	28934607
609506	1594	CYP27B1	0005	VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	CYP27B1, 1-BP DEL	
609506	1594	CYP27B1	0006	VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	CYP27B1, 1-BP DEL	
609506	1594	CYP27B1	0007	VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	CYP27B1, 1-BP DEL, 958G	
609506	1594	CYP27B1	0008	VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	CYP27B1, 7-BP DUP	
609506	1594	CYP27B1	0009	VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	CYP27B1, THR321ARG	118204007
609506	1594	CYP27B1	0010	VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	CYP27B1, IVS3, G-A, +1	
609506	1594	CYP27B1	0011	VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	CYP27B1, THR409ILE	118204008
609506	1594	CYP27B1	0012	VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, INCLUDED	CYP27B1, ARG389HIS	118204009
609506	1594	CYP27B1	0013	VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	CYP27B1, 5-BP DEL/6-BP INS	
609506	1594	CYP27B1	0014	VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	CYP27B1, IVS2, G-A, +1	
609506	1594	CYP27B1	0015	VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	CYP27B1, ARG389GLY	118204010
609506	1594	CYP27B1	0016	VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, INCLUDED	CYP27B1, LEU343PHE	118204011
609506	1594	CYP27B1	0017	VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, INCLUDED	CYP27B1, GLU189GLY	118204012
609507	10210	TOPORS	0001	RETINITIS PIGMENTOSA 31	TOPORS, 1-BP INS, 2474A	
609507	10210	TOPORS	0002	RETINITIS PIGMENTOSA 31	TOPORS, 2-BP DEL, 2552GA	
609510	133396	IL31RA	0001	AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 2	IL31RA, SER521PHE	
609512	25978	CHMP2B	0001	FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED	CHMP2B, IVS5AS, G-C	
609512	25978	CHMP2B	0002	FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED	CHMP2B, ASP148TYR	63750653
609512	25978	CHMP2B	0003	AMYOTROPHIC LATERAL SCLEROSIS 17	CHMP2B, GLN206HIS	63751126
609512	25978	CHMP2B	0004	FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED	CHMP2B, GLN165TER	63750355
609512	25978	CHMP2B	0005	AMYOTROPHIC LATERAL SCLEROSIS 17 FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED, INCLUDED	CHMP2B, ILE29VAL	
609512	25978	CHMP2B	0006	AMYOTROPHIC LATERAL SCLEROSIS 17	CHMP2B, THR104ASN	
609520	55145	THAP1	0001	DYSTONIA 6, TORSION	THAP1, 5-BP INS/3-BP DEL, NT134	
609520	55145	THAP1	0002	DYSTONIA 6, TORSION	THAP1, PHE81LEU	118204013
609520	55145	THAP1	0003	DYSTONIA 6, TORSION	THAP1, 1-BP DEL, 460C	
609520	55145	THAP1	0004	DYSTONIA 6, TORSION	THAP1, LYS89ARG	
609520	55145	THAP1	0005	DYSTONIA 6, TORSION	THAP1, 2-BP DEL, 388TC	
609520	55145	THAP1	0006	DYSTONIA 6, TORSION	THAP1, 1-BP DEL, 474A	
609520	55145	THAP1	0007	DYSTONIA 6, TORSION	THAP1, GLY9CYS	
609520	55145	THAP1	0008	DYSTONIA 6, TORSION	THAP1, LYS24GLU	
609520	55145	THAP1	0009	DYSTONIA 6, TORSION	THAP1, HIS23PRO	
609523	224	ALDH3A2	0001	SJOGREN-LARSSON SYNDROME	ALDH3A2, 1-BP DEL, 525T	
609523	224	ALDH3A2	0002	SJOGREN-LARSSON SYNDROME	ALDH3A2, 1-BP DEL, 808G	
609523	224	ALDH3A2	0003	SJOGREN-LARSSON SYNDROME	ALDH3A2, 3-BP DEL/21-BP INS, ALA314GLY, PRO315ALA	
609523	224	ALDH3A2	0004	SJOGREN-LARSSON SYNDROME	ALDH3A2, CYS214TYR	72547564
609523	224	ALDH3A2	0005	SJOGREN-LARSSON SYNDROME	ALDH3A2, PRO315SER	72547571
609523	224	ALDH3A2	0006	SJOGREN-LARSSON SYNDROME	ALDH3A2, 2-BP DEL, 1297GA	
609523	224	ALDH3A2	0007	SJOGREN-LARSSON SYNDROME	ALDH3A2, 5-BP INS, NT1311	
609523	224	ALDH3A2	0008	SJOGREN-LARSSON SYNDROME	ALDH3A2, LYS266ASN	72547569
609523	224	ALDH3A2	0009	SJOGREN-LARSSON SYNDROME	ALDH3A2, ASN386SER	72547575
609526	25894	PLEKHG4	0001	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	PLEKHG4, -16C-T	
609562	57094	CPA6	0001	FEBRILE SEIZURES, FAMILIAL, 11	CPA6, ALA270VAL	
609562	57094	CPA6	0002	EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	CPA6, GLY267ARG	
609575	37	ACADVL	0001	VLCAD DEFICIENCY	ACADVL, 105-BP DEL	
609575	37	ACADVL	0002	VLCAD DEFICIENCY	ACADVL, IVS11, G-A, +1	
609575	37	ACADVL	0003	VLCAD DEFICIENCY	ACADVL, ARG613TRP	118204014
609575	37	ACADVL	0004	VLCAD DEFICIENCY	ACADVL, IVS5, 1-BP DEL, G, -1	
609575	37	ACADVL	0005	VLCAD DEFICIENCY	ACADVL, 135-BP DEL	
609575	37	ACADVL	0006	VLCAD DEFICIENCY	ACADVL, 3-BP DEL, GLU130DEL	
609575	37	ACADVL	0007	VLCAD DEFICIENCY	ACADVL, 3-BP DEL, LYS299DEL	
609575	37	ACADVL	0008	VLCAD DEFICIENCY	ACADVL, LYS382GLN	118204015
609575	37	ACADVL	0009	VLCAD DEFICIENCY	ACADVL, GLY401ASP	2309689
609575	37	ACADVL	0010	VLCAD DEFICIENCY	ACADVL, ARG410HIS	118204016
609575	37	ACADVL	0011	VLCAD DEFICIENCY	ACADVL, PRO65LEU AND LYS247GLN	28934585
609575	37	ACADVL	0012	VLCAD DEFICIENCY	ACADVL, PHE458LEU	118204017
609575	37	ACADVL	0013	VLCAD DEFICIENCY	ACADVL, ALA416THR	118204018
609575	37	ACADVL	0014	VLCAD DEFICIENCY	ACADVL, ARG450HIS	118204016
609577	9820	CUL7	0001	3@M SYNDROME	CUL7, ARG1445TER	121918228
609577	9820	CUL7	0002	3@M SYNDROME	CUL7, HIS1464PRO	121918229
609577	9820	CUL7	0003	3@M SYNDROME	CUL7, 2-BP DEL, 4450TG	
609577	9820	CUL7	0004	YAKUT SHORT STATURE SYNDROME	CUL7, 1-BP INS, 4582T	
609577	9820	CUL7	0005	3@M SYNDROME	CUL7, 2-BP DEL, 4449GT	
609577	9820	CUL7	0006	3@M SYNDROME	CUL7, 2-BP DEL, 3379TG	
609577	9820	CUL7	0007	3@M SYNDROME	CUL7, IVS6AS, C-A, -3	
609584	79944	L2HGDH	0001	L-2-HYDROXYGLUTARIC ACIDURIA	L2HGDH, PRO302LEU	118204020
609584	79944	L2HGDH	0002	L-2-HYDROXYGLUTARIC ACIDURIA	L2HGDH, 1-BP DEL, 1115T	
609584	79944	L2HGDH	0003	L-2-HYDROXYGLUTARIC ACIDURIA	L2HGDH, IVS7, G-T, +1	
609584	79944	L2HGDH	0004	L-2-HYDROXYGLUTARIC ACIDURIA	L2HGDH, GLY55ASP	118204021
609584	79944	L2HGDH	0005	L-2-HYDROXYGLUTARIC ACIDURIA	L2HGDH, EX1-9 DEL	
609584	79944	L2HGDH	0006	L-2-HYDROXYGLUTARIC ACIDURIA	L2HGDH, HIS98ARG	
609584	79944	L2HGDH	0007	L-2-HYDROXYGLUTARIC ACIDURIA	L2HGDH, ARG335TER	
609588	51218	GLRX5	0001	ANEMIA, SIDEROBLASTIC, PYRIDOXINE-REFRACTORY, AUTOSOMAL RECESSIVE	GLRX5, GLN98GLN	121908584
609595	284654	RSPO1	0001	PALMOPLANTAR HYPERKERATOSIS WITH SQUAMOUS CELL CARCINOMA OF SKIN AND SEX REVERSAL	RSPO1, 1-BP INS, 896G	
609595	284654	RSPO1	0002	PALMOPLANTAR HYPERKERATOSIS WITH SQUAMOUS CELL CARCINOMA OF SKIN AND SEX REVERSAL	RSPO1, EX4 DEL	
609595	284654	RSPO1	0003	PALMOPLANTAR HYPERKERATOSIS AND TRUE HERMAPHRODITISM	RSPO1, IVS5DS, G-A, +1	
609607	81607	PVRL4	0001	ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 1	PVRL4, ARG284GLN	
609607	81607	PVRL4	0002	ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 1	PVRL4, THR185MET	
609607	81607	PVRL4	0003	ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 1	PVRL4, 1-BP DEL, 906T	
609607	81607	PVRL4	0004	ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 1	PVRL4, PRO212ARG	
609617	7780	SLC30A2	0001	ZINC DEFICIENCY, TRANSIENT NEONATAL	SLC30A2, HIS54ARG	
609617	7780	SLC30A2	0002	ZINC DEFICIENCY, TRANSIENT NEONATAL	SLC30A2, GLY87ARG	
609644	57697	FANCM	0001	FANCONI ANEMIA, COMPLEMENTATION GROUP M	FANCM, SER724TER	137852864
609644	57697	FANCM	0002	FANCONI ANEMIA, COMPLEMENTATION GROUP M	FANCM, 2,554-BP DEL	
609648	91662	NLRP12	0001	FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2	NLRP12, ARG284TER	104895564
609648	91662	NLRP12	0002	FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2	NLRP12, IVS3DS, 1-BP INS, +3T	
609653	91942	NDUFAF2	0001	MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFAF2, ARG45TER	137852863
609653	91942	NDUFAF2	0002	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFAF2, 1-BP DEL, 103A	
609661	199713	NLRP7	0001	HYDATIDIFORM MOLE, RECURRENT, 1	NLRP7, IVS3DS, G-A, +1	
609661	199713	NLRP7	0002	HYDATIDIFORM MOLE, RECURRENT, 1	NLRP7, IVS7DS, G-A, +1	
609661	199713	NLRP7	0003	HYDATIDIFORM MOLE, RECURRENT, 1	NLRP7, ARG693TRP	104895506
609661	199713	NLRP7	0004	HYDATIDIFORM MOLE, RECURRENT, 1	NLRP7, ARG693PRO	104895502
609661	199713	NLRP7	0005	HYDATIDIFORM MOLE, RECURRENT, 1	NLRP7, ASN913SER	104895503
609661	199713	NLRP7	0006	HYDATIDIFORM MOLE, RECURRENT, 1	NLRP7, ARG432TER	104895530
609661	199713	NLRP7	0007	HYDATIDIFORM MOLE, RECURRENT, 1	NLRP7, 1-BP INS, 337G	
609661	199713	NLRP7	0008	HYDATIDIFORM MOLE, RECURRENT, 1	NLRP7, ARG693GLN	
609661	199713	NLRP7	0009	HYDATIDIFORM MOLE, RECURRENT, 1	NLRP7, LEU398ARG	
609661	199713	NLRP7	0010	HYDATIDIFORM MOLE, RECURRENT, 1	NLRP7, PRO651SER	
609661	199713	NLRP7	0011	HYDATIDIFORM MOLE, RECURRENT, 1	NLRP7, 14-BP DUP, NT939	
609661	199713	NLRP7	0012	HYDATIDIFORM MOLE, RECURRENT, 1	NLRP7, 1-BP DEL, 2030T	
609669	134430	WDR36	0001	GLAUCOMA 1, OPEN ANGLE, G	WRD36, ASP658GLY	34595252
609669	134430	WDR36	0002	GLAUCOMA 1, OPEN ANGLE, G	WRD36, ASN355SER	118204022
609669	134430	WDR36	0003	GLAUCOMA 1, OPEN ANGLE, G	WRD36, ALA449THR	35703638
609669	134430	WDR36	0004	GLAUCOMA 1, OPEN ANGLE, G	WRD36, ARG529GLN	116529882
609671	55240	STEAP3	0001	ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2 (1 family)	STEAP3, CYS100TER	
609678	114798	SLITRK1	0001	TOURETTE SYNDROME TRICHOTILLOMANIA, INCLUDED	SLITRK1, 1-BP DEL, 1264C	193302861
609678	114798	SLITRK1	0002	TOURETTE SYNDROME	SLITRK1, +689G-A, 3-PRIME UTR	191284403
609695	3242	HPD	0001	TYROSINEMIA, TYPE III	HPD, TYR160CYS	137852865
609695	3242	HPD	0002	TYROSINEMIA, TYPE III	HPD, TYR258TER	137852866
609695	3242	HPD	0003	TYROSINEMIA, TYPE III	HPD, TYR200TER	137852867
609695	3242	HPD	0004	TYROSINEMIA, TYPE III	HPD, ILE335MET	137852868
609695	3242	HPD	0005	HAWKINSINURIA	HPD, ALA33THR	1154510
609701	4669	NAGLU	0001	MUCOPOLYSACCHARIDOSIS TYPE IIIB	NAGLU, ARG674HIS	104894590
609701	4669	NAGLU	0002	MUCOPOLYSACCHARIDOSIS TYPE IIIB	NAGLU, ARG626TER	104894591
609701	4669	NAGLU	0003	MUCOPOLYSACCHARIDOSIS TYPE IIIB	NAGLU, ARG297TER	104894592
609701	4669	NAGLU	0004	MUCOPOLYSACCHARIDOSIS TYPE IIIB	NAGLU, ARG643HIS	104894593
609701	4669	NAGLU	0005	MUCOPOLYSACCHARIDOSIS TYPE IIIB	NAGLU, 10-BP DEL, NT503	
609701	4669	NAGLU	0006	MUCOPOLYSACCHARIDOSIS TYPE IIIB	NAGLU, ARG643CYS	104894594
609701	4669	NAGLU	0007	MUCOPOLYSACCHARIDOSIS TYPE IIIB	NAGLU, PRO521LEU	104894595
609701	4669	NAGLU	0008	MUCOPOLYSACCHARIDOSIS TYPE IIIB	NAGLU, ARG565TRP	104894597
609701	4669	NAGLU	0009	MUCOPOLYSACCHARIDOSIS TYPE IIIB	NAGLU, ARG565PRO	104894598
609701	4669	NAGLU	0010	MUCOPOLYSACCHARIDOSIS TYPE IIIB	NAGLU, PHE48LEU	104894599
609701	4669	NAGLU	0011	MUCOPOLYSACCHARIDOSIS TYPE IIIB	NAGLU, PHE314LEU	104894600
609701	4669	NAGLU	0012	MUCOPOLYSACCHARIDOSIS TYPE IIIB	NAGLU, ARG482TRP	104894596
609701	4669	NAGLU	0013	MUCOPOLYSACCHARIDOSIS TYPE IIIB	NAGLU, ARG234CYS	104894601
609701	4669	NAGLU	0014	MUCOPOLYSACCHARIDOSIS TYPE IIIB	NAGLU, ARG565GLN	
609708	4023	LPL	0001	LIPOPROTEIN LIPASE DEFICIENCY	LPL, ALA176THR	118204056
609708	4023	LPL	0002	LIPOPROTEIN LIPASE DEFICIENCY	LPL, GLY188GLU	118204057
609708	4023	LPL	0003	LIPOPROTEIN LIPASE DEFICIENCY	LPL, INS	
609708	4023	LPL	0004	LIPOPROTEIN LIPASE DEFICIENCY	LPL, 2-KB DUP	
609708	4023	LPL	0005	LIPOPROTEIN LIPASE DEFICIENCY	LPL, 6-KB DEL	
609708	4023	LPL	0006	LIPOPROTEIN LIPASE DEFICIENCY	LPL, GLN106TER	118204058
609708	4023	LPL	0007	LIPOPROTEIN LIPASE DEFICIENCY	LPL, SER244THR	118204059
609708	4023	LPL	0008	LIPOPROTEIN LIPASE DEFICIENCY	LPL, IVS2DS, G-A	
609708	4023	LPL	0009	LIPOPROTEIN LIPASE DEFICIENCY	LPL, PRO207LEU	118204060
609708	4023	LPL	0010	LIPOPROTEIN LIPASE DEFICIENCY	LPL, ILE194THR	118204061
609708	4023	LPL	0011	LIPOPROTEIN LIPASE DEFICIENCY	LPL, ARG243HIS	118204062
609708	4023	LPL	0012	LIPOPROTEIN LIPASE DEFICIENCY	LPL, GLY142GLU	118204063
609708	4023	LPL	0013	LIPOPROTEIN LIPASE DEFICIENCY	LPL, ASP156GLY	118204064
609708	4023	LPL	0014	LIPOPROTEIN LIPASE POLYMORPHISM	LPL, SER447TER	328
609708	4023	LPL	0015	LIPOPROTEIN LIPASE DEFICIENCY	LPL, IVS2DS, G-A, +1	
609708	4023	LPL	0016	LIPOPROTEIN LIPASE DEFICIENCY	LPL, TYR61TER	118204065
609708	4023	LPL	0017	LIPOPROTEIN LIPASE DEFICIENCY	LPL, TRP382TER	118204066
609708	4023	LPL	0018	LIPOPROTEIN LIPASE DEFICIENCY	LPL, ASP204GLU	118204067
609708	4023	LPL	0019	LIPOPROTEIN LIPASE DEFICIENCY LPL-ARITA	LPL, 1-BP DEL, 916G	
609708	4023	LPL	0020	LIPOPROTEIN LIPASE DEFICIENCY	LPL, ASP250ASN	118204068
609708	4023	LPL	0021	LIPOPROTEIN LIPASE DEFICIENCY	LPL, TRP86ARG	118204069
609708	4023	LPL	0023	LIPOPROTEIN LIPASE DEFICIENCY	LPL, TRP64TER	118204070
609708	4023	LPL	0024	LIPOPROTEIN LIPASE DEFICIENCY	LPL, IVS1, G-C, +1	
609708	4023	LPL	0025	LIPOPROTEIN LIPASE DEFICIENCY	LPL, ALA334THR	118204071
609708	4023	LPL	0026	LIPOPROTEIN LIPASE DEFICIENCY	LPL, SER172CYS	118204072
609708	4023	LPL	0027	LIPOPROTEIN LIPASE DEFICIENCY	LPL, ARG75SER	118204073
609708	4023	LPL	0028	LIPOPROTEIN LIPASE DEFICIENCY	LPL, TYR73TER	118204074
609708	4023	LPL	0029	LIPOPROTEIN LIPASE DEFICIENCY	LPL, GLY195GLU	118204075
609708	4023	LPL	0030	LIPOPROTEIN LIPASE DEFICIENCY	LPL, ASP180GLU	118204076
609708	4023	LPL	0031	LIPOPROTEIN LIPASE DEFICIENCY	LPL, ARG243CYS	118204077
609708	4023	LPL	0032	COMBINED HYPERLIPIDEMIA, FAMILIAL	LPL, -39T-C	
609708	4023	LPL	0033	COMBINED HYPERLIPIDEMIA, FAMILIAL	LPL, ASN291SER	268
609708	4023	LPL	0034	LIPOPROTEIN LIPASE DEFICIENCY	LPL, LEU365VAL	118204078
609708	4023	LPL	0035	COMBINED HYPERLIPIDEMIA, FAMILIAL	LPL, ASP9ASN	1801177
609708	4023	LPL	0036	LIPOPROTEIN LIPASE DEFICIENCY	LPL, CYS418TYR	118204079
609708	4023	LPL	0037	LIPOPROTEIN LIPASE DEFICIENCY	LPL, ILE225THR	118204080
609708	4023	LPL	0038	COMBINED HYPERLIPIDEMIA, FAMILIAL	LPL, -93T-G	
609708	4023	LPL	0039	LIPOPROTEIN LIPASE DEFICIENCY LIPOPROTEIN LIPASE (OLBIA)	LPL, TYR302TER	118204081
609708	4023	LPL	0040	LIPOPROTEIN LIPASE DEFICIENCY	LPL, CYS239TRP	118204082
609708	4023	LPL	0041	LIPOPROTEIN LIPASE DEFICIENCY	LPL, 1-BP DEL, CODON 172	
609708	4023	LPL	0042	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 11	LPL, A-G	326
609708	4023	LPL	0043	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 11	LPL, T-C	
609712	5313	PKLR	0001	PYRUVATE KINASE DEFICIENCY	PKLR, 1-BP DEL	
609712	5313	PKLR	0002	PYRUVATE KINASE DEFICIENCY	PKLR, ARG132CYS	118204083
609712	5313	PKLR	0003	PYRUVATE KINASE DEFICIENCY	PKLR, THR353MET	74315362
609712	5313	PKLR	0004	PYRUVATE KINASE DEFICIENCY	PKLR, THR384MET	74315362
609712	5313	PKLR	0005	PYRUVATE KINASE DEFICIENCY	PKLR, GLN421LYS	118204084
609712	5313	PKLR	0006	PYRUVATE KINASE DEFICIENCY, AMISH TYPE	PKLR, ARG479HIS	118204085
609712	5313	PKLR	0007	PYRUVATE KINASE DEFICIENCY	PKLR, ARG510GLN	113403872
609712	5313	PKLR	0008	ADENOSINE TRIPHOSPHATE, ELEVATED, OF ERYTHROCYTES	PKLR, GLY37GLN	118204087
609712	5313	PKLR	0009	PYRUVATE KINASE DEFICIENCY	PKLR, ARG486TRP	116100695
609712	5313	PKLR	0010	PYRUVATE KINASE DEFICIENCY	PKLR, SER130TYR	118204089
609712	5313	PKLR	0011	PYRUVATE KINASE DEFICIENCY	PKLR, -83G-C	
609712	5313	PKLR	0012	PYRUVATE KINASE DEFICIENCY	PKLR, 1318G-T	
609712	5313	PKLR	0013	PYRUVATE KINASE DEFICIENCY	PKLR, 1269G-A	
609712	5313	PKLR	0014	PYRUVATE KINASE DEFICIENCY	PKLR, 1-BP DEL, 823G	
609739	286676	ILDR1	0001	DEAFNESS, AUTOSOMAL RECESSIVE 42	ILDR1, GLU379TER	
609739	286676	ILDR1	0002	DEAFNESS, AUTOSOMAL RECESSIVE 42	ILDR1, MET1?	
609739	286676	ILDR1	0003	DEAFNESS, AUTOSOMAL RECESSIVE 42	ILDR1, GLN195TER	
609739	286676	ILDR1	0004	DEAFNESS, AUTOSOMAL RECESSIVE 42	ILDR1, 1-BP DEL, 1032G	
609751	51	ACOX1	0001	PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY	ACOX1, 17-KB DEL	
609751	51	ACOX1	0002	PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY	ACOX1, MET278VAL	118204090
609751	51	ACOX1	0003	PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY	ACOX1, GLY178CYS	118204091
609751	51	ACOX1	0004	PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY	ACOX1, GLN309ARG	118204092
609751	51	ACOX1	0005	PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY	ACOX1, ARG148TER	118204093
609751	51	ACOX1	0006	PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY	ACOX1, 18-BP DEL, NT372	
609751	51	ACOX1	0007	PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY	ACOX1, 15.5-KB DEL	
609761	11078	TRIOBP	0001	DEAFNESS, AUTOSOMAL RECESSIVE 28	TRIOBP, ARG347TER	118204026
609761	11078	TRIOBP	0002	DEAFNESS, AUTOSOMAL RECESSIVE 28	TRIOBP, GLN581TER	118204027
609761	11078	TRIOBP	0003	DEAFNESS, AUTOSOMAL RECESSIVE 28	TRIOBP, GLN297TER	118204028
609761	11078	TRIOBP	0004	DEAFNESS, AUTOSOMAL RECESSIVE 28	TRIOBP, ARG788TER	118204029
609761	11078	TRIOBP	0005	DEAFNESS, AUTOSOMAL RECESSIVE 28	TRIOBP, ARG1068TER	118204030
609761	11078	TRIOBP	0006	DEAFNESS, AUTOSOMAL RECESSIVE 28	TRIOBP, ARG1117TER	118204031
609761	11078	TRIOBP	0007	DEAFNESS, AUTOSOMAL RECESSIVE 28	TRIOBP, 2-BP DEL, 3202CG	
609761	11078	TRIOBP	0008	DEAFNESS, AUTOSOMAL RECESSIVE 28	TRIOBP, 1-BP INS, 3225C	
609762	388552	BLOC1S3	0001	HERMANSKY-PUDLAK SYNDROME 8	BLOC1S3, 1-BP DEL, 448C	111060589
609799	284086	NEK8	0001	NEPHRONOPHTHISIS 9	NEK8, HIS425TYR	118204032
609802	283652	SLC24A5	0001	SKIN/HAIR/EYE PIGMENTATION 4, FAIR/DARK SKIN	SLC24A5, ALA111THR	1426654
609806	3145	HMBS	0001	PORPHYRIA, ACUTE INTERMITTENT, NONERYTHROID VARIANT	HMBS, IVS1DS, G-A, +1	
609806	3145	HMBS	0002	PORPHYRIA, ACUTE INTERMITTENT	HMBS, EX12DEL	
609806	3145	HMBS	0003	PORPHYRIA, ACUTE INTERMITTENT, NONERYTHROID VARIANT	HMBS, IVS1DS, G-T, +1	
609806	3145	HMBS	0004	PORPHYRIA, ACUTE INTERMITTENT	HMBS, ARG116TRP	118204094
609806	3145	HMBS	0005	PORPHYRIA, ACUTE INTERMITTENT	HMBS, ARG167GLN	118204095
609806	3145	HMBS	0006	PORPHYRIA, ACUTE INTERMITTENT	HMBS, ARG173GLN	118204096
609806	3145	HMBS	0007	PORPHYRIA, ACUTE INTERMITTENT	HMBS, GLN155TER	118204097
609806	3145	HMBS	0008	PORPHYRIA, ACUTE INTERMITTENT	HMBS, ARG149GLN	118204098
609806	3145	HMBS	0009	PORPHYRIA, ACUTE INTERMITTENT	HMBS, LEU245ARG	118204099
609806	3145	HMBS	0010	PORPHYRIA, ACUTE INTERMITTENT	HMBS, 1-BP DEL, 900T	
609806	3145	HMBS	0011	PORPHYRIA, ACUTE INTERMITTENT	HMBS, 9-BP DEL, EX10	
609806	3145	HMBS	0012	PORPHYRIA, ACUTE INTERMITTENT	HMBS, TRP198TER	118204100
609806	3145	HMBS	0013	PORPHYRIA, ACUTE INTERMITTENT	HMBS, ARG167TRP	118204101
609806	3145	HMBS	0014	PORPHYRIA, ACUTE INTERMITTENT	HMBS, ARG167LEU	118204095
609806	3145	HMBS	0015	PORPHYRIA, ACUTE INTERMITTENT	HMBS, ARG26HIS	118204103
609806	3145	HMBS	0016	PORPHYRIA, ACUTE INTERMITTENT	HMBS, ALA31THR	118204104
609806	3145	HMBS	0017	PORPHYRIA, ACUTE INTERMITTENT	HMBS, GLN34LYS	118204105
609806	3145	HMBS	0018	PORPHYRIA, ACUTE INTERMITTENT	HMBS, ALA55SER	118204106
609806	3145	HMBS	0019	PORPHYRIA, ACUTE INTERMITTENT	HMBS, 1-BP DEL, 174C	
609806	3145	HMBS	0020	PORPHYRIA, ACUTE INTERMITTENT	HMBS, 1-BP INS, 182G	
609806	3145	HMBS	0021	PORPHYRIA, ACUTE INTERMITTENT	HMBS, IVS5DS, G-A, +1	
609806	3145	HMBS	0022	PORPHYRIA, ACUTE INTERMITTENT	HMBS, 2-BP DEL, 218AG	
609806	3145	HMBS	0023	PORPHYRIA, ACUTE INTERMITTENT	HMBS, GLY111ARG	118204107
609806	3145	HMBS	0024	PORPHYRIA, ACUTE INTERMITTENT	HMBS, IVS9AS, G-A, -1	
609806	3145	HMBS	0025	PORPHYRIA, ACUTE INTERMITTENT	HMBS, LEU177ARG	118204108
609806	3145	HMBS	0026	PORPHYRIA, ACUTE INTERMITTENT	HMBS, ARG201TRP	118204109
609806	3145	HMBS	0027	PORPHYRIA, ACUTE INTERMITTENT	HMBS, GLU223LYS	118204110
609806	3145	HMBS	0028	PORPHYRIA, ACUTE INTERMITTENT	HMBS, 2-BP DEL, 730CT	
609806	3145	HMBS	0029	PORPHYRIA, ACUTE INTERMITTENT	HMBS, CYS247ARG	118204111
609806	3145	HMBS	0030	PORPHYRIA, ACUTE INTERMITTENT	HMBS, 8-BP INS	
609806	3145	HMBS	0031	PORPHYRIA, ACUTE INTERMITTENT	HMBS, GLU250LYS	118204112
609806	3145	HMBS	0032	PORPHYRIA, ACUTE INTERMITTENT	HMBS, ALA252THR	118204113
609806	3145	HMBS	0033	PORPHYRIA, ACUTE INTERMITTENT	HMBS, ALA252VAL	118204114
609806	3145	HMBS	0034	PORPHYRIA, ACUTE INTERMITTENT	HMBS, HIS256ASN	118204115
609806	3145	HMBS	0035	PORPHYRIA, ACUTE INTERMITTENT	HMBS, IVS12DS, G-C, +1	
609806	3145	HMBS	0036	PORPHYRIA, ACUTE INTERMITTENT	HMBS, IVS14DS, G-A, +1	
609806	3145	HMBS	0037	PORPHYRIA, ACUTE INTERMITTENT	HMBS, IVS6DS, G-C, +1	
609806	3145	HMBS	0038	PORPHYRIA, ACUTE INTERMITTENT	HMBS, GLY216ASP	118204116
609806	3145	HMBS	0039	PORPHYRIA, ACUTE INTERMITTENT	HMBS, 2-BP DEL, 847TG	
609806	3145	HMBS	0040	PORPHYRIA, ACUTE INTERMITTENT	HMBS, ALU INS	
609806	3145	HMBS	0041	PORPHYRIA, ACUTE INTERMITTENT, NONERYTHROID VARIANT	HMBS, 1-BP DEL, -154G	
609806	3145	HMBS	0042	PORPHYRIA, ACUTE INTERMITTENT, NONERYTHROID VARIANT	HMBS, 1-BP DEL, 41A	
609806	3145	HMBS	0043	PORPHYRIA, ACUTE INTERMITTENT	HMBS, TRP283TER	118204117
609806	3145	HMBS	0044	PORPHYRIA, ACUTE INTERMITTENT, NONERYTHROID VARIANT	HMBS, MET1VAL	118204118
609806	3145	HMBS	0045	PORPHYRIA, ACUTE INTERMITTENT	HMBS, LEU81PRO	118204119
609806	3145	HMBS	0046	PORPHYRIA, ACUTE INTERMITTENT	HMBS, ARG149TER	118204120
609825	27235	COQ2	0001	COENZYME Q10 DEFICIENCY, PRIMARY, 1	COQ2, TYR297CYS	121918230
609825	27235	COQ2	0002	COENZYME Q10 DEFICIENCY, PRIMARY, 1	COQ2, 1-BP DEL, 1198T	
609825	27235	COQ2	0003	COENZYME Q10 DEFICIENCY, PRIMARY, 1	COQ2, ARG197HIS	121918231
609825	27235	COQ2	0004	COENZYME Q10 DEFICIENCY, PRIMARY, 1	COQ2, ASN228SER	121918232
609825	27235	COQ2	0005	COENZYME Q10 DEFICIENCY, PRIMARY, 1	COQ2, SER146ASN	121918233
609826	142680	SLC34A3	0001	HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	SLC34A3, 1-BP DEL, 905C	
609826	142680	SLC34A3	0002	HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	SLC34A3, ARG353LEU	121918234
609826	142680	SLC34A3	0003	HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	SLC34A3, ALA413GLU	121918235
609826	142680	SLC34A3	0004	HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	SLC34A3, PRO282PRO	121918236
609826	142680	SLC34A3	0005	HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	SLC34A3, 1-BP DEL, 228C	
609826	142680	SLC34A3	0006	HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	SLC34A3, GLY196ARG	121918237
609826	142680	SLC34A3	0007	HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	SLC34A3, ARG468TRP	121918238
609826	142680	SLC34A3	0008	HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	SLC34A3, 101-BP DEL, NT2259	
609826	142680	SLC34A3	0009	HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	SLC34A3, GLN252GLN	121918239
609826	142680	SLC34A3	0010	HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	SLC34A3, 85-BP DEL, NT2615	
609831	25974	MMACHC	0001	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE	MMACHC, 1-BP DUP, 271A	
609831	25974	MMACHC	0002	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE	MMACHC, LEU116PRO	121918240
609831	25974	MMACHC	0003	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE	MMACHC, ARG132TER	121918241
609831	25974	MMACHC	0004	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE	MMACHC, ARG111TER	121918242
609831	25974	MMACHC	0005	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE	MMACHC, ARG161GLN	121918243
609831	25974	MMACHC	0006	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE	MMACHC, TRP203TER	
609831	25974	MMACHC	0007	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE	MMACHC, 3-BP DEL, 658AAG	
609840	123041	SLC24A4	0001	SKIN/HAIR/EYE PIGMENTATION 6, BLOND/BROWN HAIR SKIN/HAIR/EYE PIGMENTATION 6, BLUE/GREEN EYES, INCLUDED	SLC24A4, G/T	12896399
609845	6476	SI	0001	SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	SI, GLN1098PRO	121912611
609845	6476	SI	0002	SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	SI, LEU340PRO	
609845	6476	SI	0003	SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	SI, GLN117ARG	121912612
609845	6476	SI	0004	SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	SI, LEU620PRO	121912613
609845	6476	SI	0005	SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	SI, CYS1229TYR	121912614
609845	6476	SI	0006	SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	SI, PHE1745CYS	79717168
609845	6476	SI	0007	SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	SI, VAL577GLY	121912615
609845	6476	SI	0008	SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	SI, GLY1073ASP	121912616
609856	83893	SPATA16	0001	SPERMATOGENIC FAILURE 6	SPATA16, ARG283GLN	137853118
609862	164656	TMPRSS6	0001	IRON-REFRACTORY IRON DEFICIENCY ANEMIA	TMPRSS6, 2-BP INS, 1906GC	
609862	164656	TMPRSS6	0002	IRON-REFRACTORY IRON DEFICIENCY ANEMIA	TMPRSS6, 1-BP DEL, 1813G	
609862	164656	TMPRSS6	0003	IRON-REFRACTORY IRON DEFICIENCY ANEMIA	TMPRSS6, IVS13, G-A, +1	
609862	164656	TMPRSS6	0004	IRON-REFRACTORY IRON DEFICIENCY ANEMIA	TMPRSS6, IVS16, G-C, +1	
609862	164656	TMPRSS6	0005	IRON-REFRACTORY IRON DEFICIENCY ANEMIA	TMPRSS6, GLY442ARG	137853119
609862	164656	TMPRSS6	0006	IRON-REFRACTORY IRON DEFICIENCY ANEMIA	TMPRSS6, ASP521ASN	137853120
609862	164656	TMPRSS6	0007	IRON-REFRACTORY IRON DEFICIENCY ANEMIA	TMPRSS6, TYR355TER	137853121
609862	164656	TMPRSS6	0008	IRON-REFRACTORY IRON DEFICIENCY ANEMIA	TMPRSS6, 1-BP DEL, 1383A	
609862	164656	TMPRSS6	0009	IRON-REFRACTORY IRON DEFICIENCY ANEMIA	TMPRSS6, TYR393TER	137853122
609862	164656	TMPRSS6	0010	IRON-REFRACTORY IRON DEFICIENCY ANEMIA	TMPRSS6, ARG599TER	137853123
609862	164656	TMPRSS6	0011	IRON-REFRACTORY IRON DEFICIENCY ANEMIA	TMPRSS6, 4-BP INS, 2172CCCC	
609862	164656	TMPRSS6	0012	IRON-REFRACTORY IRON DEFICIENCY ANEMIA	TMPRSS6, ALA118ASP	
609862	164656	TMPRSS6	0013	IRON-REFRACTORY IRON DEFICIENCY ANEMIA	TMPRSS6, GLU522LYS	
609863	79600	TCTN1	0001	JOUBERT SYNDROME 13	TCTN1, IVS1AS, A-G, -2	
609868	55812	SPATA7	0001	LEBER CONGENITAL AMAUROSIS 3	SPATA7, ARG108TER	80044281
609868	55812	SPATA7	0002	LEBER CONGENITAL AMAUROSIS 3	SPATA7, 1-BP DUP, 961A	
609868	55812	SPATA7	0003	RETINITIS PIGMENTOSA, JUVENILE, SPATA7-RELATED	SPATA7, ARG395TER	75895925
609868	55812	SPATA7	0004	RETINITIS PIGMENTOSA, JUVENILE, SPATA7-RELATED	SPATA7, 1-BP DEL, 1546A	
609868	55812	SPATA7	0005	LEBER CONGENITAL AMAUROSIS 3	SPATA7, 4-BP DEL, 265CTCA	
609868	55812	SPATA7	0006	LEBER CONGENITAL AMAUROSIS 3	SPATA7, 3-BP DEL, 1227CAC	
609868	55812	SPATA7	0007	LEBER CONGENITAL AMAUROSIS 3	SPATA7, ARG85TER	
609875	220202	ATOH7	0001	RETINAL NONATTACHMENT, NONSYNDROMIC CONGENITAL	ATOH7, 6.5-KB DEL, -21.7 KB	
609883	54903	MKS1	0001	MECKEL SYNDROME, TYPE 1	MKS1, 29-BP DEL	
609883	54903	MKS1	0002	MECKEL SYNDROME, TYPE 1	MKS1, 5-BP INS, NT50	
609883	54903	MKS1	0003	MECKEL SYNDROME, TYPE 1	MKS1, IVS1, T-C, +2	
609883	54903	MKS1	0004	MECKEL SYNDROME, TYPE 1	MKS1, IVS11DS, G-A, +1	
609883	54903	MKS1	0005	MECKEL SYNDROME, TYPE 1	MKS1, 417G-A	
609883	54903	MKS1	0006	BARDET-BIEDL SYNDROME 13	MKS1, CYS492TRP	137853105
609883	54903	MKS1	0007	BARDET-BIEDL SYNDROME 13	MKS1, 3-BP DEL, PHE371	
609884	91147	TMEM67	0001	MECKEL SYNDROME, TYPE 3	TMEM67, 2-BP DEL, 383AC	
609884	91147	TMEM67	0002	MECKEL SYNDROME, TYPE 3	TMEM67, 1-BP DEL, 647A	
609884	91147	TMEM67	0003	MECKEL SYNDROME, TYPE 3	TMEM67, IVS8, A-G, -2	
609884	91147	TMEM67	0004	MECKEL SYNDROME, TYPE 3	TMEM67, GLN376PRO	137853106
609884	91147	TMEM67	0005	MECKEL SYNDROME, TYPE 3	TMEM67, IVS15, G-A, +1	
609884	91147	TMEM67	0006	JOUBERT SYNDROME 6 COACH SYNDROME, INCLUDED	TMEM67, TYR513CYS	137853107
609884	91147	TMEM67	0007	JOUBERT SYNDROME 6	TMEM67, 13-BP DEL, 2-BP INS	
609884	91147	TMEM67	0008	JOUBERT SYNDROME 6	TMEM67, IVS23+5G-C	
609884	91147	TMEM67	0009	JOUBERT SYNDROME 6	TMEM67, IVS6+2T-G	
609884	91147	TMEM67	0010	JOUBERT SYNDROME 6	TMEM67, GLY545GLU, 2341G-A	
609884	91147	TMEM67	0011	MECKEL SYNDROME, TYPE 3 JOUBERT SYNDROME 6, INCLUDED	TMEM67, ARG208TER	137853108
609884	91147	TMEM67	0012	BARDET-BIEDL SYNDROME 14, MODIFIER OF	TMEM67, SER320CYS	111619594
609884	91147	TMEM67	0013	COACH SYNDROME JOUBERT SYNDROME 6, INCLUDED	TMEM67, ILE833THR	
609884	91147	TMEM67	0014	COACH SYNDROME	TMEM67, IVS24DS, G-T, +1	
609884	91147	TMEM67	0015	COACH SYNDROME	TMEM67, IVS2DS, G-A, +5	
609884	91147	TMEM67	0016	COACH SYNDROME	TMEM67, PHE590SER	
609884	91147	TMEM67	0017	COACH SYNDROME	TMEM67, IVS19AS, A-C, -2	
609884	91147	TMEM67	0018	NEPHRONOPHTHISIS 11	TMEM67, GLY821SER	
609884	91147	TMEM67	0019	NEPHRONOPHTHISIS 11 JOUBERT SYNDROME 6, INCLUDED	TMEM67, CYS615ARG	
609884	91147	TMEM67	0020	NEPHRONOPHTHISIS 11	TMEM67, TRP290LEU	
609884	91147	TMEM67	0021	NEPHRONOPHTHISIS 11 JOUBERT SYNDROME 6, INCLUDED	TMEM67, GLY821ARG	
609884	91147	TMEM67	0022	JOUBERT SYNDROME 6	TMEM67, GLN44TER	
609884	91147	TMEM67	0023	JOUBERT SYNDROME 6	TMEM67, MET252THR	
609884	91147	TMEM67	0024	JOUBERT SYNDROME 6	TMEM67, PRO358LEU	
609922	23301	EHBP1	0001	PROSTATE CANCER, HEREDITARY, 12	EHBP1, IVS, A-G	721048
609927	137492	VPS37A	0001	SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	VPS37A, LYS382ASN	
609948	54476	RNF216	0001	CEREBELLAR ATAXIA AND HYPOGONADOTROPIC HYPOGONADISM	RNF216, ARG751CYS	
609948	54476	RNF216	0002	CEREBELLAR ATAXIA AND HYPOGONADOTROPIC HYPOGONADISM	RNF216, CYS597TER	
609948	54476	RNF216	0003	CEREBELLAR ATAXIA AND HYPOGONADOTROPIC HYPOGONADISM	RNF216, 2-BP DEL, 615GA	
610036	149461	CLDN19	0001	HYPOMAGNESEMIA 5, RENAL, WITH OCULAR INVOLVEMENT	CLDN19, GLY20ASP	118203979
610036	149461	CLDN19	0002	HYPOMAGNESEMIA 5, RENAL, WITH OCULAR INVOLVEMENT	CLDN19, GLN57GLU	118203980
610036	149461	CLDN19	0003	HYPOMAGNESEMIA 5, RENAL, WITH OCULAR INVOLVEMENT	CLDN19, LEU90PRO	118203981
610045	7915	ALDH5A1	0001	SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	ALDH5A1, IVS9, G-T, +1	
610045	7915	ALDH5A1	0002	SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	ALDH5A1, IVS5, G-A, +1	
610045	7915	ALDH5A1	0003	SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	ALDH5A1, TRP204TER	118203982
610045	7915	ALDH5A1	0004	SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	ALDH5A1, ARG412TER	118203983
610045	7915	ALDH5A1	0005	SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	ALDH5A1, GLY409ASP	118203984
610045	7915	ALDH5A1	0006	SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	ALDH5A1, EX7DEL	
610053	85378	TUBGCP6	0001	MICROCEPHALY WITH CHORIORETINOPATHY	TUBGCP6, TER1820GLY	
610055	54862	CC2D1A	0001	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 3	CC2D1A, IVS13-16DEL	
610057	9524	TECR	0001	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14	TECR, PRO182LEU	
610060	9533	POLR1C	0001	TREACHER COLLINS SYNDROME 3	POLR1C, ARG279GLN	
610060	9533	POLR1C	0002	TREACHER COLLINS SYNDROME 3	POLR1C, IVS8, 4-BP DEL, +3	
610060	9533	POLR1C	0003	TREACHER COLLINS SYNDROME 3	POLR1C, LYS327TER	
610060	9533	POLR1C	0004	TREACHER COLLINS SYNDROME 3	POLR1C, 1-BP DEL, 87T	
610060	9533	POLR1C	0005	TREACHER COLLINS SYNDROME 3	POLR1C, ARG279TRP	
610062	83544	DNAL1	0001	CILIARY DYSKINESIA, PRIMARY, 16	DNAL1, ASN150SER	
610079	54414	SIAE	0001	AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 6	SIAE, THR312MET	
610079	54414	SIAE	0002	AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 6	SIAE, CYS196PHE	
610079	54414	SIAE	0003	AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 6	SIAE, MET89VAL	78778622
610079	54414	SIAE	0004	AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 6	SIAE, PHE404SER	
610083	55714	TENM3	0001	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9	ODZ3, 1-BP DUP, 2083A	
610110	63982	ANO3	0001	DYSTONIA 24	ANO3, ARG494TRP	
610110	63982	ANO3	0002	DYSTONIA 24	ANO3, TRP490CYS	
610110	63982	ANO3	0003	DYSTONIA 24	ANO3, SER685GLY	
610110	63982	ANO3	0004	DYSTONIA 24	ANO3, LYS862ASN	
610113	54507	ADAMTSL4	0001	ECTOPIA LENTIS 2, ISOLATED, AUTOSOMAL RECESSIVE	ADAMTSL4, TYR595TER	118203985
610113	54507	ADAMTSL4	0002	ECTOPIA LENTIS 2, ISOLATED, AUTOSOMAL RECESSIVE	ADAMTSL4, IVS4, G-A, -1	
610113	54507	ADAMTSL4	0003	ECTOPIA LENTIS ET PUPILLAE ECTOPIA LENTIS 2, ISOLATED, AUTOSOMAL RECESSIVE, INCLUDED	ADAMTSL4, 20-BP DEL, NT767	
610113	54507	ADAMTSL4	0004	ECTOPIA LENTIS 2, ISOLATED, AUTOSOMAL RECESSIVE ECTOPIA LENTIS ET PUPILLAE, INCLUDED	ADAMTSL4, 11-BP DEL, NT826	
610113	54507	ADAMTSL4	0005	ECTOPIA LENTIS 2, ISOLATED, AUTOSOMAL RECESSIVE	ADAMTSL4, ARG670TER	
610113	54507	ADAMTSL4	0006	ECTOPIA LENTIS 2, ISOLATED, AUTOSOMAL RECESSIVE	ADAMTSL4, 1-BP DEL, 237C	
610113	54507	ADAMTSL4	0007	ECTOPIA LENTIS 2, ISOLATED, AUTOSOMAL RECESSIVE	ADAMTSL4, 1-BP DUP, 2270G	
610132	81839	VANGL1	0001	CAUDAL REGRESSION SYNDROME	VANGL1, VAL239ILE	121918218
610132	81839	VANGL1	0002	NEURAL TUBE DEFECTS	VANGL1, ARG274GLN	121918219
610132	81839	VANGL1	0003	NEURAL TUBE DEFECTS	VANGL1, MET328THR	121918220
610142	80184	CEP290	0001	JOUBERT SYNDROME 5	CEP290, GLY1890TER	137852832
610142	80184	CEP290	0002	JOUBERT SYNDROME 5	CEP290, 1-BP DEL, 4656A	
610142	80184	CEP290	0003	JOUBERT SYNDROME 5	CEP290, TRP7CYS	62635288
610142	80184	CEP290	0004	SENIOR-LOKEN SYNDROME 6	CEP290, 5-BP DEL	
610142	80184	CEP290	0005	LEBER CONGENITAL AMAUROSIS 10	CEP290, 2991+1655A-G	
610142	80184	CEP290	0006	LEBER CONGENITAL AMAUROSIS 10	CEP290, LEU750TER	137852833
610142	80184	CEP290	0007	JOUBERT SYNDROME 5 LEBER CONGENITAL AMAUROSIS 10, INCLUDED	CEP290, LYS1575TER	137852834
610142	80184	CEP290	0008	MECKEL SYNDROME, TYPE 4 LEBER CONGENITAL AMAUROSIS 10, INCLUDED	CEP290, 4-BP DEL, 384TAGA	
610142	80184	CEP290	0009	MECKEL SYNDROME, TYPE 4	CEP290, EX3, T-A, +2	
610142	80184	CEP290	0010	MECKEL SYNDROME, TYPE 4	CEP290, ARG205TER	137852835
610142	80184	CEP290	0011	LEBER CONGENITAL AMAUROSIS 10	CEP290, 5-BP DEL, 1260TAAAG	
610142	80184	CEP290	0012	MECKEL SYNDROME, TYPE 4	CEP290, 1-BP DEL, 5489A	
610142	80184	CEP290	0013	BARDET-BIEDL SYNDROME 14	CEP290, GLU1903TER	
610148	79738	BBS10	0001	BARDET-BIEDL SYNDROME 10	C10ORF58, 1-BP DUP, 271T	
610148	79738	BBS10	0002	BARDET-BIEDL SYNDROME 10	C12ORF58, ARG34PRO	137852836
610148	79738	BBS10	0003	BARDET-BIEDL SYNDROME 10	C12ORF58, SER303 FS	
610148	79738	BBS10	0004	BARDET-BIEDL SYNDROME 10	C12ORF58, SER311ALA	137852837
610148	79738	BBS10	0005	BARDET-BIEDL SYNDROME 10	C12ORF58, VAL11GLY	137852838
610148	79738	BBS10	0006	BARDET-BIEDL SYNDROME 10	C12ORF58, 2-BP DEL, 1044	
610148	79738	BBS10	0007	BARDET-BIEDL SYNDROME 10	C10ORF58, CYS91TRP	
610150	22948	CCT5	0001	NEUROPATHY, HEREDITARY SENSORY, WITH SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE	CCT5, HIS147ARG	118203986
610162	79140	CCDC28B	0001	BARDET-BIEDL SYNDROME, MODIFIER OF	CCDC28B, 430C-T	
610192	169792	GLIS3	0001	DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM	GLIS3, 1-BP INS, 2067C	
610194	148789	B3GALNT2	0001	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11	B3GALNT2, GLY247GLU	
610194	148789	B3GALNT2	0002	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11	B3GALNT2, ARG292PRO	
610194	148789	B3GALNT2	0003	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11	B3GALNT2, 2-BP DEL, NT308	
610194	148789	B3GALNT2	0004	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11	B3GALNT2, VAL252GLY	
610194	148789	B3GALNT2	0005	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11	B3GALNT2, VAL268MET	
610194	148789	B3GALNT2	0006	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11	B3GALNT2, GLN475TER	
610197	81857	MED25	0001	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B2	MED25, ALA335VAL	
610206	83959	SLC4A11	0001	CORNEAL ENDOTHELIAL DYSTROPHY 2	SLC4A11, ARG755GLN	121909387
610206	83959	SLC4A11	0002	CORNEAL ENDOTHELIAL DYSTROPHY 2	SLC4A11, SER489LEU	121909388
610206	83959	SLC4A11	0003	CORNEAL ENDOTHELIAL DYSTROPHY 2	SLC4A11, GLY464ASP	121909389
610206	83959	SLC4A11	0004	CORNEAL ENDOTHELIAL DYSTROPHY 2	SLC4A11, ARG605TER	121909390
610206	83959	SLC4A11	0005	CORNEAL ENDOTHELIAL DYSTROPHY 2	SLC4A11, 4-BP DEL	
610206	83959	SLC4A11	0006	CORNEAL ENDOTHELIAL DYSTROPHY 2	SLC4A11, ARG869CYS	121909391
610206	83959	SLC4A11	0007	CORNEAL ENDOTHELIAL DYSTROPHY 2	SLC4A11, IVS15AS, -6, DEL/INS	
610206	83959	SLC4A11	0008	CORNEAL ENDOTHELIAL DYSTROPHY 2	SLC4A11, ARG869HIS	121909392
610206	83959	SLC4A11	0009	CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS	SLC4A11, 8-BP DEL, NT473	
610206	83959	SLC4A11	0010	CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS	SLC4A11, 4-BP DEL/1-BP INS, NT460	
610206	83959	SLC4A11	0011	CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS	SLC4A11, ARG488LYS	121909393
610206	83959	SLC4A11	0012	CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS	SLC4A11, LEU843PRO	121909394
610206	83959	SLC4A11	0013	CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS	SLC4A11, 8-BP DUP, NT2233	
610206	83959	SLC4A11	0014	CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS	SLC4A11, 32-BP DEL, NT2423	
610206	83959	SLC4A11	0015	CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS	SLC4A11, SER213PRO	121909395
610206	83959	SLC4A11	0016	CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS	SLC4A11, MET856VAL	121909396
610206	83959	SLC4A11	0017	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 4	SLC4A11, GLY709GLU	
610206	83959	SLC4A11	0018	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 4	SLC4A11, THR754MET	
610206	83959	SLC4A11	0019	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 4	SLC4A11, 2-BP DEL, 99TC	
610206	83959	SLC4A11	0020	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 4	SLC4A11, GLU399LYS	
610219	494513	DFNB59	0001	DEAFNESS, AUTOSOMAL RECESSIVE 59	DFNB59, ARG183TRP	111706634
610219	494513	DFNB59	0002	DEAFNESS, AUTOSOMAL RECESSIVE 59	DFNB59, THR54ILE	118203988
610219	494513	DFNB59	0003	DEAFNESS, AUTOSOMAL RECESSIVE 59	DFNB59, 1-BP INS, 113T	
610219	494513	DFNB59	0004	DEAFNESS, AUTOSOMAL RECESSIVE 59	DFNB59, ARG167TER	118203989
610219	494513	DFNB59	0005	DEAFNESS, AUTOSOMAL RECESSIVE 59	DFNB59, 1-BP DEL, 726T	
610219	494513	DFNB59	0006	DEAFNESS, AUTOSOMAL RECESSIVE 59	DFNB59, 1-BP DEL, 988G	
610219	494513	DFNB59	0007	DEAFNESS, AUTOSOMAL RECESSIVE 59	DFNB59, 1-BP DEL, 122A	
610222	54453	RIN2	0001	MACROCEPHALY, ALOPECIA, CUTIS LAXA, AND SCOLIOSIS	RIN2, 1-BP DEL, 1731C	
610222	54453	RIN2	0002	MACROCEPHALY, ALOPECIA, CUTIS LAXA, AND SCOLIOSIS	RIN2, 2-BP DEL, 1914GC	
610226	79755	ZNF750	0001	SEBORRHEA-LIKE DERMATITIS WITH PSORIASIFORM ELEMENTS	ZNF750, 2-BP DUP, 56CC	
610226	79755	ZNF750	0002	VARIANT OF UNKNOWN SIGNIFICANCE	ZNF750, -625A-C	
610230	55687	TRMU	0001	DEAFNESS, MITOCHONDRIAL, MODIFIER OF	TRMU, 28G-T, ALA10SER	11090865
610230	55687	TRMU	0002	LIVER FAILURE, INFANTILE, TRANSIENT	TRMU, TYR77HIS	118203990
610230	55687	TRMU	0003	LIVER FAILURE, INFANTILE, TRANSIENT	TRMU, IVS3AS, G-A, -1	
610230	55687	TRMU	0004	LIVER FAILURE, INFANTILE, TRANSIENT	TRMU, GLY272ASP	118203991
610230	55687	TRMU	0005	LIVER FAILURE, INFANTILE, TRANSIENT	TRMU, MET1LYS	118203992
610230	55687	TRMU	0006	LIVER FAILURE, INFANTILE, TRANSIENT	TRMU, VAL279MET	
610230	55687	TRMU	0007	LIVER FAILURE, INFANTILE, TRANSIENT	TRMU, IVS11AS, C-G, -3	
610243	118813	ZFYVE27	0001	SPASTIC PARAPLEGIA 33, AUTOSOMAL DOMINANT	ZFYVE27, GLY191VAL	35077384
610273	93183	PIGM	0001	GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	PIGM, -270C-G	
610274	55650	PIGV	0001	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 1	PIGV, ALA341GLU	
610274	55650	PIGV	0002	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 1	PIGV, HIS385PRO	
610274	55650	PIGV	0003	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 1	PIGV, GLN256LYS	
610274	55650	PIGV	0004	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 1	PIGV, ALA341VAL	
610274	55650	PIGV	0005	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 1	PIGV, CYS156TYR	
610277	84876	ORAI1	0001	IMMUNE DYSFUNCTION WITH T-CELL INACTIVATION DUE TO CALCIUM ENTRY DEFECT 1	ORAI1, ARG91TRP	118203993
610285	285489	DOK7	0001	MYASTHENIA, LIMB-GIRDLE, FAMILIAL	DOK7, 4-BP DUP, 1124TGCC	
610285	285489	DOK7	0002	MYASTHENIA, LIMB-GIRDLE, FAMILIAL	DOK7, 1-BP INS, 1263C	
610285	285489	DOK7	0003	MYASTHENIA, LIMB-GIRDLE, FAMILIAL	DOK7, 4-BP DEL, 548TCCT	
610285	285489	DOK7	0004	MYASTHENIA, LIMB-GIRDLE, FAMILIAL	DOK7, 4-BP DUP, 1339CTGG	
610285	285489	DOK7	0005	MYASTHENIA, LIMB-GIRDLE, FAMILIAL	DOK7, 1-BP INS, 1143C	
610285	285489	DOK7	0006	MYASTHENIA, LIMB-GIRDLE, FAMILIAL	DOK7, GLY180ALA	118203994
610285	285489	DOK7	0007	MYASTHENIA, LIMB-GIRDLE, FAMILIAL	DOK7, ARG201TER	118203995
610285	285489	DOK7	0008	MYASTHENIA, LIMB-GIRDLE, FAMILIAL	DOK7, IVS2, G-T, -1	
610285	285489	DOK7	0009	MYASTHENIA, LIMB-GIRDLE, FAMILIAL FETAL AKINESIA DEFORMATION SEQUENCE, INCLUDED	DOK7, IVS3DS, G-T, +1	
610285	285489	DOK7	0010	MYASTHENIA, LIMB-GIRDLE, FAMILIAL	DOK7, 1-BP INS, 1378C	
610290	79695	GALNT12	0001	COLORECTAL CANCER, SUSCEPTIBILITY TO, 1	GALNT12, MET1ILE	
610290	79695	GALNT12	0002	COLORECTAL CANCER, SUSCEPTIBILITY TO, 1	GALNT12, THR491MET	
610290	79695	GALNT12	0003	COLORECTAL CANCER, SUSCEPTIBILITY TO, 1	GALNT12, TYR395TER	
610292	55024	BANK1	0001	SYSTEMIC LUPUS ERYTHMATOSUS, ASSOCIATION WITH	BANK1, ARG61HIS	10516487
610308	145173	B3GALTL	0001	PETERS-PLUS SYNDROME	B3GALTL, IVS8, G-A, +1	80338851
610308	145173	B3GALTL	0002	PETERS-PLUS SYNDROME	B3GALTL, IVS5, G-A, +5	80338850
610308	145173	B3GALTL	0003	PETERS-PLUS SYNDROME	B3GALTL, IVS6, G-A, +1	
610308	145173	B3GALTL	0004	PETERS-PLUS SYNDROME	B3GALTL, 1-BP INS, 230T	
610308	145173	B3GALTL	0005	PETERS-PLUS SYNDROME	B3GALTL, GLY393GLU	
610316	87178	PNPT1	0001	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13	PNPT1, GLN387ARG	
610316	87178	PNPT1	0002	DEAFNESS, AUTOSOMAL RECESSIVE 70	PNPT1, GLU475GLY	
610326	79621	RNASEH2B	0001	AICARDI-GOUTIERES SYNDROME 2	RNASEH2B, ALA177THR	75184679
610326	79621	RNASEH2B	0002	AICARDI-GOUTIERES SYNDROME 2	RNASEH2B, VAL185GLY	74555752
610330	84153	RNASEH2C	0001	AICARDI-GOUTIERES SYNDROME 3	RNASEH2C, ARG69TRP	78635798
610330	84153	RNASEH2C	0002	AICARDI-GOUTIERES SYNDROME 3	RNASEH2C, LYS143ILE	75146158
610339	64175	LEPRE1	0001	OSTEOGENESIS IMPERFECTA, TYPE VIII	LEPRE1, IVS5, G-T, +1	
610339	64175	LEPRE1	0002	OSTEOGENESIS IMPERFECTA, TYPE VIII	LEPRE1, IVS9, G-T, +1	
610339	64175	LEPRE1	0003	OSTEOGENESIS IMPERFECTA, TYPE VIII	LEPRE1, 1-BP DEL, 747C	
610339	64175	LEPRE1	0004	OSTEOGENESIS IMPERFECTA, TYPE VIII	LEPRE1, TYR552TER	72659355
610339	64175	LEPRE1	0005	OSTEOGENESIS IMPERFECTA, TYPE VIII	LEPRE1, 2-BP DEL/1-BP INS, NT1365	
610339	64175	LEPRE1	0006	OSTEOGENESIS IMPERFECTA, TYPE VIII	LEPRE1, ARG368TER	118203996
610339	64175	LEPRE1	0007	OSTEOGENESIS IMPERFECTA, TYPE VIII	LEPRE1, IVS14, G-A, +18	
610341	55214	LEPREL1	0001	MYOPIA, HIGH, WITH CATARACT AND VITREORTINAL DEGENERATION	LEPREL1, GLY508VAL	
610345	55750	AGK	0001	SENGERS SYNDROME	AGK, IVS3DS, T-C, +2	
610345	55750	AGK	0002	SENGERS SYNDROME	AGK, TYR390TER	
610345	55750	AGK	0003	SENGERS SYNDROME	AGK, IVS13DS, G-T, +1	
610345	55750	AGK	0004	SENGERS SYNDROME	AGK, MET1ILE	
610345	55750	AGK	0005	SENGERS SYNDROME	AGK, GLN173TER	
610345	55750	AGK	0006	SENGERS SYNDROME	AGK, TYR102TER	
610345	55750	AGK	0007	SENGERS SYNDROME	AGK, ARG281TER	
610345	55750	AGK	0008	SENGERS SYNDROME	AGK, TYR224TER	
610345	55750	AGK	0009	SENGERS SYNDROME	AGK, IVS16DS, G-A, +5	
610345	55750	AGK	0010	CATARACT, AUTOSOMAL RECESSIVE CONGENITAL 5	AGK, 424-3C-G	
610355	79728	PALB2	0001	FANCONI ANEMIA, COMPLEMENTATION GROUP N	PALB2, TYR551TER	118203997
610355	79728	PALB2	0002	FANCONI ANEMIA, COMPLEMENTATION GROUP N	PALB2, EX 2-6 DEL	
610355	79728	PALB2	0003	FANCONI ANEMIA, COMPLEMENTATION GROUP N BREAST CANCER, SUSCEPTIBILITY TO, INCLUDED	PALB2, TYR1183TER	118203998
610355	79728	PALB2	0004	FANCONI ANEMIA, COMPLEMENTATION GROUP N BREAST CANCER, SUSCEPTIBILITY TO, INCLUDED	PALB2, GLN988TER	118203999
610355	79728	PALB2	0005	FANCONI ANEMIA, COMPLEMENTATION GROUP N BREAST CANCER, SUSCEPTIBILITY TO, INCLUDED	PALB2, 1-BP DEL, 3116A	
610355	79728	PALB2	0006	BREAST CANCER, SUSCEPTIBILITY TO	PALB2, 1-BP DEL, 1592T	
610355	79728	PALB2	0007	PANCREATIC CANCER, SUSCEPTIBILITY TO, 3	PALB2, 4-BP DEL, 172TTGT	
610355	79728	PALB2	0008	PANCREATIC CANCER, SUSCEPTIBILITY TO, 3	PALB2, IVS5, G-T, -1	
610355	79728	PALB2	0009	PANCREATIC CANCER, SUSCEPTIBILITY TO, 3	PALB2, 1-BP DEL, 3116A	
610355	79728	PALB2	0010	PANCREATIC CANCER, SUSCEPTIBILITY TO, 3	PALB2, 3256C-T	
610362	84839	RAX2	0001	MACULAR DEGENERATION, AGE-RELATED, 6	RAXL1, ARG87GLN	121908280
610362	84839	RAX2	0002	CONE-ROD DYSTROPHY 11	RAXL1, GLY137ARG	121908281
610362	84839	RAX2	0003	CONE-ROD DYSTROPHY 11	RAXL1, 6-BP INS	
610389	28956	LAMTOR2	0001	IMMUNODEFICIENCY DUE TO DEFECT IN MAPBP-INTERACTING PROTEIN	MAPBPIP, IVS4DS, C-A, +23, 3-PRIME UTR	
610436	25914	RTTN	0001	POLYMICROGYRIA WITH SEIZURES	RTTN, LEU932PHE	
610436	25914	RTTN	0002	POLYMICROGYRIA WITH SEIZURES	RTTN, CYS27TYR	
610453	138050	HGSNAT	0001	MUCOPOLYSACCHARIDOSIS TYPE IIIC	HGSNAT, IVS4, G-A, +1	
610453	138050	HGSNAT	0002	MUCOPOLYSACCHARIDOSIS TYPE IIIC	HGSNAT, 1-BP INS, 1345G	
610453	138050	HGSNAT	0003	MUCOPOLYSACCHARIDOSIS TYPE IIIC	HGSNAT, PRO311LEU	121908282
610453	138050	HGSNAT	0004	MUCOPOLYSACCHARIDOSIS TYPE IIIC	HGSNAT, LEU349TER	121908283
610453	138050	HGSNAT	0005	MUCOPOLYSACCHARIDOSIS TYPE IIIC	HGSNAT, MET510LYS	121908284
610453	138050	HGSNAT	0006	MUCOPOLYSACCHARIDOSIS TYPE IIIC	HGSNAT, 1-BP INS, 525T	
610453	138050	HGSNAT	0007	MUCOPOLYSACCHARIDOSIS TYPE IIIC	HGSNAT, IVS3AS, A-G, -2	
610453	138050	HGSNAT	0008	MUCOPOLYSACCHARIDOSIS TYPE IIIC	HGSNAT, ARG344CYS	121908285
610453	138050	HGSNAT	0009	MUCOPOLYSACCHARIDOSIS TYPE IIIC	HGSNAT, SER518PHE	121908286
610453	138050	HGSNAT	0010	MUCOPOLYSACCHARIDOSIS TYPE IIIC	HGSNAT, IVS2DS, G-A, +1	
610456	54809	SAMD9	0001	TUMORAL CALCINOSIS, FAMILIAL, NORMOPHOSPHATEMIC	SAMD9, LYS1495GLU	121918554
610511	10484	SEC23A	0001	CRANIOLENTICULOSUTURAL DYSPLASIA	SEC23A, PHE382LEU	118204000
610511	10484	SEC23A	0002	CRANIOLENTICULOSUTURAL DYSPLASIA	SEC23A, MET702VAL	
610512	10483	SEC23B	0001	ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE II	SEC23B, GLU109LYS	121918221
610512	10483	SEC23B	0002	ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE II	SEC23B, ARG14TRP	121918222
610512	10483	SEC23B	0003	ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE II	SEC23B, ARG530TRP	121918223
610512	10483	SEC23B	0004	ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE II	SEC23B, ARG264TER	121918224
610512	10483	SEC23B	0005	ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE II	SEC23B, ARG324TER	121918225
610512	10483	SEC23B	0006	ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE II	SEC23B, ARG217TER	121918226
610513	23400	ATP13A2	0001	KUFOR-RAKEB SYNDROME	ATP13A2, 1-BP DEL, 3057C	
610513	23400	ATP13A2	0002	KUFOR-RAKEB SYNDROME	ATP13A2, IVS13, G-A, +5	
610513	23400	ATP13A2	0003	KUFOR-RAKEB SYNDROME	ATP13A2, 22-BP DUP	
610513	23400	ATP13A2	0004	KUFOR-RAKEB SYNDROME	ATP13A2, GLY504ARG	121918227
610513	23400	ATP13A2	0005	KUFOR-RAKEB SYNDROME	ATP13A2, 2-BP INS, 1103GA	
610513	23400	ATP13A2	0006	KUFOR-RAKEB SYNDROME	ATP13A2, 2-BP DEL, 2742TT	
610516	132158	GLYCTK	0001	D-GLYCERIC ACIDURIA	GLYCTK, 1-BP DEL, 1448T	
610516	132158	GLYCTK	0002	D-GLYCERIC ACIDURIA	GLYCTK, PHE493CYS	
610516	132158	GLYCTK	0003	D-GLYCERIC ACIDURIA	GLYCTK, 1-BP DEL, 1558C	
610523	95681	CEP41	0001	JOUBERT SYNDROME 15	CEP41, IVS1DS, T-G, +2	
610523	95681	CEP41	0002	JOUBERT SYNDROME 15	CEP41, 3-BP DEL, IVS1DS, 97GAG	
610523	95681	CEP41	0003	JOUBERT SYNDROME 15	CEP41, IVS6AS, A-C, -2	
610523	95681	CEP41	0004	JOUBERT SYNDROME 12/15, DIGENIC	CEP41, ARG179HIS	
610523	95681	CEP41	0005	JOUBERT SYNDROME 9/15, DIGENIC	CEP41, MET36THR	
610523	95681	CEP41	0006	JOUBERT SYNDROME 9/15, DIGENIC	CEP41, ARG360CYS	
610523	95681	CEP41	0007	JOUBERT SYNDROME 15	CEP41, SER28TER	
610528	57680	CHD8	0001	AUTISM, SUSCEPTIBILITY TO, 18	CHD8, SER62TER	
610528	57680	CHD8	0002	AUTISM, SUSCEPTIBILITY TO, 18	CHD8, 1-BP INS, T	
610528	57680	CHD8	0003	AUTISM, SUSCEPTIBILITY TO, 18	CHD8, NT3519, A-G, -2	
610528	57680	CHD8	0004	AUTISM, SUSCEPTIBILITY TO, 18	CHD8, GLN1238TER	
610528	57680	CHD8	0005	AUTISM, SUSCEPTIBILITY TO, 18	CHD8, ARG1337TER	
610528	57680	CHD8	0006	AUTISM, SUSCEPTIBILITY TO, 18	CHD8, 4-BP DEL, CTTC	
610528	57680	CHD8	0007	AUTISM, SUSCEPTIBILITY TO, 18	CHD8, 2-BP DEL, CT	
610528	57680	CHD8	0008	AUTISM, SUSCEPTIBILITY TO, 18	CHD8, 1-BP INS, T	
610528	57680	CHD8	0009	AUTISM, SUSCEPTIBILITY TO, 18	CHD8, 3-BP DEL, GGT	
610531	84668	FAM126A	0001	LEUKODYSTROPHY, HYPOMYELINATING, 5	FAM126A, IVS2, G-A, +1	72549405
610531	84668	FAM126A	0002	LEUKODYSTROPHY, HYPOMYELINATING, 5	FAM126A, IVS5, G-T, +1	72549406
610531	84668	FAM126A	0003	LEUKODYSTROPHY, HYPOMYELINATING, 5	FAM126A, LEU53PRO	72549407
610531	84668	FAM126A	0004	LEUKODYSTROPHY, HYPOMYELINATING, 5	FAM126A, 4-KB DEL	
610533	23286	WWC1	0001	MEMORY, ENHANCED, ASSOCIATION WITH	WWC1, IVS9, C-T	17070145
610540	149775	GNAS-AS1	0001	PSEUDOHYPOPARATHYROIDISM, TYPE IB	GNASAS, 4.7-KB DEL	
610550	4143	MAT1A	0001	METHIONINE ADENOSYLTRANSFERASE DEFICIENCY, AUTOSOMAL RECESSIVE	MAT1A, ILE322MET	118204001
610550	4143	MAT1A	0002	METHIONINE ADENOSYLTRANSFERASE DEFICIENCY, AUTOSOMAL RECESSIVE	MAT1A, ALA55ASP	118204002
610550	4143	MAT1A	0003	METHIONINE ADENOSYLTRANSFERASE DEFICIENCY, AUTOSOMAL RECESSIVE	MAT1A, PRO357LEU	118204003
610550	4143	MAT1A	0004	METHIONINE ADENOSYLTRANSFERASE DEFICIENCY, AUTOSOMAL RECESSIVE	MAT1A, LEU305PRO	118204004
610550	4143	MAT1A	0005	METHIONINE ADENOSYLTRANSFERASE DEFICIENCY, AUTOSOMAL RECESSIVE	MAT1A, 1-BP INS, 827G	
610550	4143	MAT1A	0006	METHIONINE ADENOSYLTRANSFERASE DEFICIENCY, AUTOSOMAL RECESSIVE	MAT1A, 2-BP DEL, 1043TG	
610550	4143	MAT1A	0007	METHIONINE ADENOSYLTRANSFERASE DEFICIENCY, AUTOSOMAL DOMINANT	MAT1A, ARG264HIS	72558181
610550	4143	MAT1A	0008	METHIONINE ADENOSYLTRANSFERASE DEFICIENCY, AUTOSOMAL RECESSIVE	MAT1A, 2-BP INS, 539TG	
610550	4143	MAT1A	0009	METHIONINE ADENOSYLTRANSFERASE DEFICIENCY, AUTOSOMAL RECESSIVE	MAT1A, ARG264CYS	118204005
610550	4143	MAT1A	0010	METHIONINE ADENOSYLTRANSFERASE DEFICIENCY, AUTOSOMAL RECESSIVE	MAT1A, GLY336ARG	118204006
610564	57107	PDSS2	0001	COENZYME Q10 DEFICIENCY, PRIMARY, 3	PDSS2, GLN322TER	118203955
610564	57107	PDSS2	0002	COENZYME Q10 DEFICIENCY, PRIMARY, 3	PDSS2, SER382LEU	118203956
610564	57107	PDSS2	0003	REMOVED FROM DATABASE *FIELD* RF 1. Lopez, L. C.; Schuelke, M.; Quinzii, C. M.; Kanki, T.; Rodenburg, R. J. T.; Naini, A.; DiMauro, S.; Hirano, M.: Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase	subunit 2 (PDSS2) mutations. Am. J. Hum. Genet. 79: 1125-1129, 2006.	
610572	153562	MARVELD2	0001	DEAFNESS, AUTOSOMAL RECESSIVE 49	MARVELD2, IVS3AS, G-A, -1	
610572	153562	MARVELD2	0002	DEAFNESS, AUTOSOMAL RECESSIVE 49	MARVELD2, 4-BP DEL, IVS4+2TGAG	
610572	153562	MARVELD2	0003	DEAFNESS, AUTOSOMAL RECESSIVE 49	MARVELD2, IVS4DS, T-C, +2	
610572	153562	MARVELD2	0004	DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 49	MARVELD2, ARG500TER	118203957
610572	153562	MARVELD2	0005	DEAFNESS, AUTOSOMAL RECESSIVE 49	MARVELD2, IVS4DS, G-A, +1	
610573	343637	RSPO4	0001	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 4	RSPO4, GLN65ARG	74315420
610573	343637	RSPO4	0002	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 4	RSPO4, CYS107ARG	74315421
610573	343637	RSPO4	0003	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 4	RSPO4, CYS118TYR	74315422
610573	343637	RSPO4	0004	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 4	RSPO4, CYS73TYR	74315423
610573	343637	RSPO4	0005	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 4	RSPO4, 1-BP INS, 92G	
610573	343637	RSPO4	0006	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 4	RSPO4, GLN101TER	
610573	343637	RSPO4	0007	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 4	RSPO4, ARG64CYS	
610573	343637	RSPO4	0008	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 4	RSPO4, GLY67ARG	
610576	64333	ARHGAP9	0001	CORONARY ARTERY SPASM 3, SUSCEPTIBILITY TO	ARHGAP9, ALA370SER	11544238
610598	768206	PRCD	0001	RETINITIS PIGMENTOSA 36	PRCD, CYS2TYR	121918369
610598	768206	PRCD	0002	RETINITIS PIGMENTOSA 36	PRCD, ARG22TER	
610613	1584	CYP11B1	0001	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASE DEFICIENCY	CYP11B1, ARG448HIS	28934586
610613	1584	CYP11B1	0002	GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM	CYP11B1, CYP11B1/CYP11B2 ANTI-LEPORE-LIKE CHIMERA	
610613	1584	CYP11B1	0003	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASE DEFICIENCY	CYP11B1, THR318MET	104894061
610613	1584	CYP11B1	0004	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASE DEFICIENCY	CYP11B1, ARG374GLN	104894062
610613	1584	CYP11B1	0005	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASE DEFICIENCY	CYP11B1, 2-BP INS	
610613	1584	CYP11B1	0006	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASE DEFICIENCY	CYP11B1, TRP116TER	104894066
610613	1584	CYP11B1	0007	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASE DEFICIENCY	CYP11B1, ASN133HIS	104894067
610613	1584	CYP11B1	0008	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASE DEFICIENCY	CYP11B1, THR319MET	104894068
610613	1584	CYP11B1	0009	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASE DEFICIENCY	CYP11B1, PRO42SER	104894069
610613	1584	CYP11B1	0010	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASE DEFICIENCY	CYP11B1, 954G-A	
610613	1584	CYP11B1	0011	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASE DEFICIENCY	CYP11B1, IVS8, A-G, +4	
610613	1584	CYP11B1	0012	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASE DEFICIENCY	CYP11B1, CYP11B1/CYP11B2 CHIMERA	
610613	1584	CYP11B1	0013	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASE DEFICIENCY	CYP11B1, IVS3DS, G-T, +16	
610613	1584	CYP11B1	0014	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASE DEFICIENCY	CYP11B1, CYP11B1/CYP11B2 CHIMERA	
610613	1584	CYP11B1	0015	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASE DEFICIENCY	CYP11B1, TYR423TER	
610613	1584	CYP11B1	0016	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASE DEFICIENCY	CYP11B1, PRO94LEU	104894070
610613	1584	CYP11B1	0017	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASE DEFICIENCY	CYP11B1, ALA368ASP	104894071
610619	2161	F12	0001	FACTOR XII (WASHINGTON D.C.)	F12, CYS571SER	
610619	2161	F12	0002	FACTOR XII (LOCARNO)	F12, ARG353PRO	118204454
610619	2161	F12	0003	FACTOR XII DEFICIENCY	F12, IVS13, 11396G-A, -1	
610619	2161	F12	0004	FACTOR XII POLYMORPHISM	F12, 46C-T	1801020
610619	2161	F12	0005	FACTOR XII (TENRI)	F12, TYR34CYS	118204455
610619	2161	F12	0006	ANGIOEDEMA, HEREDITARY, TYPE III	F12, THR309LYS	118204456
610619	2161	F12	0007	ANGIOEDEMA, HEREDITARY, TYPE III	F12, THR309ARG	118204456
610622	80199	FUZ	0001	NEURAL TUBE DEFECTS	FUZZY, PRO39SER	
610622	80199	FUZ	0002	NEURAL TUBE DEFECTS	FUZZY, ASP354TYR	
610622	80199	FUZ	0003	NEURAL TUBE DEFECTS	FUZZY, ARG404GLU	
610635	115908	CTHRC1	0001	BARRETT ESOPHAGUS/ESOPHAGEAL ADENOCARCINOMA	CTHRC1, GLN44PRO	
610647	339983	NAT8L	0001	N-ACETYLASPARTATE DEFICIENCY	NAT8L, 19-BP DEL, NT213	
610657	9897	KIAA0196	0001	SPASTIC PARAPLEGIA 8, AUTOSOMAL DOMINANT	KIAA0196, VAL626PHE	80338867
610657	9897	KIAA0196	0002	SPASTIC PARAPLEGIA 8, AUTOSOMAL DOMINANT	KIAA0196, LEU619PHE	80338866
610657	9897	KIAA0196	0003	SPASTIC PARAPLEGIA 8, AUTOSOMAL DOMINANT	KIAA0196, ASN471ASP	80338865
610661	55768	NGLY1	0001	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iv (1 family)	NGLY1, 1-BP DEL, 1891C	
610661	55768	NGLY1	0002	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iv (1 family)	NGLY1, ARG401TER	
610665	2215	FCGR3B	0001	NEUTROPHIL-SPECIFIC ANTIGENS NA1/NA2	FCGR3B, ARG36SER, ASN65SER, ASP82ASN, AND VAL106ILE	
610670	113612	CYP2U1	0001	SPASTIC PARAPLEGIA 56, AUTOSOMAL RECESSIVE	CYP2U1, ASP316VAL	
610670	113612	CYP2U1	0002	SPASTIC PARAPLEGIA 56, AUTOSOMAL RECESSIVE	CYP2U1, GLU380GLY	
610670	113612	CYP2U1	0003	SPASTIC PARAPLEGIA 56, AUTOSOMAL RECESSIVE	CYP2U1, 13-BP DEL, NT61	
610670	113612	CYP2U1	0004	SPASTIC PARAPLEGIA 56, AUTOSOMAL RECESSIVE	CYP2U1, CYS262ARG	
610670	113612	CYP2U1	0005	SPASTIC PARAPLEGIA 56, AUTOSOMAL RECESSIVE	CYP2U1, ARG488TRP	
610681	5213	PFKM	0001	GLYCOGEN STORAGE DISEASE VII	PFKM, IVS15DS, G-T, +1	
610681	5213	PFKM	0002	GLYCOGEN STORAGE DISEASE VII	PFKM, IVS6AS, A-C, -2	
610681	5213	PFKM	0003	GLYCOGEN STORAGE DISEASE VII	PFKM, ARG39PRO	121918193
610681	5213	PFKM	0004	GLYCOGEN STORAGE DISEASE VII	PFKM, ASP543ALA	121918194
610681	5213	PFKM	0005	GLYCOGEN STORAGE DISEASE VII	PFKM, IVS5DS, G-A, +1	
610681	5213	PFKM	0006	GLYCOGEN STORAGE DISEASE VII	PFKM, ARG39LEU	
610681	5213	PFKM	0007	GLYCOGEN STORAGE DISEASE VII	PFKM, ARG95TER	121918195
610681	5213	PFKM	0008	GLYCOGEN STORAGE DISEASE VII	PFKM, TRP686CYS	121918196
610681	5213	PFKM	0010	GLYCOGEN STORAGE DISEASE VII	PFKM, 1-BP DEL, 2003C	
610683	166379	BBS12	0001	BARDET-BIEDL SYNDROME 12	BBS12, ARG355TER	121918327
610683	166379	BBS12	0002	BARDET-BIEDL SYNDROME 12	BBS12, 3-BP DEL, 335TAG	
610683	166379	BBS12	0003	BARDET-BIEDL SYNDROME 12	BBS12, 2-BP DEL, 1483GA	
610683	166379	BBS12	0004	BARDET-BIEDL SYNDROME 12	BBS12, ALA289PRO	121918328
610683	166379	BBS12	0005	BARDET-BIEDL SYNDROME 12	BBS12, 2-BP DEL, 1114TT	
610690	26275	HIBCH	0001	3-@HYDROXYISOBUTYRYL-CoA HYDROLASE DEFICIENCY	HIBCH, IVS3AS, T-G, -9	
610690	26275	HIBCH	0002	3-@HYDROXYISOBUTYRYL-CoA HYDROLASE DEFICIENCY	HIBCH, TYR122CYS	121918329
610690	26275	HIBCH	0003	3-@HYDROXYISOBUTYRYL-CoA HYDROLASE DEFICIENCY	HIBCH, IVS2AS, C-G, -3	
610693	219844	HYLS1	0001	HYDROLETHALUS SYNDROME	HYLS1, ASP211GLY	104894232
610745	64220	STRA6	0001	MICROPHTHALMIA, SYNDROMIC 9	STRA6, PRO293LEU	118203958
610745	64220	STRA6	0002	MICROPHTHALMIA, SYNDROMIC 9	STRA6, 1-BP DEL, 145C	
610745	64220	STRA6	0003	MICROPHTHALMIA, SYNDROMIC 9	STRA6, ARG655CYS	118203959
610745	64220	STRA6	0004	MICROPHTHALMIA, SYNDROMIC 9	STRA6, THR644MET	118203960
610745	64220	STRA6	0005	MICROPHTHALMIA, SYNDROMIC 9	STRA6, PRO90LEU	118203961
610745	64220	STRA6	0006	MICROPHTHALMIA, SYNDROMIC 9	STRA6, THR321PRO	118203962
610745	64220	STRA6	0007	MICROPHTHALMIA, SYNDROMIC 9	STRA6, 3-BP DEL/2-BP INS	
610745	64220	STRA6	0008	MICROPHTHALMIA, SYNDROMIC 9	STRA6, 1-BP INS, 527G	
610745	64220	STRA6	0009	MICROPHTHALMIA, SYNDROMIC 9	STRA6, 2-BP INS, 277CC	
610745	64220	STRA6	0010	MICROPHTHALMIA, SYNDROMIC 9	STRA6, TRP23TER	
610745	64220	STRA6	0011	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 8 MICROPHTHALMIA, SYNDROMIC 9, INCLUDED	STRA6, GLY304LYS	
610745	64220	STRA6	0012	MICROPHTHALMIA, SYNDROMIC 9	STRA6, ASP560HIS	
610745	64220	STRA6	0013	MICROPHTHALMIA, SYNDROMIC 9	STRA6, ARG655HIS	
610746	22845	DOLK	0001	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im	DOLK, CYS99SER	137853109
610746	22845	DOLK	0002	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im	DOLK, TYR441SER	137853110
610746	22845	DOLK	0003	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im	DOLK, HIS408ASP	
610746	22845	DOLK	0004	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im	DOLK, TRP304CYS	
610746	22845	DOLK	0005	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im	DOLK, MET1ILE	
610767	55054	ATG16L1	0001	INFLAMMATORY BOWEL DISEASE 10, SUSCEPTIBILITY TO	ATG16L1, THR300ALA,	2241880
610804	23169	SLC35D1	0001	SCHNECKENBECKEN DYSPLASIA	SLC35D1, 1-BP DEL, 125A	
610804	23169	SLC35D1	0002	SCHNECKENBECKEN DYSPLASIA	SLC35D1, TRP311TER	137853111
610804	23169	SLC35D1	0003	SCHNECKENBECKEN DYSPLASIA	SLC35D1, IVS7, G-T, +1	
610804	23169	SLC35D1	0004	SCHNECKENBECKEN DYSPLASIA	SLC35D1, ARG107TER	
610804	23169	SLC35D1	0005	SCHNECKENBECKEN DYSPLASIA	SLC35D1, IVS4DS, A-G, +3	
610804	23169	SLC35D1	0006	SCHNECKENBECKEN DYSPLASIA	SLC35D1, 4.9-KB DEL, EX7	
610804	23169	SLC35D1	0007	SCHNECKENBECKEN DYSPLASIA	SLC35D1, THR65PRO	
610812	54768	HYDIN	0001	CILIARY DYSKINESIA, PRIMARY, 5, WITHOUT SITUS INVERSUS	HYDIN, 3985G-T	
610812	54768	HYDIN	0002	CILIARY DYSKINESIA, PRIMARY, 5, WITHOUT SITUS INVERSUS	HYDIN, LYS307TER	
610819	54977	SLC25A38	0001	ANEMIA, SIDEROBLASTIC, PYRIDOXINE-REFRACTORY, AUTOSOMAL RECESSIVE	SLC25A38, ARG117TER	121918330
610819	54977	SLC25A38	0002	ANEMIA, SIDEROBLASTIC, PYRIDOXINE-REFRACTORY, AUTOSOMAL RECESSIVE	SLC25A38, 2-BP DEL, 698CT	
610819	54977	SLC25A38	0003	ANEMIA, SIDEROBLASTIC, PYRIDOXINE-REFRACTORY, AUTOSOMAL RECESSIVE	SLC25A38, ARG187PRO	121918331
610819	54977	SLC25A38	0004	ANEMIA, SIDEROBLASTIC, PYRIDOXINE-REFRACTORY, AUTOSOMAL RECESSIVE	SLC25A38, IVS3AS, G-A, -1	
610819	54977	SLC25A38	0005	ANEMIA, SIDEROBLASTIC, PYRIDOXINE-REFRACTORY, AUTOSOMAL RECESSIVE	SLC25A38, LYS264TER	121918332
610827	63925	ZNF335	0001	MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE	ZNF335, ARG1111HIS	
610844	80208	SPG11	0001	SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE	SPG11, ARG2034TER	118203963
610844	80208	SPG11	0002	SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE	SPG11, 5-BP DEL, 529ATATT	
610844	80208	SPG11	0003	SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE	SPG11, 118C-T, GLN40TER	
610844	80208	SPG11	0004	SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE	SPG11, 2-BP DEL, 733AT	
610844	80208	SPG11	0005	SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE	SPG11, 1-BP INS, 2472T	
610844	80208	SPG11	0006	SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE	SPG11, IVS2DS, G-C, +1	
610844	80208	SPG11	0007	SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE	SPG11, IVS39AS, G-C, -1	
610844	80208	SPG11	0008	SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE	SPG11, GLN1875TER	
610844	80208	SPG11	0009	SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE	SPG11, 1-BP DUP, 3067A	
610855	22852	ANKRD26	0001	THROMBOCYTOPENIA 2	ANKRD26, -134G-A	
610855	22852	ANKRD26	0002	THROMBOCYTOPENIA 2	ANKRD26, -127A-T	
610855	22852	ANKRD26	0003	THROMBOCYTOPENIA 2	ANKRD26, -128G-A	
610860	178	AGL	0001	GLYCOGEN STORAGE DISEASE, TYPE IIIa	AGL, 1-BP INS, 4529A	
610860	178	AGL	0002	GLYCOGEN STORAGE DISEASE, TYPE IIIb	AGL, GLN6TER	113994126
610860	178	AGL	0003	GLYCOGEN STORAGE DISEASE, TYPE IIIb	AGL, TRP680TER	113994129
610860	178	AGL	0004	GLYCOGEN STORAGE DISEASE, TYPE IIIb	AGL, 2-BP DEL, 17AG	113994127
610860	178	AGL	0005	GLYCOGEN STORAGE DISEASE, TYPE IIIa	AGL, 1-BP DEL, 4455T	
610860	178	AGL	0006	GLYCOGEN STORAGE DISEASE, TYPE IIIb GLYCOGEN STORAGE DISEASE, TYPE IIIa, INCLUDED	AGL, IVS32AS, A-G, -12	113994133
610860	178	AGL	0007	GLYCOGEN STORAGE DISEASE, TYPE IIIa	AGL, IVS14DS, G-T, +1	
610860	178	AGL	0008	GLYCOGEN STORAGE DISEASE, TYPE IIIa	AGL, EcoRI FRAGMENT INS	
610860	178	AGL	0009	GLYCOGEN STORAGE DISEASE, TYPE IIIa	AGL, GLY1448ARG	118203964
610860	178	AGL	0010	GLYCOGEN STORAGE DISEASE, TYPE IIIa	AGL, 1-BP DEL, 3964T	
610860	178	AGL	0011	GLYCOGEN STORAGE DISEASE, TYPE IIIb	AGL, 1-BP DEL, 2399C	
610860	178	AGL	0012	GLYCOGEN STORAGE DISEASE, TYPE IIIb	AGL, IVS33DS, G-A, +5	
610860	178	AGL	0013	GLYCOGEN STORAGE DISEASE, TYPE IIIa	AGL, ARG408TER	113994128
610860	178	AGL	0014	GLYCOGEN STORAGE DISEASE, TYPE IIIc	AGL, ARG1147GLY	
610860	178	AGL	0015	GLYCOGEN STORAGE DISEASE, TYPE IIIa	AGL, TRP1327TER	
610863	59345	GNB4	0001	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE F	GNB4, GLY53ASP	
610863	59345	GNB4	0002	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE F	GNB4, LYS89GLU	
610865	55640	FLVCR2	0001	PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME	FLVCR2, THR430ARG	
610865	55640	FLVCR2	0002	PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME	FLVCR2, 6-BP DEL, NT329	
610865	55640	FLVCR2	0003	PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME	FLVCR2, LEU398VAL	
610865	55640	FLVCR2	0004	PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME	FLVCR2, SER158TER	
610865	55640	FLVCR2	0005	PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME	FLVCR2, PRO280ARG	
610865	55640	FLVCR2	0006	PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME	FLVCR2, ALA326VAL	
610865	55640	FLVCR2	0007	PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME	FLVCR2, IVS7DS, T-C, +2	
610865	55640	FLVCR2	0008	PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME	FLVCR2, TYR134TER	
610897	128866	CHMP4B	0001	CATARACT, POSTERIOR POLAR, 3	CHMP4B, ASP129VAL	118203965
610897	128866	CHMP4B	0002	CATARACT, POSTERIOR POLAR, 3	CHMP4B, GLU161LYS	118203966
610911	57514	ARHGAP31	0001	ADAMS-OLIVER SYNDROME 1	ARHGAP31, GLN683TER	
610911	57514	ARHGAP31	0002	ADAMS-OLIVER SYNDROME 1	ARHGAP31, 1-BP DEL, 3260A	
610916	54888	NSUN2	0001	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	NSUN2, GLN227TER	
610916	54888	NSUN2	0002	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	NSUN2, GLN372TER	
610916	54888	NSUN2	0003	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	NSUN2, IVS5, A-C	
610916	54888	NSUN2	0004	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	NSUN2, GLY679ARG	
610916	54888	NSUN2	0005	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	NSUN2, IVS5AS, G-C, -1	
610928	64321	SOX17	0001	VESICOURETERAL REFLUX 3	SOX17, TYR259ASN	
610928	64321	SOX17	0002	VESICOURETERAL REFLUX 3	SOX17, GLY178CYS	
610928	64321	SOX17	0003	VESICOURETERAL REFLUX 3	SOX17, 6-BP INS, NT51	
610931	57623	ZFAT	0001	AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3	ZFAT1, IVS9, A-T	
610933	90678	LRSAM1	0001	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2P	LRSAM1, G-A	
610933	90678	LRSAM1	0002	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2P	LRSAM1, 2-BP INS, 2121GC	
610933	90678	LRSAM1	0003	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2P	LRSAM1, IVS24AS, G-A, -1	
610934	135935	NOBOX	0001	PREMATURE OVARIAN FAILURE 5	NOBOX, ARG355HIS	
610936	29968	PSAT1	0001	PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	PSAT1, 1-BP DEL, 107G	
610936	29968	PSAT1	0002	PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	PSAT1, ASP100ALA	118203967
610937	23322	RPGRIP1L	0001	JOUBERT SYNDROME 7	RPGRIP1L, LYS233TER	121918197
610937	23322	RPGRIP1L	0002	JOUBERT SYNDROME 7	RPGRIP1L, THR615PRO	121918198
610937	23322	RPGRIP1L	0003	JOUBERT SYNDROME 7	RPGRIP1L, GLN253TER	121918199
610937	23322	RPGRIP1L	0004	JOUBERT SYNDROME 7	RPGRIP1L, ALA695PRO	121918200
610937	23322	RPGRIP1L	0005	MECKEL SYNDROME, TYPE 5	RPGRIP1L, ARG132TER	121918201
610937	23322	RPGRIP1L	0006	MECKEL SYNDROME, TYPE 5	RPGRIP1L, GLN345TER	121918202
610937	23322	RPGRIP1L	0007	MECKEL SYNDROME, TYPE 5	RPGRIP1L, GLN872TER	121918203
610937	23322	RPGRIP1L	0008	JOUBERT SYNDROME 7	RPGRIP1L, 1-BP DEL, 1721A	
610937	23322	RPGRIP1L	0009	JOUBERT SYNDROME 7	RPGRIP1L, GLN684TER	121918204
610937	23322	RPGRIP1L	0010	JOUBERT SYNDROME 7	RPGRIP1L, 1-BP DEL, 2268A	61747071
610937	23322	RPGRIP1L	0011	COACH SYNDROME	RPGRIP1L, ARG805TER	
610937	23322	RPGRIP1L	0012	COACH SYNDROME	RPGRIP1L, SER659PRO	
610937	23322	RPGRIP1L	0013	RETINITIS PIGMENTOSA IN CILIOPATHIES, MODIFIER OF	RPGRIP1L, ALA229THR	
610949	255928	SYT14	0001	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11	SYT14, GLY484ASP	
610956	55157	DARS2	0001	LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION	DARS2, 2-BP DEL/1-BP INS	193302863
610956	55157	DARS2	0002	LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION	DARS2, LEU626VAL	121918205
610956	55157	DARS2	0003	LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION	DARS2, ARG263TER	121918206
610956	55157	DARS2	0004	LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION	DARS2, ARG263GLN	121918207
610956	55157	DARS2	0005	LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION	DARS2, CYS152PHE	121918208
610956	55157	DARS2	0006	LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION	DARS2, IVS5DS, T-C, +2	142433332
610956	55157	DARS2	0007	LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION	DARS2, SER45GLY	121918209
610956	55157	DARS2	0008	LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION	DARS2, ARG179HIS	121918210
610956	55157	DARS2	0009	LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION	DARS2, GLU425TER	121918211
610956	55157	DARS2	0010	LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION	DARS2, LEU613PHE	121918212
610956	55157	DARS2	0011	LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION	DARS2, LEU626GLN	121918213
610956	55157	DARS2	0012	LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION	DARS2, IVS2, T-A, -22	
610956	55157	DARS2	0013	LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION, MILD	DARS2, ARG609TRP	
610957	51067	YARS2	0001	MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2	YARS2, PHE52LEU	
610966	79068	FTO	0001	GROWTH RETARDATION, DEVELOPMENTAL DELAY, COARSE FACIES, AND EARLY DEATH	FTO, ARG316GLN	121918214
610982	64423	INF2	0001	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 5	INF2, SER186PRO	
610982	64423	INF2	0002	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 5	INF2, ARG218GLN	
610982	64423	INF2	0003	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 5	INF2, ARG218TRP	
610982	64423	INF2	0004	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 5	INF2, ARG214HIS	
610982	64423	INF2	0005	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 5	INF2, LEU42PRO	
610982	64423	INF2	0006	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE E	INF2, CYS104ARG	
610982	64423	INF2	0007	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE E	INF2, CYS104PHE	
610982	64423	INF2	0008	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE E	INF2, CYS104TRP	
610982	64423	INF2	0009	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE E	INF2, LEU128PRO	
610982	64423	INF2	0010	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE E	INF2, LEU132ARG	
610982	64423	INF2	0011	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE E	INF2, 9-BP DEL, NT490	
610991	23363	OBSL1	0001	THREE M SYNDROME 2	OBSL1, 1-BP INS, 1273A	
610991	23363	OBSL1	0002	THREE M SYNDROME 2	OBSL1, CYS383TER	121918215
610991	23363	OBSL1	0003	THREE M SYNDROME 2	OBSL1, 10-BP DEL, NT1256	
610991	23363	OBSL1	0004	THREE M SYNDROME 2	OBSL1, 1-BP INS, 690C	
610991	23363	OBSL1	0005	THREE M SYNDROME 2	OBSL1, ARG489TER	121918216
611026	79152	FA2H	0001	SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	FA2H, IVS5DS, G-A, +1	
611026	79152	FA2H	0002	SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	FA2H, ASP35TYR	121918217
611026	79152	FA2H	0003	SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	FA2H, ARG235CYS	
611026	79152	FA2H	0004	SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	FA2H, 18-BP DEL	
611026	79152	FA2H	0005	SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	FA2H, ARG154CYS	
611026	79152	FA2H	0006	SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	FA2H, 2-BP DEL, 509AC	
611026	79152	FA2H	0007	SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	FA2H, PHE236SER	
611026	79152	FA2H	0008	SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	FA2H, 28-KB DEL	
611034	10786	SLC17A3	0001	URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 4	SLC17A3, PHE304SER	
611034	10786	SLC17A3	0002	GOUT SUSCEPTIBILITY 4	SLC17A3, ASN68HIS	
611045	92579	G6PC3	0001	NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE	G6PC3, ARG253HIS	118203968
611045	92579	G6PC3	0002	NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE	G6PC3, LEU185PRO	118203969
611045	92579	G6PC3	0003	NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE	G6PC3, TYR47TER	118203970
611045	92579	G6PC3	0004	NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE	G6PC3, GLY262ARG	118203971
611045	92579	G6PC3	0005	NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE	G6PC3, 1-BP DUP, 935T	
611045	92579	G6PC3	0006	DURSUN SYNDROME	G6PC3, MET116VAL	
611045	92579	G6PC3	0007	NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE	G6PC3, GLY260ARG	
611051	152137	CCDC50	0001	DEAFNESS, AUTOSOMAL DOMINANT 44	CCDC50, 8-BP DUP	
611060	26040	SETBP1	0001	SCHINZEL-GIEDION MIDFACE RETRACTION SYNDROME	SETBP1, ILE871THR	
611060	26040	SETBP1	0002	SCHINZEL-GIEDION MIDFACE RETRACTION SYNDROME	SETBP1, ASP868ASN	
611060	26040	SETBP1	0003	SCHINZEL-GIEDION MIDFACE RETRACTION SYNDROME	SETBP1, ASP868ALA	
611060	26040	SETBP1	0004	SCHINZEL-GIEDION MIDFACE RETRACTION SYNDROME	SETBP1, GLY870ASP	
611060	26040	SETBP1	0005	SCHINZEL-GIEDION MIDFACE RETRACTION SYNDROME	SETBP1, GLY870SER	
611061	56975	FAM20C	0001	RAINE SYNDROME	FAM20C, GLY365ARG	
611061	56975	FAM20C	0002	RAINE SYNDROME	FAM20C, LEU374ARG	
611061	56975	FAM20C	0003	RAINE SYNDROME	FAM20C, ARG535TRP	
611061	56975	FAM20C	0004	RAINE SYNDROME	FAM20C, IVS4, C-G, -3	
611061	56975	FAM20C	0005	RAINE SYNDROME	FAM20C, GLY365GLU	
611061	56975	FAM20C	0006	RAINE SYNDROME	FAM20C, IVS7, A-G, -2	
611061	56975	FAM20C	0007	RAINE SYNDROME	FAM20C, IVS4, G-C, +5	
611061	56975	FAM20C	0008	RAINE SYNDROME	FAM20C, IVS8, G-A, -1	
611061	56975	FAM20C	0009	RAINE SYNDROME	FAM20C, ASP437ASN	
611061	56975	FAM20C	0010	RAINE SYNDROME	FAM20C, ILE244ASN	
611061	56975	FAM20C	0011	RAINE SYNDROME	FAM20C, GLY266ARG	
611061	56975	FAM20C	0012	RAINE SYNDROME	FAM20C, PRO314SER	
611062	54757	FAM20A	0001	AMELOGENESIS IMPERFECTA AND GINGIVAL FIBROMATOSIS SYNDROME	FAM20A, ARG136TER (g.64063478C-T, NCBI36)	
611062	54757	FAM20A	0002	AMELOGENESIS IMPERFECTA AND GINGIVAL FIBROMATOSIS SYNDROME	FAM20A, 2-BP DEL, 34CT	
611062	54757	FAM20A	0003	AMELOGENESIS IMPERFECTA AND GINGIVAL FIBROMATOSIS SYNDROME	FAM20A, IVS5, A-G, -2	
611062	54757	FAM20A	0004	AMELOGENESIS IMPERFECTA AND GINGIVAL FIBROMATOSIS SYNDROME	FAM20A, 5-BP DEL, NT1175	
611062	54757	FAM20A	0005	AMELOGENESIS IMPERFECTA AND GINGIVAL FIBROMATOSIS SYNDROME	FAM20A, IVS2, A-G, -2	
611062	54757	FAM20A	0006	AMELOGENESIS IMPERFECTA AND GINGIVAL FIBROMATOSIS SYNDROME	FAM20A, ARG276TER	
611065	152926	PPM1K	0001	MAPLE SYRUP URINE DISEASE, MILD VARIANT	PPM1K, 2-BP DEL, 417TA	
611082	440823	MIAT	0001	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO	MIAT, HAPLOTYPE, TAAAAT	
611089	64419	MTMR14	0001	MYOPATHY, CENTRONUCLEAR, AUTOSOMAL DOMINANT, MODIFIER OF	MTMR14, ARG336GLN	121434509
611089	64419	MTMR14	0002	MYOPATHY, CENTRONUCLEAR, AUTOSOMAL DOMINANT, MODIFIER OF	MTMR14, TYR462CYS	121434510
611101	57449	PLEKHG5	0001	SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4	PLEKHG5, PHE647SER	63750315
611103	28976	ACAD9	0001	ACAD9 DEFICIENCY	ACAD9, 4-BP INS, TAAG	
611103	28976	ACAD9	0002	MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	ACAD9, PHE44ILE	
611103	28976	ACAD9	0003	MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	ACAD9, ARG266GLN	
611103	28976	ACAD9	0004	MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	ACAD9, ARG417CYS	
611103	28976	ACAD9	0005	MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	ACAD9, ALA326PRO	
611103	28976	ACAD9	0006	MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	ACAD9, ARG532TRP	
611104	121512	FGD4	0001	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H	FGD4, ARG224TER	118203972
611104	121512	FGD4	0002	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H	FGD4, 893T-G	
611104	121512	FGD4	0003	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H	FGD4, 2-BP DEL, 1626AG	
611104	121512	FGD4	0004	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H	FGD4, GLY586TER	118203973
611104	121512	FGD4	0005	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H	FGD4, MET298THR	63749871
611104	121512	FGD4	0006	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H	FGD4, ARG275TER	118203974
611104	121512	FGD4	0007	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H	FGD4, IVS14AS, A-G, -2	
611119	55975	KLHL7	0001	RETINITIS PIGMENTOSA 42	KLHL7, SER150ASN	137853112
611119	55975	KLHL7	0002	RETINITIS PIGMENTOSA 42	KLHL7, ALA153VAL	137853113
611119	55975	KLHL7	0003	RETINITIS PIGMENTOSA 42	KLHL7, ALA153THR	137853114
611124	256471	MFSD8	0001	CEROID LIPOFUSCINOSIS, NEURONAL, 7	MFSD8, GLY310ASP	118203975
611124	256471	MFSD8	0002	CEROID LIPOFUSCINOSIS, NEURONAL, 7	MFSD8, GLY429ASP	118203976
611124	256471	MFSD8	0003	CEROID LIPOFUSCINOSIS, NEURONAL, 7	MFSD8, TYR298TER	118203977
611124	256471	MFSD8	0004	CEROID LIPOFUSCINOSIS, NEURONAL, 7	MFSD8, TYR121CYS	118203978
611124	256471	MFSD8	0005	CEROID LIPOFUSCINOSIS, NEURONAL, 7	MFSD8, PRO412LEU	
611124	256471	MFSD8	0006	CEROID LIPOFUSCINOSIS, NEURONAL, 7	MFSD8, THR294LYS	
611124	256471	MFSD8	0007	CEROID LIPOFUSCINOSIS, NEURONAL, 7	MFSD8, 2-BP DEL/2-BP INS	
611145	169026	SLC30A8	0001	DIABETES MELLITUS, NONINSULIN-DEPENDENT, SUSCEPTIBILITY TO	SLC30A8, ARG325TRP	13266634
611146	55532	SLC30A10	0001	HYPERMANGANESEMIA WITH DYSTONIA, POLYCYTHEMIA, AND CIRRHOSIS	SLC30A10, 9-BP DEL, NT314	
611146	55532	SLC30A10	0002	HYPERMANGANESEMIA WITH DYSTONIA, POLYCYTHEMIA, AND CIRRHOSIS	SLC30A10, LEU89PRO	
611146	55532	SLC30A10	0003	HYPERMANGANESEMIA WITH DYSTONIA, POLYCYTHEMIA, AND CIRRHOSIS	SLC30A10, 1-BP DEL, NT585	
611146	55532	SLC30A10	0004	HYPERMANGANESEMIA WITH DYSTONIA, POLYCYTHEMIA, AND CIRRHOSIS	SLC30A10, 1-BP DEL, 507G	
611146	55532	SLC30A10	0005	HYPERMANGANESEMIA WITH DYSTONIA, POLYCYTHEMIA, AND CIRRHOSIS	SLC30A10, 1-BP DEL, 1235A	
611150	25814	ATXN10	0001	SPINOCEREBELLAR ATAXIA 10	ATXN10, (ATTCT)n EXPANSION	193922931
611153	7507	XPA	0001	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A	XPA, IVS3AS, G-C	
611153	7507	XPA	0002	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A	XPA, CYS108PHE	104894131
611153	7507	XPA	0003	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A	XPA, 5-BP DEL	
611153	7507	XPA	0004	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A	XPA, ARG228TER	104894132
611153	7507	XPA	0005	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A	XPA, ARG207TER	104894133
611153	7507	XPA	0006	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A	XPA, TYR116TER	104894134
611153	7507	XPA	0007	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A	XPA, IVS1DS, T-G, +2	
611177	57560	IFT80	0001	ASPHYXIATING THORACIC DYSTROPHY 2	IFT80, HIS105GLN	137853115
611177	57560	IFT80	0002	ASPHYXIATING THORACIC DYSTROPHY 2	IFT80, 3-BP DEL, TTA	
611177	57560	IFT80	0003	ASPHYXIATING THORACIC DYSTROPHY 2	IFT80, ALA701PRO	137853116
611184	9780	PIEZO1	0001	DEHYDRATED HEREDITARY STOMATOCYTOSIS	PIEZO1, MET2225ARG	
611184	9780	PIEZO1	0002	DEHYDRATED HEREDITARY STOMATOCYTOSIS	PIEZO1, ARG2456HIS	
611184	9780	PIEZO1	0003	DEHYDRATED HEREDITARY STOMATOCYTOSIS AND PSEUDOHYPERKALEMIA	PIEZO1, ALA2020THR	
611184	9780	PIEZO1	0004	DEHYDRATED HEREDITARY STOMATOCYTOSIS	PIEZO1, ARG1358PRO	
611184	9780	PIEZO1	0005	DEHYDRATED HEREDITARY STOMATOCYTOSIS AND PSEUDOHYPERKALEMIA	PIEZO1, THR2127MET	
611184	9780	PIEZO1	0006	DEHYDRATED HEREDITARY STOMATOCYTOSIS	PIEZO1, 6-BP DUP, NT7479	
611184	9780	PIEZO1	0007	DEHYDRATED HEREDITARY STOMATOCYTOSIS	PIEZO1, SER1117LEU AND ALA2020VAL	
611184	9780	PIEZO1	0008	DEHYDRATED HEREDITARY STOMATOCYTOSIS WITH PSEUDOHYPERKALEMIA AND PERINATAL EDEMA	PIEZO1, 1848+31C-G, GLY782SER, AND ARG808GLN	
611192	29123	ANKRD11	0001	KBG SYNDROME	ANKRD11, IVS10, G-C, -1	
611192	29123	ANKRD11	0002	KBG SYNDROME	ANKRD11, 1-BP DEL, 2305T	
611192	29123	ANKRD11	0003	KBG SYNDROME	ANKRD11, 2-BP DEL, 5953CA	
611203	80331	DNAJC5	0001	CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT	DNAJC5, 3-BP DEL, 346CTC	
611203	80331	DNAJC5	0002	CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT	DNAJC5, LEU115ARG	
611204	440193	CCDC88C	0001	HYDROCEPHALUS, NONSYNDROMIC, AUTOSOMAL RECESSIVE	CCDC88C, IVS29DS, G-A, +1	
611204	440193	CCDC88C	0002	HYDROCEPHALUS, NONSYNDROMIC, AUTOSOMAL RECESSIVE	CCDC88C, ARG312TER	
611204	440193	CCDC88C	0003	HYDROCEPHALUS, NONSYNDROMIC, AUTOSOMAL RECESSIVE	CCDC88C, 2-BP DEL, 5841AG	
611223	10000	AKT3	0001	MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME	AKT3, ARG465TRP	
611223	10000	AKT3	0002	MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME	AKT3, ASN229SER	
611223	10000	AKT3	0003	MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME, SOMATIC	AKT3, GLU17LYS	
611224	8802	SUCLG1	0001	MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITH METHYLMALONIC ACIDURIA)	SUCLG1, 2-BP DEL, 113AT	
611224	8802	SUCLG1	0002	MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITH METHYLMALONIC ACIDURIA)	SUCLG1, GLY72ALA	
611224	8802	SUCLG1	0003	MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITH METHYLMALONIC ACIDURIA)	SUCLG1, PRO170ARG	
611224	8802	SUCLG1	0004	MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITH METHYLMALONIC ACIDURIA)	SUCLG1, IVS1DS, G-C, +3	
611224	8802	SUCLG1	0005	MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITH METHYLMALONIC ACIDURIA)	SUCLG1, GLN150TER	
611236	55151	TMEM38B	0001	OSTEOGENESIS IMPERFECTA, TYPE XIV	TMEM38B, 88-BP DEL, NT455	
611254	374654	KIF7	0001	HYDROLETHALUS SYNDROME 2 ACROCALLOSAL SYNDROME, INCLUDED	KIF7, 2-BP DEL	
611254	374654	KIF7	0002	ACROCALLOSAL SYNDROME	KIF7, ARG154TER	
611254	374654	KIF7	0003	ACROCALLOSAL SYNDROME	KIF7, GLN1001TER	
611254	374654	KIF7	0004	ACROCALLOSAL SYNDROME	KIF7, 1-BP DUP, 587T	
611254	374654	KIF7	0005	ACROCALLOSAL SYNDROME	KIF7, 1-BP DEL, 687G	
611254	374654	KIF7	0006	JOUBERT SYNDROME 12	KIF7, 1-BP DEL, 217G	
611254	374654	KIF7	0007	JOUBERT SYNDROME 12 JOUBERT SYNDROME 12/15, DIGENIC, INCLUDED	KIF7, 1-BP DEL, 811G	
611254	374654	KIF7	0008	VARIANT OF UNKNOWN SIGNIFICANCE	KIF7, 12-BP DEL, NT3986	
611258	23424	TDRD7	0001	CATARACT, AUTOSOMAL RECESSIVE CONGENITAL 4	TDRD7, 3-BP DEL, VAL618	
611259	54901	CDKAL1	0001	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	CDKAL1,	7754840
611259	54901	CDKAL1	0002	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	CDKAL1,	7756992
611290	79840	NHEJ1	0001	SEVERE COMBINED IMMUNODEFICIENCY WITH MICROCEPHALY, GROWTH RETARDATION, AND SENSITIVITY TO IONIZING RADIATION	NHEJ1, ARG57GLY	118204451
611290	79840	NHEJ1	0002	SEVERE COMBINED IMMUNODEFICIENCY WITH MICROCEPHALY, GROWTH RETARDATION, AND SENSITIVITY TO IONIZING RADIATION	NHEJ1, CYS123ARG	118204452
611290	79840	NHEJ1	0003	SEVERE COMBINED IMMUNODEFICIENCY WITH MICROCEPHALY, GROWTH RETARDATION, AND SENSITIVITY TO IONIZING RADIATION	NHEJ1, ARG178TER	118204453
611290	79840	NHEJ1	0004	SEVERE COMBINED IMMUNODEFICIENCY WITH MICROCEPHALY, GROWTH RETARDATION, AND SENSITIVITY TO IONIZING RADIATION	NHEJ1, 1-BP DEL, 267G, AND IVS2DS, A-T, +3	
611290	79840	NHEJ1	0005	SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION DUE TO NHEJ1 DEFICIENCY	NHEJ1, 1-BP INS, 12T	
611313	387715	ARMS2	0001	MACULAR DEGENERATION, AGE-RELATED, 8, SUSCEPTIBILITY TO	ARMS2, ALA69SER	10490924
611313	387715	ARMS2	0002	MACULAR DEGENERATION, AGE-RELATED, 8, SUSCEPTIBILITY TO	ARMS2, 443-BP DEL/54-BP INS	
611317	23533	PIK3R5	0001	ATAXIA-OCULOMOTOR APRAXIA 3 (1 family)	PIK3R5, PRO629SER dbSNP rs61761068	
611332	10049	DNAJB6	0001	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1E	DNAJB6, PHE93LEU, 277T-C	
611332	10049	DNAJB6	0002	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1E	DNAJB6, PRO96ARG	
611332	10049	DNAJB6	0003	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1E	DNAJB6, PHE93LEU, 279C-G	
611332	10049	DNAJB6	0004	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1E	DNAJB6, PHE93LEU, 279C-A	
611332	10049	DNAJB6	0005	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1E	DNAJB6, PHE89ILE	
611358	84282	RNF135	0001	OVERGROWTH SYNDROME, RNF135-RELATED	RNF135, GLN243TER	121918161
611358	84282	RNF135	0002	OVERGROWTH SYNDROME, RNF135-RELATED	RNF135, 1-BP DEL, 742C	
611358	84282	RNF135	0003	OVERGROWTH SYNDROME, RNF135-RELATED	RNF135, 1-BP DEL, 1015G	
611358	84282	RNF135	0004	OVERGROWTH SYNDROME, RNF135-RELATED	RNF135, ARG286HIS	121918162
611360	55215	FANCI	0001	FANCONI ANEMIA, COMPLEMENTATION GROUP I	FANCI, 2T-C	
611360	55215	FANCI	0002	FANCONI ANEMIA, COMPLEMENTATION GROUP I	FANCI, ARG1285GLN	121918163
611360	55215	FANCI	0003	FANCONI ANEMIA, COMPLEMENTATION GROUP I	FANCI, ARG1285TER	121918164
611360	55215	FANCI	0004	FANCONI ANEMIA, COMPLEMENTATION GROUP I	FANCI, IVS31AS, A-G, -88	
611379	57609	DIP2B	0001	MENTAL RETARDATION, FRA12A TYPE	DIP2B, CGG(n) EXPANSION	
611408	167691	LCA5	0001	LEBER CONGENITAL AMAUROSIS 5	LCA5, 1-BP DEL, 1151C	
611408	167691	LCA5	0002	LEBER CONGENITAL AMAUROSIS 5	LCA5, 1-BP DUP, 1476A	
611408	167691	LCA5	0003	LEBER CONGENITAL AMAUROSIS 5	LCA5, GLN279TER	121918165
611408	167691	LCA5	0004	LEBER CONGENITAL AMAUROSIS 5	LCA5, 1,598-BP DEL	
611409	4948	OCA2	0001	ALBINISM, OCULOCUTANEOUS, TYPE II BROWN OCULOCUTANEOUS ALBINISM, INCLUDED	OCA2, 2.7-KB DEL, EX7DEL	
611409	4948	OCA2	0002	ALBINISM, OCULOCUTANEOUS, TYPE II	OCA2, IVS17DS, G-T, +1	
611409	4948	OCA2	0003	ALBINISM, OCULOCUTANEOUS, TYPE II	OCA2, ALA481THR	74653330
611409	4948	OCA2	0004	ALBINISM, OCULOCUTANEOUS, TYPE II	OCA2, VAL443ILE	121918166
611409	4948	OCA2	0005	ALBINISM, OCULOCUTANEOUS, TYPE II	OCA2, PRO743LEU	121918167
611409	4948	OCA2	0006	ALBINISM, OCULOCUTANEOUS, TYPE II	OCA2, 1-BP DEL	
611409	4948	OCA2	0007	ALBINISM, OCULOCUTANEOUS, TYPE II	OCA2, ALA334VAL	121918168
611409	4948	OCA2	0008	ALBINISM, OCULOCUTANEOUS, TYPE II	OCA2, 122.5-KB DEL	
611409	4948	OCA2	0009	ALBINISM, OCULOCUTANEOUS, TYPE II	OCA2, TRP679CYS	121918169
611409	4948	OCA2	0010	ALBINISM, OCULOCUTANEOUS, TYPE II	OCA2, ASN489ASP	121918170
611409	4948	OCA2	0011	SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES SKIN/HAIR/EYE PIGMENTATION 1, BLUE/BROWN EYES, INCLUDED	OCA2, ARG305TRP	1800401
611409	4948	OCA2	0012	SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES	OCA2, ARG419GLN	1800407
611409	4948	OCA2	0013	SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES SKIN/HAIR/EYE PIGMENTATION 1, BLUE/BROWN EYES, INCLUDED;; SKIN/HAIR/EYE PIGMENTATION 1, BLOND/BROWN HAIR, INCLUDED	OCA2, IVS1, HAPLOTYPE 1	4778138
611409	4948	OCA2	0014	ALBINISM, OCULOCUTANEOUS, TYPE II	OCA2, MET394ILE	121918171
611409	4948	OCA2	0015	ALBINISM, OCULOCUTANEOUS, TYPE II	OCA2, 184-KB DEL	
611414	125972	CALR3	0001	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 19	CALR3, LYS82ARG	
611420	25792	CIZ1	0001	VARIANT OF UNKNOWN SIGNIFICANCE	CIZ1, SER264GLY	
611421	10847	SRCAP	0001	FLOATING-HARBOR SYNDROME	SRCAP, ARG2444TER	
611421	10847	SRCAP	0002	FLOATING-HARBOR SYNDROME	SRCAP, ARG2435TER	
611421	10847	SRCAP	0003	FLOATING-HARBOR SYNDROME	SRCAP, 1-BP DEL, 7549C	
611421	10847	SRCAP	0004	FLOATING-HARBOR SYNDROME	SRCAP, 1-BP DUP, NT7863	
611423	9662	CEP135	0001	MICROCEPHALY 8, PRIMARY, AUTOSOMAL RECESSIVE	CEP135, 1-BP DEL, 970C	
611432	81704	DOCK8	0001	HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL RECESSIVE	DOCK8, LYS405ARG	112321280
611432	81704	DOCK8	0002	HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL RECESSIVE	DOCK8, EX10-23, DEL	
611432	81704	DOCK8	0003	HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL RECESSIVE	DOCK8, EX5-24, DEL	
611458	2720	GLB1	0001	GM1-GANGLIOSIDOSIS, TYPE I	GLB1, ARG49CYS	72555358
611458	2720	GLB1	0002	GM1-GANGLIOSIDOSIS, TYPE I	GLB1, ARG457TER	72555359
611458	2720	GLB1	0003	GM1-GANGLIOSIDOSIS, TYPE II	GLB1, ARG201CYS	72555360
611458	2720	GLB1	0004	GM1-GANGLIOSIDOSIS, TYPE III	GLB1, ILE51THR	72555390
611458	2720	GLB1	0005	GM1-GANGLIOSIDOSIS, TYPE I	GLB1, 165-BP DUP	
611458	2720	GLB1	0006	GM1-GANGLIOSIDOSIS, TYPE I	GLB1, GLY123ARG	28934274
611458	2720	GLB1	0007	GM1-GANGLIOSIDOSIS, TYPE I	GLB1, TYR316CYS	72555361
611458	2720	GLB1	0008	GM1-GANGLIOSIDOSIS, TYPE III	GLB1, ARG457GLN	28934886
611458	2720	GLB1	0009	MUCOPOLYSACCHARIDOSIS TYPE IVB	GLB1, TRP273LEU	72555362
611458	2720	GLB1	0010	MUCOPOLYSACCHARIDOSIS TYPE IVB GM1-GANGLIOSIDOSIS, TYPE I, INCLUDED	GLB1, ARG482HIS	72555391
611458	2720	GLB1	0011	MUCOPOLYSACCHARIDOSIS TYPE IVB	GLB1, TRP509CYS	72555363
611458	2720	GLB1	0012	GM1-GANGLIOSIDOSIS, TYPE I	GLB1, 23-BP DUP	
611458	2720	GLB1	0013	GM1-GANGLIOSIDOSIS, TYPE III	GLB1, THR82MET	
611458	2720	GLB1	0014	GM1-GANGLIOSIDOSIS, TYPE I	GLB1, IVS1DS, 1-BP INS, +3	
611458	2720	GLB1	0015	MUCOPOLYSACCHARIDOSIS TYPE IVB	GLB1, TYR83HIS	72555364
611458	2720	GLB1	0016	MUCOPOLYSACCHARIDOSIS TYPE IVB	GLB1, ARG482CYS	72555365
611458	2720	GLB1	0017	GM1-GANGLIOSIDOSIS, TYPE I	GLB1, ARG208CYS	72555366
611458	2720	GLB1	0018	MUCOPOLYSACCHARIDOSIS TYPE IVB	GLB1, GLY438GLU	72555367
611458	2720	GLB1	0019	GM1-GANGLIOSIDOSIS, TYPE I, WITH CARDIAC INVOLVEMENT	GLB1, ARG351TER	72555372
611458	2720	GLB1	0020	MUCOPOLYSACCHARIDOSIS TYPE IVB	GLB1, THR500ALA	72555368
611458	2720	GLB1	0021	MUCOPOLYSACCHARIDOSIS TYPE IVB	GLB1, GLN408PRO	72555369
611458	2720	GLB1	0022	GM1-GANGLIOSIDOSIS, TYPE II	GLB1, ARG68TRP	72555370
611458	2720	GLB1	0023	GM1-GANGLIOSIDOSIS, TYPE I, WITH CARDIAC INVOLVEMENT GM1-GANGLIOSIDOSIS, TYPE I, INCLUDED	GLB1, ARG59HIS	72555392
611458	2720	GLB1	0024	GM1-GANGLIOSIDOSIS, TYPE I, WITH CARDIAC INVOLVEMENT	GLB1, IVS14AS, A-G, -2	
611458	2720	GLB1	0025	GM1-GANGLIOSIDOSIS, TYPE I, WITH CARDIAC INVOLVEMENT	GLB1, TYR591ASN	72555373
611458	2720	GLB1	0026	GM1-GANGLIOSIDOSIS, TYPE I, WITH CARDIAC INVOLVEMENT	GLB1, TYR591CYS	72555371
611466	9842	PLEKHM1	0001	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 6	PLEKHM1, IVS3, G-A, +1	
611472	55777	MBD5	0001	MENTAL RETARDATION, AUTOSOMAL DOMINANT 1	MBD5, 200-KB DEL	
611492	760	CA2	0001	CARBONIC ANHYDRASE II VARIANT	CA2, ASN252ASP	2228063
611492	760	CA2	0002	CARBONIC ANHYDRASE II VARIANT	CA2, LYS17GLU	118203931
611492	760	CA2	0003	CARBONIC ANHYDRASE II VARIANT	CA2, PRO237HIS	118203932
611492	760	CA2	0004	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3	CA2, HIS107TYR	118203933
611492	760	CA2	0005	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3	CA2, IVS5, G-C, -1	
611492	760	CA2	0006	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3	CA2, IVS2, G-A, +1	
611492	760	CA2	0007	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3	CA2, TYR40TER	118203934
611492	760	CA2	0008	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3	CA2, 1-BP DEL, 207C	
611495	126410	CYP4F22	0001	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 5	CYP4F22, HIS435TYR	118203935
611495	126410	CYP4F22	0002	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 5	CYP4F22, HIS436ASP	118203936
611495	126410	CYP4F22	0003	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 5	CYP4F22, ARG243HIS	118203937
611495	126410	CYP4F22	0004	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 5	CYP4F22, EX3-12DEL	
611495	126410	CYP4F22	0005	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 5	CYP4F22, TRP521TER	
611499	2990	GUSB	0001	MUCOPOLYSACCHARIDOSIS TYPE VII	GUSB, ALA619VAL	121918172
611499	2990	GUSB	0002	MUCOPOLYSACCHARIDOSIS TYPE VII	GUSB, ARG382CYS	121918173
611499	2990	GUSB	0003	MUCOPOLYSACCHARIDOSIS TYPE VII	GUSB, ARG216TRP	121918174
611499	2990	GUSB	0004	MUCOPOLYSACCHARIDOSIS TYPE VII	GUSB, ALA354VAL	121918175
611499	2990	GUSB	0005	MUCOPOLYSACCHARIDOSIS TYPE VII	GUSB, ARG611TRP	121918176
611499	2990	GUSB	0006	MUCOPOLYSACCHARIDOSIS TYPE VII	GUSB, PRO148SER	121918177
611499	2990	GUSB	0007	MUCOPOLYSACCHARIDOSIS TYPE VII	GUSB, TYR495CYS	121918178
611499	2990	GUSB	0008	MUCOPOLYSACCHARIDOSIS TYPE VII	GUSB, TRP507TER	121918179
611499	2990	GUSB	0009	MUCOPOLYSACCHARIDOSIS TYPE VII	GUSB, 38-BP DEL, NT1642	
611499	2990	GUSB	0010	MUCOPOLYSACCHARIDOSIS TYPE VII	GUSB, IVS8+0.6-KB, 2-BP DEL, TC	
611499	2990	GUSB	0011	MUCOPOLYSACCHARIDOSIS TYPE VII	GUSB, TRP446TER	121918180
611499	2990	GUSB	0012	MUCOPOLYSACCHARIDOSIS TYPE VII	GUSB, LEU176PHE	121918181
611499	2990	GUSB	0013	MUCOPOLYSACCHARIDOSIS TYPE VII	GUSB, LYS350ASN	121918182
611499	2990	GUSB	0014	MUCOPOLYSACCHARIDOSIS TYPE VII	GUSB, ARG577LEU	121918183
611499	2990	GUSB	0015	MUCOPOLYSACCHARIDOSIS TYPE VII	GUSB, TRP627CYS	121918184
611499	2990	GUSB	0016	MUCOPOLYSACCHARIDOSIS TYPE VII	GUSB, ARG356TER	121918185
611501	23261	CAMTA1	0001	CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION	CAMTA1, 81-KB DEL, EX4	
611501	23261	CAMTA1	0002	CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION	CAMTA1, 539-KB DUP, EX3-5	
611501	23261	CAMTA1	0003	CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION	CAMTA1, 49-KB DEL, EX2-3	
611507	493856	CISD2	0001	WOLFRAM SYNDROME 2	CISD2, GLU37GLN	63749888
611524	57038	RARS2	0001	PONTOCEREBELLAR HYPOPLASIA, TYPE 6	RARS2, IVS2, A-G, +5	63749985
611524	57038	RARS2	0002	PONTOCEREBELLAR HYPOPLASIA, TYPE 6	RARS2, MET342VAL	
611524	57038	RARS2	0003	PONTOCEREBELLAR HYPOPLASIA, TYPE 6	RARS2, GLN12ARG	
611531	10436	EMG1	0001	BOWEN-CONRADI SYNDROME	EMG1, ASP86GLY	74435397
611539	27022	FOXD3	0001	AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 1	FOXD3, -639G-T	
611542	411	ARSB	0001	MUCOPOLYSACCHARIDOSIS TYPE VI, INTERMEDIATE	ARSB, GLY137VAL	118203938
611542	411	ARSB	0002	MUCOPOLYSACCHARIDOSIS TYPE VI, SEVERE	ARSB, CYS117ARG	118203939
611542	411	ARSB	0003	MUCOPOLYSACCHARIDOSIS TYPE VI, MILD	ARSB, LEU236PRO	118203940
611542	411	ARSB	0004	MUCOPOLYSACCHARIDOSIS TYPE VI, SEVERE	ARSB, CYS405TYR	118203941
611542	411	ARSB	0005	MUCOPOLYSACCHARIDOSIS TYPE VI, SEVERE	ARSB, 1-BP DEL, 238G	
611542	411	ARSB	0006	MUCOPOLYSACCHARIDOSIS TYPE VI, SEVERE	ARSB, 1-BP DEL, 743C	
611542	411	ARSB	0007	MUCOPOLYSACCHARIDOSIS TYPE VI, SEVERE	ARSB, 11-BP DEL AND LEU72GLN	
611542	411	ARSB	0008	MUCOPOLYSACCHARIDOSIS TYPE VI	ARSB, ARG95GLN	118203942
611542	411	ARSB	0009	MUCOPOLYSACCHARIDOSIS TYPE VI	ARSB, TYR210CYS	118203943
611542	411	ARSB	0010	MUCOPOLYSACCHARIDOSIS TYPE VI	ARSB, HIS393PRO	118203944
611542	411	ARSB	0011	MUCOPOLYSACCHARIDOSIS TYPE VI	ARSB, IVS5AS, G-C,-1	
611542	411	ARSB	0012	MUCOPOLYSACCHARIDOSIS TYPE VI	ARSB, IVS5AS, T-G, -8	
611550	259197	NCR3	0001	MALARIA, MILD, SUSCEPTIBILITY TO	NCR3, -412G-C, 5-PRIME UTR	2736191
611559	7380	UPK3A	0001	RENAL ADYSPLASIA UROGENITAL ADYSPLASIA, INCLUDED	UPK3A, PRO273LEU	121918186
611559	7380	UPK3A	0002	RENAL ADYSPLASIA	UPK3A, 1003T-C	
611559	7380	UPK3A	0003	RENAL ADYSPLASIA	UPK3A, GLY202ASP	121918187
611562	124404	SEPT12	0001	SPERMATOGENIC FAILURE 10, SUSCEPTIBILITY TO	SEPT12, 474G-A	
611562	124404	SEPT12	0002	SPERMATOGENIC FAILURE 10, SUSCEPTIBILITY TO	SEPT12, THR89MET	
611562	124404	SEPT12	0003	SPERMATOGENIC FAILURE 10, SUSCEPTIBILITY TO	SEPT12, ASP197ASN	
611570	2203	FBP1	0001	FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	FBP1, 1-BP INS, 960G	
611570	2203	FBP1	0002	FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	FBP1, GLY164SER	121918188
611570	2203	FBP1	0003	FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	FBP1, ALA177ASP	121918189
611570	2203	FBP1	0004	FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	FBP1, GLU30TER	121918190
611570	2203	FBP1	0005	FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	FBP1, PHE194SER	121918191
611570	2203	FBP1	0006	FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	FBP1, PRO284ARG	121918192
611592	10667	FARS2	0001	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14	FARS2, TYR144CYS	
611592	10667	FARS2	0002	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14	FARS2, ILE329THR	
611592	10667	FARS2	0003	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14	FARS2, ASP391VAL	
611605	11160	ERLIN2	0001	SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE	ERLIN2, 2-BP INS, 812AC	
611606	407053	MIR96	0001	DEAFNESS, AUTOSOMAL DOMINANT 50	MIR96, 13G-A	
611606	407053	MIR96	0002	DEAFNESS, AUTOSOMAL DOMINANT 50	MIR96, 14C-A	
611632	29914	UBIAD1	0001	CORNEAL DYSTROPHY, SCHNYDER	UBIAD1, ASN102SER	118203945
611632	29914	UBIAD1	0002	CORNEAL DYSTROPHY, SCHNYDER	UBIAD1, GLY177ARG	118203946
611632	29914	UBIAD1	0003	CORNEAL DYSTROPHY, SCHNYDER	UBIAD1, ARG119GLY	118203947
611632	29914	UBIAD1	0004	CORNEAL DYSTROPHY, SCHNYDER	UBIAD1, THR175ILE	118203948
611632	29914	UBIAD1	0005	CORNEAL DYSTROPHY, SCHNYDER	UBIAD1, ASN232SER	118203949
611632	29914	UBIAD1	0006	CORNEAL DYSTROPHY, SCHNYDER	UBIAD1, ASP112GLY	118203950
611632	29914	UBIAD1	0007	CORNEAL DYSTROPHY, SCHNYDER	UBIAD1, SER171PRO	118203951
611632	29914	UBIAD1	0008	CORNEAL DYSTROPHY, SCHNYDER	UBIAD1, GLY186ARG	118203952
611632	29914	UBIAD1	0009	CORNEAL DYSTROPHY, SCHNYDER	UBIAD1, ASP236GLU	118203953
611632	29914	UBIAD1	0010	CORNEAL DYSTROPHY, SCHNYDER	UBIAD1, GLY177GLU	
611642	220296	HEPACAM	0001	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A	HEPACAM, SER196TYR	
611642	220296	HEPACAM	0002	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A	HEPACAM, TRP263TER	
611642	220296	HEPACAM	0003	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A	HEPACAM, ARG92GLN	
611642	220296	HEPACAM	0004	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A	HEPACAM, ASP211ASN	
611642	220296	HEPACAM	0005	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A	HEPACAM, ARG98CYS	
611642	220296	HEPACAM	0006	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION	HEPACAM, GLY89SER	
611642	220296	HEPACAM	0007	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH MENTAL RETARDATION	HEPACAM, GLY89ASP	
611642	220296	HEPACAM	0008	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION	HEPACAM, ARG92TRP	
611672	113235	SLC46A1	0001	FOLATE MALABSORPTION, HEREDITARY	SLC46A1, IVS2AS, G-A, -1	80338775
611672	113235	SLC46A1	0002	FOLATE MALABSORPTION, HEREDITARY	SLC46A1, 1-BP DEL, 194G	80338769
611672	113235	SLC46A1	0003	FOLATE MALABSORPTION, HEREDITARY	SLC46A1, ARG113SER	80338770
611672	113235	SLC46A1	0004	FOLATE MALABSORPTION, HEREDITARY	SLC46A1, SER318ARG	80338772
611672	113235	SLC46A1	0005	FOLATE MALABSORPTION, HEREDITARY	SLC46A1, ARG376TRP	80338773
611672	113235	SLC46A1	0006	FOLATE MALABSORPTION, HEREDITARY	SLC46A1, ARG113CYS	80338770
611672	113235	SLC46A1	0007	FOLATE MALABSORPTION, HEREDITARY	SLC46A1, 1-BP INS, 17C	
611672	113235	SLC46A1	0008	FOLATE MALABSORPTION, HEREDITARY	SLC46A1, ALA335ASP	
611672	113235	SLC46A1	0009	FOLATE MALABSORPTION, HEREDITARY	SLC46A1, 2-BP DEL, 204CC	
611672	113235	SLC46A1	0010	FOLATE MALABSORPTION, HEREDITARY	SLC46A1, GLY338ARG	
611684	9733	SART3	0001	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	SART3, VAL591MET	118203954
611687	154288	KHDC3L	0001	HYDATIDIFORM MOLE, RECURRENT, 2	KDHC3L, 3G-T	
611687	154288	KHDC3L	0002	HYDATIDIFORM MOLE, RECURRENT, 2	KDHC3L, 4-BP DEL, 322GACT	
611687	154288	KHDC3L	0003	HYDATIDIFORM MOLE, RECURRENT, 2	KDHC3L, 1A-G	
611693	79827	CLMP	0001	CONGENITAL SHORT BOWEL AND MALROTATION SYNDROME	CLMP, 1-BP DEL, 230A	
611693	79827	CLMP	0002	CONGENITAL SHORT BOWEL AND MALROTATION SYNDROME	CLMP, 1180G-A	
611693	79827	CLMP	0003	CONGENITAL SHORT BOWEL AND MALROTATION SYNDROME	CLMP, ARG222TER	
611693	79827	CLMP	0004	CONGENITAL SHORT BOWEL AND MALROTATION SYNDROME	CLMP, VAL124ASP	
611695	146057	TTBK2	0001	SPINOCEREBELLAR ATAXIA 11	TTBK2, 1-BP INS, 1329A	80356538
611695	146057	TTBK2	0002	SPINOCEREBELLAR ATAXIA 11	TTBK2, 2-BP DEL, 1284GA	80356539
611715	79644	SRD5A3	0001	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iq	SRD5A3, 3-BP DEL/10-BP INS, NT286	
611715	79644	SRD5A3	0002	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iq	SRD5A3, TRP107TER	
611715	79644	SRD5A3	0003	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iq	SRD5A3, ARG142TER	
611715	79644	SRD5A3	0004	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iq	SRD5A3, TYR163TER	
611715	79644	SRD5A3	0005	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iq	SRD5A3, SER10TER	
611715	79644	SRD5A3	0006	KAHRIZI SYNDROME	SRD5A3, 1-BP DUP, 203C	
611716	23545	ATP6V0A2	0001	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA	ATP6V0A2, GLN765TER	80356758
611716	23545	ATP6V0A2	0002	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA	ATP6V0A2, ARG63TER	80356750
611716	23545	ATP6V0A2	0003	WRINKLY SKIN SYNDROME	ATP6V0A2, 10132G-A	
611716	23545	ATP6V0A2	0004	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA	ATP6V0A2, 7-BP DEL, NT2355	
611716	23545	ATP6V0A2	0005	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA	ATP6V0A2, 1-BP INS, 100A	
611725	154881	KCTD7	0001	EPILEPSY, PROGRESSIVE MYOCLONIC 3, WITHOUT INTRACELLULAR INCLUSIONS	KCTD7, ARG99TER	
611725	154881	KCTD7	0002	EPILEPSY, PROGRESSIVE MYOCLONIC 3, WITH INTRACELLULAR INCLUSIONS	KCTD7, ARG184CYS	
611725	154881	KCTD7	0003	EPILEPSY, PROGRESSIVE MYOCLONIC 3, WITHOUT INTRACELLULAR INCLUSIONS	KCTD7, ARG94TRP	
611725	154881	KCTD7	0004	EPILEPSY, PROGRESSIVE MYOCLONIC 3, WITHOUT INTRACELLULAR INCLUSIONS	KCTD7, 1-BP DEL, 594C	
611725	154881	KCTD7	0005	EPILEPSY, PROGRESSIVE MYOCLONIC 3, WITHOUT INTRACELLULAR INCLUSIONS	KCTD7, ASN273ILE	
611725	154881	KCTD7	0006	EPILEPSY, PROGRESSIVE MYOCLONIC 3, WITHOUT INTRACELLULAR INCLUSIONS	KCTD7, ASP115TYR	
611725	154881	KCTD7	0007	EPILEPSY, PROGRESSIVE MYOCLONIC 3, WITHOUT INTRACELLULAR INCLUSIONS	KCTD7, LEU108MET	
611731	324	APC	0001	FAMILIAL ADENOMATOUS POLYPOSIS 1	APC, 2-BP DEL, EX7	
611731	324	APC	0002	FAMILIAL ADENOMATOUS POLYPOSIS 1	APC, ARG-TER, 904C-T	
611731	324	APC	0003	FAMILIAL ADENOMATOUS POLYPOSIS 1	APC, 1-BP DEL, EX10	
611731	324	APC	0004	FAMILIAL ADENOMATOUS POLYPOSIS 1	APC, TYR-TER, 1500T-G	
611731	324	APC	0005	GARDNER SYNDROME	APC, ARG414CYS	137854567
611731	324	APC	0006	FAMILIAL ADENOMATOUS POLYPOSIS 1 GARDNER SYNDROME, INCLUDED	APC, ARG302TER	137854568
611731	324	APC	0007	GARDNER SYNDROME	APC, SER280TER	137854569
611731	324	APC	0008	GARDNER SYNDROME	APC, SER713TER	137854570
611731	324	APC	0009	COLORECTAL CANCER, SOMATIC	APC, GLN1338TER	121913327
611731	324	APC	0010	GASTRIC CANCER, SOMATIC	APC, GLY1120GLU	28933379
611731	324	APC	0011	GASTRIC CANCER, SOMATIC	APC, GLN1067TER	137854571
611731	324	APC	0012	FAMILIAL ADENOMATOUS POLYPOSIS 1	APC, 4-BP DEL, CODON 169	
611731	324	APC	0013	FAMILIAL ADENOMATOUS POLYPOSIS 1	APC, 1-BP INS, ILE357	
611731	324	APC	0014	FAMILIAL ADENOMATOUS POLYPOSIS 1 BRAIN TUMOR-POLYPOSIS SYNDROME 2, INCLUDED	APC, GLN541TER	137854572
611731	324	APC	0015	FAMILIAL ADENOMATOUS POLYPOSIS 1	APC, ARG554TER	137854573
611731	324	APC	0016	FAMILIAL ADENOMATOUS POLYPOSIS 1	APC, ARG564TER	137854574
611731	324	APC	0017	FAMILIAL ADENOMATOUS POLYPOSIS 1	APC, 1-BP INS, CODON 629	
611731	324	APC	0018	FAMILIAL ADENOMATOUS POLYPOSIS 1	APC, TYR935TER	137854575
611731	324	APC	0019	GARDNER SYNDROME ADENOMA, PERIAMPULLARY, SOMATIC, INCLUDED	APC, 2-BP DEL, CODON 1465	
611731	324	APC	0020	ADENOMA, PERIAMPULLARY, SOMATIC	APC, 4-BP DEL, CODON 1464	
611731	324	APC	0021	FAMILIAL ADENOMATOUS POLYPOSIS 1, ATTENUATED	APC, TRP157TER	137854576
611731	324	APC	0022	FAMILIAL ADENOMATOUS POLYPOSIS 1 BRAIN TUMOR-POLYPOSIS SYNDROME 2, INCLUDED	APC, GLN215TER	137854577
611731	324	APC	0023	FAMILIAL ADENOMATOUS POLYPOSIS 1 GARDNER SYNDROME, INCLUDED;; ADENOMATOUS POLYPOSIS COLI WITH CONGENITAL CHOLESTEATOMA, INCLUDED	APC, 5-BP DEL, CODON 1309	
611731	324	APC	0024	HEPATOBLASTOMA, SOMATIC	APC, SER1395CYS	137854578
611731	324	APC	0025	DESMOID DISEASE, HEREDITARY	APC, 2-BP INS, CODON 1924	
611731	324	APC	0026	DESMOID DISEASE, HEREDITARY	APC, 4-BP DEL, NT5844	
611731	324	APC	0027	FAMILIAL ADENOMATOUS POLYPOSIS 1	APC, 1-BP DEL, EX15	
611731	324	APC	0028	FAMILIAL ADENOMATOUS POLYPOSIS 1, ATTENUATED	APC, 4-BP DEL, EX15	
611731	324	APC	0029	FAMILIAL ADENOMATOUS POLYPOSIS 1, SUSCEPTIBILITY TO BREAST CANCER, SUSCEPTIBILITY TO, INCLUDED	APC, ILE1307LYS	1801155
611731	324	APC	0030	GARDNER SYNDROME	APC, 2-BP DEL, 1538AG	
611731	324	APC	0031	GARDNER SYNDROME	APC, ARG499TER	137854580
611731	324	APC	0032	FAMILIAL ADENOMATOUS POLYPOSIS 1	APC, TYR486TER	
611731	324	APC	0033	FAMILIAL ADENOMATOUS POLYPOSIS 1	APC, 3-BP DEL	
611731	324	APC	0034	FAMILIAL ADENOMATOUS POLYPOSIS 1, ATTENUATED	APC, 2-BP DEL	
611731	324	APC	0035	FAMILIAL ADENOMATOUS POLYPOSIS 1, ATTENUATED	APC, 2-BP DEL	
611731	324	APC	0036	FAMILIAL ADENOMATOUS POLYPOSIS 1, ATTENUATED	APC, GLU1317GLN	1801166
611731	324	APC	0037	FAMILIAL ADENOMATOUS POLYPOSIS 1	APC, 1-BP DEL, 5960A	
611731	324	APC	0038	FAMILIAL ADENOMATOUS POLYPOSIS 1, ATTENUATED	APC, 2-BP DEL, 937GA	
611731	324	APC	0039	GARDNER SYNDROME	APC, LEU698TER	137854582
611731	324	APC	0040	DESMOID DISEASE, HEREDITARY	APC, 337-BP INS	
611731	324	APC	0042	FAMILIAL ADENOMATOUS POLYPOSIS 1, ATTENUATED	APC, DEL	
611731	324	APC	0043	FAMILIAL ADENOMATOUS POLYPOSIS 1, ATTENUATED	APC, IVS3AS, G-A, -1	
611731	324	APC	0044	FAMILIAL ADENOMATOUS POLYPOSIS 1	APC, 11-BP INS, NT1060	
611731	324	APC	0045	DESMOID DISEASE, HEREDITARY	APC, 4-BP DEL, 7929TCTA	
611731	324	APC	0046	DESMOID TUMOR, SOMATIC	APC, 1-BP DEL, 3720T	
611731	324	APC	0047	GARDNER SYNDROME	APC, GLN208TER	137854583
611731	324	APC	0048	HEPATOCELLULAR CARCINOMA, SOMATIC	APC, 1-BP DEL	
611731	324	APC	0049	FAMILIAL ADENOMATOUS POLYPOSIS 1, ATTENUATED	APC, 56-KB DEL, EX15DEL	
611731	324	APC	0050	FAMILIAL ADENOMATOUS POLYPOSIS 1	APC, 73-KB DEL, EX15DEL	
611731	324	APC	0051	FAMILIAL ADENOMATOUS POLYPOSIS 1	APC, 5-BP DEL, NT3221	
611744	54726	OTUD4	0001	VARIANT OF UNKNOWN SIGNIFICANCE	OTUD4, GLY333VAL	
611761	64788	LMF1	0001	LIPASE DEFICIENCY, COMBINED	LMF1, TYR439TER	121909397
611766	123263	MTFMT	0001	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15 LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY, INCLUDED	MTFMT, SER209LEU	
611766	123263	MTFMT	0002	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15	MTFMT, ARG128TER	
611766	123263	MTFMT	0003	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15	MTFMT, SER125LEU	
611766	123263	MTFMT	0004	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY	MTFMT, ARG332TER	
611770	137814	NKX2-6	0001	PERSISTENT TRUNCUS ARTERIOSUS	NKX2-6, PHE151LEU	
611776	29078	NDUFAF4	0001	MITOCHONDRIAL COMPLEX I DEFICIENCY	C6ORF66, LEU65PRO	63751061
611778	23171	GPD1L	0001	BRUGADA SYNDROME 2	GPD1L, ALA280VAL	72552291
611778	23171	GPD1L	0002	BRUGADA SYNDROME 2	GPD1L, GLU83LYS	72552292
611778	23171	GPD1L	0003	BRUGADA SYNDROME 2	GPD1L, ILE124VAL	72552293
611778	23171	GPD1L	0004	BRUGADA SYNDROME 2	GPD1L, ARG273CYS	72552294
611908	91869	RFT1	0001	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE In	RFT1, ARG67CYS	118203913
611910	387700	SLC16A12	0001	CATARACT, JUVENILE, WITH MICROCORNEA AND RENAL GLUCOSURIA	SLC16A12, GLN215TER	121909386
611911	23479	ISCU	0001	MYOPATHY WITH LACTIC ACIDOSIS, HEREDITARY	ISCU, IVS5, G-C, +382	
611911	23479	ISCU	0002	MYOPATHY WITH LACTIC ACIDOSIS, HEREDITARY	ISCU, GLY50GLU	
611925	349149	GJC3	0001	VARIANT OF UNKNOWN SIGNIFICANCE	GJC3, GLU269ASP	
611927	286077	FAM83H	0001	AMELOGENESIS IMPERFECTA, TYPE III	FAM83H, ARG325TER	137854435
611927	286077	FAM83H	0002	AMELOGENESIS IMPERFECTA, TYPE III	FAM83H, GLN398TER	137854436
611927	286077	FAM83H	0003	AMELOGENESIS IMPERFECTA, TYPE III	FAM83H, GLU415TER	137854437
611927	286077	FAM83H	0004	AMELOGENESIS IMPERFECTA, TYPE III	FAM83H, TYR297TER	137854438
611927	286077	FAM83H	0005	AMELOGENESIS IMPERFECTA, TYPE III	FAM83H, TRP460TER	137854439
611927	286077	FAM83H	0006	AMELOGENESIS IMPERFECTA, TYPE III	FAM83H, GLN677TER	137854440
611927	286077	FAM83H	0007	AMELOGENESIS IMPERFECTA, TYPE III	FAM83H, GLN470TER	137854441
611927	286077	FAM83H	0008	AMELOGENESIS IMPERFECTA, TYPE III	FAM83H, SER287TER	137854442
611927	286077	FAM83H	0009	AMELOGENESIS IMPERFECTA, TYPE III, LOCALIZED	FAM83H, GLU694TER	137854443
611927	286077	FAM83H	0010	AMELOGENESIS IMPERFECTA, TYPE III, LOCALIZED	FAM83H, 2-BP DEL, 1872CC	
611927	286077	FAM83H	0011	AMELOGENESIS IMPERFECTA, TYPE III	FAM83H, 2-BP DEL, 923TC	
611927	286077	FAM83H	0012	AMELOGENESIS IMPERFECTA, TYPE III	FAM83H, TRP460TER	137854444
611927	286077	FAM83H	0013	AMELOGENESIS IMPERFECTA, TYPE III	FAM83H, GLN456TER	
611935	27249	MMADHC	0001	HOMOCYSTINURIA, cblD TYPE, VARIANT 1	MMADHC, LEU259PRO	118204044
611935	27249	MMADHC	0002	HOMOCYSTINURIA, cblD TYPE, VARIANT 1	MMADHC, THR182ASN	118204045
611935	27249	MMADHC	0003	HOMOCYSTINURIA, cblD TYPE, VARIANT 1	MMADHC, TYR249CYS	118204046
611935	27249	MMADHC	0004	METHYLMALONIC ACIDURIA, cblD TYPE, VARIANT 2	MMADHC, 8-BP DEL, NT57	
611935	27249	MMADHC	0005	METHYLMALONIC ACIDURIA, cblD TYPE, VARIANT 2	MMADHC, ARG54TER	118204047
611935	27249	MMADHC	0006	METHYLMALONIC ACIDURIA, cblD TYPE, VARIANT 2	MMADHC, 18-BP DUP, NT307	
611935	27249	MMADHC	0007	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblD TYPE	MMADHC, ARG250TER	118204048
611935	27249	MMADHC	0008	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblD TYPE	MMADHC, 1-BP DUP, 419A	
611935	27249	MMADHC	0009	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblD TYPE	MMADHC, IVS7DS, 4-BP DEL	
611951	80776	B9D2	0001	MECKEL SYNDROME, TYPE 10	B9D2, SER101ARG	
611966	83696	TRAPPC9	0001	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13	TRAPPC9, ARG475TER	
611966	83696	TRAPPC9	0002	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13	TRAPPC9, ARG570TER	
611966	83696	TRAPPC9	0003	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13	TRAPPC9, 4-BP DEL, 2311TGTT	
611966	83696	TRAPPC9	0004	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13	TRAPPC9, IVS17AS, A-C, -2	
612003	26058	GIGYF2	0001	PARKINSON DISEASE 11	GIGYF2, ASN56SER	72554080
612003	26058	GIGYF2	0002	PARKINSON DISEASE 11	GIGYF2, ASN457THR	116074753
612003	26058	GIGYF2	0003	PARKINSON DISEASE 11	GIGYF2, ASP606GLU	118203903
612003	26058	GIGYF2	0004	PARKINSON DISEASE 11	GIGYF2, ILE278VAL	118203904
612003	26058	GIGYF2	0005	PARKINSON DISEASE 11	GIGYF2, LYS421ARG	
612012	23503	ZFYVE26	0001	SPASTIC PARAPLEGIA 15, AUTOSOMAL RECESSIVE	ZFYVE26, ARG1438TER	118204049
612012	23503	ZFYVE26	0002	SPASTIC PARAPLEGIA 15, AUTOSOMAL RECESSIVE	ZFYVE26, IVS28AS, G-A, -1	
612012	23503	ZFYVE26	0003	SPASTIC PARAPLEGIA 15, AUTOSOMAL RECESSIVE	ZFYVE26, 70-BP DEL, NT6702	
612012	23503	ZFYVE26	0004	SPASTIC PARAPLEGIA 15, AUTOSOMAL RECESSIVE	ZFYVE26, GLN493TER	118204050
612012	23503	ZFYVE26	0005	SPASTIC PARAPLEGIA 15, AUTOSOMAL RECESSIVE	ZFYVE26, 1-BP DEL, 5036T	
612012	23503	ZFYVE26	0006	SPASTIC PARAPLEGIA 15, AUTOSOMAL RECESSIVE	ZFYVE26, GLN1808TER	
612013	57545	CC2D2A	0001	JOUBERT SYNDROME 9	CC2D2A, IVS19DS, G-C, +1	
612013	57545	CC2D2A	0002	MECKEL SYNDROME, TYPE 6	CC2D2A, 1762C-T	
612013	57545	CC2D2A	0003	JOUBERT SYNDROME 9	CC2D2A, PRO1122SER	118204051
612013	57545	CC2D2A	0004	JOUBERT SYNDROME 9	CC2D2A, ARG1528CYS	118204052
612013	57545	CC2D2A	0005	JOUBERT SYNDROME 9	CC2D2A, ARG950TER	118204053
612013	57545	CC2D2A	0006	JOUBERT SYNDROME 9	CC2D2A, 1-BP DEL, 3289G	
612013	57545	CC2D2A	0007	COACH SYNDROME JOUBERT SYNDROME 9/15, DIGENIC, INCLUDED	CC2D2A, ARG1049TER	
612013	57545	CC2D2A	0008	COACH SYNDROME	CC2D2A, THR1116MET	
612013	57545	CC2D2A	0009	JOUBERT SYNDROME 9/15, DIGENIC	CC2D2A, GLU1447ALA	
612014	79809	TTC21B	0001	NEPHRONOPHTHISIS 12	TTC21B, PRO209LEU	
612014	79809	TTC21B	0002	NEPHRONOPHTHISIS 12	TTC21B, CYS552TER	
612014	79809	TTC21B	0003	NEPHRONOPHTHISIS 12	TTC21B, IVS20AS, A-G, -2	
612014	79809	TTC21B	0004	ASPHYXIATING THORACIC DYSTROPHY 4	TTC21B, ARG411TER	
612014	79809	TTC21B	0005	ASPHYXIATING THORACIC DYSTROPHY 4	TTC21B, LEU795PRO	
612025	389434	IYD	0001	THYROID DYSHORMONOGENESIS 4	IYD, ARG101TRP	121918138
612025	389434	IYD	0002	THYROID DYSHORMONOGENESIS 4	IYD, 3-BP DEL, 315CAT	
612025	389434	IYD	0003	THYROID DYSHORMONOGENESIS 4	IYD, ILE116THR	121918139
612025	389434	IYD	0004	THYROID DYSHORMONOGENESIS 4	IYD, ALA220TYR	121918140
612026	51574	LARP7	0001	ALAZAMI SYNDROME	LARP7, 7-BP DUP, NT1024	
612026	51574	LARP7	0002	ALAZAMI SYNDROME	LARP7, K276fs	
612035	57505	AARS2	0001	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 8	AARS2, ARG592TRP	
612035	57505	AARS2	0002	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 8	AARS2, LEU155ARG	
612041	285498	RNF212	0001	RECOMBINATION RATE QUANTITATIVE TRAIT LOCUS 1	RNF212, IVS, C/T	3796619
612041	285498	RNF212	0002	RECOMBINATION RATE QUANTITATIVE TRAIT LOCUS 1	RNF212, IVS, C/T	1670533
612048	79188	TMEM43	0001	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 5	TMEM43, SER358LEU	63750743
612048	79188	TMEM43	0002	EMERY-DREIFUSS MUSCULAR DYSTROPHY 7, AUTOSOMAL DOMINANT	TMEM43, GLU85LYS	
612048	79188	TMEM43	0003	EMERY-DREIFUSS MUSCULAR DYSTROPHY 7, AUTOSOMAL DOMINANT	TMEM43, ILE91VAL	
612051	146227	BEAN1	0001	SPINOCEREBELLAR ATAXIA 31	BEAN, 2.5- TO 3.8-KB INS	
612074	55131	RBM28	0001	ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME	RBM28, LEU351PRO	118204055
612078	84627	ZNF469	0001	BRITTLE CORNEA SYNDROME 1	ZNF469, 1-BP DEL, 5943A	
612078	84627	ZNF469	0002	BRITTLE CORNEA SYNDROME 1	ZNF469, 1-BP DEL, 9527G	
612078	84627	ZNF469	0003	BRITTLE CORNEA SYNDROME 1	ZNF469, CYS3339TYR	
612078	84627	ZNF469	0004	BRITTLE CORNEA SYNDROME 1	ZNF469, GLU1392TER	
612080	27089	UQCRQ	0001	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4	UQCRQ, SER45PHE	11544803
612105	100144748	KLLN	0001	COWDEN DISEASE 4	KLLN, PROMOTER HYPERMETHYLATION	
612120	63924	CIDEC	0001	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 5 (1 family)	CIDEC, GLU186TER	
612121	285848	PNPLA1	0001	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 10	PNPLA1, GLU131TER	
612121	285848	PNPLA1	0002	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 10	PNPLA1, ALA59VAL	
612163	219931	TPCN2	0001	SKIN/HAIR/EYE PIGMENTATION 10, BLOND/BROWN HAIR	TPCN2, MET484LEU	35264875
612163	219931	TPCN2	0002	SKIN/HAIR/EYE PIGMENTATION 10, BLOND/BROWN HAIR	TPCN2, GLY734GLU	3829241
612182	10	NAT2	0001	ACETYLATION, SLOW	NAT2, ARG197GLN	1799930
612182	10	NAT2	0002	ACETYLATION, SLOW	NAT2, ILE114THR	1801280
612182	10	NAT2	0003	ACETYLATION, SLOW	NAT2, LYS268ARG	1208
612182	10	NAT2	0004	ACETYLATION, SLOW	NAT2, GLY286GLU	1799931
612182	10	NAT2	0005	ACETYLATION, SLOW	NAT2, 191G-A	
612192	346171	ZFP57	0001	DIABETES MELLITUS, TRANSIENT NEONATAL, 1	ZFP57, CYS241TER	61730328
612192	346171	ZFP57	0002	DIABETES MELLITUS, TRANSIENT NEONATAL, 1	ZFP57, 2-BP DEL, 257AG	
612192	346171	ZFP57	0003	DIABETES MELLITUS, TRANSIENT NEONATAL, 1	ZFP57, 1-BP DEL, 1323C	
612192	346171	ZFP57	0004	DIABETES MELLITUS, TRANSIENT NEONATAL, 1	ZFP57, HIS438ASP	79020217
612192	346171	ZFP57	0005	DIABETES MELLITUS, TRANSIENT NEONATAL, 1	ZFP57, ARG228HIS	77625743
612192	346171	ZFP57	0006	DIABETES MELLITUS, TRANSIENT NEONATAL, 1	ZFP57, HIS257ASN	78378398
612192	346171	ZFP57	0007	DIABETES MELLITUS, TRANSIENT NEONATAL, 1	ZFP57, 8-BP DEL, NT838	
612222	2588	GALNS	0001	MUCOPOLYSACCHARIDOSIS TYPE IVA	GALNS, ASN204LYS	118204435
612222	2588	GALNS	0002	MUCOPOLYSACCHARIDOSIS TYPE IVA	GALNS, ALA138VAL	118204436
612222	2588	GALNS	0003	MUCOPOLYSACCHARIDOSIS TYPE IVA	GALNS, ARG386CYS	118204437
612222	2588	GALNS	0004	MUCOPOLYSACCHARIDOSIS TYPE IVA	GALNS, 2-BP DEL, 1343CA	
612222	2588	GALNS	0005	MUCOPOLYSACCHARIDOSIS TYPE IVA	GALNS, ILE113PHE	118204438
612222	2588	GALNS	0006	MUCOPOLYSACCHARIDOSIS TYPE IVA	GALNS, GLN473TER	118204439
612222	2588	GALNS	0007	MUCOPOLYSACCHARIDOSIS TYPE IVA	GALNS, ASN487SER	118204440
612222	2588	GALNS	0008	MUCOPOLYSACCHARIDOSIS TYPE IVA	GALNS, ARG94GLY	118204441
612222	2588	GALNS	0009	MUCOPOLYSACCHARIDOSIS TYPE IVA	GALNS, ARG259GLN	118204442
612222	2588	GALNS	0010	MUCOPOLYSACCHARIDOSIS TYPE IVA	GALNS, GLY301CYS	118204443
612222	2588	GALNS	0011	MUCOPOLYSACCHARIDOSIS TYPE IVA	GALNS, SER162PHE	118204444
612222	2588	GALNS	0012	MUCOPOLYSACCHARIDOSIS TYPE IVA	GALNS, PHE69VAL	118204445
612222	2588	GALNS	0013	MUCOPOLYSACCHARIDOSIS TYPE IVA	GALNS, THR312SER	118204446
612222	2588	GALNS	0014	MUCOPOLYSACCHARIDOSIS TYPE IVA	GALNS, ASP60ASN	118204447
612222	2588	GALNS	0015	MUCOPOLYSACCHARIDOSIS TYPE IVA	GALNS, ALA291THR	118204448
612222	2588	GALNS	0016	MUCOPOLYSACCHARIDOSIS TYPE IVA	GALNS, TRP230TER	118204449
612222	2588	GALNS	0017	MUCOPOLYSACCHARIDOSIS TYPE IVA	GALNS, 1-BP DEL, 1374T	
612222	2588	GALNS	0018	MUCOPOLYSACCHARIDOSIS TYPE IVA	GALNS, GLY340ASP	
612277	9719	ADAMTSL2	0001	GELEOPHYSIC DYSPLASIA 1	ADAMTSL2, PRO147LEU	113994121
612277	9719	ADAMTSL2	0002	GELEOPHYSIC DYSPLASIA 1	ADAMTSL2, ARG113HIS	113994122
612277	9719	ADAMTSL2	0003	GELEOPHYSIC DYSPLASIA 1	ADAMTSL2, GLU114LYS	113994123
612277	9719	ADAMTSL2	0004	GELEOPHYSIC DYSPLASIA 1	ADAMTSL2, GLU811ARG	113994124
612277	9719	ADAMTSL2	0005	GELEOPHYSIC DYSPLASIA 1	ADAMTSL2, TRP862TER	113994125
612277	9719	ADAMTSL2	0006	GELEOPHYSIC DYSPLASIA 1	ADAMTSL2, ARG72GLN	
612277	9719	ADAMTSL2	0007	GELEOPHYSIC DYSPLASIA 1	ADAMTSL2, ARG221CYS	
612280	2517	FUCA1	0001	FUCOSIDOSIS	FUCA1, GLN351TER	118204450
612280	2517	FUCA1	0002	FUCOSIDOSIS	FUCA1, 2-EX DEL	
612280	2517	FUCA1	0003	FUCOSIDOSIS	FUCA1, GLU375TER	80358195
612280	2517	FUCA1	0004	FUCOSIDOSIS	FUCA1, IVS5DS, G-A, +1	
612280	2517	FUCA1	0005	FUCOSIDOSIS	FUCA1, GLN77TER	80358196
612280	2517	FUCA1	0006	FUCOSIDOSIS	FUCA1, TRP382TER	80358197
612280	2517	FUCA1	0007	FUCOSIDOSIS	FUCA1, TYR211TER	80358198
612280	2517	FUCA1	0008	FUCOSIDOSIS	FUCA1, 1-BP DEL, EX2	
612280	2517	FUCA1	0009	FUCOSIDOSIS	FUCA1, 1-BP DEL, EX5	
612280	2517	FUCA1	0010	FUCOSIDOSIS	FUCA1, 1-BP DEL, EX3	
612280	2517	FUCA1	0011	FU1/FU2 POLYMORPHISM	FUCA1, GLN281ARG	13551
612280	2517	FUCA1	0012	FUCOSIDOSIS	FUCA1, LEU405ARG	80358199
612283	5624	PROC	0001	THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT	PROC, ARG306TER	121918141
612283	5624	PROC	0002	THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT	PROC, TRP402CYS	121918142
612283	5624	PROC	0003	THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE	PROC, ARG12TRP	
612283	5624	PROC	0004	THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE, INCLUDED	PROC, ARG169TRP	121918143
612283	5624	PROC	0005	THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE	PROC, ALA259VAL	121918144
612283	5624	PROC	0006	THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE	PROC, PRO168LEU	121918145
612283	5624	PROC	0007	THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE	PROC, ALA267THR	121918146
612283	5624	PROC	0008	THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE	PROC, GLY301SER	121918147
612283	5624	PROC	0009	THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE	PROC, GLU20ALA	121918148
612283	5624	PROC	0010	THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE	PROC, VAL34MET	121918149
612283	5624	PROC	0011	THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE	PROC, GLY292SER	121918150
612283	5624	PROC	0012	THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE	PROC, PRO247LEU	121918151
612283	5624	PROC	0013	THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT	PROC, ARG178TRP	121918152
612283	5624	PROC	0014	THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT	PROC, ARG178GLN	121918153
612283	5624	PROC	0015	THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT	PROC, 1-BP DEL, 8857G	
612283	5624	PROC	0016	THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT	PROC, ARG230CYS	121918154
612283	5624	PROC	0017	THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT	PROC, 2-BP INS, 6139TT	
612283	5624	PROC	0018	THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT	PROC, IVS7DS, C-T, +9	
612283	5624	PROC	0019	THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT	PROC, GLN184HIS	121918155
612283	5624	PROC	0020	THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE	PROC, LEU223PHE	121918156
612283	5624	PROC	0021	THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE	PROC, ILE403MET	121918157
612283	5624	PROC	0022	THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT	PROC, VAL297MET	121918158
612283	5624	PROC	0023	THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT	PROC, -14T-C	
612283	5624	PROC	0024	THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT	PROC, HIS107PRO	121918159
612283	5624	PROC	0025	THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT	PROC, SER270LEU	121918160
612309	2153	F5	0001	THROMBOPHILIA DUE TO FACTOR V LEIDEN STROKE, ISCHEMIC, SUSCEPTIBILITY TO, INCLUDED;; BUDD-CHIARI SYNDROME, SUSCEPTIBILITY TO, INCLUDED;; PREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 1, INCLUDED	F5, ARG506GLN	6025
612309	2153	F5	0002	FACTOR V HONG KONG	F5, ARG306GLY	118203905
612309	2153	F5	0003	THROMBOPHILIA DUE TO ACTIVATED PROTEIN C RESISTANCE	F5, ARG306THR	118203906
612309	2153	F5	0004	FACTOR V DEFICIENCY	F5, 4-BP DEL, EX13	
612309	2153	F5	0005	FACTOR V DEFICIENCY	F5, 4-BP INS, 2805ATTG	
612309	2153	F5	0006	FACTOR V DEFICIENCY	F5, 8-BP DEL, NT1131	
612309	2153	F5	0007	FACTOR V DEFICIENCY	F5, TYR1702CYS	118203907
612309	2153	F5	0008	FACTOR V DEFICIENCY	F5, GLN773TER	118203908
612309	2153	F5	0009	FACTOR V DEFICIENCY	F5, ARG1133TER	118203909
612309	2153	F5	0010	FACTOR V DEFICIENCY	F5, 1-BP DEL, 2952T	
612309	2153	F5	0011	FACTOR V DEFICIENCY	F5, 1-BP INS, 5493G	
612309	2153	F5	0012	FACTOR V DEFICIENCY	F5, ARG2074CYS	118203910
612309	2153	F5	0013	THROMBOPHILIA DUE TO ACTIVATED PROTEIN C RESISTANCE	F5, ILE359THR	118203911
612309	2153	F5	0014	THROMBOPHILIA DUE TO ACTIVATED PROTEIN C RESISTANCE	F5, GLU119TER	118203912
612322	22868	FASTKD2	0001	MITOCHONDRIAL COMPLEX IV DEFICIENCY	FASTKD2, ARG416TER	118203917
612325	22858	ICK	0001	ENDOCRINE-CEREBROOSTEODYSPLASIA	ICK, ARG272GLN	118203918
612349	5053	PAH	0001	PHENYLKETONURIA	PAH, IVS12DS, G-A, +1	
612349	5053	PAH	0002	PHENYLKETONURIA	PAH, ARG408TRP	5030858
612349	5053	PAH	0003	PHENYLKETONURIA	PAH, LEU311PRO	62642936
612349	5053	PAH	0004	PHENYLKETONURIA	PAH, GLU280LYS	62508698
612349	5053	PAH	0005	PHENYLKETONURIA	PAH, ARG111TER	76296470
612349	5053	PAH	0006	PHENYLKETONURIA	PAH, ARG261GLN	5030849
612349	5053	PAH	0007	PHENYLKETONURIA	PAH, ARG252TRP	5030847
612349	5053	PAH	0008	PHENYLKETONURIA	PAH, EX3DEL	
612349	5053	PAH	0009	PHENYLKETONURIA HYPERPHENYLALANINEMIA, NON-PKU, INCLUDED	PAH, MET1VAL	62514891
612349	5053	PAH	0010	PHENYLKETONURIA	PAH, ARG158GLN	5030843
612349	5053	PAH	0011	PHENYLKETONURIA	PAH, ARG243TER	5030846
612349	5053	PAH	0012	PHENYLKETONURIA	PAH, PRO281LEU	5030851
612349	5053	PAH	0013	PHENYLKETONURIA	PAH, TYR204CYS	62514927
612349	5053	PAH	0014	PHENYLKETONURIA	PAH, ARG243GLN	62508588
612349	5053	PAH	0015	PHENYLKETONURIA	PAH, TRP326TER	62514959
612349	5053	PAH	0016	PHENYLKETONURIA	PAH, ARG413PRO	79931499
612349	5053	PAH	0017	HYPERPHENYLALANINEMIA, NON-PKU	PAH, TYR414CYS	5030860
612349	5053	PAH	0018	PHENYLKETONURIA	PAH, IVS4AS, G-A, -1	
612349	5053	PAH	0019	PHENYLKETONURIA	PAH, TYR356TER	62516095
612349	5053	PAH	0020	PHENYLKETONURIA	PAH, GLY272TER	62514952
612349	5053	PAH	0021	PHENYLKETONURIA	PAH, 3-BP DEL, CTT	
612349	5053	PAH	0023	PHENYLKETONURIA	PAH, SER273PHE	62514953
612349	5053	PAH	0025	PHENYLKETONURIA	PAH, IVS7DS, G-A, +1	
612349	5053	PAH	0026	PHENYLKETONURIA	PAH, LEU255SER	62642930
612349	5053	PAH	0027	PHENYLKETONURIA	PAH, 1197A-T	
612349	5053	PAH	0028	PHENYLKETONURIA	PAH, ALA259VAL	118203921
612349	5053	PAH	0029	PHENYLKETONURIA	PAH, TYR277ASP	78655458
612349	5053	PAH	0030	PHENYLKETONURIA	PAH, 3-BP DEL, ATC	
612349	5053	PAH	0031	PHENYLKETONURIA	PAH, PHE39LEU	62642926
612349	5053	PAH	0032	PHENYLKETONURIA	PAH, SER349ARG	
612349	5053	PAH	0033	PHENYLKETONURIA	PAH, IVS10AS, G-A, -11	
612349	5053	PAH	0034	PHENYLKETONURIA	PAH, LEU48SER	5030841
612349	5053	PAH	0035	PHENYLKETONURIA	PAH, GLU221GLY	62514934
612349	5053	PAH	0036	PHENYLKETONURIA	PAH, ARG261TER	5030850
612349	5053	PAH	0037	PHENYLKETONURIA	PAH, 1-BP DEL, CODON 55	
612349	5053	PAH	0038	PHENYLKETONURIA	PAH, ARG408GLN	5030859
612349	5053	PAH	0039	PHENYLKETONURIA	PAH, PHE299CYS	62642933
612349	5053	PAH	0040	PHENYLKETONURIA	PAH, IVS7DS, T-A, +2	
612349	5053	PAH	0041	PHENYLKETONURIA	PAH, SER349PRO	62508646
612349	5053	PAH	0042	HYPERPHENYLALANINEMIA, NON-PKU MILD	PAH, ALA322GLY	62514958
612349	5053	PAH	0043	HYPERPHENYLALANINEMIA, NON-PKU	PAH, ASP415ASN	62644499
612349	5053	PAH	0044	HYPERPHENYLALANINEMIA, NON-PKU	PAH, ILE306VAL	62642934
612349	5053	PAH	0045	PHENYLKETONURIA	PAH, VAL388MET	62516101
612349	5053	PAH	0046	PHENYLKETONURIA	PAH, 15-BP DEL, EX11	
612349	5053	PAH	0047	PHENYLKETONURIA	PAH, PRO244LEU	118203923
612349	5053	PAH	0048	PHENYLKETONURIA	PAH, MET1ILE	62514893
612349	5053	PAH	0049	PHENYLKETONURIA	PAH, IVS10AS, C-T, -3	
612349	5053	PAH	0050	HYPERPHENYLALANINEMIA, NON-PKU	PAH, LEU333PHE	62516060
612349	5053	PAH	0051	HYPERPHENYLALANINEMIA, NON-PKU PHENYLKETONURIA, INCLUDED	PAH, GLU390GLY	5030856
612349	5053	PAH	0052	PHENYLKETONURIA	PAH, SER359TER	5030854
612349	5053	PAH	0053	HYPERPHENYLALANINEMIA, NON-PKU MILD	PAH, LEU98SER	62517167
612349	5053	PAH	0054	HYPERPHENYLALANINEMIA, NON-PKU	PAH, THR380MET	62642937
612349	5053	PAH	0055	PHENYLKETONURIA	PAH, GLY46SER	74603784
612349	5053	PAH	0056	HYPERPHENYLALANINEMIA, NON-PKU	PAH, ALA47VAL	118203925
612349	5053	PAH	0057	HYPERPHENYLALANINEMIA, NON-PKU	PAH, SER87ARG	62516151
612349	5053	PAH	0058	HYPERPHENYLALANINEMIA, NON-PKU	PAH, ARG176LEU	74486803
612349	5053	PAH	0059	HYPERPHENYLALANINEMIA, NON-PKU	PAH, VAL245ALA	76212747
612349	5053	PAH	0060	HYPERPHENYLALANINEMIA, NON-PKU	PAH, IVS10DS, A-G, +3	
612349	5053	PAH	0061	PHENYLKETONURIA	PAH, 1-BP DEL, 1129T	
612349	5053	PAH	0062	PHENYLKETONURIA	PAH, PRO407LEU	62644473
612349	5053	PAH	0063	PHENYLKETONURIA	PAH, ILE65THR	75193786
612349	5053	PAH	0064	PHENYLKETONURIA	PAH, EX9-11DEL	
612349	5053	PAH	0066	HYPERPHENYLALANINEMIA, NON-PKU	PAH, 3.7-KB DEL, -3.3 KB	
612349	5053	PAH	0067	HYPERPHENYLALANINEMIA, NON-PKU	PAH, GLU76GLY	62507347
612358	3827	KNG1	0001	KININOGEN DEFICIENCY, TOTAL	KNG1, ARG196TER	121918131
612358	3827	KNG1	0002	HIGH MOLECULAR WEIGHT KININOGEN DEFICIENCY	KNG1, 1-BP DEL, 1492A	
612358	3827	KNG1	0003	HIGH MOLECULAR WEIGHT KININOGEN DEFICIENCY	KNG1, 17-BP DEL/17-BP INS, NT1559	
612358	3827	KNG1	0004	HIGH MOLECULAR WEIGHT KININOGEN DEFICIENCY	KNG1, 1-BP INS, 1217C	
612360	79133	NDUFAF5	0001	MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFAF5, LEU229PRO	118203929
612360	79133	NDUFAF5	0002	MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFAF5, LEU159PHE	
612373	55315	SLC29A3	0001	HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	SLC29A3, GLY427SER	121912583
612373	55315	SLC29A3	0002	HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	SLC29A3, GLY437ARG	121912584
612373	55315	SLC29A3	0003	HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	SLC29A3, 1-BP DEL, 1045C	
612373	55315	SLC29A3	0004	HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	SLC29A3, GLU444TER	
612373	55315	SLC29A3	0005	HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	SLC29A3, 1-BP DEL, 940T	
612373	55315	SLC29A3	0006	HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	SLC29A3, MET116ARG	
612373	55315	SLC29A3	0007	HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	SLC29A3, THR449ARG	
612373	55315	SLC29A3	0008	HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	SLC29A3, IVS2, G-A, +1	
612373	55315	SLC29A3	0009	HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	SLC29A3, PHE103TER	
612373	55315	SLC29A3	0010	HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	SLC29A3, ARG363GLN	
612373	55315	SLC29A3	0011	HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	SLC29A3, ARG363TRP	
612373	55315	SLC29A3	0012	HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	SLC29A3, 1-BP DEL, 243A	
612373	55315	SLC29A3	0013	HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	SLC29A3, ARG386GLN	
612373	55315	SLC29A3	0014	HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	SLC29A3, SER203PRO	
612386	2235	FECH	0001	PROTOPORPHYRIA, ERYTHROPOIETIC	FECH, GLY55CYS	3848519
612386	2235	FECH	0002	PROTOPORPHYRIA, ERYTHROPOIETIC	FECH, MET267ILE	118204037
612386	2235	FECH	0003	PROTOPORPHYRIA, ERYTHROPOIETIC	FECH, IVS1, C-T, -23	
612386	2235	FECH	0004	PROTOPORPHYRIA, ERYTHROPOIETIC	FECH, PHE417SER	118204039
612386	2235	FECH	0005	PROTOPORPHYRIA, ERYTHROPOIETIC	FECH, IVS9, G-A, +1	
612386	2235	FECH	0006	PROTOPORPHYRIA, ERYTHROPOIETIC	FECH, IVS10, A-G, +3	
612386	2235	FECH	0007	PROTOPORPHYRIA, ERYTHROPOIETIC	FECH, VAL363GLY	118204040
612386	2235	FECH	0008	PROTOPORPHYRIA, ERYTHROPOIETIC	FECH, IVS3, T-G, +2	
612386	2235	FECH	0009	PROTOPORPHYRIA, ERYTHROPOIETIC	FECH, IVS3, A-C, +6	
612386	2235	FECH	0010	PROTOPORPHYRIA, ERYTHROPOIETIC	FECH, IVS10DS, A-T, -3	
612386	2235	FECH	0011	PROTOPORPHYRIA, ERYTHROPOIETIC	FECH, 1-BP DEL, 1135A	
612386	2235	FECH	0012	PROTOPORPHYRIA, ERYTHROPOIETIC	FECH, IVS2, A-G, +11	
612386	2235	FECH	0013	PROTOPORPHYRIA, ERYTHROPOIETIC	FECH, 5-BP DEL, NT580	
612386	2235	FECH	0014	PROTOPORPHYRIA, ERYTHROPOIETIC	FECH, ASN408LYS, PRO409SER, AND CYS411GLY	
612386	2235	FECH	0015	PROTOPORPHYRIA, ERYTHROPOIETIC	FECH, IVS3AS, T-C, -48	
612386	2235	FECH	0016	PROTOPORPHYRIA, ERYTHROPOIETIC	FECH, ALA185THR	
612392	137682	NDUFAF6	0001	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY	C8ORF38, GLN99ARG	137853184
612395	1120	CHKB	0001	MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE	CHKB, TYR270TER	
612395	1120	CHKB	0002	MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE	CHKB, SER39TER	
612395	1120	CHKB	0003	MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE	CHKB, 1-BP DUP, NT458	
612395	1120	CHKB	0004	MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE	CHKB, GLN308TER	
612395	1120	CHKB	0005	MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE	CHKB, IVS5DS, G-A, +1	
612414	220074	LRTOMT	0001	DEAFNESS, AUTOSOMAL RECESSIVE 63	LRTOMT, IVS8DS, A-C, +4	
612414	220074	LRTOMT	0002	DEAFNESS, AUTOSOMAL RECESSIVE 63	LRTOMT, ARG81GLN	137853185
612414	220074	LRTOMT	0003	DEAFNESS, AUTOSOMAL RECESSIVE 63	LRTOMT, TRP105ARG	137853186
612414	220074	LRTOMT	0004	DEAFNESS, AUTOSOMAL RECESSIVE 63	LRTOMT, GLU110LYS	137853187
612414	220074	LRTOMT	0005	DEAFNESS, AUTOSOMAL RECESSIVE 63	LRTOMT, TYR71TER	137853188
612418	54968	TMEM70	0001	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2	TMEM70, IVS2AS, A-G, -2	
612418	54968	TMEM70	0002	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2	TMEM70, 2-BP INS, 118GT	
612418	54968	TMEM70	0003	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2	TMEM70, TYR112TER	
612418	54968	TMEM70	0004	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2	TMEM70, ARG80TER	
612418	54968	TMEM70	0005	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2	TMEM70, 2-BP DEL, 578CA	
612424	346007	EYS	0001	RETINITIS PIGMENTOSA 25	EYS, 17-BP DEL, NT2710	
612424	346007	EYS	0002	RETINITIS PIGMENTOSA 25	EYS, EX15-19 DEL	
612424	346007	EYS	0003	RETINITIS PIGMENTOSA 25	EYS, EX12 DEL	
612424	346007	EYS	0004	RETINITIS PIGMENTOSA 25	EYS, GLU1953TER	137853189
612424	346007	EYS	0005	RETINITIS PIGMENTOSA 25	EYS, TYR3156TER	137853190
612424	346007	EYS	0006	RETINITIS PIGMENTOSA 25	EYS, 1-BP DELETION, 6714T	
612452	284058	KANSL1	0001	KOOLEN-DE VRIES SYNDROME	KANSL1, ARG606TER	
612452	284058	KANSL1	0002	KOOLEN-DE VRIES SYNDROME	KANSL1, 2-BP DEL, 2785AG	
612452	284058	KANSL1	0003	KOOLEN-DE VRIES SYNDROME	KANSL1, GLN306TER	
612452	284058	KANSL1	0004	KOOLEN-DE VRIES SYNDROME	KANSL1, IVS6DS, G-A, +1	
612453	84466	MEGF10	0001	MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET	MEGF10, 10-BP DUP, NT2288	
612453	84466	MEGF10	0002	MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET	MEGF10, TRP520TER	
612453	84466	MEGF10	0003	MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET	MEGF10, CYS767TER	
612453	84466	MEGF10	0004	MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET	MEGF10, TYR1048TER	
612453	84466	MEGF10	0005	MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET	MEGF10, 1-BP DEL, 1325C	
612453	84466	MEGF10	0006	MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET, MILD VARIANT, INCLUDED	MEGF10, CYS774ARG	
612453	84466	MEGF10	0007	MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET, MILD VARIANT	MEGF10, CYS326ARG	
612453	84466	MEGF10	0008	MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET, MILD VARIANT	MEGF10, ARG71TRP	
612502	78989	COLEC11	0001	3MC SYNDROME 2	COLEC11, SER169PRO	
612502	78989	COLEC11	0002	3MC SYNDROME 2	COLEC11, 1-BP DEL, 45C	
612502	78989	COLEC11	0003	3MC SYNDROME 2	COLEC11, GLY204SER	
612502	78989	COLEC11	0004	3MC SYNDROME 2	COLEC11, 3-BP DEL, 648CTC	
612502	78989	COLEC11	0005	3MC SYNDROME 2	COLEC11, 1-BP DEL, 300T	
612502	78989	COLEC11	0006	3MC SYNDROME 2	COLEC11, EX1-3DEL	
612515	80067	DCAF17	0001	WOODHOUSE-SAKATI SYNDROME	DCAF17, 1-BP DEL, 436C	
612515	80067	DCAF17	0002	WOODHOUSE-SAKATI SYNDROME	DCAF17, 1-BP DEL, 50C	
612515	80067	DCAF17	0003	WOODHOUSE-SAKATI SYNDROME	DCAF17, IVS13, G-T, +5	
612515	80067	DCAF17	0004	WOODHOUSE-SAKATI SYNDROME	DCAF17, IVS10, T-G, +6	
612515	80067	DCAF17	0005	WOODHOUSE-SAKATI SYNDROME	DCAF17, TRP129TER	
612515	80067	DCAF17	0006	WOODHOUSE-SAKATI SYNDROME	DCAF17, TRP302TER	
612515	80067	DCAF17	0007	WOODHOUSE-SAKATI SYNDROME	DCAF17, SER114TER	
612515	80067	DCAF17	0008	WOODHOUSE-SAKATI SYNDROME	DCAF17, 3-BP DEL/2-BP INS, 127TAG/AA	
612517	55172	DNAAF2	0001	CILIARY DYSKINESIA, PRIMARY, 10	KTU, 16-BP INS, NT1214	
612517	55172	DNAAF2	0002	CILIARY DYSKINESIA, PRIMARY, 10	KTU, SER8TER	137853191
612570	2201	FBN2	0001	CONTRACTURAL ARACHNODACTYLY, CONGENITAL	FBN2, CYS1252TYR	137852825
612570	2201	FBN2	0002	CONTRACTURAL ARACHNODACTYLY, CONGENITAL	FBN2, GLU390LYS	137852826
612570	2201	FBN2	0004	CONTRACTURAL ARACHNODACTYLY, CONGENITAL	FBN2, IVS33, A-T, -2	
612570	2201	FBN2	0005	CONTRACTURAL ARACHNODACTYLY, CONGENITAL	FBN2, IVS28, A-G, -15	
612570	2201	FBN2	0006	CONTRACTURAL ARACHNODACTYLY, CONGENITAL	FBN2, IVS30, G-T, -26	
612570	2201	FBN2	0007	CONTRACTURAL ARACHNODACTYLY, CONGENITAL	FBN2, ASP1114HIS	137852827
612570	2201	FBN2	0008	CONTRACTURAL ARACHNODACTYLY, CONGENITAL	FBN2, CYS1141PHE	137852828
612570	2201	FBN2	0009	CONTRACTURAL ARACHNODACTYLY, CONGENITAL	FBN2, CYS1252TRP	28931602
612570	2201	FBN2	0010	CONTRACTURAL ARACHNODACTYLY, CONGENITAL	FBN2, ASN1259LYS	
612625	55788	LMBRD1	0001	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblF TYPE	LMBRD1, 1-BP DEL, 1056G	
612625	55788	LMBRD1	0002	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblF TYPE	LMBRD1, 2-BP DEL, 515AC	
612625	55788	LMBRD1	0003	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblF TYPE	LMRBD1, 1-BP DEL, 404C	
612638	126328	NDUFA11	0001	MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFA11, IVS1DS, G-A, +5	
612641	286	ANK1	0001	SPHEROCYTOSIS, TYPE 1, DUE TO ANKYRIN-RAKOVNIK	ANK1, GLU1669TER	137852829
612641	286	ANK1	0002	SPHEROCYTOSIS, TYPE 1, AUTOSOMAL RECESSIVE	ANK1, -108T-C	
612641	286	ANK1	0003	SPHEROCYTOSIS, TYPE 1, DUE TO ANKYRIN SAINT-ETIENNE 1	ANK1, TRP1721TER	137852830
612641	286	ANK1	0004	SPHEROCYTOSIS, TYPE 1, DUE TO ANKYRIN SAINT-ETIENNE 2	ANK1, ARG1833TER	137852831
612641	286	ANK1	0005	SPHEROCYTOSIS, TYPE 1, DUE TO ANKYRIN FLORIANOPOLIS	ANK1, 1-BP INS, 506C	
612641	286	ANK1	0006	SPHEROCYTOSIS, TYPE 1, AUTOSOMAL RECESSIVE	ANK1, -153G-A	
612641	286	ANK1	0007	SPHEROCYTOSIS, TYPE 1, AUTOSOMAL RECESSIVE	ANK1, IVS16AS, G-A, -17	
612641	286	ANK1	0008	SPHEROCYTOSIS, TYPE 1, AUTOSOMAL RECESSIVE	ANK1, 20-BP DEL, NT604	
612641	286	ANK1	0009	SPHEROCYTOSIS, TYPE 1, AUTOSOMAL RECESSIVE	ANK1, 2-BP DEL, -72TG	
612647	345895	RSPH4A	0001	CILIARY DYSKINESIA, PRIMARY, 11	RSPH4A, GLN154TER	118204041
612647	345895	RSPH4A	0002	CILIARY DYSKINESIA, PRIMARY, 11	RSPH4A, GLN109TER	118204042
612647	345895	RSPH4A	0003	CILIARY DYSKINESIA, PRIMARY, 11	RSPH4A, ARG490TER	118204043
612648	221421	RSPH9	0001	CILIARY DYSKINESIA, PRIMARY, 12	RSPH9, 3-BP DEL, 801GAA	
612659	222546	RFX6	0001	DIABETES, NEONATAL, WITH PANCREATIC HYPOPLASIA, INTESTINAL ATRESIA, AND GALLBLADDER APLASIA OR HYPOPLASIA	RFX6, IVS2, T-C, +2	
612659	222546	RFX6	0002	DIABETES, NEONATAL, WITH PANCREATIC HYPOPLASIA, INTESTINAL ATRESIA, AND GALLBLADDER APLASIA OR HYPOPLASIA	RFX6, IVS1, A-G, -12	
612659	222546	RFX6	0003	DIABETES, NEONATAL, WITH PANCREATIC HYPOPLASIA, INTESTINAL ATRESIA, AND GALLBLADDER APLASIA OR HYPOPLASIA	RFX6, IVS6, T-G, +2	
612659	222546	RFX6	0004	DIABETES, NEONATAL, WITH PANCREATIC HYPOPLASIA, INTESTINAL ATRESIA, AND GALLBLADDER APLASIA OR HYPOPLASIA	RFX6, SER217PRO	
612659	222546	RFX6	0005	DIABETES, NEONATAL, WITH PANCREATIC HYPOPLASIA, INTESTINAL ATRESIA, AND GALLBLADDER APLASIA OR HYPOPLASIA	RFX6, ARG181GLN	
612659	222546	RFX6	0006	DIABETES, NEONATAL, WITH PANCREATIC HYPOPLASIA, INTESTINAL ATRESIA, AND GALLBLADDER APLASIA OR HYPOPLASIA	RFX6, 13-BP DEL, INTRON/EXON 7	
612661	55135	WRAP53	0001	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 3	WRAP53, PHE164LEU	
612661	55135	WRAP53	0002	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 3	WRAP53, ARG398TRP	
612661	55135	WRAP53	0003	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 3	WRAP53, HIS376TYR	
612661	55135	WRAP53	0004	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 3	WRAP53, GLY435ARG	
612676	5860	QDPR	0001	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C	QDPR, 3-BP INS, 390ACT	
612676	5860	QDPR	0002	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C	QDPR, GLY23ASP	104893863
612676	5860	QDPR	0003	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C	QDPR, TRP108GLY	104893864
612676	5860	QDPR	0004	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C	QDPR, TRP36ARG	104893865
612676	5860	QDPR	0005	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C	QDPR, IVS3, A-G, 152-BP INS	
612676	5860	QDPR	0006	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C	QDPR, TYR150CYS	104893866
612676	5860	QDPR	0007	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C	QDPR, TRP90TER	104893867
612688	165918	RNF168	0001	RIDDLE SYNDROME	RNF168, 1-BP DUP, 397G	
612688	165918	RNF168	0002	RIDDLE SYNDROME	RNF168, 4-BP DEL, 1323ACAA	
612719	5805	PTS	0001	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A	PTS, ARG25GLN	104894273
612719	5805	PTS	0002	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A, DUE TO PARTIAL PTS DEFICIENCY	PTS, ARG16CYS	104894274
612719	5805	PTS	0003	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A, DUE TO PARTIAL PTS DEFICIENCY	PTS, 14-BP DEL, NT370	
612719	5805	PTS	0004	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A	PTS, ASN52SER	104894275
612719	5805	PTS	0005	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A	PTS, PRO87SER	104894276
612719	5805	PTS	0006	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A	PTS, VAL56MET	104894277
612719	5805	PTS	0007	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A, DUE TO PARTIAL PTS DEFICIENCY	PTS, ASN47ASP	104894278
612719	5805	PTS	0008	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A, DUE TO PARTIAL PTS DEFICIENCY	PTS, ASP116GLY	104894279
612719	5805	PTS	0009	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A	PTS, ASP96ASN	104894280
612719	5805	PTS	0010	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A	PTS, 55-BP DEL, NT694	
612719	5805	PTS	0011	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A	PTS, IVS1, -322A-T	
612724	229	ALDOB	0001	FRUCTOSE INTOLERANCE	ALDOB, ALA149PRO	1800546
612724	229	ALDOB	0002	FRUCTOSE INTOLERANCE	ALDOB, ALA174ASP	76917243
612724	229	ALDOB	0003	FRUCTOSE INTOLERANCE	ALDOB, LEU288DEL	118204425
612724	229	ALDOB	0004	FRUCTOSE INTOLERANCE	ALDOB, 4-BP DEL	
612724	229	ALDOB	0005	FRUCTOSE INTOLERANCE	ALDOB, CYS240TER	118204426
612724	229	ALDOB	0006	FRUCTOSE INTOLERANCE	ALDOB, ASN334LYS	78340951
612724	229	ALDOB	0007	FRUCTOSE INTOLERANCE	ALDOB, 7-BP DEL/1-BP INS, 3-PRIME IVS8	
612724	229	ALDOB	0008	FRUCTOSE INTOLERANCE	ALDOB, ARG3TER	118204428
612724	229	ALDOB	0009	FRUCTOSE INTOLERANCE	ALDOB, ARG59TER	118204429
612724	229	ALDOB	0010	FRUCTOSE INTOLERANCE	ALDOB, IVS6AS, G-A, -1	
612724	229	ALDOB	0011	FRUCTOSE INTOLERANCE	ALDOB, 6-BP DEL, EXON 6	
612724	229	ALDOB	0012	FRUCTOSE INTOLERANCE	ALDOB, TRP147ARG	118204430
612724	229	ALDOB	0013	FRUCTOSE INTOLERANCE	ALDOB, 6.5-KB DEL	
612724	229	ALDOB	0014	FRUCTOSE INTOLERANCE	ALDOB, ARG46TRP	
612724	229	ALDOB	0015	FRUCTOSE INTOLERANCE	ALDOB, TYR343HIS	
612732	1371	CPOX	0001	COPROPORPHYRIA	CPOX, ARG331TRP	
612732	1371	CPOX	0002	COPROPORPHYRIA	CPOX, IVS6, G-A, -1	
612732	1371	CPOX	0003	HARDEROPORPHYRIA	CPOX, LYS404GLU	
612732	1371	CPOX	0004	COPROPORPHYRIA	CPOX, 5-BP INS, NT129	
612732	1371	CPOX	0005	COPROPORPHYRIA	CPOX, 21-BP DEL	
612732	1371	CPOX	0006	COPROPORPHYRIA	CPOX, HIS295ASP	
612732	1371	CPOX	0007	HARDEROPORPHYRIA	CPOX, IVS6DS, A-G, +3	
612732	1371	CPOX	0008	COPROPORPHYRIA	CPOX, GLN29TER	
612732	1371	CPOX	0009	COPROPORPHYRIA	CPOX, ARG447CYS	28931603
612732	1371	CPOX	0010	COPROPORPHYRIA	CPOX, SER208PHE	
612732	1371	CPOX	0011	COPROPORPHYRIA	CPOX, ARG328CYS	
612732	1371	CPOX	0012	COPROPORPHYRIA	CPOX, 1-BP INS, NT857	
612732	1371	CPOX	0013	COPROPORPHYRIA, DIGENIC	CPOX, GLY279ARG	
612753	147372	CCBE1	0001	HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	CCBE1, CYS75SER	121908250
612753	147372	CCBE1	0002	HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	CCBE1, CYS102SER	121908251
612753	147372	CCBE1	0003	HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	CCBE1, GLY237ARG	121908252
612753	147372	CCBE1	0004	HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	CCBE1, 1-BP INS, 683T	
612753	147372	CCBE1	0005	HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	CCBE1, ARG158CYS	121908253
612753	147372	CCBE1	0006	HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	CCBE1, CYS174ARG	121908254
612761	56916	SMARCAD1	0001	ADERMATOGLYPHIA	SMARCAD1, IVS1, G-T, +1	
612772	405753	DUOXA2	0001	THYROID DYSHORMONOGENESIS 5	DUOXA2, TYR246TER	4774518
612773	4059	BCAM	0001	LUTHERAN BLOOD GROUP POLYMORPHISM Lu(a)/Lu(b)	BCAM, HIS77ARG	28399653
612773	4059	BCAM	0002	AUBERGER BLOOD GROUP POLYMORPHISM Au(a)/Au(b)	BCAM, THR539ALA	1135062
612773	4059	BCAM	0003	BLOOD GROUP--LUTHERAN NULL	BCAM, ARG231TER	121918132
612773	4059	BCAM	0004	BLOOD GROUP--LUTHERAN NULL	BCAM, DEL EX3-4	
612773	4059	BCAM	0005	BLOOD GROUP--LUTHERAN NULL	BCAM, CYS237TER	3810141
612773	4059	BCAM	0006	BLOOD GROUP--LUTHERAN NULL	BCAM, ARG121TER	121918133
612779	1806	DPYD	0001	DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY 5-@FLUOROURACIL TOXICITY, INCLUDED	DPYD, IVS14, G-A, +1	
612779	1806	DPYD	0002	5-@FLUOROURACIL TOXICITY	DPYD, ASP974VAL	72547602
612779	1806	DPYD	0003	DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	DPYD, 4-BP DEL, 296TCAT	
612779	1806	DPYD	0004	DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	DPYD, CYS29ARG	1801265
612779	1806	DPYD	0005	DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	DPYD, 1-BP DEL, 1897C	
612779	1806	DPYD	0006	DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	DPYD, ARG886HIS	1801267
612799	124454	EARS2	0001	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12	EARS2, ARG108TRP	
612799	124454	EARS2	0002	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12	EARS2, ARG168GLY AND 3-BP INS, 1279TCC	
612799	124454	EARS2	0003	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12	EARS2, GLY110SER	
612799	124454	EARS2	0004	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12	EARS2, GLY204SER	
612799	124454	EARS2	0005	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12	EARS2, GLU96LYS	
612799	124454	EARS2	0006	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12	EARS2, CYS167TYR	
612799	124454	EARS2	0007	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12	EARS2, LYS65GLU	
612804	54938	SARS2	0001	HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS	SARS2, ASP390GLY	
612837	57017	COQ9	0001	COENZYME Q10 DEFICIENCY, PRIMARY, 5	COQ9, ARG244TER	
612848	644096	SDHAF1	0001	MITOCHONDRIAL COMPLEX II DEFICIENCY	SDHAF1, GLY57ARG	137853192
612848	644096	SDHAF1	0002	MITOCHONDRIAL COMPLEX II DEFICIENCY	SDHAF1, ARG55PRO	137853193
612850	347733	TUBB2B	0001	POLYMICROGYRIA, ASYMMETRIC	TUBB2B, SER172PRO	137853194
612850	347733	TUBB2B	0002	POLYMICROGYRIA, ASYMMETRIC	TUBB2B, LEU228PRO	137853195
612850	347733	TUBB2B	0003	POLYMICROGYRIA, ASYMMETRIC	TUBB2B, PHE265LEU	137853196
612850	347733	TUBB2B	0004	POLYMICROGYRIA, SYMMETRIC	TUBB2B, ASP417ASN	
612850	347733	TUBB2B	0005	POLYMICROGYRIA, SYMMETRIC	TUBB2B, ASN256SER	
612850	347733	TUBB2B	0006	POLYMICROGYRIA, SYMMETRIC	TUBB2B, LEU117PRO	
612870	55023	PHIP	0001	VARIANT OF UNKNOWN SIGNIFICANCE	PHIP, TYR1149TER	
612878	23086	EXPH5	0001	EPIDERMOLYSIS BULLOSA, NONSPECIFIC, AUTOSOMAL RECESSIVE	EXPH5, 1-BP DEL, 5786C	
612901	81027	TUBB1	0001	MACROTHROMBOCYTOPENIA, AUTOSOMAL DOMINANT, TUBB1-RELATED	TUBB1, ARG318TRP	121918555
612911	25915	NDUFAF3	0001	MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFAF3, GLY77ARG	121918134
612911	25915	NDUFAF3	0002	MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFAF3, ARG122PRO	121918135
612911	25915	NDUFAF3	0003	MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFAF3, MET1THR	121918136
612920	54084	TSPEAR	0001	DEAFNESS, AUTOSOMAL RECESSIVE 98	TSPEAR, 1726G-T and 1-BP DEL, 1728C	
612931	5224	PGAM2	0001	GLYCOGEN STORAGE DISEASE X	PGAM2, TRP78TER	10250779
612931	5224	PGAM2	0002	GLYCOGEN STORAGE DISEASE X	PGAM2, GLU89ALA	104894030
612931	5224	PGAM2	0003	GLYCOGEN STORAGE DISEASE X	PGAM2, ARG90TRP	104894034
612931	5224	PGAM2	0004	GLYCOGEN STORAGE DISEASE X	PGAM2, GLY97ASP	77938727
612944	8635	RNASET2	0001	LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY	RNASET2, CYS184ARG	121918137
612944	8635	RNASET2	0002	LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY	RNASET2, 2.5-KB DEL	
612944	8635	RNASET2	0003	LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY	RNASET2, IVS5AS, A-G, -2	
612944	8635	RNASET2	0004	LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY	RNASET2, 1-BP DEL, 332+1G	
612944	8635	RNASET2	0005	LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY	RNASET2, 15-BP DEL	
612944	8635	RNASET2	0006	LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY	RNASET2, 567G-A	
612958	51204	TACO1	0001	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX IV DEFICIENCY	TACO1, 1-BP INS, 472C	
612971	79955	PDZD7	0001	RETINAL DISEASE IN USHER SYNDROME TYPE IIA, MODIFIER OF	PDZD7, 1-BP INS, 166C	
612971	79955	PDZD7	0002	USHER SYNDROME, TYPE IIC, GPR98/PDZD7 DIGENIC	PDZD7, 9-BP INS, NT2194	
612988	84233	TMEM126A	0001	OPTIC ATROPHY 7	TMEM126A, ARG55TER	121434508
612990	171023	ASXL1	0001	BOHRING-OPITZ SYNDROME	ASXL1, GLN925TER	
612990	171023	ASXL1	0002	BOHRING-OPITZ SYNDROME	ASXL1, ARG404TER	
612990	171023	ASXL1	0003	BOHRING-OPITZ SYNDROME	ASXL1, SER1028TER	
612990	171023	ASXL1	0004	BOHRING-OPITZ SYNDROME	ASLX1, 1-BP DUP, NT2535	
612990	171023	ASXL1	0005	BOHRING-OPITZ SYNDROME	ASLX1, GLN733TER	
612990	171023	ASXL1	0006	BOHRING-OPITZ SYNDROME	ASLX1, 5-BP DEL, NT2407	
612990	171023	ASXL1	0007	BOHRING-OPITZ SYNDROME	ASLX1, ARG965TER	
613004	3064	HTT	0001	HUNTINGTON DISEASE	HTT, (CAG)n EXPANSION	
613009	51091	SEPSECS	0001	PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	SEPSECS, TYR334CYS	
613009	51091	SEPSECS	0002	PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	SEPSECS, ALA239THR	
613012	131669	UROC1	0001	UROCANASE DEFICIENCY	UROC1, ARG450CYS	137852795
613012	131669	UROC1	0002	UROCANASE DEFICIENCY	UROC1, LEU70PRO	137852796
613018	6898	TAT	0001	TYROSINEMIA, TYPE II	TAT, ARG57TER	118203914
613018	6898	TAT	0002	TYROSINEMIA, TYPE II	TAT, SER223TER	118203915
613018	6898	TAT	0003	TYROSINEMIA, TYPE II	TAT, ARG417TER	118203916
613018	6898	TAT	0004	TYROSINEMIA, TYPE II	TAT, IVS8DS, T-G, +2 AND GLY362VAL	
613018	6898	TAT	0005	TYROSINEMIA, TYPE II	TAT, IVS2AS, A-G, -5	
613019	54949	SDHAF2	0001	PARAGANGLIOMAS 2	SDHAF2, GLY78ARG	113560320
613037	56623	INPP5E	0001	MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS	INPP5E, GLN627TER	121918127
613037	56623	INPP5E	0002	JOUBERT SYNDROME 1	INPP5E, ARG515TRP	13297509
613037	56623	INPP5E	0003	JOUBERT SYNDROME 1	INPP5E, ARG563HIS	121918128
613037	56623	INPP5E	0004	JOUBERT SYNDROME 1	INPP5E, ARG435GLN	121918129
613037	56623	INPP5E	0005	JOUBERT SYNDROME 1	INPP5E, ARG378CYS	121918130
613072	125336	LOXHD1	0001	DEAFNESS, AUTOSOMAL RECESSIVE 77	LOXHD1, ARG670TER	121918370
613072	125336	LOXHD1	0002	DEAFNESS, AUTOSOMAL RECESSIVE 77	LOXHD1, ARG1572TER	
613072	125336	LOXHD1	0003	VARIANT OF UNKNOWN SIGNIFICANCE	LOXHD1, ARG547CYS	
613109	2760	GM2A	0001	GM2-GANGLIOSIDOSIS, AB VARIANT	GM2A, CYS107ARG	137852797
613109	2760	GM2A	0002	GM2-GANGLIOSIDOSIS, AB VARIANT	GM2A, ARG169PRO	104893892
613109	2760	GM2A	0003	GM2-GANGLIOSIDOSIS, AB VARIANT	GM2A, 3-BP DEL, 262AAG	
613109	2760	GM2A	0004	GM2-GANGLIOSIDOSIS, AB VARIANT	GM2A, 1-BP DEL, 410A	
613109	2760	GM2A	0005	GM2-GANGLIOSIDOSIS, AB VARIANT	GM2A, GLU54TER	104893897
613111	5476	CTSA	0001	GALACTOSIALIDOSIS, LATE INFANTILE	CTSA, PHE412VAL	137854540
613111	5476	CTSA	0002	GALACTOSIALIDOSIS, ADULT	CTSA, IVS7, A-G, +3	
613111	5476	CTSA	0003	GALACTOSIALIDOSIS	CTSA, GLN49ARG	137854541
613111	5476	CTSA	0004	GALACTOSIALIDOSIS	CTSA, TRP65ARG	28934603
613111	5476	CTSA	0005	GALACTOSIALIDOSIS	CTSA, SER90LEU	137854542
613111	5476	CTSA	0006	GALACTOSIALIDOSIS	CTSA, TYR395CYS	137854543
613111	5476	CTSA	0007	GALACTOSIALIDOSIS	CTSA, TYR249ASN	137854544
613111	5476	CTSA	0008	GALACTOSIALIDOSIS, LATE INFANTILE	CTSA, TYR221ASN	137854544
613111	5476	CTSA	0009	GALACTOSIALIDOSIS, EARLY INFANTILE	CTSA, VAL104MET	137854545
613111	5476	CTSA	0010	GALACTOSIALIDOSIS, EARLY INFANTILE	CTSA, LEU208PRO	137854546
613111	5476	CTSA	0011	GALACTOSIALIDOSIS, EARLY INFANTILE	CTSA, GLY411SER	137854547
613111	5476	CTSA	0012	GALACTOSIALIDOSIS, LATE INFANTILE	CTSA, MET378THR	137854548
613111	5476	CTSA	0013	GALACTOSIALIDOSIS, LATE INFANTILE	CTSA, 2-BP DEL, 517TT	
613111	5476	CTSA	0014	GALACTOSIALIDOSIS, LATE INFANTILE	CTSA, LYS453GLU	137854549
613111	5476	CTSA	0015	GALACTOSIALIDOSIS, LATE INFANTILE	CTSA, IVS8, C-G, +9	
613113	4763	NF1	0001	NEUROFIBROMATOSIS, TYPE I	NF1, ALU INS	
613113	4763	NF1	0002	NEUROFIBROMATOSIS, TYPE I	NF1, 5-BP DEL	
613113	4763	NF1	0003	NEUROFIBROMATOSIS, TYPE I	NF1, LEU348PRO	
613113	4763	NF1	0004	NEUROFIBROMATOSIS, TYPE I	NF1, ARG365TER	
613113	4763	NF1	0005	NEUROFIBROMATOSIS, TYPE I	NF1, LYS1423GLU	137854550
613113	4763	NF1	0006	NEUROFIBROMATOSIS, TYPE I	NF1, 1-BP INS, 5662C	
613113	4763	NF1	0007	NEUROFIBROMATOSIS, TYPE I	NF1, 1-BP INS, FS1841TER	
613113	4763	NF1	0008	NEUROFIBROMATOSIS, TYPE I	NF1, LEU2143MET	137854551
613113	4763	NF1	0009	NEUROFIBROMATOSIS, TYPE I	NF1, TYR2213ASN	
613113	4763	NF1	0010	WATSON SYNDROME	NF1, 42-BP DUP	
613113	4763	NF1	0011	WATSON SYNDROME	NF1, 80-KB DEL	
613113	4763	NF1	0012	NEUROFIBROMATOSIS, TYPE I	NF1, ARG1947TER	137854552
613113	4763	NF1	0013	NEUROFIBROMATOSIS, TYPE I	NF1, IVS18DS, G-A, +1	
613113	4763	NF1	0014	NEUROFIBROMATOSIS, TYPE I	NF1, 2-BP DEL, 1541AG	
613113	4763	NF1	0015	NEUROFIBROMATOSIS, TYPE I	NF1, MET1035ARG	137854553
613113	4763	NF1	0016	NEUROFIBROMATOSIS, TYPE I	NF1, ARG1391SER	137854554
613113	4763	NF1	0018	NEUROFIBROMATOSIS, FAMILIAL SPINAL	NF1, 1-BP INS, 8042A	
613113	4763	NF1	0019	LEUKEMIA, JUVENILE MYELOMONOCYTIC	NF1, TRP1538TER	137854555
613113	4763	NF1	0020	LEUKEMIA, JUVENILE MYELOMONOCYTIC	NF1, IVS34, G-A, +18	
613113	4763	NF1	0021	LEUKEMIA, JUVENILE MYELOMONOCYTIC	NF1, IVS11, A-G, -8	
613113	4763	NF1	0022	NEUROFIBROMATOSIS, TYPE I	NF1, ARG1276PRO	137854556
613113	4763	NF1	0023	NEUROFIBROMATOSIS, TYPE I	NF1, TYR489CYS	137854557
613113	4763	NF1	0024	NEUROFIBROMATOSIS, TYPE I	NF1, LEU508PRO	137854558
613113	4763	NF1	0025	NEUROFIBROMATOSIS, TYPE I	NF1, IVS9DS, G-A, +1	
613113	4763	NF1	0026	NEUROFIBROMATOSIS, TYPE I	NF1, GLN1341TER	137854559
613113	4763	NF1	0027	NEUROFIBROMATOSIS, TYPE I	NF1, ARG1362TER	137854560
613113	4763	NF1	0028	NEUROFIBROMATOSIS, FAMILIAL SPINAL	NF1, LEU2067PRO	137854561
613113	4763	NF1	0029	NEUROFIBROMATOSIS, TYPE I NEUROFIBROMATOSIS, FAMILIAL SPINAL, INCLUDED	NF1, IVS31, A-G, -5	
613113	4763	NF1	0030	NEUROFIBROMATOSIS, TYPE I	NF1, DEL	
613113	4763	NF1	0031	NEUROFIBROMATOSIS, TYPE I	NF1, ARG1241TER	137854562
613113	4763	NF1	0032	NEUROFIBROMATOSIS, TYPE I	NF1, 1-BP INS, 5406T	
613113	4763	NF1	0033	NEUROFIBROMATOSIS-NOONAN SYNDROME WATSON SYNDROME, INCLUDED	NF1, 3-BP DEL, 2970AAT	
613113	4763	NF1	0034	NEUROFIBROMATOSIS-NOONAN SYNDROME	NF1, 3-BP DEL, 4312GAA	
613113	4763	NF1	0035	NEUROFIBROMATOSIS-NOONAN SYNDROME	NF1, 2-BP INS, 4095TG	
613113	4763	NF1	0036	NEUROFIBROMATOSIS TYPE 1	NF1, 20075G-A, 20076C-A	
613113	4763	NF1	0037	NEUROFIBROMATOSIS, TYPE I	NF1, 1-BP DEL, 3775T	
613113	4763	NF1	0038	NEUROFIBROMATOSIS, TYPE I NEUROFIBROMATOSIS, FAMILIAL SPINAL, INCLUDED	NF1, LEU357PRO	137854563
613113	4763	NF1	0039	NEUROFIBROMATOSIS, FAMILIAL SPINAL	NF1, IVS39DS, A-C, +3	
613113	4763	NF1	0040	NEUROFIBROMATOSIS, TYPE I	NF1, 1-BP DEL, 4071C	
613113	4763	NF1	0041	NEUROFIBROMATOSIS, TYPE I	NF1, LEU1243PRO	137854564
613113	4763	NF1	0042	NEUROFIBROMATOSIS, TYPE I	NF1, GLU1904TER	137854565
613113	4763	NF1	0043	NEUROFIBROMATOSIS, TYPE I	NF1, LEU844ARG	137854566
613113	4763	NF1	0044	NEUROFIBROMATOSIS, TYPE I	NF1, IVS27DS, G-C, +1	
613113	4763	NF1	0045	NEUROFIBROMATOSIS-NOONAN SYNDROME	NF1, LEU1390PHE	
613113	4763	NF1	0046	NEUROFIBROMATOSIS, TYPE I	NF1, ARG192TER	
613114	54463	FAM134B	0001	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIB	FAM134B, SER309TER	137852739
613114	54463	FAM134B	0002	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIB	FAM134B, 2-BP DEL, 17CT	
613114	54463	FAM134B	0003	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIB	FAM134B, GLN145TER	137852737
613114	54463	FAM134B	0004	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIB	FAM134B, IVS7DS, T-C, +2	
613121	91624	NEXN	0001	CARDIOMYOPATHY, DILATED, 1CC	NEXN, 3-BP DEL, 1948GGA	
613121	91624	NEXN	0002	CARDIOMYOPATHY, DILATED, 1CC	NEXN, TYR652CYS	137853197
613121	91624	NEXN	0003	CARDIOMYOPATHY, DILATED, 1CC	NEXN, PRO611THR	137853198
613121	91624	NEXN	0004	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 20	NEXN, GLN131GLU	
613121	91624	NEXN	0005	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 20	NEXN, ARG279CYS	
613129	80169	CTC1	0001	CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS	CTC1, 4-BP DEL, 724AAAG	
613129	80169	CTC1	0002	CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS	CTC1, ARG987TRP	
613129	80169	CTC1	0003	CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS	CTC1, VAL871MET	
613129	80169	CTC1	0004	CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS	CTC1, VAL259MET	
613129	80169	CTC1	0005	CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS	CTC1, ARG840TRP	
613129	80169	CTC1	0006	CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS	CTC1, VAL665GLY	
613129	80169	CTC1	0007	CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS	CTC1, 1-BP DEL, 2831C	
613129	80169	CTC1	0008	CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS	CTC1, LEU1142HIS	
613129	80169	CTC1	0009	CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS	CTC1, ARG1195TER	
613129	80169	CTC1	0010	CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS	CTC1, ALA227VAL	
613129	80169	CTC1	0011	CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS	CTC1, 1-BP DEL, 1058C	
613129	80169	CTC1	0012	CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS	CTC1, 3-BP DEL, 2954GTT	
613129	80169	CTC1	0013	CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS	CTC1, ARG287TER	
613138	23554	TSPAN12	0001	EXUDATIVE VITREORETINOPATHY 5	TSPAN12, ALA237PRO	
613138	23554	TSPAN12	0002	EXUDATIVE VITREORETINOPATHY 5	TSPAN12, GLY188ARG	
613138	23554	TSPAN12	0003	EXUDATIVE VITREORETINOPATHY 5	TSPAN12, 7-BP INS, NT218	
613138	23554	TSPAN12	0004	EXUDATIVE VITREORETINOPATHY 5	TSPAN12, LEU140TER	
613138	23554	TSPAN12	0005	EXUDATIVE VITREORETINOPATHY 5	TSPAN12, IVS5AS, 5-BP DEL, NT361-1	
613138	23554	TSPAN12	0006	EXUDATIVE VITREORETINOPATHY 5	TSPAN12, LEU101HIS	
613138	23554	TSPAN12	0007	EXUDATIVE VITREORETINOPATHY 5	TSPAN12, LEU245PRO	
613146	406960	MIR184	0001	EDICT SYNDROME	MIR184, 57C-T	
613160	7450	VWF	0001	VON WILLEBRAND DISEASE, TYPE 2A	VWF, ILE1628THR	61750584
613160	7450	VWF	0002	VON WILLEBRAND DISEASE, TYPE 2A	VWF, ARG1597TRP	61750117
613160	7450	VWF	0003	VON WILLEBRAND DISEASE, TYPE 2A	VWF, VAL1607ASP	61750579
613160	7450	VWF	0004	VON WILLEBRAND DISEASE, TYPE 2B	VWF, TRP1313CYS	61749392
613160	7450	VWF	0005	VON WILLEBRAND DISEASE, TYPE 2B	VWF, ARG1306TRP	61749384
613160	7450	VWF	0006	VON WILLEBRAND DISEASE, TYPE 2B	VWF, ARG1308CYS	61749387
613160	7450	VWF	0007	VON WILLEBRAND DISEASE, TYPE 2B	VWF, VAL1316MET	61749397
613160	7450	VWF	0008	VON WILLEBRAND DISEASE, TYPE 2B	VWF, ARG1341GLN	61749403
613160	7450	VWF	0009	VON WILLEBRAND DISEASE, TYPE 2A	VWF, SER1613PRO	61750581
613160	7450	VWF	0010	VON WILLEBRAND FACTOR POLYMORPHISM	VWF, ARG1399HIS	1800382
613160	7450	VWF	0011	VON WILLEBRAND DISEASE, TYPE 2N	VWF, THR791MET	61748477
613160	7450	VWF	0012	VON WILLEBRAND DISEASE, TYPE 2N	VWF, ARG816TRP	121964894
613160	7450	VWF	0013	VON WILLEBRAND DISEASE, TYPE 2N VON WILLEBRAND DISEASE, TYPE 1, INCLUDED	VWF, ARG854GLN	41276738
613160	7450	VWF	0015	VON WILLEBRAND DISEASE, TYPE 3 VON WILLEBRAND DISEASE, TYPE 1, INCLUDED	VWF, ARG1659TER	61750595
613160	7450	VWF	0016	VON WILLEBRAND DISEASE, TYPE 3 VON WILLEBRAND DISEASE, TYPE 1, INCLUDED	VWF, ARG1852TER	61750612
613160	7450	VWF	0017	VON WILLEBRAND DISEASE, TYPE 3	VWF, ARG2635TER	61751296
613160	7450	VWF	0018	VON WILLEBRAND DISEASE, TYPE 2M	VWF, GLY1324SER	61749398
613160	7450	VWF	0019	VON WILLEBRAND DISEASE, TYPE 2A	VWF, CYS1272ARG	61749372
613160	7450	VWF	0020	VON WILLEBRAND DISEASE, TYPE 2B	VWF, VAL1314LEU	61749393
613160	7450	VWF	0021	VON WILLEBRAND DISEASE, TYPE 3	VWF, 1-BP DEL, EX18, C	
613160	7450	VWF	0022	VON WILLEBRAND DISEASE, TYPE 2A	VWF, PHE1514CYS	61750101
613160	7450	VWF	0023	VON WILLEBRAND DISEASE, TYPE 2A	VWF, GLY550ARG	61754011
613160	7450	VWF	0024	VON WILLEBRAND DISEASE, TYPE 2A	VWF, CYS2773ARG	61751310
613160	7450	VWF	0026	VON WILLEBRAND DISEASE, TYPE 2A	VWF, 6-BP INS, NT1212	
613160	7450	VWF	0027	VON WILLEBRAND DISEASE, TYPE 1 VON WILLEBRAND FACTOR VICENZA	VWF, ARG1205HIS	121964895
613160	7450	VWF	0028	VON WILLEBRAND DISEASE, TYPE 1	VWF, CYS1149ARG	61748511
613160	7450	VWF	0029	VON WILLEBRAND DISEASE, TYPE 1, SUSCEPTIBILITY TO	VWF, TYR1584CYS	1800386
613160	7450	VWF	0030	VON WILLEBRAND DISEASE, TYPE 2M	VWF, SER1285PHE	61749380
613160	7450	VWF	0031	VON WILLEBRAND DISEASE, TYPE 2N	VWF, TYR795CYS	
613160	7450	VWF	0032	VON WILLEBRAND DISEASE, TYPE 2N	VWF, CYS804PHE	
613160	7450	VWF	0033	VON WILLEBRAND DISEASE, TYPE 2B	WVF, PRO1266LEU	
613160	7450	VWF	0034	VON WILLEBRAND DISEASE, TYPE 3	VWF, CYS2362PHE	61750630
613160	7450	VWF	0035	VON WILLEBRAND DISEASE, TYPE 2N	VWF, TYR357TER	
613160	7450	VWF	0036	VON WILLEBRAND DISEASE, TYPE 2N	VWF, CYS1060ARG	
613160	7450	VWF	0037	VON WILLEBRAND DISEASE, TYPE 2A	VWF, ASN528SER	
613160	7450	VWF	0038	VON WILLEBRAND DISEASE, TYPE 3 VON WILLEBRAND DISEASE, TYPE 1, INCLUDED	VWF, 8.6-KB DEL, EX4-5	
613160	7450	VWF	0039	VON WILLEBRAND DISEASE, TYPE 2A/IIE	VWF, TYR1146CYS	
613160	7450	VWF	0040	VON WILLEBRAND DISEASE, TYPE 2CB	VWF, TRP1745CYS	
613160	7450	VWF	0041	VON WILLEBRAND DISEASE, TYPE 1	VWF, ARG760HIS	
613160	7450	VWF	0042	VON WILLEBRAND DISEASE, TYPE 2CB	VWF, SER1783ALA	
613165	124583	CANT1	0001	DESBUQUOIS DYSPLASIA	CANT1, 2,703-BP DEL	
613165	124583	CANT1	0002	DESBUQUOIS DYSPLASIA	CANT1, 1-BP DEL, 734C	
613165	124583	CANT1	0003	DESBUQUOIS DYSPLASIA	CANT1, ARG300CYS	
613165	124583	CANT1	0004	DESBUQUOIS DYSPLASIA	CANT1, ARG300HIS	
613165	124583	CANT1	0005	DESBUQUOIS DYSPLASIA	CANT1, 5-BP INS, NT907	
613165	124583	CANT1	0006	DESBUQUOIS DYSPLASIA	CANT1, TRP125TER	
613165	124583	CANT1	0007	DESBUQUOIS DYSPLASIA	CANT1, PRO299LEU	
613165	124583	CANT1	0008	DESBUQUOIS DYSPLASIA	CANT1, 5-BP DUP, 893GCCGC	
613165	124583	CANT1	0009	DESBUQUOIS DYSPLASIA	CANT1, 1-BP INS, 228C	
613165	124583	CANT1	0010	DESBUQUOIS DYSPLASIA	CANT1, 2-BP DEL, 277CT	
613165	124583	CANT1	0011	DESBUQUOIS DYSPLASIA	CANT1, LEU224PRO	
613165	124583	CANT1	0012	DESBUQUOIS DYSPLASIA	CANT1, TRP125CYS	
613165	124583	CANT1	0013	DESBUQUOIS DYSPLASIA, KIM VARIANT	CANT1, VAL226MET	
613165	124583	CANT1	0014	DESBUQUOIS DYSPLASIA, KIM VARIANT	CANT1, ALA360ASP	
613165	124583	CANT1	0015	DESBUQUOIS DYSPLASIA	CANT1, -342, G-A, +1	
613168	5345	SERPINF2	0001	ALPHA-2-PLASMIN INHIBITOR DEFICIENCY	SERPINF2, 1-BP INS, 1438C	
613168	5345	SERPINF2	0002	ALPHA-2-PLASMIN INHIBITOR DEFICIENCY	SERPINF2, GLU137DEL	121965061
613168	5345	SERPINF2	0003	ALPHA-2-PLASMIN INHIBITOR DEFICIENCY	SERPINF2, VAL384MET	121965062
613169	200942	KLHDC8B	0001	HODGKIN LYMPHOMA	KLHDC8B, 5-PRIME UTR, +28C-T	
613171	282996	RBM20	0001	CARDIOMYOPATHY, DILATED, 1DD	RBM20, PRO638LEU	
613171	282996	RBM20	0002	CARDIOMYOPATHY, DILATED, 1DD	RBM20, ARG634GLN	
613171	282996	RBM20	0003	CARDIOMYOPATHY, DILATED, 1DD	RBM20, ARG636SER	
613171	282996	RBM20	0004	CARDIOMYOPATHY, DILATED, 1DD	RBM20, ARG636HIS	
613171	282996	RBM20	0005	CARDIOMYOPATHY, DILATED, 1DD	RBM20, SER637GLY	
613183	388962	BOLA3	0001	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2	BOLA3, 1-BP DUP, 123A	
613190	123872	DNAAF1	0001	CILIARY DYSKINESIA, PRIMARY, 13	DNAAF1, 1-BP INS, 1349C	
613190	123872	DNAAF1	0002	CILIARY DYSKINESIA, PRIMARY, 13	DNAAF1, ARG271TER	
613190	123872	DNAAF1	0003	CILIARY DYSKINESIA, PRIMARY, 13	DNAAF1, TYR264TER	
613190	123872	DNAAF1	0004	CILIARY DYSKINESIA, PRIMARY, 13	DNAAF1, 1-BP INS, 508G	
613190	123872	DNAAF1	0005	CILIARY DYSKINESIA, PRIMARY, 13	DNAAF1, LEU175ARG	
613208	7508	XPC	0001	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C	XPC, PRO218HIS	74737358
613208	7508	XPC	0002	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C	XPC, 83-BP INS, NT462	
613208	7508	XPC	0003	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C	XPC, 3-BP INS, GGT, CODON 580 AND LYS822GLN	
613208	7508	XPC	0004	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C	XPC, 2-BP DEL, 1132AA	
613208	7508	XPC	0005	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C	XPC, IVS9DS, T-G, +2	
613208	7508	XPC	0006	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C	XPC, 2-BP DEL, 669AT	
613208	7508	XPC	0007	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C	XPC, ARG579TER	121965088
613208	7508	XPC	0008	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C	XPC, IVS3AS, T-A, -9	
613208	7508	XPC	0009	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C	XPC, IVS3AS, A-G, -24	
613208	7508	XPC	0010	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C	XPC, 2-BP DEL, 1744TG	
613213	1727	CYB5R3	0001	METHEMOGLOBINEMIA, TYPE II	CYB5R3, SER128PRO	121965006
613213	1727	CYB5R3	0002	METHEMOGLOBINEMIA, TYPE I	CYB5R3, ARG58GLN	121965007
613213	1727	CYB5R3	0003	METHEMOGLOBINEMIA, TYPE I	CYB5R3, LEU149PRO	121965008
613213	1727	CYB5R3	0004	METHEMOGLOBINEMIA, TYPE I	CYB5R3, VAL106MET	121965009
613213	1727	CYB5R3	0005	METHEMOGLOBINEMIA, TYPE II	CYB5R3, IVS8AS, G-T, -1	
613213	1727	CYB5R3	0006	METHEMOGLOBINEMIA, TYPE II	CYB5R3, IVS5DS, G-C, +8	
613213	1727	CYB5R3	0007	METHEMOGLOBINEMIA, TYPE II	CYB5R3, ARG219TER	121965010
613213	1727	CYB5R3	0008	METHEMOGLOBINEMIA, TYPE II	CYB5R3, CYS204ARG	121965011
613213	1727	CYB5R3	0009	METHEMOGLOBINEMIA, TYPE II	CYB5R3, 3-BP DEL, MET273DEL	
613213	1727	CYB5R3	0010	METHEMOGLOBINEMIA, TYPE II	CYB5R3, 3-BP DEL, 895TTC	121965012
613213	1727	CYB5R3	0011	NADH-CYTOCHROME b5 REDUCTASE POLYMORPHISM	CYB5R3, THR117SER	1800457
613213	1727	CYB5R3	0012	METHEMOGLOBINEMIA, TYPE II	CYB5R3, IVS5AS, A-C, -2	
613213	1727	CYB5R3	0013	METHEMOGLOBINEMIA, TYPE I	CYB5R3, LEU73PRO	121965013
613213	1727	CYB5R3	0014	METHEMOGLOBINEMIA, TYPE II	CYB5R3, GLN77TER	121965014
613213	1727	CYB5R3	0015	METHEMOGLOBINEMIA, TYPE II	CYB5R3, ARG160TER	61732609
613213	1727	CYB5R3	0016	METHEMOGLOBINEMIA, TYPE I	CYB5R3, CYS204TYR	121965015
613213	1727	CYB5R3	0017	METHEMOGLOBINEMIA, TYPE I	CYB5R3, GLY292ASP	121965016
613213	1727	CYB5R3	0018	METHEMOGLOBINEMIA, TYPE I	CYB5R3, GLU256DEL	121965017
613213	1727	CYB5R3	0019	METHEMOGLOBINEMIA, TYPE I	CYB5R3, ASP240GLY	121965018
613214	256764	WDR72	0001	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA3	WDR72, SER783TER	
613214	256764	WDR72	0002	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA3	WDR72, TRP978TER	
613214	256764	WDR72	0003	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA3	WDR72, 1-BP DEL, 2857A	
613218	1528	CYB5A	0001	METHEMOGLOBINEMIA, TYPE IV	CYB5A, IVS1AS, A-G, -2	
613228	175	AGA	0001	ASPARTYLGLUCOSAMINURIA, FINNISH TYPE	AGA, CYS163SER	121964904
613228	175	AGA	0002	ASPARTYLGLUCOSAMINURIA	AGA, GLY302ARG	121964905
613228	175	AGA	0003	ASPARTYLGLUCOSAMINURIA	AGA, CYS306ARG	121964906
613228	175	AGA	0004	ASPARTYLGLUCOSAMINURIA	AGA, GLY60ASP	121964907
613228	175	AGA	0005	ASPARTYLGLUCOSAMINURIA	AGA, ALA101VAL	121964908
613228	175	AGA	0006	ASPARTYLGLUCOSAMINURIA	AGA, 7-BP DEL, NT102	
613228	175	AGA	0007	ASPARTYLGLUCOSAMINURIA	AGA, 1-BP INS, 800T	
613228	175	AGA	0008	ASPARTYLGLUCOSAMINURIA	AGA, 6-BP INS, NT127	
613228	175	AGA	0009	ASPARTYLGLUCOSAMINURIA	AGA, IVS8DS, G-T, +1	
613228	175	AGA	0010	ASPARTYLGLUCOSAMINURIA	AGA, 1-BP DEL, 800T	
613228	175	AGA	0012	ASPARTYLGLUCOSAMINURIA	AGA, SER72PRO	121964909
613230	5184	PEPD	0001	PROLIDASE DEFICIENCY	PEPD, ASP276ASN	121917721
613230	5184	PEPD	0002	PROLIDASE DEFICIENCY	PEPD, EX14DEL	
613230	5184	PEPD	0003	PROLIDASE DEFICIENCY	PEPD, ARG184GLN	121917722
613230	5184	PEPD	0004	PROLIDASE DEFICIENCY	PEPD, GLY278ASP	121917723
613230	5184	PEPD	0005	PROLIDASE DEFICIENCY	PEPD, GLY448ARG	121917724
613230	5184	PEPD	0006	PROLIDASE DEFICIENCY	PEPD, 3-BP DEL, GLU452DEL	
613230	5184	PEPD	0007	PROLIDASE DEFICIENCY	PEPD, 3-BP DEL, 707TAC	
613230	5184	PEPD	0008	PROLIDASE DEFICIENCY	PEPD, ARG265TER	121917725
613230	5184	PEPD	0009	PROLIDASE DEFICIENCY	PEPD, GLU412LYS	
613230	5184	PEPD	0010	PROLIDASE DEFICIENCY	PEPD, 13-BP DUP	
613230	5184	PEPD	0011	PROLIDASE DEFICIENCY	PEPD, SER202PHE	
613236	100134444	KCNJ18	0001	THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 2	KCNJ18, 1-BP DEL, 428C	
613236	100134444	KCNJ18	0002	THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 2	KCNJ18, THR354MET	
613236	100134444	KCNJ18	0003	THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 2	KCNJ18, ARG205HIS	
613236	100134444	KCNJ18	0004	THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 2	KCNJ18, LYS366ARG	
613276	79650	USB1	0001	POIKILODERMA WITH NEUTROPENIA	C16ORF57, IVS4, A-C, -1	137853970
613276	79650	USB1	0002	POIKILODERMA WITH NEUTROPENIA	C16ORF57, 12-BP DEL, NT683	137853972
613276	79650	USB1	0003	POIKILODERMA WITH NEUTROPENIA	C16ORF57, EXON 4, 502A-G	137853971
613276	79650	USB1	0004	POIKILODERMA WITH NEUTROPENIA	C16ORF57, 1-BP DEL, 179C	
613277	51259	TMEM216	0001	JOUBERT SYNDROME 2	TMEM216, ARG73LEU	
613277	51259	TMEM216	0002	JOUBERT SYNDROME 2 MECKEL SYNDROME, TYPE 2, INCLUDED	TMEM216, ARG73HIS	
613277	51259	TMEM216	0003	MECKEL SYNDROME, TYPE 2	TMEM216, LEU114ARG	
613277	51259	TMEM216	0004	MECKEL SYNDROME, TYPE 2	TMEM216, GLY77ALA	
613278	84464	SLX4	0001	FANCONI ANEMIA, COMPLEMENTATION GROUP P	SLX4, 1-BP DEL, 286A	
613278	84464	SLX4	0002	FANCONI ANEMIA, COMPLEMENTATION GROUP P	SLX4, 1-BP DEL, 1093C	
613278	84464	SLX4	0003	FANCONI ANEMIA, COMPLEMENTATION GROUP P	SLX4, IVS5DS, 1-BP DUP, T, +3	
613278	84464	SLX4	0004	FANCONI ANEMIA, COMPLEMENTATION GROUP P	SLX4, IVS5DS, T-A, +2	
613278	84464	SLX4	0005	FANCONI ANEMIA, COMPLEMENTATION GROUP P	SLX4, 1-BP DEL, 514C	
613278	84464	SLX4	0006	FANCONI ANEMIA, COMPLEMENTATION GROUP P	SLX4, 4,890-BP DEL/2-BP INS	
613283	389207	GRXCR1	0001	DEAFNESS, AUTOSOMAL RECESSIVE 25	GRXCR1, IVS2, C-A, -9	
613283	389207	GRXCR1	0002	DEAFNESS, AUTOSOMAL RECESSIVE 25	GRXCR1, IVS2, A-T, +19	
613283	389207	GRXCR1	0003	DEAFNESS, AUTOSOMAL RECESSIVE 25	GRXCR1, GLN77TER	
613283	389207	GRXCR1	0004	DEAFNESS, AUTOSOMAL RECESSIVE 25	GRXCR1, ARG138CYS	
613289	724066	ATXN8	0001	SPINOCEREBELLAR ATAXIA 8	ATXN8, (CAG)n EXPANSION	
613293	285590	SH3PXD2B	0001	FRANK-TER HAAR SYNDROME	SH3PXD2B, 1-BP INS, 147T	
613293	285590	SH3PXD2B	0002	FRANK-TER HAAR SYNDROME	SH3PXD2B, 1-BP DEL, 969G	
613293	285590	SH3PXD2B	0003	FRANK-TER HAAR SYNDROME	SH3PXD2B, ARG43TRP	
613293	285590	SH3PXD2B	0004	FRANK-TER HAAR SYNDROME	SH3PXD2B, 76, A-C, -2	
613326	1807	DPYS	0001	DIHYDROPYRIMIDINASE DEFICIENCY	DPYS, GLN334ARG	121964923
613326	1807	DPYS	0002	DIHYDROPYRIMIDINASE DEFICIENCY	DPYS, GLY435ARG	
613326	1807	DPYS	0003	DIHYDROPYRIMIDINASE DEFICIENCY	DPYS, TRP360ARG	121964924
613326	1807	DPYS	0004	DIHYDROPYRIMIDINASE DEFICIENCY	DPYS, ARG412MET	
613349	4942	OAT	0001	GYRATE ATROPHY OF CHOROID AND RETINA	OAT, MET1ILE	121965034
613349	4942	OAT	0002	GYRATE ATROPHY OF CHOROID AND RETINA	OAT, 1-BP DEL, 159C	
613349	4942	OAT	0003	GYRATE ATROPHY OF CHOROID AND RETINA	OAT, 3-BP DEL, 550GCT	121965035
613349	4942	OAT	0004	GYRATE ATROPHY OF CHOROID AND RETINA	OAT, ARG396TER	121965036
613349	4942	OAT	0005	GYRATE ATROPHY OF CHOROID AND RETINA	OAT, TYR55HIS	121965037
613349	4942	OAT	0006	GYRATE ATROPHY OF CHOROID AND RETINA	OAT, CYS93PHE	121965038
613349	4942	OAT	0007	GYRATE ATROPHY OF CHOROID AND RETINA	OAT, ARG154LEU	121965039
613349	4942	OAT	0008	GYRATE ATROPHY OF CHOROID AND RETINA	OAT, ARG180THR	121965040
613349	4942	OAT	0009	GYRATE ATROPHY OF CHOROID AND RETINA	OAT, ALA270PRO	121965041
613349	4942	OAT	0010	GYRATE ATROPHY OF CHOROID AND RETINA	OAT, ARG271LYS	121965042
613349	4942	OAT	0011	GYRATE ATROPHY OF CHOROID AND RETINA	OAT, LEU402PRO	121965043
613349	4942	OAT	0012	GYRATE ATROPHY OF CHOROID AND RETINA	OAT, PRO417LEU	121965044
613349	4942	OAT	0013	OAT POLYMORPHISM	OAT, LEU437PHE	1800456
613349	4942	OAT	0014	GYRATE ATROPHY OF CHOROID AND RETINA	OAT, GLY375ALA	121965045
613349	4942	OAT	0016	GYRATE ATROPHY OF CHOROID AND RETINA	OAT, TYR245CYS	121965046
613349	4942	OAT	0017	OAT POLYMORPHISM	OAT, ASN378ASN	11461
613349	4942	OAT	0018	GYRATE ATROPHY OF CHOROID AND RETINA WITH PYRIDOXINE-RESPONSIVE ORNITHINEMIA	OAT, VAL332MET	121965047
613349	4942	OAT	0019	GYRATE ATROPHY OF CHOROID AND RETINA	OAT, ASN54LYS	121965048
613349	4942	OAT	0020	GYRATE ATROPHY OF CHOROID AND RETINA	OAT, HIS319TYR	121965049
613349	4942	OAT	0022	GYRATE ATROPHY OF CHOROID AND RETINA	OAT, EX5DEL	
613349	4942	OAT	0023	GYRATE ATROPHY OF CHOROID AND RETINA	OAT, ALU INS	
613349	4942	OAT	0024	GYRATE ATROPHY OF CHOROID AND RETINA	OAT, ARG184THR	121965050
613349	4942	OAT	0025	GYRATE ATROPHY OF CHOROID AND RETINA	OAT, PRO241LEU	121965051
613349	4942	OAT	0026	GYRATE ATROPHY OF CHOROID AND RETINA	OAT, ARG250PRO	121965052
613349	4942	OAT	0027	GYRATE ATROPHY OF CHOROID AND RETINA	OAT, GLY353ASP	121965053
613349	4942	OAT	0028	GYRATE ATROPHY OF CHOROID AND RETINA	OAT, TRP391TER	
613349	4942	OAT	0029	GYRATE ATROPHY OF CHOROID AND RETINA	OAT, CYS394ARG	121965054
613349	4942	OAT	0030	GYRATE ATROPHY OF CHOROID AND RETINA	OAT, GLY401TER	121965055
613349	4942	OAT	0031	GYRATE ATROPHY OF CHOROID AND RETINA	OAT, 1,072-BP DEL	
613349	4942	OAT	0032	GYRATE ATROPHY OF CHOROID AND RETINA	OAT, TYR209TER	121965056
613349	4942	OAT	0033	GYRATE ATROPHY OF CHOROID AND RETINA	OAT, TYR299TER	121965057
613349	4942	OAT	0034	GYRATE ATROPHY OF CHOROID AND RETINA	OAT, ARG426TER	121965058
613349	4942	OAT	0035	GYRATE ATROPHY OF CHOROID AND RETINA	OAT, 2-BP DEL, CODONS 64-65	
613349	4942	OAT	0036	GYRATE ATROPHY OF CHOROID AND RETINA	OAT, TRP178TER	
613349	4942	OAT	0037	GYRATE ATROPHY OF CHOROID AND RETINA	OAT, TRP275TER	
613349	4942	OAT	0038	GYRATE ATROPHY OF CHOROID AND RETINA WITH PYRIDOXINE-RESPONSIVE ORNITHINEMIA	OAT, ALA226VAL	121965059
613349	4942	OAT	0039	GYRATE ATROPHY OF CHOROID AND RETINA	OAT, GLN90GLU	121965060
613349	4942	OAT	0040	GYRATE ATROPHY OF CHOROID AND RETINA	OAT, PRO199GLN	
613350	113278	SLC52A3	0001	BROWN-VIALETTO-VAN LAERE SYNDROME 1	SLC52A3, 2-BP DEL, 1325TG	
613350	113278	SLC52A3	0002	BROWN-VIALETTO-VAN LAERE SYNDROME 1	SLC52A3, GLU71TER	
613350	113278	SLC52A3	0003	BROWN-VIALETTO-VAN LAERE SYNDROME 1	SLC52A3, ARG132TRP	
613350	113278	SLC52A3	0004	BROWN-VIALETTO-VAN LAERE SYNDROME 1	SLC52A3, PHE224LEU	
613350	113278	SLC52A3	0005	BROWN-VIALETTO-VAN LAERE SYNDROME 1, MILD	SLC52A3, GLU36LYS	
613350	113278	SLC52A3	0006	BROWN-VIALETTO-VAN LAERE SYNDROME 1, MILD	SLC52A3, VAL413ALA	
613350	113278	SLC52A3	0007	BROWN-VIALETTO-VAN LAERE SYNDROME 1	SLC52A3, PRO28THR	
613350	113278	SLC52A3	0008	FAZIO-LONDE DISEASE	SLC52A3, 1198A-C, -2	
613350	113278	SLC52A3	0009	BROWN-VIALETTO-VAN LAERE SYNDROME 1	SLC52A3, TRP17ARG	
613350	113278	SLC52A3	0010	BROWN-VIALETTO-VAN LAERE SYNDROME 1	SLC52A3, TYR213TER	
613354	286262	TPRN	0001	DEAFNESS, AUTOSOMAL RECESSIVE 79	TPRN, TRP352TER	
613354	286262	TPRN	0002	DEAFNESS, AUTOSOMAL RECESSIVE 79	TPRN, 1-BP DEL, 1244C	
613354	286262	TPRN	0003	DEAFNESS, AUTOSOMAL RECESSIVE 79	TPRN, 11-BP DUP, NT44	
613354	286262	TPRN	0004	DEAFNESS, AUTOSOMAL RECESSIVE 79	TPRN, 11-BP DEL, NT42	
613354	286262	TPRN	0005	DEAFNESS, AUTOSOMAL RECESSIVE 79	TPRN, 1-BP DEL, 1347G	
613381	875	CBS	0001	HOMOCYSTINURIA, PYRIDOXINE-NONRESPONSIVE HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED, INCLUDED	CBS, GLY307SER	121964962
613381	875	CBS	0002	HOMOCYSTINURIA, PYRIDOXINE-RESPONSIVE	CBS, PRO145LEU	121964963
613381	875	CBS	0003	HOMOCYSTINURIA, PYRIDOXINE-RESPONSIVE	CBS, ALA114VAL	121964964
613381	875	CBS	0004	HOMOCYSTINURIA, PYRIDOXINE-RESPONSIVE HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED, INCLUDED	CBS, ILE278THR	5742905
613381	875	CBS	0005	HOMOCYSTINURIA, PYRIDOXINE-RESPONSIVE	CBS, GLY139ARG	121964965
613381	875	CBS	0006	HOMOCYSTINURIA, PYRIDOXINE-RESPONSIVE	CBS, GLU144LYS	121964966
613381	875	CBS	0007	HOMOCYSTINURIA, PYRIDOXINE-RESPONSIVE	CBS, LYS384GLU	121964967
613381	875	CBS	0008	HOMOCYSTINURIA, PYRIDOXINE-RESPONSIVE	CBS, LEU539SER	121964968
613381	875	CBS	0009	HOMOCYSTINURIA, PYRIDOXINE-RESPONSIVE	CBS, ARG266LYS	121964969
613381	875	CBS	0010	HOMOCYSTINURIA, PYRIDOXINE-RESPONSIVE HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED, INCLUDED	CBS, ASP444ASN	28934891
613381	875	CBS	0011	HOMOCYSTINURIA, PYRIDOXINE-RESPONSIVE	CBS, VAL168MET	121964970
613381	875	CBS	0012	HOMOCYSTINURIA, PYRIDOXINE-RESPONSIVE	CBS, IVS11AS, A-C, -2	
613381	875	CBS	0013	HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	CBS, PRO422LEU	28934892
613381	875	CBS	0014	HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	CBS, SER466LEU	121964971
613381	875	CBS	0015	HOMOCYSTINURIA, PYRIDOXINE-NONRESPONSIVE	CBS, THR353MET	121964972
613381	875	CBS	0016	HOMOCYSTINURIA, PYRIDOXINE-NONRESPONSIVE	CBS, THR191MET	121964973
613381	875	CBS	0017	CYSTATHIONINE BETA-SYNTHETASE POLYMORPHISM	CBS, 68-BP INS	
613386	51371	POMP	0001	KERATOSIS LINEARIS WITH ICHTHYOSIS CONGENITA AND SCLEROSING KERATODERMA	POMP, 1-BP DEL, -95C	
613401	63894	VIPAS39	0001	ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	VIPAR, GLN179TER	
613401	63894	VIPAS39	0002	ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	VIPAR, 5-BP DEL, NT748	
613401	63894	VIPAS39	0003	ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	VIPAR, ARG220TER	
613401	63894	VIPAS39	0004	ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	VIPAR, GLN291TER	
613401	63894	VIPAS39	0005	ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	VIPAR, MET1ARG	
613403	55654	TMEM127	0001	PHEOCHROMOCYTOMA, SUSCEPTIBILITY TO	TMEM127, IVS3AS, A-C, -2	121908826
613403	55654	TMEM127	0002	PHEOCHROMOCYTOMA, SUSCEPTIBILITY TO	TMEM127, GLN159TER	121908830
613403	55654	TMEM127	0003	PHEOCHROMOCYTOMA, SUSCEPTIBILITY TO	TMEM127, IVS2AS, G-T, -1	121908821
613403	55654	TMEM127	0004	PHEOCHROMOCYTOMA, SUSCEPTIBILITY TO	TMEM127, 1-BP INS, 150A	121908817
613405	100422910	MIR2861	0001	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 15	MIR2861, 33C-G	
613425	388939	C2orf71	0001	RETINITIS PIGMENTOSA 54	C2ORF71, TRP253TER	
613425	388939	C2orf71	0002	RETINITIS PIGMENTOSA 54	C2ORF71, ILE201PHE	
613425	388939	C2orf71	0003	RETINITIS PIGMENTOSA 54	C2ORF71, 1-BP DEL, 946A	
613425	388939	C2orf71	0004	RETINITIS PIGMENTOSA 54	C2ORF71, GLN186TER	
613425	388939	C2orf71	0005	RETINITIS PIGMENTOSA 54	C2ORF71, 13-BP DEL, NT2756	
613441	6948	TCN2	0001	TRANSCOBALAMIN II DEFICIENCY	TCN2, 4-BP DEL	
613441	6948	TCN2	0002	TCN2 POLYMORPHISM	TCN2, PRO259ARG	1801198
613441	6948	TCN2	0003	TRANSCOLABAMIN II DEFICIENCY	TCN2, IVS3DS, T-G, +2	
613441	6948	TCN2	0004	TRANSCOLABAMIN II DEFICIENCY	TCN2, 2,152-BP DEL AND 4-BP INS	
613441	6948	TCN2	0005	TRANSCOLABAMIN II DEFICIENCY	TCN2, IVS4DS, A-T, +624	
613468	427	ASAH1	0001	FARBER LIPOGRANULOMATOSIS	ASAH1, THR222LYS	
613468	427	ASAH1	0002	FARBER LIPOGRANULOMATOSIS	ASAH1, GLU138VAL	
613468	427	ASAH1	0003	FARBER LIPOGRANULOMATOSIS	ASAH1, TYR36CYS	
613468	427	ASAH1	0004	FARBER LIPOGRANULOMATOSIS	ASAH1, ASN320ASP	
613468	427	ASAH1	0005	FARBER LIPOGRANULOMATOSIS	ASAH1, LEU182VAL	
613468	427	ASAH1	0006	SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	ASAH1, THR42MET	
613468	427	ASAH1	0007	SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	ASAH1, DEL	
613469	60495	HPSE2	0001	UROFACIAL SYNDROME 1	HPSE2, ARG506TER	
613469	60495	HPSE2	0002	UROFACIAL SYNDROME 1	HPSE2, 2-BP DEL, 1465AA	
613469	60495	HPSE2	0003	UROFACIAL SYNDROME 1	HPSE2, 2-BP DEL, 241CT	
613469	60495	HPSE2	0004	UROFACIAL SYNDROME 1	HPSE2, EX8-9DEL	
613469	60495	HPSE2	0005	UROFACIAL SYNDROME 1	HPSE2, EX3DEL	
613469	60495	HPSE2	0006	UROFACIAL SYNDROME 1	HPSE2, ARG472TER	
613469	60495	HPSE2	0007	UROFACIAL SYNDROME 1	HPSE2, ARG153TER	
613469	60495	HPSE2	0008	UROFACIAL SYNDROME 1	HPSE2, 1-BP INS, 57C	
613497	3988	LIPA	0001	WOLMAN DISEASE CHOLESTERYL ESTER STORAGE DISEASE, INCLUDED	LIPA, LEU179PRO	121965086
613497	3988	LIPA	0002	CHOLESTERYL ESTER STORAGE DISEASE	LIPA, 934G-A	
613497	3988	LIPA	0003	CHOLESTERYL ESTER STORAGE DISEASE	LIPA, GLY245TER	
613497	3988	LIPA	0004	WOLMAN DISEASE CHOLESTERYL ESTER STORAGE DISEASE, INCLUDED	LIPA, 1-BP INS, 634T	
613497	3988	LIPA	0005	WOLMAN DISEASE	LIPA, IVS8, G-A, +1	
613497	3988	LIPA	0006	WOLMAN DISEASE	LIPA, TYR22TER	121965087
613497	3988	LIPA	0007	WOLMAN DISEASE	LIPA, 1-BP DEL, 482A	
613521	7389	UROD	0001	PORPHYRIA CUTANEA TARDA	UROD, GLY281VAL	
613521	7389	UROD	0002	PORPHYRIA, HEPATOERYTHROPOIETIC PORPHYRIA CUTANEA TARDA, INCLUDED	UROD, GLY281GLU	121918057
613521	7389	UROD	0003	PORPHYRIA CUTANEA TARDA	UROD, EX6DEL	
613521	7389	UROD	0004	PORPHYRIA, HEPATOERYTHROPOIETIC	UROD, GLU167LYS	121918058
613521	7389	UROD	0005	PORPHYRIA, HEPATOERYTHROPOIETIC	UROD, ARG292GLY	121918059
613521	7389	UROD	0006	PORPHYRIA, HEPATOERYTHROPOIETIC	UROD, PRO62LEU	121918060
613521	7389	UROD	0007	PORPHYRIA, HEPATOERYTHROPOIETIC	UROD, TYR311CYS	121918061
613521	7389	UROD	0008	PORPHYRIA CUTANEA TARDA	UROD, GLU314GLU	121918062
613521	7389	UROD	0009	PORPHYRIA CUTANEA TARDA	UROD, MET165ARG	121918063
613521	7389	UROD	0010	PORPHYRIA CUTANEA TARDA	UROD, LEU195PHE	121918064
613521	7389	UROD	0011	PORPHYRIA CUTANEA TARDA	UROD, ASN304LYS	121918065
613521	7389	UROD	0012	PORPHYRIA CUTANEA TARDA	UROD, ARG332HIS	121918066
613522	611	OPN1SW	0001	TRITANOPIA	OPN1SW, GLY79ARG	104894031
613522	611	OPN1SW	0002	TRITANOPIA	OPN1SW, SER214PRO	104894032
613522	611	OPN1SW	0003	TRITANOPIA	OPN1SW, PRO264SER	104894033
613524	10806	SDCCAG8	0001	SENIOR-LOKEN SYNDROME 7	SDCCAG8, 1-BP DEL, 1420G	
613524	10806	SDCCAG8	0002	SENIOR-LOKEN SYNDROME 7	SDCCAG8, 1-BP INS, 1339G	
613524	10806	SDCCAG8	0003	SENIOR-LOKEN SYNDROME 7	SDCCAG8, 4-BP DEL, 1946GTGT	
613524	10806	SDCCAG8	0004	SENIOR-LOKEN SYNDROME 7	SDCCAG8, IVS7, C-T	
613524	10806	SDCCAG8	0005	SENIOR-LOKEN SYNDROME 7	SDCCAG8, LYS227TER	
613529	22995	CEP152	0001	MICROCEPHALY 9, PRIMARY, AUTOSOMAL RECESSIVE	CEP152, GLN265PRO	
613529	22995	CEP152	0002	MICROCEPHALY 9, PRIMARY, AUTOSOMAL RECESSIVE	CEP152, ARG987TER	
613529	22995	CEP152	0003	SECKEL SYNDROME 5	CEP152, IVS4DS, G-C, +1	
613529	22995	CEP152	0004	SECKEL SYNDROME 5	CEP152, TYR678TER	
613529	22995	CEP152	0005	SECKEL SYNDROME 5	CEP152, IVS19DS, G-T, +1	
613529	22995	CEP152	0006	SECKEL SYNDROME 5	CEP152, 2-BP DEL, 4210	
613529	22995	CEP152	0007	SECKEL SYNDROME 5	CEP152, LYS667ARG	
613534	22909	FAN1	0001	INTERSTITIAL NEPHRITIS, KARYOMEGALIC	FAN1, TRP707TER	
613534	22909	FAN1	0002	INTERSTITIAL NEPHRITIS, KARYOMEGALIC	FAN1, IVS2DS, T-A, +2	
613534	22909	FAN1	0003	INTERSTITIAL NEPHRITIS, KARYOMEGALIC	FAN1, 2-BP DEL, 2036GA	
613534	22909	FAN1	0004	INTERSTITIAL NEPHRITIS, KARYOMEGALIC	FAN1, ARG749TER	
613534	22909	FAN1	0005	INTERSTITIAL NEPHRITIS, KARYOMEGALIC	FAN1, 1-BP DEL, 2616A	
613534	22909	FAN1	0006	INTERSTITIAL NEPHRITIS, KARYOMEGALIC	FAN1, IVS3DS, G-A, +1	
613534	22909	FAN1	0007	INTERSTITIAL NEPHRITIS, KARYOMEGALIC	FAN1, 2-BP DEL, 2774TT	
613534	22909	FAN1	0008	INTERSTITIAL NEPHRITIS, KARYOMEGALIC	FAN1, GLY937ARG	
613541	91574	C12orf65	0001	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7	C10ORF65, 1-BP DEL, 248T	
613541	91574	C12orf65	0002	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7	C10ORF65, 1-BP DEL, 210A	
613541	91574	C12orf65	0003	SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE	C10ORF65, ARG132TER	
613553	63929	XPNPEP3	0001	NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	XPNPEP3, GLY453CYS	
613553	63929	XPNPEP3	0002	NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	XPNPEP3, 4-BP DEL, 931AACA	
613577	57465	TBC1D24	0001	MYOCLONIC EPILEPSY, INFANTILE, FAMILIAL	TBC1D24, ASP147HIS	
613577	57465	TBC1D24	0002	MYOCLONIC EPILEPSY, INFANTILE, FAMILIAL	TBC1D24, ALA509VAL	
613577	57465	TBC1D24	0003	MYOCLONIC EPILEPSY, INFANTILE, FAMILIAL	TBC1D24, PHE251LEU	
613580	51057	WDPCP	0001	BARDET-BIEDL SYNDROME 15	C2ORF86, NT76, G-T, -1	
613580	51057	WDPCP	0002	BARDET-BIEDL SYNDROME 12, MODIFIER OF	C2ORF86, LEU208PHE	
613580	51057	WDPCP	0003	MECKEL SYNDROME, TYPE 6, MODIFIER OF	C2ORF86, ARG55LYS	
613583	284403	WDR62	0001	MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH CORTICAL MALFORMATIONS	WDR62, 4-BP DEL, TGCC	
613583	284403	WDR62	0002	MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH CORTICAL MALFORMATIONS	WDR62, GLU526LYS	
613583	284403	WDR62	0003	MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH CORTICAL MALFORMATIONS	WDR62, TRP224SER	
613583	284403	WDR62	0004	MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH CORTICAL MALFORMATIONS	WDR62, GLN470TER	
613583	284403	WDR62	0005	MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH CORTICAL MALFORMATIONS	WDR62, 17-BP DEL	
613583	284403	WDR62	0006	MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE	WDR62, ARG438HIS	
613583	284403	WDR62	0007	MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE	WDR62, 1-BP DUP, 4241T	
613583	284403	WDR62	0008	MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE	WDR62, ASP511ASN	
613583	284403	WDR62	0009	MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH CORTICAL MALFORMATIONS	WDR62, 1-BP INS, 3936C	
613583	284403	WDR62	0010	MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH CORTICAL MALFORMATIONS	WDR62, 1-BP DEL, 363T	
613583	284403	WDR62	0011	MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICAL MALFORMATIONS	WDR62, VAL65MET	
613583	284403	WDR62	0012	MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH CORTICAL MALFORMATIONS	WDR62, 1-BP DEL, 2083A	
613583	284403	WDR62	0013	MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH CORTICAL MALFORMATIONS	WDR62, 2-BP DEL, 2472AG	
613596	84140	FAM161A	0001	RETINITIS PIGMENTOSA 28	FAM161A, ARG229TER	
613596	84140	FAM161A	0002	RETINITIS PIGMENTOSA 28	FAM161A, ARG437TER	
613596	84140	FAM161A	0003	RETINITIS PIGMENTOSA 28	FAM161A, 2-BP DEL, 1355CA	
613596	84140	FAM161A	0004	RETINITIS PIGMENTOSA 28	FAM161A, ARG523TER	
613596	84140	FAM161A	0005	RETINITIS PIGMENTOSA 28	FAM161A, ARG596TER	
613597	112817	HOGA1	0001	HYPEROXALURIA, PRIMARY, TYPE III	HOGA1, 3-BP DEL, 944AGG	
613597	112817	HOGA1	0002	HYPEROXALURIA, PRIMARY, TYPE III	HOGA1, GLY287VAL	
613597	112817	HOGA1	0003	HYPEROXALURIA, PRIMARY, TYPE III	HOGA1, ARG97CYS	
613597	112817	HOGA1	0004	HYPEROXALURIA, PRIMARY, TYPE III	HOGA1, IVS, G-T, +4	
613597	112817	HOGA1	0005	HYPEROXALURIA, PRIMARY, TYPE III	HOGA1, ARG70PRO	
613597	112817	HOGA1	0006	HYPEROXALURIA, PRIMARY, TYPE III	HOGA1, CYS257GLY	
613598	130557	ZNF513	0001	RETINITIS PIGMENTOSA 58	ZNF513, CYS339ARG	
613599	26090	ABHD12	0001	POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA, AND CATARACT	ABHD12, 2-BP DEL/3-BP INS, 337GA/TTT	
613599	26090	ABHD12	0002	POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA, AND CATARACT	ABHD12, 14-KB DEL	
613599	26090	ABHD12	0003	POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA, AND CATARACT	ABHD12, 7-BP DUP, NT846	
613599	26090	ABHD12	0004	POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA, AND CATARACT	ABHD12, ARG352TER	
613602	57539	WDR35	0001	CRANIOECTODERMAL DYSPLASIA 2	WDR35, IVS2AS, A-G, -2	
613602	57539	WDR35	0002	CRANIOECTODERMAL DYSPLASIA 2	WDR35, GLU626GLY	
613602	57539	WDR35	0003	CRANIOECTODERMAL DYSPLASIA 2	WDR35, 1-BP DEL, 2891C	
613602	57539	WDR35	0004	CRANIOECTODERMAL DYSPLASIA 2	WDR35, ALA875THR	
613602	57539	WDR35	0005	SHORT RIB-POLYDACTYLY SYNDROME V	WDR35, 2847-BP DEL	
613602	57539	WDR35	0006	SHORT RIB-POLYDACTYLY SYNDROME V	WDR35, ARG545TER	
613602	57539	WDR35	0007	SHORT RIB-POLYDACTYLY SYNDROME V	WDR35, TRP261ARG	
613609	3077	HFE	0001	HEMOCHROMATOSIS PORPHYRIA CUTANEA TARDA, SUSCEPTIBILITY TO, INCLUDED;; PORPHYRIA VARIEGATA, SUSCEPTIBILITY TO, INCLUDED;; HEMOCHROMATOSIS, JUVENILE, DIGENIC, INCLUDED;; ALZHEIMER DISEASE, SUSCEPTIBILITY TO, INCLUDED;; TRANSFERRIN SERUM LEVEL QUANTITATIVE TRAIT LOCUS 2, INCLUDED;; MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 7, INCLUDED	HFE, CYS282TYR	1800562
613609	3077	HFE	0002	HEMOCHROMATOSIS MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 7, INCLUDED	HFE, HIS63ASP	1799945
613609	3077	HFE	0003	HEMOCHROMATOSIS	HFE, SER65CYS	1800730
613609	3077	HFE	0004	HFE INTRONIC POLYMORPHISM	HFE, 5569G-A	
613609	3077	HFE	0005	HFE POLYMORPHISM	HFE, VAL53MET	28934889
613609	3077	HFE	0006	HFE POLYMORPHISM	HFE, VAL59MET	111033557
613609	3077	HFE	0007	HEMOCHROMATOSIS	HFE, GLN127HIS	28934595
613609	3077	HFE	0008	HEMOCHROMATOSIS	HFE, ARG330MET	111033558
613609	3077	HFE	0009	HEMOCHROMATOSIS	HFE, ILE105THR	28934596
613609	3077	HFE	0010	HEMOCHROMATOSIS	HFE, GLY93ARG	28934597
613609	3077	HFE	0011	HEMOCHROMATOSIS	HFE, GLN283PRO	111033563
613619	91179	SCARF2	0001	VAN DEN ENDE-GUPTA SYNDROME	SCARF2, CYS258TYR	
613619	91179	SCARF2	0002	VAN DEN ENDE-GUPTA SYNDROME	SCARF2, 2-BP DEL, 1328TG	
613621	80224	NUBPL	0001	MITOCHONDRIAL COMPLEX I DEFICIENCY	NUBPL, GLY56ARG AND 815-27T-C	
613621	80224	NUBPL	0002	MITOCHONDRIAL COMPLEX I DEFICIENCY	NUBPL, 240-KB DEL AND 130-KB DUP	
613621	80224	NUBPL	0003	MITOCHONDRIAL COMPLEX I DEFICIENCY	NUBPL, 10-BP INS, NT667	
613621	80224	NUBPL	0004	MITOCHONDRIAL COMPLEX I DEFICIENCY	NUBPL, ASP105TYR	
613621	80224	NUBPL	0005	MITOCHONDRIAL COMPLEX I DEFICIENCY	NUBPL, IVS8DS, G-A, +1	
613621	80224	NUBPL	0006	MITOCHONDRIAL COMPLEX I DEFICIENCY	NUBPL, LEU193PHE	
613622	55572	FOXRED1	0001	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY	FOXRED1, GLN232TER	
613622	55572	FOXRED1	0002	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY	FOXRED1, ASN430SER	
613622	55572	FOXRED1	0003	MITOCHONDRIAL COMPLEX I DEFICIENCY	FOXRED1, ARG352TRP	
613624	9640	ZNF592	0001	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 5	ZNF592, GLY1046ARG	
613653	9907	AP5Z1	0001	SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE	KIAA0415, 4-BP DEL/22-BP INS, NT80	
613653	9907	AP5Z1	0002	SPASTIC PARAPLEGIA 48	KIAA0415, 14-BP DEL, NT1413	
613655	338567	KCNK18	0001	MIGRAINE, WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 13	KCNK18, 2-BP DEL, 414CT	
613665	2532	DARC	0001	DUFFY BLOOD GROUP SYSTEM, FYA/FYB POLYMORPHISM	DARC, GLY42ASP	
613665	2532	DARC	0002	DUFFY BLOOD GROUP SYSTEM, FY(a-b-) PHENOTYPE PLASMODIUM VIVAX, RESISTANCE TO, INCLUDED;; WHITE BLOOD CELL COUNT QUANTITATIVE TRAIT LOCUS 1, INCLUDED	DARC, -67T-C	
613665	2532	DARC	0003	DUFFY BLOOD GROUP SYSTEM, FY(bwk) PHENOTYPE	DARC, ARG89CYS	
613665	2532	DARC	0004	DUFFY BLOOD GROUP SYSTEM, FY(a-b-) PHENOTYPE	DARC, 14-BP DEL, NT286	
613666	440138	ALG11	0001	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip	ALG11, LEU86SER	
613666	440138	ALG11	0002	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip	ALG11, 18-BP DEL, NT623	
613666	440138	ALG11	0003	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip	ALG11, TYR279SER	
613666	440138	ALG11	0004	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip	ALG11, LEU381SER	
613666	440138	ALG11	0005	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip	ALG11, GLU398LYS	
613666	440138	ALG11	0006	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip	ALG11, GLN318PRO	
613667	55084	SOBP	0001	MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS	SOBP, ARG661TER	
613669	55149	MTPAP	0001	SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE	MTPAP, ASN478ASP	
613698	788	SLC25A20	0001	CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	SLC25A20, 1-BP INS, FS323TER	
613698	788	SLC25A20	0002	CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	SLC25A20, 128-BP DEL	
613698	788	SLC25A20	0003	CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	SLC25A20, 110-BP DEL	
613698	788	SLC25A20	0004	CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	SLC25A20, ARG166TER	
613698	788	SLC25A20	0005	CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	SLC25A20, 1-BP DEL, 146T	
613698	788	SLC25A20	0006	CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	SLC25A20, IVS2AS, T-G, -10	
613698	788	SLC25A20	0007	CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	SLC25A20, GLN238ARG	
613715	51082	POLR1D	0001	TREACHER COLLINS SYNDROME 2	POLR1D, ARG87TER	
613715	51082	POLR1D	0002	TREACHER COLLINS SYNDROME 2	POLR1D, GLU47LYS	
613715	51082	POLR1D	0003	TREACHER COLLINS SYNDROME 2	POLR1D, LEU51ARG	
613715	51082	POLR1D	0004	TREACHER COLLINS SYNDROME 2	POLR1D, 2-BP DEL, 326CA	
613715	51082	POLR1D	0005	TREACHER COLLINS SYNDROME 2	POLR1D, 2-BP DUP, 263G	
613715	51082	POLR1D	0006	TREACHER COLLINS SYNDROME 2	POLR1D, 2-BP INS, 88TG	
613719	253827	MSRB3	0001	DEAFNESS, AUTOSOMAL RECESSIVE 74	MSRB3, CYS89GLY	
613719	253827	MSRB3	0002	DEAFNESS, AUTOSOMAL RECESSIVE 74	MSRB3, ARG19TER	
613726	55129	ANO10	0001	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 10	ANO10, LEU510ARG	
613726	55129	ANO10	0002	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 10	ANO10, 2-BP DEL, 1150TT	
613726	55129	ANO10	0003	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 10	ANO10, IVS9DS, G-T, +1	
613726	55129	ANO10	0004	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 10	ANO10, LEU535TER	
613727	390594	KBTBD13	0001	NEMALINE MYOPATHY 6	KBTBD13, LYS390ASN	
613727	390594	KBTBD13	0002	NEMALINE MYOPATHY 6	KBTBD13, ARG408CYS	
613727	390594	KBTBD13	0003	NEMALINE MYOPATHY 6	KBTBD13, ARG248SER	
613733	4221	MEN1	0001	MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	MEN1, LEU22ARG	
613733	4221	MEN1	0002	MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	MEN1, 4-BP DEL, NT357	
613733	4221	MEN1	0003	MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	MEN1, 1-BP DEL, 416C	
613733	4221	MEN1	0004	MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	MEN1, 3-BP DEL, LYS119DEL	
613733	4221	MEN1	0005	MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	MEN1, 1-BP DEL, 512C	
613733	4221	MEN1	0006	MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	MEN1, TRP198TER	
613733	4221	MEN1	0007	MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	MEN1, 4-BP DEL, NT735	
613733	4221	MEN1	0008	MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	MEN1, 1-BP DEL, 1132G	
613733	4221	MEN1	0009	MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	MEN1, 3-BP DEL, GLU363DEL	
613733	4221	MEN1	0010	MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	MEN1, TRP436ARG	
613733	4221	MEN1	0011	MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	MEN1, TRP436TER	
613733	4221	MEN1	0012	MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	MEN1, ARG527TER	
613733	4221	MEN1	0013	PARATHYROID ADENOMA, SOMATIC	MEN1, GLU26LYS	
613733	4221	MEN1	0014	MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	MEN1, GLN260TER	
613733	4221	MEN1	0015	CARCINOID TUMOR OF LUNG	MEN1, 1-BP INS, 1650C	
613733	4221	MEN1	0016	MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	MEN1, ARG460TER	
613733	4221	MEN1	0017	LIPOMA, SOMATIC	MEN1, 4-BP DEL	
613733	4221	MEN1	0018	ANGIOFIBROMA, SOMATIC	MEN1, LYS135ILE	
613733	4221	MEN1	0019	ANGIOFIBROMA, SOMATIC	MEN1, 1184GG-AA, GLU359LYS	
613733	4221	MEN1	0020	HYPERPARATHYROIDISM, FAMILIAL ISOLATED PRIMARY	MEN1, GLU255LYS	
613733	4221	MEN1	0021	HYPERPARATHYROIDISM, FAMILIAL ISOLATED PRIMARY	MEN1, VAL184GLU	
613733	4221	MEN1	0022	ADRENAL ADENOMA, SOMATIC	MEN1, THR552SER	
613733	4221	MEN1	0023	MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	MEN1, HIS139ASP	
613733	4221	MEN1	0024	MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	MEN1, IVS4, G-A, -9	
613733	4221	MEN1	0025	MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	MEN1, 3-BP DEL, 2641GAA	
613733	4221	MEN1	0026	MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	MEN1, 4-BP DEL, 4480CAGT	
613733	4221	MEN1	0027	MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	MEN1, ASP418ASN	
613733	4221	MEN1	0028	MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	MEN1, 1-BP DEL, 7773C	
613733	4221	MEN1	0029	MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	MEN1, CYS354TER	
613733	4221	MEN1	0030	MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	MEN1, 6-BP INS, NT879	
613733	4221	MEN1	0031	HYPERPARATHYROIDISM, FAMILIAL ISOLATED PRIMARY	MEN1, IVS9, G-A, +1	
613733	4221	MEN1	0032	MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	MEN1, 12-BP DEL, NT1466	
613733	4221	MEN1	0033	MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	MEN1, 1-BP INS, 1657C	
613733	4221	MEN1	0034	MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	MEN1, IVS5, G-A, +1	
613733	4221	MEN1	0035	MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	MEN1, IVS3DS, G-A, +1	
613741	5836	PYGL	0001	GLYCOGEN STORAGE DISEASE VI	PYGL, IVS14DS, G-A, +1	
613741	5836	PYGL	0002	GLYCOGEN STORAGE DISEASE VI	PYGL, IVS4AS, G-C, -1	
613741	5836	PYGL	0003	GLYCOGEN STORAGE DISEASE VI	PYGL, ASN338SER	
613741	5836	PYGL	0004	GLYCOGEN STORAGE DISEASE VI	PYGL, ASN376LYS	
613741	5836	PYGL	0005	GLYCOGEN STORAGE DISEASE VI	PYGL, IVS13DS, G-A, +1	
613742	2538	G6PC	0001	GLYCOGEN STORAGE DISEASE Ia	G6PC, 2-BP INS, 459AT	
613742	2538	G6PC	0002	GLYCOGEN STORAGE DISEASE Ia	G6PC, ARG83CYS	
613742	2538	G6PC	0003	GLYCOGEN STORAGE DISEASE Ia	G6PC, ARG295CYS	
613742	2538	G6PC	0004	GLYCOGEN STORAGE DISEASE Ia	G6PC, GLN347TER	
613742	2538	G6PC	0005	GLYCOGEN STORAGE DISEASE Ia	G6PC, IVS4AS, G-T, +86	
613742	2538	G6PC	0006	GLYCOGEN STORAGE DISEASE Ia	G6PC, ASP38VAL	
613742	2538	G6PC	0007	GLYCOGEN STORAGE DISEASE Ia	G6PC, TRP77ARG	
613742	2538	G6PC	0008	GLYCOGEN STORAGE DISEASE Ia	G6PC, IVS1DS, A-G, +4	
613742	2538	G6PC	0009	GLYCOGEN STORAGE DISEASE Ia	G6PC, GLU110LYS	
613742	2538	G6PC	0010	GLYCOGEN STORAGE DISEASE Ia	G6PC, ALA124THR	
613742	2538	G6PC	0011	GLYCOGEN STORAGE DISEASE Ia	G6PC, GLY184GLU	
613742	2538	G6PC	0012	GLYCOGEN STORAGE DISEASE Ia	G6PC, GLY188ARG	
613742	2538	G6PC	0013	GLYCOGEN STORAGE DISEASE Ia	G6PC, ILE341ASP	
613742	2538	G6PC	0014	GLYCOGEN STORAGE DISEASE Ia	G6PC, VAL166GLY	
613768	57674	RNF213	0001	MOYAMOYA DISEASE 2, SUSCEPTIBILITY TO	RNF213, ARG4859LYS	
613768	57674	RNF213	0002	MOYAMOYA DISEASE 2, SUSCEPTIBILITY TO	RNF213, ARG4810LYS	
613768	57674	RNF213	0003	MOYAMOYA DISEASE 2, SUSCEPTIBILITY TO	RNF213, ASP4013ASN	
613798	339829	CCDC39	0001	CILIARY DYSKINESIA, PRIMARY, 14	CCDC39, 1-BP DEL, 2190A	
613798	339829	CCDC39	0002	CILIARY DYSKINESIA, PRIMARY, 14	CCDC39, 1-BP DEL, 1072A	
613798	339829	CCDC39	0003	CILIARY DYSKINESIA, PRIMARY, 14	CCDC39, IVS3DS, G-C, +1	
613798	339829	CCDC39	0004	CILIARY DYSKINESIA, PRIMARY, 14	CCDC39, 3-BP DEL/1-BP INS, NT2357	
613799	55036	CCDC40	0001	CILIARY DYSKINESIA, PRIMARY, 15	CCDC40, 1-BP DEL, 248C	
613799	55036	CCDC40	0002	CILIARY DYSKINESIA, PRIMARY, 15	CCDC40, GLN439TER	
613799	55036	CCDC40	0003	CILIARY DYSKINESIA, PRIMARY, 15	CCDC40, GLN651TER	
613799	55036	CCDC40	0004	CILIARY DYSKINESIA, PRIMARY, 15	CCDC40, ARG449TER	
613814	54902	TTC19	0001	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2	TTC19, LEU219TER	
613814	54902	TTC19	0002	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2	TTC19, GLN173TER	
613815	1589	CYP21A2	0001	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY, CLASSIC TYPE	CYP21A2, ILE172ASN	
613815	1589	CYP21A2	0002	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY, NONCLASSIC TYPE ADENOMA, CORTISOL-PRODUCING, INCLUDED;; CARCINOMA, ADRENOCORTICAL, ANDROGEN-SECRETING, INCLUDED	CYP21A2, VAL281LEU	
613815	1589	CYP21A2	0003	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY, CLASSIC TYPE	CYP21A2, ARG356TRP	
613815	1589	CYP21A2	0004	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY, NONCLASSIC TYPE	CYP21A2, PRO30LEU	
613815	1589	CYP21A2	0005	21-@HYDROXYLASE POLYMORPHISM	CYP21A2, SER268THR	
613815	1589	CYP21A2	0006	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	CYP21A2, IVS2AS, A/C-G, -13	
613815	1589	CYP21A2	0007	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY, SALT-WASTING TYPE	CYP21A2, GLY292SER	
613815	1589	CYP21A2	0008	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY, CLASSIC TYPE	CYP21A2, 2-BP DEL/1-BP INS, ARG484FS	
613815	1589	CYP21A2	0009	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY, LATE-ONSET FORM	CYP21A2, -4C-T, PRO105LEU, AND PRO453SER	
613815	1589	CYP21A2	0010	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY, NONCLASSIC TYPE	CYP21A2, PRO453SER	
613815	1589	CYP21A2	0011	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY, SALT-WASTING TYPE	CYP21A2, 30-KB DEL	
613815	1589	CYP21A2	0012	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY, SALT-WASTING TYPE	CYP21A2, GENE CONVERSION CYP21 FROM CYP21P	
613815	1589	CYP21A2	0013	21-@HYDROXYLASE POLYMORPHISM	CYP21A2, 3-BP INS, LEU10INS	
613815	1589	CYP21A2	0014	21-@HYDROXYLASE POLYMORPHISM	CYP21A2, TYR102ARG	
613815	1589	CYP21A2	0015	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY, SALT-WASTING TYPE	CYP21A2, 8-BP DEL	
613815	1589	CYP21A2	0016	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY, SALT-WASTING TYPE	CYP21A2, ILE236ASN, VAL237GLU, MET239LYS	
613815	1589	CYP21A2	0018	MOVED TO 613815.0016 .0019 ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY, SALT-WASTING TYPE	CYP21A2, IVS7DS, G-C, +1	
613815	1589	CYP21A2	0020	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY, SALT-WASTING TYPE	CYP21A2, GLN318TER	
613815	1589	CYP21A2	0021	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY, NONCLASSIC TYPE	CYP21A2, ARG339HIS AND PRO453SER	
613815	1589	CYP21A2	0022	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY, SALT-WASTING TYPE	CYP21A2, TRP406TER	
613815	1589	CYP21A2	0023	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY, SALT-WASTING TYPE	CYP21A2, GLU380ASP	
613815	1589	CYP21A2	0025	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	CYP21A2, GLY424SER	
613815	1589	CYP21A2	0026	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY, CLASSIC TYPE	CYP21A2, ARG426HIS	
613815	1589	CYP21A2	0027	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY, CLASSIC TYPE	CYP21A2, 1-BP INS, 82C	
613815	1589	CYP21A2	0028	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY, CLASSIC TYPE	CYP21A2, IVS2, A-G, -2	
613815	1589	CYP21A2	0029	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY, CLASSIC TYPE	CYP21A2, 1-BP INS, 1003A	
613815	1589	CYP21A2	0030	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY, CLASSIC TYPE	CYP21A2, ARG408CYS	
613815	1589	CYP21A2	0031	HYPERANDROGENISM, NONCLASSIC TYPE, DUE TO 21-HYDROXYLASE DEFICIENCY	CYP21A2, VAL304MET	
613815	1589	CYP21A2	0032	HYPERANDROGENISM, NONCLASSIC TYPE, DUE TO 21-HYDROXYLASE DEFICIENCY	CYP21A2, GLY375SER	
613815	1589	CYP21A2	0033	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	CYP21A2, VAL281LEU, PHE306+1, GLN318TER, AND ARG356TRP	
613815	1589	CYP21A2	0034	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	CYP21A2, HIS62LEU	
613815	1589	CYP21A2	0035	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	CYP21A2, LYS121GLN	
613846	79867	TCTN2	0001	MECKEL SYNDROME, TYPE 8	TCTN2, IVS13, A-G, -2	
613847	26123	TCTN3	0001	OROFACIODIGITAL SYNDROME IV	TCTN3, GLN480TER	
613847	26123	TCTN3	0002	OROFACIODIGITAL SYNDROME IV	TCTN3, 3-BP DEL, NT650	
613847	26123	TCTN3	0003	OROFACIODIGITAL SYNDROME IV	TCTN3, GLN443TER	
613847	26123	TCTN3	0004	OROFACIODIGITAL SYNDROME IV	TCTN3, 1-BP DEL, NT566	
613847	26123	TCTN3	0005	OROFACIODIGITAL SYNDROME IV	TCTN3, 1-BP DEL, NT1348	
613847	26123	TCTN3	0006	JOUBERT SYNDROME 18	TCTN3, GLY314ARG	
613858	646960	PRSS56	0001	MICROPHTHALMIA, ISOLATED 6	PRSS56, 1-BP DUP, 1066C	
613858	646960	PRSS56	0002	MICROPHTHALMIA, ISOLATED 6	PRSS56, TRP309SER	
613858	646960	PRSS56	0003	MICROPHTHALMIA, ISOLATED 6	PRSS56, ARG176GLY	
613858	646960	PRSS56	0004	MICROPHTHALMIA, ISOLATED 6	PRSS56, PRO599ALA	
613868	6563	SLC14A1	0001	KIDD BLOOD POLYMORPHISM Jk(a)/Jk(b)	SLC14A1, ASP280ASN	
613868	6563	SLC14A1	0002	JK-NULL VARIANT	SLC14A1, IVS5AS, G-A, -1	
613868	6563	SLC14A1	0003	JK-NULL VARIANT	SLC14A1, IVS7DS, G-T, +1	
613868	6563	SLC14A1	0004	JK-NULL VARIANT, FINNISH TYPE	SLC14A1, SER291PRO	
613868	6563	SLC14A1	0005	JK-NULL VARIANT	SLC14A1, EX4-5 DEL	
613871	2184	FAH	0001	TYROSINEMIA, TYPE I	FAH, ASN16ILE	
613871	2184	FAH	0002	TYROSINEMIA, TYPE I	FAH, ALA134ASP	
613871	2184	FAH	0003	TYROSINEMIA, TYPE I	FAH, IVS12, G-A, +5	
613871	2184	FAH	0004	TYROSINEMIA, TYPE I	FAH, GLU357TER	
613871	2184	FAH	0005	TYROSINEMIA, TYPE I	FAH, GLU364TER	
613871	2184	FAH	0006	FUMARYLACETOACETASE PSEUDODEFICIENCY	FAH, ARG341TRP	
613871	2184	FAH	0007	TYROSINEMIA, TYPE I	FAH, GLU337SER	
613871	2184	FAH	0008	TYROSINEMIA, TYPE I	FAH, ARG381GLY	
613871	2184	FAH	0009	TYROSINEMIA, TYPE I	FAH, TRP262TER	
613871	2184	FAH	0010	TYROSINEMIA, TYPE I	FAH, IVS6, G-T, -1	
613871	2184	FAH	0011	TYROSINEMIA, TYPE I	FAH, GLN279ARG	
613872	2159	F10	0001	FACTOR X DEFICIENCY	F10, ARG366CYS	
613872	2159	F10	0002	FACTOR X DEFICIENCY	F10, 1-BP DEL, C, EX7	
613872	2159	F10	0003	FACTOR X DEFICIENCY	F10, GLU14LYS	
613872	2159	F10	0004	FACTOR X DEFICIENCY	F10, PRO343SER	
613872	2159	F10	0005	FACTOR X DEFICIENCY	F10, G-A, -20	
613872	2159	F10	0006	FACTOR X DEFICIENCY	F10, SER334PRO	
613872	2159	F10	0007	FACTOR X DEFICIENCY	F10, GLU102LYS	
613872	2159	F10	0008	FACTOR X DEFICIENCY	F10, ASP282ASN	
613872	2159	F10	0009	FACTOR X DEFICIENCY	F10, GLU7GLY	
613872	2159	F10	0010	FACTOR X DEFICIENCY	F10, GLU14GLY	
613872	2159	F10	0011	FACTOR X DEFICIENCY	F10, GLU32GLN	
613872	2159	F10	0012	FACTOR X DEFICIENCY, AUTOSOMAL DOMINANT	F10, GLY249ARG	
613872	2159	F10	0013	FACTOR X DEFICIENCY	F10, VAL298MET	
613872	2159	F10	0014	FACTOR X DEFICIENCY	F10, ARG287TRP	
613872	2159	F10	0015	FACTOR X DEFICIENCY	F10, THR318MET	
613878	2155	F7	0001	FACTOR VII PADUA	F7, ARG304GLN	
613878	2155	F7	0002	FACTOR VII DEFICIENCY	F7, CYS310PHE	
613878	2155	F7	0003	FACTOR VII DEFICIENCY	F7, CYS178TYR	
613878	2155	F7	0004	FACTOR VII DEFICIENCY	F7, ARG247HIS	
613878	2155	F7	0005	FACTOR VII DEFICIENCY	F7, THR359MET	
613878	2155	F7	0006	FACTOR VII DEFICIENCY	F7, ALA244VAL	
613878	2155	F7	0007	FACTOR VII DEFICIENCY	F7, ASN57ASP	
613878	2155	F7	0008	FACTOR VII DEFICIENCY	F7, IVS4DS, G-A, +1	
613878	2155	F7	0009	FACTOR VII DEFICIENCY	F7, LEU-26PRO	
613878	2155	F7	0010	FACTOR VII DEFICIENCY	F7, ALA294VAL	
613878	2155	F7	0011	FACTOR VII DEFICIENCY	F7, 17-BP DEL	
613878	2155	F7	0012	FACTOR VII DEFICIENCY	F7, 1-BP DEL, 11128C	
613878	2155	F7	0013	MYOCARDIAL INFARCTION, DECREASED SUSCEPTIBILITY TO	F7, 10-BP INS, NT-323	
613878	2155	F7	0014	MYOCARDIAL INFARCTION, DECREASED SUSCEPTIBILITY TO	F7, ARG353GLN	
613878	2155	F7	0015	FACTOR VII DEFICIENCY	F7, -61T-G	
613878	2155	F7	0016	FACTOR VII DEFICIENCY	F7, -94C-G	
613878	2155	F7	0017	FACTOR VII DEFICIENCY	F7, -55C-T	
613878	2155	F7	0018	FACTOR VII DEFICIENCY	F7, CYS61TER	
613878	2155	F7	0019	FACTOR VII DEFICIENCY	F7, CYS329GLY	
613878	2155	F7	0020	FACTOR VII DEFICIENCY	F7, GLN211TER	
613878	2155	F7	0021	FACTOR VII DEFICIENCY	F7, GLU25LYS	
613878	2155	F7	0022	FACTOR VII DEFICIENCY	F7, HIS348GLN	
613878	2155	F7	0023	FACTOR VII DEFICIENCY	F7, GLY354CYS	
613878	2155	F7	0024	FACTOR VII DEFICIENCY	F7, PHE328SER	
613883	3792	KEL	0001	KELL K/k BLOOD GROUP POLYMORPHISM	KEL, THR193MET	
613883	3792	KEL	0002	KELL-NULL PHENOTYPE	KEL, IVS3DS, G-C	
613883	3792	KEL	0003	KEL6 ANTIGEN	KEL, LEU597PRO	
613890	3284	HSD3B2	0001	3-@BETA-HYDROXYSTEROID DEHYDROGENASE, TYPE II, DEFICIENCY OF	HSD3B2, TRP171TER	
613890	3284	HSD3B2	0002	3-@BETA-HYDROXYSTEROID DEHYDROGENASE, TYPE II, DEFICIENCY OF	HSD3B2, 1-BP INS	
613890	3284	HSD3B2	0003	3-@BETA-HYDROXYSTEROID DEHYDROGENASE, TYPE II, DEFICIENCY OF	HSD3B2, VAL248ASN	
613890	3284	HSD3B2	0004	3-@BETA-HYDROXYSTEROID DEHYDROGENASE, TYPE II, DEFICIENCY OF	HSD3B2, ARG249TER	
613890	3284	HSD3B2	0005	3-@BETA-HYDROXYSTEROID DEHYDROGENASE, TYPE II, DEFICIENCY OF	HSD3B2, ALA10GLU	
613890	3284	HSD3B2	0006	3-@BETA-HYDROXYSTEROID DEHYDROGENASE, TYPE II, DEFICIENCY OF	HSD3B2, TER373CYS	
613890	3284	HSD3B2	0007	3-@BETA-HYDROXYSTEROID DEHYDROGENASE, TYPE II, DEFICIENCY OF	HSD3B2, GLU142LYS	
613890	3284	HSD3B2	0008	3-@BETA-HYDROXYSTEROID DEHYDROGENASE, TYPE II, DEFICIENCY OF	HSD3B2, PRO222THR	
613890	3284	HSD3B2	0009	3-@BETA-HYDROXYSTEROID DEHYDROGENASE, TYPE II, DEFICIENCY OF	HSD3B2, THR259MET	
613890	3284	HSD3B2	0010	3-@BETA-HYDROXYSTEROID DEHYDROGENASE, TYPE II, DEFICIENCY OF	HSD3B2, 1-BP DEL, 867G	
613890	3284	HSD3B2	0011	3-@BETA-HYDROXYSTEROID DEHYDROGENASE, TYPE II, DEFICIENCY OF	HSD3B2, PRO341LEU	
613891	7372	UMPS	0001	OROTIC ACIDURIA	UMPS, ARG96GLY AND GLY429ARG	
613891	7372	UMPS	0002	OROTIC ACIDURIA	UMPS, VAL109GLY	
613893	283417	DPY19L2	0001	SPERMATOGENIC FAILURE 9	DPY19L2, DEL	
613896	669	BPGM	0001	BISPHOSPHOGLYCERATE MUTASE DEFICIENCY, ERYTHROCYTOSIS DUE TO	BPGM, ARG89CYS	
613896	669	BPGM	0002	BISPHOSPHOGLYCERATE MUTASE DEFICIENCY	BPGM, 1-BP DEL, 205C	
613897	2188	FANCF	0001	FANCONI ANEMIA, COMPLEMENTATION GROUP F	FANCF, 23-BP DEL	
613897	2188	FANCF	0002	FANCONI ANEMIA, COMPLEMENTATION GROUP F	FANCF, 47-BP DEL	
613897	2188	FANCF	0003	FANCONI ANEMIA, COMPLEMENTATION GROUP F	FANCF, GLN6TER	
613897	2188	FANCF	0004	FANCONI ANEMIA, COMPLEMENTATION GROUP F	FANCF, 2-BP DEL	
613897	2188	FANCF	0005	FANCONI ANEMIA, COMPLEMENTATION GROUP F	FANCF, TYR109TER	
613898	3155	HMGCL	0001	HMG-CoA LYASE DEFICIENCY	HMGCL, 2-BP DEL, CODON 69	
613898	3155	HMGCL	0002	HMG-CoA LYASE DEFICIENCY	HMGCL, VAL70LEU	
613898	3155	HMGCL	0003	HMG-CoA LYASE DEFICIENCY	HMGCL, 930-BP DEL, EX3-6DEL	
613898	3155	HMGCL	0004	HMG-CoA LYASE DEFICIENCY	HMGCL, ARG41GLN	
613898	3155	HMGCL	0005	HMG-CoA LYASE DEFICIENCY	HMGCL, GLU279LYS	
613898	3155	HMGCL	0006	HMG-CoA LYASE DEFICIENCY	HMGCL, 2-BP DEL, TT, CODON 305	
613899	2176	FANCC	0001	FANCONI ANEMIA, COMPLEMENTATION GROUP C	FANCC, LEU554PRO	
613899	2176	FANCC	0002	FANCONI ANEMIA, COMPLEMENTATION GROUP C	FANCC, ARG185TER	
613899	2176	FANCC	0003	FANCONI ANEMIA, COMPLEMENTATION GROUP C	FANCC, IVS4, A-T, +4	
613899	2176	FANCC	0004	FANCONI ANEMIA, COMPLEMENTATION GROUP C	FANCC, GLN13TER	
613899	2176	FANCC	0005	FANCONI ANEMIA, COMPLEMENTATION GROUP C	FANCC, ARG548TER	
613899	2176	FANCC	0006	FANCONI ANEMIA, COMPLEMENTATION GROUP C	FANCC, 1-BP INS, 1806A	
613899	2176	FANCC	0007	FANCONI ANEMIA, COMPLEMEMENTATION GROUP C	FANCC, 1-BP DEL, 322G	
613899	2176	FANCC	0008	FANCONI ANEMIA, COMPLEMEMENTATION GROUP C	FANCC, LEU496ARG	
613899	2176	FANCC	0009	FANCONI ANEMIA, COMPLEMEMENTATION GROUP C	FANCC, IVS2DS, G-T, +1	
613899	2176	FANCC	0010	FANCONI ANEMIA, COMPLEMEMENTATION GROUP C	FANCC, 250-BP DEL	
613900	343641	TGM6	0001	SPINOCEREBELLAR ATAXIA 35	TGM6, LEU517TRP	
613900	343641	TGM6	0002	SPINOCEREBELLAR ATAXIA 35	TGM6, ASP327GLY	
613900	343641	TGM6	0003	SPINOCEREBELLAR ATAXIA 35	TGM6, ASP510HIS	
613920	493753	COA5	0001	CARDIOMYOPATHY, HYPERTROPHIC, LETHAL NEONATAL, DUE TO CYTOCHROME c OXIDASE DEFICIENCY	COA5, ALA53PRO	
613924	643418	LIPN	0001	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 8	LIPN, 2-BP DEL, 399GA	
613927	717	C2	0001	C2 DEFICIENCY, TYPE I	C2, 28-BP DEL	
613927	717	C2	0002	C2 DEFICIENCY, TYPE II	C2, SER189PHE	
613927	717	C2	0003	C2 DEFICIENCY, TYPE II	C2, GLY444ARG	
613927	717	C2	0004	MACULAR DEGENERATION, AGE-RELATED, REDUCED RISK OF	C2, GLU318ASP	
613927	717	C2	0005	MACULAR DEGENERATION, AGE-RELATED, REDUCED RISK OF	C2, IVS10, G-T	
613976	2178	FANCE	0001	FANCONI ANEMIA, COMPLEMENTATION GROUP E	FANCE, GLN119TER	
613976	2178	FANCE	0002	FANCONI ANEMIA, COMPLEMENTATION GROUP E	FANCE, ARG141TER	
613976	2178	FANCE	0003	FANCONI ANEMIA, COMPLEMENTATION GROUP E	FANCE, IVS5AS, G-A, -8	
613979	24148	PRPF6	0001	RETINITIS PIGMENTOSA 60	PRPF6, ARG729TRP	
613984	2177	FANCD2	0001	FANCONI ANEMIA, COMPLEMENTATION GROUP D2	FANCD2, ARG1236HIS	
613984	2177	FANCD2	0002	FANCONI ANEMIA, COMPLEMENTATION GROUP D2	FANCD2, 376A-G	
613984	2177	FANCD2	0003	FANCONI ANEMIA, COMPLEMENTATION GROUP D2	FANCD2, ARG302TRP	
613984	2177	FANCD2	0004	FANCONI ANEMIA, COMPLEMENTATION GROUP D2	FANCD2, GLN320TER	
613984	2177	FANCD2	0005	FANCONI ANEMIA, COMPLEMENTATION GROUP D2	FANCD2, EX17 DEL	
614010	54928	IMPAD1	0001	CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	IMPAD1, ASP177ASN	
614010	54928	IMPAD1	0002	CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	IMPAD1, THR183PRO	
614010	54928	IMPAD1	0003	CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	IMPAD1, ARG187TER	
614041	5925	RB1	0001	RETINOBLASTOMA, SOMATIC	RB1, 1-BP DEL, 2657G	
614041	5925	RB1	0002	RETINOBLASTOMA, SOMATIC	RB1, IVS19, T-C, +2	
614041	5925	RB1	0003	RETINOBLASTOMA	RB1, ARG445TER	
614041	5925	RB1	0004	RETINOBLASTOMA	RB1, SER567LEU	
614041	5925	RB1	0005	RETINOBLASTOMA	RB1, ARG787TER	
614041	5925	RB1	0006	RETINOBLASTOMA, SOMATIC	RB1, 1-BP DEL, 2381G	
614041	5925	RB1	0007	RETINOBLASTOMA, SOMATIC	RB1, IVS10, G-T, +1	
614041	5925	RB1	0008	RETINOBLASTOMA	RB1, ARG358TER	
614041	5925	RB1	0009	BLADDER CANCER, SOMATIC	RB1, IVS20, A-G, -2	
614041	5925	RB1	0010	SMALL CELL CANCER OF THE LUNG, SOMATIC	RB1, GLU748TER	
614041	5925	RB1	0011	RETINOBLASTOMA, SOMATIC	RB1, IVS12, G-A, +1	
614041	5925	RB1	0012	RETINOBLASTOMA	RB1, 5-BP DEL, EX8	
614041	5925	RB1	0013	RETINOBLASTOMA	RB1, 55-BP DUP, EX10	
614041	5925	RB1	0014	RETINOBLASTOMA	RB1, 10-BP DEL, EX18	
614041	5925	RB1	0015	RETINOBLASTOMA	RB1, 9-BP DEL, EX19	
614041	5925	RB1	0016	RETINOBLASTOMA, SOMATIC	RB1, EX22DEL	
614041	5925	RB1	0017	RETINOBLASTOMA	RB1, 189G-T, PROMOTER MUTATION	
614041	5925	RB1	0018	RETINOBLASTOMA	RB1, 198G-A, PROMOTER MUTATION	
614041	5925	RB1	0019	RETINOBLASTOMA	RB1, ARG661TRP	
614041	5925	RB1	0020	RETINOBLASTOMA	RB1, GLN675TER	
614041	5925	RB1	0021	RETINOBLASTOMA	RB1, IVS21, G-A, -1	
614041	5925	RB1	0022	RETINOBLASTOMA, TRILATERAL	RB1, ARG556TER	
614041	5925	RB1	0023	RETINOBLASTOMA	RB1, 3-BP DEL	
614041	5925	RB1	0024	RETINOBLASTOMA	RB1, CYS712ARG	
614041	5925	RB1	0025	RETINOBLASTOMA	RB1, IVS6, G-T, +1	
614041	5925	RB1	0026	RETINOBLASTOMA	RB1, TYR606TER	
614041	5925	RB1	0027	RETINOBLASTOMA	RB1, 23-BP DUP, NT43	
614041	5925	RB1	0028	RETINOBLASTOMA	RB1, IVS23AS, A-G, -1398	
614058	3795	KHK	0001	FRUCTOSURIA, ESSENTIAL	KHK, GLY40ARG	
614058	3795	KHK	0002	FRUCTOSURIA, ESSENTIAL	KHK, ALA43THR	
614064	9841	ZBTB24	0001	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 2	ZBTB24, ARG320TER	
614064	9841	ZBTB24	0002	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 2	ZBTB24, SER16TER	
614064	9841	ZBTB24	0003	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 2	ZBTB24, SER278TER	
614064	9841	ZBTB24	0004	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 2	ZBTB24, CYS408GLY	
614064	9841	ZBTB24	0005	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 2	ZBTB24, ARG457TER	
614064	9841	ZBTB24	0006	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 2	ZBTB24, 2-BP DEL, 396TA	
614068	112752	IFT43	0001	CRANIOECTODERMAL DYSPLASIA 3	IFT43, MET1VAL	
614088	3386	ICAM4	0001	LW BLOOD GROUP SYSTEM, LW(a)/LW(b) POLYMORPHISM	ICAM4, GLN100ARG	
614088	3386	ICAM4	0002	LW BLOOD GROUP SYSTEM, LW(a-b-) PHENOTYPE	ICAM4, 10-BP DEL, NT346	
614123	54499	TMCO1	0001	CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	TMCO1, 2-BP DEL, 139AG	
614140	23384	SPECC1L	0001	FACIAL CLEFTING, OBLIQUE, 1	SPECC1L, GLN415PRO	
614144	27077	B9D1	0001	MECKEL SYNDROME, TYPE 9	B9D1, 505, T-C, +2	
614144	27077	B9D1	0002	MECKEL SYNDROME, TYPE 9	B9D1, 1.71-MB DEL	
614145	83987	CCDC8	0001	THREE M SYNDROME 3	CCDC8, 1-BP DUP, 612G	
614145	83987	CCDC8	0002	THREE M SYNDROME 3	CCDC8, 1-BP DUP, 84T	
614154	10528	NOP56	0001	SPINOCEREBELLAR ATAXIA 36	NOP56, (GGCCTG)n EXPANSION	
614159	84146	ZNF644	0001	MYOPIA 21, AUTOSOMAL DOMINANT	ZNF644, SER672GLY	
614159	84146	ZNF644	0002	MYOPIA 21, AUTOSOMAL DOMINANT	ZNF644, ILE587VAL	
614159	84146	ZNF644	0003	MYOPIA 21, AUTOSOMAL DOMINANT	ZNF644, G-A, +592	
614161	11107	PRDM5	0001	BRITTLE CORNEA SYNDROME 2	PRDM5, 52.46-KB DEL	
614161	11107	PRDM5	0002	BRITTLE CORNEA SYNDROME 2	PRDM5, ARG590TER	
614161	11107	PRDM5	0003	BRITTLE CORNEA SYNDROME 2	PRDM5, IVS1DS, G-A, +1	
614161	11107	PRDM5	0004	BRITTLE CORNEA SYNDROME 2	PRDM5, TYR107CYS	
614161	11107	PRDM5	0005	BRITTLE CORNEA SYNDROME 2	PRDM5, 1-BP DEL, 947G	
614161	11107	PRDM5	0006	BRITTLE CORNEA SYNDROME 2	PRDM5, IVS1DS, T-C, +2	
614169	23218	NBEAL2	0001	GRAY PLATELET SYNDROME	NBEAL2, ARG901TER	
614169	23218	NBEAL2	0002	GRAY PLATELET SYNDROME	NBEAL2, SER294TER	
614169	23218	NBEAL2	0003	GRAY PLATELET SYNDROME	NBEAL2, LEU388PRO	
614169	23218	NBEAL2	0004	GRAY PLATELET SYNDROME	NBEAL2, GLU643VAL	
614169	23218	NBEAL2	0005	GRAY PLATELET SYNDROME	NBEAL2, PRO2100LEU	
614169	23218	NBEAL2	0006	GRAY PLATELET SYNDROME	NBEAL2, TRP607TER	
614169	23218	NBEAL2	0007	GRAY PLATELET SYNDROME	NBEAL2, 1-BP DUP, 5413G	
614184	129563	DIS3L2	0001	PERLMAN SYNDROME	DIS3L2, 82.8-KB DEL, EX6DEL	
614184	129563	DIS3L2	0002	PERLMAN SYNDROME	DIS3L2, 22-KB DEL, EX9DEL	
614184	129563	DIS3L2	0003	PERLMAN SYNDROME	DIS3L2, CYS489TYR	
614184	129563	DIS3L2	0004	PERLMAN SYNDROME	DIS3L2, IVS19, G-A, +5	
614191	9681	DEPDC5	0001	EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI	DEPDC5, TYR7TER	
614191	9681	DEPDC5	0002	EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI	DEPDC5, ARG555TER	
614191	9681	DEPDC5	0003	EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI	DEPDC5, 3-BP DEL, 488TGT	
614191	9681	DEPDC5	0004	EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI	DEPDC5, TRP1369TER	
614191	9681	DEPDC5	0005	EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI	DEPDC5, 1-BP DEL, 1122A	
614191	9681	DEPDC5	0006	EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI	DEPDC5, ARG239TER	
614191	9681	DEPDC5	0007	EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI	DEPDC5, ARG328TER	
614194	57572	DOCK6	0001	ADAMS-OLIVER SYNDROME 2	DOCK6, 4-BP DEL, 1362AACT	
614194	57572	DOCK6	0002	ADAMS-OLIVER SYNDROME 2	DOCK6, 1-BP DUP, 1245T	
614194	57572	DOCK6	0003	ADAMS-OLIVER SYNDROME 2	DOCK6, 1-BP DUP, 2520T	
614194	57572	DOCK6	0004	ADAMS-OLIVER SYNDROME 2	DOCK6, IVS32AS, G-C, -1	
614215	51008	ASCC1	0001	BARRETT ESOPHAGUS/ESOPHAGEAL ADENOCARCINOMA	ASCC1, ASN290SER	
614218	124997	WDR81	0001	CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 2	WDR81, PRO856LEU	
614232	3291	HSD11B2	0001	APPARENT MINERALOCORTICOID EXCESS	HSD11B2, ARG208CYS	
614232	3291	HSD11B2	0002	APPARENT MINERALOCORTICOID EXCESS	HSD11B2, ARG213CYS	
614232	3291	HSD11B2	0003	APPARENT MINERALOCORTICOID EXCESS	HSD11B2, ARG337CYS	
614232	3291	HSD11B2	0004	APPARENT MINERALOCORTICOID EXCESS	HSD11B2, ARG208HIS	
614232	3291	HSD11B2	0005	APPARENT MINERALOCORTICOID EXCESS	HSD11B2, ARG337HIS, TYR338DEL	
614232	3291	HSD11B2	0006	APPARENT MINERALOCORTICOID EXCESS	HSD11B2, ARG279CYS	
614232	3291	HSD11B2	0007	APPARENT MINERALOCORTICOID EXCESS, MILD	HSD11B2, PRO227LEU	
614232	3291	HSD11B2	0008	APPARENT MINERALOCORTICOID EXCESS, MILD	HSD11B2, 6-BP DEL, LEU114/GLU115	
614232	3291	HSD11B2	0009	APPARENT MINERALOCORTICOID EXCESS	HSD11B2, ASP223ASN	
614232	3291	HSD11B2	0010	APPARENT MINERALOCORTICOID EXCESS	HSD11B2, TYR299DEL	
614232	3291	HSD11B2	0011	APPARENT MINERALOCORTICOID EXCESS	HSD11B2, IVS3, C-T, +14	
614232	3291	HSD11B2	0012	APPARENT MINERALOCORTICOID EXCESS	HSD11B2, TYR338HIS	
614232	3291	HSD11B2	0013	APPARENT MINERALOCORTICOID EXCESS	HSD11B2, 2-BP DEL	
614243	26873	OPLAH	0001	5-@OXOPROLINASE DEFICIENCY	OPLAH, 1-BP INS, 2601C	
614243	26873	OPLAH	0002	5-@OXOPROLINASE DEFICIENCY	OPLAH, SER323ARG	
614243	26873	OPLAH	0003	5-@OXOPROLINASE DEFICIENCY	OPLAH, VAL1089ILE	
614245	197322	ACSF3	0001	COMBINED MALONIC AND METHYLMALONIC ACIDURIA	ACSF3, ARG558TRP	
614245	197322	ACSF3	0002	COMBINED MALONIC AND METHYLMALONIC ACIDURIA	ACSF3, ARG523TER	
614245	197322	ACSF3	0003	COMBINED MALONIC AND METHYLMALONIC ACIDURIA	ACSF3, GLU359LYS	
614245	197322	ACSF3	0004	COMBINED MALONIC AND METHYLMALONIC ACIDURIA	ACSF3, ARG471TRP	
614245	197322	ACSF3	0005	COMBINED MALONIC AND METHYLMALONIC ACIDURIA	ACSF3, ARG471GLN	
614245	197322	ACSF3	0006	COMBINED MALONIC AND METHYLMALONIC ACIDURIA	ACSF3, THR358ILE	
614245	197322	ACSF3	0007	COMBINED MALONIC AND METHYLMALONIC ACIDURIA	ACSF3, PRO243LEU	
614245	197322	ACSF3	0008	COMBINED MALONIC AND METHYLMALONIC ACIDURIA	ACSF3, MET198ARG	
614245	197322	ACSF3	0009	COMBINED MALONIC AND METHYLMALONIC ACIDURIA	ACSF3, LYS462THR AND GLY465_GLY470 DEL	
614258	11128	POLR3A	0001	LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	POLR3A, GLY672GLU	
614258	11128	POLR3A	0002	LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OLIGODONTIA	POLR3A, IVS14DS, G-A, +18	
614258	11128	POLR3A	0003	LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OLIGODONTIA AND HYPOGONADOTROPIC HYPOGONADISM LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OLIGODONTIA, INCLUDED	POLR3A, MET852VAL	
614258	11128	POLR3A	0004	LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OLIGODONTIA AND HYPOGONADOTROPIC HYPOGONADISM	POLR3A, IVS19AS, G-A, -1	
614258	11128	POLR3A	0005	LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OLIGODONTIA	POLR3A, ARG140TER	
614258	11128	POLR3A	0006	LEUKODYSTROPHY, HYPOMYELINATING, 7, WITHOUT OLIGODONTIA OR HYPOGONADOTROPIC HYPOGONADISM	POLR3A, ILE897ASN	
614258	11128	POLR3A	0007	LEUKODYSTROPHY, HYPOMYELINATING, 7, WITHOUT OLIGODONTIA OR HYPOGONADOTROPIC HYPOGONADISM	POLR3A, ARG1005CYS	
614259	149465	WDR65	0001	RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	WDR65, ASP523TYR	
614260	203228	C9orf72	0001	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS	C9ORF72, (GGGGCC)n EXPANSION	
614283	113263	GLCCI1	0001	GLUCOCORTICOID THERAPY, RESPONSE TO	GLCCI1, -1106A-G	
614295	80114	BICC1	0001	RENAL DYSPLASIA, CYSTIC, SUSCEPTIBILITY TO	BICC1, GLN87TER	
614295	80114	BICC1	0002	RENAL DYSPLASIA, CYSTIC, SUSCEPTIBILITY TO	BICC1, GLU932GLY	
614297	83636	C19orf12	0001	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4	C19ORF12, 11-BP DEL, NT204	
614297	83636	C19orf12	0002	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4	C19ORF12, THR11MET	
614297	83636	C19orf12	0003	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4	C19ORF12, GLY69ARG	
614297	83636	C19orf12	0004	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4	C19ORF12, LYS142GLU	
614297	83636	C19orf12	0005	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4	C19ORF12, LEU121GLN	
614309	152992	TRMT44	0001	VARIANT OF UNKNOWN SIGNIFICANCE	METTL19, GLY400ALA	
614366	55703	POLR3B	0001	LEUKODYSTROPHY, HYPOMYELINATING, 8, WITHOUT HYPODONTIA AND WITH HYPOGONADOTROPIC HYPOGONADISM	POLR3B, IVS17AS, A-C, -2	
614366	55703	POLR3B	0002	LEUKODYSTROPHY, HYPOMYELINATING, 8, WITHOUT HYPODONTIA AND WITH HYPOGONADOTROPIC HYPOGONADISM	POLR3B, ARG768HIS	
614366	55703	POLR3B	0003	LEUKODYSTROPHY, HYPOMYELINATING, 8, WITHOUT HYPODONTIA OR HYPOGONADOTROPIC HYPOGONADISM	POLR3B, ARG550TER	
614366	55703	POLR3B	0004	LEUKODYSTROPHY, HYPOMYELINATING, 8, WITHOUT HYPODONTIA OR HYPOGONADOTROPIC HYPOGONADISM	POLR3B, ASP926GLU	
614366	55703	POLR3B	0005	LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH HYPODONTIA AND HYPOGONADOTROPIC HYPOGONADISM	POLR3B, VAL523GLU	
614366	55703	POLR3B	0006	LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH HYPODONTIA AND HYPOGONADOTROPIC HYPOGONADISM	POLR3B, THR503LYS	
614366	55703	POLR3B	0007	LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH HYPODONTIA AND WITHOUT HYPOGONADOTROPIC HYPOGONADISM	POLR3B, 1-BP DEL, 1533T	
614366	55703	POLR3B	0008	LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH HYPODONTIA AND HYPOGONADOTROPIC HYPOGONADISM	POLR3B, LYS896TER	
614386	112476	PRRT2	0001	EPISODIC KINESIGENIC DYSKINESIA 1 CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS, INCLUDED;; SEIZURES, BENIGN FAMILIAL INFANTILE, 2, INCLUDED	PRRT2, 1-BP DUP, 649C	
614386	112476	PRRT2	0002	EPISODIC KINESIGENIC DYSKINESIA 1	PRRT2, 4-BP DEL, 514TCTG	
614386	112476	PRRT2	0003	EPISODIC KINESIGENIC DYSKINESIA 1	PRRT2, 1-BP DEL, 972A	
614386	112476	PRRT2	0004	CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS	PRRT2, 1-BP INS, 629C	
614386	112476	PRRT2	0005	CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS	PRRT2, SER317ASN	
614386	112476	PRRT2	0006	SEIZURES, BENIGN FAMILIAL INFANTILE, 2	PRRT2, IVS2DS, G-A, +5	
614386	112476	PRRT2	0007	CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS	PRRT2, ARG240TER	
614386	112476	PRRT2	0008	CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS	PRRT2, 1-BP INS, 516T	
614386	112476	PRRT2	0009	EPISODIC KINESIGENIC DYSKINESIA 1 CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS, INCLUDED	PRRT2, GLN163TER	
614386	112476	PRRT2	0010	EPISODIC KINESIGENIC DYSKINESIA 1	PRRT2, ARG266TRP	
614386	112476	PRRT2	0011	EPISODIC KINESIGENIC DYSKINESIA 1	PRRT2, 1-BP DEL, 649C	
614386	112476	PRRT2	0012	CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS	PRRT2, GLN188TER	
614386	112476	PRRT2	0013	SEIZURES, BENIGN FAMILIAL INFANTILE, 2	PRRT2, 1-BP DEL, 629C	
614386	112476	PRRT2	0014	SEIZURES, BENIGN FAMILIAL INFANTILE, 2	PRRT2, 1-BP DEL, 291C	
614386	112476	PRRT2	0015	EPISODIC KINESIGENIC DYSKINESIA 1 SEIZURES, BENIGN FAMILIAL INFANTILE, 2, INCLUDED	PRRT2, GLN250TER	
614404	79651	RHBDF2	0001	TYLOSIS WITH ESOPHAGEAL CANCER	RHBDF2, ILE186THR	
614404	79651	RHBDF2	0003	TYLOSIS WITH ESOPHAGEAL CANCER	RHBDF2, PRO189LEU	
614423	65062	TMEM237	0001	JOUBERT SYNDROME 14	TMEM237, ARG18TER	
614423	65062	TMEM237	0002	JOUBERT SYNDROME 14	TMEM237, IVS9DS, G-T, +1	
614423	65062	TMEM237	0003	JOUBERT SYNDROME 14	TMEM237, 1-BP DUP, 1066C	
614423	65062	TMEM237	0004	JOUBERT SYNDROME 14	TMEM237, GLN26TER	
614423	65062	TMEM237	0005	JOUBERT SYNDROME 14	TMEM237, IVS11DS, G-T, +1	
614427	10194	TSHZ1	0001	AURAL ATRESIA, CONGENITAL	TSHZ1, 1-BP INS, 946A	
614427	10194	TSHZ1	0002	AURAL ATRESIA, CONGENITAL	TSHZ1, TRP241TER	
614459	51524	TMEM138	0001	JOUBERT SYNDROME 16	TMEM138, IVS2DS, G-A, +5	
614459	51524	TMEM138	0002	JOUBERT SYNDROME 16	TMEM138, HIS96ARG	
614459	51524	TMEM138	0003	JOUBERT SYNDROME 16	TMEM138, ALA127VAL	
614459	51524	TMEM138	0004	JOUBERT SYNDROME 16	TMEM138, ALA126THR	
614459	51524	TMEM138	0005	JOUBERT SYNDROME 16	TMEM138, TYR130CYS	
614477	157657	C8orf37	0001	RETINITIS PIGMENTOSA 64	C8ORF37, LEU166TER	
614477	157657	C8orf37	0002	CONE-ROD DYSTROPHY 16	C8ORF37, IVS1, A-G, -2	
614477	157657	C8orf37	0003	CONE-ROD DYSTROPHY 16	C8ORF37, ARG177TRP	
614477	157657	C8orf37	0004	RETINITIS PIGMENTOSA 64	C8ORF37, GLN182ARG	
614478	84987	COX14	0001	MITOCHONDRIAL COMPLEX IV DEFICIENCY	C12ORF62, MET19ILE	
614505	55033	FKBP14	0001	EHLERS-DANLOS SYNDROME WITH PROGRESSIVE KYPHOSCOLIOSIS, MYOPATHY, AND HEARING LOSS	FKBP14, 1-BP INS, 362C	
614505	55033	FKBP14	0002	EHLERS-DANLOS SYNDROME WITH PROGRESSIVE KYPHOSCOLIOSIS, MYOPATHY, AND HEARING LOSS	FKBP14, 19-BP DEL, NT42	
614506	221927	BRAT1	0001	RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL	BRAT1, 1-BP INS, 638A	
614515	440435	GPR179	0001	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E	GPR179, HIS603TYR	
614515	440435	GPR179	0002	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E	GPR179, 1-BP DEL, 278C	
614515	440435	GPR179	0003	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E	GPR179, ARG200TER	
614515	440435	GPR179	0004	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E	GPR179, IVS8, G-A, +1	
614515	440435	GPR179	0005	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E	GPR179, 1-BP DEL, 984C	
614515	440435	GPR179	0006	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E	GPR179, 1-BP DEL, 187C	
614515	440435	GPR179	0007	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E	GPR179, TYR220CYS	
614518	57798	GATAD1	0001	CARDIOMYOPATHY, DILATED, 2B	GATAD1, SER102PRO	
614530	55967	NDUFA12	0001	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY	NDUFA12, ARG60TER	
614537	83938	C10orf11	0001	ALBINISM, OCULOCUTANEOUS, TYPE V	C10ORF11, ARG194TER	
614537	83938	C10orf11	0002	ALBINISM, OCULOCUTANEOUS, TYPE V	C10ORF11, 1-BP DUP, 66C	
614556	57492	ARID1B	0001	MENTAL RETARDATION, AUTOSOMAL DOMINANT 12	ARID1B, GLN1307TER	
614556	57492	ARID1B	0002	MENTAL RETARDATION, AUTOSOMAL DOMINANT 12	ARID1B, 11-BP DEL, NT6463	
614556	57492	ARID1B	0003	MENTAL RETARDATION, AUTOSOMAL DOMINANT 12	ARID1B, ARG1102TER	
614556	57492	ARID1B	0004	MENTAL RETARDATION, AUTOSOMAL DOMINANT 12	ARID1B, 2-BP DEL, 3323AA	
614556	57492	ARID1B	0005	MENTAL RETARDATION, AUTOSOMAL DOMINANT 12	ARID1B, TYR1346TER	
614556	57492	ARID1B	0006	MENTAL RETARDATION, AUTOSOMAL DOMINANT 12	ARID1B, GLN635TER	
614556	57492	ARID1B	0007	MENTAL RETARDATION, AUTOSOMAL DOMINANT 12	ARID1B, 1-BP DEL, 5632G	
614556	57492	ARID1B	0008	MENTAL RETARDATION, AUTOSOMAL DOMINANT 12	ARID1B, LYS1777TER	
614556	57492	ARID1B	0009	MENTAL RETARDATION, AUTOSOMAL DOMINANT 12	ARID1B, ARG1075TER	
614556	57492	ARID1B	0010	MENTAL RETARDATION, AUTOSOMAL DOMINANT 12	ARID1B, 10-BP DEL, NT4619	
614566	352909	DNAAF3	0001	CILIARY DYSKINESIA, PRIMARY, 2	DNAAF3, LEU108PRO	
614566	352909	DNAAF3	0002	CILIARY DYSKINESIA, PRIMARY, 2	DNAAF3, ARG136TER	
614566	352909	DNAAF3	0003	CILIARY DYSKINESIA, PRIMARY, 2	DNAAF3, 1-BP INS, 762T	
614567	81624	DIAPH3	0001	AUDITORY NEUROPATHY, AUTOSOMAL DOMINANT, 1	DIAPH3, -172G-A	
614571	65250	C5orf42	0001	JOUBERT SYNDROME 17	C5ORF42, ARG1336TRP	
614571	65250	C5orf42	0002	JOUBERT SYNDROME 17	C5ORF42, IVS35DS, G-A, +1	
614571	65250	C5orf42	0003	JOUBERT SYNDROME 17	C5ORF42, 1-BP DEL, NT6407	
614571	65250	C5orf42	0004	JOUBERT SYNDROME 17	C5ORF42, ARG1602TER	
614571	65250	C5orf42	0005	JOUBERT SYNDROME 17	C5ORF42, ARG2493TER	
614571	65250	C5orf42	0006	VARIANT OF UNKNOWN SIGNIFICANCE	C5ORF42, ALA1564THR	
614574	79641	ROGDI	0001	KOHLSCHUTTER-TONZ SYNDROME	ROGDI, 2-BP DEL, 229CT	
614574	79641	ROGDI	0002	KOHLSCHUTTER-TONZ SYNDROME	ROGDI, GLN96TER	
614574	79641	ROGDI	0003	KOHLSCHUTTER-TONZ SYNDROME	ROGDI, IVS7DS, G-C, +5	
614574	79641	ROGDI	0004	KOHLSCHUTTER-TONZ SYNDROME	ROGDI, IVS7AS, A-T, -2	
614574	79641	ROGDI	0005	KOHLSCHUTTER-TONZ SYNDROME	ROGDI, ARG157TER	
614574	79641	ROGDI	0006	KOHLSCHUTTER-TONZ SYNDROME	ROGDI, 1-BP DEL, 507C	
614574	79641	ROGDI	0007	KOHLSCHUTTER-TONZ SYNDROME	ROGDI, 8-BP DEL, INTRON 1	
614574	79641	ROGDI	0008	KOHLSCHUTTER-TONZ SYNDROME	ROGDI, 12-BP DEL, INTRON 1	
614589	9652	TTC37	0001	TRICHOHEPATOENTERIC SYNDROME 1	TTC37, TRP936TER	
614589	9652	TTC37	0002	TRICHOHEPATOENTERIC SYNDROME 1	TTC37, IVS28, G-A, -2	
614589	9652	TTC37	0003	TRICHOHEPATOENTERIC SYNDROME 1	TTC37, IVS17, 1-BP DEL, G, +1	
614589	9652	TTC37	0004	TRICHOHEPATOENTERIC SYNDROME 1	TTC37, GLN147TER	
614589	9652	TTC37	0005	TRICHOHEPATOENTERIC SYNDROME 1	TTC37, GLN751TER	
614589	9652	TTC37	0006	TRICHOHEPATOENTERIC SYNDROME 1	TTC37, IVS23, G-C, +1	
614589	9652	TTC37	0007	TRICHOHEPATOENTERIC SYNDROME 1	TTC37, IVS24, 5-BP DEL, -7	
614589	9652	TTC37	0008	TRICHOHEPATOENTERIC SYNDROME 1	TTC37, IVS42, G-C, +1	
614591	388551	CEACAM16	0001	DEAFNESS, AUTOSOMAL DOMINANT 4B	CEACAM16, THR140PRO	
614603	80821	DDHD1	0001	SPASTIC PARAPLEGIA 28, AUTOSOMAL RECESSIVE	DDHD1, 1766G-A	
614603	80821	DDHD1	0002	SPASTIC PARAPLEGIA 28, AUTOSOMAL RECESSIVE	DDHD1, 1-BP DEL, 1874T	
614603	80821	DDHD1	0003	SPASTIC PARAPLEGIA 28, AUTOSOMAL RECESSIVE	DDHD1, GLN417TER	
614603	80821	DDHD1	0004	SPASTIC PARAPLEGIA 28, AUTOSOMAL RECESSIVE	DDHD1, IVS11AS, G-T, -1	
614620	9742	IFT140	0001	MAINZER-SALDINO SYNDROME	IFT140, GLU664LYS	
614620	9742	IFT140	0002	MAINZER-SALDINO SYNDROME	IFT140, IVS19DS, G-T, +1	
614620	9742	IFT140	0003	MAINZER-SALDINO SYNDROME	IFT140, TYR311CYS	
614620	9742	IFT140	0004	MAINZER-SALDINO SYNDROME	IFT140, 4-BP DEL, NT857	
614620	9742	IFT140	0005	MAINZER-SALDINO SYNDROME	IFT140, GLY212ARG	
614620	9742	IFT140	0006	MAINZER-SALDINO SYNDROME	IFT140, 1-BP DUP, NT3916	
614631	729920	ISPD	0001	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7	ISPD, IVS8AS, G-T, -1	
614631	729920	ISPD	0002	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7	ISPD, DEL, EX3	
614631	729920	ISPD	0003	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7	ISPD, IVS4DS, T-G, +2	
614631	729920	ISPD	0004	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7	ISPD, 3-BP DEL, 277ATT	
614631	729920	ISPD	0005	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7	ISPD, ALA216ASP	
614631	729920	ISPD	0006	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7	ISPD, LYS278TER	
614631	729920	ISPD	0007	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7	ISPD, ALA122PRO	
614631	729920	ISPD	0008	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7	ISPD, ARG268TER	
614631	729920	ISPD	0009	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7	ISPD, MET213ARG	
614631	729920	ISPD	0010	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7	ISPD, EX3-6DEL	
614631	729920	ISPD	0011	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7	ISPD, ASP156ASN	
614631	729920	ISPD	0012	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7	ISPD, THR238ILE	
614631	729920	ISPD	0013	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7	ISPD, ARG86TER	
614632	57654	UVSSA	0001	UV-SENSITIVE SYNDROME 3	UVSSA, LYS123TER	
614632	57654	UVSSA	0002	UV-SENSITIVE SYNDROME 3	UVSSA, 1-BP DEL, 87G	
614632	57654	UVSSA	0003	UV-SENSITIVE SYNDROME 3	UVSSA, CYS32ARG	
614647	51004	COQ6	0001	COENZYME Q10 DEFICIENCY, PRIMARY, 6	COQ6, GLY255ARG	
614647	51004	COQ6	0002	COENZYME Q10 DEFICIENCY, PRIMARY, 6	COQ6, ALA353ASP	
614647	51004	COQ6	0003	COENZYME Q10 DEFICIENCY, PRIMARY, 6	COQ6, TRP447TER	
614647	51004	COQ6	0004	COENZYME Q10 DEFICIENCY, PRIMARY, 6	COQ6, 1-BP DEL, 1383G	
614647	51004	COQ6	0005	COENZYME Q10 DEFICIENCY, PRIMARY, 6	COQ6, ARG162TER	
614647	51004	COQ6	0006	COENZYME Q10 DEFICIENCY, PRIMARY, 6	COQ6, TRP188TER	
614649	81790	RNF170	0001	ATAXIA, SENSORY, 1, AUTOSOMAL DOMINANT	RNF170, ARG199CYS	
614666	124093	CCDC78	0001	MYOPATHY, CENTRONUCLEAR 4	CCDC78, IVS1AS, G-A, -1	
614667	25821	MTO1	0001	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	MTO1, 1-BP DUP, 1858A	
614667	25821	MTO1	0002	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	MTO1, ALA428THR	
614677	388389	CCDC103	0001	CILIARY DYSKINESIA, PRIMARY, 17	CCDC103, 1-BP INS, 383G	
614677	388389	CCDC103	0002	CILIARY DYSKINESIA, PRIMARY, 17	CCDC103, HIS154PRO	
614683	85007	PHYKPL	0001	PHOSPHOHYDROXYLYSINURIA	AGXT2L2, GLY240ARG	
614683	85007	PHYKPL	0002	PHOSPHOHYDROXYLYSINURIA	AGXT2L2, GLU437VAL	
614724	80254	CEP63	0001	SECKEL SYNDROME 6	CEP63, TRP43TER	
614725	84947	SERAC1	0001	3-@METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME	SERAC1, ARG148TER	
614725	84947	SERAC1	0002	3-@METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME	SERAC1, IVS13DS, G-C, +1	
614725	84947	SERAC1	0003	3-@METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME	SERAC1, 4-BP DEL, 1167TCAG	
614725	84947	SERAC1	0004	3-@METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME	SERAC1, 3-BP DEL, 1435CTT	
614725	84947	SERAC1	0005	3-@METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME	SERAC1, 2-BP DUP, 1627TC	
614726	55858	TMEM165	0001	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIk	TMEM165, IVS4DS, G-A, +182	
614726	55858	TMEM165	0002	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIk	TMEM165, ARG126HIS	
614726	55858	TMEM165	0003	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIk	TMEM165, ARG126CYS	
614726	55858	TMEM165	0004	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIk	TMEM165, GLY304ARG	
614730	84720	PIGO	0001	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2	PIGO, LEU957PHE	
614730	84720	PIGO	0002	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2	PIGO, 1-BP DUP, 2361C	
614730	84720	PIGO	0003	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2	PIGO, IVS8DS, G-A, +5	
614738	51660	MPC1	0001	MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	BRP44L, ARG97TRP	
614738	51660	MPC1	0002	MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	BRP44L, LEU79HIS	
614757	387733	IFITM5	0001	OSTEOGENESIS IMPERFECTA, TYPE V	IFITM5, -14C-T	
614759	220136	CCDC11	0001	HETEROTAXY, VISCERAL, 6, AUTOSOMAL	CCDC11, IVS6DS, G-A, +1	
614780	29887	SNX10	0001	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 8	SNX10, ARG51GLN	
614783	25886	POC1A	0001	SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	POC1A, ARG81TER	
614783	25886	POC1A	0002	SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	POC1A, LEU171PRO	
614785	56947	MFF	0001	VARIANT OF UNKNOWN SIGNIFICANCE	MFF, GLN64TER	
614789	285203	EOGT	0001	ADAMS-OLIVER SYNDROME 4	EOGT, TRP207SER	
614789	285203	EOGT	0002	ADAMS-OLIVER SYNDROME 4	EOGT, 1-BP DEL, 1074A	
614789	285203	EOGT	0003	ADAMS-OLIVER SYNDROME 4	EOGT, ARG377GLN	
614828	84892	GTDC2	0001	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	GTDC2, ARG445TER	
614828	84892	GTDC2	0002	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	GTDC2, ARG158HIS	
614828	84892	GTDC2	0003	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	GTDC2, TRP197TER	
614829	152816	C4orf26	0001	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA4	C4ORF26, ARG77TER	
614829	152816	C4orf26	0002	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA4	C4ORF26, CYS43TER	
614829	152816	C4orf26	0003	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA4	C4ORF26, IVS1AS, A-T, -2	
614829	152816	C4orf26	0004	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA4	C4ORF26, TRP106TER	
614829	152816	C4orf26	0005	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA4	C4ORF26, 6-BP DEL/16-BP INS, NT51	
614848	22897	CEP164	0001	NEPHRONOPHTHISIS 15	CEP164, TER1460TRP	
614848	22897	CEP164	0002	NEPHRONOPHTHISIS 15	CEP164, GLN11PRO	
614848	22897	CEP164	0003	NEPHRONOPHTHISIS 15	CEP164, ARG93TRP	
614848	22897	CEP164	0004	NEPHRONOPHTHISIS 15	CEP164, GLN525TER	
614848	22897	CEP164	0005	NEPHRONOPHTHISIS 15	CEP164, ARG576TER	
614864	54919	HEATR2	0001	CILIARY DYSKINESIA, PRIMARY, 18, WITH OR WITHOUT SITUS INVERSUS	HEATR2, LEU795PRO	
614888	79719	AAGAB	0001	KERATODERMA, PALMOPLANTAR, PUNCTATE TYPE IA	AAGAB, ARG161TER	
614888	79719	AAGAB	0002	KERATODERMA, PALMOPLANTAR, PUNCTATE TYPE IA	AAGAB, ARG124TER	
614888	79719	AAGAB	0003	KERATODERMA, PALMOPLANTAR, PUNCTATE TYPE IA	AAGAB, 2-BP DEL, 348AG	
614888	79719	AAGAB	0004	KERATODERMA, PALMOPLANTAR, PUNCTATE TYPE IA	AAGAB, 1-BP DEL, NT473	
614888	79719	AAGAB	0005	KERATODERMA, PALMOPLANTAR, PUNCTATE TYPE IA	AAGAB, 4-BP DEL, NT200	
614888	79719	AAGAB	0006	KERATODERMA, PALMOPLANTAR, PUNCTATE TYPE IA	AAGAB, IVS, G-A, +1	
614901	10295	BCKDK	0001	BCKDK DEFICIENCY	BCKDK, ARG156TER	
614901	10295	BCKDK	0002	BCKDK DEFICIENCY	BCKDK, 1-BP DEL, 222G	
614901	10295	BCKDK	0003	BCKDK DEFICIENCY	BCKDK, ARG224PRO	
614917	55005	RMND1	0001	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11	RMND1, IVS2DS, G-A, +1	
614917	55005	RMND1	0002	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11	RMND1, ARG417GLN	
614925	283310	OTOGL	0001	DEAFNESS, AUTOSOMAL RECESSIVE 84B	OTOGL, 1-BP DEL, 1430T	
614925	283310	OTOGL	0002	DEAFNESS, AUTOSOMAL RECESSIVE 84B	OTOGL, ARG183TER	
614925	283310	OTOGL	0003	DEAFNESS, AUTOSOMAL RECESSIVE 84B	OTOGL, 5238, G-A, +5	
614930	23639	LRRC6	0001	CILIARY DYSKINESIA, PRIMARY, 19	LRRC6, 2-BP DEL, 598AA	
614930	23639	LRRC6	0002	CILIARY DYSKINESIA, PRIMARY, 19	LRRC6, GLN192TER	
614930	23639	LRRC6	0003	CILIARY DYSKINESIA, PRIMARY, 19	LRRC6, 1-BP DUP, 576A	
614930	23639	LRRC6	0004	CILIARY DYSKINESIA, PRIMARY, 19	LRRC6, ALA74PRO	
614930	23639	LRRC6	0005	CILIARY DYSKINESIA, PRIMARY, 19	LRRC6, ASP146HIS	
614949	79583	TMEM231	0001	JOUBERT SYNDROME 20	TMEM231, TYR4TER	
614949	79583	TMEM231	0002	JOUBERT SYNDROME 20	TMEM231, ASP209ASN	
614982	23347	SMCHD1	0001	FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 2, DIGENIC	SMCHD1, 5-BP DEL, NT1302	
614982	23347	SMCHD1	0002	FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 2, DIGENIC	SMCHD1, PRO690SER	
614982	23347	SMCHD1	0003	FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 2, DIGENIC	SMCHD1, 1-BP DEL, NT1608	
614982	23347	SMCHD1	0004	FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 2, DIGENIC	SMCHD1, IVS29DS, G-A, +1	
614982	23347	SMCHD1	0005	FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 2, DIGENIC	SMCHD1, THR1522THR	
614984	55526	DHTKD1	0001	2-@AMINOADIPIC 2-OXOADIPIC ACIDURIA	DHTKD1, 1A-G	
614984	55526	DHTKD1	0002	2-@AMINOADIPIC 2-OXOADIPIC ACIDURIA	DHTKD1, GLY729ARG	
614984	55526	DHTKD1	0003	2-@AMINOADIPIC 2-OXOADIPIC ACIDURIA	DHTKD1, ARG410TER	
614984	55526	DHTKD1	0004	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Q	DHTKD1, TYR485TER	
614998	57459	GATAD2B	0001	MENTAL RETARDATION, AUTOSOMAL DOMINANT 18	GATAD2B, GLN470TER	
614998	57459	GATAD2B	0002	MENTAL RETARDATION, AUTOSOMAL DOMINANT 18	GATAD2B, ASN195LYSfs*30	
615000	9895	TECPR2	0001	SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	TECPR2, 1-BP DEL, 3416T	
615003	23259	DDHD2	0001	SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE	DDHD2, 1-BP INS, 1804T	
615003	23259	DDHD2	0002	SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE	DDHD2, 1-BP DEL, 2057A	
615003	23259	DDHD2	0003	SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE	DDHD2, 1-BP DUP, 138C	
615003	23259	DDHD2	0004	SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE	DDHD2, ASP660HIS	
615003	23259	DDHD2	0005	SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE	DDHD2, ARG516TER	
615003	23259	DDHD2	0006	SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE	DDHD2, ARG287TER	
615004	345193	LRIT3	0001	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1F	LRIT3, CYS328TYR	
615004	345193	LRIT3	0002	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1F	LRIT3, ARG440TER	
615004	345193	LRIT3	0003	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1F	LRIT3, SER384TER	
615004	345193	LRIT3	0004	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1F	LRIT3, 2-BP DEL, NT1538	
615016	442186	OR2J3	0001	C3HEX, ABILITY TO SMELL	OR2J3, THR113ALA	
615016	442186	OR2J3	0002	C3HEX, ABILITY TO SMELL	OR2J3, ARG226GLN	
615038	93233	CCDC114	0001	CILIARY DYSKINESIA, PRIMARY, 20	CCDC114, 742G-A	
615038	93233	CCDC114	0002	CILIARY DYSKINESIA, PRIMARY, 20	CCDC114, IVS5DS, G-A, +1	
615038	93233	CCDC114	0003	CILIARY DYSKINESIA, PRIMARY, 20	CCDC114, IVS5AS, A-G, -2	
615038	93233	CCDC114	0004	CILIARY DYSKINESIA, PRIMARY, 20	CCDC114, IVS12DS, G-A, +5	
615038	93233	CCDC114	0005	CILIARY DYSKINESIA, PRIMARY, 20	CCDC114, 1-BP DEL, 939T	
615054	136371	ASB10	0001	GLAUCOMA 1, OPEN ANGLE, F	ASB10, THR255THR	
615054	136371	ASB10	0002	GLAUCOMA 1, OPEN ANGLE, F	ASB10, CYS173TER	
615054	136371	ASB10	0003	GLAUCOMA 1, OPEN ANGLE, F	ASB10, VAL192LEU	
615054	136371	ASB10	0004	GLAUCOMA 1, OPEN ANGLE, F	ASB10, ARG72HIS	
615068	57724	EPG5	0001	VICI SYNDROME	EPG5, GLN1530TER	
615068	57724	EPG5	0002	VICI SYNDROME	EPG5, 1-BP DUP, 5704T	
615068	57724	EPG5	0003	VICI SYDROME	EPG5, ARG1161TER	
615068	57724	EPG5	0004	VICI SYNDROME	EPG5, GLU859TER	
615068	57724	EPG5	0005	VICI SYNDROME	EPG5, ARG2078TER	
615076	92667	MGME1	0001	MITOCHONDRIAL DNA DEPLETION SYNDROME 11	MGME1, TRP152TER	
615076	92667	MGME1	0002	MITOCHONDRIAL DNA DEPLETION SYNDROME 11	MGME1, TYR233CYS	
615140	113246	C12orf57	0001	TEMTAMY SYNDROME	C12ORF57, 1A-G	
615140	113246	C12orf57	0002	TEMTAMY SYNDROME	C12ORF57, LEU51GLN	
615187	27315	PGAP2	0001	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3	PGAP2, TYR99CYS	
615187	27315	PGAP2	0002	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3	PGAP2, ARG177PRO	
615187	27315	PGAP2	0003	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3	PGAP2, LEU127SER	
615187	27315	PGAP2	0004	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3	PGAP2, ARG16TRP	
615187	27315	PGAP2	0005	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3	PGAP2, THR160ILE	
615242	388588	SMIM1	0001	VEL BLOOD GROUP SYSTEM, VEL-NULL PHENOTYPE	SMIM1, 17-BP DEL, NT64	
615247	84197	-	0001	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12 (1 family)	SGK196, LEU137ARG	
615247	84197	-	0002	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12 (1 family)	SGK196, GLN258ARG	
615276	204219	CERS3	0001	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 9	CERS3, IVS9DS, G-T, +1	
615288	92749	DRC1	0001	CILIARY DYSKINESIA, PRIMARY, 21	DRC1, LYS686TER	
615288	92749	DRC1	0002	CILIARY DYSKINESIA, PRIMARY, 21	DRC1, GLN118TER	
